,CID,name,smiles,7.1-Drug Indication,8.1-Pharmacodynamics,8.2-MeSH Pharmacological Classification,"8.5-Absorption, Distribution and Excretion",8.6-Metabolism/Metabolites,8.7-Biological Half-Life
0,90001,2-(Bromomethyl)-9H-thioxanthen-9-one,C1=CC=C2C(=C1)C(=O)C3=C(S2)C=CC(=C3)CBr,,,,,,
1,90002,"9,10-Anthracenedione, 4,8-diamino-2-[4-(2-ethoxyethoxy)phenyl]-1,5-dihydroxy-",CCOCCOC1=CC=C(C=C1)C2=CC(=C3C(=C2O)C(=O)C4=C(C=CC(=C4C3=O)O)N)N,,,,,,
2,90003,"Acetamide, N-[3-[bis[2-(acetyloxy)ethyl]amino]-4-methoxyphenyl]-",CC(=O)NC1=CC(=C(C=C1)OC)N(CCOC(=O)C)CCOC(=O)C,,,,,,
3,90004,"Benzenepropanamide, N,N'-1,6-hexanediylbis(3,5-bis(1,1-dimethylethyl)-4-hydroxy-",CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)CCC(=O)NCCCCCCNC(=O)CCC2=CC(=C(C(=C2)C(C)(C)C)O)C(C)(C)C,,,,,,
4,90005,1-tert-Butyl-3-nitrobenzene,CC(C)(C)C1=CC(=CC=C1)[N+](=O)[O-],,,,,,
5,90006,1-Propyl-4-piperidone,CCCN1CCC(=O)CC1,,,,,,
6,90007,4-Ethylphenyl isocyanate,CCC1=CC=C(C=C1)N=C=O,,,,,,
7,90008,"(3R,4R,5R)-1,3,4,5,6-pentahydroxyhexan-2-one",C([C@H]([C@H]([C@H](C(=O)CO)O)O)O)O,,,,,,
8,90009,6-Methyl-5-nitroquinoline,CC1=C(C2=C(C=C1)N=CC=C2)[N+](=O)[O-],,,,,,
9,90010,Carbetapentane citrate,CCN(CC)CCOCCOC(=O)C1(CCCC1)C2=CC=CC=C2.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,,,"['Agents that suppress cough. They act centrally on the medullary cough center. EXPECTORANTS, also used in the treatment of cough, act locally. (See all compounds classified as Antitussive Agents.)']",,,
10,90011,"Acetamide, 2-(3-bromo-4-butoxyphenyl)-",CCCCOC1=C(C=CC(=C1)NC(=O)C)Br,,,,,,
11,90012,"1-Octanol, 8-chloro-",C(CCCCCl)CCCO,,,,,,
12,90013,5-Chlorobenzofuran,C1=CC2=C(C=CO2)C=C1Cl,,,,,,
13,90014,"5,7-Dichlorobenzofuran",C1=COC2=C(C=C(C=C21)Cl)Cl,,,,,,
14,90015,5-Bromobenzofuran,C1=CC2=C(C=CO2)C=C1Br,,,,,,
15,90016,7-(3-Hydroxypropyl)theophylline,CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CCCO,,,,,,
16,90017,"7-(2-Bromoethyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione",CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CCBr,,,,,,
17,90018,"7-(3-Bromopropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione",CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CCCBr,,,,,,
18,90019,"N,N'-(Iminodiethylene)bis(4-hydroxybutyramide)",C(CC(=O)NCCNCCNC(=O)CCCO)CO,,,,,,
19,90020,2-(tert-Butylamino)ethyl methacrylate hydrochloride,CC(=C)C(=O)OCCNC(C)(C)C.Cl,,,,,,
20,90021,4-Chloro-1-isothiocyanato-2-methylbenzene,CC1=C(C=CC(=C1)Cl)N=C=S,,,,,,
21,90022,"2,2',2''-Nitrilotrisethanol phenolate",C1=CC=C(C=C1)[O-].C(CO)[NH+](CCO)CCO,,,,,,
22,90023,Hexadec-7-en-1-yl acetate,CCCCCCCCC=CCCCCCCOC(=O)C,,,,,,
23,90024,"1,6-Bis(3-(2-hydroxyethyl)-ureido)-n-hexane",C(CCCNC(=O)NCCO)CCNC(=O)NCCO,,,,,,
24,90025,"1H-1,2,4-Triazole, 3-(4-chlorophenyl)-",C1=CC(=CC=C1C2=NC=NN2)Cl,,,,,,
25,90026,"3-Methylbutyl (2,4,5-trichlorophenoxy)acetate",CC(C)CCOC(=O)COC1=CC(=C(C=C1Cl)Cl)Cl,,,,,,
26,90027,"2,2,2-Trifluoroethyl trichloromethanesulfonate",C(C(F)(F)F)OS(=O)(=O)C(Cl)(Cl)Cl,,,,,,
27,90028,"Methyl 5-deoxy-2,3-O-isopropylidene-beta-D-ribofuranoside",C[C@@H]1[C@@H]2[C@H]([C@@H](O1)OC)OC(O2)(C)C,,,,,,
28,90029,"5-Hydroxy-1H-benz(de)isoquinoline-1,3(2H)-dione",C1=CC2=CC(=CC3=C2C(=C1)C(=O)NC3=O)O,,,,,,
29,90030,"p-Benzoquinone, 2,5-bis(di-2'-chloroethylamino)-",C1=C(C(=O)C=C(C1=O)NCCCl)NCCCl,,,,,,
30,90031,Hexa(cyano-C)cobaltate(4-),[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[Co+2],,,,,,
31,90032,"Carbonic acid, (4-methoxyphenyl)methyl 2,4,5-trichlorophenyl ester",COC1=CC=C(C=C1)COC(=O)OC2=CC(=C(C=C2Cl)Cl)Cl,,,,,,
32,90033,"(2R,3S)-2,3-Diaminosuccinic acid",[C@@H]([C@@H](C(=O)O)N)(C(=O)O)N,,,,,,
33,90034,6-Hydroxy-5-((2-nitrophenyl)azo)naphthalene-2-sulphonic acid,C1=CC=C(C(=C1)N=NC2=C(C=CC3=C2C=CC(=C3)S(=O)(=O)O)O)[N+](=O)[O-],,,,,,
34,90035,"2-Nitro-p-xylene-alpha,alpha'-diol",C1=CC(=C(C=C1CO)[N+](=O)[O-])CO,,,,,,
35,90036,CID 90036,C(=NC(=O)N)(N)S,,,,,,
36,90037,CID 90037,CC(=O)OC1=C(C=C(C=C1Br)Cl)C(=NC2=CC=C(C=C2)Br)S,,,,,,
37,90038,Ditrimethylolpropane,CCC(CO)(CO)COCC(CC)(CO)CO,,,,,,
38,90039,"3,6-Dioxaoctanedioic acid",C(COCC(=O)O)OCC(=O)O,,,,,,
39,90040,5-Amino-4-(aminocarbonyl)-1H-pyrazole-3-acetic acid,C(C1=C(C(=NN1)N)C(=O)N)C(=O)O,,,,,,
40,90041,CID 90041,C1=CC2=CNNC2=CC1=O,,,,,,
41,90042,"3,5-Diisopropylbenzyl chloride",CC(C)C1=CC(=CC(=C1)CCl)C(C)C,,,,,,
42,90043,Disodium;2-[carboxylatomethyl(carboxymethyl)amino]acetate;methane,C.C(C(=O)O)N(CC(=O)[O-])CC(=O)[O-].[Na+].[Na+],,,,,,
43,90044,S-[2-(acetylamino)ethyl] 3-oxobutanethioate,CC(=O)CC(=O)SCCNC(=O)C,,,,,,
44,90045,Dimaprit Dihydrochloride,CN(C)CCCSC(=N)N.Cl.Cl,,,['Drugs that bind to and activate histamine receptors. Although they have been suggested for a variety of clinical applications histamine agonists have so far been more widely used in research than therapeutically. (See all compounds classified as Histamine Agonists.)'],,,
45,90046,1-[2-[[4-[(2-Cyano-4-nitrophenyl)azo]phenyl]ethylamino]ethyl]pyridinium chloride,CCN(CC[N+]1=CC=CC=C1)C2=CC=C(C=C2)N=NC3=C(C=C(C=C3)[N+](=O)[O-])C#N.[Cl-],,,,,,
46,90047,1-[2-[[4-[(2-Cyano-4-nitrophenyl)azo]phenyl]ethylamino]ethyl]pyridinium,CCN(CC[N+]1=CC=CC=C1)C2=CC=C(C=C2)N=NC3=C(C=C(C=C3)[N+](=O)[O-])C#N,,,,,,
47,90048,5-Quinolinesulfonic acid,C1=CC2=C(C=CC=N2)C(=C1)S(=O)(=O)O,,,,,,
48,90049,"3-(4,8-Dimethylnona-3,7-dienyl)furan",CC(=CCCC(=CCCC1=COC=C1)C)C,,,,,,
49,90050,Cyclooctyl formate,C1CCCC(CCC1)OC=O,,,,,,
50,90051,"N,N''-(Iminoethylene)diurea",C(CNC(=O)N)NCCNC(=O)N,,,,,,
51,90052,CID 90052,C1=CC(=CC=C1N)S(=O)(=O)[N-]C2=NN=C(C=C2)Cl.[Na+],,,,,,
52,90053,CID 90053,C1[C@@H]([C@@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=C(OC4=CC(=O)C=C(C4=C3O)O)C5=CC(=C(C=C5)O)O)O)O)O)O)O)O,,,,,,
53,90054,"4,5-Dimethyl-1H-indene",CC1=C(C2=C(CC=C2)C=C1)C,,,,,,
54,90055,"6,7-Dimethyl-1H-indene",CC1=C(C2=C(C=CC2)C=C1)C,,,,,,
55,90056,"Benzoic acid, 4-methyl-, zinc salt",CC1=CC=C(C=C1)C(=O)[O-].CC1=CC=C(C=C1)C(=O)[O-].[Zn+2],,,,,,
56,90057,"1-Naphthalenesulfonic acid, 6-diazo-5,6-dihydro-5-oxo-, phenyl ester",C1=CC=C(C=C1)OS(=O)(=O)C2=CC=CC3=C2C=CC(=C3[O-])[N+]#N,,,,,,
57,90058,1-Hydroxy-5-phenoxysulfonylnaphthalene-2-diazonium,C1=CC=C(C=C1)OS(=O)(=O)C2=CC=CC3=C2C=CC(=C3O)[N+]#N,,,,,,
58,90059,Einecs 245-566-1,CC1=C(SC(=N1)N2C(=NN(N2)C3=CC=CC=C3)C4=CC=CC=C4)C,,,,,,
59,90060,"1,1'-(3,3'-Dimethoxybiphenyl-4,4'-diyl)bis(3,5-diphenyl-2,3-dihydro-1h-tetrazole)",COC1=C(C=CC(=C1)C2=CC(=C(C=C2)N3C(=NN(N3)C4=CC=CC=C4)C5=CC=CC=C5)OC)N6C(=NN(N6)C7=CC=CC=C7)C8=CC=CC=C8,,,,,,
60,90061,"Benzenamine, 4-(ethylsulfonyl)-2-nitro-",CCS(=O)(=O)C1=CC(=C(C=C1)N)[N+](=O)[O-],,,,,,
61,90062,"Benzenamine, 4,4'-(diphenylmethylene)bis[N,N-diethyl-",CCN(CC)C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=C(C=C4)N(CC)CC,,,,,,
62,90063,"Diazene, bis(4-propoxyphenyl)-, 1-oxide",CCCOC1=CC=C(C=C1)N=[N+](C2=CC=C(C=C2)OCCC)[O-],,,,,,
63,90064,1-Deoxy-1-(octylamino)-D-glucitol,CCCCCCCCNC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O,,,,,,
64,90065,"Acetamide, 2,2,2-trichloro-N-(2-nitrophenyl)-",C1=CC=C(C(=C1)NC(=O)C(Cl)(Cl)Cl)[N+](=O)[O-],,,,,,
65,90066,2-(2-(2-Hydroxyethoxy)ethoxy)ethyl laurate,CCCCCCCCCCCC(=O)OCCOCCOCCO,,,,,,
66,90067,4-Chloromorpholine,C1COCCN1Cl,,,,,,
67,90068,2-Heptadecyl-1H-imidazole,CCCCCCCCCCCCCCCCCC1=NC=CN1,,,,,,
68,90069,Trimethylolethane triheptanoate,CCCCCCC(=O)OCC(C)(COC(=O)CCCCCC)COC(=O)CCCCCC,,,,,,
69,90070,5-Cyanoisophthalic acid,C1=C(C=C(C=C1C(=O)O)C(=O)O)C#N,,,,,,
70,90071,"N,N'-Dipropylbutane-1,4-diamine",CCCNCCCCNCCC,,,,,,
71,90072,4-(1H-Pyrrol-1-yl)phenol,C1=CN(C=C1)C2=CC=C(C=C2)O,,,,,,
72,90073,5-Bromoisophthalic acid,C1=C(C=C(C=C1C(=O)O)Br)C(=O)O,,,,,,
73,90074,N-(4-Hydroxycyclohexyl)acetamide,CC(=O)NC1CCC(CC1)O,,,,,,
74,90075,Cherylline,CN1C[C@H](C2=CC(=C(C=C2C1)O)OC)C3=CC=C(C=C3)O,,,,,,
75,90076,"Benzenesulfonic acid, 2-methyl-, methyl ester",CC1=CC=CC=C1S(=O)(=O)OC,,,,,,
76,90077,"1,3-Bis[3-(3-phenoxyphenoxy)phenoxy]benzene",C1=CC=C(C=C1)OC2=CC(=CC=C2)OC3=CC(=CC=C3)OC4=CC(=CC=C4)OC5=CC=CC(=C5)OC6=CC=CC(=C6)OC7=CC=CC=C7,,,,,,
77,90078,"3,5-Dichloro-2-hydroxybenzenesulfonyl chloride",C1=C(C=C(C(=C1S(=O)(=O)Cl)O)Cl)Cl,,,,,,
78,90079,2-amino-4-chloro-N-(2-methylphenyl)-5-sulfamoylbenzamide,CC1=CC=CC=C1NC(=O)C2=CC(=C(C=C2N)Cl)S(=O)(=O)N,,,,,,
79,90080,2-Aminoethanol hydrobromide,C(CO)N.Br,,,,,,
80,90081,"Propaneperoxoic acid, 2,2-dimethyl-, 1-methyl-1-phenylethyl ester",CC(C)(C)C(=O)OOC(C)(C)C1=CC=CC=C1,,,,,,
81,90082,"Methanesulfonamide, N-(2,4-dichlorophenyl)-1,1,1-trifluoro-",C1=CC(=C(C=C1Cl)Cl)NS(=O)(=O)C(F)(F)F,,,,,,
82,90083,"N-(4-Chlorophenyl)-1,1,1-trifluoromethanesulfonamide",C1=CC(=CC=C1NS(=O)(=O)C(F)(F)F)Cl,,,,,,
83,90084,"Methanesulfonamide, 1,1,1-trifluoro-N-(3-(trifluoromethyl)phenyl)-",C1=CC(=CC(=C1)NS(=O)(=O)C(F)(F)F)C(F)(F)F,,,,,,
84,90085,"N-(2,4-Difluorophenyl)-1,1,1-trifluoromethanesulfonamide",C1=CC(=C(C=C1F)F)NS(=O)(=O)C(F)(F)F,,,,,,
85,90086,"2',3'-Difluoropropiophenone",CCC(=O)C1=C(C(=CC=C1)F)F,,,,,,
86,90087,"2,4,6-Trichlorophenetole",CCOC1=C(C=C(C=C1Cl)Cl)Cl,,,,,,
87,90088,"Ethyl 1,3-dihydro-1-oxoisobenzofuran-5-carboxylate",CCOC(=O)C1=CC2=C(C=C1)C(=O)OC2,,,,,,
88,90089,Iron(2+) bis(dibutylcarbamodithioate),CCCCN(CCCC)C(=S)[S-].CCCCN(CCCC)C(=S)[S-].[Fe+2],,,,,,
89,90090,CID 90090,CCCCN=C(S)[S-].CCCCN=C(S)[S-].[Zn+2],,,,,,
90,90091,Trimethylsilyl 4-(triethoxysilyl)butyrate,CCO[Si](CCCC(=O)O[Si](C)(C)C)(OCC)OCC,,,,,,
91,90092,"cis-1,5-Cyclooctanediol",C1CC(CCCC(C1)O)O,,,,,,
92,90093,"Methanone, (oxybis(2,1-ethanediyloxy(2-hydroxy-4,1-phenylene)))bis(phenyl-",C1=CC=C(C=C1)C(=O)C2=C(C=C(C=C2)OCCOCCOC3=CC(=C(C=C3)C(=O)C4=CC=CC=C4)O)O,,,,,,
93,90094,"Trisodium 1-amino-4-[3-[[4-chloro-6-(3-sulphonatoanilino)-1,3,5-triazin-2-yl]amino]-4-sulphonatoanilino]-9,10-dihydro-9,10-dioxoanthracene-2-sulphonate",C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3NC4=CC(=C(C=C4)S(=O)(=O)[O-])NC5=NC(=NC(=N5)NC6=CC(=CC=C6)S(=O)(=O)[O-])Cl)S(=O)(=O)[O-])N.[Na+].[Na+].[Na+],,,,,,
94,90095,"Methyl 7-(5-acetamido-2-methoxyphenyl)-3-oxo-2,4,10-trioxa-7-azaundecan-11-oate",CC(=O)NC1=CC(=C(C=C1)OC)N(CCOC(=O)OC)CCOC(=O)OC,,,,,,
95,90096,"2,4,10-Trioxa-7-azaundecan-11-oic acid, 7-[5-(acetylamino)-4-[(2-bromo-4,6-dinitrophenyl)azo]-2-methoxyphenyl]-3-oxo-, methyl ester",CC(=O)NC1=CC(=C(C=C1N=NC2=C(C=C(C=C2Br)[N+](=O)[O-])[N+](=O)[O-])OC)N(CCOC(=O)OC)CCOC(=O)OC,,,,,,
96,90097,Methyl 2-bromo-2-methylpropionate,CC(C)(C(=O)OC)Br,,,,,,
97,90098,Methyl (3-(trimethoxysilyl)propyl)carbamate,COC(=O)NCCC[Si](OC)(OC)OC,,,,,,
98,90099,Isopentyl p-tolyl ether,CC1=CC=C(C=C1)OCCC(C)C,,,,,,
99,90100,"4,4-Bis(tert-butylperoxy)butyl valerate",CCCCC(=O)OCCCC(OOC(C)(C)C)OOC(C)(C)C,,,,,,
100,90101,"Boron, (3-chlorobenzenamine-kappaN)trifluoro-, (T-4)-",B(F)(F)F.C1=CC(=CC(=C1)Cl)N,,,,,,
101,90102,CID 90102,CCCCCCCCCCCCCCCCCC1=NN=C(N1NC(=O)NC2=CC=C(C=C2)S(=O)(=O)F)S,,,,,,
102,90103,CID 90103,CCCCCCCCCCCCCCCCCC1=NN=C(N1NC(=O)NC2=CC(=CC=C2)S(=O)(=O)[O-])S.[Na+],,,,,,
103,90104,CID 90104,CCCCCCCCCCCCCCCCCC1=NN=C(N1NC(=O)NC2=CC(=CC=C2)S(=O)(=O)O)S,,,,,,
104,90105,"3,3-Dimethyl-1-(p-iodophenyl)triazene",CN(C)N=NC1=CC=C(C=C1)I,,,,,,
105,90106,"3,3-Dimethyl-1-(4-fluorophenyl)triazene",CN(C)N=NC1=CC=C(C=C1)F,,,,,,
106,90107,"Triazene, 1-(p-cyanophenyl)-3,3-dimethyl-",CN(C)N=NC1=CC=C(C=C1)C#N,,,,,,
107,90108,"4,4-Dimethyl-3-oxo-pentanal",CC(C)(C)C(=O)CC=O,,,,,,
108,90109,Dihydro-2H-pyran-3(4H)-one,C1CC(=O)COC1,,,,,,
109,90110,"Ethanethiol, 2-(4-phenylbutyl)amino-, hydrogen sulfate (ester)",C1=CC=C(C=C1)CCCCNCCSS(=O)(=O)O,,,,,,
110,90111,Choline stearate,CCCCCCCCCCCCCCCCCC(=O)OCC[N+](C)(C)C,,,,,,
111,90112,Ethyl 1-methylpyrrole-2-carboxylate,CCOC(=O)C1=CC=CN1C,,,,,,
112,90113,6-Chloropiperonyl chloride,C1OC2=C(O1)C=C(C(=C2)CCl)Cl,,,,,,
113,90114,"2-Morpholinoethyl 2-(alpha,alpha,alpha-trifluoro-m-toluidino)nicotinate monohydrochloride",C1COCCN1CCOC(=O)C2=C(N=CC=C2)NC3=CC=CC(=C3)C(F)(F)F.Cl,,,,,,
114,90115,m-(Isopropylamino)phenol,CC(C)NC1=CC(=CC=C1)O,,,,,,
115,90116,"1-Naphthalenesulfonic acid, 4-[(4-hydroxy-1-naphthalenyl)azo]-",C1=CC=C2C(=C1)C(=CC=C2O)N=NC3=CC=C(C4=CC=CC=C43)S(=O)(=O)O,,,,,,
116,90117,Ethyl 4-(4-chlorophenyl)-4-hydroxypiperidine-1-carboxylate,CCOC(=O)N1CCC(CC1)(C2=CC=C(C=C2)Cl)O,,,,,,
117,90118,Ethyl 4-hydroxy-4-(3-(trifluoromethyl)phenyl)piperidine-1-carboxylate,CCOC(=O)N1CCC(CC1)(C2=CC(=CC=C2)C(F)(F)F)O,,,,,,
118,90119,Diethyl(2-((4-phenylpiperidin-4-yl)oxy))ethylamine,CCN(CC)CCOC1(CCNCC1)C2=CC=CC=C2,,,,,,
119,90120,"[(1,1-Dimethyl-2-propenyl)oxy]dimethylsilane",CC(C)(C=C)O[SiH](C)C,,,,,,
120,90121,"Phosphonodithioic acid, chloromethyl-, O-isopropyl S-(p-methoxyphenyl) ester",CC(C)OP(=S)(CCl)SC1=CC=C(C=C1)OC,,,,,,
121,90122,"Pentanoic acid, 2-phenoxyethyl ester",CCCCC(=O)OCCOC1=CC=CC=C1,,,,,,
122,90123,"Phosphorothioic acid, O,O-dimethyl S-(O',O'-dipropylphosphoramido)ethyl ester",CCCOP(=O)(NCCSP(=O)(OC)OC)OCCC,,,,,,
123,90124,"Phosphorothioic acid, O,O-dimethyl S-(O',O'-diisopropylphosphoramido)ethyl ester",CC(C)OP(=O)(NCCSP(=O)(OC)OC)OC(C)C,,,,,,
124,90125,"Phosphorothioic acid, O-methyl O-phenyl S-(O',O'-diisopropyl-N-methylphosphoramido)ethyl ester",CC(C)OP(=O)(N(C)CCSP(=O)(OC)OC1=CC=CC=C1)OC(C)C,,,,,,
125,90126,"s-(4-Amino-3,5,8-trioxa-4-phosphadecan-10-yl) o,o-diethyl phosphorothioate",CCOP(N)OCCOCCSP(=O)(OCC)OCC,,,,,,
126,90127,2-diethoxyphosphinothioylsulfanyl-N-diethoxyphosphorylethanamine,CCOP(=O)(NCCSP(=S)(OCC)OCC)OCC,,,,,,
127,90128,N-diethoxyphosphoryl-2-dipropoxyphosphorylsulfanylethanamine,CCCOP(=O)(OCCC)SCCNP(=O)(OCC)OCC,,,,,,
128,90129,"s-{2-[(Dipropoxyphosphoryl)amino]ethyl} o,o-dipropyl phosphorothioate",CCCOP(=O)(NCCSP(=O)(OCCC)OCCC)OCCC,,,,,,
129,90130,(2S)-2-amino-6-(octadec-9-enoylamino)hexanoic acid,CCCCCCCCC=CCCCCCCCC(=O)NCCCC[C@@H](C(=O)O)N,,,,,,
130,90131,"6-Tert-butyl-3-(chloromethyl)-2,4-dimethylphenol",CC1=CC(=C(C(=C1CCl)C)O)C(C)(C)C,,,,,,
131,90132,"1,3-Bis(6-isocyanatohexyl)-1,3-diazetidine-2,4-dione",C(CCCN1C(=O)N(C1=O)CCCCCCN=C=O)CCN=C=O,,,,,,
132,90133,[3-(Dimethylamino)phenyl]methanol,CN(C)C1=CC=CC(=C1)CO,,,,,,
133,90134,2-(Methylsulfonyl)-10h-phenothiazine,CS(=O)(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2,,,,,,
134,90135,4-Isopropylresorcinol,CC(C)C1=C(C=C(C=C1)O)O,,,,,,
135,90136,2-Phenoxyethyl butyrate,CCCC(=O)OCCOC1=CC=CC=C1,,,,,,
136,90137,"(1S,2R,5R)-2,10-Epoxypinane",CC1([C@@H]2CC[C@@]3([C@H]1C2)CO3)C,,,,,,
137,90138,"1-(4-Aminophenyl)-2,2,2-trifluoroethan-1-one",C1=CC(=CC=C1C(=O)C(F)(F)F)N,,,,,,
138,90139,Zirconium(IV) Propoxide,CCC[O-].CCC[O-].CCC[O-].CCC[O-].[Zr+4],,,,,,
139,90140,5-((p-(Dimethylamino)phenyl)azo)quinoxaline,CN(C)C1=CC=C(C=C1)N=NC2=CC=CC3=NC=CN=C32,,,,,,
140,90141,6-((p-(Dimethylamino)phenyl)azo)quinoxaline,CN(C)C1=CC=C(C=C1)N=NC2=CC3=NC=CN=C3C=C2,,,,,,
141,90142,Cis-1-Bromo-2-ethoxyethene,CCOC=CBr,,,,,,
142,90143,S-2-((3-Aminopropyl)amino)ethyl hydrogen thiosulfate hydrochloride,C(CN)CNCCSS(=O)(=O)O.Cl,,,,,,
143,90144,Thiosulfuric acid S-[2-[(3-aminopropyl)amino]ethyl] ester,C(CN)CNCCSS(=O)(=O)O,,,,,,
144,90145,S-2-((4-Aminobutyl)amino)ethyl hydrogen thiosulfate hydrochloride,C(CCNCCSS(=O)(=O)O)CN.Cl,,,,,,
145,90146,Thiosulfuric acid S-[2-[(4-aminobutyl)amino]ethyl] ester,C(CCNCCSS(=O)(=O)O)CN,,,,,,
146,90147,S-2-((6-Aminohexyl)amino)ethyl hydrogen thiosulfate hydrobromide,C(CCCNCCSS(=O)(=O)O)CCN.Br,,,,,,
147,90148,Thiosulfuric acid S-[2-[(6-aminohexyl)amino]ethyl] ester,C(CCCNCCSS(=O)(=O)O)CCN,,,,,,
148,90149,S-(2-((3-Aminopropyl)amino)-2-methyl) hydrogen thiosulfate hydrochloride,CC(C)(CSS(=O)(=O)O)NCCCN.Cl,,,,,,
149,90150,2-(3-Aminopropylamino)-2-methyl-1-sulfosulfanylpropane,CC(C)(CSS(=O)(=O)O)NCCCN,,,,,,
150,90151,S-(2-((2-Cyanoethyl)amino)-2-methyl)propyl hydrogen thiosulfate,CC(C)(CSS(=O)(=O)O)NCCC#N,,,,,,
151,90152,2-((3-Aminopropyl)amino)-2-methylpropanethiol dihydrochloride,CC(C)(CS)NCCCN.Cl.Cl,,,,,,
152,90153,2-(3-Aminopropylamino)-2-methylpropane-1-thiol,CC(C)(CS)NCCCN,,,,,,
153,90154,"Propanethiol, 2-((2-cyanoethyl)amino)-2-methyl-, hydrochloride",CC(C)(CS)NCCC#N.Cl,,,,,,
154,90155,3-[(2-Methyl-1-sulfanylpropan-2-yl)amino]propanenitrile,CC(C)(CS)NCCC#N,,,,,,
155,90156,"Butanamide, N-(aminocarbonyl)-",CCCC(=O)NC(=O)N,,,,,,
156,90157,"Benzenesulfonamide, 3,3'-[(9,10-dihydro-9,10-dioxo-1,4-anthracenediyl)diimino]bis[N-cyclohexyl-2,4,6-trimethyl-",CC1=CC(=C(C(=C1NC2=C3C(=C(C=C2)NC4=C(C(=C(C=C4C)C)S(=O)(=O)NC5CCCCC5)C)C(=O)C6=CC=CC=C6C3=O)C)S(=O)(=O)NC7CCCCC7)C,,,,,,
157,90158,"9,10-Anthracenedione, 1-hydroxy-4-[(4-methoxyphenyl)amino]-",COC1=CC=C(C=C1)NC2=C3C(=C(C=C2)O)C(=O)C4=CC=CC=C4C3=O,,,,,,
158,90159,"4-Amino-6-((6-amino-2-hydroxy-4-sulpho-1-naphthyl)azo)-5-hydroxynaphthalene-1,3-disulphonic acid",C1=CC2=C(C(=CC(=C2C=C1N)S(=O)(=O)O)O)N=NC3=C(C4=C(C=C3)C(=CC(=C4N)S(=O)(=O)O)S(=O)(=O)O)O,,,,,,
159,90160,Acetaldehyde dibenzyl acetal,CC(OCC1=CC=CC=C1)OCC2=CC=CC=C2,,,,,,
160,90161,CID 90161,C([C@H]([C@H]([C@@H](C(=O)COP(=O)(O)[O-])O)O)O)OP(=O)(O)O.[Na+],,,,,,
161,90162,"exo-2-(1,7,7-Trimethylbicyclo(2.2.1)hept-2-yl)-p-cresol",CC1=CC(=C(C=C1)O)[C@H]2C[C@@H]3CC[C@]2(C3(C)C)C,,,,,,
162,90163,"2-Chlorodibenz(b,e)oxepin-11(6H)-one",C1C2=CC=CC=C2C(=O)C3=C(O1)C=CC(=C3)Cl,,,,,,
163,90164,"Phosphorodichloridic acid, 2-(chloromethyl)-4-nitrophenyl ester",C1=CC(=C(C=C1[N+](=O)[O-])CCl)OP(=O)(Cl)Cl,,,,,,
164,90165,N-(4-Butoxyphenyl)acetamide,CCCCOC1=CC=C(C=C1)NC(=O)C,,,,,,
165,90166,2-((3-Ethylaminopropyl)amino)ethanethiol dihydrochloride,CCNCCCCCS.Cl.Cl,,,,,,
166,90167,5-(Ethylamino)pentane-1-thiol,CCNCCCCCS,,,,,,
167,90168,S-2-((Anilinoethyl)amino)ethyl hydrogen thiosulfate,C1=CC=C(C=C1)NCCNCCSS(=O)(=O)O,,,,,,
168,90169,[3-(2-Sulfosulfanylethylamino)propylamino]benzene,C1=CC=C(C=C1)NCCCNCCSS(=O)(=O)O,,,,,,
169,90170,S-2-((3-Cyclohexylaminopropyl)amino)ethyl hydrogen thiosulfate hemihydrate,C.C1CCC(CC1)NCCCNCCSS(=O)(=O)O.C1CCC(CC1)NCCCNCCSS(=O)(=O)O,,,,,,
170,90171,[3-(2-Sulfosulfanylethylamino)propylamino]cyclohexane,C1CCC(CC1)NCCCNCCSS(=O)(=O)O,,,,,,
171,90172,Bis(p-chlorobenzyl) sulphide,C1=CC(=CC=C1CSCC2=CC=C(C=C2)Cl)Cl,,,,,,
172,90173,L-Talose,C([C@@H]([C@H]([C@H]([C@H](C=O)O)O)O)O)O,,,,,,
173,90174,"4-(1,2,3,4-Thiatriazol-5-ylamino)phenol",C1=CC(=CC=C1NC2=NN=NS2)O,,,,,,
174,90175,5-Isopropyl-1-methyl-2-nitro-1H-imidazole,CC(C)C1=CN=C(N1C)[N+](=O)[O-],,,,,,
175,90176,1-Ethyl-5-methyl-2-nitroimidazole,CCN1C(=CN=C1[N+](=O)[O-])C,,,,,,
176,90177,5-Methyl-2-nitroimidazole-1-ethanol,CC1=CN=C(N1CCO)[N+](=O)[O-],,,,,,
177,90178,"Imidazole-1-ethanol, 5-ethyl-2-nitro-",CCC1=CN=C(N1CCO)[N+](=O)[O-],,,,,,
178,90179,1-(2-Chloroethyl)-5-methyl-2-nitroimidazole,CC1=CN=C(N1CCCl)[N+](=O)[O-],,,,,,
179,90180,1-(2-Chloroethyl)-5-ethyl-2-nitroimidazole,CCC1=CN=C(N1CCCl)[N+](=O)[O-],,,,,,
180,90181,2-(5-Ethyl-2-nitroimidazolyl)ethyl succinate,CCC1=CN=C(N1CCOC(=O)CCC(=O)O)[N+](=O)[O-],,,,,,
181,90182,"Imidazole-5-ethanol, 1-methyl-2-nitro-",CN1C(=CN=C1[N+](=O)[O-])CCO,,,,,,
182,90183,5-(2-Chloroethyl)-1-methyl-2-nitroimidazole,CN1C(=CN=C1[N+](=O)[O-])CCCl,,,,,,
183,90184,"1H-Imidazole-1-acetic acid, 5-ethyl-2-nitro-, ethyl ester",CCC1=CN=C(N1CC(=O)OCC)[N+](=O)[O-],,,,,,
184,90185,"Imidazole-1-acetamide, 5-ethyl-N-methyl-2-nitro-",CCC1=CN=C(N1CC(=O)NC)[N+](=O)[O-],,,,,,
185,90186,"2-Phenyl-9-diethylaminoethyl-9H-imidazo(1,2-a)benzimidazole dihydrochloride",CCN(CC)CCN1C2=C(C=CC(=C2)C3=CC=CC=C3)N4C1=NC=C4.Cl.Cl,,,,,,
186,90187,"N,N-diethyl-2-(6-phenylimidazo[1,2-a]benzimidazol-4-yl)ethanamine",CCN(CC)CCN1C2=C(C=CC(=C2)C3=CC=CC=C3)N4C1=NC=C4,,,,,,
187,90188,5-Amino-4-chloro-2-(4-(trifluoromethyl)phenyl)pyridazin-3(2H)-one,C1=CC(=CC=C1C(F)(F)F)N2C(=O)C(=C(C=N2)N)Cl,,,,,,
188,90189,"2,5-Hexanediamine, 2,5-dimethyl-",CC(C)(CCC(C)(C)N)N,,,,,,
189,90190,"Pyridine, 3-ethyl-2,6-dimethyl-",CCC1=C(N=C(C=C1)C)C,,,,,,
190,90191,5-Ethyl-2-propylpyridine,CCCC1=NC=C(C=C1)CC,,,,,,
191,90192,Bis(2-diphenylphosphinoethyl)phenylphosphine,C1=CC=C(C=C1)P(CCP(C2=CC=CC=C2)C3=CC=CC=C3)CCP(C4=CC=CC=C4)C5=CC=CC=C5,,,,,,
192,90193,"1,1,4,7,10,10-Hexaphenyl-1,4,7,10-tetraphosphadecane",C1=CC=C(C=C1)P(CCP(CCP(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC=CC=C4)CCP(C5=CC=CC=C5)C6=CC=CC=C6,,,,,,
193,90194,Bis(2-(diphenylarsino)ethyl)(phenyl)phosphine,C1=CC=C(C=C1)P(CC[As](C2=CC=CC=C2)C3=CC=CC=C3)CC[As](C4=CC=CC=C4)C5=CC=CC=C5,,,,,,
194,90195,(2-(Diphenylarsino)ethyl)diphenylphosphine,C1=CC=C(C=C1)P(CC[As](C2=CC=CC=C2)C3=CC=CC=C3)C4=CC=CC=C4,,,,,,
195,90196,Ethyl 3-(benzylamino)propanoate,CCOC(=O)CCNCC1=CC=CC=C1,,,,,,
196,90197,"Imidazole-1-acetamide, 2-nitro-N,N,5-trimethyl-",CC1=CN=C(N1CC(=O)N(C)C)[N+](=O)[O-],,,,,,
197,90198,4-Ethyl-1-methyl-2-nitroimidazole,CCC1=CN(C(=N1)[N+](=O)[O-])C,,,,,,
198,90199,"Imidazole-1-ethanol, 4-methyl-2-nitro-",CC1=CN(C(=N1)[N+](=O)[O-])CCO,,,,,,
199,90200,Thallium(III) trifluoroacetate,C(=O)(C(F)(F)F)[O-].C(=O)(C(F)(F)F)[O-].C(=O)(C(F)(F)F)[O-].[Tl+3],,,,,,
200,90201,[(3-Methylbutyl)amino]acetic acid,CC(C)CCNCC(=O)O,,,,,,
201,90202,Hexyl nicotinate,CCCCCCOC(=O)C1=CN=CC=C1,,,,,,
202,90203,3-(2-Chlorophenyl)-5-methylisoxazole-4-carboxylic acid,CC1=C(C(=NO1)C2=CC=CC=C2Cl)C(=O)O,,,,,,
203,90204,o-Bromophenyl propionate,CCC(=O)OC1=CC=CC=C1Br,,,,,,
204,90205,p-Bromophenyl propionate,CCC(=O)OC1=CC=C(C=C1)Br,,,,,,
205,90206,"3,6,9,12,15,18-Hexaoxaicosane",CCOCCOCCOCCOCCOCCOCC,,,,,,
206,90207,"2,5,8,11,14,17-Hexaoxanonadecan-19-ol",COCCOCCOCCOCCOCCOCCO,,,,,,
207,90208,"Formamide, N-(1,1-dimethylpropyl)-",CCC(C)(C)NC=O,,,,,,
208,90209,"Phosphonic acid, [1,6-hexanediylbis[nitrilobis(methylene)]]tetrakis-",C(CCCN(CP(=O)(O)O)CP(=O)(O)O)CCN(CP(=O)(O)O)CP(=O)(O)O,,,,,,
209,90210,"Iron(2+), tris(5-methyl-1,10-phenanthroline-kappaN1,kappaN10)-, sulfate (1:1)",CC1=CC2=C(C3=C1C=CC=N3)N=CC=C2.CC1=CC2=C(C3=C1C=CC=N3)N=CC=C2.CC1=CC2=C(C3=C1C=CC=N3)N=CC=C2.[O-]S(=O)(=O)[O-].[Fe+2],,,,,,
210,90211,"Benzamide, N-(3-methyl-2-pyridyl)-",CC1=C(N=CC=C1)NC(=O)C2=CC=CC=C2,,,,,,
211,90212,CID 90212,CCNC1=NC(=NC(=N1)S)N(CC)CC,,,,,,
212,90213,"4,7-Dichloro-1,2,3-benzothiadiazole",C1=CC(=C2C(=C1Cl)N=NS2)Cl,,,,,,
213,90214,"2-Pipecolinium, (4,4'-biphenylylenebis(2-oxoethylene))bis(1-methyl-, diiodide",CC1CC=CC[N+]1(C)OCCC2=CC=C(C=C2)C3=CC=C(C=C3)CCO[N+]4(CC=CCC4C)C.[I-].[I-],,,,,,
214,90215,"1-[2-[4-[4-[2-[(1,2-dimethyl-3,6-dihydro-2H-pyridin-1-ium-1-yl)oxy]ethyl]phenyl]phenyl]ethoxy]-1,2-dimethyl-3,6-dihydro-2H-pyridin-1-ium",CC1CC=CC[N+]1(C)OCCC2=CC=C(C=C2)C3=CC=C(C=C3)CCO[N+]4(CC=CCC4C)C,,,,,,
215,90216,"5-(Acetylamino)-4-hydroxy-3-((4-methoxy-3-((2-(sulphooxy)ethyl)sulphonyl)phenyl)azo)naphthalene-2,7-disulphonic acid",CC(=O)NC1=C2C(=CC(=C1)S(=O)(=O)O)C=C(C(=C2O)N=NC3=CC(=C(C=C3)OC)S(=O)(=O)CCOS(=O)(=O)O)S(=O)(=O)O,,,,,,
216,90217,"N-(2,4,5-Trichlorophenyl)acetamide",CC(=O)NC1=CC(=C(C=C1Cl)Cl)Cl,,,,,,
217,90218,Thamnosmin,CC(=C)[C@H]1[C@@H](O1)C2=C(C=C3C(=C2)C=CC(=O)O3)OC,,,,,,
218,90219,3-(Hydroxymethylamino)-4-methyl-5-(5-nitro-2-furyl)-s-triazole,CN1C(=NN=C1NCO)C2=CC=C(O2)[N+](=O)[O-],,,,,,
219,90220,p-Nitrophenyl 2-acetamido-2-deoxy-alpha-D-galactopyranoside,CC(=O)N[C@@H]1[C@H]([C@H]([C@H](O[C@@H]1OC2=CC=C(C=C2)[N+](=O)[O-])CO)O)O,,,,,,
220,90221,Spadns,C1=CC(=CC=C1N=NC2=C(C3=C(C=C(C=C3C=C2S(=O)(=O)[O-])S(=O)(=O)[O-])O)O)S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
221,90222,"1,8-Dihydroxy-2-(4-sulfophenylazo)naphthalene-3,6-disulfonic acid",C1=CC(=CC=C1N=NC2=C(C3=C(C=C(C=C3C=C2S(=O)(=O)O)S(=O)(=O)O)O)O)S(=O)(=O)O,,,,,,
222,90223,Ethyl N-ethyl-beta-alaninate,CCNCCC(=O)OCC,,,,,,
223,90224,Tributylthiocyanatostannane,CCCC[Sn](CCCC)(CCCC)SC#N,,,,,,
224,90225,CID 90225,CCCC1=CC(=O)CC[C@]1(C)[C@H]2CC[C@]3([C@]4(C2)CC[C@]3(OC(O4)CCC(=O)O)C(=O)C)C,,,,,,
225,90226,"(3aS,7aR)-Hexahydro-4beta,7beta-methanobenzotrithiole",C1C[C@H]2C[C@@H]1[C@H]3[C@@H]2SSS3,,,,,,
226,90227,"Bis(2,6-dimethylphenyl) phenyl phosphate",CC1=C(C(=CC=C1)C)OP(=O)(OC2=CC=CC=C2)OC3=C(C=CC=C3C)C,,,,,,
227,90228,"Diphenyl 2,6-dimethylphenyl phosphate",CC1=C(C(=CC=C1)C)OP(=O)(OC2=CC=CC=C2)OC3=CC=CC=C3,,,,,,
228,90229,Diisopropyltin oxide,CC(C)[Sn](=O)C(C)C,,,,,,
229,90230,"5'-O-(4,4'-Dimethoxytrityl)-2'-deoxyuridine",COC1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=C(C=C3)OC)OC[C@@H]4[C@H](C[C@@H](O4)N5C=CC(=O)NC5=O)O,,,,,,
230,90231,Methyl 4-ethoxybenzoate,CCOC1=CC=C(C=C1)C(=O)OC,,,,,,
231,90232,Ethyl 4-ethoxybenzoate,CCOC1=CC=C(C=C1)C(=O)OCC,,,"['A class of drugs that act by inhibition of sodium influx through cell membranes. Blockade of sodium channels slows the rate and amplitude of initial rapid depolarization, reduces cell excitability, and reduces conduction velocity. (See all compounds classified as Sodium Channel Blockers.)']",,,
232,90233,CID 90233,C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=N)C(=CC3=N)N(O)O,,,,,,
233,90234,Boc-Ser(Bzl)-OH,CC(C)(C)OC(=O)N[C@@H](COCC1=CC=CC=C1)C(=O)O,,,,,,
234,90235,"4-Amino-2-chloro-6,7-dimethoxyquinazoline",COC1=C(C=C2C(=C1)C(=NC(=N2)Cl)N)OC,,,,,,
235,90236,"Benzenemethanol, 4-(phenylamino)-alpha,alpha-bis[4-(phenylamino)phenyl]-",C1=CC=C(C=C1)NC2=CC=C(C=C2)C(C3=CC=C(C=C3)NC4=CC=CC=C4)(C5=CC=C(C=C5)NC6=CC=CC=C6)O,,,,,,
236,90237,4-Aminoisoquinoline,C1=CC=C2C(=C1)C=NC=C2N,,,,,,
237,90238,"1,3-Butadiene, 2-(bromomethyl)-",C=CC(=C)CBr,,,,,,
238,90239,"7-Methoxybenzo-1,3-dioxole-5-ethylamine",COC1=CC(=CC2=C1OCO2)CCN,,,,,,
239,90240,1-(o-Chlorobenzyl)-1H-pyrrole,C1=CC=C(C(=C1)CN2C=CC=C2)Cl,,,,,,
240,90241,"Iron(2+), tris(5-nitro-1,10-phenanthroline-kappaN1,kappaN10)-, sulfate (1:1)",C1=CC2=CC(=C3C=CC=NC3=C2N=C1)[N+](=O)[O-].C1=CC2=CC(=C3C=CC=NC3=C2N=C1)[N+](=O)[O-].C1=CC2=CC(=C3C=CC=NC3=C2N=C1)[N+](=O)[O-].[O-]S(=O)(=O)[O-].[Fe+2],,,,,,
241,90242,N6-(1-Oxooctyl)-L-lysine,CCCCCCCC(=O)NCCCC[C@@H](C(=O)O)N,,,,,,
242,90243,"alpha,alpha-Diethyl-3,4-methylenedioxyphenylacetamide",CCC(CC)(C1=CC2=C(C=C1)OCO2)C(=O)N,,,,,,
243,90244,"5-Benzoxazolecarboxylic acid, 2,2'-(1,4-naphthalenediyl)bis-, dimethyl ester",COC(=O)C1=CC2=C(C=C1)OC(=N2)C3=CC=C(C4=CC=CC=C43)C5=NC6=C(O5)C=CC(=C6)C(=O)OC,,,,,,
244,90245,1-(3-Methyl-2-furyl)propan-1-one,CCC(=O)C1=C(C=CO1)C,,,,,,
245,90246,S-Methyl 3-methylbutanethioate,CC(C)CC(=O)SC,,,,,,
246,90247,"7H-Benzimidazo(2,1-a)benz(de)isoquinolin-7-one",C1=CC=C2C(=C1)N=C3N2C(=O)C4=CC=CC5=C4C3=CC=C5,,,,,,
247,90248,"4,6-Bis(isopropyl)-3,3-dimethylindan-5-ol",CC(C)C1=C(C(=C2C(=C1)CCC2(C)C)C(C)C)O,,,,,,
248,90249,N-Cyclohexylnaphthalen-2-amine,C1CCC(CC1)NC2=CC=CC3=CC=CC=C32,,,,,,
249,90250,"N-Propyl-1,3-propanediamine",CCCNCCCN,,,,,,
250,90251,2-((N-(2-Hydroxyethyl)-N-phenethyl)amino)methylquinoline dihydrochloride,C1=CC=C(C=C1)CCN(CCO)CC2=NC3=CC=CC=C3C=C2.Cl.Cl,,,,,,
251,90252,2-[2-Phenylethyl(quinolin-2-ylmethyl)amino]ethanol,C1=CC=C(C=C1)CCN(CCO)CC2=NC3=CC=CC=C3C=C2,,,,,,
252,90253,CID 90253,C1=NNC2=NC(=NC(=C21)N)S,,,,,,
253,90254,Dicyclopropylacetaldehyde,C1CC1C(C=O)C2CC2,,,,,,
254,90255,2-(2-{2-[2-(2-Methoxy-ethoxy)-ethoxy]-ethoxy}-ethoxy)-ethanol,COCCOCCOCCOCCOCCO,,,,,,
255,90256,CID 90256,CC1=C(C(=C(C=C1C(C2=CC=CC=C2S(=O)(=O)[O-])(C3=CC(=C(C(=C3C)Br)O)Br)O)Br)O)Br.[Na+],,,,,,
256,90257,"2-[Bis(3,5-dibromo-4-hydroxy-2-methylphenyl)-hydroxymethyl]benzenesulfonic acid",CC1=C(C(=C(C=C1C(C2=CC=CC=C2S(=O)(=O)O)(C3=CC(=C(C(=C3C)Br)O)Br)O)Br)O)Br,,,,,,
257,90258,N-(Triethoxysilylpropyl)urea,CCO[Si](CCCNC(=O)N)(OCC)OCC,,,,,,
258,90259,"2-Oxa-7,10-diaza-3-silaundecan-11-amide, 3,3-dimethoxy-",CO[Si](CCCNCCNC(=O)N)(OC)OC,,,,,,
259,90260,4-Hydroxy-8-(trifluoromethyl)quinoline-3-carboxylic acid,C1=CC2=C(C(=C1)C(F)(F)F)NC=C(C2=O)C(=O)O,,,,,,
260,90261,8-(Trifluoromethyl)quinolin-4-ol,C1=CC2=C(C(=C1)C(F)(F)F)NC=CC2=O,,,,,,
261,90262,4-Chloro-8-(trifluoromethyl)quinoline,C1=CC2=C(C=CN=C2C(=C1)C(F)(F)F)Cl,,,,,,
262,90263,"2,5,8,11-Tetraoxatridecan-13-ol",COCCOCCOCCOCCO,,,,,,
263,90264,"D-Fructose, 1,6-bis(dihydrogen phosphate), tetrasodium salt",C([C@H]([C@H]([C@@H](C(=O)COP(=O)([O-])[O-])O)O)O)OP(=O)([O-])[O-].[Na+].[Na+].[Na+].[Na+],,,,,,
264,90265,Methyl p-tolylacetate,CC1=CC=C(C=C1)CC(=O)OC,,,,,,
265,90266,Methyl 4-methoxyphenylacetate,COC1=CC=C(C=C1)CC(=O)OC,,,,,,
266,90267,"1-Piperazineethanol, 4-[[4-[3-(4-chlorophenyl)-4,5-dihydro-1H-pyrazol-1-yl]phenyl]sulfonyl]-",C1CN(N=C1C2=CC=C(C=C2)Cl)C3=CC=C(C=C3)S(=O)(=O)N4CCN(CC4)CCO,,,,,,
267,90268,"1,1-Diethoxycyclopentane",CCOC1(CCCC1)OCC,,,,,,
268,90269,3-Methylthiophene-2-carboxylic acid,CC1=C(SC=C1)C(=O)O,,,,,,
269,90270,"Acetamide, N-[2-[(2-chloro-4,6-dinitrophenyl)azo]-5-[(2-cyanoethyl)(2-hydroxyethyl)amino]-4-methoxyphenyl]-",CC(=O)NC1=CC(=C(C=C1N=NC2=C(C=C(C=C2Cl)[N+](=O)[O-])[N+](=O)[O-])OC)N(CCC#N)CCO,,,,,,
270,90271,4-(Aminomethyl)-1-phenethylpiperidin-4-ol,C1CN(CCC1(CN)O)CCC2=CC=CC=C2,,,,,,
271,90272,[4-(4-Chlorophenoxy)phenyl]urea,C1=CC(=CC=C1NC(=O)N)OC2=CC=C(C=C2)Cl,,,,,,
272,90273,2-(2-Pyridylamino)ethyldimethylamine,CN(C)CCNC1=CC=CC=N1,,,,,,
273,90274,"2-(2,4-Dichlorophenylimino)-imidazolidine",C1CN=C(N1)NC2=C(C=C(C=C2)Cl)Cl,,,,,,
274,90275,"n-Ethylbenzene-1,2-diamine",CCNC1=CC=CC=C1N,,,,,,
275,90276,"Quinoxalino[2,3-b]phenazine, 5,12-diethyl-5,12-dihydro-",CCN1C2=CC=CC=C2N=C3C1=CC4=NC5=CC=CC=C5N(C4=C3)CC,,,,,,
276,90277,2-[4-(Tert-pentyl)phenoxy]phenylamine,CCC(C)(C)C1=CC=C(C=C1)OC2=CC=CC=C2N,,,,,,
277,90278,Ignosterol,C[C@H](CC[C@H](C)C(C)C)[C@H]1CC=C2[C@@]1(CCC3=C2CC[C@@H]4[C@@]3(CC[C@@H](C4)O)C)C,,,,,,
278,90279,"Benzene, 1-(3-bromophenoxy)-3-phenoxy-",C1=CC=C(C=C1)OC2=CC(=CC=C2)OC3=CC(=CC=C3)Br,,,,,,
279,90280,1-[3-(Trimethoxysilyl)propyl]urea,CO[Si](CCCNC(=O)N)(OC)OC,,,,,,
280,90281,"4-(4-Aminophenoxy)benzene-1,3-diamine",C1=CC(=CC=C1N)OC2=C(C=C(C=C2)N)N,,,,,,
281,90282,"1,1'-Disulfanediyldiazepan-2-one",C1CCC(=O)N(CC1)SSN2CCCCCC2=O,,,,,,
282,90283,"Dimethyl 3,3'-(iminodisulfonyl)dibenzoate",COC(=O)C1=CC(=CC=C1)S(=O)(=O)NS(=O)(=O)C2=CC=CC(=C2)C(=O)OC,,,,,,
283,90284,"Ethyl 4-oxo-8-(trifluoromethyl)-1,4-dihydroquinoline-2-carboxylate",CCOC(=O)C1=CC(=O)C2=C(N1)C(=CC=C2)C(F)(F)F,,,,,,
284,90285,"N,N-Dipropyl-2-aminotetralin",CCCN(CCC)C1CCC2=CC=CC=C2C1,,,,,,
285,90286,CID 90286,CCOC(=O)C1=CC(=C2C=CC(=O)C=C2O1)O,,,,,,
286,90287,N-((2-((3-(Trifluoromethyl)phenyl)amino)pyridin-3-yl)carbonyl)glycine,C1=CC(=CC(=C1)NC2=C(C=CC=N2)C(=O)NCC(=O)O)C(F)(F)F,,,,,,
287,90288,"4,4'-(Ethylenediimino)bis(4-oxobutyric) acid",C(CC(=O)O)C(=O)NCCNC(=O)CCC(=O)O,,,,,,
288,90289,2-Methyl-3-nitrobenzyl alcohol,CC1=C(C=CC=C1[N+](=O)[O-])CO,,,,,,
289,90290,tert-Butyl 2-bromoisobutyrate,CC(C)(C)OC(=O)C(C)(C)Br,,,,,,
290,90291,1-Hydroxy-5-sulfonatonaphthalene-2-diazonium,C1=CC2=C(C=CC(=C2O)[N+]#N)C(=C1)S(=O)(=O)[O-],,,,,,
291,90292,4-(2-(alpha-(p-Chlorophenyl)benzylamino)ethyl)morpholine,C1COCCN1CCNC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,,,,,,
292,90293,"1-(p-tert-Butylbenzyl)-4-(2-(1,2-diphenylethylamino)ethyl)piperazine",CC(C)(C)C1=CC=C(C=C1)CN2CCN(CC2)CCNCC(C3=CC=CC=C3)C4=CC=CC=C4,,,,,,
293,90294,"6-Hydroxyhexyl 1-amino-9,10-dihydro-4-hydroxy-9,10-dioxoanthracene-2-carboxylate",C1=CC=C2C(=C1)C(=O)C3=C(C=C(C(=C3C2=O)N)C(=O)OCCCCCCO)O,,,,,,
294,90295,6-Amino-1-naphthol,C1=CC2=C(C=CC(=C2)N)C(=C1)O,,,,,,
295,90296,Ethyl 5-acetamido-4-cyano-3-methylthenoate,CCOC(=O)C1=C(C(=C(S1)NC(=O)C)C#N)C,,,,,,
296,90297,"1-(Bromomethyl)-2,4-difluorobenzene",C1=CC(=C(C=C1F)F)CBr,,,,,,
297,90298,Methyl {4-chloro-3-[(prop-2-en-1-yl)oxy]phenyl}acetate,COC(=O)CC1=CC(=C(C=C1)Cl)OCC=C,,,,,,
298,90299,"9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis[(4-methylphenyl)amino]-",CC1=CC=C(C=C1)NC2=C3C(=C(C=C2)NC4=CC=C(C=C4)C)C(=O)C5=C(C=CC(=C5C3=O)O)O,,,,,,
299,90300,CID 90300,C1=CC(=NC(=C1)S)S,,,,,,
300,90301,"2,4-Dihydroxypyrimidine-5-carboxylic acid",C1=C(C(=O)NC(=O)N1)C(=O)O,,,,,,
301,90302,CID 90302,C1=C(C(=O)NC(=N1)S)C(=O)O,,,,,,
302,90303,"Ethanediamide, N-(2-ethoxyphenyl)-N'-(2-ethylphenyl)-",CCC1=CC=CC=C1NC(=O)C(=O)NC2=CC=CC=C2OCC,,,,,,
303,90304,"o-Veratric acid hydrochloride, 2-(dimethylamino)ethyl ester",CN(C)CCOC(=O)C1=C(C(=CC=C1)OC)OC.Cl,,,,,,
304,90305,"2-(Dimethylamino)ethyl 2,3-dimethoxybenzoate",CN(C)CCOC(=O)C1=C(C(=CC=C1)OC)OC,,,,,,
305,90306,"o-Veratric acid hydrochloride, 2-(diethylamino)ethyl ester",CCN(CC)CCOC(=O)C1=C(C(=CC=C1)OC)OC.Cl,,,,,,
306,90307,"2-(Diethylamino)ethyl 2,3-dimethoxybenzoate",CCN(CC)CCOC(=O)C1=C(C(=CC=C1)OC)OC,,,,,,
307,90308,"Dibutyl 2,2'-dithiodiacetate",CCCCOC(=O)CSSCC(=O)OCCCC,,,,,,
308,90309,N-(2-Dimethylaminoethyl)-2-ethoxy-3-methoxybenzamide hydrochloride,CCOC1=C(C=CC=C1OC)C(=O)NCCN(C)C.Cl,,,,,,
309,90310,N-[2-(dimethylamino)ethyl]-2-ethoxy-3-methoxybenzamide,CCOC1=C(C=CC=C1OC)C(=O)NCCN(C)C,,,,,,
310,90311,N-(2-Dimethylaminoethyl)-2-propoxy-3-methoxybenzamide hydrochloride,CCCOC1=C(C=CC=C1OC)C(=O)NCCN(C)C.Cl,,,,,,
311,90312,N-[2-(dimethylamino)ethyl]-3-methoxy-2-propoxybenzamide,CCCOC1=C(C=CC=C1OC)C(=O)NCCN(C)C,,,,,,
312,90313,"Benzamide, N-(3-diethylaminopropyl)-3-methoxy-2-propoxy-, oxalate",CCCOC1=C(C=CC=C1OC)C(=O)NCCCN(CC)CC.C(=O)(C(=O)O)O,,,,,,
313,90314,N-[3-(diethylamino)propyl]-3-methoxy-2-propoxybenzamide,CCCOC1=C(C=CC=C1OC)C(=O)NCCCN(CC)CC,,,,,,
314,90315,"Benzamide, 2-butoxy-N-(2-dimethylaminoethyl)-3-methoxy-, oxalate",CCCCOC1=C(C=CC=C1OC)C(=O)NCCN(C)C.C(=O)(C(=O)O)O,,,,,,
315,90316,2-butoxy-N-[2-(dimethylamino)ethyl]-3-methoxybenzamide,CCCCOC1=C(C=CC=C1OC)C(=O)NCCN(C)C,,,,,,
316,90317,N-(3-Diethylaminopropyl)-2-butoxy-3-methoxybenzamide oxalate,CCCCOC1=C(C=CC=C1OC)C(=O)NCCCN(CC)CC.C(=O)(C(=O)O)O,,,,,,
317,90318,2-butoxy-N-[3-(diethylamino)propyl]-3-methoxybenzamide,CCCCOC1=C(C=CC=C1OC)C(=O)NCCCN(CC)CC,,,,,,
318,90319,"3-((1-(3-Chlorophenyl)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-4-yl)azo)-4-hydroxy-5-nitrobenzenesulphonic acid",CC1=NN(C(=O)C1N=NC2=C(C(=CC(=C2)S(=O)(=O)O)[N+](=O)[O-])O)C3=CC(=CC=C3)Cl,,,,,,
319,90320,"2-Naphthalenesulfonic acid, 6-[(2,6-dimethylphenyl)amino]-4-hydroxy-",CC1=C(C(=CC=C1)C)NC2=CC3=C(C=C(C=C3C=C2)S(=O)(=O)O)O,,,,,,
320,90321,"2-(2,4,6-Tribromophenoxy)ethanol",C1=C(C=C(C(=C1Br)OCCO)Br)Br,,,,,,
321,90322,"1,4,7,13,16-Pentaoxa-10,19-diazacyclohenicosane",C1COCCOCCNCCOCCOCCOCCN1,,,,,,
322,90323,2-(6-Methoxynaphthalen-1-yl)propanoic acid,CC(C1=CC=CC2=C1C=CC(=C2)OC)C(=O)O,,,,,,
323,90324,Methyl 6-methoxynaphthalene-2-acetate,COC1=CC2=C(C=C1)C=C(C=C2)CC(=O)OC,,,,,,
324,90325,"1H-Imidazole-1-propanenitrile, 2-phenyl-",C1=CC=C(C=C1)C2=NC=CN2CCC#N,,,,,,
325,90326,"1H-Imidazole-1-propanenitrile, 2-undecyl-",CCCCCCCCCCCC1=NC=CN1CCC#N,,,,,,
326,90327,3-(2-Ethyl-4-methyl-1H-imidazol-1-yl)propanenitrile,CCC1=NC(=CN1CCC#N)C,,,,,,
327,90328,"1H-Imidazole-1-propanenitrile, 2-methyl-",CC1=NC=CN1CCC#N,,,,,,
328,90329,6-Methoxy-2-methylbenzoxazole,CC1=NC2=C(O1)C=C(C=C2)OC,,,,,,
329,90330,"N,N'-Bis(p-methoxycarbonylbenzoyl)hydrazine",COC(=O)C1=CC=C(C=C1)C(=O)NNC(=O)C2=CC=C(C=C2)C(=O)OC,,,,,,
330,90331,Hydroxychlordene,C1=C[C@@H]([C@@H]2[C@H]1[C@@]3(C(=C([C@]2(C3(Cl)Cl)Cl)Cl)Cl)Cl)O,,,,,,
331,90332,CID 90332,CCCCN1C2=CC=CC=C2C(=O)C(=C1O)N=NC3=C(C(=CC(=C3)Cl)S(=O)(=O)O)O,,,,,,
332,90333,4-Benzyl-3-methylpyridine,CC1=C(C=CN=C1)CC2=CC=CC=C2,,,,,,
333,90334,2-Amino-3-benzyloxypyridine,C1=CC=C(C=C1)COC2=C(N=CC=C2)N,,,,,,
334,90335,N-Benzyl-3-benzyloxy-2-pyridone,C1=CC=C(C=C1)CN2C=CC=C(C2=O)OCC3=CC=CC=C3,,,,,,
335,90336,O-Propyl-S-(phthalimidomethyl)-ethylphosphonodithioate,CCCOP(=S)(CC)SCN1C(=O)C2=CC=CC=C2C1=O,,,,,,
336,90337,O-Isobutyl-S-(phthalimidomethyl)-methylphosphonodithioate,CC(C)COP(=S)(C)SCN1C(=O)C2=CC=CC=C2C1=O,,,,,,
337,90338,O-Methyl-S-(phthalimidomethyl)-ethylphosphonodithioate,CCP(=S)(OC)SCN1C(=O)C2=CC=CC=C2C1=O,,,,,,
338,90339,Guaiphensin carbamate,CCOP(=S)(CC)SCN1C(=O)C2=CC=CC=C2C1=O,,,,,,
339,90340,CID 90340,C1=C(C=C(C=C1C(=O)OCCO)S(=O)(=O)[O-])C(=O)OCCO.[Na+],,,,,,
340,90341,Bis(2-hydroxyethyl) 5-sulfoisophthalic acid,C1=C(C=C(C=C1C(=O)OCCO)S(=O)(=O)O)C(=O)OCCO,,,,,,
341,90342,1-(2-Sulphonatoethyl)pyridinium,C1=CC=[N+](C=C1)CCS(=O)(=O)[O-],,,,,,
342,90343,2-Pyridin-1-ium-1-ylethanesulfonic acid,C1=CC=[N+](C=C1)CCS(=O)(=O)O,,,,,,
343,90344,N-(3-Diethylaminopropyl)-2-ethoxy-3-methoxybenzamide oxalate,CCN(CC)CCCNC(=O)C1=C(C(=CC=C1)OC)OCC.C(=O)(C(=O)O)O,,,,,,
344,90345,N-[3-(diethylamino)propyl]-2-ethoxy-3-methoxybenzamide,CCN(CC)CCCNC(=O)C1=C(C(=CC=C1)OC)OCC,,,,,,
345,90346,3-Pentyloxypyridine,CCCCCOC1=CN=CC=C1,,,,,,
346,90347,N-[2-(1-piperazinyl)ethyl]ethylenediamine,C1CN(CCN1)CCNCCN,,,,,,
347,90348,H-Glu-Pna,C1=CC(=CC=C1NC(=O)[C@H](CCC(=O)O)N)[N+](=O)[O-],,,,,,
348,90349,"N-(2-((4-(3-(4-Chlorophenyl)-4,5-dihydro-1H-pyrazol-1-yl)phenyl)sulphonyl)ethyl)acetamide",CC(=O)NCCS(=O)(=O)C1=C(C=C(C=C1)N2CCC=N2)C3=CC=C(C=C3)Cl,,,,,,
349,90350,(+)-Isopinocampheol,C[C@H]1[C@@H]2C[C@@H](C2(C)C)C[C@@H]1O,,,,,,
350,90351,Acoradiene,C[C@@H]1CC[C@H]([C@]12CCC(=CC2)C)C(=C)C,,,,,,
351,90352,5-(Hydroxymethylamino)-1-methyl-3-(5-nitro-2-furyl)-s-triazole,CN1C(=NC(=N1)NCO)C2=CC=C(O2)[N+](=O)[O-],,,,,,
352,90353,Ethyl 5-hydroxy-6-methyl-4-oxo-4H-pyran-2-carboxylate,CCOC(=O)C1=CC(=O)C(=C(O1)C)O,,,,,,
353,90354,"2-Pyrrolidinone, 1-(2-methylphenyl)-",CC1=CC=CC=C1N2CCCC2=O,,,,,,
354,90355,CID 90355,C1=CC(=O)C2=C(C3=C(C(=N)C=CC3=O)C(=O)C2=C1N(O)O)O,,,,,,
355,90356,4-Bromobutyrophenone,C1=CC=C(C=C1)C(=O)CCCBr,,,,,,
356,90357,Dichloro(3-chloropropyl)silane,C(C[SiH](Cl)Cl)CCl,,,,,,
357,90358,4-Octyloxybenzaldehyde,CCCCCCCCOC1=CC=C(C=C1)C=O,,,,,,
358,90359,"6-Chloro-2h-1,3-benzoxazine-2,4(3h)-dione",C1=CC2=C(C=C1Cl)C(=O)NC(=O)O2,,,,,,
359,90360,"1-Octyne, 8-chloro-",C#CCCCCCCCl,,,,,,
360,90361,"7H-Benz[de]anthracen-7-one, 4,9-dichloro-",C1=CC2=C(C=CC3=C2C(=C1)C4=C(C3=O)C=C(C=C4)Cl)Cl,,,,,,
361,90362,Chromium nitride,N#[Cr],,,,,,
362,90363,"N-(3,5-Dichlorophenyl)succinimide",C1CC(=O)N(C1=O)C2=CC(=CC(=C2)Cl)Cl,,,"['Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)']",,,
363,90364,2-Bromo-3-methoxypyridine,COC1=C(N=CC=C1)Br,,,,,,
364,90365,C.I. Pigment Red 123,CCOC1=CC=C(C=C1)N2C(=O)C3=C4C(=CC=C5C4=C(C=C3)C6=C7C5=CC=C8C7=C(C=C6)C(=O)N(C8=O)C9=CC=C(C=C9)OCC)C2=O,,,,,,
365,90366,3-(N-(2-Hydroxyethyl)-p-((6-nitrobenzothiazol-2-yl)azo)anilino)propiononitrile,C1=CC(=CC=C1N=NC2=NC3=C(S2)C=C(C=C3)[N+](=O)[O-])N(CCC#N)CCO,,,,,,
366,90367,Diethyl isopropylbenzyloxymalonate,CCOC(=O)C(C(C)C)(C(=O)OCC)OCC1=CC=CC=C1,,,,,,
367,90368,"2-Anthracenesulfonic acid, 1-amino-4-[(3-amino-2,4,6-trimethyl-5-sulfophenyl)amino]-9,10-dihydro-9,10-dioxo-",CC1=C(C(=C(C(=C1NC2=CC(=C(C3=C2C(=O)C4=CC=CC=C4C3=O)N)S(=O)(=O)O)C)S(=O)(=O)O)C)N,,,,,,
368,90369,p-Cumylphenyl acetate,CC(=O)OC1=CC=C(C=C1)C(C)(C)C2=CC=CC=C2,,,,,,
369,90370,"Methyl (2S-cis)-6,6-dibromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate",CC1([C@@H](N2[C@H](S1)C(C2=O)(Br)Br)C(=O)OC)C,,,,,,
370,90371,"(2s,5r,6s)-6-Bromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid",CC1([C@@H](N2[C@H](S1)[C@H](C2=O)Br)C(=O)O)C,,,,,,
371,90372,"2-Butenedioic acid (2E)-, bis(2,4,6-tribromophenyl) ester",C1=C(C=C(C(=C1Br)OC(=O)C=CC(=O)OC2=C(C=C(C=C2Br)Br)Br)Br)Br,,,,,,
372,90373,"4(5H)-Thiazolone, 2-(diphenylamino)-",C1C(=O)N=C(S1)N(C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
373,90374,"4-Imidazolidinone, 3-heptyl-1-phenyl-2-thioxo-",CCCCCCCN1C(=O)CN(C1=S)C2=CC=CC=C2,,,,,,
374,90375,"1,4-Diisopropylnaphthalene",CC(C)C1=CC=C(C2=CC=CC=C21)C(C)C,,,,,,
375,90376,"6,6-Dibromopenicillanic acid",CC1([C@@H](N2[C@H](S1)C(C2=O)(Br)Br)C(=O)O)C,,,,,,
376,90377,"2,4-Dibromostyrene",C=CC1=C(C=C(C=C1)Br)Br,,,,,,
377,90378,"2-(Bromomethyl)-2-(2,3,4-trichlorophenyl)-1,3-dioxolane",C1COC(O1)(CBr)C2=C(C(=C(C=C2)Cl)Cl)Cl,,,,,,
378,90379,"2-(Bromomethyl)-2-(2-methoxyphenyl)-1,3-dioxolane",COC1=CC=CC=C1C2(OCCO2)CBr,,,,,,
379,90380,"1-Octadecanaminium, N-(carboxymethyl)-N,N-bis(2-hydroxyethyl)-, inner salt",CCCCCCCCCCCCCCCCCC[N+](CCO)(CCO)CC(=O)[O-],,,,,,
380,90381,"N-(Carboxylatomethyl)-N,N-bis(2-hydroxyethyl)-1-octadecanaminium",CCCCCCCCCCCCCCCCCC[N+](CCO)(CCO)CC(=O)O,,,,,,
381,90382,"Propanenitrile, 3-[(2-hydroxyethyl)[4-[[6-(methylsulfonyl)-2-benzothiazolyl]azo]phenyl]amino]-",CS(=O)(=O)C1=CC2=C(C=C1)N=C(S2)N=NC3=CC=C(C=C3)N(CCC#N)CCO,,,,,,
382,90383,"N-[2-[(2-Cyano-4,6-dinitrophenyl)azo]-5-(diethylamino)phenyl]acetamide",CCN(CC)C1=CC(=C(C=C1)N=NC2=C(C=C(C=C2[N+](=O)[O-])[N+](=O)[O-])C#N)NC(=O)C,,,,,,
383,90384,Tris(2-thienyl)phosphine,C1=CSC(=C1)P(C2=CC=CS2)C3=CC=CS3,,,,,,
384,90385,4-Azidobenzaldehyde,C1=CC(=CC=C1C=O)N=[N+]=[N-],,,,,,
385,90386,CID 90386,C1=CC(=CC=C1C=O)N[N+]#N,,,,,,
386,90387,Methyl D-serinate,COC(=O)[C@@H](CO)N,,,,,,
387,90388,Ethyl L-asparaginate,CCOC(=O)[C@H](CC(=O)N)N,,,,,,
388,90389,"4-[(1S)-2,6,6-trimethylcyclohex-2-en-1-yl]but-3-en-2-one",CC1=CCCC([C@@H]1C=CC(=O)C)(C)C,,,,,,
389,90390,"1,8-Diisopropylnaphthalene",CC(C)C1=CC=CC2=C1C(=CC=C2)C(C)C,,,,,,
390,90391,CID 90391,C1=CC=C2C(=C1)C3=NC4=CC=CC=C4N3C(=N2)S,,,,,,
391,90392,4'-Methoxy-3-(2-phenethyl)aminopropiophenone hydrochloride,COC1=CC=C(C=C1)C(=O)CCNCCC2=CC=CC=C2.Cl,,,,,,
392,90393,1-(4-Methoxyphenyl)-3-(2-phenylethylamino)propan-1-one,COC1=CC=C(C=C1)C(=O)CCNCCC2=CC=CC=C2,,,,,,
393,90394,2-Hydroxy-beta-(methylamino)propiophenone hydrochloride,CNCCC(=O)C1=CC=C(C=C1)O.Cl,,,,,,
394,90395,1-(4-Hydroxyphenyl)-3-(methylamino)propan-1-one,CNCCC(=O)C1=CC=C(C=C1)O,,,,,,
395,90396,"Propiophenone, 3-(ethylamino)-2'-hydroxy-, hydrochloride",CCNCCC(=O)C1=CC=CC=C1O.Cl,,,,,,
396,90397,3-(Ethylamino)-1-(2-hydroxyphenyl)propan-1-one,CCNCCC(=O)C1=CC=CC=C1O,,,,,,
397,90398,"Propiophenone, 3-(benzylamino)-2'-hydroxy-, hydrochloride",C1=CC=C(C=C1)CNCCC(=O)C2=CC=CC=C2O.Cl,,,,,,
398,90399,3-(Benzylamino)-1-(2-hydroxyphenyl)propan-1-one,C1=CC=C(C=C1)CNCCC(=O)C2=CC=CC=C2O,,,,,,
399,90400,"Propiophenone, alpha,alpha-dimethyl-beta-(dimethylamino)-, hydrochloride",CC(C)(CC(=O)C1=CC=CC=C1)N(C)C.Cl,,,,,,
400,90401,3-(Dimethylamino)-3-methyl-1-phenylbutan-1-one,CC(C)(CC(=O)C1=CC=CC=C1)N(C)C,,,,,,
401,90402,"3-(1-Diethylamino)-2,2-dimethylpropiophenone hydrochloride",CCN(CC)CC(C)(C)C(=O)C1=CC=CC=C1.Cl,,,,,,
402,90403,"3-(Diethylamino)-2,2-dimethyl-1-phenylpropan-1-one",CCN(CC)CC(C)(C)C(=O)C1=CC=CC=C1,,,,,,
403,90404,"2,2-Dimethyl-3-(methylamino)propiophenone hydrochloride",CC(C)(CC(=O)C1=CC=CC=C1)NC.Cl,,,,,,
404,90405,3-Methyl-3-(methylamino)-1-phenylbutan-1-one,CC(C)(CC(=O)C1=CC=CC=C1)NC,,,,,,
405,90406,5-Hydroxy-2-methylpyridine 1-oxide,CC1=[N+](C=C(C=C1)O)[O-],,,,,,
406,90407,N-(2-Hydroxyethyl)salicylamide,C1=CC=C(C(=C1)C(=O)NCCO)O,,,,,,
407,90408,"2,4-Dihydroxy-N-(2-hydroxyethyl)benzamide",C1=CC(=C(C=C1O)O)C(=O)NCCO,,,,,,
408,90409,"Propiophenone, 2,2-dimethyl-3-ethylamino-, hydrochloride",CCNC(C)(C)CC(=O)C1=CC=CC=C1.Cl,,,,,,
409,90410,3-(Ethylamino)-3-methyl-1-phenylbutan-1-one,CCNC(C)(C)CC(=O)C1=CC=CC=C1,,,,,,
410,90411,"Propiophenone, 4-methoxy-beta-(phenyl-(1-piperidino))-, hydrochloride",COC1=CC=C(C=C1)C(=O)CCN2CCC(CC2)C3=CC=CC=C3.Cl,,,,,,
411,90412,1-(4-Methoxyphenyl)-3-(4-phenylpiperidin-1-yl)propan-1-one,COC1=CC=C(C=C1)C(=O)CCN2CCC(CC2)C3=CC=CC=C3,,,,,,
412,90413,"1-[2-(Ethyl{4-[(e)-(3-phenyl-1,2,4-thiadiazol-5-yl)diazenyl]phenyl}amino)ethyl]pyridiniumchloride",CCN(CC[N+]1=CC=CC=C1)C2=CC=C(C=C2)N=NC3=NC(=NS3)C4=CC=CC=C4.[Cl-],,,,,,
413,90414,"1-[2-[Ethyl[4-[(3-phenyl-1,2,4-thiadiazol-5-yl)azo]phenyl]amino]ethyl]pyridinium",CCN(CC[N+]1=CC=CC=C1)C2=CC=C(C=C2)N=NC3=NC(=NS3)C4=CC=CC=C4,,,,,,
414,90415,"Magnesium, dioctyl-",CCCCCCC[CH2-].CCCCCCC[CH2-].[Mg+2],,,,,,
415,90416,"2-(p-Dimethylaminophenyl)-1,4,6-trimethylquinolinium iodide",CC1=CC2=C(C=C1)[N+](=C(C=C2C)C3=CC=C(C=C3)N(C)C)C.[I-],,,,,,
416,90417,"N,N-dimethyl-4-(1,4,6-trimethylquinolin-1-ium-2-yl)aniline",CC1=CC2=C(C=C1)[N+](=C(C=C2C)C3=CC=C(C=C3)N(C)C)C,,,,,,
417,90418,"2-(p-Dimethylaminophenyl)-1,6-dimethylquinolinium iodide",CC1=CC2=C(C=C1)[N+](=C(C=C2)C3=CC=C(C=C3)N(C)C)C.[I-],,,,,,
418,90419,"4-(1,6-dimethylquinolin-1-ium-2-yl)-N,N-dimethylaniline",CC1=CC2=C(C=C1)[N+](=C(C=C2)C3=CC=C(C=C3)N(C)C)C,,,,,,
419,90420,"2-(p-Dimethylaminophenyl)-1,6-dimethylquinolinium bromide",CC1=CC2=C(C=C1)[N+](=C(C=C2)C3=CC=C(C=C3)N(C)C)C.[Br-],,,,,,
420,90421,"2-(p-Dimethylaminophenyl)-1,6-dimethylquinolinium chloride",CC1=CC2=C(C=C1)[N+](=C(C=C2)C3=CC=C(C=C3)N(C)C)C.[Cl-],,,,,,
421,90422,Methanesulfonyl cyanide,CS(=O)(=O)C#N,,,,,,
422,90423,Ethyl 1-benzylpiperidine-4-carboxylate,CCOC(=O)C1CCN(CC1)CC2=CC=CC=C2,,,,,,
423,90424,"N,N-Dimethyldiethylenetriamine",CN(C)CCNCCN,,,,,,
424,90425,"4,5-Dihydro-N-(5-nitro-2-thiazolyl)-2-oxazolamine",C1COC(=N1)NC2=NC=C(S2)[N+](=O)[O-],,,,,,
425,90426,"Ethyl 3-(2,6-dichlorophenyl)-5-methylisoxazole-4-carboxylate",CCOC(=O)C1=C(ON=C1C2=C(C=CC=C2Cl)Cl)C,,,,,,
426,90427,"Chromate(1-), triaqua(4-((4,5-dihydro-3-methyl-5-(oxo-kappaO)-1-(3-sulfophenyl)-1H-pyrazol-4-yl)azo-kappaN1)-3-(hydroxy-kappaO)-1-naphthalenesulfonato(4-))-, sodium (1:1)",CC1=NN(C(=C1N=NC2=C(C=C(C3=CC=CC=C32)S(=O)(=O)[O-])[O-])[O-])C4=CC(=CC=C4)S(=O)(=O)[O-].O.O.O.[Na+].[Cr+3],,,,,,
427,90428,L-Ribose,C([C@@H]([C@@H]([C@@H](C=O)O)O)O)O,,,,,,
428,90429,"Carbonic acid, 4-formylphenyl methyl ester",COC(=O)OC1=CC=C(C=C1)C=O,,,,,,
429,90430,Monobutyl tetrachlorophthalate,CCCCOC(=O)C1=C(C(=C(C(=C1Cl)Cl)Cl)Cl)C(=O)O,,,,,,
430,90431,Tris(octan-1-olato)oxovanadium,CCCCCCCCO.CCCCCCCCO.CCCCCCCCO.O=[V],,,,,,
431,90432,3-(Benzylamino)-4'-methoxypropiophenone hydrochloride,COC1=CC=C(C=C1)C(=O)CCNCC2=CC=CC=C2.Cl,,,,,,
432,90433,1-(4-Methoxyphenyl)-3-(benzylamino)-1-propanone,COC1=CC=C(C=C1)C(=O)CCNCC2=CC=CC=C2,,,,,,
433,90434,1-Methyl-1H-indol-3-yl myristate,CCCCCCCCCCCCCC(=O)OC1=CN(C2=CC=CC=C21)C,,,,,,
434,90435,Stearyl behenate,CCCCCCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCCCC,,,,,,
435,90436,"2,4-Dinitrophenyl butyrate",CCCC(=O)OC1=C(C=C(C=C1)[N+](=O)[O-])[N+](=O)[O-],,,,,,
436,90437,"L-Glutamine, N2-((1,1-dimethylethoxy)carbonyl)-, compd. with N-cyclohexylcyclohexanamine (1:1)",CC(C)(C)OC(=O)N[C@@H](CCC(=O)N)C(=O)O.C1CCC(CC1)NC2CCCCC2,,,,,,
437,90438,Ethyl piperazine-1-carboxylate monohydrochloride,CCOC(=O)N1CCNCC1.Cl,,,,,,
438,90439,"L-fucono-1,4-lactone",C[C@@H]([C@@H]1[C@H]([C@@H](C(=O)O1)O)O)O,,,,,,
439,90440,"1-Tetradecanamine, N,N-dimethyl-, acetate",CCCCCCCCCCCCCCN(C)C.CC(=O)O,,,,,,
440,90441,CID 90441,CCCC[SnH](CCCC)CCCC.CCCC[SnH](CCCC)CCCC.CC(C)(C1=CC=C(C=C1)O)C2=CC=C(C=C2)O,,,,,,
441,90442,CID 90442,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=CC(=C(C(=C3)OC)C(=O)C=CC4=CC(=C(C=C4)OC)O)O)O)O)O)O)O)O,,,,,,
442,90443,"4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-2,3-dihydro-5-hydroxy-, (S)-",C1[C@H](OC2=CC=CC(=C2C1=O)O)C3=CC(=C(C=C3)O)O,,,,,,
443,90444,"(1-Methylethylidene)di-4,1-cyclohexanediyl bis(mercaptoacetate)",CC(C)(C1CCC(CC1)OC(=O)CS)C2CCC(CC2)OC(=O)CS,,,,,,
444,90445,(p-Aminophenacyl)trimethylammonium chloride,C[N+](C)(C)CC(=O)C1=CC=C(C=C1)N.[Cl-],,,,,,
445,90446,"4-Amino-N,N,N-trimethyl-beta-oxobenzeneethanaminium",C[N+](C)(C)CC(=O)C1=CC=C(C=C1)N,,,,,,
446,90447,"2,2-Diphenylethyl acetate",CC(=O)OCC(C1=CC=CC=C1)C2=CC=CC=C2,,,,,,
447,90448,1H-Indole-1-acetic acid,C1=CC=C2C(=C1)C=CN2CC(=O)O,,,,,,
448,90449,Trioctylpropylammonium bromide,CCCCCCCC[N+](CCC)(CCCCCCCC)CCCCCCCC.[Br-],,,,,,
449,90450,"1-Octanaminium, N,N-dioctyl-N-propyl-",CCCCCCCC[N+](CCC)(CCCCCCCC)CCCCCCCC,,,,,,
450,90451,3-(2-Hydroxyethoxy)propanenitrile,C(COCCO)C#N,,,,,,
451,90452,p-Piperidinophenol,C1CCN(CC1)C2=CC=C(C=C2)O,,,,,,
452,90453,Cinchonine hydrochloride,C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@H](C3=CC=NC4=CC=CC=C34)O.Cl,,,,,,
453,90454,Cinchonine,C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@H](C3=CC=NC4=CC=CC=C34)O,,,"['Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)']",,,
454,90455,Aluminum nitride,N#[Al],,,,,,
455,90456,"N,N'-(2,5-Dimethyl-1,4-phenylene)bis(3-oxobutyramide)",CC1=CC(=C(C=C1NC(=O)CC(=O)C)C)NC(=O)CC(=O)C,,,,,,
456,90457,2-((2-Aminoethyl)thio)ethanol,C(CSCCO)N,,,,,,
457,90458,4-Dodecylresorcinol,CCCCCCCCCCCCC1=C(C=C(C=C1)O)O,,,,,,
458,90459,N-(2-Hydroxyethyl)-3-oxobutanamide,CC(=O)CC(=O)NCCO,,,,,,
459,90460,(tert-Butylthio)acetic acid,CC(C)(C)SCC(=O)O,,,,,,
460,90461,"3-(Hydroxymethyl)-1,2,3-benzotriazin-4(3H)-one",C1=CC=C2C(=C1)C(=O)N(N=N2)CO,,,,,,
461,90462,"3-(Chloromethyl)-1,2,3-benzotriazin-4(3H)-one",C1=CC=C2C(=C1)C(=O)N(N=N2)CCl,,,,,,
462,90463,"Propanamide, N-[3-[bis[2-(acetyloxy)ethyl]amino]phenyl]-",CCC(=O)NC1=CC(=CC=C1)N(CCOC(=O)C)CCOC(=O)C,,,,,,
463,90464,2-Amino-4-nitrobenzenesulfonic acid,C1=CC(=C(C=C1[N+](=O)[O-])N)S(=O)(=O)O,,,,,,
464,90465,p-Methoxybenzyl p-anisate,COC1=CC=C(C=C1)COC(=O)C2=CC=C(C=C2)OC,,,,,,
465,90466,9H-Fluorene-9-methanol,C1=CC=C2C(=C1)C(C3=CC=CC=C32)CO,,,,,,
466,90467,2-Bromobut-2-enenitrile,CC=C(C#N)Br,,,,,,
467,90468,"endo-Bicyclo[2.2.2]oct-5-ene-2,3-dicarboxylic anhydride",C1C[C@H]2C=C[C@@H]1[C@H]3[C@@H]2C(=O)OC3=O,,,,,,
468,90469,"1,4-Dihydro-3(2H)-isoquinolinone",C1C2=CC=CC=C2CNC1=O,,,,,,
469,90470,Methyl pent-2-yn-1-oate,CCC#CC(=O)OC,,,,,,
470,90471,"2,3,5,6-Tetrachloro-p-xylene-alpha,alpha'-diamine",C(C1=C(C(=C(C(=C1Cl)Cl)CN)Cl)Cl)N,,,,,,
471,90472,"Benzenesulfinic acid, 4-methyl-, zinc salt",CC1=CC=C(C=C1)S(=O)[O-].CC1=CC=C(C=C1)S(=O)[O-].[Zn+2],,,,,,
472,90473,S-adenosylmethionine chloride,C[S+](CC[C@@H](C(=O)O)N)C[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O.[Cl-],,,,,,
473,90474,"1H-Benzimidazolium, 5,6-dichloro-1-ethyl-2-methyl-3-(3-sulfopropyl)-, inner salt",CCN1C(=[N+](C2=CC(=C(C=C21)Cl)Cl)CCCS(=O)(=O)[O-])C,,,,,,
474,90475,"3-(5,6-dichloro-3-ethyl-2-methyl-3H-benzimidazol-1-ium-1-yl)-1-propanesulfonate",CCN1C(=[N+](C2=CC(=C(C=C21)Cl)Cl)CCCS(=O)(=O)O)C,,,,,,
475,90476,"1H-Benzimidazolium, 5,6-dichloro-1,3-diethyl-2-methyl-, iodide",CCN1C(=[N+](C2=CC(=C(C=C21)Cl)Cl)CC)C.[I-],,,,,,
476,90477,"5,6-Dichloro-1,3-diethyl-2-methyl-1H-benzimidazol-3-ium",CCN1C(=[N+](C2=CC(=C(C=C21)Cl)Cl)CC)C,,,,,,
477,90478,p-(5-Amino-4-((2-methoxy-5-((2-(sulphooxy)ethyl)sulphonyl)phenyl)azo)-3-methyl-1H-pyrazol-1-yl)benzenesulphonic acid,CC1=NN(C(=C1N=NC2=C(C=CC(=C2)S(=O)(=O)CCOS(=O)(=O)O)OC)N)C3=CC=C(C=C3)S(=O)(=O)O,,,,,,
478,90479,Isocarbophos,CC(C)OC(=O)C1=CC=CC=C1OP(=S)(N)OC,,,"['Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)']",,,
479,90480,"Benzo(b)naphtho(2,3-d)thiophene, 6-methyl-",CC1=C2C(=CC3=CC=CC=C13)C4=CC=CC=C4S2,,,,,,
480,90481,4-[6-(4-Hydroxyphenyl)hexyl]phenol,C1=CC(=CC=C1CCCCCCC2=CC=C(C=C2)O)O,,,,,,
481,90482,4-Methyl-1h-imidazol-1-ol 3-oxide,CC1=CN(C=[N+]1[O-])O,,,,,,
482,90483,CID 90483,C1=CC=C(C=C1)[SnH](C2=CC=CC=C2)C3=CC=CC=C3.C1=CC=C(C(=C1)C(=O)O)O,,,,,,
483,90484,Choline orotate,C[N+](C)(C)CCO.C1=C(NC(=O)NC1=O)C(=O)[O-],,,,,,
484,90485,Ethyl (E)-3-(2-methoxyphenyl)acrylate,CCOC(=O)C=CC1=CC=CC=C1OC,,,,,,
485,90486,"2-Propenoic acid,3-(1,3-benzodioxol-5-yl)-, ethyl ester, (2E)-",CCOC(=O)C=CC1=CC2=C(C=C1)OCO2,,,,,,
486,90487,N-Methyl-N-(phenylthio)benzenesulphenamide,CN(SC1=CC=CC=C1)SC2=CC=CC=C2,,,,,,
487,90488,Ethyl 3-bromobenzoate,CCOC(=O)C1=CC(=CC=C1)Br,,,,,,
488,90489,CID 90489,C(CCN)C[C@@H](C(=O)O)N.C([C@@H]([C@@H]1C(=O)C(=C(O1)O)O)O)O,,,,,,
489,90490,"3,4,5,6-Tetrabromophthalimide",C12=C(C(=C(C(=C1Br)Br)Br)Br)C(=O)NC2=O,,,,,,
490,90491,7-Chlorobenzofuran,C1=CC2=C(C(=C1)Cl)OC=C2,,,,,,
491,90492,4-(Chloromethyl)phenyltrimethoxysilane,CO[Si](C1=CC=C(C=C1)CCl)(OC)OC,,,,,,
492,90493,CID 90493,CN1CCCN=C1S,,,,,,
493,90494,1-Chloro-3-hydroxyacetone,C(C(=O)CCl)O,,,,,,
494,90495,Di-tert-butyl dicarbonate,CC(C)(C)OC(=O)OC(=O)OC(C)(C)C,,,,,,
495,90496,5-Aminoindan,C1CC2=C(C1)C=C(C=C2)N,,,,,,
496,90497,"1,1-Diethyldiethylenetriamine",CCN(CC)CCNCCN,,,,,,
497,90498,"Acetonitrile, (ethylamino)-",CCNCC#N,,,,,,
498,90499,(4-Ethylphenoxy)acetic acid,CCC1=CC=C(C=C1)OCC(=O)O,,,,,,
499,90500,Benzo[b]thiophen-3-yl acetate,CC(=O)OC1=CSC2=CC=CC=C21,,,,,,
500,90501,"1H-Pyrrole-2-acetonitrile, 1-methyl-",CN1C=CC=C1CC#N,,,,,,
501,90502,O-Ethyl S-p-tolyl chloromethylphosphonodithioate,CCOP(=S)(CCl)SC1=CC=C(C=C1)C,,,,,,
502,90503,O-Isopropyl-S-(p-bromophenyl) chloromethylphosphonodithioate,CC(C)OP(=S)(CCl)SC1=CC=C(C=C1)Br,,,,,,
503,90504,Bisphenol A bis(2-hydroxyethyl ether) diacrylate,CC(C)(C1=CC=C(C=C1)OCCOC(=O)C=C)C2=CC=C(C=C2)OCCOC(=O)C=C,,,,,,
504,90505,4-(Methylamino)benzenesulfonic acid,CNC1=CC=C(C=C1)S(=O)(=O)O,,,,,,
505,90506,"2-Undecyl-2-oxazoline-4,4-dimethanol",CCCCCCCCCCCC1=NC(CO1)(CO)CO,,,,,,
506,90507,N-Methylperfluorooctanesulfonamidoethanol,CN(CCO)S(=O)(=O)C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
507,90508,Bisphenol A bis(2-hydroxyethyl ether) dimethacrylate,CC(=C)C(=O)OCCOC1=CC=C(C=C1)C(C)(C)C2=CC=C(C=C2)OCCOC(=O)C(=C)C,,,,,,
508,90509,"5,5-Dimethylbarbituric acid",CC1(C(=O)NC(=O)NC1=O)C,,,,,,
509,90510,N-(2-Methyl-2-nitropropyl)-4-nitrosoaniline,CC(C)(CNC1=CC=C(C=C1)N=O)[N+](=O)[O-],,,,,,
510,90511,"Piperidinium, 1,1'-((1,1'-biphenyl)-4,4'-diylbis(2-oxo-2,1-ethanediyl))bis(1,4-dimethyl-, diiodide",CC1CC[N+](CC1)(C)CC(=O)C2=CC=C(C=C2)C3=CC=C(C=C3)C(=O)C[N+]4(CCC(CC4)C)C.[I-].[I-],,,,,,
511,90512,"2-(1,4-Dimethylpiperidin-1-ium-1-yl)-1-[4-[4-[2-(1,4-dimethylpiperidin-1-ium-1-yl)acetyl]phenyl]phenyl]ethanone",CC1CC[N+](CC1)(C)CC(=O)C2=CC=C(C=C2)C3=CC=C(C=C3)C(=O)C[N+]4(CCC(CC4)C)C,,,,,,
512,90513,Dodecyl chloroformate,CCCCCCCCCCCCOC(=O)Cl,,,,,,
513,90514,Methyl (R)-aminophenylacetate,COC(=O)[C@@H](C1=CC=CC=C1)N,,,,,,
514,90515,"3-((4-(Cyclohexylamino)-9,10-dihydro-9,10-dioxoanthryl)amino)-N-phenylpropionamide",C1CCC(CC1)NC2=C3C(=C(C=C2)NCCC(=O)NC4=CC=CC=C4)C(=O)C5=CC=CC=C5C3=O,,,,,,
515,90516,Heptyl stearate,CCCCCCCCCCCCCCCCCC(=O)OCCCCCCC,,,,,,
516,90517,"1,5,7,11-Tetraoxaspiro[5.5]undecane",C1COC2(OC1)OCCCO2,,,,,,
517,90518,"1-(4-Chlorophenoxy)-3,3-dimethylbutan-2-one",CC(C)(C)C(=O)COC1=CC=C(C=C1)Cl,,,,,,
518,90519,2-(Hexylthio)ethanol,CCCCCCSCCO,,,,,,
519,90520,4-Phenyl-1-(p-tolylsulphonyl)piperidine-4-carbonitrile,CC1=CC=C(C=C1)S(=O)(=O)N2CCC(CC2)(C#N)C3=CC=CC=C3,,,,,,
520,90521,N-[2-[(4-Chlorophenyl)methylamino]ethyl]benzamide,CN(CCNC(=O)C1=CC=CC=C1)C2=CC=C(C=C2)Cl,,,,,,
521,90522,"2-Nitromethylene-1,2,4,5-tetrahydro-3(3H)-benzazepine",C1CCN(C2=CC=CC=C2C1)CC3=NCCN3,,,,,,
522,90523,2-(2-(2-Methoxyethoxy)ethoxy)ethyl methacrylate,CC(=C)C(=O)OCCOCCOCCOC,,,,,,
523,90524,"5,6-Dihydro-1,4-dithiin-2,3-dicarbonitrile",C1CSC(=C(S1)C#N)C#N,,,,,,
524,90525,"Pentafluoro(1,2,2-trifluoro-2-((trifluorovinyl)oxy)-1-(trifluoromethyl)ethoxy)benzene",C1(=C(C(=C(C(=C1F)F)F)F)F)OC(C(OC(=C(F)F)F)(F)F)(C(F)(F)F)F,,,,,,
525,90526,CID 90526,C=CCN1CCN=C1S,,,,,,
526,90527,CID 90527,C1=C2C(=NC(=NC2=O)S)NN1,,,,,,
527,90528,"1-Naphthalenesulfonic acid, 2-[(2-hydroxy-1-naphthalenyl)azo]-, barium salt (1:1)",C1=CC=C2C(=C1)C=CC(=C2N=NC3=C(C4=CC=CC=C4C=C3)S(=O)(=O)[O-])[O-].[Ba+2],,,,,,
528,90529,N-(3-(Bis(2-hydroxyethyl)amino)-4-methoxyphenyl)acetamide,CC(=O)NC1=CC(=C(C=C1)OC)N(CCO)CCO,,,,,,
529,90530,N-(Hydroxymethyl)hexadecan-1-amide,CCCCCCCCCCCCCCCC(=O)NCO,,,,,,
530,90531,"1,2-Benzenedicarboxylic acid, monopentyl ester",CCCCCOC(=O)C1=CC=CC=C1C(=O)O,,,,,,
531,90532,Monohexyl Phthalate,CCCCCCOC(=O)C1=CC=CC=C1C(=O)O,,,,,,
532,90533,Nonyl hydrogen phthalate,CCCCCCCCCOC(=O)C1=CC=CC=C1C(=O)O,,,,,,
533,90534,Decyl hydrogen phthalate,CCCCCCCCCCOC(=O)C1=CC=CC=C1C(=O)O,,,,,,
534,90535,"Decane, 1-isothiocyanato-",CCCCCCCCCCN=C=S,,,,,,
535,90536,"2,6-Diethyl-4-methylaniline",CCC1=CC(=CC(=C1N)CC)C,,,,,,
536,90537,"3',6'-Dihydroxy-4',5'-dinitrospiro[isobenzofuran-1(3H),9'-[9H]xanthene]-3-one",C1=CC=C2C(=C1)C(=O)OC23C4=C(C(=C(C=C4)O)[N+](=O)[O-])OC5=C3C=CC(=C5[N+](=O)[O-])O,,,,,,
537,90538,"4,5-Dibromosalicylanilide",C1=CC=C(C=C1)NC(=O)C2=CC(=C(C=C2O)Br)Br,,,,,,
538,90539,"3,4,5-Tribromosalicylanilide",C1=CC=C(C=C1)NC(=O)C2=CC(=C(C(=C2O)Br)Br)Br,,,,,,
539,90540,D-Iditol,C([C@H]([C@@H]([C@H]([C@@H](CO)O)O)O)O)O,,,,,,
540,90541,CID 90541,[B+3].CN(C)C1=CC=C(C=C1)[N+]#N.[F-].[F-].[F-].[F-],,,,,,
541,90542,"2H-Azepin-2-one, 1-(3-aminopropyl)hexahydro-",C1CCC(=O)N(CC1)CCCN,,,,,,
542,90543,1-Propyl-3-(p-tolylsulphonyl)urea,CCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C,,,,,,
543,90544,"2,4,6-Trinitrobenzyl alcohol",C1=C(C=C(C(=C1[N+](=O)[O-])CO)[N+](=O)[O-])[N+](=O)[O-],,,,,,
544,90545,"Mercury, chloro(2-hydroxy-5-nitrophenyl)-",C1=CC(=C(C=C1[N+](=O)[O-])[Hg]Cl)O,,,,,,
545,90546,N-Carbamoyl-L-cysteine,C([C@@H](C(=O)O)NC(=O)N)S,,,,,,
546,90547,4-Hydrazinobenzoic acid hydrochloride,C1=CC(=CC=C1C(=O)O)NN.Cl,,,,,,
547,90548,(R)-4-Methoxyphenylglycine,COC1=CC=C(C=C1)[C@H](C(=O)O)N,,,,,,
548,90549,"4-Bromo-2,6-dimethylaniline",CC1=CC(=CC(=C1N)C)Br,,,,,,
549,90550,CID 90550,C1=C(NC(=O)NC1=O)C(=O)[O-].[K+],,,,,,
550,90551,Ethylene glycol methacrylate phosphate,CC(=C)C(=O)OCCOP(=O)(O)O,,,,,,
551,90552,"2,5-Dimethoxytoluene",CC1=C(C=CC(=C1)OC)OC,,,,,,
552,90553,Ytterbium nitride,N#[Yb],,,,,,
553,90554,"Disodium aniline-2,5-disulphonate",C1=CC(=C(C=C1S(=O)(=O)[O-])N)S(=O)(=O)[O-].[Na+].[Na+],,,,,,
554,90555,2-[[4-[(2-Cyanoethyl)(2-phenylethyl)amino]phenyl]azo]-5-nitrobenzonitrile,C1=CC=C(C=C1)CCN(CCC#N)C2=CC=C(C=C2)N=NC3=C(C=C(C=C3)[N+](=O)[O-])C#N,,,,,,
555,90556,Dimethyl (((1-oxoallyl)amino)methyl)phosphonate,COP(=O)(CNC(=O)C=C)OC,,,,,,
556,90557,"1,9-Diiodononane",C(CCCCI)CCCCI,,,,,,
557,90558,2-Carboxyethyl acrylate,C=CC(=O)OCCC(=O)O,,,,,,
558,90559,"5,5'-Dithiodisalicylic acid",C1=CC(=C(C=C1SSC2=CC(=C(C=C2)O)C(=O)O)C(=O)O)O,,,,,,
559,90560,Niobium nitride,N#[Nb],,,,,,
560,90561,4-Chloro-1H-indole-2-carboxylic acid,C1=CC2=C(C=C(N2)C(=O)O)C(=C1)Cl,,,,,,
561,90562,6-Nitroindan-1-one,C1CC(=O)C2=C1C=CC(=C2)[N+](=O)[O-],,,,,,
562,90563,4-Nitroindan-1-one,C1CC(=O)C2=C1C(=CC=C2)[N+](=O)[O-],,,,,,
563,90564,CID 90564,[F-].[F-].[Cl-].[Cl-].[Cl-].[SbH3],,,,,,
564,90565,"N,N-Dimethyl-1,4-phenylenediamine oxalate",CN(C)C1=CC=C(C=C1)N.C(=O)(C(=O)O)O,,,,,,
565,90566,"1-Piperazineacetic acid, 4-methyl-, hydrazide",CN1CCN(CC1)CC(=O)NN,,,,,,
566,90567,Cyclohex-3-en-1-yl(2-methylpiperidin-1-yl)methanone,CC1CCCCN1C(=O)C2CCC=CC2,,,,,,
567,90568,(p-Hydroxyphenyl)glyoxal,C1=CC(=CC=C1C(=O)C=O)O,,,,,,
568,90569,"9,10-Anthracenedione, 2-(3-methylbutyl)-",CC(C)CCC1=CC2=C(C=C1)C(=O)C3=CC=CC=C3C2=O,,,,,,
569,90570,Vanadium nitride (VN),N#[V],,,,,,
570,90571,"2,2-Dimethoxy-2-phenylacetophenone",COC(C1=CC=CC=C1)(C(=O)C2=CC=CC=C2)OC,,,,,,
571,90572,CID 90572,CCCCCCCCCCOC(=O)C=CC(=O)O.CCCCCCCCCCOC(=O)C=CC(=O)O.CCCC[Sn]CCCC,,,,,,
572,90573,4-Decoxy-4-oxobut-2-enoic acid,CCCCCCCCCCOC(=O)C=CC(=O)O,,,,,,
573,90574,2-Sulfobut-2-enedioic acid,C(=C(C(=O)O)S(=O)(=O)O)C(=O)O,,,,,,
574,90575,"2-Amino-5,6-dihydro-4H-1,3-thiazin-4-one",C1CSC(=NC1=O)N,,,,,,
575,90576,CID 90576,CC(C)(C)C1=C(C(=CC=C1)C(C)(C)C)[O-].[K+],,,,,,
576,90577,CID 90577,C1[C@H]2[C@@H]3C(O3)[C@H](N2)CC1OC(=O)[C@H](CO)C4=CC=CC=C4.Cl,,,,,,
577,90578,CID 90578,C1[C@H]2[C@@H]3C(O3)[C@H](N2)CC1OC(=O)[C@H](CO)C4=CC=CC=C4,,,,,,
578,90579,"2,3-Dihydroxybenzaldehyde",C1=CC(=C(C(=C1)O)O)C=O,,,,,,
579,90580,CID 90580,CCOC(=C1C(=O)C2=CC=CC=C2S(=O)(=O)N1C)O,,,,,,
580,90581,2H-Imidazole-2-thione,C1=NC(=S)N=C1,,,,,,
581,90582,"Silicic acid (H4SiO4), tetrakis[2-(2-methoxyethoxy)ethyl] ester",COCCOCCO[Si](OCCOCCOC)(OCCOCCOC)OCCOCCOC,,,,,,
582,90583,N-Benzoyl-4-piperidone,C1CN(CCC1=O)C(=O)C2=CC=CC=C2,,,,,,
583,90584,4-Mercaptobutane-1-sulphonic acid,C(CCS(=O)(=O)O)CS,,,,,,
584,90585,Trimethylolethane trimethacrylate,CC(=C)C(=O)OCC(C)(COC(=O)C(=C)C)COC(=O)C(=C)C,,,,,,
585,90586,"cis-3-Ethoxy-1,1,5-trimethylcyclohexane",CCO[C@@H]1C[C@@H](CC(C1)(C)C)C,,,,,,
586,90587,"cis-3,3,5-Trimethylcyclohexyl acetate",C[C@@H]1C[C@@H](CC(C1)(C)C)OC(=O)C,,,,,,
587,90588,"(3r,5s)-3-Ethoxy-1,1,5-trimethylcyclohexane",CCO[C@@H]1C[C@H](CC(C1)(C)C)C,,,,,,
588,90589,"trans-3,3,5-Trimethylcyclohexyl acetate",C[C@@H]1C[C@H](CC(C1)(C)C)OC(=O)C,,,,,,
589,90590,Fenfuram,CC1=C(C=CO1)C(=O)NC2=CC=CC=C2,,,,,,
590,90591,"2-Butenoic acid, 3-methyl-, 4-methylphenyl ester",CC1=CC=C(C=C1)OC(=O)C=C(C)C,,,,,,
591,90592,"2-Butenoic acid, 2-methyl-, 3,7-dimethyl-6-octenyl ester, (2E)-",CC=C(C)C(=O)OCCC(C)CCC=C(C)C,,,,,,
592,90593,N-Ethyl-N-(2-hydroxyethyl)stearamide,CCCCCCCCCCCCCCCCCC(=O)N(CC)CCO,,,,,,
593,90594,Aluminium tri(quinolin-8-olate),C1=CC2=C(C(=C1)[O-])N=CC=C2.C1=CC2=C(C(=C1)[O-])N=CC=C2.C1=CC2=C(C(=C1)[O-])N=CC=C2.[Al+3],,,,,,
594,90595,"Butanamide, N,N'-1,4-phenylenebis[3-oxo-",CC(=O)CC(=O)NC1=CC=C(C=C1)NC(=O)CC(=O)C,,,,,,
595,90596,3-Phenylpropane-1-thiol,C1=CC=C(C=C1)CCCS,,,,,,
596,90597,"O,O-Diethyl S-((4-oxo-1,2,3-benzotriazin-3(4H)-yl)methyl) phosphorothioate",COP(=S)(OC)OCN1C(=O)C2=CC=CC=C2N=N1,,,,,,
597,90598,4-((4-Ethoxybenzylidene)amino)benzonitrile,CCOC1=CC=C(C=C1)C=NC2=CC=C(C=C2)C#N,,,,,,
598,90599,"5-Allyl-10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5-ol",C=CCC1(C2=CC=CC=C2CCC3=CC=CC=C31)O,,,,,,
599,90600,4-Morpholinobenzophenone,C1COCCN1C2=CC=C(C=C2)C(=O)C3=CC=CC=C3,,,,,,
600,90601,"5,5-Diphenyl-1-(4-hydroxyphenylsulfonyl)hydantoin",C1=CC=C(C=C1)C2(C(=O)NC(=O)N2S(=O)(=O)C3=CC=C(C=C3)O)C4=CC=CC=C4,,,,,,
601,90602,4-[3-(4-Hydroxy-3-methoxyphenyl)propyl]-2-methoxyphenol,COC1=C(C=CC(=C1)CCCC2=CC(=C(C=C2)O)OC)O,,,,,,
602,90603,"2-Methyl-2-phenylpropane-1,3-diol",CC(CO)(CO)C1=CC=CC=C1,,,,,,
603,90604,"Carbonimidic acid, cyano-, dimethyl ester",COC(=NC#N)OC,,,,,,
604,90605,"1,8-Diiodooctane",C(CCCCI)CCCI,,,,,,
605,90606,CID 90606,C1=CC=C(C=C1)NC(=NC2=CC=CC3=CC=CC=C32)S,,,,,,
606,90607,3-Phenylpropyl salicylate,C1=CC=C(C=C1)CCCOC(=O)C2=CC=CC=C2O,,,,,,
607,90608,"Ethenetricarbonitrile, [4-(diethylamino)phenyl]-",CCN(CC)C1=CC=C(C=C1)C(=C(C#N)C#N)C#N,,,,,,
608,90609,Pentaerythritol tetracarbamate,C(C(COC(=O)N)(COC(=O)N)COC(=O)N)OC(=O)N,,,,,,
609,90610,"Formic acid, compd. with 2,2',2''-nitrilotris[ethanol] (1:1)",C(CO)N(CCO)CCO.C(=O)O,,,,,,
610,90611,"Phenoxazin-5-ium, 3,7-bis(diethylamino)-, perchlorate (1:1)",CCN(CC)C1=CC2=C(C=C1)N=C3C=CC(=[N+](CC)CC)C=C3O2.[O-]Cl(=O)(=O)=O,,,,,,
611,90612,Oxazine 1,CCN(CC)C1=CC2=C(C=C1)N=C3C=CC(=[N+](CC)CC)C=C3O2,,,,,,
612,90613,Triethoxy(3-isocyanatopropyl)silane,CCO[Si](CCCN=C=O)(OCC)OCC,,,,,,
613,90614,"3-Nitro-1,2,4-triazole",C1=NNC(=N1)[N+](=O)[O-],,,,,,
614,90615,"Ethanol, 2,2'-[(3-nitrophenyl)imino]bis-",C1=CC(=CC(=C1)[N+](=O)[O-])N(CCO)CCO,,,,,,
615,90616,CID 90616,CCCCCCCCCCCCOS(=O)(=O)O.C[C@@]1([C@H]2[C@@H]([C@H]3[C@@H](C(=O)C(=C(N)O)C(=O)[C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O)O,,,,,,
616,90617,"1,2,3-Propanetricarboxylic acid, 2-(acetyloxy)-, trihexyl ester",CCCCCCOC(=O)CC(CC(=O)OCCCCCC)(C(=O)OCCCCCC)OC(=O)C,,,,,,
617,90618,"2,6-Bis(trifluoromethyl)benzoic acid",C1=CC(=C(C(=C1)C(F)(F)F)C(=O)O)C(F)(F)F,,,,,,
618,90619,"1,7-Dinitronaphthalene",C1=CC2=C(C=C(C=C2)[N+](=O)[O-])C(=C1)[N+](=O)[O-],,,,,,
619,90620,"2,7-Dinitronaphthalene",C1=CC(=CC2=C1C=CC(=C2)[N+](=O)[O-])[N+](=O)[O-],,,,,,
620,90621,Diethyl (diphenylmethylene)malonate,CCOC(=O)C(=C(C1=CC=CC=C1)C2=CC=CC=C2)C(=O)OCC,,,,,,
621,90622,"1,3-Diethyl-1-(4-nitrophenyl)-3-phenylurea",CCN(C1=CC=CC=C1)C(=O)N(CC)C2=CC=C(C=C2)[N+](=O)[O-],,,,,,
622,90623,"2-Cyclopentene-1-tridecanoic acid, methyl ester",COC(=O)CCCCCCCCCCCCC1CCC=C1,,,,,,
623,90624,D-Allothreonine,C[C@H]([C@H](C(=O)O)N)O,,,,,,
624,90625,"1,3,5-Triazine-2,4-diamine, 6,6'-dithiobis[N,N,N'-triethyl-",CCNC1=NC(=NC(=N1)SSC2=NC(=NC(=N2)N(CC)CC)NCC)N(CC)CC,,,,,,
625,90626,2-Benzoyl-N-(2-hydroxyethyl)-N-methylbenzamide,CN(CCO)C(=O)C1=CC=CC=C1C(=O)C2=CC=CC=C2,,,,,,
626,90627,S-(p-Chlorophenyl) O-isobutyl ethanephosphonodithioate,CCP(=S)(OCC(C)C)SC1=CC=C(C=C1)Cl,,,,,,
627,90628,Allyltributylstannane,CCCC[Sn](CCCC)(CCCC)CC=C,,,,,,
628,90629,1-Acetoxy-2-pentylcyclopentene,CCCCCC1=C(CCC1)OC(=O)C,,,,,,
629,90630,CID 90630,CN1C=NN=C1S,,,,,,
630,90631,4-Hydroxy-3-nitrobenzenesulfonamide,C1=CC(=C(C=C1S(=O)(=O)N)[N+](=O)[O-])O,,,,,,
631,90632,Diammonium ethyl phosphate,CCOP(=O)(O)O.N.N,,,,,,
632,90633,"3,5-Dichloro-4-[(4-oxocyclohexa-2,5-dien-1-ylidene)amino]phenyl acetate",CC(=O)OC1=CC(=C(C(=C1)Cl)N=C2C=CC(=O)C=C2)Cl,,,,,,
633,90634,"1-Cyclopentene-1-acetic acid, 3-oxo-2-pentyl-, methyl ester",CCCCCC1=C(CCC1=O)CC(=O)OC,,,,,,
634,90635,4-(4-Biphenylyl)-2-methylthiazole,CC1=NC(=CS1)C2=CC=C(C=C2)C3=CC=CC=C3,,,,,,
635,90636,"5-Ethylpyrimidine-2,4,6-triamine",CCC1=C(N=C(N=C1N)N)N,,,,,,
636,90637,"7-Hexadecen-1-ol, (7Z)-",CCCCCCCCC=CCCCCCCO,,,,,,
637,90638,N-Methyl-L-histidine,CN[C@@H](CC1=CN=CN1)C(=O)O,,,,,,
638,90639,[(4-Chlorophenyl)amino]acetonitrile,C1=CC(=CC=C1NCC#N)Cl,,,,,,
639,90640,[(4-Methoxyphenyl)amino]acetonitrile,COC1=CC=C(C=C1)NCC#N,,,,,,
640,90641,"7-(3-(Benzylamino)propyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione",CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CCCNCC3=CC=CC=C3,,,,,,
641,90642,"5,7,12-Trimethylbenz(a)anthracene",CC1=CC2=C(C3=CC=CC=C3C(=C2C4=CC=CC=C14)C)C,,,,,,
642,90643,"Benz(a)anthracene, 7,9,12-trimethyl-",CC1=CC2=C(C=C1)C(=C3C(=C2C)C=CC4=CC=CC=C43)C,,,,,,
643,90644,3-Chloro-4-(4-chlorophenoxy)aniline,C1=CC(=CC=C1OC2=C(C=C(C=C2)N)Cl)Cl,,,,,,
644,90645,CID 90645,C1=CC(=N)C(=CC1=NCCO)N(O)O,,,,,,
645,90646,"9,12-Octadecadienoic acid (9Z,12Z)-, anhydride",CCCCCC=CCC=CCCCCCCCC(=O)OC(=O)CCCCCCCC=CCC=CCCCCC,,,,,,
646,90647,"9-Octadecenoic acid, anhydride",CCCCCCCCC=CCCCCCCCC(=O)OC(=O)CCCCCCCC=CCCCCCCCC,,,,,,
647,90648,"Vanadium, tris(cyclohexanolato)oxo-, (T-4)-",C1CCC(CC1)O.C1CCC(CC1)O.C1CCC(CC1)O.O=[V],,,,,,
648,90649,"1,4-Dichloro-2-phenoxybenzene",C1=CC=C(C=C1)OC2=C(C=CC(=C2)Cl)Cl,,,,,,
649,90650,"3,4',5-Trichlorodiphenyl ether",C1=CC(=CC=C1OC2=CC(=CC(=C2)Cl)Cl)Cl,,,,,,
650,90651,"N-Methoxy-2,6-dinitroaniline",CONC1=C(C=CC=C1[N+](=O)[O-])[N+](=O)[O-],,,,,,
651,90652,"N-Ethoxy-2,6-dinitroaniline",CCONC1=C(C=CC=C1[N+](=O)[O-])[N+](=O)[O-],,,,,,
652,90653,"Benzenediazonium, 4-methyl-2-nitro-",CC1=CC(=C(C=C1)[N+]#N)[N+](=O)[O-],,,,,,
653,90654,"(1R,9S,10R)-17-(3-methylbut-2-enyl)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol",CC(=CCN1CC[C@]23CCCC[C@H]2[C@@H]1CC4=C3C=C(C=C4)O)C,,,,,,
654,90655,Tetraallyloxirane,C=CCC1(C(O1)(CC=C)CC=C)CC=C,,,,,,
655,90656,N-Allyl-N-ethylheptadecafluorooctanesulphonamide,CCN(CC=C)S(=O)(=O)C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
656,90657,4-Nonyl-N-(4-nonylphenyl)aniline,CCCCCCCCCC1=CC=C(C=C1)NC2=CC=C(C=C2)CCCCCCCCC,,,,,,
657,90658,"Decanamide, N,N-dipropyl-",CCCCCCCCCC(=O)N(CCC)CCC,,,,,,
658,90659,"1-Amino-9,10-dihydro-4-hydroxy-9,10-dioxoanthracene-2-sulphonic acid",C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3O)S(=O)(=O)O)N,,,,,,
659,90660,1-(2-Aminoethyl)pyrrolidin-2-one,C1CC(=O)N(C1)CCN,,,,,,
660,90661,"2-Heptadecyl-3H-pyrazolo(1,5-a)benzimidazole-6-sulphonic acid",CCCCCCCCCCCCCCCCCC1=NN2C(=NC3=C2C=CC(=C3)S(=O)(=O)O)C1,,,,,,
661,90662,"D-threo-2,5-Hexodiulosonic acid, calcium salt (2:1)",C(C(=O)[C@H]([C@@H](C(=O)C(=O)[O-])O)O)O.C(C(=O)[C@H]([C@@H](C(=O)C(=O)[O-])O)O)O.[Ca+2],,,,,,
662,90663,CID 90663,C(C(=O)C([C@@H](C(=O)C(=O)O)O)O)O,,,,,,
663,90664,"Methanesulfonamide, N-[2-(4-nitrophenyl)ethyl]-",CS(=O)(=O)NCCC1=CC=C(C=C1)[N+](=O)[O-],,,,,,
664,90665,2-Acetamido-2-deoxy-D-galactonolactone,CC(=O)N[C@@H]1[C@H]([C@H]([C@H](OC1=O)CO)O)O,,,,,,
665,90666,7-Bromomethylbenzanthracene,C1=CC=C2C(=C1)C=CC3=C(C4=CC=CC=C4C=C32)CBr,,,,,,
666,90667,"3-Amino-4-hydroxy-N,N-dimethylbenzenesulfonamide",CN(C)S(=O)(=O)C1=CC(=C(C=C1)O)N,,,,,,
667,90668,"Benzo[b]naphtho[2,3-d]thiophene, 8-methyl-",CC1=CC2=CC3=C(C=C2C=C1)C4=CC=CC=C4S3,,,,,,
668,90669,"7-Methylbenzo[b]naphtho[2,3-d]thiophene",CC1=C2C=C3C(=CC2=CC=C1)C4=CC=CC=C4S3,,,,,,
669,90670,3-Cyanobenzaldehyde,C1=CC(=CC(=C1)C#N)C=O,,,,,,
670,90671,"2,6-Dichlorothiophenol",C1=CC(=C(C(=C1)Cl)S)Cl,,,,,,
671,90672,"3,5-Dimethyl-4-methoxyamphetamine hydrochloride",CC1=CC(=CC(=C1OC)C)CC(C)N.Cl,,,,,,
672,90673,"1-(4-Methoxy-3,5-dimethylphenyl)propan-2-amine",CC1=CC(=CC(=C1OC)C)CC(C)N,,,,,,
673,90674,"4-(2-Aminopropyl)-2,6-xylenol hydrochloride",CC1=CC(=CC(=C1O)C)CC(C)N.Cl,,,,,,
674,90675,"4-(2-Aminopropyl)-2,6-xylenol",CC1=CC(=CC(=C1O)C)CC(C)N,,,,,,
675,90676,"2,4,6-tri-tert-Butylnitrosobenzene",CC(C)(C)C1=CC(=C(C(=C1)C(C)(C)C)N=O)C(C)(C)C,,,,,,
676,90677,Ethyl 5-hydroxy-1H-indole-2-carboxylate,CCOC(=O)C1=CC2=C(N1)C=CC(=C2)O,,,,,,
677,90678,CID 90678,C[CH2-].C[CH2-].CC[SiH](C)O.[AlH+2],,,,,,
678,90679,Ethyl-hydroxy-methylsilane,CC[SiH](C)O,,,,,,
679,90680,Trichloromethanesulfinyl chloride,C(S(=O)Cl)(Cl)(Cl)Cl,,,,,,
680,90681,"1,3-Propanediol, 2-amino-2-ethyl-, hydrochloride",CCC(CO)(CO)N.Cl,,,,,,
681,90682,"Pyrazine, 2,3-dihydro-5,6-di-2-pyridinyl-",C1CN=C(C(=N1)C2=CC=CC=N2)C3=CC=CC=N3,,,,,,
682,90683,Isopropyl dichloroacetate,CC(C)OC(=O)C(Cl)Cl,,,,,,
683,90684,5-Bromo-2-methoxybenzaldehyde,COC1=C(C=C(C=C1)Br)C=O,,,,,,
684,90685,2-Methoxy-5-nitrobenzaldehyde,COC1=C(C=C(C=C1)[N+](=O)[O-])C=O,,,,,,
685,90686,4'-Chlorovalerophenone,CCCCC(=O)C1=CC=C(C=C1)Cl,,,,,,
686,90687,(2-Methylphenethyl)urea,CC1=CC=CC=C1CCNC(=O)N,,,,,,
687,90688,3-Methylphenethylurea,CC1=CC(=CC=C1)CCNC(=O)N,,,,,,
688,90689,"9,9-Dichloro-9H-fluorene",C1=CC=C2C(=C1)C3=CC=CC=C3C2(Cl)Cl,,,,,,
689,90690,Boc-His(Dnp)-OH,CC(C)(C)OC(=O)N[C@@H](CC1=CN(C=N1)C2=C(C=C(C=C2)[N+](=O)[O-])[N+](=O)[O-])C(=O)O,,,,,,
690,90691,Acetylthiocholine bromide,CC(=O)SCC[N+](C)(C)C.[Br-],,,,,,
691,90692,4-Chlorophenylacetyl chloride,C1=CC(=CC=C1CC(=O)Cl)Cl,,,,,,
692,90693,CID 90693,C1=CC(=C(C=C1[N+](=O)[O-])C(=N)S)N,,,,,,
693,90694,"trans-1,4-Bis(2-isothiocyanatoethyl)cyclohexane",C1CC(CCC1CCN=C=S)CCN=C=S,,,,,,
694,90695,"Propanenitrile, 3-[[2-(benzoyloxy)ethyl]phenylamino]-",C1=CC=C(C=C1)C(=O)OCCN(CCC#N)C2=CC=CC=C2,,,,,,
695,90696,"1-Dodecanaminium, N-(carboxymethyl)-N-dodecyl-N-methyl-, inner salt",CCCCCCCCCCCC[N+](C)(CCCCCCCCCCCC)CC(=O)[O-],,,,,,
696,90697,N-Carboxylatomethyl-N-dodecyl-N-methyl-1-dodecanaminium,CCCCCCCCCCCC[N+](C)(CCCCCCCCCCCC)CC(=O)O,,,,,,
697,90698,2-[Dimethyl-[3-(octadec-9-enoylamino)propyl]azaniumyl]acetate,CCCCCCCCC=CCCCCCCCC(=O)NCCC[N+](C)(C)CC(=O)[O-],,,,,,
698,90699,"1-Propanaminium, N-(carboxymethyl)-N,N-dimethyl-3-[[(9Z)-1-oxo-9-octadecenyl]amino]-, inner salt",CCCCCCCCC=CCCCCCCCC(=O)NCCC[N+](C)(C)CC(=O)O,,,,,,
699,90700,CID 90700,C1=CC=C2C(=C1)C=CC(=C2S(=O)(=O)[O-])O.[Na+],,,,,,
700,90701,"ethyl 4-chloro-2-oxo-1,3-benzothiazole-3(2H)-carboxylate",CCOC(=O)N1C2=C(C=CC=C2Cl)SC1=O,,,,,,
701,90702,"9,10-Anthracenedione, 1-amino-4-(cyclohexylamino)-2-(2-hydroxyethoxy)-",C1CCC(CC1)NC2=CC(=C(C3=C2C(=O)C4=CC=CC=C4C3=O)N)OCCO,,,,,,
702,90703,"Ethane-1,2-diylbis(oxyethane-1,2-diyl) distearate",CCCCCCCCCCCCCCCCCC(=O)OCCOCCOCCOC(=O)CCCCCCCCCCCCCCCCC,,,,,,
703,90704,2-Methylbutyl 4-(dimethylamino)benzoate,CCC(C)COC(=O)C1=CC=C(C=C1)N(C)C,,,,,,
704,90705,"Hexadecanamide, N-[2-[(2-hydroxyethyl)amino]ethyl]-",CCCCCCCCCCCCCCCC(=O)NCCNCCO,,,,,,
705,90706,"Octadecanamide, N-[3-(dimethyloxidoamino)propyl]-",CCCCCCCCCCCCCCCCCC(=O)NCCC[N+](C)(C)[O-],,,,,,
706,90707,ZINC;phenylphosphinate,C1=CC=C(C=C1)P(=O)[O-].C1=CC=C(C=C1)P(=O)[O-].[Zn+2],,,,,,
707,90708,"Acetamide, N-[3-[bis(phenylmethyl)amino]-4-methoxyphenyl]-",CC(=O)NC1=CC(=C(C=C1)OC)N(CC2=CC=CC=C2)CC3=CC=CC=C3,,,,,,
708,90709,"Acetamide, N-[5-[bis(phenylmethyl)amino]-2-[(2-bromo-4,6-dinitrophenyl)azo]-4-methoxyphenyl]-",CC(=O)NC1=CC(=C(C=C1N=NC2=C(C=C(C=C2Br)[N+](=O)[O-])[N+](=O)[O-])OC)N(CC3=CC=CC=C3)CC4=CC=CC=C4,,,,,,
709,90710,"Phosphorothioic acid, O,O-dimethyl S-(N-methyl O',O'-diisopropylphosphoramido)ethyl ester",CC(C)OP(=O)(N(C)CCSP(=O)(OC)OC)OC(C)C,,,,,,
710,90711,5-Nitro-2-furoyl chloride,C1=C(OC(=C1)[N+](=O)[O-])C(=O)Cl,,,,,,
711,90712,"Dipotassium 4,4'-(hexafluoroisopropylidene)bisphenoxide",C1=CC(=CC=C1C(C2=CC=C(C=C2)[O-])(C(F)(F)F)C(F)(F)F)[O-].[K+].[K+],,,,,,
712,90713,"Phosphinic acid, tert-butyl(p-tert-butylphenyl)-",CC(C)(C)C1=CC=C(C=C1)P(=O)(C(C)(C)C)O,,,,,,
713,90714,Triisooctyl phosphite,CC(C)CCCCCOP(OCCCCCC(C)C)OCCCCCC(C)C,,,,,,
714,90715,Triisooctyl phosphate,CC(C)CCCCCOP(=O)(OCCCCCC(C)C)OCCCCCC(C)C,,,,,,
715,90716,6-Methylheptanoic acid,CC(C)CCCCC(=O)O,,,,,,
716,90717,CID 90717,C1=CC=NC(=C1)C(=O)[O-].[K+],,,,,,
717,90718,1-Bromo-4-cyclohexylbenzene,C1CCC(CC1)C2=CC=C(C=C2)Br,,,,,,
718,90719,[2-(Hydroxymethyl)-2-(octadec-9-enoyloxymethyl)butyl] octadec-9-enoate,CCCCCCCCC=CCCCCCCCC(=O)OCC(CC)(CO)COC(=O)CCCCCCCC=CCCCCCCCC,,,,,,
719,90720,"3-Buten-2-ol, 4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, 2-acetate",CC1=C(C(CCC1)(C)C)C=CC(C)OC(=O)C,,,,,,
720,90721,Einecs 244-755-6,CC(C(=O)N1CCCC1C(=O)N2CCCC2C(=O)O)N,,,,,,
721,90722,2-(3-Methyl)guanidinoethanethiol hydrogen sulfate (ester),CN=C(N)NCCSS(=O)(=O)O,,,,,,
722,90723,2-(3-Ethyl)guanidinoethanethiol hydrogen sulfate (ester),CCNC(=NCCSS(=O)(=O)O)N,,,,,,
723,90724,2-[[N'-(2-sulfosulfanylethyl)carbamimidoyl]amino]propane,CC(C)NC(=NCCSS(=O)(=O)O)N,,,,,,
724,90725,Tetrahydrothiopyran-3-ol,C1CC(CSC1)O,,,,,,
725,90726,4-Chloro-2-(chlorophenylmethylene)butyraldehyde,C1=CC=C(C=C1)C(=C(CCCl)C=O)Cl,,,,,,
726,90727,2-Ethylvaleraldehyde,CCCC(CC)C=O,,,,,,
727,90728,2-Acetoxypropanal,CC(C=O)OC(=O)C,,,,,,
728,90729,1-(Furan-2-yl)ethanamine,CC(C1=CC=CO1)N,,,,,,
729,90730,2-[Hydroxy(diphenyl)methyl]butanenitrile,CCC(C#N)C(C1=CC=CC=C1)(C2=CC=CC=C2)O,,,,,,
730,90731,alpha-[1-(Aminomethyl)propyl]benzhydryl alcohol,CCC(CN)C(C1=CC=CC=C1)(C2=CC=CC=C2)O,,,,,,
731,90732,4-Dimethylamino-3-methyl-2-butanone,CC(CN(C)C)C(=O)C,,,,,,
732,90733,2-Dodecen-1-ol,CCCCCCCCCC=CCO,,,,,,
733,90734,2-Bromobutyryl chloride,CCC(C(=O)Cl)Br,,,,,,
734,90735,"2-Butyl-2-methyl-1,3-propanediol allylcarbamate carbamate",CCCCC(C)(COC(=O)N)COC(=O)NCC=C,,,,,,
735,90736,"2-(1-Methylbutyl)-1,3-propanediol",CCCC(C)C(CO)CO,,,,,,
736,90737,"Hydantoin, 5,5'-(dithiodimethylene)bis(3-phenyl-",C1=CC=C(C=C1)C2C(=O)N(C(=O)N2)SCCSC3C(=O)N(C(=O)N3)C4=CC=CC=C4,,,,,,
737,90738,"Hydantoin, 3,3'-diphenyl-5,5'-thiodimethylene-",C1=CC=C(C=C1)C2C(=O)N(C(=O)N2)CSCC3C(=O)N(C(=O)N3)C4=CC=CC=C4,,,,,,
738,90739,1-(4-Bromophenyl)butan-1-ol,CCCC(C1=CC=C(C=C1)Br)O,,,,,,
739,90740,"5-[(2,5-Dioxo-1-phenylimidazolidin-4-yl)methylsulfanylmethylsulfanylmethyl]-3-phenylimidazolidine-2,4-dione",C1=CC=C(C=C1)N2C(=O)C(NC2=O)CSCSCC3C(=O)N(C(=O)N3)C4=CC=CC=C4,,,,,,
740,90741,2-Phenylbutan-2-amine,CCC(C)(C1=CC=CC=C1)N,,,,,,
741,90742,13-{2-[2-(Dimethylamino)ethoxy]-2-oxoethylidene}-14-methyl-7-oxopodocarpan-3-yl 3-hydroxy-3-methylbutanoate--hydrogen chloride (1/1),CC1C2C(CCC1=CC(=O)OCCN(C)C)C3(CCC(C(C3CC2=O)(C)C)OC(=O)CC(C)(C)O)C.Cl,,,,,,
742,90743,"[7-[2-[2-(Dimethylamino)ethoxy]-2-oxoethylidene]-1,1,4a,8-tetramethyl-9-oxo-2,3,4,4b,5,6,8,8a,10,10a-decahydrophenanthren-2-yl] 3-hydroxy-3-methylbutanoate",CC1C2C(CCC1=CC(=O)OCCN(C)C)C3(CCC(C(C3CC2=O)(C)C)OC(=O)CC(C)(C)O)C,,,,,,
743,90744,"1,1,2,2,3,4,4,5,6-Nonafluorocyclohexane",C1(C(C(C(C(C1(F)F)F)(F)F)(F)F)F)F,,,,,,
744,90745,Pyrrolidonyl-beta-naphthylamide,C1CC(=O)NC1C(=O)NC2=CC3=CC=CC=C3C=C2,,,,,,
745,90746,"1H-Isoindole-1,3(2H)-dione, 2-(1,2-dichloroethyl)-",C1=CC=C2C(=C1)C(=O)N(C2=O)C(CCl)Cl,,,,,,
746,90747,"1-Benzyl-1,2-dihydro-2-[(4-methoxyphenyl)methyl]-3,4-dimethylpyridine",CC1=C(C(N(C=C1)CC2=CC=CC=C2)CC3=CC=C(C=C3)OC)C,,,,,,
747,90748,"3-Benzyl-1,2,3,4,5,6-hexahydro-6,11-dimethyl-2,6-methano-3-benzazocin-8-ol",CC1C2CC3=C(C1(CCN2CC4=CC=CC=C4)C)C=C(C=C3)O,,,,,,
748,90749,"as-Triazine, 1,4,5,6-tetrahydro-3-(10,11-dihydrodibenzo(a,d)cyclohepten-5-yl)-1-methyl-, hydrobromide",CN1CCN=C(N1)C2C3=CC=CC=C3CCC4=CC=CC=C24.Br,,,,,,
749,90750,"1-methyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenyl)-5,6-dihydro-2H-1,2,4-triazine",CN1CCN=C(N1)C2C3=CC=CC=C3CCC4=CC=CC=C24,,,,,,
750,90751,12-(p-Nitrostyryl)benz(a)acridine,C1=CC=C2C(=C1)C=CC3=NC4=CC=CC=C4C(=C32)C=CC5=CC=C(C=C5)[N+](=O)[O-],,,,,,
751,90752,"1,4,5,6-Tetrahydro-1,5-dimethyl-3-diphenylmethyl-as-triazine",CC1CN(NC(=N1)C(C2=CC=CC=C2)C3=CC=CC=C3)C,,,,,,
752,90753,"as-Triazine, 3-(p-chloro-alpha-phenylbenzyl)-1,4,5,6-tetrahydro-",C1CN=C(NN1)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,,,,,,
753,90754,"3-[(4-Chlorophenyl)(phenyl)methyl]-1-methyl-1,2,5,6-tetrahydro-1,2,4-triazine",CN1CCN=C(N1)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,,,,,,
754,90755,"3-[(4-Chlorophenyl)(phenyl)methyl]-1,5-dimethyl-1,2,5,6-tetrahydro-1,2,4-triazine",CC1CN(NC(=N1)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)C,,,,,,
755,90756,Benzoylprop,CC(C(=O)O)N(C1=CC(=C(C=C1)Cl)Cl)C(=O)C2=CC=CC=C2,,,,,,
756,90757,"(R)-alpha-(Hydroxymethyl)benzeneacetic acid (1beta,5beta)-8-(2-propenyl)-8-azabicyclo[3.2.1]octan-3alpha-yl ester",C=CCN1[C@@H]2CC[C@H]1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,,,,,,
757,90758,"1H-Indene, 1-cyclohexyloctahydro-1,3,3-trimethyl-",CC1(CC(C2C1CCCC2)(C)C3CCCCC3)C,,,,,,
758,90759,3-Hydroxy-2-phenylacrylonitrile,C1=CC=C(C=C1)C(=CO)C#N,,,,,,
759,90760,"N-(4-Chloro-2,5-dimethoxyphenyl)-2-((2-methoxy-4-nitrophenyl)azo)-3-oxobutyramide",CC(=O)C(C(=O)NC1=CC(=C(C=C1OC)Cl)OC)N=NC2=C(C=C(C=C2)[N+](=O)[O-])OC,,,,,,
760,90761,"2,4,4-Trimethylpentan-2-yl 2-ethylhexaneperoxoate",CCCCC(CC)C(=O)OOC(C)(C)CC(C)(C)C,,,,,,
761,90762,CID 90762,C1=CC(=CC=C1C(=CN=O)O)O,,,,,,
762,90763,Apazone dihydrate,CCCC1C(=O)N2C3=C(C=CC(=C3)C)N=C(N2C1=O)N(C)C.O.O,,,"['Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)', 'Gout suppressants that act directly on the renal tubule to increase the excretion of uric acid, thus reducing its concentrations in plasma. (See all compounds classified as Uricosuric Agents.)']",,,
763,90764,"2,3,3,3-Tetrafluoro-2-(pentafluorophenoxy)propionyl fluoride",C1(=C(C(=C(C(=C1F)F)F)F)F)OC(C(=O)F)(C(F)(F)F)F,,,,,,
764,90765,"3-Cinnamyl-8-propionyl-3,8-diazabicyclo(3.2.1)octan-2-one",CCC(=O)N1C2CCC1C(=O)N(C2)CC=CC3=CC=CC=C3,,,,,,
765,90766,p-Methoxymethamphetamine,CC(CC1=CC=C(C=C1)OC)NC,,,,,,
766,90767,alpha-(2-Methylpropylidene)pyridine-2-acetonitrile,CC(C)C=C(C#N)C1=CC=CC=N1,,,,,,
767,90768,"Benzenemethanol, alpha-(ethoxymethyl)-",CCOCC(C1=CC=CC=C1)O,,,,,,
768,90769,2-Methyl-1-phenyl-3-(1-piperidinyl)-1-propanone,CC(CN1CCCCC1)C(=O)C2=CC=CC=C2,,,,,,
769,90770,Dimethyl methoxymethylenemalonate,COC=C(C(=O)OC)C(=O)OC,,,,,,
770,90771,"2,6-Octadien-1-ol, 2,7-dimethyl-, (2E)-",CC(=CCCC=C(C)CO)C,,,,,,
771,90772,"2,5-Dihydro-2,5-dimethoxy-2-methylfuran",CC1(C=CC(O1)OC)OC,,,,,,
772,90773,"2-Methylene-3,5,5-trimethylhexanal",CC(CC(C)(C)C)C(=C)C=O,,,,,,
773,90774,"7-Hydroxy-2,3,7-trimethyloctanal",CC(CCCC(C)(C)O)C(C)C=O,,,,,,
774,90775,2-Ethyl-3-methylpentanoic acid,CCC(C)C(CC)C(=O)O,,,,,,
775,90776,"3,7-Dimethyl-2-methyleneocta-6-enal",CC(CCC=C(C)C)C(=C)C=O,,,,,,
776,90777,"2,3,7-Trimethyloct-6-en-1-ol",CC(CCC=C(C)C)C(C)CO,,,,,,
777,90778,"2,3,7-Trimethyloctanal",CC(C)CCCC(C)C(C)C=O,,,,,,
778,90779,6-Methylhept-5-en-2-one oxime,CC(=CCCC(=NO)C)C,,,,,,
779,90780,[(o-Bromophenoxy)methyl]oxirane,C1C(O1)COC2=CC=CC=C2Br,,,,,,
780,90781,"6-(Hexopyranosyloxy)-3,12-dihydroxy-4,4,7,14-tetramethyl-18-norcholest-24-en-20-yl hexopyranoside",CC1C2C(CC(C3C2(CCC3C(C)(CCC=C(C)C)OC4C(C(C(C(O4)CO)O)O)O)C)O)C5(CCC(C(C5C1OC6C(C(C(C(O6)CO)O)O)O)(C)C)O)C,,,,,,
781,90782,Benzyl-3-cyclohexen-1-ylidenemethyl ether,C1CC(=COCC2=CC=CC=C2)CC=C1,,,,,,
782,90783,CID 90783,CC(=O)OC1CCCC=CCC1,,,,,,
783,90784,"7-Methyl-3-methylideneocta-4,6-dien-2-ol",CC(C(=C)C=CC=C(C)C)O,,,,,,
784,90785,Bulnesol,CC1CCC2=C(CCC(CC12)C(C)(C)O)C,,,,,,
785,90786,"2(3H)-Thiazolethione, 4-phenyl-3-[(phenylmethylene)amino]-",C1=CC=C(C=C1)C=NN2C(=CSC2=S)C3=CC=CC=C3,,,,,,
786,90787,5-Methylheptan-3-one oxime,CCC(C)CC(=NO)CC,,,,,,
787,90788,Glyceric acid 3-(barium phosphate),C(C(C(=O)O)O)OP(=O)([O-])[O-].[Ba+2],,,,,,
788,90789,"1,7-Octadien-3-ol, 2,6-dimethyl-",CC(CCC(C(=C)C)O)C=C,,,,,,
789,90790,"3,7-Dimethyloct-7-ene-1,6-diol",CC(CCC(C(=C)C)O)CCO,,,,,,
790,90791,"3,5,5-Trimethylcyclohex-3-en-1-yl acetate",CC1=CC(CC(C1)OC(=O)C)(C)C,,,,,,
791,90792,1-Bicyclo(2.2.1)hept-5-en-2-yl-1-methylethyl acetate,CC(=O)OC(C)(C)C1CC2CC1C=C2,,,,,,
792,90793,"Ethanone, 2-butoxy-1,2-diphenyl-",CCCCOC(C1=CC=CC=C1)C(=O)C2=CC=CC=C2,,,,,,
793,90794,Benzoin isobutyl ether,CC(C)COC(C1=CC=CC=C1)C(=O)C2=CC=CC=C2,,,,,,
794,90795,"Ethanone, 2-(hexyloxy)-1,2-diphenyl-",CCCCCCOC(C1=CC=CC=C1)C(=O)C2=CC=CC=C2,,,,,,
795,90796,"Benzenamine, 4-[2-(4-aminophenyl)ethenyl]-N,N-dimethyl-",CN(C)C1=CC=C(C=C1)C=CC2=CC=C(C=C2)N,,,,,,
796,90797,2'-(Oxiranylmethoxy)-3-phenylpropiophenon,C1C(O1)COC2=CC=CC=C2C(=O)CCC3=CC=CC=C3,,,,,,
797,90798,"3-(Benzoyloxy)-2,2,4-trimethylpentyl isobutyrate",CC(C)C(C(C)(C)COC(=O)C(C)C)OC(=O)C1=CC=CC=C1,,,,,,
798,90799,2-Bromo-2-nitrobutyl phenylcarbamate,CCC(COC(=O)NC1=CC=CC=C1)([N+](=O)[O-])Br,,,,,,
799,90800,CID 90800,CCCC[Sn]CCCC.CC(C)OC(=O)C=CC(=O)O.CC(C)OC(=O)C=CC(=O)O,,,,,,
800,90801,Bis(2-chloropropyl)sulfide,CC(CSCC(C)Cl)Cl,,,,,,
801,90802,"3-(Methylthio)-1,2-propanediol",CSCC(CO)O,,,,,,
802,90803,"Tetrahydrofuran-3,4-diol",C1C(C(CO1)O)O,,,,,,
803,90804,"Methyl 2-cyano-3-(2,3-dihydro-2-methyl-1H-indol-1-yl)acrylate",CC1CC2=CC=CC=C2N1C=C(C#N)C(=O)OC,,,,,,
804,90805,gamma-Gurjunene,CC1CCC(C=C2C1CCC2C)C(=C)C,,,,,,
805,90806,"Tetrahydro-2,2,6-trimethyl-6-(4-methyl-3-cyclohexen-1-yl)-2H-pyran-3-ol",CC1=CCC(CC1)C2(CCC(C(O2)(C)C)O)C,,,,,,
806,90807,"(S-(R*,R*))-Dihydro-2,2,6-trimethyl-6-(4-methyl-3-cyclohexen-1-yl)-2H-pyran-3(4H)-one",CC1=CCC(CC1)C2(CCC(=O)C(O2)(C)C)C,,,,,,
807,90808,Cholest-5-en-3beta-yl p-chlorobenzoate,CC(C)CCCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC(=O)C5=CC=C(C=C5)Cl)C)C,,,,,,
808,90809,1-Cyanoprop-1-enyl acetate,CC=C(C#N)OC(=O)C,,,,,,
809,90810,"3-Butene-1,2-diol, dinitrate",C=CC(CO[N+](=O)[O-])O[N+](=O)[O-],,,,,,
810,90811,"1-Nonen-3-ol, 3-methyl-",CCCCCCC(C)(C=C)O,,,,,,
811,90812,1-Ethyl-1-methylheptyl acetate,CCCCCCC(C)(CC)OC(=O)C,,,,,,
812,90813,1-(4-Chlorophenyl)-3-(5-chlorothiophen-2-yl)prop-2-en-1-one,C1=CC(=CC=C1C(=O)C=CC2=CC=C(S2)Cl)Cl,,,,,,
813,90814,CID 90814,C1=CC=C2C(=C1)C(=O)C(=C(O2)O)C(CC(=O)C3=CC=C(C=C3)Cl)C4=CC=C(S4)Cl,,,,,,
814,90815,5-Chloromethyl-2-oxazolidinone,C1C(OC(=O)N1)CCl,,,,,,
815,90816,Ethyl 3-(bicyclo(2.2.1)hept-5-en-2-yl)-2-cyanoacrylate,CCOC(=O)C(=CC1CC2CC1C=C2)C#N,,,,,,
816,90817,2-Undecenenitrile,CCCCCCCCC=CC#N,,,,,,
817,90818,2-Tridecenenitrile,CCCCCCCCCCC=CC#N,,,,,,
818,90819,1-O-Pentylglycerol,CCCCCOCC(CO)O,,,,,,
819,90820,"5-Norbornene-2,3-dicarboxylic acid, bis(2-isocyanatoethyl) ester",C1C2C=CC1C(C2C(=O)OCCN=C=O)C(=O)OCCN=C=O,,,,,,
820,90821,1-(2-(alpha-(p-Chlorophenyl)benzylamino)ethyl)-4-(2-pyridyl)piperazine,C1CN(CCN1CCNC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)C4=CC=CC=N4,,,,,,
821,90822,1-(2-(alpha-(p-Chlorophenyl)benzylthio)ethyl)-4-(o-tolyl)piperazine oxalate,CC1=CC=CC=C1N2CCN(CC2)CCSC(C3=CC=CC=C3)C4=CC=C(C=C4)Cl.C(=O)(C(=O)O)O,,,,,,
822,90823,1-[2-[(4-Chlorophenyl)-phenylmethyl]sulfanylethyl]-4-(2-methylphenyl)piperazine,CC1=CC=CC=C1N2CCN(CC2)CCSC(C3=CC=CC=C3)C4=CC=C(C=C4)Cl,,,,,,
823,90824,1-(2-(alpha-(p-Chlorophenyl)benzyloxy)ethyl)-4-(2-hydroxypropyl)piperazine oxalate,CC(CN1CCN(CC1)CCOC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)O.C(=O)(C(=O)O)O,,,,,,
824,90825,1-[4-[2-[(4-Chlorophenyl)-phenylmethoxy]ethyl]piperazin-1-yl]propan-2-ol,CC(CN1CCN(CC1)CCOC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)O,,,,,,
825,90826,1-(2-(alpha-(p-Chlorophenyl)benzyloxy)ethyl)-4-(p-methoxyphenyl)piperazine oxalate,COC1=CC=C(C=C1)N2CCN(CC2)CCOC(C3=CC=CC=C3)C4=CC=C(C=C4)Cl.C(=O)(C(=O)O)O,,,,,,
826,90827,1-[2-[(4-Chlorophenyl)-phenylmethoxy]ethyl]-4-(4-methoxyphenyl)piperazine,COC1=CC=C(C=C1)N2CCN(CC2)CCOC(C3=CC=CC=C3)C4=CC=C(C=C4)Cl,,,,,,
827,90828,1-(2-(alpha-(p-Chlorophenyl)benzyloxy)ethyl)-4-(2-pyrimidyl)piperazine oxalate,C1CN(CCN1CCOC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)C4=NC=CC=N4.C(=O)(C(=O)O)O,,,,,,
828,90829,2-[4-[2-[(4-Chlorophenyl)-phenylmethoxy]ethyl]piperazin-1-yl]pyrimidine,C1CN(CCN1CCOC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)C4=NC=CC=N4,,,,,,
829,90830,"5,9-Methanobenzocycloocten-11-one, 1,2,3,4,5,6,7,8,9,10-decahydro-10-methyl-",CC1C2CCCC(C2=O)C3=C1CCCC3,,,,,,
830,90831,"3-(tert-Butylamino)propane-1,2-diol",CC(C)(C)NCC(CO)O,,,,,,
831,90832,"3,4-Dihydroxy-5-(3-methylbutyl)-2-(3-methyl-1-oxobutyl)-4-(4-methyl-1-oxopentyl)cyclopent-2-en-1-one",CC(C)CCC1C(=O)C(=C(C1(C(=O)CCC(C)C)O)O)C(=O)CC(C)C,,,,,,
832,90833,"3,4-Dihydroxy-4-(1-hydroxy-4-methylpentyl)-2-(3-methylbutanoyl)-5-(3-methylbutyl)cyclopent-2-en-1-one",CC(C)CCC1C(=O)C(=C(C1(C(CCC(C)C)O)O)O)C(=O)CC(C)C,,,,,,
833,90834,2-Octyldodecyl stearate,CCCCCCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC,,,,,,
834,90835,2-Octyldodecyl myristate,CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC,,,,,,
835,90836,2-Octyldodecyl palmitate,CCCCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC,,,,,,
836,90837,2-Octyldodecyl decanoate,CCCCCCCCCCC(CCCCCCCC)COC(=O)CCCCCCCCC,,,,,,
837,90838,Propylene glycol dilaurate,CCCCCCCCCCCC(=O)OCC(C)OC(=O)CCCCCCCCCCC,,,,,,
838,90839,2-Methoxybenzhydryl alcohol,COC1=CC=CC=C1C(C2=CC=CC=C2)O,,,,,,
839,90840,3-Propyloxan-2-one,CCCC1CCCOC1=O,,,,,,
840,90841,Dodecyl 5-oxo-DL-prolinate,CCCCCCCCCCCCOC(=O)C1CCC(=O)N1,,,,,,
841,90842,2-Octyldodecyl octadec-9-enoate,CCCCCCCCCCC(CCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC,,,,,,
842,90843,"Octane, 1-ethoxy-3,7-dimethyl-",CCOCCC(C)CCCC(C)C,,,,,,
843,90844,6-Butyl-6-hydroxydodecan-5-one oxime,CCCCCCC(CCCC)(C(=NO)CCCC)O,,,,,,
844,90845,"8,8-Dichloro-1,4,4-trimethyltricyclo(5.1.0.03,5)octane",CC1(C2C1CC3(C(C2)C3(Cl)Cl)C)C,,,,,,
845,90846,"Methyl 3,3-dimethylbicyclo(2.2.1)heptane-2-propionate",CC1(C2CCC(C2)C1CCC(=O)OC)C,,,,,,
846,90847,3-Cyclohexene-1-propanal,C1CC(CC=C1)CCC=O,,,,,,
847,90848,"2-Butenoic acid, octyl ester",CCCCCCCCOC(=O)C=CC,,,,,,
848,90849,CID 90849,CC(=CCS(=O)(=O)[O-])Cl.[Na+],,,,,,
849,90850,3-Chlorobut-2-ene-1-sulfonic acid,CC(=CCS(=O)(=O)O)Cl,,,,,,
850,90851,4-Acetyl-4-phenyl-1-(p-tolylsulphonyl)piperidine,CC1=CC=C(C=C1)S(=O)(=O)N2CCCC(C2)(C3=CC=CC=C3)C(=O)C,,,,,,
851,90852,"5a,7a,8-Trimethyl-5,5a,5b,6,7,7a,8,9,10,10a,10b,11,12,12a-tetradecahydro-1h-indeno[5,4-f]pyrazolo[1,5-a]quinolin-8-ol",CC12CCC3C(C1CCC2(C)O)CCC4C3(CC=C5N4NC=C5)C,,,,,,
852,90853,"1-(2-Methyl-5-pyrrolidino-2,4-pentadienylidene)pyrrolidinium perchlorate",CC(=CC=CN1CCCC1)C=[N+]2CCCC2.[O-]Cl(=O)(=O)=O,,,,,,
853,90854,"1-(4-Methyl-5-pyrrolidin-1-ium-1-ylidenepenta-1,3-dienyl)pyrrolidine",CC(=CC=CN1CCCC1)C=[N+]2CCCC2,,,,,,
854,90855,CID 90855,CC1CCN(CC1)C=CC=CC=[N+]2CCC(CC2)C.CC1CCN(CC1)C=CC=CC=[N+]2CCC(CC2)C.C1=CC=C2C(=C1)C=C(C(=C2CC3=C(C(=CC4=CC=CC=C43)C(=O)[O-])O)O)C(=O)[O-],,,,,,
855,90856,"4-Methyl-1-[5-(4-methylpiperidin-1-ium-1-ylidene)penta-1,3-dienyl]piperidine",CC1CCN(CC1)C=CC=CC=[N+]2CCC(CC2)C,,,,,,
856,90857,"1-(5-Piperidino-2,4-pentadienylidene)piperidinium chloride hydrate",C1CCN(CC1)C=CC=CC=[N+]2CCCCC2.[Cl-],,,,,,
857,90858,"1-(5-Piperidin-1-ium-1-ylidenepenta-1,3-dienyl)piperidine",C1CCN(CC1)C=CC=CC=[N+]2CCCCC2,,,,,,
858,90859,"Piperidinium, 1-(2-methyl-5-(3-methylpiperidino)-2,4-pentadienylidene)-3-methyl-, chloride, hydrate",CC1CCCN(C1)C=CC=C(C)C=[N+]2CCCC(C2)C.[Cl-],,,,,,
859,90860,"3-Methyl-1-[4-methyl-5-(3-methylpiperidin-1-ium-1-ylidene)penta-1,3-dienyl]piperidine",CC1CCCN(C1)C=CC=C(C)C=[N+]2CCCC(C2)C,,,,,,
860,90861,"1-(5-(4-Phenylpiperidino)-2,4-pentadienylidene)-4-phenylpiperidinium chloride",C1CN(CCC1C2=CC=CC=C2)C=CC=CC=[N+]3CCC(CC3)C4=CC=CC=C4.[Cl-],,,,,,
861,90862,"4-Phenyl-1-[5-(4-phenylpiperidin-1-ium-1-ylidene)penta-1,3-dienyl]piperidine",C1CN(CCC1C2=CC=CC=C2)C=CC=CC=[N+]3CCC(CC3)C4=CC=CC=C4,,,,,,
862,90863,"N-((1-Acetyl-1,2,3,4-tetrahydro-6-methyl-2-quinolyl)methyl)-N-isopropylacetamide",CC1=CC2=C(C=C1)N(C(CC2)CN(C(C)C)C(=O)C)C(=O)C,,,,,,
863,90864,"Butan-2-one O,O',O''-(methylsilylidyne)trioxime",CCC(=NO[Si](C)(ON=C(C)CC)ON=C(C)CC)C,,,,,,
864,90865,2-(Aminomethyl)piperidine,C1CCNC(C1)CN,,,,,,
865,90866,"Spiro[2H-1-benzopyran-2,2'-[2H]indol]-6-ol, 1',3'-dihydro-1',3',3'-trimethyl-",CC1(C2=CC=CC=C2N(C13C=CC4=C(O3)C=CC(=C4)O)C)C,,,,,,
866,90867,"1,2,3,4,5,6-Hexahydro-3-methyl-2,6-methano-3-benzazocine hydrochloride",CN1CCC2CC1CC3=CC=CC=C23.Cl,,,,,,
867,90868,"2,6-Methano-3-benzazocine, 1,2,3,4,5,6-hexahydro-3-methyl-",CN1CCC2CC1CC3=CC=CC=C23,,,,,,
868,90869,"Hexadecane, 2-chloro-",CCCCCCCCCCCCCCC(C)Cl,,,,,,
869,90870,1-Bromo-1-phenylpropan-2-one,CC(=O)C(C1=CC=CC=C1)Br,,,,,,
870,90871,"3-Pyrrolinium, 1-(5-(3-pyrrolino)-2,4-pentadienylidene)-, perchlorate",C1C=CCN1C=CC=CC=[N+]2CC=CC2.[O-]Cl(=O)(=O)=O,,,,,,
871,90872,"1-[5-(2,5-Dihydropyrrol-1-ium-1-ylidene)penta-1,3-dienyl]-2,5-dihydropyrrole",C1C=CCN1C=CC=CC=[N+]2CC=CC2,,,,,,
872,90873,"Diethyl 2-methyl-4,5-dioxo-1,3-cyclopentanecarboxylate",CCOC(=O)C1C(C(C(=O)C1=O)C(=O)OCC)C,,,,,,
873,90874,"4-Hydroxy-2,2,6,6-tetramethylpiperidine-4-carbonitrile",CC1(CC(CC(N1)(C)C)(C#N)O)C,,,,,,
874,90875,N-(2-Hydroxypropyl)hexanamide,CCCCCC(=O)NCC(C)O,,,,,,
875,90876,"N,N'-Bis(2,4-dinitrophenyl)-L-cysteine",C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])NC(CSSCC(C(=O)O)NC2=C(C=C(C=C2)[N+](=O)[O-])[N+](=O)[O-])C(=O)O,,,,,,
876,90877,"Ethyl 2,6,6-trimethyl-4-oxocyclohex-2-ene-1-carboxylate",CCOC(=O)C1C(=CC(=O)CC1(C)C)C,,,,,,
877,90878,1-Adamantanecarbonitrile,C1C2CC3CC1CC(C2)(C3)C#N,,,,,,
878,90879,"11-(Nitrooxy)-3,20-dioxopregna-1,4-dien-17-yl propanoate",CCC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O[N+](=O)[O-])C)C(=O)C,,,,,,
879,90880,Piperidin-3-ylmethanamine,C1CC(CNC1)CN,,,,,,
880,90881,"Diisocyanic acid, diester with 4,5-dihexyl-6-(10-hydroxydec-1-enyl)cyclohex-2-ene-1-octanol",CCCCCCC1C=CC(C(C1CCCCCC)C=CCCCCCCCCN=C=O)CCCCCCCCN=C=O,,,,,,
881,90882,"Methyl 3-acetyl-2,5-dihydro-4-hydroxy-5-oxo-2-(2-oxopropyl)-2-furoate",CC(=O)CC1(C(=C(C(=O)O1)O)C(=O)C)C(=O)OC,,,,,,
882,90883,"Ethyl 3-acetyl-2,5-dihydro-4-hydroxy-5-oxo-2-(2-oxopropyl)-2-furoate",CCOC(=O)C1(C(=C(C(=O)O1)O)C(=O)C)CC(=O)C,,,,,,
883,90884,"2,3,5,6-Tetramethyl-1,4-dioxane-2,5-diol",CC1C(OC(C(O1)(C)O)C)(C)O,,,,,,
884,90885,Einecs 245-466-8,C1=CC=C(C=C1)CNC2=CC3=C(C=C2)C4(C5=C(O3)C=C(C=C5)Cl)C6=CC=CC=C6OC4=O,,,,,,
885,90886,"2-[(1E,3E,5E)-7-[3-Ethylbenzothiazole-2(3H)-ylidene]-1,3,5-heptatrienyl]-3-ethylbenzothiazole-3-ium",CCN1C2=CC=CC=C2SC1=CC=CC=CC=CC3=[N+](C4=CC=CC=C4S3)CC,,,,,,
886,90887,"5-((3-Carboxy-5-methyl-4-oxo-2,5-cyclohexadien-1-ylidene)(4-(dimethylamino)phenyl)methyl)-3-methylsalicylic acid",CC1=CC(=CC(=C1O)C(=O)O)C(=C2C=C(C(=O)C(=C2)C(=O)O)C)C3=CC=C(C=C3)N(C)C,,,,,,
887,90888,Einecs 245-498-2,CCC(=CC1=[N+](C2=C(S1)C=CC3=CC=CC=C32)CCCS(=O)(=O)[O-])C=C4N(C5=C(S4)C=CC6=CC=CC=C65)CCCS(=O)(=O)O.CCN(CC)CC,,,,,,
888,90889,"1-(3-Sulfonatopropyl)-2-[2-[1-(3-sulfopropyl)naphtho[1,2-d]thiazole-2(1H)-ylidenemethyl]-1-butenyl]naphtho[1,2-d]thiazole-1-ium",CCC(=CC1=[N+](C2=C(S1)C=CC3=CC=CC=C32)CCCS(=O)(=O)O)C=C4N(C5=C(S4)C=CC6=CC=CC=C65)CCCS(=O)(=O)O,,,,,,
889,90890,Pentachlorophenyl N-(((4-methoxyphenyl)methoxy)carbonyl)-L-serinate,COC1=CC=C(C=C1)COC(=O)NC(CO)C(=O)OC2=C(C(=C(C(=C2Cl)Cl)Cl)Cl)Cl,,,,,,
890,90891,"3-Thiazolidineacetic acid, 5-[(3-ethyl-2(3H)-benzoxazolylidene)ethylidene]-4-oxo-2-thioxo-",CCN1C2=CC=CC=C2OC1=CC=C3C(=O)N(C(=S)S3)CC(=O)O,,,,,,
891,90892,"cis-4,5-Dihydro-2,4,5-trimethyloxazole",CC1C(OC(=N1)C)C,,,,,,
892,90893,"1,1'-Sulfinylbis(1,2-dichloroethane)",C(=C(S(=O)C(=CCl)Cl)Cl)Cl,,,,,,
893,90894,CID 90894,CC(C)C1=CC2=CCC3C(C2CC1)(CCCC3(C)C(=O)[O-])C.[K+],,,,,,
894,90895,"1,4a-Dimethyl-7-propan-2-yl-2,3,4,4b,5,6,10,10a-octahydrophenanthrene-1-carboxylic acid",CC(C)C1=CC2=CCC3C(C2CC1)(CCCC3(C)C(=O)O)C,,,,,,
895,90896,"2(5H)-Furanone, 5-(4-hexen-2-ynylidene)-",CC=CC#CC=C1C=CC(=O)O1,,,,,,
896,90897,Phenyl(piperidin-4-yl)methyl acetate hydrochloride,CC(=O)OC(C1CCNCC1)C2=CC=CC=C2.Cl,,,,,,
897,90898,[Phenyl(piperidin-4-yl)methyl] acetate,CC(=O)OC(C1CCNCC1)C2=CC=CC=C2,,,,,,
898,90899,"3-Buten-2-one, 4-(2,2,6-trimethyl-7-oxabicyclo[4.1.0]hept-1-yl)-",CC(=O)C=CC12C(CCCC1(O2)C)(C)C,,,,,,
899,90900,Mono(1-ethylhexyl) phthalate,CCCCCC(CC)OC(=O)C1=CC=CC=C1C(=O)O,,,,,,
900,90901,"Ethyl 2,3-epoxy-3,7,11-trimethyldodec-10-enoate",CCOC(=O)C1C(O1)(C)CCCC(C)CCC=C(C)C,,,,,,
901,90902,1-(3-Methoxyphenyl)ethanol,CC(C1=CC(=CC=C1)OC)O,,,,,,
902,90903,"Benzenesulfonamide, N-[4-diazo-2-[[(2-ethylphenyl)amino]sulfonyl]-2,5-cyclohexadien-1-ylidene]-4-methyl-",CCC1=CC=CC=C1NS(=O)(=O)C2=CC(=[N+]=[N-])C=CC2=NS(=O)(=O)C3=CC=C(C=C3)C,,,,,,
903,90904,CID 90904,CCC1=CC=CC=C1NS(=O)(=O)C2=C(C=CC(=C2)[N+]#N)NS(=O)(=O)C3=CC=C(C=C3)C,,,,,,
904,90905,Parasiticol,COC1=C2C(=CC(=O)OC2=C3C4C=COC4OC3=C1)CCO,,,,,,
905,90906,3-Chloro-2-methylpropyl(dimethyl)amine,CC(CN(C)C)CCl,,,,,,
906,90907,"4-Thiazolidinone, 3-ethyl-5-((1-ethyl-2(1H)-quinolinylidene)ethylidene)-2-thioxo-",CCN1C(=CC=C2C(=O)N(C(=S)S2)CC)C=CC3=CC=CC=C31,,,,,,
907,90908,Pyrrolidin-2-ylmethanol,C1CC(NC1)CO,,,,,,
908,90909,2-Butoxyethyl 2-(4-chloro-2-methylphenoxy)propionate,CCCCOCCOC(=O)C(C)OC1=C(C=C(C=C1)Cl)C,,,,,,
909,90910,"Ethanone, 1-(2,5,5-trimethylcycloheptyl)-",CC1CCC(CCC1C(=O)C)(C)C,,,,,,
910,90911,Cyclohexen-3-ylglycine,C1CC(CC=C1)C(C(=O)O)N,,,,,,
911,90912,"Benzothiazolium, 5-methyl-2-(2-((5-methyl-3-(3-sulfopropyl)-2(3H)-benzothiazolylidene)methyl)-1-butenyl)-3-(3-sulfopropyl)-, inner salt",CCC(=CC1=[N+](C2=C(S1)C=CC(=C2)C)CCCS(=O)(=O)[O-])C=C3N(C4=C(S3)C=CC(=C4)C)CCCS(=O)(=O)O,,,,,,
912,90913,2-[(E)-2-[5-Methyl-3-(3-sulfopropyl)benzothiazol-2(3H)-ylidenemethyl]-1-butenyl]-5-methyl-3-(3-sulfonatopropyl)benzothiazolium,CCC(=CC1=[N+](C2=C(S1)C=CC(=C2)C)CCCS(=O)(=O)O)C=C3N(C4=C(S3)C=CC(=C4)C)CCCS(=O)(=O)O,,,,,,
913,90914,Einecs 245-616-2,CCC(=CC1=[N+](C2=C(O1)C=CC(=C2)C3=CC=CC=C3)CCCCS(=O)(=O)O)C=C4N(C5=C(O4)C=CC(=C5)C6=CC=CC=C6)CCCCS(=O)(=O)[O-],,,,,,
914,90915,5-Phenyl-2-[2-[[5-phenyl-3-(4-sulfobutyl)benzoxazol-2(3H)-ylidene]methyl]-1-butenyl]-3-(4-sulfobutyl)benzoxazol-3-ium,CCC(=CC1=[N+](C2=C(O1)C=CC(=C2)C3=CC=CC=C3)CCCCS(=O)(=O)O)C=C4N(C5=C(O4)C=CC(=C5)C6=CC=CC=C6)CCCCS(=O)(=O)O,,,,,,
915,90916,"1,3-Diazetidine-2,4-dione, 1,3-bis((5-isocyanato-1,3,3-trimethylcyclohexyl)methyl)-",CC1(CC(CC(C1)(C)CN2C(=O)N(C2=O)CC3(CC(CC(C3)(C)C)N=C=O)C)N=C=O)C,,,,,,
916,90917,"(2-Oxo-1,3-dioxolan-4-yl)methyl chloroformate",C1C(OC(=O)O1)COC(=O)Cl,,,,,,
917,90918,Dicyclohexyl sulfosuccinate,C1CCC(CC1)OC(=O)CC(C(=O)OC2CCCCC2)S(=O)(=O)O,,,,,,
918,90919,4-(1-Hydroxyethyl)pyridine,CC(C1=CC=NC=C1)O,,,,,,
919,90920,Einecs 245-631-4,CC1C2C(CC(O1)OC3CCC4(C(C3)CCC5C4CCC6(C5(CC(C6C7=CC(=O)OC7)OC=O)O)C)C)OC(O2)(C)C,,,,,,
920,90921,3-Ethyl-5-((1-ethylpyrrolidin-2-ylidene)ethylidene)-2-thioxothiazolidin-4-one,CCN1CCCC1=CC=C2C(=O)N(C(=S)S2)CC,,,,,,
921,90922,N-(3-(Dimethoxymethylsilyl)-2-methylpropyl)ethylenediamine,CC(CNCCN)C[Si](C)(OC)OC,,,,,,
922,90923,1-Methylpropyl isobutyrate,CCC(C)OC(=O)C(C)C,,,,,,
923,90924,4-Methyl-4-nonanol,CCCCCC(C)(CCC)O,,,,,,
924,90925,"1H-Imidazo(4,5-b)quinoxalinium, 2-(2-(3,5-dimethyl-1-phenyl-1H-pyrazol-4-yl)ethenyl)-1,3-di-2-propen-1-yl-, iodide (1:1)",CC1=C(C(=NN1C2=CC=CC=C2)C)C=CC3=[N+](C4=NC5=CC=CC=C5N=C4N3CC=C)CC=C.[I-],,,,,,
925,90926,"2-[2-(3,5-Dimethyl-1-phenyl-1H-pyrazol-4-yl)ethenyl]-1,3-di(2-propenyl)-1H-imidazo[4,5-b]quinoxalin-3-ium",CC1=C(C(=NN1C2=CC=CC=C2)C)C=CC3=[N+](C4=NC5=CC=CC=C5N=C4N3CC=C)CC=C,,,,,,
926,90927,"1,3-Octanediol",CCCCCC(CCO)O,,,,,,
927,90928,"1,3-Nonanediol",CCCCCCC(CCO)O,,,,,,
928,90929,1-Chloro-3-(methylthio)propan-2-ol,CSCC(CCl)O,,,,,,
929,90930,Parabolan,CC12C=CC3=C4CCC(=O)C=C4CCC3C1CCC2OC(=O)OCC5CCCCC5,,,,,,
930,90931,"3,20-Dioxopregna-4,9(11),16-trien-21-yl acetate",CC(=O)OCC(=O)C1=CCC2C1(CC=C3C2CCC4=CC(=O)CCC43C)C,,,,,,
931,90932,"3-Chloro-2-(2,4-dichlorophenyl)oxirane-2-carboxamide",C1=CC(=C(C=C1Cl)Cl)C2(C(O2)Cl)C(=O)N,,,,,,
932,90933,3-Chloro-2-(2-chloro-4-methylphenyl)oxirane-2-carboxamide,CC1=CC(=C(C=C1)C2(C(O2)Cl)C(=O)N)Cl,,,,,,
933,90934,"3-Bromo-2-(2,4-dichlorophenyl)oxirane-2-carboxamide",C1=CC(=C(C=C1Cl)Cl)C2(C(O2)Br)C(=O)N,,,,,,
934,90935,3-Chloro-2-(2-chloro-4-fluorophenyl)oxirane-2-carboxamide,C1=CC(=C(C=C1F)Cl)C2(C(O2)Cl)C(=O)N,,,,,,
935,90936,3-Chloro-2-(4-chloro-2-methylphenyl)oxirane-2-carboxamide,CC1=C(C=CC(=C1)Cl)C2(C(O2)Cl)C(=O)N,,,,,,
936,90937,3-Chloro-2-(2-chlorophenyl)oxirane-2-carboxamide,C1=CC=C(C(=C1)C2(C(O2)Cl)C(=O)N)Cl,,,,,,
937,90938,"2-Buteneperoxoic acid, 1,1-dimethylethyl ester",CC=CC(=O)OOC(C)(C)C,,,,,,
938,90939,"4-Chloro-n-methyl-2-(1,2,3,4-tetrahydroisoquinolin-1-yl)aniline",CNC1=C(C=C(C=C1)Cl)C2C3=CC=CC=C3CCN2,,,,,,
939,90940,1-(2-Chloroacetyl)pyrrolidine-2-carboxylic acid,C1CC(N(C1)C(=O)CCl)C(=O)O,,,,,,
940,90941,1-Butanoylpyrrolidine-2-carboxylic acid,CCCC(=O)N1CCCC1C(=O)O,,,,,,
941,90942,Ginger Extract 5%,CCCCCC(CC(=O)CCC1=CC(=C(C=C1)OC)O)O,,,,,"['6-gingerol has known human metabolites that include (2S,3S,4S,5R)-3,4,5-trihydroxy-6-[1-(3-hydroxy-4-methoxyphenyl)-3-oxodecan-5-yl]oxyoxane-2-carboxylic acid and (2S,3S,4S,5R)-3,4,5-trihydroxy-6-[5-(5-hydroxy-3-oxodecyl)-2-methoxyphenoxy]oxane-2-carboxylic acid.']",
942,90943,CID 90943,CCCCCCCCCCOC(=O)CC(C(=O)OCCCCCCCCCC)S(=O)(=O)[O-].[Na+],,,,,,
943,90944,"Butanedioic acid, 2-sulfo-, 1,4-didecyl ester",CCCCCCCCCCOC(=O)CC(C(=O)OCCCCCCCCCC)S(=O)(=O)O,,,,,,
944,90945,CID 90945,CC(C)OC(=O)CC(C(=O)OC(C)C)S(=O)(=O)[O-].[Na+],,,,,,
945,90946,"1,4-Dioxo-1,4-di(propan-2-yloxy)butane-2-sulfonic acid",CC(C)OC(=O)CC(C(=O)OC(C)C)S(=O)(=O)O,,,,,,
946,90947,9-Butyl-9-borabicyclo[3.3.1]nonane,B1(C2CCCC1CCC2)CCCC,,,,,,
947,90948,S-2-((3-Aminopropyl)amino)propyl hydrogen thiosulfate hydrochloride,CC(CSS(=O)(=O)O)NCCCN.Cl,,,,,,
948,90949,2-(3-Aminopropylamino)-1-sulfosulfanylpropane,CC(CSS(=O)(=O)O)NCCCN,,,,,,
949,90950,S-2-((2-Cyanoethyl)amino)propyl hydrogen thiosulfate,CC(CSS(=O)(=O)O)NCCC#N,,,,,,
950,90951,"Benzenamine, 3-methyl-N-(3-((3-methylphenyl)amino)-2-propenylidene)-",CC1=CC(=CC=C1)NC=CC=NC2=CC=CC(=C2)C,,,,,,
951,90952,"20-(Hydroxyimino)pregna-5,16-dien-3-yl acetate",CC(=NO)C1=CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC(=O)C)C)C,,,,,,
952,90953,4-((2-Cyanopropyl)amino)-1-hydroxyanthraquinone,CC(CNC1=C2C(=C(C=C1)O)C(=O)C3=CC=CC=C3C2=O)C#N,,,,,,
953,90954,"alpha,1-Dimethyl-2-nitroimidazole-5-ethanol",CC(CC1=CN=C(N1C)[N+](=O)[O-])O,,,,,,
954,90955,Einecs 245-748-0,CC1COCC(N1CC(C)C(=O)OC)C,,,,,,
955,90956,"1-Octyn-3-ol, 3-methyl-",CCCCCC(C)(C#C)O,,,,,,
956,90957,"3-Pipecolinium, (4,4'-biphenylylenebis(2-oxoethylene))bis(1-methyl-, diiodide",CC1CCC[N+](C1)(C)CC(=O)C2=CC=C(C=C2)C3=CC=C(C=C3)C(=O)C[N+]4(CCCC(C4)C)C.[I-].[I-],,,,,,
957,90958,"2-(1,3-Dimethylpiperidin-1-ium-1-yl)-1-[4-[4-[2-(1,3-dimethylpiperidin-1-ium-1-yl)acetyl]phenyl]phenyl]ethanone",CC1CCC[N+](C1)(C)CC(=O)C2=CC=C(C=C2)C3=CC=C(C=C3)C(=O)C[N+]4(CCCC(C4)C)C,,,,,,
958,90959,"Hexanoic acid, 3,5,5-trimethyl-, lead salt",CC(CC(=O)[O-])CC(C)(C)C.CC(CC(=O)[O-])CC(C)(C)C.[Pb+2],,,,,,
959,90960,"3,5,5-Trimethylhexanoic acid",CC(CC(=O)O)CC(C)(C)C,,,,,,
960,90961,"4-(1H-Imidazol-4-ylmethyl)oxazolidine-2,5-dione",C1=C(NC=N1)CC2C(=O)OC(=O)N2,,,,,,
961,90962,"[6,9-Difluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] butanoate",CCCC(=O)OC1(CCC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C(=O)CO,,,,,,
962,90963,"6,9-Difluoro-11-hydroxy-3,20-dioxopregna-1,4-diene-17,21-diyl diacetate",CC(=O)OCC(=O)C1(CCC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)OC(=O)C,,,,,,
963,90964,"2-Ethoxy-1,2-bis(4-methoxyphenyl)ethanone",CCOC(C1=CC=C(C=C1)OC)C(=O)C2=CC=C(C=C2)OC,,,,,,
964,90965,"(1,3,3,3-Tetrachloropropyl)benzene",C1=CC=C(C=C1)C(CC(Cl)(Cl)Cl)Cl,,,,,,
965,90966,"2-Methoxy-4,5-methylenedioxyamphetamine",CC(CC1=CC2=C(C=C1OC)OCO2)N,,,,,,
966,90967,Methoxymethylenedioxyamphetamine,CC(CC1=C(C2=C(C=C1)OCO2)OC)N,,,,,,
967,90968,"1-(Hydroxymethyl)-4,5-dimethoxyimidazolidin-2-one",COC1C(N(C(=O)N1)CO)OC,,,,,,
968,90969,"(S)-2,2,3-Trimethylcyclopent-3-ene-1-acetaldehyde",CC1=CC[C@H](C1(C)C)CC=O,,,,,,
969,90970,"Butanamide, 2-((4-chloro-2-nitrophenyl)azo)-N-(4-methoxyphenyl)-3-oxo-",CC(=O)C(C(=O)NC1=CC=C(C=C1)OC)N=NC2=C(C=C(C=C2)Cl)[N+](=O)[O-],,,,,,
970,90971,"7H-2,4a-Methanonaphthalen-7-one, 1,2,3,4,5,6-hexahydro-1,1,5,5-tetramethyl-",CC1(CC(=O)C=C2C13CCC(C3)C2(C)C)C,,,,,,
971,90972,Ethyl 2-(methyldithio)propionate,CCOC(=O)C(C)SSC,,,,,,
972,90973,"3-Phenethyl-2,3,4,4a,5,6-hexahydro-1H-pyrazino(1,2-a)quinoline hydrochloride",C1CC2=CC=CC=C2N3C1CN(CC3)CCC4=CC=CC=C4.Cl,,,,,,
973,90974,"3-(2-Phenylethyl)-1,2,4,4a,5,6-hexahydropyrazino[1,2-a]quinoline",C1CC2=CC=CC=C2N3C1CN(CC3)CCC4=CC=CC=C4,,,,,,
974,90975,"Quinoline, 1,2,3,4-tetrahydro-2-((N-(2-hydroxyethyl)-N-phenethylamino)methyl)-",C1CC2=CC=CC=C2NC1CN(CCC3=CC=CC=C3)CCO,,,,,,
975,90976,"Quinoline, 1,2,3,4-tetrahydro-2-((phenethylamino)methyl)-",C1CC2=CC=CC=C2NC1CNCCC3=CC=CC=C3,,,,,,
976,90977,"2-Methyl-2-propyl-1,3-propanediol butylcarbamate",CCCCNC(=O)OCC(C)(CCC)CO,,,,,,
977,90978,Isolongifolanone,CC1(CCC(=O)C2C13CCC(C3)C2(C)C)C,,,,,,
978,90979,"2-Pentene-1,5-dione, 1,3,5-triphenyl-",C1=CC=C(C=C1)C(=CC(=O)C2=CC=CC=C2)CC(=O)C3=CC=CC=C3,,,,,,
979,90980,"Benzenesulfonic acid, 5-methoxy-4-((2-((2-methoxy-5-methyl-4-((2-(sulfooxy)ethyl)sulfonyl)phenyl)azo)-1,3-dioxobutyl)amino)-2-methyl-",CC1=CC(=C(C=C1S(=O)(=O)O)OC)NC(=O)C(C(=O)C)N=NC2=C(C=C(C(=C2)C)S(=O)(=O)CCOS(=O)(=O)O)OC,,,,,,
980,90981,"16,18-Dihydroxy-17-methoxy-1-methyl-13-oxapentacyclo[10.6.1.02,10.05,9.015,19]nonadeca-2(10),3,5(9),12(19),14-pentaene-6,11-dione",CC12C(C(C(C3=COC(=C31)C(=O)C4=C2C=CC5=C4CCC5=O)O)OC)O,,,,,,
981,90982,2-((3-Aminopropyl)amino)propanethiol dihydrochloride,CC(CS)NCCCN.Cl.Cl,,,,,,
982,90983,2-(3-Aminopropylamino)propane-1-thiol,CC(CS)NCCCN,,,,,,
983,90984,2-Mercaptopinane,CC1(C2CCC(C1C2)(C)S)C,,,,,,
984,90985,Cholest-5-en-3beta-yl p-nitrobenzoate,CC(C)CCCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC(=O)C5=CC=C(C=C5)[N+](=O)[O-])C)C,,,,,,
985,90986,"5-Hexynoic acid, 2-amino-4-methyl-",CC(CC(C(=O)O)N)C#C,,,,,,
986,90987,"1,2-Benzenedicarboxylic acid, 4-[(3-aminophenyl)hydroxymethyl]-, 1-methyl ester",COC(=O)C1=C(C=C(C=C1)C(C2=CC(=CC=C2)N)O)C(=O)O,,,,,,
987,90988,Dichlorprop-methyl,CC(C(=O)OC)OC1=C(C=C(C=C1)Cl)Cl,,,,,,
988,90989,"1,1a,2,5,6,6a,7,7a-octahydro-1,1,6,6a-tetramethyl-4H-cyclopropa[b]naphthalen-4-one",CC1CC(=O)C=C2C1(CC3C(C2)C3(C)C)C,,,,,,
989,90990,Isobutyloxirane,CC(C)CC1CO1,,,,,,
990,90991,CID 90991,CCCCC(CC)C(=O)O.CCCCC(CC)C(=O)O.CCCCC(CC)C(=O)O.CCCC[SnH],,,,,,
991,90992,"5,6-Dihydro-4,4,6-trimethyl-2-vinyl-4H-1,3-oxazine",CC1CC(N=C(O1)C=C)(C)C,,,,,,
992,90993,Rolicyprine,C1CC(=O)NC1C(=O)NC2CC2C3=CC=CC=C3,,,,,,
993,90994,1-(2-(alpha-(p-Chlorophenyl)benzylamino)ethyl)-4-(2-thiazolyl)piperazine,C1CN(CCN1CCNC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)C4=NC=CS4,,,,,,
994,90995,4-(2-(N-(alpha-(p-Chlorophenyl)benzyl)-N-methylamino)ethyl)morpholine,CN(CCN1CCOCC1)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,,,,,,
995,90996,1-(2-(alpha-(p-Chlorophenyl)benzylamino)ethyl)piperidine,C1CCN(CC1)CCNC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,,,,,,
996,90997,"1-(2-(1,2-Diphenylethylamino)ethyl)-4-methylpiperazine",CN1CCN(CC1)CCNC(CC2=CC=CC=C2)C3=CC=CC=C3,,,,,,
997,90998,"1-(2-(1,2-Diphenylethylamino)ethyl)-4-(m-methylbenzyl)piperazine",CC1=CC(=CC=C1)CN2CCN(CC2)CCNC(CC3=CC=CC=C3)C4=CC=CC=C4,,,,,,
998,90999,"1-(2-(1,2-Diphenylethylamino)ethyl)-4-(p-methoxyphenyl)piperazine",COC1=CC=C(C=C1)N2CCN(CC2)CCNC(CC3=CC=CC=C3)C4=CC=CC=C4,,,,,,
999,91000,"1-(2-(1,2-Diphenylethylamino)ethyl)-4-(2-pyridyl)piperazine",C1CN(CCN1CCNC(CC2=CC=CC=C2)C3=CC=CC=C3)C4=CC=CC=N4,,,,,,
1000,91001,"1-(2-(1,2-Diphenylethylamino)ethyl)-4-(2-thiazolyl)piperazine",C1CN(CCN1CCNC(CC2=CC=CC=C2)C3=CC=CC=C3)C4=NC=CS4,,,,,,
1001,91002,1-(2-(alpha-(p-Chlorophenyl)benzylthio)ethyl)-4-phenylpiperazine oxalate,C1CN(CCN1CCSC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)C4=CC=CC=C4.C(=O)(C(=O)O)O,,,,,,
1002,91003,1-[2-[(4-Chlorophenyl)-phenylmethyl]sulfanylethyl]-4-phenylpiperazine,C1CN(CCN1CCSC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)C4=CC=CC=C4,,,,,,
1003,91004,"5,6-Dibromohexahydro-2-benzofuran-1,3-dione",C1C2C(CC(C1Br)Br)C(=O)OC2=O,,,,,,
1004,91005,1-(3-(p-Chlorophenyl)-3-phenylpropyl)-4-phenethylpiperazine dihydrochloride,C1CN(CCN1CCC2=CC=CC=C2)CCC(C3=CC=CC=C3)C4=CC=C(C=C4)Cl.Cl.Cl,,,,,,
1005,91006,1-[3-(4-Chlorophenyl)-3-phenylpropyl]-4-(2-phenylethyl)piperazine,C1CN(CCN1CCC2=CC=CC=C2)CCC(C3=CC=CC=C3)C4=CC=C(C=C4)Cl,,,,,,
1006,91007,CID 91007,CC1=CC=C(C=C1)N2CCN(CC2)CCC(C3=CC=CC=C3)C4=CC=C(C=C4)Cl.C(=CC(=O)O)C(=O)O,,,,,,
1007,91008,1-[3-(4-Chlorophenyl)-3-phenylpropyl]-4-(4-methylphenyl)piperazine,CC1=CC=C(C=C1)N2CCN(CC2)CCC(C3=CC=CC=C3)C4=CC=C(C=C4)Cl,,,,,,
1008,91009,1-(p-Chlorophenyl)-4-(2-(alpha-(p-chlorophenyl)benzyloxy)ethyl)piperazine oxalate,C1CN(CCN1CCOC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)C4=CC=C(C=C4)Cl.C(=O)(C(=O)O)O,,,,,,
1009,91010,1-(4-Chlorophenyl)-4-[2-[(4-chlorophenyl)-phenylmethoxy]ethyl]piperazine,C1CN(CCN1CCOC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)C4=CC=C(C=C4)Cl,,,,,,
1010,91011,1-(2-(alpha-(p-Chlorophenyl)benzyloxy)ethyl)-4-(o-methoxyphenyl)piperazine oxalate,COC1=CC=CC=C1N2CCN(CC2)CCOC(C3=CC=CC=C3)C4=CC=C(C=C4)Cl.C(=O)(C(=O)O)O,,,,,,
1011,91012,1-[2-[(4-Chlorophenyl)-phenylmethoxy]ethyl]-4-(2-methoxyphenyl)piperazine,COC1=CC=CC=C1N2CCN(CC2)CCOC(C3=CC=CC=C3)C4=CC=C(C=C4)Cl,,,,,,
1012,91013,1-(2-(alpha-(p-Chlorophenyl)benzyloxy)ethyl)-4-(o-tolyl)piperazine oxalate,CC1=CC=CC=C1N2CCN(CC2)CCOC(C3=CC=CC=C3)C4=CC=C(C=C4)Cl.C(=O)(C(=O)O)O,,,,,,
1013,91014,1-[2-[(4-Chlorophenyl)-phenylmethoxy]ethyl]-4-(2-methylphenyl)piperazine,CC1=CC=CC=C1N2CCN(CC2)CCOC(C3=CC=CC=C3)C4=CC=C(C=C4)Cl,,,,,,
1014,91015,1-(2-(alpha-(p-Chlorophenyl)benzyloxy)ethyl)-4-(m-tolyl)piperazine oxalate,CC1=CC(=CC=C1)N2CCN(CC2)CCOC(C3=CC=CC=C3)C4=CC=C(C=C4)Cl.C(=O)(C(=O)O)O,,,,,,
1015,91016,1-[2-[(4-Chlorophenyl)-phenylmethoxy]ethyl]-4-(3-methylphenyl)piperazine,CC1=CC(=CC=C1)N2CCN(CC2)CCOC(C3=CC=CC=C3)C4=CC=C(C=C4)Cl,,,,,,
1016,91017,1-(4-(alpha-(p-Chlorophenyl)benzyloxy)butyl)-4-phenethylpiperazine dihydrochloride,C1CN(CCN1CCCCOC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)CCC4=CC=CC=C4.Cl.Cl,,,,,,
1017,91018,1-[4-[(4-Chlorophenyl)-phenylmethoxy]butyl]-4-(2-phenylethyl)piperazine,C1CN(CCN1CCCCOC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)CCC4=CC=CC=C4,,,,,,
1018,91019,1-(4-(alpha-(p-Chlorophenyl)benzyloxy)butyl)-4-phenylpiperazine oxalate,C1CN(CCN1CCCCOC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)C4=CC=CC=C4.C(=O)(C(=O)O)O,,,,,,
1019,91020,1-[4-[(4-Chlorophenyl)-phenylmethoxy]butyl]-4-phenylpiperazine,C1CN(CCN1CCCCOC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)C4=CC=CC=C4,,,,,,
1020,91021,1-(o-Chlorophenyl)-4-(4-(alpha-(p-chlorophenyl)benzyloxy)butyl)piperazine oxalate,C1CN(CCN1CCCCOC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)C4=CC=CC=C4Cl.C(=O)(C(=O)O)O,,,,,,
1021,91022,1-(2-Chlorophenyl)-4-[4-[(4-chlorophenyl)-phenylmethoxy]butyl]piperazine,C1CN(CCN1CCCCOC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)C4=CC=CC=C4Cl,,,,,,
1022,91023,1-(4-(alpha-(p-Chlorophenyl)benzyloxy)butyl)-4-(o-methoxyphenyl)piperazine oxalate,COC1=CC=CC=C1N2CCN(CC2)CCCCOC(C3=CC=CC=C3)C4=CC=C(C=C4)Cl.C(=O)(C(=O)O)O,,,,,,
1023,91024,1-[4-[(4-Chlorophenyl)-phenylmethoxy]butyl]-4-(2-methoxyphenyl)piperazine,COC1=CC=CC=C1N2CCN(CC2)CCCCOC(C3=CC=CC=C3)C4=CC=C(C=C4)Cl,,,,,,
1024,91025,1-(4-(alpha-(p-Chlorophenyl)benzyloxy)butyl)-4-(p-methoxyphenyl)piperazine oxalate,COC1=CC=C(C=C1)N2CCN(CC2)CCCCOC(C3=CC=CC=C3)C4=CC=C(C=C4)Cl.C(=O)(C(=O)O)O,,,,,,
1025,91026,1-[4-[(4-Chlorophenyl)-phenylmethoxy]butyl]-4-(4-methoxyphenyl)piperazine,COC1=CC=C(C=C1)N2CCN(CC2)CCCCOC(C3=CC=CC=C3)C4=CC=C(C=C4)Cl,,,,,,
1026,91027,1-(4-(alpha-(p-Chlorophenyl)benzyloxy)butyl)-4-(o-tolyl)piperazine oxalate,CC1=CC=CC=C1N2CCN(CC2)CCCCOC(C3=CC=CC=C3)C4=CC=C(C=C4)Cl.C(=O)(C(=O)O)O,,,,,,
1027,91028,1-[4-[(4-Chlorophenyl)-phenylmethoxy]butyl]-4-(2-methylphenyl)piperazine,CC1=CC=CC=C1N2CCN(CC2)CCCCOC(C3=CC=CC=C3)C4=CC=C(C=C4)Cl,,,,,,
1028,91029,1-(4-(alpha-(p-Chlorophenyl)benzyloxy)butyl)-4-(m-tolyl)piperazine oxalate,CC1=CC(=CC=C1)N2CCN(CC2)CCCCOC(C3=CC=CC=C3)C4=CC=C(C=C4)Cl.C(=O)(C(=O)O)O,,,,,,
1029,91030,1-[4-[(4-Chlorophenyl)-phenylmethoxy]butyl]-4-(3-methylphenyl)piperazine,CC1=CC(=CC=C1)N2CCN(CC2)CCCCOC(C3=CC=CC=C3)C4=CC=C(C=C4)Cl,,,,,,
1030,91031,1-(4-(alpha-(p-Chlorophenyl)benzyloxy)butyl)-4-(2-pyridyl)piperazine oxalate,C1CN(CCN1CCCCOC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)C4=CC=CC=N4.C(=O)(C(=O)O)O,,,,,,
1031,91032,1-[4-[(4-Chlorophenyl)-phenylmethoxy]butyl]-4-pyridin-2-ylpiperazine,C1CN(CCN1CCCCOC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)C4=CC=CC=N4,,,,,,
1032,91033,1-(4-(alpha-(p-Chlorophenyl)benzyloxy)butyl)-4-(2-thiazolyl)piperazine oxalate,C1CN(CCN1CCCCOC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)C4=NC=CS4.C(=O)(C(=O)O)O,,,,,,
1033,91034,"2-[4-[4-[(4-Chlorophenyl)-phenylmethoxy]butyl]piperazin-1-yl]-1,3-thiazole",C1CN(CCN1CCCCOC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)C4=NC=CS4,,,,,,
1034,91035,1-(2-(alpha-(p-Chlorophenyl)benzylthio)ethyl)-4-(2-hydroxypropyl)piperazine dioxalate,CC(CN1CCN(CC1)CCSC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)O.C(=O)(C(=O)O)O.C(=O)(C(=O)O)O,,,,,,
1035,91036,1-[4-[2-[(4-Chlorophenyl)-phenylmethyl]sulfanylethyl]piperazin-1-yl]propan-2-ol,CC(CN1CCN(CC1)CCSC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)O,,,,,,
1036,91037,1-(o-Chlorophenyl)-4-(2-(alpha-(p-chlorophenyl)benzylthio)ethyl)piperazine oxalate,C1CN(CCN1CCSC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)C4=CC=CC=C4Cl.C(=O)(C(=O)O)O,,,,,,
1037,91038,1-(2-Chlorophenyl)-4-[2-[(4-chlorophenyl)-phenylmethyl]sulfanylethyl]piperazine,C1CN(CCN1CCSC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)C4=CC=CC=C4Cl,,,,,,
1038,91039,1-(2-(alpha-(p-Chlorophenyl)benzylthio)ethyl)-4-(o-methoxyphenyl)piperazine oxalate,COC1=CC=CC=C1N2CCN(CC2)CCSC(C3=CC=CC=C3)C4=CC=C(C=C4)Cl.C(=O)(C(=O)O)O,,,,,,
1039,91040,1-[2-[(4-Chlorophenyl)-phenylmethyl]sulfanylethyl]-4-(2-methoxyphenyl)piperazine,COC1=CC=CC=C1N2CCN(CC2)CCSC(C3=CC=CC=C3)C4=CC=C(C=C4)Cl,,,,,,
1040,91041,1-(2-(alpha-(p-Chlorophenyl)benzylthio)ethyl)-4-(p-methoxyphenyl)piperazine oxalate,COC1=CC=C(C=C1)N2CCN(CC2)CCSC(C3=CC=CC=C3)C4=CC=C(C=C4)Cl.C(=O)(C(=O)O)O,,,,,,
1041,91042,1-[2-[(4-Chlorophenyl)-phenylmethyl]sulfanylethyl]-4-(4-methoxyphenyl)piperazine,COC1=CC=C(C=C1)N2CCN(CC2)CCSC(C3=CC=CC=C3)C4=CC=C(C=C4)Cl,,,,,,
1042,91043,1-(2-(alpha-(p-Chlorophenyl)benzylthio)ethyl)-4-(m-tolyl)piperazine oxalate,CC1=CC(=CC=C1)N2CCN(CC2)CCSC(C3=CC=CC=C3)C4=CC=C(C=C4)Cl.C(=O)(C(=O)O)O,,,,,,
1043,91044,1-[2-[(4-Chlorophenyl)-phenylmethyl]sulfanylethyl]-4-(3-methylphenyl)piperazine,CC1=CC(=CC=C1)N2CCN(CC2)CCSC(C3=CC=CC=C3)C4=CC=C(C=C4)Cl,,,,,,
1044,91045,1-(2-(alpha-(p-Chlorophenyl)benzylthio)ethyl)-4-(p-tolyl)piperazine oxalate,CC1=CC=C(C=C1)N2CCN(CC2)CCSC(C3=CC=CC=C3)C4=CC=C(C=C4)Cl.C(=O)(C(=O)O)O,,,,,,
1045,91046,1-[2-[(4-Chlorophenyl)-phenylmethyl]sulfanylethyl]-4-(4-methylphenyl)piperazine,CC1=CC=C(C=C1)N2CCN(CC2)CCSC(C3=CC=CC=C3)C4=CC=C(C=C4)Cl,,,,,,
1046,91047,1-(2-(alpha-(p-Chlorophenyl)benzylthio)ethyl)-4-(2-pyridyl)piperazine oxalate,C1CN(CCN1CCSC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)C4=CC=CC=N4.C(=O)(C(=O)O)O,,,,,,
1047,91048,1-[2-[(4-Chlorophenyl)-phenylmethyl]sulfanylethyl]-4-pyridin-2-ylpiperazine,C1CN(CCN1CCSC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)C4=CC=CC=N4,,,,,,
1048,91049,1-(2-(alpha-(p-Chlorophenyl)benzylthio)ethyl)-4-(2-thiazolyl)piperazine oxalate,C1CN(CCN1CCSC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)C4=NC=CS4.C(=O)(C(=O)O)O,,,,,,
1049,91050,"2-[4-[2-[(4-Chlorophenyl)-phenylmethyl]sulfanylethyl]piperazin-1-yl]-1,3-thiazole",C1CN(CCN1CCSC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)C4=NC=CS4,,,,,,
1050,91051,1-(2-(alpha-(p-Chlorophenyl)benzylamino)ethyl)-4-(2-(2-hydroxyethoxy)ethyl)piperazine,C1CN(CCN1CCNC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)CCOCCO,,,,,,
1051,91052,CID 91052,CN(CCN1CCN(CC1)CC2=CC=CC=C2)C(C3=CC=CC=C3)C4=CC=C(C=C4)Cl.C(=CC(=O)O)C(=O)O.C(=CC(=O)O)C(=O)O,,,,,,
1052,91053,2-(4-benzylpiperazin-1-yl)-N-[(4-chlorophenyl)-phenylmethyl]-N-methylethanamine,CN(CCN1CCN(CC1)CC2=CC=CC=C2)C(C3=CC=CC=C3)C4=CC=C(C=C4)Cl,,,,,,
1053,91054,1-(2-(alpha-(p-Chlorophenyl)benzylamino)ethyl)-4-(m-methylbenzyl)piperazine,CC1=CC(=CC=C1)CN2CCN(CC2)CCNC(C3=CC=CC=C3)C4=CC=C(C=C4)Cl,,,,,,
1054,91055,"1-(2-(1,2-Diphenylethylamino)ethyl)-4-(o-methoxyphenyl)piperazine hydrochloride",COC1=CC=CC=C1N2CCN(CC2)CCNC(CC3=CC=CC=C3)C4=CC=CC=C4.Cl,,,,,,
1055,91056,"N-[2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-1,2-diphenylethanamine",COC1=CC=CC=C1N2CCN(CC2)CCNC(CC3=CC=CC=C3)C4=CC=CC=C4,,,,,,
1056,91057,"1-Benzyl-1,2,5,6-tetrahydro-2-[(4-methoxyphenyl)methyl]-3,4-dimethylpyridine",CC1=C(C(N(CC1)CC2=CC=CC=C2)CC3=CC=C(C=C3)OC)C,,,,,,
1057,91058,2-Butenyl acrylate,CC=CCOC(=O)C=C,,,,,,
1058,91059,1-(o-Chlorophenyl)-4-(2-(alpha-(p-chlorophenyl)benzyloxy)ethyl)piperazine oxalate,C1CN(CCN1CCOC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)C4=CC=CC=C4Cl.C(=O)(C(=O)O)O,,,,,,
1059,91060,1-(2-Chlorophenyl)-4-[2-[(4-chlorophenyl)-phenylmethoxy]ethyl]piperazine,C1CN(CCN1CCOC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)C4=CC=CC=C4Cl,,,,,,
1060,91061,Alphadolone acetate,CC(=O)OCC(=O)C1CCC2C1(CC(=O)C3C2CCC4C3(CCC(C4)O)C)C,,,"['Agents capable of inducing a total or partial loss of sensation, especially tactile sensation and pain. They may act to induce general ANESTHESIA, in which an unconscious state is achieved, or may act locally to induce numbness or lack of sensation at a targeted site. (See all compounds classified as Anesthetics.)', 'Endogenous compounds or drugs that affect neuronal excitability through modulation of specific ionotropic receptors (e.g., GABA-A RECEPTORS). Endogenous neurosteroids are steroid hormones de novo synthesized by neurons and glial cells from steroid metabolite precursors (e.g., PREGNENOLONE). (See all compounds classified as Neurosteroids.)']",,,
1061,91062,CID 91062,CN1CCN(CC1)CCNC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl.C(=CC(=O)O)C(=O)O.C(=CC(=O)O)C(=O)O.C(=CC(=O)O)C(=O)O,,,,,,
1062,91063,N-[(4-chlorophenyl)-phenylmethyl]-2-(4-methylpiperazin-1-yl)ethanamine,CN1CCN(CC1)CCNC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,,,,,,
1063,91064,CID 91064,C1CN(CCN1CCNC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)CC4=CC=CC=C4.C(=CC(=O)O)C(=O)O.C(=CC(=O)O)C(=O)O,,,,,,
1064,91065,2-(4-benzylpiperazin-1-yl)-N-[(4-chlorophenyl)-phenylmethyl]ethanamine,C1CN(CCN1CCNC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)CC4=CC=CC=C4,,,,,,
1065,91066,CID 91066,C1CN(CCN1CCC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)C4=NC=CS4.C(=CC(=O)O)C(=O)O,,,,,,
1066,91067,"2-[4-[3-(4-Chlorophenyl)-3-phenylpropyl]piperazin-1-yl]-1,3-thiazole",C1CN(CCN1CCC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)C4=NC=CS4,,,,,,
1067,91068,CID 91068,C1CN(CCN1CCOC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)C4=CC=CC=C4.C(=CC(=O)O)C(=O)O,,,,,,
1068,91069,1-[2-[(4-Chlorophenyl)-phenylmethoxy]ethyl]-4-phenylpiperazine,C1CN(CCN1CCOC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)C4=CC=CC=C4,,,,,,
1069,91070,CID 91070,C1CN(CCN1CCOC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)C4=CC=CC=N4.C(=CC(=O)O)C(=O)O,,,,,,
1070,91071,1-[2-[(4-Chlorophenyl)-phenylmethoxy]ethyl]-4-pyridin-2-ylpiperazine,C1CN(CCN1CCOC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)C4=CC=CC=N4,,,,,,
1071,91072,CID 91072,CC(CN1CCN(CC1)CCCCOC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)O.C(=CC(=O)O)C(=O)O.C(=CC(=O)O)C(=O)O,,,,,,
1072,91073,1-[4-[4-[(4-Chlorophenyl)-phenylmethoxy]butyl]piperazin-1-yl]propan-2-ol,CC(CN1CCN(CC1)CCCCOC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)O,,,,,,
1073,91074,CID 91074,C1CN(CCN1CCCCOC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)CC4=CC=CC=C4.C(=CC(=O)O)C(=O)O,,,,,,
1074,91075,1-Benzyl-4-[4-[(4-chlorophenyl)-phenylmethoxy]butyl]piperazine,C1CN(CCN1CCCCOC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)CC4=CC=CC=C4,,,,,,
1075,91076,CID 91076,CC(C)(C)C1=CC=C(C=C1)CN2CCN(CC2)CCCCOC(C3=CC=CC=C3)C4=CC=C(C=C4)Cl.C(=CC(=O)O)C(=O)O.C(=CC(=O)O)C(=O)O,,,,,,
1076,91077,1-[(4-Tert-butylphenyl)methyl]-4-[4-[(4-chlorophenyl)-phenylmethoxy]butyl]piperazine,CC(C)(C)C1=CC=C(C=C1)CN2CCN(CC2)CCCCOC(C3=CC=CC=C3)C4=CC=C(C=C4)Cl,,,,,,
1077,91078,CID 91078,CC(CN1CCN(CC1)CCC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)O.C(=CC(=O)O)C(=O)O.C(=CC(=O)O)C(=O)O,,,,,,
1078,91079,1-[4-[3-(4-Chlorophenyl)-3-phenylpropyl]piperazin-1-yl]propan-2-ol,CC(CN1CCN(CC1)CCC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)O,,,,,,
1079,91080,CID 91080,C1CN(CCN1CCC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)CC4=CC=CC=C4.C(=CC(=O)O)C(=O)O.C(=CC(=O)O)C(=O)O,,,,,,
1080,91081,1-Benzyl-4-[3-(4-chlorophenyl)-3-phenylpropyl]piperazine,C1CN(CCN1CCC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)CC4=CC=CC=C4,,,,,,
1081,91082,CID 91082,CC1=CC(=CC=C1)CN2CCN(CC2)CCC(C3=CC=CC=C3)C4=CC=C(C=C4)Cl.C(=CC(=O)O)C(=O)O.C(=CC(=O)O)C(=O)O,,,,,,
1082,91083,1-[3-(4-Chlorophenyl)-3-phenylpropyl]-4-[(3-methylphenyl)methyl]piperazine,CC1=CC(=CC=C1)CN2CCN(CC2)CCC(C3=CC=CC=C3)C4=CC=C(C=C4)Cl,,,,,,
1083,91084,CID 91084,CC(C)(C)C1=CC=C(C=C1)CN2CCN(CC2)CCC(C3=CC=CC=C3)C4=CC=C(C=C4)Cl.C(=CC(=O)O)C(=O)O.C(=CC(=O)O)C(=O)O,,,,,,
1084,91085,1-[(4-Tert-butylphenyl)methyl]-4-[3-(4-chlorophenyl)-3-phenylpropyl]piperazine,CC(C)(C)C1=CC=C(C=C1)CN2CCN(CC2)CCC(C3=CC=CC=C3)C4=CC=C(C=C4)Cl,,,,,,
1085,91086,CID 91086,C1CN(CCN1CCC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)C4=CC=CC=C4Cl.C(=CC(=O)O)C(=O)O,,,,,,
1086,91087,1-(2-Chlorophenyl)-4-[3-(4-chlorophenyl)-3-phenylpropyl]piperazine,C1CN(CCN1CCC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)C4=CC=CC=C4Cl,,,,,,
1087,91088,CID 91088,CC1=CC=CC=C1N2CCN(CC2)CCC(C3=CC=CC=C3)C4=CC=C(C=C4)Cl.C(=CC(=O)O)C(=O)O,,,,,,
1088,91089,1-[3-(4-Chlorophenyl)-3-phenylpropyl]-4-(2-methylphenyl)piperazine,CC1=CC=CC=C1N2CCN(CC2)CCC(C3=CC=CC=C3)C4=CC=C(C=C4)Cl,,,,,,
1089,91090,CID 91090,CC1=CC(=CC=C1)N2CCN(CC2)CCC(C3=CC=CC=C3)C4=CC=C(C=C4)Cl.C(=CC(=O)O)C(=O)O,,,,,,
1090,91091,1-[3-(4-Chlorophenyl)-3-phenylpropyl]-4-(3-methylphenyl)piperazine,CC1=CC(=CC=C1)N2CCN(CC2)CCC(C3=CC=CC=C3)C4=CC=C(C=C4)Cl,,,,,,
1091,91092,CID 91092,CC(C)(C)C1=CC=C(C=C1)CN2CCN(CC2)CCSC(C3=CC=CC=C3)C4=CC=C(C=C4)Cl.C(=CC(=O)O)C(=O)O.C(=CC(=O)O)C(=O)O,,,,,,
1092,91093,1-[(4-Tert-butylphenyl)methyl]-4-[2-[(4-chlorophenyl)-phenylmethyl]sulfanylethyl]piperazine,CC(C)(C)C1=CC=C(C=C1)CN2CCN(CC2)CCSC(C3=CC=CC=C3)C4=CC=C(C=C4)Cl,,,,,,
1093,91094,CID 91094,C1CN(CCN1CCC2=CC=CC=C2)CCSC(C3=CC=CC=C3)C4=CC=C(C=C4)Cl.C(=CC(=O)O)C(=O)O.C(=CC(=O)O)C(=O)O,,,,,,
1094,91095,1-[2-[(4-Chlorophenyl)-phenylmethyl]sulfanylethyl]-4-(2-phenylethyl)piperazine,C1CN(CCN1CCC2=CC=CC=C2)CCSC(C3=CC=CC=C3)C4=CC=C(C=C4)Cl,,,,,,
1095,91096,CID 91096,C1CN(CCN1CCNC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)C4=CC=CC=C4Cl.C(=CC(=O)O)C(=O)O.C(=CC(=O)O)C(=O)O,,,,,,
1096,91097,N-[(4-chlorophenyl)-phenylmethyl]-2-[4-(2-chlorophenyl)piperazin-1-yl]ethanamine,C1CN(CCN1CCNC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)C4=CC=CC=C4Cl,,,,,,
1097,91098,2-Methoxy-4-propylcyclohexan-1-ol,CCCC1CCC(C(C1)OC)O,,,,,,
1098,91099,"[2-(2-Chloro-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl)-2-oxoethyl] acetate",CC1CC2C3CC(C4=CC(=O)C(=CC4(C3(C(CC2(C1(C(=O)COC(=O)C)O)C)O)F)C)Cl)F,,,,,,
1099,91100,Einecs 245-956-1,CC1CC2C3CC(C4=CC(=O)C=CC4(C35C(O5)CC2(C1(C(=O)CO)O)C)C)F,,,,,,
1100,91101,2-Phenylmorpholine,C1COC(CN1)C2=CC=CC=C2,,,,,,
1101,91102,"10,13-dimethyl-17-oxo-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl heptanoate",CCCCCCC(=O)OC1CCC2(C3CCC4(C(C3CC=C2C1)CCC4=O)C)C,,,,,,
1102,91103,"2,6-Dimethylocta-5,7-dien-4-one",CC(C)CC(=O)C=C(C)C=C,,,,,,
1103,91104,"1,6-Cyclodecadiene, 1-methyl-5-methylene-8-(1-methylethyl)-",CC1=CCCC(=C)C=CC(CC1)C(C)C,,,,,,
1104,91105,"1-(2-Methyl-5-piperidino-2,4-pentadienylidene)piperidinium chloride hydrate",CC(=CC=CN1CCCCC1)C=[N+]2CCCCC2.[Cl-],,,,,,
1105,91106,"1-(4-Methyl-5-piperidin-1-ium-1-ylidenepenta-1,3-dienyl)piperidine",CC(=CC=CN1CCCCC1)C=[N+]2CCCCC2,,,,,,
1106,91107,"Piperidinium, 1-(2-methyl-5-(4-phenylpiperidino)-2,4-pentadienylidene)-4-phenyl-, chloride, hydrate",CC(=CC=CN1CCC(CC1)C2=CC=CC=C2)C=[N+]3CCC(CC3)C4=CC=CC=C4.[Cl-],,,,,,
1107,91108,"1-[4-Methyl-5-(4-phenylpiperidin-1-ium-1-ylidene)penta-1,3-dienyl]-4-phenylpiperidine",CC(=CC=CN1CCC(CC1)C2=CC=CC=C2)C=[N+]3CCC(CC3)C4=CC=CC=C4,,,,,,
1108,91109,Ethyl 2-(2-(diethylamino)ethyl)acetoacetate,CCN(CC)CCC(C(=O)C)C(=O)OCC,,,,,,
1109,91110,"3-((4,5-Dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo)-4-hydroxy-5-nitrobenzenesulphonic acid",CC1=NN(C(=O)C1N=NC2=C(C(=CC(=C2)S(=O)(=O)O)[N+](=O)[O-])O)C3=CC=CC=C3,,,,,,
1110,91111,CID 91111,C1CN(CCN1CCC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)C4=CC=CC=N4.C(=CC(=O)O)C(=O)O,,,,,,
1111,91112,1-[3-(4-Chlorophenyl)-3-phenylpropyl]-4-pyridin-2-ylpiperazine,C1CN(CCN1CCC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl)C4=CC=CC=N4,,,,,,
1112,91113,CID 91113,C1CCC(CC1)N2CCN(CC2)CCOC(C3=CC=CC=C3)C4=CC=C(C=C4)Cl.C(=CC(=O)O)C(=O)O.C(=CC(=O)O)C(=O)O,,,,,,
1113,91114,1-[2-[(4-Chlorophenyl)-phenylmethoxy]ethyl]-4-cyclohexylpiperazine,C1CCC(CC1)N2CCN(CC2)CCOC(C3=CC=CC=C3)C4=CC=C(C=C4)Cl,,,,,,
1114,91115,"2,6,10-Trimethylundeca-5,9-dienal",CC(CCC=C(C)CCC=C(C)C)C=O,,,,,,
1115,91116,"5,9-Undecadien-1-ol, 2,6,10-trimethyl-",CC(CCC=C(C)CCC=C(C)C)CO,,,,,,
1116,91117,"8-Propionyl-3,8-diazabicyclo(3.2.1)octane-ethanol",CCC(=O)N1C2CCC1CN(C2)CCO,,,,,,
1117,91118,"3-[[4-Methyl-5-(4-oxo-3-prop-2-enyl-2-sulfanylidene-1,3-thiazolidin-5-ylidene)-1,3,4-thiadiazol-2-yl]sulfanyl]propanoic acid",CN1C(=C2C(=O)N(C(=S)S2)CC=C)SC(=N1)SCCC(=O)O,,,,,,
1118,91119,"2-[[5-(3-Ethyl-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene)-4-methyl-1,3,4-thiadiazol-2-yl]sulfanyl]acetic acid",CCN1C(=O)C(=C2N(N=C(S2)SCC(=O)O)C)SC1=S,,,,,,
1119,91120,3-Methyl-5-isopropyl-4-carbethoxy-2-cyclohexene-1-one,CCOC(=O)C1C(CC(=O)C=C1C)C(C)C,,,,,,
1120,91121,1-(2-Butoxypropoxy)propan-2-ol,CCCCOC(C)COCC(C)O,,,,,,
1121,91122,N-Benzyl albuterol,CC(C)(C)N(CC1=CC=CC=C1)CC(C2=CC(=C(C=C2)O)CO)O,,,,,,
1122,91123,"(4-Acetyloxy-6,10-dimethyl-3-methylidene-2-oxo-3a,4,7,8,11,11a-hexahydrocyclodeca[b]furan-7-yl) acetate",CC1=CCC(C(=CC(C2C(C1)OC(=O)C2=C)OC(=O)C)C)OC(=O)C,,,,,,
1123,91124,"Benzoxazolium, 2-[6-(acetylphenylamino)-1,3,5-hexatrienyl]-3-ethyl-, iodide",CC[N+]1=C(OC2=CC=CC=C21)C=CC=CC=CN(C3=CC=CC=C3)C(=O)C.[I-],,,,,,
1124,91125,CID 91125,CC[N+]1=C(OC2=CC=CC=C21)C=CC=C/C=C/N(C3=CC=CC=C3)C(=O)C,,,,,,
1125,91126,"2-Propenoic acid, 3-(4-(((4-cyanophenyl)methylene)amino)phenyl)-, (2S)-2-methylbutyl ester",CC[C@H](C)COC(=O)C=CC1=CC=C(C=C1)N=CC2=CC=C(C=C2)C#N,,,,,,
1126,91127,Methyl chrysanthemate,CC(=CC1C(C1(C)C)C(=O)OC)C,,,,,,
1127,91128,"cis,cis-6-tert-Butyloctahydronaphthalen-2(1H)-one",CC(C)(C)C1CCC2CC(=O)CCC2C1,,,,,,
1128,91129,"3,4-Dihydroxy-4-(1-hydroxy-4-methylpent-3-enyl)-2-(3-methylbutanoyl)-5-(3-methylbut-2-enyl)cyclopent-2-en-1-one",CC(C)CC(=O)C1=C(C(C(C1=O)CC=C(C)C)(C(CC=C(C)C)O)O)O,,,,,,
1129,91130,alpha-(4-Chlorophenyl)-1H-imidazole-1-ethanol,C1=CC(=CC=C1C(CN2C=CN=C2)O)Cl,,,,,,
1130,91131,"2',4',5'-Trimethoxycinnamic acid",COC1=CC(=C(C=C1C=CC(=O)O)OC)OC,,,,,,
1131,91132,alpha-Methylnaphthalene-1-acetonitrile,CC(C#N)C1=CC=CC2=CC=CC=C21,,,,,,
1132,91133,"6-Nonen-1-yn-3-ol, 3,7-dimethyl-",CCC(=CCCC(C)(C#C)O)C,,,,,,
1133,91134,"Methyl 9-(3,3-dimethyloxiran-2-yl)-3,7-dimethylnona-2,6-dienoate",CC(=CCCC(=CC(=O)OC)C)CCC1C(O1)(C)C,,,,,,
1134,91135,"5-Octen-2-one, 6-methyl-",CCC(=CCCC(=O)C)C,,,,,,
1135,91136,(6R-trans)-7-Amino-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid,CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)N)SC2)C(=O)O,,,,,,
1136,91137,"(6R-trans)-7-Amino-8-oxo-3-[(1,3,4-thiadiazol-2-ylthio)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",C1C(=C(N2C(S1)C(C2=O)N)C(=O)O)CSC3=NN=CS3,,,,,,
1137,91138,beta-(p-Methoxyphenyl)-beta-(1-piperidino)propiophenone hydrochloride,COC1=CC=C(C=C1)C(CC(=O)C2=CC=CC=C2)N3CCCCC3.Cl,,,,,,
1138,91139,"1-Propanone, 3-(4-methoxyphenyl)-1-phenyl-3-(1-piperidinyl)-",COC1=CC=C(C=C1)C(CC(=O)C2=CC=CC=C2)N3CCCCC3,,,,,,
1139,91140,4'-Methoxy-3-methylamino-3-phenylpropiophenone hydrochloride,CNC(CC(=O)C1=CC=C(C=C1)OC)C2=CC=CC=C2.Cl,,,,,,
1140,91141,1-(4-Methoxyphenyl)-3-(methylamino)-3-phenylpropan-1-one,CNC(CC(=O)C1=CC=C(C=C1)OC)C2=CC=CC=C2,,,,,,
1141,91142,3-(Benzylamino)-3-(p-methoxyphenyl)propiophenone hydrochloride,COC1=CC=C(C=C1)C(CC(=O)C2=CC=CC=C2)NCC3=CC=CC=C3.Cl,,,,,,
1142,91143,"1-Propanone, 3-(4-methoxyphenyl)-1-phenyl-3-[(phenylmethyl)amino]-",COC1=CC=C(C=C1)C(CC(=O)C2=CC=CC=C2)NCC3=CC=CC=C3,,,,,,
1143,91144,Farrerol,CC1=C(C(=C2C(=C1O)C(=O)CC(O2)C3=CC=C(C=C3)O)C)O,,,,,,
1144,91145,Ethyl cis-3-methyl-3-isobutyloxirane-2-carboxylate,CCOC(=O)C1C(O1)(C)CC(C)C,,,,,,
1145,91146,"4,5-Dihydro-N-(5-nitro-2-thiazolyl)-4,4,5,5-tetramethyl-2-oxazolamine",CC1(C(OC(=N1)NC2=NC=C(S2)[N+](=O)[O-])(C)C)C,,,,,,
1146,91147,"6-Butyl-3,6-dihydro-2,4-dimethyl-2H-pyran",CCCCC1C=C(CC(O1)C)C,,,,,,
1147,91148,"2H-Pyran, 2-butyl-3,6-dihydro-4,6-dimethyl-",CCCCC1CC(=CC(O1)C)C,,,,,,
1148,91149,"2H-Pyran, 2-butyltetrahydro-6-methyl-4-methylene-",CCCCC1CC(=C)CC(O1)C,,,,,,
1149,91150,"6,10-Dimethylundeca-1,5,9-triene",CC(=CCCC(=CCCC=C)C)C,,,,,,
1150,91151,"Decahydro-5,5,8a-trimethyl-2-naphthyl acetate",CC(=O)OC1CCC2C(CCCC2(C1)C)(C)C,,,,,,
1151,91152,2-[(5-Nitro-2-thiazolyl)imino]oxazolidine-3-ethanol,C1COC(=NC2=NC=C(S2)[N+](=O)[O-])N1CCO,,,,,,
1152,91153,2-[(5-Nitro-2-thiazolyl)imino]thiazolidine-3-ethanol,C1CSC(=NC2=NC=C(S2)[N+](=O)[O-])N1CCO,,,,,,
1153,91154,N-2-Imidazolidinylidene-5-nitro-2-thiazolamine,C1CN=C(N1)NC2=NC=C(S2)[N+](=O)[O-],,,,,,
1154,91155,"4,5-Dihydro-4-methyl-N-(5-nitro-2-thiazolyl)-2-oxazolamine",CC1CN=C(O1)NC2=NC=C(S2)[N+](=O)[O-],,,,,,
1155,91156,20-Formylpregn-4-en-3-one,CC(C=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C,,,,,,
1156,91157,3-Bromo-2-oxobornane-10-sulphonic acid,CC1(C2CCC1(C(=O)C2Br)CS(=O)(=O)O)C,,,,,,
1157,91158,"2-[(1S,6S)-6-isopropenyl-3-methyl-1-cyclohex-2-enyl]-5-propyl-benzene-1,3-diol",CCCC1=CC(=C(C(=C1)O)C2C=C(CCC2C(=C)C)C)O,,,,,,
1158,91159,"4,7,7-Trimethylbicyclo[4.1.0]heptan-3-one",CC1CC2C(C2(C)C)CC1=O,,,,,,
1159,91160,"Bis(2-ethylhexyl) 2,2'-thiobisacetate",CCCCC(CC)COC(=O)CSCC(=O)OCC(CC)CCCC,,,,,,
1160,91161,"1,2-Diphenylethylamine hydrochloride",C1=CC=C(C=C1)CC(C2=CC=CC=C2)N.Cl,,,,,,
1161,91162,Ethyl 2-acetylheptanoate,CCCCCC(C(=O)C)C(=O)OCC,,,,,,
1162,91163,Ethyl 2-acetyldecanoate,CCCCCCCCC(C(=O)C)C(=O)OCC,,,,,,
1163,91164,"9-Bromo-11-hydroxy-3,20-dioxopregn-4-en-17-yl acetate",CC(=O)C1(CCC2C1(CC(C3(C2CCC4=CC(=O)CCC43C)Br)O)C)OC(=O)C,,,,,,
1164,91165,"9-Chloro-6,11-difluoro-16-methyl-3,20-dioxopregna-1,4-dien-21-yl pentanoate",CCCCC(=O)OCC(=O)C1C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)Cl)F)C)C,,,,,,
1165,91166,2-Methylnonanoic acid,CCCCCCCC(C)C(=O)O,,,,,,
1166,91167,2-Methyldecanoic acid,CCCCCCCCC(C)C(=O)O,,,,,,
1167,91168,2-Methylundecanoic acid,CCCCCCCCCC(C)C(=O)O,,,,,,
1168,91169,2-Methyltridecanoic acid,CCCCCCCCCCCC(C)C(=O)O,,,,,,
1169,91170,"2,6-Bis(1-cyclohexen-1-yl)cyclohexan-1-one",C1CCC(=CC1)C2CCCC(C2=O)C3=CCCCC3,,,,,,
1170,91171,"4-Methylpentane-1,2-diol",CC(C)CC(CO)O,,,,,,
1171,91172,"4-Hydroxy-4,7,7-trimethylbicyclo[4.1.0]heptan-3-one",CC1(C2C1CC(C(=O)C2)(C)O)C,,,,,,
1172,91173,"1,1'-(3,5-Xylylimino)dipropan-2-ol",CC1=CC(=CC(=C1)N(CC(C)O)CC(C)O)C,,,,,,
1173,91174,"Morpholine, 3-ethyl-4-(3,4,5-trimethoxycinnamoyl)-",CCC1CN(CCO1)C(=O)C=CC2=CC(=C(C(=C2)OC)OC)OC,,,,,,
1174,91175,1-(4-Bromophenyl)ethanamine,CC(C1=CC=C(C=C1)Br)N,,,,,,
1175,91176,"[10-(Hydroxymethyl)-6-methyl-3-methylidene-2-oxo-3a,4,5,8,9,11a-hexahydrocyclodeca[b]furan-4-yl] 3,4-dihydroxy-2-methylidenebutanoate",CC1=CCCC(=CC2C(C(C1)OC(=O)C(=C)C(CO)O)C(=C)C(=O)O2)CO,,,,,,
1176,91177,2-Methyl-2-phenylpent-4-enal,CC(CC=C)(C=O)C1=CC=CC=C1,,,,,,
1177,91178,"1,4-Methanoanthracene-9,10-dione, 1,2,3,4,4a,9a-hexahydro-",C1CC2CC1C3C2C(=O)C4=CC=CC=C4C3=O,,,,,,
1178,91179,3-(Perfluoro-7-methyloctyl)-2-hydroxypropyl acrylate,C=CC(=O)OCC(CC(C(C(C(C(C(C(C(F)(F)F)(C(F)(F)F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)O,,,,,,
1179,91180,"3,5,5-Trimethylhexyl hydrogen maleate",CC(CCOC(=O)C=CC(=O)O)CC(C)(C)C,,,,,,
1180,91181,"3,6-Octanediol",CCC(CCC(CC)O)O,,,,,,
1181,91182,"3,3,5-Trimethylcyclohexyl formate",CC1CC(CC(C1)(C)C)OC=O,,,,,,
1182,91183,"2-Propenoic acid, 2-methyl-, (1-methylethylidene)bis(4,1-phenyleneoxy(1-methyl-2,1-ethanediyl)) ester",CC(COC1=CC=C(C=C1)C(C)(C)C2=CC=C(C=C2)OCC(C)OC(=O)C(=C)C)OC(=O)C(=C)C,,,,,,
1183,91184,"4-Oxazolemethanol, 4-ethyl-2-heptadecyl-4,5-dihydro-",CCCCCCCCCCCCCCCCCC1=NC(CO1)(CC)CO,,,,,,
1184,91185,4-Ethyl-2-octyl-2-oxazoline-4-methanol,CCCCCCCCC1=NC(CO1)(CC)CO,,,,,,
1185,91186,4-Ethyl-2-undecyl-2-oxazoline-4-methanol,CCCCCCCCCCCC1=NC(CO1)(CC)CO,,,,,,
1186,91187,N-(4-Hydroxy-3-(1-oxo-3-phenylallyl)phenyl)acetamide,CC(=O)NC1=CC(=C(C=C1)O)C(=O)C=CC2=CC=CC=C2,,,,,,
1187,91188,"2,12-Dibromocyclododecanone",C1CCCCC(C(=O)C(CCCC1)Br)Br,,,,,,
1188,91189,"2'-amino-6'-(diethylamino)spiro[isobenzofuran-1(3H),9'-[9H]xanthene]-3-one",CCN(CC)C1=CC2=C(C=C1)C3(C4=CC=CC=C4C(=O)O3)C5=C(O2)C=CC(=C5)N,,,,,,
1189,91190,"6'-(Diethylamino)-2'-(methylamino)spiro[isobenzofuran-1(3H),9'-[9H]xanthene]-3-one",CCN(CC)C1=CC2=C(C=C1)C3(C4=CC=CC=C4C(=O)O3)C5=C(O2)C=CC(=C5)NC,,,,,,
1190,91191,Copper(I) chloride complex with tris(2-ethylhexyl) phosphite,CCCCC(CC)COP(OCC(CC)CCCC)OCC(CC)CCCC.[Cl-].[Cu+],,,,,,
1191,91192,N-(1-(4-(Aminosulphonyl)phenyl)ethyl)-5-methylisoxazole-3-carboxamide,CC(C1=CC=C(C=C1)S(=O)(=O)N)NCC2=CC(=NO2)C=O,,,,,,
1192,91193,"Estra-1,3,5(10),7-tetraene-3,17beta-diol 3-acetate",CC(=O)OC1=CC2=C(C=C1)C3CCC4(C(C3=CC2)CCC4O)C,,,,,,
1193,91194,"[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] docos-13-enoate",CCCCCCCCC=CCCCCCCCCCCCC(=O)OC1CCC2(C3CCC4(C(C3CC=C2C1)CCC4C(C)CCCC(C)C)C)C,,,,,,
1194,91195,Umbellulone,CC1=CC(=O)C2(C1C2)C(C)C,,,,,,
1195,91196,Disodium bisethylphenyltriaminotriazine stilbenedisulfonate,CCNC1=NC(=NC(=N1)NC2=CC(=C(C=C2)C=CC3=C(C=C(C=C3)NC4=NC(=NC(=N4)NC5=CC=CC=C5)NCC)S(=O)(=O)[O-])S(=O)(=O)[O-])NC6=CC=CC=C6.[Na+].[Na+],,,,,,
1196,91197,"4,4'-bis(4-anilino-6 ethylamino-S-triazine-2ylamino)-2,2'-stilbenedisulphonic acid",CCNC1=NC(=NC(=N1)NC2=CC(=C(C=C2)C=CC3=C(C=C(C=C3)NC4=NC(=NC(=N4)NC5=CC=CC=C5)NCC)S(=O)(=O)O)S(=O)(=O)O)NC6=CC=CC=C6,,,,,,
1197,91198,"4-Isopropyl-5,5-dimethyl-2-phenyl-1,3-dioxane",CC(C)C1C(COC(O1)C2=CC=CC=C2)(C)C,,,,,,
1198,91199,Dioctyltin;2-ethylhexanoic acid,CCCCCCCC[Sn]CCCCCCCC.CCCCC(CC)C(=O)O.CCCCC(CC)C(=O)O,,,,,,
1199,91200,CID 91200,CCCCCCCCCCOC(=O)CC(C(=O)O)S(=O)(=O)[O-].[Na+],,,,,,
1200,91201,4-Decoxy-4-oxo-2-sulfobutanoic acid,CCCCCCCCCCOC(=O)CC(C(=O)O)S(=O)(=O)O,,,,,,
1201,91202,2-Amino-3-methylpentan-1-ol,CCC(C)C(CO)N,,,,,,
1202,91203,5-(2-Methylthioethyl)-3-phenylhydantoin,CSCCC1C(=O)N(C(=O)N1)C2=CC=CC=C2,,,,,,
1203,91204,"2-Furaldehyde, 5-nitro-, (4-diethylcarbamoylpiperazinylacetyl)hydrazone",CCN(CC)C(=O)N1CCN(CC1)CC(=O)NN=CC2=CC=C(O2)[N+](=O)[O-],,,,,,
1204,91205,"2-Furaldehyde, 5-nitro-, (4-acetylpiperazinylacetyl)hydrazone",CC(=O)N1CCN(CC1)CC(=O)NN=CC2=CC=C(O2)[N+](=O)[O-],,,,,,
1205,91206,4-Methyl-1-piperazinepropionic acid 2-(5-nitrofurfurylidene)hydrazide,CN1CCN(CC1)CCC(=O)NN=CC2=CC=C(O2)[N+](=O)[O-],,,,,,
1206,91207,Propyl 3-[chloro(dimethyl)silyl]-2-methylprop-2-enoate,CCCOC(=O)C(=C[Si](C)(C)Cl)C,,,,,,
1207,91208,"2-Furaldehyde, 5-nitro-, (4-phenethylpiperazinylacetyl)hydrazone",C1CN(CCN1CCC2=CC=CC=C2)CC(=O)NN=CC3=CC=C(O3)[N+](=O)[O-],,,,,,
1208,91209,"5-Oxo-N-1H-1,2,4-triazol-3-ylpyrrolidine-2-carboxamide",C1CC(=O)NC1C(=O)NC2=NC=NN2,,,,,,
1209,91210,"Cyclohexanamine, 2-[(4-aminocyclohexyl)methyl]-",C1CCC(C(C1)CC2CCC(CC2)N)N,,,,,,
1210,91211,3-(2-Thienyl)acrylamide,C1=CSC(=C1)C=CC(=O)N,,,,,,
1211,91212,"1,4-Benzenediamine, N,N'-bis[[4-(octyloxy)phenyl]methylene]-",CCCCCCCCOC1=CC=C(C=C1)C=NC2=CC=C(C=C2)N=CC3=CC=C(C=C3)OCCCCCCCC,,,,,,
1212,91213,"2H-Naphtho[1,2-d]triazole-5-sulfonic acid, 2-[4-[2-[4-[(1-acetyl-2-oxopropyl)azo]-2-sulfophenyl]ethenyl]-3-sulfophenyl]-",CC(=O)C(C(=O)C)N=NC1=CC(=C(C=C1)C=CC2=C(C=C(C=C2)N3N=C4C=C(C5=CC=CC=C5C4=N3)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
1213,91214,Isoprenyl aluminum,CC(=C[AlH2])C=C,,,,,,
1214,91215,"Benzoselenazolium, 3-ethyl-2-[3-(3-ethyl-2(3H)-benzoselenazolylidene)-2-methyl-1-propenyl]-, bromide",CCN1C2=CC=CC=C2[Se]C1=CC(=CC3=[N+](C4=CC=CC=C4[Se]3)CC)C.[Br-],,,,,,
1215,91216,3-Ethyl-2-[3-(3-ethylbenzoselenazol-2(3H)-ylidene)-2-methyl-1-propenyl]benzoselenazol-3-ium,CCN1C2=CC=CC=C2[Se]C1=CC(=CC3=[N+](C4=CC=CC=C4[Se]3)CC)C,,,,,,
1216,91217,"2-(2-((1-Methylnaphtho(1,2-d)thiazol-2(1H)-ylidene)methyl)-1-butenyl)-1-(3-sulphonatopropyl)naphtho(1,2-d)thiazolium",CCC(=CC1=[N+](C2=C(S1)C=CC3=CC=CC=C32)C)C=C4N(C5=C(S4)C=CC6=CC=CC=C65)CCCS(=O)(=O)[O-],,,,,,
1217,91218,"3-[2-[2-[(1-Methylbenzo[e][1,3]benzothiazol-1-ium-2-yl)methylidene]butylidene]benzo[e][1,3]benzothiazol-1-yl]propane-1-sulfonic acid",CCC(=CC1=[N+](C2=C(S1)C=CC3=CC=CC=C32)C)C=C4N(C5=C(S4)C=CC6=CC=CC=C65)CCCS(=O)(=O)O,,,,,,
1218,91219,"Hydrogen-2-(2-((5-methoxy-3-(3-sulphonatopropyl)-3H-benzoselenazol-2-ylidene)methyl)but-1-enyl)-5,6-dimethyl-3-(3-sulphonatopropyl)benzothiazolium",CCC(=CC1=[N+](C2=C([Se]1)C=CC(=C2)OC)CCCS(=O)(=O)O)C=C3N(C4=C(S3)C=C(C(=C4)C)C)CCCS(=O)(=O)[O-],,,,,,
1219,91220,"2-[2-[[5-Methoxy-3-(3-sulfopropyl)-2(3H)-benzoselenazolylidene]methyl]-1-butenyl]-5,6-dimethyl-3-(3-sulfonatopropyl)benzothiazol-3-ium",CCC(=CC1=[N+](C2=C([Se]1)C=CC(=C2)OC)CCCS(=O)(=O)O)C=C3N(C4=C(S3)C=C(C(=C4)C)C)CCCS(=O)(=O)O,,,,,,
1220,91221,"2H-1-Benzopyran-6-ol, 3,4-dihydro-2,2-dimethyl-4-(1-methylethyl)-7-octyl-",CCCCCCCCC1=CC2=C(C=C1O)C(CC(O2)(C)C)C(C)C,,,,,,
1221,91222,Thiadrine thiocyanate,CC1C(SC(=N)N1C)C2=CC=CC=C2.C(#N)S,,,,,,
1222,91223,Thiadrine,CC1C(SC(=N)N1C)C2=CC=CC=C2,,,,,,
1223,91224,"3,6,6,9-Tetramethyl-4,4a,5,6,7,9a-hexahydro-1h-benzo[7]annulene",CC1=CCC2C(C1)CC(CC=C2C)(C)C,,,,,,
1224,91225,"Benzenesulfonic acid, 4-[4,5-dihydro-4-[3-[5-hydroxy-3-methyl-1-(4-sulfophenyl)-1H-pyrazol-4-yl]-2-propenylidene]-3-methyl-5-oxo-1H-pyrazol-1-yl]-",CC1=C(C(=O)N(N1)C2=CC=C(C=C2)S(=O)(=O)O)C=CC=C3C(=NN(C3=O)C4=CC=C(C=C4)S(=O)(=O)O)C,,,,,,
1225,91226,Bornyl isobutyrate,CC(C)C(=O)OC1CC2CCC1(C2(C)C)C,,,,,,
1226,91227,"1-Undecanol, 10,11-dibromo-",C(CCCCC(CBr)Br)CCCCO,,,,,,
1227,91228,10-(3-Chloro-2-methylpropyl)-2-methoxy-10H-phenothiazine,CC(CN1C2=CC=CC=C2SC3=C1C=C(C=C3)OC)CCl,,,,,,
1228,91229,Ethyl 2-(2-oxocyclohexyl)acetate,CCOC(=O)CC1CCCCC1=O,,,,,,
1229,91230,"3-Allyl-5-((1-ethyl-1,4-dihydro-4-methyl-5H-tetrazol-5-ylidene)ethylidene)-2-thioxothiazolidin-4-one",CCN1C(=CC=C2C(=O)N(C(=S)S2)CC=C)N(N=N1)C,,,,,,
1230,91231,"4,6(1H,5H)-Pyrimidinedione, 5-(5-(1,3-diethylhexahydro-4,6-dioxo-2-thioxo-5-pyrimidinyl)-2,4-pentadienylidene)-1,3-diethyldihydro-2-thioxo-",CCN1C(=O)C(C(=O)N(C1=S)CC)C=CC=CC=C2C(=O)N(C(=S)N(C2=O)CC)CC,,,,,,
1231,91232,"2,5-Dibromohexane",CC(CCC(C)Br)Br,,,,,,
1232,91233,N-(N-((Phenylmethoxy)carbonyl)-L-isoleucyl)-L-alanine,CCC(C)C(C(=O)NC(C)C(=O)O)NC(=O)OCC1=CC=CC=C1,,,,,,
1233,91234,Tetrapropylene glycol,CC(CO)OCC(C)OCC(C)OCC(C)O,,,,,,
1234,91235,"4-[2-(17-Hydroxy-10,13-dimethyl-3,11-dioxo-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl)-2-oxoethoxy]-4-oxobutanoic acid",CC12CC(=O)C3C(C1CCC2(C(=O)COC(=O)CCC(=O)O)O)CCC4=CC(=O)C=CC34C,,,,,,
1235,91236,Hexyl 3-octyloxiran-2-octanoate,CCCCCCCCC1C(O1)CCCCCCCC(=O)OCCCCCC,,,,,,
1236,91237,2-Hexylcyclohexan-1-one,CCCCCCC1CCCCC1=O,,,,,,
1237,91238,"[2-(11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl] 2,2-dimethylpropanoate",CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)COC(=O)C(C)(C)C)O)C)O,,,,,,
1238,91239,"5-Hydroxy-2-methyl-1,3-dioxane-4-carbaldehyde",CC1OCC(C(O1)C=O)O,,,,,,
1239,91240,"2-(3-Chlorophenyl)-2,4-dihydro-4-[[2-hydroxy-5-(methylsulphonyl)phenyl]azo]-5-methyl-3h-pyrazol-3-one",CC1=NN(C(=O)C1N=NC2=C(C=CC(=C2)S(=O)(=O)C)O)C3=CC(=CC=C3)Cl,,,,,,
1240,91241,"2,3-Dichloropropyl acrylate",C=CC(=O)OCC(CCl)Cl,,,,,,
1241,91242,"17,21-Dihydroxy-16-methyl-9,11-epoxypregna-1,4-diene-3,20-dione",CC1CC2C3CCC4=CC(=O)C=CC4(C35C(O5)CC2(C1(C(=O)CO)O)C)C,,,,,,
1242,91243,CID 91243,CCCCCCCC(=O)OCCN=C(C(=NCCOC(=O)CCCCCCC)S)S,,,,,,
1243,91244,2-Methoxy-4-methylamphetamine hydrochloride,CC1=CC(=C(C=C1)CC(C)N)OC.Cl,,,,,,
1244,91245,1-(2-Methoxy-4-methylphenyl)propan-2-amine,CC1=CC(=C(C=C1)CC(C)N)OC,,,,,,
1245,91246,"3,5-Dimethoxyamphetamine hydrochloride",CC(CC1=CC(=CC(=C1)OC)OC)N.Cl,,,,,,
1246,91247,"3,5-Dimethoxyamphetamine",CC(CC1=CC(=CC(=C1)OC)OC)N,,,,,,
1247,91248,"Phenethylamine, alpha,2,4,6-tetramethyl-, hydrochloride",CC1=CC(=C(C(=C1)C)CC(C)N)C.Cl,,,,,,
1248,91249,"1-(2,4,6-Trimethylphenyl)propan-2-amine",CC1=CC(=C(C(=C1)C)CC(C)N)C,,,,,,
1249,91250,CID 91250,C1=CC=NC(=C1)C2=C(NC(=C(N2)C3=CC=CC=N3)C4=CC=CC=N4)C5=CC=CC=N5,,,,,,
1250,91251,2-Formylbut-2-enyl acetate,CC=C(COC(=O)C)C=O,,,,,,
1251,91252,1-(3-Methoxy-4-methylphenyl)-2-aminopropane,CC1=C(C=C(C=C1)CC(C)N)OC.Cl,,,,,,
1252,91253,3-Methoxy-4-methylamphetamine,CC1=C(C=C(C=C1)CC(C)N)OC,,,,,,
1253,91254,"2,3-Dimethoxyamphetamine hydrochloride",CC(CC1=C(C(=CC=C1)OC)OC)N.Cl,,,,,,
1254,91255,"2,3-Dimethoxyamphetamine",CC(CC1=C(C(=CC=C1)OC)OC)N,,,,,,
1255,91256,"2,4-Dimethoxy-3-methylamphetamine hydrochloride",CC1=C(C=CC(=C1OC)CC(C)N)OC.Cl,,,,,,
1256,91257,"1-(2,4-Dimethoxy-3-methylphenyl)propan-2-amine",CC1=C(C=CC(=C1OC)CC(C)N)OC,,,,,,
1257,91258,4-(Diphenylamino)cinnamic acid,C1=CC=C(C=C1)N(C2=CC=CC=C2)C3=CC=C(C=C3)C=CC(=O)O,,,,,,
1258,91259,Methyl p-(diphenylamino)cinnamate,COC(=O)C=CC1=CC=C(C=C1)N(C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
1259,91260,"4,5-Epoxy-2-penten-1-one",C1C(O1)C=CC=O,,,,,,
1260,91261,"1H-Imidazo(4,5-b)quinoxalinium, 1,3-diethyl-2-(2-(1-methyl-2-phenyl-1H-indol-3-yl)ethenyl)-, iodide",CCN1C(=[N+](C2=NC3=CC=CC=C3N=C21)CC)C=CC4=C(N(C5=CC=CC=C54)C)C6=CC=CC=C6.[I-],,,,,,
1261,91262,"1,3-diethyl-2-[2-(1-methyl-2-phenyl-1H-indol-3-yl)ethenyl]-1H-imidazo[4,5-b]quinoxalin-3-ium",CCN1C(=[N+](C2=NC3=CC=CC=C3N=C21)CC)C=CC4=C(N(C5=CC=CC=C54)C)C6=CC=CC=C6,,,,,,
1262,91263,"2-(5-Hydroxy-4a,6a,8,8-tetramethyl-2-oxo-2,3,4,4a,4b,5,6,6a,9a,10,10a,10b,11,12-tetradecahydro-6bH,8H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-6b-yl)-2-oxoethyl acetate",CC(=O)OCC(=O)C12C(CC3C1(CC(C4C3CCC5=CC(=O)CCC45C)O)C)OC(O2)(C)C,,,,,,
1263,91264,"1-Chloro-4-(2,2-dichloro-1-methylcyclopropyl)benzene",CC1(CC1(Cl)Cl)C2=CC=C(C=C2)Cl,,,,,,
1264,91265,"1-(2,2-Dichloro-1-methylcyclopropyl)-4-fluorobenzene",CC1(CC1(Cl)Cl)C2=CC=C(C=C2)F,,,,,,
1265,91266,"2,3-Dibromobutanenitrile",CC(C(C#N)Br)Br,,,,,,
1266,91267,Dexclamol,CC(C)[C@]1(CCN2C[C@@H]3C4=CC=CC=C4CCC5=C3C(=CC=C5)[C@H]2C1)O,,,,,,
1267,91268,Theophylline monohydrate,CN1C2=C(C(=O)N(C1=O)C)NC=N2.O,,,"['Compounds that bind to and block the stimulation of PURINERGIC P1 RECEPTORS. (See all compounds classified as Purinergic P1 Receptor Antagonists.)', 'Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)', 'Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)', 'Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases. (See all compounds classified as Phosphodiesterase Inhibitors.)']",,,
1268,91269,"3-[2-[4-(2-Methylphenyl)pyrazin-1-yl]ethyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine;hydrochloride",CC1=CC=CC=C1N2C=CN(C=C2)CCC3=NN=C4N3CCCC4.Cl,,,,,,
1269,91270,Moexipril,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CC3=CC(=C(C=C3C[C@H]2C(=O)O)OC)OC,['For the treatment of hypertension.'],"['Moexipril is a non-sulfhydryl containing precursor of the active angiotensin-converting enzyme (ACE) inhibitor moexiprilat. It is used to treat high blood pressure (hypertension). It works by relaxing blood vessels, causing them to widen. Lowering high blood pressure helps prevent strokes, heart attacks and kidney problems.']","['A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility. (See all compounds classified as Angiotensin-Converting Enzyme Inhibitors.)', 'Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)']","['Moexipril is incompletely absorbed, with bioavailability as moexiprilat of about 13% compared to intravenous (I.V.) moexipril (both measuring the metabolite moexiprilat), and is markedly affected by food, which reduces C<sub>max</sub> and AUC by about 70% and 40%, respectively, after the ingestion of a low-fat breakfast or by 80% and 50%, respectively, after the ingestion of a high-fat breakfast.', 'Moexiprilat undergoes renal elimination.', '183 L', '441 mL/min']","['Rapidly converted to moexiprilat, the active metabolite. Conversion to the active metabolite is thought to require carboxyesterases and is likely to occur in organs or tissues, other than the gastrointestinal tract, in which carboxyesterases occur. The liver is thought to be one site of conversion, but not the primary site.']",['Moexipril elimination half-life is approximately 1 hour. Moexiprilat elimination half-life is 2 to 9 hours.']
1270,91271,Deoxyspergualin trihydrochloride,C(CCCN=C(N)N)CCC(=O)N[C@H](C(=O)NCCCCNCCCN)O.Cl.Cl.Cl,,,,,,
1271,91272,Deoxyspergualin,C(CCCN=C(N)N)CCC(=O)N[C@H](C(=O)NCCCCNCCCN)O,,,"['Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. (See all compounds classified as Immunosuppressive Agents.)', 'Drugs used to protect against ionizing radiation. They are usually of interest for use in radiation therapy but have been considered for other purposes, e.g. military. (See all compounds classified as Radiation-Protective Agents.)', 'Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)', 'Substances which lower blood glucose levels. (See all compounds classified as Hypoglycemic Agents.)']",,,
1272,91273,Tandospirone,C1C[C@H]2C[C@@H]1[C@H]3[C@@H]2C(=O)N(C3=O)CCCCN4CCN(CC4)C5=NC=CC=N5,,,"['Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)', 'Endogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS. (See all compounds classified as Serotonin Receptor Agonists.)']",,,
1273,91274,Tiagabine hydrochloride,CC1=C(SC=C1)C(=CCCN2CCC[C@H](C2)C(=O)O)C3=C(C=CS3)C.Cl,,,"['Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)', 'Compounds that suppress or block the plasma membrane transport of GAMMA-AMINOBUTYRIC ACID by GABA PLASMA MEMBRANE TRANSPORT PROTEINS. (See all compounds classified as GABA Uptake Inhibitors.)']",,,
1274,91275,CID 91275,CON=C(C1=CN=C(S1)N)C(=O)N[C@H]2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC5=C4CCC5)C(=O)[O-],,,,,,
1275,91276,Roxatidine,C1CCN(CC1)CC2=CC(=CC=C2)OCCCNC(=O)CO,,,"['Drugs that selectively bind to but do not activate histamine H2 receptors, thereby blocking the actions of histamine. Their clinically most important action is the inhibition of acid secretion in the treatment of gastrointestinal ulcers. Smooth muscle may also be affected. Some drugs in this class have strong effects in the central nervous system, but these actions are not well understood. (See all compounds classified as Histamine H2 Antagonists.)', 'Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)']",,,
1276,91277,Trepipam,CN1CCC2=CC(=C(C=C2[C@H](C1)C3=CC=CC=C3)OC)OC,,,,,,
1277,91278,"4-((4-(Dimethylamino)phenyl)methylene)-2,4-dihydro-5-methyl-2-phenyl-3H-pyrazol-3-one",CC1=NN(C(=O)C1=CC2=CC=C(C=C2)N(C)C)C3=CC=CC=C3,,,,,,
1278,91279,CID 91279,C1=CSC(=C1)C(=O)[O-].[Na+],,,,,,
1279,91280,Hexahydro-1H-azepine-1-carbaldehyde,C1CCCN(CC1)C=O,,,,,,
1280,91281,"Glutarimide, N,3,3-trimethyl-",CC1(CC(=O)N(C(=O)C1)C)C,,,,,,
1281,91282,4-Cyano-4-phenylcyclohexanone,C1CC(CCC1=O)(C#N)C2=CC=CC=C2,,,,,,
1282,91283,3-Ethoxybenzonitrile,CCOC1=CC=CC(=C1)C#N,,,,,,
1283,91284,"21-Chloro-9-fluoro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl butanoate",CCCC(=O)O[C@@]1([C@H](C[C@@H]2[C@@]1(C[C@@H](C3([C@H]2CCC4=CC(=O)C=C[C@@]43C)F)O)C)C)C(=O)CCl,,,,,,
1284,91285,"Benzenesulfonic acid, 3-[[4-[(4-ethoxyphenyl)azo]-2,5-dimethoxyphenyl]azo]-",CCOC1=CC=C(C=C1)N=NC2=CC(=C(C=C2OC)N=NC3=CC(=CC=C3)S(=O)(=O)O)OC,,,,,,
1285,91286,"n,n'-Dibenzoylcystine",C1=CC=C(C=C1)C(=O)NC(CSSCC(C(=O)O)NC(=O)C2=CC=CC=C2)C(=O)O,,,,,,
1286,91287,3-[p-(Hexyloxy)phenyl]propionic acid,CCCCCCOC1=CC=C(C=C1)CCC(=O)O,,,,,,
1287,91288,"5-(Trimethylsilyl)-1,3-cyclopentadiene",C[Si](C)(C)C1C=CC=C1,,,,,,
1288,91289,(Allyloxy)propanediol,C=CCOC(CO)CO,,,,,,
1289,91290,"2-(2,6-Dichlorophenoxy)propanoic acid",CC(C(=O)O)OC1=C(C=CC=C1Cl)Cl,,,,,,
1290,91291,"1-Ethyl-2-(heptadecyl)-4,5-dihydro-1-(2-hydroxyethyl)-1H-imidazolium ethyl sulphate",CCCCCCCCCCCCCCCCCC1=NCC[N+]1(CC)CCO.CCOS(=O)(=O)[O-],,,,,,
1291,91292,"1-Ethyl-2-heptadecyl-4,5-dihydro-1-(2-hydroxyethyl)-1H-imidazol-1-ium",CCCCCCCCCCCCCCCCCC1=NCC[N+]1(CC)CCO,,,,,,
1292,91293,"Acetic acid, (2,4-dinitrophenoxy)-",C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])OCC(=O)O,,,,,,
1293,91294,"6,11-Dimethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-8-ol--hydrogen chloride (1/1)",CC1[C@@H]2CC3=C([C@]1(CCN2)C)C=C(C=C3)O.Cl,,,,,,
1294,91295,Norpentazocine,CC1[C@@H]2CC3=C([C@]1(CCN2)C)C=C(C=C3)O,,,,,,
1295,91296,N-Methyl-o-phenylenediamine dihydrochloride,CNC1=CC=CC=C1N.Cl.Cl,,,,,,
1296,91297,"Propanenitrile, 2-[(1,1-dimethylethyl)azo]-2-methyl-",CC(C)(C)N=NC(C)(C)C#N,,,,,,
1297,91298,1-(tert-Butylazo)cyclohexanecarbonitrile,CC(C)(C)N=NC1(CCCCC1)C#N,,,,,,
1298,91299,4-(tert-Butylazo)-4-cyanovaleric acid,CC(C)(C)N=NC(C)(CCC(=O)O)C#N,,,,,,
1299,91300,"6,7-Dichlorobenzo[d]thiazol-2-amine",C1=CC(=C(C2=C1N=C(S2)N)Cl)Cl,,,,,,
1300,91301,"3-((4-((6,7-Dichlorobenzothiazol-2-yl)azo)phenyl)ethylamino)propiononitrile",CCN(CCC#N)C1=CC=C(C=C1)N=NC2=NC3=C(S2)C(=CC(=C3)Cl)Cl,,,,,,
1301,91302,Dibutyltin;dodecan-1-ol;hydrate,CCCCCCCCCCCCO.CCCCCCCCCCCCO.CCCC[Sn]CCCC.CCCC[Sn]CCCC.O,,,,,,
1302,91303,CID 91303,CCCCCCCCCCCC(=O)O.CCCCCCCCCCCC(=O)O.CCCCCCCCCCCC(=O)O.CCCC[SnH],,,,,,
1303,91304,"N,N'-Dioctadecyladipamide",CCCCCCCCCCCCCCCCCCNC(=O)CCCCC(=O)NCCCCCCCCCCCCCCCCCC,,,,,,
1304,91305,"1,2-Propanediol diacrylate",CC(COC(=O)C=C)OC(=O)C=C,,,,,,
1305,91306,CID 91306,CCCCCCCCC=CCCCCCCCC(=O)OCC(CO)(CO)COC(=O)CCCCCCCC=CCCCCCCC(C)C,,,,,,
1306,91307,Aluminum antimonide,[Al]#[Sb],,,,,,
1307,91308,2-Piperazineethanol,C1CNC(CN1)CCO,,,,,,
1308,91309,"1-Amino-4-(4-dodecylsulphoanilino)-9,10-dihydro-9,10-dioxoanthracene-2-sulphonic acid",CCCCCCCCCCCCOS(=O)(=O)C1=CC=C(C=C1)NC2=CC(=C(C3=C2C(=O)C4=CC=CC=C4C3=O)N)S(=O)(=O)O,,,,,,
1309,91310,"N,N-Dimethyl-3-(octadec-9-enoylamino)propan-1-amine oxide",CCCCCCCCC=CCCCCCCCC(=O)NCCC[N+](C)(C)[O-],,,,,,
1310,91311,CID 91311,CC1[C@@H]2CC3=C([C@]1(CCN2CC4CCC4)C)C=C(C=C3)O,,,,,,
1311,91312,CID 91312,CCCC[Sn]CCCC.CC(C)CCCCCOC(=O)C=CC(=O)O.CC(C)CCCCCOC(=O)C=CC(=O)O,,,,,,
1312,91313,"2-Butenedioic acid (2Z)-, monoisooctyl ester",CC(C)CCCCCOC(=O)C=CC(=O)O,,,,,,
1313,91314,CID 91314,CCCC[Sn]CCCC.CC(C)(C)CCC(C)(C)C(=O)CO.CC(C)(C)CCC(C)(C)C(=O)O,,,,,,
1314,91315,CID 91315,CC(C)(C)CCC(C)(C)C(=O)CO,,,,,,
1315,91316,"2,2,5,5-tetramethylhexanoic Acid",CC(C)(C)CCC(C)(C)C(=O)O,,,,,,
1316,91317,"Phenol, 2-(4-phenyl-2-quinazolinyl)-",C1=CC=C(C=C1)C2=NC(=NC3=CC=CC=C32)C4=CC=CC=C4O,,,,,,
1317,91318,CID 91318,C1CN(CCN1CCC2=CC=CC=C2)CCOC(C3=CC=CC=C3)C4=CC=C(C=C4)Cl.C(=CC(=O)O)C(=O)O.C(=CC(=O)O)C(=O)O,,,,,,
1318,91319,1-[2-[(4-Chlorophenyl)-phenylmethoxy]ethyl]-4-(2-phenylethyl)piperazine,C1CN(CCN1CCC2=CC=CC=C2)CCOC(C3=CC=CC=C3)C4=CC=C(C=C4)Cl,,,,,,
1319,91320,Tripropoxypropylsilane,CCCO[Si](CCC)(OCCC)OCCC,,,,,,
1320,91321,Ethylenebis(oxyethylene) dihexanoate,CCCCCC(=O)OCCOCCOCCOC(=O)CCCCC,,,,,,
1321,91322,"3-[[4-[(5,6-Dichlorobenzothiazol-2-YL)azo]phenyl]ethylamino]propiononitrile",CCN(CCC#N)C1=CC=C(C=C1)N=NC2=NC3=CC(=C(C=C3S2)Cl)Cl,,,,,,
1322,91323,"9,10-Anthracenedione, 1-amino-4-hydroxy-2-[4-[(2-oxo-1-pyrrolidinyl)methyl]phenoxy]-",C1CC(=O)N(C1)CC2=CC=C(C=C2)OC3=C(C4=C(C(=C3)O)C(=O)C5=CC=CC=C5C4=O)N,,,,,,
1323,91324,"Phosphonothioic acid, ethyl-, O-(2,5-dichloro-4-iodophenyl) O-ethyl ester",CCOP(=S)(CC)OC1=CC(=C(C=C1Cl)I)Cl,,,,,,
1324,91325,"5,6-Dibromocholestan-3beta-ol",CC(C)CCCC(C)C1CCC2C1(CCC3C2CC(C4(C3(CCC(C4)O)C)Br)Br)C,,,,,,
1325,91326,Isopentyl cyclohexanecarboxylate,CC(C)CCOC(=O)C1CCCCC1,,,,,,
1326,91327,"Butyl 2-(2,4-dichlorophenoxy)propionate",CCCCOC(=O)C(C)OC1=C(C=C(C=C1)Cl)Cl,,,,,,
1327,91328,"2,6-Dichlorobenzaldehyde oxime",C1=CC(=C(C(=C1)Cl)C=NO)Cl,,,,,,
1328,91329,"2,2',5-Trichlorobenzophenone",C1=CC=C(C(=C1)C(=O)C2=C(C=CC(=C2)Cl)Cl)Cl,,,,,,
1329,91330,C.I. Direct Red 23,CC(=O)NC1=CC=C(C=C1)N=NC2=C(C=C3C=C(C=CC3=C2O)NC(=O)NC4=CC5=CC(=C(C(=C5C=C4)O)N=NC6=CC=CC=C6)S(=O)(=O)O)S(=O)(=O)O,,,,,,
1330,91331,[2-[[4-[(2-Chloro-4-nitrophenyl)azo]phenyl]ethylamino]ethyl]trimethylammonium chloride,CCN(CC[N+](C)(C)C)C1=CC=C(C=C1)N=NC2=C(C=C(C=C2)[N+](=O)[O-])Cl.[Cl-],,,,,,
1331,91332,(1-Hydroxycyclopentyl)phenylacetic acid,C1CCC(C1)(C(C2=CC=CC=C2)C(=O)O)O,,,,,,
1332,91333,"N,N-Bis(2-hydroxyethyl)formamide",C(CO)N(CCO)C=O,,,,,,
1333,91334,"1,1,3-Tris(3-tert-butyl-4-hydroxyphenyl)butane",CC(CC(C1=CC(=C(C=C1)O)C(C)(C)C)C2=CC(=C(C=C2)O)C(C)(C)C)C3=CC(=C(C=C3)O)C(C)(C)C,,,,,,
1334,91335,"Formaldehyde, polymer with benzenamine",C=O.C1=CC=C(C=C1)N,,,,,,
1335,91336,3-sec-Butylpyridine,CCC(C)C1=CN=CC=C1,,,,,,
1336,91337,"Cyclohexanemethanol, alpha,3,3-trimethyl-, formate",CC(C1CCCC(C1)(C)C)OC=O,,,,,,
1337,91338,"alpha,3,3-Trimethylcyclohexanemethanol",CC(C1CCCC(C1)(C)C)O,,,,,,
1338,91339,"1-(3,3-Dimethylcyclohexyl)ethyl acetate",CC(C1CCCC(C1)(C)C)OC(=O)C,,,,,,
1339,91340,Cinnamaldehyde Diethylacetal,CCOC(C=CC1=CC=CC=C1)OCC,,,,,,
1340,91341,3-Morpholino-2-cyanoacrylamide,C1COCCN1C=C(C#N)C(=O)N,,,,,,
1341,91342,2-Ethyloctanoic acid,CCCCCCC(CC)C(=O)O,,,,,,
1342,91343,Lauroylcholine chloride,CCCCCCCCCCCC(=O)OCC[N+](C)(C)C.[Cl-],,,,,,
1343,91344,"Ethanaminium, N,N,N-trimethyl-2-[(1-oxododecyl)oxy]-",CCCCCCCCCCCC(=O)OCC[N+](C)(C)C,,,,,,
1344,91345,4-Chloroindole,C1=CC2=C(C=CN2)C(=C1)Cl,,,,,,
1345,91346,"2-(2,3-Dihydroxypropoxy)benzamide",C1=CC=C(C(=C1)C(=O)N)OCC(CO)O,,,,,,
1346,91347,CID 91347,CCCCOP(=O)([O-])OCCCC.[K+],,,,,,
1347,91348,CID 91348,CCCCOP(=O)(O)[O-].[K+],,,,,,
1348,91349,"6H-Benzotriazolo[2,1-a]benzotriazol-5-ium, 1,3,7,9-tetranitro-, inner salt",C1=C(C=C(C2=C1N3N=C4C(=CC(=CC4=[N+]3[N-]2)[N+](=O)[O-])[N+](=O)[O-])[N+](=O)[O-])[N+](=O)[O-],,,,,,
1349,91350,"1,3,7,9-tetranitro-6H-benzotriazolo[2,1-a]benzotriazol-5-ium",C1=C(C=C(C2=C1N3N=C4C(=CC(=CC4=[N+]3N2)[N+](=O)[O-])[N+](=O)[O-])[N+](=O)[O-])[N+](=O)[O-],,,,,,
1350,91351,1-(Allyloxy)-2-bromobenzene,C=CCOC1=CC=CC=C1Br,,,,,,
1351,91352,1-(10H-Phenothiazin-2-yl)butan-1-one,CCCC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2,,,,,,
1352,91353,"2-Bromo-1,4-dimethoxybenzene",COC1=CC(=C(C=C1)OC)Br,,,,,,
1353,91354,Aromadendrene,CC1CCC2C1C3C(C3(C)C)CCC2=C,,,,,,
1354,91355,4-Hydroxy-6-(3-sulphoanilino)naphthalene-2-sulphonic acid,C1=CC(=CC(=C1)S(=O)(=O)O)NC2=CC3=C(C=C(C=C3C=C2)S(=O)(=O)O)O,,,,,,
1355,91356,3-(tert-Butyldioxy)-3-phenylphthalide,CC(C)(C)OOC1(C2=CC=CC=C2C(=O)O1)C3=CC=CC=C3,,,,,,
1356,91357,"5-Hydroxy-4,4-dimethylvaleronitrile",CC(C)(CCC#N)CO,,,,,,
1357,91358,"2-Naphthalenecarboxamide, N-(4-chloro-2,5-dimethoxyphenyl)-3-hydroxy-7-methoxy-",COC1=CC2=CC(=C(C=C2C=C1)O)C(=O)NC3=CC(=C(C=C3OC)Cl)OC,,,,,,
1358,91359,"7-((4,6-Dichloro-1,3,5-triazin-2-yl)amino)-4-hydroxy-3-((4-methoxy-2-sulphophenyl)azo)naphthalene-2-sulphonic acid",COC1=CC(=C(C=C1)N=NC2=C(C=C3C=C(C=CC3=C2O)NC4=NC(=NC(=N4)Cl)Cl)S(=O)(=O)O)S(=O)(=O)O,,,,,,
1359,91360,"Hexahydro-1,3,5-tris(2-hydroxypropyl)-s-triazine",CC(CN1CN(CN(C1)CC(C)O)CC(C)O)O,,,,,,
1360,91361,Isobutyl myristate,CCCCCCCCCCCCCC(=O)OCC(C)C,,,,,,
1361,91362,1-((3-(Dimethylamino)propyl)amino)-4-(methylamino)anthraquinone,CNC1=C2C(=C(C=C1)NCCCN(C)C)C(=O)C3=CC=CC=C3C2=O,,,,,,
1362,91363,CID 91363,C1=CC=C(C=C1)S(=O)(=O)NCCCS(=O)(=O)[O-].[Na+],,,,,,
1363,91364,3-(Benzenesulfonamido)propane-1-sulfonic acid,C1=CC=C(C=C1)S(=O)(=O)NCCCS(=O)(=O)O,,,,,,
1364,91365,"1,2,3,5-Tetrapropylbenzene",CCCC1=CC(=C(C(=C1)CCC)CCC)CCC,,,,,,
1365,91366,CID 91366,CC(=CC(=O)C)[O-].CC(=CC(=O)C)[O-].CC(=CC(=O)C)[O-].CC(=CC(=O)C)[O-].[Sn+4],,,,,,
1366,91367,Trimethylolpropane trilaurate,CCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCC,,,,,,
1367,91368,"2,2-Bis(tetradecanoyloxymethyl)butyl tetradecanoate",CCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCC,,,,,,
1368,91369,2-(((Heptadecafluorooctyl)sulphonyl)methylamino)ethyl acrylate,CN(CCOC(=O)C=C)S(=O)(=O)C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
1369,91370,"3,4-Dihydroxy-5-(3-methylbut-2-enyl)-4-(4-methyl-1-oxopent-3-enyl)-2-(2-methyl-1-oxopropyl)cyclopent-2-en-1-one",CC(C)C(=O)C1=C(C(C(C1=O)CC=C(C)C)(C(=O)CC=C(C)C)O)O,,,,,,
1370,91371,Lanthanum phosphide (LaP),P#[La],,,,,,
1371,91372,Cerium phosphide,P#[Ce],,,,,,
1372,91373,1-Pentadecanethiol,CCCCCCCCCCCCCCCS,,,,,,
1373,91374,"3-Ethoxy-N,N-dimethylpropylamine",CCOCCCN(C)C,,,,,,
1374,91375,"2,6-Dimethyloct-7-en-2-yl formate",CC(CCCC(C)(C)OC=O)C=C,,,,,,
1375,91376,"Cholest-5-en-3-yl 3,5-dinitrobenzoate",CC(C)CCCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC(=O)C5=CC(=CC(=C5)[N+](=O)[O-])[N+](=O)[O-])C)C,,,,,,
1376,91377,"9,10-Anthracenedione, 1-amino-2-bromo-4,8-dihydroxy-5-[(phenylmethyl)amino]-",C1=CC=C(C=C1)CNC2=C3C(=C(C=C2)O)C(=O)C4=C(C3=O)C(=CC(=C4N)Br)O,,,,,,
1377,91378,"1-Propanone, 3-(dimethylamino)-1,2-diphenyl-, hydrochloride",CN(C)CC(C1=CC=CC=C1)C(=O)C2=CC=CC=C2.Cl,,,,,,
1378,91379,"3-Dimethylamino-1,2-diphenyl-propan-1-one",CN(C)CC(C1=CC=CC=C1)C(=O)C2=CC=CC=C2,,,,,,
1379,91380,3-(Diethylamino)-2-phenylpropiophenone hydrochloride,CCN(CC)CC(C1=CC=CC=C1)C(=O)C2=CC=CC=C2.Cl,,,,,,
1380,91381,"3-(Diethylamino)-1,2-diphenylpropan-1-one",CCN(CC)CC(C1=CC=CC=C1)C(=O)C2=CC=CC=C2,,,,,,
1381,91382,"Spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one, 3'-(diethylamino)-7'-methyl-",CCN(CC)C1=CC2=C(C=C1)C3(C4=CC=CC=C4C(=O)O3)C5=C(O2)C=CC(=C5)C,,,,,,
1382,91383,"2-Propanone, 1-(1-hydroxycyclohexyl)-",CC(=O)CC1(CCCCC1)O,,,,,,
1383,91384,(Perfluorohexyl)ethylene,C=CC(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
1384,91385,CID 91385,C1=CC=C2C(=C1)C=CC(=C2S(=O)(=O)[O-])N.[Na+],,,,,,
1385,91386,"Propionic acid, 5-nitro-2-furfuryl ester",CCC(=O)OCC1=CC=C(O1)[N+](=O)[O-],,,,,,
1386,91387,Methylphosphinic acid 2-methylpropyl ester,CC(C)COP(=O)C,,,,,,
1387,91388,"3,3-Dimethylcyclohexyl methyl ketone",CC(=O)C1CCCC(C1)(C)C,,,,,,
1388,91389,6-((4-Aminophenyl)azo)-5-hydroxynaphthalene-1-sulphonic acid,C1=CC2=C(C=CC(=C2O)N=NC3=CC=C(C=C3)N)C(=C1)S(=O)(=O)O,,,,,,
1389,91390,Dimethyl (methoxymethyl)succinate,COCC(CC(=O)OC)C(=O)OC,,,,,,
1390,91391,"1,1,1-Trichloro-4-methylpent-4-en-2-ol",CC(=C)CC(C(Cl)(Cl)Cl)O,,,,,,
1391,91392,"1,1,1-Trichloro-4-methylpent-4-en-2-yl acetate",CC(=C)CC(C(Cl)(Cl)Cl)OC(=O)C,,,,,,
1392,91393,4-Ethylbenzonitrile,CCC1=CC=C(C=C1)C#N,,,,,,
1393,91394,Acid Green 50 parent,CN(C)C1=CC=C(C=C1)C(=C2C=CC(=[N+](C)C)C=C2)C3=C4C=CC(=CC4=CC(=C3O)S(=O)(=O)[O-])S(=O)(=O)O,,,,,,
1394,91395,C.I. Food Green 4,CN(C)C1=CC=C(C=C1)C(=C2C=CC(=[N+](C)C)C=C2)C3=C4C=CC(=CC4=CC(=C3O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
1395,91396,"Spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one, 3',6'-dimercapto-",C1=CC=C2C(=C1)C(=O)OC23C4=C(C=C(C=C4)S)OC5=C3C=CC(=C5)S,,,,,,
1396,91397,"3,5-Dichloro-4-hydroxybenzenesulfonic acid",C1=C(C=C(C(=C1Cl)O)Cl)S(=O)(=O)O,,,,,,
1397,91398,2-Naphthyl alpha-D-glucopyranoside,C1=CC=C2C=C(C=CC2=C1)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O,,,,,,
1398,91399,"Naphthalenesulfonic acid, dinonyl-",CCCCCCCCCC1=CC=CC2=CC(=CC(=C21)CCCCCCCCC)S(=O)(=O)O,,,,,,
1399,91400,"1-Hexadecanamine, N,N-dimethyl-, acetate",CCCCCCCCCCCCCCCCN(C)C.CC(=O)O,,,,,,
1400,91401,1-(10-Methyl-10H-phenothiazin-2-yl)ethan-1-one,CC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2C,,,,,,
1401,91402,Pheniramine hydrochloride,CN(C)CCC(C1=CC=CC=C1)C2=CC=CC=N2.Cl,,,,,,
1402,91403,Dimetridazole hydrochloride,CC1=NC=C(N1C)[N+](=O)[O-].Cl,,,,,,
1403,91404,(R)-(-)-3-Quinuclidinol,C1CN2CCC1[C@H](C2)O,,,,,,
1404,91405,endo-8-Methyl-8-azabicyclo(3.2.1)oct-3-yl 2-propylvalerate,CCCC(CCC)C(=O)OC1C[C@H]2CC[C@@H](C1)N2C,,,,,,
1405,91406,But-2-enedioic acid;1-[10-[3-(dimethylamino)propyl]phenothiazin-2-yl]propan-1-one,CCC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN(C)C.C(=CC(=O)O)C(=O)O,,,,,,
1406,91407,Spasmolytol,CCN(CC)CCOCC1=C(C(=CC(=C1)Br)Br)OC,,,,,,
1407,91408,Niacinamide hydrochloride,C1=CC(=CN=C1)C(=O)N.Cl,,,,,,
1408,91409,"Propane, 2-(1-ethoxyethoxy)-",CCOC(C)OC(C)C,,,,,,
1409,91410,Isocetyl stearate,CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C,,,,,,
1410,91411,"6-Cyclohexyl-1,3,5-triazine-2,4-diamine",C1CCC(CC1)C2=NC(=NC(=N2)N)N,,,,,,
1411,91412,"(3-Hydroxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl) octadec-9-enoate",CCCCCCCCC=CCCCCCCCC(=O)OC1COC2C1OCC2O,,,,,,
1412,91413,"4-Methylthiomorpholine 1,1-dioxide",CN1CCS(=O)(=O)CC1,,,,,,
1413,91414,3-Bromo-3-methylpentane,CCC(C)(CC)Br,,,,,,
1414,91415,2-Chloro-4-methylpentane,CC(C)CC(C)Cl,,,,,,
1415,91416,1-Bromo-2-methylpentane,CCCC(C)CBr,,,,,,
1416,91417,"Ethanethiol, 2-((3,7-dimethyloctyl)amino)-, hydrogen sulfate (ester)",CC(C)CCCC(C)CCNCCSS(=O)(=O)O,,,,,,
1417,91418,5-(2-Sulfosulfanylethylamino)pentylbenzene,C1=CC=C(C=C1)CCCCCNCCSS(=O)(=O)O,,,,,,
1418,91419,4-Ketoamyltrimethylammonium iodide,CC(=O)CCC[N+](C)(C)C.[I-],,,,,,
1419,91420,Trimethyl(4-oxopentyl)ammonium,CC(=O)CCC[N+](C)(C)C,,,,,,
1420,91421,N-[3-(cinnamylideneamino)propyl]-3-phenylprop-2-en-1-imine,C1=CC=C(C=C1)C=CC=NCCCN=CC=CC2=CC=CC=C2,,,,,,
1421,91422,"2,2-Bis(hydroxymethyl)propane-1,3-diyl dilaurate",CCCCCCCCCCCC(=O)OCC(CO)(CO)COC(=O)CCCCCCCCCCC,,,,,,
1422,91423,"2,2-Bis(hydroxymethyl)propane-1,3-diyl dipalmitate",CCCCCCCCCCCCCCCC(=O)OCC(CO)(CO)COC(=O)CCCCCCCCCCCCCCC,,,,,,
1423,91424,2-Methylpentadecanoic acid,CCCCCCCCCCCCCC(C)C(=O)O,,,,,,
1424,91425,2-Ethyltetradecanoic acid,CCCCCCCCCCCCC(CC)C(=O)O,,,,,,
1425,91426,Heptyl sulfoxide,CCCCCCCS(=O)CCCCCCC,,,,,,
1426,91427,Ethylsuccinaldehyde,CCC(CC=O)C=O,,,,,,
1427,91428,"[[(2R,3S,4R,5S)-5-(6-amino-7H-purin-8-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate",C1C=CN(C=C1C(=O)N)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)OC[C@@H]3[C@H]([C@H]([C@@H](O3)C4=NC5=NC=NC(=C5N4)N)O)O)O)O,,,,,,
1428,91429,Quinine dihydrochloride,COC1=CC2=C(C=CN=C2C=C1)[C@H]([C@@H]3C[C@@H]4CCN3C[C@@H]4C=C)O.Cl.Cl,,,"['A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358) (See all compounds classified as Muscle Relaxants, Central.)', 'A subclass of analgesic agents that typically do not bind to OPIOID RECEPTORS and are not addictive. Many non-narcotic analgesics are offered as NONPRESCRIPTION DRUGS. (See all compounds classified as Analgesics, Non-Narcotic.)', 'Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)']",,,
1429,91430,Phentolamine mesylate,CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O.CS(=O)(=O)O,,,"['Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. (See all compounds classified as Adrenergic alpha-Antagonists.)', 'Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)']",,,
1430,91431,"D-Glucose, 2-amino-2-deoxy-, hydrochloride",C([C@H]([C@H]([C@@H]([C@H](C=O)N)O)O)O)O.Cl,,,,,,
1431,91432,3h-d-Glucosamine,C(C([C@H]([C@@H]([C@H](C=O)N)O)O)O)O,,,,,,
1432,91433,"(1R,2S,4S,5'R,6R,7S,9S,12S,13S,16S,18S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane]-16-ol",C[C@@H]1CC[C@@]2([C@H](C3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC[C@@H]6[C@@]5(CC[C@@H](C6)O)C)C)C)OC1,,,,,,
1433,91434,Sambunigrin,C1=CC=C(C=C1)[C@@H](C#N)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O,,,,,,
1434,91435,Lactate,CC(C(=O)[O-])O,,,,,,
1435,91436,Octadec-9-enoate,CCCCCCCCC=CCCCCCCCC(=O)[O-],,,,,,
1436,91437,Terreic acid,CC1=C(C(=O)[C@H]2[C@@H](C1=O)O2)O,,,,,,
1437,91438,Prednisone acetate,CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CCC4=CC(=O)C=C[C@]34C)C)O,,,,,,
1438,91439,Smilagenin,C[C@@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC[C@H]6[C@@]5(CC[C@@H](C6)O)C)C)C)OC1,"[""Investigated for use/treatment in alzheimer's disease, parkinson's disease and other neurodegenerative diseases.""]","['Smilagenin is a novel non-peptide, orally bioavailable neurotrophic factor inducer that readily reverses free radical neurotoxicity produced by 1-ethyl-4- phenylpyridium (MPP+) in dopaminergic neurones and reverses the decrease of neuronal growth factors and dopamine receptors in the brain.  P58 is a protein synthesis stimulant acts by restoring levels of proteins that are altered in the ageing brain, reversing the loss of nerve receptors in the ageing brain and potentially allowing for the regrowth of neural connections. P58 therefore provides a totally novel mode of action with potential importance for diseases associated with ageing of the brain. P58 is one of a family of phytochemicals isolated from traditional treatments for the elderly that have previously been shown to offer significant benefit in the treatment of senile dementia.']",,,,
1439,91440,Sennoside B,C1=CC2=C(C(=C1)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)C(=O)C4=C([C@@H]2[C@H]5C6=C(C(=CC=C6)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)C(=O)C8=C5C=C(C=C8O)C(=O)O)C=C(C=C4O)C(=O)O,,,,,,
1440,91441,Chloroquine sulfate,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl.OS(=O)(=O)O,,,"['Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)', 'Drugs that are used to treat RHEUMATOID ARTHRITIS. (See all compounds classified as Antirheumatic Agents.)', 'Agents which are destructive to amebae, especially the parasitic species causing AMEBIASIS in man and animal. (See all compounds classified as Amebicides.)']",,,
1441,91442,Diethylpropion Hydrochloride,CCN(CC)C(C)C(=O)C1=CC=CC=C1.Cl,,,['Agents that are used to suppress appetite. (See all compounds classified as Appetite Depressants.)'],,,
1442,91443,CID 91443,C1C(NC2=C(N1)NC(=NC2=O)N)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,,,,,,
1443,91444,3-(2-Thienyl)alanine,C1=CSC(=C1)CC(C(=O)O)N,,,,,,
1444,91445,CID 91445,CC1=C(C(C[C@@H](C1)O)(C)C)C=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=CC2=C(C[C@H](CC2(C)C)O)C)C)C,,,,,,
1445,91446,CID 91446,C([C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)OC2=C(NC(=NC2=O)N)N)O)O)O)O,,,,,,
1446,91447,"1,2:5,6-Diepoxycyclooctane",C1CC2C(O2)CCC3C1O3,,,,,,
1447,91448,CID 91448,C[C@H](CCC(=O)[O-])[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C.[Na+],,,,,,
1448,91449,"(4R)-4-[(3R,5R,8R,9S,10S,12S,13R,14S)-3,12-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid",C[C@H](CCC(=O)O)C1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C,,,,,,
1449,91450,"3,3,3-Trifluoro-2-(trifluoromethyl)propene",C=C(C(F)(F)F)C(F)(F)F,,,,,,
1450,91451,17alpha-Hydroxypregnenolone,CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C)O,,,,,,
1451,91452,Fenfluramine hydrochloride,CCNC(C)CC1=CC(=CC=C1)C(F)(F)F.Cl,['Treatment of seizures associated with Dravet syndrome as an add-on therapy to other antiepileptic medicines for patients 2 years of age and older.'],,"['Drugs used for their effects on serotonergic systems. Among these are drugs that affect serotonin receptors, the life cycle of serotonin, and the survival of serotonergic neurons. (See all compounds classified as Serotonin Agents.)', 'Compounds that specifically inhibit the reuptake of serotonin in the brain. (See all compounds classified as Selective Serotonin Reuptake Inhibitors.)']",,,
1452,91453,Hecogenin,C[C@@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(C(=O)C[C@H]5[C@H]4CC[C@@H]6[C@@]5(CC[C@@H](C6)O)C)C)C)OC1,,,,,,
1453,91454,"(4R,4aS,6aR,6aS,6bR,8aR,12aR,14bS)-2,2,6a,6b,9,9,12a-heptamethyl-4-(2-methylbut-2-enoyloxy)-10-oxo-3,4,5,6,6a,7,8,8a,11,12,13,14b-dodecahydro-1H-picene-4a-carboxylic acid",CC=C(C)C(=O)O[C@@H]1CC(C[C@@H]2[C@]1(CC[C@@]3(C2=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CCC(=O)C5(C)C)C)C)C)C(=O)O)(C)C,,,,,,
1454,91455,"alpha-D-Glucopyranoside, beta-D-fructofuranosyl O-alpha-D-galactopyranosyl-(1.fwdarw.6)-O-alpha-D-galactopyranosyl-(1.fwdarw.6)-",C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)OC[C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)OC[C@@H]3[C@@H]([C@@H]([C@H]([C@H](O3)O[C@]4([C@H]([C@@H]([C@H](O4)CO)O)O)CO)O)O)O)O)O)O)O)O)O)O,,,,,,
1455,91456,beta-Thujone,C[C@H]1[C@H]2C[C@]2(CC1=O)C(C)C,,,,,['(+)-isothujone has known human metabolites that include 4-Hydroxy-beta-thujone and 7-Hydroxy-beta-thujone.'],
1456,91457,beta-Eudesmol,C[C@]12CCCC(=C)[C@@H]1C[C@@H](CC2)C(C)(C)O,,,,,,
1457,91458,Aucubin,C1=CO[C@H]([C@H]2[C@@H]1[C@@H](C=C2CO)O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O,,,,,,
1458,91459,"(1R,6R,7R,11S,17R)-4-ethylidene-7-hydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.014,17]heptadecane-3,8-dione",CC=C1C[C@H]([C@@](C(=O)OC[C@H]2CCN3[C@H]2[C@@H](CC3)OC1=O)(C)O)C,,,,,,
1459,91460,"(1R,2R,3S,5S)-3-hydroxy-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid",CN1[C@H]2CC[C@@H]1[C@H]([C@H](C2)O)C(=O)O,,,['Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS. (See all compounds classified as Narcotics.)'],,,
1460,91461,Lupinine,C1CCN2CCC[C@H]([C@H]2C1)CO,,,,,,
1461,91462,3-[(2S)-pyrrolidin-2-yl]pyridine,C1C[C@H](NC1)C2=CN=CC=C2,,,"['Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)']",,['Nornicotine is a known human metabolite of nicotine.'],
1462,91463,Sobrerol,CC1=CCC(CC1O)C(C)(C)O,,,"['Agents that increase mucous excretion. Mucolytic agents, that is drugs that liquefy mucous secretions, are also included here. (See all compounds classified as Expectorants.)']",,,
1463,91464,"[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] 2-phenyl-N-sulfooxyethanimidothioate",C1=CC=C(C=C1)CC(=NOS(=O)(=O)O)S[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O,,,,,,
1464,91465,epi-Coprostanol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)C,,,,,,
1465,91466,Matrine,C1C[C@@H]2[C@H]3CCCN4[C@H]3[C@@H](CCC4)CN2C(=O)C1,,,,,,
1466,91467,Streptovitacin A,CC1CC(CC(C1=O)C(CC2CC(=O)NC(=O)C2)O)(C)O,,,,,,
1467,91468,(+)-Isopilocarpine,CC[C@@H]1[C@H](COC1=O)CC2=CN=CN2C,,,"['Drugs that bind to and activate muscarinic cholinergic receptors (RECEPTORS, MUSCARINIC). Muscarinic agonists are most commonly used when it is desirable to increase smooth muscle tone, especially in the GI tract, urinary bladder and the eye. They may also be used to reduce heart rate. (See all compounds classified as Muscarinic Agonists.)', 'Agents causing contraction of the pupil of the eye. Some sources use the term miotics only for the parasympathomimetics but any drug used to induce miosis is included here. (See all compounds classified as Miotics.)']",,,
1468,91469,Equol,C1[C@H](COC2=C1C=CC(=C2)O)C3=CC=C(C=C3)O,,,"['Compounds derived from plants, primarily ISOFLAVONES that mimic or modulate endogenous estrogens, usually by binding to ESTROGEN RECEPTORS. (See all compounds classified as Phytoestrogens.)']",,,
1469,91470,CID 91470,CC(=CCCC(=CCCC(=CCCC(=CC=CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C)C)C)C,,,,,,
1470,91471,Lupanine,C1CCN2C[C@@H]3C[C@H]([C@@H]2C1)CN4[C@@H]3CCCC4=O,,,,,,
1471,91472,Friedelin,C[C@H]1C(=O)CC[C@@H]2[C@@]1(CC[C@H]3[C@]2(CC[C@@]4([C@@]3(CC[C@@]5([C@H]4CC(CC5)(C)C)C)C)C)C)C,,,,,,
1472,91473,7 beta-Hydroxy Cholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@H](C=C4[C@@]3(CCC(C4)O)C)O)C,,,,,,
1473,91474,7-Ketocholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C(=O)C=C4[C@@]3(CC[C@@H](C4)O)C)C,,,['Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)'],,,
1474,91475,"2-hydroxy-1-[(5R,8R,9S,10S,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone",C[C@]12CCC(C[C@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@H]4C(=O)CO)C)O,,,"['Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)', 'Agents capable of inducing a total or partial loss of sensation, especially tactile sensation and pain. They may act to induce general ANESTHESIA, in which an unconscious state is achieved, or may act locally to induce numbness or lack of sensation at a targeted site. (See all compounds classified as Anesthetics.)', 'Endogenous compounds or drugs that affect neuronal excitability through modulation of specific ionotropic receptors (e.g., GABA-A RECEPTORS). Endogenous neurosteroids are steroid hormones de novo synthesized by neurons and glial cells from steroid metabolite precursors (e.g., PREGNENOLONE). (See all compounds classified as Neurosteroids.)']",,,
1475,91476,"(2S,3R,4R,5R)-4-[(2S,3R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexane-1,2,3,5,6-pentol",C([C@@H]1[C@@H](C([C@H]([C@@H](O1)O[C@H]([C@@H](CO)O)[C@@H]([C@H](CO)O)O)O)O)O)O,,,,,,
1476,91477,Cholest-4-en-3-one,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,,,,,,
1477,91478,"2-(1-Amino-1-cyclohexylethyl)-4,6-dibromoaniline;hydrochloride",CC(C1CCCCC1)(C2=C(C(=CC(=C2)Br)Br)N)N.Cl,,,,,,
1478,91479,"2-(1-Amino-1-cyclohexylethyl)-4,6-dibromoaniline",CC(C1CCCCC1)(C2=C(C(=CC(=C2)Br)Br)N)N,,,,,,
1479,91480,Nirvanol,CCC1(C(=O)NC(=O)N1)C2=CC=CC=C2,,,['Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)'],,['Nirvanol has known human metabolites that include Nirvanol N-glucuronide.'],
1480,91481,Triphenylstannylium,C1=CC=C(C=C1)[Sn+](C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
1481,91482,DL-o-Tyrosine,C1=CC=C(C(=C1)CC(C(=O)O)N)O,,,,,,
1482,91483,6-Methyl-4-nitroquinoline 1-oxide,CC1=CC2=C(C=C[N+](=C2C=C1)[O-])[N+](=O)[O-],,,,,,
1483,91484,CID 91484,C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]4[C@@]3(C[C@@H](C4=C(CCC=C(C)C)C(=O)[O-])OC(=O)C)C)O)C.[Na+],,,,,,
1484,91485,CID 91485,CC1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]4[C@@]3(C[C@@H](C4=C(CCC=C(C)C)C(=O)O)OC(=O)C)C)O)C,,,,,,
1485,91486,Sphinganine,CCCCCCCCCCCCCCC[C@H]([C@H](CO)N)O,,,['Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)'],,,
1486,91487,"3,4-Dichloro-5-hydroxyfuran-2(5H)-one",C1(C(=C(C(=O)O1)Cl)Cl)O,,,,,,
1487,91488,Fluocinolone,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O,,,,,,
1488,91489,Diazoacetylglycinamide,C(C(=O)N)NC(=O)C=[N+]=[N-],,,,,,
1489,91490,2-[(2-Amino-2-oxoethyl)amino]-2-hydroxyethenediazonium,C(C(=O)N)NC(=C[N+]#N)O,,,,,,
1490,91491,Diethyltin dichloride,CC[Sn](CC)(Cl)Cl,,,,,,
1491,91492,"(1R,3R,4S,5R)-3-[3-(3,4-dihydroxyphenyl)prop-2-enoyloxy]-1,4,5-trihydroxycyclohexane-1-carboxylic acid",C1[C@H]([C@@H]([C@@H](C[C@]1(C(=O)O)O)OC(=O)C=CC2=CC(=C(C=C2)O)O)O)O,,,,,,
1492,91493,6-Phosphogluconic acid,C([C@H]([C@H]([C@@H]([C@H](C(=O)O)O)O)O)O)OP(=O)(O)O,,,,,,
1493,91494,5-Bromouridine,C1=C(C(=O)NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)Br,,,"['Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)', 'Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)', 'Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)']",,,
1494,91495,Dexbrompheniramine (maleate),CN(C)CCC(C1=CC=C(C=C1)Br)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O,,,,,,
1495,91496,Limonene oxide,CC(=C)C1CCC2(C(C1)O2)C,,,,,,
1496,91497,Galaxolide,CC1COCC2=CC3=C(C=C12)C(C(C3(C)C)C)(C)C,,,,"[""The systemic exposure to 1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexa-methylcyclopenta-gamma-2-benzopyran (HHCB) was determined ... in humans under simulated conditions of exposure. Ring (14)C-labeled HHCB was applied in alcoholic solutions without occlusion to three male volunteers at concentrations approximating that which might be encountered in a typical cologne type product. After a 6-hr period, all material was removed from the surface of the skin. Blood, feces and urine were collected over a 5-day period. For both materials, levels in blood and plasma were below limits of detection at all times. Based on excretion, primarily in the urine, the total absorbed dose was approximately 0.1% for HHCB. However, over the 5-day period, 19.5% of HHCB was recovered from the skin in dressings over the site of application indicating that a 'reservoir' had formed in the skin but the material in the reservoir was lost, by desquamation and/or by reverse absorption, and not available systemically. A mean of 22% was shown to evaporate under the conditions of exposure."", '... The systemic exposure to 1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexa-methylcyclopenta-gamma-2-benzopyran (HHCB) was determined in rats under occlusion. Ring (14)C-labeled HHCB was applied dermally in alcoholic solutions to rats at doses of 4.5 mg/kg and occluded for 6 hr. Urine, feces and air were collected for up to 120 hr and analyzed for radioactivity. Pairs of rats were sacrificed periodically for analysis of tissues and organs. The total amount absorbed was approximately 14% for HHCB. Significant amounts diffused into the skin, most of which was further absorbed but a significant amount of which was lost to surface dressing by reverse diffusion and/or desquamation.', 'In the current study, the bioconcentration behavior and acute toxicity of ... galaxolide 1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexa-methylcyclopenta[gamma]-2-benzopyran (HHCB), was studied in two benthic organisms ... Chironomus riparius exhibited bioconcentration factors (BCFs) for ... HHCB substantially lower than predicted for nontransformed organics. The BCF ... increased after coexposure of the organism to the cytochrome P450 inhibitor piperonyl butoxide. Thus, the low BCF values were the result of rapid biotransformation of HHCB in the midge larvae. Bioconcentration kinetics indicated that /HHCB/ induced its own cytochrome P450-mediated metabolism. Acute toxicity of /HHCB/ to midge larvae was reduced compared to predicted baseline toxicity. Bioconcentration of HHCB ... in the worm (Lumbriculus variegatus) is in agreement with predictions based on the octanol-water partition coefficients of this chemical. Acute toxicity was found to be similar to predicted values for baseline toxicity.', '/MILK/ Synthetic musk compounds are used as additives in many consumer products, including perfumes, deodorants, and detergents. Earlier studies have reported the occurrence of synthetic musks in environmental and wildlife samples collected in the United States. In this study, human breast milk samples collected from Massachusetts, were analyzed for the determination of concentrations of synthetic musks such as musk xylene (1-tert-butyl-3,5-dimethyl-2,4,6-trinitrobenzene), musk ketone (4-tert-butyl-2,6-dimethyl-3,5-dinitroacetophenone), HHCB (1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylcyclopenta[gamma]-2-benzopyran), AHTN (7-acetyl-1,1,3,4,4,6-hexamethyl-1,2,3,4-tetrahydronaphthalene), and HHCB-lactone, the oxidation product of HHCB. In addition, we estimated the daily intake of synthetic musks by infants based on the ingestion rate of breast milk. Synthetic musks were found in most of the samples analyzed, and the concentrations ranged from < 2 to 150 ng musk xylene/g, < 2 to 238 ng musk ketone/ g, < 5 to 917 ng HHCB/g, < 5 to 144 ng AHTN/g, and < 10 to 88.0 ng HHCB-lactone/g, on a lipid weight basis. The concentrations of HHCB were higher than the concentrations of other synthetic musks in breast milk samples. The mean concentration of HHCB (220 ng/g, lipid weight) was 5 times greater than the concentrations reported 10 years ago for breast milk samples collected in Germany and Denmark. Maternal age was not correlated with the concentrations of musk xylene, musk ketone, HHCB, or AHTN. There was a trend of decreasing concentrations of musk xylene, musk ketone, HHCB, and AHTN, with the number of children previously breast-fed, although the correlation was not significant. Based on average daily ingestion rate of breast milk, an infant is estimated to ingest 297 +/- 229 ng musk xylene, 780 +/- 805 ng musk ketone, 1830 +/- 1170 ng HHCB, 565 +/- 614 ng AHTN, and 649 +/- 598 ng HHCB-lactone per day. The ingestion rate of synthetic musks by infants in the United States is lower than that estimated for persistent organic pollutants (POPs) such as polychlorinated biphenyls (PCBs). Based on the residue patterns and accumulation features, it can be concluded that the exposure characteristics for synthetic musks are different from those of POPs, and that the major source of exposure to synthetic musks is probably via dermal absorption or inhalation.', 'For more Absorption, Distribution and Excretion (Complete) data for Galaxolide (11 total), please visit the HSDB record page.']","['This study investigates the metabolism and mode of action of galaxolide (HHCB) in the European sea bass -Dicentrarchus labrax- following a single intraperitoneal injection of 50 mg HHCB/kg body weight. In addition, a group of fish was injected with 50 mg/kg of ketoconazole (KCZ), a fungicide that is known to interfere with different Cyp isoenzymes. HHCB was actively metabolized by sea bass and acted as a weak inhibitor of the synthesis of oxyandrogens in gonads of male fish. Both, HHCB and a hydroxylated metabolite were detected in bile. The fungicide ketoconazole was a strong inhibitor of Cyp11beta and Cyp3a-catalyzed activities. The work contributes to the better understanding of the impact of synthetic musks on fish and proposes the determination of HHCB and/or its hydroxylated metabolite in bile as a tool to assess environmental exposure in wild fish.', 'The interactions of emerging contaminants with the xenobiotic and endogenous metabolizing system of deep-sea fish were compared. The drugs diclofenac, fluoxetine, and gemfibrozil belong to different pharmaceutical classes with diverse mechanistic actions, and the personal care products triclosan, galaxolide, and nonylphenol are representative of antibacterial agents, nitro-musks, and surfactants, respectively. The fish compared are representative of the middle and lower slope of deep-sea habitats. The species were adults of Trachyrynchus scabrus, Mora moro, Cataetix laticeps, and Alepocehalus rostratus. The hepatic metabolic system studied were the activities associated with several cytochrome P450 isoforms (CYPs): 7-ethoxyresorufin-O-deethylase (EROD), benzyloxy-4-[trifluoromethyl]-coumarin-O-debenzyloxylase (BFCOD), and 7-ethoxycoumarin-O-deethylase (ECOD). Results showed differences in baseline activities and sensitivity to chemicals which were species, chemical, and pathway dependent. T. scabrous was the most sensitive species to chemical interactions with the xenobiotic and endogenous metabolizing (EROD and BFCOD) systems, especially in the case of diclofenac interference with BFCOD activity (IC50 = 15.7 +/- 2.2 uM). Moreover, T. scabrous and A. rostratus possessed high basal ECOD activity, and this was greatly affected by in vitro exposure to diclofenac in T. scabrous also (IC50 = 6.86 +/- 1.4 uM). These results highlight the sensitivity of marine fish to emerging contaminants and propose T. scabrous (middle slope) and A. rostratus (lower slope) as sentinels and the inclusion of ECOD activity as a sensitive biomarker to these exposures.']",
1497,91498,"3beta,5alpha,6beta-Trihydroxycholestane",C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C[C@H]([C@@]4([C@@]3(CC[C@@H](C4)O)C)O)O)C,,,['Substances that lower the levels of certain LIPIDS in the BLOOD. They are used to treat HYPERLIPIDEMIAS. (See all compounds classified as Hypolipidemic Agents.)'],,,
1498,91499,Prochlorperazine edisylate,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl.C(CS(=O)(=O)O)S(=O)(=O)O,,,"['Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)', 'Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)', 'Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)']",,,
1499,91500,Indium arsenide,[As]#[In],,,,,,
1500,91501,Cadmium telluride,[Cd]=[Te],,,,,,
1501,91502,Goethite (Fe(OH)O),O[Fe]=O,,,,,,
1502,91503,Dihydroquinidine,CC[C@H]1CN2CC[C@H]1C[C@@H]2[C@H](C3=C4C=C(C=CC4=NC=C3)OC)O,,,"['Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)', 'Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)']",,,
1503,91504,"trans-2,3-Diphenyloxirane",C1=CC=C(C=C1)[C@H]2[C@@H](O2)C3=CC=CC=C3,,,,,,
1504,91505,Oxybutynin chloride,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O.Cl,,,"['Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system. (See all compounds classified as Muscarinic Antagonists.)', 'Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)', 'Drugs used in the treatment of urological conditions and diseases such as URINARY INCONTINENCE and URINARY TRACT INFECTIONS. (See all compounds classified as Urological Agents.)']",,,
1505,91506,3-Hydroxy-3-methylglutaryl-CoA,CC(C)(COP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)[C@H](C(=O)NCCC(=O)NCCSC(=O)CC(C)(CC(=O)O)O)O,,,,,,
1506,91507,CID 91507,CC1=C2C=CC=C(C2=C(C3=C1C[C@H]4[C@@H](C(=O)C(=C(N)O)C(=O)[C@]4(C3=O)O)N(C)C)O)O,,,,,,
1507,91508,alpha-Pinene oxide,CC1(C2CC1C3(C(C2)O3)C)C,,,,,,
1508,91509,4-Nitrophenyl beta-D-xyloside,C1[C@H]([C@@H]([C@H]([C@@H](O1)OC2=CC=C(C=C2)[N+](=O)[O-])O)O)O,,,,,,
1509,91510,Maackiain,C1[C@@H]2[C@H](C3=C(O1)C=C(C=C3)O)OC4=CC5=C(C=C24)OCO5,,,,,"['Maackiain has known human metabolites that include (2S,3S,4S,5R)-3,4,5-trihydroxy-6-[[(1R,12R)-5,7,11,19-tetraoxapentacyclo[10.8.0.02,10.04,8.013,18]icosa-2,4(8),9,13(18),14,16-hexaen-16-yl]oxy]oxane-2-carboxylic acid.']",
1510,91511,Bis(4-glycidyloxyphenyl)methane,C1C(O1)COC2=CC=C(C=C2)CC3=CC=C(C=C3)OCC4CO4,,,,,,
1511,91512,Cholesterylamine,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)N)C)C,,,,,,
1512,91513,Hydroxyzine hydrochloride,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl.Cl.Cl,,,"['Agents, usually topical, that relieve itching (pruritus). (See all compounds classified as Antipruritics.)', 'Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)']",,,
1513,91514,n-Benzoyl-d-alanine,C[C@H](C(=O)O)NC(=O)C1=CC=CC=C1,,,,,,
1514,91515,4-Chlorophenyl glycidyl ether,C1C(O1)COC2=CC=C(C=C2)Cl,,,,,,
1515,91516,Ethyl phenylpropiolate,CCOC(=O)C#CC1=CC=CC=C1,,,,,,
1516,91517,"1,2,4-Trimethylcyclohexane",CC1CCC(C(C1)C)C,,,,,,
1517,91518,Anguidin,CC1=C[C@@H]2[C@](CC1)([C@]3([C@@H]([C@H]([C@H]([C@]34CO4)O2)O)OC(=O)C)C)COC(=O)C,,,['Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)'],"['During the 90-min period after topical application of a single dose of /(3)H-diacetoxyscirpenol/ ([(3)H]DAS), the rat absorbed and retained more [(3)H]DAS and excreted less radioactivity through urine and feces than the mouse. By 24 hr after treatment, the rat had absorbed, excreted, and retained about twice as much [(3)H]DAS as had the mouse (p < 0.05 or < 0.005). At 7 days posttreatment, the rat had absorbed more than four times the amount of [(3)H]DAS than had the mouse (13.1 vs 57.5%; p < 0.005). However, tissues of the mouse retained a higher proportion of administered radioactivity (4.1%) than those of the rat (1.0%; p < 0.05). Total excretion of radiolabel by the rat was approximately sixfold higher than that of the mouse (56 vs 9%; p < 0.005). The ratio of excretion in urine to that in feces in the rat was about 2 to 1 (37 vs 18%) and in the mouse was about 3.5 to 1 (7 vs  2%). Significant differences in the time course of tissue distribution of [(3)H]DAS in the rat and mouse were found when data were expressed as the percentage of absorbed dose present in tissues or as specific radioactivity (dpm) per gram tissue. These results demonstrated a different pattern of absorption, excretion, and tissue distribution of topically administered [(3)H]DAS in rats and mice.']","[""Trichothecenes are a group of mycotoxins mainly produced by the fungi of Fusarium genus. Consumers are particularly concerned over the toxicity and food safety of trichothecenes and their metabolites from food-producing animals. The metabolism of T-2 toxin, deoxynivalenol (DON), nivalenol (NIV), fusarenon-X (FX), diacetoxyscirpenol (DAS), 3-acetyldeoxy-nivalenol (3-aDON), and 15-acetyldeoxynivalenol (15-aDON) in rodents, swine, ruminants, poultry, and humans are reviewed in this article. Metabolic pathways of these mycotoxins are very different. The major metabolic pathways of T-2 toxin in animals are hydrolysis, hydroxylation, de-epoxidation, and conjugation. After being transformed to HT-2 toxin, it undergoes further hydroxylation at C-3' to yield 3'-hydroxy-HT-2 toxin, which is considered as an activation pathway, whereas transformation from T-2 to T-2 tetraol is an inactivation pathway in animals. The typical metabolites of T-2 toxin in animals are HT-2 toxin, T-2 triol, T-2 tetraol, neosolaniol (NEO), 3'-hydroxy-HT-2, and 3'-hydroxy-T-2, whereas HT-2 toxin is the main metabolite in humans. De-epoxidation is an important pathway for detoxification in animals. De-epoxy products, DOM-1, and de-epoxy-NIV are the main metabolites of DON and NIV in most animals, respectively. However, the two metabolites are not found in humans. Deacetyl can occur rapidly on the acetyl derivatives, 3-aDON, 15-aDON, and FX. DAS is metabolized in animals to 15-monoacetoxyscirpenol (15-MAS) via C-4 deacetylation and then transformed to scirpentriol (SCP) via C-15 deacetylation. Finally, the epoxy is lost, yielding de-epoxy-SCP. De-epoxy-15-MAS is also the main metabolite of DAS. 15-MAS is the main metabolite in human skin. The review on the metabolism of trichothecenes will help one to well understand the fate of these toxins' future in animals and humans, as well as provide basic information for the risk assessment of them for food safety."", ""Trichothecenes like T-2 toxin, diacetoxyscirpenol, and deoxynivalenol, which occur in feed, are metabolized preponderant in a biphasic way. Oxidation and hydrolysis are carried out in phase 1, while the transformation products are conjugated with glucuronic acid in phase 2; in addition, the epoxide ring is cleaved by the gut microflora. Metabolites of T-2 toxin are HT-2 toxin, 3'-hydroxy-T-2 toxin, 3'-hydroxy-HT-2 toxin, neosolaniol, 4-deacetylneosolaniol, T-2 triol, T-2 tetraol, and de-epoxide T-2 tetraol. Diacetoxyscirpenol is transformed to 15-monoacetoxyscirpenol, scirpenetriol, de-epoxide 15-moneacetoxyscirpenol, and de-epoxide scirpenetriol. Deoxynivalenol undergoes no extensive metabolism; only the production of deoxynivalenol glucuronide and de-epoxide deoxynivalenol is assumed. As trichothecenes are rapid metabolized, the diagnosis of an intoxication by the analysis of samples of pig origin should be hardly possible; for the same reason, the possibility of an enrichment of trichothecene metabolites in edible tissues is graded as low.""]",
1518,91519,"Cytidylyl-3',5'-adenosine phosphate",C1=CN(C(=O)N=C1N)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)OP(=O)(O)OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=NC5=C(N=CN=C54)N)O)O)O,,,['Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)'],,,
1519,91520,Catalpol,C1=CO[C@H]([C@H]2[C@@H]1[C@@H]([C@H]3[C@@]2(O3)CO)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O,,,,,,
1520,91521,Glycidyl 1-naphthyl ether,C1C(O1)COC2=CC=CC3=CC=CC=C32,,,,,,
1521,91522,Tetrahydroharman,CC1C2=C(CCN1)C3=CC=CC=C3N2,,,,,,
1522,91523,Oxydeprofos,CCS(=O)CC(C)SP(=O)(OC)OC,,,,,,
1523,91524,"2-Chloro-1-(2,5-dichlorophenyl)vinyl diethyl phosphate",CCOP(=O)(OCC)OC(=CCl)C1=C(C=CC(=C1)Cl)Cl,,,,,,
1524,91525,Acid green 50,CN(C)C1=CC=C(C=C1)C(=C2C=CC(=[N+](C)C)C=C2)C3=C4C=CC(=CC4=CC(=C3O)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+],,,,,,
1525,91526,Benzenesulfonate,C1=CC=C(C=C1)S(=O)(=O)[O-],,,,,,
1526,91527,2-Aminoethyl octadec-9-enoate,CCCCCCCCC=CCCCCCCCC(=O)OCCN,,,,,,
1527,91528,"3,4-Dihydroxyphenylglycol",C1=CC(=C(C=C1C(CO)O)O)O,,,,,,
1528,91529,Isomalathion,CCOC(=O)CC(C(=O)OCC)SP(=O)(OC)SC,,,,,,
1529,91530,CID 91530,CC(=CC=CC=C(C)C=CC=C(C)C(=O)C[C@]12[C@](O1)(C[C@H](CC2(C)C)O)C)C=CC=C(C)C=C=C3[C@](C[C@H](CC3(C)C)OC(=O)C)(C)O,,,,,,
1530,91531,CID 91531,C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2NC=NC3=O)COP(=O)(O)O)O,,,,,,
1531,91532,Phosphomethylphosphonic acid adenylate ester,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(CP(=O)(O)O)O)O)O)N,,,,,,
1532,91533,Fenistil-retard; Forhistal maleate,CC(C1=CC=CC=N1)C2=C(CC3=CC=CC=C32)CCN(C)C.C(=CC(=O)O)C(=O)O,,,,,,
1533,91534,CID 91534,C1=CC(=CC=C1C2=CC(=C3C(=O)C=C(C(=C3O2)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O)O,,,,,,
1534,91535,CID 91535,C([C@@H](C(=O)[O-])N)C(=O)O.[Na+],,,,,,
1535,91536,1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol,CC(C)NC[C@@H](COC1=CC=CC2=CC=CC=C21)O,,,,,,
1536,91537,"2,2'-Azobis(2,4-dimethylvaleronitrile)",CC(C)CC(C)(C#N)N=NC(C)(CC(C)C)C#N,,,,,,
1537,91538,"3,4-Dihydro-2-methoxy-2H-pyran",COC1CCC=CO1,,,,,,
1538,91539,Pigment Yellow 17,CC(=O)C(C(=O)NC1=CC=CC=C1OC)N=NC2=C(C=C(C=C2)C3=CC(=C(C=C3)N=NC(C(=O)C)C(=O)NC4=CC=CC=C4OC)Cl)Cl,,,,,,
1539,91540,Gitoxin,C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5CC[C@]7([C@@]6(C[C@@H]([C@@H]7C8=CC(=O)OC8)O)O)C)C)C)C)O)O,,,,,,
1540,91541,5-Hydroxymethyl-2'-deoxyuridine,C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)CO)CO)O,,,['Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)'],,,
1541,91542,CID 91542,C1=CC(=C(C=C1C2=CC(=C3C(=CC(=CC3=O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O2)O)O)O,,,,,,
1542,91543,"Bis(2,3-dibromopropyl) hydrogen phosphate",C(C(CBr)Br)OP(=O)(O)OCC(CBr)Br,,,,,,
1543,91544,n-Phenyloctadec-9-enamide,CCCCCCCCC=CCCCCCCCC(=O)NC1=CC=CC=C1,,,,,,
1544,91545,"[6-[6-[[6-[[12,14-dihydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4-hydroxyoxan-2-yl]methoxy]-4-hydroxy-2-methyloxan-3-yl]oxy-3-hydroxy-2-methyloxan-4-yl] acetate",CC1C(C(CC(O1)OC2C(OC(CC2O)OCC3CC(CC(O3)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)O)C)OC(=O)C)O,,,,,,
1545,91546,CID 91546,CC(=O)C[C@H](C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,,,,,,
1546,91547,Unii-AL8MZ37Y51,[C@@H](C(=O)O)(Cl)Br.[C@H](C(=O)O)(Cl)Br,,,,,,
1547,91548,(2S)-2-bromo-2-chloroacetic acid,[C@H](C(=O)O)(Cl)Br,,,,,,
1548,91549,(R)-Bromchloressigsaure,[C@@H](C(=O)O)(Cl)Br,,,,,,
1549,91550,Glycidamide,C1C(O1)C(=O)N,,,,"['The formation of glycidamide and acrylamide adducts on the N-terminal valine of hemoglobin (Hb) is directly proportional in man and rat. Comparison of free acrylamide in plasma, valine adducts on Hb and urinary S-(2-carboxyethyl)cysteine indicate that the rate of elimination of acrylamide is at least five times lower in man than in rats. Therefore, since the integrated concentration-time ratio for glycidamide to acrylamide adducts in man (0.3) is about one-half of that for rats (0.58) at low doses, the tissue dose of glycidamide may be higher in man than in rats, on the basis of an equal uptake of acrylamide.', 'Physiologically-based toxicokinetic (""pharmacokinetic"") (PBPK or PBTK) modeling can be used as a tool to compare internal doses of acrylamide (AA) and its metabolite glycidamide (GA) in humans and rats. ... Excellent fits to a majority of the data for male Fischer 344 rats were obtained. Kinetic parameters for the human model were estimated based on fit to available human data for urinary metabolites of AA, and levels of hemoglobin adducts of AA and GA measured in studies in which human volunteers ingested known doses of AA. The simulations conducted with the rat and human models predicted that rats and humans ingesting comparable levels of AA (in mg/kg/day) would have similar levels of GA in blood and tissues. This finding stands in contrast to the default approach that assumes a 3.2-fold increase in human risk due to pharmacokinetic differences between rats and humans...', '... This study  used dual recirculating human placental perfusion to determine the transfer rate through the placenta of ...  acrylamide and its genotoxic metabolite glycidamide. ... Placentas were collected immediately after delivery and kept physiologically functional as confirmed by antipyrine kinetics, glucose consumption and leak from fetal to maternal circulation. Acrylamide (5 or 10 ug/mL) or glycidamide (5 ug/mL), both with antipyrine (100 ug/mL), was added to maternal circulation. ...  Acrylamide and glycidamide crossed the placenta from maternal to fetal circulation with similar kinetics to antipyrine, suggesting fetal exposure if the mother is exposed. The concentrations in maternal and fetal circulations equilibrated within 2 hr for both studied compounds and with both concentrations. Acrylamide metabolism into glycidamide was not detected during the 4-hr perfusions. Moreover, DNA adducts were undetectable in the placentas after perfusions...', 'The objective of this study was to compare the metabolism of acrylamide (AM) administered orally (po), dermally, intraperitoneally (ip), or by inhalation, and to measure the hemoglobin adducts produced. Rats and mice were exposed to 2.9 ppm (1,2,3-13C) and (2,3-14C)AM for 6 hr. (2,3-14C)AM (162 mg/kg) or (1,2,3-13C)AM (13 8 mg/kg) in water was administered dermally to rats for 24 hr, and (1,2,3-13C)AM was administered ip (47 mg/kg). Urine and feces were collected for 24 hr. Urine was the major elimination route in rats (ip, 62% and po, 53% of the dose; dermal, 44% of the absorbed dose; inhalation, 31% of the recovered radioactivity) and mice (inhalation, 27% of the recovered radioactivity). ...  AM-GSH was a major metabolic route in rats accounting for 69% (ip), 71% (po), 52% (dermal), and 64% (inhalation). In mice, AM-GSH accounted for only 27% (inhalation) of the total urinary metabolites. The remaining urinary metabolites were derived from GA. Valine hemoglobin adducts of AM and GA were characterized using liquid chromatography-mass spectrometry. The ratio of AM to GA adducts paralleled the flux through pathways based on urinary metabolites. This study demonstrates marked species differences in the metabolism and internal dose (Hb-adducts) of AM following inhalation exposure and marked differences in uptake comparing dermal with po and ip administration.', '... 110 5-6-year-old children were randomly selected. Their dietary habits as well as their exposure to the environmental tobacco smoke were assessed by means of a questionnaire. By means of spot urine samples, mercapturic acids of acrylamide (AAMA) and mercapturic acids of glycidamide (GAMA) were analyzed with LC-ESI-MS/MS.  Median (95th percentile) urinary levels were 36.0 (152.7) ug AAMA/L and 13.4 (55.9) ug GAMA/L. Based on the metabolite levels, the median uptake of acrylamide was calculated to be 0.54 ug/kg BW/d. A number of associations with the consumption of French fries, various potato products, as well as fried cereals could be found...']","['The major metabolite formed via the cytochrome P450 pathway is glycidamide. Species differences in the formation of this metabolite have been observed, with acrylamide converted to glycidamide to a greater extent in the mouse than in the rat, based on urinary metabolites.', 'In vivo metabolite of acrylamide in rats.', 'When acrylamide was administered to rats, the conversion to glycidamide was 51% following the administration of 5 mg/kg and decreased to 13% after 100 mg/kg, based on the measurement of hemoglobin adducts. The conversion of acrylamide to glycidamide was higher following subchronic dosing as well. Acrylamide hemoglobin adduct formation was approximately 2- or 4.5-fold greater for oral (20 mg/kg/day for 15, 21, 34 or 47 days) or intraperitoneal (50 mg/kg/day for 11 days) dosing, respectively, than glycidamide adduct formation. Oral administration resulted in approximately 30% fewer acrylamide adducts than intraperitoneal dosing; however, more glycidamide adducts were formed after oral dosing. The authors suggested that the reason for these differences was due to a higher conversion of acrylamide to glycidamide following oral dosing, when compared with intraperitoneal dosing.', 'The conversion of acrylamide to glycidamide is saturable, ranging from 50% at very low doses to 13% at 100 mg/kg bw in treated rats. Both agents are detoxified by glutathione conjugation, and glycidamide is also detoxified by hydrolysis. Both agents react directly with hemoglobin in vivo, but DNA adducts result only from the formation of glycidamide.', 'For more Metabolism/Metabolites (Complete) data for Glycidamide (14 total), please visit the HSDB record page.']","['Acrylamide is metabolized in vitro and in vivo in mice, rats and humans to the epoxide, glycidamide. Both substances are equally distributed throughout the tissues and have half-lives of about 5 hr in rats.', 'The estimated plasma half-life for acrylamide and glycidamide following oral (20 mg/kg) or intraperitoneal (50 mg/kg) administration in male Sprague Dawley rats was approximately 2 hours for both acrylamide and glycidamide following single or repeated exposures.']"
1550,91551,"3-Anilinopropane-1,2-diol",C1=CC=C(C=C1)NCC(CO)O,,,,,,
1551,91552,L-Homocysteine,C(CS)[C@@H](C(=O)O)N,,,,,,
1552,91553,4-Methylumbelliferyl glucuronide,CC1=CC(=O)OC2=C1C=CC(=C2)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C(=O)O)O)O)O,,,"['Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)']",,['4-Methylumbelliferone O-glucuronide is a known human metabolite of 4-Methylumbelliferone.'],
1553,91554,CID 91554,CC=CC(=O)O[C@@H]1C[C@@H]2C3(C1([C@]4(CC(=O)C(=C[C@H]4O2)C)C)C)CO3,,,,,,
1554,91555,Bis(4-amino-3-methylcyclohexyl)methane,CC1CC(CCC1N)CC2CCC(C(C2)C)N,,,,,,
1555,91556,CID 91556,CC(=CC=CC=C(C)C=CC=C(C)C=CC(=O)OC)C=CC=C(C)C=CC(=O)O,,,,,,
1556,91557,Diphosphomethylphosphonic acid adenosyl ester,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(CP(=O)(O)OP(=O)(O)O)O)O)O)N,,,['Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)'],,,
1557,91558,Quinine hydrochloride,COC1=CC2=C(C=CN=C2C=C1)[C@H]([C@@H]3C[C@@H]4CCN3C[C@@H]4C=C)O.Cl,,,"['A subclass of analgesic agents that typically do not bind to OPIOID RECEPTORS and are not addictive. Many non-narcotic analgesics are offered as NONPRESCRIPTION DRUGS. (See all compounds classified as Analgesics, Non-Narcotic.)', 'A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358) (See all compounds classified as Muscle Relaxants, Central.)', 'Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)']",,,
1558,91559,"(2S)-4-[2-[(2S)-2-carboxy-6-hydroxy-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3-dihydroindol-1-yl]ethenyl]-2,3-dihydropyridine-2,6-dicarboxylic acid",C1[C@H](N=C(C=C1C=CN2[C@@H](CC3=CC(=C(C=C32)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)C(=O)O)C(=O)O)C(=O)O,,,,,,
1559,91560,Ddt Technical,C1=CC=C(C(=C1)C(C2=CC=C(C=C2)Cl)C(Cl)(Cl)Cl)Cl.C1=CC(=CC=C1C(C2=CC=C(C=C2)Cl)C(Cl)(Cl)Cl)Cl,,,,,,
1560,91561,Acriflavinii chloridum,C[N+]1=C2C=C(C=CC2=CC3=C1C=C(C=C3)N)N.C1=CC(=CC2=NC3=C(C=CC(=C3)N)C=C21)N.Cl.Cl.[Cl-],,,,,,
1561,91562,Cefacetrile,CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)CC#N)SC1)C(=O)O,['Cefacetrile is a broad-spectrum first generation cephalosporin antibiotic effective in Gram-positive and Gram-negative bacterial infections.'],['Cefacetrile is effective against many Gram-positive bacterial strains and somewhat less effective against Gram-negative species. It works by inhibition of bacterial cell wall synthesis. It attains high serum levels and is excreted quickly via the urine.'],['Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)'],['Vd of 0.2 to 0.5L/.kg'],,['1.2 hours']
1562,91563,Methoxyacetaldehyde,COCC=O,,,,,,
1563,91564,"1,2-Dibromo-3-chloro-2-methylpropane",CC(CCl)(CBr)Br,,,,,,
1564,91565,4-Hydroxypropranolol,CC(C)NCC(COC1=CC=C(C2=CC=CC=C21)O)O,,,,,['4-Hydroxypropranolol is a known human metabolite of dexpropranolol (propranolol).'],
1565,91566,"2,2,2-Trichloro-1-(2-chlorophenyl)-1-(4-chlorophenyl)ethanol",C1=CC=C(C(=C1)C(C2=CC=C(C=C2)Cl)(C(Cl)(Cl)Cl)O)Cl,,,,,,
1566,91567,Repin,C[C@]1(CO1)C(=O)O[C@H]2CC(=C)[C@@H]3C[C@H]([C@]4([C@H]3[C@H]5[C@@H]2C(=C)C(=O)O5)CO4)O,,,,,,
1567,91568,CID 91568,CC=C(C)C(=O)O[C@H]1C[C@H]([C@]2(CO[C@@H]3[C@@H]2[C@]14CO[C@@]([C@H]4[C@]([C@@H]3O)(C)[C@@]56C7C[C@H]([C@@]5(O6)C)[C@]8(C=CO[C@H]8O7)O)(C(=O)OC)O)C(=O)OC)OC(=O)C,,,,,,
1568,91569,"5-[[4-(Dimethylamino)phenyl]azo]-1,4-dimethyl-1H-1,2,4-triazol-4-ium",CN1C(=[N+](C=N1)C)N=NC2=CC=C(C=C2)N(C)C,,,,,,
1569,91570,CID 91570,C(CN=C(S)[S-])N=C(S)[S-].C(CN=C(S)[S-])N=C(S)[S-].[Mn+2].[Zn+2],,,,,,
1570,91571,Photoaldrin,C1=CC2C3C4C1C2(C5(C4(C(C(C35Cl)Cl)Cl)Cl)Cl)Cl,,,,,,
1571,91572,Phaseolin,CC1(C=CC2=C(O1)C=CC3=C2O[C@@H]4[C@H]3COC5=C4C=CC(=C5)O)C,,,,,,
1572,91573,Zirconium-95,[95Zr],,,,,,
1573,91574,"Zinc, isotope of mass 65",[65Zn],,,,,,
1574,91575,N-Methyl-N'-(4-chlorophenyl)-N-nitrosourea,CN(C(=O)NC1=CC=C(C=C1)Cl)N=O,,,,,,
1575,91576,Methylglucoside,COC1[C@@H](C([C@@H](C(O1)CO)O)O)O,,,,,,
1576,91577,Vitamin K epoxide,CC(C)CCCC(C)CCCC(C)CCCC(=CCC12C(=O)C3=CC=CC=C3C(=O)C1(O2)C)C,,,,,,
1577,91578,"Methanesulfonamide, N-[2-[(4-amino-3-methylphenyl)ethylamino]ethyl]-, sulfate (2:3)",CCN(CCNS(=O)(=O)C)C1=CC(=C(C=C1)N)C.CCN(CCNS(=O)(=O)C)C1=CC(=C(C=C1)N)C.OS(=O)(=O)O.OS(=O)(=O)O.OS(=O)(=O)O,,,,,,
1578,91579,(4-Ammonio-m-tolyl)ethyl(2-hydroxyethyl)ammonium sulphate,CCN(CCO)C1=CC(=C(C=C1)N)C.OS(=O)(=O)O,,,,,,
1579,91580,Trimethylselenonium,C[Se+](C)C,,,,,,
1580,91581,(1R)-trans-Phenothrin,CC(=C[C@@H]1[C@H](C1(C)C)C(=O)OCC2=CC(=CC=C2)OC3=CC=CC=C3)C,,,"['Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)']",,,
1581,91582,"7-Methoxy-2,3-dihydro-1h-pyrrolizin-1-ol",COC1=C2C(CCN2C=C1)O,,,,,,
1582,91583,N-Acetoxy-4-acetamidostilbene,CC(=O)N(C1=CC=C(C=C1)C=CC2=CC=CC=C2)OC(=O)C,,,,,,
1583,91584,N-Acetoxy-4-acetylaminobiphenyl,CC(=O)N(C1=CC=C(C=C1)C2=CC=CC=C2)OC(=O)C,,,,,,
1584,91585,"3-(1,3-Dihydro-1-oxo-2h-isoindol-2-yl)-2,6-piperidinedione",C1CC(=O)NC(=O)C1N2CC3=CC=CC=C3C2=O,,,,,,
1585,91586,1-Cyano-2-hydroxy-3-butene,C=CC(CC#N)O,,,,,,
1586,91587,Probenazole,C=CCOC1=NS(=O)(=O)C2=CC=CC=C21,,,,,,
1587,91588,Salsolinol,C[C@H]1C2=CC(=C(C=C2CCN1)O)O,,,,,,
1588,91589,4-Chloro-4'-hydroxybiphenyl,C1=CC(=CC=C1C2=CC=C(C=C2)Cl)O,,,,,,
1589,91590,Cybutryne,CC(C)(C)NC1=NC(=NC(=N1)NC2CC2)SC,,,,,,
1590,91591,2-Amino-5-chlorophenol,C1=CC(=C(C=C1Cl)O)N,,,,,,
1591,91592,"Tentotoxin, Alternaria alternata",C[C@H]1C(=O)N[C@H](C(=O)N(C(=CC2=CC=CC=C2)C(=O)NCC(=O)N1C)C)CC(C)C,,,,,,
1592,91593,"4,4'-Methylenebis(N,N-diglycidylaniline)",C1C(O1)CN(CC2CO2)C3=CC=C(C=C3)CC4=CC=C(C=C4)N(CC5CO5)CC6CO6,,,,,,
1593,91594,3-Chloroallyl alcohol,C(C=CCl)O,,,,,,
1594,91595,"(2S,3S)-Diepoxybutane",C1[C@H](O1)[C@@H]2CO2,,,,,,
1595,91596,Ethidimuron,CCS(=O)(=O)C1=NN=C(S1)N(C)C(=O)NC,,,,,,
1596,91597,5-(m-Hydroxyphenyl)-5-phenylhydantoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC(=CC=C3)O,,,,,"[""3'-HPPH has known human metabolites that include 5-(3,4-Dihydroxyphenyl)-5-phenylhydantoin.""]",
1597,91598,Methyl 3-((dimethoxyphosphinothioyl)oxy)methacrylate,CC(=COP(=S)(OC)OC)C(=O)OC,,,,,,
1598,91599,Aluminum citrate,C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Al+3],,,,,,
1599,91600,Fluotrimazole,C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC(=CC=C3)C(F)(F)F)N4C=NC=N4,,,,,,
1600,91601,"Tris(2,4-di-tert-butylphenyl) phosphite",CC(C)(C)C1=CC(=C(C=C1)OP(OC2=C(C=C(C=C2)C(C)(C)C)C(C)(C)C)OC3=C(C=C(C=C3)C(C)(C)C)C(C)(C)C)C(C)(C)C,,,,,,
1601,91602,"1,3,5,8-Tetrachloronaphthalene",C1=CC(=C2C(=CC(=CC2=C1Cl)Cl)Cl)Cl,,,,,,
1602,91603,Methyl(neopentyl)nitrosamine,CC(C)(C)CN(C)N=O,,,,,,
1603,91604,Lyral,CC(C)(CCCC1=CCC(CC1)C=O)O,,,,,,
1604,91605,5-Fluoro-2-methyl-1-(p-methylthiobenzylidene)-3-indenyl acetic acid,CC1=C(C2=C(C1=CC3=CC=C(C=C3)SC)C=CC(=C2)F)CC(=O)O,,,,,,
1605,91606,"2,5-Diamino-4,5-diketopyrimidine",C1(C(=O)C(=O)NC(=N1)N)N,,,,,,
1606,91607,"methyl (4S,6S)-4-[2-[2-(3,4-dihydroxyphenyl)ethoxy]-2-oxoethyl]-5-ethylidene-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylate",CC=C1[C@@H](C(=CO[C@H]1O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)C(=O)OC)CC(=O)OCCC3=CC(=C(C=C3)O)O,,,,,,
1607,91608,"Benz(c)acridine, 7,11-dimethyl-",CC1=C2C(=CC=C1)C(=C3C=CC4=CC=CC=C4C3=N2)C,,,,,,
1608,91609,"6,6,9-Trimethyl-4-pentyl-6a,7,8,10a-tetrahydro-6h-benzo[c]chromen-1-ol",CCCCCC1=C2C(=C(C=C1)O)C3C=C(CCC3C(O2)(C)C)C,,,,,,
1609,91610,Gliquidone,CC1(C2=C(C=C(C=C2)OC)C(=O)N(C1=O)CCC3=CC=C(C=C3)S(=O)(=O)NC(=O)NC4CCCCC4)C,['Used in the treatment of diabetes mellitus type 2.'],"['Gliquidone is an anti-diabetic drug in the sulfonylurea class. In patients with diabetes mellitus, there is a deficiency or absence of a hormone manufactured by the pancreas called insulin. Insulin is the main hormone responsible for the control of sugar in the blood. Gliquidone is an antidiabetic medication which is used in those patients with adult maturity onset or non-insulin dependent diabetes (NIDDM). It works by lowering blood sugar levels by stimulating the production and release of insulin from the pancreas. It also promotes the movement of sugar from the blood into the cells in the body which need it.']",['Substances which lower blood glucose levels. (See all compounds classified as Hypoglycemic Agents.)'],,,['The mean terminal half-life was approximately 8 hours (range 5.7-9.4 hours)']
1610,91611,"1,7-Dimethyluric acid",CN1C2=C(NC1=O)NC(=O)N(C2=O)C,,,,,"['1,7-Dimethyluric acid is a known human metabolite of paraxanthine.']",
1611,91612,Dimefuron,CC(C)(C)C1=NN(C(=O)O1)C2=C(C=C(C=C2)NC(=O)N(C)C)Cl,,,,,,
1612,91613,2-Methylhistamine,CC1=NC=C(N1)CCN,,,,,,
1613,91614,Asoxime (dichloride),C1=CC=[N+](C(=C1)C=NO)COC[N+]2=CC=C(C=C2)C(=O)N.[Cl-].[Cl-],,,"['Agents counteracting or neutralizing the action of POISONS. (See all compounds classified as Antidotes.)', 'Drugs used to reverse the inactivation of cholinesterase caused by organophosphates or sulfonates. They are an important component of therapy in agricultural, industrial, and military poisonings by organophosphates and sulfonates. (See all compounds classified as Cholinesterase Reactivators.)']",,,
1614,91615,1-[[2-(Hydroxyiminomethyl)pyridin-1-ium-1-yl]methoxymethyl]pyridin-1-ium-4-carboxamide,C1=CC=[N+](C(=C1)C=NO)COC[N+]2=CC=C(C=C2)C(=O)N,,,,,,
1615,91616,CID 91616,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=C(C=C3)O)N)C(=O)[O-])C.[Na+],,,,,,
1616,91617,(+)-Cercosporin,C[C@H](CC1=C2C3=C(C(=C(C4=C3C5=C6C2=C(C(=O)C=C6OCOC5=CC4=O)C(=C1OC)O)O)OC)C[C@@H](C)O)O,,,,,,
1617,91618,CID 91618,C[C@H](C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](CCP(=O)(C)O)N,,,,,,
1618,91619,Glufosinate-P,CP(=O)(CC[C@@H](C(=O)O)N)O,,,"['Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)', 'Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)']",,,
1619,91620,Triethylene glycol bis(3-tert-butyl-4-hydroxy-5-methylphenyl)propionate,CC1=CC(=CC(=C1O)C(C)(C)C)CCC(=O)OCCOCCOCCOC(=O)CCC2=CC(=C(C(=C2)C)O)C(C)(C)C,,,,,,
1620,91621,"1,5-I-Aedans",C1=CC2=C(C=CC=C2S(=O)(=O)O)C(=C1)NCCNC(=O)CI,,,"['Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)']",,,
1621,91622,Bioban P-1487,CCC(CN1CCOCC1)[N+](=O)[O-].CCC(CN1CCOCC1)(CN2CCOCC2)[N+](=O)[O-],,,,,,
1622,91623,"3,4-Dihydroxybenzylamine",C1=CC(=C(C=C1CN)O)O,,,,,,
1623,91624,(2S)-2-amino-4-[(2R)-2-amino-3-hydroxypropoxy]but-3-enoic acid,C([C@H](COC=C[C@@H](C(=O)O)N)N)O,,,,,,
1624,91625,Flubenzimine,C1=CC=C(C=C1)N=C2N(C(=NC(F)(F)F)C(=NC(F)(F)F)S2)C3=CC=CC=C3,,,,,,
1625,91626,Solusprin,CC(=O)OC1=CC=CC=C1C(=O)O.C(CCN)C[C@@H](C(=O)O)N,,,"['Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)', 'Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)', 'Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)', 'Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. (See all compounds classified as Cyclooxygenase Inhibitors.)']",,,
1626,91627,Diethatyl,CCC1=C(C(=CC=C1)CC)N(CC(=O)O)C(=O)CCl,,,,,,
1627,91628,Dichlorobis(cyclopentylamine)platinum,C1CCC(C1)N.C1CCC(C1)N.[Cl-].[Cl-].[Pt+2],,,,,,
1628,91629,1-(Nitrosopropylamino)-2-propanol,CCCN(CC(C)O)N=O,,,,,,
1629,91630,1-(Nitrosopropylamino)-2-propanone,CCCN(CC(=O)C)N=O,,,,,,
1630,91631,"2,3,3',4,5,5'-Hexachlorobiphenyl",C1=C(C=C(C=C1Cl)Cl)C2=CC(=C(C(=C2Cl)Cl)Cl)Cl,,,,,,
1631,91632,Photomirex,C12C3(C4(C5(C3(C(C1(C5(C2(C4(Cl)Cl)Cl)Cl)Cl)(Cl)Cl)Cl)Cl)Cl)Cl,,,,,,
1632,91633,"2,2',3,3',4,5',6-Heptachlorobiphenyl",C1=C(C=C(C(=C1C2=C(C(=C(C=C2Cl)Cl)Cl)Cl)Cl)Cl)Cl,,,,,,
1633,91634,Azocyclotin,C1CCC(CC1)[Sn](C2CCCCC2)(C3CCCCC3)N4C=NC=N4,,,,,"['Metabolized by hydrolysis, forming 1,2,4-triazole & tricyclohexyl tin hydroxide which is further oxidized to form dicyclohexyl tin oxide.']",
1634,91635,"2,2',3,4,5,6-Hexachlorobiphenyl",C1=CC=C(C(=C1)C2=C(C(=C(C(=C2Cl)Cl)Cl)Cl)Cl)Cl,,,,,,
1635,91636,8-(4-Chlorophenylthio)-cAMP,C1[C@@H]2[C@H]([C@H]([C@@H](O2)N3C4=NC=NC(=C4N=C3SC5=CC=C(C=C5)Cl)N)O)OP(=O)(O1)O,,,"['Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)', 'Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)']",,,
1636,91637,2-Methylhippuric acid,CC1=CC=CC=C1C(=O)NCC(=O)O,,,,,,
1637,91638,Deacetyldiltiazem,CN(C)CCN1C2=CC=CC=C2S[C@H]([C@H](C1=O)O)C3=CC=C(C=C3)OC,,,,,,
1638,91639,"bis[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl] 2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-heptaenedioate",CC(=CC=CC=C(C)C=CC=C(C)C(=O)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O)O)O)C=CC=C(C)C(=O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O)O,,,,,,
1639,91640,"1-Pyrrolidineethanamine, alpha-((2-methylpropoxy)methyl)-N-phenyl-N-(phenylmethyl)-",CC(C)COCC(CN1CCCC1)N(CC2=CC=CC=C2)C3=CC=CC=C3,,,,,,
1640,91641,CID 91641,CSC1=CC=C(C=C1)C=C2CC(C3=C2C=CC(=C3)F)CC(=O)O,,,,,,
1641,91642,Acifluorfen-methyl,COC(=O)C1=C(C=CC(=C1)OC2=C(C=C(C=C2)C(F)(F)F)Cl)[N+](=O)[O-],,,,,,
1642,91643,"5,11-dimethyl-6H-pyrido[4,3-b]carbazol-9-ol",CC1=C2C=CN=CC2=C(C3=C1NC4=C3C=C(C=C4)O)C,,,"['Antimetabolites that are useful in cancer chemotherapy. (See all compounds classified as Antimetabolites, Antineoplastic.)']",,,
1643,91644,Pretilachlor,CCCOCCN(C1=C(C=CC=C1CC)CC)C(=O)CCl,,,,,,
1644,91645,"(((S)-1-((S)-2-amino-1,4,5,6-tetrahydropyrimidin-4-yl)-2-(((S)-5-amino-1,5-dioxo-1-(((S)-1-oxopropan-2-yl)amino)pentan-2-yl)amino)-2-oxoethyl)carbamoyl)-L-leucine",C[C@@H](C=O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H]([C@@H]1CCN=C(N1)N)NC(=O)N[C@@H](CC(C)C)C(=O)O,,,,,,
1645,91646,N-Butyl-N-(2-hydroxyethyl)nitrosamine,CCCCN(CCO)N=O,,,,,,
1646,91647,1-(Butylnitrosoamino)-2-propanone,CCCCN(CC(=O)C)N=O,,,,,,
1647,91648,"2,2',3,3',4,4',5,6,6'-Nonachlorobiphenyl",C1=C(C(=C(C(=C1Cl)Cl)Cl)C2=C(C(=C(C(=C2Cl)Cl)Cl)Cl)Cl)Cl,,,,,,
1648,91649,Hydroxyflutamide,CC(C)(C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F)O,,,['Compounds which inhibit or antagonize the biosynthesis or actions of androgens. (See all compounds classified as Androgen Antagonists.)'],,['2-hydroxy-flutamide is a known human metabolite of flutamide.'],
1649,91650,Pyrimethanil,CC1=CC(=NC(=N1)NC2=CC=CC=C2)C,,,,"['In the rat, rapidly absorbed, metabolized and excreted. Following single oral dose, > 95% excreted within 6-8 hours.']",['Metabolism involves oxidation to hydroxylated derivatives followed by conjugation. ... Little metabolism occurs on fruit.'],
1650,91651,"1,2,3,5-Tetrachloronaphthalene",C1=CC2=C(C(=C(C=C2C(=C1)Cl)Cl)Cl)Cl,,,,,,
1651,91652,"1,3,5,7-Tetrachloronaphthalene",C1=C(C=C(C2=C1C(=CC(=C2)Cl)Cl)Cl)Cl,,,,,,
1652,91653,"2,5-Dichloro-4'-biphenylol",C1=CC(=CC=C1C2=C(C=CC(=C2)Cl)Cl)O,,,,,,
1653,91654,"1,2,3-Trichlorodibenzo-p-dioxin",C1=CC=C2C(=C1)OC3=CC(=C(C(=C3O2)Cl)Cl)Cl,,,,,,
1654,91655,Chlorethoxyfos,CCOP(=S)(OCC)OC(C(Cl)(Cl)Cl)Cl,,,,"['Most organophosphorus pesticides are not ionized and are very lipophilic. Thus, inhaled or swallowed material will be easily taken up. /Organophosphorus Pesticides/']","['Metabolism occurs principally by oxidation, hydrolysis by esterases, and by transfer of portions of the molecule to glutathione.  Oxidation of organophosphorus insecticides may result in more or less toxic products.  In general, phosphorothioates are not directly toxic but require oxidative metabolism to the proximal toxin. The glutathione transferase reactions produce products, that are, in most cases, of low toxicity. Hydrolytic and transferase reactions affect both the thioates and their oxons. /Organophosphorus Pesticides/', 'Major metabolites are CO2 and biosynthetic intermediates such as serine, glycine and glycine conjugates.']",
1655,91656,Bitertanol,CC(C)(C)C(C(N1C=NC=N1)OC2=CC=C(C=C2)C3=CC=CC=C3)O,,,"['Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)']",,,
1656,91657,Nimustine hydrochloride,CC1=NC=C(C(=N1)N)CNC(=O)N(CCCl)N=O.Cl,,,['Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)'],,,
1657,91658,"3-(2,2-Dichlorovinyl)-2,2-dimethylcyclopropanecarboxylic acid",CC1(C(C1C(=O)O)C=C(Cl)Cl)C,,,,,,
1658,91659,"1,4,6,7-Tetrachloronaphthalene",C1=CC(=C2C=C(C(=CC2=C1Cl)Cl)Cl)Cl,,,,,,
1659,91660,Dabsyl chloride,CN(C)C1=CC=C(C=C1)N=NC2=CC=C(C=C2)S(=O)(=O)Cl,,,"['Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)']",,,
1660,91661,alpha-Chlordene,C1[C@H]2[C@H]3[C@H]([C@H]1Cl)C(=C([C@]2(C(=C3Cl)Cl)Cl)Cl)Cl,,,,,,
1661,91662,"2,2',4,6,6'-Pentachlorobiphenyl",C1=CC(=C(C(=C1)Cl)C2=C(C=C(C=C2Cl)Cl)Cl)Cl,,,,,,
1662,91663,gamma-Chlordene,C1[C@H]2[C@H]([C@H]3[C@@H]1[C@@](C(=C2Cl)Cl)(C(=C3Cl)Cl)Cl)Cl,,,,,,
1663,91664,Tolclofos-methyl,CC1=CC(=C(C(=C1)Cl)OP(=S)(OC)OC)Cl,,,,"['Male and female ICR mice, eight weeks of age, were given an oral dose of 5 mg/kg bw of [(14)C-4-methyl]-tolclofos-methyl (radiochemical purity, 99%) dissolved in corn oil, and radiocarbon was monitored in urine, feces and expired air for seven days after administration. Within 24 hr, 69-76% of the administered radiolabel was excreted in the urine, 4-6% in the feces and less than 1% in the expired air. Total radiocarbon residues in the whole body represented less than 1% of the dose seven days after administration.', 'Six-week old Sprague-Dawley rats were given an oral dose of 5 mg/kg bw of [(14)C-4-methyl]-tolclofos-methyl (radiochemical purity, 99%) dissolved in corn oil, and radiocarbon was monitored in urine, feces and expired air for seven days after administration. Within 24 hr, 62-67% of the administered dose was excreted in the urine, 16-21% in the feces and less than 1% in the expired air. Total radiocarbon residues in the whole body represented less than 1% of the dose seven days after administration. Whole-body autoradiography performed 1 and 6 hr after treatment showed the highest accumulation of radiolabel in stomach and intestines, followed by kidney and liver', 'Male and female Sprague-Dawley rats received single oral doses of 5 or 200 mg/kg bw of tolclofos-methyl labelled uniformly with (14)C in the benzene ring (radiochemical purity, > 99%). Another group of animals was treated orally for 14 consecutive days with unlabelled tolclofos-methyl at 5 mg/kg bw per day and then with a single oral dose of [(14)C-phenyl]-tolclofos-methyl at 5 mg/kg bw. The administered radiocarbon was readily excreted, more than 95% of the dose being eliminated in the urine and feces within 48 hr. The amount excreted in urine after seven days was 85-91%; elimination in feces at that time was: consecutive dose group, 9.3% in males and 12% in females; low-dose group, 20% in males and 19% in females; and high-dose group, 20% in males and 12% in females. Excretion as (14)C-carbon dioxide accounted for < 0.1% of the dose in all groups. The concentration of (14)C reached a peak within 2r h in almost all tissues. After administration of the low dose, the highest concentrations were found in the kidney; expressed in tolclofos-methyl equivalents, the levels were 4700 ng/g tissue in males and 3450 ng/g tissue in females; the levels in plasma were 1140 ng/mL in males and 1270 ng/mL in females. Those in the liver were 1240 ng/g tissue in males and 1220 ng/g tissue in females, and those in blood were 736 ng/mL in males and 835 ng/mL in females. The concentrations of (14)C in various organs 72 hr after administration were </= 5% of the respective peak concentrations. After seven days, radioactive residues accounted for less than 1% of the administered dose.', 'In male and female rats with bile-duct cannulas, cumulative excretion of (14)C over 48 hr was 5.8-12% of the dose in bile, 47-59% in urine and 42-24% in feces.']","['Male ICR mice were given 5 mg/kg bw [(14)C-4-methyl]-tolclofos- methyl orally; metabolites were isolated from the feces and urine by chromatography and identified by co-chromatography with authentic standards and/or spectroanalysis. The following major metabolites were detected in the excreta: 2,6-dichloro-4-methylphenol (9% of administered label),  O,O-dimethyl- O-(2,6- dichloro-4-carboxyphenyl)phosphate (11%), O-methyl- O-hydrogen-O-(2,6-dichloro-4-carboxyphenyl)phosphate (12%), 3,5-dichloro-4- hydroxybenzoic acid (12%) and 3,5-O-dichloro-4-hydroxybenzyl glycine (13%). The major biotransformation reactions are oxidative desulfuration to oxon and related derivatives, oxidation of the 4-methyl group to alcohols and acids, cleavage of P-O-aryl and P-O-methyl linkages and conjugation of the resultant acid with glycine. The metabolites found in mice are similar to those seen in rats, except for 3,5-O-dichloro-4-hydroxybenzylglycine', 'Male and female Sprague-Dawley rats were given an oral dose of 5 or 200 mg/kg bw tolclofos-methyl labelled with (14)C either in the 4-methyl group or uniformly in the phenyl ring, with or without pretreatment with unlabelled tolclofos-methyl at 5 mg/kg bw per day for 14 consecutive days. Metabolites were isolated from the feces, urine, bile and major tissues by chromatography and identified by co-chromatography with authentic standards and/or spectroanalysis. More than 10 metabolites were detected in the excreta. No marked differences were seen in relation to sex or dose. The major metabolites detected in the excreta were O-methyl O-hydrogen-O-(2,6-dichloro-4-methylphenyl)phosphate (10-26% of urinary (14)C), O-methyl-O-hydrogen-O-(2,6-dichloro-4- hydroxymethylphenyl) phosphorothioate (12-25%), O-methyl O-hydrogen-O-(2,6-dichloro-4-carboxyphenyl)-phosphorothioate (11-35%) and O-methyl-O-hydrogen-O-(2,6-dichloro-4-methylphenyl)-phosphorothioate (12-44%). In rats with bile cannulas, most of the radiolabel excreted into the bile within 24 hr after administration was associated with polar metabolites; the major metabolites in the bile were O-methyl-O-hydrogen-O-(2,6- dichloro-4-hydroxymethylphenyl)-phosphorothioate and 2,6-dichloro-4- methylphenol glucuronides. Radiocarbon excreted into the feces within 24 hr after administration was associated only with the parent compound. Two hours after oral administration, the major metabolites in blood, liver and kidney were O,O-dimethyl-O-(2,6-dichloro-4- carboxyphenyl) phosphorothioate, 3,5-dichloro-4- hydroxybenzaldehyde, O-methyl-O-hydrogen  O-(2,6-dichloro-4-methylphenyl)-phosphorothioate and O-methyl-O-hydrogen-O-(2,6-dichloro-4-hydroxymethylphenyl)-phosphorothioate. Only a small amount of the parent compound was detected in the liver. The major biotransformation reactions were oxidative desulfuration to oxon and related derivatives, oxidation of the 4-methyl group to alcohols and acids, cleavage of the P-O-aryl and P-O-methyl linkages and conjugation of the resultant acids and phenols with glucoronic acids.']",
1664,91665,Pyroquilon,C1CC(=O)N2CCC3=CC=CC1=C32,,,,,,
1665,91666,"3,4-Dichloronitrosopiperidine",C1CN(CC(C1Cl)Cl)N=O,,,,,,
1666,91667,Halopredone acetate,CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2C[C@H](C4=CC(=O)C(=C[C@@]43C)Br)F)F)O)C)OC(=O)C,,,,,,
1667,91668,Nomegestrol acetate,CC1=C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)OC(=O)C)C)[C@@H]4C1=CC(=O)CC4,,,,,,
1668,91669,"2,2',5,6'-Tetrabromobiphenyl",C1=CC(=C(C(=C1)Br)C2=C(C=CC(=C2)Br)Br)Br,,,,,,
1669,91670,Diflucortolone valerate,CCCCC(=O)OCC(=O)[C@H]1[C@@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O)C)C,,,['Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)'],,,
1670,91671,"2,6-Diamino-4-nitrotoluene",CC1=C(C=C(C=C1N)[N+](=O)[O-])N,,,,,,
1671,91672,Methionyl-leucyl-phenylalanine,CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CCSC)N,,,,,,
1672,91673,Etaconazole,CCC1COC(O1)(CN2C=NC=N2)C3=C(C=C(C=C3)Cl)Cl,,,,,,
1673,91674,"2,3',4,6-Tetrachlorobiphenyl",C1=CC(=CC(=C1)Cl)C2=C(C=C(C=C2Cl)Cl)Cl,,,,,,
1674,91675,N-Nitrosobis(2-acetoxypropyl)amine,CC(CN(CC(C)OC(=O)C)N=O)OC(=O)C,,,,,,
1675,91676,3-Chloro-4-benzoyloxyphenylacetic acid,C1=CC=C(C=C1)COC2=C(C=C(C=C2)CC(=O)O)Cl,,,,,,
1676,91677,Flurochloridone,C1C(C(C(=O)N1C2=CC=CC(=C2)C(F)(F)F)Cl)CCl,,,"['Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)']",,,
1677,91678,"1,2-Bis(pentabromophenoxy)ethane",C(COC1=C(C(=C(C(=C1Br)Br)Br)Br)Br)OC2=C(C(=C(C(=C2Br)Br)Br)Br)Br,,,,,,
1678,91679,Dimepiperate,CC(C)(C1=CC=CC=C1)SC(=O)N2CCCCC2,,,,,,
1679,91680,"2,2',3,3',4,6-Hexachlorobiphenyl",C1=CC(=C(C(=C1)Cl)Cl)C2=C(C(=C(C=C2Cl)Cl)Cl)Cl,,,,,,
1680,91681,Coronatine,CC[C@@H]1C[C@H]2[C@H](CCC2=O)C(=C1)C(=O)N[C@]3(C[C@@H]3CC)C(=O)O,,,,,,
1681,91682,"1,3-Propanedione, 1-[4-(1-methylethyl)phenyl]-3-phenyl-",CC(C)C1=CC=C(C=C1)C(=O)CC(=O)C2=CC=CC=C2,,,,,,
1682,91683,Nuarimol,C1=CC=C(C(=C1)C(C2=CC=C(C=C2)F)(C3=CN=CN=C3)O)Cl,,,"['Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)']",,,
1683,91684,(1-Methyl-1-phenylethyl)phenyl nonylphenyl phenyl phosphate,CCCCCCCCCC1=CC=C(C=C1)OP(=O)(OC2=CC=CC=C2)OC3=CC=C(C=C3)C(C)(C)C4=CC=CC=C4,,,,,,
1684,91685,3-(2-Chloro-4-(trifluoromethyl)phenoxy)benzoic acid,C1=CC(=CC(=C1)OC2=C(C=C(C=C2)C(F)(F)F)Cl)C(=O)O,,,,,,
1685,91686,Cycloprothrin,CCOC1=CC=C(C=C1)C2(CC2(Cl)Cl)C(=O)OC(C#N)C3=CC(=CC=C3)OC4=CC=CC=C4,,,,,,
1686,91687,Anilofos,CC(C)N(C1=CC=C(C=C1)Cl)C(=O)CSP(=S)(OC)OC,,,"['Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)']",,,
1687,91688,Kathon 930,CCCCCCCCN1C(=O)C(=C(S1)Cl)Cl,,,,"['Dermal absorption of RH-287 was examined in male Crl:CD:BR rats. There were six experimental groups of 4 rats each. Two concentrations of RH-287 were employed, 3% and 0.045%. Dermal application was made to a shaved 2 x 2 cm area on the interscapular region of the back, which was fitted with a contoured glass ring secured with cyanoacrylate glue and a porous top secured with rubber bands after application of the test substance in a dose aliquot of 60 uL. Two groups (A and B) received either 3% of 0.045% RH287 and urine and feces samples obtained at 10 hours post-dose, at which time the animals were killed and analysis for radioactivity performed in whole blood, plasma, and remaining carcass. Two additional groups (C and D) received either 3% or 0.045% RH-287 and were subjected to the same procedures as groups A and B, except exposure duration was 24 hours. The last two groups (E and F) received either 3% or 0.045 % RH-287, and urine and feces samples taken at 0, 10, 24, 48, and 72 hours post-dose. Animals in this group were sacrificed at 72 hours post-dose and analysis for radioactivity performed as for the other groups. Results of this study showed that at a dose of 0.045% RH-287, 44-50% of the dose was absorbed after a 10 hour exposure, and 70% after a 24 hour exposure. Administration of 3% RH-287 resulted in 31-34% absorption after 10 hours of exposure, and 52% absorption after 24 hours exposure.']",,
1688,91689,Ethiozin,CCSC1=NN=C(C(=O)N1N)C(C)(C)C,,,,,,
1689,91690,"4,7-Methano-1H-(1,2)diazeto(3,4-f)benzotriazole, 1-(4-chlorophenyl)-3a,4,4a,6a,7,7a-hexahydro-",C1C2C3C(C1C4C2N=NN4C5=CC=C(C=C5)Cl)N=N3,,,,,,
1690,91691,theta-Cypermethrin,CC1([C@@H]([C@H]1C(=O)O[C@H](C#N)C2=CC(=CC=C2)OC3=CC=CC=C3)C=C(Cl)Cl)C,,,,,,
1691,91692,Pencycuron,C1CCC(C1)N(CC2=CC=C(C=C2)Cl)C(=O)NC3=CC=CC=C3,,,,,,
1692,91693,Penconazole,CCCC(CN1C=NC=N1)C2=C(C=C(C=C2)Cl)Cl,,,"['Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)']",,,
1693,91694,Fenpropidin,CC(CC1=CC=C(C=C1)C(C)(C)C)CN2CCCCC2,,,"['Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)']",,,
1694,91695,"4-[3-(4-tert-Butylphenyl)-2-methylpropyl]-2,6-dimethylmorpholine",CC1CN(CC(O1)C)CC(C)CC2=CC=C(C=C2)C(C)(C)C,,,"['Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)']",,,
1695,91696,Traseolide,CC1C(C2=C(C1(C)C)C=C(C(=C2)C(=O)C)C)C(C)C,,,,,,
1696,91697,"2,2-Dimethyl-2,3-dihydro-1-benzofuran-7-amine",CC1(CC2=C(O1)C(=CC=C2)N)C,,,,,,
1697,91698,"(3,3-dimethyl-2H-1-benzofuran-5-yl) propane-1-sulfonate",CCCS(=O)(=O)OC1=CC2=C(C=C1)OCC2(C)C,,,,,,
1698,91699,Triflumizole,CCCOCC(=NC1=C(C=C(C=C1)Cl)C(F)(F)F)N2C=CN=C2,,,,"['Following oral treatment of rats with /a single oral dose of 10 mg/kg/ [phenyl- U-(14)C]-NF-114, no sex-related differences were observed in absorption, metabolism, distribution or excretion. Maximum concentrations of radioactivity in plasma were attained within 1 hour of dosing in both sexes. Low levels of radioactivity were detectable in all tissue, organ, and blood samples. Radioactivity in urine accounted for 69.5-74.4% of the dose and feces accounted for 21.7-21.9% of the dose. /From table/', 'M&F: 10 or 300 mg/kg as single oral dose: Following oral treatment of rats with [phenyl- U-(14)C]-NF-114, approximately 93.8-100.6% of the administered dose was recovered. Urine was the major route of excretion. Low levels of radioactivity were detectable in all tissue, organ, and blood samples collected 2 days (10 mg/kg group) or 4 days (300 mg/kg group) post-dose with tissue concentrations generally higher in males than females. The metabolite profile in the excreta was quantitatively and qualitatively similar between the sexes and dose groups. /From table/']","['The metabolism of triflumizole was investigated by analyzing fecal and urine samples retained from ... previous studies: single oral administration of 10 or 300 mg/kg bw and 14 consecutive oral doses of 10 mg/kg bw per day. ... Triflumizole is extensively metabolized: less than 2% of the radiolabel recovered from urine or feces was identified as parent compound. A few differences in metabolite pattern were observed between males and females after repeated low and single high doses, but not after a single low dose. The major urinary metabolites are the sulfate conjugates of FM-8-1 and FA-1-5, each representing approximately 20% of the radiolabel recovered after the single low dose from that matrix and, respectively, approximately 11% and 20% after the high dose. In feces, FD-2-1 is a major metabolite in all dose regimens (~6-10% of the recovered radiolabel). Considerable differences between dose regimens exist with respect to other major metabolites. FM-2-1 is the major metabolite after a single oral low dose (~9% of radiolabel recovered in feces), but represents less than 2% for the other dose regimens. FA-1-1 is a major metabolite after single and repeated low dosing (~5-10%), but not after single oral high dosing (<3%), whereas FD-1-1 is the major metabolite after a single oral high dose (~16%) and a minor metabolite after single and repeated low doses (<2%). The metabolite FM-6-1 was tentatively identified by TLC co-chromatography, and the radioactive band corresponding to the authentic FM-6-1 was obscure, because of its low radioactivity.']",
1699,91700,"Phenol, isobutylenated, phosphate (3:1)",CC(C)CC1=CC=C(C=C1)OP(=O)(OC2=CC=C(C=C2)CC(C)C)OC3=CC=C(C=C3)CC(C)C,,,,,,
1700,91701,Fluazifop,CC(C(=O)O)OC1=CC=C(C=C1)OC2=NC=C(C=C2)C(F)(F)F,,,"['Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)']",,,
1701,91702,"[Cyano-(4-fluoro-3-phenoxyphenyl)methyl] 3-[2-chloro-2-(4-chlorophenyl)ethenyl]-2,2-dimethylcyclopropane-1-carboxylate",CC1(C(C1C(=O)OC(C#N)C2=CC(=C(C=C2)F)OC3=CC=CC=C3)C=C(C4=CC=C(C=C4)Cl)Cl)C,,,,,,
1702,91703,"Phenol, 2,4(or 2,6)-dibromo-, homopolymer",C1=CC(=C(C(=C1)Br)O)Br.C1=CC(=C(C=C1Br)Br)O,,,,,,
1703,91704,"2,3,3',4,5'-Pentachlorobiphenyl",C1=CC(=C(C(=C1C2=CC(=CC(=C2)Cl)Cl)Cl)Cl)Cl,,,,,,
1704,91705,"2,3,3',5-Tetrachlorobiphenyl",C1=CC(=CC(=C1)Cl)C2=C(C(=CC(=C2)Cl)Cl)Cl,,,,,,
1705,91706,Lyngbyatoxin a,CC(C)[C@H]1C(=O)N[C@@H](CC2=CNC3=C(C=CC(=C23)N1C)[C@](C)(CCC=C(C)C)C=C)CO,,,,,,
1706,91707,Fenoxaprop-P-ethyl,CCOC(=O)[C@@H](C)OC1=CC=C(C=C1)OC2=NC3=C(O2)C=C(C=C3)Cl,,,,,,
1707,91708,Chlorfluazuron,C1=CC(=C(C(=C1)F)C(=O)NC(=O)NC2=CC(=C(C(=C2)Cl)OC3=C(C=C(C=N3)C(F)(F)F)Cl)Cl)F,,,,,,
1708,91709,"1,2,3-Trichloro-4-(2,4,5-trichlorophenoxy)benzene",C1=CC(=C(C(=C1OC2=CC(=C(C=C2Cl)Cl)Cl)Cl)Cl)Cl,,,,,,
1709,91710,"6aH-Indeno[2,1-a]pyren-6a-yl",C1=CC=C2C(=C1)[CH]C3=C2C=C4C=CC5=C6C4=C3C=CC6=CC=C5,,,,,,
1710,91711,CID 91711,CC1=C2C3=CC=CC=C3N=C2C=C(N1)N.CC(=O)O,,,,,,
1711,91712,"Prop-2-ynyl 2-(4-((3,5-dichloro-2-pyridyl)oxy)phenoxy)propionate",CC(C(=O)OCC#C)OC1=CC=C(C=C1)OC2=C(C=C(C=N2)Cl)Cl,,,,,,
1712,91713,CID 91713,CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],,,['Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)'],,,
1713,91714,N-Methyl-N'-phenyl-N'-methyl-N-nitrosourea,CN(C1=CC=CC=C1)C(=O)N(C)N=O,,,,,,
1714,91715,Flurazole,C1=CC=C(C=C1)COC(=O)C2=C(N=C(S2)Cl)C(F)(F)F,,,,,,
1715,91716,Mefenacet,CN(C1=CC=CC=C1)C(=O)COC2=NC3=CC=CC=C3S2,,,,,,
1716,91717,"2,3',4,5-Tetrachlorobiphenyl",C1=CC(=CC(=C1)Cl)C2=CC(=C(C=C2Cl)Cl)Cl,,,,,,
1717,91718,"2,3,3',6-Tetrachlorobiphenyl",C1=CC(=CC(=C1)Cl)C2=C(C=CC(=C2Cl)Cl)Cl,,,,,,
1718,91719,"2,3,3',5,6-Pentachlorobiphenyl",C1=CC(=CC(=C1)Cl)C2=C(C(=CC(=C2Cl)Cl)Cl)Cl,,,,,,
1719,91720,"2,3,4,4',6-Pentachlorobiphenyl",C1=CC(=CC=C1C2=C(C(=C(C=C2Cl)Cl)Cl)Cl)Cl,,,,,,
1720,91721,"2,2',3,4,4',5,6,6'-Octachlorobiphenyl",C1=C(C=C(C(=C1Cl)C2=C(C(=C(C(=C2Cl)Cl)Cl)Cl)Cl)Cl)Cl,,,,,,
1721,91722,"2,3,3',4,4',5,5',6-Octachlorobiphenyl",C1=C(C=C(C(=C1Cl)Cl)Cl)C2=C(C(=C(C(=C2Cl)Cl)Cl)Cl)Cl,,,,,,
1722,91723,"2,2',3,4',5,6,6'-Heptachlorobiphenyl",C1=C(C=C(C(=C1Cl)C2=C(C(=CC(=C2Cl)Cl)Cl)Cl)Cl)Cl,,,,,,
1723,91724,Fenpiclonil,C1=CC(=C(C(=C1)Cl)Cl)C2=CNC=C2C#N,,,,,,
1724,91725,Vascor,CC(C)COCC(CN(CC1=CC=CC=C1)C2=CC=CC=C2)N3CCCC3.O.Cl,,,"['Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)', 'A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)', 'Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)', 'Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)']",,,
1725,91726,Oxabetrinil,C1COC(O1)CON=C(C#N)C2=CC=CC=C2,,,,,,
1726,91727,Flutriafol,C1=CC=C(C(=C1)C(CN2C=NC=N2)(C3=CC=C(C=C3)F)O)F,,,"['Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)']",,,
1727,91728,"2,3,3',4',5'-Pentachlorobiphenyl",C1=CC(=C(C(=C1)Cl)Cl)C2=CC(=C(C(=C2)Cl)Cl)Cl,,,,,,
1728,91729,Thifensulfuron,CC1=NC(=NC(=N1)OC)NC(=O)NS(=O)(=O)C2=C(SC=C2)C(=O)O,,,,,,
1729,91730,Metsulfuron,CC1=NC(=NC(=N1)OC)NC(=O)NS(=O)(=O)C2=CC=CC=C2C(=O)O,,,,,,
1730,91731,Fluazinam,C1=C(C=NC(=C1Cl)NC2=C(C=C(C(=C2[N+](=O)[O-])Cl)C(F)(F)F)[N+](=O)[O-])C(F)(F)F,,,,"['Metabolites AMPA /(4-chloro-N2-[3-chloro-5- (trifluoromethyl)-2-pyridyl]-3-nitro-5-(trifluoromethyl)-1,2-benzenediamine)/, DAPA /(3-chloro-2-(2,6-diamino-3-chloro-alpha,alpha,alpha- trifluoromethyl) pyridine)/, and some related conjugates and hydrolysis products were isolated, identified and characterized from urine, feces and bile of radiolabelled fluazinam-treated rats. Fluazinam was almost completely metabolized by hydroxylation, followed by conjugation. A quantitative sex difference was not observed.', 'In a metabolism study in rats, only 33-40% of the administered dose of radio labeled fluazinam was absorbed. Most of the administered dose was recovered in the feces (>89%). Unabsorbed parent compound represented most of the identified radioactivity in the feces. Excretion via the urine was minor (<4%). Total biliary radioactivity, however, represented 25-34% of the administered dose, indicating considerable enterohepatic circulation. Analysis of chromatograms indicated that numerous metabolites were present in the bile.']","['... Fluazinam was almost completely metabolized /in treated rats/ by hydroxylation, followed by conjugation. A quantitative sex difference was not observed.']",
1731,91732,CID 91732,CC(C)C1=CC(=CC(=C1NC(=NC(C)(C)C)S)C(C)C)OC2=CC=CC=C2,,,,,,
1732,91733,Fluazifop-P,C[C@H](C(=O)O)OC1=CC=C(C=C1)OC2=NC=C(C=C2)C(F)(F)F,,,,,,
1733,91734,Teflubenzuron,C1=CC(=C(C(=C1)F)C(=O)NC(=O)NC2=CC(=C(C(=C2F)Cl)F)Cl)F,,,,,,
1734,91735,Diflufenican,C1=CC(=CC(=C1)OC2=C(C=CC=N2)C(=O)NC3=C(C=C(C=C3)F)F)C(F)(F)F,,,,,,
1735,91736,"7-[2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-1,4-dithia-7-azaspiro[4.4]nonane-8-carboxylic acid",CCOC(=O)[C@H](CCC1=CC=CC=C1)NC(C)C(=O)N2CC3(CC2C(=O)O)SCCS3,,,,,,
1736,91737,"1-(4-Chlorophenyl)-4,4-dimethyl-2-(1,2,4-triazole-1-yl)-pentene-3-ol",CC(C)(C)C(C(=CC1=CC=C(C=C1)Cl)N2C=NC=N2)O,,,,,,
1737,91738,Diclopentezol,CC(C)(C)C(C(=CC1=C(C=C(C=C1)Cl)Cl)N2C=NC=N2)O,,,,,,
1738,91739,Quinclorac,C1=CC(=C(C2=NC=C(C=C21)Cl)C(=O)O)Cl,,,"['Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)']","['The extent of oral absorption was high (> 90%), based on urinary and biliary data, with most of the biliary component reabsorbed and excreted in urine. The biliary component increased disproportionately with increasing dose from 15 to 600 mg/kg bw. Absorption of radiolabel was rapid, with maximal blood concentrations achieved between 0.25 and 1 hour for single doses of 600 mg/kg bw and below. Quinclorac was widely distributed in the body, with highest concentrations present in the blood, plasma and kidneys. Tissue levels were generally higher (< 2-fold) in females than in males. The labelled material was rapidly excreted, primarily via urine (50-90% in 24 hours). Initial plasma half-lives were calculated to be approximately 3-4 hours. Clearance from the blood was slower following repeated dosing with 600 mg/kg bw and with single doses of 1200 mg/kg bw, resulting in non-proportionate increases in the area under the concentration-time curve (AUC). The excretion pattern and tissue distribution of radioactivity were similar across administered dose levels and when the administration of radiolabelled quinclorac was preceded by 7 or 14 days of administration of the labelled or unlabelled material.', 'The metabolism of quinclorac ((2,3,4-(14)C)3,7-dichloro-8-quinolinecarboxylic acid) following oral administration was studied extensively in male and female CD rat. The compound was rapidly absorbed and eliminated in the urine following administration of single oral doses of (14)C quinclorac at 15 or 600 mg/kg and at 15 mg/kg after the animals were dosed with unlabeled quinclorac at 15 mg/kg/day for 14 days. Elimination in the urine 5 days after dosing accounted for 91 to 98% of the dose with only 1 to 4% eliminated in the feces. No radioactivity was detected in expired air. Biliary excretion was significant (11.5 to 14.5% of the dose) in animals receiving 600 mg/kg. However, most of this radioactivity was reabsorbed from the intestines and eliminated in the urine. Most of the radioactivity in the bile is associated with the glucuronide conjugate of quinclorac. The conjugate is apparently hydrolyzed in the intestines and reabsorbed. Almost all the radioactivity in the urine is unchanged quinclorac. Radioactive tissue residue levels 5 days after dosing were dose-dependent. Results from these and other (whole-body autoradiography and time-course) studies indicate that quinclorac may accumulate in the adrenal glands, bone marrow, thyroid, squamous epithelium of the non-fundic stomach, and ovaries.', 'In 7-day time-course studies (oral gavage at 15 mg/kg/day or dietary at about 1,000 mg/kg/day) maximum (14)C residue levels were detected 30 minutes after the final dose; thereafter, residue levels decreased with time. Mean (14)C residues in plasma were also detected at 30 minutes in animals receiving single oral doses of 15, 100, or 600 mg/kg or 15 mg/kg/day for 7 days. Elimination was biphasic with half-lives of 3 to 4 hours for the rapid phase at the low doses and a half-life of about 13 hours at 600 mg/kg. Peak plasma levels of radioactivity in animals receiving higher doses (1200 mg/kg or 600 mg/kg/day for 7 days) were noted for 7 to 48 hours postdosing: saturation kinetics were also noted at these higher doses.']","['Samples ... extracted and analyzed for the presence of metabolites using techniques including thin-layer chromatography and mass spectroscopy. Absorbed quinclorac was metabolized to only a limited extent, with unchanged parent compound representing approximately 80% of the excreted radiolabel. The major biotransformation product was quinclorac-glucuronide conjugate, representing approximately 5% of the administered dose. The pattern of metabolism was similar across sexes, dose levels and administration of repeated doses. A number of metabolites each representing less than 5% of the administered dose were not identified. The metabolism of quinclorac is so limited that a metabolic pathway is considered unnecessary.']","['In 7-day time-course studies (oral gavage at 15 mg/kg/day or dietary at about 1,000 mg/kg/day) maximum (14)C residue levels were detected 30 minutes after the final dose; thereafter, residue levels decreased with time. ... Elimination was biphasic with half-lives of 3 to 4 hours for the rapid phase at the low doses and a half-life of about 13 hours at 600 mg/kg. ...']"
1739,91740,Esprocarb,CCN(C(C)C(C)C)C(=O)SCC1=CC=CC=C1,,,,,,
1740,91741,Hexaflumuron,C1=CC(=C(C(=C1)F)C(=O)NC(=O)NC2=CC(=C(C(=C2)Cl)OC(C(F)F)(F)F)Cl)F,,,"['Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)']",['The substance can be absorbed into the body by inhalation.'],,
1741,91742,Diethofencarb,CCOC1=C(C=C(C=C1)NC(=O)OC(C)C)OCC,,,,,,
1742,91743,Haloxyfop-etotyl,CCOCCOC(=O)C(C)OC1=CC=C(C=C1)OC2=C(C=C(C=N2)C(F)(F)F)Cl,,,,,,
1743,91744,Dimethenamid,CC1=CSC(=C1N(C(C)COC)C(=O)CCl)C,,,"['Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)']","['Racemic dimethenamid was well absorbed after oral administration in rats, as demonstrated by addition of the amount of radioactivity excreted in the urine, via the bile duct and that remaining in the organs and carcass. Biliary excretion accounted for 75-82% of the radiolabelled carbon, with an additional 2-4% being found in the feces and 8-12% in the urine. The total excretion by bile and urine for males was 89.8% and for females was 87.5%. After adding the amount of radioactivity found in the carcass, the total absorption after oral administration was 94.5% in males and 92.8% in females; therefore, essentially 100%. Excretion was very rapid primarily in the bile. Within 7 hr, 45-64% of the orally administered dose was excreted in bile of the cannulated rats. By 168 hr after treatment, an average of 90% of the administered dose was eliminated by all routes. There were some dose-dependent differences in the pattern of excretion. At the lower dose (10 mg/kg bw), urinary radiocarbon accounted for 35-47% of the administered dose compared with 62-63% at the higher dose (1000 mg/kg bw). Radioactivity in feces was 48-58% for groups at the lower dose compared with 26-30% at the higher dose. These data indicated that biliary excretion might be saturated for the group at the higher dose, resulting in more radioactivity being eliminated via the kidney.', 'The concentration of radioactivity in the blood decreased slowly over the experimental period of 168 hr. Half-lives of elimination from blood were 255 +/-79 hr and 334 +/-192 hr for male and female rats, respectively. The radioactivity was mainly associated with erythrocytes (the concentration of radioactivity in the plasma being much lower). A similar binding phenomenon was not observed in human blood; this can be explained by differences between rat and human hemoglobins. After a single oral lower dose (10 mg/kg bw) the maximum concentration of blood radioactivity was reached at about 72 hr after administration (0.05 ug of test material/g blood in males and 0.1 ug of test material/g blood in females). Afterwards, radioactivity decreased slowly. For the oral high dose, the maximum blood radioactivity was also reached at 72 hr, but did not significantly decrease between 72 and 168 hr. In general, tissue concentrations of radioactivity were similar in both sexes, and the pattern of absorption, distribution and elimination after oral administration was similar. Radioactivity concentrations were higher at 1-4 hr in adrenals, pancreas, kidney, spleen, liver and blood. Residue concentrations decreased steadily over time, with the exception of blood. Overall, tissue concentrations were low by 168 hr after treatment. For the rats treated at the lower dose, the concentration was < 0.5 ppm in all organs and tissues. After oral administration, it appeared that there was no significant difference in the absorption, distribution, and elimination of racemic dimethenamid in males and females. There was only a slight difference in the rate of elimination of radiocarbon between single and multiple doses. Residue concentrations in tissues were similar for groups given single or multiple doses, indicating that racemic dimethenamid and its metabolites had no tendency to accumulate in rat tissues.', 'The rates of dermal penetration of racemic [(14)C]dimethenamid through human and rat skin were compared in vitro. After correcting for the difference in skin thickness, the rate of penetration through human skin is three to seven times less than that through rat skin. However, saturation has occurred at the highest dose in the rat skin, as the penetration rate no longer continues to increase linearly with dose. The predicted exposure of workers involved in the mixing, loading and application of racemic dimethenamid is at most 0.4 mg/sq cm. Therefore, the comparative values for rat/human skin at the lower doses is considered to be more appropriate for use in predicting human exposure. Overall the rate of dermal penetration of racemic dimethenamid in humans is predicted to be approximately 4%.', 'The pharmacokinetic studies indicated that dimethenamid may bind to blood components in rats. This was based on 3% of the radiolabeled material administered remaining in the blood fraction. Therefore, the nature of the interaction between dimethenamid and rat blood was investigated. The results of the study showed that dimethenamid did not produce methemoglobin in rat blood following a four day treatment. Dimethenamid was shown to bind to rat hemoglobin, primarily to the globin portion, but no binding was demonstrated using human blood. The difference in hemoglobin binding between humans and rats is explained by the difference in three dimensional structure between the 2 species. It is known from the literature that the cysteine residue beta-125 in rat hemoglobin is accessible for chemical substitution, but in human hemoglobin, the sequence does not contain a cysteine residue in position 125. In summary, it can be concluded that the interaction between dimethenamid and hemoglobin is a species-specific reaction. This binding is irrelevant for humans.']","['The plant and soil oxalamide (M23) and sulfonate (M27) metabolites of racemic dimethenamid, which also occur as products of metabolism in rats, were tested in studies of acute oral toxicity, assays for mutagenicity in bacteria and for micronucleus formation in bone-marrow cells of mice. Both compounds had low acute oral toxicity with LD50 values of > 5000 mg/kg bw. Neither compound was mutagenic in bacteria or induced micronucleus formation in bone-marrow cells of mice.', 'Racemic dimethenamid is rapidly and extensively metabolized. Only 1-2% of unchanged racemic dimethenamid was detected in excreta. About 40 metabolites were found in organic extracts that were analyzed by TLC. About 20 metabolites were identified. Metabolism occurred primarily via the glutathione conjugation pathways. Racemic dimethenamid was rapidly conjugated with glutathione and then passed through several steps to form cysteine conjugate (M25) and mercapturate (M17). M25 was further oxidized to form additional metabolites (M1, M2, M10, M13, M14, M16, M18, M19, M21, M22, M26, M27, M30, and M31). Although the glutathione adduct was not found in the study in rats, it was identified in the study in vitro. Other metabolites qualitatively identified in the study in vitro included the cysteine conjugate (M25), the mercapturate (M17), the sulfonate (M27), the sulfoxide of thiolactic acid (M30), the sulfoxide of thioglycolic acid (M31), and the thioglycolic acid (M30). Racemic dimethenamid was also metabolized by reductive dechlorination (M3), oxidation (M4, M23), hydroxylation (M5, M11, M15), O-demethylation (M7, M12) and cyclization (M6, M8, M9, M15, M20). In another supplementary study, metabolites found on maize, the sulfonate (M27) (0.025-0.030%) and sulfoxide of thioglycolic acid (M31) (0.002-0.007%), were identified in rat urine. These metabolites have also been identified in mouse urine.', 'Metabolism /in rats/ was primarily via the glutathione conjugation pathway, but racemic dimethenamid was also metabolized by cytochrome P450 enzymes via reductive dechlorination, oxidation, hydroxylation, O-demethylation, and cyclization pathways, as well as conjugation with glucuronic acid. Unchanged dimethenamid in excreta accounted for only 1-2% of the administered dose, more than 40 metabolites having been detected. At least 20 of these metabolites were structurally identified by mass spectrometry and nuclear magnetic resonance, and confirmed by reference to synthesized standards. There was no significant difference in metabolism between the sexes.']","['Half-lives of elimination from blood were 255 +/-79 hr and 334 +/-192 hr for male and female rats, respectively.']"
1744,91745,Cinmethylin,CC1=CC=CC=C1CO[C@@H]2C[C@]3(CC[C@@]2(O3)C)C(C)C,,,,,,
1745,91746,CID 91746,CCC(=C1C(=O)CC(CC1=O)C2=C(C=C(C=C2C)C)C)NOCC,,,,,,
1746,91747,Fluxofenim,C1COC(O1)CON=C(C2=CC=C(C=C2)Cl)C(F)(F)F,,,,,,
1747,91748,CID 91748,C1C(CC2=CC=CC=C2C1C3=C(OC4=CC=CC=C4C3=O)O)C5=CC=C(C=C5)OCC6=CC=C(C=C6)C(F)(F)F,,,,,,
1748,91749,Quinmerac,CC1=CC2=C(C(=C(C=C2)Cl)C(=O)O)N=C1,,,,,,
1749,91750,Pyrazosulfuron-ethyl,CCOC(=O)C1=C(N(N=C1)C)S(=O)(=O)NC(=O)NC2=NC(=CC(=N2)OC)OC,,,"['Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)']",,,
1750,91751,Prosulfuron,CC1=NC(=NC(=N1)OC)NC(=O)NS(=O)(=O)C2=CC=CC=C2CCC(F)(F)F,,,,"['Rats were administered triazine-(4-14)C prosulfuron as a single oral dose of 0.5 mg/kg, a single i.v. dose of 0.5 mg/kg, a single oral dose of 400 mg/kg and a single oral dose of triazine-(4-14)C prosulfuron following 14 days of repeated dosing with 0.5 mg/kg of nonradiolabeled compound. Approximately 90% of the administered dose was excreted within 48 hours post-dosing. Over a 168 hour period, urinary excretion of radioactivity ranged from 61.19-83.36% of the administered radioactivity and fecal excretion of radioactivity ranged from 10.46- 35.84%. Tissue radioactivity was low, less than 0.91% of the administered dose. The metabolite profile for each sex was similar regardless of the route of administration. However, females tended to excrete more radioactivity in the urine and less in the feces than males. ...', 'In a metabolism study rats were administered phenyl-(14)C prosulfuron as a single oral dose of 0.5 mg/kg, a single i.v. dose of 0.5 mg/kg, a single oral dose of 400 mg/kg and a single oral dose of phenyl-(14)C prosulfuron following 14 days of repeated dosing with 0.5 mg/kg of nonlabeled compound. Approximately 90% of the administered dose was excreted during the first 48 hours. Over the 168 hour collection period, rats in the 0.5 mg/kg group excreted 71-83% of the administered dose in the urine and 10-23% in the feces. At 400 mg/kg, a greater proportion of the administered dose was excreted in the feces (33-36%) compared to urine (61-71%). Females usually excreted more of the dose in the urine (79-91%) than males (66-79%). The parent compound represented 8-27% of the total activity in the urine of females and 5-9% in males, whereas in the feces there was 10-16% of the parent compound in females and 5-6% in males. Fifteen urinary metabolites were determined and 13 similar metabolites were confirmed in feces. 90-99% of the urinary radioactivity was identified and 75-90% of the fecal radioactivity was identified. Tissue levels were low. At 400 mg/kg, the tissue containing the most radioactivity was the skin (0.04- 0.46%). Bone contained the smallest amount of radioactivity (0.00031%-0.00050%). No measurable amount of radioactivity was found in most tissues 168 hours post-dosing in animals at 0.5 mg/kg. ...']","['Rats were administered triazine-(4-14)C prosulfuron as a single oral dose of 0.5 mg/kg, a single i.v. dose of 0.5 mg/kg, a single oral dose of 400 mg/kg and a single oral dose of triazine-(4-14)C prosulfuron following 14 days of repeated dosing with 0.5 mg/kg of nonradiolabeled compound. ... The metabolite profile for each sex was similar regardless of the route of administration. However, females tended to excrete more radioactivity in the urine and less in the feces than males. The metabolites in the greatest concentration in the urine were #2 (hydroxylation of triazinyl methyl group) and #11 (parent compound) along with #1 (O-demethylated methoxy group) and #3 (hydroxylation of trifluoropropyl group). Females excreted more parent compound than males. Males excreted more of the hydroxylated metabolites and more metabolites with a double bond on the trifluoropropyl group. At 0.5 mg/kg, the metabolites were not affected by the route or frequency of administration. The proportion of administered radioactivity in the feces increased in the 400 mg/kg group. Urinary metabolite #3 was greater at 400 mg/kg than 0.5 mg/kg, especially in males. It is believed that O-demethylation of the methoxy group and hydroxylation of the triazinyl methyl group are the primary metabolic pathways; while hydroxylation at various sites of the trifluoropropylbenzene moiety is a slower process that increases in importance as the primary pathways approach saturation.', 'In a metabolism study rats were administered phenyl-(14)C prosulfuron as a single oral dose of 0.5 mg/kg, a single i.v. dose of 0.5 mg/kg, a single oral dose of 400 mg/kg and a single oral dose of phenyl-(14)C prosulfuron following 14 days of repeated dosing with 0.5 mg/kg of nonlabeled compound. ... Fifteen urinary metabolites were determined and 13 similar metabolites were confirmed in feces. ... The major routes of metabolism occurred via hydroxylation at side chains and phenyl ring positions and O-demethylation of the triazyl methoxy group. Minor routes of metabolism included unsaturation of the trifluoropropyl side chain, hydrolysis of the phenyl-sulfonylurea link and oxidative/hydrolytic cleavage of the triazine ring system. The major metabolite (47% to 60% of urinary radioactivity at 0.5 mg/kg) was formed by hydroxylation of the triazinyl methyl group. At the 0.5 mg/kg level, metabolism was not affected by route of administration.']",
1751,91752,Cadusafos,CCC(C)SP(=O)(OCC)SC(C)CC,,,,"['... Elimination of the phosphorus-containing residue may be via the urine or feces. Some bound residues remain in exposed animals.  Binding seems to be to proteins, principally, and the turnover appears to be related to the half-life of these proteins.  There are limited data showing that incorporation of residues into DNA occurs only in trace amounts and not by direct alkylation, such as might be believed to be associated with genetic damage. /Organophosphorus Pesticides/', 'Readily absorbed, metabolized and eliminated in urine and feces.', 'Adult rats (Sprague-Dawley, 5/sex) were dosed orally with single doses of 20 mg/kg bw (14)C-labelled cadusafos. Urine and feces were collected for 7 days. Animals were then sacrificed and carcass and tissues were analyzed for residual radioactivity. About 75% of the applied radioactivity was excreted in urine and about 15% in feces over the course of 7 days. Most radioactivity was eliminated within the first 24 hours after dosing. Highest residues were measured in liver and in adipose tissue with a mean value of 0.7 ppm. Another group of rats (5/sex) was monitored for (14)CO2. Expiration amounted to 13% of the applied radioactivity within three days. No sex difference in the elimination and distribution pattern was observed.', 'Rats (Crl:CD(SD)BR, 10/sex/group) received one of four dosing regimens with (14)C-labelled cadusafos. Dosing regimens were a single oral low dose of 1 mg/kg bw, a single iv dose of 0.8 mg/kg bw, multiple oral low doses of 1 mg/kg bw nonlabelled material over 14 days followed by an additional dose of labelled material and a control group. Urine and feces were collected for 7 days and tissues were then analyzed for remaining radioactivity. Animals for which 14CO2 was monitored were sacrificed 3 days after dosing. For all groups, more than 90% of the administered radioactivity was eliminated within 48 hours after dosing. Mean total urinary excretion was about 67%, 78% and 71% after oral single, iv and oral multiple dosing, respectively. Corresponding excretion values in feces were 10%, 5% and 7%. (14)CO2 expiration varied between 13% and 16% in the three dosing regimens. Residues in tissues were low. Highest levels were measured in liver and in fat showing mean concentrations of up to about 0.07 ppm in liver and 0.03 ppm in fat after oral dosing. In the iv study mean concentration in lung was highest with mean values of about 0.05 ppm, followed by a concentration of 0.03 ppm in liver and fat. No marked sex differences were observed.']","['Metabolism occurs principally by oxidation, hydrolysis by esterases, and by transfer of portions of the molecule to glutathione.  Oxidation of organophosphorus insecticides may result in more or less toxic products.  The glutathione transferase reactions produce products, that are, in most cases, of low toxicity. Hydrolytic and transferase reactions affect both thioates and their oxons. /Organophosphorus Pesticides/', 'Hydroxy sulfones were the major metabolites /in animals/, followed by phosphorothioic and sulfonic acids.', 'Male and female rats (Sprague-Dawley, 5/sex/dose) were administered an oral dose of (14)C-labelled cadusafos (at the butyl side chains) at rates of 1 and 21 mg/kg bw. Another group received multiple oral doses of 1 mg/kg bw (labelled and non-labelled material). Results from oral dosing were compared to those from iv dosing consisting of a single dose of about 0.8 mg/kg bw. The excretion pattern found in previous experiments was confirmed. Analyses of excretion profiles showed that the majority of (14)C activity was eliminated within the first 24 hours after dosing. In the fraction of non-conjugated neutral metabolites the majority of the radioactivity excreted in urine was contributed by methyl-1-methyl-2- hydroxypropane sulfone. Other metabolites detected were 0-ethyl-S-(2-butyl) phosphorothioic acid, S,S-di-(2-butyl) phosphorodithioic acid, methyl-2-butyl-sulfone and sulfoxide. 0-ethyl-S-(2-butyl)phosphorothioic acid, methylsulfonic acid, hydroxy sulfone and sec-butyl sulfonic acid were identified. As major polar metabolites in the remaining fractions such compounds as 4-hydroxy-2-butyl sulfonic acid, 3-hydroxy-2-butyl sulfonic acid, sec-butyl sulfonic acids, and S-(2-butyl) phosphorothioic acid were detected. In feces the parent compound was found at rates of 6-64% in the different oral dosing regimens with highest values after administration of a single oral high dose. In the iv dosed group parent compound was not detected in feces. Major fecal metabolites were sec-butyl sulfonic acid and monophosphorothioic acid-related acidic compounds. Cleavage of the thio-(sec-butyl) group is the initial step producing sec-butyl mercaptan and 0-ethyl-S-(2-butyl)phosphorothioic acid as major metabolites. Further cleavage and oxidation reactions may result in S-(2-butyl)phosphorothioic acid or 0-ethyl phosphorothioic acid, methyl  sec-butyl sulfide, sulfoxide, sulfone and finally hydroxysulfones. Sec-butyl mercaptan can also be oxidized to butyl sulfonic acid, ethyl and methyl sulfonic acid. Formation of CO2 could be derived from either the sec-butyl mercaptan moiety or the corresponding sulfonic acid. CO2 may then be incorporated into urea or other endogenous substances.']",
1752,91753,Pyriproxyfen,CC(COC1=CC=C(C=C1)OC2=CC=CC=C2)OC3=CC=CC=N3,,,"['Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)']","['Male and female rats were given a single oral dose of ... ((14)C)pyriproxyfen /labeled on the phenoxyphenyl moiety/ <4-phenoxyphenyl(R,S)-2-(2-pyridyloxy)propyl ether> at 2 (low dose) or 1000 (high dose) mg/kg. (14)C was rapidly excreted into feces and urine, with the former route predominating (about 90% of the dose). Peak (1)4C concentrations in blood, kidney, liver, and other tissues except for fat occurred 2-8 hr after administration, being 0.4, 0.4, 2.5, and <0.2 g of pyriproxyfen equivalents/g of tissue (ppm), respectively. Peak (14)C concentration in fat occurred 12-24 hr after administration, being 0.3-0.5 ppm. (14)C tissue residues on the seventh day were below 0.02 and 10 ppm for the low and high doses, respectively. ... No marked sex-related differences were observed for (14)C excretion or (14)C tissue residues. However, a slight sex-related variation was found for the extent of metabolic reactions.', '... Rats were orally dosed with (14)C-labeled pyriproxyfen at 2 or 1,000 mg/kg and at repeated oral doses (14 daily doses) of unlabeled pyriproxyfen at 2 mg/kg followed by admin of a single oral dose of labeled pyriproxyfen at 2 mg/kg. Most radioactivity was excreted in the feces (81-92%) and urine (5-12%) over a 7-day collection period. ... /Radioactivity/ was not detected /in expired air/. Tissue radioactivity levels were very low (< 0.3%) except for fat. Examination of urine, feces, liver, kidney, bile, and blood metabolites yielded numerous (>20) identified metabolites when compared to synthetic standards.']","['The metabolic fate of pyriproxyfen (4-phenoxyphenyl (RS)-2-(2-pyridyloxy)propyl ether, Sumilarv) was examined in rats and mice given single oral doses of (pyridyl-2,6-(14)C)- or (phenoxyphenyl-(14)C)pyriproxyfen at doses of 2 and 1000 mg/kg. The carbon-14 was excreted almost completely into urine and feces within 7 days after dosing and fecal excretion of carbon-14 predominated in both animals. Excretion of carbon-14 into feces and urine was, respectively, 84-97% and 4-12% of the dose in rats and 64-91% and 9-38% in mice. Major metabolic reactions of pyriproxyfen were (1) hydroxylation at the 4-position of the terminal phenyl ring, (2) hydroxylation at the 2-position of the terminal phenyl ring, (3) hydroxylation at the 5-position of the pyridyl ring, (4) dephenylation, (5) cleavage of ether linkages, and (6) conjugation of the resultant phenols with sulfate or glucuronate. Although there was generally no marked difference in the metabolic profile of pyriproxyfen between the two species, significant sex-related differences were found in metabolic reactions 1, 3, and 6 in the rat but not in the mouse.', 'Levels of cytochrome P450 and b5 were investigated in microsomal enzymes of houseflies from the gut and fat body of the third instar larvae of a pyriproxyfen-resistant  strain (YPPF) and two pyriproxyfen-susceptible strains (YS and SRS). In comparison to the YS and SRS strains, YPPF microsomes had higher levels of total cytochrome P450s in both the gut and fat body. Furthermore, microsomes from the gut and fat body of YPPF larvae were found to have a much greater ability to hydroxylate aniline than YS larvae. In vitro metabolism studies of pyriproxyfen indicated that the metabolic rates were much higher in both the gut and fat body of YPPF larvae than of YS and SRS larvae. The major metabolites of pyriproxyfen in houseflies were identified to be 4\'-OH-pyriproxyfen and 5""-OH-pyriproxyfen. Cytochrome P450 inhibitors, piperonyl butoxide (PB) and 2-propynyl 2,3,6-trichlorophenyl ether (PTPE), decreased the metabolic rates significantly in all three strains. This study confirmed that microsomal cytochrome P450 monooxygenases play an important role in the pyriproxyfen resistance of the housefly. Furthermore, it suggests that the fat body must be as important as the gut for the metabolism of pyriproxyfen in resistant housefly larvae.', ""... Rats were orally dosed with (14)C-labeled pyriproxyfen at 2 or 1,000 mg/kg and at repeated oral doses (14 daily doses) of unlabeled pyriproxyfen at 2 mg/kg followed by admin of a single oral dose of labeled pyriproxyfen at 2 mg/kg. ...Examination of urine, feces, liver, kidney, bile, and blood metabolites yielded numerous (>20) identified metabolites when compared to synthetic standards. The major biotransformation reactions of pyriproxyfen include: (i) Oxidation of the 4' - position of the terminal phenyl group; (ii) Oxidation at the 5' - position of pyridine; (iii) Cleavage of the ether linkage and conjugation of the resultant phenols with sulfuric acid.""]",['... 918 days for pyriproxyfen in pepper fruits under cold storage conditions. ...']
1753,91754,Pyridaben,CC(C)(C)C1=CC=C(C=C1)CSC2=C(C(=O)N(N=C2)C(C)(C)C)Cl,,,,"['In a... rat metabolism study by the oral route, pyridaben was mainly eliminated in feces where 80-97% of the administered dose was excreted regardless of dose or site of label (pyridazinone or benzyl ring). Nearly 20% of the excreted residue in the feces was unmetabolized parent compound and there was some evidence of glucuronide conjugate(s) in the bile. The plasma levels following a single low oral dose (3 mg/kg) peaked at 2-3 hours while peak levels at the high dose (30 mg/kg) were at approximately 24 hours post-dose due, at least in part, to enterohepatic circulation where nearly 22-30% of an administered radioactive dose is excreted in bile within a period of 24 hours. Residual radioactivity was at or near background levels for most tissues by 72-168 hours. Generally, there seemed to be increased distribution to fat over time and, compared to other tissues, fat seemed to have relatively more residual radioactivity.']","['In a... rat metabolism study by the oral route, pyridaben was mainly eliminated in feces where 80-97% of the administered dose was excreted regardless of dose or site of label (pyridazinone or benzyl ring). Nearly 20% of the excreted residue in the feces was unmetabolized parent compound and there was some evidence of glucuronide conjugate(s) in the bile. The plasma levels following a single low oral dose (3 mg/kg) peaked at 2-3 hours while peak levels at the high dose (30 mg/kg) were at approximately 24 hours post-dose due, at least in part, to enterohepatic circulation where nearly 22-30% of an administered radioactive dose is excreted in bile within a period of 24 hours. Residual radioactivity was at or near background levels for most tissues by 72-168 hours. Generally, there seemed to be increased distribution to fat over time and, compared to other tissues, fat seemed to have relatively more residual radioactivity.']",
1754,91755,Flurtamone,CNC1=C(C(=O)C(O1)C2=CC=CC=C2)C3=CC(=CC=C3)C(F)(F)F,,,,,,
1755,91756,Ethametsulfuron-methyl,CCOC1=NC(=NC(=N1)NC(=O)NS(=O)(=O)C2=CC=CC=C2C(=O)OC)NC,,,,,,
1756,91757,Dithiopyr,CC(C)CC1=C(C(=NC(=C1C(=O)SC)C(F)(F)F)C(F)F)C(=O)SC,,,,,"['1. Transformation of dithiopyr by rat liver enzymes in vitro produced the corresponding monoacids as the predominant metabolites. 2. Transformations of the methylthioester functional groups in dithiopyr to the monoacids were mediated via rat liver microsomal oxygenases, and not via esterases. 3. Based on the formation of a dithiopyr-glutathione conjugate, the mechanism of monoacid formation is believed to proceed through an initial sulfur oxidation of the methylthioester group and a subsequent nucleophilic displacement reaction.']",
1757,91758,Fosthiazate,CCC(C)SP(=O)(N1CCSC1=O)OCC,,,"['Substances used in the treatment or control of nematode infestations. They are used also in veterinary practice. (See all compounds classified as Antinematodal Agents.)', 'Chemicals used to destroy pests of any sort. The concept includes fungicides (FUNGICIDES, INDUSTRIAL); INSECTICIDES; RODENTICIDES; etc. (See all compounds classified as Pesticides.)']","['Groups of 5 Crl:CD BR VAF/Plus  rats/sex per group were dosed daily for 14 days by gavage (in 2 mL/kg corn oil vehicle) with fosthiazate at 2 mg/kg. Rats were then administered 2 mg/kg labeled fosthiazate, and were killed after 24 hrs or 168 hrs, at which time tissues (including blood) were collected for radiolabel analyses. Urine, feces, and expired air were collected at intervals after dosing. Unlabeled fosthiazate was 99% pure, and ring-labeled fosthiazate was >99% pure. There was no apparent effect of pre-treatment on metabolism... Patterns of excretion and tissue residues over time were comparable to single dose treatment. Fosthiazate is rapidly absorbed, metabolized, and excreted. Urine was the major route of excretion, whereas feces and expired air were minor routes. Neither sex-related differences in route or rate of excretion were observed. Excretion was essentially complete by 24 hrs after dosing. At 24 hrs, 75 to 82% of administered dose was eliminated. By 168 hrs after termination, 70% and 13.2% of administered dose was excreted in urine and feces, respectively. About 5.3% was eliminated as CO2.', ""Groups of 5 Crl:CD BR VAF/Plus rats/sex per group were dosed once by gavage (in 2 mL/kg corn oil vehicle) with fosthiazate, either 2 or 20 mg/kg. Unlabeled fosthiazate was 99% pure, and ring-labeled fosthiazate was >99% pure. Excreta and exhaled air were sampled throughout the 7-day post-exposure period. Major tissues were examined at termination for label. Expired air contained 5-6% of administered dose (in 1 N NaOH traps, presumed to be CO2), regardless of sex or dose level. Most of this was collected in the first 12 hrs. Amounts of volatile organics collected downstream from the CO2 traps were minuscule. Urinary metabolites accounted for 66-67% of administered dose in males, and 71- 73% in females. There was no apparent difference between the dose levels. Over one-half of the urinary label was collected within 6 hrs of dosing in all cases. Fecal metabolites constituted 11-12% of administered dose, regardless of sex or dose. Most of this label was collected within 48 hrs. Total percentage of administered dose found in all body tissues combined were 11.0 and 9.4% in 2 mg/kg/day and 20 mg/kg/day males, respectively; and 8.2 and 6.8% in respective females, suggesting appreciable retention. Tissue label was widely distributed at 1 week post-treatment. Highest concentrations of label at 2 mg/kg were in liver, lung, and heart. Radioactivity was clearly not concentrated in points of entry (g.i. tract) or circulation (blood), nor in the fat. This appreciable tissue retention, coupled with the significant CO2 production of labeled carbon from metabolism of the ring component, suggests that carbon from the thiazolidinyl ring is substantially assimilated into the body's carbon pool. ..."", 'Ten Crl:CD BR VAF/Plus rats/sex/group were dosed once daily by gavage (in 2 mL/kg corn oil vehicle) with unlabeled fosthiazate at 2 mg/kg/day. On Day 15, rats were administered 2 mg/kg S-sec-butyl-labeled fosthiazate. Five/sex were sacrificed at 24 hr after dosing with label: the other 5/sex were sacrificed after 7 days. ... There was no apparent effect of the pre-treatment on distribution and excretion patterns. Fate of label in the 7-day rats in this study in percent of administered dose was: urine (73 and 74% in M and F, respectively), feces (8 and 9% in M and F), expired air as CO2 (9 and 8% in M and F), expired air as volatile organics (0.5 and 0.6% in M and F), and all tissues combined (1.8 and 1.2% in M and F). ... no sampled organ had specific radioactivity higher than 2x that of whole blood at day 7 sacrifice. Tissue sampling at 24-hr sacrifice (excluding g.i. tract, due to insufficient time for normal passage of labeled lumenal contents) found liver to have the highest specific radioactivity relative to whole blood (liver/blood ratio 4.4 in M and 2.3 in F), followed by lung (lung/blood ratio 2.0 in M and 1.6 in F), with kidney and adrenal specific concentrations slightly lower than lung, and most organs or tissues similar to or lower label concentration than whole blood. ...']","['Groups of 7 Crl:CD BR VAF/Plus rats/sex were dosed once by gavage (in 2.5 mL/kg corn oil vehicle) with fosthiazate at 18 mg/kg. Non-radiolabeled fosthiazate, which contained 13C on 50% of each of the methyl carbons of the butyl group, was 99.3% pure. S-sec-butyl-2-14C-labeled fosthiazate was 97.7% pure (by MS). Investigators evaluated fate of fosthiazate in tissues and excreta over 48 hrs, and characterized major metabolites found in urine. S-sec-butyl-2-14C-labeled group in the present study produced about the same distribution of label in excreta as had been observed in /another study/ which utilized ring-labeled 14C. This suggests that both the ring and the butyl substituents undergo degradation to release appreciable CO2 (about 10% of administered dose). Identified large MW metabolites (excluding glutathione products) underwent ring opening, often with subsequent methylation of the ring sulfur. Products of oxidation of this ring sulfur, such as sulfonic acids, sulfoxides, and sulfones, constituted about 20% of administered dose. There were several observed residues of hydrolysis of the S-sec-butyl group, similarly displaying oxidation of the sulfur, with or without methylation of the sulfur. Some of the S-secbutyl group residues underwent glutathione conjugation and were manifest as N-acetyl cysteine products (not further characterized). ...', 'Seven Crl:CD BR VAF/Plus rats/sex were dosed once by gavage (in 2.2 mL/kg corn oil) with 22 mg/kg ring-14C-fosthiazate prior to ... identifying major metabolites. ... Nine peaks /were observed/ migrating near to the solvent front formed the largest cluster of radio-labeled components, none of which were characterized. They were considered to be small, polar, and apparently uncharged based on their mobility on a reverse-phase HPLC column and the minimal influence of a basic ion-pairing agent on their mobilities. These constituted 42% of administered dose in males, and 27% of administered dose in females. It appears that ring carbons were substantially assimilated into the carbon pool, considering together the appreciable labeled CO2 output, substantial label retention in tissues, and the presence of many small MW labeled components in urine. Three metabolites retained the S-butyl substituent and underwent opening of the thiazolidinyl ring. Together these constituted about 7% of administered label in males and 18% in females. The most abundant of these was (RS)-S-sec-butyl O-ethyl N-(2-methylsulfinylethyl) phosphoramidothioate (designated BESxP). A couple of analogous metabolites had undergone loss of the S-sec-butyl group; O-ethyl S-hydrogen N-2(methylsulfonyl)ethyl phosphoramidothioate (DBSoS) in particular (4.6% of administered dose in males, and 3.0% in females). Acetamide (a rat liver carcinogen at levels about 1000 x larger than levels observed in this study) constituted 3% and 2% of administered dose in males and females, respectively. ...']","['Groups of 5 Crl:CD BR VAF/Plus rats/sex per group were dosed once by gavage (in 2 mL/kg corn oil vehicle) with fosthiazate, either 2 or 20 mg/kg. Unlabeled fosthiazate was 99% pure, and ringlabeled fosthiazate was >99% pure. ... Median initial half-life estimates (defined as peak blood concentration time to 12 hrs post-dosing) were 14.9 or 11.5 hrs for low dose males and females, respectively. High dose initial half-life estimates were 8.6 hrs for both males and females. Median half-life values for the later phase of 18 to 168 hrs were 76 and 66 hrs for 2 mg/kg males and females, respectively; and 92 and 87 hrs for 20 mg/kg males and females, respectively. ...']"
1758,91759,Flumetsulam,CC1=NC2=NC(=NN2C=C1)S(=O)(=O)NC3=C(C=CC=C3F)F,,,,"['Flumetsulam was rapidly, though incompletely, absorbed in mice and rats, with absorption half-lives of less than 1 hr following oral administration of doses of either 5 or 1000 mg/kg. Excretion was also rapid, with a urinary half-life of approximately 5-7 hr. Following oral administration of (14)C-flumetsulam, approximately 50-75% of the administered radiolabel was excreted in the urine primarily as unchanged parent material, though two minor (<20% of urinary radiolabel) metabolites, believed to be conjugates of parent flumetsulam, were found in the urine of mice. Approximately 20-35% of the dose was found in the feces, which represented apparently unabsorbed flumetsulam (based on almost total elimination in the urine of an intravenous dose to rats) and tissue levels of (14)C accounted for less than 1.5% of the administered dose. There were no differences in absorption, distribution or elimination based on sex, though slight differences were seen with increasing dose.']","['Following oral administration of (14)C-flumetsulam, approximately 50-75% of the administered radiolabel was excreted in the urine primarily as unchanged parent material, though two minor (<20% of urinary radiolabel) metabolites, believed to be conjugates of parent flumetsulam, were found in the urine of mice.']","['Flumetsulam was rapidly, though incompletely, absorbed in mice and rats, with absorption half-lives of less than 1 hr following oral administration of doses of either 5 or 1000 mg/kg. Excretion was also rapid, with a urinary half-life of approximately 5-7 hr.']"
1759,91760,Sulcotrione,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)C2C(=O)CCCC2=O)Cl,,,"['Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)']",,,
1760,91761,CID 91761,CCC(=C1C(=O)CC(CC1=O)CC(C)SCC)NOCC=CCl,,,,,,
1761,91762,Chlorimuron,COC1=CC(=NC(=N1)NC(=O)NS(=O)(=O)C2=CC=CC=C2C(=O)O)Cl,,,,,,
1762,91763,Halosulfuron-methyl,CN1C(=C(C(=N1)Cl)C(=O)OC)S(=O)(=O)NC(=O)NC2=NC(=CC(=N2)OC)OC,,,,,,
1763,91764,"(1R,3S)-((S)-cyano(3-phenoxyphenyl)methyl) 3-((Z)-3-(1,1,1,3,3,3-hexafluoropropan-2-yloxy)-3-oxoprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate",CC1([C@H]([C@H]1C(=O)O[C@H](C#N)C2=CC(=CC=C2)OC3=CC=CC=C3)C=CC(=O)OC(C(F)(F)F)C(F)(F)F)C,,,"['Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)']",,,
1764,91765,CID 91765,CCCC(=C1C(=O)CC(CC1=O)C2CCCSC2)NOCC,,,,,,
1765,91766,Flufenoxuron,C1=CC(=C(C(=C1)F)C(=O)NC(=O)NC2=C(C=C(C=C2)OC3=C(C=C(C=C3)C(F)(F)F)Cl)F)F,,,,"['/In rats/ Flufenoxuron exhibited a dose-dependant absorption following a single low dose (3.5 mg/kg) or single high dose (350 mg/kg). At the high dose, saturated absorption was observed. Approximately 86% of the low dose and 1% of the high dose was absorbed in 168 hours, the majority of which occurred within 48 hours. For the difluorobenzene ring test article, urine was a major route of excretion in the low-dose group, but not in the high-dose group (<1%). Conversely, 93-102% of the high dose and 4-19% of the low dose was eliminated in feces. Elimination via expired air was insignificant. Biliary excretion using the aniline ring label showed that all the radioactivity in the feces of females and 40% of that in males are biliary excretion products. Although, the majority of both urinary and fecal excretion occurred within 48 hours, excretion by both routes was biphasic, with slower phase occurring throughout the post-exposure, resulting in accumulation in adipose tissue. This phenomenon was probably due to entero-hepatic circulation. Accumulation of radioactivity in muscle and adipose tissue 4 hours post dosing with 3.5 mg/kg benzyl label was 30% and 42%, respectively. At 168 hours post dose, these values were 6% and 19%, respectively, suggesting an accumulation in the adipose tissue. High doses of both labels resulted in negligible tissue burden (<0.3%) indicating saturation absorption.']","['Metabolism proceeds via hydrolysis to a benzoic acid and aryloxyphenylurea and aryoxyaniline moieties.', 'The metabolic fate of flufenoxuron was determined using two radiolabeled positions (aniline and difluorobenzene ring). Flufenoxuron exhibited a dose-dependant absorption following a single low dose (3.5 mg/kg) or single high dose (350 mg/kg). ... For the flufenoxuron aniline ring test article, the parent and a total of 10 urinary metabolites accounted for approximately 5% of the administered dose, and were considered non-significant. Fecal excretion of metabolites was quantitatively greater with parent compound accounting for the greatest portion of radioactivity. However, most fecal metabolites represented < 1% of the administered dose. Both [4-(2-chloro, alpha,alpah,alpha-trifluoro-p-tolyoxy)-2-fluorophenyl urea] and [4- (2-chloro, alpha,alpah,alpha-trifluoro-p-tolyoxy)-2-fluoroaniline] were detected in the feces and urine following administration of the aniline ring labeled test article. Unextractable residues accounted for 7-8% of the dose. The major urinary metabolite of [14C- 2,6-difluorobenzene]flufenoxuron was the corresponding benzoic acid which, over 48 hours, accounted for 10-12% of the administered dose. Difluorobenzamide (<1%) was also detected in the urine along with unknown components all of which individually represented <1% of the dose. The only component detected in the feces of rats given the 2,6-difluorobenzene label was the parent compound. The results of the metabolism characterization studies with both label positions suggest that metabolism of flufenoxuron proceeds via hydrolysis to a benzoic acid metabolite, a phenyl urea metabolite ( 4-[2-chloro, alpha,alpah,alpha-trifluoro-p-tolyoxy]-2-fluorophenyl urea), an aniline metabolite (4-[2-chloro, alpha,alpah,alpha-trifluoro-p-tolyoxy]-2-fluoroaniline), and subsequently several minor components.']",
1766,91767,"1-Methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine",CC1=CC=CC=C1C2=CCN(CC2)C,,,"['Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)']",,,
1767,91768,Tau-fluvalinate,CC(C)[C@H](C(=O)OC(C#N)C1=CC(=CC=C1)OC2=CC=CC=C2)NC3=C(C=C(C=C3)C(F)(F)F)Cl,,,,,,
1768,91769,Zolantidine,C1CCN(CC1)CC2=CC(=CC=C2)OCCCNC3=NC4=CC=CC=C4S3,,,"['Drugs that selectively bind to but do not activate histamine H2 receptors, thereby blocking the actions of histamine. Their clinically most important action is the inhibition of acid secretion in the treatment of gastrointestinal ulcers. Smooth muscle may also be affected. Some drugs in this class have strong effects in the central nervous system, but these actions are not well understood. (See all compounds classified as Histamine H2 Antagonists.)']",,,
1769,91770,Imazapic,CC1=CC(=C(N=C1)C2=NC(C(=O)N2)(C)C(C)C)C(=O)O,,,"['Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)']","['Imazapic does not bioaccumulate in animals; if ingested, then rapidly excreted through urine and feces.', '5 Crl:CD BR rats/sex/group received a single dose of (14)C- Imazapic (CL 263,222) by oral gavage or intravenous injection at 10 or 1000 mg/kg. One group received 14 consecutive non-radiolabelled daily oral doses followed by one (14)C labelled oral dose (10 mg/kg). After dosing with radiolabel, animals were housed in individual metabolism cages and sacrificed 7 days later. Feces, urine, cage wash/rinse, cage wipes (methanol extracted), blood, fat, heart, spleen, ovaries, uterus, bone (femur), brain, kidney, liver, lungs, muscle (thigh), testes, and the residual carcass were analyzed for radioactivity by liquid scintillation counting (LSC). Metabolite profiles in urine, dissolved urine precipitate, and feces extract (ethyl ether) were determined using thin-layer chromatography (TLC) and high-performance liquid chromatography (HPLC). The major elimination route for dosed radioactivity was in urine. The mean percent of total dose (including cage wash and cage wipe) ranged from 94.0% to 102% (males) and 94.5% to 102% (females). The mean percent of total dose excreted in feces ranged from 0.79% to 3.44% (males) and 0.59% to 3.50% (females). The majority of radioactivity was excreted during 6 hours post-dosing. Mean radioactivity concentrations in blood 7 days after a single dose at 10 mg/kg were not detectable. At 1000 mg/kg, concentrations were 0.127 ppm for males and <0.1 ppm for females. Mean radioactivity concentrations in tissues were generally not detectable (<0.01 ppm) at 10 and 1000 mg/kg. Residual radioactivity in the carcass ranged from <0.001 ppm to 0.043 ppm.  The unchanged test article, (14)C- Imazapic, accounted for >/= 93.5% and >/= 65.9% of the total radioactivity in urine (94% to 102% of total administered dose) and feces (0.59% to 3.50% of total administered dose) respectively....']","['5 Crl:CD BR rats per sex per group received a single dose of (14)C- Imazapic (CL 263,222) by oral gavage or intravenous injection at 10 or 1000 mg/kg. One group received 14 consecutive non-radiolabelled daily oral doses followed by one (14)C labelled oral dose (10 mg/kg). After dosing with radiolabel, animals were housed in individual metabolism cages and sacrificed 7 days later.... Metabolites designated CL 303,459 and CL 263,284 ... and several minor radioactive components were also detected in small amounts (< 5% combined of the total radioactivity in the sample). In feces, metabolites CL 303,459 (4.29% (males) to 5.38% (females) of radioactivity in the sample), CL 263,284 (1.96% (males) and 0.85% (females)), and CL 290,610 (0.69% (males) and 0.70% (females)) were detected. The absolute amount of each of these corresponded to <0.2% of the administered dose. Several unknown metabolites accounted for less than 6% of total radioactivity in feces samples. The proposed metabolic pathway of (14)C- Imazapic ... was based on components identified in the excreta. Oxidation of the methyl group on the pyridine ring of (14)C- Imazapic produced metabolite CL 263,284. The presence of CL 303,459 suggested the initial step of ring closure, reduction to intermediate CL 280,442, followed by hydrolysis to CL 303,459 and further hydrolysis to CL 290,610.']",
1770,91771,Difethialone,C1C(CC2=CC=CC=C2C1C3=C(SC4=CC=CC=C4C3=O)O)C5=CC=C(C=C5)C6=CC=C(C=C6)Br,,,,"['In rats, following oral admin, difethialone is characterised by a short half-life in blood, a longer half-life in liver, and an essentially fecal elimination with almost complete absence of metabolism.']",,
1771,91772,Tribenuron,CC1=NC(=NC(=N1)OC)N(C)C(=O)NS(=O)(=O)C2=CC=CC=C2C(=O)O,,,,,,
1772,91773,Tebufenozide,CCC1=CC=C(C=C1)C(=O)NN(C(=O)C2=CC(=CC(=C2)C)C)C(C)(C)C,,,"['Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)']","['The absorption, distribution, excretion and metabolism of tebufenozide in rats was investigated. Tebufenozide is partially absorbed, is rapidly excreted and does not accumulate in tissues. Although tebufenozide is mainly excreted unchanged, a number of polar metabolites were identified.']","['In the rat, 16 whole-molecule metabolites are formed as a result of oxidation of the alkyl substituents of the aromatic rings, primarily at the benzylic positions.', 'In apples, grapes, rice, & sugar beet, the major component is unchanged tebufenozide. Metabolites which are detected in small amounts result from oxidation of the alkyl substituents of the aromatic ring, primarily at the benzylic position.', 'Although tebufenozide is mainly excreted unchanged, a number of polar metabolites were identified. These metabolites are products of oxidation of the benzylic ethyl or methyl side chains of the molecule. These metabolites were detected in plant and other animal (rat, goat, hen) metabolism studies. Common metabolic pathways for tebufenozide have been identified in both plants (grape, apple, rice and sugar beet) and animals (rat, goat, hen). The metabolic pathway common to both plants and animals involves oxidation of the alkyl substituents (ethyl and methyl groups) of the aromatic rings primarily at the benzylic positions. Extensive degradation and elimination of polar metabolites occurs in animals such that residues are unlikely to accumulate in humans or animals exposed to these residues through the diet.']",
1773,91774,Primisulfuron,C1=CC=C(C(=C1)C(=O)O)S(=O)(=O)NC(=O)NC2=NC(=CC(=N2)OC(F)F)OC(F)F,,,,,,
1774,91775,"(2E)-2,4,4-trichloro-3-formylbut-2-enoic acid",C(=O)C(=C(C(=O)O)Cl)C(Cl)Cl,,,,,,
1775,91776,Thiazopyr,CC(C)CC1=C(C(=NC(=C1C(=O)OC)C(F)F)C(F)(F)F)C2=NCCS2,,,,"[""Two metabolism studies were conducted in rats with radio- labeled thiazopyr. One with the 14C at the 4 position of the pyridine ring & one with the 14C at the 4' & 5' positions of the thiazole ring. The absorption of an orally admin dose was about 90%. The overall radiolabel recovery for all study groups was 88.9, plus or minus 0.65%. No significant sex-related differences were observed in the total % recovery. However, the distribution of recovery was sex-related. There was little radiolabel detected in tissues at study termination. Preferential sites for localization of the radiolabel included liver, adipose tissue, muscle & bone. The metabolic pathway is essentially an oxidative pathway. Vulnerable sites of the molecule are the thiazoline ring, the isobutyric side chain & the pyridine rings. Thiazapyr appears to be rapidly & extensively eliminated with low amounts of residues remaining in the tissues & carcasses. The % of radiolabel remaining in the carcasses following feeding thiazoline labeled thiazopyr was beween 6.9 & 10.8%.""]","['1. Thiazopyr was hydrolysed in vitro to its corresponding acid by rabbit & porcine liver esterases. 2. A wide range of thiazopyr esterase activity was observed in extracts from liver acetone powders from 15 animal species with bovine, rabbit & pigeon showing the highest activities. 3. Using soybean tissue culture cells & Arabidopsis seedlings, the acidic metabolite was shown to possess < 1% of the herbicidal activity of thiazopyr. 4. We propose that biotransformation of thiazopyr to the acid is a critical pathway of metab in animals & plants.']",
1776,91777,Amidosulfuron,CN(S(=O)(=O)C)S(=O)(=O)NC(=O)NC1=NC(=CC(=N1)OC)OC,,,,,,
1777,91778,Chlorfenapyr,CCOCN1C(=C(C(=C1C(F)(F)F)Br)C#N)C2=CC=C(C=C2)Cl,,,,"['An oral dose of chlorfenapyr was poorly absorbed in rats and over 80% was eliminated in the feces ...', 'Radioactive chlorfenapyr was administered to rats by oral gavage at dose levels of 20 mg/kg/day as a single dose or following a 14-day pre-treatment with non-radioactive chlorfenapyr, or at 200 mg/kg as a single dose. Based on the metabolites identified, the major deposition route of orally administered chlorfenapyr is fecal excretion of unaltered parent compound. The two rings of the molecule are not cleaved. Metabolites are excreted primarily in urine; accumulation in tissues is minimal.']","['Chlorfenapyr shows virtually no uncoupling activity but removal of the N-ethoxymethyl group through microsomal oxidation releases the corresponding free pyrrole (AC 303,268) which is a lipophilic weak acid with very strong uncoupling activity ... AC 302,268 has an acute toxicity higher than that of chlorfenapyr in both vertebrates and insects (eg, the acute oral LD50 for the rat is 29 mg/kg). Upon injection into insects it cause an almost immediate and massive stimulation of respiration whereas the parent chlorfenapyr does so only after a significant delay. All these observations support the idea that chlorfenapyr is a proinsecticide and requires metabolic conversion to the active uncoupler, AC 303,268, before it exert a toxic action.', '[2-Pyrrole-14C]CL 303,630 or [Phenyl-(U)-14C]CL 303,630 (radiochemical,purity: 99-100%, S.A. 134.7 uCi/mg and 411.4 uCi/mg, respectively) and nonlabeled CL 303,630 (...98.8% purity) were suspended in 0.5% (w/w) CMC solution and administered via gavage to 5 rats/sex as single doses of 20.7 or 206.7 mg/kg and as multiple oral doses: pretreat 5 rats/sex daily with nonlabeled CL 303,630 for 14 days prior to pulsing with 20.5 mg/kg [2-Pyrrole-14C]CL 303,630 or [Phenyl-(U)-14C]CL 303,630. Regardless of treatment regimen, 14C CL 303,630 was eliminated mainly by the fecal route. By 48 hours, 70.4-91.4% and 3.9-9.7% of the administered radioactivity was detected in feces and urine, respectively. Blood and tissue concentrations were higher in females than in males indicating that there are substantial sex-related differences. The excreted fecal residue was mainly unchanged parent compound plus minor N-dealkylated, debrominated, and hydroxylated oxidation products. Absorbed CL 303,630 was extensively metabolized in tissues and urine by N-dealkylation, debromination, ring hydroxylation, and conjugation.', 'AC 303,268, and its further degradation products, is a common metabolites of chlorfenapyr found in studies with vertebrates ... Urinary metabolites /from an oral dose admin in rats/ included products of N-alkoxy side chain oxidation and removal (eg, AC 303,268) and ring hydroxylation products and their conjugates. Similar results were obtained with goats and hens. In fish and soil, debromination is observed as an additional metabolic route.']",
1778,91779,Rimsulfuron,CCS(=O)(=O)C1=C(N=CC=C1)S(=O)(=O)NC(=O)NC2=NC(=CC(=N2)OC)OC,,,,"['In rats, rimsulfuron is excreted within the first 72 hours following dosing in the urine (64%) and the feces (30%). Low, but detectable amounts of radioactivity were found in the heart, lung, liver, kidney, and muscle...', 'The metabolism of (14)C-labeled rimsulfuron was studied in male and female rats. The low dose groups were treated once by oral gavage with 25 mg/kg (14)C -pyridine-labeled compound and the high dose groups with 250 mg/kg of either (14)C -pyridine- or (14)C-pyrimidine-labeled compound. The repeat dose groups were gavaged orally with unlabeled test compound (25 mg/kg) for 14 consecutive days, followed on the 15th day by 25 mg/kg of (14)C -pyridine-test compound. Excretion accounted for 93 to 96% of the administered radioactivity, with 58 to 67% appearing in the urine and 20 to 33% in the feces. Tissue distribution of labeled residues was low. Males showed slightly higher hepatic accumulation than females within each test group. Animals in the repeat dose groups also showed a slight accumulation in the spleen. ...']","['Metabolism of rimsulfuron in plants and other animals (poultry and ruminants) appears to be similar to its metabolism in rats. Metabolism involves either the contraction or cleavage of the sulfonylurea bridge. While the cleavage of the bridge to form the pyridinesulfonamide metabolite is expected, the contraction reaction is not. The major residue found in plants is the parent compound, rimsulfuron.', 'The metabolism of (14)C-labeled rimsulfuron was studied in male and female rats. The low dose groups were treated once by oral gavage with 25 mg/kg (14)C -pyridine-labeled compound and the high dose groups with 250 mg/kg of either (14)C -pyridine- or (14)C-pyrimidine-labeled compound. The repeat dose groups were gavaged orally with unlabeled test compound (25 mg/kg) for 14 consecutive days, followed on the 15th day by 25 mg/kg of (14)C -pyridine-test compound. ... The metabolic profiles were determined using pooled urinary and fecal samples. The highest percentage of the urinary (42 to 55%) and fecal (5 to 16%) radioactivity was attributed to unmetabolized parent compound. The parent compound is metabolized by cleavage or contraction of the sulfonylurea bridge, leading to the formation of 3- (ethylsulfonyl)-2-pyridinesulfonamide (IN-E9260) or N-(4, 6-dimethoxy-2-pyrimidinyl)-N-((3-ethylsulfonyl)-2-pyridinyl) urea (IN-70941). IN-70941 is deamidated to form IN-70942, which is sequentially demethylated and hydroxylated.']",
1779,91780,CID 91780,COC1=CC(=NC(=N1)SC2=C(C(=CC=C2)Cl)C(=O)[O-])OC.[Na+],,,,,,
1780,91781,Pyrithiobac,COC1=CC(=NC(=N1)SC2=C(C(=CC=C2)Cl)C(=O)O)OC,,,,,,
1781,91782,"15-[5-(Dimethylamino)-6-methyloxan-2-yl]oxy-19-ethyl-14-methyl-7-(2,3,4-trimethoxy-5-methylcyclohexyl)oxy-20-oxatetracyclo[10.10.0.02,10.05,9]docosane-13,21-dione",CCC1CCCC(C(C(=O)C2CC3C(C2CC(=O)O1)CCC4C3CC(C4)OC5CC(C(C(C5OC)OC)OC)C)C)OC6CCC(C(O6)C)N(C)C,,,,,,
1782,91783,"Silicic acid, trimethylsilyl ester",C[Si](C)(C)O[Si](O)(O)O,,,,,,
1783,91784,"Phenol, 2-[[4-[[4-[bis(2-hydroxyethyl)amino]-6-chloro-1,3,5-triazin-2-yl]amino]phenyl]azo]-4-methyl-",CC1=CC(=C(C=C1)O)N=NC2=CC=C(C=C2)NC3=NC(=NC(=N3)Cl)N(CCO)CCO,,,,,,
1784,91785,3-Phenylazoacetylacetone,CC(=O)C(C(=O)C)N=NC1=CC=CC=C1,,,,,,
1785,91786,2-Hexylcyclopent-2-enyl acetate,CCCCCCC1=CCCC1OC(=O)C,,,,,,
1786,91787,2-Chlorononan-1-oic acid,CCCCCCCC(C(=O)O)Cl,,,,,,
1787,91788,"1-Propanaminium, 3-(ethyl(3-methylphenyl)amino)-2-hydroxy-N,N,N-trimethyl-, chloride",CCN(CC(C[N+](C)(C)C)O)C1=CC=CC(=C1)C.[Cl-],,,,,,
1788,91789,"3-[Ethyl(m-tolyl)amino]-2-hydroxy-N,N,N-trimethyl-1-propanaminium",CCN(CC(C[N+](C)(C)C)O)C1=CC=CC(=C1)C,,,,,,
1789,91790,Hydroxylaminesulfate,CCC(=O)OC(C(C)C1C(C(CC2(O1)CCC(O2)(C)C3CCC(O3)(C)C4C(CC(O4)C5C(CC(C(O5)(CO)O)C)C)C)O)C)C(C)C(=O)O,,,,,,
1790,91791,"Benzenamine, N-ethyl-2-methyl-5-nitro-",CCNC1=C(C=CC(=C1)[N+](=O)[O-])C,,,,,,
1791,91792,(2-(2-Butoxyethoxy)ethoxy)methanol,CCCCOCCOCCOCO,,,,,,
1792,91793,"1-(4-Phenoxyphenyl)butane-1,3-dione",CC(=O)CC(=O)C1=CC=C(C=C1)OC2=CC=CC=C2,,,,,,
1793,91794,O-Methylene-D-glucose,C1OC(C(O1)C(C=O)O)C(CO)O,,,,,,
1794,91795,Ethyl N2-acetyl-L-argininate,CCOC(=O)C(CCCN=C(N)N)NC(=O)C,,,,,,
1795,91796,"3,3,5-Trimethyloxepan-2-one",CC1CCOC(=O)C(C1)(C)C,,,,,,
1796,91797,2-Isopropylphenyl isocyanate,CC(C)C1=CC=CC=C1N=C=O,,,,,,
1797,91798,2-Methoxy-4-nitrobenzenediazonium ZINC chloride(2:1:4),COC1=C(C=CC(=C1)[N+](=O)[O-])[N+]#N.COC1=C(C=CC(=C1)[N+](=O)[O-])[N+]#N.[Cl-].[Cl-].[Cl-].[Cl-].[Zn+2],,,,,,
1798,91799,2-Methoxy-4-nitrobenzenediazonium,COC1=C(C=CC(=C1)[N+](=O)[O-])[N+]#N,,,,,,
1799,91800,"4,5,6,7-Tetrabromo-1,3-dihydro-1,3-bis(2-hydroxyethyl)-2H-benzimidazol-2-one",C(CO)N1C2=C(C(=C(C(=C2Br)Br)Br)Br)N(C1=O)CCO,,,,,,
1800,91801,"2,7-Naphthalenedisulfonic acid, 3-amino-4-[[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]azo]-",C1=CC(=CC=C1N=NC2=C3C=CC(=CC3=CC(=C2N)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)CCOS(=O)(=O)O,,,,,,
1801,91802,Decyl-dimethyl-silane,CCCCCCCCCC[SiH](C)C,,,,,,
1802,91803,"1,1,4,4-Tetramethylbutane-1,4-diyl diacetate",CC(=O)OC(C)(C)CCC(C)(C)OC(=O)C,,,,,,
1803,91804,N-(2-Chloroethyl)-N'-(2-hydroxycyclohexyl)-N-nitrosourea,C1CCC(C(C1)NC(=O)N(CCCl)N=O)O,,,,,,
1804,91805,1-(4-Fluorophenyl)-4-oxocyclohexanecarbonitrile,C1CC(CCC1=O)(C#N)C2=CC=C(C=C2)F,,,,,,
1805,91806,"Hydroxy(hydroxymethanesulphinato-O1,O2)zinc",C(O)S(=O)O.O.[Zn],,,,,,
1806,91807,CID 91807,CCN(CC)C1=CC2=C(C=C1)C=C(C(=O)O2)C3=NC(=O)C4=C(N3)C=CC(=C4)S(=O)(=O)[O-].[Na+],,,,,,
1807,91808,CID 91808,CCN(CC)C1=CC2=C(C=C1)C=C(C(=O)O2)C3=NC(=O)C4=C(N3)C=CC(=C4)S(=O)(=O)O,,,,,,
1808,91809,"[6-[[3-Chloro-4-(methylamino)phenyl]imino]-4-methyl-3-oxocyclohexa-1,4-dien-1-yl]urea",CC1=CC(=NC2=CC(=C(C=C2)NC)Cl)C(=CC1=O)NC(=O)N,,,,,,
1809,91810,"4,5-Dibromo-2-phenyl-1H-imidazole",C1=CC=C(C=C1)C2=NC(=C(N2)Br)Br,,,,,,
1810,91811,"N-(3,5-Dichloro-2-hydroxy-4-methylphenyl)-2-(3-pentadecylphenoxy)butanamide",CCCCCCCCCCCCCCCC1=CC(=CC=C1)OC(CC)C(=O)NC2=CC(=C(C(=C2O)Cl)C)Cl,,,,,,
1811,91812,"1,5-Dimethyl-1H-pyrrole-2-carbonitrile",CC1=CC=C(N1C)C#N,,,,,,
1812,91813,Chlorpheniramine hydrochloride,CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2.Cl,,,,,,
1813,91814,(2S)-2-(3-acetamidopropanoylamino)-3-(1h-imidazol-5-yl)propanoic acid,CC(=O)NCCC(=O)NC(CC1=CN=CN1)C(=O)O,,,,,,
1814,91815,Para-Tolyl 4-Aminosalicylate,CC1=CC=C(C=C1)OC(=O)C2=C(C=C(C=C2)N)O,,,,,,
1815,91816,N-(2-Ethylhexyl)naphthalen-2-amine,CCCCC(CC)CNC1=CC2=CC=CC=C2C=C1,,,,,,
1816,91817,N-Tridecylnaphthalen-2-amine,CCCCCCCCCCCCCNC1=CC2=CC=CC=C2C=C1,,,,,,
1817,91818,"(1-Methylethylidene)bis(4,1-phenyleneoxy-2,1-ethanediyloxy-2,1-ethanediyl) diacrylate",CC(C)(C1=CC=C(C=C1)OCCOCCOC(=O)C=C)C2=CC=C(C=C2)OCCOCCOC(=O)C=C,,,,,,
1818,91819,1-Benzoyl-4-(1H-indol-3-yl)piperidine,C1CN(CCC1C2=CNC3=CC=CC=C32)C(=O)C4=CC=CC=C4,,,,,,
1819,91820,"2,4,6-Tris(2,4,6-tribromophenoxy)-1,3,5-triazine",C1=C(C=C(C(=C1Br)OC2=NC(=NC(=N2)OC3=C(C=C(C=C3Br)Br)Br)OC4=C(C=C(C=C4Br)Br)Br)Br)Br,,,,,,
1820,91821,2-Chloro-4-hydroxybenzoic acid,C1=CC(=C(C=C1O)Cl)C(=O)O,,,,,,
1821,91822,Tributylmethylammonium chloride,CCCC[N+](C)(CCCC)CCCC.[Cl-],,,,,,
1822,91823,"2-Amino-4,5-dimethylbenzenesulfonic acid",CC1=CC(=C(C=C1C)S(=O)(=O)O)N,,,,,,
1823,91824,"4-Bromo-3,5-dihydroxy-N-methylbenzamide",CNC(=O)C1=CC(=C(C(=C1)O)Br)O,,,,,,
1824,91825,CID 91825,C1=CC=C2C(=C1)N=C(S2)S.Cl[Zn]Cl,,,,,,
1825,91826,CID 91826,CC(=O)NCCCCC(C(=O)O)NC(=O)C.O.O.[AlH3],,,,,,
1826,91827,"2,6-Diacetamidohexanoic acid",CC(=O)NCCCCC(C(=O)O)NC(=O)C,,,,,,
1827,91828,"2-Butenedioic acid (2Z)-, mono[2-[2-[[9Z)-(1-oxo-9-octadecenyl]amino]ethoxy]ethyl] ester",CCCCCCCCC=CCCCCCCCC(=O)NCCOCCOC(=O)C=CC(=O)O,,,,,,
1828,91829,Disodium;4-[2-[2-(octadec-9-enoylamino)ethoxy]ethoxy]-4-oxo-3-sulfonatobutanoate,CCCCCCCCC=CCCCCCCCC(=O)NCCOCCOC(=O)C(CC(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+],,,,,,
1829,91830,4-[2-[2-(Octadec-9-enoylamino)ethoxy]ethoxy]-4-oxo-3-sulfobutanoic acid,CCCCCCCCC=CCCCCCCCC(=O)NCCOCCOC(=O)C(CC(=O)O)S(=O)(=O)O,,,,,,
1830,91831,1-Hexadecylnaphthalene,CCCCCCCCCCCCCCCCC1=CC=CC2=CC=CC=C21,,,,,,
1831,91832,"Naphthalene, octadecyl-",CCCCCCCCCCCCCCCCCCC1=CC=CC2=CC=CC=C21,,,,,,
1832,91833,Isopropoxymethanol,CC(C)OCO,,,,,,
1833,91834,N-[4-[[4-[(4-Hydroxyphenyl)azo]-2-methylphenyl]azo]phenyl]acetamide,CC1=C(C=CC(=C1)N=NC2=CC=C(C=C2)O)N=NC3=CC=C(C=C3)NC(=O)C,,,,,,
1834,91835,Ethyl 3-[(2-chloro-5-nitrophenyl)amino]-3-ethoxyacrylate,CCOC(=CC(=O)OCC)NC1=C(C=CC(=C1)[N+](=O)[O-])Cl,,,,,,
1835,91836,"2-Naphthalenecarboxamide, 3-hydroxy-4-[[2-methoxy-5-[(phenylamino)carbonyl]phenyl]azo]-",COC1=C(C=C(C=C1)C(=O)NC2=CC=CC=C2)N=NC3=C(C(=CC4=CC=CC=C43)C(=O)N)O,,,,,,
1836,91837,"Diphosphoric acid, monomethyl ester",COP(=O)(O)OP(=O)(O)O,,,,,,
1837,91838,CID 91838,C1=CC(=CC=C1N)NN=C2C(=CC3=C(C2=N)C(=O)C(=NNC4=CC=C(C=C4)N)C(=C3)S(=O)(=O)O)S(=O)(=O)O,,,,,,
1838,91839,"Benzothiazolium, 2-methyl-3-(3-sulfopropyl)-, inner salt",CC1=[N+](C2=CC=CC=C2S1)CCCS(=O)(=O)[O-],,,,,,
1839,91840,"3-(2-Methyl-1,3-benzothiazol-3-ium-3-yl)-1-propanesulfonate",CC1=[N+](C2=CC=CC=C2S1)CCCS(=O)(=O)O,,,,,,
1840,91841,2-Methyl-1-(3-sulphonatopropyl)pyridinium,CC1=CC=CC=[N+]1CCCS(=O)(=O)[O-],,,,,,
1841,91842,"2-Methyl-1-(3-sulfopropyl)pyridinium hydroxide, inner salt",CC1=CC=CC=[N+]1CCCS(=O)(=O)O,,,,,,
1842,91843,"12,12,23,23-Tetramethyl-2,5,8,11,13,16,19,22,24,27,30,33-dodecaoxa-12,23-disilatetratriacontane",COCCOCCOCCO[Si](C)(C)OCCOCCOCCO[Si](C)(C)OCCOCCOCCOC,,,,,,
1843,91844,Ethyl 2-benzyl-3-oxo-3-phenylpropanoate,CCOC(=O)C(CC1=CC=CC=C1)C(=O)C2=CC=CC=C2,,,,,,
1844,91845,2-(12-Hydroxyoctadec-9-enoyloxy)propyl 12-hydroxyoctadec-9-enoate,CCCCCCC(CC=CCCCCCCCC(=O)OCC(C)OC(=O)CCCCCCCC=CCC(CCCCCC)O)O,,,,,,
1845,91846,((4-Nitrophenyl)methyl)succinic acid,C1=CC(=CC=C1CC(CC(=O)O)C(=O)O)[N+](=O)[O-],,,,,,
1846,91847,"2,5-Pyrrolidinedione, 1-(2-hydroxyethyl)-3-(tetradecenyl)-",CCCC=CCCCCCCCCCC1CC(=O)N(C1=O)CCO,,,,,,
1847,91848,"Dibenzofuran-2,8-bis(sulphonohydrazide)",C1=CC2=C(C=C1S(=O)(=O)NN)C3=C(O2)C=CC(=C3)S(=O)(=O)NN,,,,,,
1848,91849,Benzyl 2-methylbutyrate,CCC(C)C(=O)OCC1=CC=CC=C1,,,,,,
1849,91850,Heptyl isovalerate,CCCCCCCOC(=O)CC(C)C,,,,,,
1850,91851,"[1,2,4]Triazolo[1,5-a]pyrimidine-2-carboxylic acid, 7-hydroxy-5-methyl-, ethyl ester",CCOC(=O)C1=NC2=NC(=CC(=O)N2N1)C,,,,,,
1851,91852,2-Methyl-1-[4-(trifluoromethoxy)phenyl]propan-1-one,CC(C)C(=O)C1=CC=C(C=C1)OC(F)(F)F,,,,,,
1852,91853,1-Bromo-4-(perfluoroethoxy)benzene,C1=CC(=CC=C1OC(C(F)(F)F)(F)F)Br,,,,,,
1853,91854,"1,5-Dimethyl-2-(p-tolyl)-1H-pyrazol-3(2H)-one",CC1=CC=C(C=C1)N2C(=O)C=C(N2C)C,,,,,,
1854,91855,Temofel,CCC(C1=CC=CC=C1)(C2=C(C=CC(=C2)C)C)O,,,,,,
1855,91856,"Disodium 4-amino-5-hydroxy-3-(4-nitrophenylazo)naphthalene-2,7-disulphonate",C1=CC(=CC=C1N=NC2=C(C3=C(C=C(C=C3C=C2S(=O)(=O)[O-])S(=O)(=O)[O-])O)N)[N+](=O)[O-].[Na+].[Na+],,,,,,
1856,91857,"4-Amino-5-hydroxy-3-(p-nitrophenylazo)-2,7-naphthalenedisulfonic acid",C1=CC(=CC=C1N=NC2=C(C3=C(C=C(C=C3C=C2S(=O)(=O)O)S(=O)(=O)O)O)N)[N+](=O)[O-],,,,,,
1857,91858,2-(Bromomethyl)-1-chloro-3-nitrobenzene,C1=CC(=C(C(=C1)Cl)CBr)[N+](=O)[O-],,,,,,
1858,91859,"(1,2,4)Triazolo(1,5-a)pyrimidin-7(1H)-one, 2-(chloromethyl)-5-methyl-",CC1=CC(=O)N2C(=N1)N=C(N2)CCl,,,,,,
1859,91860,Isoicosyl acetate,CC(C)CCCCCCCCCCCCCCCCCOC(=O)C,,,,,,
1860,91861,Heptylidene diacetate,CCCCCCC(OC(=O)C)OC(=O)C,,,,,,
1861,91862,1-Hydrazino-3-morpholinopropan-2-ol,C1COCCN1CC(CNN)O,,,,,,
1862,91863,Benzyl p-(benzyloxy)benzoate,C1=CC=C(C=C1)COC2=CC=C(C=C2)C(=O)OCC3=CC=CC=C3,,,,,,
1863,91864,"Tri(2,4,6-trimethylphenyl) phosphate",CC1=CC(=C(C(=C1)C)OP(=O)(OC2=C(C=C(C=C2C)C)C)OC3=C(C=C(C=C3C)C)C)C,,,,,,
1864,91865,4-Methyl-3-octadecylbenzenesulfonic acid,CCCCCCCCCCCCCCCCCCC1=C(C=CC(=C1)S(=O)(=O)O)C,,,,,,
1865,91866,4-O-beta-D-Galactopyranosyl-D-glucitol monopalmitate,CCCCCCCCCCCCCCCC(=O)OC[C@@H]([C@H]([C@@H]([C@@H](CO)O)OC1[C@@H]([C@H]([C@H]([C@H](O1)CO)O)O)O)O)O,,,,,,
1866,91867,"2,4-Difluorobenzyl alcohol",C1=CC(=C(C=C1F)F)CO,,,,,,
1867,91868,2-Chloro-6-fluorobenzyl alcohol,C1=CC(=C(C(=C1)Cl)CO)F,,,,,,
1868,91869,"3-(8-Quinolyloxy)-1,2-propanediol",C1=CC2=C(C(=C1)OCC(CO)O)N=CC=C2,,,,,,
1869,91870,"5-(1,1-Dimethylheptyl)resorcinol",CCCCCCC(C)(C)C1=CC(=CC(=C1)O)O,,,,,,
1870,91871,"2-Methyl-N,1-bis(1-methylethyl)cyclopentanecarboxamide",CC1CCCC1(C(C)C)C(=O)NC(C)C,,,,,,
1871,91872,N-Ethyl-2-methyl-1-(1-methylethyl)cyclopentanecarboxamide,CCNC(=O)C1(CCCC1C)C(C)C,,,,,,
1872,91873,Ethyl N-(1-isopropylcyclopentanecarbonyl)glycinate,CCOC(=O)CNC(=O)C1(CCCC1)C(C)C,,,,,,
1873,91874,N-Ethyl-1-isopropylcycloheptanecarboxamide,CCNC(=O)C1(CCCCCC1)C(C)C,,,,,,
1874,91875,Ethyl N-((1-(isopropyl)cycloheptyl)carbonyl)glycinate,CCCOC(=O)NC(=O)C1(CCCCCC1)C(C)C,,,,,,
1875,91876,1-sec-Butyl-N-ethylcycloheptanecarboxamide,CCC(C)C1(CCCCCC1)C(=O)NCC,,,,,,
1876,91877,Ethyl N-((1-(1-methylpropyl)cycloheptyl)carbonyl)glycinate,CCC(C)C1(CCCCCC1)C(=O)NCC(=O)OCC,,,,,,
1877,91878,"1-sec-Butyl-N-(2'-hydroxy-1',1'-dimethylethyl)cycloheptanecarboxamide",CCC(C)C1(CCCCCC1)C(=O)NC(C)(C)CO,,,,,,
1878,91879,Einecs 260-205-8,CC(C)C1(CCCCCC1)C(=O)NC(C)(C)C,,,,,,
1879,91880,Ethyl N-(2-isopropylcycloheptanecarbonyl)glycinate,CCOC(=O)CNC(=O)C1CCCCCC1C(C)C,,,,,,
1880,91881,N-Ethyl-1-isopropyl-2-methylcycloheptanecarboxamide,CCNC(=O)C1(CCCCCC1C)C(C)C,,,,,,
1881,91882,1-Isopropyl-N-methyl-2-methylcycloheptanecarboxamide,CC1CCCCCC1(C(C)C)C(=O)NC,,,,,,
1882,91883,Ethyl N-(1-isopropyl-2-methylcycloheptanecarbonyl)glycinate,CCOC(=O)CNC(=O)C1(CCCCCC1C)C(C)C,,,,,,
1883,91884,1-(Isopropyl)-N-(4-methoxy-2-methylphenyl)cycloheptanecarboxamide,CC1=C(C=CC(=C1)OC)NC(=O)C2(CCCCCC2)C(C)C,,,,,,
1884,91885,N-Cyclopentyl-1-isopropylcycloheptanecarboxamide,CC(C)C1(CCCCCC1)C(=O)NC2CCCC2,,,,,,
1885,91886,CID 91886,CCCCCCCCC1=NCCN1CCOCCC(=O)[O-].[Na+],,,,,,
1886,91887,"3-[2-(2-Octyl-4,5-dihydroimidazol-1-yl)ethoxy]propanoic acid",CCCCCCCCC1=NCCN1CCOCCC(=O)O,,,,,,
1887,91888,4-O-beta-D-Galactopyranosyl-D-glucitol stearate,CCCCCCCCCCCCCCCCCC(=O)OC[C@@H]([C@H]([C@@H]([C@@H](CO)O)OC1[C@@H]([C@H]([C@H]([C@H](O1)CO)O)O)O)O)O,,,,,,
1888,91889,Trifluoromethyl methacrylate,CC(=C)C(=O)OC(F)(F)F,,,,,,
1889,91890,1-(2-Cyano-1-(cyanoimino)ethyl)piperidine,C1CCN(CC1)C(=NC#N)CC#N,,,,,,
1890,91891,1-(4-Methoxyphenyl)-2-methylpropan-2-amine hydrochloride,CC(C)(CC1=CC=C(C=C1)OC)N.Cl,,,,,,
1891,91892,1-(4-Methoxyphenyl)-2-methylpropan-2-amine,CC(C)(CC1=CC=C(C=C1)OC)N,,,,,,
1892,91893,CID 91893,CCOC(=C(C#N)N=O)O,,,,,,
1893,91894,1-((3-Hydroxypropyl)amino)-4-(methylamino)anthraquinone,CNC1=C2C(=C(C=C1)NCCCO)C(=O)C3=CC=CC=C3C2=O,,,,,,
1894,91895,"3-((3,7-Dimethyl-6-octenyl)oxy)propiononitrile",CC(CCC=C(C)C)CCOCCC#N,,,,,,
1895,91896,"3-(3,7-Dimethylocta-2,6-dienoxy)propanenitrile",CC(=CCCC(=CCOCCC#N)C)C,,,,,,
1896,91897,"2-Tetradecanamine, N,N-dimethyl-",CCCCCCCCCCCCC(C)N(C)C,,,,,,
1897,91898,Einecs 260-232-5,C(CCC(=O)O)CC(=O)O.C(C(CO)(CO)COCC(CO)(CO)CO)O,,,,,,
1898,91899,"2-Propenenitrile,3-(4-bromo-3,5-dimethoxyphenyl)-2-(methoxymethyl)-",COCC(=CC1=CC(=C(C(=C1)OC)Br)OC)C#N,,,,,,
1899,91900,"Pentane, 1-chloro-4,4-dimethoxy-",CC(CCCCl)(OC)OC,,,,,,
1900,91901,4-Ethyl-2-nitrophenol,CCC1=CC(=C(C=C1)O)[N+](=O)[O-],,,,,,
1901,91902,2-Ethoxyethyl bromoacetate,CCOCCOC(=O)CBr,,,,,,
1902,91903,"1,8-Dihydroxy-4,5-bis(methylamino)anthraquinone",CNC1=C2C(=C(C=C1)O)C(=O)C3=C(C=CC(=C3C2=O)NC)O,,,,,,
1903,91904,"9,10-Anthracenedione, 1-amino-4,5-dihydroxy-8-(methylamino)-",CNC1=C2C(=C(C=C1)O)C(=O)C3=C(C=CC(=C3C2=O)N)O,,,,,,
1904,91905,"Morpholine, 4-benzylthiocarbonyl-",C1COCCN1C(=O)SCC2=CC=CC=C2,,,,,,
1905,91906,"(6aS,10aR)-1-hydroxy-6,6-dimethyl-3-(2-methyloctan-2-yl)-7,8,10,10a-tetrahydro-6aH-benzo[c]chromen-9-one",CCCCCCC(C)(C)C1=CC(=C2[C@@H]3CC(=O)CC[C@@H]3C(OC2=C1)(C)C)O,,,,,,
1906,91907,N-Ethyl-2-isopropylcycloheptanecarboxamide,CCNC(=O)C1CCCCCC1C(C)C,,,,,,
1907,91908,Diphenyl p-isopropylphenyl phosphate,CC(C)C1=CC=C(C=C1)OP(=O)(OC2=CC=CC=C2)OC3=CC=CC=C3,,,,,,
1908,91909,"2H-Pyran, 3,6-dihydro-4-(4-methyl-3-pentenyl)-",CC(=CCCC1=CCOCC1)C,,,,,,
1909,91910,"N,N-Dimethyl-4-(2-nitro-1-propenyl)-m-toluidine",CC1=C(C=CC(=C1)N(C)C)C=C(C)[N+](=O)[O-],,,,,,
1910,91911,"8-Quinolinol, 7-(2-ethyl-1-hexenyl)-",CCCCC(=CC1=C(C2=C(C=CC=N2)C=C1)O)CC,,,,,,
1911,91912,"2,6-Xylyl methacrylate",CC1=C(C(=CC=C1)C)OC(=O)C(=C)C,,,,,,
1912,91913,"9,10-Anthracenedione, 1-[[4-([1,1'-biphenyl]-4-ylcarbonyl)phenyl]amino]-",C1=CC=C(C=C1)C2=CC=C(C=C2)C(=O)C3=CC=C(C=C3)NC4=CC=CC5=C4C(=O)C6=CC=CC=C6C5=O,,,,,,
1913,91914,"9,10-Anthracenedione, 1,5-bis(phenylthio)-",C1=CC=C(C=C1)SC2=CC=CC3=C2C(=O)C4=C(C3=O)C(=CC=C4)SC5=CC=CC=C5,,,,,,
1914,91915,Sclareol glycol,CC1(CCCC2(C1CCC(C2CCO)(C)O)C)C,,,,,,
1915,91916,"2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(5-(hexahydro-1,3-bis(2-methoxyethyl)-2,4,6-trioxo-5-pyrimidinyl)-2,4-pentadienylidene)-1,3-bis(2-methoxyethyl)-",COCCN1C(=O)C(C(=O)N(C1=O)CCOC)C=CC=CC=C2C(=O)N(C(=O)N(C2=O)CCOC)CCOC,,,,,,
1916,91917,"2-Isopropyl-2,3-dimethylbutyronitrile",CC(C)C(C)(C#N)C(C)C,,,,,,
1917,91918,"4,5-Oxazoledione, 2-phenyl-, 4-((2-methylphenyl)hydrazone)",CC1=CC=CC=C1N=NC2=C(OC(=N2)C3=CC=CC=C3)O,,,,,,
1918,91919,2-(Bis(2-hydroxyethyl)amino)ethanol; 5-oxopyrrolidine-2-carboxylic acid,C1CC(=O)NC1C(=O)O.C(CO)N(CCO)CCO,,,,,,
1919,91920,"1,3,4-Thiadiazolidine-2,5-dithione, disodium salt",C1(=NN=C(S1)[S-])[S-].[Na+].[Na+],,,,,,
1920,91921,CID 91921,C1=CC(=C(C=C1N(O)O)[N+](=O)[O-])N=N.Cl,,,,,,
1921,91922,"Benzenemethanaminium, N,N-bis(2-hydroxyethyl)-N-tetradecyl-, chloride",CCCCCCCCCCCCCC[N+](CCO)(CCO)CC1=CC=CC=C1.[Cl-],,,,,,
1922,91923,"N,N-Bis(2-hydroxyethyl)-N-tetradecylbenzenemethanaminium",CCCCCCCCCCCCCC[N+](CCO)(CCO)CC1=CC=CC=C1,,,,,,
1923,91924,Propyl cyclohexaneacetate,CCCOC(=O)CC1CCCCC1,,,,,,
1924,91925,"Propanamide, N-[3-(dimethylamino)propyl]-3-[[3-(dimethylamino)propyl]amino]-2-methyl-",CC(CNCCCN(C)C)C(=O)NCCCN(C)C,,,,,,
1925,91926,2-Cyclopentyl-4-nitrophenol,C1CCC(C1)C2=C(C=CC(=C2)[N+](=O)[O-])O,,,,,,
1926,91927,"2-Benzothiazolamine, 4-bromo-6-nitro-",C1=C(C=C(C2=C1SC(=N2)N)Br)[N+](=O)[O-],,,,,,
1927,91928,"1,3-Dimethyl-2-(6-methoxy-2-benzofuranyl)-5-(methylsulfonyl)-1H-benzimidazolium methyl sulfate",CN1C2=C(C=CC(=C2)S(=O)(=O)C)[N+](=C1C3=CC4=C(O3)C=C(C=C4)OC)C.CS(=O)(=O)[O-],,,,,,
1928,91929,"1,3-Dimethyl-2-(6-methoxybenzofuran-2-yl)-5-methylsulfonyl-1H-benzimidazol-3-ium",CN1C2=C(C=CC(=C2)S(=O)(=O)C)[N+](=C1C3=CC4=C(O3)C=C(C=C4)OC)C,,,,,,
1929,91930,"2-((1,1-Dimethylethyl)azo)-4-methoxy-2,4-dimethylvaleronitrile",CC(C)(C)N=NC(C)(CC(C)(C)OC)C#N,,,,,,
1930,91931,"2-((1,1-Dimethylethyl)azo)-2,4-dimethylvaleronitrile",CC(C)CC(C)(C#N)N=NC(C)(C)C,,,,,,
1931,91932,"1-((1,1-Dimethylpropyl)azo)cyclohexanecarbonitrile",CCC(C)(C)N=NC1(CCCCC1)C#N,,,,,,
1932,91933,4-Chloro-3-nitrobenzyl alcohol,C1=CC(=C(C=C1CO)[N+](=O)[O-])Cl,,,,,,
1933,91934,CID 91934,C1N(C(=NN1C2=CC=CC=C2)NC3=CC=CC=C3)C4=CC=CC=C4.Br,,,,,,
1934,91935,CID 91935,C1N(C(=NN1C2=CC=CC=C2)NC3=CC=CC=C3)C4=CC=CC=C4,,,,,,
1935,91936,"2-Octene, 8-methoxy-2,6-dimethyl-",CC(CCC=C(C)C)CCOC,,,,,,
1936,91937,2-(Ethylsulphonyl)benzothiazol-6-amine,CCS(=O)(=O)C1=NC2=C(S1)C=C(C=C2)N,,,,,,
1937,91938,"3-Hydroxy-2,2-bis(hydroxymethyl)propyl acrylate",C=CC(=O)OCC(CO)(CO)CO,,,,,,
1938,91939,2-Amino-4-(N-methylpiperazino)-5-methylthio-6-chloropyrimidine,CN1CCN(CC1)C2=C(C(=NC(=N2)N)Cl)SC,,,,,,
1939,91940,2-Phenylamino-4-methylpiperazino-6-chloro-5-methylthio-pyrimidine,CN1CCN(CC1)C2=C(C(=NC(=N2)NC3=CC=CC=C3)Cl)SC,,,,,,
1940,91941,4-Chloro-6-(4-methylpiperazino)-5-methylthio-2-morpholinopyrimidine,CN1CCN(CC1)C2=C(C(=NC(=N2)N3CCOCC3)Cl)SC,,,,,,
1941,91942,4-Chloro-2-(2-hydroxyethylamino)-6-(4-methylpiperazino)-5-methylthiopyrimidine,CN1CCN(CC1)C2=C(C(=NC(=N2)NCCO)Cl)SC,,,,,,
1942,91943,4-Chloro-2-methylamino-5-methylthio-6-piperazinopyrimidine,CNC1=NC(=C(C(=N1)Cl)SC)N2CCNCC2,,,,,,
1943,91944,n-Methyl-4-(4-methylpiperazin-1-yl)-5-(methylsulfanyl)-6-propoxypyrimidin-2-amine,CCCOC1=NC(=NC(=C1SC)N2CCN(CC2)C)NC,,,,,,
1944,91945,2-Methyloct-5-en-2-ol,CCC=CCCC(C)(C)O,,,,,,
1945,91946,CID 91946,CN(C)CC[S-].[Na+],,,,,,
1946,91947,"5-Acetyl-2,4-dimethylpyrimidine",CC1=NC(=NC=C1C(=O)C)C,,,,,,
1947,91948,"Propanol, [2-(2-butoxymethylethoxy)methylethoxy]-",CCOCCCC(C)OCCOCC(C)CO,,,,,,
1948,91949,2-Chloro-6-cyclopentyl-4-nitrophenol,C1CCC(C1)C2=C(C(=CC(=C2)[N+](=O)[O-])Cl)O,,,,,,
1949,91950,"Phenol, 2-(2-benzothiazolylazo)-5-(diethylamino)-",CCN(CC)C1=CC(=C(C=C1)N=NC2=NC3=CC=CC=C3S2)O,,,,,,
1950,91951,Oxydipropylene disalicylate,CC(COCC(C)OC(=O)C1=CC=CC=C1O)OC(=O)C2=CC=CC=C2O,,,,,,
1951,91952,7-Chloro-1-heptanol,C(CCCO)CCCCl,,,,,,
1952,91953,2-((7-Chloroheptyl)oxy)tetrahydro-2H-pyran,C1CCOC(C1)OCCCCCCCCl,,,,,,
1953,91954,"Tetrabutylammonium, salt with benzothiazolethi-2(3H)-one (1:1)",CCCC[N+](CCCC)(CCCC)CCCC.C1=CC=C2C(=C1)N=C(S2)[S-],,,,,,
1954,91955,"Carbamic acid, (4-(octyloxy)phenyl)-, 2-(1-piperidinyl)ethyl ester, monohydrochloride",CCCCCCCCOC1=CC=C(C=C1)NC(=O)OCCN2CCCCC2.Cl,,,,,,
1955,91956,"Carbamic acid, [4-(octyloxy)phenyl]-, 2-(1-piperidinyl)ethyl ester",CCCCCCCCOC1=CC=C(C=C1)NC(=O)OCCN2CCCCC2,,,,,,
1956,91957,CID 91957,C1=CC(=C(C=C1N(O)O)Cl)N=N,,,,,,
1957,91958,"Poly(oxy-1,2-ethanediyl), alpha-(2-(methylamino)ethyl)-omega-(2-(methylamino)ethoxy)-",CNCCOCCOCCNC,,,,,,
1958,91959,1-Ethyl-4-methylquinolinium p-toluenesulfonate,CC[N+]1=CC=C(C2=CC=CC=C21)C.CC1=CC=C(C=C1)S(=O)(=O)[O-],,,,,,
1959,91960,"1H-Azepine-1-carboxamide, N-(3-((((hexahydro-2-oxo-1H-azepin-1-yl)carbonyl)amino)methyl)-3,5,5-trimethylcyclohexyl)hexahydro-2-oxo-",CC1(CC(CC(C1)(C)CNC(=O)N2CCCCCC2=O)NC(=O)N3CCCCCC3=O)C,,,,,,
1960,91961,"1,1,3,3-Tetramethyl-1-vinylpropanedisiloxane",C[SiH](C)O[Si](C)(C)C=C,,,,,,
1961,91962,CID 91962,CCC=CCCC(C)O,,,,,,
1962,91963,"1,4-Bis(4-aminobenzoyl)piperazine",C1CN(CCN1C(=O)C2=CC=C(C=C2)N)C(=O)C3=CC=C(C=C3)N,,,,,,
1963,91964,1-(o-Tolyl)piperazine dihydrochloride,CC1=CC=CC=C1N2CCNCC2.Cl.Cl,,,,,,
1964,91965,1-(2-Methylphenyl)piperazine,CC1=CC=CC=C1N2CCNCC2,,,,,,
1965,91966,2-(2-Chloroethoxy)ethyl thiocyanate,C(CSC#N)OCCCl,,,,,,
1966,91967,"Ethanone, 1-(6,6,9-trimethyl-2-methylene-4,8-cycloundecadien-1-yl)-",CC1=CCC(C=CCC(=C)C(CC1)C(=O)C)(C)C,,,,,,
1967,91968,"9,10-Anthracenedione, 1-amino-2,3-dichloro-4-(methylamino)-",CNC1=C(C(=C(C2=C1C(=O)C3=CC=CC=C3C2=O)N)Cl)Cl,,,,,,
1968,91969,"Disulfide, bis(2,3-dimethylphenyl)",CC1=C(C(=CC=C1)SSC2=CC=CC(=C2C)C)C,,,,,,
1969,91970,"N,N-Dimethylisononylamine",CC(C)CCCCCCN(C)C,,,,,,
1970,91971,CID 91971,CCOCCOCCN1C(=C2C=C(C(=O)C3=CC=CC(=C32)C1=O)N=NC4=C(C=C(C=C4)[N+](=O)[O-])C)O,,,,,,
1971,91972,"Benzenesulfonic acid, 3-[(4-amino-3-methylphenyl)azo]-",CC1=C(C=CC(=C1)N=NC2=CC(=CC=C2)S(=O)(=O)O)N,,,,,,
1972,91973,CID 91973,COC(=O)C1=CC=CC=C1N=NC2=C(NC(=NC2=O)NC#N)N,,,,,,
1973,91974,"2-Oxetanone, 4-(8Z)-8-heptadecenylidene-3-(7Z)-7-hexadecenyl-",CCCCCCCCC=CCCCCCCC=C1C(C(=O)O1)CCCCCCC=CCCCCCCCC,,,,,,
1974,91975,2-Hydroxyethyl 16-methylheptadecanoate,CC(C)CCCCCCCCCCCCCCC(=O)OCCO,,,,,,
1975,91976,(2H10)-o-Xylene,[2H]C1=C(C(=C(C(=C1[2H])C([2H])([2H])[2H])C([2H])([2H])[2H])[2H])[2H],,,,,,
1976,91977,"1-Hexanesulfonic acid, 2-ethyl-",CCCCC(CC)CS(=O)(=O)O,,,,,,
1977,91978,Isopentyl phenethyl ether,CC(C)CCOCCC1=CC=CC=C1,,,,,,
1978,91979,(E)-3-Isobutylidenephthalide,CC(C)C=C1C2=CC=CC=C2C(=O)O1,,,,,,
1979,91980,"2-(1-Hydroxy-3-phenylprop-2-enylidene)-5-methoxy-6,6-dimethylcyclohex-4-ene-1,3-dione",CC1(C(=CC(=O)C(=C(C=CC2=CC=CC=C2)O)C1=O)OC)C,,,,,,
1980,91981,Ethyltrioctylphosphonium bromide,CCCCCCCC[P+](CC)(CCCCCCCC)CCCCCCCC.[Br-],,,,,,
1981,91982,Ethyltrioctylphosphonium,CCCCCCCC[P+](CC)(CCCCCCCC)CCCCCCCC,,,,,,
1982,91983,CID 91983,CC1=CCCC2(C(O2)CC1)C,,,,,,
1983,91984,"N-(1-ethylpropyl)-3,4-dimethylaniline",CCC(CC)NC1=CC(=C(C=C1)C)C,,,,,,
1984,91985,"cis-3,4-Dimethylcyclopentene",CC1CC=CC1C,,,,,,
1985,91986,"1-(2,3-Dichlorophenyl)ethanone",CC(=O)C1=C(C(=CC=C1)Cl)Cl,,,,,,
1986,91987,4-Bromo-alpha-cyclopropyl-alpha-methylbenzyl alcohol,CC(C1CC1)(C2=CC=C(C=C2)Br)O,,,,,,
1987,91988,"Methanesulfonamide, N-[2-[(4-amino-3-methylphenyl)ethylamino]ethyl]-, phosphate (1:1)",CCN(CCNS(=O)(=O)C)C1=CC(=C(C=C1)N)C.OP(=O)(O)O,,,,,,
1988,91989,"Butanamide, 2-[(2,5-dichlorophenyl)azo]-N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-3-oxo-",CC(=O)C(C(=O)NC1=CC2=C(C=C1)NC(=O)N2)N=NC3=C(C=CC(=C3)Cl)Cl,,,,,,
1989,91990,CID 91990,CCCCCCCCCCCC(=O)O.CCCCCCCCCCCC(=O)O.CCCCCCCCCCCC(=O)O.CCCCCCCC[SnH],,,,,,
1990,91991,Octyl-lambda2-stannane,CCCCCCCC[SnH],,,,,,
1991,91992,CID 91992,C1=CC(=C(C=C1Cl)C(=O)[O-])C(=O)O.[Na+],,,,,,
1992,91993,2-(2-(Pentadecyloxy)ethoxy)ethanol,CCCCCCCCCCCCCCCOCCOCCO,,,,,,
1993,91994,Ammonium 2-(2-(2-(hexadecyloxy)ethoxy)ethoxy)ethyl sulphate,CCCCCCCCCCCCCCCCOCCOCCOCCOS(=O)(=O)O.N,,,,,,
1994,91995,2-[2-(2-Hexadecoxyethoxy)ethoxy]ethyl hydrogen sulfate,CCCCCCCCCCCCCCCCOCCOCCOCCOS(=O)(=O)O,,,,,,
1995,91996,3-(2-Hydroxyphenyl)-1-phenylpropan-1-one,C1=CC=C(C=C1)C(=O)CCC2=CC=CC=C2O,,,,,,
1996,91997,Butyl 2-thenoate,CCCCOC(=O)C1=CC=CS1,,,,,,
1997,91998,5-Isopropenyl-2-methylpyridine,CC1=NC=C(C=C1)C(=C)C,,,,,,
1998,91999,"3,5-Diethyl-2-methylpyridine",CCC1=CC(=C(N=C1)C)CC,,,,,,
1999,92000,5-Ethyl-2-(1-propen-1-yl)pyridine,CCC1=CN=C(C=C1)C=CC,,,,,,
2000,92001,"4-Cyclohexene-1,3-dicarboxylic acid, 4-methyl-6-oxo-, diethyl ester",CCOC(=O)C1CC(C(=O)C=C1C)C(=O)OCC,,,,,,
2001,92002,"2,2-Dimethyl-5-(1-methylpropenyl)tetrahydrofuran",CC=C(C)C1CCC(O1)(C)C,,,,,,
2002,92003,"2,4(1H,3H)-Pyrimidinedione, 5-fluoro-3-(1-oxopropyl)-",CCC(=O)N1C(=O)C(=CNC1=O)F,,,,,,
2003,92004,"1,1-Dipropylbutyl isocyanate",CCCC(CCC)(CCC)N=C=O,,,,,,
2004,92005,2-Ethoxy-5-fluoropyrimidin-4-amine,CCOC1=NC=C(C(=N1)N)F,,,,,,
2005,92006,Lauryl 2-ethylhexanoate,CCCCCCCCCCCCOC(=O)C(CC)CCCC,,,,,,
2006,92007,Triglycerol,C(C(COCC(COCC(CO)O)O)O)O,,,,,,
2007,92008,Aluminum;but-1-ene;ethane,C[CH2-].C[CH2-].CCC=[CH-].[Al+3],,,,,,
2008,92009,Aluminum;butane;hex-1-ene,CCC[CH2-].CCC[CH2-].CCCCC=[CH-].[Al+3],,,,,,
2009,92010,Aluminum;2-methanidylpropane;4-methylpent-1-ene,CC(C)[CH2-].CC(C)[CH2-].CC(C)CC=[CH-].[Al+3],,,,,,
2010,92011,Aluminum;hexane;oct-1-ene,CCCCC[CH2-].CCCCC[CH2-].CCCCCCC=[CH-].[Al+3],,,,,,
2011,92012,"2,6-Di-tert-amyl-4-cresol",CCC(C)(C)C1=CC(=CC(=C1O)C(C)(C)CC)C,,,,,,
2012,92013,"Benzenepropanol, 4-(1,1-dimethylethyl)-beta-methyl-",CC(CC1=CC=C(C=C1)C(C)(C)C)CO,,,,,,
2013,92014,4-Tert-butylbenzamide,CC(C)(C)C1=CC=C(C=C1)C(=O)N,,,,,,
2014,92015,"9,10-Dihydroanthracene-1,4,5,8,9,10-hexol",C1=CC(=C2C(C3=C(C=CC(=C3C(C2=C1O)O)O)O)O)O,,,,,,
2015,92016,"2,5-Dichloro-4-((4-(diethylamino)-o-tolyl)azo)benzenesulphonic acid",CCN(CC)C1=CC(=C(C=C1)N=NC2=CC(=C(C=C2Cl)S(=O)(=O)O)Cl)C,,,,,,
2016,92017,"Heptadeca-1,8,11-triene",CCCCCC=CCC=CCCCCCC=C,,,,,,
2017,92018,"2,5-Dimethyl-2-vinylhex-4-enal",CC(=CCC(C)(C=C)C=O)C,,,,,,
2018,92019,CID 92019,CCCCN=C(S)SCC,,,,,,
2019,92020,"9,10-Anthracenediol, 1,4-dihydro-",C1C=CCC2=C(C3=CC=CC=C3C(=C21)O)O,,,,,,
2020,92021,"9,10-Anthracenedione, 1,4,4a,9a-tetrahydro-",C1C=CCC2C1C(=O)C3=CC=CC=C3C2=O,,,,,,
2021,92022,"1-(6-Nitro-1,3-benzodioxol-5-yl)ethanone",CC(=O)C1=CC2=C(C=C1[N+](=O)[O-])OCO2,,,,,,
2022,92023,"1H-Pyrrole-2-methanamine, N,N,1-trimethyl-",CN1C=CC=C1CN(C)C,,,,,,
2023,92024,Methylbeta-neuraminicacid,COCC1C(CC(C(O1)(C(C(C(=O)O)O)O)N)O)O,,,,,,
2024,92025,"2-(2-Ethylhexyl)-6,7-dimethoxy-1H-benz[de]isoquinoline-1,3(2H)-dione",CCCCC(CC)CN1C(=O)C2=C3C(=CC=C(C3=C(C=C2)OC)OC)C1=O,,,,,,
2025,92026,"2,3-Bis(1-oxobutoxy)propyl stearate",CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCC)OC(=O)CCC,,,,,,
2026,92027,"2,3-Bis((1-oxooctyl)oxy)propyl stearate",CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC)OC(=O)CCCCCCC,,,,,,
2027,92028,"2,3-Bis(acetoxy)propyl docosanoate",CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)C)OC(=O)C,,,,,,
2028,92029,"2,3-Dipropionyloxypropyl docosanoate",CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CC)OC(=O)CC,,,,,,
2029,92030,"2,3-Bis((1-oxooctyl)oxy)propyl docosanoate",CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCC)OC(=O)CCCCCCC,,,,,,
2030,92031,"2-Naphthalenecarboxylic acid, 2-(2-naphthalenylcarbonyl)hydrazide",C1=CC=C2C=C(C=CC2=C1)C(=O)NNC(=O)C3=CC4=CC=CC=C4C=C3,,,,,,
2031,92032,(4-Hydroxybutyl) hydrogen succinate,C(CCOC(=O)CCC(=O)O)CO,,,,,,
2032,92033,"Acetamide, N-[5-[bis(2-hydroxyethyl)amino]-2-[(2-chloro-4,6-dinitrophenyl)azo]-4-methoxyphenyl]-",CC(=O)NC1=CC(=C(C=C1N=NC2=C(C=C(C=C2Cl)[N+](=O)[O-])[N+](=O)[O-])OC)N(CCO)CCO,,,,,,
2033,92034,"Abieta-7,13-dien-18-oyl chloride",CC(C)C1=CC2=CCC3C(C2CC1)(CCCC3(C)C(=O)Cl)C,,,,,,
2034,92035,Pentaerythrityl triheptanoate,CCCCCCC(=O)OCC(CO)(COC(=O)CCCCCC)COC(=O)CCCCCC,,,,,,
2035,92036,"2-Chloro-3',4'-dimethoxybenzil",COC1=C(C=C(C=C1)C(=O)C(=O)C2=CC=CC=C2Cl)OC,,,,,,
2036,92037,2-(Diethoxyphosphorylsulfanylmethylsulfinyl)-2-methylpropane,CCOP(=O)(OCC)SCS(=O)C(C)(C)C,,,,,,
2037,92038,"Cyclopentanone, 2-[[4-(1-methylethyl)-1-cyclohexen-1-yl]methyl]-",CC(C)C1CCC(=CC1)CC2CCCC2=O,,,,,,
2038,92039,"Acetamide, 2,2,2-trichloro-N-(3-nitrophenyl)-",C1=CC(=CC(=C1)[N+](=O)[O-])NC(=O)C(Cl)(Cl)Cl,,,,,,
2039,92040,"Benzoic acid, 4-[(trichloroacetyl)amino]-",C1=CC(=CC=C1C(=O)O)NC(=O)C(Cl)(Cl)Cl,,,,,,
2040,92041,2-Ethoxy-5-fluorouracil,CCOC1=NC=C(C(=O)N1)F,,,,,,
2041,92042,"4-(1-Bromo-2-phenylethyl)-1,1'-biphenyl",C1=CC=C(C=C1)CC(C2=CC=C(C=C2)C3=CC=CC=C3)Br,,,,,,
2042,92043,[1-(Biphenyl-4-yl)-2-phenylethyl]malonic acid,C1=CC=C(C=C1)CC(C2=CC=C(C=C2)C3=CC=CC=C3)C(C(=O)O)C(=O)O,,,,,,
2043,92044,"3-[1,1'-Biphenyl]-4-yl-3,4-dihydronaphthalen-1(2h)-one",C1C(CC(=O)C2=CC=CC=C21)C3=CC=C(C=C3)C4=CC=CC=C4,,,,,,
2044,92045,"3-([1,1'-Biphenyl]-4-yl)-1,2,3,4-tetrahydronaphthalen-1-ol",C1C(CC2=CC=CC=C2C1O)C3=CC=C(C=C3)C4=CC=CC=C4,,,,,,
2045,92046,"3-[1,1'-Biphenyl]-4-yl-1-bromo-1,2,3,4-tetrahydronaphthalene",C1C(CC2=CC=CC=C2C1Br)C3=CC=C(C=C3)C4=CC=CC=C4,,,,,,
2046,92047,"N-[(1-acetyl-6-methyl-5-nitro-3,4-dihydro-2H-quinolin-2-yl)methyl]-N-propan-2-ylacetamide",CC1=C(C2=C(C=C1)N(C(CC2)CN(C(C)C)C(=O)C)C(=O)C)[N+](=O)[O-],,,,,,
2047,92048,"1-Naphthalenol, 3-(4'-bromo[1,1'-biphenyl]-4-yl)-1,2,3,4-tetrahydro-",C1C(CC2=CC=CC=C2C1O)C3=CC=C(C=C3)C4=CC=C(C=C4)Br,,,,,,
2048,92049,4-Methoxybenzo(a)pyrene,COC1=CC2=CC3=CC=CC=C3C4=C2C5=C(C=CC=C15)C=C4,,,,,,
2049,92050,5-Methoxybenzo[pqr]tetraphene,COC1=CC2=CC=CC3=C2C4=C(C=C3)C5=CC=CC=C5C=C14,,,,,,
2050,92051,"2,5-Diethoxy-4-nitroaniline",CCOC1=CC(=C(C=C1N)OCC)[N+](=O)[O-],,,,,,
2051,92052,"2-(3,5-Dichloro-4-oxopyridin-1(4H)-yl)acetic acid",C1=C(C(=O)C(=CN1CC(=O)O)Cl)Cl,,,,,,
2052,92053,"2-(1,1-Dimethylethyl)-4-(1-methyl-1-phenylethyl)phenol",CC(C)(C)C1=C(C=CC(=C1)C(C)(C)C2=CC=CC=C2)O,,,,,,
2053,92054,"4-Propoxybenzene-1,2-diamine",CCCOC1=CC(=C(C=C1)N)N,,,,,,
2054,92055,CID 92055,CN1C(=C(C(=O)N(C1=O)C)C2=NC(=C(C#N)C3=NC4=CC=CC=C4N3)C5=CC=CC=C52)O,,,,,,
2055,92056,CID 92056,CN1C(=C(C(=O)N(C1=O)CCCOC)C2=NC(=C(C#N)C3=NC4=CC=CC=C4N3)C5=CC=CC=C52)O,,,,,,
2056,92057,CID 92057,COCCCN1C(=C(C(=O)N(C1=O)CCCOC)C2=NC(=C(C#N)C3=NC4=CC=CC=C4N3)C5=CC=CC=C52)O,,,,,,
2057,92058,Ethyl 4-methyloctanoate,CCCCC(C)CCC(=O)OCC,,,,,,
2058,92059,"4,4-Methylenebis(oxy)anisole",COC1=CC=C(C=C1)OCOC2=CC=C(C=C2)OC,,,,,,
2059,92060,"2,2,6-Trichloro-7-oxabicyclo[4.1.0]heptane-1-carbonitrile",C1CC2(C(O2)(C(C1)(Cl)Cl)C#N)Cl,,,,,,
2060,92061,"2,2,6,6-Tetrachlorocyclohexanol",C1CC(C(C(C1)(Cl)Cl)O)(Cl)Cl,,,,,,
2061,92062,2-{[(1-Hydroxypropan-2-yl)oxy]carbonyl}benzoic acid,CC(CO)OC(=O)C1=CC=CC=C1C(=O)O,,,,,,
2062,92063,CID 92063,CCCCC(CC)C(=O)O.CCCCC(CC)C(=O)O.CCCO.[AlH3],,,,,,
2063,92064,"Cholest-5-en-3-ol (3beta)-, 3-(2-methyl-2-propen-1-yl carbonate)",CC(C)CCCCCC1CCC2C1(CCC3C2CC=C4C3(CC[C@@H](C4)OC(=O)OCC(=C)C)C)C,,,,,,
2064,92065,"9-Tetradecen-1-ol, 1-formate, (9Z)-",CCCCC=CCCCCCCCCOC=O,,,,,,
2065,92066,Hexadec-9-enal,CCCCCCC=CCCCCCCCC=O,,,,,,
2066,92067,9-Hexacecenoic acid ethyl ester,CCCCCCC=CCCCCCCCC(=O)OCC,,,,,,
2067,92068,4-((6-Bromohexyl)oxy)-3-chloroanisole,COC1=CC(=C(C=C1)OCCCCCCBr)Cl,,,,,,
2068,92069,"2-Anthracenesulfonic acid, 1-amino-9,10-dihydro-4-[[(4-methylphenyl)sulfonyl]amino]-9,10-dioxo-, phenyl ester",CC1=CC=C(C=C1)S(=O)(=O)NC2=CC(=C(C3=C2C(=O)C4=CC=CC=C4C3=O)N)S(=O)(=O)OC5=CC=CC=C5,,,,,,
2069,92070,Bis(2-ethylhexyl) malate,CCCCC(CC)COC(=O)CC(C(=O)OCC(CC)CCCC)O,,,,,,
2070,92071,"O,N-Diethyl-N-nitrosohydroxylamine",CCN(N=O)OCC,,,,,,
2071,92072,CID 92072,CCCCC(CC)C(=O)O.O=[AlH],,,,,,
2072,92073,trans-4-OH CCNU,C1CC(CCC1NC(=O)N(CCCl)N=O)O,,,,,,
2073,92074,2-Hexylcyclopent-2-en-1-ol,CCCCCCC1=CCCC1O,,,,,,
2074,92075,2-tert-Butylbenzyl chloride,CC(C)(C)C1=CC=CC=C1CCl,,,,,,
2075,92076,"(1R-(1alpha,2alpha,5alpha))-6,6-Dimethylspiro(bicyclo(3.1.1)heptane-2,2'-oxirane)",CC1([C@H]2CC[C@]3([C@@H]1C2)CO3)C,,,,,,
2076,92077,CID 92077,CC(CN1C=NC2=C1C(=O)N=C(N2)N)O,,,,,,
2077,92078,Trimethyl((phenylseleno)methyl)silane,C[Si](C)(C)C[Se]C1=CC=CC=C1,,,,,,
2078,92079,1-Hexadecoxyoctadecan-1-ol,CCCCCCCCCCCCCCCCCC(O)OCCCCCCCCCCCCCCCC,,,,,,
2079,92080,"2,6-Dimethylhept-4-en-3-one",CC(C)C=CC(=O)C(C)C,,,,,,
2080,92081,"Pentanenitrile, 2-amino-4-methoxy-2,4-dimethyl-",CC(C)(CC(C)(C#N)N)OC,,,,,,
2081,92082,CID 92082,CC[PbH](CC)CC.OP(=O)(O)O,,,,,,
2082,92083,"Nona-2,4,6-trienal",CCC=CC=CC=CC=O,,,,,,
2083,92084,"Azacycloheptane-2,2-diphosphonic acid",C1CCC(NCC1)(P(=O)(O)O)P(=O)(O)O,,,,,,
2084,92085,"2-Butenal, 4,4-bis(acetyloxy)-2-methyl-, (Z)-",CC(=CC(OC(=O)C)OC(=O)C)C=O,,,,,,
2085,92086,Cefuroxime Sodium Impurity A (Cefuroxime Descarbamoyl),CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)CO)C(=O)O,,,,,,
2086,92087,(+)-(Trans)-dorzolamide,CCN[C@@H]1C[C@H](S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,,,,,,
2087,92088,Cefprozil monohydrate,CC=CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)[C@@H](C3=CC=C(C=C3)O)N)SC1)C(=O)O.O,,,['Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)'],,,
2088,92089,Nanterinone mesylate,CC1=CC(=CC2=C1NC(=O)C=C2)N3C=C(N=C3C)C.CS(=O)(=O)O,,,,,,
2089,92090,"chloromethyl (1R,9R,10S,13S,14R,16S)-13-ethyl-14-hydroxy-8-methyl-8,15-diazahexacyclo[14.2.1.01,9.02,7.010,15.012,17]nonadeca-2,4,6-triene-18-carboxylate",CC[C@@H]1[C@H](N2[C@H]3CC1C4[C@@H]2C[C@@]5([C@H]3N(C6=CC=CC=C65)C)C4C(=O)OCCl)O,,,,,,
2090,92091,CID 92091,C1=NC2=C(C(=N1)S)N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O,,,,,,
2091,92092,"(3S,4S,5R)-1,3,4,5,6-pentahydroxyhexan-2-one",C([C@H]([C@@H]([C@@H](C(=O)CO)O)O)O)O,['Intended for use as a therapeutic adjunct in the treatment of type II diabetes.'],['Oral tagatose significantly blunts the rise in plasma glucose seen after oral glucose in patients with diabetes mellitus in a dose-dependent manner without significantly affecting insulin levels. The minimal elevation of plasma tagatose levels in normal patients and the adverse gastrointestinal effects seen following larger doses of tagatose support poor absorption of this hexose and suggest that tagatose may act by attenuating glucose absorption in the intestine.'],"['Organic chemicals that form two or more coordination links with an iron ion. Once coordination has occurred, the complex formed is called a chelate. The iron-binding porphyrin group of hemoglobin is an example of a metal chelate found in biological systems. (See all compounds classified as Iron Chelating Agents.)']",['Only 15-20 percent of tagatose is absorbed in the small intestine.'],['Tagatose does not influence the level of blood glucose nor insulin levels.'],
2092,92093,N-Cyclohexyl-N'-phenyl-p-phenylenediamine,C1CCC(CC1)NC2=CC=C(C=C2)NC3=CC=CC=C3,"[""N-Cyclohexyl-N'-phenyl-1,4-phenylenediamine is approved for use within allergenic epicutaneous patch tests which are indicated for use as an aid in the diagnosis of allergic contact dermatitis (ACD) in persons 6 years of age and older.""]",,,,,
2093,92094,delta-Tocopherol,CC1=CC(=CC2=C1O[C@](CC2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O,,,,,,
2094,92095,Sarsasapogenin,C[C@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC[C@H]6[C@@]5(CC[C@@H](C6)O)C)C)C)OC1,,,,,,
2095,92096,CID 92096,CC(=CC=CC=C(C)C=CC=C(C)C=C[C@]12[C@](O1)(C[C@H](CC2(C)C)O)C)C=CC=C(C)C=C[C@]34[C@](O3)(C[C@H](CC4(C)C)O)C,,,,,,
2096,92097,Taraxerol,C[C@]12CCC(C[C@H]1[C@@]3(CC[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4(C3=CC2)C)(C)C)O)C)C)(C)C,,,,,,
2097,92098,2-Phenyl-3-butyn-2-ol,CC(C#C)(C1=CC=CC=C1)O,,,,,,
2098,92099,Dextramycin,C1=CC(=CC=C1[C@@H]([C@H](CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-],,,,,,
2099,92100,3-Fluorotyrosine,C1=CC(=C(C=C1CC(C(=O)O)N)F)O,,,"['A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. (See all compounds classified as Central Nervous System Stimulants.)']",,,
2100,92101,Ruberythric acid,C1[C@H]([C@@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=C(C4=C(C=C3)C(=O)C5=CC=CC=C5C4=O)O)O)O)O)O)O)O,,,,,,
2101,92102,Methyl 1-thio-beta-D-galactopyranoside,CS[C@H]1[C@@H](C([C@H](C(O1)CO)O)O)O,,,,,,
2102,92103,CID 92103,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@@H]([C@@H]([C@H]([C@@H](O2)OC3=C(OC4=CC(=CC(=O)C4=C3O)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)O)O)O)C6=CC=C(C=C6)O)O)O)O)O)O)O,,,,,,
2103,92104,"(3alpha,4alpha,5beta,6alpha)-3,4,5,6-Tetrachlorocyclohexene",C1=C[C@@H]([C@H]([C@@H]([C@@H]1Cl)Cl)Cl)Cl,,,,,,
2104,92105,1-Methyl-L-histidine,CN1C=C(N=C1)C[C@@H](C(=O)O)N,,,,,,
2105,92106,"Retinoic acid, methylester, 13-cis-",CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)OC)C)C,,,,,,
2106,92107,1-Chloro-3-fluoro-2-propanol,C(C(CCl)O)F,,,,,,
2107,92108,Camphane,CC1(C2CCC1(CC2)C)C,,,,,,
2108,92109,Gibberellin A4,C[C@@]12[C@H](CC[C@@]3([C@@H]1[C@@H]([C@]45[C@H]3CC[C@H](C4)C(=C)C5)C(=O)O)OC2=O)O,,,,,,
2109,92110,Cycloartenol,C[C@H](CCC=C(C)C)[C@H]1CC[C@@]2([C@@]1(CC[C@]34[C@H]2CC[C@@H]5[C@]3(C4)CC[C@@H](C5(C)C)O)C)C,,,,,,
2110,92111,CID 92111,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=CC2=C(C[C@H](CC2(C)C)O)C)C)C,,,,,,
2111,92112,Eburnamenin-14(15H)-one,CC[C@]12CCCN3[C@H]1C4=C(CC3)C5=CC=CC=C5N4C(=O)C2,,,['Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)'],,,
2112,92113,24-Methylenecholesterol,C[C@H](CCC(=C)C(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,,,,,,
2113,92114,Tylophorine,COC1=C(C=C2C(=C1)C3=C(CN4CCC[C@H]4C3)C5=CC(=C(C=C52)OC)OC)OC,,,,,,
2114,92115,"4-Hydroxy-3-methyl-2-penta-2,4-dienylcyclopent-2-en-1-one",CC1=C(C(=O)CC1O)CC=CC=C,,,,,,
2115,92116,"1H-Cycloprop(e)azulene, 1a,2,3,4,4a,5,6,7b-octahydro-1,1,4,7-tetramethyl-, (1aR,4R,4aR,7bS)-",C[C@@H]1CCC2C(C2(C)C)C3=C(CC[C@H]13)C,,,,,,
2116,92117,DL-Homocysteic acid,C(CS(=O)(=O)O)C(C(=O)O)N,,,,,,
2117,92118,"20-Ethyl-6,14,16-trimethoxy-4-(methoxymethyl)aconitane-1,7,8-triol",CCN1CC2(CCC(C34C2C(C(C31)(C5(CC(C6CC4C5C6OC)OC)O)O)OC)O)COC,,,,,,
2118,92119,Ambrosin,C[C@H]1CC[C@@H]2[C@H]([C@]3([C@H]1C=CC3=O)C)OC(=O)C2=C,,,,,,
2119,92120,Maleopimaric acid,CC(C)C1=C[C@@]23CC[C@@H]4[C@@]([C@H]2C[C@@H]1[C@@H]5[C@H]3C(=O)OC5=O)(CCC[C@@]4(C)C(=O)O)C,,,,,,
2120,92121,"(9S,14S)-10-(hydroxymethyl)-13-methyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione",CC12CC[C@H]3C([C@@H]1CCC2=O)CCC4=CC(=O)CCC34CO,,,,,,
2121,92122,beta-Peltatin,COC1=CC(=CC(=C1OC)OC)[C@H]2[C@@H]3[C@@H](CC4=C(C5=C(C=C24)OCO5)O)COC3=O,,,,,,
2122,92123,Picein,CC(=O)C1=CC=C(C=C1)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O,,,,,,
2123,92124,D-Ethionine,CCSCC[C@H](C(=O)O)N,,,,,"['THE QUANTITATIVE STUDY OF THE INVERSION OF D-ETHIONINE INTO L-ETHIONINE IN VIVO, MEASURED IN THE LIVER OF RATS BY THE FORMATION OF S-ADENOSYLETHIONINE FROM L-ETHIONINE, DEMONSTRATES HIGH EFFICIENCY OF THIS CONVERSION WHEN LOWER DOSES OF D-ETHIONINE ARE USED. AT HIGHER DOSES (MORE THAN 25 MG (80 UMOL)/100 G BODY WT), ACCUMULATION OF S-ADENOSYLETHIONINE IS RETARDED. THIS DECR OF S-ADENOSYLETHIONINE FORMATION MAY BE DUE TO AN UNKNOWN EFFECT OF D-ETHIONINE ON THE L-ETHIONINE METABOLISM.']",
2124,92125,Iodosylbenzene,C1=CC=C(C=C1)I=O,,,,,,
2125,92126,3-(3-Hydroxy-4-methoxyphenyl)prop-2-enoic acid,COC1=C(C=C(C=C1)C=CC(=O)O)O,,,,,,
2126,92127,"3-Iodo-1,2-propanediol",C(C(CI)O)O,,,,,,
2127,92128,5alpha-Cholestan-3-one,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(CCC(=O)C4)C)C,,,,,,
2128,92129,alpha-Peltatin,COC1=CC(=CC(=C1O)OC)[C@H]2[C@@H]3[C@@H](CC4=C(C5=C(C=C24)OCO5)O)COC3=O,,,,,,
2129,92130,"Benzaldehyde, (phenylmethylene)hydrazone",C1=CC=C(C=C1)C=NN=CC2=CC=CC=C2,,,,,,
2130,92131,"Labda-8(20),14-dien-13-ol, (13R)-",C[C@]12CCCC([C@@H]1CCC(=C)[C@@H]2CCC(C)(C=C)O)(C)C,,,,,,
2131,92132,5beta-Cholestan-3-one,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@H]4[C@@]3(CCC(=O)C4)C)C,,,,,,
2132,92133,Succinyl-coenzyme A,CC(C)(COP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)[C@H](C(=O)NCCC(=O)NCCSC(=O)CCC(=O)O)O,,,,,,
2133,92134,4-[2-(4-Aminophenyl)ethenyl]aniline,C1=CC(=CC=C1C=CC2=CC=C(C=C2)N)N,,,,,,
2134,92135,(R)-3-Hydroxybutyric acid,C[C@H](CC(=O)O)O,,,,,,
2135,92136,L-2-Aminoadipic acid,C(C[C@@H](C(=O)O)N)CC(=O)O,,,,,,
2136,92137,"1,2,3-Tribromo-2-methylpropane",CC(CBr)(CBr)Br,,,,,,
2137,92138,Elemol,CC(=C)[C@@H]1C[C@@H](CC[C@@]1(C)C=C)C(C)(C)O,,,,,,
2138,92139,alpha-Curcumene,CC1=CC=C(C=C1)C(C)CCC=C(C)C,,,,,,
2139,92140,Riboflavin tetrabutyrate,CCCC(=O)OC[C@H]([C@H]([C@H](CN1C2=C(C=C(C(=C2)C)C)N=C3C1=NC(=O)NC3=O)OC(=O)CCC)OC(=O)CCC)OC(=O)CCC,,,,,,
2140,92141,"4,4'-Oxydi-2-butanol",CC(CCOCCC(C)O)O,,,,,,
2141,92142,(-)-Thalidomide,C1CC(=O)NC(=O)[C@H]1N2C(=O)C3=CC=CC=C3C2=O,,,,,"[""(-)-thalidomide has known human metabolites that include (-)-thalidomide arene oxide, 5'-Hydroxythalidomide, and 5-hydroxy-thalidomide.""]",
2142,92143,4-Hydroxyphenylglycine,C1=CC(=CC=C1C(C(=O)O)N)O,,,['Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)'],,,
2143,92144,Trichlorfon ethyl,CCOP(=O)(C(C(Cl)(Cl)Cl)O)OCC,,,,,,
2144,92145,Testosterone acetate,CC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,,,,,,
2145,92146,alpha-D-Glucopyranosyl-(1->4)-alpha-D-glucopyranosyl-(1->4)-D-glucopyranose,C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@@H]2[C@H](O[C@@H]([C@@H]([C@H]2O)O)O[C@H]([C@@H](CO)O)[C@@H]([C@H](C=O)O)O)CO)O)O)O)O,,,,,,
2146,92147,CID 92147,CC(=O)O.C[SnH](C)C,,,,,,
2147,92148,Naphthalene-d8,[2H]C1=C(C(=C2C(=C(C(=C(C2=C1[2H])[2H])[2H])[2H])[2H])[2H])[2H],,,,,,
2148,92149,Testosterone isobutyrate,CC(C)C(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,,,,,,
2149,92150,Phospho-L-arginine,C(C[C@@H](C(=O)O)N)CN=C(N)NP(=O)(O)O,,,,,,
2150,92151,Biperiden hydrochloride,C1CCN(CC1)CCC(C2CC3CC2C=C3)(C4=CC=CC=C4)O.Cl,,,"['Agents used in the treatment of Parkinson&apos;s disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. (See all compounds classified as Antiparkinson Agents.)', 'Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system. (See all compounds classified as Muscarinic Antagonists.)', 'Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)']",,,
2151,92152,Silver(II) oxide,O=[Ag],,,,,,
2152,92153,acetoacetyl-CoA,CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)O,,,,,,
2153,92154,2-Methyl-2-phenylsuccinimide,CC1(CC(=O)NC1=O)C2=CC=CC=C2,,,,,,
2154,92155,Diploptene,CC(=C)[C@H]1CC[C@]2([C@H]1CC[C@@]3([C@@H]2CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CCCC5(C)C)C)C)C)C,,,,,,
2155,92156,beta-Amyrin acetate,CC(=O)O[C@H]1CC[C@]2([C@H](C1(C)C)CC[C@@]3([C@@H]2CC=C4[C@]3(CC[C@@]5([C@H]4CC(CC5)(C)C)C)C)C)C,,,,,,
2156,92157,Lupeol acetate,CC(=C)[C@@H]1CC[C@]2([C@H]1[C@H]3CC[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)OC(=O)C)C)C,,,,,,
2157,92158,Lupenone,CC(=C)[C@@H]1CC[C@]2([C@H]1[C@H]3CC[C@@H]4[C@]5(CCC(=O)C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)C)C,,,,,,
2158,92159,Phenmetrazine hydrochloride,CC1C(OCCN1)C2=CC=CC=C2.Cl,,,"['Agents that are used to suppress appetite. (See all compounds classified as Appetite Depressants.)', 'A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. (See all compounds classified as Central Nervous System Stimulants.)', 'Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. (See all compounds classified as Sympathomimetics.)']",,,
2159,92160,Cis-9-octadecenoyl coenzyme a potassium salt,CCCCCCCCC=CCCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)O,,,,,,
2160,92161,"2H-1-Benzopyran-6-ol, 3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)-",CC1=C(C2=C(CCC(O2)(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(=C1O)C)C,,,['Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)'],,,
2161,92162,"cis-2,3-Epoxybutane",C[C@@H]1[C@@H](O1)C,,,,,,
2162,92163,Prilocaine hydrochloride,CCCNC(C)C(=O)NC1=CC=CC=C1C.Cl,,,"['Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate. (See all compounds classified as Anesthetics, Local.)']",,,
2163,92164,"N-((2R,3R,4R,5R)-3,4,5,6-Tetrahydroxy-1-oxohexan-2-yl)acetamide",CC(=O)N[C@@H](C=O)[C@H]([C@H]([C@@H](CO)O)O)O,,,,,,
2164,92165,L-gamma-Glutamylhydrazide,C(CC(=O)NN)[C@@H](C(=O)O)N,,,,,,
2165,92166,2-Methyl-2-vinyloxirane,CC1(CO1)C=C,,,,,,
2166,92167,CID 92167,CC(CCl)(C(=O)[O-])Cl.[Na+],,,,,,
2167,92168,"2,3,4-Trimethylpentane-1,5-diol",CC(CO)C(C)C(C)CO,,,,,,
2168,92169,"1-Hydroxy-2,2,5,5-tetramethylpyrrolidine-3-carboxylic acid",CC1(CC(C(N1O)(C)C)C(=O)O)C,,,,,,
2169,92170,Endodiol,C(C1C(C2(C(=C(C1(C2(Cl)Cl)Cl)Cl)Cl)Cl)CO)O,,,,,,
2170,92171,"Zinc O,O,O',O'-tetrakis(1,3-dimethylbutyl) bis(phosphorodithioate)",CC(C)CC(C)OP(=S)(OC(C)CC(C)C)[S-].CC(C)CC(C)OP(=S)(OC(C)CC(C)C)[S-].[Zn+2],,,,,,
2171,92172,"2-Pentanol, 4-methyl-, hydrogen phosphorodithioate",CC(C)CC(C)OP(=S)(OC(C)CC(C)C)S,,,,,,
2172,92173,Penicillamine hydrochloride,CC(C)([C@H](C(=O)O)N)S.Cl,,,,,,
2173,92174,2-tert-Butyloxirane,CC(C)(C)C1CO1,,,,,,
2174,92175,"[(2S)-2,3-dihydroxypropyl] octadeca-9,12-dienoate",CCCCCC=CCC=CCCCCCCCC(=O)OC[C@H](CO)O,,,,,,
2175,92176,"N-hexadecyl-N,N-dimethyl-3-ammonio-1-propanesulfonate",CCCCCCCCCCCCCCCC[N+](C)(C)CCCS(=O)(=O)[O-],,,,,,
2176,92177,"1-Hexadecanaminium, N,N-dimethyl-N-(3-sulfopropyl)-",CCCCCCCCCCCCCCCC[N+](C)(C)CCCS(=O)(=O)O,,,,,,
2177,92178,Thioproperazine dimethanesulfonate,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C.CS(=O)(=O)O.CS(=O)(=O)O,,,,,,
2178,92179,CID 92179,CC1=CC=C(C=C1)C(=N)S,,,,,,
2179,92180,N-(3-Methylbut-2-EN-1-YL)-9H-purin-6-amine,CC(=CCNC1=NC=NC2=C1NC=N2)C,,,,,,
2180,92181,Glycyltryptophan,C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)CN,,,,,,
2181,92182,"1,2-Epoxy-1,2,3,4-tetrahydronaphthalene",C1CC2=CC=CC=C2C3C1O3,,,,,,
2182,92183,Acetohydroxamic acid fluoren-2-YL-O-glucuronide,CC(=O)N(C1=CC2=C(C=C1)C3=CC=CC=C3C2)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)O)O)O)O,,,,,,
2183,92184,(S)-2-Bromooctanoic acid,CCCCCC[C@@H](C(=O)O)Br,,,,,,
2184,92185,S-Ethyl-L-cysteine,CCSC[C@@H](C(=O)O)N,,,,,,
2185,92186,CID 92186,C1=C(C(=O)NC(=O)N1C2[C@@H]([C@@H]([C@H](O2)CO)O)O)Cl,,,,,,
2186,92187,2-Nitro-1-propanol,CC(CO)[N+](=O)[O-],,,,,,
2187,92188,sec-Butyl acrylate,CCC(C)OC(=O)C=C,,,,,,
2188,92189,1-Phenylethyl hydroperoxide,CC(C1=CC=CC=C1)OO,,,,,,
2189,92190,"1,4-Benzenediamine, N-(1,4-dimethylpentyl)-N'-phenyl-",CC(C)CCC(C)NC1=CC=C(C=C1)NC2=CC=CC=C2,,,,,,
2190,92191,(2S)-4-carbamoyl-2-(ethylamino)butanoic acid,CCN[C@@H](CCC(=O)N)C(=O)O,,,,,,
2191,92192,3beta-Hydroxy-5alpha-cholest-6-ene-5-hydroperoxide,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C=CC4([C@@]3(CC[C@@H](C4)O)C)OO)C,,,,,,
2192,92193,N-Phthaloyl-DL-glutamic anhydride,C1CC(=O)OC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,,,,,,
2193,92194,"3-(3,4-Epoxycyclohexyl)-8,9-epoxy-2,4-dioxaspiro(5.5)undecane",C1CC2C(O2)CC1C3OCC4(CCC5C(C4)O5)CO3,,,,,,
2194,92195,CID 92195,C(CN=C(S)S)N=C(S)S.N.N,,,,,,
2195,92196,4-Methylaminorex,CC1C(OC(=N1)N)C2=CC=CC=C2,,,"['A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. (See all compounds classified as Central Nervous System Stimulants.)']",,,
2196,92197,CID 92197,C1=CC=NC(=C1)C=NN=C(N)S,,,,,,
2197,92198,Irehdiamine A,C[C@@H]([C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)N)C)C)N,,,,,,
2198,92199,Phosphomethylphosphonic acid adenosyl ester,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(CP(=O)(O)O)O)O)O)N,,,['Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)'],,,
2199,92200,Milneb,CC1NC(SC(=S)N1CCN2C(NC(SC2=S)C)C)C,,,,,,
2200,92201,Columbianetin,CC(C)([C@@H]1CC2=C(O1)C=CC3=C2OC(=O)C=C3)O,,,,,,
2201,92202,"3,4-Dihydroxycinnamic acid methyl ester",COC(=O)C=CC1=CC(=C(C=C1)O)O,,,,,,
2202,92203,"2-Propenoic acid, 3-(4-hydroxyphenyl)-, methyl ester",COC(=O)C=CC1=CC=C(C=C1)O,,,,,,
2203,92204,"methyl 2-[(2S,3S,12bS)-3-ethyl-8-methoxy-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl]-3-methoxyprop-2-enoate",CC[C@@H]1CN2CCC3=C([C@@H]2C[C@@H]1C(=COC)C(=O)OC)NC4=C3C(=CC=C4)OC,,,,,,
2204,92205,Violet bnp,CCN(CC)C1=CC=C(C=C1)C(=C2C=CC(=[N+](CC)CC3=CC(=CC=C3)S(=O)(=O)[O-])C=C2)C4=CC=C(C=C4)N(CC)CC5=CC(=CC=C5)S(=O)(=O)[O-].[Na+],,,,,,
2205,92206,Formyl Violet,CCN(CC)C1=CC=C(C=C1)C(=C2C=CC(=[N+](CC)CC3=CC(=CC=C3)S(=O)(=O)O)C=C2)C4=CC=C(C=C4)N(CC)CC5=CC(=CC=C5)S(=O)(=O)O,,,,,,
2206,92207,Amorphigenin,COC1=C(C=C2C(=C1)[C@H]3[C@@H](CO2)OC4=C(C3=O)C=CC5=C4C[C@@H](O5)C(=C)CO)OC,,,,,,
2207,92208,N6-Benzyladenosine,C1=CC=C(C=C1)CNC2=C3C(=NC=N2)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O,,,,,,
2208,92209,2-Methoxypropanoic acid,CC(C(=O)O)OC,,,,,,
2209,92210,"2-Ethyl-4-methyl-1,3-dioxolane",CCC1OCC(O1)C,,,,,,
2210,92211,"1-Hydroxy-2,2,5,5-tetramethylpyrrolidine-3-carboxamide",CC1(CC(C(N1O)(C)C)C(=O)N)C,,,,,,
2211,92212,Bisphenol a diglycidyl ether diacrylate,CC(C)(C1=CC=C(C=C1)OCC(COC(=O)C=C)O)C2=CC=C(C=C2)OCC(COC(=O)C=C)O,,,,,,
2212,92213,"Methyl 2-(2,4,5-trichlorophenoxy)propanoate",CC(C(=O)OC)OC1=CC(=C(C=C1Cl)Cl)Cl,,,,,,
2213,92214,"1-Methyl-1,2,3,4-tetrahydroisoquinoline",CC1C2=CC=CC=C2CCN1,,,"['Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)']",,,
2214,92215,"1,2-Epoxyheptane",CCCCCC1CO1,,,,,,
2215,92216,"2,3-Dibromopropanal",C(C(C=O)Br)Br,,,,,,
2216,92217,Dihydrodigoxin,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8CC(=O)OC8)O)C)O)C)C)C)O)O,,,,,,
2217,92218,1-(4-Methoxyphenyl)-1-propanol,CCC(C1=CC=C(C=C1)OC)O,,,,,,
2218,92219,"1,3-Diphenyl-2,3-epoxy-1-propanone",C1=CC=C(C=C1)C2C(O2)C(=O)C3=CC=CC=C3,,,,,,
2219,92220,CID 92220,CCCCCCCCCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@]2(CCC4=CC(=O)CC[C@]34C)C)C,,,,,,
2220,92221,(+)-Camphene,CC1([C@@H]2CC[C@@H](C2)C1=C)C,,,,,,
2221,92222,D-Dopa,C1=CC(=C(C=C1C[C@H](C(=O)O)N)O)O,,,,,,
2222,92223,Demethylcotinine,C1CC(=O)N[C@@H]1C2=CN=CC=C2,,,,,['Norcotinine is a known human metabolite of cotinine.'],
2223,92224,3-[4-(Dimethylamino)phenyl]prop-2-enal,CN(C)C1=CC=C(C=C1)C=CC=O,,,,,,
2224,92225,2-Phthalimidoglutaric acid,C1=CC=C2C(=C1)C(=O)N(C2=O)C(CCC(=O)O)C(=O)O,,,,,,
2225,92226,"(endo,endo)-Disodium 7-Oxabicyclo(2.2.1)hept-5-ene-2,3-dicarboxylate",C1=C[C@H]2[C@H]([C@H]([C@@H]1O2)C(=O)[O-])C(=O)[O-].[Na+].[Na+],,,,,,
2226,92227,"(1R,4S)-7-oxabicyclo[2.2.1]hept-5-ene-2,3-dicarboxylic acid",C1=C[C@H]2C(C([C@@H]1O2)C(=O)O)C(=O)O,,,,,,
2227,92228,2-(4-Nitrophenyl)oxirane,C1C(O1)C2=CC=C(C=C2)[N+](=O)[O-],,,,,,
2228,92229,4-Methylumbelliferyl beta-D-xylopyranoside,CC1=CC(=O)OC2=C1C=CC(=C2)O[C@H]3[C@@H]([C@H]([C@@H](CO3)O)O)O,,,,,,
2229,92230,"Acetic acid, hydroxy[(1-oxo-2-propenyl)amino]-",C=CC(=O)NC(C(=O)O)O,,,,,,
2230,92231,Spathulenol,C[C@@]1(CC[C@@H]2[C@@H]1[C@H]3[C@H](C3(C)C)CCC2=C)O,,,,,,
2231,92232,CID 92232,C1=NC(=O)C2=C(N1)N(C=N2)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O,,,,,,
2232,92233,Difunone,CN(C)C=C1C(=C(C(=O)O1)C#N)C2=CC=CC=C2,,,,,,
2233,92234,CID 92234,C.C.C.CC1=CC=C(CC1)C(C)C.CC1=CCC(=CC1)C(C)C.CC(C)C1=CCC(=C)CC1,,,,,,
2234,92235,Triazolealanine,C1=NNC(=N1)CC(C(=O)O)N,,,,,,
2235,92236,2-(2-Naphthyloxy)propanoic acid,CC(C(=O)O)OC1=CC2=CC=CC=C2C=C1,,,,,,
2236,92237,Calcium lactate gluconate,CC(C(=O)[O-])O.C([C@H]([C@H]([C@@H]([C@H](C(=O)[O-])O)O)O)O)O.[Ca+2],,,,,,
2237,92238,4-(Hydroxymethyl)-4-methyl-1-phenylpyrazolidin-3-one,CC1(CN(NC1=O)C2=CC=CC=C2)CO,,,,,,
2238,92239,3-Methyldecane,CCCCCCCC(C)CC,,,,,,
2239,92240,"trans-1,2-Cyclohexanediaminetetraacetic Acid",C1CC[C@@H]([C@H](C1)N(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O,,,,,,
2240,92241,CID 92241,CC1C=CC=C(C(=O)N=C2C(=CNN3CCNCC3)C(=C4C(=C2O)C(=C(C5=C4C(=O)C(O5)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)C)C)C)O)O)C,,,,,,
2241,92242,Fluoromisonidazole,C1=CN(C(=N1)[N+](=O)[O-])CC(CF)O,,,['Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells. (See all compounds classified as Radiation-Sensitizing Agents.)'],,,
2242,92243,Methomyl oxime,CC(=NO)SC,,,,,,
2243,92244,Copper aspirinate,CC(=O)OC1=CC=CC=C1C(=O)[O-].CC(=O)OC1=CC=CC=C1C(=O)[O-].CC(=O)OC1=CC=CC=C1C(=O)[O-].CC(=O)OC1=CC=CC=C1C(=O)[O-].[Cu+2].[Cu+2],,,,,,
2244,92245,CID 92245,CCCCCCCCCCCCCCOCCOCCOCCOS(=O)(=O)[O-].[Na+],,,,,,
2245,92246,2-{2-[2-(Tetradecyloxy)ethoxy]ethoxy}ethyl hydrogen sulfate,CCCCCCCCCCCCCCOCCOCCOCCOS(=O)(=O)O,,,,,,
2246,92247,1-Pentacosanol,CCCCCCCCCCCCCCCCCCCCCCCCCO,,,,,,
2247,92248,"2-(2,2-Dimethylhydrazino)-4-(5-nitro-2-furyl)thiazole",CN(C)NC1=NC(=CS1)C2=CC=C(O2)[N+](=O)[O-],,,,,,
2248,92249,7-Amino-4-methylcoumarin,CC1=CC(=O)OC2=C1C=CC(=C2)N,,,"['Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)']",,,
2249,92250,"4-Amino-3,5-dichlorophenol",C1=C(C=C(C(=C1Cl)N)Cl)O,,,,,,
2250,92251,"2-Amino-2,4-dimethylpentanenitrile",CC(C)CC(C)(C#N)N,,,,,,
2251,92252,"1,3,4-Thiadiazol-2-amine, monohydrochloride",C1=NN=C(S1)N.Cl,,,,,,
2252,92253,Levobupivacaine,CCCCN1CCCC[C@H]1C(=O)NC2=C(C=CC=C2C)C,"['For the production of local or regional anesthesia for surgery and obstetrics, and for post-operative pain management']","['Levobupivacaine, a local anesthetic agent, is indicated for the production of local or regional anesthesia or analgesia for surgery, for oral surgery procedures, for diagnostic and therapeutic procedures, and for obstetrical procedures.']","['Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate. (See all compounds classified as Anesthetics, Local.)']","['The plasma concentration of levobupivacaine following therapeutic administration depends on dose and also on route of administration, because absorption from the site of administration is affected by the vascularity of the tissue. Peak levels in blood were reached approximately 30 minutes after epidural administration, and doses up to 150 mg resulted in mean C<sub>max</sub> levels of up to 1.2 g/mL.', 'Following intravenous administration, recovery of the radiolabelled dose of levobupivacaine was essentially quantitative with a mean total of about 95% being recovered in urine and feces in 48 hours. Of this 95%, about 71% was in urine while 24% was in feces.', '66.91 18.23 L [after intravenous administration of 40 mg in healthy volunteers]', '39.06 13.29 L/h [after intravenous administration of 40 mg in healthy volunteers]']","['Levobupivacaine is extensively metabolized with no unchanged levobupivacaine detected in urine or feces. In vitro studies using [14 C] levobupivacaine showed that CYP3A4 isoform and CYP1A2 isoform mediate the metabolism of levobupivacaine to desbutyl levobupivacaine and 3-hydroxy levobupivacaine, respectively. In vivo, the 3-hydroxy levobupivacaine appears to undergo further transformation to glucuronide and sulfate conjugates. Metabolic inversion of levobupivacaine to R(+)-bupivacaine was not evident both in vitro and in vivo.', 'Levobupivacaine has known human metabolites that include N-(2,6-Dimethylphenyl)piperidine-2-carboxamide.']",['3.3 hours']
2253,92254,Glycerin mononitrate,C(C(CO)O)O.[N+](=O)(O)[O-],,,,,,
2254,92255,"3,7-Dimethyl-1,3-octadiene",CC(C)CCC=C(C)C=C,,,,,,
2255,92256,Tris(4-chlorophenyl)methane,C1=CC(=CC=C1C(C2=CC=C(C=C2)Cl)C3=CC=C(C=C3)Cl)Cl,,,,,,
2256,92257,"(2R,3S,5S,6S)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol",CO[C@@H]1[C@H](C([C@@H]([C@H](O1)CO)O)O)O,,,,,,
2257,92258,Phenylacetylglutamine,C1=CC=C(C=C1)CC(=O)N[C@@H](CCC(=O)N)C(=O)O,,,,,,
2258,92259,"2,6-Diisopropylphenyl isocyanate",CC(C)C1=C(C(=CC=C1)C(C)C)N=C=O,,,,,,
2259,92260,CID 92260,C1=CC(=NNC1=O)[O-].[Na+],,,,,,
2260,92261,Tetrachlororesorcinol,C1(=C(C(=C(C(=C1Cl)Cl)Cl)O)Cl)O,,,,,,
2261,92262,4-Hydroxychlorpropham,CC(C)OC(=O)NC1=CC(=C(C=C1)O)Cl,,,,,,
2262,92263,"Urea, 3-acetyl-1-methyl-1-nitroso-",CC(=O)NC(=O)N(C)N=O,,,,,,
2263,92264,4-Methoxybutanoic acid,COCCCC(=O)O,,,,,,
2264,92265,Matricin,C[C@H]1[C@@H]2[C@H](CC(=C3C=C[C@@]([C@@H]3[C@H]2OC1=O)(C)O)C)OC(=O)C,,,,,,
2265,92266,2-Nitro-5-thiocyanatobenzoic acid,C1=CC(=C(C=C1SC#N)C(=O)O)[N+](=O)[O-],,,"['Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)', 'Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)']",,,
2266,92267,Monocerin,CCC[C@H]1C[C@@H]2[C@H](O1)C3=CC(=C(C(=C3C(=O)O2)O)OC)OC,,,,,,
2267,92268,"2,8-Dihydroxyadenine",C12=C(NC(=O)N=C1NC(=O)N2)N,,,,,,
2268,92269,3-Aminophenylboronic acid,B(C1=CC(=CC=C1)N)(O)O,,,,,,
2269,92270,"1,2,3,4-Diepoxybutane",C1[C@@H](O1)[C@H]2CO2,,,"['Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)', 'Reagents with two reactive groups, usually at opposite ends of the molecule, that are capable of reacting with and thereby forming bridges between side chains of amino acids in proteins; the locations of naturally reactive areas within proteins can thereby be identified; may also be used for other macromolecules, like glycoproteins, nucleic acids, or other. (See all compounds classified as Cross-Linking Reagents.)', 'Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)']",,,
2270,92271,N-Methyl-N-nitroso-2-propanamine,CC(C)N(C)N=O,,,,,,
2271,92272,Monoisobutyl phthalate,CC(C)COC(=O)C1=CC=CC=C1C(=O)O,,,,,,
2272,92273,"Nickel(2+) diethyl bis(((3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl)methyl)phosphonate)",CCOP(=O)(CC1=CC(=C(C(=C1)C(C)(C)C)O)C(C)(C)C)[O-].CCOP(=O)(CC1=CC(=C(C(=C1)C(C)(C)C)O)C(C)(C)C)[O-].[Ni+2],,,,,,
2273,92274,"Ethyl hydrogen ((3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl)methyl)phosphonate",CCOP(=O)(CC1=CC(=C(C(=C1)C(C)(C)C)O)C(C)(C)C)O,,,,,,
2274,92275,Isovaltrate,CC(C)CC(=O)OCC1=CO[C@H]([C@H]2C1=C[C@@H]([C@]23CO3)OC(=O)C)OC(=O)CC(C)C,,,,,,
2275,92276,"Phosphine oxide, dihexyloctyl-",CCCCCCCCP(=O)(CCCCCC)CCCCCC,,,,,,
2276,92277,"Phosphine oxide, hexyldioctyl-",CCCCCCCCP(=O)(CCCCCC)CCCCCCCC,,,,,,
2277,92278,Disperse orange 25,CCN(CCC#N)C1=CC=C(C=C1)N=NC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
2278,92279,"2,3,5-Trichloro-6-methoxypyridine",COC1=NC(=C(C=C1Cl)Cl)Cl,,,,,,
2279,92280,"9,12-Tetradecadien-1-ol, acetate, (9Z,12E)-",CC=CCC=CCCCCCCCCOC(=O)C,,,,,,
2280,92281,4-Azidobiphenyl,C1=CC=C(C=C1)C2=CC=C(C=C2)N=[N+]=[N-],,,,,,
2281,92282,"1H-1,4-Benzodiazepine-2,5-dione, 3-benzylidene-3,4-dihydro-4-methyl-",CN1C(=CC2=CC=CC=C2)C(=O)NC3=CC=CC=C3C1=O,,,,,,
2282,92283,Glucuronolactone,C(=O)[C@@H]([C@@H]1[C@@H]([C@@H](C(=O)O1)O)O)O,,,,,,
2283,92284,"2-(9-Methoxy-3,7-dimethylnona-1,3,5,7-tetraenyl)-1,3,3-trimethylcyclohexene",CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCOC)C)C,,,,,,
2284,92285,CID 92285,CC(C)(O)O.C([C@@H]([C@H]([C@@H](C(=O)CO)O)O)O)O,,,,,,
2285,92286,"Propane-2,2-diol",CC(C)(O)O,,,,,,
2286,92287,6-Amino-5-(N-methylformylamino)-1-methyluracil,CN1C(=C(C(=O)NC1=O)N(C)C=O)N,,,,,,
2287,92288,"6-Amino-5-(formyl-N-methylamino)-1,3-dimethyluracil",CN1C(=C(C(=O)N(C1=O)C)N(C)C=O)N,,,,,,
2288,92289,"1,7-Dimethylhypoxanthine",CN1C=NC2=C1C(=O)N(C=N2)C,,,,,,
2289,92290,"3,4-Dichloro-N-hydroxyaniline",C1=CC(=C(C=C1NO)Cl)Cl,,,,,,
2290,92291,"O,O-Dimethyl O-phenyl phosphorothioate",COP(=S)(OC)OC1=CC=CC=C1,,,,,,
2291,92292,Cashmeran,CC1C(C2=C(C1(C)C)C(=O)CCC2)(C)C,,,,,,
2292,92293,(Z)-Hexadec-11-enyl acetate,CCCCC=CCCCCCCCCCCOC(=O)C,,,,,,
2293,92294,7-Aminoflunitrazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)N)C3=CC=CC=C3F,,,,,,
2294,92295,Isometamidium chloride,CC[N+]1=C2C=C(C=CC2=C3C=CC(=CC3=C1C4=CC=CC=C4)N=NNC5=CC=CC(=C5)C(=N)N)N.[Cl-],,,['Agents destructive to the protozoal organisms belonging to the suborder TRYPANOSOMATINA. (See all compounds classified as Trypanocidal Agents.)'],,,
2295,92296,"Tetrakis(1-chloroisopropyl) 1,2-ethanediyl bis(phoshate)",CC(CCl)OP(=O)(OCCOP(=O)(OC(C)CCl)OC(C)CCl)OC(C)CCl,,,,,,
2296,92297,3-Methyl-4-nitroso-2-phenylmorpholine,CC1C(OCCN1N=O)C2=CC=CC=C2,,,,,,
2297,92298,4-(Trifluoromethoxy)phenyl isocyanate,C1=CC(=CC=C1N=C=O)OC(F)(F)F,,,,,,
2298,92299,Tebutam,CC(C)N(CC1=CC=CC=C1)C(=O)C(C)(C)C,,,,,,
2299,92300,"1-(4-Chlorophenyl)-3-(2,6-dichlorobenzoyl)urea",C1=CC(=C(C(=C1)Cl)C(=O)NC(=O)NC2=CC=C(C=C2)Cl)Cl,,,,,,
2300,92301,Ipsdienol,CC(=C[C@H](CC(=C)C=C)O)C,,,,,,
2301,92302,Bis(2-methylphenyl) hydrogen phosphate,CC1=CC=CC=C1OP(=O)(O)OC2=CC=CC=C2C,,,,,,
2302,92303,Meclizine Monohydrochloride,CC1=CC(=CC=C1)CN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=C(C=C4)Cl.Cl,,,"['Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)', 'Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)', 'Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)', 'Drugs that bind to but do not activate CHOLINERGIC RECEPTORS, thereby blocking the actions of ACETYLCHOLINE or cholinergic agonists. (See all compounds classified as Cholinergic Antagonists.)']",,,
2303,92304,Phosdiphen,CCOP(=O)(OC1=C(C=C(C=C1)Cl)Cl)OC2=C(C=C(C=C2)Cl)Cl,,,,,,
2304,92305,(-)-Verapamil,CC(C)[C@](CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,,,,,,
2305,92306,4-Phenylpyridinium iodide,C1=CC=C(C=C1)C2=CC=[NH+]C=C2.[I-],,,,,,
2306,92307,"Benzenemethanaminium, N,N-dimethyl-N-(9Z)-9-octadecen-1-yl-, chloride (1:1)",CCCCCCCCC=CCCCCCCCC[N+](C)(C)CC1=CC=CC=C1.[Cl-],,,,,,
2307,92308,"N-Benzyl-N,N-dimethyloctadec-9-en-1-aminium",CCCCCCCCC=CCCCCCCCC[N+](C)(C)CC1=CC=CC=C1,,,,,,
2308,92309,4-Decylaniline,CCCCCCCCCCC1=CC=C(C=C1)N,,,,,,
2309,92310,"Phosphoric acid, 2,2-bis(chloromethyl)-1,3-propanediyl tetrakis(2-chloroethyl) ester",C(CCl)OP(=O)(OCCCl)OCC(COP(=O)(OCCCl)OCCCl)(CCl)CCl,,,,,,
2310,92311,"4',5'-Diiodofluorescein",C1=CC=C2C(=C1)C(=O)OC23C4=C(C(=C(C=C4)O)I)OC5=C3C=CC(=C5I)O,,,,,,
2311,92312,cis-Dichlorobis(cyclohexylamine)platinum(II),C1CCC(CC1)N.C1CCC(CC1)N.[Cl-].[Cl-].[Pt+2],,,,,,
2312,92313,(-)-gamma-Cadinene,CC1=C[C@H]2[C@H](CC1)C(=C)CC[C@@H]2C(C)C,,,,,,
2313,92314,"1,4-Dichloro-2-(4-nitrophenoxy)benzene",C1=CC(=CC=C1[N+](=O)[O-])OC2=C(C=CC(=C2)Cl)Cl,,,,,,
2314,92315,N-(t-Butyl)-5-nitro-2-furylacrylamide,CC(C)(C)NC(=O)C=CC1=CC=C(O1)[N+](=O)[O-],,,,,,
2315,92316,Pyridafol,C1=CC=C(C=C1)C2=NNC(=CC2=O)Cl,,,,,,
2316,92317,"1-Pyrrolidinecarboxylic acid, 2,4-dichlorophenyl ester",C1CCN(C1)C(=O)OC2=C(C=C(C=C2)Cl)Cl,,,,,,
2317,92318,CID 92318,C1[C@H]([C@H]([C@@H]([C@H]1O)C=C[C@@H](COC2=CC=CC(=C2)C(F)(F)F)O)CC=CCCCC(=O)O)O,,,,,,
2318,92319,4-Cyano-4'-pentylbiphenyl,CCCCCC1=CC=C(C=C1)C2=CC=C(C=C2)C#N,,,,,,
2319,92320,CID 92320,COC1=CC2=C(C(=COC2=CC1=O)C3=CC=C(C=C3)O)O,,,,,,
2320,92321,N-Methyl-4-nitrophthalimide,CN1C(=O)C2=C(C1=O)C=C(C=C2)[N+](=O)[O-],,,,,,
2321,92322,"2-Naphthalenecarboxamide, 4,4'-[(3,3'-dichloro[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[3-hydroxy-N-phenyl-",C1=CC=C(C=C1)NC(=O)C2=CC3=CC=CC=C3C(=C2O)N=NC4=C(C=C(C=C4)C5=CC(=C(C=C5)N=NC6=C(C(=CC7=CC=CC=C76)C(=O)NC8=CC=CC=C8)O)Cl)Cl,,,,,,
2322,92323,(R)-(beta-D-Glucopyranosyloxy)(3-hydroxyphenyl)acetonitrile,C1=CC(=CC(=C1)O)[C@H](C#N)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O,,,,,,
2323,92324,N-(3-Pyrene)maleimide,C1=CC2=C3C(=C1)C=C(C4=CC=CC(=C43)C=C2)N5C(=O)C=CC5=O,,,"['Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)', 'Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)']",,,
2324,92325,Methyl 3-(4-methoxyphenyl)oxirane-2-carboxylate,COC1=CC=C(C=C1)C2C(O2)C(=O)OC,,,,,,
2325,92326,Methyldymron,CC(C)(C1=CC=CC=C1)NC(=O)N(C)C2=CC=CC=C2,,,,,,
2326,92327,4-tert-Butylnitrosopiperidine,CC(C)(C)C1CCN(CC1)N=O,,,,,,
2327,92328,Diallyl tetrabromophthalate,C=CCOC(=O)C1=C(C(=C(C(=C1Br)Br)Br)Br)C(=O)OCC=C,,,,,,
2328,92329,5-((2-Aminoethyl)amino)naphthalene-1-sulfonic acid,C1=CC2=C(C=CC=C2S(=O)(=O)O)C(=C1)NCCN,,,,,,
2329,92330,Unii-MS9HB5PQ54,CC1=CC(C(=C[C@H]2[C@@H]1CC(C2)(C)C)C=O)C=O,,,,,,
2330,92331,Cibacron Brilliant Yellow 3G-P,CC1=C(C(=O)N(N1)C2=CC(=C(C=C2Cl)S(=O)(=O)[O-])Cl)N=NC3=C(C=CC(=C3)NC4=NC(=NC(=N4)NC5=CC=C(C=C5)S(=O)(=O)[O-])Cl)S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
2331,92332,"2,5-Dichloro-4-{4-[(5-{[4-chloro-6-(4-sulfoanilino)-1,3,5-triazin-2-yl]amino}-2-sulfophenyl)diazenyl]-5-hydroxy-3-methyl-1H-pyrazol-1-yl}benzene-1-sulfonic acid",CC1=C(C(=O)N(N1)C2=CC(=C(C=C2Cl)S(=O)(=O)O)Cl)N=NC3=C(C=CC(=C3)NC4=NC(=NC(=N4)NC5=CC=C(C=C5)S(=O)(=O)O)Cl)S(=O)(=O)O,,,,,,
2332,92333,Methyl D-mannopyranoside,COC1[C@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O,,,,,,
2333,92334,5-(p-Methylphenyl)-5-phenylhydantoin,CC1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,,,,,,
2334,92335,"Hexanoic acid, 2-ethyl-, compd. with 2,4,6-tris((dimethylamino)methyl)phenol",CCCCC(CC)C(=O)O.CN(C)CC1=CC(=C(C(=C1)CN(C)C)O)CN(C)C,,,,,,
2335,92336,N-Nitrosobenzthiazuron,CN(C(=O)NC1=NC2=CC=CC=C2S1)N=O,,,,,,
2336,92337,Tarenflurbil,C[C@H](C1=CC(=C(C=C1)C2=CC=CC=C2)F)C(=O)O,"[""Investigated for use/treatment in alzheimer's disease and prostate cancer.""]",,"['Agents that suppress GAMMA-SECRETASE by inhibiting or modulating its activities. Targeted enzymatic activities include its involvement in accumulation of toxic AMYLOID BETA-PEPTIDES (e.g., A&#x3B2;42) in ALZHEIMER DISEASE and activation of NOTCH RECEPTOR mediated SIGNAL PATHWAYS in certain cancer types. (See all compounds classified as Gamma Secretase Inhibitors and Modulators.)']",,"['Flurbiprofen has known human metabolites that include (2S,3S,4S,5R)-6-[(2R)-2-(3-fluoro-4-phenylphenyl)propanoyl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid.']",
2337,92338,"(1R,4S,5'S,6R,13R,20R,21R,24S)-21,24-dihydroxy-5',6',11,13,22-pentamethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one",C[C@H]1CC[C@]2(C[C@@H]3CC(O2)CC=C(C[C@H](C=CC=C4CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)C)OC1C,,,,,,
2338,92339,"2,4-Dichlorodiphenyl ether",C1=CC=C(C=C1)OC2=C(C=C(C=C2)Cl)Cl,,,,,,
2339,92340,Molinate sulfoxide,CCS(=O)C(=O)N1CCCCCC1,,,,,,
2340,92341,Anadur,CCCCCCOC1=CC=C(C=C1)CCC(=O)O[C@H]2CC[C@@H]3[C@@]2(CC[C@H]4[C@H]3CCC5=CC(=O)CC[C@H]45)C,,,"['Compounds that interact with ANDROGEN RECEPTORS in target tissues to bring about the effects similar to those of TESTOSTERONE. Depending on the target tissues, androgenic effects can be on SEX DIFFERENTIATION; male reproductive organs, SPERMATOGENESIS; secondary male SEX CHARACTERISTICS; LIBIDO; development of muscle mass, strength, and power. (See all compounds classified as Androgens.)', 'These compounds stimulate anabolism and inhibit catabolism. They stimulate the development of muscle mass, strength, and power. (See all compounds classified as Anabolic Agents.)']",,,
2341,92342,2-Chloro-5-(trifluoromethyl)pyridine,C1=CC(=NC=C1C(F)(F)F)Cl,,,,,,
2342,92343,Cyanacure,C1=CC=C(C(=C1)N)SCCSC2=CC=CC=C2N,,,,,,
2343,92344,Bis(2-propylheptyl) phthalate,CCCCCC(CCC)COC(=O)C1=CC=CC=C1C(=O)OCC(CCC)CCCCC,,,,,,
2344,92345,4-(1-Hydroxyethyl)phenyl acetate,CC(C1=CC=C(C=C1)OC(=O)C)O,,,,,,
2345,92346,"2',5'-Dichlorobiphenyl-3-ol",C1=CC(=CC(=C1)O)C2=C(C=CC(=C2)Cl)Cl,,,,,,
2346,92347,"2',5'-Dichloro-2-hydroxybiphenyl",C1=CC=C(C(=C1)C2=C(C=CC(=C2)Cl)Cl)O,,,,,,
2347,92348,"3,4'-Dichloro-4-biphenylol",C1=CC(=CC=C1C2=CC(=C(C=C2)O)Cl)Cl,,,,,,
2348,92349,2-Methoxy-4-(oxiranylmethyl)phenol,COC1=C(C=CC(=C1)CC2CO2)O,,,,,,
2349,92350,Myclozolin,CC1(C(=O)N(C(=O)O1)C2=CC(=CC(=C2)Cl)Cl)COC,,,,,,
2350,92351,"1,3,7-Trichloronaphthalene",C1=CC(=CC2=C(C=C(C=C21)Cl)Cl)Cl,,,,,,
2351,92352,"1,3-Dibutyl-1-nitrosourea",CCCCNC(=O)N(CCCC)N=O,,,,,,
2352,92353,"3,5-Dichloro-2-methoxyphenol",COC1=C(C=C(C=C1Cl)Cl)O,,,,,,
2353,92354,Methyl 2-chloro-5-[2-chloro-4-(trifluoromethyl)phenoxy]benzoate,COC(=O)C1=C(C=CC(=C1)OC2=C(C=C(C=C2)C(F)(F)F)Cl)Cl,,,,,,
2354,92355,"3,4-Dibromonitrosopiperidine",C1CN(CC(C1Br)Br)N=O,,,,,,
2355,92356,"1,2,3,4,5,6-Hexachlorocyclohexene",C1(C(C(C(=C(C1Cl)Cl)Cl)Cl)Cl)Cl,,,,,,
2356,92357,"3-Chloro-4,4-dimethyl-2-oxazolidinone",CC1(COC(=O)N1Cl)C,,,,,,
2357,92358,"2,4,6-Tribromobiphenyl",C1=CC=C(C=C1)C2=C(C=C(C=C2Br)Br)Br,,,,,,
2358,92359,CID 92359,CC1=C(C=C(C=C1[N+](=O)[O-])N(O)O)N=O,,,,,,
2359,92360,"3,4-Dichloro-N-nitrosopyrrolidine",C1C(C(CN1N=O)Cl)Cl,,,,,,
2360,92361,6-Hydroxybentazone,CC(C)N1C(=O)C2=C(C=CC(=C2)O)NS1(=O)=O,,,,,,
2361,92362,"1H-2,1,3-Benzothiadiazin-4(3H)-one, 8-hydroxy-3-(1-methylethyl)-, 2,2-dioxide",CC(C)N1C(=O)C2=C(C(=CC=C2)O)NS1(=O)=O,,,,,,
2362,92363,"N-(2,4-Dimethylphenyl)formamide",CC1=CC(=C(C=C1)NC=O)C,,,,,,
2363,92364,Diphenyliodonium hexafluoroarsenate(1-),C1=CC=C(C=C1)[I+]C2=CC=CC=C2.[F-].[F-].[F-].[F-].[F-].[F-].[As+5],,,,,,
2364,92365,Cyometrinil,C1=CC=C(C=C1)C(=NOCC#N)C#N,,,,,,
2365,92366,L-Flamprop-isopropyl,C[C@@H](C(=O)OC(C)C)N(C1=CC(=C(C=C1)F)Cl)C(=O)C2=CC=CC=C2,,,,,,
2366,92367,"1,3-Diethyltriazene",CCNN=NCC,,,,,,
2367,92368,Trimelamol,CN(CO)C1=NC(=NC(=N1)N(C)CO)N(C)CO,,,,,,
2368,92369,Ethyl diphenylethane,CCC1=CC=C(C=C1)CCC2=CC=CC=C2,,,,,,
2369,92370,2-(tert-Butylazo)-5-methylhexan-2-ol,CC(C)CCC(C)(N=NC(C)(C)C)O,,,,,,
2370,92371,"1,2,3,4,5-Pentachloro-6-(2,3,4-trichlorophenoxy)benzene",C1=CC(=C(C(=C1OC2=C(C(=C(C(=C2Cl)Cl)Cl)Cl)Cl)Cl)Cl)Cl,,,,,,
2371,92372,"3,5-Dimethyl-1-nitrosopiperidine",CC1CC(CN(C1)N=O)C,,,,,,
2372,92373,"3,9-Dimethylphenanthrene",CC1=CC2=C(C=C1)C=C(C3=CC=CC=C32)C,,,,,,
2373,92374,"2,5-Diaminoanisole sulfate",COC1=C(C=CC(=C1)N)N.OS(=O)(=O)O,,,,,,
2374,92375,CID 92375,CC(C)(C)[N+](=O)C=C1C=CN(C=C1)[O-],,,,,,
2375,92376,"1-Nitroso-3,5-dimethylpiperazine",CC1CN(CC(N1)C)N=O,,,,,,
2376,92377,4-(Diethylamino)benzaldehyde diphenylhydrazone,CCN(CC)C1=CC=C(C=C1)C=NN(C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
2377,92378,"5-Ethyl-5-(2-methylbutyl)-1,3-bis(oxiranylmethyl)imidazolidine-2,4-dione",CCC(C)CC1(C(=O)N(C(=O)N1CC2CO2)CC3CO3)CC,,,,,,
2378,92379,"2,2',4-Trichlorodiphenyl ether",C1=CC=C(C(=C1)OC2=C(C=C(C=C2)Cl)Cl)Cl,,,,,,
2379,92380,"3-Octanone, 6-hydroxy-2,2,7,7-tetramethyl-5-(1H-1,2,4-triazol-1-yl)-, (5R,6R)-rel-",CC(C)(C)[C@@H]([C@H](CC(=O)C(C)(C)C)N1C=NC=N1)O,,,,,,
2380,92381,N-Methyldeoxynojirimycin,CN1C[C@@H]([C@H]([C@@H]([C@H]1CO)O)O)O,,,"['Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)', 'Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)', 'Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)']",,,
2381,92382,"tert-Decanoic acid, oxiranylmethyl ester",CC(C)(C)CCCCCC(=O)OCC1CO1,,,,,,
2382,92383,Pyrazoxyfen,CC1=NN(C(=C1C(=O)C2=C(C=C(C=C2)Cl)Cl)OCC(=O)C3=CC=CC=C3)C,,,,,,
2383,92384,"2,2',3,3',4,4'-Hexachlorodiphenyl ether",C1=CC(=C(C(=C1OC2=C(C(=C(C=C2)Cl)Cl)Cl)Cl)Cl)Cl,,,,,,
2384,92385,"2,2',3,3',4,4',5-Heptachlorodiphenyl ether",C1=CC(=C(C(=C1OC2=CC(=C(C(=C2Cl)Cl)Cl)Cl)Cl)Cl)Cl,,,,,,
2385,92386,"2-Propenoic acid, 3-(4-methoxyphenyl)-, 3-methylbutyl ester",CC(C)CCOC(=O)C=CC1=CC=C(C=C1)OC,,,,,,
2386,92387,2-Methyl-4'-(methylthio)-2-morpholinopropiophenone,CC(C)(C(=O)C1=CC=C(C=C1)SC)N2CCOCC2,,,,,,
2387,92388,"alpha-Nitro-2-furanacrylic acid, methyl ester",COC(=O)C(=CC1=CC=CO1)[N+](=O)[O-],,,,,,
2388,92389,Aclonifen,C1=CC=C(C=C1)OC2=C(C(=C(C=C2)[N+](=O)[O-])N)Cl,,,,,,
2389,92390,"1H-Imidazole-1-acetamide, N,N-bis(2-hydroxyethyl)-2-nitro-",C1=CN(C(=N1)[N+](=O)[O-])CC(=O)N(CCO)CCO,,,,,,
2390,92391,"2,2',3,4',5,6'-Hexachlorobiphenyl",C1=C(C=C(C(=C1C2=C(C=C(C=C2Cl)Cl)Cl)Cl)Cl)Cl,,,,,,
2391,92392,"2,2',3,4,4',6,6'-Heptachlorobiphenyl",C1=C(C=C(C(=C1Cl)C2=C(C(=C(C=C2Cl)Cl)Cl)Cl)Cl)Cl,,,,,,
2392,92393,"3-Butenoic acid, 2,2,3,4,4-pentachloro-, butyl ester",CCCCOC(=O)C(C(=C(Cl)Cl)Cl)(Cl)Cl,,,,,,
2393,92394,N-Nitroso-2-methylmorpholine,CC1COCCN1N=O,,,,,,
2394,92395,Fluoroglycofen,C1=CC(=C(C=C1C(F)(F)F)Cl)OC2=CC(=C(C=C2)[N+](=O)[O-])C(=O)OCC(=O)O,,,,,,
2395,92396,Tetcyclacis,C1[C@@H]2[C@H]3[C@@H]([C@H]1[C@H]4[C@@H]2N=NN4C5=CC=C(C=C5)Cl)N=N3,,,,,,
2396,92397,"9-Methyl-2h-furo[2,3-h]chromen-2-one",CC1=COC2=C1C3=C(C=C2)C=CC(=O)O3,,,,,,
2397,92398,Morpholinyl doxorubicin,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N6CCOCC6)O,,,,,,
2398,92399,"Benzene, 1,3,4-trichloro-2-methyl-5-(1-methylethyl)-",CC1=C(C=C(C(=C1Cl)Cl)C(C)C)Cl,,,,,,
2399,92400,Zofenopril,C[C@H](CSC(=O)C1=CC=CC=C1)C(=O)N2C[C@H](C[C@H]2C(=O)O)SC3=CC=CC=C3,,,"['A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility. (See all compounds classified as Angiotensin-Converting Enzyme Inhibitors.)', 'Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)']",,,
2400,92401,Inabenfide,C1=CC=C(C=C1)C(C2=C(C=CC(=C2)Cl)NC(=O)C3=CC=NC=C3)O,,,,,,
2401,92402,"5-Isoxazolamine, 3-(1-ethyl-1-methylpropyl)-",CCC(C)(CC)C1=NOC(=C1)N,,,,,,
2402,92403,Pentan-3-yl nitrate,CCC(CC)O[N+](=O)[O-],,,,,,
2403,92404,"3-Hexanol, nitrate",CCCC(CC)O[N+](=O)[O-],,,,,,
2404,92405,"Ethyl 6,10-dimethyl-7-oxo-4-(phenylmethyl)-8-oxa-5,11-dithia-4,6,9-triazadodec-9-enoate",CCOC(=O)CCN(CC1=CC=CC=C1)SN(C)C(=O)ON=C(C)SC,,,,,,
2405,92406,"(3S)-1-(4-chlorophenyl)-4,4-dimethyl-2-(1,2,4-triazol-1-yl)pent-1-en-3-ol",CC(C)(C)[C@@H](C(=CC1=CC=C(C=C1)Cl)N2C=NC=N2)O,,,,,,
2406,92407,"2,2',3,4,4',5,5'-Heptachlorodiphenyl ether",C1=C(C(=CC(=C1Cl)Cl)Cl)OC2=CC(=C(C(=C2Cl)Cl)Cl)Cl,,,,,,
2407,92408,"1,2,3,4,5-Pentachloro-6-(2,4,5-trichlorophenoxy)benzene",C1=C(C(=CC(=C1Cl)Cl)Cl)OC2=C(C(=C(C(=C2Cl)Cl)Cl)Cl)Cl,,,,,,
2408,92409,"N-(4,4-Diphenyl-3-butenyl)nipecotic acid",C1CC(CN(C1)CCC=C(C2=CC=CC=C2)C3=CC=CC=C3)C(=O)O,,,"['Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)', 'Substances used for their pharmacological actions on GABAergic systems. GABAergic agents include agonists, antagonists, degradation or uptake inhibitors, depleters, precursors, and modulators of receptor function. (See all compounds classified as GABA Agents.)']",,,
2409,92410,2-{4-[3-(2-Chloro-9H-thioxanthen-9-ylidene)propyl]piperazin-1-yl}ethyl acetate,CC(=O)OCCN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,,,,,,
2410,92411,"1,3-Dipropyl-8-(2-amino-4-chlorophenyl)xanthine",CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C3=C(C=C(C=C3)Cl)N,,,['Compounds that bind to and block the stimulation of ADENOSINE A1 RECEPTORS. (See all compounds classified as Adenosine A1 Receptor Antagonists.)'],,,
2411,92412,"2,3,3',4,4'-Pentachlorodiphenyl ether",C1=CC(=C(C=C1OC2=C(C(=C(C=C2)Cl)Cl)Cl)Cl)Cl,,,,,,
2412,92413,"(1S,7S,10S,13S,16S)-24-methoxy-10-[(4-methoxyphenyl)methyl]-4,7,9,13,15,29-hexamethyl-22-oxa-3,6,9,12,15,29-hexazatetracyclo[14.12.2.218,21.123,27]tritriaconta-18,20,23,25,27(31),32-hexaene-2,5,8,11,14,30-hexone",C[C@H]1C(=O)N([C@H]2CC3=CC=C(C=C3)OC4=C(C=CC(=C4)C[C@@H](C(=O)NC(C(=O)N[C@H](C(=O)N([C@H](C(=O)N1)CC5=CC=C(C=C5)OC)C)C)C)N(C2=O)C)OC)C,,,,,,
2413,92414,Flumiclorac,C1CCC2=C(C1)C(=O)N(C2=O)C3=CC(=C(C=C3F)Cl)OCC(=O)O,,,,,,
2414,92415,"Acetic acid, (((1-(5-(2-chloro-4-(trifluoromethyl)phenoxy)-2-nitrophenyl)ethylidene)amino)oxy)-, methyl ester",CC(=NOCC(=O)OC)C1=C(C=CC(=C1)OC2=C(C=C(C=C2)C(F)(F)F)Cl)[N+](=O)[O-],,,,,,
2415,92416,Triadimenol A,CC(C)(C)[C@H]([C@@H](N1C=NC=N1)OC2=CC=C(C=C2)Cl)O,,,,,,
2416,92417,2-Hydroxymethyl-N-nitrosothiazolidine,C1CSC(N1N=O)CO,,,,,,
2417,92418,"Propanoic acid, 2-(4-((6-chloro-2-quinoxalinyl)oxy)phenoxy)-, (2S)-",C[C@@H](C(=O)O)OC1=CC=C(C=C1)OC2=CN=C3C=C(C=CC3=N2)Cl,,,,,,
2418,92419,"3,3',4,4',5-Pentachlorodiphenyl ether",C1=CC(=C(C=C1OC2=CC(=C(C(=C2)Cl)Cl)Cl)Cl)Cl,,,,,,
2419,92420,Cinosulfuron,COCCOC1=CC=CC=C1S(=O)(=O)NC(=O)NC2=NC(=NC(=N2)OC)OC,,,,,,
2420,92421,Trinexapac-ethyl,CCOC(=O)C1CC(=O)C(=C(C2CC2)O)C(=O)C1,,,,,,
2421,92422,2-Hydroxypropanoic acid aluminium salt,CC(C(=O)[O-])O.CC(C(=O)[O-])O.CC(C(=O)[O-])O.[Al+3],,,,,,
2422,92423,ethyl (2S)-2-{4-[(6-chloroquinoxalin-2-yl)oxy]phenoxy}propanoate,CCOC(=O)[C@H](C)OC1=CC=C(C=C1)OC2=CN=C3C=C(C=CC3=N2)Cl,,,,,,
2423,92424,"4,4'-Methylenebis(2,6-dimethylphenylcyanate)",CC1=CC(=CC(=C1OC#N)C)CC2=CC(=C(C(=C2)C)OC#N)C,,,,,,
2424,92425,Flumioxazin,C#CCN1C(=O)COC2=CC(=C(C=C21)N3C(=O)C4=C(C3=O)CCCC4)F,,,"['Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)']","['/In rats after oral dose/ GI tract absorption >90% at 1 mg/kg & up to 50% at 100 mg/kg. At least 97% recovery in feces & urine 7 days after dosing. Highest levels of residues (36-49 ppb) in blood cells at low dose & 2800-3000 ppb at high dose (RBC levels > plasma). In addition to untransformed parent, 7 metabolites identified in urine & feces (38-46% for low dose & about 71% at high dose).', '/Rat/ males dosed with suspension of 50 /Valor/ WDG formulation in water at 0.02, 0.20 or 1.0 mg/rat (0.002, 0.020 or 0.100 sq cm. At 0.02 mg/rat, absorption ranged from 0.48% at 0.5 hr to 5.46% at 24 hr. At 0.2 mg/rat, absorption ranged from 0.007% at 0.5 hr to 0.74% at 24 hr. At 1.0 mg/rat, absorption ranged from 0.004% at 0.5 hr to 10.47% at 24 hr. Females dosed with 200 or 800 mg/kg b.w. Dermal absorption for 200 & 800 mg/kg was 3.9 & 8.0% by 48 hr after initiation of treatment for 6 hr. Blood levels at 6-24 hr after dermal dosing with 200 mg/kg were similar to those obtained at 2-6 hr after oral dosing with 1 mg/kg. Blood levels at 6-24 hr after dermal dosing with 800 mg/kg were similar to those obtained at 2-6 hr after oral dosing with 30 mg/kg.']",,
2425,92426,"1,2,3,4,6,7,8,9-Octabromo-dibenzofuran",C12=C(C(=C(C(=C1Br)Br)Br)Br)OC3=C2C(=C(C(=C3Br)Br)Br)Br,,,,,,
2426,92427,Aluminum maltolate,CC1=C(C(=O)C=CO1)[O-].CC1=C(C(=O)C=CO1)[O-].CC1=C(C(=O)C=CO1)[O-].[Al+3],,,,,,
2427,92428,"2,2',4,4',6-Pentachlorodiphenyl ether",C1=CC(=C(C=C1Cl)Cl)OC2=C(C=C(C=C2Cl)Cl)Cl,,,,,,
2428,92429,"1,2,3,4-Tetrabromodibenzo-p-dioxin",C1=CC=C2C(=C1)OC3=C(O2)C(=C(C(=C3Br)Br)Br)Br,,,,,,
2429,92430,Silafluofen,CCOC1=CC=C(C=C1)[Si](C)(C)CCCC2=CC(=C(C=C2)F)OC3=CC=CC=C3,,,,,,
2430,92431,Clodinafop-Propargyl,C[C@H](C(=O)OCC#C)OC1=CC=C(C=C1)OC2=C(C=C(C=N2)Cl)F,,,,"['Clodinafop-propargyl is rapidly and for at least for 75% absorbed in males (based on radiolabel recovered in urine, tissues, cage wash and residual carcass) within 168 hours. Oral absorption in females is higher (> or = 92%). The excretion is also rapid, mainly in the urine. Total excretion after 168 hours is higher in females (92-96%) than in males (66-85%). It is widely distributed and the highest concentration was found in fat, muscle, liver, blood and kidneys. Residues were higher in males than in females. There was a potential for accumulation in fat. Elimination from ovaries, pancreas, thymus and thyroid was slow.']","['/In animals,/ hydrolyzed to the corresponding acid, which is excreted in urine and feces. ... In plants, rapidly degraded to the acid derivative as major metabolite.', 'In a rat metabolism study, two (14)C-labeled variants of clodinofop-propargyl (one labeled on the 2 pyridil carbon & the other uniformly labeled on the phenyl ring, purity >98%) were admin to groups of male Tif:RAI f (SPF) rats, approx 7 wk of age by gavage at concns of 25.2 mg/kg ( [2-14C]pyridil) & 24.6 mg/kg ([U-14C]phenyl). In the urine, the major metabolite was determined to be (R)-2-[4-(5-chloro-3-fluoro-2-pyridinyloxy)-phenoxy]-propionic acid, reference material CGA-193469, accounting for 36.7% to 39.1% of the admin dose (AD). Metabolite fraction U3 hydrolysed to yield fraction U7 (i.e., CGA-193469), when treated with NaOH or HCl. Unchanged clodinofop-propargyl was not identified. In the feces, the major metabolite (fraction F*7) corresponded to the urinary metabolite U7 (CGA 193469), accounting for 15.7% to 16.9% of the AD. Metabolite fraction F*8 was determined to be unchanged clodinofop-propargyl, accounting for 0.4% to 1.7% of the AD. In the fat, all metabolites were reportedly acylglycerides, the majority of which were hybrid di- & triacylglycerides, (i.e., approx 3.5% & 17.0% of the AD, respectively).', 'Clodinafop-propargyl is extensively metabolized (<0.3% remaining as clodinafop-propargyl). The major metabolites evident in the excreta were clodinafop (CGA 193469) and its taurine conjugate. The metabolites in fat were diacylglycerides and triacylglycerides of clodinafop.']",
2431,92432,Melanotan II,CCCC[C@@H](C(=O)N[C@H]1CC(=O)NCCCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)CC2=CN=CN2)CC3=CC=CC=C3)CCCN=C(N)N)CC4=CNC5=CC=CC=C54)C(=O)N)NC(=O)C,,,,,,
2432,92433,Imazosulfuron,COC1=CC(=NC(=N1)NC(=O)NS(=O)(=O)C2=C(N=C3N2C=CC=C3)Cl)OC,,,,"['Two test articles were used in this study: 1. [im-(14)C]imazosulfuon, specific activity 2.15 Gbq/mmol, radiochemical purity> 99.0% together with unlabeled imazosulfuron, purity = 98.6% and 2. [pm-(14)C]imazosulfuon, specific activity 2.04 Gbq/mmol, radiochemical purity> 98.6% together with unlabeled imazosulfuron, purity = 98.6%, each of which was suspended in 0.5% carboxymethyl cellulose in ultrapure water and administered in a single dose by gavage to 1 Crl:CD (SD) rat per sex. (14)C excretion into the expired air was negligible. Fecal and urine samples were collected at 1, 2, and 3 days after the administration of the dosing compounds. For [im-(14)C]imazosulfuon, 65.3% (male) and 69.0% (female) of radio-labeled dose was eliminated in the urine and 36.8% (male) and 31.8% (female) of the radio-labeled dose was eliminated in the feces 72 hours after dosing. For [pm- (14)C]imazosulfuon, 64.4% (male) and 57.9% (female) of radio-labeled dose was eliminated in the urine and 37.2% (male) and 40.1% (female) of the radio-labeled dose was eliminated in the feces 72 hours after dosing. Both [im-(14)C]imazosulfuon and [pm-(14)C]imazosulfuon were extensively metabolized. For [im-(14)C]imazosulfuon, metabolites HMS (54.6% of the dose in the male and 58.2% of the dose in the female) and IHDU (2.7% of the dose in the male and 4.3% of the dose in the female) were excreted in the urine 24 hours after dosing and metabolites HMS (6.9% of the dose in the male and 5.6% of the dose in the female), IHDU (0.8% of the dose in male and 0.3% of the dose in female), and ACIS (6.0% of the dose in the male and 4.3% of the dose in the female) were excreted in the feces 48 hours after dosing. For [pm-(14)C]imazosulfuon, metabolites HMS (50.3% of the dose in the male and 47.8% of the dose in the female) and IHDU (5.1% of the dose in the male and 3.1% of the dose in the female) were excreted in the urine 24 hours after dosing and metabolites HMS (5.3% of the dose in the male and 13.4% of the dose in the female), IHDU (0.7% of the dose in the male and 0.5% of the dose in the female), and UK-1 (3.8% of the dose in the male and 4.0% of the dose in the female) were excreted in the feces 48 hours after dosing. From the identified metabolites, metabolic reactions were determined to be demethylation, hydroxylation of the pyrimidine ring, opening of the pyrimidine ring, and hydrolysis of the sulfonylurea bridge.', '[im-(14)C]Imazosulfuron (specific activity 2.15 Gbq/mmol, radiochemical purity> 99.0%) together with unlabeled imazosulfuron (purity = 98.6%) was suspended in 0.5% carboxymethyl cellulose in ultrapure water and administered in a single dose by gavage to 4 male Crl:CD (SD) rats. Fecal and urine samples were collected at 6 and 12 hours (urine only), and 24, 48, and 72 hours after the administration. 64.1% of radio-labeled dose was eliminated in the urine and 32.4% of the radio-labeled dose was eliminated in the feces 72 hours after dosing. The highest mean tissue concentrations of the radio-labeled dose were found in the carcass (0.15%), blood (0.04%), and liver (0.04%). [Imidazopyridinyl-3-(14)C] Imazosulfuron was extensively metabolized. Metabolites HMS (55.7% of the dose), IHDU (4.1% of the dose), and HDS (1.9% of the dose) were excreted in the urine 48 hours after dosing. Metabolites HMS (6.5% of the dose), IHDU (0.4% of the dose), HDS (2.3% of the dose), IPSN (2.9% of the dose, from extracts 1 and 3), and ACIS (3.2% of the dose from extracts 1 and 3) were excreted in the feces 48 hours after dosing. From the identified metabolites, metabolic reactions were determined to be demethylation, hydroxylation, methylation of the hydroxyl group, opening of the pyrimidine ring, and hydrolysis of the sulfonylurea bridge.', '[im-(14)C]Imazosulfuron (specific activity 2.15 Gbq/mmol, radiochemical purity> 99.0%) together with unlabeled imazosulfuron (purity = 98.6%) was suspended in 0.5% carboxymethyl cellulose in ultrapure water and administered in a single dose by gavage to 3 bile duct-cannulated male Crl:CD (SD) rats. Feces, bile, and urine samples were collected at 6 and 12 hours (urine and bile only), and 24, 48, and 72 days after the administration of the dosing material. 53.4% and 30.5% of the radio-labeled dose was eliminated in the urine and bile, respectively, 12 hours after dosing and 66.0%, 33.8%, and 1.9% of the radio-labeled dose was eliminated in the urine, bile, and feces, respectively, 24 hours after dosing. After 72 hours, 66.4%, 34.0%, 2.4%, and 0.3% of the of the radio-labeled dose had been found in the urine, bile, feces, and residual carcass, respectively. [Imidazopyridinyl-3-(14)C] Imazosulfuron was extensively metabolized. Metabolites HMS (56.9% of the dose), IHDU (4.9% of the dose), and HDS (0.5% of the dose) were excreted in the urine 24 hours after dosing. Metabolites HMS (3.8% of the dose), IHDU-glu (5.2% of the dose), HDS (1.6% of the dose), and ACIS (1.1% of the dose) were excreted in the bile 24 hours after dosing. Metabolite HMS (0.8% of the dose) was excreted in the feces 24 hours after dosing. From the identified metabolites, metabolic reactions determined to have occurred were demethylation, hydroxylation of the pyrimidine ring, methylation or glucuronidation of hydroxyl group, and opening of the pyrimidine ring and formation of guanidine.']","['Two test articles were used in this study: 1. [im-(14)C]imazosulfuon, specific activity 2.15 Gbq/mmol, radiochemical purity> 99.0% together with unlabeled imazosulfuron, purity = 98.6% and 2. [pm-(14)C]imazosulfuon, specific activity 2.04 Gbq/mmol, radiochemical purity> 98.6% together with unlabeled imazosulfuron, purity = 98.6%, each of which was suspended in 0.5% carboxymethyl cellulose in ultrapure water and administered in a single dose by gavage to 1 Crl:CD (SD) rat per sex. (14)C excretion into the expired air was negligible. Fecal and urine samples were collected at 1, 2, and 3 days after the administration of the dosing compounds. For [im-(14)C]imazosulfuon, 65.3% (male) and 69.0% (female) of radio-labeled dose was eliminated in the urine and 36.8% (male) and 31.8% (female) of the radio-labeled dose was eliminated in the feces 72 hours after dosing. For [pm- (14)C]imazosulfuon, 64.4% (male) and 57.9% (female) of radio-labeled dose was eliminated in the urine and 37.2% (male) and 40.1% (female) of the radio-labeled dose was eliminated in the feces 72 hours after dosing. Both [im-(14)C]imazosulfuon and [pm-(14)C]imazosulfuon were extensively metabolized. For [im-(14)C]imazosulfuon, metabolites HMS (54.6% of the dose in the male and 58.2% of the dose in the female) and IHDU (2.7% of the dose in the male and 4.3% of the dose in the female) were excreted in the urine 24 hours after dosing and metabolites HMS (6.9% of the dose in the male and 5.6% of the dose in the female), IHDU (0.8% of the dose in male and 0.3% of the dose in female), and ACIS (6.0% of the dose in the male and 4.3% of the dose in the female) were excreted in the feces 48 hours after dosing. For [pm-(14)C]imazosulfuon, metabolites HMS (50.3% of the dose in the male and 47.8% of the dose in the female) and IHDU (5.1% of the dose in the male and 3.1% of the dose in the female) were excreted in the urine 24 hours after dosing and metabolites HMS (5.3% of the dose in the male and 13.4% of the dose in the female), IHDU (0.7% of the dose in the male and 0.5% of the dose in the female), and UK-1 (3.8% of the dose in the male and 4.0% of the dose in the female) were excreted in the feces 48 hours after dosing. From the identified metabolites, metabolic reactions were determined to be demethylation, hydroxylation of the pyrimidine ring, opening of the pyrimidine ring, and hydrolysis of the sulfonylurea bridge.', '[im- (14)C]imazosulfuron (specific activity 2.15 Gbq/mmol, radiochemical purity> 99.0%) together with unlabeled imazosulfuron (purity = 98.6%) was suspended in 0.5% carboxymethyl cellulose in ultrapure water and administered in a single dose by gavage to 4 male Crl:CD (SD) rats. Fecal and urine samples were collected at 6 and 12 hours (urine only), and 24, 48, and 72 days after the administration. 64.1% of radio-labeled dose was eliminated in the urine and 32.4% of the radio-labeled dose was eliminated in the feces 72 hours after dosing. The highest mean tissue concentrations of the radio-labeled dose were found in the carcass (0.15%), blood (0.04%), and liver (0.04%). [Imidazopyridinyl-3-(14)C] Imazosulfuron was extensively metabolized. Metabolites HMS (55.7% of the dose), IHDU (4.1% of the dose), and HDS (1.9% of the dose) were excreted in the urine 48 hours after dosing. Metabolites HMS (6.5% of the dose), IHDU (0.4% of the dose), HDS (2.3% of the dose), IPSN (2.9% of the dose, from extracts 1 and 3), and ACIS (3.2% of the dose from extracts 1 and 3) were excreted in the feces 48 hours after dosing. From the identified metabolites, metabolic reactions were determined to be demethylation, hydroxylation, methylation of the hydroxyl group, opening of the pyrimidine ring, and hydrolysis of the sulfonylurea bridge.', '[im-(14)C]Imazosulfuron (specific activity 2.15 Gbq/mmol, radiochemical purity> 99.0%) together with unlabeled imazosulfuron (purity = 98.6%) was suspended in 0.5% carboxymethyl cellulose in ultrapure water and administered in a single dose by gavage to 3 bile duct-cannulated male Crl:CD (SD) rats. Feces, bile, and urine samples were collected at 6 and 12 hours (urine and bile only), and 24, 48, and 72 hours after the administration of the dosing material. 53.4% and 30.5% of the radio-labeled dose was eliminated in the urine and bile, respectively, 12 hours after dosing and 66.0%, 33.8%, and 1.9% of the radio-labeled dose was eliminated in the urine, bile, and feces, respectively, 24 hours after dosing. After 72 hours, 66.4%, 34.0%, 2.4%, and 0.3% of the of the radio-labeled dose had been found in the urine, bile, feces, and residual carcass, respectively. [Imidazopyridinyl-3-(14)C] Imazosulfuron was extensively metabolized. Metabolites HMS (56.9% of the dose), IHDU (4.9% of the dose), and HDS (0.5% of the dose) were excreted in the urine 24 hours after dosing. Metabolites HMS (3.8% of the dose), IHDU-glu (5.2% of the dose), HDS (1.6% of the dose), and ACIS (1.1% of the dose) were excreted in the bile 24 hours after dosing. Metabolite HMS (0.8% of the dose) was excreted in the feces 24 hours after dosing. From the identified metabolites, metabolic reactions determined to have occurred were demethylation, hydroxylation of the pyrimidine ring, methylation or glucuronidation of hydroxyl group, and opening of the pyrimidine ring and formation of guanidine.']",
2433,92434,Triflusulfuron-methyl,CC1=C(C(=CC=C1)C(=O)OC)S(=O)(=O)NC(=O)NC2=NC(=NC(=N2)OCC(F)(F)F)N(C)C,,,,,,
2434,92435,"Morpholine, 4-[[2-(5-nitro-2-thienyl)-4-thiazolyl]methyl]-",C1COCCN1CC2=CSC(=N2)C3=CC=C(S3)[N+](=O)[O-],,,,,,
2435,92436,"Thiazole, 2-(5-nitro-2-thienyl)-4-pyrrolidinylmethyl-, hydrochloride",C1CCN(C1)CC2=CSC(=N2)C3=CC=C(S3)[N+](=O)[O-].Cl,,,,,,
2436,92437,"2-(5-Nitrothiophen-2-yl)-4-(pyrrolidin-1-ylmethyl)-1,3-thiazole",C1CCN(C1)CC2=CSC(=N2)C3=CC=C(S3)[N+](=O)[O-],,,,,,
2437,92438,"4-Thiazolecarboxylic acid, 2-(5-nitro-2-thienyl)-",C1=C(SC(=C1)[N+](=O)[O-])C2=NC(=CS2)C(=O)O,,,,,,
2438,92439,2-Cyclohexylpiperidine,C1CCC(CC1)C2CCCCN2,,,,,,
2439,92440,"Acetamide, N-[2-[(2,6-dicyano-4-nitrophenyl)azo]-5-(dipropylamino)phenyl]-",CCCN(CCC)C1=CC(=C(C=C1)N=NC2=C(C=C(C=C2C#N)[N+](=O)[O-])C#N)NC(=O)C,,,,,,
2440,92441,"2-(3-Butoxypropyl)-10-chlorobenzimidazo[2,1-b]benzo[lmn][3,8]phenanthroline-1,3,6(2h)-trione",CCCCOCCCN1C(=O)C2=C3C(=CC=C4C3=C(C=C2)C5=NC6=C(N5C4=O)C=CC(=C6)Cl)C1=O,,,,,,
2441,92442,"10-chloro-2-(3-methoxypropyl)benzimidazo[2,1-b]benzo[lmn][3,8]phenanthroline-1,3,6(2H)-trione",COCCCN1C(=O)C2=C3C(=CC=C4C3=C(C=C2)C5=NC6=C(N5C4=O)C=CC(=C6)Cl)C1=O,,,,,,
2442,92443,Dibutyltin;octanoic acid;hydrate,CCCCCCCC(=O)O.CCCCCCCC(=O)O.CCCC[Sn]CCCC.CCCC[Sn]CCCC.O,,,,,,
2443,92444,"1,6-Methano-1H-indene, 2,3,3a,4,5,7-hexachloro-3a,6,7,7a-tetrahydro-, (1R,3aR,6S,7S,7aR)-rel-",C1[C@H]2C3C([C@@H]1C(=C(C3(C(=C2Cl)Cl)Cl)Cl)Cl)Cl,,,,,,
2444,92445,"Bis(2,2-dimethoxyethyl)amine",COC(CNCC(OC)OC)OC,,,,,,
2445,92446,"Acetamide, N-[2-[(2-bromo-4,6-dinitrophenyl)azo]-5-(diethylamino)-4-methoxyphenyl]-",CCN(CC)C1=C(C=C(C(=C1)NC(=O)C)N=NC2=C(C=C(C=C2Br)[N+](=O)[O-])[N+](=O)[O-])OC,,,,,,
2446,92447,Triisononanoin,CC(CC(=O)OCC(COC(=O)CC(C)CC(C)(C)C)OC(=O)CC(C)CC(C)(C)C)CC(C)(C)C,,,,,,
2447,92448,4-decanoyl-5-methyl-2-phenyl-1H-pyrazol-3-one;nickel,CCCCCCCCCC(=O)C1=C(NN(C1=O)C2=CC=CC=C2)C.CCCCCCCCCC(=O)C1=C(NN(C1=O)C2=CC=CC=C2)C.[Ni],,,,,,
2448,92449,1-(5-Hydroxy-3-methyl-1-phenyl-1H-pyrazol-4-yl)-1-decanone,CCCCCCCCCC(=O)C1=C(NN(C1=O)C2=CC=CC=C2)C,,,,,,
2449,92450,"Methylenebis((2-methyl-4,1-cyclohexanediyl)iminocarbonyloxy(1-methyl-2,1-ethanediyl)) diacrylate",CC1CC(CCC1NC(=O)OCC(C)OC(=O)C=C)CC2CCC(C(C2)C)NC(=O)OCC(C)OC(=O)C=C,,,,,,
2450,92451,"1(2H)-Pyrimidinecarboxamide, 5-fluoro-3,4-dihydro-2,4-dioxo-N-phenyl-",C1=CC=C(C=C1)NC(=O)N2C=C(C(=O)NC2=O)F,,,,,,
2451,92452,1-Methylcarbamoyl-5-fluorouracil,CNC(=O)N1C=C(C(=O)NC1=O)F,,,,,,
2452,92453,"Ethyl 4,4-diethoxy-2-(ethoxymethylene)-3-oxopentanoate",CCOC=C(C(=O)C(C)(OCC)OCC)C(=O)OCC,,,,,,
2453,92454,2-Methyl-6-(1-methylpropyl)naphthalene,CCC(C)C1=CC2=C(C=C1)C=C(C=C2)C,,,,,,
2454,92455,2-Methyl-7-(1-methylpropyl)naphthalene,CCC(C)C1=CC2=C(C=CC(=C2)C)C=C1,,,,,,
2455,92456,"Phosphoric acid, isodecyl ester",CC(C)CCCCCCCO.OP(=O)(O)O,,,,,,
2456,92457,"Trideca-7,11-dienyl acetate",CC=CCCC=CCCCCCCOC(=O)C,,,,,,
2457,92458,Dec-5-en-1-ol,CCCCC=CCCCCO,,,,,,
2458,92459,"1,2-Benzenedicarboxylic acid, 4,4'-carbonylbis-, potassium salt (1:4)",C1=CC(=C(C=C1C(=O)C2=CC(=C(C=C2)C(=O)[O-])C(=O)[O-])C(=O)[O-])C(=O)[O-].[K+].[K+].[K+].[K+],,,,,,
2459,92460,"2-ethyl-3-(nitromethylidene)-3a,4,5,6,7,7a-hexahydro-1H-isoindole",CCN1CC2CCCCC2C1=C[N+](=O)[O-],,,,,,
2460,92461,2-Ethyloctahydro-1H-isoindol-1-one,CCN1CC2CCCCC2C1=O,,,,,,
2461,92462,"1,6-Diamino-7H-benz(de)anthracen-7-one",C1=CC=C2C(=C1)C3=C(C=CC4=C3C(=C(C=C4)N)C2=O)N,,,,,,
2462,92463,Isothiocyanatocyclopropane,C1CC1N=C=S,,,,,,
2463,92464,Bis(aminomethyl)norbornane,C1CC2CC1C(C2CN)CN,,,,,,
2464,92465,3-Nitro-5-sulphosalicylic acid,C1=C(C=C(C(=C1C(=O)O)O)[N+](=O)[O-])S(=O)(=O)O,,,,,,
2465,92466,2-Amino-2-phenylethanol,C1=CC=C(C=C1)C(CO)N,,,,,,
2466,92467,1-(4-Hydroxyphenyl)piperazine,C1CN(CCN1)C2=CC=C(C=C2)O,,,,,['1-(4-hydroxyphenyl)piperazine is a known human metabolite of 1-(4-methoxyphenyl)piperazine.'],
2467,92468,"1,1'-Azobis(1-methylethyl) dipropionate",CCC(=O)OC(C)(C)N=NC(C)(C)OC(=O)CC,,,,,,
2468,92469,2-Ethyloctahydro-1H-isoindole-1-methylamine,CCN1CC2CCCCC2C1CN,,,,,,
2469,92470,"2-Naphthalenesulfonic acid, 1,4-dihydro-1,4-dioxo-, ammonium salt",C1=CC=C2C(=C1)C(=O)C=C(C2=O)S(=O)(=O)[O-].[NH4+],,,,,,
2470,92471,"1,4-Dioxonaphthalene-2-sulfonic acid",C1=CC=C2C(=C1)C(=O)C=C(C2=O)S(=O)(=O)O,,,,,,
2471,92472,N-(N-Formyl-L-alpha-aspartyl)-3-phenyl-L-alanine,C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC=O,,,,,,
2472,92473,"4-Cyano-2,6-diiodophenyl heptanoate",CCCCCCC(=O)OC1=C(C=C(C=C1I)C#N)I,,,,,,
2473,92474,"Propanenitrile, 3-(dodecyloxy)-",CCCCCCCCCCCCOCCC#N,,,,,,
2474,92475,CID 92475,CCCCCCCCCC(=O)O.CCCCCCCCCC(=O)O.O.[AlH3],,,,,,
2475,92476,CID 92476,CCCCCCCCCCCCCC(=O)O.CCCCCCCCCCCCCC(=O)O.O.[AlH3],,,,,,
2476,92477,"Ethanethiol, 2-hydroxytrimethylenediiminodi-, dihydrogen phosphorothioate (1:2)",C(CSP(=O)(O)O)NCC(CNCCSP(=O)(O)O)O,,,,,,
2477,92478,"Phosphorothioic acid, S-(2-(3-(2-hydroxyethylamino)propylamino)ethyl) ester",C(CNCCO)CNCCSP(=O)(O)O,,,,,,
2478,92479,s-{3-[(3-Aminopropyl)amino]-2-hydroxypropyl} dihydrogen phosphorothioate,C(CN)CNCC(CSP(=O)(O)O)O,,,,,,
2479,92480,Titanyl o-hydroxybenzoate,C1=CC=C(C(=C1)C(=O)[O-])O.C1=CC=C(C(=C1)C(=O)[O-])O.O=[Ti+2],,,,,,
2480,92481,CID 92481,CCC=C[C@@H]1[C@@H](C1(C)C)C(=O)Cl,,,,,,
2481,92482,Dimethyl 3-hydroxy-3-methylglutarate,CC(CC(=O)OC)(CC(=O)OC)O,,,,,,
2482,92483,"Prop-2-enoic acid,3-(5-bromo-2-furyl)-2-cyano-,methyl ester",COC(=O)C(=CC1=CC=C(O1)Br)C#N,,,,,,
2483,92484,"Hexanoic acid, 3,5,5-trimethyl-, chromium(3+) salt",CC(CC(=O)[O-])CC(C)(C)C.[Cr+3],,,,,,
2484,92485,2-Benzyl-3-methylpyridine,CC1=C(N=CC=C1)CC2=CC=CC=C2,,,,,,
2485,92486,"17-Hydroxy-16beta-methylpregna-1,4,9(11)-triene-3,20-dione 21-(ethylcarbonate)",CCOC(=O)OCC(=O)[C@]1([C@H](C[C@@H]2[C@@]1(CC=C3[C@H]2CCC4=CC(=O)C=C[C@@]43C)C)C)O,,,,,,
2486,92487,1-(Methyloctadecylamino)propan-2-ol,CCCCCCCCCCCCCCCCCCN(C)CC(C)O,,,,,,
2487,92488,"2-Naphthalenesulfonic acid, 6-amino-4-hydroxy-5-[[4-[[[4-[(4-hydroxyphenyl)azo]phenyl]amino]carbonyl]phenyl]azo]-",C1=CC(=CC=C1C(=O)NC2=CC=C(C=C2)N=NC3=CC=C(C=C3)O)N=NC4=C(C=CC5=CC(=CC(=C54)O)S(=O)(=O)O)N,,,,,,
2488,92489,"(2-Chloro-1,1,2,2-tetrafluoroethoxy)trifluoroethylene",C(=C(F)F)(OC(C(F)(F)Cl)(F)F)F,,,,,,
2489,92490,"1,3-Bis(2-ethylhexyl)hexahydro-5-methyl-5-nitropyrimidine",CCCCC(CC)CN1CC(CN(C1)CC(CC)CCCC)(C)[N+](=O)[O-],,,,,,
2490,92491,"2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-3,6-dimethyl-, hydrochloride",C[C@]12CCN([C@H](C1)CC3=C2C=C(C=C3)O)C.Cl,,,,,,
2491,92492,"(1S,9R)-1,10-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol",C[C@]12CCN([C@H](C1)CC3=C2C=C(C=C3)O)C,,,,,,
2492,92493,Tetradecyl chloroformate,CCCCCCCCCCCCCCOC(=O)Cl,,,,,,
2493,92494,"3,5-Dichloro-4-methoxyphenol",COC1=C(C=C(C=C1Cl)O)Cl,,,,,,
2494,92495,2-Methoxypropionyl chloride,CC(C(=O)Cl)OC,,,,,,
2495,92496,"1-(2,3,6-Trimethylphenyl)-2-buten-1-one",CC=CC(=O)C1=C(C=CC(=C1C)C)C,,,,,,
2496,92497,4-Acetoxy-3-methoxybenzoyl chloride,CC(=O)OC1=C(C=C(C=C1)C(=O)Cl)OC,,,,,,
2497,92498,"2,2'-(Methylimino)dipropanol",CC(CO)N(C)C(C)CO,,,,,,
2498,92499,Einecs 260-339-7,CC1=CC=C(C=C1)S(=O)(=O)NC(CCCC(=O)N[C@]2([C@@H]3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)OCOC)OC)C(=O)OCOC,,,,,,
2499,92500,"2,6-Dinitro-N-(2-nitrophenyl)aniline",C1=CC=C(C(=C1)NC2=C(C=CC=C2[N+](=O)[O-])[N+](=O)[O-])[N+](=O)[O-],,,,,,
2500,92501,"2,6-Dinitro-N-(4-nitrophenyl)aniline",C1=CC(=C(C(=C1)[N+](=O)[O-])NC2=CC=C(C=C2)[N+](=O)[O-])[N+](=O)[O-],,,,,,
2501,92502,"Deca-2,4-dienyl 3-methylbutanoate",CCCCCC=CC=CCOC(=O)CC(C)C,,,,,,
2502,92503,Vestitol,COC1=CC(=C(C=C1)C2CC3=C(C=C(C=C3)O)OC2)O,,,,,,
2503,92504,4-(2-Cyclohexylphenoxy)aniline,C1CCC(CC1)C2=CC=CC=C2OC3=CC=C(C=C3)N,,,,,,
2504,92505,4-(o-Tolyloxy)aniline,CC1=CC=CC=C1OC2=CC=C(C=C2)N,,,,,,
2505,92506,"4,4,13,13-Tetraethoxy-3,14-dioxa-8,9-dithia-4,13-disilahexadecane",CCO[Si](CCCSSCCC[Si](OCC)(OCC)OCC)(OCC)OCC,,,,,,
2506,92507,"4,4,14,14-Tetraethoxy-3,15-dioxa-8,9,10-trithia-4,14-disilaheptadecane",CCO[Si](CCCSSSCCC[Si](OCC)(OCC)OCC)(OCC)OCC,,,,,,
2507,92508,"1,1'-{[3-(Triethoxysilyl)propyl]imino}bis(3-chloropropan-2-ol)",CCO[Si](CCCN(CC(CCl)O)CC(CCl)O)(OCC)OCC,,,,,,
2508,92509,"beta-2'-Hydroxy-6-ethyl-9-methyl-6,7-benzomorphan hydrochloride",CC[C@]12CCN([C@H](C1C)CC3=C2C=C(C=C3)O)C.Cl,,,,,,
2509,92510,"(1S,9S)-1-ethyl-10,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol",CC[C@]12CCN([C@H](C1C)CC3=C2C=C(C=C3)O)C,,,,,,
2510,92511,"2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-3,6-dimethyl-11-alpha-ethyl-, hydrochloride",CCC1[C@@H]2CC3=C([C@]1(CCN2C)C)C=C(C=C3)O.Cl,,,,,,
2511,92512,"(1S,9S)-13-ethyl-1,10-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol",CCC1[C@@H]2CC3=C([C@]1(CCN2C)C)C=C(C=C3)O,,,,,,
2512,92513,CID 92513,CC(C)CCCC(C)CC[N+]1(CCCCC1)CC=C.[Br-],,,,,,
2513,92514,Piproctanyl,CC(C)CCCC(C)CC[N+]1(CCCCC1)CC=C,,,,,,
2514,92515,2-((4-(2-Methoxyethyl)phenoxy)methyl)oxirane,COCCC1=CC=C(C=C1)OCC2CO2,,,,,,
2515,92516,4-(2-Methoxyethyl)phenol,COCCC1=CC=C(C=C1)O,,,,,,
2516,92517,"1,2-Propanediol, 3-chloro-, phosphate",C(C(CCl)O)O.OP(=O)(O)O,,,,,,
2517,92518,Phenylglyoxylic acid hydrazide-2-acetylhydrazone,CC(=O)NN=C(C1=CC=CC=C1)C(=O)NN,,,,,,
2518,92519,"4,4-Diphenylbutan-1-ol",C1=CC=C(C=C1)C(CCCO)C2=CC=CC=C2,,,,,,
2519,92520,"9,10-Dichloro-12-(phosphonooxy)octadecanoic acid",CCCCCCC(CC(C(CCCCCCCC(=O)O)Cl)Cl)OP(=O)(O)O,,,,,,
2520,92521,"Calcium propionate, hydrate",CCC(=O)[O-].CCC(=O)[O-].O.[Ca+2],,,,,,
2521,92522,"2-Propenoic acid, 2-methyl-, (1-methylethylidene)bis(4,1-phenyleneoxy-2,1-ethanediyloxy-2,1-ethanediyloxy-2,1-ethanediyl) ester",CC(=C)C(=O)OCCOCCOCCOC1=CC=C(C=C1)C(C)(C)C2=CC=C(C=C2)OCCOCCOCCOC(=O)C(=C)C,,,,,,
2522,92523,"(1-Methylethylidene)bis(4,1-phenyleneoxy-2,1-ethanediyloxy-2,1-ethanediyl) bismethacrylate",CC(=C)C(=O)OCCOCCOC1=CC=C(C=C1)C(C)(C)C2=CC=C(C=C2)OCCOCCOC(=O)C(=C)C,,,,,,
2523,92524,"3-Acetoxy-2,2,6-trimethyl-6-vinyltetrahydropyran",CC(=O)OC1CCC(OC1(C)C)(C)C=C,,,,,,
2524,92525,"Pyrocatechol, 4-methyl-3,5,6-tribromo-",CC1=C(C(=C(C(=C1Br)Br)O)O)Br,,,,,,
2525,92526,"Decanamide, N-[2-[(2-hydroxyethyl)amino]ethyl]-",CCCCCCCCCC(=O)NCCNCCO,,,,,,
2526,92527,"(1,2,3-Tribromopropyl)benzene",C1=CC=C(C=C1)C(C(CBr)Br)Br,,,,,,
2527,92528,Diphenyllead;propanoic acid,CCC(=O)O.CCC(=O)O.C1=CC=C(C=C1)[Pb]C2=CC=CC=C2,,,,,,
2528,92529,4-Aminophthalonitrile,C1=CC(=C(C=C1N)C#N)C#N,,,,,,
2529,92530,"1,2,3-Cyclopentanetriol",C1CC(C(C1O)O)O,,,,,,
2530,92531,Tetraethylammonium heptadecafluorooctanesulphonate,CC[N+](CC)(CC)CC.C(C(C(C(C(F)(F)S(=O)(=O)[O-])(F)F)(F)F)(F)F)(C(C(C(F)(F)F)(F)F)(F)F)(F)F,,,,,,
2531,92532,"Benzenamine, N-ethyl-N-(2-methoxyethyl)-3-methyl-",CCN(CCOC)C1=CC=CC(=C1)C,,,,,,
2532,92533,Einecs 260-381-6,C(CN(CC(=O)[O-])CC(=O)[O-])N(CCO)CC(=O)[O-].[Na+].[Mn+2],,,,,,
2533,92534,"3-(2,5-Dimethoxyphenyl)-1-propene",COC1=CC(=C(C=C1)OC)CC=C,,,,,,
2534,92535,4-Benzyl Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)OCC2=CC=CC=C2)CO)O,,,,,,
2535,92536,"Zirconium, tetrakis(2-methyl-2-phenylpropyl)-",CC(C)([CH2-])C1=CC=CC=C1.CC(C)([CH2-])C1=CC=CC=C1.CC(C)([CH2-])C1=CC=CC=C1.CC(C)([CH2-])C1=CC=CC=C1.[Zr+4],,,,,,
2536,92537,Hexadec-7-enal,CCCCCCCCC=CCCCCCC=O,,,,,,
2537,92538,"9,10-Anthracenedione, 1,4-bis(dimethylamino)-",CN(C)C1=C2C(=C(C=C1)N(C)C)C(=O)C3=CC=CC=C3C2=O,,,,,,
2538,92539,DL-1-Acetyl-5-oxoproline,CC(=O)N1C(CCC1=O)C(=O)O,,,,,,
2539,92540,"Phosphoric acid, hexadecyl diphenyl ester",CCCCCCCCCCCCCCCCOP(=O)(OC1=CC=CC=C1)OC2=CC=CC=C2,,,,,,
2540,92541,Tricetyl phosphate,CCCCCCCCCCCCCCCCOP(=O)(OCCCCCCCCCCCCCCCC)OCCCCCCCCCCCCCCCC,,,,,,
2541,92542,"Tridecyl alcohol, phosphate ester",CCCCCCCCCCCCCO.OP(=O)(O)O,,,,,,
2542,92543,3-Methyl-4-phenylbutan-2-ol,CC(CC1=CC=CC=C1)C(C)O,,,,,,
2543,92544,"Benzenamine, 4-isononyl-N-phenyl-",CC(C)CCCCCCC1=CC=C(C=C1)NC2=CC=CC=C2,,,,,,
2544,92545,"3-Pyridinecarbonitrile, 5-[(2-cyanophenyl)azo]-2,6-bis[(2-methoxyethyl)amino]-4-methyl-",CC1=C(C(=NC(=C1N=NC2=CC=CC=C2C#N)NCCOC)NCCOC)C#N,,,,,,
2545,92546,"Acetamide, N-(2-methoxy-5-methyl-4-nitrophenyl)-",CC1=CC(=C(C=C1[N+](=O)[O-])OC)NC(=O)C,,,,,,
2546,92547,Diisooctyl phenyl phosphate,CC(C)CCCCCOP(=O)(OCCCCCC(C)C)OC1=CC=CC=C1,,,,,,
2547,92548,Trimethoxy(3-thiocyanatopropyl)silane,CO[Si](CCCSC#N)(OC)OC,,,,,,
2548,92549,Ethyl furan-3-propionate,CCOC(=O)CCC1=COC=C1,,,,,,
2549,92550,"3-(2,2-Dichlorovinyl)-2,2-dimethylcyclopropanecarboxylic anhydride",CC1(C(C1C(=O)OC(=O)C2C(C2(C)C)C=C(Cl)Cl)C=C(Cl)Cl)C,,,,,,
2550,92551,"3-(Difluoromethoxy)-1,1,1,2,2-pentafluoropropane",C(C(C(F)(F)F)(F)F)OC(F)F,,,,,,
2551,92552,"2-Propenal, 3-[3-methoxy-4-(methoxymethoxy)phenyl]-, (E)-",COCOC1=C(C=C(C=C1)C=CC=O)OC,,,,,,
2552,92553,Methyl (isobutyl)carbamate,CC(C)CNC(=O)OC,,,,,,
2553,92554,"2-Azido-N,N-dimethylpropionamide",CC(C(=O)N(C)C)N=[N+]=[N-],,,,,,
2554,92555,"4-Isoxazolecarboxaldehyde, 2,5-dihydro-2-methyl-5-oxo-3-phenyl-",CN1C(=C(C(=O)O1)C=O)C2=CC=CC=C2,,,,,,
2555,92556,Tetraacetylglucosamine mustard,CC(=O)OCC1[C@H](C([C@H](C(O1)OC(=O)C)N(CCCl)CCCl)OC(=O)C)OC(=O)C,,,,,,
2556,92557,"1,2,3,4,7,7-Hexachloro-5-(2,4,6-tribromophenyl)bicyclo[2.2.1]hept-2-ene",C1C(C2(C(=C(C1(C2(Cl)Cl)Cl)Cl)Cl)Cl)C3=C(C=C(C=C3Br)Br)Br,,,,,,
2557,92558,2-Isopropyl-5-methoxypyrazine,CC(C)C1=CN=C(C=N1)OC,,,,,,
2558,92559,"4-{4-[(e)-(2-Methoxy-5-{[2-(sulfooxy)ethyl]sulfonyl}phenyl)diazenyl]-3-methyl-5-oxo-4,5-dihydro-1h-pyrazol-1-yl}benzenesulfonic acid",CC1=NN(C(=O)C1N=NC2=C(C=CC(=C2)S(=O)(=O)CCOS(=O)(=O)O)OC)C3=CC=C(C=C3)S(=O)(=O)O,,,,,,
2559,92560,1-(3-Chloropropyl)-2-methyl-5-nitro-1H-imidazole,CC1=NC=C(N1CCCCl)[N+](=O)[O-],,,,,,
2560,92561,"Pentanamide, N-[2-chloro-5-[(hexadecylsulfonyl)amino]phenyl]-4,4-dimethyl-3-oxo-2-[4-[[4-(phenylmethoxy)phenyl]sulfonyl]phenoxy]-",CCCCCCCCCCCCCCCCS(=O)(=O)NC1=CC(=C(C=C1)Cl)NC(=O)C(C(=O)C(C)(C)C)OC2=CC=C(C=C2)S(=O)(=O)C3=CC=C(C=C3)OCC4=CC=CC=C4,,,,,,
2561,92562,"Benzoic acid, 4-[1-[[[2-chloro-5-[[4-(2,4-dipentylphenoxy)-1-oxobutyl]amino]phenyl]amino]carbonyl]-3,3-dimethyl-2-oxobutoxy]-",CCCCCC1=CC(=C(C=C1)OCCCC(=O)NC2=CC(=C(C=C2)Cl)NC(=O)C(C(=O)C(C)(C)C)OC3=CC=C(C=C3)C(=O)O)CCCCC,,,,,,
2562,92563,"4,7-Methano-1H-indene-5-methanol, octahydro-, (3aR,4R,5S,7R,7aR)-rel-",C1C[C@@H]2[C@H](C1)[C@@H]3C[C@H]2C[C@H]3CO,,,,,,
2563,92564,"1-(4-Hydroxy-2,6,6-trimethylcyclohexen-1-yl)but-2-en-1-one",CC=CC(=O)C1=C(CC(CC1(C)C)O)C,,,,,,
2564,92565,1-(3-Hydroxyphenyl)-2-[methyl(phenylmethyl)amino]ethan-1-one,CN(CC1=CC=CC=C1)CC(=O)C2=CC(=CC=C2)O,,,,,,
2565,92566,"Benzoic acid, 5-[[4-[[[4-[[2,6-diamino-3-methyl-5-[(4-sulfophenyl)azo]phenyl]azo]phenyl]amino]carbonyl]phenyl]azo]-2-hydroxy-",CC1=CC(=C(C(=C1N)N=NC2=CC=C(C=C2)NC(=O)C3=CC=C(C=C3)N=NC4=CC(=C(C=C4)O)C(=O)O)N)N=NC5=CC=C(C=C5)S(=O)(=O)O,,,,,,
2566,92567,4-Chlorotoluene-3-sulphonic acid,CC1=CC(=C(C=C1)Cl)S(=O)(=O)O,,,,,,
2567,92568,"1-(1-Phenylethyl)-4-(1-(3,4-xylyl)ethyl)benzene",CC1=C(C=C(C=C1)C(C)C2=CC=C(C=C2)C(C)C3=CC=CC=C3)C,,,,,,
2568,92569,Pentyl 3-methyl-2-butenoate,CCCCCOC(=O)C=C(C)C,,,,,,
2569,92570,Isopentyl 3-methyl-2-butenoate,CC(C)CCOC(=O)C=C(C)C,,,,,,
2570,92571,Hex-2-en-1-yl pentanoate,CCCCC(=O)OCC=CCCC,,,,,,
2571,92572,trans-2-Hexenyl caproate (hexanoate),CCCCCC(=O)OCC=CCCC,,,,,,
2572,92573,cis-3-HEXENYLVALERATE,CCCCC(=O)OCCC=CCC,,,,,,
2573,92574,1-(1-Cyclohexenyl)-2-methylpropan-1-one,CC(C)C(=O)C1=CCCCC1,,,,,,
2574,92575,CID 92575,CC1(OC2C(OC(C2O1)N3C=NC4=C3NC=NC4=O)COC(C5=CC=CC=C5)(C6=CC=CC=C6)C7=CC=CC=C7)C,,,,,,
2575,92576,Disodium 8-hydroxy-7-[(6-sulphonato-2-naphthyl)azo]quinoline-5-sulphonate,C1=CC2=C(C=C(C(=C2N=C1)O)N=NC3=CC4=C(C=C3)C=C(C=C4)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+],,,,,,
2576,92577,8-Hydroxy-7-(6-sulfo-naphthalen-2-ylazo)-quinoline-5-sulfonic acid,C1=CC2=C(C=C(C(=C2N=C1)O)N=NC3=CC4=C(C=C3)C=C(C=C4)S(=O)(=O)O)S(=O)(=O)O,,,,,,
2577,92578,CID 92578,C1=CC(=NCCO)C(=N)C=C1N(O)O,,,,,,
2578,92579,CID 92579,C1=CC(=NC(CO)(CO)CO)C(=N)C=C1N(O)O,,,,,,
2579,92580,"9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 21-hexanoate",CCCCCC(=O)OCC(=O)[C@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)F)O)C)C)O,,,,,,
2580,92581,"9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 21-nonanoate",CCCCCCCCC(=O)OCC(=O)[C@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)F)O)C)C)O,,,,,,
2581,92582,Methyl 14-methylhexadec-8-enoate,CCC(C)CCCCC=CCCCCCCC(=O)OC,,,,,,
2582,92583,"4,7-Methano-1H-indene-5-methanol, octahydro-, (3aR,4R,5R,7R,7aR)-rel-",C1C[C@@H]2[C@H](C1)[C@@H]3C[C@H]2C[C@@H]3CO,,,,,,
2583,92584,9-Chloro-7H-benzo[de]anthracen-7-one,C1=CC2=C3C(=C1)C4=C(C=C(C=C4)Cl)C(=O)C3=CC=C2,,,,,,
2584,92585,"1-(p-(alpha,alpha-Dimethylbenzyl)phenoxy)propan-2-ol",CC(COC1=CC=C(C=C1)C(C)(C)C2=CC=CC=C2)O,,,,,,
2585,92586,(Dodecyl)ethyldimethylammonium p-(hexyloxy)benzoate,CCCCCCCCCCCC[N+](C)(C)CC.CCCCCCOC1=CC=C(C=C1)C(=O)[O-],,,,,,
2586,92587,2-Pent-2-enyloxirane,CCC=CCC1CO1,,,,,,
2587,92588,Pent-2-ynyloxirane,CCC#CCC1CO1,,,,,,
2588,92589,Dipotassium hexyl phosphate,CCCCCCOP(=O)([O-])[O-].[K+].[K+],,,,,,
2589,92590,Trichlorophloroglucinol,C1(=C(C(=C(C(=C1Cl)O)Cl)O)Cl)O,,,,,,
2590,92591,2-Chloro-6-hydroxybenzoic acid,C1=CC(=C(C(=C1)Cl)C(=O)O)O,,,,,,
2591,92592,"o-Benzoquinone, 3-chloro-",C1=CC(=O)C(=O)C(=C1)Cl,,,,,,
2592,92593,"Benzenesulfonamide, 3-[(5,8-dichloro-1-hydroxy-2-naphthalenyl)azo]-4-hydroxy-",C1=CC(=C(C=C1S(=O)(=O)N)N=NC2=C(C3=C(C=CC(=C3C=C2)Cl)Cl)O)O,,,,,,
2593,92594,"Benzenesulfonic acid, 5-chloro-2,4-dinitro-",C1=C(C(=CC(=C1[N+](=O)[O-])Cl)S(=O)(=O)O)[N+](=O)[O-],,,,,,
2594,92595,"Butanoic acid, 3-methyl-, 1-phenylethyl ester",CC(C)CC(=O)OC(C)C1=CC=CC=C1,,,,,,
2595,92596,"2,3,5-Trichlorobenzaldehyde",C1=C(C=C(C(=C1C=O)Cl)Cl)Cl,,,,,,
2596,92597,3-Chloro-4-methylquinoline,CC1=C(C=NC2=CC=CC=C12)Cl,,,,,,
2597,92598,"1,2-Dichloro-4-(dichloromethyl)benzene",C1=CC(=C(C=C1C(Cl)Cl)Cl)Cl,,,,,,
2598,92599,"2-Naphthalenecarboxylic acid, 4-chloro-3-hydroxy-",C1=CC=C2C(=C1)C=C(C(=C2Cl)O)C(=O)O,,,,,,
2599,92600,"4,5-Dichlorophthalic acid",C1=C(C(=CC(=C1Cl)Cl)C(=O)O)C(=O)O,,,,,,
2600,92601,5-Chloro-2-(2-chlorophenoxy)aniline,C1=CC=C(C(=C1)OC2=C(C=C(C=C2)Cl)N)Cl,,,,,,
2601,92602,"5-Chloro-2-(2,4-dichlorophenoxy)aniline",C1=CC(=C(C=C1Cl)N)OC2=C(C=C(C=C2)Cl)Cl,,,,,,
2602,92603,2-Chloro-4-nitro-1-phenoxybenzene,C1=CC=C(C=C1)OC2=C(C=C(C=C2)[N+](=O)[O-])Cl,,,,,,
2603,92604,CID 92604,CCCCCCCCCC1=CC(=C(C=C1)O)CN(C)CC(=O)[O-].[Na+],,,,,,
2604,92605,N-[(2-Hydroxy-5-nonylphenyl)methyl]-N-methylglycine,CCCCCCCCCC1=CC(=C(C=C1)O)CN(C)CC(=O)O,,,,,,
2605,92606,"1-(5,5-Dimethyl-1-cyclohexen-1-yl)-4-penten-1-one",CC1(CCC=C(C1)C(=O)CCC=C)C,,,,,,
2606,92607,"1-(3,5,5-Trimethyl-1-cyclohexen-1-yl)pent-4-en-1-one",CC1CC(CC(=C1)C(=O)CCC=C)(C)C,,,,,,
2607,92608,"1-(3,3,5-Trimethyl-1-cyclohexen-1-yl)pent-4-en-1-one",CC1CC(=CC(C1)(C)C)C(=O)CCC=C,,,,,,
2608,92609,CID 92609,CCC=CCCC(=O)C1=CCCC(C1)(C)C,,,,,,
2609,92610,"1-(5,5-Dimethyl-1-cyclohexen-1-yl)-3-methylpent-4-en-1-one",CC(CC(=O)C1=CCCC(C1)(C)C)C=C,,,,,,
2610,92611,CID 92611,CC(C)(CO)C(=O)[O-].[Na+],,,,,,
2611,92612,"1,3,5-Triazine-2,4,6-triamine, phosphate",C1(=NC(=NC(=N1)N)N)N.OP(=O)(O)O,,,,,,
2612,92613,"Tetrahydro-5-(2-hydroxyethyl)-1,3-bis(hydroxymethyl)-1,3,5-triazine-2(1H)-thione",C1N(CN(C(=S)N1CO)CO)CCO,,,,,,
2613,92614,"1,1'-(Tetradecylimino)dipropan-2-ol",CCCCCCCCCCCCCCN(CC(C)O)CC(C)O,,,,,,
2614,92615,"2,3,4,5,6,7,8,9,10,11,12,13-Dodecahydro-3-methyl-1H-cyclopent-1-ylcyclododecen-1-one",CC1CC(=O)C2=C1CCCCCCCCCC2,,,,,,
2615,92616,6-Nitro-2-phenylquinolin-4-ol,C1=CC=C(C=C1)C2=CC(=O)C3=C(N2)C=CC(=C3)[N+](=O)[O-],,,,,,
2616,92617,"Benzene, 1,3-dichloro-5-(3,3,3-trichloro-1-methylenepropyl)-",C=C(CC(Cl)(Cl)Cl)C1=CC(=CC(=C1)Cl)Cl,,,,,,
2617,92618,1-Vinyloctyl acetate,CCCCCCCC(C=C)OC(=O)C,,,,,,
2618,92619,Dipentaerythrityl valerate,CCCCC(=O)O.C(C(CO)(CO)COCC(CO)(CO)CO)O,,,,,,
2619,92620,"2-(2,2-Diethoxyethoxy)-1,1-diethoxyethane",CCOC(COCC(OCC)OCC)OCC,,,,,,
2620,92621,"1-Chloro-1-(4-chlorophenoxy)-3,3-dimethylbutan-2-one",CC(C)(C)C(=O)C(OC1=CC=C(C=C1)Cl)Cl,,,,,,
2621,92622,"8,10-Dodecadienol",CC=CC=CCCCCCCCO,,,,,,
2622,92623,2-((3-Iodopropin-2-yl)oxy)ethanol,C(COCC#CI)O,,,,,,
2623,92624,"2-(3,4-Dimethoxyphenyl)-1,3-dithiane 1,1,3,3-tetraoxide",COC1=C(C=C(C=C1)C2S(=O)(=O)CCCS2(=O)=O)OC,,,,,,
2624,92625,Methyl 3-chloro-4-hydroxyphenylacetate,COC(=O)CC1=CC(=C(C=C1)O)Cl,,,,,,
2625,92626,"2,6-Dibromo-4-ethylphenol",CCC1=CC(=C(C(=C1)Br)O)Br,,,,,,
2626,92627,4-Azidophenacyl bromide,C1=CC(=CC=C1C(=O)CBr)N=[N+]=[N-],,,['Biologically active molecules which are covalently bound to the enzymes or binding proteins normally acting on them. Binding occurs due to activation of the label by ultraviolet light. These labels are used primarily to identify binding sites on proteins. (See all compounds classified as Photoaffinity Labels.)'],,,
2627,92628,1-(2-Bromoacetyl)-4-(diazonioamino)benzene,C1=CC(=CC=C1C(=O)CBr)N[N+]#N,,,,,,
2628,92629,1-Tert-butoxy-2-propanol,CC(COC(C)(C)C)O,,,,"['Propylene glycol mono-t-butyl ether (PGMBE) is a widely used solvent in industry and in consumer products, posing a potential for human exposure via inhalation or dermal routes. Toxicokinetic studies were conducted on F344/N rats and B6C3F1 mice of both sexes to evaluate single or repeated dose, species, and/or sex differences in PGMBE elimination kinetics following intravenous or inhalation exposure. In the first study, rats and mice received a single intravenous dose of 15 or 200 mg PGMBE/kg and serial blood samples were collected and analyzed for PGMBE. In the second study, rats and mice received a single 6-h whole-body inhalation exposure to 75, 300, or 1200 ppm PGMBE and serial blood samples were collected and analyzed for PGMBE. In the third study, rats and mice received whole-body inhalation exposures to 75, 300, or 1200 ppm PGMBE for 6 h/day, 5 days/wk for 14 (rats) or 16 (mice) wk. Serial blood samples were analyzed for PGMBE after 2, 6, 14 (rats), and 16 (mice) wk on study. Urine samples were also collected for 16 h postexposure and analyzed for creatinine and PGMBE sulfate and PGMBE glucuronide conjugates. These studies revealed that: (1) PGMBE was eliminated from blood following concentration-dependent nonlinear kinetics in both species; (2) saturable Michaelis-Menten kinetics were clearly exhibited following a single inhalation exposure at 1200 ppm, but were less obvious following repeated exposures; (3) mice were more efficient in eliminating PGMBE from blood at lower exposure concentrations (i.e., < or = 300 ppm), but at exposure concentrations potentially exceeding their elimination capacity, mice had a greater concentration-dependent decrease in PGMBE elimination than rats; (4) there were minimal but consistent sex differences in PGMBE elimination profiles for rats, with females having higher blood concentrations at all exposure concentrations and sampling times; and (5) sex differences in PGMBE elimination were in part associated with differences in urinary excretion of PGMBE metabolites.', '...Propylene glycol mono-tert-butyl ether was found to be rapidly absorbed, metabolized, and excreted, largely within 24 hr via the urine, lungs (as carbon dioxide), and, to a lesser extent, the feces, after administration of a single oral dose to rats.']",['Urinary metabolites included sulfate and glucuronide conjugates of propylene glycol mono-tert-butyl ether and a small portion of parent compound.'],
2629,92630,"2-Buten-1-one, 1-(6,6-dimethyl-2-methylene-3-cyclohexen-1-yl)-",CC=CC(=O)C1C(=C)C=CCC1(C)C,,,,,,
2630,92631,"Cyclopentanone, 2-(2-pentynyl)-",CCC#CCC1CCCC1=O,,,,,,
2631,92632,"4-Hydroxy-alpha,alpha,4-trimethylcyclohex-2-ene-1-methanol",CC1(CCC(C=C1)C(C)(C)O)O,,,,,,
2632,92633,"Cuprate(1-), (3-((3-((4-(((4-((2-amino-4-hydroxyphenyl)azo)phenyl)amino)carbonyl)phenyl)azo)-2-(hydroxy-kappaO)-4-hydroxyphenyl)azo-kappaN1)-4-(hydroxy-kappaO)benzenesulfonato(3-))-, hydrogen",[H+].C1=CC(=CC=C1C(=O)NC2=CC=C(C=C2)N=NC3=C(C=C(C=C3)O)N)N=NC4=C(C=CC(=C4[O-])N=NC5=C(C=CC(=C5)S(=O)(=O)[O-])[O-])O.[Cu+2],,,,,,
2633,92634,CID 92634,C1=CC(=CC=C1C(=O)NC2=CC=C(C=C2)N=NC3=C(C=C(C=C3)O)N)NN=C4C(=O)C=CC(=NNC5=C(C=CC(=C5)S(=O)(=O)O)O)C4=O,,,,,,
2634,92635,N-[3-(Ethylamino)-4-methoxyphenyl]acetamide,CCNC1=C(C=CC(=C1)NC(=O)C)OC,,,,,,
2635,92636,2-Methyl-3-(methylthio)propionaldehyde,CC(CSC)C=O,,,,,,
2636,92637,"4,4'-Diaminotrityl alcohol",C1=CC=C(C=C1)C(C2=CC=C(C=C2)N)(C3=CC=C(C=C3)N)O,,,,,,
2637,92638,"6-tert-Butyl-4-isobutylideneamino-3-methylthio-1,2,4-triazin-5-one",CC(C)C=NN1C(=O)C(=NN=C1SC)C(C)(C)C,,,,,,
2638,92639,CID 92639,CCCCC(CC)COC(=O)CC[S-].CCCCC(CC)COC(=O)CC[S-].C[Sn]C,,,,,,
2639,92640,2-Ethylhexyl 3-mercaptopropionate,CCCCC(CC)COC(=O)CCS,,,,,,
2640,92641,"Tris(2,5,8,11-tetraoxatridecyl) orthoborate",B(OCCOCCOCCOCCOC)(OCCOCCOCCOCCOC)OCCOCCOCCOCCOC,,,,,,
2641,92642,"3-(Acetoxy)-7-chloro-5-(2-chlorophenyl)-1,3-dihydro-2H-pyrido[3,2-E]-1,4-diazepin-2-one",CC(=O)OC1C(=O)NC2=C(C(=N1)C3=CC=CC=C3Cl)N=C(C=C2)Cl,,,,,,
2642,92643,"n-[4-(2,3-Dihydroxypropoxy)phenyl]acetamide",CC(=O)NC1=CC=C(C=C1)OCC(CO)O,,,,,,
2643,92644,Methacryloxypropyl tris(methoxyethoxy)silane,CC(=C)C(=O)OCCC[Si](OCCOC)(OCCOC)OCCOC,,,,,,
2644,92645,"alpha,6,6-Trimethyl-2-methylenecyclohex-3-ene-1-propan-1-ol",CC(CCC1C(=C)C=CCC1(C)C)O,,,,,,
2645,92646,"3,7-Dimethyl-2-octenal",CC(C)CCCC(=CC=O)C,,,,,,
2646,92647,"5-((1,3-Diethyl-1,3-dihydro-2H-benzimidazol-2-ylidene)ethylidene)-1,3-diethyldihydro-2-thioxo-1H,5H-pyrimidine-4,6-dione",CCN1C2=CC=CC=C2N(C1=CC=C3C(=O)N(C(=S)N(C3=O)CC)CC)CC,,,,,,
2647,92648,Butyl metaborate,B(=O)OCCCC,,,,,,
2648,92649,8-Acetylthiomenthan-3-one,CC1CCC(C(=O)C1)C(C)(C)SC(=O)C,,,,,,
2649,92650,S-(1-Methyl-1-(4-methyl-2-oxo-3-cyclohexen-1-yl)ethyl) ethanethioate,CC1=CC(=O)C(CC1)C(C)(C)SC(=O)C,,,,,,
2650,92651,"4-Decen-1-ol, (Z)-",CCCCCC=CCCCO,,,,,,
2651,92652,"exo-3,3-Dimethylbicyclo(2.2.1)heptane-2-carbaldehyde",CC1([C@@H]2CC[C@@H](C2)[C@H]1C=O)C,,,,,,
2652,92653,2-[N-hydroxy-C-(6-methylheptyl)carbonimidoyl]-5-methylphenol,CC1=CC(=C(C=C1)C(=NO)CCCCCC(C)C)O,,,,,,
2653,92654,Isononanoyl chloride,CC(C)CCCCCC(=O)Cl,,,,,,
2654,92655,Einecs 260-553-0,CC(COP(OC1=CC=CC=C1)OC2=CC=CC=C2)OC(C)COP(OC3=CC=CC=C3)OC4=CC=CC=C4,,,,,,
2655,92656,N-(Carboxyheptyl)maleimide,C1=CC(=O)N(C1=O)CCCCCCCC(=O)O,,,,,,
2656,92657,2-(3-Carboxyprop-2-enoylamino)-4-methylsulfanylbutanoic acid,CSCCC(C(=O)O)NC(=O)C=CC(=O)O,,,,,,
2657,92658,"6-(1-Cyclohexen-1-yl)-1,4-dioxaspiro(4.5)decane",C1CCC(=CC1)C2CCCCC23OCCO3,,,,,,
2658,92659,"1-Oxaspiro[5.5]undecan-4-ol, 4-methyl-",CC1(CCOC2(C1)CCCCC2)O,,,,,,
2659,92660,4-Hydroxyclonidine,C1CN=C(N1)NC2=C(C=C(C=C2Cl)O)Cl,,,,,,
2660,92661,4-Ethyl-2-heptyl-2-oxazoline-4-methanol,CCCCCCCC1=NC(CO1)(CC)CO,,,,,,
2661,92662,"4,4'-(1,2-Ethanediylbis(oxy))bis(3-chlorobenzoic) acid",C1=CC(=C(C=C1C(=O)O)Cl)OCCOC2=C(C=C(C=C2)C(=O)O)Cl,,,,,,
2662,92663,CID 92663,CCCCC(CC)COC(=O)CC[S-].CCCCC(CC)COC(=O)CC[S-].CCCCC(CC)COC(=O)CSC[Sn]C,,,,,,
2663,92664,[2-(2-Ethylhexoxy)-2-oxoethyl]sulfanylmethyl-methyltin,CCCCC(CC)COC(=O)CSC[Sn]C,,,,,,
2664,92665,"Benzoic acid, 4-((4-methoxyphenyl)azoxy)-",COC1=CC=C(C=C1)ON=NC2=CC=C(C=C2)C(=O)O,,,,,,
2665,92666,3-Methylhexahydrophthalic anhydride,CC1CCCC2C1C(=O)OC2=O,,,,,,
2666,92667,Pentaerythritol tris(3-(1-aziridinyl)propionate),C1CN1CCC(=O)OCC(CO)(COC(=O)CCN2CC2)COC(=O)CCN3CC3,,,,,,
2667,92668,"Ethanol, 2-[2-[[4-[(2-chloro-4,6-dinitrophenyl)azo]-1-naphthalenyl]amino]ethoxy]-, acetate (ester)",CC(=O)OCCOCCNC1=CC=C(C2=CC=CC=C21)N=NC3=C(C=C(C=C3Cl)[N+](=O)[O-])[N+](=O)[O-],,,,,,
2668,92669,"2-(2-((4-((2-Bromo-4,6-dinitrophenyl)azo)-1-naphthyl)amino)ethoxy)ethyl acetate",CC(=O)OCCOCCNC1=CC=C(C2=CC=CC=C21)N=NC3=C(C=C(C=C3Br)[N+](=O)[O-])[N+](=O)[O-],,,,,,
2669,92670,"Ethanol, 2-(2-((4-((2-chloro-4,6-dinitrophenyl)azo)-1-naphthalenyl)amino)ethoxy)-",C1=CC=C2C(=C1)C(=CC=C2N=NC3=C(C=C(C=C3Cl)[N+](=O)[O-])[N+](=O)[O-])NCCOCCO,,,,,,
2670,92671,"3-Phenyl-1,6,7,8,9,9a-hexahydro-2H-quinolizine",C1CCN2C=C(CCC2C1)C3=CC=CC=C3,,,,,,
2671,92672,"1,3-Diisopropylnaphthalene",CC(C)C1=CC2=CC=CC=C2C(=C1)C(C)C,,,,,,
2672,92673,4-Cyano-4'-dodecylbiphenyl,CCCCCCCCCCCCC1=CC=C(C=C1)C2=CC=C(C=C2)C#N,,,,,,
2673,92674,"[1,1'-Biphenyl]-4-carbonitrile, 4'-(dodecyloxy)-",CCCCCCCCCCCCOC1=CC=C(C=C1)C2=CC=C(C=C2)C#N,,,,,,
2674,92675,Einecs 260-577-1,CCCCCCCCOCC(C)NCCNCCNCCN,,,,,,
2675,92676,2-Phenylethyl oxoacetate,C1=CC=C(C=C1)CCOC(=O)C=O,,,,,,
2676,92677,3-Methyl-1-phenyl-buten-3-ol,CC(C)(C=CC1=CC=CC=C1)O,,,,,,
2677,92678,3-Hydroxy-2-(3-(morpholino)propyl)naphthalene-1-carboxamide,C1COCCN1CCCC2=C(C3=CC=CC=C3C=C2O)C(=O)N,,,,,,
2678,92679,1-Methoxyhexan-2-one,CCCCC(=O)COC,,,,,,
2679,92680,"5-Ethynyl-benzo[1,3]dioxole",C#CC1=CC2=C(C=C1)OCO2,,,,,,
2680,92681,1-Chloro-2-isothiocyanato-4-nitrobenzene,C1=CC(=C(C=C1[N+](=O)[O-])N=C=S)Cl,,,,,,
2681,92682,"2-(tert-Butyldioxy)-4,6-dimethoxy-1,3,5-triazine",CC(C)(C)OOC1=NC(=NC(=N1)OC)OC,,,,,,
2682,92683,"1,2-Ethanediamine, N-[2-[(1-methylethylidene)amino]ethyl]-N'-[2-[[2-[(1-methylethylidene)amino]ethyl]amino]ethyl]-",CC(=NCCNCCNCCNCCN=C(C)C)C,,,,,,
2683,92684,"Formaldehyde, polymer with benzenamine, hydrochloride",C1=CC(=C(C(=C1)C(=O)C2=CC=CC(=C2NCl)C=O)NCl)C=O,,,,,,
2684,92685,lambda2-Plumbanylidenelead;phthalate;hydrate,C1=CC=C(C(=C1)C(=O)[O-])C(=O)[O-].O.[Pb]=[Pb],,,,,,
2685,92686,Diplumbyne,[Pb]=[Pb],,,,,,
2686,92687,"3-Methoxyandrosta-3,5-dien-17-one",C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC=C4[C@@]3(CCC(=C4)OC)C,,,,,,
2687,92688,"2,3,5,6-Tetrabromo-p-xylene-alpha,alpha'-diyl diacetate",CC(=O)OCC1=C(C(=C(C(=C1Br)Br)COC(=O)C)Br)Br,,,,,,
2688,92689,"4,5-Dihydro-2-tridecyl-1H-imidazole-1-ethylamine",CCCCCCCCCCCCCC1=NCCN1CCN,,,,,,
2689,92690,"Benzenediazonium, 4,4'-(1,2-ethenediyl)bis[3-sulfo-, bis(inner salt)",C1=CC(=C(C=C1[N+]#N)S(=O)(=O)[O-])C=CC2=C(C=C(C=C2)[N+]#N)S(=O)(=O)[O-],,,,,,
2690,92691,Diisotridecylamine,CC(C)CCCCCCCCCCNCCCCCCCCCCC(C)C,,,,,,
2691,92692,N-((Dibutylamino)methyl)acrylamide,CCCCN(CCCC)CNC(=O)C=C,,,,,,
2692,92693,Benzyl L-argininate,C1=CC=C(C=C1)COC(=O)C(CCCN=C(N)N)N,,,,,,
2693,92694,Dipotassium 2-(dodec-11-en-1-yl)butanedioate,C=CCCCCCCCCCCC(CC(=O)[O-])C(=O)[O-].[K+].[K+],,,,,,
2694,92695,2-(11-Dodecenyl)succinic acid,C=CCCCCCCCCCCC(CC(=O)O)C(=O)O,,,,,,
2695,92696,5-Hydroxypentyl acrylate,C=CC(=O)OCCCCCO,,,,,,
2696,92697,"2,4,6-Triisopropylbenzoyl chloride",CC(C)C1=CC(=C(C(=C1)C(C)C)C(=O)Cl)C(C)C,,,,,,
2697,92698,5-Hexyl-2-(5-phenoxypentyl)pyrimidine,CCCCCCC1=CN=C(N=C1)CCCCCOC2=CC=CC=C2,,,,,,
2698,92699,5-Hexyl-2-(7-phenoxyheptyl)pyrimidine,CCCCCCC1=CN=C(N=C1)CCCCCCCOC2=CC=CC=C2,,,,,,
2699,92700,"Naphtho[1,2-d]thiazolium, 1-ethyl-2-[2-[(1-ethylnaphtho[1,2-d]thiazol-2(1H)-ylidene)methyl]-1-butenyl]-, iodide",CCC(=CC1=[N+](C2=C(S1)C=CC3=CC=CC=C32)CC)C=C4N(C5=C(S4)C=CC6=CC=CC=C65)CC.[I-],,,,,,
2700,92701,"2-[3-(1-Ethylnaphtho[1,2-d]thiazole-2-ylidene)-2-ethyl-1-propenyl]-1-ethylnaphtho[1,2-d]thiazole-1-ium",CCC(=CC1=[N+](C2=C(S1)C=CC3=CC=CC=C32)CC)C=C4N(C5=C(S4)C=CC6=CC=CC=C65)CC,,,,,,
2701,92702,CID 92702,C1=C(C=C(C(=C1O)O)O)C(=O)[O-].[Bi+3],,,,,,
2702,92703,N-(4-Chlorophenyl)-2-((4-methyl-2-nitrophenyl)azo)-3-oxobutyramide,CC1=CC(=C(C=C1)N=NC(C(=O)C)C(=O)NC2=CC=C(C=C2)Cl)[N+](=O)[O-],,,,,,
2703,92704,2-((4-Methyl-2-nitrophenyl)azo)-3-oxo-N-(p-tolyl)butyramide,CC1=CC=C(C=C1)NC(=O)C(C(=O)C)N=NC2=C(C=C(C=C2)C)[N+](=O)[O-],,,,,,
2704,92705,4-((1-(((2-Chlorophenyl)amino)carbonyl)-2-oxopropyl)azo)-3-nitrobenzenesulphonic acid,CC(=O)C(C(=O)NC1=CC=CC=C1Cl)N=NC2=C(C=C(C=C2)S(=O)(=O)O)[N+](=O)[O-],,,,,,
2705,92706,"4-((2-((4-Methyl-2-nitrophenyl)azo)-1,3-dioxobutyl)amino)benzenesulphonic acid",CC1=CC(=C(C=C1)N=NC(C(=O)C)C(=O)NC2=CC=C(C=C2)S(=O)(=O)O)[N+](=O)[O-],,,,,,
2706,92707,[2-[Ethyl[4-[(4-nitrophenyl)azo]phenyl]amino]ethyl]trimethylammonium chloride,CCN(CC[N+](C)(C)C)C1=CC=C(C=C1)N=NC2=CC=C(C=C2)[N+](=O)[O-].[Cl-],,,,,,
2707,92708,2-[N-ethyl-4-[(4-nitrophenyl)diazenyl]anilino]ethyl-trimethylazanium,CCN(CC[N+](C)(C)C)C1=CC=C(C=C1)N=NC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
2708,92709,Bis(pentabromophenyl) terephthalate,C1=CC=C(C(=C1)C(=O)OC2=C(C(=C(C(=C2Br)Br)Br)Br)Br)C(=O)OC3=C(C(=C(C(=C3Br)Br)Br)Br)Br,,,,,,
2709,92710,"Acetic acid, ((dimethoxyphosphinyl)thio)-, methyl ester",COC(=O)CSP(=O)(OC)OC,,,,,,
2710,92711,"1,2-Dimethyl-4-[1-[(1-phenylethyl)phenyl]ethyl]benzene",CC1=C(C=C(C=C1)C(C)(CCC2=CC=CC=C2)C3=CC=CC=C3)C,,,,,,
2711,92712,"2,6-Bis(6-methylheptyl)benzene-1,4-diol",CC(C)CCCCCC1=CC(=CC(=C1O)CCCCCC(C)C)O,,,,,,
2712,92713,"10-(3-(4-(2-Hydroxyethyl)piperidino)propyl)-7-methoxy-N,N-dimethyl-10H-phenothiazine-2-sulphonamide",CN(C)S(=O)(=O)C1=CC2=C(C=C1)SC3=C(N2CCCN4CCC(CC4)CCO)C=CC(=C3)OC,,,,,,
2713,92714,"Quinolinium, 1-ethyl-2-(ethylthio)-6-methyl-, iodide",CC[N+]1=C(C=CC2=C1C=CC(=C2)C)SCC.[I-],,,,,,
2714,92715,1-Ethyl-2-(ethylthio)-6-methylquinolinium,CC[N+]1=C(C=CC2=C1C=CC(=C2)C)SCC,,,,,,
2715,92716,Laudanosoline,CN1CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)O)O)O)O,,,,,,
2716,92717,"(R)-1-[(3,4-Dihydroxyphenyl)methyl]-1,2,3,4-tetrahydro-2-methylisoquinoline-6,7-diol",CN1CCC2=CC(=C(C=C2[C@H]1CC3=CC(=C(C=C3)O)O)O)O,,,,,,
2717,92718,Benz[a]anthracen-5-amine,C1=CC=C2C=C3C4=CC=CC=C4C(=CC3=CC2=C1)N,,,,,,
2718,92719,Norbinaltorphimine (nor-BNI),C1CC1CN2CC[C@]34[C@@H]5C6=C(C[C@]3([C@H]2CC7=C4C(=C(C=C7)O)O5)O)C8=C(N6)[C@H]9[C@@]12CCN([C@H]([C@@]1(C8)O)CC1=C2C(=C(C=C1)O)O9)CC1CC1,,,,,,
2719,92720,"(1S,2S,7S,8S,12S,20R,24R,32R)-11,33-bis(cyclopropylmethyl)-22-methyl-19,25-dioxa-11,22,33-triazaundecacyclo[24.9.1.18,14.01,24.02,32.04,23.05,21.07,12.08,20.030,36.018,37]heptatriaconta-4(23),5(21),14(37),15,17,26,28,30(36)-octaene-2,7,17,27-tetrol",CN1C2=C(C[C@]3([C@H]4CC5=C6[C@]3([C@H]2OC6=C(C=C5)O)CCN4CC7CC7)O)C8=C1[C@H]9[C@@]12CCN([C@H]([C@@]1(C8)O)CC1=C2C(=C(C=C1)O)O9)CC1CC1,,,,,,
2720,92721,Argatroban monohydrate,C[C@@H]1CCN([C@H](C1)C(=O)O)C(=O)[C@H](CCCN=C(N)N)NS(=O)(=O)C2=CC=CC3=C2NCC(C3)C.O,,,"['Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)', 'Endogenous factors and drugs that directly inhibit the action of THROMBIN, usually by blocking its enzymatic activity. They are distinguished from INDIRECT THROMBIN INHIBITORS, such as HEPARIN, which act by enhancing the inhibitory effects of antithrombins. (See all compounds classified as Antithrombins.)']","['Argatroban is excreted primarily in the feces, presumably through biliary secretion. In a study in which (14)C-argatroban (5 ug/kg/min) was infused for 4 hours into healthy subjects, approximately 65% of the radioactivity was recovered in the feces within 6 days of the start of infusion with little or no radioactivity subsequently detected. Approximately 22% of the radioactivity appeared in the urine within 12 hours of the start of infusion. Little or no additional urinary radioactivity was subsequently detected. Average percent recovery of unchanged drug, relative to total dose, was 16% in urine and at least 14% in feces.', 'It is not known if argatroban crosses the human placenta. the molecular weight (about 527 for the hydrated from), low metabolism, and moderate serum protein binding suggest that exposure of the embryo-fetus should be expected, especially sine the drug is given as a continuous infusion.', 'Argatroban distributes mainly in the extra cellular fluid as evidenced by an apparent steady-state volume of distribution of 174 mL/kg (12.18 L in a 70 kg adult). Argatroban is 54% bound to human serum proteins, with binding to albumin and a1 - acid glycoprotein being 20% and 34%, respectively.', '/MILK/ Argatroban is detected in rat milk.']","['The main route of argatroban metabolism is hydroxylation and aromatization of the 3-methyltetrahydroquinoline ring in the liver. The formation of each of the 4 known metabolites is catalyzed in vitro by the human liver microsomal cytochrome P450 enzymes CYP3A4/5. The primary metabolite (M1) exerts 3- to 5-fold weaker anticoagulant effects than argatroban. Unchanged argatroban is the major component in plasma. The plasma concentrations of M1 range between 0% and 20% of that of the parent drug. The other metabolites (M2 to M4) are found only in very low quantities in the urine and have not been detected in plasma or feces. These data, together with the lack of effect of erythromycin (a potent CYP3A4/5 inhibitor) on argatroban pharmacokinetics, suggest that CYP3A4/5-mediated metabolism is not an important elimination pathway in vivo.', 'Argatroban is metabolized principally by the liver via hydroxylation and aromatization of the 3-methyltetrahydroquinoline ring.']",['The terminal elimination half life is 39-51 minutes.']
2721,92722,Argatroban,C[C@@H]1CCN([C@H](C1)C(=O)O)C(=O)[C@H](CCCN=C(N)N)NS(=O)(=O)C2=CC=CC3=C2NCC(C3)C,"['Argatroban is indicated for prevention and treatment of thrombosis caused by heparin-induced thrombocytopenia (HIT). It is also indicated for use in patients with, or at risk for, HIT who are undergoing percutaneous coronary intervention.']","['Argatroban is a synthetic direct thrombin inhibitor derived from L-arginine indicated as an anticoagulant for prophylaxis or treatment of thrombosis in patients with heparin-induced thrombocytopenia. Argatroban is a direct thrombin inhibitor that reversibly binds to the thrombin active site. Argatroban does not require the co-factor antithrombin III for antithrombotic activity. Argatroban exerts its anticoagulant effects by inhibiting thrombin-catalyzed or -induced reactions, including fibrin formation; activation of coagulation factors V, VIII, and XIII; protein C; and platelet aggregation. Argatroban is highly selective for thrombin with an inhibitory constant (K<sub>i</sub>) of 0.04 &micro;M. At therapeutic concentrations, Argatroban has little or no effect on related serine proteases (trypsin, factor Xa, plasmin, and kallikrein). Argatroban is capable of inhibiting the action of both free and clot-associated thrombin.']","['Endogenous factors and drugs that directly inhibit the action of THROMBIN, usually by blocking its enzymatic activity. They are distinguished from INDIRECT THROMBIN INHIBITORS, such as HEPARIN, which act by enhancing the inhibitory effects of antithrombins. (See all compounds classified as Antithrombins.)', 'Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)']","['Bioavailability is 100% (intravenous).', 'Argatroban is excreted primarily in the feces (65%), presumably through biliary secretion; 22% is eliminated via urine.', '174 mL/kg', '5.1 L/kg/hr [infusion doses up to 40\xa0mcg/kg/min]', 'Argatroban is excreted primarily in the feces, presumably through biliary secretion. In a study in which (14)C-argatroban (5 ug/kg/min) was infused for 4 hours into healthy subjects, approximately 65% of the radioactivity was recovered in the feces within 6 days of the start of infusion with little or no radioactivity subsequently detected. Approximately 22% of the radioactivity appeared in the urine within 12 hours of the start of infusion. Little or no additional urinary radioactivity was subsequently detected. Average percent recovery of unchanged drug, relative to total dose, was 16% in urine and at least 14% in feces.', 'It is not known if argatroban crosses the human placenta. the molecular weight (about 527 for the hydrated from), low metabolism, and moderate serum protein binding suggest that exposure of the embryo-fetus should be expected, especially sine the drug is given as a continuous infusion.', 'Argatroban distributes mainly in the extra cellular fluid as evidenced by an apparent steady-state volume of distribution of 174 mL/kg (12.18 L in a 70 kg adult). Argatroban is 54% bound to human serum proteins, with binding to albumin and a1 - acid glycoprotein being 20% and 34%, respectively.', '/MILK/ Argatroban is detected in rat milk.']","['Liver via hydroxylation and aromatization of the 3-methyltetrahydroquinoline ring. Age and gender do not substantially affect the pharmacodynamic or pharmacokinetic profile of argatroban.', 'The main route of argatroban metabolism is hydroxylation and aromatization of the 3-methyltetrahydroquinoline ring in the liver. The formation of each of the 4 known metabolites is catalyzed in vitro by the human liver microsomal cytochrome P450 enzymes CYP3A4/5. The primary metabolite (M1) exerts 3- to 5-fold weaker anticoagulant effects than argatroban. Unchanged argatroban is the major component in plasma. The plasma concentrations of M1 range between 0% and 20% of that of the parent drug. The other metabolites (M2 to M4) are found only in very low quantities in the urine and have not been detected in plasma or feces. These data, together with the lack of effect of erythromycin (a potent CYP3A4/5 inhibitor) on argatroban pharmacokinetics, suggest that CYP3A4/5-mediated metabolism is not an important elimination pathway in vivo.', 'Argatroban is metabolized principally by the liver via hydroxylation and aromatization of the 3-methyltetrahydroquinoline ring.']","['39 and 51 minutes', 'The terminal elimination half life is 39-51 minutes.']"
2722,92723,"2,2,3,3-Tetramethylpentane",CCC(C)(C)C(C)(C)C,,,,,,
2723,92724,CID 92724,COC1=C(C(=NC=C1)CS(=O)C2NC3=C([N-]2)C=CC(=C3)OC(F)F)OC.[Na+],,,,,,
2724,92725,"5-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-2,3-dihydro-1H-benzimidazole",COC1=C(C(=NC=C1)CS(=O)C2NC3=C(N2)C=C(C=C3)OC(F)F)OC,,,,,,
2725,92726,CID 92726,C1=CC(=CC=C1C(=O)NCCC(=O)[O-])N=NC2=CC(=C(C=C2)O)C(=O)[O-].O.O.[Na+].[Na+],,,,,,
2726,92727,Lopinavir,CC1=C(C(=CC=C1)C)OCC(=O)N[C@@H](CC2=CC=CC=C2)[C@H](C[C@H](CC3=CC=CC=C3)NC(=O)[C@H](C(C)C)N4CCCNC4=O)O,"['The combination product lopinavir/ritonavir, marketed under the brand name Kaletra, is indicated in combination with other antiretrovirals for the treatment of HIV-1 infection in adults and pediatric patients 14 days old.']","['Lopinavir inhibits the activity of an enzyme critical for the HIV viral lifecycle. It has a moderate duration of action necessitating once or twice daily dosing. Lopinavir, like other protease inhibitors, has a propensity for participating in drug interactions - use caution when administering lopinavir to patients maintained on other pharmaceutical agents as pharmacodynamic and pharmacokinetic interactions are common. Fatal hepatotoxicity and pancreatitis have been noted in patients undergoing therapy with lopinavir and patients with an increased baseline risk of these events should be monitored closely throughout therapy.']","['Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP3A. (See all compounds classified as Cytochrome P-450 CYP3A Inhibitors.)', 'Inhibitors of HIV PROTEASE, an enzyme required for production of proteins needed for viral assembly. (See all compounds classified as HIV Protease Inhibitors.)']","['When administered alone, lopinavir has exceptionally low oral bioavailability (~25%) - for this reason, it is exclusively co-administered with ritonavir, which dramatically improves bioavailability, hinders drug metabolism, and allows for the attainment of therapeutic lopinavir concentrations. Following oral administration of lopinavir/ritonavir, maximal plasma concentrations are achieved at approximately 4.4 hours (T<sub>max</sub>), and the C<sub>max</sub> and AUC<sub>tau</sub> are 9.8  3.7 - 11.8  3.7 g/mL and 92.6  36.7 - 154.1  61.4 gh/mL, respectively.  Relative to administration in the fasted state, administration with a meal increases the AUC of the tablet formulation slightly (~19%) but dramatically increases the AUC of the oral solution formulation (~130%).', 'Lopinavir is primarily eliminated in the feces. Following oral administration, approximately 10.4  2.3% of the administered dose is excreted in the urine and 82.6  2.5% is excreted in the feces. Unchanged parent drug accounted for 2.2% and 19.8% of the administered dose in urine and feces, respectively.', 'The volume of distribution of lopinavir following oral administration is approximately 16.9 L.', 'The estimated apparent clearance following oral administration is approximately 6-7 L/h.', 'At steady state, lopinavir is approximately 98-99% bound to plasma proteins. Lopinavir binds to both alpha-1-acid glycoprotein (AAG) and albumin; however, it has a higher affinity for AAG. At steady state, lopinavir protein binding remains constant over the range of observed concentrations after 400/100 mg KALETRA twice daily, and is similar between healthy volunteers and HIV-1 positive patients.', 'In a pharmacokinetic study in HIV-1 positive subjects (n = 19), multiple dosing with 400/100 mg KALETRA twice daily with food for 3 weeks produced a mean  SD lopinavir peak plasma concentration (Cmax) of 9.8 + or - 3.7 ug/mL, occurring approximately 4 hours after administration. The mean steady-state trough concentration prior to the morning dose was 7.1 + or - 2.9 ug/mL and minimum concentration within a dosing interval was 5.5 + or - 2.7 ug/mL. Lopinavir AUC over a 12 hour dosing interval averaged 92.6 + or - 36.7 ug*h/mL. The absolute bioavailability of lopinavir co-formulated with ritonavir in humans has not been established. Under nonfasting conditions (500 kcal, 25% from fat), lopinavir concentrations were similar following administration of KALETRA co-formulated capsules and oral solution. When administered under fasting conditions, both the mean AUC and Cmax of lopinavir were 22% lower for the KALETRA oral solution relative to the capsule formulation.', 'Lopinavir and ritonavir are distributed into milk in rats; it is not known whether the drugs are distributed into human milk.', 'The pharmacokinetics of once daily Kaletra have been evaluated in HIV-1 infected subjects naive to antiretroviral treatment. Kaletra 800/200 mg was administered in combination with emtricitabine 200 mg and tenofovir DF 300 mg as part of a once daily regimen. Multiple dosing of 800/200 mg Kaletra once daily for 4 weeks with food (n = 24) produced a mean + or - 3.7 SD lopinavir peak plasma concentration (Cmax) of 11.8 + or - 3.7 ug/mL, occurring approximately 6 hours after administration. The mean steady-state lopinavir trough concentration prior to the morning dose was 3.2 + or - 3.7 2.1 ug/mL and minimum concentration within a dosing interval was 1.7 + or - 3.7 1.6 ug/mL. Lopinavir AUC over a 24 hour dosing interval averaged 154.1 + or - 3.7 61.4 ug* h/mL.', 'For more Absorption, Distribution and Excretion (Complete) data for Lopinavir (11 total), please visit the HSDB record page.']","[""Lopinavir undergoes extensive oxidative metabolism, almost exclusively via hepatic CYP3A isozymes. Co-administration with ritonavir, a potent inhibitor of CYP3A enzymes, helps to stave off lopinavir's biotransformation and increase plasma levels of active antiviral drug. Twelve metabolites have been identified _in vitro_, with the C-4 oxidation products M1, M3, and M4 being the predominant metabolites found in plasma. The structures of these primary metabolites have been identified, but precise structural information regarding the remaining minor metabolites has not been elucidated."", 'Lopinavir was metabolised in rat, dog and human primarily by hepatic CYP3A4 isoenzymes. Radioactivity in rat and dog faeces consisted largely of unchanged parent compound after oral administration. Although there were similarities in metabolite pattern between rat, dog and human, qualitative and quantitative differences were observed. The metabolism of lopinavir was sensitive to inhibition of ritonavir, which is in accordance with the inhibition of metabolic clearance of lopinavir by ritonavir observed in the rat.', 'In vitro experiments with human hepatic microsomes indicate that lopinavir primarily undergoes oxidative metabolism. Lopinavir is extensively metabolized by the hepatic cytochrome P450 system, almost exclusively by the CYP3A isozyme. Ritonavir is a potent CYP3A inhibitor which inhibits the metabolism of lopinavir, and therefore increases plasma levels of lopinavir. A (14)C-lopinavir study in humans showed that 89% of the plasma radioactivity after a single 400/100 mg Kaletra dose was due to parent drug. At least 13 lopinavir oxidative metabolites have been identified in man. Ritonavir has been shown to induce metabolic enzymes, resulting in the induction of its own metabolism. Pre-dose lopinavir concentrations decline with time during multiple dosing, stabilizing after approximately 10 to 16 days.']","['The elimination half-life of lopinavir is 6.9  2.2 hours.', 'After single dose administration, mean elimination half-life ranged between 2 to 3 hours and seemed to be increased after multiple dose administration (about 4-6 hr).']"
2727,92728,"(1S,16R)-9,10,20,24-tetramethoxy-15,15,29-trimethyl-7,22-dioxa-29-aza-15-azoniaheptacyclo[21.6.2.23,6.218,21.18,12.026,30.016,34]hexatriaconta-3(36),4,6(35),8(34),9,11,18,20,23,25,30,32-dodecaene",CN1CCC2=CC(=C3C=C2[C@@H]1CC4=CC=C(C=C4)OC5=C6[C@@H](CC7=CC(=C(O3)C=C7)OC)[N+](CCC6=CC(=C5OC)OC)(C)C)OC,,,,,,
2728,92729,gamma-Tocopherol,CC1=C(C=C2CC[C@@](OC2=C1C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O,,,"['Organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body. (See all compounds classified as Vitamins.)', 'Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)']",,,
2729,92730,11alpha-Hydroxyprogesterone,CC(=O)[C@H]1CC[C@@H]2[C@@]1(C[C@H]([C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)O)C,,,,,,
2730,92731,"2-(3,7,11,15,19,23-Hexamethyltetracosa-2,6,10,14,18,22-hexaenyl)-3-methylnaphthalene-1,4-dione",CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C,,,,,,
2731,92732,Laudanine,CN1CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)O)OC)OC,,,,,,
2732,92733,1-Hydroxy-1-phenylacetone,CC(=O)C(C1=CC=CC=C1)O,,,,,,
2733,92734,"Oxirane, 3-(1,1-dimethylethyl)-2,2-dimethyl-",CC1(C(O1)C(C)(C)C)C,,,,,,
2734,92735,Populin,C1=CC=C(C=C1)C(=O)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=CC=CC=C3CO)O)O)O,,,,,,
2735,92736,4-Chloro-3-hydroxybutyronitrile,C(C#N)C(CCl)O,,,,,,
2736,92737,"Undecanal, 2,6,10-trimethyl-",CC(C)CCCC(C)CCCC(C)C=O,,,,,,
2737,92738,2-Chloropropyldimethylamine,CC(CN(C)C)Cl,,,,,,
2738,92739,"2,2'-Oxydipropanol",CC(CO)OC(C)CO,,,,,,
2739,92740,"16(15H)-Oxaerythrinan-15-one, 14,17-dihydro-3-methoxy-, (3beta)-",CO[C@H]1CC[C@H]2CCN3[C@]2(C1)C4=C(CC3)COC(=O)C4,,,,,,
2740,92741,"4,4'-Didehydro-beta,beta-carotene-3,3'-dione",CC1=CC(=O)CC(C1=CC=C(C)C=CC=C(C)C=CC=CC(=CC=CC(=CC=C2C(=CC(=O)CC2(C)C)C)C)C)(C)C,,,,,,
2741,92742,"4,4'-Bis(dimethylamino)benzhydrol",CN(C)C1=CC=C(C=C1)C(C2=CC=C(C=C2)N(C)C)O,,,,,,
2742,92743,"2-Amino-1-(4-nitrophenyl)propane-1,3-diol",C1=CC(=CC=C1C(C(CO)N)O)[N+](=O)[O-],,,,,,
2743,92744,Sabadine,C[C@H]1CC[C@H]2[C@@]([C@]3([C@H](C[C@]4([C@@H]5CC[C@@H]6[C@@H]([C@H](CC[C@@]6([C@H]5C[C@]4([C@@H]3CN2C1)O)C)OC(=O)C)O)O)O)O)(C)O,,,,,,
2744,92745,"5beta-Pregnane-3,20-dione",CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@H]4[C@@]3(CCC(=O)C4)C)C,,,,,,
2745,92746,Zymosterol,C[C@H](CCC=C(C)C)[C@H]1CC[C@@H]2[C@@]1(CCC3=C2CC[C@@H]4[C@@]3(CC[C@@H](C4)O)C)C,,,,,,
2746,92747,(20R)-20-Hydroxypregn-4-en-3-one,C[C@H]([C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O,,,,,,
2747,92748,Allotetrahydrocortisol,C[C@]12CC[C@H](C[C@@H]1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O)O,,,,,,
2748,92749,"Phenylalanine, 3-hydroxy-alpha-methyl-",C[C@](CC1=CC(=CC=C1)O)(C(=O)O)N,,,,,,
2749,92750,11-Hydroxyprogesterone,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC([C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)O)C,,,"['Compounds that interact with PROGESTERONE RECEPTORS in target tissues to bring about the effects similar to those of PROGESTERONE. Primary actions of progestins, including natural and synthetic steroids, are on the UTERUS and the MAMMARY GLAND in preparation for and in maintenance of PREGNANCY. (See all compounds classified as Progestins.)']",,['11-Hydroxyprogesterone has known human metabolites that include 11-Hydroxyprogesterone 11-glucuronide.'],
2750,92751,Orotidine,C1=C(N(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)C(=O)O,,,,,,
2751,92752,[4-[4-(4-Sulfooxyphenyl)hex-3-en-3-yl]phenyl] hydrogen sulfate,CCC(=C(CC)C1=CC=C(C=C1)OS(=O)(=O)O)C2=CC=C(C=C2)OS(=O)(=O)O,,,,,,
2752,92753,propionyl-CoA,CCC(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)O,,,,,,
2753,92754,Methacholine bromide,CC(C[N+](C)(C)C)OC(=O)C.[Br-],,,,,,
2754,92755,1-Bromoperfluorohexane,C(C(C(C(F)(F)Br)(F)F)(F)F)(C(C(F)(F)F)(F)F)(F)F,,,,,,
2755,92756,"1,2-Difluoro-1,1,2-trichloroethane",C(C(F)(Cl)Cl)(F)Cl,,,,,,
2756,92757,"1-Bromo-1-chloro-2,2-difluoroethane",C(C(Cl)Br)(F)F,,,,,,
2757,92758,"1-Chloro-1,2,2-trifluoroethane",C(C(F)Cl)(F)F,,,,,,
2758,92759,Genisteine,C1CCN2C[C@@H]3C[C@H]([C@H]2C1)CN4[C@@H]3CCCC4,,,"['Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)', 'Drugs that stimulate contraction of the myometrium. They are used to induce LABOR, OBSTETRIC at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. They may also be used alone or with other drugs to induce abortions (ABORTIFACIENTS). Oxytocics used clinically include the neurohypophyseal hormone OXYTOCIN and certain prostaglandins and ergot alkaloids. (From AMA Drug Evaluations, 1994, p1157) (See all compounds classified as Oxytocics.)']",,,
2759,92760,Uzarigenin,C[C@]12CC[C@@H](C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@@]3(CC[C@@H]4C5=CC(=O)OC5)O)C)O,,,,,,
2760,92761,Natalensin,CO[C@H]1C[C@H]2[C@@]3(C=C1)C(CN2CC4=CC5=C(C=C34)OCO5)O,,,,,,
2761,92762,alpha-Eudesmol,CC1=CCC[C@]2([C@H]1C[C@@H](CC2)C(C)(C)O)C,,,,,,
2762,92763,Colchicoside,CC(=O)N[C@H]1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O,,,,,,
2763,92764,Triptycene,C1=CC=C2C3C4=CC=CC=C4C(C2=C1)C5=CC=CC=C35,,,,,,
2764,92765,Cryptopleurine,COC1=CC2=C(C=C1)C3=C(C[C@H]4CCCCN4C3)C5=CC(=C(C=C52)OC)OC,,,"['Compounds which inhibit the synthesis of proteins. They are usually ANTI-BACTERIAL AGENTS or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the A site of ribosomes, the misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins. (See all compounds classified as Protein Synthesis Inhibitors.)']",,,
2765,92766,Corynanthine,COC(=O)[C@@H]1[C@H](CC[C@@H]2[C@@H]1C[C@H]3C4=C(CCN3C2)C5=CC=CC=C5N4)O,,,"['Drugs used in the treatment of urological conditions and diseases such as URINARY INCONTINENCE and URINARY TRACT INFECTIONS. (See all compounds classified as Urological Agents.)', 'Agents that dilate the pupil. They may be either sympathomimetics or parasympatholytics. (See all compounds classified as Mydriatics.)', 'Drugs that bind to and block the activation of ADRENERGIC ALPHA-2 RECEPTORS. (See all compounds classified as Adrenergic alpha-2 Receptor Antagonists.)']",,,
2766,92767,1-Epilupinine,C1CCN2CCC[C@@H]([C@H]2C1)CO,,,,,,
2767,92768,Thermopsine,C1CCN2CC3CC(C2C1)CN4C3=CC=CC4=O,,,,,,
2768,92769,Indoxyl-beta-D-glucoside,C1=CC=C2C(=C1)C(=CN2)OC3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O,,,,,,
2769,92770,Nepetalactone,CC1CCC2C1C(=O)OC=C2C,,,,,,
2770,92771,CID 92771,CC1=CC(=C(C2=C1O[C@](CC2)(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C)O,,,,,,
2771,92772,"5-(3,5-Di-sec-butylcyclopent-1-enyl)-2,3,5-trihydroxyvaleric acid",CCC(C)C1CC(C(=C1)C(CC(C(C(=O)O)O)O)O)C(C)CC,,,"['Any of the hormones produced naturally in plants and active in controlling growth and other functions. There are three primary classes: auxins, cytokinins, and gibberellins. (See all compounds classified as Plant Growth Regulators.)']",,,
2772,92773,CID 92773,C1=CC(=C(C=C1C2=C(C(=C3C(=CC(=CC3=O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O2)O)O)O)O,,,,,,
2773,92774,CID 92774,COC1=CC(=CC(=C1OC)O)C2=COC3=CC(=C(C(=O)C3=C2O)OC)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O,,,,,,
2774,92775,Butin,C1[C@H](OC2=C(C1=O)C=CC(=C2)O)C3=CC(=C(C=C3)O)O,,,,,,
2775,92776,Zingiberene,CC1=CC[C@@H](C=C1)[C@@H](C)CCC=C(C)C,,,,,,
2776,92777,"(2R)-2-[2-(1,3-benzodioxol-5-yl)ethenyl]-4-methoxy-2,3-dihydropyran-6-one",COC1=CC(=O)O[C@H](C1)C=CC2=CC3=C(C=C2)OCO3,,,,,,
2777,92778,"Cyclopropanecarboxylic acid, 3-(2-carboxy-1-propenyl)-2,2-dimethyl-",CC(=CC1C(C1(C)C)C(=O)O)C(=O)O,,,,,,
2778,92779,2-Hydroxy-4-methylvaleric acid,CC(C)CC(C(=O)O)O,,,,,,
2779,92780,4-Isopropyl-2-cyclohexenone,CC(C)C1CCC(=O)C=C1,,,,,,
2780,92781,"(1S,16S,18S)-18-methoxy-15-methyl-5,7,12-trioxa-15-azapentacyclo[11.7.0.01,16.02,10.04,8]icosa-2,4(8),9,19-tetraen-13-ol",CN1CC2([C@]3([C@@H]1C[C@@H](C=C3)OC)C4=CC5=C(C=C4CO2)OCO5)O,,,,,,
2781,92782,Gibberellin A7,C[C@@]12[C@H](C=C[C@@]3([C@@H]1[C@@H]([C@]45[C@H]3CC[C@H](C4)C(=C)C5)C(=O)O)OC2=O)O,,,,,,
2782,92783,Totarol,CC(C)C1=C(C=CC2=C1CC[C@@H]3[C@@]2(CCCC3(C)C)C)O,,,,,,
2783,92784,5-Isopropylbicyclo[3.1.0]hexan-2-one,CC(C)C12CCC(=O)C1C2,,,,,,
2784,92785,Taraxerone,C[C@]12CCC(C[C@H]1[C@@]3(CC[C@@H]4[C@]5(CCC(=O)C([C@@H]5CC[C@]4(C3=CC2)C)(C)C)C)C)(C)C,,,,,,
2785,92786,Allopregnanolone,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC[C@H](C4)O)C)C,['Brexanolone is a synthetic neuroactive steroid gamma-aminobutyric acid A (GABA(a)) receptor positive modulator indicated for the treatment of postpartum depression (PPD) in adult women.'],"['Brexanolone potentiated GABA-mediated currents from recombinant human GABA(a) receptors in mammalian cells expressing 122 receptor subunits, 43 receptor subunits, and 63 receptor subunits.  Moreover, it was determined during a Phase 1 randomized, placebo and positive-controlled, double-blind, three-period crossover thorough QT study in 30 healthy adult subjects that brexanolone use did not prolong the QT interval to any clinically relevant extent when administered at 1.9-times the exposure occurring at the highest recommended infusion rate (90 mcg/kg/hour).']","['Agents capable of inducing a total or partial loss of sensation, especially tactile sensation and pain. They may act to induce general ANESTHESIA, in which an unconscious state is achieved, or may act locally to induce numbness or lack of sensation at a targeted site. (See all compounds classified as Anesthetics.)']","['It has been determined that brexanolone has a low oral bioavailability of approximately <5% in adults, which suggests infant exposure would also be expected to be low.', 'Following the administration of radiolabeled brexanolone, it was observed that 47% of the administrated dose was recovered largely as metabolites in the feces and 42% in urine, where less than 1% as recovered as unchanged brexanolone.', 'The volume of distribution documented for brexanolone is approximately 3 L/kg, a value which suggests relatively extensive distribution into tissues.', 'The total plasma clearance determined for brexanolone is approximately 1 L/h/kg.']","['Brexanolone is extensively metabolized by non-cytochrome (CYP) based pathways by way of three main routes - keto-reduction (via aldo-keto reductases), glucuronidation (via UDP-glucuronosyltransferases), and sulfation (via sulfotransferases). Three predominant circulating metabolites result from such metabolic pathways and they are all pharmacologically inactive and ultimately do not contribute to the overall efficacy of the medication.']",['The terminal half-life observed for brexanolone is approximately 9 hours.']
2786,92787,3beta-Hydroxy-5alpha-pregnan-20-one,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC[C@@H](C4)O)C)C,['Treatment of postpartum depression'],,"['Agents capable of inducing a total or partial loss of sensation, especially tactile sensation and pain. They may act to induce general ANESTHESIA, in which an unconscious state is achieved, or may act locally to induce numbness or lack of sensation at a targeted site. (See all compounds classified as Anesthetics.)']",,,
2787,92788,"(3S,10S,13R,14R,17R)-17-[(2R,5R)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,12,14,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-3-ol",C[C@H](C=C[C@H](C)C(C)C)[C@H]1CC[C@@H]2[C@@]1(CC=C3C2=CC=C4[C@@]3(CC[C@@H](C4)O)C)C,,,,,,
2788,92789,"(1R,12R,16R)-16-ethyl-15-methyl-11-methylidene-9,15-diazatetracyclo[10.3.1.02,10.03,8]hexadeca-2(10),3,5,7-tetraene",CC[C@@H]1[C@H]2CCN([C@H]1C3=C(C2=C)NC4=CC=CC=C43)C,,,,,,
2789,92790,"Acetamide, N-(5,6,7,10-tetrahydro-1,2,3,9-tetramethoxy-10-oxobenzo(a)heptalen-7-yl)-, (S)-",COC1CC2=C(C=CC1=O)C3=C(C(=C(C=C3CC[C@@H]2NC(=O)O)OC)OC)OC,,,,,,
2790,92791,Platynecine,C1CN2CC[C@H]([C@H]2[C@H]1CO)O,,,,,,
2791,92792,Cupreine,C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@@H](C3=C4C=C(C=CC4=NC=C3)O)O,,,,,,
2792,92793,Pulegol,CC1CCC(=C(C)C)C(C1)O,,,,,,
2793,92794,Prunin,C1[C@H](OC2=CC(=CC(=C2C1=O)O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)C4=CC=C(C=C4)O,,,,,,
2794,92795,Rhombifoline,C=CCCN1C[C@@H]2C[C@H](C1)C3=CC=CC(=O)N3C2,,,,,,
2795,92796,Silver carbonate,C(=O)([O-])[O-].[Ag+].[Ag+],,,,,,
2796,92797,2-O-beta-D-Glucopyranosyl-D-glucose,C([C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O[C@@H](C=O)[C@H]([C@@H]([C@@H](CO)O)O)O)O)O)O)O,,,,,,
2797,92798,Cyclopentamine hydrochloride,CC(CC1CCCC1)NC.Cl,,,,,,
2798,92799,"2-Propenoic acid, 3-phenyl-, 1,1'-anhydride",C1=CC=C(C=C1)C=CC(=O)OC(=O)C=CC2=CC=CC=C2,,,,,,
2799,92800,"9,10,12,13-Tetrahydroxyoctadecanoic acid",CCCCCC(C(CC(C(CCCCCCCC(=O)O)O)O)O)O,,,,,,
2800,92801,"4,8,13,17-Tetramethylicosa-2,4,6,8,10,12,14,16,18-nonaenedioic acid",CC(=CC=CC=C(C)C=CC=C(C)C=CC(=O)O)C=CC=C(C)C=CC(=O)O,,,,,,
2801,92802,Uvaol,C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)O)C)C)[C@@H]2[C@H]1C)C)CO,,,,,,
2802,92803,5beta-Cholanic acid,C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@H]4[C@@]3(CCCC4)C)C,,,,,,
2803,92804,A'-Neogammacer-17(21)-ene,CC(C)C1=C2CC[C@@]3([C@@H]([C@]2(CC1)C)CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CCCC5(C)C)C)C)C,,,,,,
2804,92805,Hyocholic acid,C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@@H]([C@@H]([C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C,,,,,['Hyocholic acid has known human metabolites that include hyocholic acid 24-O-glucuronide and hyocholic acid 6-O-glucuronide.'],
2805,92806,Drofenine hydrochloride,CCN(CC)CCOC(=O)C(C1CCCCC1)C2=CC=CC=C2.Cl,,,,,,
2806,92807,6-O-glucosylglucose,C([C@@H]1[C@H]([C@@H]([C@H](C(O1)OC[C@H]([C@H]([C@@H]([C@H](C=O)O)O)O)O)O)O)O)O,,,,,,
2807,92808,1-[Ethoxy(methyl)phosphoryl]sulfanyl-2-ethylsulfanylethane,CCOP(=O)(C)SCCSCC,,,,,,
2808,92809,Octadec-11-en-9-ynoic acid,CCCCCCC=CC#CCCCCCCCC(=O)O,,,,,,
2809,92810,"5alpha-Pregnane-3,20-dione",CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(CCC(=O)C4)C)C,,,,,,
2810,92811,"2-methyl-3-[(7R,11R)-3,7,11,15-tetramethylhexadec-2-enyl]naphthalene-1,4-diol",CC1=C(C2=CC=CC=C2C(=C1CC=C(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O)O,,,,,,
2811,92812,Ledol,C[C@@H]1CC[C@H]2[C@@H]1[C@H]3[C@H](C3(C)C)CC[C@@]2(C)O,,,,,,
2812,92813,"(1R,4S,5'R,6'R,10S,11R,12S,14R,15S,16S,18R,19S,20R,25S,26R,27S,29S)-4-ethyl-11,12,15,19-tetrahydroxy-6'-[(2S)-2-hydroxypropyl]-5',10,12,14,16,18,20,26,29-nonamethylspiro[24,28-dioxabicyclo[23.3.1]nonacosa-5,7,21-triene-27,2'-oxane]-13,17,23-trione",CC[C@H]1CC[C@@H]2[C@@H]([C@@H]([C@H]([C@@]3(O2)CC[C@H]([C@H](O3)C[C@H](C)O)C)C)OC(=O)C=C[C@H]([C@@H]([C@H](C(=O)[C@H]([C@@H]([C@H](C(=O)[C@@]([C@@H]([C@H](CC=CC=C1)C)O)(C)O)C)O)C)C)O)C)C,,,,,,
2813,92814,Isobutyl lactate,CC(C)COC(=O)C(C)O,,,,,,
2814,92815,Methyloxoarsine,C[As]=O,,,,,,
2815,92816,"3-[(8S,9R,10S,11S,13S,14S,17R)-9-fluoro-11,17-dihydroxy-10,13-dimethyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]propanoic acid",C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@]2([C@H](C[C@]4([C@H]3CC[C@]4(CCC(=O)O)O)C)O)F,,,,,,
2816,92817,Melezitose,C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@H]2[C@@H]([C@H](O[C@@]2(CO)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)CO)O)O)O)O)O,,,,,,
2817,92818,"1,2-Dibromo-1-chloroethane",C(C(Cl)Br)Br,,,,,,
2818,92819,"Cholesteryl octadeca-9,12-dienoate",CCCCCC=CCC=CCCCCCCCC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC=C2C1)CC[C@@H]4[C@H](C)CCCC(C)C)C)C,,,,,,
2819,92820,3-(2-Nitrophenyl)prop-2-enoic acid,C1=CC=C(C(=C1)C=CC(=O)O)[N+](=O)[O-],,,,,,
2820,92821,Propyl lactate,CCCOC(=O)C(C)O,,,,,,
2821,92822,"3-Methoxy-1,2-propanediol",COCC(CO)O,,,,,,
2822,92823,CID 92823,C1=NC2=C(N1[C@H]3[C@H]4[C@@H]([C@H](O3)CO)OP(=O)(O4)O)NC(=NC2=O)N,,,,,,
2823,92824,D-malate,C([C@H](C(=O)O)O)C(=O)O,,,,,,
2824,92825,Gypsogenin,C[C@]12CC[C@@H]([C@@]([C@@H]1CC[C@@]3([C@@H]2CC=C4[C@]3(CC[C@@]5([C@H]4CC(CC5)(C)C)C(=O)O)C)C)(C)C=O)O,,,,,,
2825,92826,Sennidin A,C1=CC2=C(C(=C1)O)C(=O)C3=C([C@@H]2[C@@H]4C5=C(C(=CC=C5)O)C(=O)C6=C4C=C(C=C6O)C(=O)O)C=C(C=C3O)C(=O)O,,,,,,
2826,92827,21-Deoxycortisol,CC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)O)C)O,,,,,,
2827,92828,"(2R)-2-[[(2R,3R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-2H-furan-5-one",C1=CC(=O)O[C@H]1CO[C@H]2[C@@H](C([C@@H]([C@H](O2)CO)O)O)O,,,,,,
2828,92829,Glycyl-L-tyrosine,C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)CN)O,,,,,,
2829,92830,"Phenol, 4,4'-(1,2-ethenediyl)bis-",C1=CC(=CC=C1C=CC2=CC=C(C=C2)O)O,,,,,,
2830,92831,ethyl (2S)-2-hydroxypropanoate,CCOC(=O)[C@H](C)O,,,,,,
2831,92832,N6-Acetyl-L-lysine,CC(=O)NCCCC[C@@H](C(=O)O)N,,,,,,
2832,92833,1-Phenyl-2-butanol,CCC(CC1=CC=CC=C1)O,,,,,,
2833,92834,19-Norandrostenedione,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=CC(=O)CC[C@H]34,['The claim that supplemental 19-norandrostenedione has anabolic effects is unsubstantiated.'],,,"['Absorption appears variable, but some absorption does occur.']","['Specific metabolites of 19-nor-5-androstene-3, 17-dione are 19-nordehydroandrosterone and 19-nordehydroepiandrosterone.']",
2834,92835,"Cholesta-3,5-diene",C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CCC=C4)C)C,,,,,,
2835,92836,2-Hydroxyhexadecanoic acid,CCCCCCCCCCCCCCC(C(=O)O)O,,,,,,
2836,92837,"2-Decenoic acid, 10-hydroxy-",C(CCCC=CC(=O)O)CCCO,,,,,,
2837,92838,Indene oxide,C1C2C(O2)C3=CC=CC=C31,,,,,,
2838,92839,1-Phenoxy-2-propanol,CC(COC1=CC=CC=C1)O,,,,"['PPh is rapidly absorbed, distributed throughout the body, metabolized, and eliminated. The major routes of elimination are via the urine and feces.']","['The following urinary metabolites were tentatively identified within Liquid Chromatography (LC) peaks using HPLC/ESI/MS and HPLC/ESI/MS/MS techniques: LC Peak A (<1%) - Glucuronide conjugate of hydroquinone LC Peak B (1-2%) - Not identified LC Peak C (1.3-3.8%) - Not identified LC Peak D (<1%) - Not identified LC Peak E/F (60-63%) - Sulfate and glutathione conjugates of phenol; Sulfate and glucuronide conjugates of PPh, sulfate conjugates of ring-hydroxylated PPh and 1- phenoxy-2-propanone LC Peak G (<1%) - Not identified LC Peak H (1-2%) - Not identified LC Peak I (4-5%) - Glucuronide conjugate of PPh LC Peak J (<1%) - Not identified LC Peak K (8-9%) - Glucuronide conjugate of PPh LC Peak L (9- 10%) - Sulfate conjugate of PPh Based on comparisons of chromatographic retention times with authentic materials, acid hydrolysis of urine yielded free phenol (61%), hydroquinone (1.5%), and parent PPh (13%).', 'PPh is rapidly absorbed, distributed, and quickly metabolized and eliminated in male rats. Virtually all the administered dose is eliminated within 48 hours in the urine and feces. The three major routes of metabolism are 1) cleavage of PPh by O-dealkylation, yielding propylene glycol and phenol, followed by excretion of phenol as a sulfate, or glutathione conjugate in the urine; 2) direct sulfate or glucuronide conjugation of parent PPh and excretion into the urine; and 3) ring hydroxylation of parent PPh or its oxidized propanone metabolite, followed by sulfate conjugation and excretion into the urine. Minor urinary metabolites included the glucuronide conjugate of hydroquinone.']",
2839,92840,"4-Phenyl-1,3-dioxane",C1COCOC1C2=CC=CC=C2,,,,,,
2840,92841,Methyl p-methoxycinnamate,COC1=CC=C(C=C1)C=CC(=O)OC,,,,,,
2841,92842,alpha-Amyrenyl acetate,C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OC(=O)C)C)C)[C@@H]2[C@H]1C)C)C,,,,,,
2842,92843,Glycyl-L-leucine,CC(C)C[C@@H](C(=O)O)NC(=O)CN,,,,,,
2843,92844,3-(Dimethylamino)propiophenone hydrochloride,CN(C)CCC(=O)C1=CC=CC=C1.Cl,,,,,,
2844,92845,CID 92845,C1=NC2=C(C(=N1)S)N=CN2[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O,,,,,,
2845,92846,Estrone acetate,CC(=O)OC1=CC2=C(C=C1)[C@H]3CC[C@]4([C@H]([C@@H]3CC2)CCC4=O)C,,,,,,
2846,92847,6alpha-Methylprogesterone,C[C@H]1C[C@H]2[C@@H]3CC[C@@H]([C@]3(CC[C@@H]2[C@@]4(C1=CC(=O)CC4)C)C)C(=O)C,,,,,,
2847,92848,"Benzoxazolium, 3-ethyl-2-[3-(3-ethyl-2(3H)-benzoxazolylidene)-1-propenyl]-, iodide",CCN1C2=CC=CC=C2OC1=CC=CC3=[N+](C4=CC=CC=C4O3)CC.[I-],,,,,,
2848,92849,2-[(E)-3-[(Z)-3-Ethylbenzoxazol-2(3H)-ylidene]-1-propenyl]-3-ethylbenzoxazolium,CCN1C2=CC=CC=C2OC1=CC=CC3=[N+](C4=CC=CC=C4O3)CC,,,,,,
2849,92850,Cholesteryl chloride,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)Cl)C)C,,,,,,
2850,92851,D-cysteine,C([C@H](C(=O)O)N)S,,,,,,
2851,92852,5-Methyl-DL-tryptophan,CC1=CC2=C(C=C1)NC=C2CC(C(=O)O)N,,,,,,
2852,92853,alpha-Styryl p-anisyl ketone,COC1=CC=C(C=C1)C(=O)C=CC2=CC=CC=C2,,,,,,
2853,92854,19-Oxoandrostenedione,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=CC(=O)CC[C@]34C=O,,,,,,
2854,92855,16-Dehydropregnenolone acetate,CC(=O)C1=CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)OC(=O)C)C)C,,,,,,
2855,92856,Crotonyl coenzyme A,CC=CC(=O)SCCNC(=O)CCNC(=O)C(C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)O,,,,,,
2856,92857,CID 92857,C1=C(C(=O)NC(=O)N1C[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)I,,,,,,
2857,92858,"5-bromo-5-fluoro-1-[(2R,4S,5S)-4-hydroxy-5-methoxyoxolan-2-yl]-6-methoxy-1,3-diazinane-2,4-dione",CO[C@@H]1[C@H](C[C@@H](O1)N2C(C(C(=O)NC2=O)(F)Br)OC)O,,,,,,
2858,92859,"3,5-Diiodo-L-thyronine",C1=CC(=CC=C1O)OC2=C(C=C(C=C2I)C[C@@H](C(=O)O)N)I,,,,,,
2859,92860,"(8S,9S,10R,13R,14S,17R)-17-[(2R,5S)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one",CC[C@@H](CC[C@@H](C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)C(C)C,,,,,,
2860,92861,Ethyl 8'-apo-caroten-8'-oate,CCOC(=O)C(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=CC1=C(CCCC1(C)C)C)C)C,,,,,,
2861,92862,"1,6,10,14-Hexadecatetraen-3-ol, 3,7,11,15-tetramethyl-",CC(=CCCC(=CCCC(=CCCC(C)(C=C)O)C)C)C,,,,,,
2862,92863,L-Penicillamine,CC(C)([C@@H](C(=O)O)N)S,,,,,,
2863,92864,Aldehydo-muramic acid,C[C@H](C(=O)O)O[C@H]([C@H](C=O)N)[C@@H]([C@@H](CO)O)O,,,,,,
2864,92865,gamma-Glutamylglutamate,C(CC(=O)N[C@@H](CCC(=O)O)C(=O)O)[C@@H](C(=O)O)N,,,,,,
2865,92866,"1,2-Dodecanediol",CCCCCCCCCCC(CO)O,,,,,,
2866,92867,Copper;octadec-9-enoate,CCCCCCCCC=CCCCCCCCC(=O)[O-].CCCCCCCCC=CCCCCCCCC(=O)[O-].[Cu+2],,,,,,
2867,92868,2-Thienylacrylic acid,C1=CSC(=C1)C=CC(=O)O,,,,,,
2868,92869,Spiro[5.6]dodecan-7-ol,C1CCC(C2(CC1)CCCCC2)O,,,,,,
2869,92870,"3-[2-(Diethylamino)ethyl]-4-phenylpiperidine-2,6-dione",CCN(CC)CCC1C(CC(=O)NC1=O)C2=CC=CC=C2,,,,,,
2870,92871,16-Dehydropregnenolone,CC(=O)C1=CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,,,,,,
2871,92872,"(1S)-3-[2-[(1R,3aR,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-1,2,3,3a,6,7-hexahydroinden-4-yl]ethenyl]-4-methylcyclohex-3-en-1-ol",CC1=C(C[C@H](CC1)O)C=CC2=CCC[C@]3([C@H]2CC[C@@H]3[C@H](C)CCCC(C)C)C,,,,,,
2872,92873,Tetrabromophenolphthalein ethyl ester,CCOC(=O)C1=CC=CC=C1C(=C2C=C(C(=O)C(=C2)Br)Br)C3=CC(=C(C(=C3)Br)O)Br,,,,,,
2873,92874,(-)-Verbenone,CC1=CC(=O)[C@H]2C[C@@H]1C2(C)C,,,,,,
2874,92875,"4-Methyl-4-phenyl-1,3-dioxane",CC1(CCOCO1)C2=CC=CC=C2,,,,,,
2875,92876,Clobutinol hydrochloride,CC(CN(C)C)C(C)(CC1=CC=C(C=C1)Cl)O.Cl,,,"['Agents that suppress cough. They act centrally on the medullary cough center. EXPECTORANTS, also used in the treatment of cough, act locally. (See all compounds classified as Antitussive Agents.)']",,,
2876,92877,5alpha-Androstan-3beta-ol,C[C@@]12CCC[C@H]1[C@@H]3CC[C@H]4C[C@H](CC[C@@]4([C@H]3CC2)C)O,,,,,,
2877,92878,CID 92878,CCC(C(=O)N[C@H]1[C@@H]2N(C1=O)[C@H](C(S2)(C)C)C(=O)[O-])OC3=CC=CC=C3.[K+],,,,,,
2878,92879,Propicillin,CCC(C(=O)N[C@H]1[C@@H]2N(C1=O)[C@H](C(S2)(C)C)C(=O)O)OC3=CC=CC=C3,,,['Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)'],,,
2879,92880,Methyl lithocholate,C[C@H](CCC(=O)OC)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)C,,,,,,
2880,92881,Dicyclopentadienyltitanium,[CH-]1C=CC=C1.[CH-]1C=CC=C1.[Ti+2],,,,,,
2881,92882,"Ferrocene, ethyl-",CCC1=CC=C[CH-]1.[CH-]1C=CC=C1.[Fe+2],,,,,,
2882,92883,"1,3-Cyclopentadiene, 5-ethyl",CCC1C=CC=C1,,,,,,
2883,92884,Cobaltocene,[CH-]1C=CC=C1.[CH-]1C=CC=C1.[Co+2],,,,,,
2884,92885,Grindelic acid,CC1=CC[C@@H]2[C@@]([C@@]13CC[C@@](O3)(C)CC(=O)O)(CCCC2(C)C)C,,,,,,
2885,92886,"trans-1,2-Cyclohexanediol",C1CC[C@H]([C@@H](C1)O)O,,,,,,
2886,92887,6-Methyluridine,CC1=CC(=O)NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O,,,,,,
2887,92888,"cis-1,2,3,6-Tetrahydrophthalimide",C1C=CC[C@H]2[C@@H]1C(=O)NC2=O,,,,,,
2888,92889,"1-(2,4-Dichlorophenyl)ethanol",CC(C1=C(C=C(C=C1)Cl)Cl)O,,,,,,
2889,92890,4-Chromanol,C1COC2=CC=CC=C2C1O,,,,,,
2890,92891,Albizziin,C([C@@H](C(=O)O)N)NC(=O)N,,,,,,
2891,92892,3-Benzyloxyaniline,C1=CC=C(C=C1)COC2=CC=CC(=C2)N,,,,,,
2892,92893,Histidine methyl ester,COC(=O)[C@H](CC1=CN=CN1)N,,,,,,
2893,92894,Quinacillin,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)C3=NC4=CC=CC=C4N=C3C(=O)O)C(=O)O)C,,,,,,
2894,92895,Estrone 3-methyl ether,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=C3C=CC(=C4)OC,,,,,,
2895,92896,"2-Propanol, 1,1'-[(1-methyl-1,2-ethanediyl)bis(oxy)]bis-",CC(COCC(C)OCC(C)O)O,,,,,,
2896,92897,Nicametate citrate,CCN(CC)CCOC(=O)C1=CN=CC=C1.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,,,['Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)'],,,
2897,92898,2-Chloro-1-phenylethanol,C1=CC=C(C=C1)C(CCl)O,,,,,,
2898,92899,3-Chloro-2-hydroxypropanoic acid,C(C(C(=O)O)O)Cl,,,,,,
2899,92900,Methyl oleanolate,C[C@]12CC[C@@H](C([C@@H]1CC[C@@]3([C@@H]2CC=C4[C@]3(CC[C@@]5([C@H]4CC(CC5)(C)C)C(=O)OC)C)C)(C)C)O,,,,,,
2900,92901,Homophenoxymethylpenicillin,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CCOC3=CC=CC=C3)C(=O)O)C,,,,,,
2901,92902,CID 92902,CCCCOC(=O)C1C(C2(C(C(C1(C2(Cl)Cl)Cl)Cl)Cl)Cl)C(=O)OCCCC,,,,,,
2902,92903,"cis-1,2-Cyclohexanediol",C1CC[C@@H]([C@@H](C1)O)O,,,,,,
2903,92904,Indole-3-lactic acid,C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)O,,,,,,
2904,92905,"1,1,3-Tris(2-methyl-4-hydroxy-5-tert-butylphenyl)butane",CC1=CC(=C(C=C1C(C)CC(C2=CC(=C(C=C2C)O)C(C)(C)C)C3=CC(=C(C=C3C)O)C(C)(C)C)C(C)(C)C)O,,,,,,
2905,92906,"(14S)-3,7,11-trimethyl-14-propan-2-ylcyclotetradeca-1,3,6,10-tetraene",CC1=CCCC(=CCC=C(C=C[C@@H](CC1)C(C)C)C)C,,,,,,
2906,92907,N-alpha-Acetyl-L-lysine,CC(=O)N[C@@H](CCCCN)C(=O)O,,,,,,
2907,92908,Stibocaptate,C1(C(S[Sb](S1)SC(C(C(=O)O)S[Sb]2SC(C(S2)C(=O)O)C(=O)O)C(=O)O)C(=O)O)C(=O)O,,,,,,
2908,92909,CID 92909,C1=C(NC(=N1)S)C[C@@H](C(=O)O)N,,,,,,
2909,92910,Melanostatin,CC(C)C[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1,,,['Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various ENDOCRINE GLANDS and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. (See all compounds classified as Hormones.)'],,,
2910,92911,Decahydroquinoline,C1CCC2C(C1)CCCN2,,,,,,
2911,92912,Magnesium dihydrogen di-L-aspartate,C([C@@H](C(=O)O)N)C(=O)[O-].C([C@@H](C(=O)O)N)C(=O)[O-].[Mg+2],,,,,,
2912,92913,Deprenyl hydrochloride,CC(CC1=CC=CC=C1)N(C)CC#C.Cl,,,"['Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. (See all compounds classified as Antidepressive Agents.)', 'Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)', 'Agents used in the treatment of Parkinson&apos;s disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. (See all compounds classified as Antiparkinson Agents.)', 'A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics, 8th ed, p414) (See all compounds classified as Monoamine Oxidase Inhibitors.)']",,,
2913,92914,"1,2,4,5-Tetramethylcyclohexane",CC1CC(C(CC1C)C)C,,,,,,
2914,92915,4-Pentyn-2-ol,CC(CC#C)O,,,,,,
2915,92916,C.I. Food Black 2,C1=CC(=CC=C1N=NC2=C3C=CC(=CC3=C(C=C2)N=NC4=C(C5=CC(=C(C=C5C=C4S(=O)(=O)[O-])S(=O)(=O)[O-])N)O)S(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+],,,,,,
2916,92917,"6-Amino-4-hydroxy-3-[[7-sulfino-4-[(4-sulfophenyl)diazenyl]naphthalen-1-yl]diazenyl]naphthalene-2,7-disulfonic acid",C1=CC(=CC=C1N=NC2=C3C=CC(=CC3=C(C=C2)N=NC4=C(C5=CC(=C(C=C5C=C4S(=O)(=O)O)S(=O)(=O)O)N)O)S(=O)O)S(=O)(=O)O,,,,,,
2917,92918,5-Methylcytidine,CC1=CN(C(=O)N=C1N)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O,,,,,,
2918,92919,CID 92919,CN(C)C1=NC(=O)C2=C(N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O,,,,,,
2919,92920,Cathine hydrochloride,C[C@@H]([C@H](C1=CC=CC=C1)O)N.Cl,,,['Agents that are used to suppress appetite. (See all compounds classified as Appetite Depressants.)'],,,
2920,92921,"(8S,9R,10S,13S,14S,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-16-methylidene-7,8,11,12,14,15-hexahydro-6H-cyclopenta[a]phenanthren-3-one",C[C@]12CC([C@]3([C@H]([C@@H]1CC(=C)[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@@]43C)F)O,,,,,,
2921,92922,Betamethasone 21-valerate,CCCCC(=O)OCC(=O)[C@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)F)O)C)C)O,,,,,,
2922,92923,Styrylacetic acid,C1=CC=C(C=C1)C=CCC(=O)O,,,,,,
2923,92924,N-Methyl-5-fluorodeoxycytidine,CNC1=NC(=O)N(C=C1F)[C@H]2C[C@@H]([C@H](O2)CO)O,,,,,,
2924,92925,Muscazone,C1=C(OC(=O)N1)C(C(=O)O)N,,,,,,
2925,92926,"2,3-Dihydroxypropyl decanoate",CCCCCCCCCC(=O)OCC(CO)O,,,,,,
2926,92927,3-Methylheptan-2-one,CCCCC(C)C(=O)C,,,,,,
2927,92928,p-Aminocinnamic acid,C1=CC(=CC=C1C=CC(=O)O)N,,,,,,
2928,92929,CID 92929,CN(CC1=CN=C2C(=N1)C(=O)N=C(N2)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,,,,,,
2929,92930,4-Nitrophenyl beta-D-glucopyranoside,C1=CC(=CC=C1[N+](=O)[O-])O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O,,,,,,
2930,92931,Methyl 3-[5-(oxiran-2-yl)pentyl]undecanoate,CCCCCCCCC(CCCCCC1CO1)CC(=O)OC,,,,,,
2931,92932,Methyl L-argininate,COC(=O)[C@H](CCCN=C(N)N)N,,,,,,
2932,92933,"2,2'-Sulfonyldiethanol",C(CS(=O)(=O)CCO)O,,,,,,
2933,92934,Firefly luciferin,C1[C@@H](N=C(S1)C2=NC3=C(S2)C=C(C=C3)O)C(=O)O,,,,,,
2934,92935,"2,3-Dichloropropionitrile",C(C(C#N)Cl)Cl,,,,,,
2935,92936,3-Fluoro-7-methylbenz[a]anthracene,CC1=C2C=CC3=C(C2=CC4=CC=CC=C14)C=CC(=C3)F,,,,,,
2936,92937,Tri-o-tolyl phosphite,CC1=CC=CC=C1OP(OC2=CC=CC=C2C)OC3=CC=CC=C3C,,,,,,
2937,92938,"4,4'-Azobis(4-cyanovaleric acid)",CC(CCC(=O)O)(C#N)N=NC(C)(CCC(=O)O)C#N,,,,,,
2938,92939,Amphetamine hydrochloride,CC(CC1=CC=CC=C1)N.Cl,,,,,,
2939,92940,Retroprogesterone,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@@H]3[C@H]2CCC4=CC(=O)CC[C@@]34C)C,,,,,,
2940,92941,2-Nitrophenyl beta-D-glucopyranoside,C1=CC=C(C(=C1)[N+](=O)[O-])O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O,,,,,,
2941,92942,Dextromoramide tartrate,C[C@H](CN1CCOCC1)C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N4CCCC4.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O,,,"['Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)', 'Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS. (See all compounds classified as Narcotics.)']",,,
2942,92943,Dextromoramide,C[C@H](CN1CCOCC1)C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N4CCCC4,,,"['Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS. (See all compounds classified as Narcotics.)', 'Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)']",,,
2943,92944,"Perfluoro-1,2-dimethylcyclobutane",C1(C(C(C1(F)F)(F)F)(C(F)(F)F)F)(C(F)(F)F)F,,,,,,
2944,92945,"all-trans 5,8-Epoxy Retinoic Acid (Mixture of Diastereomers)",CC(=CC(=O)O)C=CC=C(C)C1C=C2C(CCCC2(O1)C)(C)C,,,,,,
2945,92946,Ala-Tyr,C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N,,,,,,
2946,92947,CID 92947,CCCCCCCCC=CCCCCCCCC(=O)O.CCCC[SnH](CCCC)CCCC,,,,,,
2947,92948,Ethenyl 3-phenyl-2-propenoate,C=COC(=O)C=CC1=CC=CC=C1,,,,,,
2948,92949,1-Phenylpent-1-en-3-one,CCC(=O)C=CC1=CC=CC=C1,,,,,,
2949,92950,"2,2,4-Trimethylhexane-1,6-diamine",CC(CCN)CC(C)(C)CN,,,,,,
2950,92951,Uridylyladenosine,C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)OP(=O)(O)OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=NC5=C(N=CN=C54)N)O)O)O,,,,,,
2951,92952,Pheniramine 4-aminosalicylate,CN(C)CCC(C1=CC=CC=C1)C2=CC=CC=N2.C1=CC(=C(C=C1N)O)C(=O)O,,,,,,
2952,92953,Glycyl-L-phenylalanine,C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)CN,,,,,,
2953,92954,3-Chloro-2-hydroxypropyl acrylate,C=CC(=O)OCC(CCl)O,,,,,,
2954,92955,((Octyloxy)methyl)oxirane,CCCCCCCCOCC1CO1,,,,,,
2955,92956,"1,4-Diphenylpyrazolidine-3,5-dione",C1=CC=C(C=C1)C2C(=O)NN(C2=O)C3=CC=CC=C3,,,,,,
2956,92957,"Quinolinium, 6-(p-acetamidobenzamido)-2-(p-aminostyryl)-1-methyl-, acetate",CC(=O)NC1=CC=C(C=C1)C(=O)NC2=CC3=C(C=C2)[N+](=C(C=C3)C=CC4=CC=C(C=C4)N)C.CC(=O)[O-],,,,,,
2957,92958,4-acetamido-N-[2-[2-(4-aminophenyl)ethenyl]-1-methylquinolin-1-ium-6-yl]benzamide,CC(=O)NC1=CC=C(C=C1)C(=O)NC2=CC3=C(C=C2)[N+](=C(C=C3)C=CC4=CC=C(C=C4)N)C,,,,,,
2958,92959,3-Hydroxy-3-phenylpropanoic acid,C1=CC=C(C=C1)C(CC(=O)O)O,,,,,,
2959,92960,((Decyloxy)methyl)oxirane,CCCCCCCCCCOCC1CO1,,,,,,
2960,92961,CID 92961,CC1=CC(=CC(=C1O)C(=O)[O-])C(=C2C=C(C(=O)C(=C2)C(=O)[O-])C)C3=CC=CC=C3S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
2961,92962,"5-[(3-Carboxy-5-methyl-4-oxocyclohexa-2,5-dien-1-ylidene)-(2-sulfophenyl)methyl]-2-hydroxy-3-methylbenzoic acid",CC1=CC(=CC(=C1O)C(=O)O)C(=C2C=C(C(=O)C(=C2)C(=O)O)C)C3=CC=CC=C3S(=O)(=O)O,,,,,,
2962,92963,But-2-enedioic acid;1-[10-[2-(dimethylamino)propyl]phenothiazin-2-yl]propan-1-one,CCC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CC(C)N(C)C.C(=CC(=O)O)C(=O)O,,,,,,
2963,92964,Perezone,CC1=CC(=O)C(=C(C1=O)O)[C@H](C)CCC=C(C)C,,,,,,
2964,92965,Tolperisone hydrochloride,CC1=CC=C(C=C1)C(=O)C(C)CN2CCCCC2.Cl,,,"['A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358) (See all compounds classified as Muscle Relaxants, Central.)']",,,
2965,92966,CID 92966,CCCCCCCCCC=CCCCCCCC(=O)OCCCCCCCCC=CCCCCCCCC,,,,,,
2966,92967,"O,O-Dimethyl malathion",COC(=O)CC(C(=O)OC)SP(=S)(OC)OC,,,,,,
2967,92968,CID 92968,C1COCCN1CC2CN(C(=O)O2)N=CC3=CC=C(O3)[N+](=O)[O-].Cl,,,,,,
2968,92969,4-Nitrophenyl alpha-D-glucopyranoside,C1=CC(=CC=C1[N+](=O)[O-])O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O,,,,,,
2969,92970,4-Hydroxybenzylidenemalononitrile,C1=CC(=CC=C1C=C(C#N)C#N)O,,,,,,
2970,92971,Stilben-4-ol,C1=CC=C(C=C1)C=CC2=CC=C(C=C2)O,,,,,,
2971,92972,"D-Glucose, 2,3,4,5,6-pentaacetate",CC(=O)OC[C@H]([C@H]([C@@H]([C@H](C=O)OC(=O)C)OC(=O)C)OC(=O)C)OC(=O)C,,,,,,
2972,92973,N-methyl-D-alanine,C[C@H](C(=O)O)NC,,,,,,
2973,92974,Droxidopa,C1=CC(=C(C=C1[C@H]([C@@H](C(=O)O)N)O)O)O,"[""For treatment of neurogenic orthostatic hypotension (NOH) associated with various disorders including Multiple System Atrophy, Familial Amyloid Polyneuropathy, hemodialysis induced hypotension and Parkinson's Disease. Also investigated for use/treatment in neurologic disorders, nephropathy, blood (blood forming organ disorders, unspecified), and dizzy/fainting spells.""]","['Droxidopa is an orally active synthetic precursor of norepinephrine that increases the deficient supply of norepinephrine in patients with NOH, thereby improving orthostatic blood pressure and alleviating associated symptoms of lightheadedness, dizziness, blurred vision, and syncope through the induction of tachycardia (increased heart rate) and hypertension.']",['Agents used in the treatment of Parkinson&apos;s disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. (See all compounds classified as Antiparkinson Agents.)'],"['Oral bioavailability is 90%.', 'Droxidopa is mainly excreted in the urine, with the main metabolite being 3-O-methyldihydroxyphenylserine.']",['Droxidopa is metabolized by aromatic L-amino acid decarboxylase.'],['2-3 hours.']
2974,92975,1-Amino-3-chloropropan-2-ol,C(C(CCl)O)N,,,,,,
2975,92976,"1,1-Diphenyl-2-propyn-1-ol",C#CC(C1=CC=CC=C1)(C2=CC=CC=C2)O,,,,,,
2976,92977,CID 92977,C([C@@H]1[C@H]([C@H]([C@@H](O1)N2C3=C(C(=O)N=C(N3)N)N=C2Br)O)O)O,,,,,,
2977,92978,"2,4-Dimethyloctane",CCCCC(C)CC(C)C,,,,,,
2978,92979,"Androsta-4,16-dien-3-one",C[C@]12CC[C@H]3[C@H]([C@@H]1CC=C2)CCC4=CC(=O)CC[C@]34C,,,,,,
2979,92980,Nipecotamide,C1CC(CNC1)C(=O)N,,,,,,
2980,92981,1-Pentyn-3-ol,CCC(C#C)O,,,,,,
2981,92982,N-Methyl-L-aspartic acid,CN[C@@H](CC(=O)O)C(=O)O,,,,,,
2982,92983,Mandelonitrile benzoate,C1=CC=C(C=C1)C(C#N)OC(=O)C2=CC=CC=C2,,,,,,
2983,92984,"3,5,5-Trimethyl-1-hexene",CC(CC(C)(C)C)C=C,,,,,,
2984,92985,"Phosphonic acid, (1-(((2-chloroethoxy)(2-chloroethyl)phosphinyl)oxy)ethyl)-, 1-(bis(2-chloroethoxy)phosphinyl)ethyl 2-chloroethyl ester",CC(OP(=O)(C(C)OP(=O)(CCCl)OCCCl)OCCCl)P(=O)(OCCCl)OCCCl,,,,,,
2985,92986,alpha-Vinylbenzyl alcohol,C=CC(C1=CC=CC=C1)O,,,,,,
2986,92987,Pelletierine,CC(=O)CC1CCCCN1,,,,,,
2987,92988,Glyoxal trimer dihydrate,C1(C(OC2C(O1)OC(C(O2)O)O)O)O,,,,,,
2988,92989,Norhyoscine,C1[C@@H]2[C@@H]3[C@@H](O3)[C@@H](N2)CC1OC(=O)[C@H](CO)C4=CC=CC=C4,,,,,,
2989,92990,Quebrachamine,CC[C@]12CCCN(C1)CCC3=C(CC2)NC4=CC=CC=C34,,,,,,
2990,92991,2-Ethylcyclopentanone,CCC1CCCC1=O,,,,,,
2991,92992,Tetrakis(1-methylpropyl) orthosilicate,CCC(C)O[Si](OC(C)CC)(OC(C)CC)OC(C)CC,,,,,,
2992,92993,"2-Diphenylacetyl-1,3-indandion-1-hydrazon",C1=CC=C(C=C1)C(C2=CC=CC=C2)C(=O)C3C(=NN)C4=CC=CC=C4C3=O,,,,,,
2993,92994,"Chloroacetaldehyde (2,4-dinitrophenyl)hydrazone",C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])NN=CCCl,,,,,,
2994,92995,2-Naphthyl glycidyl ether,C1C(O1)COC2=CC3=CC=CC=C3C=C2,,,,,,
2995,92996,tert-Butyl L-tryptophyl-L-methionyl-L-alpha-aspartyl-3-phenyl-L-alaninamidoformate,CC(C)(C)OC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N,,,,,,
2996,92997,3b-Hydroxy-5-cholenoic acid,C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,,,,,,
2997,92998,Piperitone oxide,CC(C)C1CCC2(C(C1=O)O2)C,,,,,,
2998,92999,Digoxigenin bisdigitoxoside,C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@H]3CC[C@]4([C@@H](C3)CC[C@@H]5[C@@H]4C[C@H]([C@]6([C@@]5(CC[C@@H]6C7=CC(=O)OC7)O)C)O)C)C)O)O,,,,,['Digoxigenin Bisdigitoxoside is a known human metabolite of digitoxin.'],
2999,93000,"1,2-Pentanediol",CCCC(CO)O,,,,,,
3000,93001,Digoxigenin monodigitoxoside,C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2CC[C@]3([C@@H](C2)CC[C@@H]4[C@@H]3C[C@H]([C@]5([C@@]4(CC[C@@H]5C6=CC(=O)OC6)O)C)O)C)O)O,,,,,,
3001,93002,2-Hydroxytetrahydrofuran,C1CC(OC1)O,,,,,,
3002,93003,6-Chloropurine riboside,C1=NC2=C(C(=N1)Cl)N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O,,,,,,
3003,93004,Norcantharidin,C1CC2C3C(C1O2)C(=O)OC3=O,,,"['Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)', 'Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)']",,,
3004,93005,3-Nitro-2-pentanol,CCC(C(C)O)[N+](=O)[O-],,,,,,
3005,93006,Pigment Yellow 14,CC1=CC=CC=C1NC(=O)C(C(=O)C)N=NC2=C(C=C(C=C2)C3=CC(=C(C=C3)N=NC(C(=O)C)C(=O)NC4=CC=CC=C4C)Cl)Cl,,,,,,
3006,93007,Betamethasone 17-propionate,CCC(=O)O[C@@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)F)O)C)C)C(=O)CO,,,,,,
3007,93008,"Ethanimidic acid, N-cyano-, methyl ester",CC(=NC#N)OC,,,,,,
3008,93009,(-)-Bornyl acetate,CC(=O)O[C@@H]1C[C@@H]2CC[C@]1(C2(C)C)C,,,,,,
3009,93010,"1,2-Dibromo-1,2-diphenylethane",C1=CC=C(C=C1)C(C(C2=CC=CC=C2)Br)Br,,,,,,
3010,93011,"2-Chloro-N,N-dimethyl-3-oxobutanamide",CC(=O)C(C(=O)N(C)C)Cl,,,,,,
3011,93012,4-Ethyl-1-octyn-3-ol,CCCCC(CC)C(C#C)O,,,,,,
3012,93013,"Exo-1,7,7-trimethylbicyclo[2.2.1]hept-2-yl acrylate",C[C@]12CC[C@H](C1(C)C)CC2OC(=O)C=C,,,,,,
3013,93014,"2-Norbornene, 6-(bromomethyl)-1,2,3,7,7-pentachloro-",C1C(C2(C(=C(C1C2(Cl)Cl)Cl)Cl)Cl)CBr,,,,,,
3014,93015,Desacetylcephalothin,C1C(=C(N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CS3)C(=O)O)CO,,,,,,
3015,93016,Mexicanin I,C[C@@H]1C[C@H]2[C@H]([C@H]([C@]3([C@H]1C=CC3=O)C)O)C(=C)C(=O)O2,,,,,,
3016,93017,Podocarpic acid,C[C@]12CCC[C@]([C@@H]1CCC3=C2C=C(C=C3)O)(C)C(=O)O,,,,,,
3017,93018,CID 93018,C[N+]1(CCN(CC1)CC(C2CCCCC2)(C3=CC=CC=C3)O)C.OS(=O)(=O)[O-],,,,,,
3018,93019,4-Acetyl-1-methylcyclohexene,CC1=CCC(CC1)C(=O)C,,,,,,
3019,93020,Pholedrine sulfate,CC(CC1=CC=C(C=C1)O)NC.CC(CC1=CC=C(C=C1)O)NC.OS(=O)(=O)O,,,"['A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. (See all compounds classified as Central Nervous System Stimulants.)', 'Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. (See all compounds classified as Sympathomimetics.)']",,,
3020,93021,Manganese acetate tetrahydrate,CC(=O)[O-].CC(=O)[O-].O.O.O.O.[Mn+2],,,,,,
3021,93022,4-(1-Phenylethyl)-m-xylene,CC1=CC(=C(C=C1)C(C)C2=CC=CC=C2)C,,,,,,
3022,93023,CID 93023,C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2NC(=NC3=O)N)CO)OP(=O)(O)O,,,,,,
3023,93024,"2-(4-Methylcyclohex-3-en-1-yl)propane-1,2-diol",CC1=CCC(CC1)C(C)(CO)O,,,,,,
3024,93025,3-Nitro-2-butanol,CC(C(C)O)[N+](=O)[O-],,,,,,
3025,93026,2-Ethylhexyl lactate,CCCCC(CC)COC(=O)C(C)O,,,,,,
3026,93027,"Disodium 2-((4,5-dihydro-3-methyl-5-oxo-1-(4-sulphonatophenyl)-1H-pyrazol-4-yl)azo)benzoate",CC1=NN(C(=O)C1N=NC2=CC=CC=C2C(=O)[O-])C3=CC=C(C=C3)S(=O)(=O)[O-].[Na+].[Na+],,,,,,
3027,93028,"2-((4,5-Dihydro-3-methyl-5-oxo-1-(4-sulphophenyl)-1H-pyrazol-4-yl)azo)benzoic acid",CC1=NN(C(=O)C1N=NC2=CC=CC=C2C(=O)O)C3=CC=C(C=C3)S(=O)(=O)O,,,,,,
3028,93029,2-Propenylphenol,CC=CC1=CC=CC=C1O,,,,,,
3029,93030,3-Methylhexadecane,CCCCCCCCCCCCCC(C)CC,,,,,,
3030,93031,"2,3-Butanediol, dinitrate",CC(C(C)O[N+](=O)[O-])O[N+](=O)[O-],,,,,,
3031,93032,(S)-dimethyl 2-aminopentanedioate,COC(=O)CC[C@@H](C(=O)OC)N,,,,,,
3032,93033,CID 93033,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O[C@@H]4[C@H](O[C@H]([C@@H]4O)N5C=NC6=C5NC(=NC6=O)N)CO)O)O)N,,,,,,
3033,93034,Tetradecahydroanthracene,C1CCC2CC3CCCCC3CC2C1,,,,,,
3034,93035,"2,3-Epoxypropyl nitrate",C1C(O1)CO[N+](=O)[O-],,,,,,
3035,93036,5-Bromo-2'-deoxyuridine-5'-monophosphate,C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)Br)COP(=O)(O)O)O,,,,,,
3036,93037,Cortisol 21-mesylate,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)COS(=O)(=O)C)O)C)O,,,,,,
3037,93038,"1,1-Bis(tert-butylperoxy)-3,3,5-trimethylcyclohexane",CC1CC(CC(C1)(OOC(C)(C)C)OOC(C)(C)C)(C)C,,,,,,
3038,93039,Catalposide,C1=CO[C@H]([C@H]2[C@@H]1[C@@H]([C@H]3[C@@]2(O3)CO)OC(=O)C4=CC=C(C=C4)O)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O,,,,,,
3039,93040,"3-Methyl-6-methoxy-8-hydroxy-3,4-dihydroisocoumarin",CC1CC2=C(C(=CC(=C2)OC)O)C(=O)O1,,,,,,
3040,93041,"1-(2,3,6-Trihydroxyphenyl)pent-3-en-1-one",CC=CCC(=O)C1=C(C=CC(=C1O)O)O,,,,,,
3041,93042,CID 93042,CC(=NN=C(N)S)C1=CC=CC=N1,,,,,,
3042,93043,5-Methyl-5-phenylhydantoin,CC1(C(=O)NC(=O)N1)C2=CC=CC=C2,,,,,,
3043,93044,"(5beta)-3,6-Dioxocholan-24-oic acid",C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC(=O)[C@H]4[C@@]3(CCC(=O)C4)C)C,,,,,,
3044,93045,Harpagide,C[C@@]1(C[C@H]([C@]2([C@@H]1[C@@H](OC=C2)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)O)O,,,,,,
3045,93046,"2,10-Epoxypinane",CC1(C2CCC3(C1C2)CO3)C,,,,,,
3046,93047,(R)-3-(Pyrrolidin-2-yl)pyridine,C1C[C@@H](NC1)C2=CN=CC=C2,,,,,,
3047,93048,"1,5,9-Trimethyl-12-propan-2-ylcyclotetradeca-4,8,13-triene-1,3-diol",CC1=CCCC(=CC(CC(C=CC(CC1)C(C)C)(C)O)O)C,,,,,,
3048,93049,Acetylgitoxin-beta [German],CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CCC7(C6(CC(C7C8=CC(=O)OC8)OC(=O)C)O)C)C)C)C)O)O,,,,,,
3049,93050,1-Heptyn-3-ol,CCCCC(C#C)O,,,,,,
3050,93051,"3,7,11-Trimethyldodeca-2,6,10-trienoic acid",CC(=CCCC(=CCCC(=CC(=O)O)C)C)C,,,,,,
3051,93052,Heptanoate,CCCCCCC(=O)[O-],,,,,,
3052,93053,Bis(2-bromoethyl)sulfide,C(CBr)SCCBr,,,,,,
3053,93054,Einecs 231-562-7,CCN1CC2(CCC(C34C2CC(C31)C5(CC(C6CC4C5C6OC(=O)C)OC)O)O)COC,,,,,,
3054,93055,Prednisolone tebutate,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)COC(=O)CC(C)(C)C)O)CCC4=CC(=O)C=C[C@]34C)O,,,,,,
3055,93056,"Bis(2,3-dichloropropyl) Ether",C(C(CCl)Cl)OCC(CCl)Cl,,,,,,
3056,93057,Demegestone,CC(=O)[C@]1(CC[C@@H]2[C@@]1(CCC3=C4CCC(=O)C=C4CC[C@@H]23)C)C,,,,,,
3057,93058,"2,3-Dichloropropionaldehyde",C(C(C=O)Cl)Cl,,,,,,
3058,93059,1-(2-Ethoxypropoxy)propan-2-ol,CCOC(C)COCC(C)O,,,,,,
3059,93060,2-Methyl-N-octadecylaziridine-1-carboxamide,CCCCCCCCCCCCCCCCCCNC(=O)N1CC1C,,,,,,
3060,93061,Aglme,CC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)OC,,,,,,
3061,93062,sec-Butyl Methyl sulfide,CCC(C)SC,,,,,,
3062,93063,CID 93063,C[C@]12CC[C@@]34C[C@@H](CC[C@]3([C@@]1(C[C@@H](C[C@H]2C(=O)O)O)C)C)C(=C)[C@@H]4O,,,,,,
3063,93064,"Acetaldehyde, 2-(methylthio)-, oxime",CSCC=NO,,,,,,
3064,93065,6-Methyloctadecane,CCCCCCCCCCCCC(C)CCCCC,,,,,,
3065,93066,"Octadecanoic acid, ester with 1,2,3-propanetriol, sulfated",CCCCCCCCCCCCCCCCCC(=O)O.C(C(CO)O)O,,,,,,
3066,93067,"2,2'-Azobis(2-Sulphonato-4,1-phenylene)vinylene(3-sulphonato-4,1-phenylene)bis2H-naphtho1,2-dtriazole-5-sulphonate (sodium salt)",C1=CC=C2C(=C1)C(=CC3=NN(N=C23)C4=CC(=C(C=C4)C=CC5=C(C=C(C=C5)N=NC6=CC(=C(C=C6)C=CC7=C(C=C(C=C7)N8N=C9C=C(C1=CC=CC=C1C9=N8)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],,,,,,
3067,93068,2-[3-Sulfo-4-[2-[2-sulfo-4-[[3-sulfo-4-[2-[2-sulfo-4-(5-sulfobenzo[e]benzotriazol-2-yl)phenyl]ethenyl]phenyl]diazenyl]phenyl]ethenyl]phenyl]benzo[e]benzotriazole-5-sulfonic acid,C1=CC=C2C(=C1)C(=CC3=NN(N=C23)C4=CC(=C(C=C4)C=CC5=C(C=C(C=C5)N=NC6=CC(=C(C=C6)C=CC7=C(C=C(C=C7)N8N=C9C=C(C1=CC=CC=C1C9=N8)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
3068,93069,"Phosphorodithioic acid, S-(2-(2-methyl-1-piperidinyl)-2-oxoethyl) O,O-dipropyl ester, mixt. with N-(1,2-dimethylpropyl)-N'-ethyl-6-(methylthio)-1,3,5-triazine-2,4-diamine",CCCOP(=S)(OCCC)SCC(=O)N1CCCCC1C.CCNC1=NC(=NC(=N1)SC)NC(C)C(C)C,,,,,,
3069,93070,Copper D-gluconate,C(C(C(C(C(C(=O)[O-])O)O)O)O)O.C(C(C(C(C(C(=O)[O-])O)O)O)O)O.[Cu+2],,,,,,
3070,93071,5-Methyldecane,CCCCCC(C)CCCC,,,,,,
3071,93072,N-carbamoyl-L-aspartate,C([C@@H](C(=O)O)NC(=O)N)C(=O)O,,,,,,
3072,93073,"3,3-Dimethylbicyclo[2.2.1]heptan-2-one",CC1(C2CCC(C2)C1=O)C,,,,,,
3073,93074,1-Methyl-3-pyrrolidinol,CN1CCC(C1)O,,,,,,
3074,93075,"4,6-O-Ethylidene-alpha-D-glucose",CC1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@H](O2)O)O)O,,,,,,
3075,93076,"2,3,3,3-Tetrafluoro-2-(1,1,2,3,3,3-hexafluoro-2-(perfluoropropoxy)propoxy)propanoic acid",C(=O)(C(C(F)(F)F)(OC(C(C(F)(F)F)(OC(C(C(F)(F)F)(F)F)(F)F)F)(F)F)F)O,,,,,,
3076,93077,"Octadeca-9,11,13-trienoic acid",CCCCC=CC=CC=CCCCCCCCC(=O)O,,,,,,
3077,93078,L-Aspartyl-L-phenylalanine,C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)N,,,,,,
3078,93079,"2,2'-Azobis(2-methylbutyronitrile)",CCC(C)(C#N)N=NC(C)(CC)C#N,,,,,,
3079,93080,((2-Butoxyethoxy)methyl)oxirane,CCCCOCCOCC1CO1,,,,,,
3080,93081,beta-Cubebene,C[C@@H]1CC[C@H]([C@H]2[C@]13[C@@H]2C(=C)CC3)C(C)C,,,,,,
3081,93082,CID 93082,C1=NC2=C(N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(CP(=O)(O)O)O)O)O)NC(=NC2=O)N,,,,,,
3082,93083,2-(Methylamino)propanenitrile,CC(C#N)NC,,,,,,
3083,93084,Bis(cyano-C)cuprate(1-),[C-]#N.[C-]#N.[Cu+],,,,,,
3084,93085,"Phosphonic acid, (1Z)-1-propenyl-",CC=CP(=O)(O)O,,,,,,
3085,93086,Salicylamide O-acetic acid,C1=CC=C(C(=C1)C(=O)N)OCC(=O)O,,,,,,
3086,93087,N-ethyl-N-propylnitrous amide,CCCN(CC)N=O,,,,,,
3087,93088,CID 93088,CCCCCCCCCCCCCOCCOCCOCCOS(=O)(=O)[O-].[Na+],,,,,,
3088,93089,2-{2-[2-(Tridecyloxy)ethoxy]ethoxy}ethyl hydrogen sulfate,CCCCCCCCCCCCCOCCOCCOCCOS(=O)(=O)O,,,,,,
3089,93090,Isohumulone,CC(C)CC(=O)C1=C(C(C(C1=O)CC=C(C)C)(C(=O)CC=C(C)C)O)O,,,,,,
3090,93091,Titanium nitride,N#[Ti],,,,,,
3091,93092,"1,2-Ethanediamine, N,N'-bis(1,3-dimethylbutylidene)-",CC(C)CC(=NCCN=C(C)CC(C)C)C,,,,,,
3092,93093,4-Hydroxybutanal,C(CC=O)CO,,,,,,
3093,93094,"4H-1,3,5-Oxadiazine-4-thione, tetrahydro-3,5-dimethyl-",CN1COCN(C1=S)C,,,,,,
3094,93095,Fosfomycin calcium,C[C@H]1[C@H](O1)P(=O)([O-])[O-].[Ca+2],,,,,,
3095,93096,CID 93096,C1=C(OC(=C1)N(O)O)C2=CSC(=N2)N=N,,,,,,
3096,93097,CID 93097,C1=CC(=CC=C1C2=CSC(=N2)N=N)N(O)O,,,,,,
3097,93098,2-Hydrazino-4-(4-aminophenyl)thiazole,C1=CC(=CC=C1C2=CSC(=N2)NN)N,,,,,,
3098,93099,"3-Methoxy-2,2-dimethyloxirane",CC1(C(O1)OC)C,,,,,,
3099,93100,"2,4,6-Trichlororesorcinol",C1=C(C(=C(C(=C1Cl)O)Cl)O)Cl,,,,,,
3100,93101,"3,9-Bis(2,4-di-tert-butylphenoxy)-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane",CC(C)(C)C1=CC(=C(C=C1)OP2OCC3(CO2)COP(OC3)OC4=C(C=C(C=C4)C(C)(C)C)C(C)(C)C)C(C)(C)C,,,,,,
3101,93102,"1,3-Bis(3-isocyanato-4-methylphenyl)-1,3-diazetidine-2,4-dione",CC1=C(C=C(C=C1)N2C(=O)N(C2=O)C3=CC(=C(C=C3)C)N=C=O)N=C=O,,,,,,
3102,93103,"Benzamide, N-ethyl-3-methyl-",CCNC(=O)C1=CC=CC(=C1)C,,,,,['N-ethyl-m-toluamide is a known human metabolite of DEET.'],
3103,93104,"3,5-Diisopropylphenol",CC(C)C1=CC(=CC(=C1)O)C(C)C,,,,,,
3104,93105,Tin chloride (SnCl3),Cl[Sn+](Cl)Cl,,,,,,
3105,93106,Trichlorostannane,Cl[SnH](Cl)Cl,,,,,,
3106,93107,"Benzenamine, N,N-diethyl-4-(1H-1,2,4-triazol-3-ylazo)-",CCN(CC)C1=CC=C(C=C1)N=NC2=NC=NN2,,,,,,
3107,93108,"2,2,3-Tribromopropanal",C(C(C=O)(Br)Br)Br,,,,,,
3108,93109,Octyltris(2-ethylhexyloxycarbonylmethylthio)stannane,CCCCCCCC[Sn](SCC(=O)OCC(CC)CCCC)(SCC(=O)OCC(CC)CCCC)SCC(=O)OCC(CC)CCCC,,,,,,
3109,93110,4-Chloro-2-methylbenzenediazonium,CC1=C(C=CC(=C1)Cl)[N+]#N,,,,,,
3110,93111,5-Ethyl-4-hydroxy-2-methylfuran-3(2H)-one,CCC1=C(C(=O)C(O1)C)O,,,,,,
3111,93112,"Urea, 1,1'-trimethylenebis(1-nitroso-",C(CN(C(=O)N)N=O)CN(C(=O)N)N=O,,,,,,
3112,93113,Bis(N-carbamyl-N-nitroso)hexamethylenediamine,C(CCCN(C(=O)N)N=O)CCN(C(=O)N)N=O,,,,,,
3113,93114,"6-Ethyl-5-phenylpyrimidine-2,4-diamine",CCC1=C(C(=NC(=N1)N)N)C2=CC=CC=C2,,,,,,
3114,93115,"1,3,5-Tris(3,5-di-tert-butyl-4-hydroxybenzyl)-1,3,5-triazinane-2,4,6-trione",CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)CN2C(=O)N(C(=O)N(C2=O)CC3=CC(=C(C(=C3)C(C)(C)C)O)C(C)(C)C)CC4=CC(=C(C(=C4)C(C)(C)C)O)C(C)(C)C,,,,,,
3115,93116,"Benzenediazonium, 4-(benzoylamino)-2,5-dimethoxy-",COC1=CC(=C(C=C1NC(=O)C2=CC=CC=C2)OC)[N+]#N,,,,,,
3116,93117,Conen,CCCCOP(=O)(SCC)SCC1=CC=CC=C1,,,,,,
3117,93118,"1,1,1-Tris(4-hydroxyphenyl)ethane",CC(C1=CC=C(C=C1)O)(C2=CC=C(C=C2)O)C3=CC=C(C=C3)O,,,,,,
3118,93119,Dodec-8-enyl acetate,CCCC=CCCCCCCCOC(=O)C,,,,,,
3119,93120,"2,6-Dichlorophenyl acetate",CC(=O)OC1=C(C=CC=C1Cl)Cl,,,,,,
3120,93121,4-Fluoro-3-nitrophenyl azide,C1=CC(=C(C=C1N=[N+]=[N-])[N+](=O)[O-])F,,,,,,
3121,93122,DL-trans-4-Chlorostilbeneoxide,C1=CC=C(C=C1)[C@H]2[C@@H](O2)C3=CC=C(C=C3)Cl,,,,,,
3122,93123,CID 93123,C1CC(=O)N[C@@H]1C(=O)[O-].[Na+],,,,,,
3123,93124,Fmoc-Gly-OH,C1=CC=C2C(=C1)C(C3=CC=CC=C32)COC(=O)NCC(=O)O,,,,,,
3124,93125,"2-Amino-5,6-dimethylbenzimidazole",CC1=CC2=C(C=C1C)N=C(N2)N,,,,,,
3125,93126,"Benzenamine, 4-(2,6-diphenyl-4-pyridinyl)-N,N-dimethyl-",CN(C)C1=CC=C(C=C1)C2=CC(=NC(=C2)C3=CC=CC=C3)C4=CC=CC=C4,,,,,,
3126,93127,4-Hydroxyundecenal,CCCCCCCC(C=CC=O)O,,,,,,
3127,93128,MCPA-2-ethylhexyl,CCCCC(CC)COC(=O)COC1=C(C=C(C=C1)Cl)C,,,,,,
3128,93129,Pentachlorobenzaldehyde oxime,C(=NO)C1=C(C(=C(C(=C1Cl)Cl)Cl)Cl)Cl,,,,,,
3129,93130,"5-Nitro-1,2,3,4-tetrahydronaphthalene",C1CCC2=C(C1)C=CC=C2[N+](=O)[O-],,,,,,
3130,93131,Glycylsarcosine,CN(CC(=O)O)C(=O)CN,,,,,,
3131,93132,CID 93132,CCCCCCCCCCCC(=O)N[C@@H](CCC(=O)O)C(=O)[O-].[Na+],,,,,,
3132,93133,N-Lauroyl-L-glutamic acid,CCCCCCCCCCCC(=O)N[C@@H](CCC(=O)O)C(=O)O,,,,,,
3133,93134,Dimyristoylphosphatidic acid,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)O)OC(=O)CCCCCCCCCCCCC,,,,,,
3134,93135,Xanthorrhizol,CC1=C(C=C(C=C1)[C@H](C)CCC=C(C)C)O,,,,,,
3135,93136,CID 93136,C1=CC(=C(C=C1C2=C(C(=C3C(=CC(=O)C=C3O2)O)O)OC[C@H]([C@@H]([C@@H](CO)O)O)O)O)O,,,,,,
3136,93137,"Bis[3,4,6-trichloro-2-(pentyloxycarbonyl)phenyl] oxalate",CCCCCOC(=O)C1=C(C(=CC(=C1Cl)Cl)Cl)OC(=O)C(=O)OC2=C(C(=C(C=C2Cl)Cl)Cl)C(=O)OCCCCC,,,,,,
3137,93138,"9,11-Tetradecadien-1-ol, acetate, (9Z,11E)-",CCC=CC=CCCCCCCCCOC(=O)C,,,,,,
3138,93139,"5,6-Dimethyl-2-(methylamino)-4-pyrimidinyl dimethylcarbamate",CC1=C(N=C(N=C1OC(=O)N(C)C)NC)C,,,,,,
3139,93140,"6-[6-Amino-8-(methylsulfanyl)-9H-purin-9-yl]-2,5-dihydroxytetrahydro-2H,4H-2lambda~5~-furo[2,3-d][1,3,2]dioxaphosphinin-2-one",CSC1=NC2=C(N=CN=C2N1[C@H]3[C@@H](C4COP(=O)(OC4O3)O)O)N,,,,,,
3140,93141,2-Methyl-5-nitro-1H-imidazole-1-ethyl methanesulphonate,CC1=NC=C(N1CCOS(=O)(=O)C)[N+](=O)[O-],,,,,,
3141,93142,"1H-2-Benzopyran-1-one, 3,4-dihydro-3,8-dihydroxy-3-methyl-",CC1(CC2=C(C(=CC=C2)O)C(=O)O1)O,,,,,,
3142,93143,"Butane-1,4-diol; dimethyl benzene-1,4-dicarboxylate",COC(=O)C1=CC=C(C=C1)C(=O)OC.C(CCO)CO,,,,,,
3143,93144,2-Isobutylphenol,CC(C)CC1=CC=CC=C1O,,,,,,
3144,93145,4-Chloro-o-benzoquinone,C1=CC(=O)C(=O)C=C1Cl,,,,,,
3145,93146,5-Methyl-1H-pyrazol-3-amine,CC1=CC(=NN1)N,,,,,,
3146,93147,Tetrahydrocannabivarin,CCCC1=CC(=C2[C@@H]3C=C(CC[C@H]3C(OC2=C1)(C)C)C)O,"['THCV does not currently have any FDA, Health Canada, or EMA approved indications.']","['Compared to THC which demonstrates its effects through weak partial agonist activity at Cannabinoid-1 (CB1R) and Cannabinoid-2 (CB2R) receptors, THCV acts as a CB1 antagonist and a partial agonist of CB2. Further evidence has also shown that THCV acts as an agonist of GPR55 and l--lysophosphatidylinositol (LPI). Beyond the endocannabinoid system, THCV has also been reported to activate 5HT1A receptors to produce an antipsychotic effect that has therapeutic potential for ameliorating some of the negative, cognitive and positive symptoms of schizophrenia. Furthermore, THCV interacts with different transient receptor potential (TRP) channels including TRPV1, which may contribute to the analgesic, anti-inflammatory and anti-cancer effects of cannabinoids and Cannabis extracts.']",,,,
3147,93148,"Benzothiazole, 2-[(tribromomethyl)sulfonyl]-",C1=CC=C2C(=C1)N=C(S2)S(=O)(=O)C(Br)(Br)Br,,,,,,
3148,93149,"4-Methyl-1,10-phenanthroline",CC1=C2C=CC3=C(C2=NC=C1)N=CC=C3,,,,,,
3149,93150,Creatinine sulfate,CN1CC(=O)N=C1N.OS(=O)(=O)O,,,,,,
3150,93151,CID 93151,CCCC[SnH](CCCC)CCCC.CCCC[SnH](CCCC)CCCC.C1(=C(C(=C(C(=C1Cl)Cl)Cl)Cl)C(=O)O)C(=O)O,,,,,,
3151,93152,"2-Propenoic acid, 2-methyl-, 4-hydroxyphenyl ester",CC(=C)C(=O)OC1=CC=C(C=C1)O,,,,,,
3152,93153,"1-(2,3-Dimethylphenyl)-1H-pyrrole-2,5-dione",CC1=C(C(=CC=C1)N2C(=O)C=CC2=O)C,,,,,,
3153,93154,Quinupramine,C1CN2CCC1C(C2)N3C4=CC=CC=C4CCC5=CC=CC=C53,,,,,,
3154,93155,"Benzenediazonium, 2,5-diethoxy-4-(4-morpholinyl)-, sulfate (1:1)",CCOC1=CC(=C(C=C1[N+]#N)OCC)N2CCOCC2.OS(=O)(=O)[O-],,,,,,
3155,93156,"4-[2-(2,5-Dimethoxyphenyl)ethenyl]aniline",COC1=CC(=C(C=C1)OC)C=CC2=CC=C(C=C2)N,,,,,,
3156,93157,"(1,1'-Biphenyl)-2,3'-diamine",C1=CC=C(C(=C1)C2=CC(=CC=C2)N)N,,,,,,
3157,93158,2-(Octylamino)ethanol,CCCCCCCCNCCO,,,,,,
3158,93159,Bucloxic acid,C1CCC(CC1)C2=C(C=C(C=C2)C(=O)CCC(=O)O)Cl,,,"['Drugs used for their actions on skeletal muscle. Included are agents that act directly on skeletal muscle, those that alter neuromuscular transmission (NEUROMUSCULAR BLOCKING AGENTS), and drugs that act centrally as skeletal muscle relaxants (MUSCLE RELAXANTS, CENTRAL). Drugs used in the treatment of movement disorders are ANTI-DYSKINESIA AGENTS. (See all compounds classified as Neuromuscular Agents.)']",,,
3159,93160,"1,4,7,10,13,16,19-Heptaoxacyclohenicosane",C1COCCOCCOCCOCCOCCOCCO1,,,,,,
3160,93161,"Methyl 9,10-dichlorooctadecanoate",CCCCCCCCC(C(CCCCCCCC(=O)OC)Cl)Cl,,,,,,
3161,93162,4-Pentylaniline,CCCCCC1=CC=C(C=C1)N,,,,,,
3162,93163,"Benzamide, p-(3,3-dimethyl-1-triazeno)-",CN(C)N=NC1=CC=C(C=C1)C(=O)N,,,,,,
3163,93164,1-Decyl-1H-imidazole,CCCCCCCCCCN1C=CN=C1,,,,,,
3164,93165,Calcium bromolactobionate,C([C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@H]([C@@H](CO)O)[C@@H]([C@H](C(=O)[O-])O)O)O)O)O)O.C([C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@H]([C@@H](CO)O)[C@@H]([C@H](C(=O)[O-])O)O)O)O)O)O.[Ca+2].[Ca+2].[Br-].[Br-],,,,,,
3165,93166,"2,7-Dithia-3,6-diazaoctanedithioamide, N,N,N',N'-tetramethyl-",CN(C)C(=S)SNCCNSC(=S)N(C)C,,,,,,
3166,93167,"2-Butanone, O,O',O'',O'''-silanetetrayltetraoxime",CCC(=NO[Si](ON=C(C)CC)(ON=C(C)CC)ON=C(C)CC)C,,,,,,
3167,93168,"3-(3,4-Dimethoxyphenyl)-2-methyl-6-methylaminohexane-3-carbonitrile",CC(C)C(CCCNC)(C#N)C1=CC(=C(C=C1)OC)OC,,,,,['D-617 is a known human metabolite of Verapamil.'],
3168,93169,"N-(3-Methoxypropyl)-3,4,5-trimethoxybenzylamine",COCCCNCC1=CC(=C(C(=C1)OC)OC)OC,,,,,,
3169,93170,"Benz(a)anthracene, 7-bromomethyl-1-methyl-",CC1=C2C(=CC=C1)C=CC3=C(C4=CC=CC=C4C=C32)CBr,,,,,,
3170,93171,4-Bromo-7-bromomethylbenz(a)anthracene,C1=CC=C2C(=C1)C=C3C4=C(C=CC3=C2CBr)C(=CC=C4)Br,,,,,,
3171,93172,4-Chloro-7-bromomethylbenz(a)anthracene,C1=CC=C2C(=C1)C=C3C4=C(C=CC3=C2CBr)C(=CC=C4)Cl,,,,,,
3172,93173,"Ammonium bis(2,3-dibromopropyl) phosphate",C(C(CBr)Br)OP(=O)(O)OCC(CBr)Br.N,,,,,,
3173,93174,"2-Propanimine, N-chloro-",CC(=NCl)C,,,,,,
3174,93175,Dansyl fluoride,CN(C)C1=CC=CC2=C1C=CC=C2S(=O)(=O)F,,,,,,
3175,93176,L-Thioproline,C1[C@H](NCS1)C(=O)O,,,,,,
3176,93177,3-Quinolinecarbonitrile,C1=CC=C2C(=C1)C=C(C=N2)C#N,,,,,,
3177,93178,Cyclafuramid,CC1=CC(=C(O1)C)C(=O)NC2CCCCC2,,,,,,
3178,93179,"Benzenamine, 2,6-diethyl-N-methylene-",CCC1=C(C(=CC=C1)CC)N=C,,,,,,
3179,93180,"Benz(a)anthracene, 2,7,12-trimethyl-",CC1=CC2=C(C=C1)C=CC3=C(C4=CC=CC=C4C(=C32)C)C,,,,,,
3180,93181,Dodec-9-en-1-ol,CCC=CCCCCCCCCO,,,,,,
3181,93182,"2,6-Difluoro-N-(((4-fluorophenyl)amino)carbonyl)benzamide",C1=CC(=C(C(=C1)F)C(=O)NC(=O)NC2=CC=C(C=C2)F)F,,,,,,
3182,93183,Quinoline-8-carbonitrile,C1=CC2=C(C(=C1)C#N)N=CC=C2,,,,,,
3183,93184,Carbenicillin indanyl,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)C(C3=CC=CC=C3)C(=O)OC4=CC5=C(CCC5)C=C4)C(=O)O)C,"['For the treatment of acute and chronic infections of the upper and lower urinary tract and in asymptomatic bacteriuria (due to susceptible strains Escherichia coli, Proteus mirabilis, Morganella morganii, Providencia rettgeri, Proteus vulgaris, Pseudomonas, Enterobacter, and Enterococci.). Also indicated in the treatment of prostatitis (due to susceptible strains Escherichia coli Enterococcus (S. faecalis), Proteus mirabilis Enterobacter sp.).']",,['Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)'],,,
3184,93185,"3-Nitrosotetrahydro-1,3-oxazine",C1CN(COC1)N=O,,,,,,
3185,93186,Ipsenol,CC(C)C[C@@H](CC(=C)C=C)O,,,,,,
3186,93187,1-Methyleneurea,C=NC(=O)N,,,,,,
3187,93188,2-(2-Nitrophenyl)aniline,C1=CC=C(C(=C1)C2=CC=CC=C2[N+](=O)[O-])N,,,,,,
3188,93189,"2,5-Diisopropylphenol",CC(C)C1=CC(=C(C=C1)C(C)C)O,,,,,,
3189,93190,N-Heptylmethylamine,CCCCCCCNC,,,,,,
3190,93191,Acetylcholine mustard,CC(=O)OCCN(C)CCCl,,,,,,
3191,93192,3-Azetidinecarboxylic acid,C1C(CN1)C(=O)O,,,,,,
3192,93193,(2S)-2-methyl-1-nitrosopiperidine,C[C@H]1CCCCN1N=O,,,,,,
3193,93194,Meglumine indomethacinate,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O.CNC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O,,,,,,
3194,93195,"1,5-Pentanediol diacrylate",C=CC(=O)OCCCCCOC(=O)C=C,,,,,,
3195,93196,"1,8-I-Aedans",C1=CC2=C(C(=C1)NCCNC(=O)CI)C(=CC=C2)S(=O)(=O)O,,,,,,
3196,93197,"Phosphoric acid, ethyl ester",CCO.OP(=O)(O)O,,,,,,
3197,93198,Melamine cyanurate,C1(=NC(=NC(=N1)N)N)N.C1(=O)NC(=O)NC(=O)N1,,,,,,
3198,93199,4-(4-Methyl-3-pentenyl)cyclohex-3-ene-1-carbaldehyde,CC(=CCCC1=CCC(CC1)C=O)C,,,,,,
3199,93200,Etacelasil,COCCO[Si](CCCl)(OCCOC)OCCOC,,,,,,
3200,93201,"4,5-Dimethyl-2-[(1r,2r,4s)-1,7,7-trimethylbicyclo[2.2.1]hept-2-yl]phenol",CC1=CC(=C(C=C1C)O)[C@@H]2C[C@@H]3CC[C@]2(C3(C)C)C,,,,,,
3201,93202,Valeric acid hydrazide,CCCCC(=O)NN,,,,,,
3202,93203,Ethylnitrosocyanamide,CCN(C#N)N=O,,,,,,
3203,93204,"O,O-Diacetyl-4-hydroxyaminoquinoline 1-oxide",CC(=O)ONC1C=CN(C2=CC=CC=C12)OC(=O)C,,,,,,
3204,93205,(R)-N-(1-Methyl-2-phenylethyl)adenosine,C[C@H](CC1=CC=CC=C1)NC2=C3C(=NC=N2)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O,,,"['Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)', 'Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)']",,,
3205,93206,2-Acetyl-2-methyl-1-phenylhydrazine,CC(=O)N(C)NC1=CC=CC=C1,,,,,,
3206,93207,"Tetrakis(2,4-di-tert-butylphenyl) [1,1'-biphenyl]-4,4'-diylbis(phosphonite)",CC(C)(C)C1=CC(=C(C=C1)OP(C2=CC=C(C=C2)C3=CC=C(C=C3)P(OC4=C(C=C(C=C4)C(C)(C)C)C(C)(C)C)OC5=C(C=C(C=C5)C(C)(C)C)C(C)(C)C)OC6=C(C=C(C=C6)C(C)(C)C)C(C)(C)C)C(C)(C)C,,,,,,
3207,93208,N-Diazoacetylglycine methylamide,CNC(=O)CNC(=O)C=[N+]=[N-],,,,,,
3208,93209,CID 93209,CNC(=O)CNC(=C[N+]#N)O,,,,,,
3209,93210,"Platinum (II), bis(cyclopropylammine)dichloro-, trans-",C1CC1N.C1CC1N.[Cl-].[Cl-].[Pt+2],,,,,,
3210,93211,cis-Dichloro(o-phenylenediamine)platinum(II),C1=CC=C(C(=C1)N)N.[Cl-].[Cl-].[Pt+2],,,,,,
3211,93212,Dichlorobis(aziridine)platinum II,C1CN1.C1CN1.[Cl-].[Cl-].[Pt+2],,,,,,
3212,93213,"3-bromo-2-[(3R,4S,5S,7S)-7-[(2S,3S,5S)-5-ethyl-5-[(2R,5R,6S)-5-ethyl-5-hydroxy-6-methyloxan-2-yl]-3-methyloxolan-2-yl]-4-hydroxy-3,5-dimethyl-6-oxononyl]-6-hydroxy-5-methylbenzoic acid",CC[C@@H]([C@@H]1[C@H](C[C@@](O1)(CC)[C@H]2CC[C@@]([C@@H](O2)C)(CC)O)C)C(=O)[C@@H](C)[C@H]([C@H](C)CCC3=C(C=C(C(=C3C(=O)O)O)C)Br)O,,,,,,
3213,93214,4'-Isobutylacetophenone,CC(C)CC1=CC=C(C=C1)C(=O)C,,,,,,
3214,93215,"1H-Imidazole, 1-methyl-2-nitro-5-vinyl-",CN1C(=CN=C1[N+](=O)[O-])C=C,,,,,,
3215,93216,Polyoxyethylene lauryl ether phosphate,CCCCCCCCCCCCOCCO.OP(=O)(O)O,,,,,,
3216,93217,Oleyl triethoxy mono diphosphate,CCCCCCCCC=CCCCCCCCCOCCO.OP(=O)(O)O,,,,,,
3217,93218,2-Hydroxy-2-(3-phenoxyphenyl)acetonitrile,C1=CC=C(C=C1)OC2=CC=CC(=C2)C(C#N)O,,,,,,
3218,93219,1-Ethyltheobromine,CCN1C(=O)C2=C(N=CN2C)N(C1=O)C,,,,,,
3219,93220,3-hydroxyheptadecanoic Acid,CCCCCCCCCCCCCCC(CC(=O)O)O,,,,,,
3220,93221,"1,3,5-Triazine-2,4,6(1H,3H,5H)-trione, 1,3,5-tris[[4-(1,1-dimethylethyl)-3-hydroxy-2,6-dimethylphenyl]methyl]-",CC1=CC(=C(C(=C1CN2C(=O)N(C(=O)N(C2=O)CC3=C(C(=C(C=C3C)C(C)(C)C)O)C)CC4=C(C(=C(C=C4C)C(C)(C)C)O)C)C)O)C(C)(C)C,,,,,,
3221,93222,"Triazene, 1-(p-bromophenyl)-3-methyl-",CN=NNC1=CC=C(C=C1)Br,,,,,,
3222,93223,1-(4-Iodophenyl)-3-methyltriazene,CN=NNC1=CC=C(C=C1)I,,,,,,
3223,93224,"4,7-Methano-1H-isoindole-1,3(2H)-dione, 5,6-dibromohexahydro-2-phenyl-",C1C2C3C(C1C(C2Br)Br)C(=O)N(C3=O)C4=CC=CC=C4,,,,,,
3224,93225,CID 93225,CC1=C(NC(=NC1=O)N(C)C)C,,,,,,
3225,93226,1-Methyl-3-nitronaphthalene,CC1=CC(=CC2=CC=CC=C12)[N+](=O)[O-],,,,,,
3226,93227,"Ethane, 1,1'-[methylenebis(sulfonyl)]bis[2-chloro-",C(CCl)S(=O)(=O)CS(=O)(=O)CCCl,,,,,,
3227,93228,Fluoroimide,C1=CC(=CC=C1N2C(=O)C(=C(C2=O)Cl)Cl)F,,,,,,
3228,93229,2-Hydroxypropyl methanethiolsulfonate,CC(COS(=O)(=S)C)O,,,,,,
3229,93230,[Ethyl({[ethyl(phenyl)carbamothioyl]disulfanyl}carbothioyl)amino]benzene,CCN(C1=CC=CC=C1)C(=S)SSC(=S)N(CC)C2=CC=CC=C2,,,,,,
3230,93231,"2-Methyl-6-methylene-1,7-octadien-3-one",CC(=C)C(=O)CCC(=C)C=C,,,,,,
3231,93232,5-Nitro-1H-indene,C1C=CC2=C1C=CC(=C2)[N+](=O)[O-],,,,,,
3232,93233,Oxyprothepin decanoate,CCCCCCCCCC(=O)OCCCN1CCN(CC1)C2CC3=CC=CC=C3SC4=C2C=C(C=C4)SC,,,,,,
3233,93234,C.I. Basic Red 29,CN1C2=CC=CC=C2C(=C1C3=CC=CC=C3)N=NC4=[N+](C=CS4)C.[Cl-],,,,,,
3234,93235,2-(1-Methyl-2-phenyl-1H-indol-3-ylazo)-3-methylthiazol-3-ium,CN1C2=CC=CC=C2C(=C1C3=CC=CC=C3)N=NC4=[N+](C=CS4)C,,,,,,
3235,93236,"2,3,5-Trithiahexane",CSCSSC,,,,,,
3236,93237,"Methyl 2,6-dichloroisonicotinate",COC(=O)C1=CC(=NC(=C1)Cl)Cl,,,,,,
3237,93238,cis-Cccnu,C1CC(CCC1C(=O)O)NC(=O)N(CCCl)N=O,,,,,,
3238,93239,1-Nitrosohydantoin,C1C(=O)NC(=O)N1N=O,,,,,,
3239,93240,CID 93240,CCCCCCCC(=O)O.C([C@@H]1[C@H]([C@@H]([C@](O1)(CO)O[C@@H]2[C@@H]([C@H](C([C@H](O2)CO)O)O)O)O)O)O,,,,,,
3240,93241,CID 93241,C(C1[C@H]([C@@H]([C@](O1)(CO)O[C@@H]2[C@@H]([C@H](C(C(O2)CO)O)O)O)O)O)O,,,,,,
3241,93242,3-Fluoro-l-alanine,C([C@@H](C(=O)O)N)F,,,,,,
3242,93243,"4-Chloro-2-methylbenzene-1,3-diamine",CC1=C(C=CC(=C1N)Cl)N,,,,,,
3243,93244,"1,3-Benzenediamine, 4-chloro-6-methyl-",CC1=CC(=C(C=C1N)N)Cl,,,,,,
3244,93245,Trimethyloxonium,C[O+](C)C,,,,,,
3245,93246,Isopropyl phenyl phosphate,CC(C)OP(=O)(O)OC1=CC=CC=C1,,,,,,
3246,93247,"1,1-Bis(4-cyanatophenyl)ethane",CC(C1=CC=C(C=C1)OC#N)C2=CC=C(C=C2)OC#N,,,,,,
3247,93248,"Bis(1,3-diethylthiobarbiturate)trimethineoxonol",CCN1C(=O)C(C(=O)N(C1=S)CC)C=CC=C2C(=O)N(C(=S)N(C2=O)CC)CC,,,"['Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)']",,,
3248,93249,"Oxirane, 2,2'-[9H-fluoren-9-ylidenebis(4,1-phenyleneoxymethylene)]bis-",C1C(O1)COC2=CC=C(C=C2)C3(C4=CC=CC=C4C5=CC=CC=C53)C6=CC=C(C=C6)OCC7CO7,,,,,,
3249,93250,2-Oxoquazepam,C1C(=O)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F,,,,,['2-oxoquazepam has known human metabolites that include 3-Hydroxy-2-oxoquazepam and N-Desalkyl-2-oxoquazepam.'],
3250,93251,"1,2,4-Trichloronaphthalene",C1=CC=C2C(=C1)C(=CC(=C2Cl)Cl)Cl,,,,,,
3251,93252,2-(4-(Dimethylamino)phenyl)ethanol,CN(C)C1=CC=C(C=C1)CCO,,,,,,
3252,93253,"Phenol, 3-[2-chloro-4-(trifluoromethyl)phenoxy]-, acetate",CC(=O)OC1=CC=CC(=C1)OC2=C(C=C(C=C2)C(F)(F)F)Cl,,,,,,
3253,93254,"Dipropyl 1,3-dithiolan-2-ylidenepropanedioate",CCCOC(=O)C(=C1SCCS1)C(=O)OCCC,,,,,,
3254,93255,"Dibutyl 1,3-dithiolan-2-ylidenepropanedioate",CCCCOC(=O)C(=C1SCCS1)C(=O)OCCCC,,,,,,
3255,93256,Dichlorostyrene,C1=CC=C(C=C1)C=C(Cl)Cl,,,,,,
3256,93257,"1H-Benzimidazole, 2-ethyl-4-nitro-6-(trifluoromethyl)-",CCC1=NC2=C(N1)C=C(C=C2[N+](=O)[O-])C(F)(F)F,,,,,,
3257,93258,2'-Azido-2'-deoxycytidine,C1=CN(C(=O)N=C1N)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)N=[N+]=[N-],,,,,,
3258,93259,2-tert-Butylazo-2-methoxy-4-methylpentane,CC(C)CC(C)(N=NC(C)(C)C)OC,,,,,,
3259,93260,CID 93260,CCCCCCCCCCCC[S-].CCCCCCCCCCCC[S-].C[Sn]C,,,,,,
3260,93261,CID 93261,CC(=O)N=C1C=CC(=O)C(=C1)N(O)O,,,,,,
3261,93262,(2-(2-(4-(Dimethylamino)phenyl)ethenyl)-6-methyl-4H-pyran-4-ylidene)propanedinitrile,CC1=CC(=C(C#N)C#N)C=C(O1)C=CC2=CC=C(C=C2)N(C)C,,,,,,
3262,93263,Propybicyphat,CCCC12COP(=O)(OC1)OC2,,,,,,
3263,93264,"(1R,4S,6R,8R,20R,21R,24S)-6'-ethyl-21,24-dihydroxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one",CCC1C(CC[C@@]2(O1)C[C@@H]3C[C@H](O2)CC=C(CC(C=CC=C4CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)C)C,,,,,,
3264,93265,"4,4'-Dinitro-2-biphenylamine",C1=CC(=CC=C1C2=C(C=C(C=C2)[N+](=O)[O-])N)[N+](=O)[O-],,,,,,
3265,93266,"7,8-Dibromo-1,2,3,4,11,11-hexachloro-1,4,4a,5,6,7,8,9,10,10a-decahydro-1,4-methanobenzocyclooctene",C1CC(C(CCC2C1C3(C(=C(C2(C3(Cl)Cl)Cl)Cl)Cl)Cl)Br)Br,,,,,,
3266,93267,1-(3-Chlorophthalimido)cyclohexanecarboxamide,C1CCC(CC1)(C(=O)N)N2C(=O)C3=C(C2=O)C(=CC=C3)Cl,,,,,,
3267,93268,CID 93268,C.CCC(O)OCC.CCOC(C)CO,,,,,,
3268,93269,Ethoxypropanol,CCC(O)OCC,,,,,,
3269,93270,N-Acetylhystrine,CC(=O)N1CCCC(=C1)C2=NCCCC2,,,,,,
3270,93271,6-Benzoyl-2-naphthol,C1=CC=C(C=C1)C(=O)C2=CC3=C(C=C2)C=C(C=C3)O,,,,,,
3271,93272,"2-((3-Aziridin-1-ylpropionyl)methyl)-2-ethylpropane-1,3-diyl bis(aziridine-1-propionate)",CCC(COC(=O)CCN1CC1)(COC(=O)CCN2CC2)COC(=O)CCN3CC3,,,,,,
3272,93273,Hydroxymalonatodiammine platinum (II),C(C(=O)[O-])(C(=O)[O-])O.N.N.[Pt+2],,,,,,
3273,93274,Suc-D-Ala-Ala-Ala-pNA,C[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NC1=CC=C(C=C1)[N+](=O)[O-])NC(=O)CCC(=O)O,,,,,,
3274,93275,Isoprothiolane sulfoxide,CC(C)OC(=O)C(=C1SCCS1=O)C(=O)OC(C)C,,,,,,
3275,93276,"3-[2,3-Bis(3-prop-2-enoyloxypropoxy)propoxy]propyl prop-2-enoate",C=CC(=O)OCCCOCC(COCCCOC(=O)C=C)OCCCOC(=O)C=C,,,,,,
3276,93277,4-Diazo-2-methylpyrrolidinobenzene zinc chloride,CC1=C(C=CC(=C1)[N+]#N)N2CCCC2.[Cl-].[Cl-].[Cl-].[Zn+2],,,,,,
3277,93278,"Benzenediazonium, 3-methyl-4-(1-pyrrolidinyl)-",CC1=C(C=CC(=C1)[N+]#N)N2CCCC2,,,,,,
3278,93279,Methylcarbamoyloxyethyl acrylate,CNC(=O)OCCOC(=O)C=C,,,,,,
3279,93280,"2,3,4-Trimethylheptane",CCCC(C)C(C)C(C)C,,,,,,
3280,93281,"N,N'-(Ethylene)bis[4,5-dibromohexahydro-3,6-methanophthalimide]",C1C2C3C(C1C(C2Br)Br)C(=O)N(C3=O)CCN4C(=O)C5C6CC(C5C4=O)C(C6Br)Br,,,,,,
3281,93282,2-Bromo-3-methoxy-acrolein,COC=C(C=O)Br,,,,,,
3282,93283,(-)-Indoprofen,C[C@H](C1=CC=C(C=C1)N2CC3=CC=CC=C3C2=O)C(=O)O,,,,,,
3283,93284,Pentaerythritol diacrylate,C=CC(=O)OCC(CO)(CO)COC(=O)C=C,,,,,,
3284,93285,[2-(2-Aminopropoxy)-3-methylphenyl]methanol,CC1=C(C(=CC=C1)CO)OCC(C)N,,,,,,
3285,93286,"Phenol, 4-(2-aminopropoxy)-3,5-dimethyl-",CC1=CC(=CC(=C1OCC(C)N)C)O,,,,,,
3286,93287,alpha-Benzyl-N-methylphenethylamine,CNC(CC1=CC=CC=C1)CC2=CC=CC=C2,,,,,,
3287,93288,Bendacort,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)COC(=O)COC5=NN(C6=CC=CC=C65)CC7=CC=CC=C7)O)C)O,,,,,,
3288,93289,"1,3-Bis(3-chlorophenyl)-2-(trichloromethyl)imidazolidine",C1CN(C(N1C2=CC(=CC=C2)Cl)C(Cl)(Cl)Cl)C3=CC(=CC=C3)Cl,,,,,,
3289,93290,1-Ethyl-1-methylcyclopropane,CCC1(CC1)C,,,,,,
3290,93291,3-Phenoxybenzyl chloride,C1=CC=C(C=C1)OC2=CC=CC(=C2)CCl,,,,,,
3291,93292,"8,10-Dodecadien-1-ol, acetate, (8E,10E)-",CC=CC=CCCCCCCCOC(=O)C,,,,,,
3292,93293,Mercaptomethylmercury,C[Hg+].[SH-],,,,,,
3293,93294,2-Methyl-6-nitronaphthalene,CC1=CC2=C(C=C1)C=C(C=C2)[N+](=O)[O-],,,,,,
3294,93295,CID 93295,C1=CC=C(C(=C1)N=C2C=CC(=O)C=C2)N(O)O,,,,,,
3295,93296,"N,N-Bis(2-hydroxyethyl)-p-phenylenediamine sulphate",C1=CC(=CC=C1N)N(CCO)CCO.OS(=O)(=O)O,,,,,,
3296,93297,"1H-Isoindole-1,3(2H)-dione, 2-butyl-5-nitro-",CCCCN1C(=O)C2=C(C1=O)C=C(C=C2)[N+](=O)[O-],,,,,,
3297,93298,"2-Pyrrolidinone, 1-nitroso-",C1CC(=O)N(C1)N=O,,,,,,
3298,93299,1-Ethyl-1-nitroso-3-phenylurea,CCN(C(=O)NC1=CC=CC=C1)N=O,,,,,,
3299,93300,6-Methyl-1-nitronaphthalene,CC1=CC2=C(C=C1)C(=CC=C2)[N+](=O)[O-],,,,,,
3300,93301,"Propanedioic acid, (bis(methylthio)methylene)-, bis(1-methylethyl) ester",CC(C)OC(=O)C(=C(SC)SC)C(=O)OC(C)C,,,,,,
3301,93302,"1H-Pyrrole-2,5-dione, 1-[7-(dimethylamino)-4-methyl-2-oxo-2H-1-benzopyran-3-yl]-",CC1=C(C(=O)OC2=C1C=CC(=C2)N(C)C)N3C(=O)C=CC3=O,,,"['Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)', 'Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)']",,,
3302,93303,4-Desacetylvinblastine hydrazide,CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)NN)O)O)CC)OC)C(=O)OC)O,,,,,,
3303,93304,2-Ethyl-7-nitro-1-propyl-5-(trifluoromethyl)-1H-benzimidazole,CCCN1C(=NC2=C1C(=CC(=C2)C(F)(F)F)[N+](=O)[O-])CC,,,,,,
3304,93305,"2,3,6-Trichloronaphthalene",C1=CC(=CC2=CC(=C(C=C21)Cl)Cl)Cl,,,,,,
3305,93306,Phomenone,C[C@H]1[C@@H](CCC2=CC(=O)[C@]3([C@@H]([C@]12C)O3)C(=C)CO)O,,,,,,
3306,93307,"3-[1-[(2S)-2-(2,3-dihydro-1,4-benzodioxin-3-yl)-2-hydroxyethyl]piperidin-4-yl]-1H-benzimidazol-2-one",C1CN(CCC1N2C3=CC=CC=C3NC2=O)C[C@@H](C4COC5=CC=CC=C5O4)O,,,,,,
3307,93308,Butylhydrazine hydrochloride,CCCCNN.Cl,,,,,,
3308,93309,CID 93309,C1=CC=C(C=C1)CS(=O)(=O)[O-].[Na+],,,,,,
3309,93310,"1,11-Bis(8-quinolinyloxy)-3,6,9-trioxaundecane",C1=CC2=C(C(=C1)OCCOCCOCCOCCOC3=CC=CC4=C3N=CC=C4)N=CC=C2,,,,,,
3310,93311,Resorcinol bis(diphenyl phosphate),C1=CC=C(C=C1)OP(=O)(OC2=CC=CC=C2)OC3=CC(=CC=C3)OP(=O)(OC4=CC=CC=C4)OC5=CC=CC=C5,,,,,,
3311,93312,"Propane-1,3-diyl bis(4-aminobenzoate)",C1=CC(=CC=C1C(=O)OCCCOC(=O)C2=CC=C(C=C2)N)N,,,,,,
3312,93313,Disuccinimido dithiobispropionate,C1CC(=O)N(C1=O)OC(=O)CCSSCCC(=O)ON2C(=O)CCC2=O,,,"['Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)', 'Reagents with two reactive groups, usually at opposite ends of the molecule, that are capable of reacting with and thereby forming bridges between side chains of amino acids in proteins; the locations of naturally reactive areas within proteins can thereby be identified; may also be used for other macromolecules, like glycoproteins, nucleic acids, or other. (See all compounds classified as Cross-Linking Reagents.)']",,,
3313,93314,2-[(Tert-butyl)azo]butan-2-ol,CCC(C)(N=NC(C)(C)C)O,,,,,,
3314,93315,Acequinocyl,CCCCCCCCCCCCC1=C(C(=O)C2=CC=CC=C2C1=O)OC(=O)C,,,,,"['Findings of red-brown to dark-red urine were noted in both sexes /of F344 rats after oral dosing/ at 800 and 1600 ppm. This may represent a metabolite of acequinocyl, which is a colored naphthoquinone similar to Vitamin K.', 'Small groups of CD rats were dosed orally with acequinocyl, labeled with 14C in the phenyl or dodecyl moieties, using 1% methyl cellulose as vehicle. Both label placements were involved in single low dose studies (10 mg/kg). High dose (500 mg/kg) and 14-day repeat-dose studies (10 mg/kg/day) were performed with phenyl-labeled acequinocyl only. Initial studies using CO2 traps found less than 0.2% of dose in exhaled air. Absorption was about 25-42%, based on bile duct cannulation studies, which found 20-33% of administered dose in bile, plus 5-9% in urine plus cage wash. Intact rats excreted most of the dose in feces, compared with less than 15% of label being found in urine. Clearance from the body was rapid, with reductions in most tissue levels at least 10-fold between 24 hr and 72 hr post-dosing. Parent compound was not detectable in urine, and was only a minor component (typically 1-2%) of fecal residues. Cleavage of the acetyl group of acequinocyl yielded 2-hydroxy-3-dodecyl-1,4-naphthalenedione (designated ""R1"") as a major fecal metabolite (12-36% of dose). Subsequent oxidation of the dodecyl chain yielded butanoic (AKM 14) and hexanoic (AKM 15) acids, the only measurable identified urinary metabolites. An apparent final product of epoxidation of R1 was AKM 18, [2- (1,2-dioxotetradecyl)-benzoic acid], which comprised 19-40% of label in feces. All four identified metabolites were found in bile and plasma in similar proportions. There were no remarkable differences in metabolite disposition due to gender, and no effect of pre-dosing for 2 weeks. The large dose slowed transit time and appreciably reduced absorption.', 'This study utilized 5 male CD rats, 3 of which were cannulated to obtain bile samples. Bile samples were evaluated for metabolite composition from 12 rats, including 3 rats/sex/treatment at low and high dose levels (10 and 500 mg/kg single dose treatments, respectively). The present study confirmed that the only two major urinary metabolites were AKM 14 and hexanoic AKM 15 ... The present study identified the major biliary metabolite as conjugate of 2-hydroxy-3-dodecyl-1,4-naphthalenedione, /the/ de-acetylated parent compound. The conjugation moiety is presumed to be glucuronic acid, based on the MW of the conjugated product.']",
3315,93316,"3-Formazancarbonitrile, 1,5-bis(4-(trifluoromethyl)phenyl)-",C1=CC(=CC=C1C(F)(F)F)NN=C(C#N)N=NC2=CC=C(C=C2)C(F)(F)F,,,,,,
3316,93317,2-[(1S)-4-methylcyclohex-3-en-1-yl]propan-2-yl acetate,CC1=CC[C@H](CC1)C(C)(C)OC(=O)C,,,,,,
3317,93318,2-[Methyl-bis(2-octadec-9-enoyloxyethylsulfanyl)stannyl]sulfanylethyl octadec-9-enoate,CCCCCCCCC=CCCCCCCCC(=O)OCCS[Sn](C)(SCCOC(=O)CCCCCCCC=CCCCCCCCC)SCCOC(=O)CCCCCCCC=CCCCCCCCC,,,,,,
3318,93319,2-Sulfanylethyl octadec-9-enoate,CCCCCCCCC=CCCCCCCCC(=O)OCCS,,,,,,
3319,93320,5-(Methylsulfanyl)pentanenitrile,CSCCCCC#N,,,,,,
3320,93321,Lauryl glucoside,CCCCCCCCCCCCO[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O,,,,,,
3321,93322,"2,2',4,4',6,6'-Hexabromobiphenyl",C1=C(C=C(C(=C1Br)C2=C(C=C(C=C2Br)Br)Br)Br)Br,,,,,,
3322,93323,"2,2'-Oxybis(1,3-dichloropropane)",C(C(CCl)OC(CCl)CCl)Cl,,,,,,
3323,93324,"1,2-Dichloro-3-[2-chloro-1-(chloromethyl)ethoxy]propane",C(C(CCl)Cl)OC(CCl)CCl,,,,,,
3324,93325,"Thiocyanic acid, 4-methoxy-2-nitrophenyl ester",COC1=CC(=C(C=C1)SC#N)[N+](=O)[O-],,,,,,
3325,93326,2-[3-(Methylamino)-4-nitrophenoxy]ethanol,CNC1=C(C=CC(=C1)OCCO)[N+](=O)[O-],,,,,,
3326,93327,"Benzoic acid, 4-(1,1-dimethylethyl)-, compd. with 2,2',2''-nitrilotris[ethanol] (1:1)",CC(C)(C)C1=CC=C(C=C1)C(=O)O.C(CO)N(CCO)CCO,,,,,,
3327,93328,"3',5'-Diiodothyronine",C1=CC(=CC=C1CC(C(=O)O)N)OC2=CC(=C(C(=C2)I)O)I,,,,,,
3328,93329,Methyl thiazolidine-4-carboxylate,COC(=O)C1CSCN1,,,,,,
3329,93330,CID 93330,CCCC[P+](CCCC)(CCCC)CCCC.C1=CC=C(C=C1)P(=O)[O-],,,,,,
3330,93331,Vinylcyclooctane,C=CC1CCCCCCC1,,,,,,
3331,93332,Colletotrichin,CC1=C(C(=O)C(=C(O1)OC)C[C@H]2C(=C)CC[C@H]3[C@]2(CC[C@@H]([C@]3(C)CCC(C)(C)O)O)C)C(=O)OC,,,,,,
3332,93333,"Dibutyl 3,3'-(dichlorostannylene)dipropionate",CCCCOC(=O)CC[Sn](CCC(=O)OCCCC)(Cl)Cl,,,,,,
3333,93334,2-Oxo-3(2H)-benzothiazolacetonitrile,C1=CC=C2C(=C1)N(C(=O)S2)CC#N,,,,,,
3334,93335,"N-(4-Methylpentan-2-yl)-N-phenylbenzene-1,4-diamine",CC(C)CC(C)N(C1=CC=CC=C1)C2=CC=C(C=C2)N,,,,,,
3335,93336,"3-(2-Methyl-5-nitro-1h-imidazol-1-yl)propane-1,2-diol",CC1=NC=C(N1CC(CO)O)[N+](=O)[O-],,,,,,
3336,93337,CID 93337,C1=CC=C(C=C1)C(=NNC2=C(C=CC(=C2)S(=O)(=O)[O-])O)N=NC3=CC=CC=C3C(=O)O.[Na+],,,,,,
3337,93338,"5,9-Bis(ethylamino)-10-methylbenzo[a]phenoxazin-7-ium perchlorate",CCNC1=CC2=C(C3=CC=CC=C31)N=C4C=C(C(=[NH+]CC)C=C4O2)C.[O-]Cl(=O)(=O)=O,,,,,,
3338,93339,N-ethyl-9-ethylimino-10-methylbenzo[a]phenoxazin-5-amine,CCNC1=CC2=C(C3=CC=CC=C31)N=C4C=C(C(=NCC)C=C4O2)C,,,,,,
3339,93340,"Bis(2,2,6,6-tetramethyl-4-piperidyl) succinate",CC1(CC(CC(N1)(C)C)OC(=O)CCC(=O)OC2CC(NC(C2)(C)C)(C)C)C,,,,,,
3340,93341,Diclomezine,CC1=C(C=C(C=C1Cl)C2=NNC(=O)C=C2)Cl,,,,,,
3341,93342,"Cyclopropanecarboxylic acid, 3-(2,2-dichloroethenyl)-2,2-dimethyl-, ethyl ester, (1R,3R)-rel-",CCOC(=O)[C@@H]1[C@@H](C1(C)C)C=C(Cl)Cl,,,,,,
3342,93343,"Cyclopropanecarboxylic acid, 3-(2,2-dichloroethenyl)-2,2-dimethyl-, ethyl ester, (1R,3S)-rel-",CCOC(=O)[C@@H]1[C@H](C1(C)C)C=C(Cl)Cl,,,,,,
3343,93344,"Phenol, 2,4-bis(1,1-dimethylethyl)-6-(1-phenylethyl)-",CC(C1=CC=CC=C1)C2=C(C(=CC(=C2)C(C)(C)C)C(C)(C)C)O,,,,,,
3344,93345,"2,4,4',6-Tetrachlorodiphenyl ether",C1=CC(=CC=C1OC2=C(C=C(C=C2Cl)Cl)Cl)Cl,,,,,,
3345,93346,"3,4,4'-Trichlorodiphenyl ether",C1=CC(=CC=C1OC2=CC(=C(C=C2)Cl)Cl)Cl,,,,,,
3346,93347,"Benzenecarboximidamide, 4,4'-methylenebis-",C1=CC(=CC=C1CC2=CC=C(C=C2)C(=N)N)C(=N)N,,,,,,
3347,93348,"Bis(1,2,2,6,6-pentamethyl-4-piperidyl) [[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methyl]butylmalonate",CCCCC(CC1=CC(=C(C(=C1)C(C)(C)C)O)C(C)(C)C)(C(=O)OC2CC(N(C(C2)(C)C)C)(C)C)C(=O)OC3CC(N(C(C3)(C)C)C)(C)C,,,,,,
3348,93349,N'-Ethyl-N-nitro-N-nitrosoguanidine,CCN=C(N)N(N=O)[N+](=O)[O-],,,,,,
3349,93350,"1,2-Ethanediol, 1-(3-cyclohexen-1-yl)-",C1CC(CC=C1)C(CO)O,,,,,,
3350,93351,"Propanoic acid, 3-(dodecylthio)-, oxybis(2,1-ethanediyloxy-2,1-ethanediyl) ester",CCCCCCCCCCCCSCCC(=O)OCCOCCOCCOCCOC(=O)CCSCCCCCCCCCCCC,,,,,,
3351,93352,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, phenylmethyl ester, (1R,3R)-",CC(=C[C@@H]1[C@H](C1(C)C)C(=O)OCC2=CC=CC=C2)C,,,,,,
3352,93353,"2-[[(4R)-4-[(3R,5S,7S,10S,13R,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]acetic acid",C[C@H](CCC(=O)NCC(=O)O)[C@H]1CCC2[C@@]1(CCC3C2[C@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C,,,,,,
3353,93354,"2-(3,4-Dichlorophenyl)-1,1,1,3,3,3-hexafluoropropan-2-ol",C1=CC(=C(C=C1C(C(F)(F)F)(C(F)(F)F)O)Cl)Cl,,,,,,
3354,93355,"Thiophene, 4-bromo-2,3-dichlorotetrahydro-, 1,1-dioxide",C1C(C(C(S1(=O)=O)Cl)Cl)Br,,,,,,
3355,93356,MCT Oil,CCCCCCCCCC(=O)O.CCCCCCCC(=O)O.C(C(CO)O)O,,,,,,
3356,93357,alpha-Cypermethrin,CC1([C@H]([C@H]1C(=O)O[C@H](C#N)C2=CC(=CC=C2)OC3=CC=CC=C3)C=C(Cl)Cl)C,,,"['Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)']","['1. Dose excretion studies with cypermethrin (as a 1:1 cis/trans mixture) and alphacypermethrin (one of the two disasteroisomer pairs which constitute cis-cypermethrin) were out with, in each case, two volunteers per dose level. The studies included (a) single oral alphacypermethrin doses of 0.25 mg, 0.50 mg and 0.75 mg followed by repeated alphacypermethrin doses at the same levels, daily for five days, (b) repeated oral cypermethrin doses of 0.25 mg, 0.75 mg and 1.5 mg daily for five days, and (c) a single dermal application of 25 mg cypermethrin to the forearm. Urine was monitored for the free and conjugated 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylic acid before and after dosing. 2. Metabolism and rate of excretion of a single oral dose of alphacypermethrin was similar to that of cis cypermethrin, on average, 43% of the dose was excreted as the cyclopropanecarboxylic acid in the first 24 hr urine. There was no increase in urinary metabolite excretion when alphacypermethrin was administered as a repeated oral dose. Subjects excreted, on average, 49% of the dose as the cyclopropanecarboxylic acid in the subsequent 24 hr periods after dosing. 3. There was no increase in the urinary cyclopropanecarboxylic acid excretion when cypermethrin was administered as a repeated oral dose. Subjects excreted, on average, 72% of the trans isomer dose and 45% of the cis isomer dose respectively in the subsequent 24 hr periods after dosing. 4. Approximately 0.1% of the applied dermal dose of 25 mg cypermethrin was excreted within 72 hr as the urinary cyclopropanecarboxylic acid. No conclusions can be drawn from such urinary excretion data as to the concentration of cypermethrin and its metabolites in the skin or other organs, or the possibility of other routes of metabolism or excretion.', '/PYRETHROIDS/ READILY PENETRATE INSECT CUTICLE AS SHOWN BY TOPICAL LD50 TO PERIPLANETA (COCKROACH) ... /PYRETHROIDS/', 'WHEN RADIOACTIVE PYRETHROID IS ADMIN ORALLY TO MAMMALS, IT IS ABSORBED FROM INTESTINAL TRACT OF THE ANIMALS & DISTRIBUTED IN EVERY TISSUE EXAMINED. EXCRETION OF RADIOACTIVITY IN RATS ADMIN TRANS-ISOMER: DOSAGE: 500 MG/KG; INTERVAL 20 DAYS; URINE 36%; FECES 64%; TOTAL 100%. /PYRETHROIDS/', 'Pyrethrins are absorbed through intact skin when applied topically. When animals were exposed to aerosols of pyrethrins with piperonyl butoxide being released into the air, little or none of the combination was systemically absorbed. /Pyrethrins/', 'Although limited absorption may account for the low toxicity of some pyrethroids, rapid biodegradation by mammalian liver enzymes (ester hydrolysis and oxidation) is probably the major factor responsible. Most pyrethroid metabolites are promptly excreted, at least in part, by the kidney. /Pyrethroids/']","['The metabolic pathways for the breakdown of the pyrethroids vary little between mammalian species but vary somewhat with structure. ... Essentially, pyrethrum and allethrin are broken down mainly by oxidation of the isobutenyl side chain of the acid moiety and of the unsaturated side chain of the alcohol moiety with ester hydrolysis playing and important part, whereas for the other pyrethroids ester hydrolysis predominates. /Pyrethrum and pyrethroids/', 'The relative resistance of mammals to the pyrethroids is almost wholly attributable to their ability to hydrolyze the pyrethroids rapidly to their inactive acid & alcohol components, since direct injection into the mammalian CNS leads to a susceptibility similar to that seen in insects. Some additional resistance of homeothermic organisms can also be attributed to the negative temperature coefficient of action of the pyrethroids, which are thus less toxic at mammalian body temperatures, but the major effect is metabolic. Metabolic disposal of the pyrethroids is very rapid, which means that toxicity is high by the iv route, moderate by slower oral absorption, & often unmeasureably low by dermal absorption. /Pyrethroids/', 'FASTEST BREAKDOWN IS SEEN WITH PRIMARY ALCOHOL ESTERS OF TRANS-SUBSTITUTED ACIDS SINCE THEY UNDERGO RAPID HYDROLYTIC & OXIDATIVE ATTACK. FOR ALL SECONDARY ALCOHOL ESTERS & FOR PRIMARY ALCOHOL CIS-SUBSTITUTED CYCLOPROPANECARBOXYLATES, OXIDATIVE ATTACK IS PREDOMINANT. /PYRETHROIDS/', 'Pyrethrins are reportedly inactivated in the GI tract following ingestion. In animals, pyrethrins are rapidly metabolized to water soluble, inactive compounds. /Pyrethrins/', 'Synthetic pyrethroids are generally metabolized in mammals through ester hydrolysis, oxidation, and conjugation, and there is no tendency to accumulate in tissues. In the environment, synthetic pyrethroids are fairly rapidly degraded in soil and in plants. Ester hydrolysis and oxidation at various sites on the molecule are the major degradation processes. /Synthetic pyrethroids/']",
3357,93358,Fenitropan,CC(=O)OC[C@H]([C@H](C1=CC=CC=C1)OC(=O)C)[N+](=O)[O-],,,,,,
3358,93359,Dicyclopentyloxyethyl acrylate,C=CC(=O)OCCOC1CC2CC1C3C2C=CC3,,,,,,
3359,93360,"3,10-Dimethylphenanthrene",CC1=CC2=C(C=C1)C(=CC3=CC=CC=C32)C,,,,,,
3360,93361,"3,3',4-Trichlorodiphenyl ether",C1=CC(=CC(=C1)Cl)OC2=CC(=C(C=C2)Cl)Cl,,,,,,
3361,93362,Methasulfocarb,CNC(=O)SC1=CC=C(C=C1)OS(=O)(=O)C,,,,,,
3362,93363,1-Methyl-2-pyrrolidineethanol,CN1CCCC1CCO,,,,,,
3363,93364,"5-(2-Chlorophenyl)-3-methyl-7-nitro-1,3-dihydro-2h-1,4-benzodiazepin-2-one",CC1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3Cl,,,['Agents that act systemically to kill adult schistosomes. (See all compounds classified as Schistosomicides.)'],,,
3364,93365,Fenpropimorph,C[C@@H]1CN(C[C@@H](O1)C)CC(C)CC2=CC=C(C=C2)C(C)(C)C,,,"['Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)']",,,
3365,93366,"1,1-Diethoxyhex-2-ene",CCCC=CC(OCC)OCC,,,,,,
3366,93367,Lucifer Yellow carbohydrazide,[Li+].[Li+].C1=C(C=C2C3=C1C(=C(C=C3C(=O)N(C2=O)NC(=O)NN)S(=O)(=O)[O-])N)S(=O)(=O)[O-],,,"['Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)']",,,
3367,93368,Lucifer Yellow CH,C1=C(C=C2C3=C1C(=C(C=C3C(=O)N(C2=O)NC(=O)NN)S(=O)(=O)O)N)S(=O)(=O)O,,,"['Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)']",,,
3368,93369,"N-(2,2-Diethoxyethyl)-2,2-diethoxy-N-nitrosoethanamine",CCOC(CN(CC(OCC)OCC)N=O)OCC,,,,,,
3369,93370,CID 93370,CCCCCCCCC=CCCCCCCCC(=O)OCC[S-].CCCCCCCCC=CCCCCCCCC(=O)OCC[S-].C[Sn]C,,,,,,
3370,93371,"Butanedioic acid, sulfo-, 4-[2-[(12-hydroxy-1-oxo-9-octadecenyl)amino]ethyl] ester, disodium salt",CCCCCCC(CC=CCCCCCCCC(=O)NCCOC(=O)CC(C(=O)[O-])S(=O)(=O)[O-])O.[Na+].[Na+],,,,,,
3371,93372,4-{2-[(12-Hydroxyoctadec-9-enoyl)amino]ethoxy}-4-oxo-2-sulfobutanoic acid,CCCCCCC(CC=CCCCCCCCC(=O)NCCOC(=O)CC(C(=O)O)S(=O)(=O)O)O,,,,,,
3372,93373,"Acetamide, N-(3-chloro-2,6-dimethylphenyl)-2-methoxy-N-(tetrahydro-2-oxo-3-furanyl)-",CC1=C(C(=C(C=C1)Cl)C)N(C2CCOC2=O)C(=O)COC,,,,,,
3373,93374,"1,3,5-Triazine-2,4,6-triamine, polymer with formaldehyde, methylated",C=O.C1(=NC(=NC(=N1)N)N)N,,,,,,
3374,93375,"2,4-Dimethylcyclohex-3-ene-1-carbaldehyde",CC1C=C(CCC1C=O)C,,,,,,
3375,93376,"2,2-Di-sec-butoxyacetophenone",CCC(C)OC(C(=O)C1=CC=CC=C1)OC(C)CC,,,,,,
3376,93377,Basic blue 99,C[N+](C)(C)C1=CC=CC(=C1)N=C2C=C(C3=C(C2=O)C(=CC(=C3O)Br)N)N.[Cl-],,,,,,
3377,93378,"3-[(4-Amino-6-bromo-1-hydroxy-8-imino-5-oxo-5,8-dihydronaphthalen-2-yl)amino]-N,N,N-trimethylanilinium",C[N+](C)(C)C1=CC=CC(=C1)N=C2C=C(C3=C(C2=O)C(=CC(=C3O)Br)N)N,,,,,,
3378,93379,Forchlorfenuron,C1=CC=C(C=C1)NC(=O)NC2=CC(=NC=C2)Cl,,,"['Any of the hormones produced naturally in plants and active in controlling growth and other functions. There are three primary classes: auxins, cytokinins, and gibberellins. (See all compounds classified as Plant Growth Regulators.)']","['In both the main study and the biliary excretion study, at least 4 Sprague-Dawley rats/sex were dosed orally by gavage with 100 mg/kg of CPPU-UL-phenyl-(14)C (radiochemical purity: 99.16%; specific activity: 28.04 mCi/mmol) fortified with unlabeled Forchlorfenuron technical (purity: 98.2%). In the main study, urine, feces and air samples were collected periodically for 7 days post-dose. In the biliary excretion study, bile samples were collected periodically via the bile duct cannula up to 72 hours post-dose. The primary route of excretion was in the urine ((M) urine: 79%, feces: 16%, (F) urine: 68%, feces: 28%). During the 1st 24 hours post-dose, 82% of the radiolabel was recovered from the males and 66% from the females. Less than 0.1% of the administered dose was recovered in the air. The excretory half-lives ranged from 13 to 16 hours for both sexes for both the urine and feces. Recovery in the tissues at 7 days post dose represented less than 1% of the administered dose. In the biliary excretion study, 23 and 20% of the administered radiolabel were recovered in the bile from the males and females, respectively. However, the absorption kinetics could not be readily assessed because no urine or feces samples were collected simultaneously from these study animals.', 'Absorbed by leaves, stem, cotyledon and germinated seeds.']","['At least 4 Sprague-Dawley rats/sex were dosed orally by gavage with 100 mg/kg of CPPU-UL-phenyl-(14)C (radiochemical purity: 99.16%; specific activity: 28.04 mCi/mmol) fortified with unlabeled Forchlorfenuron technical (purity: 98.2%). ... The primarily metabolite recovered in the urine was CPPU-sulfate with substitution on the phenyl ring. It represented 84 and 57% of the administered dose for the males and females, respectively. Other metabolites were products of phenyl ring hydroxylations as well. Hydroxyl-CPPU was the predominant metabolite recovered from the feces with 11 and 18% of the administered dose recovered from the males and females, respectively.']",['At least 4 Sprague-Dawley rats/sex were dosed orally by gavage with 100 mg/kg of CPPU-UL-phenyl-(14)C (radiochemical purity: 99.16%; specific activity: 28.04 mCi/mmol) fortified with unlabeled Forchlorfenuron technical (purity: 98.2%). ...  The excretory half-lives ranged from 13 to 16 hours for both sexes for both the urine and feces.']
3379,93380,1-(2-Nitroimidazol-1-yl)-3-prop-1-enoxypropan-2-ol,CC=COCC(CN1C=CN=C1[N+](=O)[O-])O,,,,,,
3380,93381,"2-Propenoic acid, 2-nitro-3-(5-nitro-2-furanyl)-, methyl ester",COC(=O)C(=CC1=CC=C(O1)[N+](=O)[O-])[N+](=O)[O-],,,,,,
3381,93382,"3-(5-Bromo-2-furyl)-2-nitropropenoic acid, methyl ester",COC(=O)C(=CC1=CC=C(O1)Br)[N+](=O)[O-],,,,,,
3382,93383,"2,7-Naphthalenedisulfonic acid, 3-[[3,3'-dimethyl-4'-[[4-[[(4-methylphenyl)sulfonyl]oxy]phenyl]azo][1,1'-biphenyl]-4-yl]azo]-4-hydroxy-5-[[(4-methylphenyl)sulfonyl]oxy]-, disodium salt",CC1=CC=C(C=C1)S(=O)(=O)OC2=CC=C(C=C2)N=NC3=C(C=C(C=C3)C4=CC(=C(C=C4)N=NC5=C(C6=C(C=C(C=C6C=C5S(=O)(=O)[O-])S(=O)(=O)[O-])OS(=O)(=O)C7=CC=C(C=C7)C)O)C)C.[Na+].[Na+],,,,,,
3383,93384,"4-Hydroxy-3-[[2-methyl-4-[3-methyl-4-[[4-(4-methylphenyl)sulfonyloxyphenyl]diazenyl]phenyl]phenyl]diazenyl]-5-(4-methylphenyl)sulfonyloxynaphthalene-2,7-disulfonic acid",CC1=CC=C(C=C1)S(=O)(=O)OC2=CC=C(C=C2)N=NC3=C(C=C(C=C3)C4=CC(=C(C=C4)N=NC5=C(C6=C(C=C(C=C6C=C5S(=O)(=O)O)S(=O)(=O)O)OS(=O)(=O)C7=CC=C(C=C7)C)O)C)C,,,,,,
3384,93385,"Urea, N-methoxy-N-methyl-N'-(4-(2-(4-methylphenyl)ethoxy)phenyl)-",CC1=CC=C(C=C1)CCOC2=CC=C(C=C2)NC(=O)N(C)OC,,,,,,
3385,93386,CID 93386,CC1=CC(=C2C=CC(=NN=C3C(=CC4=C(C3=O)C(=N)C(=NNC5=CC=C(C=C5)N(O)O)C(=C4)S(=O)(=O)[O-])S(=O)(=O)[O-])C(=C2)C)C=CC1=NN=C6C=CC(=O)C=C6.[Na+].[Na+],,,,,,
3386,93387,CID 93387,CC1=CC(=C2C=CC(=NN=C3C(=CC4=C(C3=O)C(=N)C(=NNC5=CC=C(C=C5)N(O)O)C(=C4)S(=O)(=O)O)S(=O)(=O)O)C(=C2)C)C=CC1=NN=C6C=CC(=O)C=C6,,,,,,
3387,93388,"Ethanaminium, N-(4-((4-(diethylamino)phenyl)(4-(ethylamino)-1-naphthalenyl)methylene)-2,5-cyclohexadien-1-ylidene)-N-ethyl-, molybdatephosphate",CCNC1=CC=C(C2=CC=CC=C21)C(=C3C=CC(C=C3)[NH+](CC)CC)C4=CC=C(C=C4)N(CC)CC,,,,,,
3388,93389,"4-[[4-(diethylamino)cyclohexa-2,5-dien-1-ylidene]-[4-(diethylamino)phenyl]methyl]-N-ethylnaphthalen-1-amine",CCNC1=CC=C(C2=CC=CC=C21)C(=C3C=CC(C=C3)N(CC)CC)C4=CC=C(C=C4)N(CC)CC,,,,,,
3389,93390,"Alcohols, C8-10, ethoxylated propoxylated",C.C.CCOCCCCCCCCO,,,,,,
3390,93391,8-Ethoxyoctan-1-ol,CCOCCCCCCCCO,,,,,,
3391,93392,Di-C7-11-alkyl phthalates,C.C.CCCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCC,,,,,,
3392,93393,"Polysulfides, di-tert-Bu",CC(C)(C)CSSCC(C)(C)C,,,,,,
3393,93394,CID 93394,COC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=C(C4=C(C=C(C=C4C=C3S(=O)(=O)O)S(=O)(=O)[O-])N)O)OC)N=NC5=C(C6=C(C=C(C=C6C=C5S(=O)(=O)O)S(=O)(=O)O)N)O.[Na+],,,,,,
3394,93395,"2,2-Dibromo-2-nitroethanol",C(C([N+](=O)[O-])(Br)Br)O,,,,,,
3395,93396,"Methyl 2,2,3-trifluoro-3-oxopropanoate",COC(=O)C(C(=O)F)(F)F,,,,,,
3396,93397,"Ethanimidothioic acid, N,N'-[1,2-ethanediylbis[thio(methylimino)carbonyloxy]]bis-, dimethyl ester",CC(=NOC(=O)N(C)SCCSN(C)C(=O)ON=C(C)SC)SC,,,,,,
3397,93398,CID 93398,CC1[C@@H]([C@H](C[C@@H](O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)NC(=O)C)O,,,,,,
3398,93399,"Propanedioic acid, ((5-nitro-2-furanyl)methylene)-, diethyl ester",CCOC(=O)C(=CC1=CC=C(O1)[N+](=O)[O-])C(=O)OCC,,,,,,
3399,93400,CID 93400,CC1=CC(=O)C(=C2C1=C(C=C(O2)O)OC)C3=C4C(=C(C=C(O4)O)OC)C(=CC3=O)C,,,,,,
3400,93401,CID 93401,CC(=O)C(C(=O)NC1=C(C=C(C=C1)C2=CC(=C(C=C2)NC(=O)C(C(=O)C)N=NC3=C(C=CC(=C3)S(=O)(=O)C)O)OC)OC)N=NC4=CC(=CC(=C4O)NC(=O)C5=CC=CC=C5)S(=O)(=O)[O-].[Na+],,,,,,
3401,93402,"3-Benzamido-4-hydroxy-5-[(1-{[4'-(2-{[2-hydroxy-5-(methanesulfonyl)phenyl]diazenyl}-3-oxobutanamido)-3,3'-dimethoxy[1,1'-biphenyl]-4-yl]amino}-1,3-dioxobutan-2-yl)diazenyl]benzene-1-sulfonic acid",CC(=O)C(C(=O)NC1=C(C=C(C=C1)C2=CC(=C(C=C2)NC(=O)C(C(=O)C)N=NC3=C(C=CC(=C3)S(=O)(=O)C)O)OC)OC)N=NC4=CC(=CC(=C4O)NC(=O)C5=CC=CC=C5)S(=O)(=O)O,,,,,,
3402,93403,"Disodium 4,4'-((3,3'-dimethoxy(1,1'-biphenyl)-4,4'-diyl)bis(iminocarbonyl(2-hydroxy-4,1-phenylene)azo))bis(3-hydroxynaphthalene-1-sulphonate)",COC1=C(C=CC(=C1)C2=CC(=C(C=C2)NC(=O)C3=CC(=C(C=C3)N=NC4=C(C=C(C5=CC=CC=C54)S(=O)(=O)[O-])O)O)OC)NC(=O)C6=CC(=C(C=C6)N=NC7=C(C=C(C8=CC=CC=C87)S(=O)(=O)[O-])O)O.[Na+].[Na+],,,,,,
3403,93404,"4,4'-{(3,3'-Dimethoxy[1,1'-biphenyl]-4,4'-diyl)bis[carbamoyl(2-hydroxy-4,1-phenylene)diazene-2,1-diyl]}bis(3-hydroxynaphthalene-1-sulfonic acid)",COC1=C(C=CC(=C1)C2=CC(=C(C=C2)NC(=O)C3=CC(=C(C=C3)N=NC4=C(C=C(C5=CC=CC=C54)S(=O)(=O)O)O)O)OC)NC(=O)C6=CC(=C(C=C6)N=NC7=C(C=C(C8=CC=CC=C87)S(=O)(=O)O)O)O,,,,,,
3404,93405,Naugard XL-1,CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)CCC(=O)OCCNC(=O)C(=O)NCCOC(=O)CCC2=CC(=C(C(=C2)C(C)(C)C)O)C(C)(C)C,,,,,,
3405,93406,"3-Ethyl-2,6-dimethyl-4H-pyrido(1,2-a)pyrimidin-4-one",CCC1=C(N=C2C=CC=C(N2C1=O)C)C,,,,,,
3406,93407,C.I. Reactive Orange 4,CN(C1=CC2=CC(=C(C(=C2C=C1)O)N=NC3=C(C4=C(C=C3)C(=CC=C4)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])C5=NC(=NC(=N5)Cl)Cl.[Na+].[Na+].[Na+],,,,,,
3407,93408,Procion orange MX-2R,CN(C1=CC2=CC(=C(C(=C2C=C1)O)N=NC3=C(C4=C(C=C3)C(=CC=C4)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)C5=NC(=NC(=N5)Cl)Cl,,,,,,
3408,93409,"Disulfide, bis(2-chlorooctyl)",CCCCCCC(CSSCC(CCCCCC)Cl)Cl,,,,,,
3409,93410,13-Ethoxytridecan-1-amine;methane,C.CCOCCCCCCCCCCCCCN,,,,,,
3410,93411,"Amines, C13-15-alkyl, ethoxylated",CCOCCCCCCCCCCCCCN,,,,,,
3411,93412,1-(2-Hydroxy-3-methoxypropyl)-2-methyl-4-nitroimidazole,CC1=NC(=CN1CC(COC)O)[N+](=O)[O-],,,,,,
3412,93413,2-Chlorobut-2-enedinitrile,C(=C(C#N)Cl)C#N,,,,,,
3413,93414,Tripropyleneglycol diacrylate,CC(COCC(C)OC(=O)C=C)OCC(C)OC(=O)C=C,,,,,,
3414,93415,"Benzene, 1,2,3-trichloro-4-(2,4-dichlorophenoxy)-",C1=CC(=C(C=C1Cl)Cl)OC2=C(C(=C(C=C2)Cl)Cl)Cl,,,,,,
3415,93416,"2,7-Naphthalenedisulfonic acid, 3-[[3,3'-dimethyl-4'-[[4-[(phenylsulfonyl)oxy]phenyl]azo][1,1'-biphenyl]-4-yl]azo]-4-hydroxy-, disodium salt",CC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=C(C=C4C=C(C=CC4=C3O)S(=O)(=O)[O-])S(=O)(=O)[O-])C)N=NC5=CC=C(C=C5)OS(=O)(=O)C6=CC=CC=C6.[Na+].[Na+],,,,,,
3416,93417,"3-[[4-[4-[[4-(Benzenesulfonyloxy)phenyl]diazenyl]-3-methylphenyl]-2-methylphenyl]diazenyl]-4-hydroxynaphthalene-2,7-disulfonic acid",CC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=C(C=C4C=C(C=CC4=C3O)S(=O)(=O)O)S(=O)(=O)O)C)N=NC5=CC=C(C=C5)OS(=O)(=O)C6=CC=CC=C6,,,,,,
3417,93418,Chimassorb LS 944LD,CC1(CC(CC(N1)(C)C)NCCCCCCNC2CC(NC(C2)(C)C)(C)C)C.CC(C)(C)CC(C)(C)N.C1(=NC(=NC(=N1)Cl)Cl)Cl,,,,,,
3418,93419,"N,N'-Bis(2,2,6,6-tetramethylpiperidin-4-yl)hexane-1,6-diamine",CC1(CC(CC(N1)(C)C)NCCCCCCNC2CC(NC(C2)(C)C)(C)C)C,,,,,,
3419,93420,"Phosphoric acid, bis(2,5-dimethylphenyl) phenyl ester",CC1=CC(=C(C=C1)C)OP(=O)(OC2=CC=CC=C2)OC3=C(C=CC(=C3)C)C,,,,,,
3420,93421,2-Chloro-6-methoxyphenol,COC1=C(C(=CC=C1)Cl)O,,,,,,
3421,93422,Triazoxide,C1=CC2=C(C=C1Cl)[N+](=NC(=N2)N3C=CN=C3)[O-],,,,,,
3422,93423,"Hexanoic acid, 2-ethyl-, 5,5-dimethyl-2-(2-methylphenyl)-3-oxo-1-cyclohexen-1-yl ester",CCCCC(CC)C(=O)OC1=C(C(=O)CC(C1)(C)C)C2=CC=CC=C2C,,,,,,
3423,93424,Tris(3-isopropylphenyl) phosphate,CC(C)C1=CC(=CC=C1)OP(=O)(OC2=CC=CC(=C2)C(C)C)OC3=CC=CC(=C3)C(C)C,,,,,,
3424,93425,N-[(butan-2-ylideneamino)oxy-ethenyl-methylsilyl]oxybutan-2-imine,CCC(=NO[Si](C)(C=C)ON=C(C)CC)C,,,,,,
3425,93426,"Di(2,6-dimethylphenyl) 2,4,6-trimethylphenyl phosphate",CC1=C(C(=CC=C1)C)OP(=O)(OC2=C(C=CC=C2C)C)OC3=C(C=C(C=C3C)C)C,,,,,,
3426,93427,"Bis(2,4,6-trimethylphenyl) 2,5-xylyl phosphate",CC1=CC(=C(C=C1)C)OP(=O)(OC2=C(C=C(C=C2C)C)C)OC3=C(C=C(C=C3C)C)C,,,,,,
3427,93428,"Phosphoric acid, 2,5-dimethylphenyl diphenyl ester",CC1=CC(=C(C=C1)C)OP(=O)(OC2=CC=CC=C2)OC3=CC=CC=C3,,,,,,
3428,93429,"2,4,6-Trimethylphenyl 2,6-dimethylphenyl phenyl phosphate",CC1=C(C(=CC=C1)C)OP(=O)(OC2=CC=CC=C2)OC3=C(C=C(C=C3C)C)C,,,,,,
3429,93430,"Phosphoric acid, 2,5-dimethylphenyl phenyl 2,4,6-trimethylphenyl ester",CC1=CC(=C(C=C1)C)OP(=O)(OC2=CC=CC=C2)OC3=C(C=C(C=C3C)C)C,,,,,,
3430,93431,"Diphenyl 2,4,6-trimethylphenyl phosphate",CC1=CC(=C(C(=C1)C)OP(=O)(OC2=CC=CC=C2)OC3=CC=CC=C3)C,,,,,,
3431,93432,"Bis(2,4,6-trimethylphenyl) phenyl phosphate",CC1=CC(=C(C(=C1)C)OP(=O)(OC2=CC=CC=C2)OC3=C(C=C(C=C3C)C)C)C,,,,,,
3432,93433,"Phosphoric acid, 2,5-dimethylphenyl 2,6-dimethylphenyl phenyl ester",CC1=CC(=C(C=C1)C)OP(=O)(OC2=CC=CC=C2)OC3=C(C=CC=C3C)C,,,,,,
3433,93434,"2,4,6-Trimethylphenyl 2,5-xylyl 2,6-xylyl phosphate",CC1=CC(=C(C=C1)C)OP(=O)(OC2=C(C=CC=C2C)C)OC3=C(C=C(C=C3C)C)C,,,,,,
3434,93435,"Phosphoric acid, bis(2,5-dimethylphenyl) 2,4,6-trimethylphenyl ester",CC1=CC(=C(C=C1)C)OP(=O)(OC2=C(C=CC(=C2)C)C)OC3=C(C=C(C=C3C)C)C,,,,,,
3435,93436,"Bis(2,6-xylyl) 2,5-xylyl phosphate",CC1=CC(=C(C=C1)C)OP(=O)(OC2=C(C=CC=C2C)C)OC3=C(C=CC=C3C)C,,,,,,
3436,93437,"Bis(2,5-xylyl) 2,6-xylyl phosphate",CC1=CC(=C(C=C1)C)OP(=O)(OC2=C(C=CC(=C2)C)C)OC3=C(C=CC=C3C)C,,,,,,
3437,93438,"Di(2,4,6-trimethylphenyl) 2,6-dimethylphenyl phosphate",CC1=C(C(=CC=C1)C)OP(=O)(OC2=C(C=C(C=C2C)C)C)OC3=C(C=C(C=C3C)C)C,,,,,,
3438,93439,"2,4,4-Trimethylpentane-1,3-diyl bis(2-methylpropanoate)",CC(C)C(=O)OCC(C)C(C(C)(C)C)OC(=O)C(C)C,,,,,,
3439,93440,"2,3,3',4,6-Pentachlorobiphenyl",C1=CC(=CC(=C1)Cl)C2=C(C(=C(C=C2Cl)Cl)Cl)Cl,,,,,,
3440,93441,"2,3',4',5',6-Pentachlorobiphenyl",C1=CC(=C(C(=C1)Cl)C2=CC(=C(C(=C2)Cl)Cl)Cl)Cl,,,,,,
3441,93442,"2,2',3,4,6,6'-Hexachlorobiphenyl",C1=CC(=C(C(=C1)Cl)C2=C(C(=C(C=C2Cl)Cl)Cl)Cl)Cl,,,,,,
3442,93443,"2,3,3',4,5',6-Hexachlorobiphenyl",C1=C(C=C(C=C1Cl)Cl)C2=C(C(=C(C=C2Cl)Cl)Cl)Cl,,,,,,
3443,93444,"2,2',3,4,5,6,6'-Heptachlorobiphenyl",C1=CC(=C(C(=C1)Cl)C2=C(C(=C(C(=C2Cl)Cl)Cl)Cl)Cl)Cl,,,,,,
3444,93445,"1H-Imidazole, 2-cyclopropyl-1-methyl-5-nitro-",CN1C(=CN=C1C2CC2)[N+](=O)[O-],,,,,,
3445,93446,"1,3-Bis(2-methyl-5-nitro-1h-imidazol-1-yl)propan-2-ol",CC1=NC=C(N1CC(CN2C(=NC=C2[N+](=O)[O-])C)O)[N+](=O)[O-],,,,,,
3446,93447,"2,7,10-Trimethyldodecane",CCC(C)CCC(C)CCCCC(C)C,,,,,,
3447,93448,"Ethanimidothioic acid, N-[[[(hydroxymethyl)methylamino]carbonyl]oxy]-, methyl ester",CC(=NOC(=O)N(C)CO)SC,,,,,,
3448,93449,Unicarb,CC1(CC2=C(O1)C(=CC=C2)OC(=O)N(C)C(=O)C[N+](C)(C)C)C.[Cl-],,,,,,
3449,93450,"2-[Methyl[[(2,3-dihydro-2,2-dimethylbenzofuran-7-yl)oxy]carbonyl]amino]-N,N,N-trimethyl-2-oxoethanaminium",CC1(CC2=C(O1)C(=CC=C2)OC(=O)N(C)C(=O)C[N+](C)(C)C)C,,,,,,
3450,93451,3-Aminopentanenitrile,CCC(CC#N)N,,,,,,
3451,93452,"Alcohols, C12-13",C.CCCCCCCCCCCCO,,,,,,
3452,93453,"5,7,11-Dodecatriyn-1-ol",C#CCCC#CC#CCCCCO,,,,,,
3453,93454,"5,7,11,13-Octadecatetrayne-1,18-diol",C(CCO)CC#CC#CCCC#CC#CCCCCO,,,,,,
3454,93455,"Benzoic acid, 2-(acetyloxy)-, (methylthio)methyl ester",CC(=O)OC1=CC=CC=C1C(=O)OCSC,,,,,,
3455,93456,Methylsulfinylmethyl 2-acetoxybenzoate,CC(=O)OC1=CC=CC=C1C(=O)OCS(=O)C,,,,,,
3456,93457,"5,12-Naphthacenedione, 7,8,9,10-tetrahydro-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-1-methoxy-8-(4-morpholinylacetyl)-6,8,11-trihydroxy-, (8S-cis)-",CC1[C@H](C(C[C@H](O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CN6CCOCC6)O)N)O,,,,,,
3457,93458,"1,3,6,8-Tetrabromodibenzo-p-dioxin",C1=C(C=C(C2=C1OC3=C(O2)C=C(C=C3Br)Br)Br)Br,,,,,,
3458,93459,Bis(2-chloropropyl) 2-chloro-1-methylethyl phosphate,CC(COP(=O)(OCC(C)Cl)OC(C)CCl)Cl,,,,,,
3459,93460,Pyraclofos,CCCSP(=O)(OCC)OC1=CN(N=C1)C2=CC=C(C=C2)Cl,,,"['Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)']",,,
3460,93461,"N,N-Diethyl-4-(9-chloro-9,10-dihydro-10-phenyl-9-acridinyl)aniline",CCN(CC)C1=CC=C(C=C1)C2(C3=CC=CC=C3N(C4=CC=CC=C42)C5=CC=CC=C5)Cl,,,,,,
3461,93462,"3,5-Dichloro-2,6-dimethoxyphenol",COC1=C(C(=C(C=C1Cl)Cl)OC)O,,,,,,
3462,93463,3'-(4-Morpholinyl)-3'-deaminodaunorubicin,CC1[C@@H]([C@H](C[C@@H](O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N6CCOCC6)O,,,,,,
3463,93464,"(((3,5-Bis(1,1-dimethylethyl)-4-hydroxyphenyl)methyl)thio)acetic acid 2-ethylhexyl ester",CCCCC(CC)COC(=O)CSCC1=CC(=C(C(=C1)C(C)(C)C)O)C(C)(C)C,,,,,,
3464,93465,Imazaquin-ammonium,CC(C)C1(C(=O)NC(=N1)C2=NC3=CC=CC=C3C=C2C(=O)O)C.N,,,"['Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)']",,,
3465,93466,"Benzene, 1,4-dichloro-2-methyl-5-(1-methylethyl)-",CC1=CC(=C(C=C1Cl)C(C)C)Cl,,,,,,
3466,93467,"Benzene, 1,2,4,5-tetrachloro-3-methyl-6-(1-methylethyl)-",CC1=C(C(=C(C(=C1Cl)Cl)C(C)C)Cl)Cl,,,,,,
3467,93468,"Benzene, 2,3-dichloro-1-methyl-4-(1-methylethyl)-",CC1=C(C(=C(C=C1)C(C)C)Cl)Cl,,,,,,
3468,93469,Threo-Triadimenol,CC(C)(C)[C@@H]([C@@H](N1C=NC=N1)OC2=CC=C(C=C2)Cl)O,,,,,,
3469,93470,"1,3,6-Trichlorodibenzo-p-dioxin",C1=CC2=C(C(=C1)Cl)OC3=C(O2)C(=CC(=C3)Cl)Cl,,,,,,
3470,93471,"1,3,8-Trichlorodibenzo-p-dioxin",C1=CC2=C(C=C1Cl)OC3=C(O2)C=C(C=C3Cl)Cl,,,,,,
3471,93472,"1,3,9-Trichlorodibenzo-p-dioxin",C1=CC2=C(C(=C1)Cl)OC3=C(O2)C=C(C=C3Cl)Cl,,,,,,
3472,93473,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (4-cyanophenyl)methyl ester, (1R-trans)-",CC(=C[C@@H]1[C@H](C1(C)C)C(=O)OCC2=CC=C(C=C2)C#N)C,,,,,,
3473,93474,"8-Acetyl-3-dodecyl-7,7,9,9-tetramethyl-1,3,8-triazaspiro[4.5]decane-2,4-dione",CCCCCCCCCCCCN1C(=O)C2(CC(N(C(C2)(C)C)C(=O)C)(C)C)NC1=O,,,,,,
3474,93475,"3-Heptanol, nitrate",CCCCC(CC)O[N+](=O)[O-],,,,,,
3475,93476,"3-Octanol, nitrate",CCCCCC(CC)O[N+](=O)[O-],,,,,,
3476,93477,"2-Ethylhexyl 10-ethyl-4-((2-((2-ethylhexyl)oxy)-2-oxoethyl)thio)-7-oxo-8-oxa-3,5-dithia-4-phosphatetradecanoate 4-oxide",CCCCC(CC)COC(=O)CSP(=O)(SCC(=O)OCC(CC)CCCC)SCC(=O)OCC(CC)CCCC,,,,,,
3477,93478,"2,3,3',4,4',5,6-Heptachlorodiphenyl ether",C1=CC(=C(C=C1OC2=C(C(=C(C(=C2Cl)Cl)Cl)Cl)Cl)Cl)Cl,,,,,,
3478,93479,"2,2',3,3',4,5',6'-Heptachlorodiphenyl ether",C1=CC(=C(C(=C1OC2=C(C(=CC(=C2Cl)Cl)Cl)Cl)Cl)Cl)Cl,,,,,,
3479,93480,"2,3,3',4,4',5,5'-Heptachlorodiphenyl ether",C1=C(C=C(C(=C1Cl)Cl)Cl)OC2=CC(=C(C(=C2Cl)Cl)Cl)Cl,,,,,,
3480,93481,"Benzenepropanoic acid, 3-(2H-benzotriazol-2-yl)-5-(1,1-dimethylethyl)-4-hydroxy-, methyl ester",CC(C)(C)C1=C(C(=CC(=C1)CCC(=O)OC)N2N=C3C=CC=CC3=N2)O,,,,,,
3481,93482,Clomeprop,CC1=C(C=CC(=C1Cl)OC(C)C(=O)NC2=CC=CC=C2)Cl,,,,,,
3482,93483,Imibenconazole,C1=CC(=CC=C1CSC(=NC2=C(C=C(C=C2)Cl)Cl)CN3C=NC=N3)Cl,,,,,,
3483,93484,Panaxytriol,CCCCCCCC(C(CC#CC#CC(C=C)O)O)O,,,,,,
3484,93485,"Carbonic acid, 1,1-dimethylethyl 4-ethenylphenyl ester",CC(C)(C)OC(=O)OC1=CC=C(C=C1)C=C,,,,,,
3485,93486,Pyributicarb,CC(C)(C)C1=CC(=CC=C1)OC(=S)N(C)C2=NC(=CC=C2)OC,,,,,['Pyributicarb has known human metabolites that include Pyributicarb metabolite 1.'],
3486,93487,"O,O-Bis(2,4,5-trichlorophenyl) methylphosphonate",CP(=O)(OC1=CC(=C(C=C1Cl)Cl)Cl)OC2=CC(=C(C=C2Cl)Cl)Cl,,,,,,
3487,93488,"4,6-Dimethyl-2-{2-[1-(2-methylphenyl)ethylidene]hydrazinyl}pyrimidine",CC1=CC=CC=C1C(=NNC2=NC(=CC(=N2)C)C)C,,,,,,
3488,93489,N-Isobutyl-5-nitro-2-furylacrylamide,CC(C)CNC(=O)C=CC1=CC=C(O1)[N+](=O)[O-],,,,,,
3489,93490,"5-Nitro-2-furanacrylic acid, propyl ester",CCCOC(=O)C=CC1=CC=C(O1)[N+](=O)[O-],,,,,,
3490,93491,"5-Nitro-2-furanacrylic acid, butyl ester",CCCCOC(=O)C=CC1=CC=C(O1)[N+](=O)[O-],,,,,,
3491,93492,"5-Nitro-2-furanacrylic acid, isopropyl ester",CC(C)OC(=O)C=CC1=CC=C(O1)[N+](=O)[O-],,,,,,
3492,93493,N-Propyl-5-nitro-2-furylacrylamide,CCCNC(=O)C=CC1=CC=C(O1)[N+](=O)[O-],,,,,,
3493,93494,"2,6-Dichloro-4-(2,3,4,6-tetrachlorophenoxy)phenol",C1=C(C=C(C(=C1Cl)O)Cl)OC2=C(C(=C(C=C2Cl)Cl)Cl)Cl,,,,,,
3494,93495,"5-Nitro-2-furanacrylic acid, isobutyl ester",CC(C)COC(=O)C=CC1=CC=C(O1)[N+](=O)[O-],,,,,,
3495,93496,1-Methyl-5-nitronaphthalene,CC1=C2C=CC=C(C2=CC=C1)[N+](=O)[O-],,,,,,
3496,93497,2-Methyl-7-nitronaphthalene,CC1=CC2=C(C=C1)C=CC(=C2)[N+](=O)[O-],,,,,,
3497,93498,N-Butyl-5-nitro-2-furylacrylamide,CCCCNC(=O)C=CC1=CC=C(O1)[N+](=O)[O-],,,,,,
3498,93499,"4,5-Dihydro-5-(4-phenyl-1-piperazinylmethyl)-2-oxazolamine",C1CN(CCN1CC2CN=C(O2)N)C3=CC=CC=C3,,,,,,
3499,93500,"5-Nitro-2-furanacrylic acid, pentyl ester",CCCCCOC(=O)C=CC1=CC=C(O1)[N+](=O)[O-],,,,,,
3500,93501,Diphenyl hydrogen orthoborate,B(O)(OC1=CC=CC=C1)OC2=CC=CC=C2,,,,,,
3501,93502,n-Butylphosphorothioic triamide,CCCCNP(=S)(N)N,,,,,,
3502,93503,"2,3,3',4,4',5'-Hexachlorodiphenyl ether",C1=CC(=C(C(=C1OC2=CC(=C(C(=C2)Cl)Cl)Cl)Cl)Cl)Cl,,,,,,
3503,93504,Levcromakalim,CC1([C@H]([C@@H](C2=C(O1)C=CC(=C2)C#N)N3CCCC3=O)O)C,,,"['Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)', 'Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)', 'Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)', 'Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)']",,,
3504,93505,6-Amino-2-benzothiazolesulfonamide,C1=CC2=C(C=C1N)SC(=N2)S(=O)(=O)N,,,,,,
3505,93506,Oxetin,C1[C@@H]([C@@H](O1)C(=O)O)N,,,,,,
3506,93507,"2,4-Dichloro-6-(2,4,6-trichlorophenoxy)phenol",C1=C(C=C(C(=C1OC2=C(C=C(C=C2Cl)Cl)Cl)O)Cl)Cl,,,,,,
3507,93508,"2,4-Dichloro-6-(2,3,4,6-tetrachlorophenoxy)phenol",C1=C(C=C(C(=C1OC2=C(C(=C(C=C2Cl)Cl)Cl)Cl)O)Cl)Cl,,,,,,
3508,93509,"2,3,4-Trichloro-6-(2,3,4,6-tetrachlorophenoxy)phenol",C1=C(C(=C(C(=C1Cl)Cl)Cl)O)OC2=C(C(=C(C=C2Cl)Cl)Cl)Cl,,,,,,
3509,93510,"2,3,6-Trichloro-4-(2,3,4,6-tetrachlorophenoxy)phenol",C1=C(C(=C(C(=C1Cl)O)Cl)Cl)OC2=C(C(=C(C=C2Cl)Cl)Cl)Cl,,,,,,
3510,93511,"Phenol, 2,3,4-trichloro-6-(2,4,6-trichlorophenoxy)-",C1=C(C=C(C(=C1Cl)OC2=CC(=C(C(=C2O)Cl)Cl)Cl)Cl)Cl,,,,,,
3511,93512,"Propanoic acid, 2-(5-(2-chloro-4-(trifluoromethyl)phenoxy)-2-nitrophenoxy)-, ethyl ester, (R)-",CCOC(=O)[C@@H](C)OC1=C(C=CC(=C1)OC2=C(C=C(C=C2)C(F)(F)F)Cl)[N+](=O)[O-],,,,,,
3512,93513,"4(1H)-Pyridinone, 3-hydroxy-1-(3-hydroxypropyl)-2-methyl-",CC1=C(C(=O)C=CN1CCCO)O,,,,,,
3513,93514,Metazosin,CC(C(=O)N1CCN(CC1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC)OC,,,,,,
3514,93515,(4-Chlorophenyl)(2-chloro-5-(trifluoromethyl)phenyl)methanone,C1=CC(=CC=C1C(=O)C2=C(C=CC(=C2)C(F)(F)F)Cl)Cl,,,,,,
3515,93516,Tebupirimfos,CCOP(=S)(OC1=CN=C(N=C1)C(C)(C)C)OC(C)C,,,,,"['A rat metabolism study demonstrated that the insecticide was readily absorbed, distributed, metabolized, and excreted and that bioaccumulation and retention of the compound and/or its metabolites are low in rats. In vivo and in vitro metabolism studies indicate that the insecticide is metabolized by mixed function oxidases to O-[2-(1,1-dimethylethyl)-5-pyrimidinyl] O-ethyl-O-(1-methylethyl) phosphorothioate (OMAT), an oxygen analog, which is rapidly hydrolyzed to 2-(1,1-dimethylethyl)-5-hydroxypyrimidine (TPHP) and excreted as the glucuronide conjugate of TBHP, a major metabolite representing 60-74% of the administered radioactivity.', 'Metabolism occurs principally by oxidation, hydrolysis by esterases, and by transfer of portions of the molecule to glutathione.  Oxidation of organophosphorus insecticides may result in more or less toxic products.  In general, phosphorothioates are not directly toxic but require oxidative metabolism to the proximal toxin. The glutathione transferase reactions produce products, that are, in most cases, of low toxicity. Hydrolytic and transferase reactions affect both the thioates and their oxons. /Organophosphorus Pesticides/']",
3516,93517,CID 93517,CC(=NN=C(NN=C(N(C)C)S)S)C1=CC=CC=N1,,,,,,
3517,93518,"Cyclopropanecarboxylic acid, 1-(phenylsulfonyl)-, methyl ester",COC(=O)C1(CC1)S(=O)(=O)C2=CC=CC=C2,,,,,,
3518,93519,"Acetamide, 2,2-dichloro-N-(2-oxo-2-(2-propenylamino)ethyl)-N-2-propenyl-",C=CCNC(=O)CN(CC=C)C(=O)C(Cl)Cl,,,,,,
3519,93520,"5-Nitro-2-furylacrylic acid, sec-butyl ester",CCC(C)OC(=O)C=CC1=CC=C(O1)[N+](=O)[O-],,,,,,
3520,93521,"5-Nitro-2-furanacrylic acid, 1,1-dimethylethyl ester",CC(C)(C)OC(=O)C=CC1=CC=C(O1)[N+](=O)[O-],,,,,,
3521,93522,N-(sec-Butyl)-5-nitro-2-furylacrylamide,CCC(C)NC(=O)C=CC1=CC=C(O1)[N+](=O)[O-],,,,,,
3522,93523,"N-(2,2-Dimethylpropyl)-5-nitro-2-furylacrylamide",CC(C)(C)CNC(=O)C=CC1=CC=C(O1)[N+](=O)[O-],,,,,,
3523,93524,CID 93524,CCC1=CC(=C2C1=CC=CC(=C2)C(C)C)S(=O)(=O)[O-].[Na+],,,,,,
3524,93525,Pyrazosulfuron,CN1C(=C(C=N1)C(=O)O)S(=O)(=O)NC(=O)NC2=NC(=CC(=N2)OC)OC,,,,,,
3525,93526,"Phosphine oxide, tris(2,4,4-trimethylpentyl)-",CC(CC(C)(C)C)CP(=O)(CC(C)CC(C)(C)C)CC(C)CC(C)(C)C,,,,,,
3526,93527,"1,3-Cyclohexanedione, 5-(2-(ethylthio)propyl)-2-(1-oxopropyl)-",CCC(=O)C1C(=O)CC(CC1=O)CC(C)SCC,,,,,,
3527,93528,Cloquintocet-mexyl,CCCCCC(C)OC(=O)COC1=C2C(=C(C=C1)Cl)C=CC=N2,,,,,,
3528,93529,"1-Decanamine, N-decyl-N-methyl-, N-oxide",CCCCCCCCCC[N+](C)(CCCCCCCCCC)[O-],,,,,,
3529,93530,"2-Butanone, O,O',O''-(ethoxysilylidyne)trioxime",CCC(=NO[Si](OCC)(ON=C(C)CC)ON=C(C)CC)C,,,,,,
3530,93531,"2-Butanone, O-(triethoxysilyl)oxime",CCC(=NO[Si](OCC)(OCC)OCC)C,,,,,,
3531,93532,Pefurazoate,CCC(C(=O)OCCCC=C)N(CC1=CC=CO1)C(=O)N2C=CN=C2,,,,,,
3532,93533,"p-Phenylenediamine, N,N'-bis(3-methylcyclohexyl)-",CC1CCCC(C1)NC2=CC=C(C=C2)NC3CCCC(C3)C,,,,,,
3533,93534,"3-Methyl-2-methylaminoimidazo[4,5-F]quinoline",CNC1=NC2=C(N1C)C=CC3=C2C=CC=N3,,,,,,
3534,93535,"3-Methyl-2-dimethylamino-imidazo[4,5-f]quinoline",CN1C2=C(C3=C(C=C2)N=CC=C3)N=C1N(C)C,,,,,,
3535,93536,Fenchlorazole,C1=CC(=C(C=C1Cl)Cl)N2C(=NC(=N2)C(=O)O)C(Cl)(Cl)Cl,,,,,,
3536,93537,CID 93537,CCOC(=O)N=C(OCC(C)C)S,,,,,,
3537,93538,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-[(1Z)-3-oxo-3-[2,2,2-trifluoro-1-(trifluoromethyl)ethoxy]-1-propenyl]-, (S)-cyano(3-phenoxyphenyl)methyl ester, (1R,3S)-",CC1(C(C1C(=O)OC(C#N)C2=CC(=CC=C2)OC3=CC=CC=C3)C=CC(=O)OC(C(F)(F)F)C(F)(F)F)C,,,"['Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)']",,,
3538,93539,Flazasulfuron,COC1=CC(=NC(=N1)NC(=O)NS(=O)(=O)C2=C(C=CC=N2)C(F)(F)F)OC,,,,"['Rapidly and extensively absorbed(90%), widely distributed and almost completely excreted (up to 90%) within 7 days, mainly in urine.', 'A series of studies were conducted to evaluate the absorption, distribution, metabolism, and excretion of (14)C-SL-160(P)/flazasulfuron/ in groups of 4 or 5 rats (CRL: CD BR VAF/Plus)/sex. In these studies, (14)C-SL-160(P) (CP-1385; 55.8 mCi/mMole; radiolabel purity variously reported as 97.29%, 97.5%. 98.49%., 99.2% and >98%) was administered orally by gavage at doses of 2 or 50 mg/kg or 2 mg/kg . In /one study/, rats had received daily oral gavage doses of nonlabeled SL-160 (Y-920205; 98.9% purity) for 14 days, prior to oral dosing with (14)C-SL-160(P) on Day 15. ... Differences were generally not noted between dose levels or between single versus repeated dose administration, but were noted between males and females. The studies demonstrated that 14C SL-160(P) is rapidly absorbed following a single oral dose of 2 or 50 mg/kg. By 48 hours post exposure, males and females absorbed 94% and 93% of the low dose, respectively, and 86% and 93% of the high dose, respectively. A similar pattern was observed when low- and high-dose animals were followed up to 168 hours with little difference noted between a single or repeated exposure. Elimination via the urine was the major route of excretion, accounting for 74-80% and 90-94% in males and females, respectively, following both low- and high-dose and single and repeated dose administration. Time course data revealed that a significant portion of the radioactivity in urine was excreted by 48-72 hours post exposure. Feces were the secondary route of elimination, accounting for 21-24% and 9-10% in males and females, respectively, following both low- and high-dose and single and repeated dose administration. The biliary excretion study determined that approximately 9.5% of the administered dose appeared in bile by 48 hours in low-dose males and females and high-dose females, with approximately 16.5% in high-dose males. Tissue distribution studies indicated that 14C-SL-160(P) is rapidly excreted from the system, with less than 4% (males) and 1% (females) of the administered radioactivity remaining in the tissues seven days after dosing. In general, the pattern of the radiolabel distribution in tissues was similar between the low- and high-dose groups in the single oral dose study and between the low-dose groups in the single and repeated dose groups. Pharmacokinetic studies confirmed the rapid absorption and elimination of 14C-SL-160(P). Following a single oral dose of (14)C-SL-160(P), tmax values (provided only for individual animals; mathematically determined value not provided) ranged from 30 minutes (3/5 animals/sex) or 4 hours (2/5 animals/sex) at 2 mg/kg, while the median tmax was 6 hours in males and 4 hours in females at the 50 mg/kg dose. At 2 and 50 mg/kg, males had slightly longer elimination half times for the blood than females (males: 27 and 36 hours, respectively; females: 18.8 and 33.8 hours, respectively). Likewise, males had a greater AUC (304 and 4440 ug-eq/g hr, respectively) than females (189 and 3080 ug-eq/g hr, respectively).']","['A series of studies were conducted to evaluate the absorption, distribution, metabolism, and excretion of (14)C-SL-160(P)/flazasulfuron/ in groups of 4 or 5 rats (CRL: CD BR VAF/Plus)/sex. In these studies, (14)C-SL-160(P) (CP-1385; 55.8 mCi/mMole; radiolabel purity variously reported as 97.29%, 97.5%. 98.49%., 99.2% and >98%) was administered orally by gavage at doses of 2 or 50 mg/kg or 2 mg/kg . In /one study/, rats had received daily oral gavage doses of nonlabeled SL-160 (Y-920205; 98.9% purity) for 14 days, prior to oral dosing with (14)C-SL-160(P) on Day 15. In the single and repeated dose studies, parent compound was the primary component in the metabolite profiles for urine (males: 19-40%; females: 51-67% of administered dose), with lesser amounts in feces (males and females: 2-5% of administered dose), and bile (males and females: 0.6-2% of administered dose). Including parent compound up to 11 fractions were detected among these matrices. The most prevalent metabolite (expressed as percent of administered dose) were HDTG+TPPG (approximately 6.5-12% in urine, approximately 0.4-2% in feces, and approximately 6.5-14% in bile), with minor amounts < 5%) of DTPU (N-(4,6-Dimethoxy-2-pyrimidinyl)-N-[3-(trifluoromethyl)-2-pyridinyl]urea), HDPU, 6-Methoxy-2-[[3-(trifluoromethyl)-2-pyridinyl]amino]-4-pyrimidinol, TPSA (3-Trifluoromethyl)-2-pyridinesulfonamide), and MTMG. Individually, unidentified fractions generally accounted for less than 2% of the administered dose in the urine and biliary metabolite profile. The fecal metabolite profile had up to 35% unidentified of the recovered dose.']",
3539,93540,"2,3,4,4',5-Pentachlorodiphenyl ether",C1=CC(=CC=C1OC2=CC(=C(C(=C2Cl)Cl)Cl)Cl)Cl,,,,,,
3540,93541,Novaluron,C1=CC(=C(C(=C1)F)C(=O)NC(=O)NC2=CC(=C(C=C2)OC(C(OC(F)(F)F)F)(F)F)Cl)F,,,"['Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)']",,,
3541,93542,Fluthiacet-methyl,COC(=O)CSC1=C(C=C(C(=C1)N=C2N3CCCCN3C(=O)S2)F)Cl,,,,,"['...Fluthiacet-methyl was absorbed rapidly at both the low and high dose for both male and female rats. Repeated oral dosing had no effect on extent of absorption. Tissue levels of 14C-fluthiacet-methyl derived radioactivity in the single and repeated low dose groups did not exceed 0.018 ppm for any tissue. At the single high dose, female rats showed higher levels of 14C-fluthiacet-methyl derived radioactivity in tissues than males except for muscle, brain, fat and plasma. Excretion in males was predominantly in feces for all dose groups, with between 67-87% of administered radioactivity excreted by this route. In females, the percentage of administered radioactivity in urine across all dose groups (40-48%) was approximately equivalent to the percent excreted in feces (39-52%). The greater fecal excretion in males was based on a greater percentage excretion in bile for males (37%) vs. females (19%).']",
3542,93543,"2,3,5-Trimethyl-6-(3-pyridylmethyl)-1,4-benzoquinone",CC1=C(C(=O)C(=C(C1=O)C)CC2=CN=CC=C2)C,,,,,,
3543,93544,Methyl 5-(2-chloro-5-(trifluoromethyl)phenoxy)-2-nitrobenzoate,COC(=O)C1=C(C=CC(=C1)OC2=C(C=CC(=C2)C(F)(F)F)Cl)[N+](=O)[O-],,,,,,
3544,93545,"1-Octadecanaminium, N,N-dimethyl-N-octadecyl-, sulfate (1:1)",CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC.OS(=O)(=O)[O-],,,,,,
3545,93546,CID 93546,CC(=NN=C(NNC(=NC1=CC=CC=C1Cl)S)S)C2=CC=CC=N2,,,,,,
3546,93547,"2,2',4,5,6'-Pentachlorodiphenyl ether",C1=CC(=C(C(=C1)Cl)OC2=CC(=C(C=C2Cl)Cl)Cl)Cl,,,,,,
3547,93548,"Cyclopentanecarboxylic acid, 1-((4-bromophenyl)sulfonyl)-, methyl ester",COC(=O)C1(CCCC1)S(=O)(=O)C2=CC=C(C=C2)Br,,,,,,
3548,93549,"Cyclobutanecarboxylic acid, 1-((4-methylphenyl)sulfonyl)-, ethyl ester",CCOC(=O)C1(CCC1)S(=O)(=O)C2=CC=C(C=C2)C,,,,,,
3549,93550,Hexamethonium chloride,C[N+](C)(C)CCCCCC[N+](C)(C)C.[Cl-].[Cl-],,,"['Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)', 'Drugs that bind to nicotinic cholinergic receptors (RECEPTORS, NICOTINIC) and block the actions of acetylcholine or cholinergic agonists. Nicotinic antagonists block synaptic transmission at autonomic ganglia, the skeletal neuromuscular junction, and at central nervous system nicotinic synapses. (See all compounds classified as Nicotinic Antagonists.)', 'Agents having as their major action the interruption of neural transmission at nicotinic receptors on postganglionic autonomic neurons. Because their actions are so broad, including blocking of sympathetic and parasympathetic systems, their therapeutic use has been largely supplanted by more specific drugs. They may still be used in the control of blood pressure in patients with acute dissecting aortic aneurysm and for the induction of hypotension in surgery. (See all compounds classified as Ganglionic Blockers.)']",,,
3550,93551,2-Hydroxycarbazole,C1=CC=C2C(=C1)C3=C(N2)C=C(C=C3)O,,,,,,
3551,93552,"2,6-Naphthalenediol",C1=CC2=C(C=CC(=C2)O)C=C1O,,,,,,
3552,93553,Cupric stearate,CCCCCCCCCCCCCCCCCC(=O)[O-].CCCCCCCCCCCCCCCCCC(=O)[O-].[Cu+2],,,,,,
3553,93554,"1-Hexadecanaminium, N-(carboxymethyl)-N,N-dimethyl-, inner salt",CCCCCCCCCCCCCCCC[N+](C)(C)CC(=O)[O-],,,,,,
3554,93555,"n-(Carboxymethyl)-n,n-dimethylhexadecan-1-aminium",CCCCCCCCCCCCCCCC[N+](C)(C)CC(=O)O,,,,,,
3555,93556,Dihydrothymine,CC1CNC(=O)NC1=O,,,,,,
3556,93557,CID 93557,C1=NC2=C(N(C=NC2=N1)O)N,,,,,,
3557,93558,"Purine, 6-(benzylthio)-",C1=CC=C(C=C1)CSC2=NC=NC3=C2NC=N3,,,,,,
3558,93559,"3,4-Dibromo-5-hydroxyfuran-2(5H)-one",C1(C(=C(C(=O)O1)Br)Br)O,,,,,,
3559,93560,Chlorodifluoroacetaldehyde,C(=O)C(F)(F)Cl,,,,,,
3560,93561,Dialuminium trioxalate,C(=O)(C(=O)[O-])[O-].C(=O)(C(=O)[O-])[O-].C(=O)(C(=O)[O-])[O-].[Al+3].[Al+3],,,,,,
3561,93562,Dichlorodipropylstannane,CCC[Sn](CCC)(Cl)Cl,,,,,,
3562,93563,Di-n-octyltin oxide,CCCCCCCC[Sn](=O)CCCCCCCC,,,,,,
3563,93564,"2,2-Diphenyloxirane",C1C(O1)(C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
3564,93565,Acetylcholine perchlorate,CC(=O)OCC[N+](C)(C)C.[O-]Cl(=O)(=O)=O,,,"['Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)', 'Drugs that bind to and activate cholinergic receptors. (See all compounds classified as Cholinergic Agonists.)']",,,
3565,93566,"2,3,5-Trichloro-6-methoxyphenol",COC1=C(C(=C(C=C1Cl)Cl)Cl)O,,,,,,
3566,93567,"Diazene, bis(4-methylphenyl)-, 1-oxide",CC1=CC=C(C=C1)N=[N+](C2=CC=C(C=C2)C)[O-],,,,,,
3567,93568,Bromotriphenylstannane,C1=CC=C(C=C1)[Sn](C2=CC=CC=C2)(C3=CC=CC=C3)Br,,,,,,
3568,93569,Dibutyltin dibromide,CCCC[Sn](CCCC)(Br)Br,,,,,,
3569,93570,CID 93570,CCCC[SnH](CCCC)CCCC.CO,,,,,,
3570,93571,CID 93571,CCCC[SnH](CCCC)CCCC.O,,,,,,
3571,93572,1-(2-Thiazolylazo)-2-naphthol,C1=CC=C2C(=C1)C=CC(=C2N=NC3=NC=CS3)O,,,,,,
3572,93573,"2-Amino-2-(hydroxymethyl)propane-1,3-diol hydrochloride",C(C(CO)(CO)N)O.Cl,,,,,,
3573,93574,CID 93574,C1=CC=C(C=C1)[SnH](C2=CC=CC=C2)C3=CC=CC=C3.C1=CC=C(C=C1)[SnH](C2=CC=CC=C2)C3=CC=CC=C3.O,,,,,,
3574,93575,N-(4-Bromobutyl)phthalimide,C1=CC=C2C(=C1)C(=O)N(C2=O)CCCCBr,,,,,,
3575,93576,2-Methyl-5-nitrophenol,CC1=C(C=C(C=C1)[N+](=O)[O-])O,,,,,,
3576,93577,4-Methylumbelliferyl-galactopyranoside,CC1=CC(=O)OC2=C1C=CC(=C2)O[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O,,,"['Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)']",,,
3577,93578,Nicotinyl alcohol tartrate,C1=CC(=CN=C1)CO.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O,,,['Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)'],,,
3578,93579,6-Deoxyglucose,C[C@H]([C@H]([C@@H]([C@H](C=O)O)O)O)O,,,,,,
3579,93580,N-Methyl-N'-(p-methoxyphenyl)-N-nitrosourea,CN(C(=O)NC1=CC=C(C=C1)OC)N=O,,,,,,
3580,93581,"Cyclobutanecarboxylic acid, 1-((4-methylphenyl)sulfonyl)-, 1-methylethyl ester",CC(C)OC(=O)C1(CCC1)S(=O)(=O)C2=CC=CC=C2,,,,,,
3581,93582,"Cyclobutanecarboxylic acid, 1-(phenylsulfonyl)-, methyl ester",COC(=O)C1(CCC1)S(=O)(=O)C2=CC=CC=C2,,,,,,
3582,93583,"Cyclohexanecarboxylic acid, 1-(phenylsulfonyl)-, methyl ester",COC(=O)C1(CCCCC1)S(=O)(=O)C2=CC=CC=C2,,,,,,
3583,93584,"1,2,4-Methenoazulene, decahydro-1,5,5,8a-tetramethyl-, (1S,2R,3aR,4R,8aR,9S)-",C[C@]12CCCC([C@@H]3[C@H]1CC4C3C24C)(C)C,,,,,,
3584,93585,"(1S,5'R,6R,6'R,7S,8R,10S,11S,12R,14S,15R,16S,22S,25R,27R,28R,29S)-22-ethyl-7,11,14,15-tetrahydroxy-6'-[(2S)-2-hydroxypropyl]-5',6,8,10,12,14,16,28,29-nonamethylspiro[2,26-dioxabicyclo[23.3.1]nonacosa-4,18,20-triene-27,2'-oxane]-3,3',9,13-tetrone",CC[C@H]1CC[C@@H]2[C@@H]([C@@H]([C@H]([C@@]3(O2)C(=O)C[C@H]([C@H](O3)C[C@H](C)O)C)C)OC(=O)C=C[C@H]([C@@H]([C@H](C(=O)[C@H]([C@@H]([C@H](C(=O)[C@@]([C@@H]([C@H](CC=CC=C1)C)O)(C)O)C)O)C)C)O)C)C,,,,,,
3585,93586,"8-Hydroxy-3,6-dimethylidene-2-oxodecahydro-2H-spiro[azuleno[4,5-b]furan-9,2'-oxiran]-4-yl 3-chloro-2-hydroxy-2-methylpropanoatato(2-)",CC(CCl)(C(=O)OC1CC(=C)C2CC(C3(C2C4C1C(=C)C(=O)O4)CO3)O)O,,,,,,
3586,93587,"3a,7a-Dihydro-1,2,3-benzothiadiazole",C1=CC2C(C=C1)SN=N2,,,,,,
3587,93588,(1-Ethylbenz(cd)indol-2(1H)-ylidene)malononitrile,CCN1C2=CC=CC3=C2C(=CC=C3)C1=C(C#N)C#N,,,,,,
3588,93589,"N-((4-((1-Amino-9,10-dihydro-4-hydroxy-9,10-dioxo-2-anthryl)oxy)phenyl)methyl)-2-chloroacetamide",C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3O)OC4=CC=C(C=C4)CNC(=O)CCl)N,,,,,,
3589,93590,"N,2-Bis(isopropyl)-5-methylcyclohexanecarboxamide",CC1CCC(C(C1)C(=O)NC(C)C)C(C)C,,,,,,
3590,93591,"N,N-Diethyl-2-isopropyl-5-methylcyclohexanecarboxamide",CCN(CC)C(=O)C1CC(CCC1C(C)C)C,,,,,,
3591,93592,CID 93592,CCCCCCCCCCCCCCCCOC(=O)NC1=CC(=C(C=C1)Cl)NC2=NN(C(=O)C2)C3=C(C=C(C=C3Cl)Cl)Cl,,,,,,
3592,93593,"1,1,3,3,4,6-Hexamethylindan-5-ol",CC1=CC2=C(C(=C1O)C)C(CC2(C)C)(C)C,,,,,,
3593,93594,CID 93594,CC(C=CC(C)(C)C1=CC=C(C=C1)O)C2=CC=C(C=C2)O,,,,,,
3594,93595,"1-Dodecanaminium, N,N,N-trimethyl-, diphenyl phosphate",CCCCCCCCCCCC[N+](C)(C)C.C1=CC=C(C=C1)OP(=O)([O-])OC2=CC=CC=C2,,,,,,
3595,93596,4-Butyl-5-methylthiazole,CCCCC1=C(SC=N1)C,,,,,,
3596,93597,"Thiazole, 4-ethyl-5-propyl-",CCCC1=C(N=CS1)CC,,,,,,
3597,93598,CID 93598,C1=CC2=C(C(=C1)O)C(=C(C=C2S(=O)(=O)[O-])S(=O)(=O)O)N.[K+],,,,,,
3598,93599,"7H-Benz(de)anthracen-7-one, 6,11-dichloro-",C1=CC2=C3C(=C1)C4=C(C=CC=C4Cl)C(=O)C3=C(C=C2)Cl,,,,,,
3599,93600,"Ethyl 2,3-dihydro-2-(3-hydroxy-2-quinolyl)-1,3-dioxo-1H-indene-5-carboxylate",CCOC(=O)C1=CC2=C(C=C1)C(=O)C(C2=O)C3=NC4=CC=CC=C4C=C3O,,,,,,
3600,93601,"1-(3,4-Dichlorophenyl)piperazine",C1CN(CCN1)C2=CC(=C(C=C2)Cl)Cl,,,,,,
3601,93602,Ammonium 2-hydroxyethanesulphonate,C(CS(=O)(=O)[O-])O.[NH4+],,,,,,
3602,93603,"3-((alpha-Ethoxycarbonyl)-p-toluoyl)-8-methyl-3,8-diazabicyclo(3.2.1)octane",CCOC(=O)CC1=CC=C(C=C1)C(=O)N2CCC3CC2N(C3)C,,,,,,
3603,93604,"3,8-Diazabicyclo(3.2.1)octane, 8-methyl-3-(o-nitrobenzoyl)-",CN1CC2CCN(C1C2)C(=O)C3=CC=CC=C3[N+](=O)[O-],,,,,,
3604,93605,"3-(alpha-Fluoro-alpha-phenyl)acetyl-8-methyl-3,8-diazabicyclo(3.2.1)octane",CN1CC2CCN(C1C2)C(=O)C(C3=CC=CC=C3)F,,,,,,
3605,93606,"3-(p-Ethoxyphenyl)acetyl-8-methyl-3,8-diazabicyclo(3.2.1)octane",CCOC1=CC=C(C=C1)CC(=O)N2CCC3CC2N(C3)C,,,,,,
3606,93607,"8-Methyl-3-(2'-nitrothien-5'-yl)carbonyl-3,8-diazabicyclo(3.2.1)octane",CN1CC2CCN(C1C2)C(=O)C3=CC=C(S3)[N+](=O)[O-],,,,,,
3607,93608,CID 93608,CN1CC2CCN(C1C2)C(=O)C=CC3=CC=C(S3)[N+](=O)[O-],,,,,,
3608,93609,"3,8-Diazabicyclo(3.2.1)octane, 8-isobutyryl-3-methyl-",CC(C)C(=O)N1CC2CCN(C1C2)C,,,,,,
3609,93610,"3,8-Diazabicyclo(3.2.1)octane, 3-methyl-8-valeryl-",CCCCC(=O)N1CC2CCN(C1C2)C,,,,,,
3610,93611,"8-((alpha-Ethoxycarbonyl)-p-toluoyl)-3-methyl-3,8-diazabicyclo(3.2.1)octane",CCOC(=O)CC1=CC=C(C=C1)C(=O)N2CC3CCN(C2C3)C,,,,,,
3611,93612,"8-((alpha-Carboxy)-p-toluoyl)-3-methyl-3,8-diazabicyclo(3.2.1)octane",CN1CCC2CC1N(C2)C(=O)C3=CC=C(C=C3)CC(=O)O,,,,,,
3612,93613,"8-(p-Ethoxyphenylacetyl)-3-methyl-3,8-diazabicyclo(3.2.1)octane",CCOC1=CC=C(C=C1)CC(=O)N2CC3CCN(C2C3)C,,,,,,
3613,93614,"3-Methyl-8-(2-nitro-5-thenoyl)-3,8-diazabicyclo(3.2.1)octane",CN1CCC2CC1N(C2)C(=O)C3=CC=C(S3)[N+](=O)[O-],,,,,,
3614,93615,CID 93615,CN1CCC2CC1N(C2)C(=O)C=CC3=CC=C(S3)[N+](=O)[O-],,,,,,
3615,93616,"8-Propionyl-3,8-diazabicyclo(3.2.1)octane",CCC(=O)N1CC2CCNC1C2,,,,,,
3616,93617,"5-((4-(Dimethylamino)phenyl)methylene)-1,3-dimethylbarbituric acid",CN1C(=O)C(=CC2=CC=C(C=C2)N(C)C)C(=O)N(C1=O)C,,,,,,
3617,93618,N-Butylsalicylamide,CCCCNC(=O)C1=CC=CC=C1O,,,,,,
3618,93619,4-(Bicyclo[2.2.1]hept-5-en-2-yl)but-3-en-2-one,CC(=O)C=CC1CC2CC1C=C2,,,,,,
3619,93620,"2',4'-Dihydroxy-2-methoxyacetophenone",COCC(=O)C1=C(C=C(C=C1)O)O,,,,,,
3620,93621,CID 93621,CC1CCOC(O1)C(C)CCC=C(C)C,,,,,,
3621,93622,"2-(2,6-Dimethylhepta-1,5-dienyl)-4-methyl-1,3-dioxane",CC1CCOC(O1)C=C(C)CCC=C(C)C,,,,,,
3622,93623,"Benzonitrile, 2-amino-4,6-dichloro-",CC(=O)O.C(CCN)CC(C(=O)O)N,,,,,,
3623,93624,"Phosphorane, chloromethyltriphenyl-",CP(C1=CC=CC=C1)(C2=CC=CC=C2)(C3=CC=CC=C3)Cl,,,,,,
3624,93625,"3,3'-(Phenylimino)bispropane-1,2-diol",C1=CC=C(C=C1)N(CC(CO)O)CC(CO)O,,,,,,
3625,93626,"N,N-Diethylhexadecan-1-amide",CCCCCCCCCCCCCCCC(=O)N(CC)CC,,,,,,
3626,93627,"N,N-Dibutyloctanamide",CCCCCCCC(=O)N(CCCC)CCCC,,,,,,
3627,93628,"(4-Ethoxyphenyl)-[(1,3,3-trimethylindol-2-ylidene)methyl]diazene",CCOC1=CC=C(C=C1)N=NC=C2C(C3=CC=CC=C3N2C)(C)C,,,,,,
3628,93629,"1H-Indole, 2,3-dihydro-1,3,3-trimethyl-2-[[(4-methylphenyl)azo]methylene]-",CC1=CC=C(C=C1)N=NC=C2C(C3=CC=CC=C3N2C)(C)C,,,,,,
3629,93630,"Dihydro-3-(1,3,5,7-tetramethyl-2-octenyl)furan-2,5-dione",CC(C)CC(C)CC(=CC(C)C1CC(=O)OC1=O)C,,,,,,
3630,93631,6-Aminophthalide,C1C2=C(C=C(C=C2)N)C(=O)O1,,,,,,
3631,93632,CID 93632,CC1=C(N2[C@@H]([C@@H](C2=O)N(CC(=O)O)OC3=CC=CC=C3)SC1)C(=O)O,,,,,,
3632,93633,"3-[(4-Anilinonaphthalen-1-yl)diazenyl]naphthalene-2,6-disulfonic acid",C1=CC=C(C=C1)NC2=CC=C(C3=CC=CC=C32)N=NC4=C(C=C5C=CC(=CC5=C4)S(=O)(=O)O)S(=O)(=O)O,,,,,,
3633,93634,"3-Chloro-1,2-propanediol dimethacrylate",CC(=C)C(=O)OCC(CCl)OC(=O)C(=C)C,,,,,,
3634,93635,N-(1H-Tetrazol-5-yl)phthalimide,C1=CC=C2C(=C1)C(=O)N(C2=O)C3=NNN=N3,,,,,,
3635,93636,"6alpha,9-Difluoro-11beta,17,21-trihydroxypregna-1,4-diene-3,20-dione 21-(dihydrogen phosphate)",C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1CC[C@@]2(C(=O)COP(=O)(O)O)O)C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O,,,,,,
3636,93637,6-Bromoquinolin-8-amine,C1=CC2=CC(=CC(=C2N=C1)N)Br,,,,,,
3637,93638,4-(Bromomethyl)azobenzene,C1=CC=C(C=C1)N=NC2=CC=C(C=C2)CBr,,,,,,
3638,93639,"5H-3,5a-Epoxynaphth[2,1-c]oxepin, dodecahydro-3,8,8,11a-tetramethyl-",CC1(CCCC2(C1CCC34C2CCC(O3)(OC4)C)C)C,,,,,,
3639,93640,"2-Buten-1-one, 1-(2,2,6-trimethyl-3-cyclohexen-1-yl)-",CC=CC(=O)C1C(CC=CC1(C)C)C,,,,,,
3640,93641,Hexyl 5-oxo-L-prolinate,CCCCCCOC(=O)C1CCC(=O)N1,,,,,,
3641,93642,Methyl 2-carbamoyl-3-phenylpropionate,COC(=O)C(CC1=CC=CC=C1)C(=O)N,,,,,,
3642,93643,"Benzenamine, 4-(hexahydro-1H-azepin-1-yl)-",C1CCCN(CC1)C2=CC=C(C=C2)N,,,,,,
3643,93644,"(1S-(1alpha,2beta,3alpha,5alpha))-(2,6,6-Trimethylbicyclo(3.1.1)hept-3-yl)methylamine",C[C@@H]1[C@H](C[C@H]2C[C@@H]1C2(C)C)CN,,,,,,
3644,93645,Reactive Orange 86,C1=CC(=C(C=C1NC2=NC(=NC(=N2)Cl)Cl)NC(=O)N)N=NC3=CC4=C(C=C(C=C4C=C3S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
3645,93646,"7-((2-((Aminocarbonyl)amino)-4-((4,6-dichloro-1,3,5-triazin-2-yl)amino)phenyl)azo)naphthalene-1,3,6-trisulphonic acid",C1=CC(=C(C=C1NC2=NC(=NC(=N2)Cl)Cl)NC(=O)N)N=NC3=CC4=C(C=C(C=C4C=C3S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
3646,93647,"2-Naphthalenecarboxamide, N-[4-[4-(1,1-dimethylethyl)phenoxy]phenyl]-1-hydroxy-4-(phenylazo)-",CC(C)(C)C1=CC=C(C=C1)OC2=CC=C(C=C2)NC(=O)C3=C(C4=CC=CC=C4C(=C3)N=NC5=CC=CC=C5)O,,,,,,
3647,93648,2-Amino-N-cyclohexyl-N-methylbenzylamine,CN(CC1=CC=CC=C1N)C2CCCCC2,,,,,,
3648,93649,Benzyl eugenol,COC1=C(C=CC(=C1)CC=C)OCC2=CC=CC=C2,,,,,,
3649,93650,1-(2-Hydroxy-5-tert-nonylphenyl)ethan-1-one,CC(C)C(C)CC(C)(C)C1=CC(=C(C=C1)O)C(=O)C,,,,,,
3650,93651,"Bis(2,4,6-tribromophenyl) terephthalate",C1=CC(=CC=C1C(=O)OC2=C(C=C(C=C2Br)Br)Br)C(=O)OC3=C(C=C(C=C3Br)Br)Br,,,,,,
3651,93652,CID 93652,CCCCC(CC)C(=O)O.CC(C)O.CC(C)O.[AlH3],,,,,,
3652,93653,5-Chloro-2-fluorobenzonitrile,C1=CC(=C(C=C1Cl)C#N)F,,,,,,
3653,93654,2-Bromo-5-fluorobenzonitrile,C1=CC(=C(C=C1F)C#N)Br,,,,,,
3654,93655,4-Chloro-2-fluorobenzonitrile,C1=CC(=C(C=C1Cl)F)C#N,,,,,,
3655,93656,2-Chloro-5-fluorobenzonitrile,C1=CC(=C(C=C1F)C#N)Cl,,,,,,
3656,93657,Ethyl 2-thienylacetate,CCOC(=O)CC1=CC=CS1,,,,,,
3657,93658,"1,1-Dimethoxypropan-2-amine",CC(C(OC)OC)N,,,,,,
3658,93659,"2,4-Bis(methylsulphonyl)phenylhydrazine",CS(=O)(=O)C1=CC(=C(C=C1)NN)S(=O)(=O)C,,,,,,
3659,93660,"1,3-Propanediamine, N-methyl-N'-(2-nitrophenyl)-N-[3-[(2-nitrophenyl)amino]propyl]-",CN(CCCNC1=CC=CC=C1[N+](=O)[O-])CCCNC2=CC=CC=C2[N+](=O)[O-],,,,,,
3660,93661,CID 93661,CCCCCC=CC(=O)OCCCC,,,,,,
3661,93662,1-Chloro-4-(chloromethyl)-2-nitrobenzene,C1=CC(=C(C=C1CCl)[N+](=O)[O-])Cl,,,,,,
3662,93663,"alpha-(((1,1-Dimethylethoxy)carbonyl)amino)cyclohexa-1,4-diene-1-acetic acid",CC(C)(C)OC(=O)NC(C1=CCC=CC1)C(=O)O,,,,,,
3663,93664,"Hexadecanamide, N,N-bis(1-methylethyl)-",CCCCCCCCCCCCCCCC(=O)N(C(C)C)C(C)C,,,,,,
3664,93665,N-Octyl-N'-(2-(octylamino)ethyl)ethylenediamine,CCCCCCCCNCCNCCNCCCCCCCC,,,,,,
3665,93666,Tetradecyl mercaptoacetate,CCCCCCCCCCCCCCOC(=O)CS,,,,,,
3666,93667,"Glycine, N-[5-(acetylamino)-4-[(2-bromo-4,6-dinitrophenyl)azo]-2-methoxyphenyl]-N-2-propenyl-, methyl ester",CC(=O)NC1=CC(=C(C=C1N=NC2=C(C=C(C=C2Br)[N+](=O)[O-])[N+](=O)[O-])OC)N(CC=C)CC(=O)OC,,,,,,
3667,93668,"Decanediamide, N,N'-bis(3,4-dicyanophenyl)-",C1=CC(=C(C=C1NC(=O)CCCCCCCCC(=O)NC2=CC(=C(C=C2)C#N)C#N)C#N)C#N,,,,,,
3668,93669,"N-(2-Pyridylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide",C1=CC=NC(=C1)CNC(=O)C2=C(C=CC(=C2)OCC(F)(F)F)OCC(F)(F)F,,,,,,
3669,93670,Isotridecyl mercaptoacetate,CC(C)CCCCCCCCCCOC(=O)CS,,,,,,
3670,93671,2-[(4-Chlorobenzoyl)amino]pentanedioic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)Cl,,,,,,
3671,93672,"1-Chloro-4-methyldibenzo(b,e)thiin-10-one",CC1=C2C(=C(C=C1)Cl)C(=O)C3=CC=CC=C3S2,,,,,,
3672,93673,"Neodecanoic acid, magnesium salt",CC(C)(C)CC(C)(C)CC(=O)[O-].[Mg+2],,,,,,
3673,93674,"3,3,5,5-tetramethylhexanoic Acid",CC(C)(C)CC(C)(C)CC(=O)O,,,,,,
3674,93675,"3,6,9,12-Tetraoxatridec-1-yl methacrylate",CC(=C)C(=O)OCCOCCOCCOCCOC,,,,,,
3675,93676,"N,N'-[Oxybis(methylene)]bis[N-phenylaniline]",C1=CC=C(C=C1)N(COCN(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC=CC=C4,,,,,,
3676,93677,((2-(p-(Oxiranylmethoxy)benzyl)phenoxy)methyl)oxirane,C1C(O1)COC2=CC=C(C=C2)CC3=CC=CC=C3OCC4CO4,,,,,,
3677,93678,"Ethyl ((1,1-dimethylethyl)sulphinyl)acetate",CCOC(=O)CS(=O)C(C)(C)C,,,,,,
3678,93679,Diethyl (3-pyridylmethyl)malonate,CCOC(=O)C(CC1=CN=CC=C1)C(=O)OCC,,,,,,
3679,93680,N-[2-[(2-Hydroxyethyl)amino]ethyl]stearamide monoacetate,CCCCCCCCCCCCCCCCCC(=O)NCCNCCO.CC(=O)O,,,,,,
3680,93681,2-(2-Chlorophenyl)-1-phenylethan-1-one,C1=CC=C(C=C1)C(=O)CC2=CC=CC=C2Cl,,,,,,
3681,93682,4-Chloro-2-methoxybenzoic acid,COC1=C(C=CC(=C1)Cl)C(=O)O,,,,,,
3682,93683,Methyl 2-chlorophenylacetate,COC(=O)CC1=CC=CC=C1Cl,,,,,,
3683,93684,"3,6,9,12,15,18,21,24-Octaoxahexacosane-1,26-diyl diacrylate",C=CC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC(=O)C=C,,,,,,
3684,93685,"Benzenamine, 2,2'-[methylenebis(thio)]bis-",C1=CC=C(C(=C1)N)SCSC2=CC=CC=C2N,,,,,,
3685,93686,"Ethanone, 1-(1,6-dimethyl-4-(4-methyl-3-pentenyl)-3-cyclohexen-1-yl)-",CC1CC(=CCC1(C)C(=O)C)CCC=C(C)C,,,,,,
3686,93687,"3,5-Morpholinedione, 4-methyl-",CN1C(=O)COCC1=O,,,,,,
3687,93688,Tetrasodium ditartronate,C(C(=O)[O-])(C(=O)[O-])OC(C(=O)[O-])C(=O)[O-].[Na+].[Na+].[Na+].[Na+],,,,,,
3688,93689,"Propanedioic acid, 2,2'-oxybis-",C(C(=O)O)(C(=O)O)OC(C(=O)O)C(=O)O,,,,,,
3689,93690,"6,7-Dichloro-5-hydroxy-2-methyl-2-phenylindan-1-one",CC1(CC2=CC(=C(C(=C2C1=O)Cl)Cl)O)C3=CC=CC=C3,,,,,,
3690,93691,7-tert-Butyloxepan-2-one,CC(C)(C)C1CCCCC(=O)O1,,,,,,
3691,93692,"2,8,8-Trimethylnonane-2,7-diol",CC(C)(C)C(CCCCC(C)(C)O)O,,,,,,
3692,93693,"1(3H)-Isobenzofuranone, 6-(dimethylamino)-3-[4-(dimethylamino)phenyl]-",CN(C)C1=CC=C(C=C1)C2C3=C(C=C(C=C3)N(C)C)C(=O)O2,,,,,,
3693,93694,"1,5,7,11-Tetraoxaspiro(5.5)undecane, 3-methylene-",C=C1COC2(OCCCO2)OC1,,,,,,
3694,93695,"2,3,7,8-Tetrabromo-1-ethoxyoctane",CCOCC(C(CCCC(CBr)Br)Br)Br,,,,,,
3695,93696,"3,5-Dimethyl-4-(3-methyl-2-butenyl)-2-cyclohexen-1-one",CC1CC(=O)C=C(C1CC=C(C)C)C,,,,,,
3696,93697,"Butanoyl chloride, 2-methyl-",CCC(C)C(=O)Cl,,,,,,
3697,93698,"Octahydro-4,7-methano-1H-indene-5-methanol",C1CC2C(C1)C3CC2CC3CO,,,,,,
3698,93699,(S)-1-(p-(Benzyloxy)phenoxy)-3-(isopropylamino)propan-2-ol,CC(C)NCC(COC1=CC=C(C=C1)OCC2=CC=CC=C2)O,,,,,,
3699,93700,"2-(1-Chloroethyl)-1,4-dimethylbenzene",CC1=CC(=C(C=C1)C)C(C)Cl,,,,,,
3700,93701,Thiazol-2-amine mononitrate,C1=CSC(=N1)N.[N+](=O)(O)[O-],,,,,,
3701,93702,"3,3'-[(2,5-Dichloro-1,4-phenylene)bis[imino(1-acetyl-2-oxoethane-1,2-diyl)azo]]bisphthalic acid",CC(=O)C(C(=O)NC1=CC(=C(C=C1Cl)NC(=O)C(C(=O)C)N=NC2=CC=CC(=C2C(=O)O)C(=O)O)Cl)N=NC3=CC=CC(=C3C(=O)O)C(=O)O,,,,,,
3702,93703,CID 93703,CCC(=CC1[NH+](C2=C(O1)C=CC(=C2)C3=CC=CC=C3)CCCCS(=O)(=O)[O-])C=C4N(C5=C(O4)C=CC(=C5)C6=CC=CC=C6)CCCCS(=O)(=O)[O-].CC[NH+](CC)CC,,,,,,
3703,93704,"4-[5-phenyl-2-[2-[[5-phenyl-3-(4-sulfobutyl)-1,3-benzoxazol-2-ylidene]methyl]but-1-enyl]-2H-1,3-benzoxazol-3-yl]butane-1-sulfonic acid",CCC(=CC1N(C2=C(O1)C=CC(=C2)C3=CC=CC=C3)CCCCS(=O)(=O)O)C=C4N(C5=C(O4)C=CC(=C5)C6=CC=CC=C6)CCCCS(=O)(=O)O,,,,,,
3704,93705,"3,7-Dihydro-1,3-dimethyl-1H-purine-2,6-dione, potassium salt",CN1C2=C(C(=O)N(C1=O)C)NC=N2.[K+],,,,,,
3705,93706,Bis(2-hexyldecyl) adipate,CCCCCCCCC(CCCCCC)COC(=O)CCCCC(=O)OCC(CCCCCC)CCCCCCCC,,,,,,
3706,93707,"Benzoic acid, 3,5-dinitro-, silver(1+) salt",C1=C(C=C(C=C1[N+](=O)[O-])[N+](=O)[O-])C(=O)[O-].[Ag+],,,,,,
3707,93708,"1,2-Bis(2-aminophenylthio)propane",CC(CSC1=CC=CC=C1N)SC2=CC=CC=C2N,,,,,,
3708,93709,"Piperidine, 1-(2-(3,4,5-trimethoxyphenyl)sulfonylethyl)-",COC1=CC(=CC(=C1OC)OC)S(=O)(=O)CCN2CCCCC2,,,,,,
3709,93710,CID 93710,CC1=CC=C(C=C1)S(=O)(=O)SC2C(C(=O)N2C(=C(O)OCC3=CC=C(C=C3)[N+](=O)[O-])C(=O)C)NC(=O)COC4=CC=CC=C4,,,,,,
3710,93711,CID 93711,CC1=CC=C(C=C1)S(=O)(=O)S[C@H]2C(C(=O)N2[C@H](C(=C)C)C(=O)OC(C3=CC=CC=C3)C4=CC=CC=C4)NC(=O)COC5=CC=CC=C5,,,,,,
3711,93712,CID 93712,CC1=CC=C(C=C1)S(=O)(=O)S[C@H]2C(C(=O)N2C(=C(C)OC)C(=O)OC(C3=CC=CC=C3)C4=CC=CC=C4)NC(=O)COC5=CC=CC=C5,,,,,,
3712,93713,"Diphenylmethyl (5R-(5alpha,6alpha,7beta))-3-methoxy-8-oxo-7-(phenoxyacetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate 5-oxide",COC1=C(N2[C@@H](C(C2=O)NC(=O)COC3=CC=CC=C3)S(=O)C1)C(=O)OC(C4=CC=CC=C4)C5=CC=CC=C5,,,,,,
3713,93714,"Acetamide, N-(2-((4,5-dicyano-1-methyl-1H-imidazol-2-yl)azo)-5-(diethylamino)phenyl)-",CCN(CC)C1=CC(=C(C=C1)N=NC2=NC(=C(N2C)C#N)C#N)NC(=O)C,,,,,,
3714,93715,"N-[2-[(4,5-Dicyano-1H-imidazol-2-YL)azo]-5-(diethylamino)phenyl]acetamide",CCN(CC)C1=CC(=C(C=C1)N=NC2=NC(=C(N2)C#N)C#N)NC(=O)C,,,,,,
3715,93716,"1-Hexyl-1,2-dihydro-6-hydroxy-4-methyl-2-oxonicotinonitrile",CCCCCCN1C(=O)C=C(C(=C1O)C#N)C,,,,,,
3716,93717,"8,10,19,20-Tetraoxatrispiro[5.2.2.5.2.2]heneicosane",C1CCC2(CC1)COC3(OC2)OCC4(CCCCC4)CO3,,,,,,
3717,93718,"Ethanol, 2,2'-[[3-(dimethylamino)propyl]imino]bis-",CN(C)CCCN(CCO)CCO,,,,,,
3718,93719,"1,2-Cyclohexanedicarboxylic acid, 4-methyl-",CC1CCC(C(C1)C(=O)O)C(=O)O,,,,,,
3719,93720,"Titanium, (acetato-kappaO)tris(2-propanolato)-, (T-4)-",CC(C)O.CC(C)O.CC(C)O.CC(=O)O.[Ti],,,,,,
3720,93721,"(2alpha,6alpha,11R*)-3-Benzyl-1,2,3,4,5,6-hexahydro-6,11-dimethyl-2,6-methano-3-benzazocin-8-ol",CC1[C@@H]2CC3=C([C@]1(CCN2CC4=CC=CC=C4)C)C=C(C=C3)O,,,,,,
3721,93722,CID 93722,C1COCCN1P(=O)(OC(Br)(Br)Br)Cl,,,,,,
3722,93723,"2-Cyclohexene-1-acetonitrile, 2,6,6-trimethyl-",CC1=CCCC(C1CC#N)(C)C,,,,,,
3723,93724,"1-Cyclohexene-1-acetonitrile, 2,6,6-trimethyl-",CC1=C(C(CCC1)(C)C)CC#N,,,,,,
3724,93725,Hexadecyl acetoacetate,CCCCCCCCCCCCCCCCOC(=O)CC(=O)C,,,,,,
3725,93726,3-Phenylprop-2-enyl 3-oxobutanoate,CC(=O)CC(=O)OCC=CC1=CC=CC=C1,,,,,,
3726,93727,"5-((4-(Benzylmethylamino)phenyl)azo)-1,4-dimethyl-1H-1,2,4-triazolium methyl sulphate",CN1C=NN(C1N=NC2=CC=C(C=C2)[NH+](C)CC3=CC=CC=C3)C.COS(=O)(=O)[O-],,,,,,
3727,93728,"1,4-Dimethyl-5-[4-(methylbenzylamino)phenylazo]-4,5-dihydro-1H-1,2,4-triazole",CN1C=NN(C1N=NC2=CC=C(C=C2)N(C)CC3=CC=CC=C3)C,,,,,,
3728,93729,"2-((8-Amino-1-hydroxy-3,6-disulpho-2-naphthyl)azo)naphthalene-1,5-disulphonic acid",C1=CC2=C(C=CC(=C2S(=O)(=O)O)N=NC3=C(C4=C(C=C(C=C4C=C3S(=O)(=O)O)S(=O)(=O)O)N)O)C(=C1)S(=O)(=O)O,,,,,,
3729,93730,2-Tetradec-11-enoxyoxane,CCC=CCCCCCCCCCCOC1CCCCO1,,,,,,
3730,93731,"3,3-Dimethoxypropanenitrile",COC(CC#N)OC,,,,,,
3731,93732,4-Decenoic acid,CCCCCC=CCCC(=O)O,,,,,,
3732,93733,"1,3-Propanediol, bis(4-nitrobenzoate)",C1=CC(=CC=C1C(=O)OCCCOC(=O)C2=CC=C(C=C2)[N+](=O)[O-])[N+](=O)[O-],,,,,,
3733,93734,"Benzenamine, 4-[2-[5-[4-(diethylamino)phenyl]-4,5-dihydro-1-phenyl-1H-pyrazol-3-yl]ethenyl]-N,N-diethyl-",CCN(CC)C1=CC=C(C=C1)C=CC2=NN(C(C2)C3=CC=C(C=C3)N(CC)CC)C4=CC=CC=C4,,,,,,
3734,93735,"Benzene, 2-methyl-4-nitro-1-nitroso-",CC1=C(C=CC(=C1)[N+](=O)[O-])N=O,,,,,,
3735,93736,"Ethyl 2-hydroxy-5-methylpyrazolo[1,5-a]pyrimidine-6-carboxylate",CCOC(=O)C1=CN2C(=CC(=O)N2)N=C1C,,,,,,
3736,93737,"N,N-Dibutyl-5-oxopyrrolidine-2-carboxamide",CCCCN(CCCC)C(=O)C1CCC(=O)N1,,,,,,
3737,93738,"1-Benzoyl-5-oxo-N,N-dipropylpyrrolidine-2-carboxamide",CCCN(CCC)C(=O)C1CCC(=O)N1C(=O)C2=CC=CC=C2,,,,,,
3738,93739,"1-Benzoyl-N,N-dibutyl-5-oxopyrrolidine-2-carboxamide",CCCCN(CCCC)C(=O)C1CCC(=O)N1C(=O)C2=CC=CC=C2,,,,,,
3739,93740,"1-Benzoyl-N,N-diethyl-5-oxopyrrolidine-2-carboxamide",CCN(CC)C(=O)C1CCC(=O)N1C(=O)C2=CC=CC=C2,,,,,,
3740,93741,"1-Benzoyl-n,n-dihexyl-5-oxoprolinamide",CCCCCCN(CCCCCC)C(=O)C1CCC(=O)N1C(=O)C2=CC=CC=C2,,,,,,
3741,93742,"1-Benzoyl-5-oxo-n,n-dipentylprolinamide",CCCCCN(CCCCC)C(=O)C1CCC(=O)N1C(=O)C2=CC=CC=C2,,,,,,
3742,93743,1-Benzoyl-5-(pyrrolidine-1-carbonyl)pyrrolidin-2-one,C1CCN(C1)C(=O)C2CCC(=O)N2C(=O)C3=CC=CC=C3,,,,,,
3743,93744,"1-Benzoyl-n,n-dimethyl-5-oxoprolinamide",CN(C)C(=O)C1CCC(=O)N1C(=O)C2=CC=CC=C2,,,,,,
3744,93745,"4-(4H-1,2,4-Triazol-4-yl)morpholine",C1COCCN1N2C=NN=C2,,,,,,
3745,93746,4-(Triethoxysilyl)butane-2-thiol,CCO[Si](CCC(C)S)(OCC)OCC,,,,,,
3746,93747,N-Methyl-3-phenyl-1H-indol-1-amine,CNN1C=C(C2=CC=CC=C21)C3=CC=CC=C3,,,,,,
3747,93748,Ethyl cyclopent-1-ene-1-acetate,CCOC(=O)CC1=CCCC1,,,,,,
3748,93749,CID 93749,C1CNCCC1N2C3=CC=CC=C3N=C2S,,,,,,
3749,93750,N'-[4-(carbamimidoyldiazenyl)anilino]ethanimidamide,CC(=NNC1=CC=C(C=C1)N=NC(=N)N)N,,,,,,
3750,93751,CID 93751,C(C(=O)O)N1C(=NN=N1)S,,,,,,
3751,93752,6-Hexadecanone,CCCCCCCCCCC(=O)CCCCC,,,,,,
3752,93753,"(2R,9aR)-2-(4-chlorophenyl)-1,3,4,6,7,8,9,9a-octahydroquinolizin-2-ol",C1CCN2CC[C@@](C[C@H]2C1)(C3=CC=C(C=C3)Cl)O,,,,,,
3753,93754,"2H-Quinolizine, 2-equatorial-(4-chlorophenyl)-2-axial-hydroxy-",C1CCN2CCC(C[C@@H]2C1)(C3=CC=C(C=C3)Cl)O,,,,,,
3754,93755,2-equatorial-Hydroxy-2-axial-(4-trifluorophenyl)quinolizidine,C1CCN2CCC(C[C@H]2C1)(C3=CC=C(C=C3)C(F)(F)F)O,,,,,,
3755,93756,2-axial-Hydroxy-2-equatorial-(4-trifluorophenyl)quinolizidine,C1CCN2CCC(C[C@@H]2C1)(C3=CC=C(C=C3)C(F)(F)F)O,,,,,,
3756,93757,"2H-Quinolizine, 2-axial-(3-chlorophenyl)-2-equatorial-hydroxy-",C1CCN2CCC(C[C@H]2C1)(C3=CC(=CC=C3)Cl)O,,,,,,
3757,93758,2-equatorial-Hydroxy-2-axial-(3-trifluorophenyl)quinolizidine,C1CCN2CCC(C[C@H]2C1)(C3=CC(=CC=C3)C(F)(F)F)O,,,,,,
3758,93759,"Methanone, (4-fluorophenyl)(octahydro-2H-quinolizin-2-yl)-, trans-",C1CCN2CC[C@H](C[C@H]2C1)C(=O)C3=CC=C(C=C3)F,,,,,,
3759,93760,"2H-Quinolizine, octahydro-2-axial-(4-fluorobenzoyl)-",C1CCN2CC[C@@H](C[C@H]2C1)C(=O)C3=CC=C(C=C3)F,,,,,,
3760,93761,4-tert-Butylcyclohexyl phenylacetate,CC(C)(C)C1CCC(CC1)OC(=O)CC2=CC=CC=C2,,,,,,
3761,93762,CID 93762,C1=CC=NC(=C1)C(=O)[O-].[Na+],,,,,,
3762,93763,"1,1'-(4-Bromobutylidene)bis(4-fluorobenzene)",C1=CC(=CC=C1C(CCCBr)C2=CC=C(C=C2)F)F,,,,,,
3763,93764,Diethyl phenethylphosphoramidate,CCOP(=O)(NCCC1=CC=CC=C1)OCC,,,,,,
3764,93765,2-Chloro-3-(1-methylethyl)pyrazine,CC(C)C1=NC=CN=C1Cl,,,,,,
3765,93766,"2,2-Bis{[(octadec-9-enoyl)oxy]methyl}butyl octadec-9-enoate (non-preferred name)",CCCCCCCCC=CCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC,,,,,,
3766,93767,"3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,12-Henicosafluorododecyl dihydrogen phosphate",C(COP(=O)(O)O)C(C(C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
3767,93768,"3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,14-Pentacosafluorotetradecyl dihydrogen phosphate",C(COP(=O)(O)O)C(C(C(C(C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
3768,93769,5-Propylfuran-2(5H)-one,CCCC1C=CC(=O)O1,,,,,,
3769,93770,"9-Octadecenoic acid (9Z)-, isooctadecyl ester",CCCCCCCCC=CCCCCCCCC(=O)OCCCCCCCCCCCCCCCC(C)C,,,,,,
3770,93771,Bis(2-(succinimidooxycarbonyloxy)ethyl)sulfone,C1CC(=O)N(C1=O)OC(=O)OCCS(=O)(=O)CCOC(=O)ON2C(=O)CCC2=O,,,,,,
3771,93772,"3,5,5-Trimethylcyclohexane-1,2-dione",CC1CC(CC(=O)C1=O)(C)C,,,,,,
3772,93773,"2-(Dimethylamino)-3,5,5-trimethylcyclohex-2-en-1-one",CC1=C(C(=O)CC(C1)(C)C)N(C)C,,,,,,
3773,93774,4-(Tert-Butoxy)Benzaldehyde,CC(C)(C)OC1=CC=C(C=C1)C=O,,,,,,
3774,93775,"Piperidine, 1-(4-methoxybenzoyl)-",COC1=CC=C(C=C1)C(=O)N2CCCCC2,,,,,,
3775,93776,1-(5-Bromo-7-ethyl-1-benzofuran-2-yl)-2-chloroethanol,CCC1=C2C(=CC(=C1)Br)C=C(O2)C(CCl)O,,,,,,
3776,93777,"5,5-Dimethoxy-2-pentene",CC=CCC(OC)OC,,,,,,
3777,93778,1-(2-Nitrophenyl)piperidin-4-amine,C1CN(CCC1N)C2=CC=CC=C2[N+](=O)[O-],,,,,,
3778,93779,"N1-(1-benzylpiperidin-4-yl)benzene-1,2-diamine",C1CN(CCC1NC2=CC=CC=C2N)CC3=CC=CC=C3,,,,,,
3779,93780,"N-(1-(3-(2-(4-Fluorophenyl)-1,3-dioxolan-2-yl)propyl)piperidin-4-yl)benzene-1,4-diamine",C1CN(CCC1NC2=CC=C(C=C2)N)CCCC3(OCCO3)C4=CC=C(C=C4)F,,,,,,
3780,93781,4-(Ethoxymethyl)phenol,CCOCC1=CC=C(C=C1)O,,,,,,
3781,93782,4-Amino-5-methylaminosulphonyl-o-anisic acid,CNS(=O)(=O)C1=C(C=CC(=C1OC)C(=O)O)N,,,,,,
3782,93783,"5-(Aminosulphonyl)-2,3-dimethoxybenzoyl chloride",COC1=CC(=CC(=C1OC)C(=O)Cl)S(=O)(=O)N,,,,,,
3783,93784,"Methyl 2,3-dimethoxy-5-((methylamino)sulphonyl)benzoate",CNS(=O)(=O)C1=CC(=C(C(=C1)OC)OC)C(=O)OC,,,,,,
3784,93785,1-(Benzyl)-2-(nitromethylene)pyrrolidine,C1CC(=C[N+](=O)[O-])N(C1)CC2=CC=CC=C2,,,,,,
3785,93786,"4,7,10,13-Tetraoxahexadecanedinitrile",C(COCCOCCOCCOCCC#N)C#N,,,,,,
3786,93787,Icosyloxirane,CCCCCCCCCCCCCCCCCCCCC1CO1,,,,,,
3787,93788,"4,4'-(2-Furylmethylene)bis(N,N-dimethylaniline)",CN(C)C1=CC=C(C=C1)C(C2=CC=C(C=C2)N(C)C)C3=CC=CO3,,,,,,
3788,93789,Butyl 4-dimethylaminobenzoate,CCCCOC(=O)C1=CC=C(C=C1)N(C)C,,,,,,
3789,93790,"7-Oxabicyclo(4.1.0)heptane-3-methanol, alpha,alpha,6-trimethyl-",CC12CCC(CC1O2)C(C)(C)O,,,,,,
3790,93791,"2,6-Dihydroxybenzonitrile",C1=CC(=C(C(=C1)O)C#N)O,,,,,,
3791,93792,"Benzeneacetic acid, 2,4-dihydroxy-alpha-oxo-, ethyl ester",CCOC(=O)C(=O)C1=C(C=C(C=C1)O)O,,,,,,
3792,93793,"N,N-Dibenzyl-1',3'-dihydro-3',3'-dimethyl-1'-phenylspiro[2H-1-benzopyran-2,2'-(2')indol]-7-amine",CC1(C2=CC=CC=C2N(C13C=CC4=C(O3)C=C(C=C4)N(CC5=CC=CC=C5)CC6=CC=CC=C6)C7=CC=CC=C7)C,,,,,,
3793,93794,Disuccinimido pentamethylenedicarbonate,C1CC(=O)N(C1=O)OC(=O)OCCCCCOC(=O)ON2C(=O)CCC2=O,,,,,,
3794,93795,Lorazepam pivalate,CC(C)(C)C(=O)OC1C(=O)NC2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3Cl,,,,,,
3795,93796,"1-((4-Nitrophenyl)sulfonyl)-1H-1,2,4-triazole",C1=CC(=CC=C1[N+](=O)[O-])S(=O)(=O)N2C=NC=N2,,,,,,
3796,93797,"(8S,10S,11S,13S,14S,16S,17R)-17-acetyl-9-chloro-11,17-dihydroxy-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one",C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4(C3([C@H](C[C@@]2([C@]1(C(=O)C)O)C)O)Cl)C,,,,,,
3797,93798,"(6R,8S,10S,11S,13S,14S)-2-bromo-6,9-difluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one",C[C@]12C[C@@H](C3([C@H]([C@@H]1CCC2(C(=O)CO)O)C[C@H](C4=CC(=O)C(=C[C@@]43C)Br)F)F)O,,,,,,
3798,93799,"2-Bromo-9,11-dichloro-6-fluoro-3,20-dioxopregna-1,4-diene-17,21-diyl diacetate",CC(=O)OCC(=O)C1(CC[C@@H]2[C@@]1(C[C@@H](C3([C@H]2C[C@H](C4=CC(=O)C(=C[C@@]43C)Br)F)Cl)Cl)C)OC(=O)C,,,,,,
3799,93800,"2-Bromo-6,9-difluoro-11,16,17-trihydroxy-3,20-dioxopregna-1,4-dien-21-yl acetate",CC(=O)OCC(=O)C1([C@@H](C[C@@H]2[C@@]1(C[C@@H](C3([C@H]2C[C@H](C4=CC(=O)C(=C[C@@]43C)Br)F)F)O)C)O)O,,,,,,
3800,93801,"2-Bromo-6,9-difluoro-11,17-dihydroxy-3,20-dioxopregna-1,4-dien-21-yl acetate",CC(=O)OCC(=O)C1(CC[C@@H]2[C@@]1(C[C@@H](C3([C@H]2C[C@H](C4=CC(=O)C(=C[C@@]43C)Br)F)F)O)C)O,,,,,,
3801,93802,"2-Bromo-6-fluoro-16-methyl-3,20-dioxopregna-1,4,9(11)-triene-17,21-diyl diacetate",C[C@@H]1C[C@H]2[C@@H]3C[C@H](C4=CC(=O)C(=C[C@@]4(C3=CC[C@@]2(C1(C(=O)COC(=O)C)OC(=O)C)C)C)Br)F,,,,,,
3802,93803,"(6|A,16|A,17xi)-2-bromo-6-fluoro-16-methyl-3,20-dioxopregna-1,4,9(11)-triene-17,21-diyl diacetate",C[C@H]1C[C@H]2[C@@H]3C[C@H](C4=CC(=O)C(=C[C@@]4(C3=CC[C@@]2(C1(C(=O)COC(=O)C)OC(=O)C)C)C)Br)F,,,,,,
3803,93804,"2-Bromo-9,11-dichloro-6-fluoro-16-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl diacetate",C[C@H]1C[C@H]2[C@@H]3C[C@H](C4=CC(=O)C(=C[C@@]4([C@]3([C@H](C[C@@]2(C1(C(=O)COC(=O)C)OC(=O)C)C)Cl)Cl)C)Br)F,,,,,,
3804,93805,Einecs 260-962-4,C[C@@H]1C[C@H]2[C@@H]3C[C@H](C4=CC(=O)C(=C[C@@]4([C@]35[C@@H](O5)C[C@@]2(C1(C(=O)COC(=O)C)OC(=O)C)C)C)Br)F,,,,,,
3805,93806,"4-(2,6-Dichloroisonicotinoyl)morpholine",C1COCCN1C(=O)C2=CC(=NC(=C2)Cl)Cl,,,,,,
3806,93807,"Oxazolidine, 3-(2,6-dichloroisonicotinoyl)-",C1COCN1C(=O)C2=CC(=NC(=C2)Cl)Cl,,,,,,
3807,93808,"Morpholine, 4-(2,6-dibutoxyisonicotinoyl)-",CCCCOC1=CC(=CC(=N1)OCCCC)C(=O)N2CCOCC2,,,,,,
3808,93809,"Propanoic acid, 3-chloro-, isooctyl ester",CC(C)CCCCCOC(=O)CCCl,,,,,,
3809,93810,"Acetic acid, ((chlorodimethylstannyl)thio)-, isooctyl ester",CC(C)CCCCCOC(=O)CS[Sn](C)(C)Cl,,,,,,
3810,93811,CID 93811,CCCCCCCCCCCC(=O)O.CCC[SnH](CCC)CCC,,,,,,
3811,93812,"2-Bromo-6-fluoro-3,20-dioxopregna-1,4,9(11)-triene-17,21-diyl diacetate",CC(=O)OCC(=O)C1(CC[C@@H]2[C@@]1(CC=C3[C@H]2C[C@H](C4=CC(=O)C(=C[C@]34C)Br)F)C)OC(=O)C,,,,,,
3812,93813,"2-Bromo-9beta,11beta-epoxy-6beta-fluoro-17,21-dihydroxypregna-1,4-diene-3,20-dione 17,21-di(acetate)",CC(=O)OCC(=O)C1(CC[C@@H]2[C@@]1(C[C@H]3[C@@]4([C@H]2C[C@H](C5=CC(=O)C(=C[C@@]54C)Br)F)O3)C)OC(=O)C,,,,,,
3813,93814,2-Mercaptoethyl octanoate,CCCCCCCC(=O)OCCS,,,,,,
3814,93815,CID 93815,CCCCCCCC(=O)OCC[S-].CCCCCCCC(=O)OCC[S-].C[Sn]C,,,,,,
3815,93816,"Octanoic acid, (methylstannylidyne)tris(thio-2,1-ethanediyl) ester",CCCCCCCC(=O)OCCS[Sn](C)(SCCOC(=O)CCCCCCC)SCCOC(=O)CCCCCCC,,,,,,
3816,93817,Ethyl 4-[[(methylphenylamino)methylene]amino]benzoate,CCOC(=O)C1=CC=C(C=C1)N=CN(C)C2=CC=CC=C2,,,,,,
3817,93818,"Benzoic acid, 4-[[[[4-(ethoxycarbonyl)phenyl]amino]methylene]amino]-, ethyl ester",CCOC(=O)C1=CC=C(C=C1)NC=NC2=CC=C(C=C2)C(=O)OCC,,,,,,
3818,93819,Triphenylsulfonium hexafluorophosphate,C1=CC=C(C=C1)[S+](C2=CC=CC=C2)C3=CC=CC=C3.F[P-](F)(F)(F)(F)F,,,,,,
3819,93820,Triphenylsulfonium hexafluoroantimonate,C1=CC=C(C=C1)[S+](C2=CC=CC=C2)C3=CC=CC=C3.F[Sb-](F)(F)(F)(F)F,,,,,,
3820,93821,"N,N,N',N'-Tetrakis(2-hydroxypropyl)adipamide",CC(CN(CC(C)O)C(=O)CCCCC(=O)N(CC(C)O)CC(C)O)O,,,,,,
3821,93822,Ethyl (2'-(4-methoxybenzoyl)hydrazido)oxalate,CCOC(=O)C(=O)NNC(=O)C1=CC=C(C=C1)OC,,,,,,
3822,93823,4'-Chloroacetophenone phenylhydrazone,CC(=NNC1=CC=CC=C1)C2=CC=C(C=C2)Cl,,,,,,
3823,93824,"2,5-Dibromo-3-(dibromomethyl)thiophene",C1=C(SC(=C1C(Br)Br)Br)Br,,,,,,
3824,93825,"(S)-1,2,3,4,5,6,7,8-Octahydro-1-[(4-methoxyphenyl)methyl]isoquinoline",COC1=CC=C(C=C1)CC2C3=C(CCCC3)CCN2,,,,,,
3825,93826,"N2-((1,1-Dimethylethoxy)carbonyl)-N6-((2-(methylsulphonyl)ethoxy)carbonyl)-L-lysine",CC(C)(C)OC(=O)NC(CCCCNC(=O)OCCS(=O)(=O)C)C(=O)O,,,,,,
3826,93827,"Piperidine, 1-(methyleneamino)-2,2,6,6-tetramethyl-",CC1(CCCC(N1N=C)(C)C)C,,,,,,
3827,93828,Calcium bis(dinonylnaphthalenesulphonate),CCCCCCCCCC1=CC2=CC=CC=C2C(=C1CCCCCCCCC)S(=O)(=O)[O-].[Ca+2],,,,,,
3828,93829,"2,3-dinonylnaphthalene-1-sulfonic Acid",CCCCCCCCCC1=CC2=CC=CC=C2C(=C1CCCCCCCCC)S(=O)(=O)O,,,,,,
3829,93830,Phenylphosphonothioic acid O-ethyl O-(2-nitrophenyl) ester,CCOP(=S)(C1=CC=CC=C1)OC2=CC=CC=C2[N+](=O)[O-],,,,,,
3830,93831,Allyl decanoate,CCCCCCCCCC(=O)OCC=C,,,,,,
3831,93832,Hex-3-en-1-yl 2-methylpropanoate,CCC=CCCOC(=O)C(C)C,,,,,,
3832,93833,"2,2'-Methylenebis(4,6-dibromophenol)",C1=C(C=C(C(=C1CC2=C(C(=CC(=C2)Br)Br)O)O)Br)Br,,,,,,
3833,93834,O-(6-Chloropyridin-2-yl) O-ethyl phenylthiophosphonate,CCOP(=S)(C1=CC=CC=C1)OC2=NC(=CC=C2)Cl,,,,,,
3834,93835,Methyl 2-(acetyloxy)-2-methylpropanoate,CC(=O)OC(C)(C)C(=O)OC,,,,,,
3835,93836,S-Benzyl(2-2H1)DL-cysteine,[2H]C(CSCC1=CC=CC=C1)(C(=O)O)N,,,,,,
3836,93837,2-Amino-1-methoxybutane,CCC(COC)N,,,,,,
3837,93838,6-Acetoxydihydrotheaspirane,CC1CCC2(O1)C(CCCC2(C)OC(=O)C)(C)C,,,,,,
3838,93839,Triphenylsulfonium hexafluoroarsenate,C1=CC=C(C=C1)[S+](C2=CC=CC=C2)C3=CC=CC=C3.F[As-](F)(F)(F)(F)F,,,,,,
3839,93840,[2-[(2-Acetyloxy-4-methylpentan-2-yl)diazenyl]-4-methylpentan-2-yl] acetate,CC(C)CC(C)(N=NC(C)(CC(C)C)OC(=O)C)OC(=O)C,,,,,,
3840,93841,2-(2-Acetyloxybutan-2-yldiazenyl)butan-2-yl acetate,CCC(C)(N=NC(C)(CC)OC(=O)C)OC(=O)C,,,,,,
3841,93842,2-{[(Benzyloxy)carbonyl]amino}-3-{[(benzyloxy)carbonyl]sulfanyl}propanoic acid,C1=CC=C(C=C1)COC(=O)NC(CSC(=O)OCC2=CC=CC=C2)C(=O)O,,,,,,
3842,93843,Bis(p-isopropylphenyl) sulphone,CC(C)C1=CC=C(C=C1)S(=O)(=O)C2=CC=C(C=C2)C(C)C,,,,,,
3843,93844,2-Methyl-3-(2-methylphenyl)propanal,CC1=CC=CC=C1CC(C)C=O,,,,,,
3844,93845,(Hexyloxy)acetic acid,CCCCCCOCC(=O)O,,,,,,
3845,93846,Isopropenyl chloroformate,CC(=C)OC(=O)Cl,,,,,,
3846,93847,"Ethyl 2-ethyl-6,6-dimethylcyclohex-2-ene-1-carboxylate",CCC1=CCCC(C1C(=O)OCC)(C)C,,,,,,
3847,93848,"1-(2-Ethyl-6,6-dimethylcyclohexen-1-yl)but-2-en-1-one",CCC1=C(C(CCC1)(C)C)C(=O)C=CC,,,,,,
3848,93849,"1-(2-Ethyl-6,6-dimethylcyclohex-2-en-1-yl)but-2-en-1-one",CCC1=CCCC(C1C(=O)C=CC)(C)C,,,,,,
3849,93850,"1-(6-Ethylidene-2,2-dimethylcyclohexyl)but-2-en-1-one",CC=CC(=O)C1C(=CC)CCCC1(C)C,,,,,,
3850,93851,p-Nitrophenol tin(II) salt,C1=CC(=CC=C1[N+](=O)[O-])[O-].[Sn+2],,,,,,
3851,93852,Ethyl N-((2-hydroxyphenyl)methyl)glycinate,CCOC(=O)CNCC1=CC=CC=C1O,,,,,,
3852,93853,2-[[(2-Hydroxyphenyl)methyl]amino]acetamide,C1=CC=C(C(=C1)CNCC(=O)N)O,,,,,,
3853,93854,CID 93854,CCOC(=O)C=C(C)NC(C1=CC=C(C=C1)O)C(=O)[O-].[K+],,,,,,
3854,93855,2-[(4-Ethoxy-4-oxobut-2-en-2-yl)amino]-2-(4-hydroxyphenyl)acetic acid,CCOC(=O)C=C(C)NC(C1=CC=C(C=C1)O)C(=O)O,,,,,,
3855,93856,Ethyl (cyclohexyloxy)acetate,CCOC(=O)COC1CCCCC1,,,,,,
3856,93857,"(1R,4S,5'R,6'R,10S,11R,12R,14R,15R,16S,18R,19S,20R,25S,26R,27S,29S)-4-ethyl-11,15,19-trihydroxy-6'-[(2S)-2-hydroxypropyl]-5',10,12,14,16,18,20,26,29-nonamethylspiro[24,28-dioxabicyclo[23.3.1]nonacosa-5,7,21-triene-27,2'-oxane]-13,17,23-trione",CC[C@H]1CC[C@@H]2[C@@H]([C@@H]([C@H]([C@@]3(O2)CC[C@H]([C@H](O3)C[C@H](C)O)C)C)OC(=O)C=C[C@H]([C@@H]([C@H](C(=O)[C@H]([C@@H]([C@H](C(=O)[C@@H]([C@@H]([C@H](CC=CC=C1)C)O)C)C)O)C)C)O)C)C,,,,,,
3857,93858,Tosufloxacin tosylate,CC1=CC=C(C=C1)S(=O)(=O)O.C1CN(CC1N)C2=C(C=C3C(=O)C(=CN(C3=N2)C4=C(C=C(C=C4)F)F)C(=O)O)F,,,,,,
3858,93859,"7-(3-Aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid--hydrogen chloride--water (1/1/1)",C1CN(CC1N)C2=C(C=C3C(=O)C(=CN(C3=N2)C4=C(C=C(C=C4)F)F)C(=O)O)F.O.Cl,,,,,,
3859,93860,[(1S)-3-methyl-1-[[(2R)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acid,B([C@@H](CC(C)C)NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,,,,,,
3860,93861,3-Maleimidobenzoyl N-hydroxysuccinimide,C1CC(=O)N(C1=O)OC(=O)C2=CC(=CC=C2)N3C(=O)C=CC3=O,,,"['Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)']",,,
3861,93862,7-Chloro-4-methyl-1-indanone,CC1=C2CCC(=O)C2=C(C=C1)Cl,,,,,,
3862,93863,(S)-5-((1-Benzyl-2-((4-methyl-2-oxo-2H-1-benzopyran-7-yl)amino)-2-oxoethyl)amino)-5-oxovaleric acid,CC1=CC(=O)OC2=C1C=CC(=C2)NC(=O)C(CC3=CC=CC=C3)NC(=O)CCCC(=O)O,,,,,,
3863,93864,"Carbamic acid, (4-methyl-2-oxo-2H-1-benzopyran-7-yl)-, ethyl ester",CCOC(=O)NC1=CC2=C(C=C1)C(=CC(=O)O2)C,,,,,,
3864,93865,2-(tert-Butoxycarbonyloximino)-2-phenylacetonitrile,CC(C)(C)OC(=O)ON=C(C#N)C1=CC=CC=C1,,,,,,
3865,93866,"Octenylsuccinic acid, dipotassium salt",C=CCCCCCCC(CC(=O)[O-])C(=O)[O-].[K+].[K+],,,,,,
3866,93867,Oct-7-enylsuccinic acid,C=CCCCCCCC(CC(=O)O)C(=O)O,,,,,,
3867,93868,2-(Isopropyl)-5-methylcyclohexyl benzoate,CC1CCC(C(C1)OC(=O)C2=CC=CC=C2)C(C)C,,,,,,
3868,93869,cis-2-Pentylcyclopropanecarboxylic acid,CCCCCC1CC1C(=O)O,,,,,,
3869,93870,Einecs 261-377-7,CC(=O)NCSCC(C(=O)OC1=CC=C(C=C1)[N+](=O)[O-])NC(=O)OC(C)(C)C,,,,,,
3870,93871,"[(8R,9S,10R,13S,14S)-17-acetyl-13-methyl-6-methylidene-3-oxo-2,7,8,9,10,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate",CC(=O)C1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC(=C)C4=CC(=O)CC[C@H]34)C)OC(=O)C,,,,,,
3871,93872,2-methyl-N-(5-methylhexan-2-ylideneamino)propan-2-amine,CC(C)CCC(=NNC(C)(C)C)C,,,,,,
3872,93873,1-Bicyclo[2.2.1]hept-2-ylethanone,CC(=O)C1CC2CCC1C2,,,,,,
3873,93874,N-Isopropylpyridine-2-methylamine,CC(C)NCC1=CC=CC=N1,,,,,,
3874,93875,"1-Tetradecanol, 2-decyl-",CCCCCCCCCCCCC(CCCCCCCCCC)CO,,,,,,
3875,93876,"Diethyl 1H-1,2,4-triazol-1-ylphosphonite",CCOP(N1C=NC=N1)OCC,,,,,,
3876,93877,"2,4,5-Tribromocumene",CC(C)C1=CC(=C(C=C1Br)Br)Br,,,,,,
3877,93878,"2,4,5-Tribromo-alpha-methylstyrene",CC(=C)C1=CC(=C(C=C1Br)Br)Br,,,,,,
3878,93879,"(6R-trans)-3-(Acetoxymethyl)-7-((4-chloro-1,3-dioxobutyl)amino)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid",CC(=O)OCC1=C(N2C(C(C2=O)NC(=O)CC(=O)CCl)SC1)C(=O)O,,,,,,
3879,93880,"5-Amino-2,4-dihydro-4-methyl-2-phenyl-3H-pyrazol-3-one",CC1C(=NN(C1=O)C2=CC=CC=C2)N,,,,,,
3880,93881,Einecs 261-392-9,C1=CC=C(C=C1)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)N,,,,,,
3881,93882,"5,5-Dimethyl-1,3-dioxane-2-propionaldehyde",CC1(COC(OC1)CCC=O)C,,,,,,
3882,93883,"2-Naphthalenecarboxylic acid, 3-methoxy-, 2-((3-methoxy-2-naphthalenyl)carbonyl)hydrazide",COC1=CC2=CC=CC=C2C=C1C(=O)NNC(=O)C3=CC4=CC=CC=C4C=C3OC,,,,,,
3883,93884,N-(2-Thienylmethyl)-2-thiophenemethanamine,C1C=CSC(=C1)NC2=CCC=CS2,,,,,,
3884,93885,"1,1,1,2,3,3-Hexafluoro-4-methoxybutane",COCC(C(C(F)(F)F)F)(F)F,,,,,,
3885,93886,"1,2,3,8-Tetrahydro-1,2,3,3,8-pentamethyl-5-(trifluoromethyl)-7H-pyrrolo[3,2-g]quinolin-7-one",CC1C(C2=C(N1C)C=C3C(=C2)C(=CC(=O)N3C)C(F)(F)F)(C)C,,,,,,
3886,93887,N-Dodecanoyl-proline,CCCCCCCCCCCC(=O)N1CCCC1C(=O)O,,,,,,
3887,93888,N~2~-(1-Hydroxyhexadecylidene)arginine,CCCCCCCCCCCCCCCC(=O)NC(CCCN=C(N)N)C(=O)O,,,,,,
3888,93889,2-Aminobenzonorbornene,C1C2CC(C1C3=CC=CC=C23)N,,,,,,
3889,93890,4-Cyano-4'-ethylbiphenyl,CCC1=CC=C(C=C1)C2=CC=C(C=C2)C#N,,,,,,
3890,93891,"[1,1'-Biphenyl]-4-carbonitrile, 4'-propyl-",CCCC1=CC=C(C=C1)C2=CC=C(C=C2)C#N,,,,,,
3891,93892,"4'-Methoxy-[1,1'-biphenyl]-4-carbonitrile",COC1=CC=C(C=C1)C2=CC=C(C=C2)C#N,,,,,,
3892,93893,"[1,1'-Biphenyl]-4-carbonitrile, 4'-ethoxy-",CCOC1=CC=C(C=C1)C2=CC=C(C=C2)C#N,,,,,,
3893,93894,5-Hexenyltrimethoxysilane,CO[Si](CCCCC=C)(OC)OC,,,,,,
3894,93895,"2,4,6-Triiodo-3-(methylacetamido)-5-((methylamino)carbonyl)benzoylchloride",CC(=O)N(C)C1=C(C(=C(C(=C1I)C(=O)Cl)I)C(=O)NC)I,,,,,,
3895,93896,Phenethyl nonanoate,CCCCCCCCC(=O)OCCC1=CC=CC=C1,,,,,,
3896,93897,"Benzenamine, 4-[[2,5-dimethoxy-4-[(4-nitrophenyl)azo]phenyl]azo]-N,N-diethyl-",CCN(CC)C1=CC=C(C=C1)N=NC2=CC(=C(C=C2OC)N=NC3=CC=C(C=C3)[N+](=O)[O-])OC,,,,,,
3897,93898,4-Chloro-2-fluoroaniline,C1=CC(=C(C=C1Cl)F)N,,,,,,
3898,93899,2-Bromo-4-(trifluoromethyl)aniline,C1=CC(=C(C=C1C(F)(F)F)Br)N,,,,,,
3899,93900,"1-Propene, 3,3'-[oxybis(2,1-ethanediyloxy)]bis-",C=CCOCCOCCOCC=C,,,,,,
3900,93901,Einecs 261-039-9,CCOC(=O)CCN(CCC(=O)OCC)C(C)C1=CC=CC=C1,,,,,,
3901,93902,6-Benzylpyridin-2-amine,C1=CC=C(C=C1)CC2=NC(=CC=C2)N,,,,,,
3902,93903,"[1,1'-Biphenyl]-4-ol, 3,3''-thiobis[4',5-bis(1,1-dimethylethyl)-",CC(C)(C)C1=CC=C(C=C1)C2=CC(=C(C(=C2)SC3=CC(=CC(=C3O)C(C)(C)C)C4=CC=C(C=C4)C(C)(C)C)O)C(C)(C)C,,,,,,
3903,93904,"4-methyl-7-morpholino-2H-pyrano[2,3-b]pyridin-2-one",CC1=CC(=O)OC2=C1C=CC(=N2)N3CCOCC3,,,,,,
3904,93905,"7-(Dimethylamino)-4-methoxy-1-methyl-1,8-naphthyridin-2(1H)-one",CN1C(=O)C=C(C2=C1N=C(C=C2)N(C)C)OC,,,,,,
3905,93906,"4-Pyridinecarboxaldehyde, O-methyloxime",CON=CC1=CC=NC=C1,,,,,,
3906,93907,"(Z,E)-Trideca-4,7-dien-1-yl acetate",CCCCCC=CCC=CCCCOC(=O)C,,,,,,
3907,93908,"4,7-Tridecadien-1-ol, (4Z,7Z)-",CCCCCC=CCC=CCCCO,,,,,,
3908,93909,"2-Chloro-1,4-phenylene diacetate",CC(=O)OC1=CC(=C(C=C1)OC(=O)C)Cl,,,,,,
3909,93910,"1,2-Dichloro-1,2-diethoxyethane",CCOC(C(OCC)Cl)Cl,,,,,,
3910,93911,4-(4-Bromophenyl)piperidin-4-ol,C1CNCCC1(C2=CC=C(C=C2)Br)O,,,,,['4-(4-Bromophenyl)piperidin-4-ol is a known human metabolite of bromperidol.'],
3911,93912,4-(p-Tolyl)piperidin-4-ol,CC1=CC=C(C=C1)C2(CCNCC2)O,,,,,,
3912,93913,"n-Benzyloxycarbonyloxy-5-norbornene-2,3-dicarboximide",C1C2C=CC1C3C2C(=O)N(C3=O)OC(=O)OCC4=CC=CC=C4,,,,,,
3913,93914,"1-Ethoxy-1,1-dimethoxyethane",CCOC(C)(OC)OC,,,,,,
3914,93915,"1-(4-Fluorophenyl)-1,3,8-triazaspiro[4.5]decan-4-one",C1CNCCC12C(=O)NCN2C3=CC=C(C=C3)F,,,,,,
3915,93916,"[2-[(6R,8S,9R,10S,11S,13S,14S,16R)-17-acetyloxy-2-bromo-9,11-dichloro-6-fluoro-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate",C[C@@H]1C[C@H]2[C@@H]3C[C@H](C4=CC(=O)C(=C[C@@]4([C@]3([C@H](C[C@@]2(C1(C(=O)COC(=O)C)OC(=O)C)C)Cl)Cl)C)Br)F,,,,,,
3916,93917,Dimethyl formylsuccinate,COC(=O)CC(C=O)C(=O)OC,,,,,,
3917,93918,"[2,3-dichloro-4-(1H-tetrazol-5-ylmethoxy)phenyl] 2-thienyl ketone",C1=CSC(=C1)C(=O)C2=C(C(=C(C=C2)OCC3=NNN=N3)Cl)Cl,,,,,,
3918,93919,CID 93919,CN(C)CCN(CC1=CC=CC=C1)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O,,,,,,
3919,93920,4-Ethyloct-1-en-3-ol,CCCCC(CC)C(C=C)O,,,,,,
3920,93921,"Ethyl 2-(2,4-dichlorophenoxy)propionate",CCOC(=O)C(C)OC1=C(C=C(C=C1)Cl)Cl,,,,,,
3921,93922,"3,3-Dimethylcyclopentene",CC1(CCC=C1)C,,,,,,
3922,93923,"Acetamide, N-[5-[bis(2-methoxyethyl)amino]-2-[(2-chloro-6-cyano-4-nitrophenyl)azo]-4-methoxyphenyl]-",CC(=O)NC1=CC(=C(C=C1N=NC2=C(C=C(C=C2Cl)[N+](=O)[O-])C#N)OC)N(CCOC)CCOC,,,,,,
3923,93924,N-Butylpyridine-2-methylamine,CCCCNCC1=CC=CC=N1,,,,,,
3924,93925,"alpha-D-Glucopyranoside, beta-D-fructofuranosyl, dioctanoate",CCCCCCCC(=O)OCC1C(C(C(O1)(CO)OC2C(C(C(C(O2)CO)O)O)O)O)OC(=O)CCCCCCC,,,,,,
3925,93926,"9,10-Anthracenedione, 1,4-diamino-2-chloro-3-[(2-hydroxyethyl)thio]-",C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C(=C3N)SCCO)Cl)N,,,,,,
3926,93927,"9,10-Anthracenedione, 2-[[2-(acetyloxy)ethyl]thio]-1,4-diamino-3-chloro-",CC(=O)OCCSC1=C(C2=C(C(=C1Cl)N)C(=O)C3=CC=CC=C3C2=O)N,,,,,,
3927,93928,Dichloro(2-methoxyethyl)methylsilane,COCC[Si](C)(Cl)Cl,,,,,,
3928,93929,"Ethanol, 2-[ethyl(3-methyl-4-nitrosophenyl)amino]-",CCN(CCO)C1=CC(=C(C=C1)N=O)C,,,,,,
3929,93930,CID 93930,CCC1=CC(=C(C=C1Cl)S(=O)(=O)[O-])N=NC2=C(C=C(C3=CC=CC=C32)C(=O)[O-])O.[Ca+2],,,,,,
3930,93931,4-[(4-Chloro-5-ethyl-2-sulfophenyl)diazenyl]-3-hydroxynaphthalene-1-carboxylic acid,CCC1=CC(=C(C=C1Cl)S(=O)(=O)O)N=NC2=C(C=C(C3=CC=CC=C32)C(=O)O)O,,,,,,
3931,93932,"Tetraethyl 2,2'-(methylenebis(4,1-phenyleneiminocarbonyl))bismalonate",CCOC(=O)C(C(=O)NC1=CC=C(C=C1)CC2=CC=C(C=C2)NC(=O)C(C(=O)OCC)C(=O)OCC)C(=O)OCC,,,,,,
3932,93933,"1H-Imidazole, 4,5-dihydro-1-[3-(triethoxysilyl)propyl]-",CCO[Si](CCCN1CCN=C1)(OCC)OCC,,,,,,
3933,93934,(4-Methoxybutyl)cyclohexane,COCCCCC1CCCCC1,,,,,,
3934,93935,"Benzenesulfonyl chloride, 4-(dodecyloxy)-",CCCCCCCCCCCCOC1=CC=C(C=C1)S(=O)(=O)Cl,,,,,,
3935,93936,"1,1-Dichloro-2-oxo-2-p-tolylethyl thiocyanate",CC1=CC=C(C=C1)C(=O)C(SC#N)(Cl)Cl,,,,,,
3936,93937,"4,4'-Methylenebis(6-chloro-o-cresol)",CC1=CC(=CC(=C1O)Cl)CC2=CC(=C(C(=C2)C)O)Cl,,,,,,
3937,93938,p-Nitrophenyl N2-(tert-butoxycarbonyl)-N6-((2-(methylsulphonyl)ethoxy)carbonyl)-L-lysinate,CC(C)(C)OC(=O)N[C@@H](CCCCNC(=O)OCCS(=O)(=O)C)C(=O)OC1=CC=C(C=C1)[N+](=O)[O-],,,,,,
3938,93939,"Methanone, (2-hydroxy-5-nonylphenyl)phenyl-",CCCCCCCCCC1=CC(=C(C=C1)O)C(=O)C2=CC=CC=C2,,,,,,
3939,93940,"3,5-Dinonylphenol",CCCCCCCCCC1=CC(=CC(=C1)O)CCCCCCCCC,,,,,,
3940,93941,(2-Hydroxytrimethylene)bis(trimethylammonium) dibromide,C[N+](C)(C)CC(C[N+](C)(C)C)O.[Br-].[Br-],,,,,,
3941,93942,"3-Cyclohexyl-5-[5-(3-ethyl-4,5-diphenyl-1,3-oxazol-2-ylidene)pent-3-en-2-ylidene]-2-sulfanylidene-1,3-thiazolidin-4-one",CCN1C(=CC=CC(=C2C(=O)N(C(=S)S2)C3CCCCC3)C)OC(=C1C4=CC=CC=C4)C5=CC=CC=C5,,,,,,
3942,93943,((p-(Methylsulphonyl)phenoxy)methyl)oxirane,CS(=O)(=O)C1=CC=C(C=C1)OCC2CO2,,,,,,
3943,93944,"Formamide, N-(4,5,6,7-tetrahydrobenzo[b]thien-4-yl)-",C1CC(C2=C(C1)SC=C2)NC=O,,,,,,
3944,93945,"(1S-(1alpha,2beta,3alpha,5alpha))-2,6,6-Trimethylbicyclo(3.1.1)heptane-3-carboxylic acid",CC1[C@H](C[C@H]2C[C@@H]1C2(C)C)C(=O)O,,,,,,
3945,93946,"(1r,2r,3r,5s)-2,6,6-Trimethylbicyclo[3.1.1]heptane-3-carboxylic acid",C[C@H]1[C@@H](C[C@@H]2C[C@H]1C2(C)C)C(=O)O,,,,,,
3946,93947,Caryophyllene formate,CC1(CC2C1CCC3(CCCC2(C3)OC=O)C)C,,,,,,
3947,93948,"3a,7-Methano-3aH-cyclopentacycloocten-3-ol, decahydro-1,1,7-trimethyl-, formate",CC1(CC(C23C1CCC(C2)(CCC3)C)OC=O)C,,,,,,
3948,93949,CID 93949,CCCC[SnH2+].CCCC[SnH].C(C[S-])C(=O)O.C(C[S-])C(=O)O.C(C[S-])C(=O)O,,,,,,
3949,93950,CID 93950,COC1=CC=C(C=C1)NC2=C(C=C(C=C2)N[N+]#N)C(=O)[O-],,,,,,
3950,93951,CID 93951,COC1=CC=C(C=C1)NC2=C(C=C(C=C2)N[N+]#N)C(=O)O,,,,,,
3951,93952,"3-Butenal, 2-methyl-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-",CC1=CCCC(C1C=CC(C)C=O)(C)C,,,,,,
3952,93953,2-((4-((2-Cyanoethyl)methylamino)phenyl)azo)-N-cyclohexylbenzenesulphonamide,CN(CCC#N)C1=CC=C(C=C1)N=NC2=CC=CC=C2S(=O)(=O)NC3CCCCC3,,,,,,
3953,93954,"Benzenemethanamine, N-methyl-N-(4-(1H-1,2,4-triazol-3-ylazo)phenyl)-",CN(CC1=CC=CC=C1)C2=CC=C(C=C2)N=NC3=NC=NN3,,,,,,
3954,93955,"Ethanol, 2,2'-[[3-chloro-4-[(2-chloro-4-nitrophenyl)azo]phenyl]imino]bis-",C1=CC(=C(C=C1N(CCO)CCO)Cl)N=NC2=C(C=C(C=C2)[N+](=O)[O-])Cl,,,,,,
3955,93956,"Propanenitrile, 3-[[4-[(2-chloro-4-nitrophenyl)azo]phenyl][2-(2-cyanoethoxy)ethyl]amino]-",C1=CC(=CC=C1N=NC2=C(C=C(C=C2)[N+](=O)[O-])Cl)N(CCC#N)CCOCCC#N,,,,,,
3956,93957,"2-Naphthalenesulfonamide, 6-hydroxy-N-(2-hydroxyethyl)-N-methyl-5-[[4-(phenylazo)phenyl]azo]-",CN(CCO)S(=O)(=O)C1=CC2=C(C=C1)C(=C(C=C2)O)N=NC3=CC=C(C=C3)N=NC4=CC=CC=C4,,,,,,
3957,93958,Allyl 2-ethylhexanoate,CCCCC(CC)C(=O)OCC=C,,,,,,
3958,93959,"1-(2,6,6-Trimethyl-1-cyclohexen-1-yl)hepta-1,6-dien-3-one",CC1=C(C(CCC1)(C)C)C=CC(=O)CCC=C,,,,,,
3959,93960,"4-Piperidinecarboxylic acid, 2,2,6,6-tetramethyl-, methyl ester",CC1(CC(CC(N1)(C)C)C(=O)OC)C,,,,,,
3960,93961,"Octyl (3,5-bis(tert-butyl)-4-hydroxyphenyl)carbamate",CCCCCCCCOC(=O)NC1=CC(=C(C(=C1)C(C)(C)C)O)C(C)(C)C,,,,,,
3961,93962,"2,3,4,5-Tetrahydro-1,5-benzothiazepine hydrochloride",C1CNC2=CC=CC=C2SC1.Cl,,,,,,
3962,93963,"2,3,4,5-Tetrahydro-1,5-benzothiazepine",C1CNC2=CC=CC=C2SC1,,,,,,
3963,93964,"2,2,5,5-Tetramethylthiazolidine-4-carboxylic acid",CC1(C(NC(S1)(C)C)C(=O)O)C,,,,,,
3964,93965,"4,5-Dimethylsalicylic acid",CC1=CC(=C(C=C1C)O)C(=O)O,,,,,,
3965,93966,Durene isocyanate,CC1=CC(=C(C(=C1C)N=C=O)C)C,,,,,,
3966,93967,1-(6-Methoxy-1-naphthyl)ethan-1-one,CC(=O)C1=CC=CC2=C1C=CC(=C2)OC,,,,,,
3967,93968,(3-Aminopropyl)silanetriol,C(CN)C[Si](O)(O)O,,,,,,
3968,93969,"Benzoic acid, 4-[1-[[(2,4-dichlorophenyl)amino]carbonyl]-3,3-dimethyl-2-oxobutoxy]-",CC(C)(C)C(=O)C(C(=O)NC1=C(C=C(C=C1)Cl)Cl)OC2=CC=C(C=C2)C(=O)O,,,,,,
3969,93970,5-[1-Hydroxy-2-naphthalenylcarbonyl[3-(1-oxooctadecylamino)phenylmethyl]amino]isophthalic acid,CCCCCCCCCCCCCCCCCC(=O)NC1=CC=CC(=C1)CN(C2=CC(=CC(=C2)C(=O)O)C(=O)O)C(=O)C3=C(C4=CC=CC=C4C=C3)O,,,,,,
3970,93971,"(2R,4S,6S)-2-(hydroxymethyl)-6-[[(2R,4S)-3,4,5-trihydroxy-5-(hydroxymethyl)oxolan-2-yl]methoxy]oxane-3,4,5-triol",C([C@@H]1C([C@@H](C([C@H](O1)OC[C@@H]2C([C@@H](C(O2)(CO)O)O)O)O)O)O)O,,,,,,
3971,93972,Tetrabromo-m-cresol,CC1=C(C(=C(C(=C1Br)Br)Br)O)Br,,,,,,
3972,93973,beta-Methoxy-alpha-phenylphenethyl alcohol,COC(C1=CC=CC=C1)C(C2=CC=CC=C2)O,,,,,,
3973,93974,CID 93974,C1=CC(=CC(=C1)C(F)(F)F)C=CC#N,,,,,,
3974,93975,CID 93975,[Li+].[B-](N1C=CC=C1)(N2C=CC=C2)(N3C=CC=C3)N4C=CC=C4,,,,,,
3975,93976,Tetrakis(1H-pyrrole-1-yl) boronanion,[B-](N1C=CC=C1)(N2C=CC=C2)(N3C=CC=C3)N4C=CC=C4,,,,,,
3976,93977,"N,N-Dibenzyl-3'-methyl-2,2'-spirobi(2H-1-benzopyran)-7-amine",CC1=CC2=CC=CC=C2OC13C=CC4=C(O3)C=C(C=C4)N(CC5=CC=CC=C5)CC6=CC=CC=C6,,,,,,
3977,93978,"N,N-diethylspiro[2H-1-benzopyran-2,3'-[3H]naphtho[2,1-b]pyran]-7-amine",CCN(CC)C1=CC2=C(C=C1)C=CC3(O2)C=CC4=C(O3)C=CC5=CC=CC=C54,,,,,,
3978,93979,2-Isopropyl-5-methylhex-4-enal,CC(C)C(CC=C(C)C)C=O,,,,,,
3979,93980,"7-Hydroxy-1,2,3,4-tetrahydroquinoline",C1CC2=C(C=C(C=C2)O)NC1,,,,,,
3980,93981,4-Nitrobenzylpiperazine,C1CN(CCN1)CC2=CC=C(C=C2)[N+](=O)[O-].Cl,,,,,,
3981,93982,1-(4-Nitrobenzyl)piperazine,C1CN(CCN1)CC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
3982,93983,"2-(2,6,7-Trimethyl-3-tricyclo[5.3.2.01,6]dodec-2-enyl)acetaldehyde",CC1=C(CCC2(C13CCCC2(CC3)C)C)CC=O,,,,,,
3983,93984,"2-Chloro-N-(2-(hexadecyloxy)-5-((methylamino)sulphonyl)phenyl)-4,4-dimethyl-3-oxovaleramide",CCCCCCCCCCCCCCCCOC1=C(C=C(C=C1)S(=O)(=O)NC)NC(=O)C(C(=O)C(C)(C)C)Cl,,,,,,
3984,93985,N-[2-[(2-Chloro-6-cyano-4-nitrophenyl)azo]-5-[(3-methoxybutyl)(2-methoxyethyl)amino]phenyl]acetamide,CC(CCN(CCOC)C1=CC(=C(C=C1)N=NC2=C(C=C(C=C2Cl)[N+](=O)[O-])C#N)NC(=O)C)OC,,,,,,
3985,93986,"3-Hydroxyestra-1(10),2,4,6-tetraen-17-yl acetate",CC(=O)OC1CCC2C1(CCC3C2C=CC4=C3C=CC(=C4)O)C,,,,,,
3986,93987,9-(Methylthio)nonanenitrile,CSCCCCCCCCC#N,,,,,,
3987,93988,"Butanoic acid, 3-methyl-, 2-phenoxyethyl ester",CC(C)CC(=O)OCCOC1=CC=CC=C1,,,,,,
3988,93989,2-(2-Hydroxyethoxy)benzaldehyde,C1=CC=C(C(=C1)C=O)OCCO,,,,,,
3989,93990,"2,4-Dodecadienoyl chloride, 3,7,11-trimethyl-, (2E,4E)-",CC(C)CCCC(C)CC=CC(=CC(=O)Cl)C,,,,,,
3990,93991,N-(4-Amino-2-methylphenyl)-4-chlorophthalimide,CC1=C(C=CC(=C1)N)N2C(=O)C3=C(C2=O)C=C(C=C3)Cl,,,,,,
3991,93992,"6-Amino-2,3-dihydro-2-methyl-1,3-dioxo-1H-benz(de)isoquinoline-5-sulphonic acid",CN1C(=O)C2=CC=CC3=C2C(=CC(=C3N)S(=O)(=O)O)C1=O,,,,,,
3992,93993,"3-(Acetyloxymethyl)-7-[[2-(2-amino-1,3-thiazol-4-yl)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",CC(=O)OCC1=C(N2C(C(C2=O)NC(=O)CC3=CSC(=N3)N)SC1)C(=O)O,,,,,,
3993,93994,"Dithiophosphoric acid O,O-bis(3-methylbutyl)S-sodium salt",CC(C)CCOP(=S)(OCCC(C)C)[S-].[Na+],,,,,,
3994,93995,"O,O'-Diisopentyl hydrogen dithiophosphate",CC(C)CCOP(=S)(OCCC(C)C)S,,,,,,
3995,93996,"Dithiophosphoric acid O,O-bis(1,3-dimethylbutyl)S-sodium salt",CC(C)CC(C)OP(=S)(OC(C)CC(C)C)[S-].[Na+],,,,,,
3996,93997,"Dihydro-3-(isooctadecenyl)furan-2,5-dione",CC(C)CCCCC=CCCCCCCCCCC1CC(=O)OC1=O,,,,,,
3997,93998,2-Ethylhexyl (3-isocyanatomethylphenyl)-carbamate,CCCCC(CC)COC(=O)NC1=CC=CC(=C1)CN=C=O,,,,,,
3998,93999,"1,1,4,4-Tetramethyl-6-ethyl-7-chloromethyltetralin",CCC1=CC2=C(C=C1CCl)C(CCC2(C)C)(C)C,,,,,,
3999,94000,"1,1,4,4-Tetramethyl-6-ethyl-7-cyanotetralin",CCC1=CC2=C(C=C1C#N)C(CCC2(C)C)(C)C,,,,,,
4000,94001,"1,3-Dioxolane, 4-methyl-2-(4-methylphenyl)-",CC1COC(O1)C2=CC=C(C=C2)C,,,,,,
4001,94002,"Bis(4,5-dimethoxy-2-nitrophenyl)disulfide",COC1=C(C=C(C(=C1)[N+](=O)[O-])SSC2=CC(=C(C=C2[N+](=O)[O-])OC)OC)OC,,,,,,
4002,94003,2-(Benzoyloxymethyl)benzoic acid,C1=CC=C(C=C1)C(=O)OCC2=CC=CC=C2C(=O)O,,,,,,
4003,94004,2-(Benzoyloxymethyl)benzoyl chloride,C1=CC=C(C=C1)C(=O)OCC2=CC=CC=C2C(=O)Cl,,,,,,
4004,94005,"2,6-Bis(tert-butylamino)-4-methylpyridin-3-yl methyl ketone",CC1=CC(=NC(=C1C(=O)C)NC(C)(C)C)NC(C)(C)C,,,,,,
4005,94006,Octadec-8-enyl formate,CCCCCCCCCC=CCCCCCCCOC=O,,,,,,
4006,94007,2-Dodecanoyloxyethyl octadec-9-enoate,CCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCC=CCCCCCCCC,,,,,,
4007,94008,"2,2,5,9-Tetramethyldeca-4,8-dienenitrile",CC(=CCCC(=CCC(C)(C)C#N)C)C,,,,,,
4008,94009,m-(Chlorocarbonyl)benzenesulphonic acid,C1=CC(=CC(=C1)S(=O)(=O)O)C(=O)Cl,,,,,,
4009,94010,Bis(1-methylpentadecyl) adipate,CCCCCCCCCCCCCCC(C)OC(=O)CCCCC(=O)OC(C)CCCCCCCCCCCCCC,,,,,,
4010,94011,Trichloro(2-((chloromethyl)phenyl)ethyl)silane,C1=CC=C(C(=C1)CC[Si](Cl)(Cl)Cl)CCl,,,,,,
4011,94012,Trichloro[2-(3-methylphenyl)ethyl]silane,CC1=CC(=CC=C1)CC[Si](Cl)(Cl)Cl,,,,,,
4012,94013,"1,6-Dioxacyclohexadecane-7,16-dione",C1CCCCC(=O)OCCCCOC(=O)CCC1,,,,,,
4013,94014,8-Undecenal,CCC=CCCCCCCC=O,,,,,,
4014,94015,N-(2-Amino-5-(phenylthio)phenyl)-2-methoxyacetamide,COCC(=O)NC1=C(C=CC(=C1)SC2=CC=CC=C2)N,,,,,,
4015,94016,CID 94016,C1=CC2=C(C=CC(=C2)S(=O)(=O)[O-])C=C1N.[Na+],,,,,,
4016,94017,"Tricyclo(2.2.1.02,6)hept-3-yl phenyl ketone",C1C2CC3C1C3C2C(=O)C4=CC=CC=C4,,,,,,
4017,94018,"6,7-Dihydro-6-propyl-5H-dibenz(c,e)azepine",CCCN1CC2=CC=CC=C2C3=CC=CC=C3C1,,,,,,
4018,94019,"6-Butyl-5,7-dihydrobenzo[d][2]benzazepine",CCCCN1CC2=CC=CC=C2C3=CC=CC=C3C1,,,,,,
4019,94020,"5H-Dibenz(c,e)azepine, 6-benzyl-6,7-dihydro-",C1C2=CC=CC=C2C3=CC=CC=C3CN1CC4=CC=CC=C4,,,,,,
4020,94021,"beta,6-Dimethyl-7-oxabicyclo(4.1.0)heptane-3-ethyl acetate",CC(COC(=O)C)C1CCC2(C(C1)O2)C,,,,,,
4021,94022,"1H,5H,11H-[1]Benzopyrano[6,7,8-ij]quinolizin-11-one, 2,3,6,7-tetrahydro-",C1CC2=C3C(=C4C(=C2)C=CC(=O)O4)CCCN3C1,,,,,,
4022,94023,"1,2,3,8-Tetrahydro-1,2,3,3,5-pentamethyl-7H-pyrrolo[3,2-g]quinolin-7-one",CC1C(C2=C(N1C)C=C3C(=C2)C(=CC(=O)N3)C)(C)C,,,,,,
4023,94024,2-(2-Tetradecen-1-yl)butanedioic acid,CCCCCCCCCCCC=CCC(CC(=O)O)C(=O)O,,,,,,
4024,94025,9-(2-Nitroethenyl)anthracene,C1=CC=C2C(=C1)C=C3C=CC=CC3=C2C=C[N+](=O)[O-],,,,,,
4025,94026,"Butanoic acid, 4-[(9Z)-9-octadecenylamino]-4-oxosulfo-, disodium salt",CCCCCCCCC=CCCCCCCCCNC(=O)CC(C(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+],,,,,,
4026,94027,4-(Octadec-9-enylamino)-4-oxo-2-sulfobutanoic acid,CCCCCCCCC=CCCCCCCCCNC(=O)CC(C(=O)O)S(=O)(=O)O,,,,,,
4027,94028,"Benzenesulfonyl chloride, 4-(phenylazo)-",C1=CC=C(C=C1)N=NC2=CC=C(C=C2)S(=O)(=O)Cl,,,,,,
4028,94029,5-Methylcytosine hydrochloride,CC1=C(NC(=O)N=C1)N.Cl,,,,,,
4029,94030,"3-Methylanthra(1,2-c)isoxazole-6,11-dione",CC1=C2C=CC3=C(C2=NO1)C(=O)C4=CC=CC=C4C3=O,,,,,,
4030,94031,CID 94031,C1=CC=C(C=C1)NN=C2C(=CC3=C(C2=O)C(=N)C(=NNC4=CC=C(C=C4)C5=NC6=C(N5)C=C(C=C6)N=NC7=C(C=C(C=C7)N)N)C(=C3)S(=O)(=O)O)S(=O)(=O)O,,,,,,
4031,94032,"3,5-Dichloropentan-2-one",CC(=O)C(CCCl)Cl,,,,,,
4032,94033,CID 94033,CP(COS(=O)(=O)C(F)(F)F)(OC1=CC=CC=C1)(OC2=CC=CC=C2)OC3=CC=CC=C3,,,,,,
4033,94034,"Imidazo[2,1-b]thiazole, 6-phenyl-5-(1H-1,2,4-triazol-3-ylazo)-",C1=CC=C(C=C1)C2=C(N3C=CSC3=N2)N=NC4=NC=NN4,,,,,,
4034,94035,Isoxsuprine lactate,CC(COC1=CC=CC=C1)NC(C)C(C2=CC=C(C=C2)O)O.CC(C(=O)O)O,,,,,,
4035,94036,beta-Methylenepyridine-2-ethanol,C=C(CO)C1=CC=CC=N1,,,,,,
4036,94037,Benzyl 2-ethylhexyl adipate,CCCCC(CC)COC(=O)CCCCC(=O)OCC1=CC=CC=C1,,,,,,
4037,94038,"(2S,5R,8S)-4,4,8-trimethyltricyclo[6.3.1.02,5]dodecan-1-ol",C[C@@]12CCCC(C1)([C@H]3CC([C@@H]3CC2)(C)C)O,,,,,,
4038,94039,Lead 12-hydroxyoctadecanoate,CCCCCCC(CCCCCCCCCCC(=O)[O-])O.CCCCCCC(CCCCCCCCCCC(=O)[O-])O.[Pb+2],,,,,,
4039,94040,"4,5,6,7-Tetrahydro-3-(4-methoxyphenyl)-1H-indazole",COC1=CC=C(C=C1)C2=NNC3=C2CCCC3,,,,,,
4040,94041,Methyl 3-thienylacetate,COC(=O)CC1=CSC=C1,,,,,,
4041,94042,"1,5,9,13-Tetramethyl-1-vinyltetradecyl acetate",CC(C)CCCC(C)CCCC(C)CCCC(C)(C=C)OC(=O)C,,,,,,
4042,94043,3-(Bis(2-hydroxyethyl)amino)propanesulphonic acid,C(CN(CCO)CCO)CS(=O)(=O)O,,,,,,
4043,94044,1-[(2-Aminoethyl)amino]octadecan-2-ol,CCCCCCCCCCCCCCCCC(CNCCN)O,,,,,,
4044,94045,"Ethanol, 2-(3,3-dimethylbicyclo[2.2.1]hept-2-ylidene)-, acetate",CC(=O)OCC=C1C2CCC(C2)C1(C)C,,,,,,
4045,94046,"Ethanol, 2-(3,3-dimethylbicyclo[2.2.1]hept-2-ylidene)-",CC1(C2CCC(C2)C1=CCO)C,,,,,,
4046,94047,"1,2,5,6-Tetrabromohexane",C(CC(CBr)Br)C(CBr)Br,,,,,,
4047,94048,"16-Chlorohexadeca-5,9-diyne",CCCCC#CCCC#CCCCCCCCl,,,,,,
4048,94049,6-((2-Hydroxyethyl)amino)-4-methyl-2-((3-(2-phenoxyethoxy)propyl)amino)nicotinonitrile,CC1=CC(=NC(=C1C#N)NCCCOCCOC2=CC=CC=C2)NCCO,,,,,,
4049,94050,"1-Phenylicosane-1,3-dione",CCCCCCCCCCCCCCCCCC(=O)CC(=O)C1=CC=CC=C1,,,,,,
4050,94051,"2,6-Bis-(diphenylhydroxymethyl)-pyridine",C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=NC(=CC=C3)C(C4=CC=CC=C4)(C5=CC=CC=C5)O)O,,,,,,
4051,94052,"2,6-Bis(phenylbenzylhydroxymethyl)-pyridine",C1=CC=C(C=C1)CC(C2=CC=CC=C2)(C3=NC(=CC=C3)C(CC4=CC=CC=C4)(C5=CC=CC=C5)O)O,,,,,,
4052,94053,"2,6-Bis-(dibenzylhydroxymethyl)-pyridine",C1=CC=C(C=C1)CC(CC2=CC=CC=C2)(C3=NC(=CC=C3)C(CC4=CC=CC=C4)(CC5=CC=CC=C5)O)O,,,,,,
4053,94054,"2,6-Bis(diphenylhydroxymethyl)-piperidine",C1CC(NC(C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O,,,,,,
4054,94055,"2,6-Bis-(phenylbenzylhydroxymethyl)-piperidine",C1CC(NC(C1)C(CC2=CC=CC=C2)(C3=CC=CC=C3)O)C(CC4=CC=CC=C4)(C5=CC=CC=C5)O,,,,,,
4055,94056,"2,6-Bis-(dibenzylhydroxymethyl)-piperidine",C1CC(NC(C1)C(CC2=CC=CC=C2)(CC3=CC=CC=C3)O)C(CC4=CC=CC=C4)(CC5=CC=CC=C5)O,,,,,,
4056,94057,3-Benzyloxy-4-methoxybenzoic acid,COC1=C(C=C(C=C1)C(=O)O)OCC2=CC=CC=C2,,,,,,
4057,94058,2-Bromo-3-(trifluoromethyl)aniline,C1=CC(=C(C(=C1)N)Br)C(F)(F)F,,,,,,
4058,94059,2-Bromo-6-(trifluoromethyl)aniline,C1=CC(=C(C(=C1)Br)N)C(F)(F)F,,,,,,
4059,94060,"4-Hexen-1-ol, 5-methyl-2-(1-methylethenyl)-",CC(=CCC(CO)C(=C)C)C,,,,,,
4060,94061,"2,3,5-Trichloro-6-hydrazino-4-(propylthio)pyridine",CCCSC1=C(C(=NC(=C1Cl)Cl)NN)Cl,,,,,,
4061,94062,"2,4,6-Tripropoxybenzaldehyde",CCCOC1=CC(=C(C(=C1)OCCC)C=O)OCCC,,,,,,
4062,94063,"Phenol, 4-nitro-2-[[(2,4,6-tripropoxyphenyl)methylene]amino]-",CCCOC1=CC(=C(C(=C1)OCCC)C=NC2=C(C=CC(=C2)[N+](=O)[O-])O)OCCC,,,,,,
4063,94064,"5-(6-Benzoylbenz(cd)indol-2(1H)-ylidene)-1,3-dimethyl-1H,3H,5H-pyrimidine-2,4,6-trione",CN1C(=C(C(=O)N(C1=O)C)C2=NC3=C4C2=CC=CC4=C(C=C3)C(=O)C5=CC=CC=C5)O,,,,,,
4064,94065,"1,3-Dimethyl-5-(6-(phenylthio)benz(cd)indol-2(1H)-ylidene)barbituric acid",CN1C(=C(C(=O)N(C1=O)C)C2=NC3=C4C2=CC=CC4=C(C=C3)SC5=CC=CC=C5)O,,,,,,
4065,94066,CID 94066,C1=C(NC(=NC1=O)N)N.OS(=O)(=O)O,,,,,,
4066,94067,"N-Ethyl-5-fluoro-3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinecarboxamide",CCNC(=O)NC(=O)N1C=C(C1=O)F,,,,,,
4067,94068,"2-[4-(1-Ethylbenzo[e][1,3]benzothiazol-2-ylidene)-1-phenylbut-2-enylidene]propanedinitrile",CCN1C(=CC=CC(=C(C#N)C#N)C2=CC=CC=C2)SC3=C1C4=CC=CC=C4C=C3,,,,,,
4068,94069,"Benzoic acid, 4-[(4-amino-9,10-dihydro-9,10-dioxo-1-anthracenyl)amino]-",C1=CC=C2C(=C1)C(=O)C3=C(C=CC(=C3C2=O)NC4=CC=C(C=C4)C(=O)O)N,,,,,,
4069,94070,"Benzoic acid, 3-[(4-amino-9,10-dihydro-9,10-dioxo-1-anthracenyl)amino]-",C1=CC=C2C(=C1)C(=O)C3=C(C=CC(=C3C2=O)NC4=CC=CC(=C4)C(=O)O)N,,,,,,
4070,94071,"Benzenamine, 4,4'-cyclohexylidenebis[N,N-bis(4-methylphenyl)-",CC1=CC=C(C=C1)N(C2=CC=C(C=C2)C)C3=CC=C(C=C3)C4(CCCCC4)C5=CC=C(C=C5)N(C6=CC=C(C=C6)C)C7=CC=C(C=C7)C,,,,,,
4071,94072,Didecyl mercaptosuccinate,CCCCCCCCCCOC(=O)CC(C(=O)OCCCCCCCCCC)S,,,,,,
4072,94073,"Benzothiazolium, 3,3'-(1,10-decanediyl)bis-, dibromide",C1=CC=C2C(=C1)[N+](=CS2)CCCCCCCCCC[N+]3=CSC4=CC=CC=C43.[Br-].[Br-],,,,,,
4073,94074,"N,N'-Diallyl-L-tartardiamide",C=CCNC(=O)[C@@H]([C@H](C(=O)NCC=C)O)O,,,,,,
4074,94075,10-Benzyl-10H-phenothiazine,C1=CC=C(C=C1)CN2C3=CC=CC=C3SC4=CC=CC=C42,,,,,,
4075,94076,CID 94076,[Li+].CCCCCCC(CCCCCCCCCCC(=O)[O-])O.[Ca+2],,,,,,
4076,94077,exo-Bornyl butyrate,CCCC(=O)OC1CC2(CC[C@@H]1C2(C)C)C,,,,,,
4077,94078,tert-Butylchlorodiphenylsilane,CC(C)(C)[Si](C1=CC=CC=C1)(C2=CC=CC=C2)Cl,,,,,,
4078,94079,"Naphtho[1,2-d]thiazolium, 1,2-dimethyl-, salt with 4-methylbenzenesulfonic acid (1:1)",CC1=CC=C(C=C1)S(=O)(=O)[O-].CC1=[N+](C2=C(S1)C=CC3=CC=CC=C32)C,,,,,,
4079,94080,"1,2-Dimethylnaphtho[1,2-d]thiazol-3-ium",CC1=[N+](C2=C(S1)C=CC3=CC=CC=C32)C,,,,,,
4080,94081,"Furan-2,5-dicarbonitrile",C1=C(OC(=C1)C#N)C#N,,,,,,
4081,94082,"4,4'-(Diphenylmethylene)bis[1,1-dimethylsemicarbazide]",CN(C)NC(=O)NC(C1=CC=CC=C1)(C2=CC=CC=C2)NC(=O)NN(C)C,,,,,,
4082,94083,N-(2-Chloroethyl)-N'-(trans-2-hydroxycyclohexyl)-N-nitrosourea,C1CC[C@H]([C@@H](C1)NC(=O)N(CCCl)N=O)O,,,,,,
4083,94084,"Benzonitrile, 4-[[4-[bis(2-hydroxyethyl)amino]-2-methylphenyl]azo]-2-chloro-",CC1=C(C=CC(=C1)N(CCO)CCO)N=NC2=CC(=C(C=C2)C#N)Cl,,,,,,
4084,94085,Bis(1-oxoisononyl) peroxide,CC(C)CCCCCC(=O)OOC(=O)CCCCCC(C)C,,,,,,
4085,94086,"2,5-Diisopropylbenzyl chloride",CC(C)C1=CC(=C(C=C1)C(C)C)CCl,,,,,,
4086,94087,"Carbamimidothioic acid, 3-(trimethoxysilyl)propyl ester, monohydrochloride",CO[Si](CCCSC(=N)N)(OC)OC.Cl,,,,,,
4087,94088,2-[3-(Trimethoxysilyl)propyl]isothiourea,CO[Si](CCCSC(=N)N)(OC)OC,,,,,,
4088,94089,1-Octyl-5-oxopyrrolidine-3-carboxylic acid,CCCCCCCCN1CC(CC1=O)C(=O)O,,,,,,
4089,94090,"3-Hydroxy-alpha,alpha,4-trimethylcyclohexanemethanol",CC1CCC(CC1O)C(C)(C)O,,,,,,
4090,94091,1-Tridecanesulfonyl chloride,CCCCCCCCCCCCCS(=O)(=O)Cl,,,,,,
4091,94092,"Methyl 1-(1-(((2-(hexadecyloxy)-5-((methylamino)sulphonyl)phenyl)amino)carbonyl)-3,3-dimethyl-2-oxobutyl)-1H-imidazole-5-carboxylate",CCCCCCCCCCCCCCCCOC1=C(C=C(C=C1)S(=O)(=O)NC)NC(=O)C(C(=O)C(C)(C)C)N2C=NC=C2C(=O)OC,,,,,,
4092,94093,"2-(3-Oxo-1h,3h-benzo[de]isochromen-1-yl)-1h-indole-7-carboxylic acid",C1=CC2=C3C(=C1)C(OC(=O)C3=CC=C2)C4=CC5=C(N4)C(=CC=C5)C(=O)O,,,,,,
4093,94094,13-Methyltetradecanol,CC(C)CCCCCCCCCCCCO,,,,,,
4094,94095,3-Isopropoxycyclohex-2-en-1-one,CC(C)OC1=CC(=O)CCC1,,,,,,
4095,94096,2-Acetamido-5-nitrobenzenesulphonic acid,CC(=O)NC1=C(C=C(C=C1)[N+](=O)[O-])S(=O)(=O)O,,,,,,
4096,94097,"3,4-Diacetoxybenzoic acid",CC(=O)OC1=C(C=C(C=C1)C(=O)O)OC(=O)C,,,,,,
4097,94098,Isopropyloxymagnesium chloride,CC(C)[O-].[Mg+2].[Cl-],,,,,,
4098,94099,"Ethyl 3-ethyl-4,7-dimethyl-2,6-octadienoate",CCC(=CC(=O)OCC)C(C)CC=C(C)C,,,,,,
4099,94100,"Ethyl 2-ethyl-3,4,4-trimethylcyclohexene-1-carboxylate",CCC1=C(CCC(C1C)(C)C)C(=O)OCC,,,,,,
4100,94101,"((1,1,3,3-Tetramethylbutyl)thio)acetic acid",CC(C)(C)CC(C)(C)SCC(=O)O,,,,,,
4101,94102,Methyl N-L-seryl-L-tryptophanate,COC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CO)N,,,,,,
4102,94103,"Acetamide, N-[5-[bis(2-hydroxyethyl)amino]-2-[[2,5-dichloro-4-[(diethylamino)sulfonyl]phenyl]azo]phenyl]-",CCN(CC)S(=O)(=O)C1=C(C=C(C(=C1)Cl)N=NC2=C(C=C(C=C2)N(CCO)CCO)NC(=O)C)Cl,,,,,,
4103,94104,"2-((2,3-Dihydro-2-oxo-5-benzoxazol-yl)carbonyl)benzoic acid",C1=CC=C(C(=C1)C(=O)C2=CC3=C(C=C2)OC(=O)N3)C(=O)O,,,,,,
4104,94105,"3-(4-Oxo-3-oxatricyclo[7.3.1.05,13]trideca-1(12),5,7,9(13),10-pentaen-2-ylidene)indole-7-carboxylic acid;hydrochloride",C1=CC2=C3C(=C1)C(=C4C=NC5=C4C=CC=C5C(=O)O)OC(=O)C3=CC=C2.Cl,,,,,,
4105,94106,"3-(4-Oxo-3-oxatricyclo[7.3.1.05,13]trideca-1(12),5,7,9(13),10-pentaen-2-ylidene)indole-7-carboxylic acid",C1=CC2=C3C(=C1)C(=C4C=NC5=C4C=CC=C5C(=O)O)OC(=O)C3=CC=C2,,,,,,
4106,94107,"3-Bromo-1-ethyl-1,3-dioxolo(4,5-g)cinnolin-4(1H)-one",CCN1C2=CC3=C(C=C2C(=O)C(=N1)Br)OCO3,,,,,,
4107,94108,"Spiro[2H-1-benzopyran-2,2'(3'H)-benzothiazole], 3,4-dihydro-8-methoxy-3'-methyl-4-[(3-methyl-2(3H)-benzothiazolylidene)methyl]-",CN1C2=CC=CC=C2SC1=CC3CC4(N(C5=CC=CC=C5S4)C)OC6=C3C=CC=C6OC,,,,,,
4108,94109,"N,N-Bis(2-hydroxyethyl)benzamide",C1=CC=C(C=C1)C(=O)N(CCO)CCO,,,,,,
4109,94110,Diethyl hydroxymethylmalonate,CCOC(=O)C(CO)C(=O)OCC,,,,,,
4110,94111,(Ethoxymethoxy)cyclododecane,CCOCOC1CCCCCCCCCCC1,,,,,,
4111,94112,"2-Henicosyl-4,5-dihydro-1H-imidazole-1-ethylamine",CCCCCCCCCCCCCCCCCCCCCC1=NCCN1CCN,,,,,,
4112,94113,"Methanaminium, N-(1-chloroethylidene)-N-methyl-, chloride",CC(=[N+](C)C)Cl.[Cl-],,,,,,
4113,94114,1-Chloroethylidene(dimethyl)azanium,CC(=[N+](C)C)Cl,,,,,,
4114,94115,"[1,1'-Biphenyl]-4-carbonyl chloride, 4'-heptyl-",CCCCCCCC1=CC=C(C=C1)C2=CC=C(C=C2)C(=O)Cl,,,,,,
4115,94116,"7-Oxabicyclo[4.1.0]heptan-3-ol, 6-methyl-3-(1-methylethyl)-",CC(C)C1(CCC2(C(C1)O2)C)O,,,,,,
4116,94117,"N,N'''-1,4-Butanediylbisguanidine dihydrochloride",C(CCN=C(N)N)CN=C(N)N.Cl.Cl,,,,,,
4117,94118,"2,2'-(Octane-1,8-diylbis(thio))bisethanol",C(CCCCSCCO)CCCSCCO,,,,,,
4118,94119,"4-Chlorobenzene-1,3-dithiol",C1=CC(=C(C=C1S)S)Cl,,,,,,
4119,94120,Octadec-13-enal,CCCCC=CCCCCCCCCCCCC=O,,,,,,
4120,94121,"2-Naphthalenesulfonyl chloride, 5-[bis(methylsulfonyl)amino]-1-[(methylsulfonyl)oxy]-",CS(=O)(=O)N(C1=CC=CC2=C1C=CC(=C2OS(=O)(=O)C)S(=O)(=O)Cl)S(=O)(=O)C,,,,,,
4121,94122,CID 94122,CS(=O)(=O)N(C1=CC=CC2=C1C=CC(=C2OS(=O)(=O)C)S(=O)(=O)[O-])S(=O)(=O)C.[Na+],,,,,,
4122,94123,5-[Bis(methylsulfonyl)amino]-1-methylsulfonyloxynaphthalene-2-sulfonic acid,CS(=O)(=O)N(C1=CC=CC2=C1C=CC(=C2OS(=O)(=O)C)S(=O)(=O)O)S(=O)(=O)C,,,,,,
4123,94124,"2-Naphthalenesulfonic acid, 5-amino-1-hydroxy-",C1=CC2=C(C=CC(=C2O)S(=O)(=O)O)C(=C1)N,,,,,,
4124,94125,"2-Naphthalenesulfonyl chloride, 5-(acetylamino)-1-(acetyloxy)-",CC(=O)NC1=CC=CC2=C1C=CC(=C2OC(=O)C)S(=O)(=O)Cl,,,,,,
4125,94126,"2,5-Furandione, 3-(docosenyl)dihydro-",CCCCCCCCCCCC=CCCCCCCCCCC1CC(=O)OC1=O,,,,,,
4126,94127,"(Tetrachloro-1,4-phenylene)bismethylene diacrylate",C=CC(=O)OCC1=C(C(=C(C(=C1Cl)Cl)COC(=O)C=C)Cl)Cl,,,,,,
4127,94128,"(Tetrachloro-1,3-phenylene)bis(methylene) bismethacrylate",CC(=C)C(=O)OCC1=C(C(=C(C(=C1Cl)Cl)Cl)COC(=O)C(=C)C)Cl,,,,,,
4128,94129,"(Tetrachloro-1,4-phenylene)bis(methylene) bismethacrylate",CC(=C)C(=O)OCC1=C(C(=C(C(=C1Cl)Cl)COC(=O)C(=C)C)Cl)Cl,,,,,,
4129,94130,"4'-(2-Methylbutoxy)[1,1'-biphenyl]-4-carbonitrile",CCC(C)COC1=CC=C(C=C1)C2=CC=C(C=C2)C#N,,,,,,
4130,94131,"Hydrazinecarbonitrile, 1-(1-methylethyl)-",CC(C)N(C#N)N,,,,,,
4131,94132,"3,7,9-Trimethyl-2,6-decadien-1-al",CC(C)CC(=CCCC(=CC=O)C)C,,,,,,
4132,94133,N-[2-[4-(2-methylpropyl)phenyl]propylidene]hydroxylamine,CC(C)CC1=CC=C(C=C1)C(C)C=NO,,,,,,
4133,94134,2-Amino-3-hydroxy-3-phenylpropanoic acid,C1=CC=C(C=C1)C(C(C(=O)O)N)O,,,,,,
4134,94135,Phenyltrimethylammonium iodide,C[N+](C)(C)C1=CC=CC=C1.[I-],,,"['Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)']",,,
4135,94136,2'-Adenylic acid,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)OP(=O)(O)O)N,,,,,,
4136,94137,"3a,4,5,6,7,7a-Hexahydro-4,7-methano-1H-inden-5-ol",C1C=CC2C1C3CC2C(C3)O,,,,,,
4137,94138,"N,N'-Bis(1-ethyl-3-methylpentyl)-p-phenylenediamine",CCC(C)CC(CC)NC1=CC=C(C=C1)NC(CC)CC(C)CC,,,,,,
4138,94139,Copper 2-ethylhexanoate,CCCCC(CC)C(=O)[O-].CCCCC(CC)C(=O)[O-].[Cu+2],,,,,,
4139,94140,stearoyl-CoA,CCCCCCCCCCCCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)O,,,,,,
4140,94141,11beta-Hydroxyandrostenedione,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CCC4=O)C)O,,,,,,
4141,94142,4'-Fluoro-4-dimethylaminostilbene,CN(C)C1=CC=C(C=C1)C=CC2=CC=C(C=C2)F,,,,,,
4142,94143,alpha-Cyclocitral,CC1=CCCC(C1C=O)(C)C,,,,,,
4143,94144,5alpha-Androstane,C[C@@]12CCC[C@H]1[C@@H]3CC[C@H]4CCCC[C@@]4([C@H]3CC2)C,,,,,,
4144,94145,"8a-(5-Vinyl-1-azabicyclo[2.2.2]oct-2-yl)-2,3,8,8a-tetrahydro-3ah-furo[2,3-b]indol-3a-ol",C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@@]34[C@@](CCO3)(C5=CC=CC=C5N4)O,,,,,,
4145,94146,Alloxanic acid,C1(=O)C(NC(=O)N1)(C(=O)O)O,,,,,,
4146,94147,(+)-cis-Sabinol,CC(C)[C@@]12C[C@@H]1C(=C)[C@@H](C2)O,,,,,,
4147,94148,Estroxide,C[C@]12CC[C@H]3[C@H]([C@@H]1C[C@@H]4[C@H]2O4)CCC5=C3C=CC(=C5)O,,,,,,
4148,94149,Capaurine,COC1=C(C2=C(C[C@H]3C4=C(C(=C(C=C4CCN3C2)OC)OC)O)C=C1)OC,,,,,,
4149,94150,Cularine,CN1CCC2=C3[C@@H]1CC4=CC(=C(C=C4OC3=C(C=C2)OC)OC)OC,,,,,,
4150,94151,Cinchonamine,C=C[C@H]1CN2CC[C@H]1C[C@H]2C3=C(C4=CC=CC=C4N3)CCO,,,,,,
4151,94152,Acidum mersalylicum,[H+].COC([CH2-])CNC(=O)C1=CC=CC=C1OCC(=O)[O-].[OH-].[Hg+2],,,,,,
4152,94153,2-[2-(2-Methoxypropylcarbamoyl)phenoxy]acetic acid,CC(CNC(=O)C1=CC=CC=C1OCC(=O)O)OC,,,,,,
4153,94154,D-Arabinitol,C([C@H](C([C@@H](CO)O)O)O)O,,,,,,
4154,94155,"Bis[2-(methoxycarbonyl)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl] 2,4-diphenylcyclobutane-1,3-dicarboxylate, stereoisomer",CN1[C@H]2CC[C@@H]1[C@H]([C@H](C2)OC(=O)C3C(C(C3C4=CC=CC=C4)C(=O)O[C@H]5C[C@@H]6CC[C@H]([C@H]5C(=O)OC)N6C)C7=CC=CC=C7)C(=O)OC,,,,,,
4155,94156,Flavan,C1CC2=CC=CC=C2OC1C3=CC=CC=C3,,,,,,
4156,94157,1-(1-Methylpyrrolidin-2-yl)acetone,CC(=O)CC1CCCN1C,,,,,,
4157,94158,Oxirane-2-carboxylic acid,C1C(O1)C(=O)O,,,,,,
4158,94159,Icos-9-enoic acid,CCCCCCCCCCC=CCCCCCCCC(=O)O,,,,,,
4159,94160,Mitraphylline,C[C@H]1[C@H]2CN3CC[C@]4([C@@H]3C[C@@H]2C(=CO1)C(=O)OC)C5=CC=CC=C5NC4=O,,,,,,
4160,94161,Diphepanol,CC(C(C1=CC=CC=C1)(C2=CC=CC=C2)O)N3CCCCC3,,,,,,
4161,94162,Sugiol,CC(C)C1=C(C=C2C(=C1)C(=O)C[C@@H]3[C@@]2(CCCC3(C)C)C)O,,,,,,
4162,94163,CID 94163,CC1=C(C(C[C@H](C1)O)(C)C)C=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)[C@H]2C=C3[C@](O2)(C[C@H](CC3(C)C)O)C)C)C,,,,,,
4163,94164,alpha-Santalene,CC(=CCCC1(C2CC3C1(C3C2)C)C)C,,,,,,
4164,94165,"3',4'-Didehydro-beta,psi-caroten-16'-oic acid",CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=CC=C(C)C=CC=C(C)C(=O)O)C)C,,,,,,
4165,94166,11-Ketoprogesterone,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,,,,,,
4166,94167,NoName_1541,CCCCCCCC(=O)NC1C2N(C1=O)C(C(S2)(C)C)C(=O)O,,,,,,
4167,94168,"2,6-Dideoxy-D-ribo-hexose",C[C@H]([C@H]([C@H](CC=O)O)O)O,,,,,,
4168,94169,Isomaltitol,C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)OC[C@H]([C@H]([C@@H]([C@H](CO)O)O)O)O)O)O)O)O,,,,"['The in vivo metabolism of isomalt in the large intestine was simulated in an in vitro fermentation study to investigate its degradation using chyme from pigs as a basic substrate additionally inoculated with feces. In the first week, the fermentation of isomalt (3.65%) by non-adapted microflora was investigated. In the second week, isomalt fermentation by adapted microflora taken from pigs fed a basic diet supplemented with isomalt was studied. In the third week, both /non-adapted and adapted/ flora were studied in fermentation experiments with a high concentration of isomalt (7.30%). Isomalt was degraded to lactic acid, volatile fatty acids, and gases (CO2, CH4, and hydrogen). ...', 'Fistulated and normal pigs were fed 10% sucrose between meals, 5 or 10% isomalt between meals, or 10% isomalt with meals. The passage and absorption rate of these substances were determined at the terminal ileum (10 pigs per treatment) or over the whole distance of the digestive tract (4 pigs per treatment). Ten percent sucrose was completely digested and absorbed in the small intestine. In the 3 isomalt treatments, 61-64% of the ingested compound passed the terminal ileum in the form of intact isomalt plus free sorbitol, free mannitol, and free glucose. None of these sugars were excreted in the feces, indicating that isomalt and its constituents passing the terminal ileum are completely broken down in the large intestine.', 'Renal clearance studies were conducted in adult female rats (250 g b.w.) infused with 1.8 g isomalt, alpha-O-D-glucopyranosyl-1,6-D-sorbitol, or alpha-O-D-glucopyranosyl-1,6-D-mannitol over a period of 3 hours. Maximum plasma concentrations of 25 mM were obtained. These compounds were readily cleared and urinary concentrations of up to 100 mg/mL were recorded, which compares with a maximum urinary concentration of 0.6 mg/mL in rats receiving 5 g isomalt per day orally. After the infusion of either isomalt or alpha-O-D-glucopyranosyl-1,6-D-sorbitol, free sorbitol was not detected in blood or urine, and blood glucose concentrations were unchanged, demonstrating the metabolic inertness of these disaccharide alcohols. From the infusion and excretion rates and the plasma concentrations that were observed, the authors concluded that alpha-O-D-glucopyranosyl-1,6-D-sorbitol is distributed in extracellular water, but does not reach the intracellular compartments.', 'When isomalt was fed to rats for several weeks it was observed that fecal excretion declined steadily, while the cecum enlarged. The authors concluded that this resulted from adaptation and metabolism by the gut microflora. Similarly, during a 17-day feeding period in which 6 female rats received 3.5 g isomalt daily, the fecal content fell from 25% of the dose at the beginning to 1% at the end.', 'For more Absorption, Distribution and Excretion (Complete) data for Isomalt (9 total), please visit the HSDB record page.']","['Rat intestinal maltase was shown to be active against isomalt, alpha-O-D-glucopyranosyl-1,6-D-sorbitol, and alpha-O-D-glucopyranosyl-1,6-D-mannitol, but the rates of hydrolysis were slow. The ratio of the rates of hydrolysis of sucrose, isomaltulose, and isomalt by rat intestinal alpha-glucosidases was 100:30:12. Similarly, sucrose was hydrolysed about 20 times faster than alpha-O-D-glucopyranosyl-1,6-D-sorbitol or alpha-O-D-glucopyranosyl-1,6-D-mannitol by disaccharidases from the small intestine of the pig, and the relative rates of hydrolysis of maltose, sucrose, isomaltulose and isomalt by human intestinal alpha-glucosidases were 100:25:11:2.', 'The fate of isomalt in the gastrointestinal tract of female rats that had been adapted to the compound was investigated by increasing its dietary concentration from 10% to 34.5% over a period of 3-4 weeks. After administration of 1.7 g isomalt in 5 g feed, the contents of the stomach, small intestine, cecum, and large intestine were examined at intervals up to 6 hr. From the content of alpha-O-D-glucopyranosyl-1,6-D-sorbitol, alpha-O-D-glucopyranosyl-1,6-D-mannitol, sorbitol, mannitol, and sucrose found in these organs, the authors concluded that alpha-O-D-glucopyranosyl-1,6-D-sorbitol and alpha-O-D-glucopyranosyl-1,6-D-mannitol were only partially hydrolyzed by the carbohydrases in the small intestine, while a substantial proportion of these compounds reached the cecum where further hydrolysis of glycosidic bonds occurred. Fermentation of the liberated hexitols occurred in the cecum, which was enlarged, and only small amounts of alpha-O-D-glucopyranosyl-1,6-D-sorbitol, alpha-O-D-glucopyranosyl-1,6-D-mannitol, and hexitols reached the large intestine.']",
4169,94170,Mycobacidin,C1C(=O)NC(S1)CCCCCC(=O)O,,,,,,
4170,94171,"2,6,10,14,19,23,27,31-Octamethyldotriaconta-2,6,10,12,14,16,18,22,26,30-decaene",CC(=CCCC(=CCCC(=CCCC(=CC=CC=C(C)C=CC=C(C)CCC=C(C)CCC=C(C)C)C)C)C)C,,,,,,
4171,94172,CID 94172,C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@H]([C@@H]([C@@H](CO)O)O)C(=O)CO)O)O)O)O,,,,,,
4172,94173,"(1S,5S)-6,6-dimethyl-2-methylidenebicyclo[3.1.1]heptan-3-ol",CC1([C@H]2C[C@@H]1C(=C)C(C2)O)C,,,,,,
4173,94174,Viridiflorol (incomplete stereochemistry),C[C@@H]1CC[C@H]2[C@@H]1C3[C@H](C3(C)C)CC[C@]2(C)O,,,,,,
4174,94175,Epiquinidine,COC1=CC2=C(C=CN=C2C=C1)[C@H]([C@H]3C[C@@H]4CCN3C[C@@H]4C=C)O,,,,"['Following oral administration of a single 600-mg dose of quinine sulfate in healthy adults, the mean plasma clearance was 0.08-0.47 L/hour per kg (median: 0.17 L/hour per kg) and the mean plasma elimination half-life was 9.7-12.5 hours. Following oral administration of 10 mg/kg of quinine sulfate in patients with uncomplicated malaria, mean total clearance of quinine was decreased (approximately 0.09 L/hour per kg) during the acute phase of the infection and increased (approximately 0.16 L/hour per kg) during the recovery or convalescent phase.', 'Following oral administration of a single 600-mg dose of quinine sulfate in geriatric and younger adults, the mean clearance of the drug was decreased (0.06 versus 0.08 L/hour per kg) and the mean elimination half-life was significantly increased (18.4 versus 10.5 hours) in geriatric adults compared with younger adults. Although renal clearance of quinine was similar in geriatric and younger adults, geriatric adults excreted a larger proportion of the dose in urine as unchanged drug compared with younger adults (16.6 versus 11.2%). The steady-state pharmacokinetics after a quinine sulfate dosage of 648 mg 3 times daily for 7 days were similar in healthy geriatric adults 65-78 years of age and healthy younger adults 20-39 years of age; however, the mean elimination half-life was 24 hours in the geriatric individuals compared with 20 hours in the younger adults.', 'Following oral administration of a single dose of 10 mg/kg of quinine sulfate in healthy children or pediatric patients 1.5-12 years of age with uncomplicated Plasmodium falciparum malaria, the mean total clearance (0.06 versus 0.3 L/hour per kg) is reduced and the plasma elimination half-life increased (12.1 versus 3.21 hours) in pediatric patients with malaria as compared to that observed in healthy children.', 'In 15 patients with uncomplicated malaria who received a 10 mg/kg oral dose of quinine sulfate, the mean total clearance of quinine was slower (approximately 0.09 L/hr/kg) during the acute phase of the infection, and faster (approximately 0.16 L/hr/kg) during the recovery or convalescent phase.', 'For more Absorption, Distribution and Excretion (Complete) data for QUININE (19 total), please visit the HSDB record page.']","['In vitro studies using human liver microsomes and recombinant P450 enzymes have shown that quinine is metabolized mainly by CYP3A4. Depending on the in vitro experimental conditions, other enzymes, including CYP1A2, CYP2C8, CYP2C9, CYP2C19, CYP2D6, and CYP2E1 were shown to have some role in the metabolism of quinine.', ""Quinine is metabolized almost exclusively via hepatic oxidative cytochrome P450 (CYP) pathways, resulting in four primary metabolites, 3-hydroxyquinine, 2'-quinone, O-desmethylquinine, and 10,11-dihydroxydihydroquinine. Six secondary metabolites result from further biotransformation of the primary metabolites. The major metabolite, 3-hydroxyquinine, is less active than the parent drug.""]","['Compared with administration of quinine alone, administration of a single 600-mg dose of quinine sulfate in healthy individuals who were receiving ritonavir (200 mg every 12 hours) resulted in an increased quinine mean elimination half-life (11.2 hours versus 13.4 hours).', 'The plasma elimination half-life of quinine reportedly averages 8-21 hours in adults with malaria and 7-12 hours in healthy or convalescing adults.', 'The steady-state pharmacokinetics after a quinine sulfate dosage of 648 mg 3 times daily for 7 days were similar in healthy geriatric adults 65-78 years of age and healthy younger adults 20-39 years of age; however, the mean elimination half-life was 24 hours in the geriatric individuals compared with 20 hours in the younger adults.', 'In children 1-12 years of age, the plasma elimination half-life of quinine reportedly averages 11-12 hours in those with malaria and 6 hours in those convalescing from the disease.', 'At toxic levels elimination half life is reported to be 26.5 + or - 5.8 hrs.']"
4175,94176,D-Erythrose,C([C@H]([C@H](C=O)O)O)O,,,,,,
4176,94177,(3s)-3-Amino-3-(carbamoylamino)propanoic acid,C([C@@H](N)NC(=O)N)C(=O)O,,,,,,
4177,94178,"1,2-Diphenylethanol",C1=CC=C(C=C1)CC(C2=CC=CC=C2)O,,,,,,
4178,94179,"1,2,4-Benzenetriamine dihydrochloride",C1=CC(=C(C=C1N)N)N.Cl.Cl,,,,,,
4179,94180,2-Hydroxyoctanoic acid,CCCCCCC(C(=O)O)O,,,,,,
4180,94181,Di-sec-butyl succinate,CCC(C)OC(=O)CCC(=O)OC(C)CC,,,,,,
4181,94182,"1,2-Propanediol, 1-acetate",CC(COC(=O)C)O,,,,,,
4182,94183,Anthanthrone,C1=CC2=C3C(=C1)C(=O)C4=C5C3=C(C=C2)C(=O)C6=CC=CC(=C65)C=C4,,,,,,
4183,94184,Panthenyl ethyl ether,CCOCCCNC(=O)[C@@H](C(C)(C)CO)O,,,,,,
4184,94185,1-Phenyl-2-propanol,CC(CC1=CC=CC=C1)O,,,,,,
4185,94186,"Riboflavin, 2',3',4',5'-tetraacetate",CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)CC(C(C(COC(=O)C)OC(=O)C)OC(=O)C)OC(=O)C,,,,,,
4186,94187,"2-Bromo-1,1,3-trimethoxypropane",COCC(C(OC)OC)Br,,,,,,
4187,94188,Tin(II) tartrate,C(C(C(=O)[O-])O)(C(=O)[O-])O.[Sn+2],,,,,,
4188,94189,Methyl 2-ethylpentanoate,CCCC(CC)C(=O)OC,,,,,,
4189,94190,"1,2-Distearoyl-sn-glycero-3-phosphocholine",CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,,,,,,
4190,94191,DI-Stearoyl-3-SN-phosphatidylcholine,CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC,,,,,,
4191,94192,"3,7-Dioxo-5beta-cholanoic acid",C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C(=O)C[C@H]4[C@@]3(CCC(=O)C4)C)C,,,,,,
4192,94193,Nandrolone undecylate,CCCCCCCCCCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@H]34)C,,,,,,
4193,94194,Pregnenediol,C[C@@H]([C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C)O,,,,,,
4194,94195,Clionasterol acetate,CC[C@@H](CC[C@@H](C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)OC(=O)C)C)C)C(C)C,,,,,,
4195,94196,5-Hydroxyuridine,C1=C(C(=O)NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)O,,,,,,
4196,94197,Phenyl p-methoxystyryl ketone,COC1=CC=C(C=C1)C=CC(=O)C2=CC=CC=C2,,,,,,
4197,94198,2'-Fluoro-4-dimethylaminostilbene,CN(C)C1=CC=C(C=C1)C=CC2=CC=CC=C2F,,,,,,
4198,94199,"16alpha,17alpha-Epoxypregnenolone",CC(=O)[C@]12[C@H](O1)C[C@@H]3[C@@]2(CC[C@H]4[C@H]3CC=C5[C@@]4(CC[C@@H](C5)O)C)C,,,,,,
4199,94200,"Iron(2+);1-methylcyclopenta-1,3-diene",CC1=CC=C[CH-]1.CC1=CC=C[CH-]1.[Fe+2],,,,,,
4200,94201,Di(2-ethylhexyl) tetrahydrophthalate,CCCCC(CC)COC(=O)C1=C(CCCC1)C(=O)OCC(CC)CCCC,,,,,,
4201,94202,5alpha-Dihydronandrolone,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CC[C@@H]4[C@@H]3CCC(=O)C4,,,,,,
4202,94203,"methyl (4R)-4-[(3R,5S,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoate",C[C@H](CCC(=O)OC)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2C(C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C,,,,,,
4203,94204,24-Methylenecycloartanol,C[C@H](CCC(=C)C(C)C)[C@H]1CC[C@@]2([C@@]1(CC[C@]34[C@H]2CC[C@@H]5[C@]3(C4)CC[C@@H](C5(C)C)O)C)C,,,,,,
4204,94205,2-Ethylpiperidine,CCC1CCCCN1,,,,,,
4205,94206,D-Alloisoleucine,CC[C@H](C)[C@H](C(=O)O)N,,,,,,
4206,94207,CID 94207,C1=CC=C2C(=C1)[N-]C(=N2)N[N+]#N,,,,,,
4207,94208,CID 94208,C1=CC=C2C(=C1)NC(=N2)N[N+]#N,,,,,,
4208,94209,"(1R,9S,10R)-4-methoxy-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene",COC1=CC2=C(C[C@H]3[C@H]4[C@@]2(CCCC4)CCN3)C=C1,,,,,,
4209,94210,"Ethanol, 2-[2-[(2-ethylhexyl)oxy]ethoxy]-",CCCCC(CC)COCCOCCO,,,,,,
4210,94211,"4-(Aminomethyl)octane-1,8-diamine",C(CCN)CC(CCCN)CN,,,,,,
4211,94212,"2-Propanol, 1,1'-[2-butyne-1,4-diylbis(oxy)]bis[3-chloro-",C(C#CCOCC(CCl)O)OCC(CCl)O,,,,,,
4212,94213,5-Methylundecane,CCCCCCC(C)CCCC,,,,,,
4213,94214,Methyl beta-D-galactopyranoside,CO[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO)O)O)O,,,,,,
4214,94215,"3-Ethoxy-1,2-propanediol",CCOCC(CO)O,,,,,,
4215,94216,3-Hydroxydodecanoic acid,CCCCCCCCCC(CC(=O)O)O,,,,,,
4216,94217,"1,2-Cyclohexanediol, 1-methyl-4-(1-methylethenyl)-",CC(=C)C1CCC(C(C1)O)(C)O,,,,,,
4217,94218,Glycidyl laurate,CCCCCCCCCCCC(=O)OCC1CO1,,,,,,
4218,94219,"1,2,3,6-Tetrahydro-N-methylphthalimide",CN1C(=O)C2CC=CCC2C1=O,,,,,,
4219,94220,Lactamide,CC(C(=O)N)O,,,,,,
4220,94221,(-)-trans-Carveol,CC1=CC[C@H](C[C@@H]1O)C(=C)C,,,,,,
4221,94222,1-Methylpropyl carbamate,CCC(C)OC(=O)N,,,,,,
4222,94223,CID 94223,C1[C@@H]([C@H](O[C@@H]1N2C=NC3=C2N=C(N=C3S)N)CO)O,,,,,,
4223,94224,Antimony 2-ethylhexanoate,CCCCC(CC)C(=O)[O-].CCCCC(CC)C(=O)[O-].CCCCC(CC)C(=O)[O-].[Sb+3],,,,,,
4224,94225,Taraxerol acetate,CC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@@H]5CC(CC[C@@]5(CC=C4[C@@]3(CC[C@H]2C1(C)C)C)C)(C)C)C)C,,,,,,
4225,94226,4-Nonene,CCCCC=CCCC,,,,,,
4226,94227,Tetrahydrofurfuryl benzoate,C1CC(OC1)COC(=O)C2=CC=CC=C2,,,,,,
4227,94228,Isoallolithocholic acid,C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC[C@@H](C4)O)C)C,,,,,,
4228,94229,(S)-Ethyl 2-acetamido-3-phenylpropanoate,CCOC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C,,,,,,
4229,94230,N-Acetyl-L-tryptophanamide,CC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N,,,,,,
4230,94231,Adenylyl-(3'-5')-adenosine,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O[C@@H]4[C@H](O[C@H]([C@@H]4O)N5C=NC6=C(N=CN=C65)N)CO)O)O)N,,,,,,
4231,94232,Tetrahydrofurfuryl acrylate,C=CC(=O)OCC1CCCO1,,,,,,
4232,94233,"5-(4-Hydroxyphenyl)imidazolidine-2,4-dione",C1=CC(=CC=C1C2C(=O)NC(=O)N2)O,,,,,,
4233,94234,"1,2-Hexadecadiene, 3,7,11,15-tetramethyl-",CC(C)CCCC(C)CCCC(C)CCCC(=C=C)C,,,,,,
4234,94235,"3,7-Dihydroxy-12-oxocholanoic acid",C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(C(=O)C[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C,,,,,,
4235,94236,Methyl 2-methylhexadecanoate,CCCCCCCCCCCCCCC(C)C(=O)OC,,,,,,
4236,94237,Cytidylyl-(3'-5')-cytidine,C1=CN(C(=O)N=C1N)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O[C@@H]3[C@H](O[C@H]([C@@H]3O)N4C=CC(=NC4=O)N)CO)O)O,,,,,,
4237,94238,Arachidonic Acid methyl ester-[d8],CCCCCC=CCC=CCC=CCC=CCCCC(=O)OC,,,,,,
4238,94239,Methyl pyrrolidine-2-carboxylate,COC(=O)C1CCCN1,,,,,,
4239,94240,1-(4-Hydroxyphenyl)-3-phenylprop-2-en-1-one,C1=CC=C(C=C1)C=CC(=O)C2=CC=C(C=C2)O,,,,,,
4240,94241,"2-Chloro-1-(2,4,5-trichlorophenyl)ethenyl diethyl phosphate",CCOP(=O)(OCC)OC(=CCl)C1=CC(=C(C=C1Cl)Cl)Cl,,,,,,
4241,94242,"Benzene, (3-chloro-1-propenyl)-",C1=CC=C(C=C1)C=CCCl,,,,,,
4242,94243,3-Phenyl-1-butanol,CC(CCO)C1=CC=CC=C1,,,,,,
4243,94244,Leucyl-leucine,CC(C)CC(C(=O)NC(CC(C)C)C(=O)O)N,,,,,,
4244,94245,"Glutamic acid, iron (2+) salt (1:1)",C(CC(=O)[O-])[C@@H](C(=O)[O-])N.[Fe+2],,,,,,
4245,94246,"2-Propenoic acid, 2-hydroxy-1-methylethyl ester",CC(CO)OC(=O)C=C,,,,,,
4246,94247,Benzyl glycidyl ether,C1C(O1)COCC2=CC=CC=C2,,,,,,
4247,94248,Dehydrodeoxycholic acid,C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(C(=O)C[C@H]3[C@H]2CC[C@H]4[C@@]3(CCC(=O)C4)C)C,,,,,,
4248,94249,2-Methyldecalin,CC1CCC2CCCCC2C1,,,,,,
4249,94250,3-(4-(Methylamino)butyl)pyridine,CCCC(C1=CN=CC=C1)NC,,,,,,
4250,94251,2-Methyloctanoic acid,CCCCCCC(C)C(=O)O,,,,,,
4251,94252,Prochlorperazine hydrogen methanesulfonate,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl.CS(=O)(=O)O,,,,,,
4252,94253,Vulgarin,C[C@H]1[C@@H]2CC[C@@]3([C@@H]([C@H]2OC1=O)[C@](C=CC3=O)(C)O)C,,,,,,
4253,94254,1-Methyl-4-(1-methylethylidene)-2-(1-methylvinyl)-1-vinylcyclohexane,CC(=C1CCC(C(C1)C(=C)C)(C)C=C)C,,,,,,
4254,94255,Vincadifformine,CC[C@@]12CCCN3[C@@H]1[C@@]4(CC3)C5=CC=CC=C5NC4=C(C2)C(=O)OC,,,,,,
4255,94256,Trioctadec-9-en-1-yl phosphate,CCCCCCCCC=CCCCCCCCCOP(=O)(OCCCCCCCCC=CCCCCCCCC)OCCCCCCCCC=CCCCCCCCC,,,,,,
4256,94257,Viridin,C[C@]12[C@@H]([C@@H](C(=O)C3=COC(=C31)C(=O)C4=C2C=CC5=C4CCC5=O)OC)O,,,,,,
4257,94258,"Heptafluoropropyl 1,2,2,2-tetrafluoroethyl ether",C(C(F)(F)F)(OC(C(C(F)(F)F)(F)F)(F)F)F,,,,,,
4258,94259,"1H-Pyrrolizine-1-methanol, hexahydro-, (1S-cis)-",C1C[C@@H]2[C@H](CCN2C1)CO,,,,,,
4259,94260,CID 94260,C1=NC2=C(N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O[C@@H]4[C@H](O[C@H]([C@@H]4O)N5C=NC6=C5NC(=NC6=O)N)CO)O)O)NC(=NC2=O)N,,,,,,
4260,94261,CID 94261,C1C(OC(=N1)S)COC2=CC=CC(=C2)C(F)(F)F,,,,,,
4261,94262,Fdurd-C8,CCCCCCCC(=O)OC[C@@H]1[C@H](C[C@@H](O1)N2C=C(C(=O)NC2=O)F)OC(=O)CCCCCCC,,,,,,
4262,94263,2-Piperidinemethanol,C1CCNC(C1)CO,,,,,,
4263,94264,2-Cyclohexyloxirane,C1CCC(CC1)C2CO2,,,,,,
4264,94265,"1b,6,8-Trihydroxy-6a-methyl-8-(prop-1-en-2-yl)hexahydrospiro[2,5-methanooxireno[3,4]cyclopenta[1,2-d]oxepine-7,2'-oxiran]-3(2h)-one",CC(=C)C1(C2C(C3(C4(CO4)C5C(C3(C1C(=O)O2)O)O5)C)O)O,,,,,,
4265,94266,Sabinyl acetate,CC(C)C12CC1C(=C)C(C2)OC(=O)C,,,,,,
4266,94267,Leucine sarcolysine,CCOC(=O)[C@H](CC(C)C)NC(=O)C(CC1=CC=C(C=C1)N(CCCl)CCCl)NC(=O)C,,,,,,
4267,94268,"2-Pentenal, 3-methyl-",CCC(=CC=O)C,,,,,,
4268,94269,"5,9,14,18-Tetramethyl-20-(2,6,6-trimethylcyclohexen-1-yl)icosa-3,5,7,9,11,13,15,17,19-nonaen-2-one",CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=CC(=O)C)C)C,,,,,,
4269,94270,"(2R,3S,4S,5R)-2,3,4,5-tetrahydroxyhexanal",C[C@H]([C@@H]([C@@H]([C@H](C=O)O)O)O)O,,,,,,
4270,94271,Cyclobutadithymine,C[C@@]12[C@@H]([C@H]3[C@@]1(C(=O)NC(=O)N3)C)NC(=O)NC2=O,,,,,,
4271,94272,CID 94272,CO[C@H]1CC[C@@]23[C@@H](C1)N(CC2O)CC4=C(C5=C(C=C34)OCO5)OC,,,,,,
4272,94273,Dechloro Griseofulvin,CC1CC(=O)C=C(C12C(=O)C3=C(O2)C=C(C=C3OC)OC)OC,,,,,,
4273,94274,"Phenol, 4-(3-hydroxy-1-propenyl)-",C1=CC(=CC=C1C=CCO)O,,,"['Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)', 'Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)', 'Chemical substances or agents with contraceptive activity in males. Use for male contraceptive agents in general or for which there is no specific heading. (See all compounds classified as Contraceptive Agents, Male.)', 'Substances that eliminate free radicals. Among other effects, they protect PANCREATIC ISLETS against damage by CYTOKINES and prevent myocardial and pulmonary REPERFUSION INJURY. (See all compounds classified as Free Radical Scavengers.)']",,,
4274,94275,delta-Guaiene,C[C@H]1CCC2=C(CC[C@H](C[C@@H]12)C(=C)C)C,,,,,,
4275,94276,"1,2,3,5-Tetramethylcyclohexane",CC1CC(C(C(C1)C)C)C,,,,,,
4276,94277,"1,2,3,4-Tetramethylcyclohexane",CC1CCC(C(C1C)C)C,,,,,,
4277,94278,1-Hydroperoxy-1-vinylcyclohex-3-ene,C=CC1(CCC=CC1)OO,,,,,,
4278,94279,Dimetacrine bitartrate,CC1(C2=CC=CC=C2N(C3=CC=CC=C31)CCCN(C)C)C.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O,,,,,,
4279,94280,Dimetacrine,CC1(C2=CC=CC=C2N(C3=CC=CC=C31)CCCN(C)C)C,,['Little is known about the pharmacology of dimetacrine.'],,"['Approximately 70% of the doses were excreted in urine and feces within 2 days after treatment. (PMID 5312397)', 'The highest concentrations of dimetacrine were found at 1 hour after administration but at 3 hours in brain, heart, lung, liver, spleen, kidney, skeletal muscle and adipose tissue of testes. (Carried out in mice, PMID 5312397).']",,['Approximately 10 hours. (PMID 5312397)']
4280,94281,"(2S,3S,4S,5R)-2,3,4,5-tetrahydroxy-6-oxohexanamide",C(=O)[C@@H]([C@H]([C@@H]([C@@H](C(=O)N)O)O)O)O,,,,,,
4281,94282,Dec-2-enoic acid,CCCCCCCC=CC(=O)O,,,,,,
4282,94283,Methyl 3-(3-hydroxyphenyl)-2-propenoate,COC(=O)C=CC1=CC(=CC=C1)O,,,,,,
4283,94284,"3,4-Dehydro-L-proline",C1C=C[C@H](N1)C(=O)O,,,,,,
4284,94285,"L-Valine, methyl ester",CC(C)[C@@H](C(=O)OC)N,,,,,,
4285,94286,"[(2S)-2,3-di(octadec-9-enoyloxy)propyl] 2-(trimethylazaniumyl)ethyl phosphate",CCCCCCCCC=CCCCCCCCC(=O)OC[C@@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC,,,,,,
4286,94287,"2-[[(2S)-2,3-di(octadec-9-enoyloxy)propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium",CCCCCCCCC=CCCCCCCCC(=O)OC[C@@H](COP(=O)(O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC,,,,,,
4287,94288,"2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(3-hydroxy-1-methylbutyl)-",CCC1(C(=O)NC(=O)NC1=O)C(C)CC(C)O,,,,,,
4288,94289,2-Ethylhexyl carbamate,CCCCC(CC)COC(=O)N,,,,,,
4289,94290,"2-Propanol, 1-chloro-3-(1-methylethoxy)-",CC(C)OCC(CCl)O,,,,,,
4290,94291,"20,22-Dihydrodigoxigenin",C[C@]12CC[C@@H](C[C@H]1CC[C@@H]3[C@@H]2C[C@H]([C@]4([C@@]3(CC[C@@H]4[C@H]5CC(=O)OC5)O)C)O)O,,,,,,
4291,94292,2-Methyl-3-buten-1-ol,CC(CO)C=C,,,,,,
4292,94293,"3,4-Dihydro-2,2,5-trimethyl-2H-pyrrole 1-oxide",CC1=[N+](C(CC1)(C)C)[O-],,,,,,
4293,94294,"N,N-Dimethyl-2-chloropropylamine hydrochloride",CC(CN(C)C)Cl.Cl,,,,,,
4294,94295,Dimethyl-{4-[2-(4-nitro-phenyl)-vinyl]-phenyl}-amine,CN(C)C1=CC=C(C=C1)C=CC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
4295,94296,17-Hydroxyprogesterone heptanoate,CCCCCCC(=O)O[C@@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)C(=O)C,,,,,,
4296,94297,4-Methoxybut-3-en-2-one,CC(=O)C=COC,,,,,,
4297,94298,Cryptocyanine iodide,CCN1C=CC(=CC=CC2=CC=[N+](C3=CC=CC=C23)CC)C4=CC=CC=C41.[I-],,,,,,
4298,94299,1-Ethyl-4-[3-[1-ethylquinolin-4(1H)-ylidene]-1-propenyl]quinolinium,CCN1C=CC(=CC=CC2=CC=[N+](C3=CC=CC=C23)CC)C4=CC=CC=C41,,,,,,
4299,94300,1-Chloro-3-phenoxypropan-2-ol,C1=CC=C(C=C1)OCC(CCl)O,,,,,,
4300,94301,3-Methyl-2-butenenitrile,CC(=CC#N)C,,,,,,
4301,94302,Cervident,CC(=C)C(=O)OCC(CN(CC(=O)O)C1=CC=CC=C1)O,,,"['Agents that modify interfacial tension of water; usually substances that have one lipophilic and one hydrophilic group in the molecule; includes soaps, detergents, emulsifiers, dispersing and wetting agents, and several groups of antiseptics. (See all compounds classified as Surface-Active Agents.)']",,,
4302,94303,Mansonone E,CC1COC2=C(C(=O)C(=O)C3=C(C=CC1=C32)C)C,,,,,,
4303,94304,Mansonone F,CC1=C2C3=C(C=C1)C(=COC3=C(C(=O)C2=O)C)C,,,,,,
4304,94305,"5-(1,3-Benzodioxol-5-yl)penta-2,4-dienoic acid",C1OC2=C(O1)C=C(C=C2)C=CC=CC(=O)O,,,,,,
4305,94306,Furfuryl glycidyl ether,C1C(O1)COCC2=CC=CO2,,,,,,
4306,94307,"Methyl 3-(3,4-dimethoxyphenyl)prop-2-enoate",COC1=C(C=C(C=C1)C=CC(=O)OC)OC,,,,,,
4307,94308,3-Dimethylaminopropylchloride hydrochloride,CN(C)CCCCl.Cl,,,,,,
4308,94309,2-Methylserine,CC(CO)(C(=O)O)N,,,,,,
4309,94310,2-Ethylhexyl benzoate,CCCCC(CC)COC(=O)C1=CC=CC=C1,,,,,,
4310,94311,Isopropyl-p-methoxycinnamate,CC(C)OC(=O)C=CC1=CC=C(C=C1)OC,,,,,,
4311,94312,"5,6-Dihydrouridine",C1CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O,,,,,,
4312,94313,2-Hydroxyvaleronitrile,CCCC(C#N)O,,,,,,
4313,94314,Di-sec-butyl disulfide,CCC(C)SSC(C)CC,,,,,,
4314,94315,Isopilocarpine nitrate,CC[C@@H]1[C@H](COC1=O)CC2=CN=CN2C.[N+](=O)(O)[O-],,,,,,
4315,94316,Clemizole penicillin,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C.C1CCN(C1)CC2=NC3=CC=CC=C3N2CC4=CC=C(C=C4)Cl,,,,,,
4316,94317,4-Methyl-2-heptanone,CCCC(C)CC(=O)C,,,,,,
4317,94318,(S)-3-Hydroxybutyric acid,C[C@@H](CC(=O)O)O,,,,,,
4318,94319,"Benzoic acid, 4-(cyclohexyloxy)-, 3-(2-methyl-1-piperidinyl)propyl ester, sulfate (2:1)",CC1CCCCN1CCCOC(=O)C2=CC=C(C=C2)OC3CCCCC3.CC1CCCCN1CCCOC(=O)C2=CC=C(C=C2)OC3CCCCC3.OS(=O)(=O)O,,,,,,
4319,94320,Acetoxolone,CC(=O)O[C@H]1CC[C@]2([C@H](C1(C)C)CC[C@@]3([C@@H]2C(=O)C=C4[C@]3(CC[C@@]5([C@H]4C[C@@](CC5)(C)C(=O)O)C)C)C)C,,,,,,
4320,94321,3-Methylheptadecane,CCCCCCCCCCCCCCC(C)CC,,,,,,
4321,94322,3-Methylnonadecane,CCCCCCCCCCCCCCCCC(C)CC,,,,,,
4322,94323,Aizen Cathilon Red 6B,CCN(CCCl)C1=CC(=C(C=C1)C=CC2=[N+](C3=CC=CC=C3C2(C)C)C)C.[Cl-],,,,,,
4323,94324,"2-[2-[4-[(2-Chloroethyl)ethylamino]-2-methylphenyl]ethenyl]-1,3,3-trimethyl-3H-indolium",CCN(CCCl)C1=CC(=C(C=C1)C=CC2=[N+](C3=CC=CC=C3C2(C)C)C)C,,,,,,
4324,94325,1-Chloro-3-phenoxybenzene,C1=CC=C(C=C1)OC2=CC(=CC=C2)Cl,,,,,,
4325,94326,Pigment yellow 3,CC(=O)C(C(=O)NC1=CC=CC=C1Cl)N=NC2=C(C=C(C=C2)Cl)[N+](=O)[O-],,,,,,
4326,94327,2-Cyclohexylcyclohexanol,C1CCC(CC1)C2CCCCC2O,,,,,,
4327,94328,Quinidine gluconate,COC1=CC2=C(C=CN=C2C=C1)[C@@H]([C@H]3C[C@@H]4CCN3C[C@@H]4C=C)O.C([C@H]([C@H]([C@@H]([C@H](C(=O)O)O)O)O)O)O,,,"['Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)']",,,
4328,94329,CID 94329,COC1=CC2=C(C=CN=C2C=C1)C([C@H]3C[C@@H]4CCN3CC4C=C)O,,,,,,
4329,94330,Cortisol octanoate,CCCCCCCC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)O)C)O,,,,,,
4330,94331,3-Methoxy-alpha-methyl-L-tyrosine,C[C@](CC1=CC(=C(C=C1)O)OC)(C(=O)O)N,,,,,,
4331,94332,Cytidine 5'-monophosphate disodium salt,C1=CN(C(=O)N=C1N)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)([O-])[O-])O)O.[Na+].[Na+],,,,,,
4332,94333,19-Nortestosterone 17-hemisuccinate,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2OC(=O)CCC(=O)O)CCC4=CC(=O)CC[C@H]34,,,,,,
4333,94334,Widdrol,C[C@@]12CCCC(C1=CC[C@@](CC2)(C)O)(C)C,,,,,,
4334,94335,"1,2-Hexanediol",CCCCC(CO)O,,,,,,
4335,94336,"(2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-yl propionate",CCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(CCCC1(C)C)C,,,,,,
4336,94337,4'-Chloro-4-dimethylaminostilbene,CN(C)C1=CC=C(C=C1)C=CC2=CC=C(C=C2)Cl,,,,,,
4337,94338,"N,N,4'-Trimethyl-4-stilbenamine",CC1=CC=C(C=C1)C=CC2=CC=C(C=C2)N(C)C,,,,,,
4338,94339,Propylene glycol dicaprylate,CCCCCCCC(=O)OCC(C)OC(=O)CCCCCCC,,,,,,
4339,94340,gamma-Glutamyltyrosine,C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)CC[C@@H](C(=O)O)N)O,,,,,,
4340,94341,"3,4-Hexanediol, 3,4-bis(4-hydroxyphenyl)-",CCC(C1=CC=C(C=C1)O)(C(CC)(C2=CC=C(C=C2)O)O)O,,,,,,
4341,94342,Dibozane,C1CN(CCN1CC2COC3=CC=CC=C3O2)CC4COC5=CC=CC=C5O4,,,,,,
4342,94343,"1,2,3,6-Tetrahydro-N-octyl-3,6-methanophthalimide",CCCCCCCCN1C(=O)C2C3CC(C2C1=O)C=C3,,,,,,
4343,94344,"1,3,5-Triazine, 2,4,6-tris(2-methyl-1-aziridinyl)-",CC1CN1C2=NC(=NC(=N2)N3CC3C)N4CC4C,,,,,,
4344,94345,2-Hexenedinitrile,C(CC#N)C=CC#N,,,,,,
4345,94346,"Cyclobutane, 1,1,2,3,3,4-hexafluoro-2,4-bis(trifluoromethyl)-",C1(C(C(C1(F)F)(C(F)(F)F)F)(F)F)(C(F)(F)F)F,,,,,,
4346,94347,"Benzene, 1,4-bis[2-(2-methylphenyl)ethenyl]-",CC1=CC=CC=C1C=CC2=CC=C(C=C2)C=CC3=CC=CC=C3C,,,,,,
4347,94348,"(3S,5S,8R,9S,10S,13R,14S,17R)-5,14-dihydroxy-3-[(2R,4S,5R,6R)-4-hydroxy-6-methyl-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-10-carbaldehyde",C[C@@H]1[C@@H]([C@H](C[C@@H](O1)O[C@H]2CC[C@@]3([C@H]4CC[C@@]5([C@H](CC[C@@]5([C@@H]4CC[C@@]3(C2)O)O)C6=CC(=O)OC6)C)C=O)O)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O,,,,,,
4348,94349,Isomintlactone,CC1CCC2=C(C(=O)OC2C1)C,,,,,,
4349,94350,"[(7S,11S,12R,13S,14R,15R,16R,17S,18S)-2,15,17-trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23,27,29-tetraoxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(28),2,4,9,19,21,25-heptaen-13-yl] acetate",C[C@H]1C=CC=C(C(=O)NC2=CC(=O)C3=C(C2=O)C(=C(C4=C3C(=O)[C@](O4)(OC=C[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)C,,,,,,
4350,94351,"2-Chloro-1-(2,4-dichlorophenyl)ethanol",C1=CC(=C(C=C1Cl)Cl)C(CCl)O,,,,,,
4351,94352,"Piperazine, 1,4-bis(alpha-methylphenethyl)-, dihydrochloride",CC(CC1=CC=CC=C1)N2CCN(CC2)C(C)CC3=CC=CC=C3.Cl.Cl,,,,,,
4352,94353,Diphenazine,CC(CC1=CC=CC=C1)N2CCN(CC2)C(C)CC3=CC=CC=C3,,,,,,
4353,94354,"13-Oxabicyclo[10.1.0]trideca-4,8-diene, 1,5,9-trimethyl-",CC1=CCCC2(C(O2)CCC(=CCC1)C)C,,,,,,
4354,94355,"2-Amino-2,3-dimethylbutanenitrile",CC(C)C(C)(C#N)N,,,,,,
4355,94356,Einecs 246-995-7,C1CC2=C(CCC=N2)C=C1,,,,,,
4356,94357,"Cholanthrene, 11,12-dihydro-3-methyl-",CC1=C2CCC3=C2C(=CC4=C3CCC5=CC=CC=C54)C=C1,,,,,,
4357,94358,Bstfa,C[Si](C)(C)N=C(C(F)(F)F)O[Si](C)(C)C,,,,,,
4358,94359,Zirconium nitride,N#[Zr],,,,,,
4359,94360,CID 94360,CCCCCCCCCCCC(=O)C.CCCCCCCCCCCC(=O)C.C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@]2([C@H]([C@@H]([C@H](O2)CO)O)O)CO)O)O)O)O,,,,,,
4360,94361,CID 94361,C(C1[C@H]([C@@H]([C@H]([C@H](O1)O[C@]2([C@H]([C@@H](C(O2)CO)O)O)CO)O)O)O)O,,,,,,
4361,94362,"Ethanol, 2-[2-[2-(hexyloxy)ethoxy]ethoxy]-",CCCCCCOCCOCCOCCO,,,,,,
4362,94363,"2,2-Dichloropropanoyl chloride",CC(C(=O)Cl)(Cl)Cl,,,,,,
4363,94364,N-Acetyl-D-cysteine,CC(=O)N[C@H](CS)C(=O)O,,,,,,
4364,94365,"3,5-Dihydroxybenzaldehyde",C1=C(C=C(C=C1O)O)C=O,,,,,,
4365,94366,CID 94366,C1=C(C(=N)C=C(C1=N)Cl)N(O)O,,,,,,
4366,94367,"Benzene, 2-azido-1,3-dimethyl-",CC1=C(C(=CC=C1)C)N=[N+]=[N-],,,,,,
4367,94368,CID 94368,CCCC[SnH](CCCC)CCCC.CCCC[SnH](CCCC)CCCC.OS(=O)(=O)O,,,,,,
4368,94369,Diisotridecyl adipate,CC(C)CCCCCCCCCCOC(=O)CCCCC(=O)OCCCCCCCCCCC(C)C,,,,,,
4369,94370,"Acetic acid, 2,2',2''-[(octylstannylidyne)tris(thio)]tris-, triisooctyl ester",CCCCCCCC[Sn](SCC(=O)OCCCCCC(C)C)(SCC(=O)OCCCCCC(C)C)SCC(=O)OCCCCCC(C)C,,,,,,
4370,94371,Nandrolone laurate,CCCCCCCCCCCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@H]34)C,,,,,,
4371,94372,"Urea, 1,1'-(methyl-m-phenylene)bis(3,3-dimethyl-",CC1=CC(=CC(=C1)NC(=O)N(C)C)NC(=O)N(C)C,,,,,,
4372,94373,"2,6-Dimethyldodeca-2,6,8-trien-10-one",CCC(=O)C=CC=C(C)CCC=C(C)C,,,,,,
4373,94374,Bis(vinylsulfonylmethyl) ether,C=CS(=O)(=O)COCS(=O)(=O)C=C,,,,,,
4374,94375,"Benz(a)anthracene, 7-(iodomethyl)-12-methyl-",CC1=C2C(=C(C3=CC=CC=C13)CI)C=CC4=CC=CC=C42,,,,,,
4375,94376,"7,8-Dihydrocannabinol",CCCCCC1=CC(=C2C(=C1)OC(C3=C2C=C(CC3)C)(C)C)O,,,,,,
4376,94377,"N,N,N',N'-Tetrabutylhexane-1,6-diamine",CCCCN(CCCC)CCCCCCN(CCCC)CCCC,,,,,,
4377,94378,Paradol,CCCCCCCC(=O)CCC1=CC(=C(C=C1)O)OC,,,,,,
4378,94379,"trans-1-Phenyl-1,2-cyclohexanediol",C1CC[C@]([C@H](C1)O)(C2=CC=CC=C2)O,,,,,,
4379,94380,"Dodecanoic acid, ester with 1,2-propanediol",CCCCCCCCCCCC(=O)O.CC(CO)O,,,,,,
4380,94381,Coumarin 7,CCN(CC)C1=CC2=C(C=C1)C=C(C(=O)O2)C3=NC4=CC=CC=C4N3,,,,,,
4381,94382,Quinonamid,C1=CC=C2C(=C1)C(=O)C(=C(C2=O)Cl)NC(=O)C(Cl)Cl,,,,,,
4382,94383,"Ethanol, 2-bromo-, phosphate (3:1)",C(CBr)OP(=O)(OCCBr)OCCBr,,,,,,
4383,94384,"(1-Methylethylidene)bis(4,1-phenyleneoxy-3,1-propanediyl) bismethacrylate",CC(=C)C(=O)OCCCOC1=CC=C(C=C1)C(C)(C)C2=CC=C(C=C2)OCCCOC(=O)C(=C)C,,,,,,
4384,94385,2-Chloropropionamide,CC(C(=O)N)Cl,,,,,,
4385,94386,Methyl (S)-(-)-lactate,C[C@@H](C(=O)OC)O,,,,,,
4386,94387,"N,N-bis(2-hydroxyethyl)octadeca-6,9-dienamide",CCCCCCCCC=CCC=CCCCCC(=O)N(CCO)CCO,,,,,,
4387,94388,Bnps-skatole,CC1(C2=CC=CC=C2N=C1SC3=CC=CC=C3[N+](=O)[O-])Br,,,,,,
4388,94389,Tetrafluron,CN(C)C(=O)NC1=CC(=CC=C1)OC(C(F)F)(F)F,,,,,,
4389,94390,CID 94390,CC(C)C1=CC2=C(C=C1)[C@]3(CCC[C@@]([C@@H]3CC2)(C)C(=O)[O-])C.[Na+],,,,,,
4390,94391,Dehydroabietic acid,CC(C)C1=CC2=C(C=C1)[C@]3(CCC[C@@]([C@@H]3CC2)(C)C(=O)O)C,,,,,,
4391,94392,"2,6-Difluorophenol",C1=CC(=C(C(=C1)F)O)F,,,,,,
4392,94393,CID 94393,CC1=C(C=CC(=C1)Cl)N=C(N(C)C)S,,,,,,
4393,94394,"Octane, 1-(ethenylsulfonyl)-",CCCCCCCCS(=O)(=O)C=C,,,,,,
4394,94395,Pyrroline,C1CNC=C1,,,,,,
4395,94396,1-Oxacycloheptadec-10-en-2-one,C1CCCC=CCCCCCCOC(=O)CCC1,,,,,,
4396,94397,"Acetic acid, chloro-, bicyclo(2.2.1)hept-5-en-2-ylmethyl ester",C1C2CC(C1C=C2)COC(=O)CCl,,,,,,
4397,94398,"2,4-Dichloro-1,3-dinitro-5-(trifluoromethyl)benzene",C1=C(C(=C(C(=C1[N+](=O)[O-])Cl)[N+](=O)[O-])Cl)C(F)(F)F,,,,,,
4398,94399,"Benzenamine, 3-chloro-2,6-dinitro-N,N-dipropyl-4-(trifluoromethyl)-",CCCN(CCC)C1=C(C=C(C(=C1[N+](=O)[O-])Cl)C(F)(F)F)[N+](=O)[O-],,,,,,
4399,94400,Nonadecylbenzene,CCCCCCCCCCCCCCCCCCCC1=CC=CC=C1,,,,,,
4400,94401,"1,4-Naphthalenedione, 2-ethyl-3-hydroxy-",CCC1=C(C2=CC=CC=C2C(=O)C1=O)O,,,,,,
4401,94402,"1-Butene, 1-methoxy-",CCC=COC,,,,,,
4402,94403,Farnesyl acetate,CC(=CCCC(=CCCC(=CCOC(=O)C)C)C)C,,,,,,
4403,94404,Ethyl 10-iodostearate,CCCCCCCCC(CCCCCCCCC(=O)OCC)I,,,,,,
4404,94405,"Formaldehyde, polymer with 2-methylphenol, reaction products with epichlorohydrin",CC1=CC=CC=C1O.C=O.C1C(O1)CCl,,,,,,
4405,94406,"Benzenamine, 4-butyl-N-[(4-ethoxyphenyl)methylene]-",CCCCC1=CC=C(C=C1)N=CC2=CC=C(C=C2)OCC,,,,,,
4406,94407,Cadmium mercury telluride,[Cd].[Te]=[Hg],,,,,,
4407,94408,6-(4-Dimethylaminophenyl)azoquinoline,CN(C)C1=CC=C(C=C1)N=NC2=CC3=C(C=C2)N=CC=C3,,,,,,
4408,94409,Malvidin 3-galactoside,COC1=CC(=CC(=C1O)OC)C2=[O+]C3=CC(=CC(=C3C=C2O[C@H]4[C@@H]([C@H]([C@H]([C@H](O4)CO)O)O)O)O)O.[Cl-],,,,,,
4409,94410,"5-hydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-7-one",COC1=CC(=CC(=C1O)OC)C2=C(C=C3C(=CC(=O)C=C3O2)O)O[C@H]4[C@@H]([C@H]([C@H]([C@H](O4)CO)O)O)O,,,,,,
4410,94411,2-Amino-n-isopropylbenzamide,CC(C)NC(=O)C1=CC=CC=C1N,,,,,,
4411,94412,"Pentyl 3,5,6-trichlorosalicylate",CCCCCOC(=O)C1=C(C(=CC(=C1Cl)Cl)Cl)O,,,,,,
4412,94413,1-Ethyl-3-hydroxy-2-methylpyridin-4(1H)-one,CCN1C=CC(=O)C(=C1C)O,,,,,,
4413,94414,3-Hydroxy-1-(2-hydroxyethyl)-2-methylpyridin-4(1h)-one,CC1=C(C(=O)C=CN1CCO)O,,,,,,
4414,94415,CID 94415,CC1=C2C(=C(C3=CC=CC=C13)OC(=O)C4=CC=CC=C4)C=CC5=CC=CC=C52,,,,,,
4415,94416,4-Isopropylphenyl isocyanate,CC(C)C1=CC=C(C=C1)N=C=O,,,,,,
4416,94417,p-Nitrosoacetophenone,CC(=O)C1=CC=C(C=C1)N=O,,,,,,
4417,94418,Hippuryl-histidyl-leucine,CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)CNC(=O)C2=CC=CC=C2,,,,,,
4418,94419,"Dimethyl 5,5'-methylenedianthranilate",COC(=O)C1=C(C=CC(=C1)CC2=CC(=C(C=C2)N)C(=O)OC)N,,,,,,
4419,94420,CID 94420,CNS(=O)(=O)C(C(C(C(C(C(C(C(CF)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
4420,94421,"2,4-Dibromotoluene",CC1=C(C=C(C=C1)Br)Br,,,,,,
4421,94422,Isodecyl stearate,CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCC(C)C,,,,,,
4422,94423,(R)-1-(o-(Allyloxy)phenoxy)-3-(isopropylamino)propan-2-ol,CC(C)NC[C@H](COC1=CC=CC=C1OCC=C)O,,,,,,
4423,94424,"1,3-Dimethyl-2-cyanoguanidine",CNC(=NC)NC#N,,,,,,
4424,94425,CID 94425,COC1=C(C=C(C=C1)C2=CC(=C3C(=CC(=CC3=O)OC)O2)O)O,,,,,,
4425,94426,1-Piperonylpiperazine,C1CN(CCN1)CC2=CC3=C(C=C2)OCO3,,,,,,
4426,94427,"Malonic acid, di-sec-butyl ester",CCC(C)OC(=O)CC(=O)OC(C)CC,,,,,,
4427,94428,"4-Hydroxy-5-((2-hydroxybenzylidene)amino)naphthalene-2,7-disulfonic acid",C1=CC=C(C(=C1)C=NC2=C3C(=CC(=C2)S(=O)(=O)O)C=C(C=C3O)S(=O)(=O)O)O,,,,,,
4428,94429,Triphosgene,C(=O)(OC(Cl)(Cl)Cl)OC(Cl)(Cl)Cl,,,,,,
4429,94430,"3,5-Diamino-2,4,6-trimethylbenzenesulfonic acid",CC1=C(C(=C(C(=C1N)C)S(=O)(=O)O)C)N,,,,,,
4430,94431,n-Heptafluorobutyrylimidazole,C1=CN(C=N1)C(=O)C(C(C(F)(F)F)(F)F)(F)F,,,,,,
4431,94432,8-S-Benzyl cyclic amp,C1[C@@H]2[C@H]([C@H]([C@@H](O2)N3C4=NC=NC(=C4N=C3SCC5=CC=CC=C5)N)O)OP(=O)(O1)O,,,,,,
4432,94433,Tetrabutylammonium hydrogen sulfate,CCCC[N+](CCCC)(CCCC)CCCC.OS(=O)(=O)[O-],,,"['Purifying or cleansing agents, usually salts of long-chain aliphatic bases or acids, that exert cleansing (oil-dissolving) and antimicrobial effects through a surface action that depends on possessing both hydrophilic and hydrophobic properties. (See all compounds classified as Detergents.)']",,,
4433,94434,"1,2-Propanediol, 2(or 3)-(oxiranylmethoxy)-",C1C(O1)COCC(CO)O,,,,,,
4434,94435,"1-Octadecanol, 2-tetradecyl-",CCCCCCCCCCCCCCCCC(CCCCCCCCCCCCCC)CO,,,,,,
4435,94436,6-Methylenehydroxyprogesterone Acetate,CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC(=C)C4=CC(=O)CC[C@]34C)C)OC(=O)C,,,,,,
4436,94437,Pyrogallol Red,C1=CC=C2C(=C1)C3(C4=C(C(=C(C=C4)O)O)OC5=C3C=CC(=C5O)O)OS2(=O)=O,,,['Chemicals and substances that impart color including soluble dyes and insoluble pigments. They are used in INKS; PAINTS; and as INDICATORS AND REAGENTS. (See all compounds classified as Coloring Agents.)'],,,
4437,94438,"1,2-Bis(dimethoxyphosphorylsulfanyl)ethane",COP(=O)(OC)SCCSP(=O)(OC)OC,,,,,,
4438,94439,"Bromochloro-5,5-dimethylimidazolidine-2,4-dione",C(C1(C(=O)NC(=O)N1)CBr)Cl,,,,,,
4439,94440,"3-(4-tert-Butylphenyl)-1,1-dimethylurea",CC(C)(C)C1=CC=C(C=C1)NC(=O)N(C)C,,,,,,
4440,94441,Octyl octadec-9-enoate,CCCCCCCCC=CCCCCCCCC(=O)OCCCCCCCC,,,,,,
4441,94442,Dansyl hydrazine,CN(C)C1=CC=CC2=C1C=CC=C2S(=O)(=O)NN,,,"['Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)']",,,
4442,94443,"but-2-enedioic acid;N,N-dimethyl-N'-pyridin-2-yl-N'-(thiophen-2-ylmethyl)ethane-1,2-diamine",CN(C)CCN(CC1=CC=CS1)C2=CC=CC=N2.CN(C)CCN(CC1=CC=CS1)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O.C(=CC(=O)O)C(=O)O.C(=CC(=O)O)C(=O)O,,,,,,
4443,94444,CID 94444,C[C@H]1C=CC=C(C(=O)N=C2C(=CNN3CCN(CC3)CC4=CC=CC=C4)C(=C5C(=C2O)C(=C(C6=C5C(=O)[C@](O6)(OC=C[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C,,,,,,
4444,94445,"Phosphoric acid, 1,2-ethanediyl tetrakis(2-chloroethyl) ester",C(COP(=O)(OCCCl)OCCCl)OP(=O)(OCCCl)OCCCl,,,,,,
4445,94446,"Phenol, 2,2'-(2-methylpropylidene)bis(4,6-dimethyl-",CC1=CC(=C(C(=C1)C(C2=CC(=CC(=C2O)C)C)C(C)C)O)C,,,,,,
4446,94447,Ampicillin benzathine,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)C(=O)O)C.CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)C(=O)O)C.C1=CC=C(C=C1)CNCCNCC2=CC=CC=C2,,,,,,
4447,94448,Panose,C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@H](O2)O[C@H]([C@@H](CO)O)[C@@H]([C@H](C=O)O)O)O)O)O)O)O)O)O,,,,,,
4448,94449,Bipinnatin,C[C@H]1CC[C@@H]2[C@H]([C@]3([C@H]1[C@@H](CC3=O)O)C)OC(=O)C2=C,,,,,,
4449,94450,"1-Piperidinyloxy, 4-((bis(1-aziridinyl)phosphinothioyl)amino)-2,2,6,6-tetramethyl-",CC1(CC(CC(N1[O-])(C)C)NP(=S)(N2CC2)N3CC3)C,,,,,,
4450,94451,3-Chloro-2-hydroxypropiononitrile,C(C(C#N)O)Cl,,,,,,
4451,94452,"2,2,6,6-Tetramethylpiperidin-4-one hydrochloride",CC1(CC(=O)CC(N1)(C)C)C.Cl,,,,,,
4452,94453,6-Isopropyldecahydronaphthalen-2-OL,CC(C)C1CCC2CC(CCC2C1)O,,,,,,
4453,94454,Hexyl laurate,CCCCCCCCCCCC(=O)OCCCCCC,,,,,,
4454,94455,CID 94455,CC1=NC(=O)C=C(N1)C(=O)O,,,,,,
4455,94456,"Glucuronic acid, 2-O-(fluoren-2-ylamino)-",C1C2=CC=CC=C2C3=C1C=C(C=C3)NO[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)O)O)O)O,,,,,,
4456,94457,Deacetoxycephalothin,CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)CC3=CC=CS3)SC1)C(=O)O,,,,,,
4457,94458,"2H-1-Benzopyran-2-one, 3-(4-chloro-1H-pyrazol-1-yl)-7-(4-methyl-5-phenyl-2H-1,2,3-triazol-2-yl)-",CC1=NN(N=C1C2=CC=CC=C2)C3=CC4=C(C=C3)C=C(C(=O)O4)N5C=C(C=N5)Cl,,,,,,
4458,94459,1-(2-Pyridyl)piperazine,C1CN(CCN1)C2=CC=CC=N2,,,,,,
4459,94460,"3,5-Dichlorophenyl isocyanate",C1=C(C=C(C=C1Cl)Cl)N=C=O,,,,,,
4460,94461,"Guanidine, N-(2-methylpropyl)-N'-nitro-",CC(C)CN=C(N)N[N+](=O)[O-],,,,,,
4461,94462,"1-Propanaminium, N,N,N-trimethyl-3-(trimethoxysilyl)-, chloride",C[N+](C)(C)CCC[Si](OC)(OC)OC.[Cl-],,,,,,
4462,94463,3-(Trimethoxysilyl)propyltrimethylaminium,C[N+](C)(C)CCC[Si](OC)(OC)OC,,,,,,
4463,94464,8-Quinolinesulfonamide,C1=CC2=C(C(=C1)S(=O)(=O)N)N=CC=C2,,,,,,
4464,94465,1-Chloroindan,C1CC2=CC=CC=C2C1Cl,,,,,,
4465,94466,"Dibenzo(def,mno)chrysene, 1,2,3,7,8,9-hexahydro-",C1CC2=C3C(=CC4=C5C3=C(C=C2)C=C6C5=C(CCC6)C=C4)C1,,,,,,
4466,94467,C.I. Pigment Red 63:2,[H+].C1=CC=C2C(=C1)C=CC(=C2S(=O)(=O)[O-])N=NC3=C(C(=CC4=CC=CC=C43)C(=O)[O-])[O-].[Mn+2],,,,,,
4467,94468,"Benzene, 1-isocyanato-4-[(4-isocyanatocyclohexyl)methyl]-",C1CC(CCC1CC2=CC=C(C=C2)N=C=O)N=C=O,,,,,,
4468,94469,"6-(Dimethylamino)-2-(2-(2,5-dimethyl-1-phenyl-1H-pyrrol-3-yl)vinyl)-1-methylquinolinium iodide",CC1=CC(=C(N1C2=CC=CC=C2)C)C=CC3=[N+](C4=C(C=C3)C=C(C=C4)N(C)C)C.[I-],,,,,,
4469,94470,Ethyltriphenylphosphonium acetate,CC[P+](C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3.CC(=O)[O-],,,,,,
4470,94471,"(1R,4S)-1,7,7-Trimethyl-3-(phenylmethylene)bicyclo[2.2.1]heptan-2-one",C[C@@]12CC[C@@H](C1(C)C)C(=CC3=CC=CC=C3)C2=O,,,,,,
4471,94472,CID 94472,CCCCCCCC(=O)O.CCCCCCCC(=O)O.C(C(CO)O)O,,,,,,
4472,94473,Salicyloylaminotriazole,C1=CC=C(C(=C1)C(=O)NC2=NC=NN2)O,,,,,,
4473,94474,"Propane, 1,1,3,3-tetrabromo-1,2,2,3-tetrafluoro-",C(C(F)(Br)Br)(C(F)(Br)Br)(F)F,,,,,,
4474,94475,"[14-formyl-10,22-dihydroxy-7,18-dimethyl-19-(5-oxo-2H-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.03,12.05,10.015,23.018,22]pentacosan-9-yl] acetate",CC1CC(C2(C(O1)OC3CC4CCC5C(C4(CC3O2)C=O)CCC6(C5(CCC6C7=CC(=O)OC7)O)C)O)OC(=O)C,,,,,,
4475,94476,CID 94476,CC1=NSC(=N1)S,,,,,,
4476,94477,1-(2-Aminoethyl)-3-hydroxy-4(1H)-pyridinone,C1=CN(C=C(C1=O)O)CCN,,,,,,
4477,94478,CID 94478,CC1=CC(N=C(N1C2=CC(=CC=C2)[N+](=O)[O-])S)(C)C,,,,,,
4478,94479,Ethyl 13-docosenoate,CCCCCCCCC=CCCCCCCCCCCCC(=O)OCC,,,,,,
4479,94480,Disodium stearoyl glutamate,CCCCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-].[Na+].[Na+],,,,,,
4480,94481,Stearoyl glutamic acid,CCCCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)O)C(=O)O,,,,,,
4481,94482,Fosfructose trisodium anhydrous,C([C@H]([C@H]([C@@H](C(=O)COP(=O)(O)[O-])O)O)O)OP(=O)([O-])[O-].[Na+].[Na+].[Na+],,,"['Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)', 'Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)', 'Agents that affect the rate or intensity of cardiac contraction, blood vessel diameter, or blood volume. (See all compounds classified as Cardiovascular Agents.)', 'Biologically active substances whose activities affect or play a role in the functioning of the immune system. (See all compounds classified as Immunologic Factors.)']",,,
4482,94483,"2,2-Bis(4-(3,4-dicarboxyphenoxy)phenyl)propane dianhydride",CC(C)(C1=CC=C(C=C1)OC2=CC3=C(C=C2)C(=O)OC3=O)C4=CC=C(C=C4)OC5=CC6=C(C=C5)C(=O)OC6=O,,,,,,
4483,94484,CID 94484,CC(=O)N(CC1=CC=C(C=C1)O)C(=O)NC2=CC=C(C=C2)C(=O)O,,,,,,
4484,94485,Tetratriacontanoic acid,CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC(=O)O,,,,,,
4485,94486,4-Pentylphenyl 4-methoxybenzoate,CCCCCC1=CC=C(C=C1)OC(=O)C2=CC=C(C=C2)OC,,,,,,
4486,94487,CID 94487,CN=C(NCCSCC1=CN=CN1)S,,,,,,
4487,94488,"Iron(3+); 2,3,4,5,6-pentahydroxyhexanoate",C(C(C(C(C(C(=O)[O-])O)O)O)O)O.C(C(C(C(C(C(=O)[O-])O)O)O)O)O.C(C(C(C(C(C(=O)[O-])O)O)O)O)O.[Fe+3],,,,,,
4488,94489,N-Diazoacetylglycine ethylamide,CCNC(=O)CNC(=O)C=[N+]=[N-],,,,,,
4489,94490,CID 94490,CCNC(=O)CNC(=C[N+]#N)O,,,,,,
4490,94491,cis-Bis(cyclobutylammine)dichloroplatinum(II),C1CC(C1)N.C1CC(C1)N.[Cl-].[Cl-].[Pt+2],,,,,,
4491,94492,"Cyclohexane, 1,1'-(1,1,3-trimethyl-1,3-propanediyl)bis-",CC(CC(C)(C)C1CCCCC1)C2CCCCC2,,,,,,
4492,94493,alpha-Tocopherol phosphate,CC1=C(C(=C(C2=C1O[C@](CC2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C)OP(=O)(O)O)C,,,,,,
4493,94494,4-Chlorobenzo[d]thiazol-2(3H)-one,C1=CC2=C(C(=C1)Cl)NC(=O)S2,,,,,,
4494,94495,"Ethanol, 2-(nonyloxy)-",CCCCCCCCCOCCO,,,,,,
4495,94496,"Benzenesulfonic acid, heptadecyl-",CCCCCCCCCCCCCCCCCC1=CC=C(C=C1)S(=O)(=O)O,,,,,,
4496,94497,Cyperquat chloride,C[N+]1=CC=C(C=C1)C2=CC=CC=C2.[Cl-],,,"['Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses (POACEAE), and woody plants. Some plants develop HERBICIDE RESISTANCE. (See all compounds classified as Herbicides.)']",,,
4497,94498,Oxadiargyl,CC(C)(C)C1=NN(C(=O)O1)C2=CC(=C(C=C2Cl)Cl)OCC#C,,,,,,
4498,94499,"1,5-Dimethyl-1H-benzo[d]imidazol-2-amine",CC1=CC2=C(C=C1)N(C(=N2)N)C,,,,,,
4499,94500,4-Pentyloxyaniline,CCCCCOC1=CC=C(C=C1)N,,,,,,
4500,94501,"Phosphorothioic acid, O,O-diethyl S-((4-oxo-1,2,3-benzotriazin-3(4H)-yl)methyl) ester",CCOP(=O)(OCC)SCN1C(=O)C2=CC=CC=C2N=N1,,,,,,
4501,94502,Neodecanoyl chloride,CC(C)(C)CCCCCC(=O)Cl,,,,,,
4502,94503,"9H-Xanthene-2-carboxylic acid, 7-(methylthio)-9-oxo-",CSC1=CC2=C(C=C1)OC3=C(C2=O)C=C(C=C3)C(=O)O,,,,,,
4503,94504,Bursehernin,COC1=C(C=C(C=C1)C[C@@H]2[C@H](COC2=O)CC3=CC4=C(C=C3)OCO4)OC,,,,,,
4504,94505,"2,7-Diisopropylnaphthalene",CC(C)C1=CC2=C(C=C1)C=CC(=C2)C(C)C,,,,,,
4505,94506,"N-Nitrosotetrahydro-1,2-oxazin",C1CCON(C1)N=O,,,,,,
4506,94507,Harmol hydrochloride,CC1=C2C(=C3C=CC(=O)C=C3N2)C=CN1.Cl,,,,,,
4507,94508,"Triazene, 3-methyl-1-(p-nitrophenyl)-",CN=NNC1=CC=C(C=C1)[N+](=O)[O-],,,,,,
4508,94509,"4-(2,4-Dichlorophenoxy)phenol",C1=CC(=CC=C1O)OC2=C(C=C(C=C2)Cl)Cl,,,,,,
4509,94510,Difluoromethanesulphonic acid,C(F)(F)S(=O)(=O)O,,,,,,
4510,94511,"3,5,6-Trichlorosalicylic acid",C1=C(C(=C(C(=C1Cl)Cl)C(=O)O)O)Cl,,,,,,
4511,94512,"1,2-Benzisothiazole-3-carboxylic acid",C1=CC=C2C(=C1)C(=NS2)C(=O)O,,,,,,
4512,94513,"2-[[4-(Diethylamino)-6-[4-[2-[4-[[4-(diethylamino)-6-(2,5-disulfonatoanilino)-1,3,5-triazin-2-yl]amino]-2-sulfonatophenyl]ethenyl]-3-sulfonatoanilino]-1,3,5-triazin-2-yl]amino]benzene-1,4-disulfonate",CCN(CC)C1=NC(=NC(=N1)NC2=C(C=CC(=C2)S(=O)(=O)[O-])S(=O)(=O)[O-])NC3=CC(=C(C=C3)C=CC4=C(C=C(C=C4)NC5=NC(=NC(=N5)N(CC)CC)NC6=C(C=CC(=C6)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-],,,,,,
4513,94514,"2-[[4-(Diethylamino)-6-[4-[2-[4-[[4-(diethylamino)-6-(2,5-disulfoanilino)-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]ethenyl]-3-sulfoanilino]-1,3,5-triazin-2-yl]amino]benzene-1,4-disulfonic acid",CCN(CC)C1=NC(=NC(=N1)NC2=C(C=CC(=C2)S(=O)(=O)O)S(=O)(=O)O)NC3=CC(=C(C=C3)C=CC4=C(C=C(C=C4)NC5=NC(=NC(=N5)N(CC)CC)NC6=C(C=CC(=C6)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
4514,94515,"Ethanol, 2,2'-[methylenebis(sulfonyl)]bis-",C(CS(=O)(=O)CS(=O)(=O)CCO)O,,,,,,
4515,94516,"Phosphonic acid, methyl-, (5-ethyl-2-methyl-2-oxido-1,3,2-dioxaphosphorinan-5-yl)methyl methyl ester",CCC1(COP(=O)(OC1)C)COP(=O)(C)OC,,,,,,
4516,94517,Coumarin 102,CC1=CC(=O)OC2=C1C=C3CCCN4C3=C2CCC4,,,,,,
4517,94518,Silaid,C[Si](CCCl)(OCC1=CC=CC=C1)OCC2=CC=CC=C2,,,,,,
4518,94519,4-(p-Tolyloxy)aniline,CC1=CC=C(C=C1)OC2=CC=C(C=C2)N,,,,,,
4519,94520,cis-Bis(isopropylammine)dichloroplatinum(II),CC(C)N.CC(C)N.[Cl-].[Cl-].[Pt+2],,,,,,
4520,94521,"3,4,4a,5,8,8a-Hexahydro-3',6-dimethylspiro[1,4-methanonaphthalene-2(1H),2'-oxirane]",CC1C2(O1)CC3CC2C4C3CC(=CC4)C,,,,,,
4521,94522,"Spiro(1,4-methanonaphthalene-2(1H),2'-oxirane), 3,4,4a,5,8,8a-hexahydro-3',7-dimethyl-",CC1C2(O1)CC3CC2C4C3CC=C(C4)C,,,,,,
4522,94523,"2H-1-Benzopyran-2-one, 7-(diethylamino)-4-(trifluoromethyl)-",CCN(CC)C1=CC2=C(C=C1)C(=CC(=O)O2)C(F)(F)F,,,,,,
4523,94524,2-Chlorotrityl chloride,C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)Cl,,,,,,
4524,94525,5-Methoxyflavone,COC1=CC=CC2=C1C(=O)C=C(O2)C3=CC=CC=C3,,,,,,
4525,94526,"Phosphonic acid, methyl-, bis((5-ethyl-2-methyl-2-oxido-1,3,2-dioxaphosphorinan-5-yl)methyl) ester",CCC1(COP(=O)(OC1)C)COP(=O)(C)OCC2(COP(=O)(OC2)C)CC,,,,,,
4526,94527,Pivaloyl cyanide,CC(C)(C)C(=O)C#N,,,,,,
4527,94528,"Diethyl N-(4-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-L-glutamate",CCOC(=O)CC[C@@H](C(=O)OCC)NC(=O)C1=CC=C(C=C1)N(C)CC2=CN=C3C(=N2)C(=NC(=N3)N)N,,,,,,
4528,94529,"1,3-Benzenediamine, 2-chloro-4-methyl-",CC1=C(C(=C(C=C1)N)Cl)N,,,,,,
4529,94530,Benzyldimethyl[2-[(2-methyl-1-oxoallyl)oxy]ethyl]ammonium chloride,CC(=C)C(=O)OCC[N+](C)(C)CC1=CC=CC=C1.[Cl-],,,,,,
4530,94531,2-(Methacryloyloxy)ethylbenzyldimethylaminium,CC(=C)C(=O)OCC[N+](C)(C)CC1=CC=CC=C1,,,,,,
4531,94532,Etafedrine,CCN(C)[C@@H](C)[C@@H](C1=CC=CC=C1)O,"['Conditions characterized by bronchial congestion and bronchospasm when an expectorant or bronchodilator action is required, such as acute bronchitis, acute episodes of chronic bronchitis and bronchial asthma,.']","['Etafedrine helps to control the cough which is associated with irritation of the mouth and throat that is not alleviated by cough medications that are less strong.  The results of one study in 48 individuals showed that lung FEV1 (forced expiratory volume) and lung VC (vital capacity) were significantly improved with etafedrine, sleep improved, and patients showed improved appetite in addition to the suppression of cough.']",,"['Similar to its parent drug, ephedrine, it is readily and completely absorbed from the gastrointestinal tract; plasma peak concentrations are reached an hour after ingestion.              A single oral dose of 24 mg produced an average peak plasma concentration of 0.10 mg/L.', 'Excreted mainly in the urine.', 'Similar to ephedrine, at about 3L/kg.']",,['It has a plasma half-life ranging from 3 to 6 hours depending on urinary pH.']
4532,94533,Acetic acid;2-[1-(diaminomethylidenehydrazinylidene)propan-2-ylideneamino]guanidine,CC(=NN=C(N)N)C=NN=C(N)N.CC(=O)O.CC(=O)O,,,,,,
4533,94534,"1,3-Benzenediamine, 2,4-dichloro-6-methyl-",CC1=CC(=C(C(=C1N)Cl)N)Cl,,,,,,
4534,94535,"1,3-Benzenediamine, 4,6-dichloro-2-methyl-",CC1=C(C(=CC(=C1N)Cl)Cl)N,,,,,,
4535,94536,"1,3-Benzenediamine, 4,5-dichloro-6-methyl-",CC1=C(C(=C(C=C1N)N)Cl)Cl,,,,,,
4536,94537,"Bis(1,1-dimethylethyl) 1,3-dithiolan-2-ylidenepropanedioate",CC(C)(C)OC(=O)C(=C1SCCS1)C(=O)OC(C)(C)C,,,,,,
4537,94538,n-Methyl-3-phenoxybenzamide,CNC(=O)C1=CC(=CC=C1)OC2=CC=CC=C2,,,,,,
4538,94539,"Benzaldehyde, 2-hydroxy-5-nonyl-, oxime",CCCCCCCCCC1=CC(=C(C=C1)O)C=NO,,,,,,
4539,94540,4-(Ethyl(2-methoxyethyl)ammonio)-o-toluidinium di(toluene-4-sulphonate),CCN(CCOC)C1=CC(=C(C=C1)N)C.CC1CC=C(C=C1)S(=O)(=O)O.CC1CC=C(C=C1)S(=O)(=O)O,,,,,,
4540,94541,"N'-Ethyl-N'-(2-methoxyethyl)-2-methylbenzene-1,4-diamine",CCN(CCOC)C1=CC(=C(C=C1)N)C,,,,,,
4541,94542,"4-Methylcyclohexa-1,5-diene-1-sulfonic acid",CC1CC=C(C=C1)S(=O)(=O)O,,,,,,
4542,94543,2-(p-Octylphenoxy)ethanol,CCCCCCCCC1=CC=C(C=C1)OCCO,,,,,,
4543,94544,1-(Bromomethyl)-3-phenoxybenzene,C1=CC=C(C=C1)OC2=CC=CC(=C2)CBr,,,,,,
4544,94545,"2-Butenoic acid, 3-bromo-2-chloro-4-oxo-",C(=O)C(=C(C(=O)O)Cl)Br,,,,,,
4545,94546,"2,5-Dimethylaniline hydrochloride",CC1=CC(=C(C=C1)C)N.Cl,,,,,,
4546,94547,Butylamphetamine,CCCCNC(C)CC1=CC=CC=C1,,,,,,
4547,94548,"Tetradeca-9,12-dien-1-OL",CC=CCC=CCCCCCCCCO,,,,,,
4548,94549,Smipine,C1CCN(C(C1)C2=NCCC2)C=O,,,,,,
4549,94550,"Phosphonium, tetrakis(hydroxymethyl)-, ethanedioate (2:1) (salt)",C(O)[P+](CO)(CO)CO.C(O)[P+](CO)(CO)CO.C(=O)(C(=O)[O-])[O-],,,,,,
4550,94551,"3-(2,2-Dichlorovinyl)-2,2-dimethylcyclopropanecarbonyl chloride",CC1(C(C1C(=O)Cl)C=C(Cl)Cl)C,,,,,,
4551,94552,CID 94552,CCCCCCCCCCCCC1=CC=C(C=C1)N=NC2C(=NN(C2=O)C3=CC(=C(C=C3Cl)S(=O)(=O)[O-])Cl)C.[Na+],,,,,,
4552,94553,Acid Yellow 72,CCCCCCCCCCCCC1=CC=C(C=C1)N=NC2C(=NN(C2=O)C3=CC(=C(C=C3Cl)S(=O)(=O)O)Cl)C,,,,,,
4553,94554,5-Chlororesorcinol,C1=C(C=C(C=C1O)Cl)O,,,,,,
4554,94555,"Methyl N-(2,6-dimethylphenyl)-DL-alaninate",CC1=C(C(=CC=C1)C)NC(C)C(=O)OC,,,,,,
4555,94556,"Ethane, 1,1'-[oxybis(methylenesulfonyl)]bis[2-chloro-",C(CCl)S(=O)(=O)COCS(=O)(=O)CCCl,,,,,,
4556,94557,CID 94557,CCCCO.OP(=O)(O)[O-].[K+],,,,,,
4557,94558,2-Chloro-2-butenal,CC=C(C=O)Cl,,,,,,
4558,94559,"2-Propenoic acid, 2-methyl-, 2-(dimethylamino)ethyl ester, polymer with 1-ethenyl-2-pyrrolidinone, compd. with diethyl sulfate",CCOS(=O)(=O)OCC.CC(=C)C(=O)OCCN(C)C.C=CN1CCCC1=O,,,,,,
4559,94560,"2,5-Dimethylbenzyl alcohol",CC1=CC(=C(C=C1)C)CO,,,,,,
4560,94561,"Cyclohexanol, 1-[(1,1-dimethylethyl)azo]-",CC(C)(C)N=NC1(CCCCC1)O,,,,,,
4561,94562,"(1,3-oxathiolan-4-ylideneamino) N-methylcarbamate",CNC(=O)ON=C1COCS1,,,,,,
4562,94563,"4-(Methylcarbamoyloximino)-5-methyl-1,3-oxathiolane",CC1C(=NOC(=O)NC)SCO1,,,,,,
4563,94564,"[(5-propyl-1,3-oxathiolan-4-ylidene)amino] N-methylcarbamate",CCCC1C(=NOC(=O)NC)SCO1,,,,,,
4564,94565,"[(5-propan-2-yl-1,3-oxathiolan-4-ylidene)amino] N-methylcarbamate",CC(C)C1C(=NOC(=O)NC)SCO1,,,,,,
4565,94566,"Benzene, 1,2,4-trimethyl-5-(1-methylethenyl)-",CC1=CC(=C(C=C1C)C(=C)C)C,,,,,,
4566,94567,"Piperazine, 1-methyl-4-((1-methyl-5-nitro-1H-imidazol-2-yl)methyl)-",CN1CCN(CC1)CC2=NC=C(N2C)[N+](=O)[O-],,,,,,
4567,94568,Vinyl neononanoate,CC(C)(C)CCCCC(=O)OC=C,,,,,,
4568,94569,"2-Butyl-4,4,6-trimethyl-1,3-dioxane",CCCCC1OC(CC(O1)(C)C)C,,,,,,
4569,94570,"1,2-Dichloro-3-(trifluoromethyl)benzene",C1=CC(=C(C(=C1)Cl)Cl)C(F)(F)F,,,,,,
4570,94571,(Z)-6-Henicosen-11-one,CCCCCCCCCCC(=O)CCCC=CCCCCC,,,,,,
4571,94572,5-Ethylchrysene,CCC1=CC2=CC=CC=C2C3=C1C4=CC=CC=C4C=C3,,,,,,
4572,94573,"5,8-Dimethylbenzo[c]phenanthrene",CC1=CC2=C(C3=CC=CC=C13)C4=CC=CC=C4C(=C2)C,,,,,,
4573,94574,"1-Pyrrolidinecarboxylic acid, phenyl ester",C1CCN(C1)C(=O)OC2=CC=CC=C2,,,,,,
4574,94575,"Benzenesulfonamide, p-(3,3-dimethyl-1-triazeno)-",CN(C)N=NC1=CC=C(C=C1)S(=O)(=O)N,,,,,,
4575,94576,"3,5-Dimethyl-4-nitrosomorpholine",CC1COCC(N1N=O)C,,,,,,
4576,94577,Cepharadione A,CN1C2=CC3=CC=CC=C3C4=C2C(=CC5=C4OCO5)C(=O)C1=O,,,,,,
4577,94578,Phenisopham,CCN(C1=CC=CC=C1)C(=O)OC2=CC=CC(=C2)NC(=O)OC(C)C,,,,,,
4578,94579,Isopulegyl acetate,C[C@@H]1CC[C@H]([C@@H](C1)OC(=O)C)C(=C)C,,,,,,
4579,94580,Methyltris(2-ethylhexyloxycarbonylmethylthio)stannane,CCCCC(CC)COC(=O)CS[Sn](C)(SCC(=O)OCC(CC)CCCC)SCC(=O)OCC(CC)CCCC,,,,,,
4580,94581,CID 94581,CCCCC(CC)COC(=O)C[S-].CCCCC(CC)COC(=O)C[S-].C[Sn]C,,,,,,
4581,94582,2-tert-Butylazo-2-hydroxypropane,CC(C)(C)N=NC(C)(C)O,,,,,,
4582,94583,Flamprop-m-isopropyl,C[C@H](C(=O)OC(C)C)N(C1=CC(=C(C=C1)F)Cl)C(=O)C2=CC=CC=C2,,,,,,
4583,94584,Phenylhydroquinone diacetate,CC(=O)OC1=CC(=C(C=C1)OC(=O)C)C2=CC=CC=C2,,,,,,
4584,94585,2-Methoxy-5-propylphenol,CCCC1=CC(=C(C=C1)OC)O,,,,,,
4585,94586,Trifop-methyl,CC(C(=O)OC)OC1=CC=C(C=C1)OC2=CC=C(C=C2)C(F)(F)F,,,,,,
4586,94587,"9-Octadecenoic acid (9Z)-, 8-methylnonyl ester",CCCCCCCCC=CCCCCCCCC(=O)OCCCCCCCC(C)C,,,,,,
4587,94588,"2,6-Diamino-9-(2-hydroxyethoxymethyl)purine",C1=NC2=C(N=C(N=C2N1COCCO)N)N,,,,,,
4588,94589,"1,3-Dipalmitoyl-2-phosphatidylcholine",CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OP(=O)([O-])OCC[N+](C)(C)C,,,,,,
4589,94590,O-[[1-(1-Oxohexadecyloxymethyl)-2-(1-oxohexadecyloxy)ethoxy]oxylatophosphinyl]choline,CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OP(=O)(O)OCC[N+](C)(C)C,,,,,,
4590,94591,"Methyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate",CC1(C(C1C(=O)OC)C=C(Cl)Cl)C,,,,,,
4591,94592,"2,2'-[[4-[(2,4-Dinitrophenyl)azo]phenyl]imino]bisethanol",C1=CC(=CC=C1N=NC2=C(C=C(C=C2)[N+](=O)[O-])[N+](=O)[O-])N(CCO)CCO,,,,,,
4592,94593,alpha-(Methoxymethyl)-2-methyl-5-nitroimidazole-1-ethanol,CC1=NC=C(N1CC(COC)O)[N+](=O)[O-],,,,,,
4593,94594,N-hydroxy-4-aminostilbene,C1=CC=C(C=C1)C=CC2=CC=C(C=C2)NO,,,,,,
4594,94595,"3-Bromo-4,4-dimethyloxazolidin-2-one",CC1(COC(=O)N1Br)C,,,,,,
4595,94596,"Acetic acid, [(3,5,6-trichloro-2-pyridinyl)oxy]-, methyl ester",COC(=O)COC1=NC(=C(C=C1Cl)Cl)Cl,,,,,,
4596,94597,"Pyrimidine, 2-(1,1-dimethylethyl)-",CC(C)(C)C1=NC=CC=N1,,,,,,
4597,94598,Methyl 5-[2-chloro-4-(trifluoromethyl)phenyl]sulfanyl-2-nitrobenzoate,COC(=O)C1=C(C=CC(=C1)SC2=C(C=C(C=C2)C(F)(F)F)Cl)[N+](=O)[O-],,,,,,
4598,94599,[3-(Dodecanoylamino)propyl](hydroxy)dimethylammonium,CCCCCCCCCCCC(=O)NCCC[N+](C)(C)[O-],,,,,,
4599,94600,Polyoxyethylene isodecyl ether,CC(C)CCCCCCCOCCO,,,,,,
4600,94601,"Acetic acid, [(trioctylstannyl)thio]-, 2-ethylhexyl ester",CCCCCCCC[Sn](CCCCCCCC)(CCCCCCCC)SCC(=O)OCC(CC)CCCC,,,,,,
4601,94602,"2,4-Dimethylbenzyl acetate",CC1=CC(=C(C=C1)COC(=O)C)C,,,,,,
4602,94603,"5,5'-Dithiobis(1-methyltetrazole)",CN1C(=NN=N1)SSC2=NN=NN2C,,,,,,
4603,94604,2'-Methyl-4-dimethylaminostilbene,CC1=CC=CC=C1C=CC2=CC=C(C=C2)N(C)C,,,,,,
4604,94605,"N,N,3'-Trimethyl-4-stilbenamine",CC1=CC(=CC=C1)C=CC2=CC=C(C=C2)N(C)C,,,,,,
4605,94606,CID 94606,C1=CC=C(C=C1)CCS[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O,,,,,,
4606,94607,"2H-Indazole, 3-chloro-2-(4-chloro-2-fluorophenyl)-4,5,6,7-tetrahydro-",C1CCC2=NN(C(=C2C1)Cl)C3=C(C=C(C=C3)Cl)F,,,,,,
4607,94608,1-Cyclohexylethyl butyrate,CCCC(=O)OC(C)C1CCCCC1,,,,,,
4608,94609,"Propanoic acid, 2-hydroxy-, 1-methylethyl ester, (2S)-",C[C@@H](C(=O)OC(C)C)O,,,,,,
4609,94610,"Methyl 2,2,3,3-tetrafluoro-3-((1,1,1,2,3,3-hexafluoro-3-((trifluoroethenyl)oxy)propan-2-yl)oxy)propanoate",COC(=O)C(C(OC(C(OC(=C(F)F)F)(F)F)(C(F)(F)F)F)(F)F)(F)F,,,,,,
4610,94611,"2,2-Bis({[3-(2-methylaziridin-1-yl)propanoyl]oxy}methyl)butyl 3-(2-methylaziridin-1-yl)propanoate",CCC(COC(=O)CCN1CC1C)(COC(=O)CCN2CC2C)COC(=O)CCN3CC3C,,,,,,
4611,94612,"1-Propanone, 1-(4-fluorophenyl)-2,2-dimethyl-",CC(C)(C)C(=O)C1=CC=C(C=C1)F,,,,,,
4612,94613,"3H-Indolium, 2-[3-(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)-1-propenyl]-1,3,3-trimethyl-, acetate",CC(=O)[O-].CC1(C2=CC=CC=C2[N+](=C1C=CC=C3C(C4=CC=CC=C4N3C)(C)C)C)C,,,,,,
4613,94614,"1,1,3,3-Tetramethyl-2-nitrosobutyl nitrate",CC(C)(C)C(C(C)(C)O[N+](=O)[O-])N=O,,,,,,
4614,94615,Arachidyl propionate,CCCCCCCCCCCCCCCCCCCCOC(=O)CC,,,,,,
4615,94616,"ethyl (7S)-3,7,11-trimethyldodeca-2,4-dienoate",CCOC(=O)C=C(C)C=CC[C@@H](C)CCCC(C)C,,,,,,
4616,94617,"1-(4-Chlorophenyl)-4,4-dimethyl-3-pentanone",CC(C)(C)C(=O)CCC1=CC=C(C=C1)Cl,,,,,,
4617,94618,"Cuprate(3-), [mu-[4-[[4'-[[6-amino-1-(hydroxy-kappaO)-3-sulfo-2-naphthalenyl]azo-kappaN1]-3,3'-di(hydroxy-kappaO)[1,1'-biphenyl]-4-yl]azo-kappaN1]-3-(hydroxy-kappaO)-2,7-naphthalenedisulfonato(7-)]]di-, trisodium",C1=CC(=C(C=C1C2=CC(=C(C=C2)N=NC3=C(C=C4C=C(C=CC4=C3[O-])N)S(=O)(=O)[O-])[O-])[O-])N=NC5=C6C=CC(=CC6=CC(=C5[O-])S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Cu+2].[Cu+2],,,,,,
4618,94619,"4-({4'-[(6-Amino-1-hydroxy-3-sulfonaphthalen-2-yl)diazenyl]-3,3'-dihydroxy[1,1'-biphenyl]-4-yl}diazenyl)-3-hydroxynaphthalene-2,7-disulfonic acid",C1=CC(=C(C=C1C2=CC(=C(C=C2)N=NC3=C(C=C4C=C(C=CC4=C3O)N)S(=O)(=O)O)O)O)N=NC5=C6C=CC(=CC6=CC(=C5O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
4619,94620,"Urea, (4-(3,3-dimethyl-1-triazenyl)phenyl)-",CN(C)N=NC1=CC=C(C=C1)NC(=O)N,,,,,,
4620,94621,"Butanoic acid, (5-fluoro-3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)methyl ester",CCCC(=O)OCN1C=C(C(=O)NC1=O)F,,,,,,
4621,94622,2-(2-Bromoethenyl)-5-nitrofuran,C1=C(OC(=C1)[N+](=O)[O-])C=CBr,,,,,,
4622,94623,"Hexadecyl 3,5-di-tert-butyl-4-hydroxybenzoate",CCCCCCCCCCCCCCCCOC(=O)C1=CC(=C(C(=C1)C(C)(C)C)O)C(C)(C)C,,,,,,
4623,94624,"1,2,4-Triazolo[4,3-a]pyridin-3(2H)-one, 2-(2,4-dichloro-5-methoxyphenyl)-5,6,7,8-tetrahydro-",COC1=C(C=C(C(=C1)N2C(=O)N3CCCCC3=N2)Cl)Cl,,,,,,
4624,94625,Isopropyl isostearate,CC(C)CCCCCCCCCCCCCCC(=O)OC(C)C,,,,,,
4625,94626,"Ethanol, 2-(ethyl(3-methyl-4-(phenylazo)phenyl)amino)-",CCN(CCO)C1=CC(=C(C=C1)N=NC2=CC=CC=C2)C,,,,,,
4626,94627,"2-Propanamine, 2-methyl-N-[(4-morpholinylthioxomethyl)thio]-",CC(C)(C)NSC(=S)N1CCOCC1,,,,,,
4627,94628,CID 94628,CC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=C(C=C(C=C3)O)O)C)NN=C4C(=CC5=C(C4=N)C(=O)C(=NNC6=CC=C(C=C6)S(=O)(=O)[O-])C(=C5)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
4628,94629,CID 94629,CC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=C(C=C(C=C3)O)O)C)NN=C4C(=CC5=C(C4=N)C(=O)C(=NNC6=CC=C(C=C6)S(=O)(=O)O)C(=C5)S(=O)(=O)O)S(=O)(=O)O,,,,,,
4629,94630,Alkanes,C.CCCC,,,,,,
4630,94631,Basic yellow 57,CC1=NN(C(=O)C1N=NC2=CC(=CC=C2)[N+](C)(C)C)C3=CC=CC=C3.[Cl-],,,,,,
4631,94632,Basic Yellow 57 Base,CC1=NN(C(=O)C1N=NC2=CC(=CC=C2)[N+](C)(C)C)C3=CC=CC=C3,,,,,,
4632,94633,"1,3,5-Tribromo-2-(2-bromoethoxy)benzene",C1=C(C=C(C(=C1Br)OCCBr)Br)Br,,,,,,
4633,94634,"Hydrocarbons, C2-6, chloro",C.C.CCCl,,,,,,
4634,94635,"2-Hydroxyethyl 2,3-dibromopropionate",C(COC(=O)C(CBr)Br)O,,,,,,
4635,94636,1-(2-Hydroxy-5-tert-nonylphenyl)ethan-1-one oxime,CC(=NO)C1=C(C=CC(=C1)CCCCCC(C)(C)C)O,,,,,,
4636,94637,"Hydrocarbons, C8-11",C.CCCCCCCC,,,,,,
4637,94638,CID 94638,C.CCCCCCCCCCCCCOS(=O)(=O)[O-].[Na+],,,,,,
4638,94639,Einecs 272-029-9,CC(C)CCCCCOP(=S)(OCCCC(C)C(C)C)S,,,,,,
4639,94640,"2,3,5,6-Tetrachlorothioanisole",CSC1=C(C(=CC(=C1Cl)Cl)Cl)Cl,,,,,,
4640,94641,"3H-Indolium, 1,3,3-trimethyl-2-[2-(2-methyl-3H-indol-3-yl)ethenyl]-, sulfate (1:1)",CC1=NC2=CC=CC=C2C1C=CC3=[N+](C4=CC=CC=C4C3(C)C)C.OS(=O)(=O)[O-],,,,,,
4641,94642,"1,3,3-trimethyl-2-[2-(2-methyl-3H-indol-3-yl)ethenyl]indol-1-ium",CC1=NC2=CC=CC=C2C1C=CC3=[N+](C4=CC=CC=C4C3(C)C)C,,,,,,
4642,94643,"7,7-Dimethyloctanoic acid;dimethyltin",CC(C)(C)CCCCCC(=O)O.CC(C)(C)CCCCCC(=O)O.C[Sn]C,,,,,,
4643,94644,"9,9-Dimethyldecan-1-amine;methane",C.CC(C)(C)CCCCCCCCN,,,,,,
4644,94645,tert-Dodecanamine,CC(C)(C)CCCCCCCCN,,,,,,
4645,94646,Pentaerythritol tetraisopalmitate,CC(C)CCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC(C)C)(COC(=O)CCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCC(C)C,,,,,,
4646,94647,"2,3-Dichloro-5-(trichloromethyl)pyridine",C1=C(C=NC(=C1Cl)Cl)C(Cl)(Cl)Cl,,,,,,
4647,94648,"2,2-Dimethyl-3-(3-methylpenta-2,4-dienyl)oxirane",CC(=CCC1C(O1)(C)C)C=C,,,,,,
4648,94649,"Propanoic acid, 2,2,3,3-tetrafluoro-3-[1,2,2,2-tetrafluoro-1-(fluorocarbonyl)ethoxy]-, methyl ester",COC(=O)C(C(OC(C(=O)F)(C(F)(F)F)F)(F)F)(F)F,,,,,,
4649,94650,"Methyl perfluoro(8-(fluoroformyl)-5-methyl-4,7-dioxanonanoate)",COC(=O)C(C(OC(C(OC(C(=O)F)(C(F)(F)F)F)(F)F)(C(F)(F)F)F)(F)F)(F)F,,,,,,
4650,94651,"2-Propen-1-ol, 2,3-dibromo-, (2Z)-",C(C(=CBr)Br)O,,,,,,
4651,94652,"2,2-Bis[4-(4-aminophenoxy)phenyl]hexafluoropropane",C1=CC(=CC=C1C(C2=CC=C(C=C2)OC3=CC=C(C=C3)N)(C(F)(F)F)C(F)(F)F)OC4=CC=C(C=C4)N,,,,,,
4652,94653,3-(4-tert-Butylphenoxy)benzaldehyde,CC(C)(C)C1=CC=C(C=C1)OC2=CC=CC(=C2)C=O,,,,,,
4653,94654,meta-Imazamethabenz methyl,CC1=CC(=C(C=C1)C2=NC(C(=O)N2)(C)C(C)C)C(=O)OC,,,,,,
4654,94655,"1,3,6-Naphthalenetrisulfonic acid, 7-[[2-[(aminocarbonyl)amino]-4-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]phenyl]azo]-, trisodium salt",C1=CC(=C(C=C1NC2=NC(=NC(=N2)N)Cl)NC(=O)N)N=NC3=CC4=C(C=C(C=C4C=C3S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
4655,94656,"7-((2-((Aminocarbonyl)amino)-4-((4-amino-6-chloro-1,3,5-triazin-2-yl)amino)phenyl)azo)naphthalene-1,3,6-trisulphonic acid",C1=CC(=C(C=C1NC2=NC(=NC(=N2)N)Cl)NC(=O)N)N=NC3=CC4=C(C=C(C=C4C=C3S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
4656,94657,CID 94657,CC1=CC(=C(C=C1N=NC2=C(C=C(C=C2)C3=CC(=C(C=C3)NN=C4C(=CC5=C(C4=O)C=CC(=N)C5=NNC6=CC7=NNN=C7C=C6)S(=O)(=O)[O-])OC)OC)C(=O)[O-])O.[Na+].[Na+],,,,,,
4657,94658,CID 94658,CC1=CC(=C(C=C1N=NC2=C(C=C(C=C2)C3=CC(=C(C=C3)NN=C4C(=CC5=C(C4=O)C=CC(=N)C5=NNC6=CC7=NNN=C7C=C6)S(=O)(=O)O)OC)OC)C(=O)O)O,,,,,,
4658,94659,"2,3,5,6-Tetrachloroanisidine",COC1=C(C(=C(C(=C1Cl)Cl)N)Cl)Cl,,,,,,
4659,94660,"Trisodium 2-[[6-[(4-amino-6-chloro-1,3,5-triazin-2-yl)methylamino]-1-hydroxy-3-sulphonato-2-naphthyl]azo]naphthalene-1,5-disulphonate",CN(C1=CC2=CC(=C(C(=C2C=C1)O)N=NC3=C(C4=C(C=C3)C(=CC=C4)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])C5=NC(=NC(=N5)N)Cl.[Na+].[Na+].[Na+],,,,,,
4660,94661,"2-[[6-[(4-Amino-6-chloro-1,3,5-triazin-2-yl)methylamino]-1-hydroxy-3-sulpho-2-naphthyl]azo]naphthalene-1,5-disulphonic acid",CN(C1=CC2=CC(=C(C(=C2C=C1)O)N=NC3=C(C4=C(C=C3)C(=CC=C4)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)C5=NC(=NC(=N5)N)Cl,,,,,,
4661,94662,"Benzaldehyde, 4-chloro-, O-((methylamino)carbonyl)oxime",CNC(=O)ON=CC1=CC=C(C=C1)Cl,,,,,,
4662,94663,"Alcohols, C8-10, ethoxylated",C.CCCCCCCCOCC,,,,,,
4663,94664,1-Ethoxyoctane,CCCCCCCCOCC,,,,,,
4664,94665,"Phenol, 2-[(ethylamino)methyl]-4-nitro-",CCNCC1=C(C=CC(=C1)[N+](=O)[O-])O,,,,,,
4665,94666,"11,13-Hexadecadienal, (11E,13Z)-",CCC=CC=CCCCCCCCCCC=O,,,,,,
4666,94667,CID 94667,COC1=CC(=C2C=CC(=NN=C3C(=CC4=C(C3=O)C=CC(=N)C4=NNC5=C(C=C(C=C5)N(O)O)C(=O)[O-])S(=O)(=O)[O-])C(=C2)OC)C=CC1=NN=C6C7=C(C=CC6=O)C=C(C=C7)S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
4667,94668,CID 94668,COC1=CC(=C2C=CC(=NN=C3C(=CC4=C(C3=O)C=CC(=N)C4=NNC5=C(C=C(C=C5)N(O)O)C(=O)O)S(=O)(=O)O)C(=C2)OC)C=CC1=NN=C6C7=C(C=CC6=O)C=C(C=C7)S(=O)(=O)O,,,,,,
4668,94669,CID 94669,C1=CC(=N)C(=N)C=C1N(O)O.[Cl-].[Cl-].[Pt+2],,,,,,
4669,94670,Ethyl 6-quinolinecarboxylate,CCOC(=O)C1=CC2=C(C=C1)N=CC=C2,,,,,,
4670,94671,Ethanesulfenothioic acid,CCSS,,,,,,
4671,94672,Sesaminol,C1[C@H]2[C@H](CO[C@@H]2C3=CC4=C(C=C3O)OCO4)[C@H](O1)C5=CC6=C(C=C5)OCO6,,,,,,
4672,94673,"3,5-Dinitrobenzyl chloride",C1=C(C=C(C=C1[N+](=O)[O-])[N+](=O)[O-])CCl,,,,,,
4673,94674,"2-(2-(1,3-Benzodioxol-5-yl)ethenyl)-5-nitro-1H-imidazole-1-ethanol",C1OC2=C(O1)C=C(C=C2)C=CC3=NC=C(N3CCO)[N+](=O)[O-],,,,,,
4674,94675,2-Methyl-5-nitro-N-2-pyrimidinyl-1H-imidazole-1-acetamide,CC1=CN=C(N1CC(=O)NC2=NC=CC=N2)[N+](=O)[O-],,,,,,
4675,94676,alpha-((Diethylamino)methyl)-2-methyl-5-nitro-1H-imidazole-1-ethanol,CCN(CC)CC(CN1C(=NC=C1[N+](=O)[O-])C)O,,,,,,
4676,94677,"Piperazine, 1-methyl-4-(2-(5-nitro-1H-imidazol-1-yl)ethyl)-",CN1CCN(CC1)CCN2C=NC=C2[N+](=O)[O-],,,,,,
4677,94678,"Benzoic acid, 2-(acetyloxy)-, (methylsulfonyl)methyl ester",CC(=O)OC1=CC=CC=C1C(=O)OCS(=O)(=O)C,,,,,,
4678,94679,"3,6-Dichloro-2-methoxyphenol",COC1=C(C=CC(=C1O)Cl)Cl,,,,,,
4679,94680,"2-Cyclohexen-1-one, 5-(2-(ethylthio)propyl)-3-hydroxy-2-(1-oxobutyl)-",CCCC(=C1C(=O)CC(CC1=O)CC(C)SCC)O,,,,,,
4680,94681,"Cyclopropanecarboxylic acid, 3-(((2,2-dimethylpropoxy)imino)methyl)-2,2-dimethyl-, cyano(3-phenoxyphenyl)methyl ester",CC1(C(C1C(=O)OC(C#N)C2=CC(=CC=C2)OC3=CC=CC=C3)C=NOCC(C)(C)C)C,,,,,,
4681,94682,"7,8,9,10-Tetrahydro-6,8,11-trihydroxy-8-(1-hydroxyethyl)-1-methoxy-10-((2,3,6-trideoxy-3-(4-morpholinyl)-alpha-L-lyxo-hexopyranosyl)oxy)-5,12-naphthacenedione hydrochloride",C[C@H]1[C@H]([C@H](C[C@@H](O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(C)O)O)N6CCOCC6)O.Cl,,,,,,
4682,94683,"7,8,9,10-Tetrahydro-6,8,11-trihydroxy-8-(1-hydroxyethyl)-1-methoxy-10-[[3-(4-morpholinyl)-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl]oxy]-5,12-naphthacenedione",C[C@H]1[C@H]([C@H](C[C@@H](O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(C)O)O)N6CCOCC6)O,,,,,,
4683,94684,"2-(2-(4-Chlorophenyl)ethyl)-2-(1,1-dimethylethyl)oxirane",CC(C)(C)C1(CO1)CCC2=CC=C(C=C2)Cl,,,,,,
4684,94685,"(3S)-heptadeca-1,9-dien-4,6-diyn-3-ol",CCCCCCCC=CCC#CC#C[C@H](C=C)O,,,,,,
4685,94686,Benzofenap,CC1=CC=C(C=C1)C(=O)COC2=C(C(=NN2C)C)C(=O)C3=C(C(=C(C=C3)Cl)C)Cl,,,,,,
4686,94687,2-Dodecyl-9H-thioxanthen-9-one,CCCCCCCCCCCCC1=CC2=C(C=C1)SC3=CC=CC=C3C2=O,,,,,,
4687,94688,3-Bromo-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-hydroxy-6-methoxybenzamide,CCN1CCC[C@H]1CNC(=O)C2=C(C=CC(=C2O)Br)OC,,,,,,
4688,94689,"Benzene, 1,1'-(2-nitrobutylidene)bis(4-methoxy-",CCC(C(C1=CC=C(C=C1)OC)C2=CC=C(C=C2)OC)[N+](=O)[O-],,,,,,
4689,94690,"Benzene, 1,1'-(2-nitroethylidene)bis(4-methoxy-",COC1=CC=C(C=C1)C(C[N+](=O)[O-])C2=CC=C(C=C2)OC,,,,,,
4690,94691,5-Fluoro-1-(butoxycarbonyl)uracil,CCCCOC(=O)N1C=C(C(=O)NC1=O)F,,,,,,
4691,94692,"5,5-Diethyl-2-isopropoxy-4,6(1H,5H)-pyrimidinedione",CCC1(C(=O)NC(=NC1=O)OC(C)C)CC,,,,,,
4692,94693,"Potassium;sodium;6-[[3-hydroxy-5-methyl-2-[4-(2-sulfonatooxyethylsulfonyl)phenyl]-3,4-dihydropyrazol-4-yl]diazenyl]-5-sulfonaphthalene-1-sulfonate",CC1=NN(C(C1N=NC2=C(C3=C(C=C2)C(=CC=C3)S(=O)(=O)[O-])S(=O)(=O)O)O)C4=CC=C(C=C4)S(=O)(=O)CCOS(=O)(=O)[O-].[Na+].[K+],,,,,,
4693,94694,"2-[(5-Hydroxy-3-methyl-1-{4-[2-(sulfooxy)ethanesulfonyl]phenyl}-4,5-dihydro-1H-pyrazol-4-yl)diazenyl]naphthalene-1,5-disulfonic acid",CC1=NN(C(C1N=NC2=C(C3=C(C=C2)C(=CC=C3)S(=O)(=O)O)S(=O)(=O)O)O)C4=CC=C(C=C4)S(=O)(=O)CCOS(=O)(=O)O,,,,,,
4694,94695,"[2-(9-Chloro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl)-2-oxoethyl] 4-(acetamidomethyl)cyclohexane-1-carboxylate",CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)COC(=O)C5CCC(CC5)CNC(=O)C)O)C)O)Cl)C,,,,,,
4695,94696,"2,2'-(3,7,7,11-Tetramethyl-2,5,9,12-tetraoxatridecane-1,13-diyl)bis(oxirane)",CC(COCC(C)(C)COCC(C)OCC1CO1)OCC2CO2,,,,,,
4696,94697,"Urea, (3-(methylsulfonyl)phenyl)-",CS(=O)(=O)C1=CC=CC(=C1)NC(=O)N,,,,,,
4697,94698,"4-[6-[(3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-2,4-dihydro-1H-tetracen-1-yl)oxy]-3-hydroxy-2-methyloxan-4-yl]morpholine-3-carbonitrile",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N6CCOCC6C#N)O,,,,,,
4698,94699,CID 94699,CCCCCCCC(=O)OC1=CC=C(C=C1)S(=O)(=O)[O-].[Na+],,,,,,
4699,94700,"Octanoic acid, 4-sulfophenyl ester",CCCCCCCC(=O)OC1=CC=C(C=C1)S(=O)(=O)O,,,,,,
4700,94701,diprotin A,CC[C@H](C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)N,,,['Compounds that suppress the degradation of INCRETINS by blocking the action of DIPEPTIDYL-PEPTIDASE IV. This helps to correct the defective INSULIN and GLUCAGON secretion characteristic of TYPE 2 DIABETES MELLITUS by stimulating insulin secretion and suppressing glucagon release. (See all compounds classified as Dipeptidyl-Peptidase IV Inhibitors.)'],,,
4701,94702,"1,2,3,5-Tetrachloro-4-(3,5-dichloro-4-methoxyphenoxy)benzene",COC1=C(C=C(C=C1Cl)OC2=C(C(=C(C=C2Cl)Cl)Cl)Cl)Cl,,,,,,
4702,94703,3-(Dodecylsulfanyl)-2-methyl-N-(2-(2-(propan-2-yl)imidazolidin-1-yl)ethyl)propanamide,CCCCCCCCCCCCSCC(C)C(=O)NCCN1CCNC1C(C)C,,,,,,
4703,94704,"2-Butanone, O,O'-(diethoxysilylene)dioxime",CCC(=NO[Si](OCC)(OCC)ON=C(C)CC)C,,,,,,
4704,94705,Isopropyl N-(3-chloro-4-methoxyphenyl)carbamate,CC(C)OC(=O)NC1=CC(=C(C=C1)OC)Cl,,,,,,
4705,94706,6-Hydroxyethoxy-2-benzothiazolesulfonamide,C1=CC2=C(C=C1OCCO)SC(=N2)S(=O)(=O)N,,,,,,
4706,94707,2-Methylpropyl 2-ethyl-2-methylbutanoate,CCC(C)(CC)C(=O)OCC(C)C,,,,,,
4707,94708,"alpha-Methyl-5-nitro-2-furanacrylic acid, methyl ester",CC(=CC1=CC=C(O1)[N+](=O)[O-])C(=O)OC,,,,,,
4708,94709,"1,3,5-Trichloro-2-(3,5-dichloro-2-methoxyphenoxy)benzene",COC1=C(C=C(C=C1Cl)Cl)OC2=C(C=C(C=C2Cl)Cl)Cl,,,,,,
4709,94710,"1,3-Propanediamine, N-[3-(triethoxysilyl)propyl]-",CCO[Si](CCCNCCCN)(OCC)OCC,,,,,,
4710,94711,4-Amino-7-chloroquinoline,C1=CC2=C(C=CN=C2C=C1Cl)N,,,,,,
4711,94712,4-Methoxybenzaldoxime,COC1=CC=C(C=C1)C=NO,,,,,,
4712,94713,2-Methyl-2-phenylpropanamide,CC(C)(C1=CC=CC=C1)C(=O)N,,,,,,
4713,94714,beta-Benzoylacrylic acid,C1=CC=C(C=C1)C(=O)C=CC(=O)O,,,,,,
4714,94715,D-Glucuronic Acid,[C@@H]1([C@@H]([C@H](OC([C@@H]1O)O)C(=O)O)O)O,,,,,,
4715,94716,"Salicylic acid, butyrate",CCCC(=O)OC1=CC=CC=C1C(=O)O,,,,,,
4716,94717,2-Hexanoyloxybenzoic acid,CCCCCC(=O)OC1=CC=CC=C1C(=O)O,,,,,,
4717,94718,"Phosphoric triamide, N,N',N''-triphenyl-",C1=CC=C(C=C1)NP(=O)(NC2=CC=CC=C2)NC3=CC=CC=C3,,,,,,
4718,94719,9-Acridinecarbonitrile,C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)C#N,,,,,,
4719,94720,"4,4''-Azobiphenyl",C1=CC=C(C=C1)C2=CC=C(C=C2)N=NC3=CC=C(C=C3)C4=CC=CC=C4,,,,,,
4720,94721,9-Acridinecarboxylic acid,C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)C(=O)O,,,,,,
4721,94722,2-Bromo-N-(4-methylphenyl)acetamide,CC1=CC=C(C=C1)NC(=O)CBr,,,,,,
4722,94723,2-Furaldehyde phenylhydrazone,C1=CC=C(C=C1)NN=CC2=CC=CO2,,,,,,
4723,94724,"Acetic acid, (2-((phenylamino)carbonyl)phenoxy)-",C1=CC=C(C=C1)NC(=O)C2=CC=CC=C2OCC(=O)O,,,,,,
4724,94725,"Phosphorothioic triamide, N,N',N''-tricyclohexyl-",C1CCC(CC1)NP(=S)(NC2CCCCC2)NC3CCCCC3,,,,,,
4725,94726,1-(4-Nitrophenyl)propan-1-one,CCC(=O)C1=CC=C(C=C1)[N+](=O)[O-],,,,,,
4726,94727,"2,5-Cyclohexadiene-1,4-dione, 2,5-bis(4-methoxyphenyl)-",COC1=CC=C(C=C1)C2=CC(=O)C(=CC2=O)C3=CC=C(C=C3)OC,,,,,,
4727,94728,2-Aminobenzhydrazide,C1=CC=C(C(=C1)C(=O)NN)N,,,,,,
4728,94729,CID 94729,CCC1=CC=CC=C1NC(=NC2=CC=CC=C2CC)S,,,,,,
4729,94730,CID 94730,C1=CC=C(C=C1)C=NNC(=NN)S,,,,,,
4730,94731,CID 94731,C1=CC=C(C=C1)C=CC=NN=C(N)S,,,,,,
4731,94732,CID 94732,CC(=C(C)N=O)NN=C(N)S,,,,,,
4732,94733,CID 94733,CCCCCCC=NN=C(N)S,,,,,,
4733,94734,CID 94734,C1OC2=C(O1)C=C(C=C2)C=NN=C(N)S,,,,,,
4734,94735,CID 94735,C1=CSC(=C1)C=NN=C(N)S,,,,,,
4735,94736,CID 94736,COC1=C(C=CC(=C1)C=NN=C(N)S)O,,,,,,
4736,94737,Bis(1-aziridinyl)morpholinophosphine oxide,C1CN1P(=O)(N2CC2)N3CCOCC3,,,,,,
4737,94738,"Tri(2-methyl-2,4-pentanediol)biborate",B1(OC(CC(O1)(C)C)C)OC(C)CC(C)(C)OB2OC(CC(O2)(C)C)C,,,,,,
4738,94739,"Benzaldehyde, 2-hydroxy-, [(2-hydroxyphenyl)methylene]hydrazone",C1=CC=C(C(=C1)C=NN=CC2=CC=CC=C2O)O,,,,,,
4739,94740,"2,4,4-Trimethyl-2-pentanol",CC(C)(C)CC(C)(C)O,,,,,,
4740,94741,16-Hentriacontanone,CCCCCCCCCCCCCCCC(=O)CCCCCCCCCCCCCCC,,,,,,
4741,94742,"2,2'-Dithiobis(5-chloroaniline)",C1=CC(=C(C=C1Cl)N)SSC2=C(C=C(C=C2)Cl)N,,,,,,
4742,94743,Bis[p-[dimethylamino]phenyl]disulfide,CN(C)C1=CC=C(C=C1)SSC2=CC=C(C=C2)N(C)C,,,,,,
4743,94744,Isovaline,CCC(C)(C(=O)O)N,,,,,,
4744,94745,"1,3-Diazaspiro[4.4]nonane-2,4-dione",C1CCC2(C1)C(=O)NC(=O)N2,,,,,,
4745,94746,"alpha,alpha-Dimethyl-gamma-butyrolactone",CC1(CCOC1=O)C,,,,,,
4746,94747,"2-Heptanone, oxime",CCCCCC(=NO)C,,,,,,
4747,94748,1-Methyl-4-propoxybenzene,CCCOC1=CC=C(C=C1)C,,,,,,
4748,94749,5-(p-Methoxybenzylidene)-hydantoin,COC1=CC=C(C=C1)C=C2C(=O)NC(=O)N2,,,,,,
4749,94750,4-tert-Butylanisole,CC(C)(C)C1=CC=C(C=C1)OC,,,,,,
4750,94751,Diethyl benzylidenemalonate,CCOC(=O)C(=CC1=CC=CC=C1)C(=O)OCC,,,,,,
4751,94752,beta-D-Galactose pentaacetate,CC(=O)OC[C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)OC(=O)C)OC(=O)C)OC(=O)C)OC(=O)C,,,,,,
4752,94753,"1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine",CN1C2=NC=NC(=C2C=N1)N,,,,,,
4753,94754,CID 94754,C1=C2C(=NC(=O)N=C2S)NN1,,,,,,
4754,94755,2-(m-Nitrobenzylideneamino)phenol,C1=CC=C(C(=C1)N=CC2=CC(=CC=C2)[N+](=O)[O-])O,,,,,,
4755,94756,"Phenol, p-((m-nitrobenzylidene)amino)-",C1=CC(=CC(=C1)[N+](=O)[O-])C=NC2=CC=C(C=C2)O,,,,,,
4756,94757,CID 94757,CCOC(=O)C1=CN=C(NC1=O)S,,,,,,
4757,94758,"Hydrazinecarboxamide,2-[(2-hydroxyphenyl)methylene]-",C1=CC=C(C(=C1)C=NNC(=O)N)O,,,,,,
4758,94759,2-Bromo-N-decylacetamide,CCCCCCCCCCNC(=O)CBr,,,,,,
4759,94760,"((2,4,6-Tribromophenoxy)methyl)oxirane",C1C(O1)COC2=C(C=C(C=C2Br)Br)Br,,,,,,
4760,94761,Dinonylamine,CCCCCCCCCNCCCCCCCCC,,,,,,
4761,94762,"2,4-Pentanedione dioxime",CC(=NO)CC(=NO)C,,,,,,
4762,94763,4-(1-Phenylethyl)phenol,CC(C1=CC=CC=C1)C2=CC=C(C=C2)O,,,,,,
4763,94764,"Quinoline, 2-(2-phenylhydrazino)-",C1=CC=C(C=C1)NNC2=NC3=CC=CC=C3C=C2,,,,,,
4764,94765,9-Phenanthrenecarboxylic acid,C1=CC=C2C(=C1)C=C(C3=CC=CC=C23)C(=O)O,,,,,,
4765,94766,Benzopinacol,C1=CC=C(C=C1)C(C2=CC=CC=C2)(C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O,,,,,,
4766,94767,"(2S,3S,5R)-2-methoxyoxane-3,4,5-triol",CO[C@@H]1[C@H](C([C@@H](CO1)O)O)O,,,,,,
4767,94768,"1,2-Bis(4-methoxybenzylidene)hydrazine",COC1=CC=C(C=C1)C=NN=CC2=CC=C(C=C2)OC,,,,,,
4768,94769,Cyclohexanepentanoic acid,C1CCC(CC1)CCCCC(=O)O,,,,,,
4769,94770,12-Oxooctadecanoic acid,CCCCCCC(=O)CCCCCCCCCCC(=O)O,,,,,,
4770,94771,"3,4-Bis(4-methoxyphenyl)hexan-3-ol",CCC(C1=CC=C(C=C1)OC)C(CC)(C2=CC=C(C=C2)OC)O,,,,,,
4771,94772,Methyl 3-(phenylthio)isobutyrate,CC(CSC1=CC=CC=C1)C(=O)OC,,,,,,
4772,94773,"13-Docosen-1-ol, (13Z)-",CCCCCCCCC=CCCCCCCCCCCCCO,,,,,,
4773,94774,"Trihexyl prop-1-ene-1,2,3-tricarboxylate",CCCCCCOC(=O)CC(=CC(=O)OCCCCCC)C(=O)OCCCCCC,,,,,,
4774,94775,"1,1-Bis(4-chlorophenyl)ethylene",C=C(C1=CC=C(C=C1)Cl)C2=CC=C(C=C2)Cl,,,,,,
4775,94776,N-(2-Methylphenyl)phthalimide,CC1=CC=CC=C1N2C(=O)C3=CC=CC=C3C2=O,,,,,,
4776,94777,Etofesalamide,CCOC1=CC=C(C=C1)NC(=O)C2=CC=CC=C2O,,,,,,
4777,94778,Pyruvic acid phenylhydrazone,CC(=NNC1=CC=CC=C1)C(=O)O,,,,,,
4778,94779,"2-Chlorocyclohexyl 2,4-dinitrophenyl sulfide",C1CCC(C(C1)SC2=C(C=C(C=C2)[N+](=O)[O-])[N+](=O)[O-])Cl,,,,,,
4779,94780,"(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexanal",C([C@H]([C@H]([C@H]([C@@H](C=O)O)O)O)O)O,,,,,,
4780,94781,3-Propoxypropiononitrile,CCCOCCC#N,,,,,,
4781,94782,CID 94782,CC(=C(C1=CC=CC=C1)N=O)NO,,,,,,
4782,94783,"Oxonane, hexadecafluoro-",C1(C(C(C(C(OC(C(C1(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
4783,94784,"Phosphorochloridic acid, dibutyl ester",CCCCOP(=O)(OCCCC)Cl,,,,,,
4784,94785,Bis(2-hydroxyethylthio)methane,C(CSCSCCO)O,,,,,,
4785,94786,2-Bromobenzo[B]thiophene,C1=CC=C2C(=C1)C=C(S2)Br,,,,,,
4786,94787,3-Nitro-9H-fluorene,C1C2=C(C=C(C=C2)[N+](=O)[O-])C3=CC=CC=C31,,,,,,
4787,94788,"2-(2,5-Dichlorophenyl)acetic acid",C1=CC(=C(C=C1Cl)CC(=O)O)Cl,,,,,,
4788,94789,Ethanol lumiflavine,CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)CCO,,,,,,
4789,94790,"1,5-Diaminobiuret",C(=O)(NC(=O)NN)NN,,,,,,
4790,94791,"N1,N1,N6,N6-Tetramethyladipamide",CN(C)C(=O)CCCCC(=O)N(C)C,,,,,,
4791,94792,4-Myristoylmorpholine,CCCCCCCCCCCCCC(=O)N1CCOCC1,,,,,,
4792,94793,4-Lauroylmorpholine,CCCCCCCCCCCC(=O)N1CCOCC1,,,,,,
4793,94794,"Dodecanamide, N-phenyl-",CCCCCCCCCCCC(=O)NC1=CC=CC=C1,,,,,,
4794,94795,"Morpholine, 4-octanoyl-",CCCCCCCC(=O)N1CCOCC1,,,,,,
4795,94796,2-(Carbamoylhydrazinylidene)propanoic acid,CC(=NNC(=O)N)C(=O)O,,,,,,
4796,94797,"2,5-Bis(1-aziridinyl)hydroquinone",C1CN1C2=CC(=C(C=C2O)N3CC3)O,,,,,,
4797,94798,CID 94798,CN(C)C1=CC=C(C=C1)C=NN=C(N)S,,,,,,
4798,94799,4-((p-Hydroxyphenyl)azo)anisole,COC1=CC=C(C=C1)N=NC2=CC=C(C=C2)O,,,,,,
4799,94800,4-(3-Pentyloxyallyl)morpholine,CCCCCOC=CCN1CCOCC1,,,,,,
4800,94801,N-Decanoylmorpholine,CCCCCCCCCC(=O)N1CCOCC1,,,,,,
4801,94802,"Carbamic acid, (4-hydroxyphenyl)-, 1-methylethyl ester",CC(C)OC(=O)NC1=CC=C(C=C1)O,,,,,,
4802,94803,"1-(2,4-Dinitrophenyl)aziridine",C1CN1C2=C(C=C(C=C2)[N+](=O)[O-])[N+](=O)[O-],,,,,,
4803,94804,CID 94804,C1=CC(=CC=C1C=NN=C(N)S)O,,,,,,
4804,94805,4-Benzoyl-4-(2-cyanoethyl)heptanedinitrile,C1=CC=C(C=C1)C(=O)C(CCC#N)(CCC#N)CCC#N,,,,,,
4805,94806,2-Iodo-4-nitroanisole,COC1=C(C=C(C=C1)[N+](=O)[O-])I,,,,,,
4806,94807,"4,4'-Diaminobiphenyl-3,3'-disulfonic acid",C1=CC(=C(C=C1C2=CC(=C(C=C2)N)S(=O)(=O)O)S(=O)(=O)O)N,,,,,,
4807,94808,Diethyl ((m-chloroanilino)methylene)malonate,CCOC(=O)C(=CNC1=CC(=CC=C1)Cl)C(=O)OCC,,,,,,
4808,94809,5-Bromo-6-methoxy-8-nitroquinoline,COC1=C(C2=C(C(=C1)[N+](=O)[O-])N=CC=C2)Br,,,,,,
4809,94810,"Diazene, bis(4-nitrophenyl)-, 1-oxide",C1=CC(=CC=C1N=[N+](C2=CC=C(C=C2)[N+](=O)[O-])[O-])[N+](=O)[O-],,,,,,
4810,94811,"Acetamide, 2-amino-N-hydroxy-",C(C(=O)NO)N,,,,,,
4811,94812,Pentyl octadec-9-enoate,CCCCCCCCC=CCCCCCCCC(=O)OCCCCC,,,,,,
4812,94813,CID 94813,CCCCOC(=O)CC(=CC(=O)OCCCC)C(=O)OCCCC,,,,,,
4813,94814,5-Chloro-2-[(4-chloro-2-hydroxyphenyl)methyl]phenol,C1=CC(=C(C=C1Cl)O)CC2=C(C=C(C=C2)Cl)O,,,,,,
4814,94815,10-Undecenamide,C=CCCCCCCCCC(=O)N,,,,,,
4815,94816,3-Bromoacenaphthene,C1CC2=C(C=CC3=C2C1=CC=C3)Br,,,,,,
4816,94817,5-Methyl-L-norleucine,CC(C)CC[C@@H](C(=O)O)N,,,,,,
4817,94818,2-Bromo-N-phenylacetamide,C1=CC=C(C=C1)NC(=O)CBr,,,,,,
4818,94819,"Acetamide, 2,2-dichloro-N-octyl-",CCCCCCCCNC(=O)C(Cl)Cl,,,,,,
4819,94820,"Acetamide, N,N-dibutyl-2,2-dichloro-",CCCCN(CCCC)C(=O)C(Cl)Cl,,,,,,
4820,94821,CID 94821,C1=CC(=CN=C1)C2=CC(=NN2)[N+](=O)[O-],,,,,,
4821,94822,p-Dimethylaminophenylazophenylarsonic acid,CN(C)C1=CC=C(C=C1)N=NC2=CC=C(C=C2)[As](=O)(O)O,,,,,,
4822,94823,"Ethyl 2,6-dichloroisonicotinate",CCOC(=O)C1=CC(=NC(=C1)Cl)Cl,,,,,,
4823,94824,"N,N'-Diacetyl-4,4'-hydroxymethylenedianiline",CC(=O)NC1=CC=C(C=C1)C(C2=CC=C(C=C2)NC(=O)C)O,,,,,,
4824,94825,"1,1'-Ethynylenedicyclohexanol",C1CCC(CC1)(C#CC2(CCCCC2)O)O,,,,,,
4825,94826,"(2,3-Epoxypropyl)benzene",C1C(O1)CC2=CC=CC=C2,,,,,,
4826,94827,Ethyl-m-nitrocinnamate,CCOC(=O)C=CC1=CC(=CC=C1)[N+](=O)[O-],,,,,,
4827,94828,2-sec-Butylcyclohexanol,CCC(C)C1CCCCC1O,,,,,,
4828,94829,"1H-Tetrazole, 5-guanidino-",C1(=NNN=N1)N=C(N)N,,,,,,
4829,94830,"2,6-Dichloroisonicotinic acid",C1=C(C=C(N=C1Cl)Cl)C(=O)O,,,,,,
4830,94831,CID 94831,C1=CC=C(C(=C1)N=C(N)S)O,,,,,,
4831,94832,Wln: T56 BN doj cmnu1R dsw2,CCS(=O)(=O)C1=CC=C(C=C1)C=NNC2=NC3=CC=CC=C3O2,,,,,,
4832,94833,Benzoylnitromethane,C1=CC=C(C=C1)C(=O)C[N+](=O)[O-],,,,,,
4833,94834,Camphoric anhydride,CC1(C2CCC1(C(=O)OC2=O)C)C,,,,,,
4834,94835,2-Bromo-2-methyl-N-phenylpropanamide,CC(C)(C(=O)NC1=CC=CC=C1)Br,,,,,,
4835,94836,"3,4-Dihydroxyphenyl thiocyanate",C1=CC(=C(C=C1SC#N)O)O,,,,,,
4836,94837,"Thiocyanic acid, 5-hydroxycarvacryl ester",CC1=CC(=C(C=C1SC#N)C(C)C)O,,,,,,
4837,94838,"9,10-Anthracenediol, diacetate",CC(=O)OC1=C2C=CC=CC2=C(C3=CC=CC=C31)OC(=O)C,,,,,,
4838,94839,"n-(1,3,4-Thiadiazol-2-yl)acetamide",CC(=O)NC1=NN=CS1,,,,,,
4839,94840,N-Butylidenebutylamine,CCCCN=CCCC,,,,,,
4840,94841,4-tert-Butyl-1-ethynylcyclohexanol,CC(C)(C)C1CCC(CC1)(C#C)O,,,,,,
4841,94842,"4-((Hydroxyimino)methyl)benzene-1,3-diol",C1=CC(=C(C=C1O)O)C=NO,,,,,,
4842,94843,CID 94843,C1=CC=C(C=C1)NC(=NCC(=O)O)S,,,,,,
4843,94844,6-Chloro-9-methylpurine,CN1C=NC2=C1N=CN=C2Cl,,,,,,
4844,94845,"9H-Purin-6-amine, N,9-dimethyl-",CNC1=C2C(=NC=N1)N(C=N2)C,,,,,,
4845,94846,"1,1'-(4,4'-Biphenylene)bis(3,3-dimethyl triazene)",CN(C)N=NC1=CC=C(C=C1)C2=CC=C(C=C2)N=NN(C)C,,,,,,
4846,94847,"Triazene, 1-(4-biphenylyl)-3,3-dimethyl-",CN(C)N=NC1=CC=C(C=C1)C2=CC=CC=C2,,,,,,
4847,94848,"4,4'-Bis((4-amino-1-naphthyl)azo)stilbene-2,2'-disulphonic acid",C1=CC=C2C(=C1)C(=CC=C2N=NC3=CC(=C(C=C3)C=CC4=C(C=C(C=C4)N=NC5=CC=C(C6=CC=CC=C65)N)S(=O)(=O)O)S(=O)(=O)O)N,,,,,,
4848,94849,2-Pyridinesulfonic acid,C1=CC=NC(=C1)S(=O)(=O)O,,,,,,
4849,94850,CID 94850,C1=CC(=CC=C1C2=COC3=CC(=CC(=O)C3=C2O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O,,,,,,
4850,94851,N-Butylideneaniline,CCCC=NC1=CC=CC=C1,,,,,,
4851,94852,9-Fluoreneacetic acid,C1=CC=C2C(=C1)C(C3=CC=CC=C32)CC(=O)O,,,,,,
4852,94853,"Phosphorous acid, dimethyl ester",COP(O)OC,,,,,,
4853,94854,4-Pyrenol,C1=CC2=C3C(=C1)C=C(C4=CC=CC(=C43)C=C2)O,,,,,,
4854,94855,1-(1-Cyclohexen-1-yl)naphthalene,C1CCC(=CC1)C2=CC=CC3=CC=CC=C32,,,,,,
4855,94856,2-Cumyl-4-methylphenol,CC1=CC(=C(C=C1)O)C(C)(C)C2=CC=CC=C2,,,,,,
4856,94857,3-Hydroxy-4-methoxy-5-nitrobenzaldehyde,COC1=C(C=C(C=C1O)C=O)[N+](=O)[O-],,,,,,
4857,94858,"Glycine, N-(3-nitrobenzoyl)-",C1=CC(=CC(=C1)[N+](=O)[O-])C(=O)NCC(=O)O,,,,,,
4858,94859,4-Methyl-N-(4-nitrophenyl)benzenamine,CC1=CC=C(C=C1)NC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
4859,94860,"2-Nitrophenanthrene-9,10-dione",C1=CC=C2C(=C1)C3=C(C=C(C=C3)[N+](=O)[O-])C(=O)C2=O,,,,,,
4860,94861,"Phosphorotetrathioic acid, triethyl ester",CCSP(=S)(SCC)SCC,,,,,,
4861,94862,3-Nitrobenzalacetophenone,C1=CC=C(C=C1)C(=O)C=CC2=CC(=CC=C2)[N+](=O)[O-],,,,,,
4862,94863,"2,5-Diphenylhex-3-yne-2,5-diol",CC(C#CC(C)(C1=CC=CC=C1)O)(C2=CC=CC=C2)O,,,,,,
4863,94864,"Octadecanoic acid, 2-sulfo-",CCCCCCCCCCCCCCCCC(C(=O)O)S(=O)(=O)O,,,,,,
4864,94865,1-(Methylamino)cyclohexanecarbonitrile,CNC1(CCCCC1)C#N,,,,,,
4865,94866,"Dimethyl 2,5-dioxocyclohexane-1,4-dicarboxylate",COC(=O)C1CC(=O)C(CC1=O)C(=O)OC,,,,,,
4866,94867,"3-(Dibutylamino)propane-1,2-diol",CCCCN(CCCC)CC(CO)O,,,,,,
4867,94868,CID 94868,C1=CC=C(C=C1)C(=O)N=C(N)S,,,,,,
4868,94869,CID 94869,C1=CC=C(C=C1)C(=O)N=C(NC2=CC=C(C=C2)NC(=NC(=O)C3=CC=CC=C3)S)S,,,,,,
4869,94870,Diffractaic acid,CC1=CC(=C(C(=C1C(=O)O)O)C)OC(=O)C2=C(C(=C(C=C2C)OC)C)OC,,,,,,
4870,94871,"2,4-Diacetylaminotoluene",CC1=C(C=C(C=C1)NC(=O)C)NC(=O)C,,,,,,
4871,94872,"Cyclohexanecarboxamide, N,N-diethyl-",CCN(CC)C(=O)C1CCCCC1,,,,,,
4872,94873,Dibenzhydroxamic acid,C1=CC=C(C=C1)C(=O)NOC(=O)C2=CC=CC=C2,,,,,,
4873,94874,2-Phenylethyl trichloroacetate,C1=CC=C(C=C1)CCOC(=O)C(Cl)(Cl)Cl,,,,,,
4874,94875,Isopentyl 4-nitrobenzoate,CC(C)CCOC(=O)C1=CC=C(C=C1)[N+](=O)[O-],,,,,,
4875,94876,4-Chloro-2-nitro-m-cresol,CC1=C(C=CC(=C1[N+](=O)[O-])O)Cl,,,,,,
4876,94877,"5,5-Dibromobarbituric acid",C1(=O)C(C(=O)NC(=O)N1)(Br)Br,,,,,,
4877,94878,"2,4-Dibromo-1-naphthol",C1=CC=C2C(=C1)C(=CC(=C2O)Br)Br,,,,,,
4878,94879,2-Butoxy-N-cyclohexylacetamide,CCCCOCC(=O)NC1CCCCC1,,,,,,
4879,94880,"Naphtho[1,2-d]thiazol-2-amine",C1=CC=C2C(=C1)C=CC3=C2N=C(S3)N,,,,,,
4880,94881,5-Nitro-2-furonitrile,C1=C(OC(=C1)[N+](=O)[O-])C#N,,,,,,
4881,94882,Methyl 5-nitro-2-furoate,COC(=O)C1=CC=C(O1)[N+](=O)[O-],,,,,,
4882,94883,Tripropyl trithiophosphite,CCCSP(SCCC)SCCC,,,,,,
4883,94884,Tributylthiophosphate,CCCCOP(=S)(OCCCC)OCCCC,,,,,,
4884,94885,"Benzeneacetic acid, 2-propynyl ester",C#CCOC(=O)CC1=CC=CC=C1,,,,,,
4885,94886,"2-Hexyl-4,5-dimethyl-1,3-dioxolane",CCCCCCC1OC(C(O1)C)C,,,,,,
4886,94887,4-Ethylphenyl butyrate,CCCC(=O)OC1=CC=C(C=C1)CC,,,,,,
4887,94888,"N,N'-Diphenylformamidine",C1=CC=C(C=C1)NC=NC2=CC=CC=C2,,,,,,
4888,94889,"Propionic acid, 6-chloro-o-tolyl ester",CCC(=O)OC1=C(C=CC=C1Cl)C,,,,,,
4889,94890,3-Nitrophenyl 4-methylbenzenesulfonate,CC1=CC=C(C=C1)S(=O)(=O)OC2=CC=CC(=C2)[N+](=O)[O-],,,,,,
4890,94891,"p-Toluenesulfonic acid, o-nitrophenyl ester",CC1=CC=C(C=C1)S(=O)(=O)OC2=CC=CC=C2[N+](=O)[O-],,,,,,
4891,94892,"Propionanilide, N-butyl-",CCCCN(C1=CC=CC=C1)C(=O)CC,,,,,,
4892,94893,"Propionanilide, N-isopentyl-",CCC(=O)N(CCC(C)C)C1=CC=CC=C1,,,,,,
4893,94894,"Propionamide, N-phenethyl-",CCC(=O)NCCC1=CC=CC=C1,,,,,,
4894,94895,N-benzyl-2-methylpropanamide,CC(C)C(=O)NCC1=CC=CC=C1,,,,,,
4895,94896,"Dodecanamide, N-butyl-",CCCCCCCCCCCC(=O)NCCCC,,,,,,
4896,94897,"Propionamide, N,N-dibenzyl-2-methyl-",CC(C)C(=O)N(CC1=CC=CC=C1)CC2=CC=CC=C2,,,,,,
4897,94898,2-Methylthioadenine,CSC1=NC(=C2C(=N1)N=CN2)N,,,,,,
4898,94899,12-Oxooctadec-9-enoic acid,CCCCCCC(=O)CC=CCCCCCCCC(=O)O,,,,,,
4899,94900,Bis(2-methoxyethyl) carbonate,COCCOC(=O)OCCOC,,,,,,
4900,94901,Heptyl thiocyanate,CCCCCCCSC#N,,,,,,
4901,94902,6-Hydrazinopurine,C1=NC2=C(N1)C(=NC=N2)NN,,,,,,
4902,94903,CID 94903,C1=CN=C(N=C1NN)S,,,,,,
4903,94904,2-Chloroadenine,C1=NC2=NC(=NC(=C2N1)N)Cl,,,,,,
4904,94905,2-hydroxyethyl (12R)-12-hydroxyoctadec-9-enoate,CCCCCC[C@H](CC=CCCCCCCCC(=O)OCCO)O,,,,,,
4905,94906,8-Amino-1-naphthol,C1=CC2=C(C(=C1)N)C(=CC=C2)O,,,,,,
4906,94907,Dimethyl 2-cyanosuccinate,COC(=O)CC(C#N)C(=O)OC,,,,,,
4907,94908,"[1,1'-Binaphthalene]-8,8'-dicarboxylic acid",C1=CC2=C(C(=C1)C3=CC=CC4=C3C(=CC=C4)C(=O)O)C(=CC=C2)C(=O)O,,,,,,
4908,94909,CID 94909,CN1C=NC2=C1C(=O)N=C(N2)S,,,,,,
4909,94910,"Benzoyl chloride, 4-(pentyloxy)-",CCCCCOC1=CC=C(C=C1)C(=O)Cl,,,,,,
4910,94911,Benzylarsonic acid,C1=CC=C(C=C1)C[As](=O)(O)O,,,,,,
4911,94912,Tribromomethanol,C(O)(Br)(Br)Br,,,,,,
4912,94913,1-(3-Bromopropoxy)-3-methylbenzene,CC1=CC(=CC=C1)OCCCBr,,,,,,
4913,94914,"Benzene, 1,1'-(2-methylpropylidene)bis(4-methoxy-",CC(C)C(C1=CC=C(C=C1)OC)C2=CC=C(C=C2)OC,,,,,,
4914,94915,Trimethylallyl isocyanurate,CC(=C)CN1C(=O)N(C(=O)N(C1=O)CC(=C)C)CC(=C)C,,,,,,
4915,94916,o-Chlorophenol chloroacetate,C1=CC=C(C(=C1)OC(=O)CCl)Cl,,,,,,
4916,94917,4-Nitrophenyl chloroacetate,C1=CC(=CC=C1[N+](=O)[O-])OC(=O)CCl,,,,,,
4917,94918,2-chloro-N-ethyl-N-phenylacetamide,CCN(C1=CC=CC=C1)C(=O)CCl,,,,,,
4918,94919,3-Phenylpropyl cyclohexanepropionate,C1CCC(CC1)CCC(=O)OCCCC2=CC=CC=C2,,,,,,
4919,94920,2-chloro-N-(4-chlorophenyl)acetamide,C1=CC(=CC=C1NC(=O)CCl)Cl,,,,,,
4920,94921,2-Chloro-N-phenethylacetamide,C1=CC=C(C=C1)CCNC(=O)CCl,,,,,,
4921,94922,"2-Ethyl-1,4-naphthoquinone",CCC1=CC(=O)C2=CC=CC=C2C1=O,,,,,,
4922,94923,3-Hexylthiopropionic acid,CCCCCCSCCC(=O)O,,,,,,
4923,94924,Sulphamoprine,COC1=CC(=NC(=N1)NS(=O)(=O)C2=CC=C(C=C2)N)OC,,,,,,
4924,94925,"2,3-Bis-(p-methoxystyryl-)chinoxalin",COC1=CC=C(C=C1)C=CC2=NC3=CC=CC=C3N=C2C=CC4=CC=C(C=C4)OC,,,,,,
4925,94926,"Benzenesulfonic acid, 4-[[ethyl(3-methylphenyl)amino]methyl]-",CCN(CC1=CC=C(C=C1)S(=O)(=O)O)C2=CC=CC(=C2)C,,,,,,
4926,94927,"2,4-Dinitrobiphenyl",C1=CC=C(C=C1)C2=C(C=C(C=C2)[N+](=O)[O-])[N+](=O)[O-],,,,,,
4927,94928,Ethyl (2E)-3-anilino-2-butenoate,CCOC(=O)C=C(C)NC1=CC=CC=C1,,,,,,
4928,94929,8-Methylthiocaffeine,CN1C2=C(N=C1SC)N(C(=O)N(C2=O)C)C,,,,,,
4929,94930,"9-Ethyl-1,3,7-trimethyluric acid",CCN1C2=C(C(=O)N(C(=O)N2C)C)N(C1=O)C,,,,,,
4930,94931,"9-Allyl-1,3,7-trimethyluric acid",CN1C2=C(N(C(=O)N(C2=O)C)C)N(C1=O)CC=C,,,,,,
4931,94932,"4,4'-Isopropylidenedicyclohexanol",CC(C)(C1CCC(CC1)O)C2CCC(CC2)O,,,,,,
4932,94933,(2-Chlorophenyl)arsonic acid,C1=CC=C(C(=C1)Cl)[As](=O)(O)O,,,,,,
4933,94934,2-(2-Methoxyethoxy)ethyl chloride,COCCOCCCl,,,,,,
4934,94935,Furfuryl phenylacetate,C1=CC=C(C=C1)CC(=O)OCC2=CC=CO2,,,,,,
4935,94936,CID 94936,CCOC(=O)C1=CN=C(N=C1N)S,,,,,,
4936,94937,6-Fluoro-DL-tryptophan,C1=CC2=C(C=C1F)NC=C2CC(C(=O)O)N,,,,,,
4937,94938,"2-Benzothiazolamine, 5,6-dimethoxy-",COC1=C(C=C2C(=C1)N=C(S2)N)OC,,,,,,
4938,94939,"Naphthalene, 1,2,3,4-tetrachloro-1,2,3,4-tetrahydro-",C1=CC=C2C(C(C(C(C2=C1)Cl)Cl)Cl)Cl,,,,,,
4939,94940,N-2-Acetylamino-7-iodofluorene,CC(=O)NC1=CC2=C(C=C1)C3=C(C2)C=C(C=C3)I,,,,,,
4940,94941,CID 94941,C1=COC(=C1)C=NN=C(N)S,,,,,,
4941,94942,2-Thymoloxytriethylamine,CCN(CC)CCOC1=C(C=CC(=C1)C)C(C)C,,,,,,
4942,94943,"Phosphine oxide, tris(p-chlorophenyl)-",C1=CC(=CC=C1P(=O)(C2=CC=C(C=C2)Cl)C3=CC=C(C=C3)Cl)Cl,,,,,,
4943,94944,Diethyl 2-bromo-2-methylmalonate,CCOC(=O)C(C)(C(=O)OCC)Br,,,,,,
4944,94945,"1,3-Benzodioxole, 5-(2-nitroethenyl)-",C1OC2=C(O1)C=C(C=C2)C=C[N+](=O)[O-],,,,,,
4945,94946,4-Benzylidene-2-methyloxazol-5(4H)-one,CC1=NC(=CC2=CC=CC=C2)C(=O)O1,,,,,,
4946,94947,"9H-Carbazole, 2,4-dimethyl-",CC1=CC(=C2C3=CC=CC=C3NC2=C1)C,,,,,,
4947,94948,"9,10-Phenanthrenedione, 4-nitro-",C1=CC=C2C(=C1)C3=C(C=CC=C3[N+](=O)[O-])C(=O)C2=O,,,,,,
4948,94949,"1,2-Dibromo-4,5-difluorobenzene",C1=C(C(=CC(=C1Br)Br)F)F,,,,,,
4949,94950,"2,6-Dichloro-4-fluorophenol",C1=C(C=C(C(=C1Cl)O)Cl)F,,,,,,
4950,94951,"4-Fluoro-2,6-dinitrophenol",C1=C(C=C(C(=C1[N+](=O)[O-])O)[N+](=O)[O-])F,,,,,,
4951,94952,"2,5-Difluorophenol",C1=CC(=C(C=C1F)O)F,,,,,,
4952,94953,"2,4,5-Trifluoroaniline",C1=C(C(=CC(=C1F)F)F)N,,,,,,
4953,94954,2-Fluoro-5-nitrobenzotrifluoride,C1=CC(=C(C=C1[N+](=O)[O-])C(F)(F)F)F,,,,,,
4954,94955,4-Nitro-3-(trifluoromethyl)aniline,C1=CC(=C(C=C1N)C(F)(F)F)[N+](=O)[O-],,,,,['4-nitro-3-(trifluoromethyl)aniline has known human metabolites that include 2-amino-5-nitro-4-(trifluoromethyl)phenol and N-[4-nitro-3-(trifluoromethyl)phenyl]-acetamide.'],
4955,94956,5-Fluoro-2-nitrotoluene,CC1=C(C=CC(=C1)F)[N+](=O)[O-],,,,,,
4956,94957,4-Fluoroantipyrine,CC1=CC(=O)N(N1C)C2=CC=C(C=C2)F,,,,,,
4957,94958,"Benzenemethanesulfonamide, N-(4-phenylmethyl)-",CC1=CC=C(C=C1)NS(=O)(=O)CC2=CC=CC=C2,,,,,,
4958,94959,"2-Chloro-4H-pyrido[1,2-a]pyrimidin-4-one",C1=CC2=NC(=CC(=O)N2C=C1)Cl,,,,,,
4959,94960,2-Hydroxy-6-methylpyridine-3-carboxylic acid,CC1=CC=C(C(=O)N1)C(=O)O,,,,,,
4960,94961,CID 94961,CCOC(=C(C(=O)C)N=O)O,,,,,,
4961,94962,Ethyl N-formyl-N-benzylglycinate,CCOC(=O)CN(CC1=CC=CC=C1)C=O,,,,,,
4962,94963,"2,7-Dinitrodibenzofuran",C1=CC2=C(C=C1[N+](=O)[O-])OC3=C2C=C(C=C3)[N+](=O)[O-],,,,,,
4963,94964,"Disulfide, bis(2-chloroethyl)",C(CCl)SSCCCl,,,,,,
4964,94965,Bis(2-chloroethyl) phthalate,C1=CC=C(C(=C1)C(=O)OCCCl)C(=O)OCCCl,,,,,,
4965,94966,"1,2,2-Triphenylethanone",C1=CC=C(C=C1)C(C2=CC=CC=C2)C(=O)C3=CC=CC=C3,,,,,,
4966,94967,2-Hydroxy-N-(2-hydroxyethyl)acetamide,C(CO)NC(=O)CO,,,,,,
4967,94968,"1H-Tetrazol-5-amine, 1-octyl-",CCCCCCCCN1C(=NN=N1)N,,,,,,
4968,94969,2-(Pentyloxy)acetic acid,CCCCCOCC(=O)O,,,,,,
4969,94970,"p-Toluenesulfonic acid, p-nitrophenyl ester",CC1=CC=C(C=C1)S(=O)(=O)OC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
4970,94971,6-Ethylmercaptopurine,CCSC1=NC=NC2=C1NC=N2,,,,,,
4971,94972,6-(Propylthio)purine,CCCSC1=NC=NC2=C1NC=N2,,,,,,
4972,94973,"2,4-Hexadiyne-1,6-diol",C(C#CC#CCO)O,,,,,,
4973,94974,"1,3-Diallyl-1,3,5-triazinane-2,4,6-trione",C=CCN1C(=O)NC(=O)N(C1=O)CC=C,,,,,,
4974,94975,Benzoyl leuco methylene blue,CN(C)C1=CC2=C(C=C1)N(C3=C(S2)C=C(C=C3)N(C)C)C(=O)C4=CC=CC=C4,,,,,,
4975,94976,"9,10-Anthracenediol, 9,10-dihydro-9,10-diphenyl-",C1=CC=C(C=C1)C2(C3=CC=CC=C3C(C4=CC=CC=C42)(C5=CC=CC=C5)O)O,,,,,,
4976,94977,"2,3-Dibromobenzo[b]thiophene",C1=CC=C2C(=C1)C(=C(S2)Br)Br,,,,,,
4977,94978,1-Methyl-6-nitrobenzimidazole,CN1C=NC2=C1C=C(C=C2)[N+](=O)[O-],,,,,,
4978,94979,"2,2-Bis(4-methoxyphenyl)acetic acid",COC1=CC=C(C=C1)C(C2=CC=C(C=C2)OC)C(=O)O,,,,,,
4979,94980,Tetradecyl sulfide,CCCCCCCCCCCCCCSCCCCCCCCCCCCCC,,,,,,
4980,94981,"Stannane, iodotrimethyl-",C[Sn](C)(C)I,,,,,,
4981,94982,"Stannane, iodotriphenyl-",C1=CC=C(C=C1)[Sn](C2=CC=CC=C2)(C3=CC=CC=C3)I,,,,,,
4982,94983,CID 94983,C1=NC2=C(N1)C(=O)N=C(N2)Cl,,,,,,
4983,94984,"2H-Purin-2-one, 1,3-dihydro-, hydrazone",C1=C2C(=NC(=N1)NN)N=CN2,,,,,,
4984,94985,5-Butyluracil,CCCCC1=CNC(=O)NC1=O,,,,,,
4985,94986,"1,4-Benzenediol, 2,5-bis((diethylamino)methyl)-",CCN(CC)CC1=CC(=C(C=C1O)CN(CC)CC)O,,,,,,
4986,94987,"9H-Fluorene, 9-((4-methoxyphenyl)methylene)-",COC1=CC=C(C=C1)C=C2C3=CC=CC=C3C4=CC=CC=C42,,,,,,
4987,94988,"2,2'-Azoxyfluorene",C1C2=CC=CC=C2C3=C1C=C(C=C3)N=[N+](C4=CC5=C(C=C4)C6=CC=CC=C6C5)[O-],,,,,,
4988,94989,9-Hydroxy-2-nitrofluorene,C1=CC=C2C3=C(C=C(C=C3)[N+](=O)[O-])C(C2=C1)O,,,,,,
4989,94990,"4,4'-Diacetamidodiphenylmethane",CC(=O)NC1=CC=C(C=C1)CC2=CC=C(C=C2)NC(=O)C,,,,,,
4990,94991,CID 94991,C1CCN(CC1)CC2=CN=C(NC2=O)S,,,,,,
4991,94992,4-Chlorobenzenesulfonyl fluoride,C1=CC(=CC=C1S(=O)(=O)F)Cl,,,,,,
4992,94993,"Ethane, 2-chloro-1,1-bis(2-chloroethoxy)-",C(CCl)OC(CCl)OCCCl,,,,,,
4993,94994,"Arsine, 4-carbamidophenyloxo-",C1=CC(=CC=C1NC(=O)N)[As]=O,,,,,,
4994,94995,CID 94995,COC1=CC=C(C=C1)C=C2C(=O)N=C(S2)S,,,,,,
4995,94996,"1,3-Bis(4-chlorophenyl)urea",C1=CC(=CC=C1NC(=O)NC2=CC=C(C=C2)Cl)Cl,,,,,,
4996,94997,CID 94997,C1=CC(=CC=C1C=NN=C(N)S)[N+](=O)[O-],,,,,,
4997,94998,N-(Trichloromethylthio)succinimide,C1CC(=O)N(C1=O)SC(Cl)(Cl)Cl,,,,,,
4998,94999,"3-Pyridinecarbonitrile, 1,2-dihydro-4-(methoxymethyl)-6-methyl-2-oxo-",CC1=CC(=C(C(=O)N1)C#N)COC,,,,,,
4999,95000,"2,2-Diphenyl-4-(1-piperidinyl)pentanenitrile",CC(CC(C#N)(C1=CC=CC=C1)C2=CC=CC=C2)N3CCCCC3,,,,,,
5000,95001,"3-Amino-7-chloro-1,2,4-benzotriazine",C1=CC2=C(C=C1Cl)N=NC(=N2)N,,,,,,
5001,95002,4-(3-Pyridylthioacetyl)morpholine,C1COCCN1C(=S)CC2=CN=CC=C2,,,,,,
5002,95003,"1,3-Di(4-sulfamoylphenyl)triazene",C1=CC(=CC=C1NN=NC2=CC=C(C=C2)S(=O)(=O)N)S(=O)(=O)N,,,,,,
5003,95004,"Benzeneacetamide, N-(aminocarbonyl)-4-nitro-",C1=CC(=CC=C1CC(=O)NC(=O)N)[N+](=O)[O-],,,,,,
5004,95005,4-Amino-N-(aminocarbonyl)benzeneacetamide,C1=CC(=CC=C1CC(=O)NC(=O)N)N,,,,,,
5005,95006,"Phthalimide, N-((morpholinocarbonyl)methyl)-",C1COCCN1C(=O)CN2C(=O)C3=CC=CC=C3C2=O,,,,,,
5006,95007,2-Butoxy-2-oxoethyl butyrate,CCCCOC(=O)COC(=O)CCC,,,,,,
5007,95008,"1-Phenyl-1,2-ethanediol diacetate",CC(=O)OCC(C1=CC=CC=C1)OC(=O)C,,,,,,
5008,95009,"4,4'-(Propane-1,3-diyl)bismorpholine",C1COCCN1CCCN2CCOCC2,,,,,,
5009,95010,N-Propyldibutylamine,CCCCN(CCC)CCCC,,,,,,
5010,95011,(4-Bromophenyl)phosphonic acid,C1=CC(=CC=C1P(=O)(O)O)Br,,,,,,
5011,95012,(2-Chlorophenyl)phosphonic acid,C1=CC=C(C(=C1)P(=O)(O)O)Cl,,,,,,
5012,95013,p-Sulfamoylphenylphosphonic acid,C1=CC(=CC=C1P(=O)(O)O)S(=O)(=O)N,,,,,,
5013,95014,4-Aminophthalhydrazide,C1=CC2=C(C=C1N)C(=O)NNC2=O,,,['Compound such as LUMINESCENT PROTEINS that cause or emit light (PHYSICAL LUMINESCENCE). (See all compounds classified as Luminescent Agents.)'],,,
5014,95015,"2-Furancarboxamide, N-(aminocarbonyl)-5-bromo-",C1=C(OC(=C1)Br)C(=O)NC(=O)N,,,,,,
5015,95016,Propyl anthranilate,CCCOC(=O)C1=CC=CC=C1N,,,,,,
5016,95017,4-Arsono-2-nitrofluorobenzene,C1=CC(=C(C=C1[As](=O)(O)O)[N+](=O)[O-])F,,,,,,
5017,95018,(4-Fluorophenyl)arsonic acid,C1=CC(=CC=C1F)[As](=O)(O)O,,,,,,
5018,95019,Arsacetin,CC(=O)NC1=CC=C(C=C1)[As](=O)(O)O,,,,,,
5019,95020,"1,2-Diacetoxy-3-chloropropane",CC(=O)OCC(CCl)OC(=O)C,,,,,,
5020,95021,"2-Chloro-4,6-bis(diallylamino)-s-triazine",C=CCN(CC=C)C1=NC(=NC(=N1)Cl)N(CC=C)CC=C,,,,,,
5021,95022,"2-Benzoyl-1H-indene-1,3(2H)-dione",C1=CC=C(C=C1)C(=O)C2C(=O)C3=CC=CC=C3C2=O,,,,,,
5022,95023,"7H-Purine, 2-dimethylamino-6-methylamino-",CNC1=NC(=NC2=C1NC=N2)N(C)C,,,,,,
5023,95024,"Theophylline, 8-(dimethylamino)-",CN1C2=C(C(=O)N(C1=O)C)NC(=N2)N(C)C,,,,,,
5024,95025,8-Butyltheophylline,CCCCC1=NC2=C(N1)C(=O)N(C(=O)N2C)C,,,,,,
5025,95026,"Theophylline, 8-(o-chloroanilino)-",CN1C2=C(C(=O)N(C1=O)C)NC(=N2)NC3=CC=CC=C3Cl,,,,,,
5026,95027,"Theophylline, 8-(p-chloroanilino)-",CN1C2=C(C(=O)N(C1=O)C)NC(=N2)NC3=CC=C(C=C3)Cl,,,,,,
5027,95028,7-Benzyltheophylline,CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC3=CC=CC=C3,,,,,,
5028,95029,"Phenol, 2,2'-ethylidenebis(4-chloro-",CC(C1=C(C=CC(=C1)Cl)O)C2=C(C=CC(=C2)Cl)O,,,,,,
5029,95030,8-Methyltheophylline,CC1=NC2=C(N1)C(=O)N(C(=O)N2C)C,,,,,,
5030,95031,8-Allyltheophylline,CN1C2=C(C(=O)N(C1=O)C)NC(=N2)CC=C,,,,,,
5031,95032,4-Bromoantipyrine,CC1=C(C(=O)N(N1C)C2=CC=CC=C2)Br,,,,,,
5032,95033,"1,3-dimethyl-8-(3-phenylprop-2-enyl)-7H-purine-2,6-dione",CN1C2=C(C(=O)N(C1=O)C)NC(=N2)CC=CC3=CC=CC=C3,,,,,,
5033,95034,"Theophylline, 8-amino-",CN1C2=C(C(=O)N(C1=O)C)NC(=N2)N,,,,,,
5034,95035,Theophylline-8-acetic acid,CN1C2=C(C(=O)N(C1=O)C)NC(=N2)CC(=O)O,,,,,,
5035,95036,Theophylline-8-butyric acid,CN1C2=C(C(=O)N(C1=O)C)NC(=N2)CCCC(=O)O,,,,,,
5036,95037,"Theophylline, 8-(2-cyclohexylethyl)-",CN1C2=C(C(=O)N(C1=O)C)NC(=N2)CCC3CCCCC3,,,,,,
5037,95038,"Theophylline, 8,8'-ethylenebis-",CN1C2=C(C(=O)N(C1=O)C)NC(=N2)CCC3=NC4=C(N3)C(=O)N(C(=O)N4C)C,,,,,,
5038,95039,"2,5-Cyclohexadien-1-one, 2,6-bis(1,1-dimethylethyl)-4-ethylidene-",CC=C1C=C(C(=O)C(=C1)C(C)(C)C)C(C)(C)C,,,,,,
5039,95040,"9H-Purin-6-amine, 9-ethyl-N,N-dimethyl-",CCN1C=NC2=C1N=CN=C2N(C)C,,,,,,
5040,95041,CID 95041,C1=CN=C(NC1=O)[SeH],,,,,,
5041,95042,CID 95042,CC1(C(=NC(=N1)S)S)C,,,,,,
5042,95043,N-(4-Methoxy-3-nitrophenyl)acetamide,CC(=O)NC1=CC(=C(C=C1)OC)[N+](=O)[O-],,,,,,
5043,95044,CID 95044,C1=CC(=CC=C1NC(=NC(=NC2=CC=C(C=C2)Cl)S)S)Cl,,,,,,
5044,95045,"4-(p-Dimethylaminophenyl)imino-2-methyl-2,5-cyclohexadiene-1-one",CC1=CC(=NC2=CC=C(C=C2)N(C)C)C=CC1=O,,,,,,
5045,95046,"4-(p-Dimethylaminophenyl)imino-2-methoxy-2,5-cyclohexadiene-1-one",CN(C)C1=CC=C(C=C1)N=C2C=CC(=O)C(=C2)OC,,,,,,
5046,95047,5-Acenaphtheneacetic acid,C1CC2=CC=C(C3=CC=CC1=C23)CC(=O)O,,,,,,
5047,95048,5-Chlorothiophene-2-carboxylic acid,C1=C(SC(=C1)Cl)C(=O)O,,,,,,
5048,95049,"Acetamide, N-(4-bromophenyl)-2,2,2-trichloro-",C1=CC(=CC=C1NC(=O)C(Cl)(Cl)Cl)Br,,,,,,
5049,95050,4-(Phenylsulfonyl)morpholine,C1COCCN1S(=O)(=O)C2=CC=CC=C2,,,,,,
5050,95051,1-((4-Bromophenyl)sulfonyl)piperidine,C1CCN(CC1)S(=O)(=O)C2=CC=C(C=C2)Br,,,,,,
5051,95052,9-Benzoylcarbazole,C1=CC=C(C=C1)C(=O)N2C3=CC=CC=C3C4=CC=CC=C42,,,,,,
5052,95053,"N,N-Dicyclohexylbenzamide",C1CCC(CC1)N(C2CCCCC2)C(=O)C3=CC=CC=C3,,,,,,
5053,95054,CID 95054,C1=CC(=CC=C1C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N,,,,,,
5054,95055,"Tetrahydro-3,6-pyridazinedione",C1CC(=O)NNC1=O,,,,,,
5055,95056,"Phenol, p-(1,2,3,6-tetrahydro-1-methyl-4-pyridyl)-",CN1CCC(=CC1)C2=CC=C(C=C2)O,,,,,"['P-hydroxy-MPTP is a known human metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.']",
5056,95057,6-Chloro-7-methylpurine,CN1C=NC2=C1C(=NC=N2)Cl,,,,,,
5057,95058,"Morpholine, 4-(1-oxohexyl)-",CCCCCC(=O)N1CCOCC1,,,,,,
5058,95059,"N,N'-Dimethyl-1H-purine-2,6-diamine",CNC1=NC(=NC2=C1NC=N2)NC,,,,,,
5059,95060,p-Toluenestibonic acid,CC1=CC=C(C=C1)[Sb](=O)(O)O,,,,,,
5060,95061,"5,6-Dichlorobenzo[d][1,3]dioxole",C1OC2=CC(=C(C=C2O1)Cl)Cl,,,,,,
5061,95062,6-Bromopiperonal,C1OC2=C(O1)C=C(C(=C2)C=O)Br,,,,,,
5062,95063,"5-Bromo-6-(bromomethyl)benzo[d][1,3]dioxole",C1OC2=C(O1)C=C(C(=C2)CBr)Br,,,,,,
5063,95064,"3-Cyclohexyl-N,N-diethylpropanamide",CCN(CC)C(=O)CCC1CCCCC1,,,,,,
5064,95065,"Purine, 6-(phenylthio)-",C1=CC=C(C=C1)SC2=NC=NC3=C2NC=N3,,,,,,
5065,95066,"Purine, 6-((o-chlorobenzyl)thio)-",C1=CC=C(C(=C1)CSC2=NC=NC3=C2NC=N3)Cl,,,,,,
5066,95067,"4-Amino-N,N-diethylbenzenesulfonamide",CCN(CC)S(=O)(=O)C1=CC=C(C=C1)N,,,,,,
5067,95068,"L-Proline, 1-(2-cyanoethyl)-5-oxo-",C1CC(=O)N(C1C(=O)O)CCC#N,,,,,,
5068,95069,Phenazine-1-carboxylic acid,C1=CC=C2C(=C1)N=C3C=CC=C(C3=N2)C(=O)O,,,,,,
5069,95070,N-Stearoylglycine,CCCCCCCCCCCCCCCCCC(=O)NCC(=O)O,,,,,,
5070,95071,Bis[4-(2-hydroxyethoxy)phenyl] sulfone,C1=CC(=CC=C1OCCO)S(=O)(=O)C2=CC=C(C=C2)OCCO,,,,,,
5071,95072,2-Nitrodibenzothiophene,C1=CC=C2C(=C1)C3=C(S2)C=CC(=C3)[N+](=O)[O-],,,,,,
5072,95073,"2,3-Naphthalenedicarboxylic acid",C1=CC=C2C=C(C(=CC2=C1)C(=O)O)C(=O)O,,,,,,
5073,95074,"2-Butyl-3a,4,7,7a-tetrahydro-1H-isoindole-1,3(2H)-dione",CCCCN1C(=O)C2CC=CCC2C1=O,,,,,,
5074,95075,"4,5-Phenanthrenedicarboxylic acid",C1=CC2=C(C(=C1)C(=O)O)C3=C(C=CC=C3C(=O)O)C=C2,,,,,,
5075,95076,C.I. Pigment Red 38,CCOC(=O)C1=NN(C(=O)C1N=NC2=C(C=C(C=C2)C3=CC(=C(C=C3)N=NC4C(=NN(C4=O)C5=CC=CC=C5)C(=O)OCC)Cl)Cl)C6=CC=CC=C6,,,,,,
5076,95077,"1,1,1-Trinitropropane",CCC([N+](=O)[O-])([N+](=O)[O-])[N+](=O)[O-],,,,,,
5077,95078,2-Cyclohexylacetamide,C1CCC(CC1)CC(=O)N,,,,,,
5078,95079,"Pyrrole-2-acetic acid, 5-phenyl-",C1=CC=C(C=C1)C2=CC=C(N2)CC(=O)O,,,,,,
5079,95080,"p-Toluenesulfonamide, N-(2-diethylaminoethyl)-",CCN(CC)CCNS(=O)(=O)C1=CC=C(C=C1)C,,,,,,
5080,95081,"Benzenesulfonic acid, 4-nitro-, ethyl ester",CCOS(=O)(=O)C1=CC=C(C=C1)[N+](=O)[O-],,,,,,
5081,95082,N-(4-Methoxy-2-methylphenyl)acetamide,CC1=C(C=CC(=C1)OC)NC(=O)C,,,,,,
5082,95083,N-phenethylbenzamide,C1=CC=C(C=C1)CCNC(=O)C2=CC=CC=C2,,,,,,
5083,95084,4-Oxoheptanedioic acid,C(CC(=O)O)C(=O)CCC(=O)O,,,,,,
5084,95085,3-Ethoxy-4-hydroxybenzoic acid,CCOC1=C(C=CC(=C1)C(=O)O)O,,,,,,
5085,95086,Dehydrodivanillin,COC1=CC(=CC(=C1O)C2=C(C(=CC(=C2)C=O)OC)O)C=O,,,,,,
5086,95087,"(2S,3R,4S,5S,6S)-6-(methoxycarbonyl)tetrahydro-2H-pyran-2,3,4,5-tetrayl tetraacetate",CC(=O)O[C@H]1[C@@H]([C@H](O[C@H]([C@@H]1OC(=O)C)OC(=O)C)C(=O)OC)OC(=O)C,,,,,,
5087,95088,"3,4,5-Triacetoxybenzoic acid",CC(=O)OC1=CC(=CC(=C1OC(=O)C)OC(=O)C)C(=O)O,,,,,,
5088,95089,Didecyl isophthalate,CCCCCCCCCCOC(=O)C1=CC(=CC=C1)C(=O)OCCCCCCCCCC,,,,,,
5089,95090,"1,1-Diphenylpropan-2-amine",CC(C(C1=CC=CC=C1)C2=CC=CC=C2)N,,,,,,
5090,95091,Pigment orange 1,CC1=CC=CC=C1NC(=O)C(C(=O)C)N=NC2=C(C=C(C=C2)OC)[N+](=O)[O-],,,,,,
5091,95092,"Purin-2-ol, 6-(benzylthio)-",C1=CC=C(C=C1)CSC2=NC(=O)NC3=C2NC=N3,,,,,,
5092,95093,"4'-Bromo-[1,1'-biphenyl]-4-ol",C1=CC(=CC=C1C2=CC=C(C=C2)Br)O,,,,,,
5093,95094,4-Benzyl-2-chlorophenol,C1=CC=C(C=C1)CC2=CC(=C(C=C2)O)Cl,,,,,,
5094,95095,CID 95095,CN(C)NC(=NCC=C)S,,,,,,
5095,95096,CID 95096,CN(C)NC(=NC1=CC=CC=C1)S,,,,,,
5096,95097,Pyroporphyrin dimethyl ester,CC1=CC2=CC3=C(C=C(N3)C=C4C(=C(C(=N4)C=C5C(=C(C(=N5)C=C1N2)C)CCC(=O)OC)CCC(=O)OC)C)C,,,,,,
5097,95098,"2,2-Dimethylthiomorpholin-3-one",CC1(C(=O)NCCS1)C,,,,,,
5098,95099,"3-Thiomorpholinone, 2,2-diethyl-",CCC1(C(=O)NCCS1)CC,,,,,,
5099,95100,"1,1-Dibromo-1-nitroethane",CC([N+](=O)[O-])(Br)Br,,,,,,
5100,95101,"2-Propanol, 2-methyl-1-nitro-",CC(C)(C[N+](=O)[O-])O,,,,,,
5101,95102,1-Amino-2-methylpropan-2-ol,CC(C)(CN)O,,,,,,
5102,95103,"2-Oxazoline, 4,4-dimethyl-2-undecyl-",CCCCCCCCCCCC1=NC(CO1)(C)C,,,,,,
5103,95104,"Octadecanoic acid, (2-heptadecyl-4(5H)-oxazolylidene)bis(methylene) ester",CCCCCCCCCCCCCCCCCC1=NC(CO1)(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC,,,,,,
5104,95105,Diethyl 2-acetamido-2-((5-(phenylmethoxy)indol-3-yl)methyl)malonate,CCOC(=O)C(CC1=CNC2=C1C=C(C=C2)OCC3=CC=CC=C3)(C(=O)OCC)NC(=O)C,,,,,,
5105,95106,"m-Toluamide, N,N-dipropyl-",CCCN(CCC)C(=O)C1=CC=CC(=C1)C,,,,,,
5106,95107,CID 95107,C1=CNC(=C1)C=NN=C(N)S,,,,,,
5107,95108,"Purine, 6-((p-fluorobenzyl)thio)-",C1=CC(=CC=C1CSC2=NC=NC3=C2NC=N3)F,,,,,,
5108,95109,"Purine, 6-(m-fluorobenzylthio)-",C1=CC(=CC(=C1)F)CSC2=NC=NC3=C2NC=N3,,,,,,
5109,95110,"Purine, 6-((o-fluorobenzyl)thio)-",C1=CC=C(C(=C1)CSC2=NC=NC3=C2NC=N3)F,,,,,,
5110,95111,"o-Toluidine, N,N-bis(2-chloroethyl)-",CC1=CC=CC=C1N(CCCl)CCCl,,,,,,
5111,95112,"4-Chloro-N,N-bis(2-chloroethyl)aniline",C1=CC(=CC=C1N(CCCl)CCCl)Cl,,,,,,
5112,95113,"N,N-bis(2-chloroethyl)-3-methylaniline",CC1=CC(=CC=C1)N(CCCl)CCCl,,,,,,
5113,95114,"N,N-Diallylacrylamide",C=CCN(CC=C)C(=O)C=C,,,,,,
5114,95115,"Phenol, p-arsenoso-",C1=CC(=CC=C1O)[As]=O,,,,,,
5115,95116,"3,3'-Dithiodipropionic acid",C(CSSCCC(=O)O)C(=O)O,,,,,,
5116,95117,5-Norbornene-2-carboxaldehyde,C1C2CC(C1C=C2)C=O,,,,,,
5117,95118,Diethyl 2-methylenemalonate,CCOC(=O)C(=C)C(=O)OCC,,,,,,
5118,95119,"N,N,N',N'-Tetrabutylpropane-1,3-diamine",CCCCN(CCCC)CCCN(CCCC)CCCC,,,,,,
5119,95120,"Butyl hexa-2,4-dienoate",CCCCOC(=O)C=CC=CC,,,,,,
5120,95121,9-Cyclohexyladenine,C1CCC(CC1)N2C=NC3=C(N=CN=C32)N,,,,,,
5121,95122,"2,4,7-Triamino-6-o-tolylpteridine",CC1=CC=CC=C1C2=NC3=C(N=C(N=C3N=C2N)N)N,,,,,,
5122,95123,"3,4,6-Trichloropyridazine",C1=C(C(=NN=C1Cl)Cl)Cl,,,,,,
5123,95124,CID 95124,C1CCC(C1)N2C=NC3=C2N=CN=C3S,,,,,,
5124,95125,Bis(p-acetylaminophenyl) ether,CC(=O)NC1=CC=C(C=C1)OC2=CC=C(C=C2)NC(=O)C,,,,,,
5125,95126,"N-Methyl-N,N'-diphenylurea",CN(C1=CC=CC=C1)C(=O)NC2=CC=CC=C2,,,,,,
5126,95127,"L-Cysteine, S-(1-methylethyl)-",CC(C)SC[C@@H](C(=O)O)N,,,,,,
5127,95128,CID 95128,C1CN=C(SSC(=N1)S)S,,,,,,
5128,95129,CID 95129,C1=CC(=CC=C1C=NN=C(N)S)N,,,,,,
5129,95130,"5-[(4,6-Dianilino-1,3,5-triazin-2-yl)amino]-2-[2-[4-[(4,6-dianilino-1,3,5-triazin-2-yl)amino]-2-sulfophenyl]ethenyl]benzenesulfonic acid",C1=CC=C(C=C1)NC2=NC(=NC(=N2)NC3=CC(=C(C=C3)C=CC4=C(C=C(C=C4)NC5=NC(=NC(=N5)NC6=CC=CC=C6)NC7=CC=CC=C7)S(=O)(=O)O)S(=O)(=O)O)NC8=CC=CC=C8,,,,,,
5130,95131,"s-Triazine, 2-amino-4-(p-(methylthio)anilino)-",CSC1=CC=C(C=C1)NC2=NC=NC(=N2)N,,,,,,
5131,95132,"s-Triazine, 2-amino-4-(p-(propylthio)anilino)-",CCCSC1=CC=C(C=C1)NC2=NC=NC(=N2)N,,,,,,
5132,95133,"(2R,3R,4R,5S)-6-hydroxyiminohexane-1,2,3,4,5-pentol",C([C@H]([C@H]([C@@H]([C@H](C=NO)O)O)O)O)O,,,,,,
5133,95134,"Phosphonic acid, piperidino-, dimethyl ester",COP(=O)(N1CCCCC1)OC,,,,,,
5134,95135,"1,2,3-Propanetriyl tris(bromoacetate)",C(C(COC(=O)CBr)OC(=O)CBr)OC(=O)CBr,,,,,,
5135,95136,"1,3-Benzodioxole, 5-(diethoxymethyl)-",CCOC(C1=CC2=C(C=C1)OCO2)OCC,,,,,,
5136,95137,CID 95137,CC(C)C(=C(C)O)N=O,,,,,,
5137,95138,CID 95138,CC1=CC=CC=C1NC(=CN=O)O,,,,,,
5138,95139,"Acetamide, N,N'-2,6-pyridinediylbis-",CC(=O)NC1=NC(=CC=C1)NC(=O)C,,,,,,
5139,95140,"Benzamide, N-isobutyl-",CC(C)CNC(=O)C1=CC=CC=C1,,,,,,
5140,95141,"2-Naphthaleneethanol, 1,2,3,4-tetrahydro-",C1CC2=CC=CC=C2CC1CCO,,,,,,
5141,95142,"N,N'-Dicarbobenzyloxy-L-cystine",C1=CC=C(C=C1)COC(=O)NC(CSSCC(C(=O)O)NC(=O)OCC2=CC=CC=C2)C(=O)O,,,,,,
5142,95143,"Methyl 2,3,4,6-tetra-O-methyl-alpha-D-glucopyranoside",COC[C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)OC)OC)OC)OC,,,,,,
5143,95144,alpha-D-Glucopyranoside methyl tetraacetate,CC(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)OC)OC(=O)C)OC(=O)C)OC(=O)C,,,,,,
5144,95145,Diphenyl(p-tolyl)methanol,CC1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)O,,,,,,
5145,95146,"Bis(2,4-dinitrophenyl) ether",C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])OC2=C(C=C(C=C2)[N+](=O)[O-])[N+](=O)[O-],,,,,,
5146,95147,"Carbamic acid, butyl-, 1-naphthalenyl ester",CCCCNC(=O)OC1=CC=CC2=CC=CC=C21,,,,,,
5147,95148,1-Lauroyl-2-pyrrolidinone,CCCCCCCCCCCC(=O)N1CCCC1=O,,,,,,
5148,95149,N-Allylacrylamide,C=CCNC(=O)C=C,,,,,,
5149,95150,Allyl laurate,CCCCCCCCCCCC(=O)OCC=C,,,,,,
5150,95151,"2-Butenedioic acid (2Z)-, didodecyl ester",CCCCCCCCCCCCOC(=O)C=CC(=O)OCCCCCCCCCCCC,,,,,,
5151,95152,Cinnamic Acid Phenyl Ester,C1=CC=C(C=C1)C=CC(=O)OC2=CC=CC=C2,,,,,,
5152,95153,2-(4-Nitrophenyl)ethanamine,C1=CC(=CC=C1CCN)[N+](=O)[O-],,,,,,
5153,95154,"3,3-Dimethylfuran-2,4(3H,5H)-dione",CC1(C(=O)COC1=O)C,,,,,,
5154,95155,2-Methyleneglutaric acid,C=C(CCC(=O)O)C(=O)O,,,,,,
5155,95156,Tetramethyl ethylenetetracarboxylate,COC(=O)C(=C(C(=O)OC)C(=O)OC)C(=O)OC,,,,,,
5156,95157,3-Hydroxy-1-methylpyridazin-6(1H)-one,CN1C(=O)C=CC(=O)N1,,,,,,
5157,95158,5-Bromo-N-(carboxymethyl)anthranilic acid,C1=CC(=C(C=C1Br)C(=O)O)NCC(=O)O,,,,,,
5158,95159,"2,3,4,6-Tetrachlorophenyl acetate",CC(=O)OC1=C(C(=C(C=C1Cl)Cl)Cl)Cl,,,,,,
5159,95160,"Benzene, 3-ethoxy-1,2,4,5-tetrachloro-",CCOC1=C(C(=CC(=C1Cl)Cl)Cl)Cl,,,,,,
5160,95161,"1-(3-Nitrophenyl)butane-1,3-dione",CC(=O)CC(=O)C1=CC(=CC=C1)[N+](=O)[O-],,,,,,
5161,95162,"1,3-Butanedione, 1-(4-nitrophenyl)-",CC(=O)CC(=O)C1=CC=C(C=C1)[N+](=O)[O-],,,,,,
5162,95163,Bis(m-bromophenyl)phosphinic acid,C1=CC(=CC(=C1)Br)P(=O)(C2=CC(=CC=C2)Br)O,,,,,,
5163,95164,"Phosphinic acid, (m-chlorophenyl)phenyl-",C1=CC=C(C=C1)P(=O)(C2=CC(=CC=C2)Cl)O,,,,,,
5164,95165,"Phosphinic acid, (m-nitrophenyl)phenyl-",C1=CC=C(C=C1)P(=O)(C2=CC=CC(=C2)[N+](=O)[O-])O,,,,,,
5165,95166,"Phosphinic acid, (p-nitrophenyl)phenyl-",C1=CC=C(C=C1)P(=O)(C2=CC=C(C=C2)[N+](=O)[O-])O,,,,,,
5166,95167,Galaktoseoxim,C([C@H]([C@@H]([C@@H]([C@H](C=NO)O)O)O)O)O,,,,,,
5167,95168,Osajin,CC(=CCC1=C2C(=C3C(=C1O)C(=O)C(=CO3)C4=CC=C(C=C4)O)C=CC(O2)(C)C)C,,,,,,
5168,95169,Terephthaloylbis(1-aziridine),C1CN1C(=O)C2=CC=C(C=C2)C(=O)N3CC3,,,,,,
5169,95170,"2,2',4,4'-Tetrabromodiphenyl ether",C1=CC(=C(C=C1Br)Br)OC2=C(C=C(C=C2)Br)Br,,,,,,
5170,95171,"1,4-Dipropionylpiperazine",CCC(=O)N1CCN(CC1)C(=O)CC,,,,,,
5171,95172,Benzyl iodoacetate,C1=CC=C(C=C1)COC(=O)CI,,,,,,
5172,95173,"4-(1,1-Dimethylethyl)cyclohexyl formate",CC(C)(C)C1CCC(CC1)OC=O,,,,,,
5173,95174,2-Amino-3-(4-aminophenyl)propanoic acid,C1=CC(=CC=C1CC(C(=O)O)N)N,,,,,,
5174,95175,"7H-Purine, 6-(cyclopentylthio)-",C1CCC(C1)SC2=NC=NC3=C2NC=N3,,,,,,
5175,95176,"1H-Purine, 6-(2-propynylthio)-",C#CCSC1=NC=NC2=C1NC=N2,,,,,,
5176,95177,6-(Octylthio)purine,CCCCCCCCSC1=NC=NC2=C1NC=N2,,,,,,
5177,95178,CID 95178,CC(=NN=C(N)S)C=NN=C(N)S,,,,,,
5178,95179,"Sulfilimine, S,S-bis(2-chloroethyl)-N-((4-methylphenyl)sulfonyl)-",CC1=CC=C(C=C1)S(=O)(=O)N=S(CCCl)CCCl,,,,,,
5179,95180,"4,5-Dihydro-2-pentyl-1H-imidazole-1-ethylamine",CCCCCC1=NCCN1CCN,,,,,,
5180,95181,4-(Acetyloxy)-3-penten-2-one,CC(=CC(=O)C)OC(=O)C,,,,,,
5181,95182,Tetrabutyl thiodisuccinate,CCCCOC(=O)CC(C(=O)OCCCC)SC(CC(=O)OCCCC)C(=O)OCCCC,,,,,,
5182,95183,Ethyl N-cyclohexylcarbamate,CCOC(=O)NC1CCCCC1,,,,,,
5183,95184,"4,7-Methano-5H-inden-5-one, 1,3a,4,6,7,7a-hexahydro-",C1C=CC2C1C3CC2C(=O)C3,,,,,,
5184,95185,"1H-Pyrazole-3-acetonitrile, 5-amino-4-cyano-",C(C#N)C1=C(C(=NN1)N)C#N,,,,,,
5185,95186,"Sulfide, nitroso trityl",C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)SN=O,,,,,,
5186,95187,8-methyl-7H-purin-6-amine,CC1=NC2=NC=NC(=C2N1)N,,,,,,
5187,95188,CID 95188,CC1=NC2=C(N1)C(=O)N=C(N2)N,,,,,,
5188,95189,CID 95189,CCN1C=NC2=C1NC(=NC2=O)N,,,,,,
5189,95190,"1H-Purine, 6-[(2-methylpropyl)thio]-",CC(C)CSC1=NC=NC2=C1NC=N2,,,,,,
5190,95191,6-(Hexylthio)-1H-purine,CCCCCCSC1=NC=NC2=C1NC=N2,,,,,,
5191,95192,6-(Heptylthio)-1H-purine,CCCCCCCSC1=NC=NC2=C1NC=N2,,,,,,
5192,95193,CID 95193,CCCCC1=C(NC(=NC1=O)S)C,,,,,,
5193,95194,1-Aminocyclooctanecarboxylic acid,C1CCCC(CCC1)(C(=O)O)N,,,,,,
5194,95195,"1,3-Diazaspiro[4.7]dodecane-2,4-dione",C1CCCC2(CCC1)C(=O)NC(=O)N2,,,,,,
5195,95196,4'-Bromo-5-nitrosalicylanilide,C1=CC(=CC=C1NC(=O)C2=C(C=CC(=C2)[N+](=O)[O-])O)Br,,,,,,
5196,95197,"Benzene, 1,1'-(bromomethylene)bis(4chloro-",C1=CC(=CC=C1C(C2=CC=C(C=C2)Cl)Br)Cl,,,,,,
5197,95198,Cyclohexaneethanesulfonamide,C1CCC(CC1)CCS(=O)(=O)N,,,,,,
5198,95199,"1H-Indene-1,3(2H)-dione, 2-benzo[f]quinolin-3-yl-",C1=CC=C2C(=C1)C=CC3=C2C=CC(=N3)C4C(=O)C5=CC=CC=C5C4=O,,,,,,
5199,95200,S-Methyl methanesulfinothioate,CSS(=O)C,,,,,,
5200,95201,CID 95201,C12=C(NC(=NC1=O)N)N=C(N2)N,,,,,,
5201,95202,"Ethyl 2-(1,3-dioxoisoindolin-2-yl)acetate",CCOC(=O)CN1C(=O)C2=CC=CC=C2C1=O,,,,,,
5202,95203,10-Phenylphenothiazine,C1=CC=C(C=C1)N2C3=CC=CC=C3SC4=CC=CC=C42,,,,,,
5203,95204,1-Phenyl-5-methyltetrazole,CC1=NN=NN1C2=CC=CC=C2,,,,,,
5204,95205,2-(3-Phenylpropyl)propanedioic acid,C1=CC=C(C=C1)CCCC(C(=O)O)C(=O)O,,,,,,
5205,95206,2-Amino-2-ethylbutanoic acid,CCC(CC)(C(=O)O)N,,,,,,
5206,95207,Phenyl 3-nitrobenzenesulfonate,C1=CC=C(C=C1)OS(=O)(=O)C2=CC=CC(=C2)[N+](=O)[O-],,,,,,
5207,95208,CID 95208,CC(=CN=NC(=NC)S)NNC(=NC)S,,,,,,
5208,95209,"Acetamide, 2-(benzylthio)-",C1=CC=C(C=C1)CSCC(=O)N,,,,,,
5209,95210,"8-Amino-1H-purine-2,6(3H,7H)-dione",C12=C(NC(=O)NC1=O)N=C(N2)N,,,,,,
5210,95211,"2,2,2-Trifluoro-N-(2-hydroxyethyl)acetamide",C(CO)NC(=O)C(F)(F)F,,,,,,
5211,95212,"Phosphoric acid, diethyl 2-propynyl ester",CCOP(=O)(OCC)OCC#C,,,,,,
5212,95213,N-(4-isopropoxyphenyl)acetamide,CC(C)OC1=CC=C(C=C1)NC(=O)C,,,,,['O-isopropyl acetaminophen has known human metabolites that include N-(4-Methoxyphenyl)formamide and acetaminophen.'],
5213,95214,Methyl 4-(carbamoylamino)-4-oxobut-2-enoate,COC(=O)C=CC(=O)NC(=O)N,,,,,,
5214,95215,CID 95215,C1=NC2=NC(=O)NC2=C(N1)N,,,,,,
5215,95216,CID 95216,C1=CC(=CC=C1N=NC2=NC3=C(N2)C(=O)N=C(N3)N)S(=O)(=O)O,,,,,,
5216,95217,"1H-Purine, 8-(methylthio)-",CSC1=NC2=NC=NC=C2N1,,,,,,
5217,95218,3-Methoxybutyl acrylate,CC(CCOC(=O)C=C)OC,,,,,,
5218,95219,"7-Acetyl-4,4a,4b,5,6,7,8,8a,9,10-decahydrophenanthren-2(3h)-one",CC(=O)C1CCC2C(C1)CCC3=CC(=O)CCC23,,,,,,
5219,95220,2-(Chloromethyl)-2-methyloxirane,CC1(CO1)CCl,,,,,,
5220,95221,"Allyl 2,3-epoxypropyl phthalate",C=CCOC(=O)C1=CC=CC=C1C(=O)OCC2CO2,,,,,,
5221,95222,4-Methyl-3-hydroxyanthranilic acid,CC1=C(C(=C(C=C1)C(=O)O)N)O,,,,,,
5222,95223,10-Nitrosophenanthren-9-ol,C1=CC=C2C(=C1)C3=CC=CC=C3C(=C2N=O)O,,,,,,
5223,95224,CID 95224,C1=CC(=CN=C1)C=C2C(=O)N=C(S2)S,,,,,,
5224,95225,4H-1-Benzothiopyran-4-one,C1=CC=C2C(=C1)C(=O)C=CS2,,,,,,
5225,95226,CID 95226,C1=CC(=CC=C1NC(=NC2=CC=C(C=C2)[N+](=O)[O-])S)[N+](=O)[O-],,,,,,
5226,95227,4-tert-Butylcyclohexyl hexanoate,CCCCCC(=O)OC1CCC(CC1)C(C)(C)C,,,,,,
5227,95228,"Cyclohexanecarboxamide, N-(p-tolyl)-",CC1=CC=C(C=C1)NC(=O)C2CCCCC2,,,,,,
5228,95229,"2,3-Epoxy-3-(o-nitrophenyl)propiophenone",C1=CC=C(C=C1)C(=O)C2C(O2)C3=CC=CC=C3[N+](=O)[O-],,,,,,
5229,95230,4-Propionylbiphenyl,CCC(=O)C1=CC=C(C=C1)C2=CC=CC=C2,,,,,,
5230,95231,"2,5-Bis(4-biphenylyl)oxazole",C1=CC=C(C=C1)C2=CC=C(C=C2)C3=CN=C(O3)C4=CC=C(C=C4)C5=CC=CC=C5,,,,,,
5231,95232,Ethyl 4-hydroxyiminopentanoate,CCOC(=O)CCC(=NO)C,,,,,,
5232,95233,Carboxymethyl methanesulfonate,CS(=O)(=O)OCC(=O)O,,,,,,
5233,95234,"6,6'-Dinitrodiphenic acid",C1=CC(=C(C(=C1)[N+](=O)[O-])C2=C(C=CC=C2[N+](=O)[O-])C(=O)O)C(=O)O,,,,,,
5234,95235,CID 95235,COC1=C(C=C(C=C1)Cl)N=C(N)S,,,,,,
5235,95236,N-Benzylbenzenesulfonamide,C1=CC=C(C=C1)CNS(=O)(=O)C2=CC=CC=C2,,,,,,
5236,95237,"N,N'-Ditosylethylenediamine",CC1=CC=C(C=C1)S(=O)(=O)NCCNS(=O)(=O)C2=CC=C(C=C2)C,,,,,,
5237,95238,"Acetamide, N-(2-(dimethylamino)ethyl)-",CC(=O)NCCN(C)C,,,,,,
5238,95239,"Barbituric acid, 5-ethyl-5-(2-hydroxyethyl)-",CCC1(C(=O)NC(=O)NC1=O)CCO,,,,,,
5239,95240,"Benzamide, 4-methoxy-N-(3-(4-morpholinyl)propyl)-",COC1=CC=C(C=C1)C(=O)NCCCN2CCOCC2,,,,,,
5240,95241,"1-Benzylpyrrolidine-2,5-dione",C1CC(=O)N(C1=O)CC2=CC=CC=C2,,,,,,
5241,95242,2-Oxo-1-oxaspiro[4.5]decane-4-carboxylic acid,C1CCC2(CC1)C(CC(=O)O2)C(=O)O,,,,,,
5242,95243,"Tris(2-ethylhexyl) 2-hydroxypropane-1,2,3-tricarboxylate",CCCCC(CC)COC(=O)CC(CC(=O)OCC(CC)CCCC)(C(=O)OCC(CC)CCCC)O,,,,,,
5243,95244,"1,3-Diphenethylurea",C1=CC=C(C=C1)CCNC(=O)NCCC2=CC=CC=C2,,,,,,
5244,95245,Trityl hydroperoxide,C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)OO,,,,,,
5245,95246,"2-Benzyl-5-ethyl-4-propyl-1,3-dioxane",CCCC1C(COC(O1)CC2=CC=CC=C2)CC,,,,,,
5246,95247,"1,1'-Benzylidenedipiperidine",C1CCN(CC1)C(C2=CC=CC=C2)N3CCCCC3,,,,,,
5247,95248,"2,4,8,10-Tetraoxa-3,9-dithiaspiro[5.5]undecane 3,9-dioxide",C1C2(COS(=O)O1)COS(=O)OC2,,,,,,
5248,95249,"Adenine, 9-benzyl-N,N-dimethyl-",CN(C)C1=NC=NC2=C1N=CN2CC3=CC=CC=C3,,,,,,
5249,95250,(1E)-1-Phenylethanone [(E)-1-phenylethylidene]hydrazone,CC(=NN=C(C)C1=CC=CC=C1)C2=CC=CC=C2,,,,,,
5250,95251,"1-Methylmercapto-2,4-dinitrobenzene",CSC1=C(C=C(C=C1)[N+](=O)[O-])[N+](=O)[O-],,,,,,
5251,95252,"Sarcosine, N-(p-tolylsulfonyl)-, ethyl ester",CCOC(=O)CN(C)S(=O)(=O)C1=CC=C(C=C1)C,,,,,,
5252,95253,Benzhydrylurea,C1=CC=C(C=C1)C(C2=CC=CC=C2)NC(=O)N,,,,,,
5253,95254,1-Naphthalenepropionic acid,C1=CC=C2C(=C1)C=CC=C2CCC(=O)O,,,,,,
5254,95255,"Carbamic acid, N-phenyl-, 3-diethylaminophenyl ester",CCN(CC)C1=CC(=CC=C1)OC(=O)NC2=CC=CC=C2,,,,,,
5255,95256,"Nicotinic acid, cyclohexyl ester",C1CCC(CC1)OC(=O)C2=CN=CC=C2,,,,,,
5256,95257,"1,2-Ethanediol, dicarbamate",C(COC(=O)N)OC(=O)N,,,,,,
5257,95258,2-Acetylamino-4-chlorophenol,CC(=O)NC1=C(C=CC(=C1)Cl)O,,,,,,
5258,95259,L-xylose,C([C@@H]([C@H]([C@@H](C=O)O)O)O)O,,,,,,
5259,95260,"N,N-Diethyl-3,4,5-trimethoxybenzamide",CCN(CC)C(=O)C1=CC(=C(C(=C1)OC)OC)OC,,,,,,
5260,95261,"1,1'-Succinylbis-aziridine",C1CN1C(=O)CCC(=O)N2CC2,,,,,,
5261,95262,"1,1'-Adipoylbisaziridine",C1CN1C(=O)CCCCC(=O)N2CC2,,,,,,
5262,95263,6-Benzylthioinosine,C1=CC=C(C=C1)CSC2=NC=NC3=C2N=CN3C4C(C(C(O4)CO)O)O,,,,,,
5263,95264,2-Fluoro-5-nitropyridine,C1=CC(=NC=C1[N+](=O)[O-])F,,,,,,
5264,95265,CID 95265,C1=CC=C(C=C1)N2C=NC3=C2NC(=NC3=O)N,,,,,,
5265,95266,"2-Benzyl-4,4,6-trimethyl-1,3-dioxane",CC1CC(OC(O1)CC2=CC=CC=C2)(C)C,,,,,,
5266,95267,"2-Benzyl-5-butyl-5-ethyl-1,3-dioxane",CCCCC1(COC(OC1)CC2=CC=CC=C2)CC,,,,,,
5267,95268,5-Chloro-6-methyluracil,CC1=C(C(=O)NC(=O)N1)Cl,,,,,,
5268,95269,"(2-Methyl-1,3-dioxolan-4-yl)methanol",CC1OCC(O1)CO,,,,,,
5269,95270,1-Pyrrolidineacetonitrile,C1CCN(C1)CC#N,,,,,,
5270,95271,1-Chloro-2-(1-methylethoxy)benzene,CC(C)OC1=CC=CC=C1Cl,,,,,,
5271,95272,"Anthranilic acid, N-(2-naphthyl)-",C1=CC=C2C=C(C=CC2=C1)NC3=CC=CC=C3C(=O)O,,,,,,
5272,95273,6-Chlorochroman-4-one,C1COC2=C(C1=O)C=C(C=C2)Cl,,,,,,
5273,95274,2-(((2-Hydroxyphenyl)methylene)amino)benzoic acid,C1=CC=C(C(=C1)C=NC2=CC=CC=C2C(=O)O)O,,,,,,
5274,95275,Octaziridinocyclotetraphosphazene,C1CN1P2(=NP(=NP(=NP(=N2)(N3CC3)N4CC4)(N5CC5)N6CC6)(N7CC7)N8CC8)N9CC9,,,,,,
5275,95276,"1-Benzyl-1,4-dihydronicotinamide",C1C=CN(C=C1C(=O)N)CC2=CC=CC=C2,,,,,,
5276,95277,p-Malonotoluidide,CC1=CC=C(C=C1)NC(=O)CC(=O)NC2=CC=C(C=C2)C,,,,,,
5277,95278,"1,2,3,4,5,6,7,8,9,10,11,12-Dodecahydrotriphenylene",C1CCC2=C3CCCCC3=C4CCCCC4=C2C1,,,,,,
5278,95279,"Bis(1,1-dioxidotetrahydro-3-thienyl) ether",C1CS(=O)(=O)CC1OC2CCS(=O)(=O)C2,,,,,,
5279,95280,"(E)-Benzo[d][1,3]dioxole-5-carbaldehyde oxime",C1OC2=C(O1)C=C(C=C2)C=NO,,,,,,
5280,95281,"Benzaldehyde, 2,3-dimethoxy-, oxime",COC1=CC=CC(=C1OC)C=NO,,,,,,
5281,95282,2-Hydroxy-n-(4-iodophenyl)-5-nitrobenzamide,C1=CC(=CC=C1NC(=O)C2=C(C=CC(=C2)[N+](=O)[O-])O)I,,,,,,
5282,95283,"n,n,n',n'-Tetrakis(2-hydroxyethyl)adipamide",C(CCC(=O)N(CCO)CCO)CC(=O)N(CCO)CCO,,,,,,
5283,95284,{[(Thiophen-2-yl)methylidene]amino}urea,C1=CSC(=C1)C=NNC(=O)N,,,,,,
5284,95285,Phenosulfazole,C1=CC(=CC=C1O)S(=O)(=O)NC2=NC=CS2,,,,,,
5285,95286,N-Hydroxymethylsuccinimide,C1CC(=O)N(C1=O)CO,,,,,,
5286,95287,"1-Pentanone, 1-(2-furanyl)-4-methyl-",CC(C)CCC(=O)C1=CC=CO1,,,,,,
5287,95288,"Urea, (3,4-dimethoxyphenethyl)-",COC1=C(C=C(C=C1)CCNC(=O)N)OC,,,,,,
5288,95289,Sarisan,COC1=CC2=C(C=C1CC=C)OCO2,,,,,,
5289,95290,2-Methyl-N-(m-tolyl)benzamide,CC1=CC(=CC=C1)NC(=O)C2=CC=CC=C2C,,,,,,
5290,95291,4-Nitro-2-picoline N-oxide,CC1=[N+](C=CC(=C1)[N+](=O)[O-])[O-],,,,,,
5291,95292,5-Acetyl-2-methylpyridine,CC1=NC=C(C=C1)C(=O)C,,,,,,
5292,95293,2-Naphthaleneacetamide,C1=CC=C2C=C(C=CC2=C1)CC(=O)N,,,,,,
5293,95294,2-(4-Methylphenyl)ethanol,CC1=CC=C(C=C1)CCO,,,,,,
5294,95295,"2,2-Dichloro-N,N-dimethylacetamide",CN(C)C(=O)C(Cl)Cl,,,,,,
5295,95296,"2,3-Diphenylpropanenitrile",C1=CC=C(C=C1)CC(C#N)C2=CC=CC=C2,,,,,,
5296,95297,1-Phenyl-3-(4-dimethylaminophenyl)-1-oxo-prop-2-ene,CN(C)C1=CC=C(C=C1)C=CC(=O)C2=CC=CC=C2,,,,,,
5297,95298,Ethyl phenylcyanoacetate,CCOC(=O)C(C#N)C1=CC=CC=C1,,,,,,
5298,95299,1-Aminopentan-2-ol,CCCC(CN)O,,,,,,
5299,95300,2-Ethyl-2-methylpentanoic acid,CCCC(C)(CC)C(=O)O,,,,,,
5300,95301,N-cinnamoylaniline,C1=CC=C(C=C1)C=CC(=O)NC2=CC=CC=C2,,,,,,
5301,95302,Cyclohexylphenylacetonitrile,C1CCC(CC1)C(C#N)C2=CC=CC=C2,,,,,,
5302,95303,3-(4-Pyridyl)-acrylic acid,C1=CN=CC=C1C=CC(=O)O,,,,,,
5303,95304,4-Chlorostilbene,C1=CC=C(C=C1)C=CC2=CC=C(C=C2)Cl,,,,,,
5304,95305,"2,2,3-Trimethylhexan-3-ol",CCCC(C)(C(C)(C)C)O,,,,,,
5305,95306,"2,4,4-Trimethylpentanoic acid",CC(CC(C)(C)C)C(=O)O,,,,,,
5306,95307,"Anthranilic acid, N-(alpha-(8-hydroxy-7-quinolyl)benzyl)-",C1=CC=C(C=C1)C(C2=C(C3=C(C=CC=N3)C=C2)O)NC4=CC=CC=C4C(=O)O,,,,,,
5307,95308,"2-Butenoic acid, 3-amino-, ethyl ester",CCOC(=O)C=C(C)N,,,,,,
5308,95309,4-Aminopentan-1-ol,CC(CCCO)N,,,,,,
5309,95310,Diethyl succinylo succinate,CCOC(=O)C1CC(=O)C(CC1=O)C(=O)OCC,,,,,,
5310,95311,"4,5-Diphenyl-1,5-dihydroimidazol-2-one",C1=CC=C(C=C1)C2C(=NC(=O)N2)C3=CC=CC=C3,,,,,,
5311,95312,"2-Bromo-3,3-dimethyl-N-phenylbutanamide",CC(C)(C)C(C(=O)NC1=CC=CC=C1)Br,,,,,,
5312,95313,"1-Cyclohexene-1-carboxaldehyde, 4-(1-methylethenyl)-, oxime",CC(=C)C1CCC(=CC1)C=NO,,,,,,
5313,95314,"1,2-Dibromocyclohexane",C1CCC(C(C1)Br)Br,,,,,,
5314,95315,3-Methylhexanoic acid,CCCC(C)CC(=O)O,,,,,,
5315,95316,Allyl lactate,CC(C(=O)OCC=C)O,,,,,,
5316,95317,2-(4-sec-Butylphenoxy)ethanol,CCC(C)C1=CC=C(C=C1)OCCO,,,,,,
5317,95318,Tryptazan,C1=CC2=C(NN=C2C=C1)CC(C(=O)O)N,,,,,,
5318,95319,6-Methyl-DL-tryptophan,CC1=CC2=C(C=C1)C(=CN2)CC(C(=O)O)N,,,,,,
5319,95320,"2-(Chloromethyl)-2,3-dihydro-1,4-benzodioxine",C1C(OC2=CC=CC=C2O1)CCl,,,,,,
5320,95321,"2-Propenoic acid, 3-(2,6-dichlorophenyl)-",C1=CC(=C(C(=C1)Cl)C=CC(=O)O)Cl,,,,,,
5321,95322,2-(1-Phenylethyl)phenol,CC(C1=CC=CC=C1)C2=CC=CC=C2O,,,,,,
5322,95323,4-Methyl-2-(1-phenylethyl)phenol,CC1=CC(=C(C=C1)O)C(C)C2=CC=CC=C2,,,,,,
5323,95324,"2,3-Dibromosuccinic acid",C(C(C(=O)O)Br)(C(=O)O)Br,,,,,,
5324,95325,"Ethyl alpha,gamma-diphenylacetoacetate",CCOC(=O)C(C1=CC=CC=C1)C(=O)CC2=CC=CC=C2,,,,,,
5325,95326,3-(3-Chlorophenyl)-1-phenylprop-2-en-1-one,C1=CC=C(C=C1)C(=O)C=CC2=CC(=CC=C2)Cl,,,,,,
5326,95327,"1,5-Diphenyl-2,4-pentadien-1-one",C1=CC=C(C=C1)C=CC=CC(=O)C2=CC=CC=C2,,,,,,
5327,95328,alpha-Cyanostilbene,C1=CC=C(C=C1)C=C(C#N)C2=CC=CC=C2,,,,,,
5328,95329,Dypnone,CC(=CC(=O)C1=CC=CC=C1)C2=CC=CC=C2,,,,,,
5329,95330,Isobornyl methyl ether,CC1(C2CCC1(C(C2)OC)C)C,,,,,,
5330,95331,2-Isopropylcyclohexanol,CC(C)C1CCCCC1O,,,,,,
5331,95332,"1,2,3,6-Tetrahydro-3-methylphthalic anhydride",CC1C=CCC2C1C(=O)OC2=O,,,,,,
5332,95333,Ethyl 2-bromoheptanoate,CCCCCC(C(=O)OCC)Br,,,,,,
5333,95334,2-Phenylbutanenitrile,CCC(C#N)C1=CC=CC=C1,,,,,,
5334,95335,Dimethyl mercaptosuccinate,COC(=O)CC(C(=O)OC)S,,,,,,
5335,95336,"Cyclohexanone, 2,6-bis(phenylmethylene)-",C1CC(=CC2=CC=CC=C2)C(=O)C(=CC3=CC=CC=C3)C1,,,,,,
5336,95337,2-Hexyl-1-decanol,CCCCCCCCC(CCCCCC)CO,,,,,,
5337,95338,"1-Undecanol, 2-heptyl-",CCCCCCCCCC(CCCCCCC)CO,,,,,,
5338,95339,1-Chloro-4-(2-nitrovinyl)benzene,C1=CC(=CC=C1C=C[N+](=O)[O-])Cl,,,,,,
5339,95340,"2-Propen-1-one, 3-(4-chlorophenyl)-1-phenyl-",C1=CC=C(C=C1)C(=O)C=CC2=CC=C(C=C2)Cl,,,,,,
5340,95341,"1-(2,4-Dichlorophenoxy)propan-2-ol",CC(COC1=C(C=C(C=C1)Cl)Cl)O,,,,,,
5341,95342,"2,3-Dibromo-3-phenylpropiophenone",C1=CC=C(C=C1)C(C(C(=O)C2=CC=CC=C2)Br)Br,,,,,,
5342,95343,Desyl chloride,C1=CC=C(C=C1)C(C(=O)C2=CC=CC=C2)Cl,,,,,,
5343,95344,"Lactic acid, 2-chloroallyl ester",CC(C(=O)OCC(=C)Cl)O,,,,,,
5344,95345,"1,1'-Oxybis(2-chloroethanol)",C(C(O)OC(CCl)O)Cl,,,,,,
5345,95346,Dehydroabietylnitrile,CC(C)C1=CC2=C(C=C1)C3(CCCC(C3CC2)(C)C#N)C,,,,,,
5346,95347,Abietan-18-oic acid,CC(C)C1CCC2C(C1)CCC3C2(CCCC3(C)C(=O)O)C,,,,,,
5347,95348,1-(3-Fluorophenyl)ethanol,CC(C1=CC(=CC=C1)F)O,,,,,,
5348,95349,"(2,2-Dichlorocyclopropyl)benzene",C1C(C1(Cl)Cl)C2=CC=CC=C2,,,,,,
5349,95350,Pantoyltaurine,CC(C)(CO)C(C(=O)NCCS(=O)(=O)O)O,,,,,,
5350,95351,3-(Oxolan-2-ylmethoxy)propanenitrile,C1CC(OC1)COCCC#N,,,,,,
5351,95352,1-(4-Bromophenyl)ethanol,CC(C1=CC=C(C=C1)Br)O,,,,,,
5352,95353,1-(4-Nitro-phenyl)-3-phenyl-propenone,C1=CC=C(C=C1)C=CC(=O)C2=CC=C(C=C2)[N+](=O)[O-],,,,,,
5353,95354,"2-(11-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-ylidene)ethyl acetate",CC(=O)OCC=C1CCC2C1(CC(C3C2CCC4=CC(=O)CCC34C)O)C,,,,,,
5354,95355,"2,4-Dinitro-1-(2-phenylethenyl)benzene",C1=CC=C(C=C1)C=CC2=C(C=C(C=C2)[N+](=O)[O-])[N+](=O)[O-],,,,,,
5355,95356,"1,2-Diphenyl-2-propanol",CC(CC1=CC=CC=C1)(C2=CC=CC=C2)O,,,,,,
5356,95357,"3-Chloro-2-methylpropane-1,2-diol",CC(CO)(CCl)O,,,,,,
5357,95358,CID 95358,C1=CC(=CC(=C1)[N+](=O)[O-])C=CC(=O)C=CC2=CC(=CC=C2)[N+](=O)[O-],,,,,,
5358,95359,"2,3-Dimethylpiperidine",CC1CCCNC1C,,,,,,
5359,95360,2-Chloro-alpha-(nitromethyl)benzyl alcohol,C1=CC=C(C(=C1)C(C[N+](=O)[O-])O)Cl,,,,,,
5360,95361,2-Ethoxyethyl lactate,CCOCCOC(=O)C(C)O,,,,,,
5361,95362,"2-Methylbutane-2,3-diol",CC(C(C)(C)O)O,,,,,,
5362,95363,3-(3-Thienyl)-DL-alanine,C1=CSC=C1CC(C(=O)O)N,,,,,,
5363,95364,"4-Oxo-2,4-diphenylbutanenitrile",C1=CC=C(C=C1)C(CC(=O)C2=CC=CC=C2)C#N,,,,,,
5364,95365,3-Phenylphthalide,C1=CC=C(C=C1)C2C3=CC=CC=C3C(=O)O2,,,,,,
5365,95366,"2,3-Dibromopentane",CCC(C(C)Br)Br,,,,,,
5366,95367,2-Hydroxy-3-methylbutanal,CC(C)C(C=O)O,,,,,,
5367,95368,Ethyl 3-(furan-2-yl)prop-2-enoate,CCOC(=O)C=CC1=CC=CO1,,,,,,
5368,95369,N-(4-phenylbut-3-en-2-ylidene)hydroxylamine,CC(=NO)C=CC1=CC=CC=C1,,,,,,
5369,95370,"2-Propenoic acid, 3-(4-nitrophenyl)-, ethyl ester",CCOC(=O)C=CC1=CC=C(C=C1)[N+](=O)[O-],,,,,,
5370,95371,Oxolan-2-ylmethyl octadec-9-enoate,CCCCCCCCC=CCCCCCCCC(=O)OCC1CCCO1,,,,,,
5371,95372,1-Phenyl-1-butanol,CCCC(C1=CC=CC=C1)O,,,,,,
5372,95373,Tetrahydrofurfuryl palmitate,CCCCCCCCCCCCCCCC(=O)OCC1CCCO1,,,,,,
5373,95374,Diethyl N-(4-nitrobenzoyl)-L-glutamate,CCOC(=O)CCC(C(=O)OCC)NC(=O)C1=CC=C(C=C1)[N+](=O)[O-],,,,,,
5374,95375,(4-Methoxyphenyl)(phenyl)methanol,COC1=CC=C(C=C1)C(C2=CC=CC=C2)O,,,,,,
5375,95376,2-(4-Methylphenyl)propan-1-ol,CC1=CC=C(C=C1)C(C)CO,,,,,,
5376,95377,4-Methylbenzhydrol,CC1=CC=C(C=C1)C(C2=CC=CC=C2)O,,,,,,
5377,95378,4-(2-Acetyl-2-morpholino-1-phenylethyl)morpholine,CC(=O)C(C(C1=CC=CC=C1)N2CCOCC2)N3CCOCC3,,,,,,
5378,95379,"3,6-Dimethyloctane-3,6-diol",CCC(C)(CCC(C)(CC)O)O,,,,,,
5379,95380,N-sec-Butylphthalimide,CCC(C)N1C(=O)C2=CC=CC=C2C1=O,,,,,,
5380,95381,2-Phenylethyl but-2-enoate,CC=CC(=O)OCCC1=CC=CC=C1,,,,,,
5381,95382,4-(2-Methyl-1-pyrrolidyl)-7-chloroquinoline,CC1CCCN1C2=C3C=CC(=CC3=NC=C2)Cl,,,,,,
5382,95383,CID 95383,CC1=CC(N=C(N1C2CCCCC2C3CCCCC3)S)(C)C,,,,,,
5383,95384,Menthyl propionate,CCC(=O)OC1CC(CCC1C(C)C)C,,,,,,
5384,95385,Dibutyl malate,CCCCOC(=O)CC(C(=O)OCCCC)O,,,,,,
5385,95386,"2,3-Dibromobutyric acid",CC(C(C(=O)O)Br)Br,,,,,,
5386,95387,1-Diethylamino-2-propanol,CCN(CC)CC(C)O,,,,,,
5387,95388,5-Diethylamino-2-pentanol,CCN(CC)CCCC(C)O,,,,,,
5388,95389,Ethyl 3-oxo-2-phenylbutanoate,CCOC(=O)C(C1=CC=CC=C1)C(=O)C,,,,,,
5389,95390,"5-Methyl-3-[(5-nitrofuran-2-yl)methylideneamino]-1,3-oxazolidine-2-thione",CC1CN(C(=S)O1)N=CC2=CC=C(O2)[N+](=O)[O-],,,,,,
5390,95391,"2(3H)-Benzofuranone, hexahydro-",C1CCC2C(C1)CC(=O)O2,,,,,,
5391,95392,"Ethyl 2,4-dimethyl-1,3-dioxolane-2-acetate",CCOC(=O)CC1(OCC(O1)C)C,,,,,,
5392,95393,"4-Methyl-2-phenyl-1,3-dioxane",CC1CCOC(O1)C2=CC=CC=C2,,,,,,
5393,95394,CID 95394,CC1CCOC(O1)C=CC2=CC=CC=C2,,,,,,
5394,95395,(Tetrahydrofuryl)methyl phenylacetate,C1CC(OC1)COC(=O)CC2=CC=CC=C2,,,,,,
5395,95396,Isoamyl mandelate,CC(C)CCOC(=O)C(C1=CC=CC=C1)O,,,,,,
5396,95397,"4-Methyl-2-nonyl-1,3-dioxolane",CCCCCCCCCC1OCC(O1)C,,,,,,
5397,95398,Ethyl 2-acetylpentanoate,CCCC(C(=O)C)C(=O)OCC,,,,,,
5398,95399,"Diethyl 2,3-diacetylsuccinate",CCOC(=O)C(C(C(=O)C)C(=O)OCC)C(=O)C,,,,,,
5399,95400,"2-Hexyl-2,4-dimethyl-1,3-dioxolane",CCCCCCC1(OCC(O1)C)C,,,,,,
5400,95401,"2-Hexyl-4-methyl-1,3-dioxane",CCCCCCC1OCCC(O1)C,,,,,,
5401,95402,1-Allyloxy-3-chloro-2-propanol,C=CCOCC(CCl)O,,,,,,
5402,95403,"4-Methyl-2-propyl-1,3-dioxane",CCCC1OCCC(O1)C,,,,,,
5403,95404,p-Methyl-alpha-propylbenzyl alcohol,CCCC(C1=CC=C(C=C1)C)O,,,,,,
5404,95405,4-Amino-4-methylpentan-2-ol,CC(CC(C)(C)N)O,,,,,,
5405,95406,"Dimethyl 2,3-dichlorosuccinate",COC(=O)C(C(C(=O)OC)Cl)Cl,,,,,,
5406,95407,n-(3-Oxoandrost-4-en-17-yl)acetamide,CC(=O)NC1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C,,,,,,
5407,95408,"2,3-Dihydroxypropyl 12-hydroxyoctadecanoate",CCCCCCC(CCCCCCCCCCC(=O)OCC(CO)O)O,,,,,,
5408,95409,Butyl 12-hydroxyoctadecanoate,CCCCCCC(CCCCCCCCCCC(=O)OCCCC)O,,,,,,
5409,95410,"1,2-Epoxy-2,4,4-trimethylpentane",CC1(CO1)CC(C)(C)C,,,,,,
5410,95411,"Tartaric anhydride, diacetate",CC(=O)OC1C(C(=O)OC1=O)OC(=O)C,,,,,,
5411,95412,"Diethyl 2,6-dibromoheptanedioate",CCOC(=O)C(CCCC(C(=O)OCC)Br)Br,,,,,,
5412,95413,"1,2,4-Triphenyl-1,4-butanedione",C1=CC=C(C=C1)C(CC(=O)C2=CC=CC=C2)C(=O)C3=CC=CC=C3,,,,,,
5413,95414,1-(4-Methoxyphenyl)-1-buten-3-one,CC(=O)C=CC1=CC=C(C=C1)OC,,,,,,
5414,95415,"2-Hydroxy-1,2-bis(4-methoxyphenyl)ethanone",COC1=CC=C(C=C1)C(C(=O)C2=CC=C(C=C2)OC)O,,,,,,
5415,95416,Benzoin acetate,CC(=O)OC(C1=CC=CC=C1)C(=O)C2=CC=CC=C2,,,,,,
5416,95417,"1,4-Pentadien-3-one, 1,5-diphenyl-",C1=CC=C(C=C1)C=CC(=O)C=CC2=CC=CC=C2,,,,,,
5417,95418,Butyl 2-bromobutanoate,CCCCOC(=O)C(CC)Br,,,,,,
5418,95419,"4,4,6-Trimethyl-2-(prop-1-en-1-yl)-1,3-dioxane",CC=CC1OC(CC(O1)(C)C)C,,,,,,
5419,95420,"D-Glucose, diethyl mercaptal",CCSC(C(C(C(C(CO)O)O)O)O)SCC,,,,,,
5420,95421,"1,12-Octadecanediol",CCCCCCC(CCCCCCCCCCCO)O,,,,,,
5421,95422,Ethyl acetamidocyanoacetate,CCOC(=O)C(C#N)NC(=O)C,,,,,,
5422,95423,"2,4-Dimethylpiperidine",CC1CCNC(C1)C,,,,,,
5423,95424,Ethyl 3-bromobutyrate,CCOC(=O)CC(C)Br,,,,,,
5424,95425,2-Ethylhexyl propionate,CCCCC(CC)COC(=O)CC,,,,,,
5425,95426,"N-((2,4-Dichlorophenoxy)acetyl)-L-leucine",CC(C)CC(C(=O)O)NC(=O)COC1=C(C=C(C=C1)Cl)Cl,,,,,,
5426,95427,Bis(tetrahydrofurfuryl) adipate,C1CC(OC1)COC(=O)CCCCC(=O)OCC2CCCO2,,,,,,
5427,95428,"Methyl 2,3-dibromopropionate",COC(=O)C(CBr)Br,,,,,,
5428,95429,"Methyl 2,3-dichloropropionate",COC(=O)C(CCl)Cl,,,,,,
5429,95430,1-Bromo-2-methylcyclohexane,CC1CCCCC1Br,,,,,,
5430,95431,1-Bromo-3-methylcyclohexane,CC1CCCC(C1)Br,,,,,,
5431,95432,"1,3-Propanediol, 2-isobutyl-2-methyl-, dicarbamate",CC(C)CC(C)(COC(=O)N)COC(=O)N,,,,,,
5432,95433,2-Hydroxy-2-methylbutyric acid,CCC(C)(C(=O)O)O,,,,,,
5433,95434,1-Cyclopentylethanol,CC(C1CCCC1)O,,,,,,
5434,95435,alpha-Phenylpyridine-2-ethanol,C1=CC=C(C=C1)C(CC2=CC=CC=N2)O,,,,,,
5435,95436,2-Phenoxypropionyl chloride,CC(C(=O)Cl)OC1=CC=CC=C1,,,,,,
5436,95437,"1,2-Bis(4-cyanophenyl)ethylene",C1=CC(=CC=C1C=CC2=CC=C(C=C2)C#N)C#N,,,,,,
5437,95438,alpha-Methyl-DL-tryptophan,CC(CC1=CNC2=CC=CC=C21)(C(=O)O)N,,,,,,
5438,95439,"2,2,4,6-Tetramethylpiperidine",CC1CC(NC(C1)(C)C)C,,,,,,
5439,95440,DL-2-Methylglutamic acid,CC(CCC(=O)O)(C(=O)O)N,,,,,,
5440,95441,L-Glutamic acid 5-benzyl ester,C1=CC=C(C=C1)COC(=O)CCC(C(=O)O)N,,,['Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)'],,,
5441,95442,1-Cyano-1-carboethoxy-2-(3-indolyl)ethylene,CCOC(=O)C(=CC1=CNC2=CC=CC=C21)C#N,,,,,,
5442,95443,"8-Phenylocta-1,3,5,7-tetraenylbenzene",C1=CC=C(C=C1)C=CC=CC=CC=CC2=CC=CC=C2,,,,,,
5443,95444,2-Bromo-1-indanol,C1C(C(C2=CC=CC=C21)O)Br,,,,,,
5444,95445,5-Ethyl-1-phenylbarbituric acid,CCC1C(=O)NC(=O)N(C1=O)C2=CC=CC=C2,,,,,,
5445,95446,"Ethanone, 1-[4-(dimethylamino)phenyl]-2-hydroxy-2-phenyl-",CN(C)C1=CC=C(C=C1)C(=O)C(C2=CC=CC=C2)O,,,,,,
5446,95447,Hydrobenzoin,C1=CC=C(C=C1)C(C(C2=CC=CC=C2)O)O,,,,,,
5447,95448,Ethyl 2-acetylpent-4-enoate,CCOC(=O)C(CC=C)C(=O)C,,,,,,
5448,95449,Diethyl (1-methylbutyl)malonate,CCCC(C)C(C(=O)OCC)C(=O)OCC,,,,,,
5449,95450,Diethyl ethyl(1-methylbutyl)malonate,CCCC(C)C(CC)(C(=O)OCC)C(=O)OCC,,,,,,
5450,95451,Diethyl (1-methylbutyl)allylmalonate,CCCC(C)C(CC=C)(C(=O)OCC)C(=O)OCC,,,,,,
5451,95452,[4-(2-Hydroxypropoxy)phenyl]arsonic acid,CC(COC1=CC=C(C=C1)[As](=O)(O)O)O,,,,,,
5452,95453,Iridomirmecina,CC1CCC2C1COC(=O)C2C,,,,,,
5453,95454,"2-Propanol, 1,1'-thiobis-",CC(CSCC(C)O)O,,,,,,
5454,95455,1-(2-Bromophenyl)ethanol,CC(C1=CC=CC=C1Br)O,,,,,,
5455,95456,N-Ethyl-2-hydroxypropionamide,CCNC(=O)C(C)O,,,,,,
5456,95457,2-Hydroxy-N-(2-hydroxyethyl)propanamide,CC(C(=O)NCCO)O,,,,,,
5457,95458,"N,N-Didecyllactamide",CCCCCCCCCCN(CCCCCCCCCC)C(=O)C(C)O,,,,,,
5458,95459,Phenylsuccinic acid,C1=CC=C(C=C1)C(CC(=O)O)C(=O)O,,,,,,
5459,95460,"3-Buten-2-one,4-[4-(dimethylamino)phenyl]-, (3E)-",CC(=O)C=CC1=CC=C(C=C1)N(C)C,,,,,,
5460,95461,"Pyridine, 2,6-bis(2-phenylethenyl)-",C1=CC=C(C=C1)C=CC2=NC(=CC=C2)C=CC3=CC=CC=C3,,,,,,
5461,95462,CID 95462,CCC1(C(=NC(=N1)S)S)C2=CC=CC=C2,,,,,,
5462,95463,2-Bromo-4-butanolide,C1COC(=O)C1Br,,,,,,
5463,95464,alpha-Hydroxypyridine-4-methanesulphonic acid,C1=CN=CC=C1C(O)S(=O)(=O)O,,,,,,
5464,95465,2-Pyridylhydroxymethanesulfonic acid,C1=CC=NC(=C1)C(O)S(=O)(=O)O,,,,,,
5465,95466,Ethyl 2-acetylhexanoate,CCCCC(C(=O)C)C(=O)OCC,,,,,,
5466,95467,Glycerol monolactate,CC(C(=O)OCC(CO)O)O,,,,,,
5467,95468,"1,5-Bis(2-tetrahydrofuryl)-3-pentanol",C1CC(OC1)CCC(CCC2CCCO2)O,,,,,,
5468,95469,3-Chlorophthalide,C1=CC=C2C(=C1)C(OC2=O)Cl,,,,,,
5469,95470,[3-Amino-4-(2-hydroxypropoxy)phenyl]arsonic acid,CC(COC1=C(C=C(C=C1)[As](=O)(O)O)N)O,,,,,,
5470,95471,(1E)-5-methyl-1-phenylhex-1-en-3-one,CC(C)CC(=O)C=CC1=CC=CC=C1,,,,,,
5471,95472,NSC 11863;Piperonylideneacetophenone,C1OC2=C(O1)C=C(C=C2)C=CC(=O)C3=CC=CC=C3,,,,,,
5472,95473,"Ethyl 2,3-epoxy-3-methylvalerate",CCC1(C(O1)C(=O)OCC)C,,,,,,
5473,95474,"1,2-Dimethoxy-4-(2-nitroprop-1-enyl)benzene",CC(=CC1=CC(=C(C=C1)OC)OC)[N+](=O)[O-],,,,,,
5474,95475,2-Amino-3-cyclohexylpropanoic acid,C1CCC(CC1)CC(C(=O)O)N,,,,,,
5475,95476,"Urea, (2,2,2-trichloro-1-hydroxyethyl)-",C(C(Cl)(Cl)Cl)(NC(=O)N)O,,,,,,
5476,95477,"1,2,3,4-Tetrahydrobenzo[h]quinolin-3-ol",C1C(CNC2=C1C=CC3=CC=CC=C32)O,,,,,,
5477,95478,Desethylchloroquine,CCNCCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl,,,,,,
5478,95479,"Urea, (hexahydro-6-methyl-2-oxo-4-pyrimidinyl)-",CC1CC(NC(=O)N1)NC(=O)N,,,,,,
5479,95480,Fluoroquine,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)F,,,,,,
5480,95481,"Glutaconic acid, 3-hydroxy-, dimethyl ester, diethyl phosphate",CCOP(=O)(OCC)OC(=CC(=O)OC)CC(=O)OC,,,,,,
5481,95482,S-carboxamidomethyl cysteine,C(C(C(=O)O)N)SCC(=O)N,,,,,,
5482,95483,"3,4-Dimethyl-1-pentyn-3-ol",CC(C)C(C)(C#C)O,,,,,,
5483,95484,"6-Octen-3-ol, 3,6-dimethyl-",CCC(C)(CCC(=CC)C)O,,,,,,
5484,95485,"Benzene, (1-ethoxyethoxy)-",CCOC(C)OC1=CC=CC=C1,,,,,,
5485,95486,"2,2,5-Trimethyloxazolidine",CC1CNC(O1)(C)C,,,,,,
5486,95487,"2,2'-Oxybis(5-methyl-5-propyl-1,3,2-dioxaphosphorinane) 2,2'-dioxide",CCCC1(COP(=O)(OC1)OP2(=O)OCC(CO2)(C)CCC)C,,,,,,
5487,95488,"3-(2,4-Dichlorophenoxy)-1,2-propanediol",C1=CC(=C(C=C1Cl)Cl)OCC(CO)O,,,,,,
5488,95489,"1,2,3,4-Tetrahydroisoquinoline-3-carboxylic acid",C1C(NCC2=CC=CC=C21)C(=O)O,,,,,,
5489,95490,1-Methyl-5-phenylpyrazolidin-3-one,CN1C(CC(=O)N1)C2=CC=CC=C2,,,,,,
5490,95491,2-Methylpyrrolidine-2-carboxylic acid,CC1(CCCN1)C(=O)O,,,,,,
5491,95492,5-Hydantoinacetic acid,C(C1C(=O)NC(=O)N1)C(=O)O,,,,,,
5492,95493,5-Carboxymethylidenehydantoin,C(=C1C(=O)NC(=O)N1)C(=O)O,,,,,,
5493,95494,"4,4-Dimethyl-1-phenylpent-1-en-3-one",CC(C)(C)C(=O)C=CC1=CC=CC=C1,,,,,,
5494,95495,"6,10-Dimethylundecan-2-one",CC(C)CCCC(C)CCCC(=O)C,,,,,,
5495,95496,Carbocysteine sulfoxide,C(C(C(=O)O)N)S(=O)CC(=O)O,,,,,,
5496,95497,"1,2-Cyclopentanediol",C1CC(C(C1)O)O,,,,,,
5497,95498,"2,4-Dicyano-3-methylglutaramide",CC(C(C#N)C(=O)N)C(C#N)C(=O)N,,,,,,
5498,95499,Octyl lactate,CCCCCCCCOC(=O)C(C)O,,,,,,
5499,95500,"2,5-Diethoxytetrahydrofuran",CCOC1CCC(O1)OCC,,,,,,
5500,95501,"Methyl 11-methoxy-19-methyl-16,17-didehydro-18-oxayohimban-16-carboxylate",CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=C4C=CC(=C5)OC,,,,,,
5501,95502,3-Methoxybutyl isobutyrate,CC(C)C(=O)OCCC(C)OC,,,,,,
5502,95503,"3-(1,3-Benzodioxol-5-yl)prop-2-en-1-ol",C1OC2=C(O1)C=C(C=C2)C=CCO,,,,,,
5503,95504,"5-(2-Bromopropyl)-1,3-benzodioxole",CC(CC1=CC2=C(C=C1)OCO2)Br,,,,,,
5504,95505,"1-(Benzo[d][1,3]dioxol-5-yl)propan-2-ol",CC(CC1=CC2=C(C=C1)OCO2)O,,,,,,
5505,95506,"1-(1,3-Benzodioxol-5-yl)-5-hydroxy-5-methylhex-1-en-3-one",CC(C)(CC(=O)C=CC1=CC2=C(C=C1)OCO2)O,,,,,,
5506,95507,1-Chloro-3-methyl-1-pentyn-3-ol,CCC(C)(C#CCl)O,,,,,,
5507,95508,2-Bromo-2-nitroethanol,C(C([N+](=O)[O-])Br)O,,,,,,
5508,95509,"Octa-2,4,6-trienic acid",CC=CC=CC=CC(=O)O,,,,,,
5509,95510,2-Phenyl-2-(pyridin-2-yl)acetonitrile,C1=CC=C(C=C1)C(C#N)C2=CC=CC=N2,,,,,,
5510,95511,"3-Hydroxy-2,3-diphenylpropanoic acid",C1=CC=C(C=C1)C(C(C2=CC=CC=C2)O)C(=O)O,,,,,,
5511,95512,"[1,1'-Biphenyl]-4-yl(phenyl)methanol",C1=CC=C(C=C1)C2=CC=C(C=C2)C(C3=CC=CC=C3)O,,,,,,
5512,95513,"1,2-Dipyridin-2-ylethane-1,2-diol",C1=CC=NC(=C1)C(C(C2=CC=CC=N2)O)O,,,,,,
5513,95514,"5-(4-Hydroxybutyl)imidazolidine-2,4-dione",C(CCO)CC1C(=O)NC(=O)N1,,,,,,
5514,95515,DL-alpha-Methylleucine,CC(C)CC(C)(C(=O)O)N,,,,,,
5515,95516,CID 95516,C=CC=CC(=O)O,,,,,,
5516,95517,2-(2-Carboxyethenyl)benzoic acid,C1=CC=C(C(=C1)C=CC(=O)O)C(=O)O,,,,,,
5517,95518,4-[(Hydroxyimino)methyl]-2-methoxyphenol,COC1=C(C=CC(=C1)C=NO)O,,,,,,
5518,95519,Diisoeugenol,CCC1C(C(C2=CC(=C(C=C12)OC)O)C3=CC(=C(C=C3)O)OC)C,,,,,,
5519,95520,"1,1,2,3,3,5-Hexamethylindan",CC1C(C2=C(C1(C)C)C=C(C=C2)C)(C)C,,,,,,
5520,95521,"1,3-Cyclopentanedicarboxylic acid, 4,5-dioxo-, diethyl ester",CCOC(=O)C1CC(C(=O)C1=O)C(=O)OCC,,,,,,
5521,95522,"2,3-Dihydro-1H-cyclopenta(b)quinoxaline-1,3-dicarboxylic acid diethyl ester",CCOC(=O)C1CC(C2=NC3=CC=CC=C3N=C12)C(=O)OCC,,,,,,
5522,95523,"2-(3-Oxo-1,3-dihydro-2-benzofuran-1-ylidene)acetic acid",C1=CC=C2C(=C1)C(=CC(=O)O)OC2=O,,,,,,
5523,95524,Isobutyl 2-ethylhexyl phthalate,CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)OCC(C)C,,,,,,
5524,95525,N-(4-Nitrobenzoyl)glutamic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)[N+](=O)[O-],,,,,,
5525,95526,2-Acetamido-3-phenylsulfanylpropanoic acid,CC(=O)NC(CSC1=CC=CC=C1)C(=O)O,,,,,,
5526,95527,"1,1,2-Triphenylethane-1,2-diol",C1=CC=C(C=C1)C(C(C2=CC=CC=C2)(C3=CC=CC=C3)O)O,,,,,,
5527,95528,2-Methylthiomorpholin-3-one,CC1C(=O)NCCS1,,,,,,
5528,95529,"2,5-Diethylthiomorpholin-3-one",CCC1CSC(C(=O)N1)CC,,,,,,
5529,95530,"3-Thiomorpholinone, 2,5,5-trimethyl-",CC1C(=O)NC(CS1)(C)C,,,,,,
5530,95531,"3-Thiomorpholinone, 5,5-dimethyl-2-ethyl-",CCC1C(=O)NC(CS1)(C)C,,,,,,
5531,95532,"3-Thiomorpholinone, 2,2-dimethyl-5-ethyl-",CCC1CSC(C(=O)N1)(C)C,,,,,,
5532,95533,"3-Thiomorpholinone, 2,2,5-trimethyl-",CC1CSC(C(=O)N1)(C)C,,,,,,
5533,95534,"3-Thiomorpholinone, 2,5-dimethyl-",CC1CSC(C(=O)N1)C,,,,,,
5534,95535,"3-Thiomorpholinone, 5,5-dimethyl-2-propyl-",CCCC1C(=O)NC(CS1)(C)C,,,,,,
5535,95536,2-Chloro-1-nitro-propane,CC(C[N+](=O)[O-])Cl,,,,,,
5536,95537,1-Nitro-2-propanol,CC(C[N+](=O)[O-])O,,,,,,
5537,95538,1-Nitrobutan-2-ol,CCC(C[N+](=O)[O-])O,,,,,,
5538,95539,Butyl 2-methylvalerate,CCCCOC(=O)C(C)CCC,,,,,,
5539,95540,Pentyl 2-methylpentanoate,CCCCCOC(=O)C(C)CCC,,,,,,
5540,95541,"Butanoic acid, 3-(tetrahydro-2-furanyl)propyl ester",CCCC(=O)OCCCC1CCCO1,,,,,,
5541,95542,2-Phenyl-1-butanol,CCC(CO)C1=CC=CC=C1,,,,,,
5542,95543,Ethyl 2-oxocyclohexanecarboxylate,CCOC(=O)C1CCCCC1=O,,,,,,
5543,95544,Ethyl 2-acetyl-3-methylbutanoate,CCOC(=O)C(C(C)C)C(=O)C,,,,,,
5544,95545,3-Phenyl-N-(N-((phenylmethoxy)carbonyl)-L-alpha-glutamyl)-L-alanine,C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)OCC2=CC=CC=C2,,,,,,
5545,95546,Phenylmandelic acid,C1=CC=C(C=C1)C2=CC=C(C=C2)C(C(=O)O)O,,,,,,
5546,95547,2'-Hydroxy-4-methoxy-chalcone,COC1=CC=C(C=C1)C=CC(=O)C2=CC=CC=C2O,,,,,,
5547,95548,"2-Chloro-1,1,3-triethoxypropane",CCOCC(C(OCC)OCC)Cl,,,,,,
5548,95549,CID 95549,C1=CNC2=NC=C(C2=C1)CC(C(=O)O)N,,,,,,
5549,95550,"2H-1-Benzopyran-2-one, 3,4-dihydro-4-methyl-",CC1CC(=O)OC2=CC=CC=C12,,,,,,
5550,95551,"2-Octanol, 1-nitro-",CCCCCCC(C[N+](=O)[O-])O,,,,,,
5551,95552,"3,4-Xylidino-D-ribitol",CC1=C(C=C(C=C1)NCC(C(C(CO)O)O)O)C,,,,,,
5552,95553,Diethylmercaptal-D-arabinose,CCSC(C(C(C(CO)O)O)O)SCC,,,,,,
5553,95554,"Butanoic acid, 2-ethyl-, 2-methylpropyl ester",CCC(CC)C(=O)OCC(C)C,,,,,,
5554,95555,N-Acetylaminooctanoic acid,CCCCCCC(C(=O)O)NC(=O)C,,,,,,
5555,95556,"1-Phenyl-2,2,2-trifluoroethanol",C1=CC=C(C=C1)C(C(F)(F)F)O,,,,,,
5556,95557,2-(4-Methylbenzyl)succinic acid,CC1=CC=C(C=C1)CC(CC(=O)O)C(=O)O,,,,,,
5557,95558,Tetrahydro-2H-pyran-2-methanol acetate,CC(=O)OCC1CCCCO1,,,,,,
5558,95559,"3,4-Dihydro-2H-pyran-2-methanol",C1CC(OC=C1)CO,,,,,,
5559,95560,2-Cyclohexylpropanal,CC(C=O)C1CCCCC1,,,,,,
5560,95561,"2-Nonanone, 5-ethyl-",CCCCC(CC)CCC(=O)C,,,,,,
5561,95562,2-Amino-5-hydroxypentanoic acid,C(CC(C(=O)O)N)CO,,,,,,
5562,95563,"[4-(Dimethylamino)-6-[8-[4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]-11-hydroxy-5-methyl-2-(2-methyl-3-prop-1-enyloxiran-2-yl)-4,7,12-trioxonaphtho[2,3-h]chromen-10-yl]-2,4-dimethyloxan-3-yl] acetate",CC=CC1C(O1)(C)C2=CC(=O)C3=C(O2)C4=C(C=C3C)C(=O)C5=C(C4=O)C(=C(C=C5C6CC(C(C(O6)C)O)N(C)C)C7CC(C(C(O7)C)OC(=O)C)(C)N(C)C)O,,,,,,
5563,95564,1-Methyl-4-phenylperhydroazepine-4-carbonitrile,CN1CCCC(CC1)(C#N)C2=CC=CC=C2,,,,,,
5564,95565,"1,5-Bis(5-nitro-2-furyl)penta-1,4-dien-3-one",C1=C(OC(=C1)[N+](=O)[O-])C=CC(=O)C=CC2=CC=C(O2)[N+](=O)[O-],,,,,,
5565,95566,1-Bromo-3-chloro-2-methylpropane,CC(CCl)CBr,,,,,,
5566,95567,"4-Methyl-2-(1-phenylhept-1-en-2-yl)-1,3-dioxolane",CCCCCC(=CC1=CC=CC=C1)C2OCC(O2)C,,,,,,
5567,95568,2-Ethylhexyl formate,CCCCC(CC)COC=O,,,,,,
5568,95569,"2,2,4-Trimethylpentane-1,3-diyl diformate",CC(C)C(C(C)(C)COC=O)OC=O,,,,,,
5569,95570,sec-Butyl benzoate,CCC(C)OC(=O)C1=CC=CC=C1,,,,,,
5570,95571,2-Ethylhexyl valerate,CCCCC(CC)COC(=O)CCCC,,,,,,
5571,95572,"4-Methyl-2-octyl-1,3-dioxolane",CCCCCCCCC1OCC(O1)C,,,,,,
5572,95573,"9-Fluoro-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one",CC12CCC(=O)C=C1CCC3C2(C(CC4(C3CC(C4(C(=O)CO)O)O)C)O)F,,,,,,
5573,95574,"Corticosterone, 9-fluoro-16alpha,17-(isopropylidenedioxy)-",CC1(OC2CC3C4CCC5=CC(=O)CCC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C,,,,,,
5574,95575,DL-Propargylglycine,C#CCC(C(=O)O)N,,,['Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)'],,,
5575,95576,Methyl 2-bromopropionate,CC(C(=O)OC)Br,,,,,,
5576,95577,Methyl 2-bromobutyrate,CCC(C(=O)OC)Br,,,,,,
5577,95578,Methyl 2-bromohexanoate,CCCCC(C(=O)OC)Br,,,,,,
5578,95579,Methyl 2-bromooctanoate,CCCCCCC(C(=O)OC)Br,,,,,,
5579,95580,Ethyl 2-bromooctanoate,CCCCCCC(C(=O)OCC)Br,,,,,,
5580,95581,Ethyl 2-bromodecanoate,CCCCCCCCC(C(=O)OCC)Br,,,,,,
5581,95582,Ethyl 2-bromoundecanoate,CCCCCCCCCC(C(=O)OCC)Br,,,,,,
5582,95583,Ethyl 2-bromododecanoate,CCCCCCCCCCC(C(=O)OCC)Br,,,,,,
5583,95584,"Pregna-4,11-diene-3,20-dione(7CI,8CI,9CI)",CC(=O)C1CCC2C1(C=CC3C2CCC4=CC(=O)CCC34C)C,,,,,,
5584,95585,"17-acetyl-13-methyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one",CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C,,,,,,
5585,95586,(E)-2-(2-Nitroethenyl)thiophene,C1=CSC(=C1)C=C[N+](=O)[O-],,,,,,
5586,95587,Chrysanthin,CC1=CC(C2C(CC3(C(O3)CC1)C)OC(=O)C2=C)OC(=O)C,,,,,,
5587,95588,Ethyl 1-oxaspiro[2.5]octane-2-carboxylate,CCOC(=O)C1C2(O1)CCCCC2,,,,,,
5588,95589,"1,4-Dicarbethoxy-2-methylpiperazine",CCOC(=O)N1CCN(C(C1)C)C(=O)OCC,,,,,,
5589,95590,"Chlorendic acid, diallyl ester",C=CCOC(=O)C1C(C2(C(=C(C1(C2(Cl)Cl)Cl)Cl)Cl)Cl)C(=O)OCC=C,,,,,,
5590,95591,Di-2-ethylhexyl chlorendate,CCCCC(CC)COC(=O)C1C(C2(C(=C(C1(C2(Cl)Cl)Cl)Cl)Cl)Cl)C(=O)OCC(CC)CCCC,,,,,,
5591,95592,2-Phenylcyclohexanone,C1CCC(=O)C(C1)C2=CC=CC=C2,,,,,,
5592,95593,2-Methyl-3-phenylpropanal,CC(CC1=CC=CC=C1)C=O,,,,,,
5593,95594,2-Methyl-3-(p-tolyl)propionaldehyde,CC1=CC=C(C=C1)CC(C)C=O,,,,,,
5594,95595,p-Isopropylcinnamaldehyde,CC(C)C1=CC=C(C=C1)C=CC=O,,,,,,
5595,95596,1-Methyl-4-(4-methyl-3-pentenyl)cyclohex-3-ene-1-carbaldehyde,CC(=CCCC1=CCC(CC1)(C)C=O)C,,,,,,
5596,95597,4-Cyclohexylbut-3-en-2-one,CC(=O)C=CC1CCCCC1,,,,,,
5597,95598,"1,2,3,4,5,6,7,8-Octahydro-2,8,8-trimethylnaphthalene-2-carbaldehyde",CC1(CCCC2=C1CC(CC2)(C)C=O)C,,,,,,
5598,95599,"1-(1,2,3,4,5,6,7,8-Octahydro-2,8,8-trimethyl-2-naphthyl)ethan-1-one",CC(=O)C1(CCC2=C(C1)C(CCC2)(C)C)C,,,,,,
5599,95600,"1-(1,2,3,4,5,6,7,8-Octahydro-3,3,8,8-tetramethyl-2-naphthyl)ethan-1-one",CC(=O)C1CC2=C(CCCC2(C)C)CC1(C)C,,,,,,
5600,95601,"Ethanone, 1-(1,2,3,4,5,6,7,8-octahydro-8,8-dimethyl-2-naphthalenyl)-",CC(=O)C1CCC2=C(C1)C(CCC2)(C)C,,,,,,
5601,95602,4-[(2-Ethylhexyl)amino]-4-oxobut-2-enoic acid,CCCCC(CC)CNC(=O)C=CC(=O)O,,,,,,
5602,95603,4-(Methylamino)-4-oxobut-2-enoic acid,CNC(=O)C=CC(=O)O,,,,,,
5603,95604,"4,7-Methano-1H-indene, 5-chloro-3a,4,5,6,7,7a-hexahydro-",C1C=CC2C1C3CC2C(C3)Cl,,,,,,
5604,95605,Dihydrodicyclopentadiene,C1CC2CC1C3C2C=CC3,,,,,,
5605,95606,"Octahydro-4,7-methano-1H-inden-5-ol",C1CC2C(C1)C3CC2CC3O,,,,,,
5606,95607,6-(sec-Butylthio)purine,CCC(C)SC1=NC=NC2=C1NC=N2,,,,,,
5607,95608,"Methyl 3,12-dihydroxycholan-24-oate",CC(CCC(=O)OC)C1CCC2C1(C(CC3C2CCC4C3(CCC(C4)O)C)O)C,,,,,,
5608,95609,4-Hydroxyhexan-3-one,CCC(C(=O)CC)O,,,,,,
5609,95610,"11,20-Dioxopregnan-3-yl acetate",CC(=O)C1CCC2C1(CC(=O)C3C2CCC4C3(CCC(C4)OC(=O)C)C)C,,,,,,
5610,95611,Glycidyldiethylamine,CCN(CC)CC1CO1,,,,,,
5611,95612,"4-Methyl-2-pentyl-1,3-dioxane",CCCCCC1OCCC(O1)C,,,,,,
5612,95613,"1,3-Dioxane, 4,4,6-trimethyl-2-pentyl-",CCCCCC1OC(CC(O1)(C)C)C,,,,,,
5613,95614,3-Methyl-4-[4-(1-methylethyl)phenyl]-3-buten-2-one,CC(C)C1=CC=C(C=C1)C=C(C)C(=O)C,,,,,,
5614,95615,3-Methyl-4-(4-isopropylphenyl)butan-2-one,CC(C)C1=CC=C(C=C1)CC(C)C(=O)C,,,,,,
5615,95616,"9-fluoro-17-hydroxy-10,13,17-trimethyl-2,4,5,6,7,8,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,11-dione",CC12CCC(=O)CC1CCC3C2(C(=O)CC4(C3CCC4(C)O)C)F,,,,,,
5616,95617,"9-fluoro-10,13,17-trimethyl-2,3,4,5,6,7,8,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthrene-3,11,17-triol",CC12CCC(CC1CCC3C2(C(CC4(C3CCC4(C)O)C)O)F)O,,,,,,
5617,95618,alpha-((Ethylamino)methyl)benzyl alcohol,CCNCC(C1=CC=CC=C1)O,,,,,,
5618,95619,"Chrysanthemic acid, isopropyl ester",CC(C)OC(=O)C1C(C1(C)C)C=C(C)C,,,,,,
5619,95620,"17-hydroxy-2-(hydroxymethylidene)-10,13-dimethyl-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one",CC12CCC3C(C1CCC2O)CCC4C3(CC(=CO)C(=O)C4)C,,,,,,
5620,95621,"DL-Phenylalanine, N-(dichloroacetyl)-",C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(Cl)Cl,,,,,,
5621,95622,"2-Propenal,3-(1,3-benzodioxol-5-YL)-2-methyl-",CC(=CC1=CC2=C(C=C1)OCO2)C=O,,,,,,
5622,95623,Nalco L-699,CC(CN(CCN(CC(C)O)CC(C)O)CCO)O,,,,,,
5623,95624,alpha-Pyridoin,C1=CC=NC(=C1)C(C(=O)C2=CC=CC=N2)O,,,,,,
5624,95625,Bis(tetrahydrofurfuryl) sebacate,C1CC(OC1)COC(=O)CCCCCCCCC(=O)OCC2CCCO2,,,,,,
5625,95626,2-Methyl-1-phenylpropan-1-ol,CC(C)C(C1=CC=CC=C1)O,,,,,,
5626,95627,(alpha-Methylphenethyl)urea,CC(CC1=CC=CC=C1)NC(=O)N,,,,,,
5627,95628,"3-(m-Tolyloxy)-1,2-propanediol",CC1=CC(=CC=C1)OCC(CO)O,,,,,,
5628,95629,"Levoglucosan, triacetate",CC(=O)OC1C2COC(O2)C(C1OC(=O)C)OC(=O)C,,,,,,
5629,95630,Ethyl 2-ethoxy-2-hydroxyacetate,CCOC(C(=O)OCC)O,,,,,,
5630,95631,alpha-Acetamidocinnamic acid,CC(=O)NC(=CC1=CC=CC=C1)C(=O)O,,,,,,
5631,95632,"4,4,6-Trimethyl-2-phenyl-1,3-dioxane",CC1CC(OC(O1)C2=CC=CC=C2)(C)C,,,,,,
5632,95633,"2-Benzyl-4-methyl-1,3-dioxolane",CC1COC(O1)CC2=CC=CC=C2,,,,,,
5633,95634,"2-Benzyl-4-methyl-1,3-dioxane",CC1CCOC(O1)CC2=CC=CC=C2,,,,,,
5634,95635,"2-Propanol, 1-ethoxy-3-isopropoxy-",CCOCC(COC(C)C)O,,,,,,
5635,95636,Enallylpropymal,CC(C)C1(C(=O)NC(=O)N(C1=O)C)CC=C,,,,,,
5636,95637,3-Bromosulfolane,C1CS(=O)(=O)CC1Br,,,,,,
5637,95638,"1,3,2-Dioxathiane, 5-methyl-5-propyl-, 2-oxide",CCCC1(COS(=O)OC1)C,,,,,,
5638,95639,"1,2-Dipyridin-4-ylethane-1,2-diol",C1=CN=CC=C1C(C(C2=CC=NC=C2)O)O,,,,,,
5639,95640,2-Methyl-3-phenylpropanol,CC(CC1=CC=CC=C1)CO,,,,,,
5640,95641,CID 95641,COC1=CC=C(C=C1)C=CCO,,,,,,
5641,95642,"6,8-Dimethylnon-5-en-2-one",CC(C)CC(=CCCC(=O)C)C,,,,,,
5642,95643,Ethyl 3-methyl-3-nonyloxirane-2-carboxylate,CCCCCCCCCC1(C(O1)C(=O)OCC)C,,,,,,
5643,95644,"3,6-Dimethylcyclohex-3-ene-1-carbaldehyde",CC1CC=C(CC1C=O)C,,,,,,
5644,95645,"1-Ethoxy-1,3-dimethoxyoctane",CCCCCC(CC(OC)OCC)OC,,,,,,
5645,95646,"1-Ethoxy-1,3-dimethoxynonane",CCCCCCC(CC(OC)OCC)OC,,,,,,
5646,95647,"1-Ethoxy-1,3-dimethoxydodecane",CCCCCCCCCC(CC(OC)OCC)OC,,,,,,
5647,95648,4-(4-Hydroxyphenyl)-3-buten-2-one,CC(=O)C=CC1=CC=C(C=C1)O,,,,,,
5648,95649,"5,9-Dimethyldec-2-enal",CC(C)CCCC(C)CC=CC=O,,,,,,
5649,95650,"1,2-Propanediol, 3-isopentyloxy-",CC(C)CCOCC(CO)O,,,,,,
5650,95651,"2-Hydroxy-1,2-bis(2-methoxyphenyl)ethanone",COC1=CC=CC=C1C(C(=O)C2=CC=CC=C2OC)O,,,,,,
5651,95652,"2(3H)-Furanone, dihydro-4-hydroxy-",C1C(COC1=O)O,,,,,,
5652,95653,"9,10,12,13,15,16-Hexabromooctadecanoic acid",CCC(C(CC(C(CC(C(CCCCCCCC(=O)O)Br)Br)Br)Br)Br)Br,,,,,,
5653,95654,CID 95654,CC1(OC2C(OC(C2O1)N3C=NC4=C3N=CN=C4S)CO)C,,,,,,
5654,95655,"1,1'-(Methylimino)dipropan-2-ol",CC(CN(C)CC(C)O)O,,,,,,
5655,95656,"p-Amino-N,alpha-dimethylphenethylamine",CC(CC1=CC=C(C=C1)N)NC,,,,,,
5656,95657,2-(((Benzyloxy)carbonyl)amino)propanoic acid,CC(C(=O)O)NC(=O)OCC1=CC=CC=C1,,,,,,
5657,95658,"4-Isopropyl-2-(4-methoxyphenyl)-5,5-dimethyl-1,3-dioxane",CC(C)C1C(COC(O1)C2=CC=C(C=C2)OC)(C)C,,,,,,
5658,95659,2-Methylbenzhydrol,CC1=CC=CC=C1C(C2=CC=CC=C2)O,,,,,,
5659,95660,Cinnamalmalonsaure,C1=CC=C(C=C1)C=CC=C(C(=O)O)C(=O)O,,,,,,
5660,95661,"Propanedioic acid, (acetylamino)(1H-indol-3-ylmethyl)-, diethyl ester",CCOC(=O)C(CC1=CNC2=CC=CC=C21)(C(=O)OCC)NC(=O)C,,,,,,
5661,95662,"1-Propanone, 1-(4-hydroxy-3-methoxyphenyl)-3-(1-piperidinyl)-",COC1=C(C=CC(=C1)C(=O)CCN2CCCCC2)O,,,,,,
5662,95663,CID 95663,CC(=C(N=O)Cl)O,,,,,,
5663,95664,N-Benzoylaspartic acid,C1=CC=C(C=C1)C(=O)NC(CC(=O)O)C(=O)O,,,,,,
5664,95665,"5,7-Dimethylcoumarin",CC1=CC(=C2C=CC(=O)OC2=C1)C,,,,,,
5665,95666,"5-(3,4-Dichlorophenyl)imidazolidine-2,4-dione",C1=CC(=C(C=C1C2C(=O)NC(=O)N2)Cl)Cl,,,,,,
5666,95667,1-(2-Bromoethoxy)-4-methylbenzene,CC1=CC=C(C=C1)OCCBr,,,,,,
5667,95668,Cyclohexyl(phenyl)methanol,C1CCC(CC1)C(C2=CC=CC=C2)O,,,,,,
5668,95669,"2,4,6-Triethyl-1,3,5-trioxane",CCC1OC(OC(O1)CC)CC,,,,,,
5669,95670,1-Butyl-3-ethylurea,CCCCNC(=O)NCC,,,,,,
5670,95671,1-Phenylurazole,C1=CC=C(C=C1)N2C(=O)NC(=O)N2,,,,,,
5671,95672,5-Phenylpyrrolidin-2-one,C1CC(=O)NC1C2=CC=CC=C2,,,,,,
5672,95673,"9(10H)-Acridinone, 10-methyl-2-nitro-",CN1C2=C(C=C(C=C2)[N+](=O)[O-])C(=O)C3=CC=CC=C31,,,,,,
5673,95674,"9(10H)-Acridinone, 3-nitro-",C1=CC=C2C(=C1)C(=O)C3=C(N2)C=C(C=C3)[N+](=O)[O-],,,,,,
5674,95675,6-Amino-1-ethyl-3-propyluracil,CCCN1C(=O)C=C(N(C1=O)CC)N,,,,,,
5675,95676,3-(2-Chlorophenyl)propionic acid,C1=CC=C(C(=C1)CCC(=O)O)Cl,,,,,,
5676,95677,Benzylidenemalonic acid,C1=CC=C(C=C1)C=C(C(=O)O)C(=O)O,,,,,,
5677,95678,"Acetamide, N,N'-p-phenylenebis(2,2,2-trichloro-",C1=CC(=CC=C1NC(=O)C(Cl)(Cl)Cl)NC(=O)C(Cl)(Cl)Cl,,,,,,
5678,95679,CID 95679,CC1=CC(=O)C2=C(C=C(OC2=C1)O)C,,,,,,
5679,95680,"1H-Purine, 2,6-bis(methylthio)-",CSC1=NC(=NC2=C1NC=N2)SC,,,,,,
5680,95681,"Purine, 6-(2,2,2-trifluoroethoxy)-",C1=NC2=C(N1)C(=NC=N2)OCC(F)(F)F,,,,,,
5681,95682,"1-(1,3-Benzodioxol-5-yl)-1-propanone",CCC(=O)C1=CC2=C(C=C1)OCO2,,,,,,
5682,95683,"Benzamide, N-(2-methoxyphenyl)-2-methyl-",CC1=CC=CC=C1C(=O)NC2=CC=CC=C2OC,,,,,,
5683,95684,"Formamide, N-(1,1'-biphenyl)-4-yl-",C1=CC=C(C=C1)C2=CC=C(C=C2)NC=O,,,,,,
5684,95685,Isopropyl dimethylcarbamate,CC(C)OC(=O)N(C)C,,,,,,
5685,95686,2-(2-(((Benzyloxy)carbonyl)amino)acetamido)acetic acid,C1=CC=C(C=C1)COC(=O)NCC(=O)NCC(=O)O,,,,,,
5686,95687,"(5-Hydroxy-4,6-dimethylpyridin-3-YL)methyl dihydrogen phosphate",CC1=C(C(=NC=C1COP(=O)(O)O)C)O,,,,,,
5687,95688,5-Norbornen-2-yl acetate,CC(=O)OC1CC2CC1C=C2,,,,,,
5688,95689,4-(Isopropyl)cyclohexyl propionate,CCC(=O)OC1CCC(CC1)C(C)C,,,,,,
5689,95690,"Purine, 6-(o-tolyloxy)-",CC1=CC=CC=C1OC2=NC=NC3=C2NC=N3,,,,,,
5690,95691,"Phosphoric triamide, N,N-bis(2-chloroethyl)-",C(CCl)N(CCCl)P(=O)(N)N,,,,,,
5691,95692,4-Methylnicotinamide,CC1=C(C=NC=C1)C(=O)N,,,,,,
5692,95693,1-(3-Hydroxy-4-methoxyphenyl)ethanone,CC(=O)C1=CC(=C(C=C1)OC)O,,,,,,
5693,95694,CID 95694,C12=C(NC(=NC1=NC(=O)N2)N)N,,,,,,
5694,95695,2-Hydroxy-5-methoxybenzaldehyde,COC1=CC(=C(C=C1)O)C=O,,,,,,
5695,95696,2-(4-Chloro-3-methylphenoxy)acetic acid,CC1=C(C=CC(=C1)OCC(=O)O)Cl,,,,,,
5696,95697,3-Phenoxypropylene di(acetate),CC(=O)OCC(COC1=CC=CC=C1)OC(=O)C,,,,,,
5697,95698,N-(Hydroxymethyl)salicylamide,C1=CC=C(C(=C1)C(=O)NCO)O,,,,,,
5698,95699,"Hydroquinone, 2,5-bis((dimethylamino)methyl)-",CN(C)CC1=CC(=C(C=C1O)CN(C)C)O,,,,,,
5699,95700,"Urea, 1-morpholinomethyl-",C1COCCN1CNC(=O)N,,,,,,
5700,95701,2-Butoxypyridine,CCCCOC1=CC=CC=N1,,,,,,
5701,95702,"N,N-Dimethyl(2-thienylmethyl)amine",CN(C)CC1=CC=CS1,,,,,,
5702,95703,3-Ethylpent-4-en-1-yn-3-ol,CCC(C=C)(C#C)O,,,,,,
5703,95704,"N-(Diethylaminoethyl)-2-norbornene-5,6-dicarboximide",CCN(CC)CCN1C(=O)C2C3CC(C2C1=O)C=C3,,,,,,
5704,95705,"5-Ethyl-5-methyl-1H,3H,5H-pyrimidin-2,4,6-trione",CCC1(C(=O)NC(=O)NC1=O)C,,,,,,
5705,95706,"9(10H)-Acridinone, 2-nitro-",C1=CC=C2C(=C1)C(=O)C3=C(N2)C=CC(=C3)[N+](=O)[O-],,,,,,
5706,95707,"Anthraquinone, 2-acetamido-",CC(=O)NC1=CC2=C(C=C1)C(=O)C3=CC=CC=C3C2=O,,,,,,
5707,95708,Acronycidine,COC1=CC(=C(C2=C1C(=C3C=COC3=N2)OC)OC)OC,,,,,,
5708,95709,(2-Hydroxyphenyl)diphenylmethanol,C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3O)O,,,,,,
5709,95710,"Phosphonic diamide, 4-(chloromethyl)-",C(P(=O)(N)N)Cl,,,,,,
5710,95711,Trimethylphosphoramide,CNP(=O)(NC)NC,,,,,,
5711,95712,"Phosphoramidic acid, methyl-, diethyl ester",CCOP(=O)(NC)OCC,,,,,,
5712,95713,3-(1-Aziridinyl)butyronitrile,CC(CC#N)N1CC1,,,,,,
5713,95714,"2,5-Cyclohexadiene-1,4-dione, 2,5-bis(1-aziridinyl)-3,6-dichloro-",C1CN1C2=C(C(=O)C(=C(C2=O)Cl)N3CC3)Cl,,,,,,
5714,95715,Ethylenimine quinone,C1CN1C2=CC(=O)C(=CC2=O)N3CC3,,,,,,
5715,95716,6-Bromoisatin,C1=CC2=C(C=C1Br)NC(=O)C2=O,,,,,,
5716,95717,"9,10-Dihydrobenzo[a]pyren-7(8h)-one",C1CC2=C(C=C3C=CC4=C5C3=C2C=CC5=CC=C4)C(=O)C1,,,,,,
5717,95718,"9,10-Diethylanthracene",CCC1=C2C=CC=CC2=C(C3=CC=CC=C31)CC,,,,,,
5718,95719,"Tribenz[a,c,h]anthracene",C1=CC=C2C(=C1)C=CC3=CC4=C(C=C32)C5=CC=CC=C5C6=CC=CC=C64,,,,,,
5719,95720,N-Methyl-N'-nitrosoguanidine,CN=C(N)NN=O,,,,,,
5720,95721,Ethyl 5-(benzyloxy)-1H-indole-2-carboxylate,CCOC(=O)C1=CC2=C(N1)C=CC(=C2)OCC3=CC=CC=C3,,,,,,
5721,95722,"Benz(a)anthracene, 7-chloromethyl-",C1=CC=C2C(=C1)C=CC3=C(C4=CC=CC=C4C=C32)CCl,,,,,,
5722,95723,3-Ethylcholanthrene,CCC1=C2CCC3=C2C(=CC4=C3C=CC5=CC=CC=C54)C=C1,,,,,,
5723,95724,3-Phenanthrol,C1=CC=C2C(=C1)C=CC3=C2C=C(C=C3)O,,,,,,
5724,95725,"Dibenz[a,h]anthracene-7,14-dione",C1=CC=C2C(=C1)C=CC3=C2C(=O)C4=C(C3=O)C5=CC=CC=C5C=C4,,,,,,
5725,95726,"Benz(j)aceanthrylene, 1,2-dihydro-3,11-dimethyl-",CC1=C2CCC3=C2C(=CC4=C3C=C(C5=CC=CC=C54)C)C=C1,,,,,,
5726,95727,5-(4-Methoxy-benzyl)-hydantoin,COC1=CC=C(C=C1)CC2C(=O)NC(=O)N2,,,,,,
5727,95728,CID 95728,COC1=CC=C(C=C1)C=C2C(=O)N=C(N2)S,,,,,,
5728,95729,2-(4-Methoxyphenoxy)benzoic acid,COC1=CC=C(C=C1)OC2=CC=CC=C2C(=O)O,,,,,,
5729,95730,CID 95730,CCOC1=CC=CC=C1N=C(N)S,,,,,,
5730,95731,"1,4,5,8,9,10-Anthracenehexol",C1=CC(=C2C(=C1O)C(=C3C(=CC=C(C3=C2O)O)O)O)O,,,,,,
5731,95732,Dodecahydro-1H-carbazole,C1CCC2C(C1)C3CCCCC3N2,,,,,,
5732,95733,"N-Butyl-1,3-diaminopropane",CCCCNCCCN,,,,,,
5733,95734,"Piperidine, 4-(diphenylmethylene)-1-methyl-",CN1CCC(=C(C2=CC=CC=C2)C3=CC=CC=C3)CC1,,,,,,
5734,95735,Tetraethyleniminobenzo-quinone,C1CN1C2=C(C(=O)C(=C(C2=O)N3CC3)N4CC4)N5CC5,,,,,,
5735,95736,Monofluoroacetylglycine,C(C(=O)O)NC(=O)CF,,,,,,
5736,95737,3-Mercaptobenzoic acid,C1=CC(=CC(=C1)S)C(=O)O,,,,,,
5737,95738,4-Mercaptobenzoic acid,C1=CC(=CC=C1C(=O)O)S,,,,,,
5738,95739,"3-Amino-2,2-dimethylpropanoic acid",CC(C)(CN)C(=O)O,,,,,,
5739,95740,"Rhodanine, 3-cyclohexyl-",C1CCC(CC1)N2C(=O)CSC2=S,,,,,,
5740,95741,"Rhodanine, 3-(m-tolyl)-",CC1=CC(=CC=C1)N2C(=O)CSC2=S,,,,,,
5741,95742,"Benzaldehyde, hydrazone",C1=CC=C(C=C1)C=NN,,,,,,
5742,95743,1-(2-Chlorophenyl)propan-1-one,CCC(=O)C1=CC=CC=C1Cl,,,,,,
5743,95744,"2,2-Difluoropropane-1,3-diol",C(C(CO)(F)F)O,,,,,,
5744,95745,"4-(1,3-Benzothiazol-2-yl)phenol",C1=CC=C2C(=C1)N=C(S2)C3=CC=C(C=C3)O,,,,,,
5745,95746,"1,3-Benzenediol, 4-(2-benzothiazolyl)-",C1=CC=C2C(=C1)N=C(S2)C3=C(C=C(C=C3)O)O,,,,,,
5746,95747,"2-(2-Ethoxyphenyl)-1,3-benzothiazole",CCOC1=CC=CC=C1C2=NC3=CC=CC=C3S2,,,,,,
5747,95748,"1,4-Bis(2-phenoxyethyl)piperazine",C1CN(CCN1CCOC2=CC=CC=C2)CCOC3=CC=CC=C3,,,,,,
5748,95749,"1,4-Bis(3-phenoxypropyl)piperazine",C1CN(CCN1CCCOC2=CC=CC=C2)CCCOC3=CC=CC=C3,,,,,,
5749,95750,3-(4-Methoxyphenyl)propanoic acid,COC1=CC=C(C=C1)CCC(=O)O,,,,,,
5750,95751,"Benzothiazole, 2-(2,4-dichlorophenyl)-",C1=CC=C2C(=C1)N=C(S2)C3=C(C=C(C=C3)Cl)Cl,,,,,,
5751,95752,2-(4-Chlorophenyl)benzothiazole,C1=CC=C2C(=C1)N=C(S2)C3=CC=C(C=C3)Cl,,,,,,
5752,95753,2-(4-Methoxyphenyl)benzothiazole,COC1=CC=C(C=C1)C2=NC3=CC=CC=C3S2,,,,,,
5753,95754,"Phenol, 2-(2-benzothiazolyl)-6-methoxy-",COC1=CC=CC(=C1O)C2=NC3=CC=CC=C3S2,,,,,,
5754,95755,"4-(1,3-Benzothiazol-2-yl)-N,N-dimethylaniline",CN(C)C1=CC=C(C=C1)C2=NC3=CC=CC=C3S2,,,,,,
5755,95756,"2,4-Dichlorobenzyl mercaptan",C1=CC(=C(C=C1Cl)Cl)CS,,,,,,
5756,95757,"3-Oxo-5,6-diphenyl-2,3-dihydropyridazine-4-carbonitrile",C1=CC=C(C=C1)C2=C(C(=O)NN=C2C3=CC=CC=C3)C#N,,,,,,
5757,95758,CID 95758,CC1=NC2=C(NC(=NC2=NC1=O)N)N,,,,,,
5758,95759,"2,7-Dinitro-9,10-phenanthrenedione",C1=CC2=C(C=C1[N+](=O)[O-])C(=O)C(=O)C3=C2C=CC(=C3)[N+](=O)[O-],,,,,,
5759,95760,Heptyl acetoacetate,CCCCCCCOC(=O)CC(=O)C,,,,,,
5760,95761,"Phenol, 2,4,5-trichloro-, carbanilate",C1=CC=C(C=C1)NC(=O)OC2=CC(=C(C=C2Cl)Cl)Cl,,,,,,
5761,95762,"Benzothiazole, 2-(2-nitrophenyl)-",C1=CC=C(C(=C1)C2=NC3=CC=CC=C3S2)[N+](=O)[O-],,,,,,
5762,95763,"2-(2-Chlorophenyl)-1,3-benzothiazole",C1=CC=C(C(=C1)C2=NC3=CC=CC=C3S2)Cl,,,,,,
5763,95764,"Benzothiazole, 2-(2-methoxyphenyl)-",COC1=CC=CC=C1C2=NC3=CC=CC=C3S2,,,,,,
5764,95765,1-Cyclopropyl-ethanone oxime,CC(=NO)C1CC1,,,,,,
5765,95766,1-(2-Phenoxyethyl)-4-phenylpiperazine,C1CN(CCN1CCOC2=CC=CC=C2)C3=CC=CC=C3,,,,,,
5766,95767,2-[2-(Phenylmethoxy)ethyl]pyridine,C1=CC=C(C=C1)COCCC2=CC=CC=N2,,,,,,
5767,95768,Ibazole nitrile,CC(C)(CCC#N)C1=NC2=C(S1)N=C(S2)C(C)(C)CCC#N,,,,,,
5768,95769,"[1,2,5]Thiadiazolo[3,4-d]pyrimidin-7-amine",C1=NC2=NSN=C2C(=N1)N,,,,,,
5769,95770,"2,3-Oxiranedimethanol",C(C1C(O1)CO)O,,,,,,
5770,95771,CID 95771,CCS(=O)(=O)C1=C2C(=NC=N2)N=CN1,,,,,,
5771,95772,CID 95772,CCCS(=O)(=O)C1=C2C(=NC=N2)N=CN1,,,,,,
5772,95773,CID 95773,CCCCS(=O)(=O)C1=C2C(=NC=N2)N=CN1,,,,,,
5773,95774,5-Bromoorotic acid,C1(=C(NC(=O)NC1=O)C(=O)O)Br,,,,,,
5774,95775,"4,6-dimethyl-2-oxo-2H-pyran-5-carboxylic acid",CC1=CC(=O)OC(=C1C(=O)O)C,,,,,,
5775,95776,"Phosphine sulfide, dimorpholinophenyl-",C1COCCN1P(=S)(C2=CC=CC=C2)N3CCOCC3,,,,,,
5776,95777,"Phosphonothioic diamide, N,N'-bis(3,4-dichlorophenyl)-p-phenyl-",C1=CC=C(C=C1)P(=S)(NC2=CC(=C(C=C2)Cl)Cl)NC3=CC(=C(C=C3)Cl)Cl,,,,,,
5777,95778,"5-Phenyl-1H-1,2,4-triazol-3-amine",C1=CC=C(C=C1)C2=NC(=NN2)N,,,,,,
5778,95779,Thymohydroquinone,CC1=CC(=C(C=C1O)C(C)C)O,,,,,['Thymoquinol is a known human metabolite of Thymol.'],
5779,95780,2-Naphthalen-2-yl-2-oxoacetaldehyde,C1=CC=C2C=C(C=CC2=C1)C(=O)C=O,,,,,,
5780,95781,CID 95781,C1=CC2=C(C=C1Cl)NC(=N2)S,,,,,,
5781,95782,"3-Benzylidene-2,4-pentanedione",CC(=O)C(=CC1=CC=CC=C1)C(=O)C,,,,,,
5782,95783,"1,3-Bis(3,4-dichlorophenyl)urea",C1=CC(=C(C=C1NC(=O)NC2=CC(=C(C=C2)Cl)Cl)Cl)Cl,,,,,,
5783,95784,N-(1-Cyano-1-methylethyl)acetamide,CC(=O)NC(C)(C)C#N,,,,,,
5784,95785,"3-{[(Furan-2-yl)methylidene]amino}-1,3-oxazolidin-2-one",C1COC(=O)N1N=CC2=CC=CO2,,,,,,
5785,95786,"p-Benzoquinone, (p-ethoxyphenyl)-",CCOC1=CC=C(C=C1)C2=CC(=O)C=CC2=O,,,,,,
5786,95787,(Allyloxy)pentachlorobenzene,C=CCOC1=C(C(=C(C(=C1Cl)Cl)Cl)Cl)Cl,,,,,,
5787,95788,2-Hydrazino-1H-benzimidazole,C1=CC=C2C(=C1)NC(=N2)NN,,,,,,
5788,95789,"Carbamic acid, pentyl-, ethyl ester",CCCCCNC(=O)OCC,,,,,,
5789,95790,4'-Bromo-3-chloropropiophenone,C1=CC(=CC=C1C(=O)CCCl)Br,,,,,,
5790,95791,"1,3-Bis(2-chloroethyl)urea",C(CCl)NC(=O)NCCCl,,,,,,
5791,95792,"3-Quinolinecarbamic acid, ethyl ester",CCOC(=O)NC1=CC2=CC=CC=C2N=C1,,,,,,
5792,95793,n-(9-Oxo-9h-fluoren-3-yl)acetamide,CC(=O)NC1=CC2=C(C=C1)C(=O)C3=CC=CC=C32,,,,,,
5793,95794,3-Amino-4-chlorobenzenesulfonamide,C1=CC(=C(C=C1S(=O)(=O)N)N)Cl,,,,,,
5794,95795,2-Amino-6-nitrobenzoic acid,C1=CC(=C(C(=C1)[N+](=O)[O-])C(=O)O)N,,,,,,
5795,95796,Ethylideneaniline,CC=NC1=CC=CC=C1,,,,,,
5796,95797,(4-Aminophenoxy)acetic acid,C1=CC(=CC=C1N)OCC(=O)O,,,,,,
5797,95798,4-Amino-2-methoxy-5-methylaniline,CC1=CC(=C(C=C1N)OC)N,,,,,,
5798,95799,"4-Biphenylsulfonic acid, 4'-amino-",C1=CC(=CC=C1C2=CC=C(C=C2)S(=O)(=O)O)N,,,,,,
5799,95800,"Benzaldehyde, phenylhydrazone",C1=CC=C(C=C1)C=NNC2=CC=CC=C2,,,,,,
5800,95801,N-Benzyl-p-toluenesulfonamide,CC1=CC=C(C=C1)S(=O)(=O)NCC2=CC=CC=C2,,,,,,
5801,95802,"Purine, 2-amino-6-propoxy-",CCCOC1=NC(=NC2=C1NC=N2)N,,,,,,
5802,95803,6-butoxy-9H-purin-2-amine,CCCCOC1=NC(=NC2=C1NC=N2)N,,,,,,
5803,95804,"1H-Purin-2-amine, 6-(1-methylethoxy)-",CC(C)OC1=NC(=NC2=C1NC=N2)N,,,,,,
5804,95805,6-Ethylguanine,CCOC1=NC(=NC2=C1NC=N2)N,,,,,,
5805,95806,N(6)-(2-Carboxyethyl)adenine,C1=NC2=C(N1)C(=NC=N2)NCCC(=O)O,,,,,,
5806,95807,"[4,4'-Bi-3H-pyrazole]-3,3'-dione, 2,2',4,4'-tetrahydro-5,5'-dimethyl-2,2'-diphenyl-",CC1=NN(C(=O)C1C2C(=NN(C2=O)C3=CC=CC=C3)C)C4=CC=CC=C4,,,,,,
5807,95808,1-Benzofuran-2-yl(phenyl)methanone,C1=CC=C(C=C1)C(=O)C2=CC3=CC=CC=C3O2,,,,,,
5808,95809,Perchlorofulvalene,C1(=C2C(=C(C(=C2Cl)Cl)Cl)Cl)C(=C(C(=C1Cl)Cl)Cl)Cl,,,,,,
5809,95810,"Propionamide, 2-(allylthio)-2-methyl-",CC(C)(C(=O)N)SCC=C,,,,,,
5810,95811,"2-but-2-enylsulfanyl-N,2-dimethylpropanamide",CC=CCSC(C)(C)C(=O)NC,,,,,,
5811,95812,"Benzamide, 4-allyloxy-N,N-dimethyl-3,5-dipropyl-",CCCC1=CC(=CC(=C1OCC=C)CCC)C(=O)N(C)C,,,,,,
5812,95813,N-(3-methylbutoxy)-1-(6-methylpyridin-2-yl)methanimine,CC1=NC(=CC=C1)C=NOCCC(C)C,,,,,,
5813,95814,2-pyridinecarbaldehyde O-propyloxime,CCCON=CC1=CC=CC=N1,,,,,,
5814,95815,nicotinaldehyde O-isopentyloxime,CC(C)CCON=CC1=CN=CC=C1,,,,,,
5815,95816,2-pyridinecarbaldehyde O-isopentyloxime,CC(C)CCON=CC1=CC=CC=N1,,,,,,
5816,95817,"4-Allyloxy-3,5-dipropyl-N-methylbenzamide",CCCC1=CC(=CC(=C1OCC=C)CCC)C(=O)NC,,,,,,
5817,95818,N-propoxy-1-pyridin-3-ylmethanimine,CCCON=CC1=CN=CC=C1,,,,,,
5818,95819,"Benzamide, 4-allyloxy-3,5-dimethyl-",CC1=CC(=CC(=C1OCC=C)C)C(=O)N,,,,,,
5819,95820,"4-Allyloxy-3,5-diisopropylbenzamide",CC(C)C1=CC(=CC(=C1OCC=C)C(C)C)C(=O)N,,,,,,
5820,95821,"Benzamide, 4-allyloxy-N,N,3,5-tetraethyl-",CCC1=CC(=CC(=C1OCC=C)CC)C(=O)N(CC)CC,,,,,,
5821,95822,"Hexanoic acid, 6-[[(4-methylphenyl)sulfonyl]amino]-",CC1=CC=C(C=C1)S(=O)(=O)NCCCCCC(=O)O,,,,,,
5822,95823,"Propanedioic acid, 2,2'-(1,4-phenylenedimethylidyne)bis-, tetraethyl ester",CCOC(=O)C(=CC1=CC=C(C=C1)C=C(C(=O)OCC)C(=O)OCC)C(=O)OCC,,,,,,
5823,95824,5-Mercapto-1-methyl-4-nitroimidazole,CN1C=NC(=C1S)[N+](=O)[O-],,,,,,
5824,95825,"5-Imidazolesulfonamide, 1-methyl-4-nitro-",CN1C=NC(=C1S(=O)(=O)N)[N+](=O)[O-],,,,,,
5825,95826,"2,5-Pyrrolidinedione, 1-(2-phenylethyl)-",C1CC(=O)N(C1=O)CCC2=CC=CC=C2,,,,,,
5826,95827,5-Amino-4-chloropyridazin-3(2H)-one,C1=NNC(=O)C(=C1N)Cl,,,,,,
5827,95828,"1,3,5,7,2,4,6,8-Tetrazatraphosphocine, 2,2,4,4,6,6,8,8-octaamino-2,2,4,4,6,6,8,8-octahydro-",NP1(=NP(=NP(=NP(=N1)(N)N)(N)N)(N)N)N,,,,,,
5828,95829,2-(4-Chlorophenyl)-1-phenylethanone,C1=CC=C(C=C1)C(=O)CC2=CC=C(C=C2)Cl,,,,,,
5829,95830,"Methanone, (2-hydroxy-1-naphthalenyl)phenyl-",C1=CC=C(C=C1)C(=O)C2=C(C=CC3=CC=CC=C32)O,,,,,,
5830,95831,N-Benzylidenebenzylamine,C1=CC=C(C=C1)CN=CC2=CC=CC=C2,,,,,,
5831,95832,CID 95832,C1=CC=C(C=C1)CN2C=NC3=C2NC=NC3=O,,,,,,
5832,95833,N-(3-Chlorophenyl)benzamide,C1=CC=C(C=C1)C(=O)NC2=CC(=CC=C2)Cl,,,,,,
5833,95834,4-(3-Chloropropyl)morpholine,C1COCCN1CCCCl,,,,,,
5834,95835,"Ethyl 2,2-diethoxypropionate",CCOC(=O)C(C)(OCC)OCC,,,,,,
5835,95836,"(3,4-Dihydro-2H-pyran-2-yl)methyl 3,4-dihydro-2H-pyran-2-carboxylate",C1CC(OC=C1)COC(=O)C2CCC=CO2,,,,,,
5836,95837,1-(9H-carbazol-9-yl)ethanone,CC(=O)N1C2=CC=CC=C2C3=CC=CC=C31,,,,,,
5837,95838,"5,11-Dihydroindolo[3,2-b]carbazole",C1=CC=C2C(=C1)C3=CC4=C(C=C3N2)C5=CC=CC=C5N4,,,,,,
5838,95839,"D-Threitol-1,4-bis(methanesulfonate)",CS(=O)(=O)OC[C@H]([C@@H](COS(=O)(=O)C)O)O,,,,,,
5839,95840,"2-Allyl-1,2-benzisothiazol-3(2H)-one 1,1-dioxide",C=CCN1C(=O)C2=CC=CC=C2S1(=O)=O,,,,,,
5840,95841,"1,2-Benzisothiazol-3(2H)-one, 2-(phenylmethyl)-, 1,1-dioxide",C1=CC=C(C=C1)CN2C(=O)C3=CC=CC=C3S2(=O)=O,,,,,,
5841,95842,"1,3-Dimethyl-8-azaxanthin",CN1C2=NNN=C2C(=O)N(C1=O)C,,,,,,
5842,95843,"Phenazine, 1,2,3,4-tetrahydro-, 5,10-dioxide",C1CCC2=C(C1)N(C3=CC=CC=C3[N+]2=O)[O-],,,,,,
5843,95844,"Purine, 6-(o-nitrobenzylthio)-",C1=CC=C(C(=C1)CSC2=NC=NC3=C2NC=N3)[N+](=O)[O-],,,,,,
5844,95845,CID 95845,CCCCN1C=NC2=C1N=C(N=C2S)N,,,,,,
5845,95846,"(2R,3R,4S,5R)-2-(6-(Ethylthio)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol",CCSC1=NC=NC2=C1N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O,,,,,,
5846,95847,4-(3-Oxobutyl)phenyl propionate,CCC(=O)OC1=CC=C(C=C1)CCC(=O)C,,,,,,
5847,95848,4-(3-Oxobutyl)phenyl butyrate,CCCC(=O)OC1=CC=C(C=C1)CCC(=O)C,,,,,,
5848,95849,Ethyl 2-(methylamino)acetate,CCOC(=O)CNC,,,,,,
5849,95850,"Benzenesulfonic acid, p-chlorothio-, S-(p-chlorophenyl) ester",C1=CC(=CC=C1SS(=O)(=O)C2=CC=C(C=C2)Cl)Cl,,,,,,
5850,95851,"Piperazine, 1,4-diacetyl-",CC(=O)N1CCN(CC1)C(=O)C,,,,,,
5851,95852,4-Methylbenzylideneacetophenone,CC1=CC=C(C=C1)C=CC(=O)C2=CC=CC=C2,,,,,,
5852,95853,"Glutarimide, 3-methyl-3-propyl-",CCCC1(CC(=O)NC(=O)C1)C,,,,,,
5853,95854,"4-Methyl-4-phenylpiperidine-2,6-dione",CC1(CC(=O)NC(=O)C1)C2=CC=CC=C2,,,,,,
5854,95855,"Glutarimide, 3-methyl-3-pentyl-",CCCCCC1(CC(=O)NC(=O)C1)C,,,,,,
5855,95856,"2,4-Dicyano-3-methyl-3-propylglutarimide",CCCC1(C(C(=O)NC(=O)C1C#N)C#N)C,,,,,,
5856,95857,"4,4-Dipropyl-2,6-piperidinedione",CCCC1(CC(=O)NC(=O)C1)CCC,,,,,,
5857,95858,3-Methylglutarimide,CC1CC(=O)NC(=O)C1,,,,,,
5858,95859,"1,5-Diamino-2-chloro-9,10-anthracenedione",C1=CC2=C(C(=C1)N)C(=O)C3=C(C2=O)C(=C(C=C3)Cl)N,,,,,,
5859,95860,10-Nitroanthracen-9(10h)-one,C1=CC=C2C(=C1)C(C3=CC=CC=C3C2=O)[N+](=O)[O-],,,,,,
5860,95861,"3-Amino-1,2-dihydroxyanthraquinone",C1=CC=C2C(=C1)C(=O)C3=CC(=C(C(=C3C2=O)O)O)N,,,,,,
5861,95862,"1,2-Diacetoxynaphthalene",CC(=O)OC1=C(C2=CC=CC=C2C=C1)OC(=O)C,,,,,,
5862,95863,"Glycolic acid, dicyclohexyl-",C1CCC(CC1)C(C2CCCCC2)(C(=O)O)O,,,,,,
5863,95864,Benzo[b]thiophene-2-carboxylic acid,C1=CC=C2C(=C1)C=C(S2)C(=O)O,,,,,,
5864,95865,p-Acetylaminobenzalacetophenon,CC(=O)NC1=CC=C(C=C1)C(=O)C=CC2=CC=CC=C2,,,,,,
5865,95866,"Urea, methoxy-",CONC(=O)N,,,,,,
5866,95867,"3-Methyl-3h-[1,2,3]triazolo[4,5-d]pyrimidin-7-amine",CN1C2=NC=NC(=C2N=N1)N,,,,,,
5867,95868,"3H-v-Triazolo(4,5-d)pyrimidine, 3-methyl-7-(methylamino)-",CNC1=C2C(=NC=N1)N(N=N2)C,,,,,,
5868,95869,CID 95869,C1=CC=C(C=C1)N=C(S)SCCC(=O)O,,,,,,
5869,95870,"2,4-Dimethyl-1,2,4-thiadiazolidine-3,5-dithione",CN1C(=S)N(SC1=S)C,,,,,,
5870,95871,"Bis(2,4-dichlorophenyl) carbonate",C1=CC(=C(C=C1Cl)Cl)OC(=O)OC2=C(C=C(C=C2)Cl)Cl,,,,,,
5871,95872,"N-(2,4,6-Trichlorophenyl)acetamide",CC(=O)NC1=C(C=C(C=C1Cl)Cl)Cl,,,,,,
5872,95873,3-Isopropyl-6-methylpyrocatechol,CC1=C(C(=C(C=C1)C(C)C)O)O,,,,,"['P-Cymene-2,3-diol is a known human metabolite of Thymol.']",
5873,95874,"Ethyl 4,4-diethoxy-3-oxopentanoate",CCOC(=O)CC(=O)C(C)(OCC)OCC,,,,,,
5874,95875,2-[2-(2-Aminoethoxy)ethoxy]ethanol,C(COCCOCCO)N,,,,,,
5875,95876,Tetraisopropylthiuram disulfide,CC(C)N(C(C)C)C(=S)SSC(=S)N(C(C)C)C(C)C,,,,,,
5876,95877,1-(8-Hydroxyquinolin-5-yl)ethanone,CC(=O)C1=C2C=CC=NC2=C(C=C1)O,,,,,,
5877,95878,"1,2-Dimethyl-3-phenylaziridine",CC1C(N1C)C2=CC=CC=C2,,,,,,
5878,95879,CID 95879,CC1=CC(N=C(N1C2=CC=C(C=C2)Cl)S)(C)C,,,,,,
5879,95880,CID 95880,CCCC(C1=C(OC2=CC=CC=C2C1=O)O)C3=C(OC4=CC=CC=C4C3=O)O,,,,,,
5880,95881,CID 95881,C1=CC=C2C(=C1)C(=O)C(=C(O2)O)SC3=C(OC4=CC=CC=C4C3=O)O,,,,,,
5881,95882,CID 95882,C1=C(N=C(N=C1S)N)S,,,,,,
5882,95883,"2S,4R-4-Methylglutamate",C[C@H](C[C@@H](C(=O)O)N)C(=O)O,,,,,,
5883,95884,Phenyl 4-nitrobenzoate,C1=CC=C(C=C1)OC(=O)C2=CC=C(C=C2)[N+](=O)[O-],,,,,,
5884,95885,"Valeronitrile, 5-(dimethylamino)-2,2-diphenyl-",CN(C)CCCC(C#N)(C1=CC=CC=C1)C2=CC=CC=C2,,,,,,
5885,95886,Dimethyl 4-aminophthalate,COC(=O)C1=C(C=C(C=C1)N)C(=O)OC,,,,,,
5886,95887,N-[4-(quinoxalin-2-ylsulfamoyl)phenyl]acetamide,CC(=O)NC1=CC=C(C=C1)S(=O)(=O)NC2=NC3=CC=CC=C3N=C2,,,,,,
5887,95888,4-(Hydroxyamino)benzoic acid,C1=CC(=CC=C1C(=O)O)NO,,,,,,
5888,95889,"2-Hexyl-5-methyl-5-propyl-1,3-dioxane",CCCCCCC1OCC(CO1)(C)CCC,,,,,,
5889,95890,1-Methylbenzimidazole,CN1C=NC2=CC=CC=C21,,,,,,
5890,95891,CID 95891,C1=CC=C(C=C1)C2=CC(=O)N=C(N2)N,,,,,,
5891,95892,"Hydroquinone, bis[bis(1-aziridinyl)phosphinate]",C1CN1P(=O)(N2CC2)OC3=CC=C(C=C3)OP(=O)(N4CC4)N5CC5,,,,,,
5892,95893,"4,4'-(Diazoamino)dibenzenesulfonic acid",C1=CC(=CC=C1NN=NC2=CC=C(C=C2)S(=O)(=O)O)S(=O)(=O)O,,,,,,
5893,95894,3-Chloro-1H-indazole,C1=CC2=C(NN=C2C=C1)Cl,,,,,,
5894,95895,2-Amino-2-butylhexanoic acid,CCCCC(CCCC)(C(=O)O)N,,,,,,
5895,95896,CID 95896,CC(=O)C1=CC(=O)N=C(N1)N,,,,,,
5896,95897,"N-[(2,3-dimethoxyphenyl)methylideneamino]-5-nitropyridin-2-amine",COC1=CC=CC(=C1OC)C=NNC2=NC=C(C=C2)[N+](=O)[O-],,,,,,
5897,95898,5-nitro-N-[(4-nitrophenyl)methylideneamino]pyridin-2-amine,C1=CC(=CC=C1C=NNC2=NC=C(C=C2)[N+](=O)[O-])[N+](=O)[O-],,,,,,
5898,95899,N-[(2-methoxyphenyl)methylideneamino]-5-nitropyridin-2-amine,COC1=CC=CC=C1C=NNC2=NC=C(C=C2)[N+](=O)[O-],,,,,,
5899,95900,CID 95900,C1=CC(=O)C(=CN=NC2=NC=C(C=C2)N(O)O)C=C1Cl,,,,,,
5900,95901,"Propionic acid, 3-(1-aziridinyl)-, allyl ester",C=CCOC(=O)CCN1CC1,,,,,,
5901,95902,N-[(2-ethoxyphenyl)methylideneamino]-5-nitropyridin-2-amine,CCOC1=CC=CC=C1C=NNC2=NC=C(C=C2)[N+](=O)[O-],,,,,,
5902,95903,N-[(4-methoxyphenyl)methylideneamino]-5-nitropyridin-2-amine,COC1=CC=C(C=C1)C=NNC2=NC=C(C=C2)[N+](=O)[O-],,,,,,
5903,95904,2-{2-[(Naphthalen-1-yl)methylidene]hydrazinyl}-5-nitropyridine,C1=CC=C2C(=C1)C=CC=C2C=NNC3=NC=C(C=C3)[N+](=O)[O-],,,,,,
5904,95905,5-nitro-N-[(2-nitrophenyl)methylideneamino]pyridin-2-amine,C1=CC=C(C(=C1)C=NNC2=NC=C(C=C2)[N+](=O)[O-])[N+](=O)[O-],,,,,,
5905,95906,p-Acetoxybenzyl alcohol,CC(=O)OC1=CC=C(C=C1)CO,,,,,,
5906,95907,"2-Benzyl-5-methyl-5-propyl-1,3-dioxane",CCCC1(COC(OC1)CC2=CC=CC=C2)C,,,,,,
5907,95908,N-(Cyclohexyl)succinimide,C1CCC(CC1)N2C(=O)CCC2=O,,,,,,
5908,95909,4-[2-(2-Pyridyl)ethyl]morpholine,C1COCCN1CCC2=CC=CC=N2,,,,,,
5909,95910,1-(Pyridin-2-Yl)Propan-2-One,CC(=O)CC1=CC=CC=N1,,,,,,
5910,95911,"1,1,1-Trifluoro-2-octanone",CCCCCCC(=O)C(F)(F)F,,,,,,
5911,95912,"Benzaldehyde,2,4-dichloro-, 2-(5-nitro-2-pyridinyl)hydrazone",C1=CC(=C(C=C1Cl)Cl)C=NNC2=NC=C(C=C2)[N+](=O)[O-],,,,,,
5912,95913,Benzaldehyde-(5-nitro-2-pyridyl)hydrazone,C1=CC=C(C=C1)C=NNC2=NC=C(C=C2)[N+](=O)[O-],,,,,,
5913,95914,CID 95914,CCOC1=CC(=CN=NC2=NC=C(C=C2)N(O)O)C=CC1=O,,,,,,
5914,95915,4-Isopropylbenzaldehyde-(5-nitro-2-pyridyl)hydrazone,CC(C)C1=CC=C(C=C1)C=NNC2=NC=C(C=C2)[N+](=O)[O-],,,,,,
5915,95916,"N-[(3,4-diethoxyphenyl)methylideneamino]-5-nitropyridin-2-amine",CCOC1=C(C=C(C=C1)C=NNC2=NC=C(C=C2)[N+](=O)[O-])OCC,,,,,,
5916,95917,CID 95917,CCN(CC)C1=CC=C(C=C1)C=NNC2=NC=C(C=C2)[N+](=O)[O-],,,,,,
5917,95918,tert-Butyl 2-phenylpropionate,CC(C1=CC=CC=C1)C(=O)OC(C)(C)C,,,,,,
5918,95919,"Phenetole, beta,beta'-thiodi-",C1=CC=C(C=C1)OCCSCCOC2=CC=CC=C2,,,,,,
5919,95920,2-Chloroethyl chloroacetate,C(CCl)OC(=O)CCl,,,,,,
5920,95921,Butyl dichloroacetate,CCCCOC(=O)C(Cl)Cl,,,,,,
5921,95922,"N',N'-Dibenzylbenzohydrazide",C1=CC=C(C=C1)CN(CC2=CC=CC=C2)NC(=O)C3=CC=CC=C3,,,,,,
5922,95923,"Carbamic acid, (dimethoxyphosphinyl)-, methyl ester",COC(=O)NP(=O)(OC)OC,,,,,,
5923,95924,Avenin,CC(C)OC(=O)NP(=O)(OC)OC,,,,,,
5924,95925,"Benzaldehyde, 4-nitro-, hydrazone",C1=CC(=CC=C1C=NN)[N+](=O)[O-],,,,,,
5925,95926,2-(3-(Trifluoromethyl)phenyl)ethanol,C1=CC(=CC(=C1)C(F)(F)F)CCO,,,,,,
5926,95927,Bis(p-bromophenyl) sulfone,C1=CC(=CC=C1S(=O)(=O)C2=CC=C(C=C2)Br)Br,,,,,,
5927,95928,CID 95928,C1=CC(=O)C=CC1=CN=NC2=NC=C(C=C2)N(O)O,,,,,,
5928,95929,N-(cinnamylideneamino)-5-nitropyridin-2-amine,C1=CC=C(C=C1)C=CC=NNC2=NC=C(C=C2)[N+](=O)[O-],,,,,,
5929,95930,5-nitro-N-(2-phenylethylideneamino)pyridin-2-amine,C1=CC=C(C=C1)CC=NNC2=NC=C(C=C2)[N+](=O)[O-],,,,,,
5930,95931,N-(heptylideneamino)-5-nitropyridin-2-amine,CCCCCCC=NNC1=NC=C(C=C1)[N+](=O)[O-],,,,,,
5931,95932,Bis(1-aziridinyl)phosphinic acid butyl ester,CCCCOP(=O)(N1CC1)N2CC2,,,,,,
5932,95933,9-Methyl-9h-fluoren-9-ol,CC1(C2=CC=CC=C2C3=CC=CC=C31)O,,,,,,
5933,95934,"N,N'-Ethylenedisalicylamide",C1=CC=C(C(=C1)C(=O)NCCNC(=O)C2=CC=CC=C2O)O,,,,,,
5934,95935,"4H-1-Benzopyran-2-carboxylic acid, 4-oxo-7-(phenylmethoxy)-, ethyl ester",CCOC(=O)C1=CC(=O)C2=C(O1)C=C(C=C2)OCC3=CC=CC=C3,,,,,,
5935,95936,1-Piperidinoanthraquinone,C1CCN(CC1)C2=CC=CC3=C2C(=O)C4=CC=CC=C4C3=O,,,,,,
5936,95937,"1,3,5-Triphenyl-4,5-dihydro-1H-pyrazole",C1C(N(N=C1C2=CC=CC=C2)C3=CC=CC=C3)C4=CC=CC=C4,,,,,,
5937,95938,2-Propionyloxybenzoic acid,CCC(=O)OC1=CC=CC=C1C(=O)O,,,,,,
5938,95939,1-Methyl-2-naphthol,CC1=C(C=CC2=CC=CC=C12)O,,,,,,
5939,95940,"2,6-Dimethoxyaniline",COC1=C(C(=CC=C1)OC)N,,,,,,
5940,95941,Citraconimide,CC1=CC(=O)NC1=O,,,,,,
5941,95942,4-(Allyloxy)benzaldehyde,C=CCOC1=CC=C(C=C1)C=O,,,,,,
5942,95943,"Carbamic acid, (3-nitrophenyl)-, 1-methylethyl ester",CC(C)OC(=O)NC1=CC(=CC=C1)[N+](=O)[O-],,,,,,
5943,95944,"Phosphorothioic acid, S-2-chloroethyl O,O-diethyl ester",CCOP(=O)(OCC)SCCCl,,,,,,
5944,95945,"2,6-Dimethyl-3-nitroaniline",CC1=C(C(=C(C=C1)[N+](=O)[O-])C)N,,,,,,
5945,95946,4-(Butylamino)benzoic acid,CCCCNC1=CC=C(C=C1)C(=O)O,,,,,,
5946,95947,{2-[Hydroxy(imino)methyl]hydrazinylidene}acetic acid,C(=NNC(=O)N)C(=O)O,,,,,,
5947,95948,2-Chloroethyl-sec-butyl sulfide,CCC(C)SCCCl,,,,,,
5948,95949,"1,3-Benzodioxol-5-ylmethyl isovalerate",CC(C)CC(=O)OCC1=CC2=C(C=C1)OCO2,,,,,,
5949,95950,3-Methylbutyl tetradecanoate,CCCCCCCCCCCCCC(=O)OCCC(C)C,,,,,,
5950,95951,"Phosphoric acid, tris(2-methylallyl)-",CC(=C)COP(=O)(OCC(=C)C)OCC(=C)C,,,,,,
5951,95952,2-Chloroethyl benzoate,C1=CC=C(C=C1)C(=O)OCCCl,,,,,,
5952,95953,"4-Cyclopentene-1,3-dione, 2,2,4,5-tetrachloro-",C1(=C(C(=O)C(C1=O)(Cl)Cl)Cl)Cl,,,,,,
5953,95954,Laurohydroxamic acid,CCCCCCCCCCCC(=O)NO,,,,,,
5954,95955,Dibenzyl diselenide,C1=CC=C(C=C1)C[Se][Se]CC2=CC=CC=C2,,,,,,
5955,95956,"7,12-Dihydroxy-7,12-dimethylbenz(a)anthracene",CC1(C2=C(C3=CC=CC=C3C=C2)C(C4=CC=CC=C41)(C)O)O,,,,,,
5956,95957,"Nonanoic acid, 9,9-dimethoxy-, methyl ester",COC(CCCCCCCC(=O)OC)OC,,,,,,
5957,95958,CID 95958,C1CCC(CC1)N=C(C(=NC2CCCCC2)S)S,,,,,,
5958,95959,"5-Methyl-2,5-dipropyl-1,3-dioxane",CCCC1OCC(CO1)(C)CCC,,,,,,
5959,95960,"Sulfide, bis(2,4-dinitrophenyl)",C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])SC2=C(C=C(C=C2)[N+](=O)[O-])[N+](=O)[O-],,,,,,
5960,95961,1-Methylthymine,CC1=CN(C(=O)NC1=O)C,,,,,,
5961,95962,N-Benzylideneisopropylamine,CC(C)N=CC1=CC=CC=C1,,,,,,
5962,95963,"1-(2-Hydroxyethyl)-2,5-dimethylpyrrole",CC1=CC=C(N1CCO)C,,,,,,
5963,95964,1-Cyclopentenecarboxylic acid,C1CC=C(C1)C(=O)O,,,,,,
5964,95965,"3-Methylbenzo[1,2,4]triazine",CC1=NC2=CC=CC=C2N=N1,,,,,,
5965,95966,"Benzene, 1,3,5-tris((2-ethyl-aziridinyl)-carbonyl)-",CCC1CN1C(=O)C2=CC(=CC(=C2)C(=O)N3CC3CC)C(=O)N4CC4CC,,,,,,
5966,95967,"Purine, 6-(2-pyridylmethylthio)-",C1=CC=NC(=C1)CSC2=NC=NC3=C2NC=N3,,,,,,
5967,95968,"2-Hydroxy-2,2-diphenylacetohydrazide",C1=CC=C(C=C1)C(C2=CC=CC=C2)(C(=O)NN)O,,,,,,
5968,95969,1-[4-(Allyloxy)phenyl]ethanone,CC(=O)C1=CC=C(C=C1)OCC=C,,,,,,
5969,95970,"N-(2-Hydroxyethyl)-3,4,5-trimethoxybenzamide",COC1=CC(=CC(=C1OC)OC)C(=O)NCCO,,,,,,
5970,95971,N-(2-Chloroethyl)-N-nitroso-p-toluenesulfonamide,CC1=CC=C(C=C1)S(=O)(=O)N(CCCl)N=O,,,,,,
5971,95972,CID 95972,C1(=C(N=C(N=C1N)S)N)N,,,,,,
5972,95973,CID 95973,C1=CN=C2C(=N1)C(=O)N=C(N2)S,,,,,,
5973,95974,"Acetamide, 2,2-dichloro-N-(1,2,3,4-tetrahydro-2,4-dioxo-5-pyrimidinyl)-",C1=C(C(=O)NC(=O)N1)NC(=O)C(Cl)Cl,,,,,,
5974,95975,"2-chloro-N,N-dimethylpyrimidin-4-amine",CN(C)C1=NC(=NC=C1)Cl,,,,,,
5975,95976,"9-Methoxy-4-nitro-7h-furo[3,2-g]chromen-7-one",COC1=C2C(=C(C3=C1OC=C3)[N+](=O)[O-])C=CC(=O)O2,,,,,,
5976,95977,CID 95977,C1=CC=C(C=C1)C2=CN=C(N2)S,,,,,,
5977,95978,Pentyl 3-methylbutanoate,CCCCCOC(=O)CC(C)C,,,,,,
5978,95979,"1,1-Dimethoxy-3-phenylpropane",COC(CCC1=CC=CC=C1)OC,,,,,,
5979,95980,"1,1-Dibenzyloxy-2-phenylethane",C1=CC=C(C=C1)CC(OCC2=CC=CC=C2)OCC3=CC=CC=C3,,,,,,
5980,95981,"2-Naphthalenamine, N-nitroso-N-phenyl-",C1=CC=C(C=C1)N(C2=CC3=CC=CC=C3C=C2)N=O,,,,,,
5981,95982,"2,5,5-Trimethyl-2-(4-methyl-3-pentenyl)-1,3-dioxane",CC(=CCCC1(OCC(CO1)(C)C)C)C,,,,,,
5982,95983,1H-Benzimidazol-2-ylmethanethiol,C1=CC=C2C(=C1)NC(=N2)CS,,,,,,
5983,95984,"2-(Bis(2-chloroethyl)amino)-tetrahydro-2H-1,3,2-oxazaphosphorine 2-sulfide",C1CNP(=S)(OC1)N(CCCl)CCCl,,,,,,
5984,95985,"Phosphorodiamidic acid, N,N-bis(2-chloroethyl)-N'-(3-hydroxypropyl)-, ethyl ester",CCOP(=O)(NCCCO)N(CCCl)CCCl,,,,,,
5985,95986,"Tetrahydro-2-(N-(2-chloroethyl)-N-(2-chloropropyl)amino)-2H-1,3,2-oxazaphosphorine 2-oxide",CC(CN(CCCl)P1(=O)NCCCO1)Cl,,,,,,
5986,95987,"Phosphorodiamidic acid, N,N-bis(2-chloroethyl)-N'-(3-hydroxypropyl)-, (3-chloropropyl) ester",C(CNP(=O)(N(CCCl)CCCl)OCCCCl)CO,,,,,,
5987,95988,"Tetrahydro-2-(bis(2-chloroethyl)amino)-5-methyl-2H-1,3,2-oxazaphosphorine 2-oxide",CC1CNP(=O)(OC1)N(CCCl)CCCl,,,,,,
5988,95989,"2-Butene-1,1-diol, 1,1-diacetate",CC=CC(OC(=O)C)OC(=O)C,,,,,,
5989,95990,"2,4-Pentanedione, 3-(m-nitrobenzylidene)-",CC(=O)C(=CC1=CC(=CC=C1)[N+](=O)[O-])C(=O)C,,,,,,
5990,95991,5'-Bromo-2'-hydroxyacetophenone,CC(=O)C1=C(C=CC(=C1)Br)O,,,,,,
5991,95992,5'-Fluoro-2'-hydroxyacetophenone,CC(=O)C1=C(C=CC(=C1)F)O,,,,,,
5992,95993,1-(2-Hydroxy-3-methoxyphenyl)ethanone,CC(=O)C1=C(C(=CC=C1)OC)O,,,,,,
5993,95994,Bis(4-nitrophenyl) adipate,C1=CC(=CC=C1[N+](=O)[O-])OC(=O)CCCCC(=O)OC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
5994,95995,CID 95995,C([C@@H]1[C@H]([C@H]([C@@H](O1)N2C3=NC(=NC(=O)C3=NN2)N)O)O)O,,,,,,
5995,95996,"9(2H)-Acridinone, 1,3,4,10-tetrahydro-",C1CCC2=C(C1)C(=O)C3=CC=CC=C3N2,,,,,,
5996,95997,"3',5'-Dimethoxyacetophenone",CC(=O)C1=CC(=CC(=C1)OC)OC,,,,,,
5997,95998,N-octadecyloctadec-9-enamide,CCCCCCCCCCCCCCCCCCNC(=O)CCCCCCCC=CCCCCCCCC,,,,,,
5998,95999,"1,3-Diazaspiro(4.4)nonane-2,4-dione, 1-acetyl-",CC(=O)N1C(=O)NC(=O)C12CCCC2,,,,,,
5999,96000,"4,7-Epoxy-1H-isoindole-1,3(2H)-dione, 3a,4,7,7a-tetrahydro-",C1=CC2C3C(C1O2)C(=O)NC3=O,,,,,,
6000,96001,"1,4-Dithiaspiro[4.5]decane",C1CCC2(CC1)SCCS2,,,,,,
6001,96002,"Acetamide, N-((dimethylamino)methyl)-",CC(=O)NCN(C)C,,,,,,
6002,96003,2-Isopropylbenzenethiol,CC(C)C1=CC=CC=C1S,,,,,,
6003,96004,"Formamide, N-1-naphthalenyl-",C1=CC=C2C(=C1)C=CC=C2NC=O,,,,,,
6004,96005,"Formamide, N-2-naphthalenyl-",C1=CC=C2C=C(C=CC2=C1)NC=O,,,,,,
6005,96006,CID 96006,CC1=NC=C(C(=C1O)C=NN=C(N)S)CO,,,,,,
6006,96007,(4-Methoxyphenyl)ethanone oxime,CC(=NO)C1=CC=C(C=C1)OC,,,,,,
6007,96008,4-{4-[(2-Chloroethyl)(ethyl)amino]phenyl}butanoic acid,CCN(CCCl)C1=CC=C(C=C1)CCCC(=O)O,,,,,,
6008,96009,4-Hydroxyphenyl acetate,CC(=O)OC1=CC=C(C=C1)O,,,,,,
6009,96010,"4-(Hydroxyiminomethyl)-2,6-diiodophenol",C1=C(C=C(C(=C1I)O)I)C=NO,,,,,,
6010,96011,"1,2:5,6-Di-O-isopropylidene-D-mannitol",CC1(OC[C@@H](O1)[C@H]([C@@H]([C@H]2COC(O2)(C)C)O)O)C,,,,,,
6011,96012,"1,1',3,3'-Tetramethyldibutylamine",CC(C)CC(C)NC(C)CC(C)C,,,,,,
6012,96013,"1-Pentene, 2-(chloromethyl)-4,4-dimethyl-",CC(C)(C)CC(=C)CCl,,,,,,
6013,96014,"2,4-Diethylenimino-6-chloropyrimidine",C1CN1C2=CC(=NC(=N2)N3CC3)Cl,,,,,,
6014,96015,"1,5-Bis(salicylidene)carbohydrazide",C1=CC=C(C(=C1)C=NNC(=O)NN=CC2=CC=CC=C2O)O,,,,,,
6015,96016,2-Fluoro-9H-fluoren-9-one,C1=CC=C2C(=C1)C3=C(C2=O)C=C(C=C3)F,,,,,,
6016,96017,3-Nitro-6H-benzo[c]chromen-6-one,C1=CC=C2C(=C1)C3=C(C=C(C=C3)[N+](=O)[O-])OC2=O,,,,,,
6017,96018,CID 96018,C1CC(=C(C(=NO)C1)O)N=O,,,,,,
6018,96019,Allylnitrosourea,C=CCN(C(=O)N)N=O,,,,,,
6019,96020,4-Tert-butyl-2-(hydroxymethyl)phenol,CC(C)(C)C1=CC(=C(C=C1)O)CO,,,,,,
6020,96021,"4-Isopropyl-5,5-dimethyl-1,3-dioxane",CC(C)C1C(COCO1)(C)C,,,,,,
6021,96022,"Pyruvic acid, 3-(p-(bis(2-chloroethyl)amino)phenyl)-",C1=CC(=CC=C1CC(=O)C(=O)O)N(CCCl)CCCl,,,,,,
6022,96023,"1,2-Benzothiazolin-3-one, 6-methyl-",CC1=CC2=C(C=C1)C(=O)NS2,,,,,,
6023,96024,"Phenol, 4-chloro-2-methyl-, acetate",CC1=C(C=CC(=C1)Cl)OC(=O)C,,,,,,
6024,96025,"Purine, 6-((3,4-dimethylbenzyl)thio)-",CC1=C(C=C(C=C1)CSC2=NC=NC3=C2NC=N3)C,,,,,,
6025,96026,2-Hydroxybutanedihydrazide,C(C(C(=O)NN)O)C(=O)NN,,,,,,
6026,96027,"3-Pyridinol, 4,5-bis(mercaptomethyl)-2-methyl-",CC1=NC=C(C(=C1O)CS)CS,,,,,,
6027,96028,8-Mercaptoquinoline,C1=CC2=C(C(=C1)S)N=CC=C2,,,,,,
6028,96029,6-Nitroquinoxaline,C1=CC2=NC=CN=C2C=C1[N+](=O)[O-],,,,,,
6029,96030,"6-aminoquinoxaline-2,3(1H,4H)-dione",C1=CC2=C(C=C1N)NC(=O)C(=O)N2,,,,,,
6030,96031,"2,4-Dihydroxy-5,6-dimethylpyrimidine",CC1=C(NC(=O)NC1=O)C,,,,,,
6031,96032,1-Cyclohexylthymine,CC1=CN(C(=O)NC1=O)C2CCCCC2,,,,,,
6032,96033,2-Cyanoethylurea,C(CNC(=O)N)C#N,,,,,,
6033,96034,"2,5-Dimethylpyrrolidine",CC1CCC(N1)C,,,,,,
6034,96035,2-(Acetylthio)benzoic acid,CC(=O)SC1=CC=CC=C1C(=O)O,,,,,,
6035,96036,"2H-1,3,5-Thiadiazine-2-thione, tetrahydro-3,5-diethyl-",CCN1CN(C(=S)SC1)CC,,,,,,
6036,96037,"2(1H)-Pyridone, 1,5-dihydroxy-6-methyl-",CC1=C(C=CC(=O)N1O)O,,,,,,
6037,96038,"2,6-Dimethoxyhydroquinone",COC1=CC(=CC(=C1O)OC)O,,,,,,
6038,96039,"N,N-Bis(2-chloroethyl)-p-toluenesulfonamide",CC1=CC=C(C=C1)S(=O)(=O)N(CCCl)CCCl,,,,,,
6039,96040,Hexahydroazepinylbis(aziridinyl)phosphine oxide,C1CCCN(CC1)P(=O)(N2CC2)N3CC3,,,,,,
6040,96041,Tetraphenylhydrazine,C1=CC=C(C=C1)N(C2=CC=CC=C2)N(C3=CC=CC=C3)C4=CC=CC=C4,,,,,,
6041,96042,2-Bromoethyl methanesulfonate,CS(=O)(=O)OCCBr,,,,,,
6042,96043,"(2,4-Dichlorophenoxy)-2-propanone",CC(=O)COC1=C(C=C(C=C1)Cl)Cl,,,,,,
6043,96044,N-methyl-N-(oxiran-2-ylmethyl)aniline,CN(CC1CO1)C2=CC=CC=C2,,,,,,
6044,96045,2-(N-Phenylcarbamoyl)-3-naphthyl acetate,CC(=O)OC1=CC2=CC=CC=C2C=C1C(=O)NC3=CC=CC=C3,,,,,,
6045,96046,"5-Nitro-2,1,3-benzoselenadiazole",C1=CC2=N[Se]N=C2C=C1[N+](=O)[O-],,,,,,
6046,96047,4-Chloroisatin,C1=CC2=C(C(=C1)Cl)C(=O)C(=O)N2,,,,,,
6047,96048,Nbtgr,C1=CC(=CC=C1CSC2=NC(=NC3=C2N=CN3[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O)N)[N+](=O)[O-],,,,,,
6048,96049,CID 96049,CC1=CC(N=C(N1C)S)(C)C,,,,,,
6049,96050,CID 96050,CCCCN1C(=CC(N=C1S)(C)C)C,,,,,,
6050,96051,CID 96051,CC1=CC(=CC=C1)N2C(=CC(N=C2S)(C)C)C,,,,,,
6051,96052,CID 96052,CC1=CC=C(C=C1)N2C(=CC(N=C2S)(C)C)C,,,,,,
6052,96053,CID 96053,CC1=CC(N=C(N1C2=CC=CC=C2O)S)(C)C,,,,,,
6053,96054,CID 96054,CC1=CC(N=C(N1C2=CC=C(C=C2)O)S)(C)C,,,,,,
6054,96055,CID 96055,CC1=CC(N=C(N1C2=CC(=CC=C2)Cl)S)(C)C,,,,,,
6055,96056,CID 96056,CC1=CC(N=C(N1C2=C(C=CC(=C2)Cl)Cl)S)(C)C,,,,,,
6056,96057,CID 96057,CC1=CC(N=C(N1C2=CC=C(C=C2)N=NC3=CC=CC=C3)S)(C)C,,,,,,
6057,96058,CID 96058,CC1=CC(N=C(N1C2=CC=C(C=C2)N(C)C)S)(C)C,,,,,,
6058,96059,CID 96059,CC1=CC(N=C(N1C2=CC=CC3=CC=CC=C32)S)(C)C,,,,,,
6059,96060,CID 96060,CC1=CC(N=C(N1C2=CC3=CC=CC=C3C=C2)S)(C)C,,,,,,
6060,96061,CID 96061,CC1=C(C=C(C=C1)N2C(=CC(N=C2S)(C)C)C)N3C(=CC(N=C3S)(C)C)C,,,,,,
6061,96062,CID 96062,CC1=CC(N=C(N1C2=CC=C(C=C2)S(=O)(=O)O)S)(C)C,,,,,,
6062,96063,"5,6-Dinitro-1H-indazole",C1=C2C=NNC2=CC(=C1[N+](=O)[O-])[N+](=O)[O-],,,,,,
6063,96064,CID 96064,C1CN(CCN1)CCN=C(C(=NCCN2CCNCC2)S)S,,,,,,
6064,96065,CID 96065,C1CN(C(=NC1=O)S)CC2=CC=CC=C2,,,,,,
6065,96066,Bicyclo[2.2.1]hept-5-en-2-ol,C1C2CC(C1C=C2)O,,,,,,
6066,96067,"Pyrrole, 2,4-dinitro-1-ethyl-",CCN1C=C(C=C1[N+](=O)[O-])[N+](=O)[O-],,,,,,
6067,96068,"1-(N,N-Diethylcarbamylmethyl)-2,4-dinitropyrrole",CCN(CC)C(=O)CN1C=C(C=C1[N+](=O)[O-])[N+](=O)[O-],,,,,,
6068,96069,"1,3-Propanedione, 1-(4-methoxyphenyl)-3-phenyl-",COC1=CC=C(C=C1)C(=O)CC(=O)C2=CC=CC=C2,,,,,,
6069,96070,1-Bromo-5-chloropentane,C(CCCl)CCBr,,,,,,
6070,96071,CID 96071,C1(=O)NC(=NC(=O)N1)S,,,,,,
6071,96072,CID 96072,C1(=NC(=NC(=O)N1)S)S,,,,,,
6072,96073,4-Chloro-3-nitrobenzanilide,C1=CC=C(C=C1)NC(=O)C2=CC(=C(C=C2)Cl)[N+](=O)[O-],,,,,,
6073,96074,"Purine, 6-((m-chlorobenzyl)thio)-",C1=CC(=CC(=C1)Cl)CSC2=NC=NC3=C2NC=N3,,,,,,
6074,96075,"2-(1-Aziridinyl)-4,6-dichloropyrimidine",C1CN1C2=NC(=CC(=N2)Cl)Cl,,,,,,
6075,96076,"Acetamide, 2,2-dichloro-N,N-dipropyl-",CCCN(CCC)C(=O)C(Cl)Cl,,,,,,
6076,96077,Pentyl trichloroacetate,CCCCCOC(=O)C(Cl)(Cl)Cl,,,,,,
6077,96078,Benzyl trichloroacetate,C1=CC=C(C=C1)COC(=O)C(Cl)(Cl)Cl,,,,,,
6078,96079,Propylhydrazine oxalate,CCCNN.C(=O)(C(=O)O)O,,,,,,
6079,96080,"Propionic acid, 3-(p-(bis(2-chloroethyl)amino)phenoxy)-",C1=CC(=CC=C1N(CCCl)CCCl)OCCC(=O)O,,,,,,
6080,96081,4-(Phenylthio)aniline,C1=CC=C(C=C1)SC2=CC=C(C=C2)N,,,,,,
6081,96082,"Sulfide, tert-butyl octyl",CCCCCCCCSC(C)(C)C,,,,,,
6082,96083,6-Iodouracil,C1=C(NC(=O)NC1=O)I,,,,,,
6083,96084,N-(3-Chloropropyl)dibutylamine,CCCCN(CCCC)CCCCl,,,,,,
6084,96085,"P,P-Bis(1-aziridinyl)-N-butylphosphinic amide",CCCCNP(=O)(N1CC1)N2CC2,,,,,,
6085,96086,"Acetamide, N-(acetyloxy)-N-(7-fluoro-9H-fluoren-2-yl)-",CC(=O)N(C1=CC2=C(C=C1)C3=C(C2)C=C(C=C3)F)OC(=O)C,,,,,,
6086,96087,9H-Fluoren-1-ol,C1C2=CC=CC=C2C3=C1C(=CC=C3)O,,,,,,
6087,96088,3-Hydroxyfluorene,C1C2=C(C=C(C=C2)O)C3=CC=CC=C31,,,,,,
6088,96089,2-Fluoronicotinic acid,C1=CC(=C(N=C1)F)C(=O)O,,,,,,
6089,96090,2-Fluoro-6-methylpyridine,CC1=NC(=CC=C1)F,,,,,,
6090,96091,2-Methoxy-1-[(2-methoxynaphthalen-1-yl)methyl]naphthalene,COC1=C(C2=CC=CC=C2C=C1)CC3=C(C=CC4=CC=CC=C43)OC,,,,,,
6091,96092,2-Phthalimidoethanesulfonamide,C1=CC=C2C(=C1)C(=O)N(C2=O)CCS(=O)(=O)N,,,,,,
6092,96093,"N-(2,4-Difluorophenyl)acetamide",CC(=O)NC1=C(C=C(C=C1)F)F,,,,,,
6093,96094,Bis(4-fluorophenyl)methane,C1=CC(=CC=C1CC2=CC=C(C=C2)F)F,,,,,,
6094,96095,4-Fluorobenzanilide,C1=CC=C(C=C1)NC(=O)C2=CC=C(C=C2)F,,,,,,
6095,96096,"Salicylic acid, 2-isopropylhydrazide",CC(C)NNC(=O)C1=CC=CC=C1O,,,,,,
6096,96097,N-[(2-nitrophenyl)methylidene]hydroxylamine,C1=CC=C(C(=C1)C=NO)[N+](=O)[O-],,,,,,
6097,96098,3-Methylisoxazole,CC1=NOC=C1,,,,,,
6098,96099,CID 96099,C1=CC(=O)C(=CN=NC2=NC=C(C=C2)N(O)O)C=C1Br,,,,,,
6099,96100,2-[[(5-Nitropyridin-2-yl)hydrazinylidene]methyl]benzoic acid,C1=CC=C(C(=C1)C=NNC2=NC=C(C=C2)[N+](=O)[O-])C(=O)O,,,,,,
6100,96101,"N-[(3,4-dimethoxyphenyl)methylideneamino]-5-nitropyridin-2-amine",COC1=C(C=C(C=C1)C=NNC2=NC=C(C=C2)[N+](=O)[O-])OC,,,,,,
6101,96102,3-[[(5-Nitropyridin-2-yl)hydrazinylidene]methyl]phenol,C1=CC(=CC(=C1)O)C=NNC2=NC=C(C=C2)[N+](=O)[O-],,,,,,
6102,96103,N-[(2-methyl-3-phenylprop-2-enylidene)amino]-5-nitropyridin-2-amine,CC(=CC1=CC=CC=C1)C=NNC2=NC=C(C=C2)[N+](=O)[O-],,,,,,
6103,96104,5-nitro-N-(nonylideneamino)pyridin-2-amine,CCCCCCCCC=NNC1=NC=C(C=C1)[N+](=O)[O-],,,,,,
6104,96105,"N,N-Bis(2-chloroethyl)tetrahydro-1,3,2-diazaphosphorin-2-amine 2-oxide",C1CNP(=O)(NC1)N(CCCl)CCCl,,,,,,
6105,96106,"1,3-Dichloro-2-(4-nitrophenoxy)benzene",C1=CC(=C(C(=C1)Cl)OC2=CC=C(C=C2)[N+](=O)[O-])Cl,,,,,,
6106,96107,4-Bromophenyl butyrate,CCCC(=O)OC1=CC=C(C=C1)Br,,,,,,
6107,96108,"3,5-Bis(benzyl)pyridine",C1=CC=C(C=C1)CC2=CC(=CN=C2)CC3=CC=CC=C3,,,,,,
6108,96109,4-Nitrothioanisole,CSC1=CC=C(C=C1)[N+](=O)[O-],,,,,,
6109,96110,"Pentanamide, N-(2-chloro-5-nitrophenyl)-4,4-dimethyl-3-oxo-",CC(C)(C)C(=O)CC(=O)NC1=C(C=CC(=C1)[N+](=O)[O-])Cl,,,,,,
6110,96111,5-Iodo-8-quinolinol,C1=CC2=C(C=CC(=C2N=C1)O)I,,,,,,
6111,96112,Bicyclo[2.2.1]hept-5-ene-2-carboxamide,C1C2CC(C1C=C2)C(=O)N,,,,,,
6112,96113,(5-Nitrofuran-2-yl)methylidenehydrazine,C1=C(OC(=C1)[N+](=O)[O-])C=NN,,,,,,
6113,96114,CID 96114,C(C#N)C(=N)S,,,,,,
6114,96115,"1H-Isoindole-1,3(2H)-dione, 2-((bis(2-chloroethyl)amino)methyl)-",C1=CC=C2C(=C1)C(=O)N(C2=O)CN(CCCl)CCCl,,,,,,
6115,96116,"N,N-Dipentylglycine ethyl ester",CCCCCN(CCCCC)CC(=O)OCC,,,,,,
6116,96117,Dotriacontanol,CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO,,,,,,
6117,96118,"4',5,6,7-Tetramethoxyflavone",COC1=CC=C(C=C1)C2=CC(=O)C3=C(C(=C(C=C3O2)OC)OC)OC,,,,,,
6118,96119,"1,4-Butanediol, 2,2-dimethyl-, dimethanesulfonate",CC(C)(CCOS(=O)(=O)C)COS(=O)(=O)C,,,,,,
6119,96120,Ethyl 2-hydroxyvalerate,CCCC(C(=O)OCC)O,,,,,,
6120,96121,"2-Phenyl-1,3,2-benzodioxaborole",B1(OC2=CC=CC=C2O1)C3=CC=CC=C3,,,,,,
6121,96122,"1H-1,3,2-Benzodiazaborole, 2,3-dihydro-2-phenyl-",B1(NC2=CC=CC=C2N1)C3=CC=CC=C3,,,,,,
6122,96123,1-(Cyclohexylamino)cyclohexanecarbonitrile,C1CCC(CC1)NC2(CCCCC2)C#N,,,,,,
6123,96124,"(2R,3R,4S,5R)-2-(6-((2-Hydroxyethyl)amino)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol",C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)NCCO,,,,,,
6124,96125,4-Bromo-1H-imidazole,C1=C(NC=N1)Br,,,,,,
6125,96126,"Uracil, 5-(methylthio)-",CSC1=CNC(=O)NC1=O,,,,,,
6126,96127,Ethyl N-acetyl-N-phenylglycinate,CCOC(=O)CN(C1=CC=CC=C1)C(=O)C,,,,,,
6127,96128,2-Phenylindolizine,C1=CC=C(C=C1)C2=CN3C=CC=CC3=C2,,,,,,
6128,96129,2-Amino-5-methyl-4-phenylthiazole,CC1=C(N=C(S1)N)C2=CC=CC=C2,,,,,,
6129,96130,"1-Propanol, 3-(m-methoxyphenyl)-",COC1=CC=CC(=C1)CCCO,,,,,,
6130,96131,"2,6-Dichloro-N,N-dimethyl-4-nitroaniline",CN(C)C1=C(C=C(C=C1Cl)[N+](=O)[O-])Cl,,,,,,
6131,96132,"Propanenitrile, 3-(bis(2-hydroxyethyl)amino)-",C(CN(CCO)CCO)C#N,,,,,,
6132,96133,3-Chlorocoumarin,C1=CC=C2C(=C1)C=C(C(=O)O2)Cl,,,,,,
6133,96134,Isophthaloyl bisphthalimide,C1=CC=C2C(=C1)C(=O)N(C2=O)C(=O)C3=CC=CC=C3C(=O)N4C(=O)C5=CC=CC=C5C4=O,,,,,,
6134,96135,5-Iodoacetamidosalicylic acid,C1=CC(=C(C=C1NC(=O)CI)C(=O)O)O,,,,,,
6135,96136,Undec-10-enyl propanoate,CCC(=O)OCCCCCCCCCC=C,,,,,,
6136,96137,"2-Nitro-6H-dibenzo[b,d]pyran-6-one",C1=CC=C2C(=C1)C3=C(C=CC(=C3)[N+](=O)[O-])OC2=O,,,,,,
6137,96138,"2,2,4-Trimethylpentyl 2-methylpropanoate",CC(C)CC(C)(C)COC(=O)C(C)C,,,,,,
6138,96139,"Pyrazole, 3,5-dimethyl-1-((trichloromethyl)thio)-",CC1=CC(=NN1SC(Cl)(Cl)Cl)C,,,,,,
6139,96140,"Thiomorpholine, 4-(2-chloroethyl)-",C1CSCCN1CCCl,,,,,,
6140,96141,6-Chloro-3-methyluracil,CN1C(=O)C=C(NC1=O)Cl,,,,,,
6141,96142,"Piperazine, 1-methyl-4-(3,4,5-trimethoxybenzoyl)-",CN1CCN(CC1)C(=O)C2=CC(=C(C(=C2)OC)OC)OC,,,,,,
6142,96143,1-(1-Naphthylmethyl)piperidine,C1CCN(CC1)CC2=CC=CC3=CC=CC=C32,,,,,,
6143,96144,CID 96144,CC1=CC(=O)N=C(N1)NS(=O)(=O)C2=CC=C(C=C2)N,,,,,,
6144,96145,"Benzenebutanoic acid, 4-(1-methylethyl)-gamma-oxo-",CC(C)C1=CC=C(C=C1)C(=O)CCC(=O)O,,,,,,
6145,96146,"Ethanedioic acid, bis[(phenylmethylene)hydrazide]",C1=CC=C(C=C1)C=NNC(=O)C(=O)NN=CC2=CC=CC=C2,,,,,,
6146,96147,N-[(5-tert-butyl-2-methoxyphenyl)methylideneamino]-5-nitropyridin-2-amine,CC(C)(C)C1=CC(=C(C=C1)OC)C=NNC2=NC=C(C=C2)[N+](=O)[O-],,,,,,
6147,96148,N-Methyl-N-nitrosoformamide,CN(C=O)N=O,,,,,,
6148,96149,"p-Benzoquinone, 2,5-dichloro-3,6-dimorpholino-",C1COCCN1C2=C(C(=O)C(=C(C2=O)Cl)N3CCOCC3)Cl,,,,,,
6149,96150,CID 96150,C1CC(=C(C(=NO)C1)N=O)NO,,,,,,
6150,96151,CID 96151,CNS(=O)(=O)C1=C2C(=NC=N2)N=CN1,,,,,,
6151,96152,"Thiocyanic acid, 4-chlorobenzyl ester",C1=CC(=CC=C1CSC#N)Cl,,,,,,
6152,96153,"1-(4-Fluorophenyl)-1H-pyrrole-2,5-dione",C1=CC(=CC=C1N2C(=O)C=CC2=O)F,,,,,,
6153,96154,(2-Hydroxy-4-methoxyphenyl)(4-methoxyphenyl)methanone,COC1=CC=C(C=C1)C(=O)C2=C(C=C(C=C2)OC)O,,,,,,
6154,96155,"Glycine, N-nitroso-N-propyl-",CCCN(CC(=O)O)N=O,,,,,,
6155,96156,"Glycine, N-(1-methylethyl)-N-nitroso-",CC(C)N(CC(=O)O)N=O,,,,,,
6156,96157,"Glycine, N-nitroso-N-pentyl-",CCCCCN(CC(=O)O)N=O,,,,,,
6157,96158,Methyl 2-phenylthio-6-quinolyl ether,COC1=CC2=C(C=C1)N=C(C=C2)SC3=CC=CC=C3,,,,,,
6158,96159,"2-Methyl-1,3-indandione",CC1C(=O)C2=CC=CC=C2C1=O,,,,,,
6159,96160,N-Methylpropargylamine,CNCC#C,,,,,,
6160,96161,"Methyl 4-chloro-3,5-dinitrobenzoate",COC(=O)C1=CC(=C(C(=C1)[N+](=O)[O-])Cl)[N+](=O)[O-],,,,,,
6161,96162,p-Chlorobenzyl-p-chlorophenyl sulfone,C1=CC(=CC=C1CS(=O)(=O)C2=CC=C(C=C2)Cl)Cl,,,,,,
6162,96163,CID 96163,C1=NC2=NNN=C(C2=N1)N,,,,,,
6163,96164,N-Octadecylaniline,CCCCCCCCCCCCCCCCCCNC1=CC=CC=C1,,,,,,
6164,96165,1-Bromo-3-phenoxybenzene,C1=CC=C(C=C1)OC2=CC(=CC=C2)Br,,,,,,
6165,96166,"Aziridine, 1,1'-(m-phenylenedisulfonyl)bis-",C1CN1S(=O)(=O)C2=CC(=CC=C2)S(=O)(=O)N3CC3,,,,,,
6166,96167,"Triethylamine, 2',2''-dichloro-1,1-dimethyl-",CC(C)(C)N(CCCl)CCCl,,,,,,
6167,96168,"Benzoic acid, 4-methoxy-, butyl ester",CCCCOC(=O)C1=CC=C(C=C1)OC,,,,,,
6168,96169,"N,N-diethyl-4-oxopentanamide",CCN(CC)C(=O)CCC(=O)C,,,,,,
6169,96170,"1,4-Dioxane-2,3-diol",C1COC(C(O1)O)O,,,,,,
6170,96171,Palmitanilide,CCCCCCCCCCCCCCCC(=O)NC1=CC=CC=C1,,,,,,
6171,96172,p-Chloroacetophenone oxime,CC(=NO)C1=CC=C(C=C1)Cl,,,,,,
6172,96173,1-Methyl-5-nitrobenzimidazole,CN1C=NC2=C1C=CC(=C2)[N+](=O)[O-],,,,,,
6173,96174,"10-Phenothiazineethylamine, N,N-bis(2-chloroethyl)-",C1=CC=C2C(=C1)N(C3=CC=CC=C3S2)CCN(CCCl)CCCl,,,,,,
6174,96175,Actinocin,CC1=C2C(=C(C=C1)C(=O)O)N=C3C(=C(C(=O)C(=C3O2)C)N)C(=O)O,,,,,,
6175,96176,1-(4-Biphenylyl)ethanol,CC(C1=CC=C(C=C1)C2=CC=CC=C2)O,,,,,,
6176,96177,"2,4-Diamino-6-nitrotoluene",CC1=C(C=C(C=C1[N+](=O)[O-])N)N,,,,,,
6177,96178,"1-((Bis(2-chloroethyl)amino)methyl)-1H-indole-2,3-dione",C1=CC=C2C(=C1)C(=O)C(=O)N2CN(CCCl)CCCl,,,,,,
6178,96179,"Bis(3,5,5-trimethylhexyl) hydrogen phosphate",CC(CCOP(=O)(O)OCCC(C)CC(C)(C)C)CC(C)(C)C,,,,,,
6179,96180,"Ethanol, 2-(salicylamino)-",C1=CC=C(C(=C1)CNCCO)O,,,,,,
6180,96181,Ethylhydrazine oxalate,CCNN.C(=O)(C(=O)O)O,,,,,,
6181,96182,"2-(2,5-Dioxopyrrolidin-1-yl)acetic acid",C1CC(=O)N(C1=O)CC(=O)O,,,,,,
6182,96183,"1-(2-Chloroethyl)pyrrolidine-2,5-dione",C1CC(=O)N(C1=O)CCCl,,,,,,
6183,96184,"N-(2,5-Dichlorophenyl)benzamide",C1=CC=C(C=C1)C(=O)NC2=C(C=CC(=C2)Cl)Cl,,,,,,
6184,96185,"Thiocyanic acid, 1H-purin-6-yl ester",C1=NC2=C(N1)C(=NC=N2)SC#N,,,,,,
6185,96186,"Benzenamine, N,N-bis(2-chloroethyl)-4-phenoxy-",C1=CC=C(C=C1)OC2=CC=C(C=C2)N(CCCl)CCCl,,,,,,
6186,96187,CID 96187,CC(C)C1=CC(=O)N=C(N1)S,,,,,,
6187,96188,6-n-Propyluracil,CCCC1=CC(=O)NC(=O)N1,,,,,,
6188,96189,Di-sec-butyl adipate,CCC(C)OC(=O)CCCCC(=O)OC(C)CC,,,,,,
6189,96190,7-Acetamidonitrazepam,CC(=O)NC1=CC2=C(C=C1)NC(=O)CN=C2C3=CC=CC=C3,,,,,,
6190,96191,Rubiadin 1-methyl ether,CC1=C(C=C2C(=C1OC)C(=O)C3=CC=CC=C3C2=O)O,,,,,,
6191,96192,Triglycidyl cyanurate,C1C(O1)COC2=NC(=NC(=N2)OCC3CO3)OCC4CO4,,,,,,
6192,96193,"2-Chloroethyl phenyl N,N-bis(2-chloroethyl)phosphoramidate",C1=CC=C(C=C1)OP(=O)(N(CCCl)CCCl)OCCCl,,,,,,
6193,96194,CID 96194,C1=CNC2=C1C(=O)N=CN2,,,,,,
6194,96195,S-Methyl 1-piperidinecarbothioate,CSC(=O)N1CCCCC1,,,,,,
6195,96196,"Hexahydro-4,7-methanoisobenzofuran-1,3-dione",C1CC2CC1C3C2C(=O)OC3=O,,,,,,
6196,96197,1-(4-Ethylphenyl)ethanone oxime,CCC1=CC=C(C=C1)C(=NO)C,,,,,,
6197,96198,"Phosphoramidothioic dichloride, N,N-bis(2-chloroethyl)-",C(CCl)N(CCCl)P(=S)(Cl)Cl,,,,,,
6198,96199,Bis(2-aminopropyl)amine,CC(CNCC(C)N)N,,,,,,
6199,96200,1-[6-(Diethylamino)-2-hexynyl]pyrrolidine,CCN(CC)CCCC#CCN1CCCC1,,,,,,
6200,96201,"1,1-Bis(4-hydroxyphenyl)cyclopentane",C1CCC(C1)(C2=CC=C(C=C2)O)C3=CC=C(C=C3)O,,,,,,
6201,96202,"N,N-Diallylaniline",C=CCN(CC=C)C1=CC=CC=C1,,,,,,
6202,96203,Diethyl 2-cyclopenten-1-ylmalonate,CCOC(=O)C(C1CCC=C1)C(=O)OCC,,,,,,
6203,96204,2-Lauroleic acid,CCCCCCCCCC=CC(=O)O,,,,,,
6204,96205,"2-Propanol, 1,1'-iminobis(3-allyloxy-",C=CCOCC(CNCC(COCC=C)O)O,,,,,,
6205,96206,2-Cyclohexylideneacetic acid,C1CCC(=CC(=O)O)CC1,,,,,,
6206,96207,3-Ethylbenzoic acid,CCC1=CC(=CC=C1)C(=O)O,,,,,,
6207,96208,"(2,3-Dimethylphenyl)methanol",CC1=C(C(=CC=C1)CO)C,,,,,,
6208,96209,"Butanamide, N-(6-ethoxy-2-benzothiazolyl)-3-oxo-",CCOC1=CC2=C(C=C1)N=C(S2)NC(=O)CC(=O)C,,,,,,
6209,96210,4-(2-Cyclohexenyloxy)benzoic acid,C1CC=CC(C1)OC2=CC=C(C=C2)C(=O)O,,,,,,
6210,96211,"(2-Hydrazinylidene-1,2-diphenylethylidene)hydrazine",C1=CC=C(C=C1)C(=NN)C(=NN)C2=CC=CC=C2,,,,,,
6211,96212,"1,2-Ethanediol, 1,2-bis(6-methylpyridyl)-",CC1=NC(=CC=C1)C(C(C2=CC=CC(=N2)C)O)O,,,,,,
6212,96213,Niazo,CCCCOC1=NC=C(C=C1)N=NC2=C(N=C(C=C2)N)N,,,,,,
6213,96214,"2,4,6-Triisopropylbenzoic acid",CC(C)C1=CC(=C(C(=C1)C(C)C)C(=O)O)C(C)C,,,,,,
6214,96215,Imidazoleacetic acid,C1=C(NC=N1)CC(=O)O,,,,,,
6215,96216,2-Cyclopentene-1-acetic acid,C1CC(C=C1)CC(=O)O,,,,,,
6216,96217,"3-Chloro-1,1-diethoxypropane",CCOC(CCCl)OCC,,,,,,
6217,96218,3-Bromophthalide,C1=CC=C2C(=C1)C(OC2=O)Br,,,,,,
6218,96219,(p-Chlorobenzoyl)urea,C1=CC(=CC=C1C(=O)NC(=O)N)Cl,,,,,,
6219,96220,"1,3,5-Pentanetricarboxylic acid",C(CC(=O)O)C(CCC(=O)O)C(=O)O,,,,,,
6220,96221,3-Amino-1H-pyrazol-5-ol,C1=C(NNC1=O)N,,,,,,
6221,96222,2-Butylidene-1-cyclohexanone,CCCC=C1CCCCC1=O,,,,,,
6222,96223,3-(2-Oxocyclohexyl)propanenitrile,C1CCC(=O)C(C1)CCC#N,,,,,,
6223,96224,Hexahydro-1-lauroyl-1H-azepine,CCCCCCCCCCCC(=O)N1CCCCCC1,,,,,,
6224,96225,"7-Allyloxy-4,8-dimethylcoumarin",CC1=CC(=O)OC2=C1C=CC(=C2C)OCC=C,,,,,,
6225,96226,"2-Butoxy-7,10-dichlorobenzo[b][1,5]naphthyridine",CCCCOC1=NC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)Cl,,,,,,
6226,96227,Allenolic acid,C1=CC2=C(C=CC(=C2)O)C=C1CCC(=O)O,,,,,,
6227,96228,"(R*,S*)-2,3-Dichlorosuccinic acid",C(C(C(=O)O)Cl)(C(=O)O)Cl,,,,,,
6228,96229,Diantipyrylmethane,CC1=C(C(=O)N(N1C)C2=CC=CC=C2)CC3=C(N(N(C3=O)C4=CC=CC=C4)C)C,,,,,,
6229,96230,4-{(1E)-1-ethyl-2-[4-(palmitoyloxy)phenyl]-1-butenyl}phenyl palmitate,CCCCCCCCCCCCCCCC(=O)OC1=CC=C(C=C1)C(=C(CC)C2=CC=C(C=C2)OC(=O)CCCCCCCCCCCCCCC)CC,,,,,,
6230,96231,CID 96231,CC1=C(NC(=NC1=O)S)C,,,,,,
6231,96232,Isopropyl sulfone,CC(C)S(=O)(=O)C(C)C,,,,,,
6232,96233,N-Benzyl-2-chloroacetamide,C1=CC=C(C=C1)CNC(=O)CCl,,,,,,
6233,96234,3-Chlorobenzothiophene,C1=CC=C2C(=C1)C(=CS2)Cl,,,,,,
6234,96235,4-Methyl-2-nitrobenzonitrile,CC1=CC(=C(C=C1)C#N)[N+](=O)[O-],,,,,,
6235,96236,"Diethyl 2,3-diethoxysuccinate",CCOC(C(C(=O)OCC)OCC)C(=O)OCC,,,,,,
6236,96237,"1,5-Naphthalenedisulfonamide",C1=CC2=C(C=CC=C2S(=O)(=O)N)C(=C1)S(=O)(=O)N,,,,,,
6237,96238,(Z)-9-oxabicyclo[6.1.0]non-4-ene,C1CC2C(O2)CCC=C1,,,,,,
6238,96239,o-Chlorobenzaldoxime,C1=CC=C(C(=C1)C=NO)Cl,,,,,,
6239,96240,"1,3-Benzenedisulfonyl chloride",C1=CC(=CC(=C1)S(=O)(=O)Cl)S(=O)(=O)Cl,,,,,,
6240,96241,3-O-Methyl-D-glucopyranose,CO[C@H]1[C@@H]([C@H](OC([C@@H]1O)O)CO)O,,,,,,
6241,96242,CID 96242,COCCCNS(=O)(=O)C1=C2C(=NC=N2)N=CN1,,,,,,
6242,96243,CID 96243,CC(C)CNS(=O)(=O)C1=C2C(=NC=N2)N=CN1,,,,,,
6243,96244,CID 96244,C1=CC=C(C=C1)CNS(=O)(=O)C2=C3C(=NC=N3)N=CN2,,,,,,
6244,96245,"Benzenebutanoic acid, 4-(4-chlorophenoxy)-gamma-oxo-",C1=CC(=CC=C1C(=O)CCC(=O)O)OC2=CC=C(C=C2)Cl,,,,,,
6245,96246,"N,N'-Dimethylterephthalamide",CNC(=O)C1=CC=C(C=C1)C(=O)NC,,,,,,
6246,96247,CID 96247,CC(C)N1C=NC2=C1N=CN=C2S,,,,,,
6247,96248,"Ethanethiol, 2-phthalimido-",C1=CC=C2C(=C1)C(=O)N(C2=O)CCS,,,,,,
6248,96249,CID 96249,CCOCCNS(=O)(=O)C1=C2C(=NC=N2)N=CN1,,,,,,
6249,96250,CID 96250,CCCNS(=O)(=O)C1=C2C(=NC=N2)N=CN1,,,,,,
6250,96251,1-Acetylpyrene,CC(=O)C1=C2C=CC3=CC=CC4=C3C2=C(C=C4)C=C1,,,,,,
6251,96252,"2-Pyrimidinol, 4-amino-6-(3,4-dichloroanilino)-",C1=CC(=C(C=C1NC2=NC(=O)NC(=C2)N)Cl)Cl,,,,,,
6252,96253,CID 96253,C1=CNC2=C1C(=O)N=C(N2)N,,,,,,
6253,96254,3-Chlorophthalic acid,C1=CC(=C(C(=C1)Cl)C(=O)O)C(=O)O,,,,,,
6254,96255,"1H-Purine-2,6,8(3H)-trione, 7,9-dihydro-1,3-dimethyl-, 8-hydrazone",CN1C2=C(C(=O)N(C1=O)C)NC(=N2)NN,,,,,,
6255,96256,8-(4-Methylpiperidinoazo)theophyline,CC1CCN(CC1)N=NC2=NC3=C(N2)C(=O)N(C(=O)N3C)C,,,,,,
6256,96257,Trimethylene dinitrate,C(CO[N+](=O)[O-])CO[N+](=O)[O-],,,,,,
6257,96258,"2,5-Pyrrolidinedione, 1-((bis(2-chloroethyl)amino)methyl)-",C1CC(=O)N(C1=O)CN(CCCl)CCCl,,,,,,
6258,96259,Diethyl 3-hydroxyglutarate,CCOC(=O)CC(CC(=O)OCC)O,,,,,,
6259,96260,"2,6-Dibromonaphthalene-1,5-diol",C1=CC(=C(C2=C1C(=C(C=C2)Br)O)O)Br,,,,,,
6260,96261,Ethyl benzilate,CCOC(=O)C(C1=CC=CC=C1)(C2=CC=CC=C2)O,,,,,,
6261,96262,tert-Butyl 2-chloroethyl sulfide,CC(C)(C)SCCCl,,,,,,
6262,96263,"3-chloro-N,N-bis(2-chloroethyl)aniline",C1=CC(=CC(=C1)Cl)N(CCCl)CCCl,,,,,,
6263,96264,"3,5-Dimethyl-4-nitropyridine 1-oxide",CC1=C[N+](=CC(=C1[N+](=O)[O-])C)[O-],,,,,,
6264,96265,"4H-1,2,4-Triazole, 4-amino-3,5-dibenzyl-",C1=CC=C(C=C1)CC2=NN=C(N2N)CC3=CC=CC=C3,,,,,,
6265,96266,Isochroman,C1COCC2=CC=CC=C21,,,,,,
6266,96267,"3',4'-Dihydroxypropiophenone",CCC(=O)C1=CC(=C(C=C1)O)O,,,,,,
6267,96268,4-Methylpimelic acid,CC(CCC(=O)O)CCC(=O)O,,,,,,
6268,96269,"Benzamide, 4-allyloxy-N,N-diethyl-3,5-dipropyl-",CCCC1=CC(=CC(=C1OCC=C)CCC)C(=O)N(CC)CC,,,,,,
6269,96270,9-Acetamidoacridine,CC(=O)NC1=C2C=CC=CC2=NC3=CC=CC=C31,,,,,,
6270,96271,Bis(2-chloroethyl)phosphoramidic dichloride,C(CCl)N(CCCl)P(=O)(Cl)Cl,,,,,,
6271,96272,Hexafosfamid,C1CCC(CC1)NP(=S)(N2CC2)N3CC3,,,,,,
6272,96273,"Propane, 1,1'-thiobis(3-chloro-",C(CSCCCCl)CCl,,,,,,
6273,96274,Tetrakis[p-(dimethylamino)phenyl]ethylene,CN(C)C1=CC=C(C=C1)C(=C(C2=CC=C(C=C2)N(C)C)C3=CC=C(C=C3)N(C)C)C4=CC=C(C=C4)N(C)C,,,,,,
6274,96275,CID 96275,C1=CN=C2C1=C(NC=N2)Cl,,,,,,
6275,96276,Allyl p-tolyl sulfone,CC1=CC=C(C=C1)S(=O)(=O)CC=C,,,,,,
6276,96277,Methyl 2-(4-chlorophenoxy)acetate,COC(=O)COC1=CC=C(C=C1)Cl,,,,,,
6277,96278,"L-glycero-beta-L-gluco-Heptopyranosylamine, 4-deoxy-4-((((14-methyl-1-oxopentadecyl)amino)acetyl)amino)-N-1H-purin-6-yl-",CC(C)CCCCCCCCCCCCC(=O)NCC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1[C@H](CO)O)NC2=NC=NC3=C2NC=N3)O)O,,,,,,
6278,96279,1-(Trichloromethylmercapto) pyrazole,C1=CN(N=C1)SC(Cl)(Cl)Cl,,,,,,
6279,96280,CID 96280,C1=CC=C2C(=C1)N3C(=NN=C3S2)S,,,,,,
6280,96281,"Pyrimido(4,5-e)-1,2,4-thiadiazine, 8-amino-6-methylthio-, 1,1-dioxide",CSC1=NC2=NC=NS(=C2C(=N1)N)(=O)O,,,,,,
6281,96282,"4,6-Diamino-2-methylthio-5-pyrimidine sulfonamide",CSC1=NC(=C(C(=N1)N)S(=O)(=O)N)N,,,,,,
6282,96283,"5-Pyrimidinesulfonic acid, 4,6-diamino-2-methylthio-",CSC1=NC(=C(C(=N1)N)S(=O)(=O)O)N,,,,,,
6283,96284,"5-Pyrimidinesulfonic acid, 4,6-diamino-2-hydroxy-",C1(=C(NC(=O)N=C1N)N)S(=O)(=O)O,,,,,,
6284,96285,"9-Octadecenoic acid (9Z)-, 2,2-dimethyl-1,3-propanediyl ester",CCCCCCCCC=CCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCC=CCCCCCCCC,,,,,,
6285,96286,"2,2-Dimethyl-1,3-propanediyl bis(mercaptoacetate)",CC(C)(COC(=O)CS)COC(=O)CS,,,,,,
6286,96287,Tris((3-ethyl-3-oxetanyl)methyl) phosphite,CCC1(COC1)COP(OCC2(COC2)CC)OCC3(COC3)CC,,,,,,
6287,96288,"1-(4-Nitrophenyl)propane-1,2-dione",CC(=O)C(=O)C1=CC=C(C=C1)[N+](=O)[O-],,,,,,
6288,96289,"1,2,3,4-Tetrahydroquinaldine",CC1CCC2=CC=CC=C2N1,,,,,,
6289,96290,"1-(2,2-Diethoxyethyl)pyrrolidine",CCOC(CN1CCCC1)OCC,,,,,,
6290,96291,Tetrahydrolavandulol,CC(C)CCC(CO)C(C)C,,,,,,
6291,96292,CID 96292,C1=CC2=C(C=C(OC2=CC1=O)O)CC(=O)O,,,,,,
6292,96293,2-Phenylglutaric anhydride,C1CC(=O)OC(=O)C1C2=CC=CC=C2,,,,,,
6293,96294,p-Isoamylphenol,CC(C)CCC1=CC=C(C=C1)O,,,,,,
6294,96295,CID 96295,CCCC[GeH](CCCC)CCCC.CC(=O)O,,,,,,
6295,96296,CID 96296,CC[GeH](CC)CC.CC(=O)O,,,,,,
6296,96297,"N-{[(2,3-dichlorophenyl)methylidene]amino}guanidine",C1=CC(=C(C(=C1)Cl)Cl)C=NN=C(N)N,,,,,,
6297,96298,2-[(4-Chlorophenyl)methylideneamino]guanidine,C1=CC(=CC=C1C=NN=C(N)N)Cl,,,,,,
6298,96299,"Acetamide, N-(7-aminofluoren-2-yl)-",CC(=O)NC1=CC2=C(C=C1)C3=C(C2)C=C(C=C3)N,,,,,,
6299,96300,"Acetamide, 2,2-dichloro-N-(2-fluorenyl)-",C1C2=CC=CC=C2C3=C1C=C(C=C3)NC(=O)C(Cl)Cl,,,,,,
6300,96301,N-(9H-fluoren-2-yl)methanesulfonamide,CS(=O)(=O)NC1=CC2=C(C=C1)C3=CC=CC=C3C2,,,,,,
6301,96302,Pentachloro((chloromethyl)thio)benzene,C(SC1=C(C(=C(C(=C1Cl)Cl)Cl)Cl)Cl)Cl,,,,,,
6302,96303,CID 96303,C1=C2C(=NC(=O)N2)NC(=N1)N,,,,,,
6303,96304,"2,5-Bis(dimethylamino)-1,4-benzoquinone",CN(C)C1=CC(=O)C(=CC1=O)N(C)C,,,,,,
6304,96305,"1,2-Bis(pyridin-2-ylmethylene)hydrazine",C1=CC=NC(=C1)C=NN=CC2=CC=CC=N2,,,,,,
6305,96306,"4,4'-(Hydrazinediylidenedimethanylylidene)dipyridine",C1=CN=CC=C1C=NN=CC2=CC=NC=C2,,,,,,
6306,96307,Isonicotinaldehyde O-benzyloxime,C1=CC=C(C=C1)CON=CC2=CC=NC=C2,,,,,,
6307,96308,4-{[(4-Chlorophenyl)sulfanyl]methyl}phenylamine,C1=CC(=CC=C1CSC2=CC=C(C=C2)Cl)N,,,,,,
6308,96309,N-(4-Methoxybenzylideneamino)guanidine,COC1=CC=C(C=C1)C=NN=C(N)N,,,,,,
6309,96310,p-Nitrobenzylidenaminoguanidin,C1=CC(=CC=C1C=NN=C(N)N)[N+](=O)[O-],,,,,,
6310,96311,2-[[4-(Dimethylamino)phenyl]methylideneamino]guanidine,CN(C)C1=CC=C(C=C1)C=NN=C(N)N,,,,,,
6311,96312,O-Methylguanosine,COC1=NC(=NC2=C1N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N,,,,,,
6312,96313,CID 96313,CC(=O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C2NC=NC3=O)OC(=O)C)OC(=O)C,,,,,,
6313,96314,"Phosphonic acid, (m-bromophenyl)-",C1=CC(=CC(=C1)Br)P(=O)(O)O,,,,,,
6314,96315,"N,N'-Biphthalimide",C1=CC=C2C(=C1)C(=O)N(C2=O)N3C(=O)C4=CC=CC=C4C3=O,,,,,,
6315,96316,"3-Methylpentane-2,4-diol",CC(C(C)O)C(C)O,,,,,,
6316,96317,"1,2-Dihydro-3,4,5,6-tetraphenylphthalic anhydride",C1=CC=C(C=C1)C2=C(C(=C(C3C2C(=O)OC3=O)C4=CC=CC=C4)C5=CC=CC=C5)C6=CC=CC=C6,,,,,,
6317,96318,Bacimethrin,COC1=NC=C(C(=N1)N)CO,,,,,,
6318,96319,3-(2-Carboxyethylsulfanyl)propanoic acid;dioctyltin,CCCCCCCC[Sn]CCCCCCCC.C(CSCCC(=O)O)C(=O)O,,,,,,
6319,96320,"Phosphinothioic amide, P,P-bis(1-aziridinyl)-N-(3-methoxypropyl)-",COCCCNP(=S)(N1CC1)N2CC2,,,,,,
6320,96321,m-Nitrobenzaldehyde guanylhydrazone,C1=CC(=CC(=C1)[N+](=O)[O-])C=NN=C(N)N,,,,,,
6321,96322,"1H-Purine-2,6-dione, 3,7-dihydro-8-(bis(2-hydroxyethyl)amino)-1,3,7-trimethyl-",CN1C2=C(N=C1N(CCO)CCO)N(C(=O)N(C2=O)C)C,,,,,,
6322,96323,"Pyridine-2,6-dialdehyde dioxime",C1=CC(=NC(=C1)C=NO)C=NO,,,,,,
6323,96324,"2-Methylthio-1,4-naphthoquinone",CSC1=CC(=O)C2=CC=CC=C2C1=O,,,,,,
6324,96325,Cyclohexyl phenylacetate,C1CCC(CC1)OC(=O)CC2=CC=CC=C2,,,,,,
6325,96326,N-Benzyl-N-nitrosourea,C1=CC=C(C=C1)CN(C(=O)N)N=O,,,,,,
6326,96327,2-[(4-Bromophenyl)methylideneamino]guanidine,C1=CC(=CC=C1C=NN=C(N)N)Br,,,,,,
6327,96328,"(2,2-Diethoxyethoxy)benzene",CCOC(COC1=CC=CC=C1)OCC,,,,,,
6328,96329,1-Naphthylmethyl acetate,CC(=O)OCC1=CC=CC2=CC=CC=C21,,,,,,
6329,96330,Diisopropyl glutarate,CC(C)OC(=O)CCCC(=O)OC(C)C,,,,,,
6330,96331,Isobutyl p-anisate,CC(C)COC(=O)C1=CC=C(C=C1)OC,,,,,,
6331,96332,2-Ethylbutyric anhydride,CCC(CC)C(=O)OC(=O)C(CC)CC,,,,,,
6332,96333,"Alanine, N-(bromoacetyl)-2-methyl-, p-nitrophenyl ester",CC(C)(C(=O)OC1=CC=C(C=C1)[N+](=O)[O-])NC(=O)CBr,,,,,,
6333,96334,"Dimethyl 2,3-dichlorobut-2-enedioate",COC(=O)C(=C(C(=O)OC)Cl)Cl,,,,,,
6334,96335,"Phenol, 2,2'-(1,2-ethanediylidenedinitrilo)bis-",C1=CC=C(C(=C1)N=CC=NC2=CC=CC=C2O)O,,,"['Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)']",,,
6335,96336,CID 96336,C1=CC=C(C=C1)[S-].C1=CC=C(C=C1)[PbH](C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
6336,96337,Tris(2-propylphenyl) phosphate,CCCC1=CC=CC=C1OP(=O)(OC2=CC=CC=C2CCC)OC3=CC=CC=C3CCC,,,,,,
6337,96338,"2-Chloro-N-(2,6-diethylphenyl)acetamide",CCC1=C(C(=CC=C1)CC)NC(=O)CCl,,,,,"['2-Chloro-N-(2,6-diethylphenyl)acetamide is a known human metabolite of Alachlor and Butachlor.']",
6338,96339,p-Nitrobenzaldoxime,C1=CC(=CC=C1C=NO)[N+](=O)[O-],,,,,,
6339,96340,5-Benzyloxyindole-3-acetic acid,C1=CC=C(C=C1)COC2=CC3=C(C=C2)NC=C3CC(=O)O,,,,,,
6340,96341,"1,3-Propanediol, 2,2-diethyl-, diacetate",CCC(CC)(COC(=O)C)COC(=O)C,,,,,,
6341,96342,"3,5-Pyrazolidinedione, 1,2-diphenyl-4-isopropylidene-",CC(=C1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3)C,,,,,,
6342,96343,"2-(2,4,6-Trichlorophenoxy)ethanol",C1=C(C=C(C(=C1Cl)OCCO)Cl)Cl,,,,,,
6343,96344,Ethyl 5-methyl-3-oxohexanoate,CCOC(=O)CC(=O)CC(C)C,,,,,,
6344,96345,tert-Butyl ethyl malonate,CCOC(=O)CC(=O)OC(C)(C)C,,,,,,
6345,96346,"2,2'-Thiodiethyl dipropionate",CCC(=O)OCCSCCOC(=O)CC,,,,,,
6346,96347,Ethyl 4-hydroxypyrimidine-5-carboxylate,CCOC(=O)C1=CN=CNC1=O,,,,,,
6347,96348,"Urea, 1-(p-fluorophenyl)-3-methyl-",CNC(=O)NC1=CC=C(C=C1)F,,,,,,
6348,96349,1-Butyl-3-methylurea,CCCCNC(=O)NC,,,,,,
6349,96350,3-Bromo-2-methylthiophene,CC1=C(C=CS1)Br,,,,,,
6350,96351,6-Methylnicotinamide,CC1=NC=C(C=C1)C(=O)N,,,,,,
6351,96352,5-Hydroxy-pseudouric acid,C1(=O)C(C(=O)NC(=O)N1)(NC(=O)N)O,,,,,,
6352,96353,"Thiophene, 1,1,2,3,4,5-hexahydro-1-((trichloroacetyl)imino)-",C1CCS(=NC(=O)C(Cl)(Cl)Cl)C1,,,,,,
6353,96354,"Phosphinic amide, bis(1-aziridinyl)-N-bis(2-chloroethyl)-",C1CN1P(=O)(N2CC2)N(CCCl)CCCl,,,,,,
6354,96355,"Phosphorodiamidic acid, N,N-bis(2-chloroethyl)-, compd. with cyclohexanamine (1:1)",C1CCC(CC1)N.C(CCl)N(CCCl)P(=O)(N)O,,,,,,
6355,96356,Phosphoramide mustard,C(CCl)N(CCCl)P(=O)(N)O,,,,,,
6356,96357,Cyclohexyl cyanoacetate,C1CCC(CC1)OC(=O)CC#N,,,,,,
6357,96358,N-{[4-(propan-2-yl)phenyl]methylidene}hydroxylamine,CC(C)C1=CC=C(C=C1)C=NO,,,,,,
6358,96359,2-Ethylhexyl cyanoacetate,CCCCC(CC)COC(=O)CC#N,,,,,,
6359,96360,"Morpholine, 4-(10-undecenoyl)-",C=CCCCCCCCCC(=O)N1CCOCC1,,,,,,
6360,96361,"Phthalic acid, butyl dodecyl ester",CCCCCCCCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC,,,,,,
6361,96362,"1,4-Butanediyl bis(cyanoacetate)",C(CCOC(=O)CC#N)COC(=O)CC#N,,,,,,
6362,96363,Ethylene bis(cyanoacetate),C(COC(=O)CC#N)OC(=O)CC#N,,,,,,
6363,96364,Olivacine,CC1=C2C=CNC(=C2C=C3C1=NC4=CC=CC=C43)C,,,,,,
6364,96365,4-(2-Nitrophenyl)morpholine,C1COCCN1C2=CC=CC=C2[N+](=O)[O-],,,,,,
6365,96366,N-Cyclohexylbenzo[d]thiazole-2-sulfonamide,C1CCC(CC1)NS(=O)(=O)C2=NC3=CC=CC=C3S2,,,,,,
6366,96367,"Acetamide, N-chloro-N-9H-fluoren-2-yl-",CC(=O)N(C1=CC2=C(C=C1)C3=CC=CC=C3C2)Cl,,,,,,
6367,96368,"(2S,3S,4S,5R)-2-(6-Amino-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol",C1=NC(=C2C(=N1)N(C=N2)[C@@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N,,,"['Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)', 'Drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways. (From AMA Drug Evaluations Annual, 1994, p2033) (See all compounds classified as Antimetabolites.)']",,,
6368,96369,Oxymethacil,CC1=C(C(=O)NC(=O)N1)O,,,"['Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)', 'Agents counteracting or neutralizing the action of POISONS. (See all compounds classified as Antidotes.)']",,,
6369,96370,"1,3-dimethyl-5-nitropyrimidine-2,4(1H,3H)-dione",CN1C=C(C(=O)N(C1=O)C)[N+](=O)[O-],,,,,,
6370,96371,(Pyridin-4-ylmethylideneamino)urea,C1=CN=CC=C1C=NNC(=O)N,,,,,,
6371,96372,Tetramethylenebis(m-nitrogenzenesulfonate),C1=CC(=CC(=C1)S(=O)(=O)OCCCCOS(=O)(=O)C2=CC=CC(=C2)[N+](=O)[O-])[N+](=O)[O-],,,,,,
6372,96373,1-Methylguanosine,CN1C(=O)C2=C(N=C1N)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O,,,,,,
6373,96374,4-Methyl-DL-tryptophan,CC1=C2C(=CC=C1)NC=C2CC(C(=O)O)N,,,,,,
6374,96375,2-Methoxyethyl phenyl ether,COCCOC1=CC=CC=C1,,,,,,
6375,96376,Ethyl(phenyl)carbamoyl chloride,CCN(C1=CC=CC=C1)C(=O)Cl,,,,,,
6376,96377,2-(Tribromomethyl)quinoxaline,C1=CC=C2C(=C1)N=CC(=N2)C(Br)(Br)Br,,,,,,
6377,96378,"Acetic acid, (1,3,2-dithiarsolan-2-ylthio)-",C1CS[As](S1)SCC(=O)O,,,,,,
6378,96379,Isobutyl cyclohexylpropionate,CC(C)COC(=O)CCC1CCCCC1,,,,,,
6379,96380,N-Isobutylphthalimide,CC(C)CN1C(=O)C2=CC=CC=C2C1=O,,,,,,
6380,96381,"1,3-Benzodioxole, 2-hexyl-2-methyl-",CCCCCCC1(OC2=CC=CC=C2O1)C,,,,,,
6381,96382,3-Phenylpropiolonitrile,C1=CC=C(C=C1)C#CC#N,,,,,,
6382,96383,"Acetaldehyde, (4-methoxyphenoxy)-",COC1=CC=C(C=C1)OCC=O,,,,,,
6383,96384,"3-(2,4-Dihydroxyphenyl)propanoic acid",C1=CC(=C(C=C1O)O)CCC(=O)O,,,,,,
6384,96385,2-Methyl-1-Benzyloxybenzene,CC1=CC=CC=C1OCC2=CC=CC=C2,,,,,,
6385,96386,1-Ethoxydodecane,CCCCCCCCCCCCOCC,,,,,,
6386,96387,4-Phenylpiperidin-4-ol,C1CNCCC1(C2=CC=CC=C2)O,,,,,,
6387,96388,N-Methyl-3-aminomethylindole,CNCC1=CNC2=CC=CC=C21,,,,,,
6388,96389,1H-Indole-2-carbaldehyde,C1=CC=C2C(=C1)C=C(N2)C=O,,,,,,
6389,96390,N-(4-Phenyl-4-piperidylmethyl)formamide,C1CNCCC1(CNC=O)C2=CC=CC=C2,,,,,,
6390,96391,4-Hydroxy-1-butanesulfonic acid,C(CCS(=O)(=O)O)CO,,,,,,
6391,96392,"2,6-Bis(2-(dimethylamino)ethoxy)pyridine",CN(C)CCOC1=NC(=CC=C1)OCCN(C)C,,,,,,
6392,96393,"(3,5-Dimethyl-1H-pyrazol-1-yl)methanol",CC1=CC(=NN1CO)C,,,,,,
6393,96394,Ethyl 4-hydroxypiperidine-1-carboxylate,CCOC(=O)N1CCC(CC1)O,,,,,,
6394,96395,N-Nitrosophenylethylurea,C1=CC=C(C=C1)CCN(C(=O)N)N=O,,,,,,
6395,96396,"Cyclopropyl 2,4-xylyl ketone",CC1=CC(=C(C=C1)C(=O)C2CC2)C,,,,,,
6396,96397,"Cyclopropyl 2,5-xylyl ketone",CC1=CC(=C(C=C1)C)C(=O)C2CC2,,,,,,
6397,96398,"Cyclopropyl 3,4-xylyl ketone",CC1=C(C=C(C=C1)C(=O)C2CC2)C,,,,,,
6398,96399,Cyclopropyl 4-ethylphenyl ketone,CCC1=CC=C(C=C1)C(=O)C2CC2,,,,,,
6399,96400,"2,3-Naphthalenedicarboxaldehyde",C1=CC=C2C=C(C(=CC2=C1)C=O)C=O,,,"['Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)']",,,
6400,96401,"Ethane, 2-chloro-1,1-di-p-tolyl-",CC1=CC=C(C=C1)C(CCl)C2=CC=C(C=C2)C,,,,,,
6401,96402,"Benzene, 1,1'-(2,2-dichloroethylidene)bis(4-methyl-",CC1=CC=C(C=C1)C(C2=CC=C(C=C2)C)C(Cl)Cl,,,,,,
6402,96403,"2,4-Dimethoxytoluene",CC1=C(C=C(C=C1)OC)OC,,,,,,
6403,96404,"2,6-Dimethoxybenzaldehyde",COC1=C(C(=CC=C1)OC)C=O,,,,,,
6404,96405,3-Fluoroquinoline,C1=CC=C2C(=C1)C=C(C=N2)F,,,,,,
6405,96406,2-Ethoxy-3-methoxybenzaldehyde,CCOC1=C(C=CC=C1OC)C=O,,,,,,
6406,96407,4-Methyleneglutamic acid,C=C(CC(C(=O)O)N)C(=O)O,,,,,,
6407,96408,"2-(2,4-Bis(1,1-dimethylpropyl)phenoxy)ethyl acrylate",CCC(C)(C)C1=CC(=C(C=C1)OCCOC(=O)C=C)C(C)(C)CC,,,,,,
6408,96409,9-Furfuryladenine,C1=COC(=C1)CN2C=NC3=C(N=CN=C32)N,,,,,,
6409,96410,8-Azaadenosine,C1=NC(=C2C(=N1)N(N=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N,,,,,,
6410,96411,1-Benzyl-4-(methylamino)piperidine-4-carboxamide,CNC1(CCN(CC1)CC2=CC=CC=C2)C(=O)N,,,,,,
6411,96412,N-Hydroxy-N'-methylurea,CNC(=O)NO,,,,,,
6412,96413,"4-Fluoro-4'-nitro-1,1'-biphenyl",C1=CC(=CC=C1C2=CC=C(C=C2)F)[N+](=O)[O-],,,,,,
6413,96414,4-Chloro-4'-methoxybutyrophenone,COC1=CC=C(C=C1)C(=O)CCCCl,,,,,,
6414,96415,"2-Hexanone, oxime",CCCCC(=NO)C,,,,,,
6415,96416,Hydrazodiisobutyronitrile,CC(C)(C#N)NNC(C)(C)C#N,,,,,,
6416,96417,2-(Hydroxyiminomethyl)-6-methoxyphenol,COC1=CC=CC(=C1O)C=NO,,,,,,
6417,96418,CID 96418,CC(=NN=C(N)S)C(=O)O,,,,,,
6418,96419,"1(2H)-Pyrimidinepropanoic acid, 3,4-dihydro-2,4-dioxo-",C1=CN(C(=O)NC1=O)CCC(=O)O,,,,,,
6419,96420,6-Dimethylaminonicotinamide,CN(C)C1=NC=C(C=C1)C(=O)N,,,,,,
6420,96421,5-Benzyloxy-3-(2-nitro-vinyl)-indole,C1=CC=C(C=C1)COC2=CC3=C(C=C2)NC=C3C=C[N+](=O)[O-],,,,,,
6421,96422,1-Benzyl-4-[(3-chlorophenyl)amino]piperidine-4-carbonitrile,C1CN(CCC1(C#N)NC2=CC(=CC=C2)Cl)CC3=CC=CC=C3,,,,,,
6422,96423,1-Benzyl-4-phenylpiperidine-4-carboxamide,C1CN(CCC1(C2=CC=CC=C2)C(=O)N)CC3=CC=CC=C3,,,,,,
6423,96424,"4-Oxo-4-[4-(1,3-thiazol-2-ylsulfamoyl)anilino]but-2-enoic acid",C1=CC(=CC=C1NC(=O)C=CC(=O)O)S(=O)(=O)NC2=NC=CS2,,,,,,
6424,96425,"2,4-Dichloro-3,5-dinitrobenzamide",C1=C(C(=C(C(=C1[N+](=O)[O-])Cl)[N+](=O)[O-])Cl)C(=O)N,,,,,,
6425,96426,(3-Bromopropyl)cyclohexane,C1CCC(CC1)CCCBr,,,,,,
6426,96427,"4,4'-(1-Methylpropylidene)bis(o-cresol)",CCC(C)(C1=CC(=C(C=C1)O)C)C2=CC(=C(C=C2)O)C,,,,,,
6427,96428,4-Anilinopiperidine-4-carboxamide,C1CNCCC1(C(=O)N)NC2=CC=CC=C2,,,,,,
6428,96429,"3(2H)-Pyridazinone, 6-methoxy-2-methyl-",CN1C(=O)C=CC(=N1)OC,,,,,,
6429,96430,"4,4'-Dibromobenzil",C1=CC(=CC=C1C(=O)C(=O)C2=CC=C(C=C2)Br)Br,,,,,,
6430,96431,"2-(Diethylamino)-1,1-diphenylethanol",CCN(CC)CC(C1=CC=CC=C1)(C2=CC=CC=C2)O,,,,,,
6431,96432,Diethyl hexadecylmalonate,CCCCCCCCCCCCCCCCC(C(=O)OCC)C(=O)OCC,,,,,,
6432,96433,Dimethylketene dimer,CC(=C1C(C(=O)O1)(C)C)C,,,,,,
6433,96434,1-Formylpyrrolidine-2-carboxylic acid,C1CC(N(C1)C=O)C(=O)O,,,,,,
6434,96435,6-Ethylcoumarin,CCC1=CC2=C(C=C1)OC(=O)C=C2,,,,,,
6435,96436,"Pyrocatechol, 3,6-diisopropyl-",CC(C)C1=C(C(=C(C=C1)C(C)C)O)O,,,,,,
6436,96437,1-Phenethyl-4-piperidone,C1CN(CCC1=O)CCC2=CC=CC=C2,,,,,,
6437,96438,N-(1H-indol-3-ylmethyl)cyclohexanamine,C1CCC(CC1)NCC2=CNC3=CC=CC=C32,,,,,,
6438,96439,Penicilloic V Acid,CC1(C(NC(S1)C(C(=O)O)NC(=O)COC2=CC=CC=C2)C(=O)O)C,,,,,,
6439,96440,2-(Dodecyloxy)pyridine,CCCCCCCCCCCCOC1=CC=CC=N1,,,,,,
6440,96441,2-(Hexadecyloxy)pyridine,CCCCCCCCCCCCCCCCOC1=CC=CC=N1,,,,,,
6441,96442,"Phosphinic acid, diethyl-, anhydride with diethyl phosphate",CCOP(=O)(OCC)OP(=O)(CC)CC,,,,,,
6442,96443,6-Methyl-8-nitroquinoline,CC1=CC2=C(C(=C1)[N+](=O)[O-])N=CC=C2,,,,,,
6443,96444,"Phosphonic acid, butyl-, monoethyl ester, anhydride with diethyl phosphate",CCCCP(=O)(OCC)OP(=O)(OCC)OCC,,,,,,
6444,96445,Diethoxyphosphinothioyloxy-ethoxy-ethyl-thioxo-phosphorane,CCOP(=S)(CC)OP(=S)(OCC)OCC,,,,,,
6445,96446,5-(4-Bis(2-chloroethyl)aminophenyl)pentanoic acid,C1=CC(=CC=C1CCCCC(=O)O)N(CCCl)CCCl,,,,,,
6446,96447,CID 96447,CC1=CC(N=C(N1C2=CC=CC=C2Cl)S)(C)C,,,,,,
6447,96448,"Theobromine, 1-propyl-",CCCN1C(=O)C2=C(N=CN2C)N(C1=O)C,,,,,,
6448,96449,"Theobromine, 1-(2'-methylallyl)-",CC(=C)CN1C(=O)C2=C(N=CN2C)N(C1=O)C,,,,,,
6449,96450,4-Isoquinolinecarbonitrile,C1=CC=C2C(=C1)C=NC=C2C#N,,,,,,
6450,96451,"Chromone, 8-benzoyl-3-chloro-6-methyl-2-phenyl-",CC1=CC2=C(C(=C1)C(=O)C3=CC=CC=C3)OC(=C(C2=O)Cl)C4=CC=CC=C4,,,,,,
6451,96452,"Fluoren-1-ol, 2-amino-",C1C2=CC=CC=C2C3=C1C(=C(C=C3)N)O,,,,,,
6452,96453,7-Nitro-9h-fluorene-1-carboxylic acid,C1C2=C(C=CC(=C2)[N+](=O)[O-])C3=C1C(=CC=C3)C(=O)O,,,,,,
6453,96454,"2,3,7,8-Tetrathiaspiro(4.4)nonane",C1C2(CSS1)CSSC2,,,,,,
6454,96455,2-Anilinobenzamide,C1=CC=C(C=C1)NC2=CC=CC=C2C(=O)N,,,,,,
6455,96456,"2,6-Dimethylpyran-4-thione",CC1=CC(=S)C=C(O1)C,,,,,,
6456,96457,2-Aminopropanediamide,C(C(=O)N)(C(=O)N)N,,,,,,
6457,96458,"4-((4-Chlorophenyl)azo)-1,5-diphenyl-1H-pyrazole",C1=CC=C(C=C1)C2=C(C=NN2C3=CC=CC=C3)N=NC4=CC=C(C=C4)Cl,,,,,,
6458,96459,"Bis(2-ethylhexyl) 2,2,2-trichloro-1-hydroxyethanephosphonate",CCCCC(CC)COP(=O)(C(C(Cl)(Cl)Cl)O)OCC(CC)CCCC,,,,,,
6459,96460,"Pyridazine, 3,6-dimethyl-4-nitro-, 1-oxide",CC1=CC(=C(N=[N+]1[O-])C)[N+](=O)[O-],,,,,,
6460,96461,"1,3-Dioxolane, 2-(2-furanyl)-4-methyl-",CC1COC(O1)C2=CC=CO2,,,,,,
6461,96462,Octyl nicotinate,CCCCCCCCOC(=O)C1=CN=CC=C1,,,,,,
6462,96463,"Itaconic acid, diester with allyl lactate",CC(C(=O)OCC=C)OC(=O)CC(=C)C(=O)OC(C)C(=O)OCC=C,,,,,,
6463,96464,"Spiro[1H-isoindole-1,9'-[9H]xanthen]-3(2H)-one, 3',6'-bis(diethylamino)-2-phenyl-",CCN(CC)C1=CC2=C(C=C1)C3(C4=C(O2)C=C(C=C4)N(CC)CC)C5=CC=CC=C5C(=O)N3C6=CC=CC=C6,,,,,,
6464,96465,"1-(2,4-Dimethoxyphenyl)-3-phenyl-1,3-propanedione",COC1=CC(=C(C=C1)C(=O)CC(=O)C2=CC=CC=C2)OC,,,,,,
6465,96466,"1-Pyrrolidinebutanamide, 2-methyl-alpha,alpha-diphenyl-",CC1CCCN1CCC(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N,,,,,,
6466,96467,3-(5-phenyl-1H-pyrrol-2-yl)propanoic acid,C1=CC=C(C=C1)C2=CC=C(N2)CCC(=O)O,,,,,,
6467,96468,"2,3-Diphenylsuccinic acid",C1=CC=C(C=C1)C(C(C2=CC=CC=C2)C(=O)O)C(=O)O,,,,,,
6468,96469,"Butanal, 3-methyl-, oxime",CC(C)CC=NO,,,,,,
6469,96470,"1,4-Naphthalenedione, 2-(1,1-dimethylethyl)-",CC(C)(C)C1=CC(=O)C2=CC=CC=C2C1=O,,,,,,
6470,96471,"2,3-Dihydro-1,5-benzothiazepin-4(5H)-one",C1CSC2=CC=CC=C2NC1=O,,,,,,
6471,96472,"Glycine, N-(ethoxycarbonyl)-",CCOC(=O)NCC(=O)O,,,,,,
6472,96473,CID 96473,C12=NNNC1=NC(=NC2=O)S,,,,,,
6473,96474,4-(Methylamino)piperidine-4-carboxamide,CNC1(CCNCC1)C(=O)N,,,,,,
6474,96475,Methyl pyridine-3-acetate,COC(=O)CC1=CN=CC=C1,,,,,,
6475,96476,6-Methyl-2-heptanol,CC(C)CCCC(C)O,,,,,,
6476,96477,1-(4-Chlorobutoxy)-2-methylbenzene,CC1=CC=CC=C1OCCCCCl,,,,,,
6477,96478,1-(4-Chlorobutoxy)-3-methylbenzene,CC1=CC(=CC=C1)OCCCCCl,,,,,,
6478,96479,1-(4-Chlorobutoxy)-4-methylbenzene,CC1=CC=C(C=C1)OCCCCCl,,,,,,
6479,96480,"3-Pyridinol, 2-(piperidinomethyl)-",C1CCN(CC1)CC2=C(C=CC=N2)O,,,,,,
6480,96481,CID 96481,C1=CC(=CC=C1N=NC2=CC(=O)C(=O)C=C2)N(O)O,,,,,,
6481,96482,"1-(1-Benzyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-benzo[d]imidazol-2(3H)-one",C1CN(CC=C1N2C3=CC=CC=C3NC2=O)CC4=CC=CC=C4,,,,,,
6482,96483,2-(Octadecyloxy)pyridine,CCCCCCCCCCCCCCCCCCOC1=CC=CC=N1,,,,,,
6483,96484,Algol Pink BBK,C1=CC=C(C=C1)C(=O)NC2=C3C(=C(C=C2)O)C(=O)C4=C(C3=O)C=CC=C4NC(=O)C5=CC=CC=C5,,,,,,
6484,96485,"2(1H)-Pyrimidinone, tetrahydro-1-nitroso-",C1CNC(=O)N(C1)N=O,,,,,,
6485,96486,"(1,4'-Bipiperidine)-4'-carboxamide",C1CCN(CC1)C2(CCNCC2)C(=O)N,,,,,,
6486,96487,"4,4'-Dibromodiphenylmethane",C1=CC(=CC=C1CC2=CC=C(C=C2)Br)Br,,,,,,
6487,96488,"Triethyl pentane-1,3,5-tricarboxylate",CCOC(=O)CCC(CCC(=O)OCC)C(=O)OCC,,,,,,
6488,96489,3-Fluoro-o-xylene,CC1=C(C(=CC=C1)F)C,,,,,,
6489,96490,Ethyl 3-pyridylacetate,CCOC(=O)CC1=CN=CC=C1,,,,,,
6490,96491,CID 96491,C12=NNN=C1N=C(N=C2N)S,,,,,,
6491,96492,Di-O-acetylkojic acid,CC(=O)OCC1=CC(=O)C(=CO1)OC(=O)C,,,,,,
6492,96493,"2,2',2'',4,4',4'',6,6',6''-Nonanitro-m-terphenyl",C1=C(C=C(C(=C1[N+](=O)[O-])C2=C(C(=C(C=C2[N+](=O)[O-])[N+](=O)[O-])C3=C(C=C(C=C3[N+](=O)[O-])[N+](=O)[O-])[N+](=O)[O-])[N+](=O)[O-])[N+](=O)[O-])[N+](=O)[O-],,,,,,
6493,96494,2-Isopropenylaniline,CC(=C)C1=CC=CC=C1N,,,,,,
6494,96495,"1,2-Bis(dichloroacetyl)hydrazine",C(C(=O)NNC(=O)C(Cl)Cl)(Cl)Cl,,,,,,
6495,96496,6-Chloro-2-naphthol,C1=CC2=C(C=CC(=C2)Cl)C=C1O,,,,,,
6496,96497,"2,4-Dichloro-3,5-dinitrobenzoic acid",C1=C(C(=C(C(=C1[N+](=O)[O-])Cl)[N+](=O)[O-])Cl)C(=O)O,,,,,,
6497,96498,2-(2-Diethylaminoethyl)pyridine,CCN(CC)CCC1=CC=CC=N1,,,,,,
6498,96499,2-(2-Pyridyloxy)ethyl(dimethyl)amine,CN(C)CCOC1=CC=CC=N1,,,,,,
6499,96500,"2,4,6-Trinitrobiphenyl",C1=CC=C(C=C1)C2=C(C=C(C=C2[N+](=O)[O-])[N+](=O)[O-])[N+](=O)[O-],,,,,,
6500,96501,"2-(2,3-dihydro-1H-inden-1-yl)acetic acid",C1CC2=CC=CC=C2C1CC(=O)O,,,,,,
6501,96502,3-Phenylindole,C1=CC=C(C=C1)C2=CNC3=CC=CC=C32,,,,,,
6502,96503,"2',3',5'-Tri-O-acetyladenosine",CC(=O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)OC(=O)C)OC(=O)C,,,,,,
6503,96504,CID 96504,C1=CC=C(C=C1)CN2C=NC(=C3C2=NC=N3)N,,,,,,
6504,96505,1-Cyclohexyluracil,C1CCC(CC1)N2C=CC(=O)NC2=O,,,,,,
6505,96506,"5,6,7,8,4'-Pentahydroxyflavone",C1=CC(=CC=C1C2=CC(=O)C3=C(C(=C(C(=C3O2)O)O)O)O)O,,,,,,
6506,96507,"1,3-Dimethyl-4-nitro-1H-pyrazole-5-carbonitrile",CC1=NN(C(=C1[N+](=O)[O-])C#N)C,,,,,,
6507,96508,4-Hydroxy-6-nitro-3-quinolinecarboxylic acid,C1=CC2=C(C=C1[N+](=O)[O-])C(=O)C(=CN2)C(=O)O,,,,,,
6508,96509,Corodane,C1CC2C(C1)C3CC2CC3=O,,,,,,
6509,96510,"2,4-Bis(benzyl)pyridine",C1=CC=C(C=C1)CC2=CC(=NC=C2)CC3=CC=CC=C3,,,,,,
6510,96511,"2-Isopropyl-8-methoxy-9-methyl-3,9-dihydrofuro[2,3-b]quinolin-4(2H)-one",CC(C)C1CC2=C(O1)N(C3=C(C2=O)C=CC=C3OC)C,,,,,,
6511,96512,9-Allyl-9H-purin-6-amine,C=CCN1C=NC2=C(N=CN=C21)N,,,,,,
6512,96513,"Theophylline, (8-propylthio)-",CCCSC1=NC2=C(N1)C(=O)N(C(=O)N2C)C,,,,,,
6513,96514,"Theophylline, 8-butylthio-",CCCCSC1=NC2=C(N1)C(=O)N(C(=O)N2C)C,,,,,,
6514,96515,8-(N-Heptylthio)theophylline,CCCCCCCSC1=NC2=C(N1)C(=O)N(C(=O)N2C)C,,,,,,
6515,96516,"m,p'-DDD",C1=CC(=CC(=C1)Cl)C(C2=CC=C(C=C2)Cl)C(Cl)Cl,,,,,,
6516,96517,"5-Pyrimidinesulfonamide, 4,6-diamino-2-methylsulfonyl-",CS(=O)(=O)C1=NC(=C(C(=N1)N)S(=O)(=O)N)N,,,,,,
6517,96518,"2H-Pyrimido(4,5-e)-1,2,4-thiadiazine, 3,4-dihydro-8-amino-6-methylthio-, 1,1-dioxide",CSC1=NC(=C2C(=N1)NCNS2(=O)=O)N,,,,,,
6518,96519,"Urea, N-(2-chloroethyl)-N'-(4-methoxyphenyl)-N-nitroso-",COC1=CC=C(C=C1)NC(=O)N(CCCl)N=O,,,,,,
6519,96520,"1,3-Dimethyl-1-(methylcarbamoyl)urea",CNC(=O)N(C)C(=O)NC,,,,,,
6520,96521,"Glycine, N,N'-(6-chloro-s-triazine-2,4-diyl)di-, diethyl ester",CCOC(=O)CNC1=NC(=NC(=N1)Cl)NCC(=O)OCC,,,,,,
6521,96522,4'-Hydroxyacetophenone Oxime,CC(=NO)C1=CC=C(C=C1)O,,,,,,
6522,96523,Methyl 2-acetamido-2-deoxy-alpha-D-glucopyranoside,CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@@H]1OC)CO)O)O,,,,,,
6523,96524,Methyl butylcarbamate,CCCCNC(=O)OC,,,,,,
6524,96525,"1,1-Bis(2-chloroethyl)-2-sulfinylhydrazine",C(CCl)N(CCCl)N=S=O,,,,,,
6525,96526,1-Chloro-3-pentanone,CCC(=O)CCCl,,,,,,
6526,96527,3-(1H-Pyrrol-1-yl)propanenitrile,C1=CN(C=C1)CCC#N,,,,,,
6527,96528,Ethyl o-tolylacetate,CCOC(=O)CC1=CC=CC=C1C,,,,,,
6528,96529,"1,2,4-Trivinylcyclohexane",C=CC1CCC(C(C1)C=C)C=C,,,,,,
6529,96530,"9H-Purine, 9-butyl-6-(methylthio)-",CCCCN1C=NC2=C1N=CN=C2SC,,,,,,
6530,96531,8-Iodotheophylline,CN1C2=C(C(=O)N(C1=O)C)NC(=N2)I,,,,,,
6531,96532,"Phenol, 2,6-diallyl-4-methoxy-",COC1=CC(=C(C(=C1)CC=C)O)CC=C,,,,,,
6532,96533,"Biphenyl-3,3'-dicarboxylic acid",C1=CC(=CC(=C1)C(=O)O)C2=CC(=CC=C2)C(=O)O,,,,,,
6533,96534,"3,6-Dimethyl-2,4-dinitrophenol",CC1=CC(=C(C(=C1O)[N+](=O)[O-])C)[N+](=O)[O-],,,,,,
6534,96535,"Phosphonic acid, 4-chlorobutyl-, ethyl p-nitrophenyl ester",CCOP(=O)(CCCCCl)OC1=CC=C(C=C1)[N+](=O)[O-],,,,,,
6535,96536,(1-Naphthylmethyl)phosphonic acid,C1=CC=C2C(=C1)C=CC=C2CP(=O)(O)O,,,,,,
6536,96537,"Propionitrile, 3,3',3'',3'''-((2,3-dihydroxy-1,4-naphthylene)bis(methylenenitrilo))tetra-",C1=CC=C2C(=C1)C(=C(C(=C2CN(CCC#N)CCC#N)O)O)CN(CCC#N)CCC#N,,,,,,
6537,96538,"o-Tolunitrile, 4-(bis(2-chloroethyl)amino)-",CC1=C(C=CC(=C1)N(CCCl)CCCl)C#N,,,,,,
6538,96539,Gardenin B,COC1=CC=C(C=C1)C2=CC(=O)C3=C(C(=C(C(=C3O2)OC)OC)OC)O,,,,,,
6539,96540,"4H-1,2,4-Triazole-3,4,5-triamine",C1(=NN=C(N1N)N)N,,,,,,
6540,96541,"Dihydro-1,3,2-dioxathiolo(1,3,2)dioxathiole 2,2,5,5-tetraoxide",C12C(OS(=O)(=O)O1)OS(=O)(=O)O2,,,,,,
6541,96542,CID 96542,CC1(CN=C(O1)S)C,,,,,,
6542,96543,"Adenosine, 8-bromo-, 2',3',5'-triacetate",CC(=O)OC[C@@H]1C(C([C@@H](O1)N2C3=NC=NC(=C3N=C2Br)N)OC(=O)C)OC(=O)C,,,,,,
6543,96544,8-Bromoadenosine,C1=NC(=C2C(=N1)N(C(=N2)Br)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N,,,,,,
6544,96545,8-Bromoxanthosine,C([C@@H]1[C@H]([C@H]([C@@H](O1)N2C3=C(C(=O)NC(=O)N3)N=C2Br)O)O)O,,,,,,
6545,96546,CID 96546,C([C@@H]1[C@H]([C@H]([C@@H](O1)N2C3=C(C(=O)N=C(N3)N)N=C2S)O)O)O,,,,,,
6546,96547,8-Bromo-2'-deoxyadenosine,C1[C@@H]([C@H](O[C@H]1N2C3=NC=NC(=C3N=C2Br)N)CO)O,,,,,,
6547,96548,"1,3-Dimethyl-1h-pyrrolo[2,3-d]pyrimidine-2,4(3h,7h)-dione",CN1C2=C(C=CN2)C(=O)N(C1=O)C,,,,,,
6548,96549,"o-Toluidine, N-(p-(bis(2-chloroethyl)amino)-o-methylbenzylidene)-p-fluoro-",CC1=C(C=CC(=C1)N(CCCl)CCCl)C=NC2=C(C=C(C=C2)F)C,,,,,,
6549,96550,3-(4-Chlorophenoxy)propanenitrile,C1=CC(=CC=C1OCCC#N)Cl,,,,,,
6550,96551,"Hydracrylamide, 3,3-diphenyl-",C1=CC=C(C=C1)C(CC(=O)N)(C2=CC=CC=C2)O,,,,,,
6551,96552,"Propionamide, 3-hydroxy-2,3,3-triphenyl-",C1=CC=C(C=C1)C(C(=O)N)C(C2=CC=CC=C2)(C3=CC=CC=C3)O,,,,,,
6552,96553,"Quinoxaline, 1,2,3,4-tetrahydro-1,4-diacryloyl-6,7-dimethyl-",CC1=CC2=C(C=C1C)N(CCN2C(=O)C=C)C(=O)C=C,,,,,,
6553,96554,"7,14-Diazadispiro(5.1.5.2)pentadecan-15-one",C1CCC2(CC1)C(=O)NC3(N2)CCCCC3,,,,,,
6554,96555,"N-(Bromoacetyl)glycine, ethyl ester",CCOC(=O)CNC(=O)CBr,,,,,,
6555,96556,1-(2-Bromoethyl)-3-phenylurea,C1=CC=C(C=C1)NC(=O)NCCBr,,,,,,
6556,96557,"Urea, 1-(2-chloroethyl)-3-(1-naphthyl)-",C1=CC=C2C(=C1)C=CC=C2NC(=O)NCCCl,,,,,,
6557,96558,"Urea, 1-cyclohexyl-3-methyl-3-nitroso-",CN(C(=O)NC1CCCCC1)N=O,,,,,,
6558,96559,1-Fluoro-4-isopropylbenzene,CC(C)C1=CC=C(C=C1)F,,,,,,
6559,96560,"Diethyl ((alpha,alpha,alpha-trifluoro-m-toluidino)methylene)malonate",CCOC(=O)C(=CNC1=CC=CC(=C1)C(F)(F)F)C(=O)OCC,,,,,,
6560,96561,"Dibutyl pyridine-2,6-dicarboxylate",CCCCOC(=O)C1=NC(=CC=C1)C(=O)OCCCC,,,,,,
6561,96562,Octadecylsuccinic anhydride,CCCCCCCCCCCCCCCCCCC1CC(=O)OC1=O,,,,,,
6562,96563,Dipin,C1CN1P(=O)(N2CC2)N3CCN(CC3)P(=O)(N4CC4)N5CC5,,,"['A class of drugs that differs from other alkylating agents used clinically in that they are monofunctional and thus unable to cross-link cellular macromolecules. Among their common properties are a requirement for metabolic activation to intermediates with antitumor efficacy and the presence in their chemical structures of N-methyl groups, that after metabolism, can covalently modify cellular DNA. The precise mechanisms by which each of these drugs acts to kill tumor cells are not completely understood. (From AMA, Drug Evaluations Annual, 1994, p2026) (See all compounds classified as Antineoplastic Agents, Alkylating.)', 'Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)', 'Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)']",,,
6563,96564,"9,10-Phenanthrenediamine",C1=CC=C2C(=C1)C3=CC=CC=C3C(=C2N)N,,,,,,
6564,96565,6-Azathymidine,CC1=NN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)O,,,,,,
6565,96566,"N-(Dimethylamino)-endo-5-norbornene-cis-2,3-dicarboximide",CN(C)N1C(=O)C2C3CC(C2C1=O)C=C3,,,,,,
6566,96567,"2-Pyrazoline-3-carboxylic acid, 5-oxo-, hydrazide",C1C(=NNC1=O)C(=O)NN,,,,,,
6567,96568,"1-(2-Chloroethyl)-3-(2,5-dichlorophenyl)urea",C1=CC(=C(C=C1Cl)NC(=O)NCCCl)Cl,,,,,,
6568,96569,2-Acetyl-5-iodothiophene,CC(=O)C1=CC=C(S1)I,,,,,,
6569,96570,3-Thianaphthenoyltrifluoroacetone,C1=CC=C2C(=C1)C(=CS2)C(=O)CC(=O)C(F)(F)F,,,,,,
6570,96571,Bcnyu,C1CCC(CC1)NC(=O)N(C2CCCCC2)N=O,,,,,,
6571,96572,"2,4,6-Trinitro-m-toluidine",CC1=C(C(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])N)[N+](=O)[O-],,,,,,
6572,96573,4-(Ethylamino)piperidine-4-carboxamide,CCNC1(CCNCC1)C(=O)N,,,,,,
6573,96574,Ethyl m-tolylacetate,CCOC(=O)CC1=CC=CC(=C1)C,,,,,,
6574,96575,"4-Bromo-2,2-diphenylbutyronitrile",C1=CC=C(C=C1)C(CCBr)(C#N)C2=CC=CC=C2,,,,,,
6575,96576,1-Benzyl-4-phenylpiperidine-4-carboxylic acid,C1CN(CCC1(C2=CC=CC=C2)C(=O)O)CC3=CC=CC=C3,,,,,,
6576,96577,CID 96577,CCCCC(CC)C(=O)O.CCCC[SnH](CCCC)CCCC,,,,,,
6577,96578,Pimprinine,CC1=NC=C(O1)C2=CNC3=CC=CC=C32,,,,,,
6578,96579,"p-Toluidine, alpha-((p-bromophenyl)imino)-N-(2-chloroethyl)-N-(2-fluoroethyl)-",C1=CC(=CC=C1C=NC2=CC=C(C=C2)Br)N(CCF)CCCl,,,,,,
6579,96580,3-Hydroxyphthalic anhydride,C1=CC2=C(C(=C1)O)C(=O)OC2=O,,,,,,
6580,96581,CID 96581,C1CCC(CC1)N=C(NNC(=O)C2=CC=NC=C2)S,,,,,,
6581,96582,"6,7-Dichloroquinoline-5,8-dione",C1=CC2=C(C(=O)C(=C(C2=O)Cl)Cl)N=C1,,,,,,
6582,96583,"6-Amino-7-chloro-5,8-dioxoquinoline",C1=CC2=C(C(=O)C(=C(C2=O)N)Cl)N=C1,,,,,,
6583,96584,"trans-N,N''-1,2-Cyclohexanediylbis(N'-(2-chloroethyl)-N'-nitrosourea)",C1CCC(C(C1)NC(=O)N(CCCl)N=O)NC(=O)N(CCCl)N=O,,,,,,
6584,96585,"Urea, 1,1'-p-phenylenebis(3-(2-chloroethyl)-3-nitroso-",C1=CC(=CC=C1NC(=O)N(CCCl)N=O)NC(=O)N(CCCl)N=O,,,,,,
6585,96586,"Urea, 1,1'-(1,2-cyclohexylene)bis(3-(2-chloroethyl)-, (Z,Z)-",C1CCC(C(C1)NC(=O)NCCCl)NC(=O)NCCCl,,,,,,
6586,96587,"Urea, 1-(2-chloroethyl)-3-cycloheptyl-",C1CCCC(CC1)NC(=O)NCCCl,,,,,,
6587,96588,Benzothiazoline,C1NC2=CC=CC=C2S1,,,,,,
6588,96589,2-Methoxybenzothiazole,COC1=NC2=CC=CC=C2S1,,,,,,
6589,96590,3-(2-Chlorophenyl)-5-methylisoxazole-4-carbonyl chloride,CC1=C(C(=NO1)C2=CC=CC=C2Cl)C(=O)Cl,,,,,,
6590,96591,N-(1H-Indol-3-ylmethylene)cyclohexylamine,C1CCC(CC1)N=CC2=CNC3=CC=CC=C32,,,,,,
6591,96592,"8-(4-Ethoxy-3-methoxyphenyl)-1,5-diazabicyclo[3.2.1]octane",CCOC1=C(C=C(C=C1)C2N3CCCN2CC3)OC,,,,,,
6592,96593,"1,5-Diazabicyclo(3.2.1)octane, 8-(3,4,5-trimethoxyphenyl)-",COC1=CC(=CC(=C1OC)OC)C2N3CCCN2CC3,,,,,,
6593,96594,"3,6-Dichlorofluorenone",C1=CC2=C(C=C1Cl)C3=C(C2=O)C=CC(=C3)Cl,,,,,,
6594,96595,"3,5-Difluoroaniline",C1=C(C=C(C=C1F)F)N,,,,,,
6595,96596,"2,6-Difluoro-p-phenylenediamine",C1=C(C=C(C(=C1F)N)F)N,,,,,,
6596,96597,"Propanamide, N-9H-fluoren-2-yl-",CCC(=O)NC1=CC2=C(C=C1)C3=CC=CC=C3C2,,,,,,
6597,96598,Ethyl 5-methyl-1H-pyrrole-2-carboxylate,CCOC(=O)C1=CC=C(N1)C,,,,,,
6598,96599,"4-Morpholinecarbodithioic acid, 2-hydroxyethyl ester",C1COCCN1C(=S)SCCO,,,,,,
6599,96600,"1H-Pyrazolo[4,3-d]pyrimidin-7-amine",C1=NNC2=C1N=CN=C2N,,,,,,
6600,96601,4-((Bis(2-chloropropyl)amino)methyl)-6-chlororesorcinol,CC(CN(CC1=CC(=C(C=C1O)O)Cl)CC(C)Cl)Cl,,,,,,
6601,96602,"2-Amino-3,4,5-trimethoxybenzoic acid",COC1=C(C(=C(C(=C1)C(=O)O)N)OC)OC,,,,,,
6602,96603,"1,4,7,9b-Tetraazaphenalene-1,4,7(2H,5H,8H)-tricarboxamide, N,N',N''-tris(2-chlorophenyl)hexahydro-",C1CN(C2CCN(C3N2C1N(CC3)C(=O)NC4=CC=CC=C4Cl)C(=O)NC5=CC=CC=C5Cl)C(=O)NC6=CC=CC=C6Cl,,,,,,
6603,96604,"Theophylline, S-((3,3-dimethylbutyl)thio)-",CC(C)(C)CCSC1=NC2=C(N1)C(=O)N(C(=O)N2C)C,,,,,,
6604,96605,"Theophylline, 8-(decylthio)-",CCCCCCCCCCSC1=NC2=C(N1)C(=O)N(C(=O)N2C)C,,,,,,
6605,96606,8-(Propylthio)theobromine,CCCSC1=NC2=C(N1C)C(=O)NC(=O)N2C,,,,,,
6606,96607,8-(Butylthio)theobromine,CCCCSC1=NC2=C(N1C)C(=O)NC(=O)N2C,,,,,,
6607,96608,8-(Octylthio)theobromine,CCCCCCCCSC1=NC2=C(N1C)C(=O)NC(=O)N2C,,,,,,
6608,96609,"Xanthine, 8-(ethylthio)-",CCSC1=NC2=C(N1)C(=O)NC(=O)N2,,,,,,
6609,96610,8-(Butylthio)xanthine,CCCCSC1=NC2=C(N1)C(=O)NC(=O)N2,,,,,,
6610,96611,Mesitylglyoxal,CC1=CC(=C(C(=C1)C)C(=O)C=O)C,,,,,,
6611,96612,"3-Formyl-2,2,5,5-tetramethylthiazolidine-4-carboxylic acid",CC1(C(N(C(S1)(C)C)C=O)C(=O)O)C,,,,,,
6612,96613,"2,6-Di-tert-butyl-4-(3,5-di-tert-butyl-4-hydroxybenzylidene)-2,5-cyclohexadien-1-one",CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)C=C2C=C(C(=O)C(=C2)C(C)(C)C)C(C)(C)C,,,,,,
6613,96614,"Pyruvic acid, 3-(p-(bis-(2-fluoroethyl)amino)phenyl)-",C1=CC(=CC=C1CC(=O)C(=O)O)N(CCF)CCF,,,,,,
6614,96615,"p-Toluidine, N,N-bis(2-fluoroethyl)-alpha-((p-nitrophenyl)imino)-",C1=CC(=CC=C1C=NC2=CC=C(C=C2)[N+](=O)[O-])N(CCF)CCF,,,,,,
6615,96616,CID 96616,C=CCN=C(NNC1=CC=CC=C1)S,,,,,,
6616,96617,2-{[(Azepan-1-yl)imino]methyl}phenol,C1CCCN(CC1)N=CC2=CC=CC=C2O,,,,,,
6617,96618,1-(2-Bromoethyl)-3-cyclohexyl-1-nitrosourea,C1CCC(CC1)NC(=O)N(CCBr)N=O,,,,,,
6618,96619,"Urea, N,N'-diphenyl-N-nitroso-",C1=CC=C(C=C1)NC(=O)N(C2=CC=CC=C2)N=O,,,,,,
6619,96620,"1,3-Diethyl-1-nitrosourea",CCNC(=O)N(CC)N=O,,,,,,
6620,96621,"1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidine-2,4-dione",C1=C(C(=O)NC(=O)N1[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O)I,,,,,,
6621,96622,5-Hydroxy-2'-deoxyuridine,C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)O)CO)O,,,,,,
6622,96623,Methoxyacetyl chloride,COCC(=O)Cl,,,,,,
6623,96624,CID 96624,C1CCC(CC1)N=C(NN)S,,,,,,
6624,96625,"1,5-Diazabicyclo(3.2.1)octane, 8-(4-pyridyl)-",C1CN2CCN(C1)C2C3=CC=NC=C3,,,,,,
6625,96626,"2,6-Diisopropyl-4-methylphenol",CC1=CC(=C(C(=C1)C(C)C)O)C(C)C,,,,,,
6626,96627,"3-Hydroxy-2,4,6-triiodobenzoic acid",C1=C(C(=C(C(=C1I)O)I)C(=O)O)I,,,,,,
6627,96628,9-(Chloromethyl)phenanthrene,C1=CC=C2C(=C1)C=C(C3=CC=CC=C23)CCl,,,,,,
6628,96629,"Hydrazine, 1,1-dimethyl-2-isonicotinyl-",CN(C)NC(=O)C1=CC=NC=C1,,,,,,
6629,96630,"Phosphoramidic dichloride, (4-chloro-5-nitro-2-pyrimidinyl)-",C1=C(C(=NC(=N1)NP(=O)(Cl)Cl)Cl)[N+](=O)[O-],,,,,,
6630,96631,CID 96631,C1=NC2=C(N=CN(C2=N1)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N,,,,,,
6631,96632,"Phosphonic acid, (cyclopropylcarbonyl)-, diethyl ester",CCOP(=O)(C(=O)C1CC1)OCC,,,,,,
6632,96633,Bis(p-nitrophenyl) sulfoxide,C1=CC(=CC=C1[N+](=O)[O-])S(=O)C2=CC=C(C=C2)[N+](=O)[O-],,,,,,
6633,96634,"3-Phenyl-1,3,5-pentanetricarbonitrile",C1=CC=C(C=C1)C(CCC#N)(CCC#N)C#N,,,,,,
6634,96635,"alpha,alpha-Dibromo-4-xylenesulfonic acid",C1=CC(=C(C=C1CBr)S(=O)(=O)O)CBr,,,,,,
6635,96636,"1,2-Hydrazinedicarboxylic acid, dihydrazide",C(=O)(NN)NNC(=O)NN,,,,,,
6636,96637,"5-(4-Nitrophenyl)-1,3,4-thiadiazol-2-amine",C1=CC(=CC=C1C2=NN=C(S2)N)[N+](=O)[O-],,,,,,
6637,96638,"N-(2,2-Diethoxyethyl)pyridine-4-methylamine",CCOC(CNCC1=CC=NC=C1)OCC,,,,,,
6638,96639,n-[3-(Hydroxymethyl)phenyl]acetamide,CC(=O)NC1=CC=CC(=C1)CO,,,,,,
6639,96640,2-Chloro-1-iodo-4-nitrobenzene,C1=CC(=C(C=C1[N+](=O)[O-])Cl)I,,,,,,
6640,96641,"3,5-Dichlorophenyl acetate",CC(=O)OC1=CC(=CC(=C1)Cl)Cl,,,,,,
6641,96642,CID 96642,C1=CC=C(C=C1)C2=NC(=O)NN2,,,,,,
6642,96643,2-(Dimethylamino)ethyl propionate,CCC(=O)OCCN(C)C,,,,,,
6643,96644,Chloromethyl m-nitrobenzyl ether,C1=CC(=CC(=C1)[N+](=O)[O-])COCCl,,,,,,
6644,96645,2-(Dimethylamino)ethyl myristate,CCCCCCCCCCCCCC(=O)OCCN(C)C,,,,,,
6645,96646,N-(4-Chlorophenyl)benzamide,C1=CC=C(C=C1)C(=O)NC2=CC=C(C=C2)Cl,,,,,,
6646,96647,2-Nitrophenyl-beta-D-galactopyranoside,C1=CC=C(C(=C1)[N+](=O)[O-])O[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O,,,,,,
6647,96648,N-(3-Methyl-2-butenyl)phthalimide,CC(=CCN1C(=O)C2=CC=CC=C2C1=O)C,,,,,,
6648,96649,5-Amino-N-ethyl-2-methyl-N-phenylbenzenesulphonamide,CCN(C1=CC=CC=C1)S(=O)(=O)C2=C(C=CC(=C2)N)C,,,,,,
6649,96650,1-Benzylpiperidin-3-one,C1CC(=O)CN(C1)CC2=CC=CC=C2,,,,,,
6650,96651,1-(1-Oxobutyl)-1H-indole,CCCC(=O)N1C=CC2=CC=CC=C21,,,,,,
6651,96652,3-Chloro-6-nitro-1H-indazole,C1=CC2=C(NN=C2C=C1[N+](=O)[O-])Cl,,,,,,
6652,96653,Cycloheptanecarbonitrile,C1CCCC(CC1)C#N,,,,,,
6653,96654,"Ethanol, 2-decylthio-",CCCCCCCCCCSCCO,,,,,,
6654,96655,"5,6-Dimethyl-2,1,3-benzoselenadiazole",CC1=CC2=N[Se]N=C2C=C1C,,,,,,
6655,96656,"Ethanethiol, 2-phenethylamino-",C1=CC=C(C=C1)CCNCCS,,,,,,
6656,96657,4-Iodobenzaldehyde,C1=CC(=CC=C1C=O)I,,,,,,
6657,96658,CID 96658,C1=NC2=C(C(=N1)S)N=CN2[C@H]3[C@@H]([C@H]([C@H](O3)CO)O)O,,,,,,
6658,96659,4-Nitrophenyl diphenylphosphinate,C1=CC=C(C=C1)P(=O)(C2=CC=CC=C2)OC3=CC=C(C=C3)[N+](=O)[O-],,,,,,
6659,96660,Tetramethylbiphosphine disulfide,CP(=S)(C)P(=S)(C)C,,,,,,
6660,96661,Phosphazine,C1CN1P(=O)(NC2=NC=CC=N2)N3CC3,,,,,,
6661,96662,"Phosphonic acid, (hexahydro-1H-azepin-1-yl)-, cyclic O,O,O',O'-neopentanetetrayl ester",C1CCCN(CC1)P2(=O)OCC3(CO2)COP(=O)(OC3)N4CCCCCC4,,,,,,
6662,96663,"Urea, 1-(2-chloroethyl)-3-(m-anisyl)-",COC1=CC=CC(=C1)NC(=O)NCCCl,,,,,,
6663,96664,"4-Amino-1,2,5-selenadiazole-3-carboxamide",C1(=N[Se]N=C1N)C(=O)N,,,,,,
6664,96665,"2,2-Diethyl-2H-1,4-thiazin-3(4H)-one",CCC1(C(=O)NC=CS1)CC,,,,,,
6665,96666,"Methyl 2,3-O-isopropylidene-beta-D-ribofuranoside",CC1(O[C@@H]2[C@H](O[C@H]([C@@H]2O1)OC)CO)C,,,,,,
6666,96667,"Benzaldehyde, p-(bis(2-fluoroethyl)amino)-",C1=CC(=CC=C1C=O)N(CCF)CCF,,,,,,
6667,96668,"Phosphine oxide, bis(1-aziridinyl)anilino-",C1CN1P(=O)(N)N2CC2,,,,,,
6668,96669,1-Aziridinylbis(dimethylamino)phosphine oxide,CN(C)P(=O)(N1CC1)N(C)C,,,,,,
6669,96670,2-Butyl-3-(4-hydroxybenzoyl)benzofuran,CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC=C(C=C3)O,,,,,,
6670,96671,"Benzaldehyde, (4-nitrophenyl)hydrazone",C1=CC=C(C=C1)C=NNC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
6671,96672,"3,6-Bis(morpholinomethyl)pyrocatechol",C1COCCN1CC2=C(C(=C(C=C2)CN3CCOCC3)O)O,,,,,,
6672,96673,3-(Morpholinomethyl)pyrocatechol,C1COCCN1CC2=C(C(=CC=C2)O)O,,,,,,
6673,96674,"Benzo(1,2-e:4,5-e')bis(1,3)oxazine, 2,3,4,7,8,9-hexahydro-3,8-dimethyl-",CN1CC2=CC3=C(CN(CO3)C)C=C2OC1,,,,,,
6674,96675,"s-Triazin-2(1H)-one, tetrahydro-5-cyclohexyl-",C1CCC(CC1)N2CNC(=O)NC2,,,,,,
6675,96676,S-Trichloromethyl p-toluenethiosulfonate,CC1=CC=C(C=C1)S(=O)(=O)SC(Cl)(Cl)Cl,,,,,,
6676,96677,Pentachloro(chloromethyl)benzene,C(C1=C(C(=C(C(=C1Cl)Cl)Cl)Cl)Cl)Cl,,,,,,
6677,96678,4-(m-Tolylazo)-o-toluidine,CC1=CC(=CC=C1)N=NC2=CC(=C(C=C2)N)C,,,,,,
6678,96679,"1,1-Diphenylbutane-1,4-diol",C1=CC=C(C=C1)C(CCCO)(C2=CC=CC=C2)O,,,,,,
6679,96680,Ethyl 5-methyl-1-phenyl-1H-pyrazole-4-carboxylate,CCOC(=O)C1=C(N(N=C1)C2=CC=CC=C2)C,,,,,,
6680,96681,4-(Ethylaminomethyl)pyridine,CCNCC1=CC=NC=C1,,,,,,
6681,96682,CID 96682,CN=C(S)SC,,,,,,
6682,96683,"4-Amino-n-butyl-1,2,5-selenadiazole-3-carboxamide",CCCCNC(=O)C1=N[Se]N=C1N,,,,,,
6683,96684,"Urea, 1-(2-chloroethyl)-3-(8-quinolyl)-",C1=CC2=C(C(=C1)NC(=O)NCCCl)N=CC=C2,,,,,,
6684,96685,1H-benzimidazol-2-ylcyanamide,C1=CC=C2C(=C1)NC(=N2)NC#N,,,,,,
6685,96686,"Benzoic acid, 2-[[(2-thioxo-3(2H)-benzothiazolyl)methyl]amino]-",C1=CC=C(C(=C1)C(=O)O)NCN2C3=CC=CC=C3SC2=S,,,,,,
6686,96687,2-Pentadecanol,CCCCCCCCCCCCCC(C)O,,,,,,
6687,96688,"Phosphorodiamidic acid, N,N-bis(2-chloroethyl)-N'-(2-hydroxyethyl)-, ethyl ester",CCOP(=O)(NCCO)N(CCCl)CCCl,,,,,,
6688,96689,4-(Methylamino)-3-nitrophenyl phenyl ketone,CNC1=C(C=C(C=C1)C(=O)C2=CC=CC=C2)[N+](=O)[O-],,,,,,
6689,96690,"3,3'-Dinitrobenzophenone",C1=CC(=CC(=C1)[N+](=O)[O-])C(=O)C2=CC(=CC=C2)[N+](=O)[O-],,,,,,
6690,96691,3-(Trifluoromethyl)anisole,COC1=CC=CC(=C1)C(F)(F)F,,,,,,
6691,96692,3-Ethylbenzonitrile,CCC1=CC(=CC=C1)C#N,,,,,,
6692,96693,"(1,1'-Biphenyl)-4,4'-diamine, N-methyl-",CNC1=CC=C(C=C1)C2=CC=C(C=C2)N,,,,,,
6693,96694,N-(3-Allyl-4-hydroxyphenyl)acetamide,CC(=O)NC1=CC(=C(C=C1)O)CC=C,,,,,,
6694,96695,2-Quinoxalinecarboxylic acid,C1=CC=C2C(=C1)N=CC(=N2)C(=O)O,,,,,,
6695,96696,"2,2'-((2-Methylpropyl)imino)bisethanol",CC(C)CN(CCO)CCO,,,,,,
6696,96697,N-(2-hydroxyphenyl)butanamide,CCCC(=O)NC1=CC=CC=C1O,,,,,,
6697,96698,"alpha,alpha'-Dimethylpiperazine-1,4-diethanol",CC(CN1CCN(CC1)CC(C)O)O,,,,,,
6698,96699,"1-Piperazineethanol, 4-phenyl-",C1CN(CCN1CCO)C2=CC=CC=C2,,,,,,
6699,96700,"1-Piperazineethanol, 4-o-tolyl-",CC1=CC=CC=C1N2CCN(CC2)CCO,,,,,,
6700,96701,"2-Propanol, 1,3-bis(o-tolyloxy)-",CC1=CC=CC=C1OCC(COC2=CC=CC=C2C)O,,,,,,
6701,96702,"1,4-Bis(1,3-benzodioxol-5-ylmethyl)piperazine",C1CN(CCN1CC2=CC3=C(C=C2)OCO3)CC4=CC5=C(C=C4)OCO5,,,,,,
6702,96703,"1-Piperazineethanol, 4-(3-chlorophenyl)-",C1CN(CCN1CCO)C2=CC(=CC=C2)Cl,,,,,,
6703,96704,"Ethyl 3,5-dibromo-4-hydroxybenzoate",CCOC(=O)C1=CC(=C(C(=C1)Br)O)Br,,,,,,
6704,96705,"Phenothiaphosphine, 10-hydroxy-2,8-dimethyl-, 10-oxide",CC1=CC2=C(C=C1)SC3=C(P2(=O)O)C=C(C=C3)C,,,,,,
6705,96706,2-nitro-1H-pyrrole,C1=CNC(=C1)[N+](=O)[O-],,,,,,
6706,96707,"4-Pyridinecarboxamide, N-methyl-",CNC(=O)C1=CC=NC=C1,,,,,,
6707,96708,1-Nitro-4-(phenylsulfonyl)benzene,C1=CC=C(C=C1)S(=O)(=O)C2=CC=C(C=C2)[N+](=O)[O-],,,,,,
6708,96709,Aristolochic acid I methyl ester,COC1=CC=CC2=C3C(=C(C=C21)[N+](=O)[O-])C(=CC4=C3OCO4)C(=O)OC,,,,,,
6709,96710,Aristololactam,COC1=CC=CC2=C3C4=C(C=C21)NC(=O)C4=CC5=C3OCO5,,,,,,
6710,96711,"8-Methoxy-6-nitronaphtho[2,1-g][1,3]benzodioxole",COC1=CC=CC2=C3C(=C(C=C21)[N+](=O)[O-])C=CC4=C3OCO4,,,,,,
6711,96712,"Diindeno[1,2,3-cd:1',2',3'-lm]perylene",C1=CC2=C3C=CC4=C5C=CC6=C7C=CC=CC7=C8C6=C5C(=C9C4=C3C(=C2C=C1)C=C9)C=C8,,,,,,
6712,96713,4-Chloro-3-nitrobenzenesulfonyl fluoride,C1=CC(=C(C=C1S(=O)(=O)F)[N+](=O)[O-])Cl,,,,,,
6713,96714,"(4-bromo-3,5-dimethyl-1H-pyrazol-1-yl)methanol",CC1=C(C(=NN1CO)C)Br,,,,,,
6714,96715,3-Chlorobenzal bromide,C1=CC(=CC(=C1)Cl)C(Br)Br,,,,,,
6715,96716,4-(Isopropylamino)piperidine-4-carboxamide,CC(C)NC1(CCNCC1)C(=O)N,,,,,,
6716,96717,CID 96717,C1=CC=C(C=C1)N2C(=C3C(=CC(=O)NC3=O)N2)N,,,,,,
6717,96718,Isopropyl 1H-indole-1-propionate,CC(C)OC(=O)CCN1C=CC2=CC=CC=C21,,,,,,
6718,96719,Isopropyl 1H-indole-3-propionate,CC(C)OC(=O)CCC1=CNC2=CC=CC=C21,,,,,,
6719,96720,CID 96720,C1=CC(=CC=C1CN2C=NC3=C2NC=NC3=O)[N+](=O)[O-],,,,,,
6720,96721,"Phosphoramidic acid, (5-nitro-2-pyridyl)-, diphenyl ester",C1=CC=C(C=C1)OP(=O)(NC2=NC=C(C=C2)[N+](=O)[O-])OC3=CC=CC=C3,,,,,,
6721,96722,4-Pyridineethanesulfonic acid,C1=CN=CC=C1CCS(=O)(=O)O,,,,,,
6722,96723,"2,2'-((2-Methylphenyl)imino)bisethanol",CC1=CC=CC=C1N(CCO)CCO,,,,,,
6723,96724,2-Pyridineethanesulfonic acid,C1=CC=NC(=C1)CCS(=O)(=O)O,,,,,,
6724,96725,4-Aminophenyl-beta-D-galactopyranoside,C1=CC(=CC=C1N)O[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O,,,,,,
6725,96726,CID 96726,CC1=NC2=C(C(=O)N=C(N2)N)NC1=O,,,,,,
6726,96727,"4-Piperidinecarboxaldehyde, 1-benzyl-4-phenyl-",C1CN(CCC1(C=O)C2=CC=CC=C2)CC3=CC=CC=C3,,,,,,
6727,96728,2-(Biphenyl-4-yl)-5-phenyloxazole,C1=CC=C(C=C1)C2=CC=C(C=C2)C3=NC=C(O3)C4=CC=CC=C4,,,,,,
6728,96729,methyl 4-(dimethylaminodiazenyl)-1H-imidazole-5-carboxylate,CN(C)N=NC1=C(NC=N1)C(=O)OC,,,,,,
6729,96730,1-Nitro-9H-carbazole,C1=CC=C2C(=C1)C3=C(N2)C(=CC=C3)[N+](=O)[O-],,,,,,
6730,96731,CID 96731,C1=CC=C2C(=C1)C3=CC(=N)C(=CC3=N2)N(O)O,,,,,,
6731,96732,"2,2-Diphenylpentanoic acid",CCCC(C1=CC=CC=C1)(C2=CC=CC=C2)C(=O)O,,,,,,
6732,96733,2-(6-methylpyridin-2-yl)-1H-benzimidazole,CC1=NC(=CC=C1)C2=NC3=CC=CC=C3N2,,,,,,
6733,96734,2-(5-bromo-1H-indol-3-yl)acetic acid,C1=CC2=C(C=C1Br)C(=CN2)CC(=O)O,,,,,,
6734,96735,5-Bromo-DL-tryptophan,C1=CC2=C(C=C1Br)C(=CN2)CC(C(=O)O)N,,,,,,
6735,96736,4-(Cyclohexylamino)piperidine-4-carboxamide,C1CCC(CC1)NC2(CCNCC2)C(=O)N,,,,,,
6736,96737,"2-(3-Bromophenyl)-5-phenyl-1,3,4-oxadiazole",C1=CC=C(C=C1)C2=NN=C(O2)C3=CC(=CC=C3)Br,,,,,,
6737,96738,3-Chloro-n'-(3-chlorobenzoyl)benzohydrazide,C1=CC(=CC(=C1)Cl)C(=O)NNC(=O)C2=CC(=CC=C2)Cl,,,,,,
6738,96739,"2,2-Bis(4-fluorophenyl)tetrahydrofuran",C1CC(OC1)(C2=CC=C(C=C2)F)C3=CC=C(C=C3)F,,,,,,
6739,96740,"2-(3-Bromophenyl)-5-(2-naphthyl)-1,3,4-oxadiazole",C1=CC=C2C=C(C=CC2=C1)C3=NN=C(O3)C4=CC(=CC=C4)Br,,,,,,
6740,96741,2'-(3-Bromobenzoyl)-2-naphthohydrazide,C1=CC=C2C=C(C=CC2=C1)C(=O)NNC(=O)C3=CC(=CC=C3)Br,,,,,,
6741,96742,2'-(4-Bromobenzoyl)-1-naphthohydrazide,C1=CC=C2C(=C1)C=CC=C2C(=O)NNC(=O)C3=CC=C(C=C3)Br,,,,,,
6742,96743,2-Bromo-5-fluorotoluene,CC1=C(C=CC(=C1)F)Br,,,,,,
6743,96744,2'-Fluoroacetophenone,CC(=O)C1=CC=CC=C1F,,,,,,
6744,96745,3-Bromo-4-fluorotoluene,CC1=CC(=C(C=C1)F)Br,,,,,,
6745,96746,"3,5-Bis(trifluoromethyl)benzonitrile",C1=C(C=C(C=C1C(F)(F)F)C(F)(F)F)C#N,,,,,,
6746,96747,2-Chloro-4-fluorotoluene,CC1=C(C=C(C=C1)F)Cl,,,,,,
6747,96748,4-Methoxy-3-nitrobenzotrifluoride,COC1=C(C=C(C=C1)C(F)(F)F)[N+](=O)[O-],,,,,,
6748,96749,2-Bromo-1-(4-fluorophenyl)ethanone,C1=CC(=CC=C1C(=O)CBr)F,,,,,,
6749,96750,5-Fluoroindole-3-acetic acid,C1=CC2=C(C=C1F)C(=CN2)CC(=O)O,,,,,,
6750,96751,"Hydrazine, 1,2-bis(m-fluorobenzoyl)-",C1=CC(=CC(=C1)F)C(=O)NNC(=O)C2=CC(=CC=C2)F,,,,,,
6751,96752,3-Cyclohexyl-1-(2-methoxyethyl)-1-nitrosourea,COCCN(C(=O)NC1CCCCC1)N=O,,,,,,
6752,96753,4-(Allylthio)-2-phenylpyrimidine,C=CCSC1=NC(=NC=C1)C2=CC=CC=C2,,,,,,
6753,96754,"2,9-Dibenzyl-1,2,3,8,9,10-hexahydrobenzo(2,1-e:3,4-e')bis(1,3)oxazine",C1C2=C(C=CC3=C2CN(CO3)CC4=CC=CC=C4)OCN1CC5=CC=CC=C5,,,,,,
6754,96755,"Uracil, 3-(((5-chloro-3-methylsalicyl)methylamino)methyl)-",CC1=CC(=CC(=C1O)CN(C)CN2C(=O)C=CNC2=O)Cl,,,,,,
6755,96756,"Propanenitrile, 3,3',3'',3'''-((1,5-dihydroxy-2,6-naphthalenediyl)bis(methylenenitrilo))tetrakis-",C1=CC2=C(C=CC(=C2O)CN(CCC#N)CCC#N)C(=C1CN(CCC#N)CCC#N)O,,,,,,
6756,96757,Glycyl-dl-methionine,CSCCC(C(=O)O)NC(=O)CN,,,,,,
6757,96758,N-(4-Iodophenyl)maleimide,C1=CC(=CC=C1N2C(=O)C=CC2=O)I,,,,,,
6758,96759,2'-(2-Methylbenzoyl)-1-naphthohydrazide,CC1=CC=CC=C1C(=O)NNC(=O)C2=CC=CC3=CC=CC=C32,,,,,,
6759,96760,2'-(2-Methylbenzoyl)-2-naphthohydrazide,CC1=CC=CC=C1C(=O)NNC(=O)C2=CC3=CC=CC=C3C=C2,,,,,,
6760,96761,2'-(4-Methylbenzoyl)-1-naphthohydrazide,CC1=CC=C(C=C1)C(=O)NNC(=O)C2=CC=CC3=CC=CC=C32,,,,,,
6761,96762,2'-(4-Methylbenzoyl)-2-naphthohydrazide,CC1=CC=C(C=C1)C(=O)NNC(=O)C2=CC3=CC=CC=C3C=C2,,,,,,
6762,96763,2'-(3-Methylbenzoyl)-2-naphthohydrazide,CC1=CC(=CC=C1)C(=O)NNC(=O)C2=CC3=CC=CC=C3C=C2,,,,,,
6763,96764,2'-(4-Methoxybenzoyl)-1-naphthohydrazide,COC1=CC=C(C=C1)C(=O)NNC(=O)C2=CC=CC3=CC=CC=C32,,,,,,
6764,96765,S-2-((5-Cyclohexylpentyl)amino)ethyl thiosulfate,C1CCC(CC1)CCCCCNCCSS(=O)(=O)O,,,,,,
6765,96766,1-Methyl-4-[4-(2-sulfosulfanylethylamino)butyl]cyclohexane,CC1CCC(CC1)CCCCNCCSS(=O)(=O)O,,,,,,
6766,96767,3-Bromophenanthrene,C1=CC=C2C(=C1)C=CC3=C2C=C(C=C3)Br,,,,,,
6767,96768,9-Fluorophenanthrene,C1=CC=C2C(=C1)C=C(C3=CC=CC=C23)F,,,,,,
6768,96769,"Phenanthro(2,3-d)(1,3)dioxole-5-carboxylic acid",C1OC2=C(O1)C=C3C4=CC=CC=C4C(=CC3=C2)C(=O)O,,,,,,
6769,96770,Benzoylglycylglycine,C1=CC=C(C=C1)C(=O)NCC(=O)NCC(=O)O,,,,,,
6770,96771,Hippuryl-glycyl-glycine,C1=CC=C(C=C1)C(=O)NCC(=O)NCC(=O)NCC(=O)O,,,,,,
6771,96772,Coproporphyrin I tetramethyl ester,CC1=C(C2=CC3=NC(=CC4=NC(=CC5=C(C(=C(N5)C=C1N2)CCC(=O)OC)C)C(=C4C)CCC(=O)OC)C(=C3C)CCC(=O)OC)CCC(=O)OC,,,,,,
6772,96773,CID 96773,CCCCCC(=C(C)NNC(=NC)S)N=NC(=NC)S,,,,,,
6773,96774,3-Aminopyrazole-4-carboxylic acid,C1=NNC(=C1C(=O)O)N,,,,,,
6774,96775,"2,3-Dihydro-1H-benz(e)indene",C1CC2=C(C1)C3=CC=CC=C3C=C2,,,,,,
6775,96776,N-[(4-Phenyl-4-piperidinyl)methyl]acetamide,CC(=O)NCC1(CCNCC1)C2=CC=CC=C2,,,,,,
6776,96777,"Adenosine, 5'-nicotinate",C1=CC(=CN=C1)C(=O)OC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC4=C(N=CN=C43)N)O)O,,,,,,
6777,96778,Dianhydrogossypol,CC1=CC2=C(C(=C(C3=COC(=C23)C1=C4C(=CC5=C(C(=O)C(=O)C6=COC4=C56)C(C)C)C)O)O)C(C)C,,,,,,
6778,96779,"p-Toluidine, alpha-(p-tolylthio)-",CC1=CC=C(C=C1)SCC2=CC=C(C=C2)N,,,,,,
6779,96780,"p-Toluidine, N,N-dimethyl-alpha-(phenylthio)-",CN(C)C1=CC=C(C=C1)CSC2=CC=CC=C2,,,,,,
6780,96781,1-(p-Cyanophenyl)-3-(hexahydro-1H-azepin-1-yl)urea,C1CCCN(CC1)NC(=O)NC2=CC=C(C=C2)C#N,,,,,,
6781,96782,"Urea, 1-(2,5-dichlorophenyl)-3-(hexahydro-1H-azepin-1-yl)-",C1CCCN(CC1)NC(=O)NC2=C(C=CC(=C2)Cl)Cl,,,,,,
6782,96783,4-Cyclohexylphenylacetic acid,C1CCC(CC1)C2=CC=C(C=C2)CC(=O)O,,,,,,
6783,96784,4-[(Phenylsulfanyl)methyl]aniline,C1=CC=C(C=C1)SCC2=CC=C(C=C2)N,,,,,,
6784,96785,"Acetamide, 2-(diisopropylamino)-N-(2,5-dimethylpyrrol-1-yl)-",CC1=CC=C(N1NC(=O)CN(C(C)C)C(C)C)C,,,,,,
6785,96786,"Purine, 6-chloro-9-(p-methoxyphenyl)-",COC1=CC=C(C=C1)N2C=NC3=C2N=CN=C3Cl,,,,,,
6786,96787,CID 96787,CCCCCCCCN1C(=O)CCN=C1S,,,,,,
6787,96788,5-{[2-(Quinolin-2-yl)hydrazinylidene]methyl}quinolin-8-ol,C1=CC=C2C(=C1)C=CC(=N2)NN=CC3=C4C=CC=NC4=C(C=C3)O,,,,,,
6788,96789,"7-Quinolinemethanol, 8-hydroxy-5-methyl-",CC1=CC(=C(C2=C1C=CC=N2)O)CO,,,,,,
6789,96790,"4,4',5,5'-Tetramethyl-2,2'-bisimidazole",CC1=C(N=C(N1)C2=NC(=C(N2)C)C)C,,,,,,
6790,96791,"2-(2-Bromophenyl)-5-phenyl-1,3,4-oxadiazole",C1=CC=C(C=C1)C2=NN=C(O2)C3=CC=CC=C3Br,,,,,,
6791,96792,9H-Fluoren-9-ylideneacetic acid,C1=CC=C2C(=C1)C3=CC=CC=C3C2=CC(=O)O,,,,,,
6792,96793,1-Benzyl-4-phenylpiperidine-4-methanol,C1CN(CCC1(CO)C2=CC=CC=C2)CC3=CC=CC=C3,,,,,,
6793,96794,"[(2R,3S,4S,5R,6R)-3,4,5-triacetyloxy-6-(4-nitrophenoxy)oxan-2-yl]methyl acetate",CC(=O)OC[C@@H]1[C@@H]([C@@H]([C@H]([C@H](O1)OC2=CC=C(C=C2)[N+](=O)[O-])OC(=O)C)OC(=O)C)OC(=O)C,,,,,,
6794,96795,"beta-D-Galactopyranoside, 4-nitrophenyl, 2,3,4,6-tetraacetate",CC(=O)OC[C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)OC2=CC=C(C=C2)[N+](=O)[O-])OC(=O)C)OC(=O)C)OC(=O)C,,,,,,
6795,96796,alanyl-D-alanine,C[C@@H](C(=O)N[C@H](C)C(=O)O)N,,,,,,
6796,96797,Glycyl-4-hydroxyproline,C1[C@H](N(CC1O)C(=O)CN)C(=O)O,,,,,,
6797,96798,l-Alanylglycylglycine,C[C@@H](C(=O)NCC(=O)NCC(=O)O)N,,,,,,
6798,96799,l-Alanyl-l-valine,C[C@@H](C(=O)N[C@@H](C(C)C)C(=O)O)N,,,,,,
6799,96800,"N-(2,4-Dinitrophenyl)-L-serine",C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])N[C@@H](CO)C(=O)O,,,,,,
6800,96801,l-Alanyl-l-leucine,C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)N,,,,,,
6801,96802,"N2-(2,4-Dinitrophenyl)-L-asparagine",C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])N[C@@H](CC(=O)N)C(=O)O,,,,,,
6802,96803,"4-(2,4-Dinitroanilino)butanoic acid",C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])NCCCC(=O)O,,,,,,
6803,96804,"N-(2,4-Dinitrophenyl)-L-threonine",CC([C@@H](C(=O)O)NC1=C(C=C(C=C1)[N+](=O)[O-])[N+](=O)[O-])O,,,,,,
6804,96805,N-(N-Glycyl-L-leucyl)glycine,CC(C)C[C@@H](C(=O)NCC(=O)O)NC(=O)CN,,,,,,
6805,96806,DL-Leucylglycylglycine,CC(C)CC(C(=O)NCC(=O)NCC(=O)O)N,,,,,,
6806,96807,"N-(2,4-Dinitrophenyl)-L-proline",C1C[C@H](N(C1)C2=C(C=C(C=C2)[N+](=O)[O-])[N+](=O)[O-])C(=O)O,,,,,,
6807,96808,"2-(2,4-Dinitroanilino)pentanedioic acid",C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])NC(CCC(=O)O)C(=O)O,,,,,,
6808,96809,"N2-(2,4-Dinitrophenyl)-L-glutamine",C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])N[C@@H](CCC(=O)N)C(=O)O,,,,,,
6809,96810,"N-(2,4-Dinitrophenyl)-L-valine",CC(C)[C@@H](C(=O)O)NC1=C(C=C(C=C1)[N+](=O)[O-])[N+](=O)[O-],,,,,,
6810,96811,Glycyl-prolyl-glycyl-glycine,C1C[C@H](N(C1)C(=O)CN)C(=O)NCC(=O)NCC(=O)O,,,,,,
6811,96812,"6-((2,4-Dinitrophenyl)amino)hexanoic acid",C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])NCCCCCC(=O)O,,,,,,
6812,96813,Einecs 216-744-6,CCC(C)[C@@H](C(=O)O)NC1=C(C=C(C=C1)[N+](=O)[O-])[N+](=O)[O-],,,,,,
6813,96814,Alanylphenylalanine,C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N,,,,,,
6814,96815,Hippuryl-L-arginine,C1=CC=C(C=C1)C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)O,,,,,,
6815,96816,Z-Gly-Leu-OH,CC(C)C[C@@H](C(=O)O)NC(=O)CNC(=O)OCC1=CC=CC=C1,,,,,,
6816,96817,Glycyl-leucyl-tyrosine,CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)NC(=O)CN,,,,,,
6817,96818,Bis(dinitrophenyl)lysine,C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])NCCCC[C@@H](C(=O)O)NC2=C(C=C(C=C2)[N+](=O)[O-])[N+](=O)[O-],,,,,,
6818,96819,Z-Gly-phe-NH2,C1=CC=C(C=C1)C[C@@H](C(=O)N)NC(=O)CNC(=O)OCC2=CC=CC=C2,,,,,,
6819,96820,Benzyloxycarbonylglutamyltyrosine,C1=CC=C(C=C1)COC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O,,,,,,
6820,96821,dl-Alanyl-dl-serine,CC(C(=O)NC(CO)C(=O)O)N,,,,,,
6821,96822,2-(2-Aminopropanamido)pentanoic acid,CCCC(C(=O)O)NC(=O)C(C)N,,,,,,
6822,96823,CID 96823,CCSC1=NC(=O)C=C(N1)N,,,,,,
6823,96824,"5-Methyl-2,1,3-benzoselenadiazole",CC1=CC2=N[Se]N=C2C=C1,,,,,,
6824,96825,CID 96825,C1=CC(=C(C=C1N(O)O)[N+](=O)[O-])NC(=O)N=N,,,,,,
6825,96826,"2,5-Dimethylcyclopentanone",CC1CCC(C1=O)C,,,,,,
6826,96827,"4-Amino-2,5-dimethoxybenzenesulphonamide",COC1=CC(=C(C=C1N)OC)S(=O)(=O)N,,,,,,
6827,96828,3'-Fluoro-4'-methoxyacetophenone,CC(=O)C1=CC(=C(C=C1)OC)F,,,,,,
6828,96829,"2-(2,4-Dichlorophenoxy)aniline",C1=CC=C(C(=C1)N)OC2=C(C=C(C=C2)Cl)Cl,,,,,,
6829,96830,2-Methyl-1-nitroprop-1-ene,CC(=C[N+](=O)[O-])C,,,,,,
6830,96831,"4,4'-Dimethoxytrityl chloride",COC1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=C(C=C3)OC)Cl,,,,,,
6831,96832,2-Isopropyl-3-methylbutanoic acid,CC(C)C(C(C)C)C(=O)O,,,,,,
6832,96833,CID 96833,CN=C(NN=CCCCC=NNC(=NC)S)S,,,,,,
6833,96834,CID 96834,C(CC=NN=C(N)S)CC=NN=C(N)S,,,,,,
6834,96835,"[(4aR,6S,7R,8S,8aR)-6-methoxy-7-(4-methylphenyl)sulfonyloxy-2-phenyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-8-yl] 4-methylbenzenesulfonate",CC1=CC=C(C=C1)S(=O)(=O)O[C@H]2[C@H]3[C@@H](COC(O3)C4=CC=CC=C4)O[C@@H]([C@@H]2OS(=O)(=O)C5=CC=C(C=C5)C)OC,,,,,,
6835,96836,"Phosphine oxide, bis(1-aziridinyl)diallylamino-",C=CCN(CC=C)P(=O)(N1CC1)N2CC2,,,,,,
6836,96837,"Phosphine oxide, bis(2-methyl-1-aziridinyl)diallylamino-",CC1CN1P(=O)(N2CC2C)N(CC=C)CC=C,,,,,,
6837,96838,"Phosphine oxide, (1-aziridinyl)(2-methyl-1-aziridinyl)diallylamino-",CC1CN1P(=O)(N2CC2)N(CC=C)CC=C,,,,,,
6838,96839,Sebacil,C1CCCCC(=O)C(=O)CCC1,,,"['Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. (See all compounds classified as Cholinesterase Inhibitors.)', 'Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)']",,,
6839,96840,"2,5-Bis(4-biphenylyl)-1,3,4-oxadiazole",C1=CC=C(C=C1)C2=CC=C(C=C2)C3=NN=C(O3)C4=CC=C(C=C4)C5=CC=CC=C5,,,,,,
6840,96841,"Uracil, 1,3-dimethyl-6-(methylamino)-5-nitro-",CNC1=C(C(=O)N(C(=O)N1C)C)[N+](=O)[O-],,,,,,
6841,96842,"2-(2-Fluorophenyl)-5-phenyl-1,3,4-oxadiazole",C1=CC=C(C=C1)C2=NN=C(O2)C3=CC=CC=C3F,,,,,,
6842,96843,"2-(3-Fluorophenyl)-5-phenyl-1,3,4-oxadiazole",C1=CC=C(C=C1)C2=NN=C(O2)C3=CC(=CC=C3)F,,,,,,
6843,96844,2-(2-Fluorophenyl)-5-phenyloxazole,C1=CC=C(C=C1)C2=CN=C(O2)C3=CC=CC=C3F,,,,,,
6844,96845,"2-(4-Fluorophenyl)-5-(2-naphthyl)-1,3,4-oxadiazole",C1=CC=C2C=C(C=CC2=C1)C3=NN=C(O3)C4=CC=C(C=C4)F,,,,,,
6845,96846,"2-(3-Methoxyphenyl)-5-(2-naphthyl)-1,3,4-oxadiazole",COC1=CC=CC(=C1)C2=NN=C(O2)C3=CC4=CC=CC=C4C=C3,,,,,,
6846,96847,"2-(4-Methoxyphenyl)-5-(1-naphthyl)-1,3,4-oxadiazole",COC1=CC=C(C=C1)C2=NN=C(O2)C3=CC=CC4=CC=CC=C43,,,,,,
6847,96848,"2-(4-Methoxyphenyl)-5-(2-naphthyl)-1,3,4-oxadiazole",COC1=CC=C(C=C1)C2=NN=C(O2)C3=CC4=CC=CC=C4C=C3,,,,,,
6848,96849,CID 96849,C([C@@H]1[C@H]([C@H]([C@@H](O1)N2C3=C(C(=O)N=C(N3)N)N=C2N)O)O)O,,,,,,
6849,96850,CID 96850,COC1=NC2=C(N1[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)NC(=NC2=O)N,,,,,,
6850,96851,8-Aminoadenosine,C1=NC(=C2C(=N1)N(C(=N2)N)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N,,,,,,
6851,96852,8-Oxoadenosine,C1=NC(=C2C(=N1)N(C(=O)N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N,,,,,,
6852,96853,"3-Ethyl-3-phenylpentane-1,5-diol",CCC(CCO)(CCO)C1=CC=CC=C1,,,,,,
6853,96854,"2-(2,4-Dichlorophenyl)-5-phenyl-1,3,4-oxadiazole",C1=CC=C(C=C1)C2=NN=C(O2)C3=C(C=C(C=C3)Cl)Cl,,,,,,
6854,96855,"2-(3,4-Dichlorophenyl)-5-phenyl-1,3,4-oxadiazole",C1=CC=C(C=C1)C2=NN=C(O2)C3=CC(=C(C=C3)Cl)Cl,,,,,,
6855,96856,"2,5-Bis(2-fluorophenyl)-1,3,4-oxadiazole",C1=CC=C(C(=C1)C2=NN=C(O2)C3=CC=CC=C3F)F,,,,,,
6856,96857,"2,5-Bis(3-fluorophenyl)-1,3,4-oxadiazole",C1=CC(=CC(=C1)F)C2=NN=C(O2)C3=CC(=CC=C3)F,,,,,,
6857,96858,"3,5-Diiodo-D-thyronine",C1=CC(=CC=C1O)OC2=C(C=C(C=C2I)C[C@H](C(=O)O)N)I,,,,,,
6858,96859,"2-(2-Fluorophenyl)-5-(1-naphthyl)-1,3,4-oxadiazole",C1=CC=C2C(=C1)C=CC=C2C3=NN=C(O3)C4=CC=CC=C4F,,,,,,
6859,96860,"2-(2-Fluorophenyl)-5-(2-naphthyl)-1,3,4-oxadiazole",C1=CC=C2C=C(C=CC2=C1)C3=NN=C(O3)C4=CC=CC=C4F,,,,,,
6860,96861,"2-(3-Fluorophenyl)-5-(1-naphthyl)-1,3,4-oxadiazole",C1=CC=C2C(=C1)C=CC=C2C3=NN=C(O3)C4=CC(=CC=C4)F,,,,,,
6861,96862,"5,12-Dihydrotetracene",C1C2=CC=CC=C2CC3=CC4=CC=CC=C4C=C31,,,,,,
6862,96863,"1H,3H,5H-Oxazolo(3,4-c)oxazole, 3,5-diphenyl-7a-hydroxymethyl-",C1C2(COC(N2C(O1)C3=CC=CC=C3)C4=CC=CC=C4)CO,,,,,,
6863,96864,"2,4-Dichloro-1-iodobenzene",C1=CC(=C(C=C1Cl)Cl)I,,,,,,
6864,96865,N-(2-Anthryl)acetamide,CC(=O)NC1=CC2=CC3=CC=CC=C3C=C2C=C1,,,,,,
6865,96866,"Urea, 1-(7-nitrofluoren-2-yl)-3-propyl-",CCCNC(=O)NC1=CC2=C(C=C1)C3=C(C2)C=C(C=C3)[N+](=O)[O-],,,,,,
6866,96867,CID 96867,C1=CC=C(C(=C1)C=C2C(=O)NC(=NC2=O)S)C(=O)O,,,,,,
6867,96868,CID 96868,CN(C)C1=CC=C(C=C1)C=C2C(=O)NC(=NC2=O)S,,,,,,
6868,96869,"2,3,7-Trimethylindole",CC1=C2C(=CC=C1)C(=C(N2)C)C,,,,,,
6869,96870,"Isopropyl 2-((3,5-dibromo-4-hydroxyphenyl)(3,5-dibromo-4-oxo-2,5-cyclohexadien-1-ylidene)methyl)benzoate",CC(C)OC(=O)C1=CC=CC=C1C(=C2C=C(C(=O)C(=C2)Br)Br)C3=CC(=C(C(=C3)Br)O)Br,,,,,,
6870,96871,CID 96871,CCC(=NN=C(N)S)C(=NN=C(N)S)C,,,,,,
6871,96872,4-(5-Nitropyridin-2-yl)morpholine,C1COCCN1C2=NC=C(C=C2)[N+](=O)[O-],,,,,,
6872,96873,"Pyridine, 2-((2-methoxyethyl)amino)-5-nitro-",COCCNC1=NC=C(C=C1)[N+](=O)[O-],,,,,,
6873,96874,"p-Tolunitrile, alpha,alpha'-(hexamethylenedinitrilo)di-",C1=CC(=CC=C1C=NCCCCCCN=CC2=CC=C(C=C2)C#N)C#N,,,,,,
6874,96875,3-Methylene-2-norbornanone,C=C1C2CCC(C2)C1=O,,,,,,
6875,96876,Indane-5-sulfonamide,C1CC2=C(C1)C=C(C=C2)S(=O)(=O)N,,,,,,
6876,96877,(Hexadecanoyloxy)acetic acid,CCCCCCCCCCCCCCCC(=O)OCC(=O)O,,,,,,
6877,96878,N-Cyclodecylmethylamine,CNC1CCCCCCCCC1,,,,,,
6878,96879,Methyl 1-benzyl-1H-imidazole-5-carboxylate,COC(=O)C1=CN=CN1CC2=CC=CC=C2,,,,,,
6879,96880,CID 96880,COC(=O)C1=CN=C(N1CC2=CC=CC=C2)S,,,,,,
6880,96881,"Benzhydrol, 4,4'-dichloro-alpha-(trifluoromethyl)-",C1=CC(=CC=C1C(C2=CC=C(C=C2)Cl)(C(F)(F)F)O)Cl,,,,,,
6881,96882,"4-Bromo-4'-fluoro-1,1'-biphenyl",C1=CC(=CC=C1C2=CC=C(C=C2)Br)F,,,,,,
6882,96883,"N-[2,2,2-Trichloro-1,1-bis(4-chlorophenyl)ethyl]acetamide",CC(=O)NC(C1=CC=C(C=C1)Cl)(C2=CC=C(C=C2)Cl)C(Cl)(Cl)Cl,,,,,,
6883,96884,N-(2-Chloroethyl)-N'-(5-nitro-2-thiazolyl)urea,C1=C(SC(=N1)NC(=O)NCCCl)[N+](=O)[O-],,,,,,
6884,96885,"[2-[3-[2-(Carbamoylhydrazinylidene)ethyl]-2,4-dioxopyrimidin-1-yl]ethylideneamino]urea",C1=CN(C(=O)N(C1=O)CC=NNC(=O)N)CC=NNC(=O)N,,,,,,
6885,96886,Bis(fluoroethyl)nitrosourea,C(CF)NC(=O)N(CCF)N=O,,,,,,
6886,96887,"Urea, 1-(2-chloroethyl)-3-(2,6-xylyl)-",CC1=C(C(=CC=C1)C)NC(=O)NCCCl,,,,,,
6887,96888,"Urea, 1-(2-chloroethyl)-3-(2-indanyl)-",C1C(CC2=CC=CC=C21)NC(=O)NCCCl,,,,,,
6888,96889,"Urea, 1-(2-chloroethyl)-1-nitroso-3-(2,6-xylyl)-",CC1=C(C(=CC=C1)C)NC(=O)N(CCCl)N=O,,,,,,
6889,96890,2-(Pyridin-2-yloxy)ethanamine,C1=CC=NC(=C1)OCCN,,,,,,
6890,96891,"1,2,3,4-Tetrahydroacridine-9-carboxylic acid",C1CCC2=NC3=CC=CC=C3C(=C2C1)C(=O)O,,,,,,
6891,96892,"3-Pyridinecarboxamide, 6-(diethylamino)-",CCN(CC)C1=NC=C(C=C1)C(=O)N,,,,,,
6892,96893,"Succinamide, N,N,N',N'-tetraethyl-",CCN(CC)C(=O)CCC(=O)N(CC)CC,,,,,,
6893,96894,"delta(sup 1),alpha-Acenaphthenemalononitrile, 2-oxo-",C1=CC2=C3C(=C1)C(=C(C#N)C#N)C(=O)C3=CC=C2,,,,,,
6894,96895,2-Ethylbicyclo[2.2.1]hept-5-ene-2-carboxamide,CCC1(CC2CC1C=C2)C(=O)N,,,,,,
6895,96896,Benzo[b]phenazine,C1=CC=C2C=C3C(=CC2=C1)N=C4C=CC=CC4=N3,,,,,,
6896,96897,5-(sec-Pentyl)barbituric acid,CCCC(C)C1C(=O)NC(=O)NC1=O,,,,,,
6897,96898,"Barbituric acid, 5-nonyl-",CCCCCCCCCC1C(=O)NC(=O)NC1=O,,,,,,
6898,96899,"1,4-Cyclohexadiene-1,2-dicarbonitrile, 4,5-dibromo-3,6-dioxo-",C(#N)C1=C(C(=O)C(=C(C1=O)Br)Br)C#N,,,,,,
6899,96900,CID 96900,CC1=C2C(=C3C=C(C=CC3=N2)OC)C=CN1,,,,,,
6900,96901,Tetramethylenebis(p-nitrobenzenesulfonate),C1=CC(=CC=C1[N+](=O)[O-])S(=O)(=O)OCCCCOS(=O)(=O)C2=CC=C(C=C2)[N+](=O)[O-],,,,,,
6901,96902,"Stannane, tetrapentyl-",CCCCC[Sn](CCCCC)(CCCCC)CCCCC,,,,,,
6902,96903,"1-Propanol, 3-(trimethylsilyl)-, carbamate",C[Si](C)(C)CCCOC(=O)N,,,,,,
6903,96904,4-(3-Phenanthryl)butanoic acid,C1=CC=C2C(=C1)C=CC3=C2C=C(C=C3)CCCC(=O)O,,,,,,
6904,96905,"Methyl-dec-2-en-4,6-diynoate",CCCC#CC#CC=CC(=O)OC,,,,,,
6905,96906,"s-Triazine, 2,4-diamino-6-morpholino-",C1COCCN1C2=NC(=NC(=N2)N)N,,,,,,
6906,96907,"Phosphine sulfide, bis(1-aziridinyl)diallylamino-",C=CCN(CC=C)P(=S)(N1CC1)N2CC2,,,,,,
6907,96908,"Phosphine sulfide, bis(2-methyl-1-aziridinyl)diallylamino-",CC1CN1P(=S)(N2CC2C)N(CC=C)CC=C,,,,,,
6908,96909,"Phosphine sulfide, (1-aziridinyl)(2-methyl-1-aziridinyl)diallylamino-",CC1CN1P(=S)(N2CC2)N(CC=C)CC=C,,,,,,
6909,96910,"Phosphine oxide, (1-aziridinyl)bis(diallylamino)-",C=CCN(CC=C)P(=O)(N1CC1)N(CC=C)CC=C,,,,,,
6910,96911,"4-Amino-N-methyl-1,2,5-selenadiazole-3-carboxamide",CNC(=O)C1=N[Se]N=C1N,,,,,,
6911,96912,"1-(2-Chloroethyl)-3-[4-[[2-chloroethyl(nitroso)carbamoyl]amino]-2,3,5,6-tetramethylphenyl]-1-nitrosourea",CC1=C(C(=C(C(=C1NC(=O)N(CCCl)N=O)C)C)NC(=O)N(CCCl)N=O)C,,,,,,
6912,96913,1-Benzylindole,C1=CC=C(C=C1)CN2C=CC3=CC=CC=C32,,,,,,
6913,96914,"1,3,2-Benzothiazaphosphorine, 3-methyl-2-(p-tolyloxy)-",CC1=CC=C(C=C1)OP2(=O)N(C3=CC=CC=C3S2)C,,,,,,
6914,96915,"5-Pyrimidinecarboxamide, 2-(dimethylamino)-",CN(C)C1=NC=C(C=N1)C(=O)N,,,,,,
6915,96916,Gladiolic acid,CC1=CC(=C(C(=C1OC)C(=O)O)C=O)C=O,,,,,,
6916,96917,3(2H)-Isothiazolone,C1=CSNC1=O,,,,,,
6917,96918,Atherosperminine,CN(C)CCC1=CC(=C(C2=C1C=CC3=CC=CC=C32)OC)OC,,,,,,
6918,96919,"Propane-1,2,3-triyl tris(12-hydroxyoctadec-9-enoate)",CCCCCCC(CC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC(CCCCCC)O)OC(=O)CCCCCCCC=CCC(CCCCCC)O)O,,,,,,
6919,96920,"Benzenepropanenitrile, 4-amino-beta-oxo-",C1=CC(=CC=C1C(=O)CC#N)N,,,,,,
6920,96921,"4,4'-Difluoro-2,2'-dinitrobibenzyl",C1=CC(=C(C=C1F)[N+](=O)[O-])CCC2=C(C=C(C=C2)F)[N+](=O)[O-],,,,,,
6921,96922,"2,5-Dimethyl-1,3,4-thiadiazole",CC1=NN=C(S1)C,,,,,,
6922,96923,1-Hexadecanesulfonyl chloride,CCCCCCCCCCCCCCCCS(=O)(=O)Cl,,,,,,
6923,96924,4-Chloro-2-nitrobenzonitrile,C1=CC(=C(C=C1Cl)[N+](=O)[O-])C#N,,,,,,
6924,96925,"Methyl 2,2-dimethylacetoacetate",CC(=O)C(C)(C)C(=O)OC,,,,,,
6925,96926,"3-Cyclohexene-1-carboxylic acid, methyl ester",COC(=O)C1CCC=CC1,,,,,,
6926,96927,5-Furfurylidenebarbituric acid,C1=COC(=C1)C=C2C(=O)NC(=O)NC2=O,,,,,,
6927,96928,"2-Chloropyridazino[6,1-b]quinazolin-10-one",C1=CC=C2C(=C1)C(=O)N3C(=N2)C=CC(=N3)Cl,,,,,,
6928,96929,Coumarin 2,CCNC1=CC2=C(C=C1C)C(=CC(=O)O2)C,,,,,,
6929,96930,"3,7-Dimethyl-8-azaxanthin",CN1C2=C(N=N1)N(C(=O)NC2=O)C,,,,,,
6930,96931,"3-(1,3-benzodioxol-5-yl)-N-(2-methylpropyl)prop-2-enamide",CC(C)CNC(=O)C=CC1=CC2=C(C=C1)OCO2,,,,,,
6931,96932,Papaveraldine,COC1=C(C=C(C=C1)C(=O)C2=NC=CC3=CC(=C(C=C32)OC)OC)OC,,,,,,
6932,96933,"3-Pyridinecarboxamide, N-methyl-6-(methylamino)-",CNC1=NC=C(C=C1)C(=O)NC,,,,,,
6933,96934,"Urea, 1,1'-(1,4-piperazinediylbis(trimethylene))bis(3-(p-bromophenyl)-",C1CN(CCN1CCCNC(=O)NC2=CC=C(C=C2)Br)CCCNC(=O)NC3=CC=C(C=C3)Br,,,,,,
6934,96935,"Urea, N,N''-(1,4-piperazinediyldi-3,1-propanediyl)bis(N'-(2-chlorophenyl)-",C1CN(CCN1CCCNC(=O)NC2=CC=CC=C2Cl)CCCNC(=O)NC3=CC=CC=C3Cl,,,,,,
6935,96936,"Urea, N,N''-(1,4-piperazinediyldi-3,1-propanediyl)bis(N'-(4-chlorophenyl)-",C1CN(CCN1CCCNC(=O)NC2=CC=C(C=C2)Cl)CCCNC(=O)NC3=CC=C(C=C3)Cl,,,,,,
6936,96937,"Urea, 1,1'-(1,4-piperazinediylbis(trimethylene))bis(3-butyl-",CCCCNC(=O)NCCCN1CCN(CC1)CCCNC(=O)NCCCC,,,,,,
6937,96938,"5,8-Tridecadiyn-7-one",CCCCC#CC(=O)C#CCCCC,,,,,,
6938,96939,CID 96939,C1=CC2=C3C=CC(=O)C=C3OC(=C2C=C1)O,,,,,,
6939,96940,1-Butyl-3-phenylurea,CCCCNC(=O)NC1=CC=CC=C1,,,,,,
6940,96941,"4,4'-Oxybis(phthalonitrile)",C1=CC(=C(C=C1OC2=CC(=C(C=C2)C#N)C#N)C#N)C#N,,,,,,
6941,96942,Murrayanine,COC1=CC(=CC2=C1NC3=CC=CC=C32)C=O,,,,,,
6942,96943,Girinimbine,CC1=CC2=C(C3=C1OC(C=C3)(C)C)NC4=CC=CC=C42,,,,,,
6943,96944,Glycozoline,CC1=CC2=C(C=C1)NC3=C2C=C(C=C3)OC,,,,,,
6944,96945,2-(N-Propylformimidoyl)pyrrole,CCCN=CC1=CC=CN1,,,,,,
6945,96946,2-[6-(2-Hydroxy-2-phenylethyl)-1-methyl-2-piperidyl]-1-phenylethanol,CN1C(CCCC1CC(C2=CC=CC=C2)O)CC(C3=CC=CC=C3)O,,,,,,
6946,96947,"2,5-Cyclohexadiene-1,4-dione, 2,5-bis(1-azirdinyl)-3,6-dimethoxy-",COC1=C(C(=O)C(=C(C1=O)N2CC2)OC)N3CC3,,,,,,
6947,96948,"Phosphoramidic acid, N-(2-pyrimidyl)-, diphenyl ester",C1=CC=C(C=C1)OP(=O)(NC2=NC=CC=N2)OC3=CC=CC=C3,,,,,,
6948,96949,"N-Amidinophosphoramidothioic acid O,O-diethyl ester",CCOP(=S)(N=C(N)N)OCC,,,,,,
6949,96950,"1,4-Naphthalenedione, 2-methoxy-3-(3-methyl-2-butenyl)-",CC(=CCC1=C(C(=O)C2=CC=CC=C2C1=O)OC)C,,,,,,
6950,96951,2-Acetamido-4-methylthiazole-5-sulfonyl chloride,CC1=C(SC(=N1)NC(=O)C)S(=O)(=O)Cl,,,,,,
6951,96952,3-Amino-4-methoxybenzenesulfonyl fluoride,COC1=C(C=C(C=C1)S(=O)(=O)F)N,,,,,,
6952,96953,"Urea, 1-(2,6-xylyl)-",CC1=C(C(=CC=C1)C)NC(=O)N,,,,,,
6953,96954,"Urea, 3-(4-tert-butylcyclohexyl)-1-(2-chloroethyl)-1-nitroso-, trans-",CC(C)(C)C1CCC(CC1)NC(=O)N(CCCl)N=O,,,,,,
6954,96955,"Benzoic acid, 4-[(phenylmethylene)amino]-, ethyl ester",CCOC(=O)C1=CC=C(C=C1)N=CC2=CC=CC=C2,,,,,,
6955,96956,N-[(4-nitrophenyl)methyl]aniline,C1=CC=C(C=C1)NCC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
6956,96957,N-Benzylidene-4-chloroaniline,C1=CC=C(C=C1)C=NC2=CC=C(C=C2)Cl,,,,,,
6957,96958,CID 96958,C1=CC(=C(N=C1)C=NN=C(N)S)O,,,,,,
6958,96959,4-Hydroxy-3-methoxy-2-nitrobenzaldehyde,COC1=C(C=CC(=C1[N+](=O)[O-])C=O)O,,,,,,
6959,96960,CID 96960,CN1C2=C(C(=O)N(C1=S)C)NC(=N2)S,,,,,,
6960,96961,CID 96961,CN1C(=C2C(=NC(=N2)S)N(C1=O)C)S,,,,,,
6961,96962,CID 96962,CN1C(=C2C(=NC(=N2)S)N(C1=S)C)S,,,,,,
6962,96963,"1,3-Dimethyl-8-(methylsulfanyl)-2-thioxo-1,2,3,7-tetrahydro-6h-purin-6-one",CN1C2=C(C(=O)N(C1=S)C)NC(=N2)SC,,,,,,
6963,96964,CID 96964,CN1C(=C2C(=NC(=N2)SC)N(C1=O)C)S,,,,,,
6964,96965,CID 96965,CN1C(=C2C(=NC(=N2)SC)N(C1=S)C)S,,,,,,
6965,96966,CID 96966,CCSC1=NC2=C(N(C(=O)N(C2=N1)C)C)S,,,,,,
6966,96967,"Theophylline, 8-ethylthio-2-thio-",CCSC1=NC2=C(N1)C(=O)N(C(=S)N2C)C,,,,,,
6967,96968,CID 96968,CN1C(=C2C(=NC(=N2)SCC=C)N(C1=O)C)S,,,,,,
6968,96969,CID 96969,CCCSC1=NC2=C(N(C(=O)N(C2=N1)C)C)S,,,,,,
6969,96970,"Theophylline, 8-propylthio-2-thio-",CCCSC1=NC2=C(N1)C(=O)N(C(=S)N2C)C,,,,,,
6970,96971,CID 96971,CCCSC1=NC2=C(N(C(=S)N(C2=N1)C)C)S,,,,,,
6971,96972,CID 96972,CCCCSC1=NC2=C(N(C(=O)N(C2=N1)C)C)S,,,,,,
6972,96973,"Theophylline, 8-butylthio-2-thio-",CCCCSC1=NC2=C(N1)C(=O)N(C(=S)N2C)C,,,,,,
6973,96974,CID 96974,CC(C)CSC1=NC2=C(N(C(=O)N(C2=N1)C)C)S,,,,,,
6974,96975,CID 96975,CCC(C)SC1=NC2=C(N(C(=O)N(C2=N1)C)C)S,,,,,,
6975,96976,CID 96976,COC1=CC=C(C=C1)C=C2C(=O)NC(=NC2=O)S,,,,,,
6976,96977,CID 96977,CCCCCSC1=NC2=C(N(C(=O)N(C2=N1)C)C)S,,,,,,
6977,96978,"Theophylline, 8-pentylthio-2-thio-",CCCCCSC1=NC2=C(N1)C(=O)N(C(=S)N2C)C,,,,,,
6978,96979,CID 96979,CN1C(=C2C(=NC(=N2)SC3CCCCC3)N(C1=O)C)S,,,,,,
6979,96980,"Theophylline, 8-cyclohexylthio-2-thio-",CN1C2=C(C(=O)N(C1=S)C)NC(=N2)SC3CCCCC3,,,,,,
6980,96981,"Theophylline, 8-hexylthio-2-thio-",CCCCCCSC1=NC2=C(N1)C(=O)N(C(=S)N2C)C,,,,,,
6981,96982,CID 96982,CCCCCCSC1=NC2=C(N(C(=O)N(C2=N1)C)C)S,,,,,,
6982,96983,CID 96983,CCCCCCCSC1=NC2=C(N(C(=O)N(C2=N1)C)C)S,,,,,,
6983,96984,2-Thio-8-(N-heptylthio)theophylline,CCCCCCCSC1=NC2=C(N1)C(=O)N(C(=S)N2C)C,,,,,,
6984,96985,"Theophylline, 8,8'-methylenebis(2-thio-",CN1C2=C(C(=O)N(C1=S)C)NC(=N2)CC3=NC4=C(N3)C(=O)N(C(=S)N4C)C,,,,,,
6985,96986,CID 96986,CCCCCCCCSC1=NC2=C(N(C(=O)N(C2=N1)C)C)S,,,,,,
6986,96987,"Theophylline, 8-octylthio-2-thio-",CCCCCCCCSC1=NC2=C(N1)C(=O)N(C(=S)N2C)C,,,,,,
6987,96988,"8,8'-Ethylenebis(2-thiotheophylline)",CN1C2=C(C(=O)N(C1=S)C)NC(=N2)CCC3=NC4=C(N3)C(=O)N(C(=S)N4C)C,,,,,,
6988,96989,CID 96989,CCCCCCCCCSC1=NC2=C(N(C(=O)N(C2=N1)C)C)S,,,,,,
6989,96990,2-Thio-8-(N-nonylthio)theophylline,CCCCCCCCCSC1=NC2=C(N1)C(=O)N(C(=S)N2C)C,,,,,,
6990,96991,"Theophylline, 8,8'-trimethylenebis(2-thio-",CN1C2=C(C(=O)N(C1=S)C)NC(=N2)CCCC3=NC4=C(N3)C(=O)N(C(=S)N4C)C,,,,,,
6991,96992,CID 96992,CCCCCCCCCCCSC1=NC2=C(N(C(=O)N(C2=N1)C)C)S,,,,,,
6992,96993,CID 96993,CCCCCCCCCCCCSC1=NC2=C(N(C(=O)N(C2=N1)C)C)S,,,,,,
6993,96994,"Dihydropyrimidine-2,4,5(3H)-trione",C1C(=O)C(=O)NC(=O)N1,,,,,,
6994,96995,"Urea, 1-(2-chloroethyl)-3-(p-(dimethylcarbamoyl)phenyl)-3-nitroso-",CN(C)C(=O)C1=CC=C(C=C1)NC(=O)N(CCCl)N=O,,,,,,
6995,96996,1-(2-Chloroethyl)-3-(1-phenylcyclohexyl)urea,C1CCC(CC1)(C2=CC=CC=C2)NC(=O)NCCCl,,,,,,
6996,96997,1-(2-Chloroethyl)-3-(1-methylcyclopentyl)-1-nitrosourea,CC1(CCCC1)NC(=O)N(CCCl)N=O,,,,,,
6997,96998,"1,4-Dimethyl-9H-carbazole",CC1=C2C3=CC=CC=C3NC2=C(C=C1)C,,,,,,
6998,96999,"N-(3,4-Dichlorobenzylidene)-2-aminoethanol",C1=CC(=C(C=C1C=NCCO)Cl)Cl,,,,,,
6999,97000,1beta-D-Arabinofuranosyl-5-methylcytosine,CC1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O,,,,,,
7000,97001,"N-(2,4-Dinitrophenyl)-DL-methionine",CSCCC(C(=O)O)NC1=C(C=C(C=C1)[N+](=O)[O-])[N+](=O)[O-],,,,,,
7001,97002,"N-(2,4-Dinitrophenyl)-DL-norleucine",CCCCC(C(=O)O)NC1=C(C=C(C=C1)[N+](=O)[O-])[N+](=O)[O-],,,,,,
7002,97003,4-Fluorobenzyl iodide,C1=CC(=CC=C1CI)F,,,,,,
7003,97004,Dimethyl acid pyrophosphate,COP(=O)(O)OP(=O)(O)OC,,,,,,
7004,97005,2-((5-Nitropyridin-2-yl)amino)ethanol,C1=CC(=NC=C1[N+](=O)[O-])NCCO,,,,,,
7005,97006,4-Chloro-N-ethyl-2-nitroaniline,CCNC1=C(C=C(C=C1)Cl)[N+](=O)[O-],,,,,,
7006,97007,"2,4,6,8-Tetrachloropyrimido[5,4-d]pyrimidine",C12=C(C(=NC(=N1)Cl)Cl)N=C(N=C2Cl)Cl,,,,,,
7007,97008,"Methanol, (trimethylsilyl)-, carbamate",C[Si](C)(C)COC(=O)N,,,,,,
7008,97009,"Carbamic acid, (butyldimethylsilyl)methyl ester",CCCC[Si](C)(C)COC(=O)N,,,,,,
7009,97010,"Methanol, (butylmethylsilylene)di-, dicarbamate (ester)",CCCC[Si](C)(COC(=O)N)COC(=O)N,,,,,,
7010,97011,CID 97011,C1=C(NC2=NC(=NC(=O)C2=N1)N)C(=O)O,,,,,,
7011,97012,3-Iodobenzylamine,C1=CC(=CC(=C1)I)CN,,,,,,
7012,97013,"Cyclohexanecarbonitrile, 1-(1-pyrrolidinyl)-",C1CCC(CC1)(C#N)N2CCCC2,,,,,,
7013,97014,"Naphtho[2,1,8,7-klmn]xanthene",C1=CC2=C3C(=C1)OC4=CC=CC5=C4C3=C(C=C2)C=C5,,,,,,
7014,97015,3-Methylbenzyl thiocyanate,CC1=CC(=CC=C1)CSC#N,,,,,,
7015,97016,Pyrrolidine-1-valeronitrile,C1CCN(C1)CCCCC#N,,,,,,
7016,97017,4-Cyanopentylmorpholine,C1COCCN1CCCCC#N,,,,,,
7017,97018,"1,4-Bis(1,2-dibromoethyl)benzene",C1=CC(=CC=C1C(CBr)Br)C(CBr)Br,,,,,,
7018,97019,Ethyl 4-hydroxy-7-(trifluoromethyl)quinoline-3-carboxylate,CCOC(=O)C1=CNC2=C(C1=O)C=CC(=C2)C(F)(F)F,,,,,,
7019,97020,(Pentafluorophenoxy)acetyl chloride,C(C(=O)Cl)OC1=C(C(=C(C(=C1F)F)F)F)F,,,,,,
7020,97021,Methyl 1-phenyl-1H-imidazole-5-carboxylate,COC(=O)C1=CN=CN1C2=CC=CC=C2,,,,,,
7021,97022,CID 97022,COC(=O)C1=CN=C(N1C2=CC=CC=C2)S,,,,,,
7022,97023,"2,3-Bis(2-pyridyl)quinoxaline",C1=CC=C2C(=C1)N=C(C(=N2)C3=CC=CC=N3)C4=CC=CC=N4,,,,,,
7023,97024,5-Chloro-2-methyl-1-phenyl-1H-benzimidazole,CC1=NC2=C(N1C3=CC=CC=C3)C=CC(=C2)Cl,,,,,,
7024,97025,CID 97025,C1=C(N2C(=NC1=O)N=CN2)N,,,,,,
7025,97026,"3,3'5,5'-Tetrachlorodiphenoquinone",C1=C(C(=O)C(=CC1=C2C=C(C(=O)C(=C2)Cl)Cl)Cl)Cl,,,,,,
7026,97027,3-Bromonaphthalen-2-amine,C1=CC=C2C=C(C(=CC2=C1)N)Br,,,,,,
7027,97028,"2-Cyclohexen-1-one, 2-methyl-5-(1-methylethenyl)-, oxime, (1E)-",CC1=CCC(CC1=NO)C(=C)C,,,,,,
7028,97029,CID 97029,CCN(CC)C1=CC=C(C=C1)C=C2C(=O)N=C(S2)S,,,,,,
7029,97030,"Heptanamide, N-((4-hydroxy-3-methoxyphenyl)methyl)-",CCCCCCC(=O)NCC1=CC(=C(C=C1)O)OC,,,,,,
7030,97031,Dibutylphosphinic acid,CCCCP(=O)(CCCC)O,,,,,,
7031,97032,"3,3',5,5'-Tetrachloro-4,4'-biphenyldiol",C1=C(C=C(C(=C1Cl)O)Cl)C2=CC(=C(C(=C2)Cl)O)Cl,,,,,,
7032,97033,"Benzenesulfonic acid, 4-[[4-(dibutylamino)phenyl]azo]-",CCCCN(CCCC)C1=CC=C(C=C1)N=NC2=CC=C(C=C2)S(=O)(=O)O,,,,,,
7033,97034,"p-Toluenesulfonamide, N-(5-isobutyl-1,3,4-thiadiazol-2-yl)-",CC1=CC=C(C=C1)S(=O)(=O)NC2=NN=C(S2)CC(C)C,,,,,,
7034,97035,N-Phenylphthalimidine,C1C2=CC=CC=C2C(=O)N1C3=CC=CC=C3,,,,,,
7035,97036,di-p-Toluoyl-L-tartaric acid,CC1=CC=C(C=C1)C(=O)OC(C(C(=O)O)OC(=O)C2=CC=C(C=C2)C)C(=O)O,,,,,,
7036,97037,9-Benzoylanthracene,C1=CC=C(C=C1)C(=O)C2=C3C=CC=CC3=CC4=CC=CC=C42,,,,,,
7037,97038,"2,4,6-Trimethylbenzoyl chloride",CC1=CC(=C(C(=C1)C)C(=O)Cl)C,,,,,,
7038,97039,Benzo[c]phenanthren-2-ol,C1=CC=C2C(=C1)C=CC3=C2C4=C(C=C3)C=CC(=C4)O,,,,,,
7039,97040,Benzo[c]phenanthren-5-ol,C1=CC=C2C(=C1)C=CC3=C2C4=CC=CC=C4C(=C3)O,,,,,,
7040,97041,"2,3-Dihydrobenzo(C)phenanthren-4(1H)-one",C1CC2=C(C=CC3=C2C4=CC=CC=C4C=C3)C(=O)C1,,,,,,
7041,97042,"Benz[a]anthracen-5-ol, 7-methyl-",CC1=C2C=C(C3=CC=CC=C3C2=CC4=CC=CC=C14)O,,,,,,
7042,97043,"Benz(a)anthracene, 7,12-dimethyl-4-fluoro-",CC1=C2C=CC3=C(C2=C(C4=CC=CC=C14)C)C=CC=C3F,,,,,,
7043,97044,"2-Naphthaldehyde, 1,4-dimethyl-3-(o-formylphenyl)-",CC1=C(C(=C(C2=CC=CC=C12)C)C3=CC=CC=C3C=O)C=O,,,,,,
7044,97045,3-Oxo-3-phenylpropanoic acid,C1=CC=C(C=C1)C(=O)CC(=O)O,,,,,,
7045,97046,"Uridine 2',3',5'-tribenzoate",C1=CC=C(C=C1)C(=O)OC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC(=O)NC3=O)OC(=O)C4=CC=CC=C4)OC(=O)C5=CC=CC=C5,,,,,,
7046,97047,1-(2-nitrophenyl)-N-[(2-nitrophenyl)methylideneamino]methanimine,C1=CC=C(C(=C1)C=NN=CC2=CC=CC=C2[N+](=O)[O-])[N+](=O)[O-],,,,,,
7047,97048,Glycyl-beta-alanine,C(CNC(=O)CN)C(=O)O,,,,,,
7048,97049,beta-Alanyl-glycyl-glycine,C(CN)C(=O)NCC(=O)NCC(=O)O,,,,,,
7049,97050,H-Pro-gly-gly-OH,C1C[C@H](NC1)C(=O)NCC(=O)NCC(=O)O,,,,,,
7050,97051,Glycyl-glycyl-proline,C1C[C@H](N(C1)C(=O)CNC(=O)CN)C(=O)O,,,,,,
7051,97052,N-(1-Glycyl-L-prolyl)-alanine,CC(C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)CN,,,,,,
7052,97053,"glycine, N-methyl-N-[(phenylmethoxy)carbonyl]-",CN(CC(=O)O)C(=O)OCC1=CC=CC=C1,,,,,,
7053,97054,Tryptophylglycine,C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)NCC(=O)O)N,,,,,,
7054,97055,CID 97055,CCCCCCSC1=NC2=C(N(C(=S)N(C2=N1)C)C)S,,,,,,
7055,97056,CID 97056,CCCCCCCSC1=NC2=C(N(C(=S)N(C2=N1)C)C)S,,,,,,
7056,97057,"Theophylline, 2-thio-8-undecylthio-",CCCCCCCCCCCSC1=NC2=C(N1)C(=O)N(C(=S)N2C)C,,,,,,
7057,97058,"Theophylline, 8-dodecylthio-2-thio-",CCCCCCCCCCCCSC1=NC2=C(N1)C(=O)N(C(=S)N2C)C,,,,,,
7058,97059,CID 97059,CN1C(=C2C(=NC(=N2)SCC3=CC=CC=N3)N(C1=O)C)S,,,,,,
7059,97060,CID 97060,CN1C(=C2C(=NC(=N2)SCC3=CN=CC=C3)N(C1=O)C)S,,,,,,
7060,97061,CID 97061,CN1C(=C2C(=NC(=N2)SCC3=CC=NC=C3)N(C1=O)C)S,,,,,,
7061,97062,CID 97062,CN1C(=C2C(=NC(=N2)SCCN3CCCCC3)N(C1=O)C)S,,,,,,
7062,97063,CID 97063,CN1C(=C2C(=NC(=N2)SCC3CCCO3)N(C1=O)C)S,,,,,,
7063,97064,"2,5-Pyrrolidinedione, 1-(phenylamino)-",C1CC(=O)N(C1=O)NC2=CC=CC=C2,,,,,,
7064,97065,"Thiocyanic acid, di-, 1,2-cyclooctylene ester, DL-(E)-",C1CCCC(C(CC1)SC#N)SC#N,,,,,,
7065,97066,"Propanedinitrile, ((2,6-dichlorophenyl)methylene)-",C1=CC(=C(C(=C1)Cl)C=C(C#N)C#N)Cl,,,,,,
7066,97067,(3-Chlorobenzylidene)propanedinitrile,C1=CC(=CC(=C1)Cl)C=C(C#N)C#N,,,,,,
7067,97068,4-Bromo-2-tert-butylphenol,CC(C)(C)C1=C(C=CC(=C1)Br)O,,,,,,
7068,97069,N-(4-tert-Butyl-2-nitrophenyl)acetamide,CC(=O)NC1=C(C=C(C=C1)C(C)(C)C)[N+](=O)[O-],,,,,,
7069,97070,"Methanone, 9H-fluoren-2-ylphenyl-",C1C2=CC=CC=C2C3=C1C=C(C=C3)C(=O)C4=CC=CC=C4,,,,,,
7070,97071,CID 97071,CC1=C(N=C(N=C1N)S)C(=O)O,,,,,,
7071,97072,6-Amino-2-hydroxy-5-methyl-4-pyrimidinecarboxylic acid,CC1=C(NC(=O)N=C1N)C(=O)O,,,,,,
7072,97073,CID 97073,CC1=C(NC(=O)N=C1S)C(=O)O,,,,,,
7073,97074,CID 97074,CC1=C(N=C(N=C1S)S)C(=O)O,,,,,,
7074,97075,N6-Benzoyladenine,C1=CC=C(C=C1)C(=O)NC2=NC=NC3=C2NC=N3,,,,,,
7075,97076,"2,3,5-Tri-O-benzyl-1-O-(4-nitrobenzoyl)-D-arabinofuranose",C1=CC=C(C=C1)COC[C@@H]2[C@H]([C@@H](C(O2)OC(=O)C3=CC=C(C=C3)[N+](=O)[O-])OCC4=CC=CC=C4)OCC5=CC=CC=C5,,,,,,
7076,97077,"N-((1,3-Dihydro-1,3-dioxo-2H-isoindol-2-yl)acetyl)-3-phenyl-DL-alanine",C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN2C(=O)C3=CC=CC=C3C2=O,,,,,,
7077,97078,N-Allyladenosine,C=CCNC1=C2C(=NC=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O,,,,,,
7078,97079,CID 97079,C1=CC(=C(N=C1)S)[N+](=O)[O-],,,,,,
7079,97080,9-Bromoellipticine,CC1=C2C=CN=CC2=C(C3=C1NC4=C3C=C(C=C4)Br)C,,,,,,
7080,97081,"5-Phenyl-1,2,4-triazin-3-amine",C1=CC=C(C=C1)C2=CN=NC(=N2)N,,,,,,
7081,97082,"6H-Pyrido(4,3-b)carbazole, 5,9,11-trimethyl-",CC1=CC2=C(C=C1)NC3=C2C(=C4C=NC=CC4=C3C)C,,,,,,
7082,97083,"1,3-Bis(4-chlorophenyl)propane-1,3-dione",C1=CC(=CC=C1C(=O)CC(=O)C2=CC=C(C=C2)Cl)Cl,,,,,,
7083,97084,Tripiperidinophosphine,C1CCN(CC1)P(N2CCCCC2)N3CCCCC3,,,,,,
7084,97085,Tricyclohexyltin bromide,C1CCC(CC1)[Sn](C2CCCCC2)(C3CCCCC3)Br,,,,,,
7085,97086,"Stannane, bis(2-methyl-2-phenylpropyl)oxo-",CC(C)(C[Sn](=O)CC(C)(C)C1=CC=CC=C1)C2=CC=CC=C2,,,,,,
7086,97087,"Stannane, tetrakis(2-methyl-2-phenylpropyl)-",CC(C)(C[Sn](CC(C)(C)C1=CC=CC=C1)(CC(C)(C)C2=CC=CC=C2)CC(C)(C)C3=CC=CC=C3)C4=CC=CC=C4,,,,,,
7087,97088,"1-Propanethiol, 3-(diethylamino)-",CCN(CC)CCCS,,,,,,
7088,97089,CID 97089,CCCC[SnH](CCCC)CCCC.CCC(=O)O,,,,,,
7089,97090,CID 97090,CCCC[SnH](CCCC)CCCC.C=CCCCCCCCCC(=O)O,,,,,,
7090,97091,2-(4-Chlorophenoxy)acetamide,C1=CC(=CC=C1OCC(=O)N)Cl,,,,,,
7091,97092,Deacetylamino-7-oxocolchicine,COC1=CC=C2C(=CC1=O)C(=O)CCC3=CC(=C(C(=C32)OC)OC)OC,,,,,,
7092,97093,"Cyclopentanecarboxylic acid, 1-(3-(2-chloroethyl)-3-nitrosoureido)-, ethyl ester",CCOC(=O)C1(CCCC1)NC(=O)N(CCCl)N=O,,,,,,
7093,97094,CID 97094,C1=CN(C2=C1C(=O)N=CN2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O,,,,,,
7094,97095,"Diazene, bis(3-bromophenyl)-, 1-oxide",C1=CC(=CC(=C1)Br)N=[N+](C2=CC(=CC=C2)Br)[O-],,,,,,
7095,97096,CID 97096,CN1C(=C2C(=NC(=N2)SCCN3CCCC3)N(C1=O)C)S,,,,,,
7096,97097,CID 97097,CN1C(=C2C(=NC(=N2)SCCN)N(C1=O)C)S,,,,,,
7097,97098,"Theophylline, 8-((2-pyridylmethyl)thio)-2-thio-",CN1C2=C(C(=O)N(C1=S)C)NC(=N2)SCC3=CC=CC=N3,,,,,,
7098,97099,"Theophylline, 8-((3-pyridylmethyl)thio)-2-thio-",CN1C2=C(C(=O)N(C1=S)C)NC(=N2)SCC3=CN=CC=C3,,,,,,
7099,97100,CID 97100,CC(=O)CSC1=NC2=C(N(C(=O)N(C2=N1)C)C)S,,,,,,
7100,97101,2-Allylanisole,COC1=CC=CC=C1CC=C,,,,,,
7101,97102,N-[benzyl(phenyl)-lambda4-sulfanylidene]-4-methylbenzenesulfonamide,CC1=CC=C(C=C1)S(=O)(=O)N=S(CC2=CC=CC=C2)C3=CC=CC=C3,,,,,,
7102,97103,6-Cyclopentylthio-9-hydroxymethylpurine,C1CCC(C1)SC2=NC=NC3=C2N=CN3CO,,,,,,
7103,97104,"Pyrimidine, 5-amino-6-chloro-4-(phenethylamino)-",C1=CC=C(C=C1)CCNC2=C(C(=NC=N2)Cl)N,,,,,,
7104,97105,Cyclohexylideneacetonitrile,C1CCC(=CC#N)CC1,,,,,,
7105,97106,"2-[(4,6-Dichloro-1,3,5-triazin-2-yl)amino]ethanol",C(CO)NC1=NC(=NC(=N1)Cl)Cl,,,,,,
7106,97107,"6-Methyl-2,3-dihydro-2-phenyl-1H-1,3,2-benzothiazaphosphole-2-sulfide",CC1=CC2=C(C=C1)NP(=S)(S2)C3=CC=CC=C3,,,,,,
7107,97108,"1,3,2-Benzothiazaphospholine, 5-chloro-2-phenyl-, 2-sulfide",C1=CC=C(C=C1)P2(=S)NC3=C(S2)C=CC(=C3)Cl,,,,,,
7108,97109,"Ellipticine, 6-methyl",CC1=C2C=CN=CC2=C(C3=C1N(C4=CC=CC=C43)C)C,,,,,,
7109,97110,2-Naphthoylmethyl thiocyanate,C1=CC=C2C=C(C=CC2=C1)C(=O)CSC#N,,,,,,
7110,97111,"2(3H)-Furanone, 3-(triphenylphosphoranylidene)-",C1COC(=O)C1=P(C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4,,,,,,
7111,97112,CID 97112,C1OC2=C(O1)C=C(C=C2)C3=COC4=CC(=O)C=CC4=C3O,,,,,,
7112,97113,4-Chloro-2-methylthiopyrimidine,CSC1=NC=CC(=N1)Cl,,,,,,
7113,97114,p-(Salicylideneamino)benzoic acid,C1=CC=C(C(=C1)C=NC2=CC=C(C=C2)C(=O)O)O,,,,,,
7114,97115,"3,5-Dimethyl-4-iodopyrazole",CC1=C(C(=NN1)C)I,,,,,,
7115,97116,"3,4,5-Trimethoxy-2-nitrobenzoic acid",COC1=C(C(=C(C(=C1)C(=O)O)[N+](=O)[O-])OC)OC,,,,,,
7116,97117,S-phenyl benzenecarbothioate,C1=CC=C(C=C1)C(=O)SC2=CC=CC=C2,,,,,,
7117,97118,O-Methyltyrosine,COC1=CC=C(C=C1)CC(C(=O)O)N,,,,,,
7118,97119,8-Amino-2'-deoxyadenosine,C1[C@@H]([C@H](O[C@H]1N2C3=NC=NC(=C3N=C2N)N)CO)O,,,,,,
7119,97120,"Propionic acid, 3-(1-aziridinyl)-, decyl ester",CCCCCCCCCCOC(=O)CCN1CC1,,,,,,
7120,97121,"2,6-Bis(1-aziridinyl)-2,6-dimethyl-4-heptanone",CC(C)(CC(=O)CC(C)(C)N1CC1)N2CC2,,,,,,
7121,97122,"s-Triazine, 4,6-dichloro-2-(N-methoxy-N-methylamino)-",CN(C1=NC(=NC(=N1)Cl)Cl)OC,,,,,,
7122,97123,"Urea, 1-(2-chloroethyl)-1-nitroso-3-(5,6,7,8-tetrahydro-2-naphthyl)-",C1CCC2=C(C1)C=CC(=C2)NC(=O)N(CCCl)N=O,,,,,,
7123,97124,"5-(4-Chlorophenyl)imidazolidine-2,4-dione",C1=CC(=CC=C1C2C(=O)NC(=O)N2)Cl,,,,,,
7124,97125,"5-(3,4-Dimethoxyphenyl)hydantoin",COC1=C(C=C(C=C1)C2C(=O)NC(=O)N2)OC,,,,,,
7125,97126,3-((2-Pyridylmethylene)amino)quinoline,C1=CC=C2C(=C1)C=C(C=N2)N=CC3=CC=CC=N3,,,,,,
7126,97127,3-((3-Pyridylmethylene)amino)quinoline,C1=CC=C2C(=C1)C=C(C=N2)N=CC3=CN=CC=C3,,,,,,
7127,97128,3-((4-Pyridylmethylene)amino)quinoline,C1=CC=C2C(=C1)C=C(C=N2)N=CC3=CC=NC=C3,,,,,,
7128,97129,2-(N-3-Pyridylformimidoyl)quinoline,C1=CC=C2C(=C1)C=CC(=N2)C=NC3=CN=CC=C3,,,,,,
7129,97130,"2-Propanol, 1,3-diphthalimido-",C1=CC=C2C(=C1)C(=O)N(C2=O)CC(CN3C(=O)C4=CC=CC=C4C3=O)O,,,,,,
7130,97131,"(2R,3S,4R,5R)-2-(Hydroxymethyl)-5-(6-methyl-9H-purin-9-yl)tetrahydrofuran-3,4-diol",CC1=C2C(=NC=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O,,,,,,
7131,97132,"5,8-Dinitro-6-methoxyquinaldine",CC1=NC2=C(C=C1)C(=C(C=C2[N+](=O)[O-])OC)[N+](=O)[O-],,,,,,
7132,97133,CID 97133,C1CCN(CC1)CC2=C(C(=O)N=C(N2)C3=CC=CC=C3)O,,,,,,
7133,97134,"3,7-Dihydro-1,3-dimethyl-8-heptyl-1H-purine-2,6-dione",CCCCCCCC1=NC2=C(N1)C(=O)N(C(=O)N2C)C,,,,,,
7134,97135,8-Cyclopropyltheophylline,CN1C2=C(C(=O)N(C1=O)C)NC(=N2)C3CC3,,,,,,
7135,97136,8-Cyclobutyltheophylline,CN1C2=C(C(=O)N(C1=O)C)NC(=N2)C3CCC3,,,,,,
7136,97137,8-(2-Cyclopentylethyl)theophylline,CN1C2=C(C(=O)N(C1=O)C)NC(=N2)CCC3CCCC3,,,,,,
7137,97138,8-(2-Norbornyl)theophylline,CN1C2=C(C(=O)N(C1=O)C)NC(=N2)C3CC4CCC3C4,,,,,,
7138,97139,"1,4-Epoxy-1,4-dihydronaphthalene",C1=CC=C2C3C=CC(C2=C1)O3,,,,,,
7139,97140,"1,3-diphenyl-2H-cyclopenta[l]phenanthren-2-one",C1=CC=C(C=C1)C2=C3C4=CC=CC=C4C5=CC=CC=C5C3=C(C2=O)C6=CC=CC=C6,,,,,,
7140,97141,3-Hydroxy-4'-methoxyflavone,COC1=CC=C(C=C1)C2=C(C(=O)C3=CC=CC=C3O2)O,,,,,"['3-Hydroxy-4p-methoxyflavone has known human metabolites that include (2S,3S,4S,5R)-3,4,5-trihydroxy-6-[2-(4-methoxyphenyl)-4-oxochromen-3-yl]oxyoxane-2-carboxylic acid.']",
7141,97142,"3-Hydroxy-3',4',5,7-tetramethoxyflavone",COC1=C(C=C(C=C1)C2=C(C(=O)C3=C(O2)C=C(C=C3OC)OC)O)OC,,,,,,
7142,97143,"3-Hydroxy-3',4'-dimethoxyflavone",COC1=C(C=C(C=C1)C2=C(C(=O)C3=CC=CC=C3O2)O)OC,,,,,,
7143,97144,"2,10b-dihydro-1H-fluoranthen-3-one",C1CC(=O)C2=CC=CC3=C2C1C4=CC=CC=C34,,,,,,
7144,97145,CID 97145,C=CCN=C(NC1=CC(=CC=C1)[N+](=O)[O-])S,,,,,,
7145,97146,"Urea, 1,1'-hexamethylenebis(3,3'-benzenesulfonyl-",C1=CC=C(C=C1)S(=O)(=O)NC(=O)NCCCCCCNC(=O)NS(=O)(=O)C2=CC=CC=C2,,,,,,
7146,97147,CID 97147,COC1=CC=CC=C1C=C2C(=O)N=C(S2)S,,,,,,
7147,97148,CID 97148,C1=CC=C2C(=C1)C(=CC3=C(N=C(S3)S)O)C=N2,,,,,,
7148,97149,1-(2-Chloroethyl)-3-mesitylurea,CC1=CC(=C(C(=C1)C)NC(=O)NCCCl)C,,,,,,
7149,97150,3'-Chloro-2-((m-chlorophenyl)imino)cyclopentanecarboxanilide,C1CC(C(=NC2=CC(=CC=C2)Cl)C1)C(=O)NC3=CC(=CC=C3)Cl,,,,,,
7150,97151,Linderoflavone B,COC1=C(C(=C(C2=C1C(=O)C=C(O2)C3=CC4=C(C=C3)OCO4)OC)OC)OC,,,,,,
7151,97152,"Plumbane, (4-bromobutyl)triphenyl-",C1=CC=C(C=C1)[Pb](CCCCBr)(C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
7152,97153,"2-(1-(4-Triphenylplumbylbutyl)-1H-1,2,3-triazol-5-yl)-2-propanol",CC(C)(C1=CN=NN1CCCC[Pb](C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4)O,,,,,,
7153,97154,9h-Fluoren-2-ylurea,C1C2=CC=CC=C2C3=C1C=C(C=C3)NC(=O)N,,,,,,
7154,97155,"2,6-Dichloro-3-nitrotoluene",CC1=C(C=CC(=C1Cl)[N+](=O)[O-])Cl,,,,,,
7155,97156,"Phosphoramidic acid, (1-methylethyl)-, diethyl ester",CCOP(=O)(NC(C)C)OCC,,,,,,
7156,97157,CID 97157,CC[PbH](CC)CC.CC(=O)O,,,,,,
7157,97158,5-Nitro-2-piperidinopyridine,C1CCN(CC1)C2=NC=C(C=C2)[N+](=O)[O-],,,,,,
7158,97159,CID 97159,CCC[PbH](CCC)CCC.CC(=O)O,,,,,,
7159,97160,Ethyl 8-chloro-4-hydroxyquinoline-3-carboxylate,CCOC(=O)C1=CNC2=C(C1=O)C=CC=C2Cl,,,,,,
7160,97161,CID 97161,CC(=O)O.CC(=O)O.CC(=O)O.C1=CC=C(C=C1)[PbH],,,,,,
7161,97162,CID 97162,C1=CC=C(C=C1)[PbH],,,,,,
7162,97163,CID 97163,CCCC[PbH](CCCC)CCCC.C1=CN=C[N-]1,,,,,,
7163,97164,CID 97164,CCCC[SnH](CCCC)CCCC.C(C(=O)O)Cl,,,,,,
7164,97165,"D-galactono-1,4-lactone",C([C@H]([C@H]1[C@@H]([C@H](C(=O)O1)O)O)O)O,,,,,,
7165,97166,Diethyl N-hexylamidophosphate,CCCCCCNP(=O)(OCC)OCC,,,,,,
7166,97167,Lumogallion,C1=CC(=C(C=C1O)O)N=NC2=C(C(=CC(=C2)Cl)S(=O)(=O)O)O,,,,,,
7167,97168,1-(p-Fluorophenyl)-N-methylcyclohexylamine,CNC1(CCCCC1)C2=CC=C(C=C2)F,,,,,,
7168,97169,6-(3-Methoxypropyl)-8-oxa-6-azabicyclo[3.2.1]octane,COCCCN1CC2CCCC1O2,,,,,,
7169,97170,6-Butyl-8-oxa-6-azabicyclo[3.2.1]octane,CCCCN1CC2CCCC1O2,,,,,,
7170,97171,"8-Oxa-6-azabicyclo(3.2.1)octane, 6-(2-hydroxyethyl)-",C1CC2CN(C(C1)O2)CCO,,,,,,
7171,97172,"Urea, 1-(2-chloroethyl)-3-mesityl-1-nitroso-",CC1=CC(=C(C(=C1)C)NC(=O)N(CCCl)N=O)C,,,,,,
7172,97173,CID 97173,CC(=O)C(=NNC1=CC=CC=C1)C(=O)C,,,,,,
7173,97174,"[9,9'-Bianthracene]-10,10'(9H,9'H)-dione",C1=CC=C2C(=C1)C(C3=CC=CC=C3C2=O)C4C5=CC=CC=C5C(=O)C6=CC=CC=C46,,,,,,
7174,97175,CID 97175,CCCC[SnH](CCCC)CCCC.C1=CC(=C(C=C1Cl)Cl)O,,,,,,
7175,97176,Canthin-6-one,C1=CC=C2C(=C1)C3=C4N2C(=O)C=CC4=NC=C3,,,"['Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)']",,,
7176,97177,"(2S,3S,4S,5R,6R)-6-[(S)-cyano(phenyl)methoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid",C1=CC=C(C=C1)[C@@H](C#N)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C(=O)O)O)O)O,,,,,,
7177,97178,1-Methylcyclooctanol,CC1(CCCCCCC1)O,,,,,,
7178,97179,2-Iodopyridin-3-ol,C1=CC(=C(N=C1)I)O,,,,,,
7179,97180,Phenyl 3-phenylpropyl sulfone,C1=CC=C(C=C1)CCCS(=O)(=O)C2=CC=CC=C2,,,,,,
7180,97181,"p-Benzoquinone, 3,6-bis(octadecylamino)-2,5-dichloro-",CCCCCCCCCCCCCCCCCCNC1=C(C(=O)C(=C(C1=O)Cl)NCCCCCCCCCCCCCCCCCC)Cl,,,,,,
7181,97182,CID 97182,C1[C@@H]([C@H]([C@H]([C@@H]1N2C=NC3=C2NC=NC3=O)O)O)CO,,,,,,
7182,97183,1-(2-Chloroethyl)-1-nitroso-3-(tetrahydro-2H-thiopyran-4-yl)urea,C1CSCCC1NC(=O)N(CCCl)N=O,,,,,,
7183,97184,9-(2-Deoxy-beta-D-ribofuranosyl)-6-methylpurine,CC1=C2C(=NC=N1)N(C=N2)[C@H]3C[C@@H]([C@H](O3)CO)O,,,,,,
7184,97185,Ara-ata,CC(=O)OC[C@@H]1[C@H]([C@@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)OC(=O)C)OC(=O)C,,,,,,
7185,97186,5-Bromotubercidin,C1=C(C2=C(N=CN=C2N1[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N)Br,,,,,,
7186,97187,"2H-1,2,6-Thiadiazine, 3,4-dihydro-3,3,5-trimethyl-, 1,1-dioxide",CC1=NS(=O)(=O)NC(C1)(C)C,,,,,,
7187,97188,2-Amino-2'-deoxyadenosine,C1[C@@H]([C@H](O[C@H]1N2C=NC3=C(N=C(N=C32)N)N)CO)O,,,,,,
7188,97189,"1-(2-Chloroethyl)-3-(alpha,alpha-dimethylphenethyl)-1-nitrosourea",CC(C)(CC1=CC=CC=C1)NC(=O)N(CCCl)N=O,,,,,,
7189,97190,"2,4-Dichloro-6-(N,N-diallylamino)-1,3,5-triazine",C=CCN(CC=C)C1=NC(=NC(=N1)Cl)Cl,,,,,,
7190,97191,6-(Hydroxymethyl)uracil,C1=C(NC(=O)NC1=O)CO,,,,,,
7191,97192,"Acetanilide, 2'-chloro-2-(dichlorophenoxy)-5'-trifluoromethyl-",C1=CC(=C(C=C1C(F)(F)F)NC(=O)COC2=C(C=C(C=C2)Cl)Cl)Cl,,,,,,
7192,97193,4-Amino-4'-cyanobiphenyl,C1=CC(=CC=C1C#N)C2=CC=C(C=C2)N,,,,,,
7193,97194,"3,10-Perylenedione",C1=CC2=C3C=CC=C4C3=C(C=CC4=O)C5=C2C(=C1)C(=O)C=C5,,,,,,
7194,97195,CID 97195,CCN(CC)CCN=C(NC1=CC=CC=C1)S,,,,,,
7195,97196,CID 97196,C1COCCN1CCN=C(NC2=CC=CC=C2)S,,,,,,
7196,97197,"Urea, 1-(2-chloroethyl)-1-nitroso-3-(tetrahydro-2H-thiopyran-4-yl)-, S,S-dioxide",C1CS(=O)(=O)CCC1NC(=O)N(CCCl)N=O,,,,,,
7197,97198,"Semicarbazide, 4,4',4''-phosphinylidynetris(1-phenyl-",C1=CC=C(C=C1)NNC(=O)NP(=O)(NC(=O)NNC2=CC=CC=C2)NC(=O)NNC3=CC=CC=C3,,,,,,
7198,97199,"(2R,4R,5R)-2-(hydroxymethyl)-5-(4-methylsulfanylpyrrolo[2,3-d]pyrimidin-7-yl)oxolane-3,4-diol",CSC1=NC=NC2=C1C=CN2[C@H]3[C@@H](C([C@H](O3)CO)O)O,,,,,,
7199,97200,CID 97200,C1=C(C2=C(N=CN=C2N1[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N)C(=N)S,,,,,,
7200,97201,"3,5-Pyridinedicarboxylic acid, 1,4-dihydro-4-(p-methoxyphenyl)-2,6-dimethyl-, diethyl ester",CCOC(=O)C1=C(NC(=C(C1C2=CC=C(C=C2)OC)C(=O)OCC)C)C,,,,,,
7201,97202,4-[(Dimethylhydrazinylidene)methyl]phenol,CN(C)N=CC1=CC=C(C=C1)O,,,,,,
7202,97203,CID 97203,C1=CC=C2C(=C1)C=C3C(=NC(=O)NC3=O)N2,,,,,,
7203,97204,"4,4'-Methylenebis(3-nitroaniline)",C1=CC(=C(C=C1N)[N+](=O)[O-])CC2=C(C=C(C=C2)N)[N+](=O)[O-],,,,,,
7204,97205,"Pyridine, 3-((o-chlorophenyl)azo)-2,6-diamino-",C1=CC=C(C(=C1)N=NC2=C(N=C(C=C2)N)N)Cl,,,,,,
7205,97206,"2,6-Diamino-3-((2,5-dichlorophenyl)azo)pyridine",C1=CC(=C(C=C1Cl)N=NC2=C(N=C(C=C2)N)N)Cl,,,,,,
7206,97207,8-(3-Cyclohexen-1-yl)theophylline,CN1C2=C(C(=O)N(C1=O)C)NC(=N2)C3CCC=CC3,,,,,,
7207,97208,"Theophylline, 8-(1-cyclohexen-1-ylmethyl)-",CN1C2=C(C(=O)N(C1=O)C)NC(=N2)CC3=CCCCC3,,,,,,
7208,97209,"8-[2-(1,3-benzodioxol-5-yl)ethenyl]-1,3-dimethyl-7H-purine-2,6-dione",CN1C2=C(C(=O)N(C1=O)C)NC(=N2)C=CC3=CC4=C(C=C3)OCO4,,,,,,
7209,97210,1-((4-Methylphenyl)azo)-2-naphthalenol,CC1=CC=C(C=C1)N=NC2=C(C=CC3=CC=CC=C32)O,,,,,,
7210,97211,CID 97211,C1=CC=C2C(=C1)C3=C(C2=NO)C=C(C=C3)N,,,,,,
7211,97212,"9H-fluoren-2-amine, 3-(methylthio)-",CSC1=C(C=C2CC3=CC=CC=C3C2=C1)N,,,,,,
7212,97213,Psilostachyin C,CC1CCC2C(C3(C1CCC(=O)O3)C)OC(=O)C2=C,,,,,,
7213,97214,Eupatorin,COC1=C(C=C(C=C1)C2=CC(=O)C3=C(C(=C(C=C3O2)OC)OC)O)O,,,,,,
7214,97215,"(6,10-Dimethyl-3-methylidene-2-oxo-3a,4,5,8,9,11a-hexahydrocyclodeca[b]furan-4-yl) acetate",CC1=CC2C(C(CC(=CCC1)C)OC(=O)C)C(=C)C(=O)O2,,,,,,
7215,97216,"Urea, 1-(2-chloroethyl)-3-(m-tolyl)-",CC1=CC(=CC=C1)NC(=O)NCCCl,,,,,,
7216,97217,CID 97217,CO[C@@H]1[C@H](O[C@H]([C@@H]1O)N2C=NC3=C2NC(=NC3=O)N)CO,,,,,,
7217,97218,CID 97218,CC1=CC(=O)N=C(N1)N2CCOCC2,,,,,,
7218,97219,CID 97219,C([C@H]([C@H]([C@@H]([C@H](C=NN=C(N)S)O)O)O)O)O,,,,,,
7219,97220,"Urea, 1-(2-chloroethyl)-1-nitroso-3-(p-tolylsulfonyl)-",CC1=CC=C(C=C1)S(=O)(=O)NC(=O)N(CCCl)N=O,,,,,,
7220,97221,"1H-Indene-1,3(2H)-dione, 2-(2,4,6-trimethylphenyl)-",CC1=CC(=C(C(=C1)C)C2C(=O)C3=CC=CC=C3C2=O)C,,,,,,
7221,97222,"2-Chloro-4-oxo-4H-pyrido[1,2-a]pyrimidine-3-carbaldehyde",C1=CC2=NC(=C(C(=O)N2C=C1)C=O)Cl,,,,,,
7222,97223,2-Allyl-2-(p-methoxyphenyl)-4-pent-1-enamide,COC1=CC=C(C=C1)C(CC=C)(CC=C)C(=O)N,,,,,,
7223,97224,"Urea, 1-(2-fluoroethyl)-1-nitroso-3-(tetrahydro-2H-thiopyran-4-yl)-, S,S-dioxide",C1CS(=O)(=O)CCC1NC(=O)N(CCF)N=O,,,,,,
7224,97225,CID 97225,CN1C2=NN=NC(=O)C2=CN1,,,,,,
7225,97226,10-Hydroxycamptothecin,CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=C(C3=C2)N=C5C=CC(=CC5=C4)O)O,,,"['Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. (See all compounds classified as Antineoplastic Agents, Phytogenic.)']",,,
7226,97227,Ethylaminopterin,CCN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,,,,,,
7227,97228,Adenopterin,CC(C1=CN=C2C(=N1)C(=NC(=N2)N)N)N(C)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,,,,,,
7228,97229,"N-2-Benzothiazolyl-2,2,2-trifluoroacetamide",C1=CC=C2C(=C1)N=C(S2)NC(=O)C(F)(F)F,,,,,,
7229,97230,"Piperazine, 1,4-bis(2-(2-pyridyl)ethyl)-",C1CN(CCN1CCC2=CC=CC=N2)CCC3=CC=CC=N3,,,,,,
7230,97231,"Acridine-9-carboxamide, 1,2,3,4-tetrahydro-N-(2-(diethylamino)ethyl)-",CCN(CC)CCNC(=O)C1=C2CCCCC2=NC3=CC=CC=C31,,,,,,
7231,97232,"Piperazine, 1-(3-amino-5-bromo-4-pyridyl)-4-(p-tolyl)-",CC1=CC=C(C=C1)N2CCN(CC2)C3=C(C=NC=C3N)Br,,,,,,
7232,97233,5-Bromo-2-nitrobenzaldehyde,C1=CC(=C(C=C1Br)C=O)[N+](=O)[O-],,,,,,
7233,97234,2-Nitrobenzimidazole,C1=CC=C2C(=C1)NC(=N2)[N+](=O)[O-],,,,,,
7234,97235,"7beta-D-Ribofuranosylpyrrolo-(2,3-d)pyrimidine",C1=CN(C2=NC=NC=C21)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O,,,,,,
7235,97236,"1-(2-Chloroethyl)-3-(3,4-dichlorophenyl)urea",C1=CC(=C(C=C1NC(=O)NCCCl)Cl)Cl,,,,,,
7236,97237,"9H-Fluoren-9-one, 1-chloro-",C1=CC=C2C(=C1)C3=C(C2=O)C(=CC=C3)Cl,,,,,,
7237,97238,"2,7-Diamino-9H-fluoren-9-one",C1=CC2=C(C=C1N)C(=O)C3=C2C=CC(=C3)N,,,,,,
7238,97239,N-(2-Methoxy-5-nitrophenyl)acetamide,CC(=O)NC1=C(C=CC(=C1)[N+](=O)[O-])OC,,,,,,
7239,97240,3-Nitrophenanthrene,C1=CC=C2C(=C1)C=CC3=C2C=C(C=C3)[N+](=O)[O-],,,,,,
7240,97241,"6-(dimethylamino)-6H-1,2,4-triazine-3,5-dione",CN(C)C1C(=O)NC(=O)N=N1,,,,,,
7241,97242,"6-(Butylthio)-as-triazine-3,5(2H,4H)-dione",CCCCSC1C(=O)NC(=O)N=N1,,,,,,
7242,97243,5-Hexylthio-6-azauracil,CCCCCCSC1C(=O)NC(=O)N=N1,,,,,,
7243,97244,"6-(Prop-2-en-1-ylsulfanyl)-1,2,4-triazine-3,5(4h,6h)-dione",C=CCSC1C(=O)NC(=O)N=N1,,,,,,
7244,97245,5-Phenylthio-6-azauracil,C1=CC=C(C=C1)SC2C(=O)NC(=O)N=N2,,,,,,
7245,97246,"6-((5-Amino-1,3,4-thiadiazol-2-yl)thio)-as-triazine-3,5(2H,4H)-dione",C1(C(=O)NC(=O)N=N1)SC2=NN=C(S2)N,,,,,,
7246,97247,CID 97247,CC1=CC=CC=C1CC2=C3C(=C4C=CC=CC4=N3)C=CN2,,,,,,
7247,97248,Dimethylaminoethanethiol S-sulfate,CN(C)CCSS(=O)(=O)O,,,,,,
7248,97249,3-(Bromomethyl)benzonitrile,C1=CC(=CC(=C1)C#N)CBr,,,,,,
7249,97250,"2,8-Quinolinediol",C1=CC2=C(C(=C1)O)NC(=O)C=C2,,,,,"['2,8-Dihydroxyquinoline has known human metabolites that include 2,8-Dihydroxyquinoline-beta-D-glucuronide.']",
7250,97251,CID 97251,C1=C2C(=CC(=O)C=C2OC(=C1)O)O,,,,,,
7251,97252,"1,4-Dimethylquinolin-2(1h)-one",CC1=CC(=O)N(C2=CC=CC=C12)C,,,,,,
7252,97253,"2,4,5-Trichlorophenyl 3-phenyl-N-((phenylmethoxy)carbonyl)-L-alaninate",C1=CC=C(C=C1)C[C@@H](C(=O)OC2=CC(=C(C=C2Cl)Cl)Cl)NC(=O)OCC3=CC=CC=C3,,,,,,
7253,97254,"Phenethylamine, N,N-bis(2-chloroethyl)-",C1=CC=C(C=C1)CCN(CCCl)CCCl,,,,,,
7254,97255,"1,3-Propanediol, 2,2-diphenyl-, carbamate",C1=CC=C(C=C1)C(CO)(COC(=O)N)C2=CC=CC=C2,,,,,,
7255,97256,"1,3-Propanediol, 2,2-diphenyl-, dicarbamate",C1=CC=C(C=C1)C(COC(=O)N)(COC(=O)N)C2=CC=CC=C2,,,,,,
7256,97257,2-Hydroxyterephthalic acid,C1=CC(=C(C=C1C(=O)O)O)C(=O)O,,,,,,
7257,97258,1-Methoxy-3-methyl-3-phospholene 1-oxide,CC1=CCP(=O)(C1)OC,,,,,,
7258,97259,"Phthalamic acid, N-(p-fluorophenyl)-",C1=CC=C(C(=C1)C(=O)NC2=CC=C(C=C2)F)C(=O)O,,,,,,
7259,97260,"9-Methoxy-5,6,11-trimethylpyrido[4,3-b]carbazole",CC1=C2C=CN=CC2=C(C3=C1N(C4=C3C=C(C=C4)OC)C)C,,,,,,
7260,97261,7-Fluoro-3-(methylsulfanyl)-9h-fluoren-2-amine,CSC1=C(C=C2CC3=C(C2=C1)C=CC(=C3)F)N,,,,,,
7261,97262,"Acetamide, N-(7-fluoro-3-(methylthio)fluoren-2-yl)-",CC(=O)NC1=C(C=C2C(=C1)CC3=C2C=CC(=C3)F)SC,,,,,,
7262,97263,"N-Acetyl-4,4'-diaminodiphenylmethane",CC(=O)NC1=CC=C(C=C1)CC2=CC=C(C=C2)N,,,,,,
7263,97264,4-Methylbenzo[h]quinoline,CC1=C2C=CC3=CC=CC=C3C2=NC=C1,,,,,,
7264,97265,1-Methylbenzo[f]quinoline,CC1=C2C(=NC=C1)C=CC3=CC=CC=C32,,,,,,
7265,97266,3-Acetoxy-2-pyridone,CC(=O)OC1=CC=CNC1=O,,,,,,
7266,97267,2-Amino-4-morpholino-s-triazine,C1COCCN1C2=NC=NC(=N2)N,,,,,,
7267,97268,"Di-tert-butyl diazene-1,2-dicarboxylate",CC(C)(C)OC(=O)N=NC(=O)OC(C)(C)C,,,,,,
7268,97269,1-(4-Acetylphenyl)piperazine,CC(=O)C1=CC=C(C=C1)N2CCNCC2,,,,,,
7269,97270,"5,6-Acenaphthenedicarboxylic acid",C1CC2=CC=C(C3=C(C=CC1=C23)C(=O)O)C(=O)O,,,,,,
7270,97271,"3,6-Diacetyl-acenaphthene",CC(=O)C1=C2CCC3=C2C(=C(C=C3)C(=O)C)C=C1,,,,,,
7271,97272,5-Deazaaminopterin,C1=CC(=CC=C1C(=O)N[C@@H](CCC(=O)O)C(=O)O)NCC2=CC3=C(N=C(N=C3N=C2)N)N,,,"['Inhibitors of the enzyme, dihydrofolate reductase (TETRAHYDROFOLATE DEHYDROGENASE), which converts dihydrofolate (FH2) to tetrahydrofolate (FH4). They are frequently used in cancer chemotherapy. (From AMA, Drug Evaluations Annual, 1994, p2033) (See all compounds classified as Folic Acid Antagonists.)']",,,
7272,97273,"2-Amino-1,2,3,4-tetrahydroisoquinoline-1,3-dione",C1C2=CC=CC=C2C(=O)N(C1=O)N,,,,,,
7273,97274,"Phosphinic amide, P,P-bis(1-aziridinyl)-N-phenyl-N-2-propenyl-",C=CCN(C1=CC=CC=C1)P(=O)(N2CC2)N3CC3,,,,,,
7274,97275,2-Thiophenecarbaldehyde oxime,C1=CSC(=C1)C=NO,,,,,,
7275,97276,3-Acetyl-6-hydroxy-4-methyl-2-pyridone,CC1=CC(=O)NC(=C1C(=O)C)O,,,,,,
7276,97277,CID 97277,C1=CC(=C(C=C1Cl)C=NN=C(N)S)O,,,,,,
7277,97278,"Acetamide, N-[4-[(dimethylamino)sulfonyl]phenyl]-",CC(=O)NC1=CC=C(C=C1)S(=O)(=O)N(C)C,,,,,,
7278,97279,3-Hydrazinopropionic acid,C(CNN)C(=O)O,,,,,,
7279,97280,"1,1,2,2-Tetrachloro-1,2-dinitroethane",C(C([N+](=O)[O-])(Cl)Cl)([N+](=O)[O-])(Cl)Cl,,,,,,
7280,97281,N-(Phenylsulphonyl)sulphanilamide,C1=CC=C(C=C1)S(=O)(=O)NS(=O)(=O)C2=CC=C(C=C2)N,,,,,,
7281,97282,2-[2-(Diaminomethylidenehydrazinylidene)ethylideneamino]guanidine,C(=NN=C(N)N)C=NN=C(N)N,,,,,,
7282,97283,10-Methoxycamptothecin,CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=C(C3=C2)N=C5C=CC(=CC5=C4)OC)O,,,,,,
7283,97284,"Ethanediamide, hydroxy-",C(=O)(C(=O)NO)N,,,,,,
7284,97285,"N,N'-Octamethylenebis(1-aziridinecarboxamide)",C1CN1C(=O)NCCCCCCCCNC(=O)N2CC2,,,,,,
7285,97286,"Phenol, 4-[[(4-methoxyphenyl)methylene]amino]-",COC1=CC=C(C=C1)C=NC2=CC=C(C=C2)O,,,,,,
7286,97287,Diethyl 3-(((carboxyamino)(3-methoxyureido)phosphinyl)carbamoyl)carbazate,CCOC(=O)NNC(=O)NP(=O)(NC(=O)NOC)NC(=O)OCC,,,,,,
7287,97288,Ethyl (bis(3-methoxyureido)phosphinyl)carbamate,CCOC(=O)NP(=O)(NC(=O)NOC)NC(=O)NOC,,,,,,
7288,97289,7-Chloro-2-naphthol,C1=CC(=CC2=C1C=CC(=C2)Cl)O,,,,,,
7289,97290,"7-chloro-3-cyclopentyl-3H-[1,2,3]triazolo[4,5-d]pyrimidine",C1CCC(C1)N2C3=C(C(=NC=N3)Cl)N=N2,,,,,,
7290,97291,"3,5-Dibromo-2,6-dihydroxybenzoic acid",C1=C(C(=C(C(=C1Br)O)C(=O)O)O)Br,,,,,,
7291,97292,N2-Trityl-L-arginine,C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)N[C@@H](CCCN=C(N)N)C(=O)O,,,,,,
7292,97293,"1-Cyclopentene-1-acetic acid, 2-(2-naphthalenyl)-5-oxo-",C1CC(=O)C(=C1C2=CC3=CC=CC=C3C=C2)CC(=O)O,,,,,,
7293,97294,Ethylphosphonic diamide cyclic 4-chloro-o-phenylene ester,CCP1(=O)NC2=C(N1)C=C(C=C2)Cl,,,,,,
7294,97295,"5-Amino-2-(2,4,6-trichloro-phenyl)-1,2-dihydro-pyrazol-3-one",C1=C(C=C(C(=C1Cl)N2C(=O)C=C(N2)N)Cl)Cl,,,,,,
7295,97296,"2,6-Dihydroxyaminopurine",C1=NC2=C(N1)C(=NC(=N2)NO)NO,,,,,,
7296,97297,5-Iodotubercidin,C1=C(C2=C(N=CN=C2N1[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N)I,,,['Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)'],,,
7297,97298,N-(3-Carboxyphenyl)anthranilic acid,C1=CC=C(C(=C1)C(=O)O)NC2=CC=CC(=C2)C(=O)O,,,,,,
7298,97299,N-Methyl-N'-(4-methylphenyl)-N-nitrosourea,CC1=CC=C(C=C1)NC(=O)N(C)N=O,,,,,,
7299,97300,1-(Trifluoromethanesulfonyl)imidazole,C1=CN(C=N1)S(=O)(=O)C(F)(F)F,,,,,,
7300,97301,1-(2-Fluoroethyl)-1-nitroso-3-(tetrahydro-2H-thiopyran-4-yl)urea,C1CSCCC1NC(=O)N(CCF)N=O,,,,,,
7301,97302,"D-Glucopyranose, 2-((((2-chloroethyl)nitrosoamino)carbonyl)amino)-2-deoxy-, 1,3,4,6-tetraacetate",CC(=O)OC[C@@H]1[C@H]([C@@H]([C@H](C(O1)OC(=O)C)NC(=O)N(CCCl)N=O)OC(=O)C)OC(=O)C,,,,,,
7302,97303,"Benzo[b]thiophene-2,3-dione",C1=CC=C2C(=C1)C(=O)C(=O)S2,,,,,,
7303,97304,Thallium cyclopentadienide,C1=CC(C=C1)[Tl],,,,,,
7304,97305,"Ethyl 2,3-dideoxy-alpha-D-erythro-hex-2-enopyranoside",CCO[C@@H]1C=C[C@@H]([C@H](O1)CO)O,,,,,,
7305,97306,CID 97306,C1=C(C(=N)C(=N)C=N1)N(O)O,,,,,,
7306,97307,"4-Acetoxy-3,5-dimethoxybenzoyl chloride",CC(=O)OC1=C(C=C(C=C1OC)C(=O)Cl)OC,,,,,,
7307,97308,"5-(2-Acetoxyacetyl)benzene-1,2,3-triyl triacetate",CC(=O)OCC(=O)C1=CC(=C(C(=C1)OC(=O)C)OC(=O)C)OC(=O)C,,,,,,
7308,97309,CID 97309,CC1=CC(=C2C=CC(=O)N=C2N1)C,,,,,,
7309,97310,N-(3-Thienyl)acetamide,CC(=O)NC1=CSC=C1,,,,,,
7310,97311,"Benzene, 1-methyl-3-(2-propenylthio)-",CC1=CC(=CC=C1)SCC=C,,,,,,
7311,97312,Ethyl (phenylthio)acetate,CCOC(=O)CSC1=CC=CC=C1,,,,,,
7312,97313,"3,4-Phenanthrenedione",C1=CC=C2C(=C1)C=CC3=C2C(=O)C(=O)C=C3,,,,,,
7313,97314,"Ethanol, 2,2'-[[4-[[4-(3,3-dimethyl-1-triazenyl)phenyl]azo]phenyl]imino]bis-",CN(C)N=NC1=CC=C(C=C1)N=NC2=CC=C(C=C2)N(CCO)CCO,,,,,,
7314,97315,"9,10-Secolycoran-1alpha-ol, 3,3a-didehydro-2beta-methoxy-O9-methyl-",COC1C=C2CCN3C2C(C1O)C4=CC(=C(C=C4C3)OC)OC,,,,,,
7315,97316,CID 97316,C1=C(C2=C(C=C(OC2=CC1=O)O)O)O,,,,,,
7316,97317,CID 97317,C1=CC(=O)C=C2C1=CC(=C(O2)O)C(=O)O,,,,,,
7317,97318,CID 97318,C1=NC2=C(N1[C@H]3[C@@H]([C@H]([C@H](O3)CO)O)O)NC(=NC2=O)N,,,,,,
7318,97319,1-Isoquinolinecarboxamide,C1=CC=C2C(=C1)C=CN=C2C(=O)N,,,,,,
7319,97320,"p,p'-Azocumene",CC(C)C1=CC=C(C=C1)N=NC2=CC=C(C=C2)C(C)C,,,,,,
7320,97321,"Tubercidin 3',5'-cyclic phosphate",C1[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC4=C(N=CN=C43)N)O)OP(=O)(O1)O,,,,,,
7321,97322,"1,2,3,4,4a,9,10,10a-Octahydro-6-methoxy-1,4a-dimethyl-1-phenanthrenecarboxylic acid (1S-(1alpha,4aalpha,10abeta))-",C[C@]12CCC[C@]([C@H]1CCC3=C2C=C(C=C3)OC)(C)C(=O)O,,,,,,
7322,97323,"Methyl (1S-(1alpha,4aalpha,10abeta))-1,2,3,4,4a,9,10,10a-octahydro-6-methoxy-1,4a-dimethylphenanthren-1-carboxylate",C[C@]12CCC[C@]([C@H]1CCC3=C2C=C(C=C3)OC)(C)C(=O)OC,,,,,,
7323,97324,4-(Phenylsulfanyl)butanoic acid,C1=CC=C(C=C1)SCCCC(=O)O,,,,,,
7324,97325,2-Methylquinoline N-oxide,CC1=[N+](C2=CC=CC=C2C=C1)[O-],,,,,,
7325,97326,Ethylenebis(p-nitrobenzenesulfonate),C1=CC(=CC=C1[N+](=O)[O-])S(=O)(=O)OCCOS(=O)(=O)C2=CC=C(C=C2)[N+](=O)[O-],,,,,,
7326,97327,"Propionic acid, 3-(2,2-dimethyl-1-aziridinyl)-, methyl ester",CC1(CN1CCC(=O)OC)C,,,,,,
7327,97328,"L-2,3-Diaminopropionic acid",C([C@@H](C(=O)O)N)N,,,,,,
7328,97329,2-(2-Chlorophenoxy)acetamide,C1=CC=C(C(=C1)OCC(=O)N)Cl,,,,,,
7329,97330,"Phosphinic acid, bis(p-aminophenyl)-",C1=CC(=CC=C1N)P(=O)(C2=CC=C(C=C2)N)O,,,,,,
7330,97331,CID 97331,C1=CC(=C(C=C1C2=C(C(=C3C(=CC(=O)C=C3O2)O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O,,,,,,
7331,97332,Quercetin pentamethyl ether,COC1=C(C=C(C=C1)C2=C(C(=O)C3=C(O2)C=C(C=C3OC)OC)OC)OC,,,,,,
7332,97333,1-Benzyl-4-phenylpiperidin-4-ol,C1CN(CCC1(C2=CC=CC=C2)O)CC3=CC=CC=C3,,,,,,
7333,97334,CID 97334,C1=NC2=C(N1[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)C(=O)NC(N2)N,,,,,,
7334,97335,(4-Thiazolylmethoxy)urea,C1=C(N=CS1)CONC(=O)N,,,,,,
7335,97336,Tetra-O-acetyl-beta-D-ribopyranose,CC(=O)O[C@@H]1CO[C@H]([C@@H]([C@@H]1OC(=O)C)OC(=O)C)OC(=O)C,,,,,,
7336,97337,"s-Triazolo[3,4-a]phthalazine",C1=CC=C2C(=C1)C=NN3C2=NN=C3,,,,,,
7337,97338,"1,2,4-Triazolo(3,4-a)phthalazine, 6-phenyl-",C1=CC=C(C=C1)C2=NN3C=NN=C3C4=CC=CC=C42,,,,,,
7338,97339,"3-Methyl-1,2,4-triazolo[3,4-A]phthalazine",CC1=NN=C2N1N=CC3=CC=CC=C32,,,,,,
7339,97340,"N,N-Dimethyl-2,4-dinitroaniline",CN(C)C1=C(C=C(C=C1)[N+](=O)[O-])[N+](=O)[O-],,,,,,
7340,97341,7-Oxabicyclo[4.1.0]hept-3-ene,C1C=CCC2C1O2,,,,,,
7341,97342,CID 97342,C1=CC2=C(C(=O)N=C2C=C1)N=NC3=CC=C(C=C3)N(O)O,,,,,,
7342,97343,"Urea, 1-phenyl-3-(4-thiazolylmethoxy)-",C1=CC=C(C=C1)NC(=O)NOCC2=CSC=N2,,,,,,
7343,97344,2-Amino-5-ethoxyphenol,CCOC1=CC(=C(C=C1)N)O,,,,,,
7344,97345,7-Nitro-9-oxo-4-fluorenecarboxylic acid,C1=CC2=C(C3=C(C2=O)C=C(C=C3)[N+](=O)[O-])C(=C1)C(=O)O,,,,,,
7345,97346,Ethyl (p-(bis(2-chloroethyl)amino)phenyl)acetate,CCOC(=O)CC1=CC=C(C=C1)N(CCCl)CCCl,,,,,,
7346,97347,"2,3-dihydro-1H-pyrrolizin-1-one",C1CN2C=CC=C2C1=O,,,,,,
7347,97348,"Urea, 1,1'-(4,4'-biphenylylenedimethylene)bis(3-(2-chloroethyl)-3-nitroso-",C1=CC(=CC=C1CNC(=O)N(CCCl)N=O)C2=CC=C(C=C2)CNC(=O)N(CCCl)N=O,,,,,,
7348,97349,"Urea, 1-methyl-1-nitroso-3-(tetrahydro-2H-pyran-4-yl)-",CN(C(=O)NC1CCOCC1)N=O,,,,,,
7349,97350,"Hydrazine, 1,1-bis(diphenylphosphino)-2,2-dimethyl-",CN(C)N(P(C1=CC=CC=C1)C2=CC=CC=C2)P(C3=CC=CC=C3)C4=CC=CC=C4,,,,,,
7350,97351,Triphenylantimony dihydroxide,C1=CC=C(C=C1)[Sb](C2=CC=CC=C2)C3=CC=CC=C3.O.O,,,,,,
7351,97352,"Galactitol, 1,6-dimethanesulfonate",CS(=O)(=O)OC[C@H]([C@@H]([C@@H]([C@H](COS(=O)(=O)C)O)O)O)O,,,,,,
7352,97353,alpha-Oxofuran-2-acetamide,C1=COC(=C1)C(=O)C(=O)N,,,,,,
7353,97354,"1,2-Bis(3-methylphenoxy)ethane",CC1=CC(=CC=C1)OCCOC2=CC=CC(=C2)C,,,,,,
7354,97355,"Urea, 3-(4-acetoxycyclohexyl)-1-(2-chloroethyl)-1-nitroso-",CC(=O)OC1CCC(CC1)NC(=O)N(CCCl)N=O,,,,,,
7355,97356,"5,6,7,8-Tetrahydrocarbazole-3-acetic acid",C1CCC2=C(C1)C3=C(N2)C=CC(=C3)CC(=O)O,,,,,,
7356,97357,1-Amino-l-proline,C1C[C@H](N(C1)N)C(=O)O,,,,,,
7357,97358,"Stannane, [[(diethylamino)thioxomethyl]thio]triphenyl-",CCN(CC)C(=S)S[Sn](C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
7358,97359,N-(3-hydroxyphenyl)benzenesulfonamide,C1=CC=C(C=C1)S(=O)(=O)NC2=CC(=CC=C2)O,,,,,,
7359,97360,7-Hydroxy-alpha-naphthoflavone,C1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C4=C(C=C3)C(=CC=C4)O,,,,,,
7360,97361,Cytidylyl-(3'.5')-uridine,C1=CN(C(=O)N=C1N)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)OP(=O)(O)OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=CC(=O)NC4=O)O)O)O,,,,,,
7361,97362,"3-Phenyl-3-propylpentane-1,5-diol",CCCC(CCO)(CCO)C1=CC=CC=C1,,,,,,
7362,97363,Glycyl-L-aspartic acid,C([C@@H](C(=O)O)NC(=O)CN)C(=O)O,,,,,,
7363,97364,Leu-Gly,CC(C)C[C@@H](C(=O)NCC(=O)O)N,,,,,,
7364,97365,"5,7-Dimethyl-1,8-naphthyridin-2-amine",CC1=CC(=NC2=C1C=CC(=N2)N)C,,,,,,
7365,97366,CID 97366,C1=C(C=C(C(=C1Cl)NCCC2=CN=C3C(=N2)C(=O)N=C(N3)N)Cl)C(=O)N[C@H](CCC(=O)O)C(=O)O,,,,,,
7366,97367,4-nitrophenyl 3-phenyl-N-[(phenylmethoxy)carbonyl]-L-alaninate,C1=CC=C(C=C1)CC(C(=O)OC2=CC=C(C=C2)[N+](=O)[O-])NC(=O)OCC3=CC=CC=C3,,,,,,
7367,97368,4-Methyl hydrogen L-aspartate,COC(=O)C[C@@H](C(=O)O)N,,,,,,
7368,97369,N-alpha-Benzoyl-L-arginine,C1=CC=C(C=C1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O,,,,,,
7369,97370,N-Benzoyl-l-phenylalanine,C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)C2=CC=CC=C2,,,['Biologically active molecules which are covalently bound to the enzymes or binding proteins normally acting on them. Binding occurs due to activation of the label by ultraviolet light. These labels are used primarily to identify binding sites on proteins. (See all compounds classified as Photoaffinity Labels.)'],,,
7370,97371,"4H-Pyran-4-one, 3-hydroxy-6-(hydroxymethyl)-2-methyl-",CC1=C(C(=O)C=C(O1)CO)O,,,,,,
7371,97372,Bis[p-chlorophenyl]acetylene,C1=CC(=CC=C1C#CC2=CC=C(C=C2)Cl)Cl,,,,,,
7372,97373,2-Thiophenamine,C1=CSC(=C1)N,,,,,,
7373,97374,"8-Quinolinamine, 4-methyl-",CC1=C2C=CC=C(C2=NC=C1)N,,,,,,
7374,97375,2-Nitrobenzenesulfonyl fluoride,C1=CC=C(C(=C1)[N+](=O)[O-])S(=O)(=O)F,,,,,,
7375,97376,Hydroxy chlorambucil,C1=CC(=CC=C1CCCC(=O)O)N(CCO)CCCl,,,,,,
7376,97377,"Urea, 1-(2-chloroethyl)-1-nitroso-3-(5-nitro-2-thiazolyl)-",C1=C(SC(=N1)NC(=O)N(CCCl)N=O)[N+](=O)[O-],,,,,,
7377,97378,CID 97378,C1=CC=C(C=C1)N=C(NOCC2=CSC=N2)S,,,,,,
7378,97379,"Urea, 1-cyclohexyl-3-(4-thiazolylmethoxy)-",C1CCC(CC1)NC(=O)NOCC2=CSC=N2,,,,,,
7379,97380,"1H-Indole-3-propanoic acid, 2-methyl-",CC1=C(C2=CC=CC=C2N1)CCC(=O)O,,,,,,
7380,97381,"Guanosine, 1-amino-2'-deoxy-",C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2N=C(N(C3=O)N)N)CO)O,,,,,,
7381,97382,CID 97382,CC(=N)CC(=N)S,,,,,,
7382,97383,3-Amino-4-chlorobenzenesulfonyl fluoride,C1=CC(=C(C=C1S(=O)(=O)F)N)Cl,,,,,,
7383,97384,1-(4-Chlorophenyl)cyclopentanecarbonitrile,C1CCC(C1)(C#N)C2=CC=C(C=C2)Cl,,,,,,
7384,97385,6-Amino-2-phenylquinolin-4-ol,C1=CC=C(C=C1)C2=CC(=O)C3=C(N2)C=CC(=C3)N,,,,,,
7385,97386,N-(Benzyloxycarbonyl)phenylalanylphenylalanine methyl ester,COC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CC=CC=C3,,,,,,
7386,97387,5-Chloro-2-(methylamino)benzamide,CNC1=C(C=C(C=C1)Cl)C(=O)N,,,,,,
7387,97388,"Urea, N,N''-(1,4-cyclohexanediylbis(methylene))bis(N'-(2-chloroethyl)-N'-nitroso-(9CI)",C1CC(CCC1CNC(=O)N(CCCl)N=O)CNC(=O)N(CCCl)N=O,,,,,,
7388,97389,"2,4-Oxazolidinedione",C1C(=O)NC(=O)O1,,,,,,
7389,97390,"4,8-Dioxatricyclo[5.1.0.03,5]octane",C1C2C(O2)CC3C1O3,,,,,,
7390,97391,"1,4-Dihydro-1,4-methanonaphthalene",C1C2C=CC1C3=CC=CC=C23,,,,,,
7391,97392,4-Hydroxybenzophenone oxime,C1=CC=C(C=C1)C(=NO)C2=CC=C(C=C2)O,,,,,,
7392,97393,5-Benzyl-2-methylbenzoxazole,CC1=NC2=C(O1)C=CC(=C2)CC3=CC=CC=C3,,,,,,
7393,97394,8-Hydroxyquinoline-4-carboxylic acid,C1=CC2=C(C=CN=C2C(=C1)O)C(=O)O,,,,,,
7394,97395,CID 97395,CC1CCCCC12C(=O)NC(=NC2=O)S,,,,,,
7395,97396,Glycyl-histidyl-glycine,C1=C(NC=N1)C[C@@H](C(=O)NCC(=O)O)NC(=O)CN,,,,,,
7396,97397,"5-Ethyl-5-pent-3-en-2-yl-1,3-diazinane-2,4,6-trione",CCC1(C(=O)NC(=O)NC1=O)C(C)C=CC,,,,,,
7397,97398,D-lyxo-Hexos-2-ulose,C([C@H]([C@@H]([C@@H](C(=O)C=O)O)O)O)O,,,,,,
7398,97399,"6-(2-Chlorophenyl)-1,3,5-triazine-2,4-diamine",C1=CC=C(C(=C1)C2=NC(=NC(=N2)N)N)Cl,,,,,,
7399,97400,Diethyl N-(4-(methylamino)benzoyl)-D-glutamate,CCOC(=O)CC[C@H](C(=O)OCC)NC(=O)C1=CC=C(C=C1)NC,,,,,,
7400,97401,2-Amino-4-methyl-5-hexenoic acid,CC(CC(C(=O)O)N)C=C,,,,,,
7401,97402,5-[[butyl(methyl)amino]diazenyl]-1H-pyrazole-4-carboxamide,CCCCN(C)N=NC1=C(C=NN1)C(=O)N,,,,,,
7402,97403,"Urea, 3-(4-acetoxycyclohexyl)-1-(2-fluoroethyl)-1-nitroso-",CC(=O)OC1CCC(CC1)NC(=O)N(CCF)N=O,,,,,,
7403,97404,"Urea, 1-(2-fluoroethyl)-1-nitroso-3-(thiochroman-4-yl)-",C1CSC2=CC=CC=C2C1NC(=O)N(CCF)N=O,,,,,,
7404,97405,"Acetamide, N-(2-(acetyloxy)-4-ethoxyphenyl)-",CCOC1=CC(=C(C=C1)NC(=O)C)OC(=O)C,,,,,,
7405,97406,"1-Naphthalenamine, N,N-bis(2-chloroethyl)-3-methyl-",CC1=CC2=CC=CC=C2C(=C1)N(CCCl)CCCl,,,,,,
7406,97407,"Benzilamide, N-(2-(diethylamino)ethyl)-",CCN(CC)CCNC(=O)C(C1=CC=CC=C1)(C2=CC=CC=C2)O,,,,,,
7407,97408,Bis(p-nitrophenyl) sulphite,C1=CC(=CC=C1[N+](=O)[O-])OS(=O)OC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
7408,97409,"Methyl 16,17-didehydroyohimban-16-carboxylate",COC(=O)C1=CCCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4,,,,,,
7409,97410,o-Hydroxybenzylideneaminorhodanine,C1C(=O)N(C(=S)S1)N=CC2=CC=CC=C2O,,,,,,
7410,97411,"2-{[(4H-1,2,4-triazol-4-yl)imino]methyl}phenol",C1=CC=C(C(=C1)C=NN2C=NN=C2)O,,,,,,
7411,97412,2-Amino-5-chloropyrimidine-4-carboxylic acid,C1=C(C(=NC(=N1)N)C(=O)O)Cl,,,,,,
7412,97413,Ethyl 4-chloro-2-(ethylthio)pyrimidine-5-carboxylate,CCOC(=O)C1=CN=C(N=C1Cl)SCC,,,,,,
7413,97414,4-Amino-2-(ethylthio)-5-pyrimidinecarboxylic acid ethyl ester,CCOC(=O)C1=CN=C(N=C1N)SCC,,,,,,
7414,97415,Glycyl-DL-phenylalanine,C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CN,,,,,,
7415,97416,4-Nitrophenyl caprylate,CCCCCCCC(=O)OC1=CC=C(C=C1)[N+](=O)[O-],,,,,,
7416,97417,Glycylvaline,CC(C)C(C(=O)O)NC(=O)CN,,,,,,
7417,97418,"Acetamide, 2-(p-(bis(2-chloroethyl)amino)phenyl)-N-ethyl-",CCNC(=O)CC1=CC=C(C=C1)N(CCCl)CCCl,,,,,,
7418,97419,"Propanenitrile,2-[(phenylmethoxy)imino]-",CC(=NOCC1=CC=CC=C1)C#N,,,,,,
7419,97420,"1,3,5-Triazine, 2,4-bis(1-aziridinyl)-6-chloro-",C1CN1C2=NC(=NC(=N2)Cl)N3CC3,,,,,,
7420,97421,"Tetrahydrofuran-2,3,4,5-tetracarboxylic Acid",C1(C(C(OC1C(=O)O)C(=O)O)C(=O)O)C(=O)O,,,,,,
7421,97422,"Tetrahydrodifuro[3,4-b:3',4'-d]furantetrone",C12C3C(C(=O)OC3=O)OC1C(=O)OC2=O,,,,,,
7422,97423,4-Aminosulphonyl-1-hydroxy-2-naphthoic acid,C1=CC=C2C(=C1)C(=CC(=C2O)C(=O)O)S(=O)(=O)N,,,,,,
7423,97424,"2-Methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole",CN1CCC2=C(C1)C3=CC=CC=C3N2,,,,,,
7424,97425,"2-Methyl-5-phenyl-1,3,4-thiadiazole",CC1=NN=C(S1)C2=CC=CC=C2,,,,,,
7425,97426,CID 97426,COC1=C(C=C(C=C1)C2=CC(=C3C(=CC(=O)C(=C3O)OC)O2)O)OC,,,,,,
7426,97427,CID 97427,COC1=C(C2=C(C=C(OC2=CC1=O)C3=CC(=C(C=C3)O)O)O)O,,,,,,
7427,97428,"1,3,4-Oxadiazole",C1=NN=CO1,,,,,,
7428,97429,"4,5,6,7-Tetrahydro-1H-indole",C1CCC2=C(C1)C=CN2,,,,,,
7429,97430,"1,2,3-Triphenylcyclopropene",C1=CC=C(C=C1)C2C(=C2C3=CC=CC=C3)C4=CC=CC=C4,,,,,,
7430,97431,2-Thiazolidinone,C1CSC(=O)N1,,,,,,
7431,97432,"2,4-Dinitrophenyl sulfone",C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])S(=O)(=O)C2=C(C=C(C=C2)[N+](=O)[O-])[N+](=O)[O-],,,,,,
7432,97433,Methyl 4-tert-butylbenzoate,CC(C)(C)C1=CC=C(C=C1)C(=O)OC,,,,,,
7433,97434,6-Benzoyl-m-toluic acid,CC1=CC(=C(C=C1)C(=O)C2=CC=CC=C2)C(=O)O,,,,,,
7434,97435,"o-Toluic acid, alpha-(p-methoxybenzoyl)-",COC1=CC=C(C=C1)C(=O)CC2=CC=CC=C2C(=O)O,,,,,,
7435,97436,3-Aminopropanethiol,C(CN)CS,,,,,,
7436,97437,Methyl cyclohexylcarbamate,COC(=O)NC1CCCCC1,,,,,,
7437,97438,"5-Hydroxy-4,6-dimethylnicotinaldehyde",CC1=C(C(=NC=C1C=O)C)O,,,,,,
7438,97439,"(-)-1,4-di-O-Tosyl-2,3-O-isopropylidene-L-threitol",CC1=CC=C(C=C1)S(=O)(=O)OC[C@H]2[C@@H](OC(O2)(C)C)COS(=O)(=O)C3=CC=C(C=C3)C,,,,,,
7439,97440,N-Butyl-N-nitrosoformamide,CCCCN(C=O)N=O,,,,,,
7440,97441,"Ethyl hydrogen [(2,4-dichlorophenyl)methylidene]carbonohydrazonate",CCOC(=O)NN=CC1=C(C=C(C=C1)Cl)Cl,,,,,,
7441,97442,"Urea, N-(2-chloroethyl)-N'-cyclohexyl-N'-methyl-N-nitroso-",CN(C1CCCCC1)C(=O)N(CCCl)N=O,,,,,,
7442,97443,4-Nitrophthalonitrile,C1=CC(=C(C=C1[N+](=O)[O-])C#N)C#N,,,,,,
7443,97444,4-(Aminocarbonyl)phenyl acetate,CC(=O)OC1=CC=C(C=C1)C(=O)N,,,,,,
7444,97445,"N'-[9-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]-N,N-dimethylmethanimidamide",CN(C)C=NC1=C2C(=NC=N1)N(C=N2)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O,,,,,,
7445,97446,"(4R-trans)-2,2-Dimethyl-1,3-dioxolane-4,5-dimethyl bis(toluene-p-sulphonate)",CC1=CC=C(C=C1)S(=O)(=O)OC[C@@H]2[C@H](OC(O2)(C)C)COS(=O)(=O)C3=CC=C(C=C3)C,,,,,,
7446,97447,1-(4-Chlorophenyl)cyclopentanecarboxylic acid,C1CCC(C1)(C2=CC=C(C=C2)Cl)C(=O)O,,,,,,
7447,97448,Deoxylapachol,CC(=CCC1=CC(=O)C2=CC=CC=C2C1=O)C,,,,,,
7448,97449,3-Amino-4-chloro-N-(2-cyanoethyl)benzenesulfonamide,C1=CC(=C(C=C1S(=O)(=O)NCCC#N)N)Cl,,,,,,
7449,97450,Ethyl 4-chloro-2-(4-fluorosulfonylphenyl)-6-quinolinecarboxylate,CCOC(=O)C1=CC2=C(C=C1)N=C(C=C2Cl)C3=CC=C(C=C3)S(=O)(=O)F,,,,,,
7450,97451,CID 97451,C1=CC(=CC=C1CC2=C(NC(=NC2=O)S)C=O)Cl,,,,,,
7451,97452,N-(4-methoxybenzyl)pyridin-2-amine,COC1=CC=C(C=C1)CNC2=CC=CC=N2,,,,,,
7452,97453,5-Chlorotubercidin,C1=C(C2=C(N=CN=C2N1[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N)Cl,,,,,,
7453,97454,"7-(3-Deoxy-beta-D-erythro-pentofuranosyl)-7H-pyrrolo(2,3-d)pyrimidin-4-amine",C1[C@H](O[C@H]([C@@H]1O)N2C=CC3=C(N=CN=C32)N)CO,,,,,,
7454,97455,5-Methyl-2-nitroanisole,CC1=CC(=C(C=C1)[N+](=O)[O-])OC,,,,,,
7455,97456,"2,5-Di-tert-amylquinone",CCC(C)(C)C1=CC(=O)C(=CC1=O)C(C)(C)CC,,,,,,
7456,97457,Cyclohexylidenecyanoacetic acid,C1CCC(=C(C#N)C(=O)O)CC1,,,,,,
7457,97458,S-Hexadecyl methanethiosulfonate,CCCCCCCCCCCCCCCCSS(=O)(=O)C,,,,,,
7458,97459,S-Hexyl p-toluenethiosulfonate,CCCCCCSS(=O)(=O)C1=CC=C(C=C1)C,,,,,,
7459,97460,S-Octyl p-toluenethiosulfonate,CCCCCCCCSS(=O)(=O)C1=CC=C(C=C1)C,,,,,,
7460,97461,S-Decyl p-toluenethiosulfonate,CCCCCCCCCCSS(=O)(=O)C1=CC=C(C=C1)C,,,,,,
7461,97462,S-Hexadecyl p-toluenethiosulfonate,CCCCCCCCCCCCCCCCSS(=O)(=O)C1=CC=C(C=C1)C,,,,,,
7462,97463,"1-(3,4-Dichlorophenyl)-3-hydroxyurea",C1=CC(=C(C=C1NC(=O)NO)Cl)Cl,,,,,,
7463,97464,N-(4-Chlorophenyl)-N'-hydroxyurea,C1=CC(=CC=C1NC(=O)NO)Cl,,,,,,
7464,97465,"Urea, ((m-nitrobenzyl)oxy)-",C1=CC(=CC(=C1)[N+](=O)[O-])CONC(=O)N,,,,,,
7465,97466,"5,8-Dihydro-1-naphthol",C1C=CCC2=C1C=CC=C2O,,,,,,
7466,97467,2-Azaadenosine,C1=NC2=C(N=NN=C2N1[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N,,,,,,
7467,97468,"Urea, 1-(2-fluoroethyl)-3-(4-methylcyclohexyl)-1-nitroso-",CC1CCC(CC1)NC(=O)N(CCF)N=O,,,,,,
7468,97469,"1H-Pyrrole-2-acetic acid, 1-methyl-, ethyl ester",CCOC(=O)CC1=CC=CN1C,,,,,,
7469,97470,"trans-Cyclobutane-1,2-dicarbonyl chloride",C1CC(C1C(=O)Cl)C(=O)Cl,,,,,,
7470,97471,Cyclobutyl 4-fluorophenyl ketone,C1CC(C1)C(=O)C2=CC=C(C=C2)F,,,,,,
7471,97472,4-Hydroxybenzylamine,C1=CC(=CC=C1CN)O,,,,,,
7472,97473,1-Aza-2-boracyclobutane,B1CCN1,,,,,,
7473,97474,2-Acetamidobenzophenone,CC(=O)NC1=CC=CC=C1C(=O)C2=CC=CC=C2,,,,,,
7474,97475,"2-Naphthalenol, 1-((2-methoxy-1-naphthalenyl)methyl)-",COC1=C(C2=CC=CC=C2C=C1)CC3=C(C=CC4=CC=CC=C43)O,,,,,,
7475,97476,"2-Naphthalenol, 1,1'-methylenebis-, diacetate",CC(=O)OC1=C(C2=CC=CC=C2C=C1)CC3=C(C=CC4=CC=CC=C43)OC(=O)C,,,,,,
7476,97477,"Stannane, dibromodicyclohexyl-",C1CCC(CC1)[Sn](C2CCCCC2)(Br)Br,,,,,,
7477,97478,1-(4-Chlorophenyl)piperazine,C1CN(CCN1)C2=CC=C(C=C2)Cl,,,,,,
7478,97479,4-Methylhippuric acid,CC1=CC=C(C=C1)C(=O)NCC(=O)O,,,,,,
7479,97480,Ara-HA,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)NO,,,,,,
7480,97481,N6-(p-Nitrobenzyl)adenosine,C1=CC(=CC=C1CNC2=C3C(=NC=N2)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O)[N+](=O)[O-],,,,,,
7481,97482,CID 97482,CC1=C(C(=NN1C(=N)S)C)N=NC2=CC=CC=C2,,,,,,
7482,97483,CID 97483,CC1=C(C(=NN1C(=N)S)C)N=NC2=CC(=CC=C2)Cl,,,,,,
7483,97484,CID 97484,CC1=C(C(=NN1C(=N)S)C)N=NC2=CC=C(C=C2)Cl,,,,,,
7484,97485,CID 97485,CC1=CC=C(C=C1)N=NC2=C(N(N=C2C)C(=N)S)C,,,,,,
7485,97486,4-Hydroxy-4'-dimethylaminoazobenzene,CN(C)C1=CC=C(C=C1)N=NC2=CC=C(C=C2)O,,,,,,
7486,97487,Koenimbine,CC1=CC2=C(C3=C1OC(C=C3)(C)C)NC4=C2C=C(C=C4)OC,,,,,,
7487,97488,4-Mercaptobenzenesulfonic acid,C1=CC(=CC=C1S)S(=O)(=O)O,,,,,,
7488,97489,2-Phenylnicotinic acid,C1=CC=C(C=C1)C2=C(C=CC=N2)C(=O)O,,,,,,
7489,97490,"Cyclopent(b)indol-3-one, 1,2,3,4-tetrahydro-",C1CC(=O)C2=C1C3=CC=CC=C3N2,,,,,,
7490,97491,"1-(Chloromethyl)-2,3,4-trimethoxybenzene",COC1=C(C(=C(C=C1)CCl)OC)OC,,,,,,
7491,97492,Oxosparteine,C1CCN2CC3CC(C2C1)C(=O)N4C3CCCC4,,,,,,
7492,97493,CID 97493,CC[C@@H]1[C@H](C[C@@H](O1)N2C=C(C(=NC2=O)S)C)O,,,,,,
7493,97494,CID 97494,CN1C2=C(NC(=NC2=O)N)N(C1=O)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O,,,,,,
7494,97495,N-(4-Methoxybenzylidene)-4-acetoxyaniline,CC(=O)OC1=CC=C(C=C1)N=CC2=CC=C(C=C2)OC,,,,,,
7495,97496,"L-arabino-Hexos-2-ulose, 6-deoxy-",C[C@@H]([C@@H]([C@H](C(=O)C=O)O)O)O,,,,,,
7496,97497,3-(Dimethylamino)prop-2-enenitrile,CN(C)C=CC#N,,,,,,
7497,97498,"(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-ethyl-4-methyloxolan-3-ol",CC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)C,,,,,,
7498,97499,"4,4'-Dinitro stilbene",C1=CC(=CC=C1C=CC2=CC=C(C=C2)[N+](=O)[O-])[N+](=O)[O-],,,,,,
7499,97500,"Benzamide, 4-(1,1-dimethylethyl)-N,N-dimethyl-",CC(C)(C)C1=CC=C(C=C1)C(=O)N(C)C,,,,,,
7500,97501,"Hydrazine, 1,2-bis(2-methylpropyl)-",CC(C)CNNCC(C)C,,,,,,
7501,97502,2-(Pentylamino)ethanol,CCCCCNCCO,,,,,,
7502,97503,2-Methyl-1-(propan-2-ylamino)propan-2-ol,CC(C)NCC(C)(C)O,,,,,,
7503,97504,"Methyl 4-(((5-amino-7-((ethoxycarbonyl)amino)-1,2-dihydropyrido(3,4-b)pyrazin-3-yl)methyl)methylamino)benzoate",CCOC(=O)NC1=NC(=C2C(=C1)NCC(=N2)CN(C)C3=CC=C(C=C3)C(=O)OC)N,,,,,,
7504,97505,"Urea, 1-(2-chloroethyl)-3-(m-dithian-5-yl)-1-nitroso-",C1C(CSCS1)NC(=O)N(CCCl)N=O,,,,,,
7505,97506,CID 97506,COC1=C(C=C(C=C1)C2=CC(=C3C(=CC(=O)C=C3O2)O)O)OC,,,,,,
7506,97507,5-Chloroacenaphthene,C1CC2=CC=C(C3=CC=CC1=C23)Cl,,,,,,
7507,97508,N-Acetyl-DL-aspartic acid,CC(=O)NC(CC(=O)O)C(=O)O,,,,,,
7508,97509,"4,4'-Dinitro-[1,1'-biphenyl]-2,2'-dicarboxylic acid",C1=CC(=C(C=C1[N+](=O)[O-])C(=O)O)C2=C(C=C(C=C2)[N+](=O)[O-])C(=O)O,,,,,,
7509,97510,"Acetamide, N-(5-methyl-p-benzoquinonyl)-",CC1=CC(=O)C(=CC1=O)NC(=O)C,,,,,,
7510,97511,2-(2-Bromophenyl)-1H-benzimidazole,C1=CC=C(C(=C1)C2=NC3=CC=CC=C3N2)Br,,,,,,
7511,97512,5-Nitroquinoxaline,C1=CC2=NC=CN=C2C(=C1)[N+](=O)[O-],,,,,,
7512,97513,phenyl N-butylcarbamate,CCCCNC(=O)OC1=CC=CC=C1,,,,,,
7513,97514,"n'-[2-(Dimethylamino)ethyl]-n,n-dimethylethylenediamine",CN(C)CCNCCN(C)C,,,,,,
7514,97515,3'-Methylamino-3'-deoxyadenosine,CN[C@@H]1[C@H](O[C@H]([C@@H]1O)N2C=NC3=C(N=CN=C32)N)CO,,,,,,
7515,97516,N-Benzylidene-o-toluidine,CC1=CC=CC=C1N=CC2=CC=CC=C2,,,,,,
7516,97517,"2-Amino-4,6-dimethyl-5-(2,4-dichlorophenylazo)pyrimidine",CC1=C(C(=NC(=N1)N)C)N=NC2=C(C=C(C=C2)Cl)Cl,,,,,,
7517,97518,"2-Amino-4,6-dimethyl-5-(4-chlorophenylazo)pyrimidine",CC1=C(C(=NC(=N1)N)C)N=NC2=CC=C(C=C2)Cl,,,,,,
7518,97519,"2-Amino-4,6-dimethyl-5-(phenylazo)pyrimidine",CC1=C(C(=NC(=N1)N)C)N=NC2=CC=CC=C2,,,,,,
7519,97520,2-Fluorophenyl isothiocyanate,C1=CC=C(C(=C1)N=C=S)F,,,,,,
7520,97521,CID 97521,CC1=C2C(=CC=C1)NC(=N2)S,,,,,,
7521,97522,"1,3-Propanediamine, N,N-dimethyl-N'-(4-(trichloromethyl)-6-(3-(trichloromethyl)phenyl)-1,3,5-triazin-2-yl)-",CN(C)CCCNC1=NC(=NC(=N1)C(Cl)(Cl)Cl)C2=CC(=CC=C2)C(Cl)(Cl)Cl,,,,,,
7522,97523,"2,4-Diamino-6-(3,4-dichlorobenzylamino)quinazoline",C1=CC(=C(C=C1CNC2=CC3=C(C=C2)N=C(N=C3N)N)Cl)Cl,,,,,,
7523,97524,Benzyloxycarbonylcysteine,C1=CC=C(C=C1)COC(=O)N[C@@H](CS)C(=O)O,,,,,,
7524,97525,"3,5-Dimethylpyrazole-1-carboxamidine",CC1=CC(=NN1C(=N)N)C,,,,,,
7525,97526,"Urea, 3-(4-ethylcyclohexyl)-1-(2-fluoroethyl)-1-nitroso-",CCC1CCC(CC1)NC(=O)N(CCF)N=O,,,,,,
7526,97527,CID 97527,CC(C)C(=O)C1=C(C(=C2C(=C(C=C(O2)O)C3=CC=CC=C3)C1=O)CC=C(C)C)O,,,,,,
7527,97528,CID 97528,C1=NC(=O)C2=NNN(C2=N1)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O,,,,,,
7528,97529,"2-Chloro-3-((2-hydroxyethyl)amino)-1,4-naphthoquinone",C1=CC=C2C(=C1)C(=O)C(=C(C2=O)Cl)NCCO,,,,,,
7529,97530,Buthiopurine,C1=NC2=C(N1)C(=NC=N2)SCCCCC(=O)O,,,,,,
7530,97531,"Phthalimide, N-(m-nitrobenzyloxy)-",C1=CC=C2C(=C1)C(=O)N(C2=O)OCC3=CC(=CC=C3)[N+](=O)[O-],,,,,,
7531,97532,L-Aspartic acid hydrazide,C([C@@H](C(=O)O)N)C(=O)NN,,,,,,
7532,97533,p-Nitrobenzyl benzoate,C1=CC=C(C=C1)C(=O)OCC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
7533,97534,tert-Butyl N-hydroxycarbamate,CC(C)(C)OC(=O)NO,,,,,,
7534,97535,"S-(2,4-dinitrophenyl)glutathione",C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N,,,,,"['S-(2,4-dinitrophenyl)glutathione is a known human metabolite of 1-chloro-2,4-dinitrobenzene.']",
7535,97536,s-Hexylglutathione,CCCCCCSC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N,,,['Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)'],,,
7536,97537,S-(p-Bromobenzyl)glutathione,C1=CC(=CC=C1CSC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N)Br,,,,,,
7537,97538,s-(p-Nitrobenzyl)glutathione,C1=CC(=CC=C1CSC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N)[N+](=O)[O-],,,,,['4-nitrobenzyl-glutathione is a known human metabolite of 4-nitrobenzyl chloride.'],
7538,97539,"Pentanoic acid, 4-(methoxymethylphosphinyl)-2,2,4-trimethyl-3-oxo-, methyl ester",CC(C)(C(=O)C(C)(C)P(=O)(C)OC)C(=O)OC,,,,,,
7539,97540,o-(o-Nitrophenoxy)toluene,CC1=CC=CC=C1OC2=CC=CC=C2[N+](=O)[O-],,,,,,
7540,97541,1-(3-nitrophenyl)-N-[(3-nitrophenyl)methoxy]methanimine,C1=CC(=CC(=C1)[N+](=O)[O-])CON=CC2=CC(=CC=C2)[N+](=O)[O-],,,,,,
7541,97542,1-(4-nitrophenyl)-N-[(3-nitrophenyl)methoxy]methanimine,C1=CC(=CC(=C1)[N+](=O)[O-])CON=CC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
7542,97543,CID 97543,C1CN(CCN1C2=CC=CC=C2)C3=NC(=O)C4=CC5=CC=CC=C5C=C4N3,,,,,,
7543,97544,CID 97544,CN1CCN(CC1)C2=NC(=O)C3=CC4=CC=CC=C4C=C3N2,,,,,,
7544,97545,CID 97545,CN1CCN(CC1)C2=NC(=O)C=C(N2)N,,,,,,
7545,97546,4-[4-(2-Fluorophenyl)piperazin-1-yl]pyridin-3-amine,C1CN(CCN1C2=C(C=NC=C2)N)C3=CC=CC=C3F,,,,,,
7546,97547,2-[(3-Nitrophenyl)methoxyiminomethyl]phenol,C1=CC=C(C(=C1)C=NOCC2=CC(=CC=C2)[N+](=O)[O-])O,,,,,,
7547,97548,2-(4-Methoxyphenyl)benzo[h]chromen-4-one,COC1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C4=CC=CC=C4C=C3,,,,,,
7548,97549,Uridylyl-(3'-5')-cytidine,C1=CN(C(=O)N=C1N)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O[C@@H]3[C@H](O[C@H]([C@@H]3O)N4C=CC(=O)NC4=O)CO)O)O,,,,,,
7549,97550,2-Methyl-5-nitro-2H-indazole,CN1C=C2C=C(C=CC2=N1)[N+](=O)[O-],,,,,,
7550,97551,"2,3,3-Trimethyl-5-nitro-3H-indole",CC1=NC2=C(C1(C)C)C=C(C=C2)[N+](=O)[O-],,,,,,
7551,97552,1-Phenethyl-3-phenylurea,C1=CC=C(C=C1)CCNC(=O)NC2=CC=CC=C2,,,,,,
7552,97553,"Urea, 3-(m-dithian-5-yl)-1-(2-fluoroethyl)-1-nitroso-",C1C(CSCS1)NC(=O)N(CCF)N=O,,,,,,
7553,97554,"Urea, 1-(2-fluoroethyl)-3-(4-isopropylcyclohexyl)-1-nitroso-",CC(C)C1CCC(CC1)NC(=O)N(CCF)N=O,,,,,,
7554,97555,"3-Methyl-3h-imidazo[4,5-f]quinoline",CN1C=NC2=C1C=CC3=C2C=CC=N3,,,,,,
7555,97556,4-Chloro-2-[(3-chlorophenyl)methoxyiminomethyl]phenol,C1=CC(=CC(=C1)Cl)CON=CC2=C(C=CC(=C2)Cl)O,,,,,,
7556,97557,CID 97557,C1=CC(=CC(=C1)Cl)N=C(NN)S,,,,,,
7557,97558,N-Ethyl-5-nitropyridin-2-amine,CCNC1=NC=C(C=C1)[N+](=O)[O-],,,,,,
7558,97559,"4,5-Dihydro-1-(4-nitrophenyl)-5-oxo-1H-pyrazole-3-carboxylic acid",C1C(=NN(C1=O)C2=CC=C(C=C2)[N+](=O)[O-])C(=O)O,,,,,,
7559,97560,Helminthosporin,CC1=CC2=C(C(=C1)O)C(=O)C3=C(C=CC(=C3C2=O)O)O,,,,,,
7560,97561,"Acetanilide, 4'-(bis(2-hydroxyethyl)sulfamoyl)-",CC(=O)NC1=CC=C(C=C1)S(=O)(=O)N(CCO)CCO,,,,,,
7561,97562,"4-(1,3-Dithiolan-2-yl)phenol",C1CSC(S1)C2=CC=C(C=C2)O,,,,,,
7562,97563,"1-(Benzyl)-1,2,3,6-tetrahydroisonicotinonitrile",C1CN(CC=C1C#N)CC2=CC=CC=C2,,,,,,
7563,97564,"3-(4,4-Dimethylcyclohexyl)-1-(2-fluoroethyl)-1-nitrosourea",CC1(CCC(CC1)NC(=O)N(CCF)N=O)C,,,,,,
7564,97565,"Urea, 1-(2-chloroethyl)-3-(2-cyclohexenyl)-1-nitroso-",C1CC=CC(C1)NC(=O)N(CCCl)N=O,,,,,,
7565,97566,"Urea, 3-(2-cyclohexen-1-yl)-1-methyl-1-nitroso-",CN(C(=O)NC1CCCC=C1)N=O,,,,,,
7566,97567,"Carbamic acid, methylphosphono-, C-m-cumenyl diethyl ester",CCOP(=O)(N(C)C(=O)OC1=CC=CC(=C1)C(C)C)OCC,,,,,,
7567,97568,"Carbamic acid, acetylmethyl-, 1-naphthalenyl ester",CC(=O)N(C)C(=O)OC1=CC=CC2=CC=CC=C21,,,,,,
7568,97569,o-Isopropoxyphenyl chloroformate,CC(C)OC1=CC=CC=C1OC(=O)Cl,,,,,,
7569,97570,"Phosphoramidothioic acid, O-isopropyl S-methyl ester",CC(C)OP(=O)(N)SC,,,,,,
7570,97571,1-Oxo-1-(para-nitrophenoxy)-2-phospholene,C1CP(=O)(C=C1)OC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
7571,97572,S-Ethyl ethylphosphonothioamidate,CCP(=O)(N)SCC,,,,,,
7572,97573,"Phosphoric acid, diethyl 1-naphthalenyl ester",CCOP(=O)(OCC)OC1=CC=CC2=CC=CC=C21,,,,,,
7573,97574,"Phosphoric acid, 2,2-dichlorovinyl diisopropyl ester",CC(C)OP(=O)(OC=C(Cl)Cl)OC(C)C,,,,,,
7574,97575,CID 97575,C1=CC(=CC=C1C(=O)O)N(CC2=CN=C3C(=N2)C(=O)N=C(N3)N)C=O,,,,,,
7575,97576,"[(2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-YL)-3,4-dihydroxytetrahydro-2-furanyl]methyl sulfamate",C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COS(=O)(=O)N)O)O)N,,,,,,
7576,97577,3-Deazacytidine,C1=CN(C(=O)C=C1N)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O,,,,,,
7577,97578,"5-(Methylthio)-2H-1,2,3-triazolo(4,5-d)pyrimidin-7-amine",CSC1=NC2=NNN=C2C(=N1)N,,,,,,
7578,97579,"3,3',4,4'-Biphenyltetrol",C1=CC(=C(C=C1C2=CC(=C(C=C2)O)O)O)O,,,,,,
7579,97580,CID 97580,C1=C(C=C(C(=C1[N+](=O)[O-])N=NC2=C(C=C(C=C2[N+](=O)[O-])[N+](=O)[O-])[N+](=O)[O-])[N+](=O)[O-])N(O)O,,,,,,
7580,97581,1-Chloromethylpyrene,C1=CC2=C3C(=C1)C=CC4=C(C=CC(=C43)C=C2)CCl,,,,,,
7581,97582,"3-Bromo-1-benzothiophene 1,1-dioxide",C1=CC=C2C(=C1)C(=CS2(=O)=O)Br,,,,,,
7582,97583,"2,3-Methylenedioxynaphthalene",C1OC2=CC3=CC=CC=C3C=C2O1,,,,,,
7583,97584,"Benzene, 1-chloro-3-(phenylthio)-",C1=CC=C(C=C1)SC2=CC(=CC=C2)Cl,,,,,,
7584,97585,3-Chlorothioanisole,CSC1=CC(=CC=C1)Cl,,,,,,
7585,97586,(2-Aminopropan-2-yl)phosphonic acid,CC(C)(N)P(=O)(O)O,,,,,,
7586,97587,3-Aminopropylphosphonic acid,C(CN)CP(=O)(O)O,,,,,,
7587,97588,(2-(Dimethylamino)ethyl)phosphonic acid,CN(C)CCP(=O)(O)O,,,,,,
7588,97589,"Benzenesulfonamide, p-((dicyanomethyl)azo)-",C1=CC(=CC=C1N=NC(C#N)C#N)S(=O)(=O)N,,,,,,
7589,97590,Isopropyl 5-oxo-DL-prolinate,CC(C)OC(=O)C1CCC(=O)N1,,,,,,
7590,97591,N-Acetylglycylglycine,CC(=O)NCC(=O)NCC(=O)O,,,,,,
7591,97592,"4,4'-Ethylenebis(1-methyl-2,6-piperazinedione)",CN1C(=O)CN(CC1=O)CCN2CC(=O)N(C(=O)C2)C,,,,,,
7592,97593,Pyridoxal phosphonate,CC1=C(C(=NC=C1CCP(=O)(O)O)C)O,,,,,,
7593,97594,"1,3-Dibromo-1,3-diphenyl-2-propanone",C1=CC=C(C=C1)C(C(=O)C(C2=CC=CC=C2)Br)Br,,,,,,
7594,97595,Ethyl 1-bromocyclobutanecarboxylate,CCOC(=O)C1(CCC1)Br,,,,,,
7595,97596,"3,7,11,11,14-Pentamethyl-16-oxatricyclo[11.2.1.01,5]hexadeca-4,6,9,13-tetraene-8,15-dione",CC1CC23C(=C1)C=C(C(=O)C=CC(CC(=C(C2=O)C)O3)(C)C)C,,,,,,
7596,97597,Oxynitidine,CN1C2=C(C=CC3=CC4=C(C=C32)OCO4)C5=CC(=C(C=C5C1=O)OC)OC,,,,,,
7597,97598,"5,10-Dihydroindeno[1,2-b]indole",C1C2=CC=CC=C2C3=C1C4=CC=CC=C4N3,,,,,,
7598,97599,1-(4-Fluoro-phenyl)-3-phenyl-propenone,C1=CC=C(C=C1)C=CC(=O)C2=CC=C(C=C2)F,,,,,,
7599,97600,"Phenol, 2-(4,6-diamino-1,3,5-triazin-2-yl)-",C1=CC=C(C(=C1)C2=NC(=NC(=N2)N)N)O,,,,,,
7600,97601,S-Trifluoromethyl p-toluenethiosulfonate,CC1=CC=C(C=C1)S(=O)(=O)SC(F)(F)F,,,,,,
7601,97602,CID 97602,C1=CC=C2C=C3C(=CC2=C1)NC(=N3)S,,,,,,
7602,97603,"Benz[a]anthracene, 4-bromo-7-methyl-",CC1=C2C=CC3=C(C2=CC4=CC=CC=C14)C=CC=C3Br,,,,,,
7603,97604,"o-Toluic acid, alpha-(4-fluoro-1-naphthyl)-",C1=CC=C(C(=C1)CC2=CC=C(C3=CC=CC=C23)F)C(=O)O,,,,,,
7604,97605,"2-Thiazoline, 2-(1-naphthylamino)-",C1CSC(=N1)NC2=CC=CC3=CC=CC=C32,,,,,,
7605,97606,1-Phenylcyclopentanecarboxamide,C1CCC(C1)(C2=CC=CC=C2)C(=O)N,,,,,,
7606,97607,"1-Triazene, 3-acetyl-3-methyl-1-phenyl-",CC(=O)N(C)N=NC1=CC=CC=C1,,,,,,
7607,97608,"Pyridine, 3-(3-ethyl-3-methyl-1-triazenyl)-",CCN(C)N=NC1=CN=CC=C1,,,,,,
7608,97609,7-Quinolinemethanol,C1=CC2=C(C=C(C=C2)CO)N=C1,,,,,,
7609,97610,"2,3-Dimethyl-9H-carbazole",CC1=CC2=C(C=C1C)NC3=CC=CC=C32,,,,,,
7610,97611,"3',5'-Difluoromethotrexate",CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=C(C=C(C=C3F)C(=O)N[C@@H](CCC(=O)O)C(=O)O)F,,,,,,
7611,97612,2-(Dimethylaminodiazenyl)benzamide,CN(C)N=NC1=CC=CC=C1C(=O)N,,,,,,
7612,97613,"Urea, 3-(m-dithian-5-yl)-1-(2-fluoroethyl)-1-nitroso-, S,S,S',S'-tetraoxide",C1C(CS(=O)(=O)CS1(=O)=O)NC(=O)N(CCF)N=O,,,,,,
7613,97614,"Urea, 1-(2-chloroethyl)-3-(m-dithian-5-yl)-1-nitroso-, S,S,S',S'-tetraoxide",C1C(CS(=O)(=O)CS1(=O)=O)NC(=O)N(CCCl)N=O,,,,,,
7614,97615,CID 97615,C1=NC2=C(N=CN(C2=N1)O)NO,,,,,,
7615,97616,tetra-O-methyl nordihydroguaiaretic acid,CC(CC1=CC(=C(C=C1)OC)OC)C(C)CC2=CC(=C(C=C2)OC)OC,,,,,,
7616,97617,10H-Phenothiazine-3-carbonitrile,C1=CC=C2C(=C1)NC3=C(S2)C=C(C=C3)C#N,,,,,,
7617,97618,3-Nitroacenaphthene,C1CC2=C(C=CC3=C2C1=CC=C3)[N+](=O)[O-],,,,,,
7618,97619,5-Acenaphthenecarboxylic acid,C1CC2=CC=C(C3=CC=CC1=C23)C(=O)O,,,,,,
7619,97620,4-Bromobenzylisothiocyanate,C1=CC(=CC=C1CN=C=S)Br,,,,,,
7620,97621,"10-Undecenamide, N-(2-(dimethylamino)ethyl)-",CN(C)CCNC(=O)CCCCCCCCC=C,,,,,,
7621,97622,Lanuginosine,COC1=CC2=C(C=C1)C3=C4C(=CC5=C3OCO5)C=CN=C4C2=O,,,,,,
7622,97623,N-Benzoylphthalimide,C1=CC=C(C=C1)C(=O)N2C(=O)C3=CC=CC=C3C2=O,,,,,,
7623,97624,"2-Methyl-n-(4-methylpyridin-2-yl)-4,5-dihydrofuran-3-carboxamide",CC1=CC(=NC=C1)NC(=O)C2=C(OCC2)C,,,,,,
7624,97625,CID 97625,C1=NC2=C(N1[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N=C(N=C2[SeH])N,,,,,,
7625,97626,"1-Fluoro-2,4,6-trinitrobenzene",C1=C(C=C(C(=C1[N+](=O)[O-])F)[N+](=O)[O-])[N+](=O)[O-],,,,,,
7626,97627,9-Riburonosyladenine,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)C(=O)O)O)O)N,,,,,,
7627,97628,4-(Fluorosulfonyl)benzoyl chloride,C1=CC(=CC=C1C(=O)Cl)S(=O)(=O)F,,,,,,
7628,97629,"5-Chloro-2,3-pyridinediol",C1=C(C(=O)NC=C1Cl)O,,,,,,
7629,97630,2-Aminobenzenesulphonyl fluoride,C1=CC=C(C(=C1)N)S(=O)(=O)F,,,,,,
7630,97631,2-Fluorosulphonylbenzenesulphonyl chloride,C1=CC=C(C(=C1)S(=O)(=O)F)S(=O)(=O)Cl,,,,,,
7631,97632,N-Methylmethanesulfonamide,CNS(=O)(=O)C,,,,,,
7632,97633,Cetyl chloroformate,CCCCCCCCCCCCCCCCOC(=O)Cl,,,,,,
7633,97634,CID 97634,C1=CC2=C(C=C(OC2=CC1=O)O)C(F)(F)F,,,,,,
7634,97635,CID 97635,C1=CC(=O)C(=CC1=O)N(O)O,,,,,,
7635,97636,N-(p-(Methylamino)benzoyl)glutamic acid,CNC1=CC=C(C=C1)C(=O)N[C@@H](CCC(=O)O)C(=O)O,,,,,,
7636,97637,Diphenylpropynone,C1=CC=C(C=C1)C#CC(=O)C2=CC=CC=C2,,,,,,
7637,97638,"4-Propylbenzene-1,2-diol",CCCC1=CC(=C(C=C1)O)O,,,,,,
7638,97639,"N,N'-bis[bis(dimethylamino)phosphinothioyl]-N,N'-dimethylmethanediamine",CN(C)P(=S)(N(C)C)N(C)CN(C)P(=S)(N(C)C)N(C)C,,,,,,
7639,97640,Pentamethylphosphorothioic triamide,CNP(=S)(N(C)C)N(C)C,,,,,,
7640,97641,"2,5-Dimethoxybenzene-1,4-diol",COC1=CC(=C(C=C1O)OC)O,,,,,,
7641,97642,"1,3-Dimethyl-6-hydrazinouracil",CN1C(=CC(=O)N(C1=O)C)NN,,,,,,
7642,97643,Trichloro(1-chloroethyl)silane,CC([Si](Cl)(Cl)Cl)Cl,,,,,,
7643,97644,"Silane, bromotrioctyl-",CCCCCCCC[Si](CCCCCCCC)(CCCCCCCC)Br,,,,,,
7644,97645,1-(4-Methylnaphthalen-1-yl)ethanone,CC1=CC=C(C2=CC=CC=C12)C(=O)C,,,,,,
7645,97646,"1,1-Dichloro-2,2,3,3-tetramethylcyclopropane",CC1(C(C1(Cl)Cl)(C)C)C,,,,,,
7646,97647,(S)-4-Nitrophenyl 2-(((benzyloxy)carbonyl)amino)-4-methylpentanoate,CC(C)C[C@@H](C(=O)OC1=CC=C(C=C1)[N+](=O)[O-])NC(=O)OCC2=CC=CC=C2,,,,,,
7647,97648,CID 97648,C1C(=NNC(=NN=C2CC3=CC=CC=C3C=C2)S)C=CC4=CC=CC=C41,,,,,,
7648,97649,"Benzamide, m-(3,3-dimethyl-1-triazeno)-",CN(C)N=NC1=CC=CC(=C1)C(=O)N,,,,,,
7649,97650,2-Amino-4-(phenylsulfanyl)butanoic acid,C1=CC=C(C=C1)SCCC(C(=O)O)N,,,,,,
7650,97651,Ethyl p-tolyl sulfone,CCS(=O)(=O)C1=CC=C(C=C1)C,,,,,,
7651,97652,1-Bromo-2-[2-(2-bromophenyl)ethyl]benzene,C1=CC=C(C(=C1)CCC2=CC=CC=C2Br)Br,,,,,,
7652,97653,Dichlorotrimethylantimony,C[Sb](C)(C)(Cl)Cl,,,,,,
7653,97654,2-(p-Toluenesulfonyl)acetophenone,CC1=CC=C(C=C1)S(=O)(=O)CC(=O)C2=CC=CC=C2,,,,,,
7654,97655,Diethyl ((ethylthio)methyl)phosphonate,CCOP(=O)(CSCC)OCC,,,,,,
7655,97656,"N-methyl-3-phenyl-N-[2-[1-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]imidazol-4-yl]ethyl]prop-2-enamide",CN(CCC1=CN(C=N1)[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)C(=O)C=CC3=CC=CC=C3,,,,,,
7656,97657,Diethyl nitromalonate,CCOC(=O)C(C(=O)OCC)[N+](=O)[O-],,,,,,
7657,97658,4-Fluoro-4'-nitrobenzophenone,C1=CC(=CC=C1C(=O)C2=CC=C(C=C2)F)[N+](=O)[O-],,,,,,
7658,97659,"1-Propanamine, 3-(dodecylthio)-",CCCCCCCCCCCCSCCCN,,,,,,
7659,97660,4-(4-Methoxyphenyl)-1-butanol,COC1=CC=C(C=C1)CCCCO,,,,,,
7660,97661,"Thiosulfuric acid, S-(2-((tetrahydro-2H-thiopyran-4-yl)amino)ethyl) ester, S,S-dioxide",C1CS(=O)(=O)CCC1NCCSS(=O)(=O)O,,,,,,
7661,97662,Oxoglaucine,COC1=C(C2=C3C(=C1)C=CN=C3C(=O)C4=CC(=C(C=C42)OC)OC)OC,,,,,,
7662,97663,Hydroxylated lecithin,C([C@@H](C(=O)O)N)C(=O)NO,,,"['Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)', 'Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)']",,,
7663,97664,5-(Methylthio)-1H-tetrazole,CSC1=NNN=N1,,,,,,
7664,97665,2-Amino-5-nitrobenzamide,C1=CC(=C(C=C1[N+](=O)[O-])C(=O)N)N,,,,,,
7665,97666,"6H-Pyrido[4,3-b]carbazole",C1=CC=C2C(=C1)C3=C(N2)C=C4C=CN=CC4=C3,,,,,,
7666,97667,Hydroxybenzindazole,C1CC2=C(C3=C1C=C(C=C3)O)NN=C2,,,,,,
7667,97668,5-Acetylacenaphthene,CC(=O)C1=CC=C2CCC3=C2C1=CC=C3,,,,,,
7668,97669,"1,3-Bis(2-methoxyphenoxy)propan-2-ol",COC1=CC=CC=C1OCC(COC2=CC=CC=C2OC)O,,,,,,
7669,97670,"(5,6-Dichloro-2-methylbenzimidazol-1-yl)-ethyl acetate",CC1=NC2=CC(=C(C=C2N1CCOC(=O)C)Cl)Cl,,,,,,
7670,97671,CID 97671,CCCCCCCC[SnH](CC)CC.CC(=O)O,,,,,,
7671,97672,CID 97672,CCCCCCCC[SnH](CC)CC,,,,,,
7672,97673,3-Benzylrhodanine,C1C(=O)N(C(=S)S1)CC2=CC=CC=C2,,,,,,
7673,97674,"2-Buten-1-one, 3-methyl-1-phenyl-",CC(=CC(=O)C1=CC=CC=C1)C,,,,,,
7674,97675,5'-Deoxy-5'-fluorothymidine,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CF)O,,,,,,
7675,97676,Bis-A-tda,C1=NN=C(S1)NCNC2=NN=CS2,,,,,,
7676,97677,2-(Benzylideneamino)ethanol,C1=CC=C(C=C1)C=NCCO,,,,,,
7677,97678,3-Nitrobenzylidene di(acetate),CC(=O)OC(C1=CC(=CC=C1)[N+](=O)[O-])OC(=O)C,,,,,,
7678,97679,Norsanguinarine,C1OC2=C(O1)C3=CN=C4C(=C3C=C2)C=CC5=CC6=C(C=C54)OCO6,,,,,,
7679,97680,Dihydroisodrin,C1CC2CC1C3C2C4(C(=C(C3(C4(Cl)Cl)Cl)Cl)Cl)Cl,,,,,,
7680,97681,CID 97681,C1=CN=C(C=N1)C=NN=C(N)S,,,,,,
7681,97682,CID 97682,C1=CC=C(C=C1)[PbH](C2=CC=CC=C2)C3=CC=CC=C3.C1=C[N-]C=C1,,,,,,
7682,97683,CID 97683,C1=CC=C(C=C1)[PbH](C2=CC=CC=C2)C3=CC=CC=C3.C1=CC=C2C(=C1)C=C[N-]2,,,,,,
7683,97684,CID 97684,C1=CC=C(C=C1)[PbH](C2=CC=CC=C2)C3=CC=CC=C3.C1=CC=C2C(=C1)C3=CC=CC=C3[N-]2,,,,,,
7684,97685,Dicyclopropanecarboxamide,C1CC1C(=O)NC(=O)C2CC2,,,,,,
7685,97686,"1,2,4,5-Tetramethoxybenzene",COC1=CC(=C(C=C1OC)OC)OC,,,,,,
7686,97687,"2-Propenoic acid, 4-nitrophenyl ester",C=CC(=O)OC1=CC=C(C=C1)[N+](=O)[O-],,,,,,
7687,97688,"Acenaphthene, 3,6-dinitro-",C1CC2=C(C=CC3=C(C=CC1=C23)[N+](=O)[O-])[N+](=O)[O-],,,,,,
7688,97689,"Hydantoin, 5,5-diphenyl-3-(2-hydroxyethyl)-",C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)CCO)C3=CC=CC=C3,,,,,,
7689,97690,4-Benzoyl-3-methyl-1-phenyl-2-pyrazolin-5-one,CC1=NN(C(=O)C1C(=O)C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
7690,97691,"N-(6,11-dihydroxy-5,12-dioxotetracen-1-yl)acetamide",CC(=O)NC1=CC=CC2=C1C(=O)C3=C(C4=CC=CC=C4C(=C3C2=O)O)O,,,,,,
7691,97692,Adenosine 5'-carboxamide,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)C(=O)N)O)O)N,,,,,,
7692,97693,"Threonine, N-(purin-6-ylcarbamoyl)-, L-",CC([C@@H](C(=O)O)NC(=O)NC1=NC=NC2=C1NC=N2)O,,,,,,
7693,97694,"4-Pyridinecarbonitrile, 2,3,5-trichloro-6-(methylsulfonyl)-",CS(=O)(=O)C1=NC(=C(C(=C1Cl)C#N)Cl)Cl,,,,,,
7694,97695,"1-(2-Methoxyphenyl)-1H-pyrrole-2,5-dione",COC1=CC=CC=C1N2C(=O)C=CC2=O,,,,,,
7695,97696,"1,3-Dimethoxyacridin-9(10h)-one",COC1=CC2=C(C(=C1)OC)C(=O)C3=CC=CC=C3N2,,,,,,
7696,97697,1-Aziridineethanamine,C1CN1CCN,,,,,,
7697,97698,2-Chloro-2-oxo-1-phenylethyl acetate,CC(=O)OC(C1=CC=CC=C1)C(=O)Cl,,,,,,
7698,97699,1-(4-Bromophenyl)-3-phenyl-2-propen-1-one,C1=CC=C(C=C1)C=CC(=O)C2=CC=C(C=C2)Br,,,,,,
7699,97700,2-Cyclohexyl-2-hydroxy-2-phenylacetic acid,C1CCC(CC1)C(C2=CC=CC=C2)(C(=O)O)O,,,,,,
7700,97701,Mono-sec-butyl phthalate,CCC(C)OC(=O)C1=CC=CC=C1C(=O)O,,,,,,
7701,97702,2-Methyl-6-benzylidenecyclohexanone,CC1CCCC(=CC2=CC=CC=C2)C1=O,,,,,,
7702,97703,3'-Cloromethotrexate,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=C(C=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O)Cl,,,,,,
7703,97704,"3,6-Dimethylpiperazine-2,5-dione",CC1C(=O)NC(C(=O)N1)C,,,,,,
7704,97705,Ethyl 2-acetyl-4-methylpent-4-enoate,CCOC(=O)C(CC(=C)C)C(=O)C,,,,,,
7705,97706,CID 97706,CC(C)CC(=O)C=CC(C)C,,,,,,
7706,97707,"2(3H)-Furanone, dihydro-4-methyl-5-pentyl-",CCCCCC1C(CC(=O)O1)C,,,,,,
7707,97708,"2-Butanone, 4-(4-methoxyphenyl)-3-methyl-",CC(CC1=CC=C(C=C1)OC)C(=O)C,,,,,,
7708,97709,1-Aminoethylphosphonic acid,CC(N)P(=O)(O)O,,,,,,
7709,97710,(1-Amino-2-phenylethyl)phosphonic acid,C1=CC=C(C=C1)CC(N)P(=O)(O)O,,,,,,
7710,97711,"5,5-Dimethyl-2-phenylmorpholine",CC1(COC(CN1)C2=CC=CC=C2)C,,,,,,
7711,97712,"2-Propanol, 1-[bis(2-hydroxyethyl)amino]-",CC(CN(CCO)CCO)O,,,,,,
7712,97713,Ethyl 2-phenylbutyrate,CCC(C1=CC=CC=C1)C(=O)OCC,,,,,,
7713,97714,"7,8,9,10-Tetrahydrobenzo[a]pyren-7-ol",C1CC(C2=C(C1)C3=C4C(=C2)C=CC5=C4C(=CC=C5)C=C3)O,,,,,"['7-hydroxy-7,8,9,10-tetrahydrobenzo[a]pyrene has known human metabolites that include 7,8,9,10-tetrahydrobenzo[a]pyren-7-yl hydrogen sulfate.']",
7714,97715,CID 97715,C1=CSC(=C1)C=C2C(=O)N=C(S2)S,,,,,,
7715,97716,CID 97716,C1=CC(=CC=C1C=C2C(=O)N=C(S2)S)Cl,,,,,,
7716,97717,"5-[(4-Chlorophenyl)methylidene]-3-ethyl-2-sulfanylidene-1,3-thiazolidin-4-one",CCN1C(=O)C(=CC2=CC=C(C=C2)Cl)SC1=S,,,,,,
7717,97718,"2,4-Imidazolidinedione, 5,5-bis(4-chlorophenyl)-",C1=CC(=CC=C1C2(C(=O)NC(=O)N2)C3=CC=C(C=C3)Cl)Cl,,,,,,
7718,97719,(4-Chlorophenyl)(pyridin-2-yl)methanol,C1=CC=NC(=C1)C(C2=CC=C(C=C2)Cl)O,,,,,,
7719,97720,2-Chloromandelic acid,C1=CC=C(C(=C1)C(C(=O)O)O)Cl,,,,,,
7720,97721,"4,4'-Azoxydicinnamic acid",C1=CC(=CC=C1C=CC(=O)O)N=[N+](C2=CC=C(C=C2)C=CC(=O)O)[O-],,,,,,
7721,97722,Anhydropodophyllol,COC1=CC(=CC(=C1OC)OC)C2C3COCC3C(C4=CC5=C(C=C24)OCO5)O,,,,,,
7722,97723,"3a,4,7,7a-tetrahydro-1H-4,7-methanoisoindole-1,3(2H)-dione",C1C2C=CC1C3C2C(=O)NC3=O,,,,,,
7723,97724,"5-Norbornene-2,3-dimethanol",C1C2C=CC1C(C2CO)CO,,,,,,
7724,97725,(S)-2-Amino-6-hydroxyhexanoic acid,C(CCO)C[C@@H](C(=O)O)N,,,,,,
7725,97726,CID 97726,C1=CC(=CC=C1C=C2C(=O)N=C(S2)S)F,,,,,,
7726,97727,3-(p-Chlorophenyl)-5-ethylrhodanine,CCC1C(=O)N(C(=S)S1)C2=CC=C(C=C2)Cl,,,,,,
7727,97728,5-Ethyl-3-phenylrhodanine,CCC1C(=O)N(C(=S)S1)C2=CC=CC=C2,,,,,,
7728,97729,3-(p-Chlorophenyl)-5-propylrhodanine,CCCC1C(=O)N(C(=S)S1)C2=CC=C(C=C2)Cl,,,,,,
7729,97730,Non-2-enoic acid,CCCCCCC=CC(=O)O,,,,,,
7730,97731,1-(Benzylamino)propan-2-ol,CC(CNCC1=CC=CC=C1)O,,,,,,
7731,97732,sec-Butyl methacrylate,CCC(C)OC(=O)C(=C)C,,,,,,
7732,97733,"Propyl hexa-2,4-dienoate",CCCOC(=O)C=CC=CC,,,,,,
7733,97734,Ethyl 2-(ethoxymethylene)-3-oxobutanoate,CCOC=C(C(=O)C)C(=O)OCC,,,,,,
7734,97735,"Cyclopentanecarboxylic acid, 1-amino-2-methyl-",CC1CCCC1(C(=O)O)N,,,,,,
7735,97736,"4-Oxazolidinone, 2,5-diphenyl-",C1=CC=C(C=C1)C2C(=O)NC(O2)C3=CC=CC=C3,,,,,,
7736,97737,"1-((2,3-Dihydro-1,4-benzodioxin-2-yl)methyl)-4-phenylpiperazine",C1CN(CCN1CC2COC3=CC=CC=C3O2)C4=CC=CC=C4,,,,,,
7737,97738,2-(Chloromethyl)tetrahydro-2H-pyran,C1CCOC(C1)CCl,,,,,,
7738,97739,3-(4-Methoxyphenyl)-2-phenylpropanoic acid,COC1=CC=C(C=C1)CC(C2=CC=CC=C2)C(=O)O,,,,,,
7739,97740,6-Chloro-9-(tetrahydro-2H-pyran-2-yl)-9H-purine,C1CCOC(C1)N2C=NC3=C2N=CN=C3Cl,,,,,,
7740,97741,N-Acetyliodocolchinol,CC(=O)NC1CCC2=CC(=C(C(=C2C3=CC(=C(C=C13)O)I)OC)OC)OC,,,,,,
7741,97742,"Cyclohexanone, 2,6-bis((4-methoxyphenyl)methylene)-",COC1=CC=C(C=C1)C=C2CCCC(=CC3=CC=C(C=C3)OC)C2=O,,,,,,
7742,97743,N-Carbobenzoxy-DL-valine,CC(C)C(C(=O)O)NC(=O)OCC1=CC=CC=C1,,,,,,
7743,97744,3-Phenylbutan-2-one,CC(C1=CC=CC=C1)C(=O)C,,,,,,
7744,97745,"3-Phenyl-1,3-propanediol diacetate",CC(=O)OCCC(C1=CC=CC=C1)OC(=O)C,,,,,,
7745,97746,gamma-Tetradecalactone,CCCCCCCCCCC1CCC(=O)O1,,,,,,
7746,97747,"2(3H)-Furanone, 5-dodecyldihydro-",CCCCCCCCCCCCC1CCC(=O)O1,,,,,,
7747,97748,Hexadec-3-enoic acid,CCCCCCCCCCCCC=CCC(=O)O,,,,,,
7748,97749,1-Amino-3-(diethylamino)propan-2-ol,CCN(CC)CC(CN)O,,,,,,
7749,97750,Diethyl 2-methyl-3-oxosuccinate,CCOC(=O)C(C)C(=O)C(=O)OCC,,,,,,
7750,97751,"4-(2,3-Epoxypropyl)morpholine",C1COCCN1CC2CO2,,,,,,
7751,97752,Ethyl 2-chloro-2-phenylacetate,CCOC(=O)C(C1=CC=CC=C1)Cl,,,,,,
7752,97753,3-Hydroxy-4-(1-oxo-3-phenyl-2-propen-1-yl)-2(5H)-furanone,C1C(=C(C(=O)O1)O)C(=O)C=CC2=CC=CC=C2,,,,,,
7753,97754,(2-Methyloxiran-2-yl)methanol,CC1(CO1)CO,,,,,,
7754,97755,"3-Buten-2-one, 4-(3-methylbicyclo[2.2.1]hept-5-en-2-yl)-",CC1C2CC(C1C=CC(=O)C)C=C2,,,,,,
7755,97756,"2(3H)-Furanone, 4-acetyldihydro-",CC(=O)C1CC(=O)OC1,,,,,,
7756,97757,"3-Benzyl-2,4-pentanedione",CC(=O)C(CC1=CC=CC=C1)C(=O)C,,,,,,
7757,97758,2-Penten-4-yn-1-ol,C#CC=CCO,,,,,,
7758,97759,1-Methylpentyl methacrylate,CCCCC(C)OC(=O)C(=C)C,,,,,,
7759,97760,"4-Chlorotetrahydrothiophene-3-ol 1,1-dioxide",C1C(C(CS1(=O)=O)Cl)O,,,,,,
7760,97761,2-Norbornanemethylamine,C1CC2CC1CC2CN,,,,,,
7761,97762,"3,3'-Dihydroxyhexestrol",CCC(C1=CC(=C(C=C1)O)O)C(CC)C2=CC(=C(C=C2)O)O,,,,,,
7762,97763,3-Oxo-2-phenylpentanenitrile,CCC(=O)C(C#N)C1=CC=CC=C1,,,,,,
7763,97764,"3-Buten-2-one, 4-(3,5,6-trimethyl-3-cyclohexen-1-yl)-",CC1C=C(CC(C1C)C=CC(=O)C)C,,,,,,
7764,97765,"6-[(1Z,2Z)-3-Hydroxy-3-phenyl-2-propene-1-ylidene]-2,4-cyclohexadiene-1-one",C1=CC=C(C=C1)C(=O)C=CC2=CC=CC=C2O,,,,,,
7765,97766,"3-(3,4-Dihydroxyphenyl)-1-(2-hydroxyphenyl)-2-propen-1-one",C1=CC=C(C(=C1)C(=O)C=CC2=CC(=C(C=C2)O)O)O,,,,,,
7766,97767,"3-(1,3-benzodioxol-5-yl)-N,N-diethylprop-2-enamide",CCN(CC)C(=O)C=CC1=CC2=C(C=C1)OCO2,,,,,,
7767,97768,Endosulfan ether,C1C2C(CO1)C3(C(=C(C2(C3(Cl)Cl)Cl)Cl)Cl)Cl,,,,,,
7768,97769,4-Ethyl-2-oxazolidinone,CCC1COC(=O)N1,,,,,,
7769,97770,2-Methylpentanamide,CCCC(C)C(=O)N,,,,,,
7770,97771,Tetrahydrofurfuryl stearate,CCCCCCCCCCCCCCCCCC(=O)OCC1CCCO1,,,,,,
7771,97772,"Phenethylamine, N,N-dimethyl-beta-ethyl-",CCC(CN(C)C)C1=CC=CC=C1,,,,,,
7772,97773,3-Carbethoxy-2-piperidone,CCOC(=O)C1CCCNC1=O,,,,,,
7773,97774,"3-Dodecyloxypropane-1,2-diol",CCCCCCCCCCCCOCC(CO)O,,,"['Substances that inhibit or arrest DENTAL CARIES formation. (Boucher&apos;s Clinical Dental Terminology, 4th ed) (See all compounds classified as Cariostatic Agents.)', 'Agents that modify interfacial tension of water; usually substances that have one lipophilic and one hydrophilic group in the molecule; includes soaps, detergents, emulsifiers, dispersing and wetting agents, and several groups of antiseptics. (See all compounds classified as Surface-Active Agents.)']",,,
7774,97775,3-Methyl-3-n-butylglutarimide,CCCCC1(CC(=O)NC(=O)C1)C,,,,,,
7775,97776,2-Ethyl-2-methylsuccinic acid,CCC(C)(CC(=O)O)C(=O)O,,,,,,
7776,97777,"Glutarimide, N,3-dimethyl-3-hexyl-",CCCCCCC1(CC(=O)N(C(=O)C1)C)C,,,,,,
7777,97778,2-Methylbutanamide,CCC(C)C(=O)N,,,,,,
7778,97779,1-(3-Chlorophenyl)ethanol,CC(C1=CC(=CC=C1)Cl)O,,,,,,
7779,97780,Ethyl bromophenylacetate,CCOC(=O)C(C1=CC=CC=C1)Br,,,,,,
7780,97781,Methyl 3-(benzylamino)-2-methylpropanoate,CC(CNCC1=CC=CC=C1)C(=O)OC,,,,,,
7781,97782,2-Benzylidenebutanal,CCC(=CC1=CC=CC=C1)C=O,,,,,,
7782,97783,2-Hydroxydodecanoic acid,CCCCCCCCCCC(C(=O)O)O,,,,,,
7783,97784,"6-Chloro-2-(4-chlorophenyl)-2,3-dihydro-4H-1-benzopyran-4-one",C1C(OC2=C(C1=O)C=C(C=C2)Cl)C3=CC=C(C=C3)Cl,,,,,,
7784,97785,"2-(1-Phenylethyl)-1,3-dioxolane",CC(C1OCCO1)C2=CC=CC=C2,,,,,,
7785,97786,Piperoin,C1OC2=C(O1)C=C(C=C2)C(C(=O)C3=CC4=C(C=C3)OCO4)O,,,,,,
7786,97787,3-Butylcarbamoyl-acrylic acid,CCCCNC(=O)C=CC(=O)O,,,,,,
7787,97788,"Phenol, 4-(3,4-dihydro-2,2,4-trimethyl-2H-1-benzopyran-4-yl)-",CC1(CC(C2=CC=CC=C2O1)(C)C3=CC=C(C=C3)O)C,,,,,,
7788,97789,"17-Hydroxy-2,17-dimethylandrostan-3-one",CC1CC2(C(CCC3C2CCC4(C3CCC4(C)O)C)CC1=O)C,,,,,,
7789,97790,4-(3-Hydroxybutyl)phenol,CC(CCC1=CC=C(C=C1)O)O,,,,,,
7790,97791,"5,5-Dimethyl-2-(1-phenylethyl)-1,3-dioxane",CC(C1OCC(CO1)(C)C)C2=CC=CC=C2,,,,,,
7791,97792,"2,5-Bis(hydroxymethyl)tetrahydrofuran",C1CC(OC1CO)CO,,,,,,
7792,97793,4-Methoxy-4'-hydroxychalcone,COC1=CC=C(C=C1)C=CC(=O)C2=CC=C(C=C2)O,,,,,,
7793,97794,"4,4'-(Ethene-1,2-diyl)dibenzoic acid",C1=CC(=CC=C1C=CC2=CC=C(C=C2)C(=O)O)C(=O)O,,,,,,
7794,97795,2-Methyl-2-phenyl-3-hydroxypropanoic acid,CC(CO)(C1=CC=CC=C1)C(=O)O,,,,,,
7795,97796,"Methyl 2,3-anhydro-4,6-O-benzylidenehexopyranoside",COC1C2C(O2)C3C(O1)COC(O3)C4=CC=CC=C4,,,,,,
7796,97797,"2-Phenyl-1,3-oxathiolane",C1CSC(O1)C2=CC=CC=C2,,,,,,
7797,97798,Ethyl 2-(2-ethoxy-2-oxoethoxy)propionate,CCOC(=O)COC(C)C(=O)OCC,,,,,,
7798,97799,2-Phenylhexanenitrile,CCCCC(C#N)C1=CC=CC=C1,,,,,,
7799,97800,"4-(Chloromethyl)-2-hexyl-1,3-dioxolane",CCCCCCC1OCC(O1)CCl,,,,,,
7800,97801,"2-(Chloromethyl)-1,4-dioxaspiro[4.5]decane",C1CCC2(CC1)OCC(O2)CCl,,,,,,
7801,97802,"3,3'-(1,4-Piperazinediyl)bis(2-methyl-1-phenyl-1-propanone)",CC(CN1CCN(CC1)CC(C)C(=O)C2=CC=CC=C2)C(=O)C3=CC=CC=C3,,,,,,
7802,97803,1-(4-Chlorophenyl)ethanamine,CC(C1=CC=C(C=C1)Cl)N,,,,,,
7803,97804,"1,1,1-Trifluoro-2-octanol",CCCCCCC(C(F)(F)F)O,,,,,,
7804,97805,Methyl N-acetyl-DL-phenylalaninate,CC(=O)NC(CC1=CC=CC=C1)C(=O)OC,,,,,,
7805,97806,N-Carbobenzoxy-DL-methionine,CSCCC(C(=O)O)NC(=O)OCC1=CC=CC=C1,,,,,,
7806,97807,"1,2-Propanediol, 3-(1,3-benzodioxol-5-yl)-",C1OC2=C(O1)C=C(C=C2)CC(CO)O,,,,,,
7807,97808,"4-Carboxymethyl-3-methylbut-2-en-1,4-olide",CC1=CC(=O)OC1CC(=O)O,,,,,,
7808,97809,N-(2-ethylbutylideneamino)-5-nitropyridin-2-amine,CCC(CC)C=NNC1=NC=C(C=C1)[N+](=O)[O-],,,,,,
7809,97810,CID 97810,C1=CC=C(C=C1)C=C2C(=O)N=C(S2)S,,,,,,
7810,97811,"Phosphonic acid, (hydroxy(3-nitrophenyl)methyl)-, diethyl ester",CCOP(=O)(C(C1=CC(=CC=C1)[N+](=O)[O-])O)OCC,,,,,,
7811,97812,Decahydroisoquinoline,C1CCC2CNCCC2C1,,,,,,
7812,97813,1-Bromo-2-phenylpropane,CC(CBr)C1=CC=CC=C1,,,,,,
7813,97814,(-)-Menthyloxyacetic acid,CC1CCC(C(C1)OCC(=O)O)C(C)C,,,,,,
7814,97815,3-Methyl-1-penten-4-yn-3-ol,CC(C=C)(C#C)O,,,,,,
7815,97816,"2-Methoxy-4-(4-methyl-1,3-dioxan-2-yl)phenol",CC1CCOC(O1)C2=CC(=C(C=C2)O)OC,,,,,,
7816,97817,Dipropylglycine,CCCC(CCC)(C(=O)O)N,,,,,,
7817,97818,"5,6-Dihydro-6-methyluracil",CC1CC(=O)NC(=O)N1,,,,,,
7818,97819,"Hydrouracil, 5-bromo-",C1C(C(=O)NC(=O)N1)Br,,,,,,
7819,97820,"2'-Hydroxy-2,4,4,7,4'-pentamethylflavan",CC1=CC(=C(C=C1)C2(CC(C3=C(O2)C=C(C=C3)C)(C)C)C)O,,,,,,
7820,97821,"2-Heptadec-8-enyl-4,5-dihydro-1,3-oxazole",CCCCCCCCC=CCCCCCCCC1=NCCO1,,,,,,
7821,97822,"2-Heptadec-8-enyl-5-methyl-4,5-dihydro-1,3-oxazole",CCCCCCCCC=CCCCCCCCC1=NCC(O1)C,,,,,,
7822,97823,2-Hydroxy-2-methylbutanenitrile,CCC(C)(C#N)O,,,,,,
7823,97824,"3-Piperidino-1,2-propanediol",C1CCN(CC1)CC(CO)O,,,,,,
7824,97825,3-(3-Amino-phenyl)-acrylic acid ethyl ester,CCOC(=O)C=CC1=CC(=CC=C1)N,,,,,,
7825,97826,Ethyl 3-(4-aminophenyl)acrylate,CCOC(=O)C=CC1=CC=C(C=C1)N,,,,,,
7826,97827,3-[2-[Bis(2-chloroethyl)amino]phenyl]prop-2-enoic acid,C1=CC=C(C(=C1)C=CC(=O)O)N(CCCl)CCCl,,,,,,
7827,97828,"1,3-Dioxolane, 4-(chloromethyl)-2-ethyl-2-methyl-",CCC1(OCC(O1)CCl)C,,,,,,
7828,97829,Sesquichamene,CC1=CCC2(CCCC(C23C1C3)(C)C)C,,,,,,
7829,97830,"2-Phenyl-1,4-dioxaspiro[4.5]decane",C1CCC2(CC1)OCC(O2)C3=CC=CC=C3,,,,,,
7830,97831,1-(1-Methyl-2-benzimidazolyl)ethanol,CC(C1=NC2=CC=CC=C2N1C)O,,,,,,
7831,97832,4-Methylimidazolidin-2-one,CC1CNC(=O)N1,,,,,,
7832,97833,"1-Oxaspiro[2.5]octane-4,5,6,7,8-pentol",C1C2(O1)C(C(C(C(C2O)O)O)O)O,,,,,,
7833,97834,CID 97834,C1CC(OC1)N2C=NC3=C2N=CN=C3S,,,,,,
7834,97835,"17-Acetyl-12-bromo-11-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one",CC(=O)C1CCC2C1(C(C(C3C2CCC4=CC(=O)CCC34C)O)Br)C,,,,,,
7835,97836,1-Methylpyrrolidine-2-methanol,CN1CCCC1CO,,,,,,
7836,97837,"m-N,N-Bis(2-chloroethyl)aminocinnamic acid",C1=CC(=CC(=C1)N(CCCl)CCCl)C=CC(=O)O,,,,,,
7837,97838,"2-Benzyl-4-phenyl-1,3-dioxolane",C1C(OC(O1)CC2=CC=CC=C2)C3=CC=CC=C3,,,,,,
7838,97839,n-(2-Oxotetrahydrofuran-3-yl)benzamide,C1COC(=O)C1NC(=O)C2=CC=CC=C2,,,,,,
7839,97840,1-Phenylethyl chloroacetate,CC(C1=CC=CC=C1)OC(=O)CCl,,,,,,
7840,97841,Pentyl 3-phenylprop-2-enoate,CCCCCOC(=O)C=CC1=CC=CC=C1,,,,,,
7841,97842,"2-Methyl-1,5-dioxaspiro[5.5]undecane",CC1CCOC2(O1)CCCCC2,,,,,,
7842,97843,"2,4-Dimethyl-2-(4-methyl-3-pentenyl)-1,3-dioxane",CC1CCOC(O1)(C)CCC=C(C)C,,,,,,
7843,97844,"2-(4-Isopropylphenyl)-4,4,6-trimethyl-1,3-dioxane",CC1CC(OC(O1)C2=CC=C(C=C2)C(C)C)(C)C,,,,,,
7844,97845,3-[4-[Bis(2-chloroethyl)amino]phenyl]prop-2-enoic acid,C1=CC(=CC=C1C=CC(=O)O)N(CCCl)CCCl,,,,,,
7845,97846,3-Acetyldihydro-5-methylfuran-2(3H)-one,CC1CC(C(=O)O1)C(=O)C,,,,,,
7846,97847,"4-(N,N-dimethylamino)-2'-hydroxychalcone",CN(C)C1=CC=C(C=C1)C=CC(=O)C2=CC=CC=C2O,,,,,,
7847,97848,Eugenol cinnamate,COC1=C(C=CC(=C1)CC=C)OC(=O)C=CC2=CC=CC=C2,,,,,,
7848,97849,"1-Methyl-2,2,3,3-tetrafluoropropyl carbamate",CC(C(C(F)F)(F)F)OC(=O)N,,,,,,
7849,97850,CID 97850,C1=CC=C(C=C1)CC2C(=O)NC(=N2)S,,,,,,
7850,97851,1-(2-Nitrophenyl)ethanol,CC(C1=CC=CC=C1[N+](=O)[O-])O,,,,,,
7851,97852,"Thiazole, 4,5-dihydro-2,5-dimethyl-",CC1CN=C(S1)C,,,,,,
7852,97853,"Butylamine, N-(1,3-dimethylbutylidene)-1,3-dimethyl-",CC(C)CC(C)N=C(C)CC(C)C,,,,,,
7853,97854,"3,5-Dimethylcyclohex-3-ene-1-carbaldehyde",CC1CC(CC(=C1)C)C=O,,,,,,
7854,97855,3-Guanidinobutyric acid,CC(CC(=O)O)N=C(N)N,,,,,,
7855,97856,N-amidinoaspartic acid,C(C(C(=O)O)N=C(N)N)C(=O)O,,,,,,
7856,97857,"5-Benzylideneimidazolidine-2,4-dione",C1=CC=C(C=C1)C=C2C(=O)NC(=O)N2,,,,,,
7857,97858,"2,5-Dihydro-1H-pyrrole-2-carboxylic acid",C1C=CC(N1)C(=O)O,,,,,,
7858,97859,Cytidine dialdehyde,C1=CN(C(=O)N=C1N)C(C=O)OC(CO)C=O,,,,,,
7859,97860,6-Methoxyflavanone,COC1=CC2=C(C=C1)OC(CC2=O)C3=CC=CC=C3,,,,,,
7860,97861,"2-Methyl-2,4-pentanediol diacetate",CC(CC(C)(C)OC(=O)C)OC(=O)C,,,,,,
7861,97862,2-Morpholino-2-phenylacetamide,C1COCCN1C(C2=CC=CC=C2)C(=O)N,,,,,,
7862,97863,"4(1H)-Pyrimidinone, tetrahydro-2-imino-6-methyl-",CC1CC(=O)NC(=N1)N,,,,,,
7863,97864,"4(1H)-Pyrimidinone, tetrahydro-2-imino-6-phenyl-",C1C(N=C(NC1=O)N)C2=CC=CC=C2,,,,,,
7864,97865,N-Acetylcolchinol,CC(=O)NC1CCC2=CC(=C(C(=C2C3=C1C=C(C=C3)O)OC)OC)OC,,,,,,
7865,97866,"Acetamide, N-(6,7-dihydro-3,9,10,11-tetramethoxy-5H-dibenzo(a,c)cyclohepten-5-yl)-, (S)-",CC(=O)NC1CCC2=CC(=C(C(=C2C3=C1C=C(C=C3)OC)OC)OC)OC,,,,,,
7866,97867,"2-Phenyl-1,2-propanediol",CC(CO)(C1=CC=CC=C1)O,,,,,,
7867,97868,"Diisobutyl 2,3-dihydroxysuccinate",CC(C)COC(=O)C(C(C(=O)OCC(C)C)O)O,,,,,,
7868,97869,"2-Propanol, 1-(methylthio)-",CC(CSC)O,,,,,,
7869,97870,"2,4-Dimethylglutaric acid",CC(CC(C)C(=O)O)C(=O)O,,,,,,
7870,97871,"3,4-Heptanediol",CCCC(C(CC)O)O,,,,,,
7871,97872,"3-(3,4-Dimethoxyphenyl)prop-2-enenitrile",COC1=C(C=C(C=C1)C=CC#N)OC,,,,,,
7872,97873,"L-Leucine, N-1H-purin-6-yl-",CC(C)CC(C(=O)O)NC1=NC=NC2=C1NC=N2,,,,,,
7873,97874,Ethyl 2-cyano-3-(2-thienyl)-2-propenoate,CCOC(=O)C(=CC1=CC=CS1)C#N,,,,,,
7874,97875,2-Biphenylyl glycidyl ether,C1C(O1)COC2=CC=CC=C2C3=CC=CC=C3,,,,,,
7875,97876,"6-(2-Phenylethenyl)-1,3,5-triazine-2,4-diamine",C1=CC=C(C=C1)C=CC2=NC(=NC(=N2)N)N,,,,,,
7876,97877,"3-[(E)-3-(5-nitrofuran-2-yl)prop-2-enylideneamino]-1,3-oxazolidin-2-one",C1COC(=O)N1/N=C/C=CC2=CC=C(O2)[N+](=O)[O-],,,,,,
7877,97878,"1,4-Diiodo-2,3-dimethoxybutane",COC(CI)C(CI)OC,,,,,,
7878,97879,2-Ethylhexyl acetoacetate,CCCCC(CC)COC(=O)CC(=O)C,,,,,,
7879,97880,3-Phenylpropyl but-2-enoate,CC=CC(=O)OCCCC1=CC=CC=C1,,,,,,
7880,97881,"Hexanoic acid, 1-methylhexyl ester",CCCCCC(C)OC(=O)CCCCC,,,,,,
7881,97882,"2-Butenoic acid, pentylester",CCCCCOC(=O)C=CC,,,,,,
7882,97883,2-Methylbutyl isobutyrate,CCC(C)COC(=O)C(C)C,,,,,,
7883,97884,"2-Propenoic acid,3-(3-furanyl)-, propyl ester",CCCOC(=O)C=CC1=COC=C1,,,,,,
7884,97885,"2-Butenoic acid, phenylmethyl ester",CC=CC(=O)OCC1=CC=CC=C1,,,,,,
7885,97886,"2,3-Diphenylbutane-2,3-diol",CC(C1=CC=CC=C1)(C(C)(C2=CC=CC=C2)O)O,,,,,,
7886,97887,"1-Aziridinecarboxamide, N,N'-hexamethylenebis(2-methyl-",CC1CN1C(=O)NCCCCCCNC(=O)N2CC2C,,,,,,
7887,97888,(2-Methyl-4-phenylpent-3-en-2-yl)benzene,CC(=CC(C)(C)C1=CC=CC=C1)C2=CC=CC=C2,,,,,,
7888,97889,Acetic acid 2-methoxy-4-(2-nitro-vinyl)-phenyl ester,CC(=O)OC1=C(C=C(C=C1)C=C[N+](=O)[O-])OC,,,,,,
7889,97890,2-(Dimethylamino)cyclohexanol,CN(C)C1CCCCC1O,,,,,,
7890,97891,"1,4-Diphenyl-2-azetidinone",C1C(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
7891,97892,"2-(2,4,5,7-Tetranitro-9-fluorenylideneaminooxy)propionic acid",CC(C(=O)O)ON=C1C2=C(C(=CC(=C2)[N+](=O)[O-])[N+](=O)[O-])C3=C1C=C(C=C3[N+](=O)[O-])[N+](=O)[O-],,,,,,
7892,97893,"1,3-Di(thiophen-2-yl)prop-2-en-1-one",C1=CSC(=C1)C=CC(=O)C2=CC=CS2,,,,,,
7893,97894,1-(5-Chloro-2-hydroxyphenyl)-3-(4-chlorophenyl)prop-2-en-1-one,C1=CC(=CC=C1C=CC(=O)C2=C(C=CC(=C2)Cl)O)Cl,,,,,,
7894,97895,1-Ethoxyethyl acetate,CCOC(C)OC(=O)C,,,,,,
7895,97896,p-Menthane-3-carboxylic acid,CC1CCC(C(C1)C(=O)O)C(C)C,,,,,,
7896,97897,Bornyl butyrate,CCCC(=O)OC1CC2CCC1(C2(C)C)C,,,,,,
7897,97898,"4-Isopropyl-5,5-dimethyl-2-(1-phenylethyl)-1,3-dioxane",CC(C)C1C(COC(O1)C(C)C2=CC=CC=C2)(C)C,,,,,,
7898,97899,"1-(3,4-Dichlorophenyl)ethanol",CC(C1=CC(=C(C=C1)Cl)Cl)O,,,,,,
7899,97900,2-Chlorobenzylideneacetophenone,C1=CC=C(C=C1)C(=O)C=CC2=CC=CC=C2Cl,,,,,,
7900,97901,3-(Biphenyl-4-yl)-1-phenylprop-2-en-1-one,C1=CC=C(C=C1)C2=CC=C(C=C2)C=CC(=O)C3=CC=CC=C3,,,,,,
7901,97902,"2-Propen-1-one,1-[1,1'-biphenyl]-4-yl-3-phenyl-",C1=CC=C(C=C1)C=CC(=O)C2=CC=C(C=C2)C3=CC=CC=C3,,,,,,
7902,97903,2-(3-Methoxyphenyl)oxirane,COC1=CC=CC(=C1)C2CO2,,,,,,
7903,97904,N-(1-Phenylethyl)formamide,CC(C1=CC=CC=C1)NC=O,,,,,,
7904,97905,sec-Butyl stearate,CCCCCCCCCCCCCCCCCC(=O)OC(C)CC,,,,,,
7905,97906,AI332778;Maleylurea,C(=CC(=O)O)C(=O)NC(=O)N,,,,,,
7906,97907,"3-O-Benzyl-1,2:5,6-di-O-isopropylidene-alpha-D-glucofuranose",CC1(OCC(O1)C2C(C3C(O2)OC(O3)(C)C)OCC4=CC=CC=C4)C,,,,,,
7907,97908,5-Benzyloxy-DL-tryptophan,C1=CC=C(C=C1)COC2=CC3=C(C=C2)NC=C3CC(C(=O)O)N,,,,,,
7908,97909,Delphinine,CC(=O)OC12CC(C3(CC(C1C3OC(=O)C4=CC=CC=C4)C56C(CCC7(C5C(C2C6N(C7)C)OC)COC)OC)O)OC,,,,,,
7909,97910,"4,5-Dimethyl-1,3,2-dioxathiolane 2-oxide",CC1C(OS(=O)O1)C,,,,,,
7910,97911,Doisynoestrol,CCC1C2=C(CCC1(C)C(=O)O)C3=C(C=C2)C=C(C=C3)OC,,,,,,
7911,97912,N-(2-ethylhexylideneamino)-5-nitropyridin-2-amine,CCCCC(CC)C=NNC1=NC=C(C=C1)[N+](=O)[O-],,,,,,
7912,97913,2-Hydroxypropyl heptanoate,CCCCCCC(=O)OCC(C)O,,,,,,
7913,97914,S-Acetylmercaptosuccinic anhydride,CC(=O)SC1CC(=O)OC1=O,,,,,,
7914,97915,"4,5-Dihydroxyimidazolidin-2-one",C1(C(NC(=O)N1)O)O,,,,,,
7915,97916,"Octadecanamide, 12-hydroxy-N-(2-hydroxyethyl)-",CCCCCCC(CCCCCCCCCCC(=O)NCCO)O,,,,,,
7916,97917,2-Bromostearic acid,CCCCCCCCCCCCCCCCC(C(=O)O)Br,,,,,,
7917,97918,"1,3-Dioxolane, 2-(2,6-dimethyl-1,5-heptadienyl)-4,5-dimethyl-",CC1C(OC(O1)C=C(C)CCC=C(C)C)C,,,,,,
7918,97919,alpha-Bromophenylacetic acid,C1=CC=C(C=C1)C(C(=O)O)Br,,,,,,
7919,97920,1-Methoxypropan-2-yl methanesulfonate,CC(COC)OS(=O)(=O)C,,,,,,
7920,97921,1-Methoxy-2-(2-nitro-vinyl)-benzene,COC1=CC=CC=C1C=C[N+](=O)[O-],,,,,,
7921,97922,Carboxymethylmercaptosuccinic acid,C(C(C(=O)O)SCC(=O)O)C(=O)O,,,,,,
7922,97923,N-(3-oxobutan-2-yl)acetamide,CC(C(=O)C)NC(=O)C,,,,,,
7923,97924,2-(Aminomethyl)tetrahydropyran,C1CCOC(C1)CN,,,,,,
7924,97925,"3,3'-(2-Methylpiperazine-1,4-diyl)dipropan-2-ol",CC1CN(CCN1CC(C)O)CC(C)O,,,,,,
7925,97926,Ethyl 2-cyano-3-(piperidin-1-yl)prop-2-enoate,CCOC(=O)C(=CN1CCCCC1)C#N,,,,,,
7926,97927,Hydroxy(6-methyl-2-pyridyl)methyl 6-methyl-2-pyridyl ketone,CC1=NC(=CC=C1)C(C(=O)C2=CC=CC(=N2)C)O,,,,,,
7927,97928,2-(2-Bromo-3-methylbutanamido)acetic acid,CC(C)C(C(=O)NCC(=O)O)Br,,,,,,
7928,97929,2-(2-Chloroacetamido)pentanoic acid,CCCC(C(=O)O)NC(=O)CCl,,,,,,
7929,97930,4-Bromomandelic acid,C1=CC(=CC=C1C(C(=O)O)O)Br,,,,,,
7930,97931,N-(Chloroacetyl)-DL-leucine,CC(C)CC(C(=O)O)NC(=O)CCl,,,,,,
7931,97932,"2,6,6-Trimethylcyclohex-2-ene-1-methanol",CC1=CCCC(C1CO)(C)C,,,,,,
7932,97933,N-(DL-2-Bromopropionyl)-DL-alanine,CC(C(=O)O)NC(=O)C(C)Br,,,,,,
7933,97934,N2-(2-Bromopropionyl)-DL-asparagine,CC(C(=O)NC(CC(=O)N)C(=O)O)Br,,,,,,
7934,97935,1-Chloro-4-(3-chloro-1-methoxypropyl)benzene,COC(CCCl)C1=CC=C(C=C1)Cl,,,,,,
7935,97936,4-Chloro-gamma-methoxybenzenebutyronitrile,COC(CCC#N)C1=CC=C(C=C1)Cl,,,,,,
7936,97937,1-Chloro-4-(3-chloro-1-ethoxypropyl)benzene,CCOC(CCCl)C1=CC=C(C=C1)Cl,,,,,,
7937,97938,N-(2-Bromopropionyl)-3-phenyl-DL-alanine,CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)Br,,,,,,
7938,97939,4-Chloro-gamma-ethoxybenzenebutyronitrile,CCOC(CCC#N)C1=CC=C(C=C1)Cl,,,,,,
7939,97940,1-Chloro-4-[3-chloro-1-(1-methylethoxy)propyl]benzene,CC(C)OC(CCCl)C1=CC=C(C=C1)Cl,,,,,,
7940,97941,4-(4-Chlorophenyl)-4-isopropoxybutyronitrile,CC(C)OC(CCC#N)C1=CC=C(C=C1)Cl,,,,,,
7941,97942,Cyclohexylphenylacetic acid,C1CCC(CC1)C(C2=CC=CC=C2)C(=O)O,,,,,,
7942,97943,"3-Hydroxyestra-1,3,5(10)-triene-16,17-dione",CC12CCC3C(C1CC(=O)C2=O)CCC4=C3C=CC(=C4)O,,,,,,
7943,97944,"1,3-Dioxolan-2-one, 4-(hydroxymethyl)-",C1C(OC(=O)O1)CO,,,,,,
7944,97945,"Ethyl 2,3-dibromopropionate",CCOC(=O)C(CBr)Br,,,,,,
7945,97946,"Ethyl 2,3-dichloropropionate",CCOC(=O)C(CCl)Cl,,,,,,
7946,97947,"3,4-Dimethyl-5-pyrazolone",CC1C(=NNC1=O)C,,,,,,
7947,97948,7-Ethyl-2-methyl-4-undecanol,CCCCC(CC)CCC(CC(C)C)O,,,,,,
7948,97949,3-(4-Hydroxyphenyl)-2-phenylpropanoic acid,C1=CC=C(C=C1)C(CC2=CC=C(C=C2)O)C(=O)O,,,,,,
7949,97950,"Ethyl 2,4-dibromobutanoate",CCOC(=O)C(CCBr)Br,,,,,,
7950,97951,"2,4-Monofurfurylidenesorbitol",C1=COC(=C1)C2OC(C(C(O2)C(CO)O)O)CO,,,,,,
7951,97952,2-Chloro-3-(1h-imidazol-5-yl)propanoic acid,C1=C(NC=N1)CC(C(=O)O)Cl,,,,,,
7952,97953,"Lactic acid, ethyl ester, ethyl carbonate",CCOC(=O)C(C)OC(=O)OCC,,,,,,
7953,97954,"2,5-Diethyl-3,4-dihydro-2H-pyran-2-carbaldehyde",CCC1=COC(CC1)(CC)C=O,,,,,,
7954,97955,3-(4-Methoxybenzylidene)phthalide,COC1=CC=C(C=C1)C=C2C3=CC=CC=C3C(=O)O2,,,,,,
7955,97956,"3-Buten-2-one, 4-(2-hydroxyphenyl)-",CC(=O)C=CC1=CC=CC=C1O,,,,,,
7956,97957,N-(2-Hydroxypropyl)morpholine,CC(CN1CCOCC1)O,,,,,,
7957,97958,"2-Ethyl-2,4,5-trimethyl-3-thiazoline",CCC1(N=C(C(S1)C)C)C,,,,,,
7958,97959,"2,5-Dimethylcyclohexanol",CC1CCC(C(C1)O)C,,,,,,
7959,97960,"3,4-Dimethylcyclohexanol",CC1CCC(CC1C)O,,,,,,
7960,97961,"1,3-Bis(2,3-epoxypropoxy)butane",CC(CCOCC1CO1)OCC2CO2,,,,,,
7961,97962,2-(1-Hydroxybutyl)cyclohexanol,CCCC(C1CCCCC1O)O,,,,,,
7962,97963,2-Amino-3-methoxypropanoic acid,COCC(C(=O)O)N,,,,,,
7963,97964,2-Phenyl-2-(pyridin-2-yl)acetamide,C1=CC=C(C=C1)C(C2=CC=CC=N2)C(=O)N,,,,,,
7964,97965,"Bicyclo[2.2.1]hept-5-ene-2,3-dicarboxylic acid",C1C2C=CC1C(C2C(=O)O)C(=O)O,,,,,,
7965,97966,(3-Chloro-1-ethoxypropyl)benzene,CCOC(CCCl)C1=CC=CC=C1,,,,,,
7966,97967,gamma-Ethoxybenzenebutyronitrile,CCOC(CCC#N)C1=CC=CC=C1,,,,,,
7967,97968,4-(3-Chloro-1-ethoxypropyl)toluene,CCOC(CCCl)C1=CC=C(C=C1)C,,,,,,
7968,97969,4-Ethoxy-4-(4-methylphenyl)butanenitrile,CCOC(CCC#N)C1=CC=C(C=C1)C,,,,,,
7969,97970,Retronscanol,CC1CCN2C1C(CC2)O,,,,,,
7970,97971,"2-(2,5-Dichlorophenoxy)propanoic acid",CC(C(=O)O)OC1=C(C=CC(=C1)Cl)Cl,,,,,,
7971,97972,[3-Chloro-1-(1-methylethoxy)propyl]benzene,CC(C)OC(CCCl)C1=CC=CC=C1,,,,,,
7972,97973,gamma-(1-Methylethoxy)benzenebutyronitrile,CC(C)OC(CCC#N)C1=CC=CC=C1,,,,,,
7973,97974,4-(3-Chloro-1-(1-methylethoxy)propyl)toluene,CC1=CC=C(C=C1)C(CCCl)OC(C)C,,,,,,
7974,97975,4-Methyl-gamma-(1-methylethoxy)benzenebutyronitrile,CC1=CC=C(C=C1)C(CCC#N)OC(C)C,,,,,,
7975,97976,"Hydrazinecarboxamide, 2-[2-[2-(2,6-dioxo-3-piperidinyl)-1-hydroxyethyl]-4,6-dimethylcyclohexylidene]-",CC1CC(C(=NNC(=O)N)C(C1)C(CC2CCC(=O)NC2=O)O)C,,,,,,
7976,97977,alpha-Allylcyclopent-2-ene-1-acetic acid,C=CCC(C1CCC=C1)C(=O)O,,,,,,
7977,97978,Ethyl 2-nitropropionate,CCOC(=O)C(C)[N+](=O)[O-],,,,,,
7978,97979,"Benzene, 1-chloro-2-(2-chloro-1-(4-chlorophenyl)ethyl)-",C1=CC=C(C(=C1)C(CCl)C2=CC=C(C=C2)Cl)Cl,,,,,,
7979,97980,2-Bromopropionyl chloride,CC(C(=O)Cl)Br,,,,,,
7980,97981,Ethyl 1-methylpiperidine-3-carboxylate,CCOC(=O)C1CCCN(C1)C,,,,,,
7981,97982,"2-(2,4-Dichlorophenoxy)butanoic acid",CCC(C(=O)O)OC1=C(C=C(C=C1)Cl)Cl,,,,,,
7982,97983,"1-Buten-3-yne, 1-methoxy-",COC=CC#C,,,,,,
7983,97984,Dibutyl 2-mercaptosuccinate,CCCCOC(=O)CC(C(=O)OCCCC)S,,,,,,
7984,97985,2-(Tetrahydrofurfuryloxy)tetrahydropyran,C1CCOC(C1)OCC2CCCO2,,,,,,
7985,97986,"5-Methyl-2,2,4-triethyl-3-thiazoline",CCC1=NC(SC1C)(CC)CC,,,,,,
7986,97987,1-Methylheptyl acetate,CCCCCCC(C)OC(=O)C,,,,,,
7987,97988,1-Chloro-3-methoxypropan-2-ol,COCC(CCl)O,,,,,,
7988,97989,Heptafluorobutyraldehyde ethyl hemiacetal,CCOC(C(C(C(F)(F)F)(F)F)(F)F)O,,,,,,
7989,97990,"2-Phenyltetrahydro-2H-1,3-thiazine",C1CNC(SC1)C2=CC=CC=C2,,,,,,
7990,97991,4-Methoxy-4-phenylbutanenitrile,COC(CCC#N)C1=CC=CC=C1,,,,,,
7991,97992,(3-Chloro-1-methoxypropyl)benzene,COC(CCCl)C1=CC=CC=C1,,,,,,
7992,97993,gamma-Methoxy-4-methylbenzenebutanenitrile,CC1=CC=C(C=C1)C(CCC#N)OC,,,,,,
7993,97994,4-(3-Chloro-1-methoxypropyl)toluene,CC1=CC=C(C=C1)C(CCCl)OC,,,,,,
7994,97995,"Bicyclo[2.2.1]heptane-2-methanol, 3-methyl-",CC1C2CCC(C2)C1CO,,,,,,
7995,97996,"3-Buten-2-one, 3-methyl-4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-",CC1=C(C(CCC1)(C)C)C=C(C)C(=O)C,,,,,,
7996,97997,Pentatriacont-17-ene,CCCCCCCCCCCCCCCCCC=CCCCCCCCCCCCCCCCC,,,,,,
7997,97998,1-Methyl-3-piperidinemethanol,CN1CCCC(C1)CO,,,,,,
7998,97999,Methyl 2-hydroxycyclohexanecarboxylate,COC(=O)C1CCCCC1O,,,,,,
7999,98000,NoName_1458,CC(C=C(C)C=C)C(=O)CC(CC1CC(=O)NC(=O)C1)O,,,,,,
8000,98001,1-Nitro-4-styrylbenzene,C1=CC=C(C=C1)C=CC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
8001,98002,2-(4-Nitrophenyl)-3-phenyloxirane,C1=CC=C(C=C1)C2C(O2)C3=CC=C(C=C3)[N+](=O)[O-],,,,,,
8002,98003,4-(4-Methoxyphenyl)-3-methylbut-3-en-2-one,CC(=CC1=CC=C(C=C1)OC)C(=O)C,,,,,,
8003,98004,2-Hydroxypropyl phenylacetate,CC(COC(=O)CC1=CC=CC=C1)O,,,,,,
8004,98005,N-(2-phenylpropylidene)hydroxylamine,CC(C=NO)C1=CC=CC=C1,,,,,,
8005,98006,Ethyl 2-benzoyl-3-ethoxyacrylate,CCOC=C(C(=O)C1=CC=CC=C1)C(=O)OCC,,,,,,
8006,98007,"Thymidine, 3',5'-diacetate",CC1=CN(C(=O)NC1=O)C2CC(C(O2)COC(=O)C)OC(=O)C,,,,,,
8007,98008,"3,7-Dimethyloctanoic acid",CC(C)CCCC(C)CC(=O)O,,,,,,
8008,98009,2-Hydroxypentanoic acid,CCCC(C(=O)O)O,,,,,,
8009,98010,Ethyl 2-cyano-3-methylpent-2-enoate,CCC(=C(C#N)C(=O)OCC)C,,,,,,
8010,98011,Ethyl 2-cyanohexanoate,CCCCC(C#N)C(=O)OCC,,,,,,
8011,98012,Bornyl salicylate,CC1(C2CCC1(C(C2)OC(=O)C3=CC=CC=C3O)C)C,,,,,,
8012,98013,"2,4-Bis(2-phenylethenyl)phenol",C1=CC=C(C=C1)C=CC2=CC(=C(C=C2)O)C=CC3=CC=CC=C3,,,,,,
8013,98014,Cyclopentylphenylacetic acid,C1CCC(C1)C(C2=CC=CC=C2)C(=O)O,,,,,,
8014,98015,1-(Allyloxy)-3-aminopropan-2-ol,C=CCOCC(CN)O,,,,,,
8015,98016,3-Hydroxy-1-methylpiperidine,CN1CCCC(C1)O,,,,,,
8016,98017,Tetrahydrofurfuryl salicylate,C1CC(OC1)COC(=O)C2=CC=CC=C2O,,,,,,
8017,98018,Ethyl 2-cyanopropanoate,CCOC(=O)C(C)C#N,,,,,,
8018,98019,3-Methyl-1-phenylbutan-2-ol,CC(C)C(CC1=CC=CC=C1)O,,,,,,
8019,98020,"2,4-Imidazolidinedione, 5-cyclopentyl-5-phenyl-",C1CCC(C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,,,,,,
8020,98021,7-Methyl-8-ethylflavine,CCC1=CC2=C(C=C1C)N=C3C(=O)NC(=O)N=C3N2CC(C(C(CO)O)O)O,,,,,,
8021,98022,"cis-endo-N-Ethyl-5-norbornene-2,3-dicarboximide",CCN1C(=O)C2C3CC(C2C1=O)C=C3,,,,,,
8022,98023,4-(Dodecylamino)-4-oxobut-2-enoic acid,CCCCCCCCCCCCNC(=O)C=CC(=O)O,,,,,,
8023,98024,"Bis(3,3,5-trimethylcyclohexyl) phthalate",CC1CC(CC(C1)(C)C)OC(=O)C2=CC=CC=C2C(=O)OC3CC(CC(C3)(C)C)C,,,,,,
8024,98025,"3,3,5-Trimethylcyclohexyl dipropylene glycol",CC1CC(CC(C1)(C)C)OC(C)COCC(C)O,,,,,,
8025,98026,Pent-2-oxycyclohexan-1-ol,CCCCCOC1CCCCC1O,,,,,,
8026,98027,"2-Propenoic acid, 3-(2-furanyl)-, 3-methylbutyl ester",CC(C)CCOC(=O)C=CC1=CC=CO1,,,,,,
8027,98028,"Thymidine, 5'-o-(p-toluenesulfonyl)-",CC1=CC=C(C=C1)S(=O)(=O)OCC2C(CC(O2)N3C=C(C(=O)NC3=O)C)O,,,,,,
8028,98029,1-(2-Butylbutoxy)propan-2-ol,CCCCC(CC)COCC(C)O,,,,,,
8029,98030,1-(1-Naphthyl)ethanol,CC(C1=CC=CC2=CC=CC=C21)O,,,,,,
8030,98031,1-Benzyl-2-phenylpiperazine,C1CN(C(CN1)C2=CC=CC=C2)CC3=CC=CC=C3,,,,,,
8031,98032,1-(3-Methoxyphenyl)-3-phenylprop-2-en-1-one,COC1=CC=CC(=C1)C(=O)C=CC2=CC=CC=C2,,,,,,
8032,98033,Hedamycin,CC1C(C(CC(O1)C2=CC(=C(C3=C2C(=O)C4=C(C3=O)C5=C(C(=C4)C)C(=O)C=C(O5)C6(C(O6)C7C(O7)C)C)O)C8CC(C(C(O8)C)O)(C)N(C)C)N(C)C)O,,,,,,
8033,98034,"Tetrahydro-2,5-dimethyl-2H-pyranmethanol",CC1CCC(OC1)(C)CO,,,,,,
8034,98035,"Undecane-1,2-diol",CCCCCCCCCC(CO)O,,,,,,
8035,98036,"1-Naphthaleneethanol, 1,2,3,4-tetrahydro-",C1CC(C2=CC=CC=C2C1)CCO,,,,,,
8036,98037,"1,2-Hexadecanediol",CCCCCCCCCCCCCCC(CO)O,,,,,,
8037,98038,"1,3-Propanediol, 2,2-diethyl-1-phenyl-",CCC(CC)(CO)C(C1=CC=CC=C1)O,,,,,,
8038,98039,"(2,5-Bis(benzylidene)-cyclopentanone)",C1CC(=CC2=CC=CC=C2)C(=O)C1=CC3=CC=CC=C3,,,,,,
8039,98040,3-Methoxybutanal,CC(CC=O)OC,,,,,,
8040,98041,"1,5-Dimethyl-1-vinyl-4-hexenyl 2-(methylamino)benzoate",CC(=CCCC(C)(C=C)OC(=O)C1=CC=CC=C1NC)C,,,,,,
8041,98042,"Benzoic acid, 2-hydroxy-, 1-ethenyl-1,5-dimethyl-4-hexenyl ester",CC(=CCCC(C)(C=C)OC(=O)C1=CC=CC=C1O)C,,,,,,
8042,98043,Nerolidol acetate,CC(=CCCC(=CCCC(C)(C=C)OC(=O)C)C)C,,,,,,
8043,98044,"Propanoic acid, 2-methyl-, 1-ethenyl-1,5,9-trimethyl-4,8-decadien-1-yl ester",CC(C)C(=O)OC(C)(CCC=C(C)CCC=C(C)C)C=C,,,,,,
8044,98045,5-Methyl-5-phenylpiperidin-2-one,CC1(CCC(=O)NC1)C2=CC=CC=C2,,,,,,
8045,98046,p-Lactophenetide,CCOC1=CC=C(C=C1)NC(=O)C(C)O,,,,,,
8046,98047,Ethyl 5-oxo-DL-prolinate,CCOC(=O)C1CCC(=O)N1,,,,,,
8047,98048,2-(4-Methoxyphenyl)oxirane,COC1=CC=C(C=C1)C2CO2,,,,,,
8048,98049,"3-(2-Ethylphenoxy)propane-1,2-diol",CCC1=CC=CC=C1OCC(CO)O,,,,,,
8049,98050,"3-(2-Chloro-6-methylphenoxy)propane-1,2-diol",CC1=C(C(=CC=C1)Cl)OCC(CO)O,,,,,,
8050,98051,"Urea, 1-(alpha-methyl-m-(trifluoromethyl)phenethyl)-",CC(CC1=CC(=CC=C1)C(F)(F)F)NC(=O)N,,,,,,
8051,98052,Methyl 2-(((8-hydroxy-7-quinolyl)phenylmethyl)amino)benzoate,COC(=O)C1=CC=CC=C1NC(C2=CC=CC=C2)C3=C(C4=C(C=CC=N4)C=C3)O,,,,,,
8052,98053,"2-Hydroxy-N,N-dimethylpropanamide",CC(C(=O)N(C)C)O,,,,,,
8053,98054,Benzyl lactate,CC(C(=O)OCC1=CC=CC=C1)O,,,,,,
8054,98055,1-Methylheptyl acrylate,CCCCCCC(C)OC(=O)C=C,,,,,,
8055,98056,"3,3,5-Trimethylcyclohexyl acrylate",CC1CC(CC(C1)(C)C)OC(=O)C=C,,,,,,
8056,98057,1-((4-(3-Chlorophenyl)-4-piperidyl)carbonyl)pyrrolidine,C1CCN(C1)C(=O)C2(CCNCC2)C3=CC(=CC=C3)Cl,,,,,,
8057,98058,8-Aza-3-hydroxy-N-methylbicyclo(3.2.1)octane N-oxide dihydrate,C[N+]1(C2CCC1CC(C2)O)[O-],,,,,,
8058,98059,"1,3-Bis(2-hydroxyphenyl)prop-2-en-1-one",C1=CC=C(C(=C1)C=CC(=O)C2=CC=CC=C2O)O,,,,,,
8059,98060,N1-Methyl-1-phenylethylenediamine,CNC(CN)C1=CC=CC=C1,,,,,,
8060,98061,2-((1-(Benzyl)-4-piperidyl)amino)butyramide,CCC(C(=O)N)NC1CCN(CC1)CC2=CC=CC=C2,,,,,,
8061,98062,2-(1-Benzylpiperidin-4-yl)-2-phenylacetonitrile,C1CN(CCC1C(C#N)C2=CC=CC=C2)CC3=CC=CC=C3,,,,,,
8062,98063,2-[(2-Bromo-4-methylpentanoyl)amino]acetic acid,CC(C)CC(C(=O)NCC(=O)O)Br,,,,,,
8063,98064,N-(2-Bromopropionyl)-DL-norvaline,CCCC(C(=O)O)NC(=O)C(C)Br,,,,,,
8064,98065,Alpha-cyclopropyl-2-thiophenemethanol,C1CC1C(C2=CC=CS2)O,,,,,,
8065,98066,2-Cyano-3-ethoxy-2-propenamide,CCOC=C(C#N)C(=O)N,,,,,,
8066,98067,2-[(1-Benzyl-4-piperidyl)amino]butyronitrile,CCC(C#N)NC1CCN(CC1)CC2=CC=CC=C2,,,,,,
8067,98068,4-Fluoromandelic acid,C1=CC(=CC=C1C(C(=O)O)O)F,,,,,,
8068,98069,3-Chloro-2-hydroxypropyl acetate,CC(=O)OCC(CCl)O,,,,,,
8069,98070,3-(4-Fluorophenyl)acrylic acid,C1=CC(=CC=C1C=CC(=O)O)F,,,,,,
8070,98071,"2,2-Diphenylcyclopropanecarboxylic acid",C1C(C1(C2=CC=CC=C2)C3=CC=CC=C3)C(=O)O,,,,,,
8071,98072,"3-(Benzyloxy)propane-1,2-diol",C1=CC=C(C=C1)COCC(CO)O,,,,,,
8072,98073,"2,4-Dimethyl-2-oxazoline-4-methanol",CC1=NC(CO1)(C)CO,,,,,,
8073,98074,Epoxypiperazine,C1CN(CCN1CC2CO2)CC3CO3,,,,,,
8074,98075,"4-Chloro-1,3-dioxolan-2-one",C1C(OC(=O)O1)Cl,,,,,,
8075,98076,"1,3-Propanediol, 2-methyl-2-(1-methylpropyl)-",CCC(C)C(C)(CO)CO,,,,,,
8076,98077,"2-Propenoic acid, 3-(4-formylphenyl)-",C1=CC(=CC=C1C=CC(=O)O)C=O,,,,,,
8077,98078,2-Phenylcyclopropanecarbonitrile,C1C(C1C2=CC=CC=C2)C#N,,,,,,
8078,98079,CID 98079,CCC1COC(=N1)S,,,,,,
8079,98080,"1,4-Bis(4-methylphenyl)-2-morpholin-4-ylbut-2-ene-1,4-dione",CC1=CC=C(C=C1)C(=O)C=C(C(=O)C2=CC=C(C=C2)C)N3CCOCC3,,,,,,
8080,98081,"2-(4-Methoxyphenyl)-4-methyl-1,3-dioxolane",CC1COC(O1)C2=CC=C(C=C2)OC,,,,,,
8081,98082,"Thymidine, 5'-O-(triphenylmethyl)-",CC1=CN(C(=O)NC1=O)C2CC(C(O2)COC(C3=CC=CC=C3)(C4=CC=CC=C4)C5=CC=CC=C5)O,,,,,,
8082,98083,"2-Ethyl-2,4-dimethyl-1,3-dioxolane",CCC1(OCC(O1)C)C,,,,,,
8083,98084,"Lactic acid, butyl carbonate, tetrahydrofurfuryl ester",CCCCOC(=O)OC(C)C(=O)OCC1CCCO1,,,,,,
8084,98085,"2-Piperidineethanol, 1-methyl-",CN1CCCCC1CCO,,,,,,
8085,98086,2-Methyl-1-phenylpiperazine,CC1CNCCN1C2=CC=CC=C2,,,,,,
8086,98087,"2,2,4-Trimethyl-5-(p-tolylsulfonyloxy)methyl-DL-erythro-1,3-dioxolane",CC1C(OC(O1)(C)C)COS(=O)(=O)C2=CC=C(C=C2)C,,,,,,
8087,98088,2-Methyl-5-norbornene-2-methanol,CC1(CC2CC1C=C2)CO,,,,,,
8088,98089,1-(1-Naphthyl)ethylamine,CC(C1=CC=CC2=CC=CC=C21)N,,,,,,
8089,98090,Methyl(oxolan-2-ylmethyl)amine,CNCC1CCCO1,,,,,,
8090,98091,"4,7-Methano-1H-indene-2,5-dimethanol, octahydro-",C1C(CC2C1C3CC(C2C3)CO)CO,,,,,,
8091,98092,"5-[5-(2,4,6-Trioxo-1,3-diazinan-5-yl)penta-2,4-dienylidene]-1,3-diazinane-2,4,6-trione",C(=CC=C1C(=O)NC(=O)NC1=O)C=CC2C(=O)NC(=O)NC2=O,,,,,,
8092,98093,1-(Thiophen-2-yl)propan-2-ol,CC(CC1=CC=CS1)O,,,,,,
8093,98094,1-Ethylpiperidin-3-amine,CCN1CCCC(C1)N,,,,,,
8094,98095,1-(2-Cyclopentenyl)-2-propanone,CC(=O)CC1CCC=C1,,,,,,
8095,98096,2-Amino-3-hydroxy-3-(thiophen-2-yl)propanoic acid,C1=CSC(=C1)C(C(C(=O)O)N)O,,,,,,
8096,98097,Benzoin methyl ether,COC(C1=CC=CC=C1)C(=O)C2=CC=CC=C2,,,,,,
8097,98098,N-(2-Carbethoxyethyl)-N-(2-carbomethoxypropyl)benzylamine,CCOC(=O)CCN(CC1=CC=CC=C1)CC(C)C(=O)OC,,,,,,
8098,98099,4-Chloro-3-methylbutyronitrile,CC(CC#N)CCl,,,,,,
8099,98100,3-(1H-indol-3-ylmethylidene)indole,C1=CC=C2C(=C1)C(=CN2)C=C3C=NC4=CC=CC=C43,,,,,,
8100,98101,N-[(benzyloxy)carbonyl]phenylalanylglycine,C1=CC=C(C=C1)CC(C(=O)NCC(=O)O)NC(=O)OCC2=CC=CC=C2,,,,,,
8101,98102,Ethyl 4-bromo-2-butenoate,CCOC(=O)C=CCBr,,,,,,
8102,98103,Ethyl 3-aminobutyrate,CCOC(=O)CC(C)N,,,,,,
8103,98104,1-Cyclopropyl-1-(4-fluorophenyl)ethanol,CC(C1CC1)(C2=CC=C(C=C2)F)O,,,,,,
8104,98105,1-Cyclopropyl-1-phenylethanol,CC(C1CC1)(C2=CC=CC=C2)O,,,,,,
8105,98106,"Hexahydro-2-hydroxymethyl-4,7-methanoindan",C1CC2CC1C3C2CC(C3)CO,,,,,,
8106,98107,Dodecylsuccinic anhydride,CCCCCCCCCCCCC1CC(=O)OC1=O,,,,,,
8107,98108,"6-[5-(2,4-Dihydroxyphenyl)-2,4-pentadienylidene]-3-hydroxy-2,4-cyclohexadien-1-one",C1=CC(=C(C=C1O)O)C=CC=CC=C2C=CC(=O)C=C2O,,,,,,
8108,98109,Chloroacetyl-dl-phenylalanine,C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CCl,,,,,,
8109,98110,"Ethanol, 1-((m-chlorophenyl)phenylphosphinyl)-2,2,2-trichloro-",C1=CC=C(C=C1)P(=O)(C2=CC(=CC=C2)Cl)C(C(Cl)(Cl)Cl)O,,,,,,
8110,98111,"N-[[5-[2,4-bis(diaminomethylideneamino)-3,5,6-trihydroxycyclohexyl]oxy-4-[4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-3-hydroxy-2-methyloxolan-3-yl]methylideneamino]pyridine-4-carboxamide",CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=NNC(=O)C4=CC=NC=C4)O,,,,,,
8111,98112,1-Methyl-DL-tryptophan,CN1C=C(C2=CC=CC=C21)CC(C(=O)O)N,,,,,,
8112,98113,3-Methyl-2-phenyloxazolidine,CN1CCOC1C2=CC=CC=C2,,,,,,
8113,98114,1-Phenyl-3-pyridin-4-ylprop-2-en-1-one,C1=CC=C(C=C1)C(=O)C=CC2=CC=NC=C2,,,,,,
8114,98115,"4-Phenyl-3a,4,7,7a-tetrahydro-2-benzofuran-1,3-dione",C1C=CC(C2C1C(=O)OC2=O)C3=CC=CC=C3,,,,,,
8115,98116,"Benzene, (3-bromo-1-propenyl)-",C1=CC=C(C=C1)C=CCBr,,,,,,
8116,98117,"1-(2-(N,N-Bis(2-hydroxypropyl)amino)ethyl)-4-(2-hydroxypropyl)piperazine",CC(CN1CCN(CC1)CCN(CC(C)O)CC(C)O)O,,,,,,
8117,98118,Aurantiol,CC(CCCC(C)(C)O)CC=NC1=CC=CC=C1C(=O)OC,,,,,,
8118,98119,"n-(2,4-Dinitrophenyl)phenylalanine",C1=CC=C(C=C1)CC(C(=O)O)NC2=C(C=C(C=C2)[N+](=O)[O-])[N+](=O)[O-],,,,,,
8119,98120,"6'-Hydroxy-4,4'-dimethoxychalcone",COC1=CC=C(C=C1)C=CC(=O)C2=C(C=C(C=C2)OC)O,,,,,,
8120,98121,Chlordene epoxide,C1C2C(C3C1O3)C4(C(=C(C2(C4(Cl)Cl)Cl)Cl)Cl)Cl,,,,,,
8121,98122,2-[2-(Furan-2-yl)ethenyl]pyridine,C1=CC=NC(=C1)C=CC2=CC=CO2,,,,,,
8122,98123,Ethyl 2-cyano-3-methylpentanoate,CCC(C)C(C#N)C(=O)OCC,,,,,,
8123,98124,"Propanoic acid, 2-hydroxy-, 2-(hexyloxy)-1-methyl-2-oxoethyl ester",CCCCCCOC(=O)C(C)OC(=O)C(C)O,,,,,,
8124,98125,2-{(E)-[(1-phenylethyl)imino]methyl}phenol,CC(C1=CC=CC=C1)N=CC2=CC=CC=C2O,,,,,,
8125,98126,4-Styryl-nicotinamide,C1=CC=C(C=C1)C=CC2=C(C=NC=C2)C(=O)N,,,,,,
8126,98127,2-[4-(Isopropyl)phenyl]cyclohexan-1-one,CC(C)C1=CC=C(C=C1)C2CCCCC2=O,,,,,,
8127,98128,Tetradecylsuccinic Anhydride,CCCCCCCCCCCCCCC1CC(=O)OC1=O,,,,,,
8128,98129,"DL-N-(p-(3,3-Dimethyltriazeno)benzoyl)glutamic acid diethyl ester",CCOC(=O)CCC(C(=O)OCC)NC(=O)C1=CC=C(C=C1)N=NN(C)C,,,,,,
8129,98130,"4-[2-(2,4,5-Trimethoxyphenyl)ethenyl]quinoline",COC1=CC(=C(C=C1C=CC2=CC=NC3=CC=CC=C23)OC)OC,,,,,,
8130,98131,2-Cyclohexylbutanoic acid,CCC(C1CCCCC1)C(=O)O,,,,,,
8131,98132,"Octahydro-4,7-methano-1H-indene-2-carboxylic acid",C1CC2CC1C3C2CC(C3)C(=O)O,,,,,,
8132,98133,"3',7'-Dihydroxy-2'-(hydroxymethyl)-2',4',7'-trimethyl-2',7'-dihydrospiro[cyclopropane-1,5'-inden]-6'(3'h)-one",CC1=C2C(C(C=C2C(C(=O)C13CC3)(C)O)(C)CO)O,,,,,,
8133,98134,"Dodecahydro-1,4,7,9b-tetraazaphenalene",C1CNC2CCNC3N2C1NCC3,,,,,,
8134,98135,"2,3-Bis(4-methoxyphenyl)prop-2-enoic acid",COC1=CC=C(C=C1)C=C(C2=CC=C(C=C2)OC)C(=O)O,,,,,,
8135,98136,"Benzenamine, 4-(1H-inden-1-ylidenemethyl)-N-methyl-",CNC1=CC=C(C=C1)C=C2C=CC3=CC=CC=C32,,,,,,
8136,98137,"Diethyl 3-isopropyl-5-oxo-2,2-pyrrolidinedicarboxylate",CCOC(=O)C1(C(CC(=O)N1)C(C)C)C(=O)OCC,,,,,,
8137,98138,"3-(Morpholin-4-ylmethylidene)-1-benzothiophene 1,1-dioxide",C1COCCN1C=C2CS(=O)(=O)C3=CC=CC=C23,,,,,,
8138,98139,1-(2-Chloroethyl)-3-[2-(2-chloroethylcarbamoylamino)ethenyl]urea,C(CCl)NC(=O)NC=CNC(=O)NCCCl,,,,,,
8139,98140,9-(4-Thiopentofuranosyl)-9h-purin-6-amine,C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(S3)CO)O)O)N,,,,,,
8140,98141,(Z)-3-[(2-nitrophenyl)carbamoyl]prop-2-enoic acid,C1=CC=C(C(=C1)NC(=O)C=CC(=O)O)[N+](=O)[O-],,,,,,
8141,98142,"4-(2,2-Dimethylhydrazinyl)-4-oxobut-2-enoic acid",CN(C)NC(=O)C=CC(=O)O,,,,,,
8142,98143,"3,9-Dicyclohex-3-enyl-2,4,8,10-tetraoxaspiro[5.5]undecane",C1CC(CC=C1)C2OCC3(CO2)COC(OC3)C4CCC=CC4,,,,,,
8143,98144,"3,4-Dihydro-2,5-dimethyl-2H-pyran-2-methanol",CC1=COC(CC1)(C)CO,,,,,,
8144,98145,5-Ethyl-3-hepten-2-one,CCC(CC)C=CC(=O)C,,,,,,
8145,98146,3-Phenyl-1-indanone,C1C(C2=CC=CC=C2C1=O)C3=CC=CC=C3,,,,,,
8146,98147,"2-Cyano-3-(3,4-dihydro-2H-quinolin-1-yl)-acrylic acid ethyl ester",CCOC(=O)C(=CN1CCCC2=CC=CC=C21)C#N,,,,,,
8147,98148,4-((1H-Inden-1-ylidene)methyl)aniline,C1=CC=C2C(=C1)C=CC2=CC3=CC=C(C=C3)N,,,,,,
8148,98149,"3,5,5-Trimethylhexylamine",CC(CCN)CC(C)(C)C,,,,,,
8149,98150,"4-(3,5,5-Trimethylthiohexanoyl)morpholine",CC(CC(=S)N1CCOCC1)CC(C)(C)C,,,,,,
8150,98151,"2-(2-Thienyl)-1,3-thiazolidine-4-carboxylic acid",C1C(NC(S1)C2=CC=CS2)C(=O)O,,,,,,
8151,98152,4-Benzylpiperidin-4-ol,C1CNCCC1(CC2=CC=CC=C2)O,,,,,,
8152,98153,Glycyl-dl-alanine,CC(C(=O)O)NC(=O)CN,,,,,,
8153,98154,N-(Hippuryl)phenylalanine,C1=CC=C(C=C1)CC(C(=O)O)NC(=O)CNC(=O)C2=CC=CC=C2,,,,,,
8154,98155,2-[(2-Methylpropoxy)methyl]oxirane,CC(C)COCC1CO1,,,,,,
8155,98156,"Octadecanoic acid, 9,10-epoxy-, allyl ester",CCCCCCCCC1C(O1)CCCCCCCC(=O)OCC=C,,,,,,
8156,98157,"Ethyl 2,3-dibromobutyrate",CCOC(=O)C(C(C)Br)Br,,,,,,
8157,98158,"Butanoic acid, (3-oxo-1(3H)-isobenzofuranylidene)di-4,1-phenylene ester",CCCC(=O)OC1=CC=C(C=C1)C2(C3=CC=CC=C3C(=O)O2)C4=CC=C(C=C4)OC(=O)CCC,,,,,,
8158,98159,2-Amino-N-(2-naphthyl)propanamide,CC(C(=O)NC1=CC2=CC=CC=C2C=C1)N,,,,,,
8159,98160,2-Bromoundecane,CCCCCCCCCC(C)Br,,,,,,
8160,98161,"2-Ethoxy-4-methyl-3,4-dihydropyran",CCOC1CC(C=CO1)C,,,,,,
8161,98162,Ethyl 4-methyl-2-oxocyclohexanecarboxylate,CCOC(=O)C1CCC(CC1=O)C,,,,,,
8162,98163,4-Pyridineacrylic acid methyl ester,COC(=O)C=CC1=CC=NC=C1,,,,,,
8163,98164,"1,2-Propanediamine, N,N,N',N'-tetramethyl-",CC(CN(C)C)N(C)C,,,,,,
8164,98165,2-Fluorohexanoic acid,CCCCC(C(=O)O)F,,,,,,
8165,98166,2-Fluoroglutaric acid,C(CC(=O)O)C(C(=O)O)F,,,,,,
8166,98167,"Urea, 3-(2-chlorocyclohexyl)-1-(2-chloroethyl)-1-nitroso-, (E)-",C1CCC(C(C1)NC(=O)N(CCCl)N=O)Cl,,,,,,
8167,98168,"5,7-Dihydroxy-4a,8-dimethyl-3-methylenedecahydroazuleno[6,5-b]furan-2(3H)-one",CC1CC2C(CC3(C1C(CC3O)O)C)C(=C)C(=O)O2,,,,,,
8168,98169,"5,7-Dihydroxy-4a,8-dimethyl-3-methylidene-2-oxododecahydroazuleno[6,5-b]furan-4,9-diyl diacetate",CC1C2C(CC(C2(C(C3C(C1OC(=O)C)OC(=O)C3=C)OC(=O)C)C)O)O,,,,,,
8169,98170,"2(3H)-Furanone, dihydro-3-(3-methylbutyl)-",CC(C)CCC1CCOC1=O,,,,,,
8170,98171,"Ethyl 2-cyano-5-phenylpenta-2,4-dienoate",CCOC(=O)C(=CC=CC1=CC=CC=C1)C#N,,,,,,
8171,98172,2-(Benzylamino)-3-methylbutanoic acid,CC(C)C(C(=O)O)NCC1=CC=CC=C1,,,,,,
8172,98173,2-Phenylbutyryl chloride,CCC(C1=CC=CC=C1)C(=O)Cl,,,,,,
8173,98174,"1H-Inden-1-one, 2-[4-[(dimethylamino)phenyl]methylene]-2,3-dihydro-",CN(C)C1=CC=C(C=C1)C=C2CC3=CC=CC=C3C2=O,,,,,,
8174,98175,"1-[(3,4,5-Trimethoxyphenyl)methylidene]indene",COC1=CC(=CC(=C1OC)OC)C=C2C=CC3=CC=CC=C32,,,,,,
8175,98176,"1,4-Pentadien-3-one, 1,5-bis(hydroxyphenyl)-",C1=CC=C(C(=C1)C=CC(=O)C=CC2=CC=CC=C2O)O,,,,,,
8176,98177,1-((2-Hydroxyethyl)amino)propan-2-ol,CC(CNCCO)O,,,,,,
8177,98178,1-Chloro-3-(2-methylpropoxy)propan-2-ol,CC(C)COCC(CCl)O,,,,,,
8178,98179,"2-Propanol, 1-chloro-3-(pentyloxy)-",CCCCCOCC(CCl)O,,,,,,
8179,98180,((m-Tolyloxy)methyl)oxirane,CC1=CC(=CC=C1)OCC2CO2,,,,,,
8180,98181,2-Fluorovaleric acid,CCCC(C(=O)O)F,,,,,,
8181,98182,"4,4-Dimethoxychalcone",COC1=CC=C(C=C1)C=CC(=O)C2=CC=C(C=C2)OC,,,,,,
8182,98183,4-Chlorobenzalacetone,CC(=O)C=CC1=CC=C(C=C1)Cl,,,,,,
8183,98184,"1-(Piperidin-2-yl)ethane-1,2-diol",C1CCNC(C1)C(CO)O,,,,,,
8184,98185,3-(Morpholinomethyl)-2-norbornanone,C1CC2CC1C(C2=O)CN3CCOCC3,,,,,,
8185,98186,2-(Benzylamino)norbornane,C1CC2CC1CC2NCC3=CC=CC=C3,,,,,,
8186,98187,"2-Norbornanol, 3-(benzylmethylaminomethyl)-",CN(CC1C2CCC(C2)C1O)CC3=CC=CC=C3,,,,,,
8187,98188,2-Nonadecanol,CCCCCCCCCCCCCCCCCC(C)O,,,,,,
8188,98189,2-(p-Chlorophenyl)-3-methyloxazolidine,CN1CCOC1C2=CC=C(C=C2)Cl,,,,,,
8189,98190,"Spiro[2.4]heptan-4-ol, phenylcarbamate",C1CC(C2(C1)CC2)OC(=O)NC3=CC=CC=C3,,,,,,
8190,98191,3-Phenyl-N-(N-((phenylmethoxy)carbonyl)-L-alanyl)-L-alanine,CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)NC(=O)OCC2=CC=CC=C2,,,,,,
8191,98192,N-Acetyl-DL-phenylalanine beta-naphthyl ester,CC(=O)NC(CC1=CC=CC=C1)C(=O)OC2=CC3=CC=CC=C3C=C2,,,,,,
8192,98193,"Methionine, N-((2,4-dichlorophenoxy)acetyl)-",CSCCC(C(=O)O)NC(=O)COC1=C(C=C(C=C1)Cl)Cl,,,,,,
8193,98194,"3-Pentylpentane-2,4-dione",CCCCCC(C(=O)C)C(=O)C,,,,,,
8194,98195,1-(2-Chloroethyl)-1-nitroso-3-(2-norbornyl)urea,C1CC2CC1CC2NC(=O)N(CCCl)N=O,,,,,,
8195,98196,Isopentaquine,CC(C)NCCCC(C)NC1=C2C(=CC(=C1)OC)C=CC=N2,,,,,,
8196,98197,"2,6-Bis(((benzyloxy)carbonyl)amino)hexanoic acid",C1=CC=C(C=C1)COC(=O)NCCCCC(C(=O)O)NC(=O)OCC2=CC=CC=C2,,,,,,
8197,98198,Z-DL-Trp-OH,C1=CC=C(C=C1)COC(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O,,,,,,
8198,98199,2-{[(Benzyloxy)carbonyl]amino}-3-(4-hydroxyphenyl)propanoic acid,C1=CC=C(C=C1)COC(=O)NC(CC2=CC=C(C=C2)O)C(=O)O,,,,,,
8199,98200,4-Nitrophenyl N-((benzyloxy)carbonyl)-L-tyrosinate,C1=CC=C(C=C1)COC(=O)NC(CC2=CC=C(C=C2)O)C(=O)OC3=CC=C(C=C3)[N+](=O)[O-],,,,,,
8200,98201,3-(4-Fluorophenyl)-1-phenylprop-2-en-1-one,C1=CC=C(C=C1)C(=O)C=CC2=CC=C(C=C2)F,,,,,,
8201,98202,"3-(N-Dodecyl-2-hydroxyethylamino)propane-1,2-diol",CCCCCCCCCCCCN(CCO)CC(CO)O,,,,,,
8202,98203,1-Ethyl-3-pyrrolidinol,CCN1CCC(C1)O,,,,,,
8203,98204,"4-Carbamoyl-2-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-YL)butanoic acid",C1=CC=C2C(=C1)C(=O)N(C2=O)C(CCC(=O)N)C(=O)O,,,,,,
8204,98205,4-[2-(4-Chlorophenyl)-1-cyanoethenyl]benzoic acid,C1=CC(=CC=C1C=C(C#N)C2=CC=C(C=C2)C(=O)O)Cl,,,,,,
8205,98206,Pro-Gly,C1CC(NC1)C(=O)NCC(=O)O,,,,,,
8206,98207,Phenylalanylglycine,C1=CC=C(C=C1)CC(C(=O)NCC(=O)O)N,,,,,,
8207,98208,n-Benzoylglycyllysine,C1=CC=C(C=C1)C(=O)NCC(=O)NC(CCCCN)C(=O)O,,,,,,
8208,98209,1-Methyl-2-tetralone,CC1C(=O)CCC2=CC=CC=C12,,,,,,
8209,98210,3-Pyrrolidinol,C1CNCC1O,,,,,,
8210,98211,CID 98211,C1OC2=C(O1)C=C(C=C2)C=C3C(=O)NC(=NC3=O)S,,,,,,
8211,98212,alpha-((1-Naphthalenyloxy)methyl)-4-morpholineethanol,C1COCCN1CC(COC2=CC=CC3=CC=CC=C32)O,,,,,,
8212,98213,3-Chlorobutenoic acid,CC(=CC(=O)O)Cl,,,,,,
8213,98214,N-[N-(Chloroacetyl)glycyl]-DL-valine,CC(C)C(C(=O)O)NC(=O)CNC(=O)CCl,,,,,,
8214,98215,N-[N-(DL-2-Bromo-4-methyl valeryl)glycyl]glycine,CC(C)CC(C(=O)NCC(=O)NCC(=O)O)Br,,,,,,
8215,98216,N-[N-(Chloroacetyl)-DL-leucyl]glycine,CC(C)CC(C(=O)NCC(=O)O)NC(=O)CCl,,,,,,
8216,98217,3-Chloro-2-norbornanone,C1CC2CC1C(C2=O)Cl,,,,,,
8217,98218,"4-Methyl-2-propyl-1,3-dioxolane",CCCC1OCC(O1)C,,,,,,
8218,98219,2-Bromononane,CCCCCCCC(C)Br,,,,,,
8219,98220,"1,2,3,4,5,6-Hexakis-O-(2-cyanoethyl)hexitol",C(COCC(C(C(C(COCCC#N)OCCC#N)OCCC#N)OCCC#N)OCCC#N)C#N,,,,,,
8220,98221,4-Bromobenzhydrol,C1=CC=C(C=C1)C(C2=CC=C(C=C2)Br)O,,,,,,
8221,98222,CID 98222,CC(C(C(=O)OCC1=CCN2C1C(CC2)O)(C(C)(C)O)O)OC,,,,,,
8222,98223,Selenocystathionine,C(C[Se]CC(C(=O)O)N)C(C(=O)O)N,,,,,,
8223,98224,"ethyl 2-cyano-3-(3,4-dihydro-2H-quinoxalin-1-yl)prop-2-enoate",CCOC(=O)C(=CN1CCNC2=CC=CC=C21)C#N,,,,,,
8224,98225,"1-(3,4-dihydro-2H-quinolin-1-yl)-3-phenylprop-2-en-1-one",C1CC2=CC=CC=C2N(C1)C(=O)C=CC3=CC=CC=C3,,,,,,
8225,98226,6-(Trichloroacetyl)-3-cyclohexene-1-carboxylic acid,C1C=CCC(C1C(=O)C(Cl)(Cl)Cl)C(=O)O,,,,,,
8226,98227,Methyl 3-pyrrolidin-1-ylbut-2-enoate,CC(=CC(=O)OC)N1CCCC1,,,,,,
8227,98228,"1-Piperazineethanol, 4-(o-chlorophenyl)-alpha-phenoxymethyl-",C1CN(CCN1CC(COC2=CC=CC=C2)O)C3=CC=CC=C3Cl,,,,,,
8228,98229,alpha-Bromo-gamma-valerolactone,CC1CC(C(=O)O1)Br,,,,,,
8229,98230,3-Methyltetrahydrofuran,CC1CCOC1,,,,,,
8230,98231,"2-Furanacrylonitrile, (E)-",C1=COC(=C1)C=CC#N,,,,,,
8231,98232,exo-2-Bromonorbornane,C1CC2CC1CC2Br,,,,,,
8232,98233,Bicyclo[2.2.1]hept-5-ene-2-carbonyl chloride,C1C2CC(C1C=C2)C(=O)Cl,,,,,,
8233,98234,2-Bromotridecane,CCCCCCCCCCCC(C)Br,,,,,,
8234,98235,Adenylyl cytidine,C1=CN(C(=O)N=C1N)C2C(C(C(O2)COP(=O)(O)OC3C(OC(C3O)N4C=NC5=C(N=CN=C54)N)CO)O)O,,,,,,
8235,98236,CID 98236,C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OCC4C(C(C(O4)N5C=NC6=C5NC(=NC6=O)N)O)O)O)N,,,,,,
8236,98237,CID 98237,COC1=CC=C(C=C1)C=CC=CC=O,,,,,,
8237,98238,"4,5-Dihydro-3,5-diphenylisoxazole",C1C(ON=C1C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
8238,98239,CID 98239,COC1=CC(=C(C=C1)C(=O)C=CC2=CC(=C(C=C2)OC)OC)O,,,,,,
8239,98240,4-Phthalimidoglutaramic acid,C1=CC=C2C(=C1)C(=O)N(C2=O)C(CCC(=O)O)C(=O)N,,,,,,
8240,98241,Adenylyl-(3'-5')-uridine,C1=CN(C(=O)NC1=O)C2C(C(C(O2)COP(=O)(O)OC3C(OC(C3O)N4C=NC5=C(N=CN=C54)N)CO)O)O,,,,,,
8241,98242,CID 98242,C1=CN(C(=O)NC1=O)C2C(C(C(O2)COP(=O)(O)OC3C(OC(C3O)N4C=NC5=C4NC(=NC5=O)N)CO)O)O,,,,,,
8242,98243,1-(2-Naphthyl)ethanol,CC(C1=CC2=CC=CC=C2C=C1)O,,,,,,
8243,98244,"Pentanoic acid, 2-(diethoxyphosphinyl)-, ethyl ester",CCCC(C(=O)OCC)P(=O)(OCC)OCC,,,,,,
8244,98245,"2-Norbornanecarbonitrile, 2-chloro-, endo-",C1CC2CC1CC2(C#N)Cl,,,,,,
8245,98246,2-exo-Hydroxy-7-methyl-7-norbornanecarboxylic acid 7-lactone,CC12C3CCC1C(C3)OC2=O,,,,,,
8246,98247,"2-Norbornene-5-endo-carboxamide, 5-exo-methyl-",CC1(CC2CC1C=C2)C(=O)N,,,,,,
8247,98248,6-Hydroxytetrahydroharman,CC1C2=C(CCN1)C3=C(N2)C=CC(=C3)O,,,,,,
8248,98249,N-Ethylmaleamic acid,CCNC(=O)C=CC(=O)O,,,,,,
8249,98250,4-Oxo-4-(propylamino)but-2-enoic acid,CCCNC(=O)C=CC(=O)O,,,,,,
8250,98251,"2,4-Dimethylcyclohexanol",CC1CCC(C(C1)C)O,,,,,,
8251,98252,"Phosphine oxide, bis(diallylamino)(2-methyl-1-aziridinyl)-",CC1CN1P(=O)(N(CC=C)CC=C)N(CC=C)CC=C,,,,,,
8252,98253,1-(2-Chloroethyl)-3-(3-methylcyclohexyl)-1-nitrosourea,CC1CCCC(C1)NC(=O)N(CCCl)N=O,,,,,,
8253,98254,1-(2-Fluoroethyl)-3-(2-norbornyl)-1-nitrosourea,C1CC2CC1CC2NC(=O)N(CCF)N=O,,,,,,
8254,98255,Ergocrystine,CC(C)C1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CN(C6CC7=CNC8=CC=CC(=C78)C6=C5)C,,,,,,
8255,98256,Ethyl tetrahydrofurfuryl ether,CCOCC1CCCO1,,,,,,
8256,98257,"2,4-Dimethyl-3-hexanol",CCC(C)C(C(C)C)O,,,,,,
8257,98258,1-Cyclopropyl-1-(4-methylphenyl)ethanol,CC1=CC=C(C=C1)C(C)(C2CC2)O,,,,,,
8258,98259,"Tetrahydro-5-oxofuran-2,3-dicarboxylic acid",C1C(C(OC1=O)C(=O)O)C(=O)O,,,,,,
8259,98260,Chlorofluoroacetic acid,C(C(=O)O)(F)Cl,,,,,['Chlorofluoroacetic acid has known human metabolites that include chloroacetyl-S-glutathione.'],
8260,98261,"Androst-4-en-3-one, 17beta,17'beta-((dimethylsilylene)dioxy)di-",CC12CCC3C(C1CCC2O[Si](C)(C)OC4CCC5C4(CCC6C5CCC7=CC(=O)CCC67C)C)CCC8=CC(=O)CCC38C,,,,,,
8261,98262,Ditestosteroxydiphenylsilane,CC12CCC3C(C1CCC2O[Si](C4=CC=CC=C4)(C5=CC=CC=C5)OC6CCC7C6(CCC8C7CCC9=CC(=O)CCC89C)C)CCC1=CC(=O)CCC31C,,,,,,
8262,98263,Diphenyl N-(1-methyl-2-phenylethyl)phosphoramidate,CC(CC1=CC=CC=C1)NP(=O)(OC2=CC=CC=C2)OC3=CC=CC=C3,,,,,,
8263,98264,"Camptothecin, acetate",CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=CC=CC=C5N=C4C3=C2)OC(=O)C,,,,,,
8264,98265,"2,2-Dimethyl-3-hexanol",CCCC(C(C)(C)C)O,,,,,,
8265,98266,"3,5-Dimethyl-3-hexanol",CCC(C)(CC(C)C)O,,,,,,
8266,98267,1-Propyl-1-cyclopentanol,CCCC1(CCCC1)O,,,,,,
8267,98268,"Cyclohexanecarboxylic acid, 1-(3-(2-chloroethyl)-3-nitrosoureido)-, ethyl ester",CCOC(=O)C1(CCCCC1)NC(=O)N(CCCl)N=O,,,,,,
8268,98269,"1-(2-Chloroethyl)-1-nitroso-3-(3,3,5-trimethylcyclohexyl)urea",CC1CC(CC(C1)(C)C)NC(=O)N(CCCl)N=O,,,,,,
8269,98270,"Urea, N,N'-bis(2-chloropropyl)-N-nitroso-",CC(CNC(=O)N(CC(C)Cl)N=O)Cl,,,,,,
8270,98271,2-(4-Chlorophenyl)thiazolidine,C1CSC(N1)C2=CC=C(C=C2)Cl,,,,,,
8271,98272,"2-(4-Methoxyphenyl)-1,3-thiazolane",COC1=CC=C(C=C1)C2NCCS2,,,,,,
8272,98273,CID 98273,C1=CC=C(C=C1)N2C(=O)C(N=C2S)CC(=O)N,,,,,,
8273,98274,CID 98274,C1=CC=C(C=C1)N2C(=O)C(N=C2S)CCC(=O)N,,,,,,
8274,98275,CID 98275,CCC(C)C1C(=O)N(C(=N1)S)C2=CC=CC=C2,,,,,,
8275,98276,CID 98276,CC(C)CC1C(=O)N(C(=N1)S)C2=CC=CC=C2,,,,,,
8276,98277,CID 98277,C1=CC=C(C=C1)N2C(=O)C(N=C2S)CC3=CNC4=CC=CC=C43,,,,,,
8277,98278,CID 98278,C1=CC=C(C=C1)NC(=NCCCCC2C(=O)N(C(=N2)S)C3=CC=CC=C3)S,,,,,,
8278,98279,4-Methyl-1-pentyn-3-ol,CC(C)C(C#C)O,,,,,,
8279,98280,L-Deoxyalliin,C=CCSCC(C(=O)O)N,,,['Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)'],,,
8280,98281,N-(2-Quinoxaloyl)-L-phenylalanine,C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C2=NC3=CC=CC=C3N=C2,,,,,,
8281,98282,4-Methyl-1-phenylpyrazolidin-3-one,CC1CN(NC1=O)C2=CC=CC=C2,,,,,,
8282,98283,alpha-Cyclopentylmandelic acid,C1CCC(C1)C(C2=CC=CC=C2)(C(=O)O)O,,,,,,
8283,98284,"2,2,3-Trimethylcyclopentaneacetic acid",CC1CCC(C1(C)C)CC(=O)O,,,,,,
8284,98285,"2,3,4,9-Tetrahydro-1H-beta-carboline-3-carboxylic acid",C1C(NCC2=C1C3=CC=CC=C3N2)C(=O)O,,,,,,
8285,98286,"1,2,3,4-Tetrahydronaphthalene-1,5-diol",C1CC(C2=C(C1)C(=CC=C2)O)O,,,,,,
8286,98287,Cyclopropyl(4-methylphenyl)methanol,CC1=CC=C(C=C1)C(C2CC2)O,,,,,,
8287,98288,1-(Pentafluorophenyl)ethanol,CC(C1=C(C(=C(C(=C1F)F)F)F)F)O,,,,,,
8288,98289,1-(p-Chlorophenyl)-2-methylpiperazine,CC1CNCCN1C2=CC=C(C=C2)Cl,,,,,,
8289,98290,2-Methyl-1-(p-tolyl)piperazine,CC1CNCCN1C2=CC=C(C=C2)C,,,,,,
8290,98291,"Pyrazine, 2,3-dihydro-5,6-diphenyl-2-methyl-",CC1CN=C(C(=N1)C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
8291,98292,5'-Trityluridine,C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)OCC4C(C(C(O4)N5C=CC(=O)NC5=O)O)O,,,,,,
8292,98293,4-Sec-butyl-2-(1-phenylethyl)phenol,CCC(C)C1=CC(=C(C=C1)O)C(C)C2=CC=CC=C2,,,,,,
8293,98294,3-Chloro-2-methylpropionitrile,CC(CCl)C#N,,,,,,
8294,98295,N-Ethyltetrahydrofurfurylamine,CCNCC1CCCO1,,,,,,
8295,98296,"2H-Pyran, tetrahydro-2-isobutoxy-",CC(C)COC1CCCCO1,,,,,,
8296,98297,2-Bromodecane,CCCCCCCCC(C)Br,,,,,,
8297,98298,"Allyl 3,4-epoxy-6-methylcyclohexanecarboxylate",CC1CC2C(O2)CC1C(=O)OCC=C,,,,,,
8298,98299,2-Bromododecane,CCCCCCCCCCC(C)Br,,,,,,
8299,98300,"5,6-Dihydrobenz(a)anthracene-5,6-diol",C1=CC=C2C=C3C4=CC=CC=C4C(C(C3=CC2=C1)O)O,,,,,,
8300,98301,"Benz[a]anthracene-5,6-diol, 5,6-dihydro-7,12-dimethyl-",CC1=C2C(C(C3=CC=CC=C3C2=C(C4=CC=CC=C14)C)O)O,,,,,,
8301,98302,CID 98302,CC(=O)NC1=NN=C(S1)S,,,,,,
8302,98303,(1-Phenoxyethyl)benzene,CC(C1=CC=CC=C1)OC2=CC=CC=C2,,,,,,
8303,98304,"Phenol, 4-(1,1-dimethylethyl)-2-(1-phenylethyl)-",CC(C1=CC=CC=C1)C2=C(C=CC(=C2)C(C)(C)C)O,,,,,,
8304,98305,Phenyl(pyridin-4-yl)methanol,C1=CC=C(C=C1)C(C2=CC=NC=C2)O,,,,,,
8305,98306,o-Methylcinnamic acid,CC1=CC=CC=C1C=CC(=O)O,,,,,,
8306,98307,3-(Naphthalen-1-yl)acrylic acid,C1=CC=C2C(=C1)C=CC=C2C=CC(=O)O,,,,,,
8307,98308,"2-Methyl-2,3-dihydrobenzofuran-7-carboxylic acid",CC1CC2=C(O1)C(=CC=C2)C(=O)O,,,,,,
8308,98309,N-(1-phenylethyl)urea,CC(C1=CC=CC=C1)NC(=O)N,,,,,,
8309,98310,2-Bromodecanoic acid,CCCCCCCCC(C(=O)O)Br,,,,,,
8310,98311,Cloran,C1C2C(CC3C1C4(C(=C(C3(C4(Cl)Cl)Cl)Cl)Cl)Cl)C(=O)OC2=O,,,,,,
8311,98312,Xanthommatin,C1=CC(=C2C(=C1)OC3=CC(=O)C4=C(C3=N2)C(=O)C=C(N4)C(=O)O)C(=O)CC(C(=O)O)N,,,,,,
8312,98313,2-Amino-2-(4-fluorophenyl)acetic acid,C1=CC(=CC=C1C(C(=O)O)N)F,,,,,,
8313,98314,Ethyl 2-acetyl-3-oxooctanoate,CCCCCC(=O)C(C(=O)C)C(=O)OCC,,,,,,
8314,98315,2'-Deoxy-6-azauridine,C1C(C(OC1N2C(=O)NC(=O)C=N2)CO)O,,,,,,
8315,98316,"(S)-4-Chloro-4-ethyl-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione",CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=CC=CC=C5N=C4C3=C2)Cl,,,,,,
8316,98317,"1-Bromo-3,5-dimethyladamantane",CC12CC3CC(C1)(CC(C3)(C2)Br)C,,,,,,
8317,98318,Ethyl 2-norbornylcarbamate,CCOC(=O)NC1CC2CCC1C2,,,,,,
8318,98319,"Cyclopentanecarboxylic acid, 3-(phenylaminocarbonyl)-1,2,2-trimethyl-",CC1(C(CCC1(C)C(=O)O)C(=O)NC2=CC=CC=C2)C,,,,,,
8319,98320,cis-3-(3-(2-Chloroethyl)-3-nitrosoureido)cyclopentanecarboxylic acid ethyl ester,CCOC(=O)C1CCCC(C1)NC(=O)N(CCCl)N=O,,,,,,
8320,98321,Fluorocinnamic acid,C1=CC=C(C=C1)C=C(C(=O)O)F,,,,,,
8321,98322,Pillaromycin A,C[C@H]1[C@@](CC[C@@H](O1)O[C@]23C=C([C@@H]([C@@H]([C@H]2CC4=C(C3=O)C(=C5C(=C4)C=CC=C5O)O)O)O)C(=O)C)(C(=O)CO)O,,,,,,
8322,98323,alpha-Methyl-gamma-butyrolactone,CC1CCOC1=O,,,,,,
8323,98324,"2-(Bromomethyl)-5-fluoro-2,3-dihydrobenzofuran",C1C(OC2=C1C=C(C=C2)F)CBr,,,,,,
8324,98325,"5-Norbornene-2,3-dicarbonyl chloride, trans-",C1C2C=CC1C(C2C(=O)Cl)C(=O)Cl,,,,,,
8325,98326,"Acetamide,n-[4-(1h-inden-1-ylidenemethyl)phenyl]-n-methyl-",CC(=O)N(C)C1=CC=C(C=C1)C=C2C=CC3=CC=CC=C32,,,,,,
8326,98327,"2,3-Diphenyl-4-thiazolidinone",C1C(=O)N(C(S1)C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
8327,98328,(2E)-Tco-OH,C1CCC=CC(CC1)O,,,,,,
8328,98329,5-Methyl-3-phenylrhodanine,CC1C(=O)N(C(=S)S1)C2=CC=CC=C2,,,,,,
8329,98330,"1,4-Dithiane-2,5-diol",C1C(SCC(S1)O)O,,,,,,
8330,98331,Cordilin,CC1CCC2C(C(C13CCC(=O)O3)(C)O)OC(=O)C2=C,,,,,,
8331,98332,"1,9-Dimethyl-5-methylidene-3,14-dioxatricyclo[8.4.0.02,6]tetradec-9-ene-4,13-dione",CC1=C2CCC(=O)OC2(C3C(CC1)C(=C)C(=O)O3)C,,,,,,
8332,98333,"2-Bromomethyl-1,4-benzodioxane",C1C(OC2=CC=CC=C2O1)CBr,,,,,,
8333,98334,"2-(1,4-Benzodioxan-2-yl)ethanol",C1C(OC2=CC=CC=C2O1)CCO,,,,,,
8334,98335,1-Diphenylamino-2-propanol,CC(CN(C1=CC=CC=C1)C2=CC=CC=C2)O,,,,,,
8335,98336,"2-[(2,3-Dihydro-benzo[1,4]dioxin-2-ylmethyl)-methyl-amino]-ethanol",CN(CCO)CC1COC2=CC=CC=C2O1,,,,,,
8336,98337,"Anthranilic acid, N-methyl-, hydrazide",CNC1=CC=CC=C1C(=O)NN,,,,,,
8337,98338,"2-Propen-1-one,3-(1,3-benzodioxol-5-YL)-2-phenyl-1-[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]-",C1CCN(C1)CCOC2=CC=C(C=C2)C(=O)C(=CC3=CC4=C(C=C3)OCO4)C5=CC=CC=C5,,,,,,
8338,98339,"Phosphonic acid, (2-phenylethenyl)-, dioctyl ester",CCCCCCCCOP(=O)(C=CC1=CC=CC=C1)OCCCCCCCC,,,,,,
8339,98340,CID 98340,CC(=C1C(=O)N=C(S1)S)C2=CC(=C(C(=C2)OC)OC)OC,,,,,,
8340,98341,2-Amino-2-cyanoacetamide,C(#N)C(C(=O)N)N,,,,,,
8341,98342,"2,4-Thiazolidinedicarboxylic acid, 2-methyl-",CC1(NC(CS1)C(=O)O)C(=O)O,,,,,,
8342,98343,CID 98343,CC(=C1C(=O)N=C(S1)S)C2=CC(=CC=C2)OC,,,,,,
8343,98344,"4-Thiazolidinecarboxylic acid, 2-ethyl-",CCC1NC(CS1)C(=O)O,,,,,,
8344,98345,2-Methylcyclohexyl acetate,CC1CCCCC1OC(=O)C,,,,,,
8345,98346,4-Methyl-1-hexanol,CCC(C)CCCO,,,,,,
8346,98347,N-(p-Tolylsulphonyl)-L-glutamic acid,CC1=CC=C(C=C1)S(=O)(=O)NC(CCC(=O)O)C(=O)O,,,,,,
8347,98348,Armepavine,CN1CCC2=CC(=C(C=C2C1CC3=CC=C(C=C3)O)OC)OC,,,,,,
8348,98349,3-(3-tert-Butylcyclohexyl)-1-(2-chloroethyl)-1-nitrosourea,CC(C)(C)C1CCCC(C1)NC(=O)N(CCCl)N=O,,,,,,
8349,98350,1-(2-Chloroethyl)-3-(4-thiochromanyl)urea,C1CSC2=CC=CC=C2C1NC(=O)NCCCl,,,,,,
8350,98351,"Urea, 1-(2-chloroethyl)-1-nitroso-3-(thiochroman-4-yl)-",C1CSC2=CC=CC=C2C1NC(=O)N(CCCl)N=O,,,,,,
8351,98352,"3-Acetylheptane-2,6-dione",CC(=O)CCC(C(=O)C)C(=O)C,,,,,,
8352,98353,"3-Chloro-3H-2,1-benzoxathiole-1,1-dioxide",C1=CC=C2C(=C1)C(OS2(=O)=O)Cl,,,,,,
8353,98354,"Ethanol, 2-[(1-methylheptyl)amino]-",CCCCCCC(C)NCCO,,,,,,
8354,98355,"13-(3,3-Dimethyloxiran-2-yl)-3,7,11-trimethyltrideca-2,6,10-trien-1-ol",CC(=CCCC(=CCO)C)CCC=C(C)CCC1C(O1)(C)C,,,,,,
8355,98356,Dihydrokavain,COC1=CC(=O)OC(C1)CCC2=CC=CC=C2,,,,,,
8356,98357,"1-(2-Methoxyphenoxy)-2,3-epoxypropane",COC1=CC=CC=C1OCC2CO2,,,,,,
8357,98358,"1,2,3,4,6,7,12,12b-Octahydroindolo[2,3-a]quinolizine",C1CCN2CCC3=C(C2C1)NC4=CC=CC=C34,,,,,,
8358,98359,3-(4-Methylphenyl)butanoic acid,CC1=CC=C(C=C1)C(C)CC(=O)O,,,,,,
8359,98360,1-(4-((1H-Inden-1-ylidene)methyl)phenyl)guanidine,C1=CC=C2C(=C1)C=CC2=CC3=CC=C(C=C3)N=C(N)N,,,,,,
8360,98361,"(1,2-Dimethylpropyl)benzene",CC(C)C(C)C1=CC=CC=C1,,,,,,
8361,98362,"2-Pyrazoline, 4-ethyl-1-methyl-5-propyl-",CCCC1C(C=NN1C)CC,,,,,,
8362,98363,Isopteropodin,CC1C2CN3CCC4(C3CC2C(=CO1)C(=O)OC)C5=CC=CC=C5NC4=O,,,,,,
8363,98364,Mansonone A,CC1CCC(C2=C1C(=O)C(=O)C(=C2)C)C(C)C,,,,,,
8364,98365,"1H-Indole-3-acetonitrile, 2,3-dihydro-2-oxo-",C1=CC=C2C(=C1)C(C(=O)N2)CC#N,,,,,,
8365,98366,"5-(2-Furyl)-4,5-dihydro-3-methyl-1H-pyrazole",CC1=NNC(C1)C2=CC=CO2,,,,,,
8366,98367,"L-Proline, 1-nitro-",C1CC(N(C1)[N+](=O)[O-])C(=O)O,,,,,,
8367,98368,"2-Piperidinecarboxylic acid, 1-nitro-, DL-",C1CCN(C(C1)C(=O)O)[N+](=O)[O-],,,,,,
8368,98369,Isoboldine,CN1CCC2=CC(=C(C3=C2C1CC4=CC(=C(C=C43)OC)O)O)OC,,,,,,
8369,98370,3-(1-Cyanoethyl)benzoic acid,CC(C#N)C1=CC(=CC=C1)C(=O)O,,,,,,
8370,98371,2-tert-Butyl-3-phenyloxaziridine,CC(C)(C)N1C(O1)C2=CC=CC=C2,,,,,,
8371,98372,2-Acetoxycinnamaldehyde,CC(=O)OC1=CC=CC=C1C=CC=O,,,,,,
8372,98373,o-Hydroxy-trans-cinnamaldehyde,C1=CC=C(C(=C1)C=CC=O)O,,,,,,
8373,98374,2-bromo-4-(inden-1-ylidenemethyl)-N-methylaniline,CNC1=C(C=C(C=C1)C=C2C=CC3=CC=CC=C32)Br,,,,,,
8374,98375,"1-Methyl-2,3,4,9-tetrahydro-1H-beta-carboline-1-carboxylic acid",CC1(C2=C(CCN1)C3=CC=CC=C3N2)C(=O)O,,,,,,
8375,98376,CID 98376,C1=CC=C(C=C1)N2C(=O)C(N=C2S)CO,,,,,,
8376,98377,CID 98377,CC(C1C(=O)N(C(=N1)S)C2=CC=CC=C2)O,,,,,,
8377,98378,"7,7-Dichlorobicyclo[3.2.0]hept-2-en-6-one",C1C=CC2C1C(=O)C2(Cl)Cl,,,,,,
8378,98379,CID 98379,CC1CC=CCC12C(=O)NC(=NC2=O)S,,,,,,
8379,98380,"11-Methyl-2,4-diazaspiro[5.5]undec-8-ene-1,3,5-trione",CC1CC=CCC12C(=O)NC(=O)NC2=O,,,,,,
8380,98381,"7-Methyl-2,4-diazaspiro[5.5]undecane-1,3,5-trione",CC1CCCCC12C(=O)NC(=O)NC2=O,,,,,,
8381,98382,CID 98382,CC1CC(=C(CC12C(=O)NC(=NC2=O)S)C)C,,,,,,
8382,98383,"11-Isopropyl-2,4-diazaspiro[5.5]undec-8-ene-1,3,5-trione",CC(C)C1CC=CCC12C(=O)NC(=O)NC2=O,,,,,,
8383,98384,"11-Propyl-2,4-diazaspiro[5.5]undec-8-ene-1,3,5-trione",CCCC1CC=CCC12C(=O)NC(=O)NC2=O,,,,,,
8384,98385,"8,9,11-Trimethyl-2,4-diazaspiro[5.5]undec-8-ene-1,3,5-trione",CC1CC(=C(CC12C(=O)NC(=O)NC2=O)C)C,,,,,,
8385,98386,"7-Propyl-2,4-diazaspiro[5.5]undecane-1,3,5-trione",CCCC1CCCCC12C(=O)NC(=O)NC2=O,,,,,,
8386,98387,1-Amino-2-methylpropylphosphonic acid,CC(C)C(N)P(=O)(O)O,,,,,,
8387,98388,2-(2-Aminoethyl)-1-methylpyrrolidine,CN1CCCC1CCN,,,,,,
8388,98389,"1-(2-Chlorophenyl)-1-(4-iodophenyl)-2,2-dichloroethane",C1=CC=C(C(=C1)C(C2=CC=C(C=C2)I)C(Cl)Cl)Cl,,,,,,
8389,98390,CID 98390,C1=CC=C(C=C1)C=C2C(=O)SC(=N2)S,,,,,,
8390,98391,CID 98391,CCOC(=O)C1CC(=C(O)OCC)C(=O)C1=O,,,,,,
8391,98392,Cyclooct-4-en-1-ol,C1CC=CCCC(C1)O,,,,,,
8392,98393,3-(2-Oxocyclohexyl)propanoic acid,C1CCC(=O)C(C1)CCC(=O)O,,,,,,
8393,98394,"1,3-Dimethyl-5-[2-(1-methyl-2-pyrrolidinylidene)ethylidene]-2-sulfanylidene-4-imidazolidinone",CN1CCCC1=CC=C2C(=O)N(C(=S)N2C)C,,,,,,
8394,98395,"3-Ethyl-5-[2-(3-methyl-1,3-thiazolidin-2-ylidene)ethylidene]-2-sulfanylidene-1,3-oxazolidin-4-one",CCN1C(=O)C(=CC=C2N(CCS2)C)OC1=S,,,,,,
8395,98396,"Tetrahydro-2,7a-dimethyl-7aH-oxazolo(2,3-b)oxazole",CC1CN2CCOC2(O1)C,,,,,,
8396,98397,"2,2-Diphenylcyclopropanecarbonitrile",C1C(C1(C2=CC=CC=C2)C3=CC=CC=C3)C#N,,,,,,
8397,98398,"2-Isopropyl-5,5-dimethylthiazolidine-4-carboxylic acid",CC(C)C1NC(C(S1)(C)C)C(=O)O,,,,,,
8398,98399,"Benzene, 1-fluoro-4-(2-nitroethenyl)-",C1=CC(=CC=C1C=C[N+](=O)[O-])F,,,,,,
8399,98400,"Ethyl 2-cyano-3-(3,4-dichlorophenyl)prop-2-enoate",CCOC(=O)C(=CC1=CC(=C(C=C1)Cl)Cl)C#N,,,,,,
8400,98401,CID 98401,CCC(C1CC2C(CC(O2)C(O1)CC=CC#C)Br)Br,,,,,,
8401,98402,"4-((1H-Inden-1-ylidene)methyl)-2,6-dichloroaniline",C1=CC=C2C(=C1)C=CC2=CC3=CC(=C(C(=C3)Cl)N)Cl,,,,,,
8402,98403,"2,6,10-Trimethylundec-9-enal",CC(CCCC(C)C=O)CCC=C(C)C,,,,,,
8403,98404,p-(Dimethylamino)cinnamonitrile,CN(C)C1=CC=C(C=C1)C=CC#N,,,,,,
8404,98405,"1,3-Dichloro-2-(2-nitroethenyl)benzene",C1=CC(=C(C(=C1)Cl)C=C[N+](=O)[O-])Cl,,,,,,
8405,98406,"5,6,7,8,9,9-Hexachloro-1,2,3,4,4a,5,8,8a-octahydro-1,4:5,8-dimethanonaphthalen-2-ol",C1C2CC(C1C3C2C4(C(=C(C3(C4(Cl)Cl)Cl)Cl)Cl)Cl)O,,,,,,
8406,98407,"(4-Hydroxy-8a-methoxy-5-methyl-6,7-dioxo-1,1a,2,6,7,8,8a,8b-octahydroazireno[2',3':3,4]pyrrolo[1,2-a]indol-8-yl)methyl carbamate",CC1=C(C2=C(C(C3(N2CC4C3N4)OC)COC(=O)N)C(=O)C1=O)O,,,,,,
8407,98408,Mitomycin derivative T 41,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)O)N4C)NC,,,,,,
8408,98409,"6,6'-Dimethoxy-2,2'-dimethylberbaman-7,12-diol",CN1CCC2=CC(=C3C=C2C1CC4=CC=C(C=C4)OC5=C(C=CC(=C5)CC6C7=C(O3)C(=C(C=C7CCN6C)OC)O)O)OC,,,,,,
8409,98410,1-Hydroxyhexadec-10-en-7-one,CCCCCC=CCCC(=O)CCCCCCO,,,,,,
8410,98411,Sclerin,CC1C2=C(C(=C(C(=C2C)C)C)O)C(=O)OC1=O,,,,,,
8411,98412,Ethyl 2-cyano-2-ethyl-3-methyl-3-hexenoate,CCC=C(C)C(CC)(C#N)C(=O)OCC,,,,,,
8412,98413,4-[2-(4-Methylsulfanylphenyl)ethenyl]quinoline,CSC1=CC=C(C=C1)C=CC2=CC=NC3=CC=CC=C23,,,,,,
8413,98414,Sorbohydroxamicacid,CC=CC=CC(=O)NO,,,,,,
8414,98415,"5-(Hydroxymethyl)-6-phenyl-4,5-dihydro-3(2H)-pyridazinone",C1C(C(=NNC1=O)C2=CC=CC=C2)CO,,,,,,
8415,98416,Lumisantonin,CC1C2CCC3(C4(C3(C2OC1=O)C=CC4=O)C)C,,,,,,
8416,98417,3-Methyleicosane,CCCCCCCCCCCCCCCCCC(C)CC,,,,,,
8417,98418,"5-But-2-en-2-yl-5-ethyl-1,3-diazinane-2,4,6-trione",CCC1(C(=O)NC(=O)NC1=O)C(=CC)C,,,,,,
8418,98419,"1-Methyl-5-pent-2-en-3-yl-5-propyl-1,3-diazinane-2,4,6-trione",CCCC1(C(=O)NC(=O)N(C1=O)C)C(=CC)CC,,,,,,
8419,98420,"2-(Bis(2-chloroethyl)amino)-5-methyl-1,3,2-oxazaphospholidine 2-oxide",CC1CNP(=O)(O1)N(CCCl)CCCl,,,,,,
8420,98421,2-Hydroxy-2-(4-methylphenyl)acetic acid,CC1=CC=C(C=C1)C(C(=O)O)O,,,,,,
8421,98422,4-Nitrophenylglycolic acid,C1=CC(=CC=C1C(C(=O)O)O)[N+](=O)[O-],,,,,,
8422,98423,"2,3-Dimethylbutane-1,2-diol",CC(C)C(C)(CO)O,,,,,,
8423,98424,Methyl 4-Oxotetrahydrothiophene-3-carboxylate,COC(=O)C1CSCC1=O,,,,,,
8424,98425,(S-Trityl)-L-cysteinyl-glycine,C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)SCC(C(=O)NCC(=O)O)N,,,,,,
8425,98426,1-Chloro-3-prop-2-ynoxypropan-2-ol,C#CCOCC(CCl)O,,,,,,
8426,98427,2-(2-Amino-3-(tritylthio)propionamido)propionic acid,CC(C(=O)O)NC(=O)C(CSC(C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3)N,,,,,,
8427,98428,2-Ethoxycyclohexan-1-ol,CCOC1CCCCC1O,,,,,,
8428,98429,2-[(1-Methylpropyl)amino]ethanol,CCC(C)NCCO,,,,,,
8429,98430,Dihydroaeruginoic acid,C1C(N=C(S1)C2=CC=CC=C2O)C(=O)O,,,,,,
8430,98431,5-(hydroxymethyl)dihydrofuran-2(3H)-one,C1CC(=O)OC1CO,,,,,,
8431,98432,5-Tert-butylazepan-2-one,CC(C)(C)C1CCC(=O)NCC1,,,,,,
8432,98433,"N-(2,5-dioxooxolan-3-yl)acetamide",CC(=O)NC1CC(=O)OC1=O,,,,,,
8433,98434,1-Methyl-2-phenylpiperidine,CN1CCCCC1C2=CC=CC=C2,,,,,,
8434,98435,"Benzyl (2,2,2-trifluoro-1-hydroxyethyl)carbamate",C1=CC=C(C=C1)COC(=O)NC(C(F)(F)F)O,,,,,,
8435,98436,"Benzyl N-(1-chloro-2,2,2-trifluoroethyl)carbamate",C1=CC=C(C=C1)COC(=O)NC(C(F)(F)F)Cl,,,,,,
8436,98437,((o-Allylphenoxy)methyl)oxirane,C=CCC1=CC=CC=C1OCC2CO2,,,,,,
8437,98438,S-(Propyl)glutathione,CCCSC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N,,,,,['Propyl-glutathione is a known human metabolite of 1-iodopropane.'],
8438,98439,"3-[2-(3,4-Dimethoxyphenyl)ethylamino]-1-(4-fluorophenyl)-2-methylprop-2-en-1-one",CC(=CNCCC1=CC(=C(C=C1)OC)OC)C(=O)C2=CC=C(C=C2)F,,,,,,
8439,98440,3-[4-(2-Chlorophenyl)piperazin-1-yl]-1-(4-fluorophenyl)-2-methylprop-2-en-1-one,CC(=CN1CCN(CC1)C2=CC=CC=C2Cl)C(=O)C3=CC=C(C=C3)F,,,,,,
8440,98441,1-(4-Fluorophenyl)-2-methyl-3-piperidin-1-ylprop-2-en-1-one,CC(=CN1CCCCC1)C(=O)C2=CC=C(C=C2)F,,,,,,
8441,98442,1-(4-Fluorophenyl)-3-piperidin-1-ylprop-2-en-1-one,C1CCN(CC1)C=CC(=O)C2=CC=C(C=C2)F,,,,,,
8442,98443,1-(4-Fluorophenyl)-3-(4-hydroxy-4-phenylpiperidin-1-yl)-2-methylprop-2-en-1-one,CC(=CN1CCC(CC1)(C2=CC=CC=C2)O)C(=O)C3=CC=C(C=C3)F,,,,,,
8443,98444,"3-[4-(3,4-Dimethylphenyl)piperazin-1-yl]-1-(4-fluorophenyl)-2-methylprop-2-en-1-one",CC1=C(C=C(C=C1)N2CCN(CC2)C=C(C)C(=O)C3=CC=C(C=C3)F)C,,,,,,
8444,98445,"8',10,11-Trimethoxytubulosan",CCC1CN2CCC3=CC(=C(C=C3C2CC1CC4C5=C(CCN4)C6=C(N5)C=CC(=C6)OC)OC)OC,,,,,,
8445,98446,"Diethyl 2,3-epoxypropylphosphonate",CCOP(=O)(CC1CO1)OCC,,,,,,
8446,98447,Narcotinediol,CN1CCC2=CC3=C(C(=C2C1C(C4=C(C(=C(C=C4)OC)OC)CO)O)OC)OCO3,,,,,,
8447,98448,Octahydro-1h-cyclopenta[b]pyridine,C1CC2CCCNC2C1,,,,,,
8448,98449,[Amino(phenyl)methyl]phosphonic acid,C1=CC=C(C=C1)C(N)P(=O)(O)O,,,,,,
8449,98450,4-Amino-4-phosphonobutanoic acid,C(CC(=O)O)C(N)P(=O)(O)O,,,,,,
8450,98451,3-Methylbutyrolactone,CC1CC(=O)OC1,,,,,,
8451,98452,3-Hydroxytetrahydro-2h-pyran-2-one,C1CC(C(=O)OC1)O,,,,,,
8452,98453,Octahydrobenzopyran-3-one,C1CCC2COC(=O)CC2C1,,,,,,
8453,98454,Methyl 2-acetamido-3-sulfamoylpropanoate,CC(=O)NC(CS(=O)(=O)N)C(=O)OC,,,,,,
8454,98455,Stepharine,COC1=C(C2=C3C(CC24C=CC(=O)C=C4)NCCC3=C1)OC,,,,,,
8455,98456,"1-Propanone, 1-[4-[2-hydroxy-3-(4-morpholinyl)propoxy]phenyl]-",CCC(=O)C1=CC=C(C=C1)OCC(CN2CCOCC2)O,,,,,,
8456,98457,"5,8a-Dimethyl-1-methylidene-3a,4,5,5a,9,9a-hexahydroazuleno[6,7-b]furan-2,8-dione",CC1CC2C(CC3(C1C=CC3=O)C)C(=C)C(=O)O2,,,,,,
8457,98458,"Benzene, 1-chloro-2-[(1E)-2-nitroethenyl]-",C1=CC=C(C(=C1)C=C[N+](=O)[O-])Cl,,,,,,
8458,98459,"4a,9-Dimethyl-3-methylideneoctahydrofuro[2',3':5,6]cyclohepta[1,2-c]pyran-2,7(3h,4h)-dione",CC1CC2C(CC3(C1CC(=O)OC3)C)C(=C)C(=O)O2,,,,,,
8459,98460,"Chrysene, octadecahydro-",C1CCC2C(C1)CCC3C2CCC4C3CCCC4,,,,,,
8460,98461,"2-Isopropyl-4-methyl-1,3-dioxolane",CC1COC(O1)C(C)C,,,,,,
8461,98462,N-(2-methylcyclohexylidene)hydroxylamine,CC1CCCCC1=NO,,,,,,
8462,98463,(2-Amino-2-thiazolin-5-yl)methylthiosulfuric acid,C1C(SC(=N1)N)CSS(=O)(=O)O,,,,,,
8463,98464,2-Methyl-3-octanol,CCCCCC(C(C)C)O,,,,,,
8464,98465,3-(Methoxycarbonyl)bicyclo[2.2.1]hept-5-ene-2-carboxylic acid,COC(=O)C1C2CC(C1C(=O)O)C=C2,,,,,,
8465,98466,"Diethyl 4-hydroxy-4-methyl-6-oxo-2-phenylcyclohexane-1,3-dicarboxylate",CCOC(=O)C1C(C(C(CC1=O)(C)O)C(=O)OCC)C2=CC=CC=C2,,,,,,
8466,98467,Citronellol epoxide,CC(CCC1C(O1)(C)C)CCO,,,,,,
8467,98468,"1-Benzyl-1,2,3,4-tetrahydroisoquinoline",C1CNC(C2=CC=CC=C21)CC3=CC=CC=C3,,,"['Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)']",,,
8468,98469,2-(4-Methoxyphenyl)-2-piperidinoacetamide,COC1=CC=C(C=C1)C(C(=O)N)N2CCCCC2,,,,,,
8469,98470,"2,3-Dimethoxy-5-methyl-6-(farnesylfarnesyl)-1,4-benzoquinone",CC1=C(C(=O)C(=C(C1=O)OC)OC)CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C,,,,,,
8470,98471,2-Acetylcyclopentanone,CC(=O)C1CCCC1=O,,,,,,
8471,98472,Norpurpureine,COC1=C(C=C2C(=C1)CC3C4=C(CCN3)C(=C(C(=C24)OC)OC)OC)OC,,,,,,
8472,98473,Purpureine,CN1CCC2=C3C1CC4=CC(=C(C=C4C3=C(C(=C2OC)OC)OC)OC)OC,,,,,,
8473,98474,4-Methyloctan-4-olide,CCCCC1(CCC(=O)O1)C,,,,,,
8474,98475,"Benzothiazole,2-(2-phenylethenyl)-",C1=CC=C(C=C1)C=CC2=NC3=CC=CC=C3S2,,,,,,
8475,98476,Desoxyharringtonin,CC(C)CCC(CC(=O)OC)(C(=O)OC1C2C3=CC4=C(C=C3CCN5C2(CCC5)C=C1OC)OCO4)O,,,,,,
8476,98477,Alkaloid B,COC1=CC23CCCN2CC(C4=CC5=C(C=C4C3C1O)OCO5)O,,,,,,
8477,98478,"4,7-Methano-1H-inden-5-ol, 3a,4,5,6,7,7a-hexahydro-, acetate",CC(=O)OC1CC2CC1C3C2CC=C3,,,,,,
8478,98479,1-(3-Bromophenyl)ethanol,CC(C1=CC(=CC=C1)Br)O,,,,,,
8479,98480,Bicyclo[2.2.1]heptan-2-amine,C1CC2CC1CC2N,,,,,,
8480,98481,"17-hydroxy-10,13-dimethylspiro[2,7,8,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthrene-6,1'-cyclopropane]-3-one",CC12CCC3C(C1CCC2O)CC4(CC4)C5=CC(=O)CCC35C,,,,,,
8481,98482,Heptachloronorbornene,C1C(C2(C(=C(C1(C2(Cl)Cl)Cl)Cl)Cl)Cl)Cl,,,,,,
8482,98483,"3-Amino-1,1,1-trichloropentan-2-ol",CCC(C(C(Cl)(Cl)Cl)O)N,,,,,,
8483,98484,"3a,4,7,7a-Tetrahydro-4,7-epoxyisobenzofuran-1,3-dione",C1=CC2C3C(C1O2)C(=O)OC3=O,,,,,,
8484,98485,"(8-Hydroxy-4,9-dimethyl-14-methylidene-13-oxo-5,12-dioxatricyclo[9.3.0.04,6]tetradec-9-en-2-yl) 2-methylprop-2-enoate",CC1=CC2C(C(CC3(C(O3)CC1O)C)OC(=O)C(=C)C)C(=C)C(=O)O2,,,,,,
8485,98486,"N,N'-Diallyltartramide",C=CCNC(=O)C(C(C(=O)NCC=C)O)O,,,,,,
8486,98487,3-Methoxybenzamide,COC1=CC=CC(=C1)C(=O)N,,,['Chemicals and drugs that inhibit the action of POLY(ADP-RIBOSE)POLYMERASES. (See all compounds classified as Poly(ADP-ribose) Polymerase Inhibitors.)'],,,
8487,98488,Benzyl p-aminobenzoate,C1=CC=C(C=C1)COC(=O)C2=CC=C(C=C2)N,,,,,,
8488,98489,Chloro TIC,C1CN=C(N1)C2=CC=C(C=C2)NC(=O)C3=CC(=C(C=C3)C(=O)NC4=CC=C(C=C4)C5=NCCN5)Cl.Cl.Cl,,,,,,
8489,98490,1-Hydroxyphenanthrene,C1=CC=C2C(=C1)C=CC3=C2C=CC=C3O,,,,,,
8490,98491,"1,1-Bis(p-chlorophenyl)-2-chloroethene",C1=CC(=CC=C1C(=CCl)C2=CC=C(C=C2)Cl)Cl,,,"['Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)']",,,
8491,98492,Pentyl phenylacetate,CCCCCOC(=O)CC1=CC=CC=C1,,,,,,
8492,98493,"1,2,4,5-Diepoxypentane",C1C(O1)CC2CO2,,,,,,
8493,98494,Benzo[f]quinoxaline,C1=CC=C2C(=C1)C=CC3=NC=CN=C32,,,,,,
8494,98495,"cis-1,2,3,6-Tetrahydrophthalic anhydride",C1C=CC[C@H]2[C@@H]1C(=O)OC2=O,,,,,"['... 3-hydroxycyclohexane-1,2-carboximide (OHHPI-1/2)2 and and 1-hydroxy-1,2-cyclohexanedicarboxylic-acid (OHHPA) were detected in urine and feces samples from noncannulated rats and in bile and urine samples from cannulated rats. 1,2-cyclohexanedicarboxylic-acid (TCDA) was detected only in urine and feces samples from noncannulated rats administered 3,4,5,6-tetrahydrophthalimide (TPI) orally. Following 3,4,5,6-tetrahydrophthalic-acid (THPA) administration, OHHPA was detected in all excreta except in feces from bile duct cannulated rats injected intravenously. TCDA was detected in feces samples from noncannulated rats administered THPA intravenously and in all excreta from bile duct cannulated rats administered THPA orally. No OHHPA was detected in rats administered TCDA. Liver, stomach, intestinal tissues plus contents, and kidneys, lung, spleen, and pancreas, plasma and blood cell samples obtained from untreated male Sprague-Dawley-rats were incubated with 40 nanomoles C14 labeled TPI or THPA for 1 hour. The mixtures were analyzed for metabolites as before. cis-1,2-Cyclohexanedicarboximide was detected in supernatants from blood cells following incubation with TPI. THPA and 3,4,5,6-tetrahydrophthalic-anhydride (TPA) were detected in the plasma and other tissues. Following incubation with THPA, trans-TCDA was detected in the intestinal tissues, OHHPA was detected in the intestine and liver, and TPA was detected in the other tissues, blood cells, and plasma.']",
8495,98496,"4-Methyl-1,2,3,6-tetrahydrophthalic anhydride",CC1=CCC2C(C1)C(=O)OC2=O,,,,,,
8496,98497,"2-(2,2,3-Trimethylcyclopent-3-en-1-yl)acetaldehyde",CC1=CCC(C1(C)C)CC=O,,,,,,
8497,98498,"2(1H)-Naphthalenone, octahydro-, (4aR,8aS)-rel-",C1CC[C@H]2CC(=O)CC[C@H]2C1,,,,,,
8498,98499,N-Benzylnicotinamide,C1=CC=C(C=C1)CNC(=O)C2=CN=CC=C2,,,,,,
8499,98500,3-Methylphthalic anhydride,CC1=C2C(=CC=C1)C(=O)OC2=O,,,,,,
8500,98501,"1(2H)-Naphthalenone, octahydro-",C1CCC2C(C1)CCCC2=O,,,,,,
8501,98502,"(2s,3s)-1,4-Dibromobutane-2,3-diol",C([C@H]([C@@H](CBr)O)O)Br,,,,,,
8502,98503,4-(4-Chlorobenzoyl)pyridine,C1=CC(=CC=C1C(=O)C2=CC=NC=C2)Cl,,,,,,
8503,98504,Lanthionine,C([C@@H](C(=O)O)N)SC[C@@H](C(=O)O)N,,,,,,
8504,98505,2-Mercaptoethyl acetate,CC(=O)OCCS,,,,,,
8505,98506,"trans-1,2-Dibromocyclohexane",C1CC[C@H]([C@@H](C1)Br)Br,,,,,,
8506,98507,"(1R,2S,6R,7R)-4-oxatricyclo[5.2.1.02,6]dec-8-ene-3,5-dione",C1[C@@H]2C=C[C@@H]1[C@H]3[C@@H]2C(=O)OC3=O,,,,,,
8507,98508,"meso-2,3-Dibromobutane",C[C@H]([C@H](C)Br)Br,,,,,,
8508,98509,DL-Alanyl-DL-methionine,CC(C(=O)NC(CCSC)C(=O)O)N,,,,,,
8509,98510,"1-Phenyl-1H-1,2,4-triazole-3,5-diamine",C1=CC=C(C=C1)N2C(=NC(=N2)N)N,,,,,,
8510,98511,cis-Stilbene oxide,C1=CC=C(C=C1)[C@H]2[C@H](O2)C3=CC=CC=C3,,,,,,
8511,98512,"1,4-Dibromo-2,3-butanediol",C(C(C(CBr)O)O)Br,,,,,,
8512,98513,CID 98513,C(C(C(=O)O)N)N(N=O)O,,,,,,
8513,98514,Benzpiperylone,CN1CCC(CC1)N2C(=O)C(=C(N2)C3=CC=CC=C3)CC4=CC=CC=C4,,,,,,
8514,98515,CID 98515,C=CCN1CC[C@]23[C@@H]4[C@@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O.Cl,,,,,,
8515,98516,"(4aR,7S,12bS)-3-prop-2-enyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol",C=CCN1CC[C@]23[C@@H]4C1CC5=C2C(=C(C=C5)O)OC3[C@H](C=C4)O,,,,,,
8516,98517,CID 98517,CN1CC[C@]23[C@@H]4[C@@H]1CC5=C2C(=C(C=C5)O)O[C@H]3C(=O)C=C4.Cl,,,,,,
8517,98518,"(4S,4aR,7aR,12bS)-9-hydroxy-3-methyl-1,2,4,4a,7a,13-hexahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one",CN1CC[C@]23[C@@H]4[C@@H]1CC5=C2C(=C(C=C5)O)O[C@H]3C(=O)C=C4,,,,,,
8518,98519,Dimethylmeperidine,CCC(=O)OC1(CC(N(CC1C)C)C)C2=CC=CC=C2.Cl,,,"['Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS. (See all compounds classified as Narcotics.)', 'Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)']",,,
8519,98520,Trimeperidine,CCC(=O)OC1(CC(N(CC1C)C)C)C2=CC=CC=C2,,,"['Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS. (See all compounds classified as Narcotics.)', 'Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)']",,,
8520,98521,4-Chlorodehydromethyltestosterone,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C)O)CCC4=C(C(=O)C=C[C@]34C)Cl,,,,,,
8521,98522,Aspirin mixture with Ethoheptazine and Meprobamate,CCCC(C)(COC(=O)N)COC(=O)N.CCOC(=O)C1(CCCN(CC1)C)C2=CC=CC=C2.CC(=O)OC1=CC=CC=C1C(=O)O,,,,,,
8522,98523,delta(9)-Tetrahydrocannabinolic acid,CCCCCC1=CC2=C([C@@H]3C=C(CC[C@H]3C(O2)(C)C)C)C(=C1C(=O)O)O,,,,,,
8523,98524,"2-acetyloxybenzoic acid;5-tert-butyl-5-prop-2-enyl-1,3-diazinane-2,4,6-trione;N-(4-ethoxyphenyl)acetamide;1,3,7-trimethylpurine-2,6-dione",CCOC1=CC=C(C=C1)NC(=O)C.CC(=O)OC1=CC=CC=C1C(=O)O.CC(C)(C)C1(C(=O)NC(=O)NC1=O)CC=C.CN1C=NC2=C1C(=O)N(C(=O)N2C)C,,,,,,
8524,98525,5-tert-Butyl-5-allylbarbituric acid,CC(C)(C)C1(C(=O)NC(=O)NC1=O)CC=C,,,,,,
8525,98526,ethyl (2R)-2-(dimethylamino)-1-phenylcyclohex-3-ene-1-carboxylate,CCOC(=O)C1(CCC=C[C@H]1N(C)C)C2=CC=CC=C2,,,,,,
8526,98527,"4-Bromo-2,5-dimethoxyphenethylamine",COC1=CC(=C(C=C1CCN)OC)Br,,,"['Compounds that bind to and activate ADRENERGIC ALPHA-1 RECEPTORS. (See all compounds classified as Adrenergic alpha-1 Receptor Agonists.)', 'Endogenous compounds and drugs that specifically stimulate SEROTONIN 5-HT2 RECEPTORS. Included under this heading are agonists for one or more of the specific 5-HT2 receptor subtypes. (See all compounds classified as Serotonin 5-HT2 Receptor Agonists.)']",,,
8527,98528,"N-Hydroxy-3,4-methylenedioxyamphetamine",CC(CC1=CC2=C(C=C1)OCO2)NO,,,,,,
8528,98529,CID 98529,CC1[C@@H]2CC3=C([C@]1(CCN2CC=C(C)C)C)C=C(C=C3)O.C=CCN1CC[C@]23[C@@H]4[C@@H]1CC5=C2C(=C(C=C5)O)O[C@H]3C(=O)CC4.Cl.Cl,,,,,,
8529,98530,CID 98530,C=CCN1CC[C@]23[C@@H]4[C@@H]1CC5=C2C(=C(C=C5)O)O[C@H]3C(=O)CC4,,,,,,
8530,98531,(mu-(Carbonato(2-)-O:O'))dihydroxydicobalt,C(=O)(O)O.O.O.[Co].[Co],,,,,,
8531,98532,Phillipsite (AlNa(SiO4).6H2O),O.O.O.O.O.O.[O-][Si]([O-])([O-])[O-].[Na+].[Al+3],,,,,,
8532,98533,3-(N-Nitrosomethylamino)propionaldehyde,CN(CCC=O)N=O,,,,,,
8533,98534,Nonyl methacrylate,CCCCCCCCCOC(=O)C(=C)C,,,,,,
8534,98535,"N,N-Bis(2-hydroxyethyl)ethylenediamine",C(CN(CCO)CCO)N,,,,,,
8535,98536,"2,2'-[Oxybis(ethane-2,1-diyloxycarbonyl)]dibenzoic acid",C1=CC=C(C(=C1)C(=O)O)C(=O)OCCOCCOC(=O)C2=CC=CC=C2C(=O)O,,,,,,
8536,98537,"3,3',3''-Nitrilotripropionic Acid",C(CN(CCC(=O)O)CCC(=O)O)C(=O)O,,,,,,
8537,98538,"2,4-Dichlorobenzyl thiocyanate",C1=CC(=C(C=C1Cl)Cl)CSC#N,,,,,,
8538,98539,"5,12-Naphthacenedione, 1-amino-6,11-dihydroxy-",C1=CC=C2C(=C1)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4N)O,,,,,,
8539,98540,"alpha,alpha'-((Phenylmethyl)phosphinylidene)bis(benzenemethanol)",C1=CC=C(C=C1)CP(=O)(C(C2=CC=CC=C2)O)C(C3=CC=CC=C3)O,,,,,,
8540,98541,"3-(Methylthio)-5-phenyl-1,2,4-triazine",CSC1=NC(=CN=N1)C2=CC=CC=C2,,,,,,
8541,98542,"3-Hydrazino-5-phenyl-1,2,4-triazine",C1=CC=C(C=C1)C2=CN=NC(=N2)NN,,,,,,
8542,98543,Phenyl o-nitrobenzenesulphonate,C1=CC=C(C=C1)OS(=O)(=O)C2=CC=CC=C2[N+](=O)[O-],,,,,,
8543,98544,"(2S,3S,4S,5R)-2-(7-aminotriazolo[4,5-d]pyrimidin-3-yl)-5-(hydroxymethyl)oxolane-3,4-diol",C1=NC(=C2C(=N1)N(N=N2)[C@@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N,,,,,,
8544,98545,"1,3,5-Tris(trichloromethyl)benzene",C1=C(C=C(C=C1C(Cl)(Cl)Cl)C(Cl)(Cl)Cl)C(Cl)(Cl)Cl,,,,,,
8545,98546,1-Ethyl-3-p-tolyltriazene,CCN=NNC1=CC=C(C=C1)C,,,,,,
8546,98547,"2,3-Dicyano-1,4-naphthoquinone",C1=CC=C2C(=C1)C(=O)C(=C(C2=O)C#N)C#N,,,,,,
8547,98548,"Butanoic acid, 4-((2-acetylphenyl)amino)-4-oxo-, methyl ester",CC(=O)C1=CC=CC=C1NC(=O)CCC(=O)OC,,,,,,
8548,98549,Diethyl methyl(phenyl)malonate,CCOC(=O)C(C)(C1=CC=CC=C1)C(=O)OCC,,,,,,
8549,98550,"Piperazine, 1-(2H-1-benzopyran-3-ylcarbonyl)-4-phenyl-",C1CN(CCN1C2=CC=CC=C2)C(=O)C3=CC4=CC=CC=C4OC3,,,,,,
8550,98551,"Piperazine, 1-(3-amino-4-pyridyl)-4-(2,5-xylyl)-",CC1=CC(=C(C=C1)C)N2CCN(CC2)C3=C(C=NC=C3)N,,,,,,
8551,98552,"Piperazine, 1-(3-amino-4-pyridyl)-4-(3,4-dichlorophenyl)-",C1CN(CCN1C2=CC(=C(C=C2)Cl)Cl)C3=C(C=NC=C3)N,,,,,,
8552,98553,"Piperazine, 1-(3-amino-4-pyridyl)-4-(1-naphthyl)-",C1CN(CCN1C2=C(C=NC=C2)N)C3=CC=CC4=CC=CC=C43,,,,,,
8553,98554,"4(1H)-Pyrimidinimine, 1-((6-chloro-2H-1-benzopyran-3-yl)carbonyl)-",C1C(=CC2=C(O1)C=CC(=C2)Cl)C(=O)N3C=CC(=N)C=C3,,,,,,
8554,98555,1-(2H-1-Benzopyran-3-ylcarbonyl)-2(1H)-pyridinimine,C1C(=CC2=CC=CC=C2O1)C(=O)N3C=CC=CC3=N,,,,,,
8555,98556,"4(1H)-Pyridinimine, 1-(2H-1-benzopyran-3-ylcarbonyl)-",C1C(=CC2=CC=CC=C2O1)C(=O)N3C=CC(=N)C=C3,,,,,,
8556,98557,2-(4-Phenylpiperidin-1-yl)pyridin-3-amine,C1CN(CCC1C2=CC=CC=C2)C3=C(C=CC=N3)N,,,,,,
8557,98558,"1-((6,8-Dichloro-2H-1-benzopyran-3-yl)carbonyl)-2(1H)-pyridinimine",C1C(=CC2=C(O1)C(=CC(=C2)Cl)Cl)C(=O)N3C=CC=CC3=N,,,,,,
8558,98559,"Piperazine, 1-(3-amino-4-pyridyl)-3-methyl-4-m-tolyl-",CC1CN(CCN1C2=CC=CC(=C2)C)C3=C(C=NC=C3)N,,,,,,
8559,98560,1-Bromo-2-methyl-1-propene,CC(=CBr)C,,,,,,
8560,98561,5-Formyl-2'-deoxyuridine,C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)C=O)CO)O,,,,,,
8561,98562,CID 98562,CCNC(=NCC=C)S,,,,,,
8562,98563,2-Chloro-6-ethoxypyridine,CCOC1=NC(=CC=C1)Cl,,,,,,
8563,98564,2-Chloro-6-fluorobenzamide,C1=CC(=C(C(=C1)Cl)C(=O)N)F,,,,,,
8564,98565,"5-Quinolinesulfonic acid, 8-hydroxy-7-(1-naphthalenylazo)-",C1=CC=C2C(=C1)C=CC=C2N=NC3=CC(=C4C=CC=NC4=C3O)S(=O)(=O)O,,,,,,
8565,98566,Nonadecanenitrile,CCCCCCCCCCCCCCCCCCC#N,,,,,,
8566,98567,5'-N-methylcarboxamidoadenosine,CNC(=O)[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O,,,,,,
8567,98568,"Ethyl 5-amino-4H-[1,2,4]triazole-3-carboxylate",CCOC(=O)C1=NC(=NN1)N,,,,,,
8568,98569,Argemonine,CN1C2CC3=CC(=C(C=C3C1CC4=CC(=C(C=C24)OC)OC)OC)OC,,,,,,
8569,98570,Allocryptopine,CN1CCC2=CC3=C(C=C2C(=O)CC4=C(C1)C(=C(C=C4)OC)OC)OCO3,,,,,,
8570,98571,Hoffer's chlorosugar,CC1=CC=C(C=C1)C(=O)OC[C@@H]2[C@H](C[C@H](O2)Cl)OC(=O)C3=CC=C(C=C3)C,,,,,,
8571,98572,"Acetamide, N,N'-(sulfonyldi-4,1-phenylene)bis(N-(acetyloxy)-",CC(=O)N(C1=CC=C(C=C1)S(=O)(=O)C2=CC=C(C=C2)N(C(=O)C)OC(=O)C)OC(=O)C,,,,,,
8572,98573,5-Hydroxynaphthalenedicarboxylic anhydride,C1=CC2=C(C=CC3=C2C(=O)OC3=O)C(=C1)O,,,,,,
8573,98574,"1,4-Phenanthrenedione",C1=CC=C2C(=C1)C=CC3=C2C(=O)C=CC3=O,,,,,,
8574,98575,5-Isopropyluracil,CC(C)C1=CNC(=O)NC1=O,,,,,,
8575,98576,"1,2,4-Triazolo(4,3-b)(1,2,4)triazine, 6,7-diphenyl-",C1=CC=C(C=C1)C2=NC3=NN=CN3N=C2C4=CC=CC=C4,,,,,,
8576,98577,"3,5-Diiodobenzoic acid",C1=C(C=C(C=C1I)I)C(=O)O,,,,,,
8577,98578,"Naphtho(2,3-b)thiophene-4,9-dione",C1=CC=C2C(=C1)C(=O)C3=C(C2=O)SC=C3,,,,,,
8578,98579,Stipitatonic acid,C1=C2C(=C(C=C(C1=O)O)O)C(=O)OC2=O,,,,,,
8579,98580,"Thiosulfuric acid, S-2-piperidinoethyl ester",C1CCN(CC1)CCSS(=O)(=O)O,,,,,,
8580,98581,dZ Nucleoside,C1[C@@H]([C@H](O[C@H]1N2C=NC(=C2N)C(=O)N)CO)O,,,,,,
8581,98582,"2,6-Dibenzylcyclohexanone",C1CC(C(=O)C(C1)CC2=CC=CC=C2)CC3=CC=CC=C3,,,,,,
8582,98583,"5,6-Dimethylbenz(a)phenazine",CC1=C(C2=NC3=CC=CC=C3N=C2C4=CC=CC=C14)C,,,,,,
8583,98584,Isonitrosoacetylacetone,CC(=C(C(=O)C)N=O)O,,,,,,
8584,98585,"3-Azetidinol, 1-cyclohexyl-",C1CCC(CC1)N2CC(C2)O,,,,,,
8585,98586,N-tert-Butylhydroxylamine,CC(C)(C)NO,,,,,,
8586,98587,"Hydantoin, 3,3'-(1,4-piperazinediyldimethylene)bis(5,5-dimethyl-",CC1(C(=O)N(C(=O)N1)CN2CCN(CC2)CN3C(=O)C(NC3=O)(C)C)C,,,,,,
8587,98588,"3,3'-(1,4-Piperazinediyldimethylene)bis(5,5-diphenylhydantoin)",C1CN(CCN1CN2C(=O)C(NC2=O)(C3=CC=CC=C3)C4=CC=CC=C4)CN5C(=O)C(NC5=O)(C6=CC=CC=C6)C7=CC=CC=C7,,,,,,
8588,98589,"Indolizino[1,2-b]quinolin-9(11h)-one",C1C2=CC3=CC=CC=C3N=C2C4=CC=CC(=O)N41,,,,,,
8589,98590,"5b,11-Dihydroindolizino(1,2-b)quinolin-9(6H)-one",C1C=CC(=O)N2C1C3=NC4=CC=CC=C4C=C3C2,,,,,,
8590,98591,Dibutyl iodomethaneboronate,B(CI)(OCCCC)OCCCC,,,,,,
8591,98592,4-(Methoxycarbonyl)-3-nitrobenzoic acid,COC(=O)C1=C(C=C(C=C1)C(=O)O)[N+](=O)[O-],,,,,,
8592,98593,Methyl 3-(p-(hexadecyloxy)phenyl)-3-oxopropionate,CCCCCCCCCCCCCCCCOC1=CC=C(C=C1)C(=O)CC(=O)OC,,,,,,
8593,98594,"Benzenesulfonic acid, 4-(acetylamino)-, phenyl ester",CC(=O)NC1=CC=C(C=C1)S(=O)(=O)OC2=CC=CC=C2,,,,,,
8594,98595,"3,5-Bis(1,1-dimethylethyl)-N,N-diethylaniline",CCN(CC)C1=CC(=CC(=C1)C(C)(C)C)C(C)(C)C,,,,,,
8595,98596,"3,5-Dinitro-4-hydroxyphenylacetic acid",C1=C(C=C(C(=C1[N+](=O)[O-])O)[N+](=O)[O-])CC(=O)O,,,,,,
8596,98597,Decanohydrazide,CCCCCCCCCC(=O)NN,,,,,,
8597,98598,4-Pyridincarboxaldehyd-2-benzothiazolylhydrazon,C1=CC=C2C(=C1)N=C(S2)NN=CC3=CC=NC=C3,,,,,,
8598,98599,"2,5-Diethoxy-4-morpholinoaniline",CCOC1=CC(=C(C=C1N)OCC)N2CCOCC2,,,,,,
8599,98600,"2-Chloro-1,3,5-trimethoxybenzene",COC1=CC(=C(C(=C1)OC)Cl)OC,,,,,,
8600,98601,N-tert-Butyldibenzylamine,CC(C)(C)N(CC1=CC=CC=C1)CC2=CC=CC=C2,,,,,,
8601,98602,Tridecyl palmitate,CCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCC,,,,,,
8602,98603,Decyl palmitate,CCCCCCCCCCCCCCCC(=O)OCCCCCCCCCC,,,,,,
8603,98604,CID 98604,C1=CC=C(C=C1)C(=CN=O)NO,,,,,,
8604,98605,"2,5-Dimethylphenyl isocyanate",CC1=CC(=C(C=C1)C)N=C=O,,,,,,
8605,98606,1-(4-Chlorophenyl)cyclopropanecarboxylic acid,C1CC1(C2=CC=C(C=C2)Cl)C(=O)O,,,,,,
8606,98607,CID 98607,C1=NC(=C(N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N)C(=N)S,,,,,,
8607,98608,Phellopterin,CC(=CCOC1=C2C(=C(C3=C1OC(=O)C=C3)OC)C=CO2)C,,,,,,
8608,98609,Tetrahydro-2-(2-propynyloxy)-2H-pyran,C#CCOC1CCCCO1,,,,,,
8609,98610,"N-(4-(((2,4-Diamino-6-pteridinyl)methyl)methylamino)-3-methoxybenzoyl)-L-glutamic acid",CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=C(C=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O)OC,,,,,,
8610,98611,"2-Phospholene, 1-hydroxy-3-methyl-, 1-oxide",CC1=CP(=O)(CC1)O,,,,,,
8611,98612,Alcophosphamide,C(CO)COP(=O)(N)N(CCCl)CCCl,,,,,,
8612,98613,2-Hydrazino-4-phenylthiazole,C1=CC=C(C=C1)C2=CSC(=N2)NN,,,,,,
8613,98614,"5,6,7,8-Tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one",C1CCC2=C(C1)C3=C(S2)N=CNC3=O,,,,,,
8614,98615,"1H-Indole, 3,5-dimethyl-",CC1=CC2=C(C=C1)NC=C2C,,,,,,
8615,98616,1-Methylnaphthalen-2-amine,CC1=C(C=CC2=CC=CC=C12)N,,,,,,
8616,98617,1H-Benz[g]indole,C1=CC=C2C(=C1)C=CC3=C2NC=C3,,,,,,
8617,98618,CID 98618,COC1=C(OC2=CC(=O)C=C(C2=C1O)O)C3=CC(=C(C=C3)O)O,,,,,,
8618,98619,Dibenyldiisocyanate,C1=CC(=CC=C1CCC2=CC=C(C=C2)N=C=O)N=C=O,,,,,,
8619,98620,"2-Chloro-1,4-dinitrobenzene",C1=CC(=C(C=C1[N+](=O)[O-])Cl)[N+](=O)[O-],,,,,,
8620,98621,1-(4-Chlorophenyl)cyclobutanecarbonitrile,C1CC(C1)(C#N)C2=CC=C(C=C2)Cl,,,,,,
8621,98622,1-(4-Methylphenyl)cyclopentanecarboxylic acid,CC1=CC=C(C=C1)C2(CCCC2)C(=O)O,,,,,,
8622,98623,1-(4-Methylphenyl)cyclopentane-1-carbonitrile,CC1=CC=C(C=C1)C2(CCCC2)C#N,,,,,,
8623,98624,1-Benzoylpyrrolidin-2-one,C1CC(=O)N(C1)C(=O)C2=CC=CC=C2,,,,,,
8624,98625,"1H-Pyrazolo(3,4-d)pyrimidine, 4-(methylthio)-1-beta-D-ribofuranosyl-",CSC1=NC=NC2=C1C=NN2[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O,,,,,,
8625,98626,2-(Methoxycarbonyl)nicotinic acid,COC(=O)C1=C(C=CC=N1)C(=O)O,,,,,,
8626,98627,"Diethyl 5-oxo-3-phenylpyrrolidine-2,2-dicarboxylate",CCOC(=O)C1(C(CC(=O)N1)C2=CC=CC=C2)C(=O)OCC,,,,,,
8627,98628,1-(4-Methylphenyl)-1-cyclopropanecarbonitrile,CC1=CC=C(C=C1)C2(CC2)C#N,,,,,,
8628,98629,1-(4-Methoxyphenyl)cyclohexanecarbonitrile,COC1=CC=C(C=C1)C2(CCCCC2)C#N,,,,,,
8629,98630,1-(4-Methoxyphenyl)cyclopentane-1-carboxylic acid,COC1=CC=C(C=C1)C2(CCCC2)C(=O)O,,,,,,
8630,98631,"2-[(4-Methoxyphenyl)methylidene]-1,1-dimethylhydrazine",CN(C)N=CC1=CC=C(C=C1)OC,,,,,,
8631,98632,Biacetyldihydrazone,CC(=NN)C(=NN)C,,,,,,
8632,98633,N-(4-Methoxybenzylidene)aniline,COC1=CC=C(C=C1)C=NC2=CC=CC=C2,,,,,,
8633,98634,"N-(3,4,5-Trimethoxybenzylidene)aniline",COC1=CC(=CC(=C1OC)OC)C=NC2=CC=CC=C2,,,,,,
8634,98635,"3,5-Dichloro-1H-1,2,4-triazole",C1(=NC(=NN1)Cl)Cl,,,,,,
8635,98636,"Cyclohexanecarboxylic acid, 4-(3-(2-chloroethyl)-3-nitrosoureido)-, methyl ester, (E)-",COC(=O)C1CCC(CC1)NC(=O)N(CCCl)N=O,,,,,,
8636,98637,"Urea, 1-(2-chloroethyl)-3-(4-methoxycyclohexyl)-1-nitroso-, (Z)-",COC1CCC(CC1)NC(=O)N(CCCl)N=O,,,,,,
8637,98638,"4-Amino-3,5-dinitrobenzamide",C1=C(C=C(C(=C1[N+](=O)[O-])N)[N+](=O)[O-])C(=O)N,,,,,,
8638,98639,1-(p-Tolyl)cyclopropanecarboxylic acid,CC1=CC=C(C=C1)C2(CC2)C(=O)O,,,,,,
8639,98640,1-Methoxy-9H-thioxanthen-9-one,COC1=C2C(=CC=C1)SC3=CC=CC=C3C2=O,,,,,,
8640,98641,3-Bromo-4-(dimethylamino)benzaldehyde,CN(C)C1=C(C=C(C=C1)C=O)Br,,,,,,
8641,98642,"1-Hydroxy-2,2,6,6-tetramethyl-4-piperidinone",CC1(CC(=O)CC(N1O)(C)C)C,,,,,,
8642,98643,N-(3-Methylbutyl)acetamide,CC(C)CCNC(=O)C,,,,,,
8643,98644,Methyl 2-acetamidoacrylate,CC(=O)NC(=C)C(=O)OC,,,,,,
8644,98645,"Butanamide, N,N'-1,3-phenylenebis[3-oxo-",CC(=O)CC(=O)NC1=CC(=CC=C1)NC(=O)CC(=O)C,,,,,,
8645,98646,"2,3-dihydro-1H-benzo[f]chromen-1-one",C1COC2=C(C1=O)C3=CC=CC=C3C=C2,,,,,,
8646,98647,"1-Triazene, 3,3-dimethyl-1-(4-(trifluoromethyl)phenyl)-",CN(C)N=NC1=CC=C(C=C1)C(F)(F)F,,,,,,
8647,98648,2-Benzothiazolesulfenamide,C1=CC=C2C(=C1)N=C(S2)SN,,,,,,
8648,98649,"2-([1,1'-Biphenyl]-4-ylmethylene)-hydrazinecarboximidamide",C1=CC=C(C=C1)C2=CC=C(C=C2)C=NN=C(N)N,,,,,,
8649,98650,3-(Trifluoromethyl)phenylhydrazine,C1=CC(=CC(=C1)NN)C(F)(F)F,,,,,,
8650,98651,Tris(m-nitrophenyl)phosphine oxide,C1=CC(=CC(=C1)P(=O)(C2=CC=CC(=C2)[N+](=O)[O-])C3=CC=CC(=C3)[N+](=O)[O-])[N+](=O)[O-],,,,,,
8651,98652,"2,4-Diamino-6-(2-naphthalenylsulfonyl)quinazoline",C1=CC=C2C=C(C=CC2=C1)S(=O)(=O)C3=CC4=C(C=C3)N=C(N=C4N)N,,,,,,
8652,98653,N-(4-Amino-2-chlorophenyl)-1-hydroxynaphthalene-2-carboxamide,C1=CC=C2C(=C1)C=CC(=C2O)C(=O)NC3=C(C=C(C=C3)N)Cl,,,,,,
8653,98654,4-(2-Bromoacetyl)benzonitrile,C1=CC(=CC=C1C#N)C(=O)CBr,,,,,,
8654,98655,3-Icosylsuccinic anhydride,CCCCCCCCCCCCCCCCCCCCC1CC(=O)OC1=O,,,,,,
8655,98656,3-Methyl-2-butanone phenyl hydrazone,CC(C)C(=NNC1=CC=CC=C1)C,,,,,,
8656,98657,CID 98657,C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2N=C(N=C3[SeH])N)CO)O,,,,,,
8657,98658,5-(3-(2-Chloroethyl)triazen-1-yl)imidazole-4-carboxamide,C1=NC(=C(N1)C(=O)N)NN=NCCCl,,,,,,
8658,98659,"Urea, 1,1'-tetramethylenebis(1-nitroso-",C(CCN(C(=O)N)N=O)CN(C(=O)N)N=O,,,,,,
8659,98660,"1'-Acetyl-1,3-dihydrospiro(2H-imidazo(4,5-b)pyridine-2,3'-(3H)indol)-2'(1'H)-one",CC(=O)N1C2=CC=CC=C2C3(C1=O)NC4=C(N3)N=CC=C4,,,,,,
8660,98661,"Piperidine, 1-[(1-hydroxy-2-naphthalenyl)carbonyl]-",C1CCN(CC1)C(=O)C2=C(C3=CC=CC=C3C=C2)O,,,,,,
8661,98662,3-Bromo-4-methoxybenzaldehyde,COC1=C(C=C(C=C1)C=O)Br,,,,,,
8662,98663,Acridine-9-carbaldehyde,C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)C=O,,,,,,
8663,98664,1-(4-Methylphenyl)cyclohexanecarboxylic acid,CC1=CC=C(C=C1)C2(CCCCC2)C(=O)O,,,,,,
8664,98665,Methoxymethyl methanesulfonate,COCOS(=O)(=O)C,,,,,,
8665,98666,1-(4-Chlorophenyl)cyclopropanecarbonitrile,C1CC1(C#N)C2=CC=C(C=C2)Cl,,,,,,
8666,98667,2-(Methylsulfonyl)pyridine,CS(=O)(=O)C1=CC=CC=N1,,,,,,
8667,98668,3-Isobutoxypropylamine,CC(C)COCCCN,,,,,,
8668,98669,"3',4'-Dimethoxybutyrophenone",CCCC(=O)C1=CC(=C(C=C1)OC)OC,,,,,,
8669,98670,"Disulfide, bis(4-methyl-2-nitrophenyl)",CC1=CC(=C(C=C1)SSC2=C(C=C(C=C2)C)[N+](=O)[O-])[N+](=O)[O-],,,,,,
8670,98671,N-(Triphenylphosphoranylidene)-m-toluidine,CC1=CC(=CC=C1)N=P(C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4,,,,,,
8671,98672,2-Methyl-N-(triphenylphosphoranylidene)aniline,CC1=CC=CC=C1N=P(C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4,,,,,,
8672,98673,4-Tridecanone,CCCCCCCCCC(=O)CCC,,,,,,
8673,98674,4-Tetradecanone,CCCCCCCCCCC(=O)CCC,,,,,,
8674,98675,4-Heptadecanone,CCCCCCCCCCCCCC(=O)CCC,,,,,,
8675,98676,5-Undecanol,CCCCCCC(CCCC)O,,,,,,
8676,98677,5-Undecanone,CCCCCCC(=O)CCCC,,,,,,
8677,98678,5-Tetradecanone,CCCCCCCCCC(=O)CCCC,,,,,,
8678,98679,7-Hexadecanone,CCCCCCCCCC(=O)CCCCCC,,,,,,
8679,98680,5-Hexadecanone,CCCCCCCCCCCC(=O)CCCC,,,,,,
8680,98681,N-Propionylglycine,CCC(=O)NCC(=O)O,,,,,,
8681,98682,"Ethyl 2-(acetylamino)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate",CCOC(=O)C1=C(SC2=C1CCCC2)NC(=O)C,,,,,,
8682,98683,"2-Bromo-1-(2,4-dimethoxyphenyl)ethanone",COC1=CC(=C(C=C1)C(=O)CBr)OC,,,,,,
8683,98684,2-Chloro-4-nitrobenzanilide,C1=CC=C(C=C1)NC(=O)C2=C(C=C(C=C2)[N+](=O)[O-])Cl,,,,,,
8684,98685,"1-Ethyl-1,3-diphenylurea",CCN(C1=CC=CC=C1)C(=O)NC2=CC=CC=C2,,,,,,
8685,98686,"Rhodanine, 3-(o-tolyl)-",CC1=CC=CC=C1N2C(=O)CSC2=S,,,,,,
8686,98687,"Urea, 1,1-bis(2-hydroxyethyl)-",C(CO)N(CCO)C(=O)N,,,,,,
8687,98688,"3',4'-Methylenedioxyacetanilide",CC(=O)NC1=CC2=C(C=C1)OCO2,,,,,,
8688,98689,1-(3-(Benzyloxy)phenyl)ethanone,CC(=O)C1=CC(=CC=C1)OCC2=CC=CC=C2,,,,,,
8689,98690,"2,2'-Ethylenedianiline",C1=CC=C(C(=C1)CCC2=CC=CC=C2N)N,,,,,,
8690,98691,N-(2-chloro-4-methylphenyl)acetamide,CC1=CC(=C(C=C1)NC(=O)C)Cl,,,,,,
8691,98692,N-(2-methylphenyl)-4-nitrobenzamide,CC1=CC=CC=C1NC(=O)C2=CC=C(C=C2)[N+](=O)[O-],,,,,,
8692,98693,Diphenylcarbodiimide,C1=CC=C(C=C1)N=C=NC2=CC=CC=C2,,,,,,
8693,98694,"Benzenecarboximidamide, N-(4-nitrophenyl)-",C1=CC=C(C=C1)C(=NC2=CC=C(C=C2)[N+](=O)[O-])N,,,,,,
8694,98695,"Benzenesulfonamide, N,N'-1,4-phenylenebis(4-methyl-",CC1=CC=C(C=C1)S(=O)(=O)NC2=CC=C(C=C2)NS(=O)(=O)C3=CC=C(C=C3)C,,,,,,
8695,98696,1-(2-Bromoethyl)-3-(p-chlorophenyl)urea,C1=CC(=CC=C1NC(=O)NCCBr)Cl,,,,,,
8696,98697,"o-Toluidine, N-(2-oxazolin-2-yl)-alpha,alpha,alpha-trifluoro-",C1COC(=N1)NC2=CC=CC=C2C(F)(F)F,,,,,,
8697,98698,"1-(5,6,7,8-Tetrahydronaphthalen-1-yl)piperazine",C1CCC2=C(C1)C=CC=C2N3CCNCC3,,,,,,
8698,98699,"1H,5H-Benzo(ij)quinolizin-9-ol, 2,3,6,7-tetrahydro-, acetate",CC(=O)OC1=CC2=C3C(=C1)CCCN3CCC2,,,,,,
8699,98700,"1H,5H-Benzo[ij]quinolizine-9-carboxaldehyde, 2,3,6,7-tetrahydro-",C1CC2=CC(=CC3=C2N(C1)CCC3)C=O,,,,,,
8700,98701,"Cyclohexylamine, N-(2-oxazolin-2-yl)-",C1CCC(CC1)NC2=NCCO2,,,,,,
8701,98702,Diethyl (ethoxymethyl)malonate,CCOCC(C(=O)OCC)C(=O)OCC,,,,,,
8702,98703,"Urea, 1-(2-bromoethyl)-3-(3,4-xylyl)-",CC1=C(C=C(C=C1)NC(=O)NCCBr)C,,,,,,
8703,98704,"1-(2-Chloroethyl)-3-(5-methyl-1,3,4-thiadiazol-2-yl)urea",CC1=NN=C(S1)NC(=O)NCCCl,,,,,,
8704,98705,"Benzanilide, 2'-formyl-",C1=CC=C(C=C1)C(=O)NC2=CC=CC=C2C=O,,,,,,
8705,98706,"3-(2,2,2-Trifluoro-1-trifluoromethylethylidene)-2-norbornanone",C1CC2CC1C(=C(C(F)(F)F)C(F)(F)F)C2=O,,,,,,
8706,98707,"Quinolinepropionic acid, 1,2,3,4-tetrahydro-",C1CC2=CC=CC=C2N(C1)CCC(=O)O,,,,,,
8707,98708,Methyl (((methoxycarbonyl)amino)(methylthio)methylene)carbamate,COC(=O)NC(=NC(=O)OC)SC,,,,,,
8708,98709,"2,6-Dimethyl-1-(2-oxazolin-2-yl)piperidine",CC1CCCC(N1C2=NCCO2)C,,,,,,
8709,98710,"2-Benzyl-4,4-dimethyl-2-oxazoline",CC1(COC(=N1)CC2=CC=CC=C2)C,,,,,,
8710,98711,"Rhodanine, 3-(p-ethoxyphenyl)-",CCOC1=CC=C(C=C1)N2C(=O)CSC2=S,,,,,,
8711,98712,"2-Norbornanone, 3-(2-chloro-1-chlorodifluoromethyl-2,2-difluoroethylidene)-",C1CC2CC1C(=C(C(F)(F)Cl)C(F)(F)Cl)C2=O,,,,,,
8712,98713,4-Bromo-1-indanone,C1CC(=O)C2=C1C(=CC=C2)Br,,,,,,
8713,98714,"Urea, 1-(2-chloroethyl)-3-(2-pyridyl)-",C1=CC=NC(=C1)NC(=O)NCCCl,,,,,,
8714,98715,"o-Toluidine, 6-chloro-N-(2-oxazolin-2-yl)-",CC1=C(C(=CC=C1)Cl)NC2=NCCO2,,,,,,
8715,98716,"1-[(2H-1,3-Benzodioxol-5-yl)methylidene]-2-phenylhydrazine",C1OC2=C(O1)C=C(C=C2)C=NNC3=CC=CC=C3,,,,,,
8716,98717,"tert-Butylamine, N-(2-oxazolin-2-yl)-",CC(C)(C)NC1=NCCO1,,,,,,
8717,98718,1-(2-Chloroethyl)-3-(2-methoxy-6-methylphenyl)urea,CC1=C(C(=CC=C1)OC)NC(=O)NCCCl,,,,,,
8718,98719,"1-(2,6-Dimethylmorpholin-4-yl)nonan-1-one",CCCCCCCCC(=O)N1CC(OC(C1)C)C,,,,,,
8719,98720,"2,4-Pentanedione, 3-(3,4-dichlorobenzylidene)-",CC(=O)C(=CC1=CC(=C(C=C1)Cl)Cl)C(=O)C,,,,,,
8720,98721,"4-(p-Chlorophenylcarbamyl)-2,6-dimethylmorpholine",CC1CN(CC(O1)C)C(=O)NC2=CC=C(C=C2)Cl,,,,,,
8721,98722,"2-Pentanone, 4-hydroxy-1-phenoxy-5,5,5-trifluoro-4-(trifluoromethyl)-",C1=CC=C(C=C1)OCC(=O)CC(C(F)(F)F)(C(F)(F)F)O,,,,,,
8722,98723,4-Acryloylmorpholine,C=CC(=O)N1CCOCC1,,,,,,
8723,98724,"Aniline, 2-methoxy-6-methyl-N-(2-oxazolinyl)-",CC1=C(C(=CC=C1)OC)NC2=NCCO2,,,,,,
8724,98725,1-(2-Chloroethyl)-3-(2-carbomethoxy-6-methylphenyl)urea,CC1=C(C(=CC=C1)C(=O)OC)NC(=O)NCCCl,,,,,,
8725,98726,"Urea, 1-benzyl-3-(2-chloroethyl)-",C1=CC=C(C=C1)CNC(=O)NCCCl,,,,,,
8726,98727,1-(2-Chloroethyl)-3-(2-furylmethyl)urea,C1=COC(=C1)CNC(=O)NCCCl,,,,,,
8727,98728,1-(2-Chloroethyl)-3-(pyridin-4-yl)urea,C1=CN=CC=C1NC(=O)NCCCl,,,,,,
8728,98729,"Quinoline-1-carboxaldehyde, 1,2,3,4-tetrahydro-6-methyl-",CC1=CC2=C(C=C1)N(CCC2)C=O,,,,,,
8729,98730,"1-Undecanone, 1-morpholino-",CCCCCCCCCCC(=O)N1CCOCC1,,,,,,
8730,98731,"1-(2-Chloroethyl)-3-(2,6-dimethoxyphenyl)urea",COC1=C(C(=CC=C1)OC)NC(=O)NCCCl,,,,,,
8731,98732,"Semicarbazide, 1-benzoyl-4-(2-chloroethyl)-",C1=CC=C(C=C1)C(=O)NNC(=O)NCCCl,,,,,,
8732,98733,2-(m-Toluidino)-2-oxazoline,CC1=CC(=CC=C1)NC2=NCCO2,,,,,,
8733,98734,CID 98734,CC1(C=CC2=C3C(=C(C4=C(N3C)C(=CC=C4)O)O)C(=O)C=C2O1)C,,,,,,
8734,98735,Methylmalondialdehyde,CC(C=O)C=O,,,,,,
8735,98736,"2-Pyrazoline, 3-amino-1-phenyl-",C1CN(N=C1N)C2=CC=CC=C2,,,,,,
8736,98737,4-tert-Butylphenyl cyclopropyl ketone,CC(C)(C)C1=CC=C(C=C1)C(=O)C2CC2,,,,,,
8737,98738,4-Phenyl-1-(p-tolylsulphonyl)piperidine-4-carboxylic acid,CC1=CC=C(C=C1)S(=O)(=O)N2CCC(CC2)(C3=CC=CC=C3)C(=O)O,,,,,,
8738,98739,"4-Chloro-2',4'-dimethoxybutyrophenone",COC1=CC(=C(C=C1)C(=O)CCCCl)OC,,,,,,
8739,98740,"4-Chloro-2',4'-dimethylbutyrophenone",CC1=CC(=C(C=C1)C(=O)CCCCl)C,,,,,,
8740,98741,"4-Chloro-2',5'-dimethylbutyrophenone",CC1=CC(=C(C=C1)C)C(=O)CCCCl,,,,,,
8741,98742,"4-Chloro-3',4'-dimethylbutyrophenone",CC1=C(C=C(C=C1)C(=O)CCCCl)C,,,,,,
8742,98743,4-Chloro-4'-ethylbutyrophenone,CCC1=CC=C(C=C1)C(=O)CCCCl,,,,,,
8743,98744,4-Chloro-4'-isopropylbutyrophenone,CC(C)C1=CC=C(C=C1)C(=O)CCCCl,,,,,,
8744,98745,4-Chloro-4'-methylbutyrophenone,CC1=CC=C(C=C1)C(=O)CCCCl,,,,,,
8745,98746,"3-(2,6-Dimethylmorpholin-4-yl)propanenitrile",CC1CN(CC(O1)C)CCC#N,,,,,,
8746,98747,4-(Dipropylamino)butanenitrile,CCCN(CCC)CCCC#N,,,,,,
8747,98748,Diethyl ((5-bromo-1H-indol-3-yl)methylene)malonate,CCOC(=O)C(=CC1=CNC2=C1C=C(C=C2)Br)C(=O)OCC,,,,,,
8748,98749,"Ethyl N,N-dipropyl-beta-alaninate",CCCN(CCC)CCC(=O)OCC,,,,,,
8749,98750,Dibutyltin;tetradecanoic acid,CCCCCCCCCCCCCC(=O)O.CCCCCCCCCCCCCC(=O)O.CCCC[Sn]CCCC,,,,,,
8750,98751,"2,4-Dichloro-3,5-dinitrobenzonitrile",C1=C(C(=C(C(=C1[N+](=O)[O-])Cl)[N+](=O)[O-])Cl)C#N,,,,,,
8751,98752,4-Phenyl-1-(p-tolylsulphonyl)piperidin-4-ol,CC1=CC=C(C=C1)S(=O)(=O)N2CCC(CC2)(C3=CC=CC=C3)O,,,,,,
8752,98753,1-(2-Methoxyphenyl)urea,COC1=CC=CC=C1NC(=O)N,,,,,,
8753,98754,Octyl 2-pyridyl ether,CCCCCCCCOC1=CC=CC=N1,,,,,,
8754,98755,Phenyl 4-chlorobutyrate,C1=CC=C(C=C1)OC(=O)CCCCl,,,,,,
8755,98756,2-(3-(2-Chloroethyl)-3-nitrosoureido)glutaric acid,C(CC(=O)O)[C@@H](C(=O)O)NC(=O)N(CCCl)N=O,,,,,,
8756,98757,CID 98757,C[As](C)S[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O,,,,,,
8757,98758,2-(2-Ethoxyethyl)pyridine,CCOCCC1=CC=CC=N1,,,,,,
8758,98759,"Ethyl 3-(2,6-dimethylmorpholin-4-yl)propanoate",CCOC(=O)CCN1CC(OC(C1)C)C,,,,,,
8759,98760,"Naphth(1,2-d)imidazol-8-ol",C1=CC(=CC2=C1C=CC3=C2N=CN3)O,,,,,,
8760,98761,"Phenol, 2,2'-(p-phenylenebis(methylidyneimino))di-",C1=CC=C(C(=C1)N=CC2=CC=C(C=C2)C=NC3=CC=CC=C3O)O,,,,,,
8761,98762,p-Nitrophenyl S-benzyl-N-(tert-butoxycarbonyl)-L-cysteinate,CC(C)(C)OC(=O)N[C@@H](CSCC1=CC=CC=C1)C(=O)OC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
8762,98763,Boc-O-benzyl-L-tyrosine,CC(C)(C)OC(=O)N[C@@H](CC1=CC=C(C=C1)OCC2=CC=CC=C2)C(=O)O,,,,,,
8763,98764,Einecs 233-852-9,CC(C)(C)OC(=O)N[C@@H](CSSCC(C(=O)O)NC(=O)OC(C)(C)C)C(=O)O,,,,,,
8764,98765,(S)-2-(((Benzyloxy)carbonyl)amino)-6-((tert-butoxycarbonyl)amino)hexanoic acid,CC(C)(C)OC(=O)NCCCC[C@@H](C(=O)O)NC(=O)OCC1=CC=CC=C1,,,,,,
8765,98766,N-(tert-Butoxycarbonyl)-L-serine,CC(C)(C)OC(=O)N[C@@H](CO)C(=O)O,,,,,,
8766,98767,Boc-Trp-OSu,CC(C)(C)OC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)ON3C(=O)CCC3=O,,,,,,
8767,98768,"tert-Butyl (S)-(1-(((2,5-dioxopyrrolidin-1-yl)oxy)carbonyl)-2-methylpropyl)carbamate",CC(C)[C@@H](C(=O)ON1C(=O)CCC1=O)NC(=O)OC(C)(C)C,,,,,,
8768,98769,N-(4-Methylphenyl)octanamide,CCCCCCCC(=O)NC1=CC=C(C=C1)C,,,,,,
8769,98770,"Phthalanilic acid, 2',3'-dimethyl-",CC1=C(C(=CC=C1)NC(=O)C2=CC=CC=C2C(=O)O)C,,,,,,
8770,98771,"Urea, N-methyl-N'-(3-(trifluoromethyl)phenyl)-",CNC(=O)NC1=CC=CC(=C1)C(F)(F)F,,,,,,
8771,98772,N-(3-Chloro-o-tolyl)benzamide,CC1=C(C=CC=C1Cl)NC(=O)C2=CC=CC=C2,,,,,,
8772,98773,"1-(3,4-Dichlorophenyl)-3-(2-hydroxyethyl)urea",C1=CC(=C(C=C1NC(=O)NCCO)Cl)Cl,,,,,,
8773,98774,N-Benzoyl-L-methionine,CSCC[C@@H](C(=O)O)NC(=O)C1=CC=CC=C1,,,,,,
8774,98775,Z-Cys(Bzl)-OH,C1=CC=C(C=C1)COC(=O)N[C@@H](CSCC2=CC=CC=C2)C(=O)O,,,,,,
8775,98776,"Urea, N,N''-1,4-butanediylbis-",C(CCNC(=O)N)CNC(=O)N,,,,,,
8776,98777,Tris[2-(diphenylphosphino)ethyl]phosphine,C1=CC=C(C=C1)P(CCP(CCP(C2=CC=CC=C2)C3=CC=CC=C3)CCP(C4=CC=CC=C4)C5=CC=CC=C5)C6=CC=CC=C6,,,,,,
8777,98778,2-pyridinecarbaldehyde O-benzyloxime,C1=CC=C(C=C1)CON=CC2=CC=CC=N2,,,,,,
8778,98779,CID 98779,CCCC[SnH](CCCC)CCCC.C1=CC=C(C=C1)C2=CC=CC=C2O,,,,,,
8779,98780,CID 98780,CCCC[SnH](CCCC)CCCC.C1=C(C(=CC(=C1Cl)Cl)Cl)O,,,,,,
8780,98781,Allyl propyl sulfide,CCCSCC=C,,,,,,
8781,98782,2-(Carboxymethylthio)-4-methylpyrimidine,CC1=NC(=NC=C1)SCC(=O)O,,,,,,
8782,98783,1H-Indole-2-methanol,C1=CC=C2C(=C1)C=C(N2)CO,,,,,,
8783,98784,"2,4-Dimethyl-5-pyrimidinemethanol",CC1=NC(=NC=C1CO)C,,,,,,
8784,98785,"Nicotinic acid, 1,6-dihydro-1-methyl-6-oxo-, ethyl ester",CCOC(=O)C1=CN(C(=O)C=C1)C,,,,,,
8785,98786,"Uracil, 3,5,6-trimethyl-",CC1=C(NC(=O)N(C1=O)C)C,,,,,,
8786,98787,"2,6-Dimethylphenyl isocyanate",CC1=C(C(=CC=C1)C)N=C=O,,,,,,
8787,98788,N-(Chloroacetyl)allylamine,C=CCNC(=O)CCl,,,,,,
8788,98789,3-Methyl-2-butenoic anhydride,CC(=CC(=O)OC(=O)C=C(C)C)C,,,,,,
8789,98790,3-Chloro-N-(6-chloro-o-tolyl)propionamide,CC1=C(C(=CC=C1)Cl)NC(=O)CCCl,,,,,,
8790,98791,n-(5-Chloro-2-methoxyphenyl)-3-oxobutanamide,CC(=O)CC(=O)NC1=C(C=CC(=C1)Cl)OC,,,,,,
8791,98792,CID 98792,C1C(=NC2=C(N1)NC(=NC2=O)N)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,,,,,,
8792,98793,"3,5-Dicyclohexyl-1,3,5-thiadiazinane-2-thione",C1CCC(CC1)N2CN(C(=S)SC2)C3CCCCC3,,,,,,
8793,98794,"2H-1,3,5-Thiadiazine-2-thione, tetrahydro-3,5-bis(3,4-dimethoxyphenethyl)-",COC1=C(C=C(C=C1)CCN2CN(C(=S)SC2)CCC3=CC(=C(C=C3)OC)OC)OC,,,,,,
8794,98795,"2-Cyclohexen-1-one, 3-(phenylamino)-",C1CC(=CC(=O)C1)NC2=CC=CC=C2,,,,,,
8795,98796,"Butanamide, N,N'-(2,5-dichloro-1,4-phenylene)bis[3-oxo-",CC(=O)CC(=O)NC1=CC(=C(C=C1Cl)NC(=O)CC(=O)C)Cl,,,,,,
8796,98797,2-((2-(Diethylamino)ethyl)amino)ethanol,CCN(CC)CCNCCO,,,,,,
8797,98798,"9H-Thioxanthene-4-carboxaldehyde, 1-[[2-(diethylamino)ethyl]amino]-9-oxo-",CCN(CC)CCNC1=C2C(=C(C=C1)C=O)SC3=CC=CC=C3C2=O,,,,,,
8798,98799,"9H-Thioxanthen-9-one, 6-chloro-1-((2-(ethylamino)ethyl)amino)-4-(hydroxymethyl)-",CCNCCNC1=C2C(=C(C=C1)CO)SC3=C(C2=O)C=CC(=C3)Cl,,,,,,
8799,98800,CID 98800,C1C(=NN(C1=O)C2=C(C=C(C=C2Cl)Cl)Cl)NC3=CC=C(C=C3)[N+](=O)[O-],,,,,,
8800,98801,6-Azasangivamycin,C1=NC(=C2C(=NN(C2=N1)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)C(=O)N)N,,,,,,
8801,98802,"N,N-Bis(2-chloroethyl)acetamide",CC(=O)N(CCCl)CCCl,,,,,,
8802,98803,Ethyl 4-(dimethylaminodiazenyl)-2-phenyl-1H-imidazole-5-carboxylate,CCOC(=O)C1=C(N=C(N1)C2=CC=CC=C2)N=NN(C)C,,,,,,
8803,98804,"4-Carbethoxy-5-(3,3-dimethyl-1-triazeno)-2-methyl imidazole",CCOC(=O)C1=C(N=C(N1)C)N=NN(C)C,,,,,,
8804,98805,CID 98805,CC(C)NC(=O)C1=CC=C(C=C1)N=NN(C)O,,,,,,
8805,98806,"5-Methyl-3-phenyl-1,2,4-oxadiazole",CC1=NC(=NO1)C2=CC=CC=C2,,,,,,
8806,98807,"1-Benzyl-2,5-dimethylpyrrole",CC1=CC=C(N1CC2=CC=CC=C2)C,,,,,,
8807,98808,"Bicyclo[2.2.0]hexa-2,5-diene",C1=CC2C1C=C2,,,,,,
8808,98809,"2-Ethoxy-1,1-dimethoxyethane",CCOCC(OC)OC,,,,,,
8809,98810,6-Oxoheptanoic acid,CC(=O)CCCCC(=O)O,,,,,,
8810,98811,"8-Benzyl-1,3,8-triazaspiro[4.5]decane-2,4-dione",C1CN(CCC12C(=O)NC(=O)N2)CC3=CC=CC=C3,,,,,,
8811,98812,"1,3,8-Triazaspiro(4.5)decan-4-one, 1-phenyl-8-(3-(2-thenoyl)propyl)-",C1CN(CCC12C(=O)NCN2C3=CC=CC=C3)CCCC(=O)C4=CC=CS4,,,,,,
8812,98813,"2-Benzimidazolinone, 1-(1-(3,3-diphenyl-4-oxohexyl)-4-piperidyl)-",CCC(=O)C(CCN1CCC(CC1)N2C3=CC=CC=C3NC2=O)(C4=CC=CC=C4)C5=CC=CC=C5,,,,,,
8813,98814,"1,3,8-Triazaspiro(4.5)decan-4-one, 8-(3-benzoylpropyl)-1-phenyl-",C1CN(CCC12C(=O)NCN2C3=CC=CC=C3)CCCC(=O)C4=CC=CC=C4,,,,,,
8814,98815,"1-Pyrrolidineethanol, acetate (ester)",CC(=O)OCCN1CCCC1,,,,,,
8815,98816,"3-Pyridinecarboxamide, N,N-diethyl-5-phenyl-",CCN(CC)C(=O)C1=CN=CC(=C1)C2=CC=CC=C2,,,,,,
8816,98817,"2-(5,6,7,8-Tetrahydro-1-naphthylamino)-2-oxazoline",C1CCC2=C(C1)C=CC=C2NC3=NCCO3,,,,,,
8817,98818,Diiodobenzotepa,C1CN1P(=O)(NC(=O)C2=C(C=CC(=C2)I)I)N3CC3,,,,,,
8818,98819,"2-Benzimidazolinone, 1-(1-(3-(p-fluorobenzoyl)propyl)-4-piperidyl)-3-hydroxymethyl-",C1CN(CCC1N2C3=CC=CC=C3N(C2=O)CO)CCCC(=O)C4=CC=C(C=C4)F,,,,,,
8819,98820,2-benzhydryl-1H-benzo[d]imidazole,C1=CC=C(C=C1)C(C2=CC=CC=C2)C3=NC4=CC=CC=C4N3,,,,,,
8820,98821,Pyridin-3-yl dimethylcarbamate,CN(C)C(=O)OC1=CN=CC=C1,,,,,,
8821,98822,"2-Oxazoline, 2-(1-phenylcyclohexylamino)-",C1CCC(CC1)(C2=CC=CC=C2)NC3=NCCO3,,,,,,
8822,98823,"Urea, 1-(2-chloroethyl)-3-(2,2,6,6-tetramethyl-4-piperidinyl)-",CC1(CC(CC(N1)(C)C)NC(=O)NCCCl)C,,,,,,
8823,98824,"2-Methyl-3,5-dinitrobenzoic acid",CC1=C(C=C(C=C1[N+](=O)[O-])[N+](=O)[O-])C(=O)O,,,,,,
8824,98825,"2-[(dimethylamino)methylene]-1H-indene-1,3(2H)-dione",CN(C)C=C1C(=O)C2=CC=CC=C2C1=O,,,,,,
8825,98826,1-(2-Chloroethyl)-3-(dicyclopropylmethyl)urea,C1CC1C(C2CC2)NC(=O)NCCCl,,,,,,
8826,98827,Dibenzyl selenide,C1=CC=C(C=C1)C[Se]CC2=CC=CC=C2,,,,,,
8827,98828,CID 98828,COC1=C(C=C(C=C1)C2=C(C(=C3C(=CC(=O)C=C3O2)O)O)OC)OC,,,,,,
8828,98829,CID 98829,COC1=CC(=O)C2=C(C(=C(OC2=C1)C3=CC(=C(C=C3)O)OC)OC)O,,,,,,
8829,98830,"Propionitrile, 3-(2-chloro-10-phenothiazinyl)-",C1=CC=C2C(=C1)N(C3=C(S2)C=CC(=C3)Cl)CCC#N,,,,,,
8830,98831,trans-4-Hexylcyclohexanecarboxylic acid,CCCCCCC1CCC(CC1)C(=O)O,,,,,,
8831,98832,4-Benzyloxy-3-methoxybenzyl alcohol,COC1=C(C=CC(=C1)CO)OCC2=CC=CC=C2,,,,,,
8832,98833,2-Ethyl-10H-phenothiazine,CCC1=CC2=C(C=C1)SC3=CC=CC=C3N2,,,,,,
8833,98834,5-Nitroisophthalamide,C1=C(C=C(C=C1C(=O)N)[N+](=O)[O-])C(=O)N,,,,,,
8834,98835,"2,3,5,6-Tetrafluoro-4-hydroxybenzoic Acid",C1(=C(C(=C(C(=C1F)F)O)F)F)C(=O)O,,,,,,
8835,98836,"2,2'-Azobis(2-acetoxypropane)",CC(=O)OC(C)(C)N=NC(C)(C)OC(=O)C,,,,,,
8836,98837,"2-Propanone, 1,3-dihydroxy-, (2,4-dinitrophenyl)hydrazone (9CI)",C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])NN=C(CO)CO,,,,,,
8837,98838,"11H-Pyrido(3',2':5,6)pyrazino(2,3-b)indole, 11-methyl-",CN1C2=C(C=CC=N2)N=C3C1=NC4=CC=CC=C43,,,,,,
8838,98839,"9H-Pyrido(3,4-b)indole, 1,2,3,4-tetrahydro-6-methylthio-",CSC1=CC2=C(C=C1)NC3=C2CCNC3,,,,,,
8839,98840,1-(1-Phenylcyclohexyl)-4-hydroxypiperidine,C1CCC(CC1)(C2=CC=CC=C2)N3CCC(CC3)O,,,,,['PCHP is a known human metabolite of phencyclidine.'],
8840,98841,10h-Phenothiazine-2-carbonitrile,C1=CC=C2C(=C1)NC3=C(S2)C=CC(=C3)C#N,,,,,,
8841,98842,"2-Picoline, 4-((p-(dimethylamino)phenyl)azo)-",CC1=NC=CC(=C1)N=NC2=CC=C(C=C2)N(C)C,,,,,,
8842,98843,"Pyridine, 4-(p-(dimethylamino)phenylazo)-",CN(C)C1=CC=C(C=C1)N=NC2=CC=NC=C2,,,,,,
8843,98844,4-[[p-(Dimethylamino)phenyl]azo]-3-methylpyridine 1-oxide,CC1=C(C=C[N+](=C1)[O-])N=NC2=CC=C(C=C2)N(C)C,,,,,,
8844,98845,"2-Methyl-1,3-thiazole-5-carboxylic acid",CC1=NC=C(S1)C(=O)O,,,,,,
8845,98846,"2,4,6-Trimethylpyridin-3-amine",CC1=CC(=NC(=C1N)C)C,,,,,,
8846,98847,Azobis(pyridine N-oxide),C1=CN(C=CC1=NN=C2C=C[N+](=O)C=C2)[O-],,,,,,
8847,98848,"9(10H)-Acridinone, 1-nitro-",C1=CC=C2C(=C1)C(=O)C3=C(N2)C=CC=C3[N+](=O)[O-],,,,,,
8848,98849,2-Methyl-4-nitropyridine,CC1=NC=CC(=C1)[N+](=O)[O-],,,,,,
8849,98850,"1,2,5-Oxadiazole, 3-methyl-4-nitro-, 5-oxide",CC1=NO[N+](=C1[N+](=O)[O-])[O-],,,,,,
8850,98851,"2-Amino-3,5-dibromopyridine",C1=C(C=NC(=C1Br)N)Br,,,,,,
8851,98852,"4,4'-Iminobisbenzonitrile",C1=CC(=CC=C1C#N)NC2=CC=C(C=C2)C#N,,,,,,
8852,98853,"Acetamide, N-[5-(acetyloxy)-1-naphthalenyl]-",CC(=O)NC1=CC=CC2=C1C=CC=C2OC(=O)C,,,,,,
8853,98854,"[(2R,3S,4S)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl formate",C1=NC(=C2C(=N1)N(C=N2)C3[C@H]([C@@H]([C@H](O3)COC=O)O)O)N,,,,,,
8854,98855,Benzo[c]phenanthren-4-ol,C1=CC=C2C(=C1)C=CC3=C2C4=C(C=C3)C(=CC=C4)O,,,,,,
8855,98856,Benzo[c]phenanthren-3-ol,C1=CC=C2C(=C1)C=CC3=C2C4=C(C=C3)C=C(C=C4)O,,,,,,
8856,98857,Benzo[c]phenanthren-6-ol,C1=CC=C2C(=C1)C=CC3=C2C4=CC=CC=C4C=C3O,,,,,,
8857,98858,CID 98858,CCN(CC)CC1=CN=C(NC1=O)S,,,,,,
8858,98859,"1-Naphthaleneacetaldehyde, alpha,alpha-bis(2-pyrrolidinoethyl)-",C1CCN(C1)CCC(CCN2CCCC2)(C=O)C3=CC=CC4=CC=CC=C43,,,,,,
8859,98860,"1-Naphthalenepropylamine, gamma,gamma'-nitrilodimethylenebis(N-ethyl-gamma-(2-(ethylmethylamino)ethyl)-N-methyl-",CCN(C)CCC(CCN(C)CC)(CN=CC(CCN(C)CC)(CCN(C)CC)C1=CC=CC2=CC=CC=C21)C3=CC=CC4=CC=CC=C43,,,,,,
8860,98861,"Pyrrolidine, 1,1'-(delta,delta'-nitriloditetramethylene)bis(gamma-(1-naphthyl)-gamma-(2-(1-pyrrolidinyl)ethyl)-",C1CCN(C1)CCC(CCN2CCCC2)(CN=CC(CCN3CCCC3)(CCN4CCCC4)C5=CC=CC6=CC=CC=C65)C7=CC=CC8=CC=CC=C87,,,,,,
8861,98862,"Benz[a]anthracene, 4-chloro-7-methyl-",CC1=C2C=CC3=C(C2=CC4=CC=CC=C14)C=CC=C3Cl,,,,,,
8862,98863,Hexahelicene,C1=CC=C2C(=C1)C=CC3=C2C4=C(C=C3)C=CC5=C4C6=CC=CC=C6C=C5,,,,,,
8863,98864,"Cyclopentanecarboxylic acid, 1-((((2-chloroethyl)nitrosoamino)carbonyl)amino)-",C1CCC(C1)(C(=O)O)NC(=O)N(CCCl)N=O,,,,,,
8864,98865,"Benzoic acid, 2-(oxophenylacetyl)-",C1=CC=C(C=C1)C(=O)C(=O)C2=CC=CC=C2C(=O)O,,,,,,
8865,98866,4-(1-Pyrrolidinyl)-2-butyn-1-ol carbamate,C1CCN(C1)CC#CCOC(=O)N,,,,,,
8866,98867,3-Methoxy-2-nitrobenzaldehyde,COC1=CC=CC(=C1[N+](=O)[O-])C=O,,,,,,
8867,98868,"Naphthalene, 1,4-diphenyl-",C1=CC=C(C=C1)C2=CC=C(C3=CC=CC=C32)C4=CC=CC=C4,,,,,,
8868,98869,"11H-Pyrido(3',2':5,6)pyrazino(2,3-b)indole, 11-(phenylmethyl)-",C1=CC=C(C=C1)CN2C3=C(C=CC=N3)N=C4C2=NC5=CC=CC=C54,,,,,,
8869,98870,"1,2-Ethanediamine, N,N-diethyl-N'-(4,5-dimethoxy-2-nitrophenyl)-",CCN(CC)CCNC1=CC(=C(C=C1[N+](=O)[O-])OC)OC,,,,,,
8870,98871,"Benzeneethanamine, N-(4,5-dimethoxy-2-nitrophenyl)-4-methoxy-",COC1=CC=C(C=C1)CCNC2=CC(=C(C=C2[N+](=O)[O-])OC)OC,,,,,,
8871,98872,"Benzeneethanamine, 3,4-dimethoxy-N-(4,5-dimethoxy-2-nitrophenyl)-",COC1=C(C=C(C=C1)CCNC2=CC(=C(C=C2[N+](=O)[O-])OC)OC)OC,,,,,,
8872,98873,"1,3-Benzodioxole-5-methanamine, N-(4,5-dimethoxy-2-nitrophenyl)-",COC1=C(C=C(C(=C1)NCC2=CC3=C(C=C2)OCO3)[N+](=O)[O-])OC,,,,,,
8873,98874,"2-Pyridineethanamine, N-(4,5-dimethoxy-2-nitrophenyl)-",COC1=C(C=C(C(=C1)NCCC2=CC=CC=N2)[N+](=O)[O-])OC,,,,,,
8874,98875,CID 98875,COC1=C(C=C2C(=C1)NC3=C4C=CC=CC4=NC3=N2)OC,,,,,,
8875,98876,Bis(4-nitrophenyl) methylphosphonate,CP(=O)(OC1=CC=C(C=C1)[N+](=O)[O-])OC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
8876,98877,n-[4-(Cyclohexylmethyl)cyclohexyl]acetamide,CC(=O)NC1CCC(CC1)CC2CCCCC2,,,,,,
8877,98878,4'-Pentylacetophenone,CCCCCC1=CC=C(C=C1)C(=O)C,,,,,,
8878,98879,4'-Heptylacetophenone,CCCCCCCC1=CC=C(C=C1)C(=O)C,,,,,,
8879,98880,N-Decylacetamide,CCCCCCCCCCNC(=O)C,,,,,,
8880,98881,CID 98881,CC[PbH](CC)CC.C1=CC(=CC=C1C(=O)O)N,,,,,,
8881,98882,4-Pentylcyclohexanecarboxylic acid,CCCCCC1CCC(CC1)C(=O)O,,,,,,
8882,98883,4-(Cyclohexylmethyl)piperidine,C1CCC(CC1)CC2CCNCC2,,,,,,
8883,98884,"Tungsten carbonyl (W(CO)6), (OC-6-11)-",[C-]#[O+].[C-]#[O+].[C-]#[O+].[C-]#[O+].[C-]#[O+].[C-]#[O+].[W],,,,,,
8884,98885,"Molybdenum carbonyl (Mo(CO)6), (OC-6-11)-",[C-]#[O+].[C-]#[O+].[C-]#[O+].[C-]#[O+].[C-]#[O+].[C-]#[O+].[Mo],,,,,,
8885,98886,"Urea, 1-(2-chloroethyl)-3-(4-hydroxymethylcyclohexyl)-1-nitroso-, formate, (E)-",C1CC(CCC1COC=O)NC(=O)N(CCCl)N=O,,,,,,
8886,98887,Neopentyl acrylate,CC(C)(C)COC(=O)C=C,,,,,,
8887,98888,N-(2-Aminoethyl)-1-aziridineethanamine,C1CN1CCNCCN,['This experimental drug was being researched for its use in the treatment of cardiovascular disease and SARS-CoV infections.'],,,,,
8888,98889,4-Hydroxyantipyrine,CC1=C(C(=O)N(N1C)C2=CC=CC=C2)O,,,,,['4-hydroxy-antipyrine is a known human metabolite of antipyrine.'],
8889,98890,3-Methyl-4-phenylhydrazino-2-pyrazolin-5-one,CC1=NNC(=O)C1NNC2=CC=CC=C2,,,,,,
8890,98891,"5-Bromo-1,2,3,4-tetrahydronaphthalene",C1CCC2=C(C1)C=CC=C2Br,,,,,,
8891,98892,"Lanthanum, tris(2-(hydroxy-kappaO)benzaldehydato-kappaO)-",C1=CC=C(C(=C1)C=O)[O-].C1=CC=C(C(=C1)C=O)[O-].C1=CC=C(C(=C1)C=O)[O-].[La+3],,,,,,
8892,98893,"1,4-Bis(2,4-dinitrophenyl)piperazine",C1CN(CCN1C2=C(C=C(C=C2)[N+](=O)[O-])[N+](=O)[O-])C3=C(C=C(C=C3)[N+](=O)[O-])[N+](=O)[O-],,,,,,
8893,98894,"Propanedinitrile, (3,5,5-trimethyl-2-cyclohexen-1-ylidene)-",CC1=CC(=C(C#N)C#N)CC(C1)(C)C,,,,,,
8894,98895,Wood reagent,COC(=N)C1=CC=C(C=C1)O,,,,,,
8895,98896,6-Bromo-5-hydroxy-2-hydroxymethyl-4-pyranone,C1=C(OC(=C(C1=O)O)Br)CO,,,,,,
8896,98897,cis-4-(3-(2-Chloroethyl)-3-nitrosoureido)cyclohexaneacetic acid,C1CC(CCC1CC(=O)O)NC(=O)N(CCCl)N=O,,,,,,
8897,98898,"2,6-Di-tert-butyl-4-methylpyridine",CC1=CC(=NC(=C1)C(C)(C)C)C(C)(C)C,,,,,,
8898,98899,4-(2-Dimethylaminoethyl)pyridine,CN(C)CCC1=CC=NC=C1,,,,,,
8899,98900,Dimethyl dibromomalonate,COC(=O)C(C(=O)OC)(Br)Br,,,,,,
8900,98901,1-Nitro-2-phenylnaphthalene,C1=CC=C(C=C1)C2=C(C3=CC=CC=C3C=C2)[N+](=O)[O-],,,,,,
8901,98902,"1,8-Octanediol, dimethanesulfonate",CS(=O)(=O)OCCCCCCCCOS(=O)(=O)C,,,,,,
8902,98903,"2,5-Bis(3-pyridyl)-1,3,4-oxadiazole",C1=CC(=CN=C1)C2=NN=C(O2)C3=CN=CC=C3,,,,,,
8903,98904,"Pyridine, 2,2'-(1,3,4-oxadiazol-2,5-ylene)di-",C1=CC=NC(=C1)C2=NN=C(O2)C3=CC=CC=N3,,,,,,
8904,98905,Methyl 9-anthracenecarboxylate,COC(=O)C1=C2C=CC=CC2=CC3=CC=CC=C31,,,,,,
8905,98906,"Rhodanine, 3-(o-ethoxyphenyl)-",CCOC1=CC=CC=C1N2C(=O)CSC2=S,,,,,,
8906,98907,CID 98907,CCC1=C(C(=CC=C1)CC)N=C(N)S,,,,,,
8907,98908,"2H-1,3,5-Thiadiazine-2-thione, tetrahydro-3,5-dibutyl-",CCCCN1CN(C(=S)SC1)CCCC,,,,,,
8908,98909,Methyl 1-benzyl-5-oxopyrrolidine-3-carboxylate,COC(=O)C1CC(=O)N(C1)CC2=CC=CC=C2,,,,,,
8909,98910,N-[(1-hydroxypyridin-2-ylidene)methylimino]-4-methylbenzenesulfonamide,CC1=CC=C(C=C1)S(=O)(=O)N=NC=C2C=CC=CN2O,,,,,,
8910,98911,Uricytin,C1=C[N+](=NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)[O-],,,,,,
8911,98912,Quindoline,C1=CC=C2C(=C1)C=C3C(=N2)C4=CC=CC=C4N3,,,,,,
8912,98913,1-(2-O-Methyl-beta-D-arabinofuranosyl)cytosine,CO[C@H]1[C@@H]([C@H](O[C@H]1N2C=CC(=NC2=O)N)CO)O,,,,,,
8913,98914,Deoxyshikonin,CC(=CCCC1=CC(=O)C2=C(C=CC(=C2C1=O)O)O)C,,,,,,
8914,98915,1-Adamantanecarbonyl chloride,C1C2CC3CC1CC(C2)(C3)C(=O)Cl,,,,,,
8915,98916,"2-Propanol, 1,1,1,3,3,3-hexafluoro-, 4-methylbenzenesulfonate",CC1=CC=C(C=C1)S(=O)(=O)OC(C(F)(F)F)C(F)(F)F,,,,,,
8916,98917,Benzyl cyclopropanecarboxylate,C1CC1C(=O)OCC2=CC=CC=C2,,,,,,
8917,98918,Diisobutyltin oxide,CC(C)C[Sn](=O)CC(C)C,,,,,,
8918,98919,1-(Tributylstannyl)-1H-imidazole,CCCC[Sn](CCCC)(CCCC)N1C=CN=C1,,,,,,
8919,98920,"Stannane, (1H-1,2,4-triazol-1-yl)triphenyl-",C1=CC=C(C=C1)[Sn](C2=CC=CC=C2)(C3=CC=CC=C3)N4C=NC=N4,,,,,,
8920,98921,Phenoxatellurine,C1=CC=C2C(=C1)OC3=CC=CC=C3[Te]2,,,,,,
8921,98922,CID 98922,CC(=NNC(=NC)S)CSCC(=NNC(=NC)S)C,,,,,,
8922,98923,"1-Naphthaleneacetaldehyde, alpha,alpha-bis(2-piperidinoethyl)-",C1CCN(CC1)CCC(CCN2CCCCC2)(C=O)C3=CC=CC4=CC=CC=C43,,,,,,
8923,98924,"1-Naphthaleneacetaldehyde, alpha,alpha-bis(2-(dimethylamino)ethyl)-",CN(C)CCC(CCN(C)C)(C=O)C1=CC=CC2=CC=CC=C21,,,,,,
8924,98925,"1-Naphthaleneacetaldehyde, alpha-sec-butyl-alpha-(2-(N-ethyl-N-methylamino)ethyl)-",CCC(C)C(CCN(C)CC)(C=O)C1=CC=CC2=CC=CC=C21,,,,,,
8925,98926,2-Benzylidenecyclohexanone,C1CCC(=O)C(=CC2=CC=CC=C2)C1,,,,,,
8926,98927,"(8-Methyl-3-methylidene-4,14-dioxo-5,9,15-trioxatetracyclo[11.2.1.02,6.08,10]hexadec-13(16)-en-12-yl) acetate",CC(=O)OC1CC2C(O2)(CC3C(C4C=C1C(=O)O4)C(=C)C(=O)O3)C,,,,,,
8927,98928,3-Acetylthiazolidine-4-carboxylic acid,CC(=O)N1CSCC1C(=O)O,,,,,,
8928,98929,"3,3,4-Trimethyl-1,2-dioxetane",CC1C(OO1)(C)C,,,,,,
8929,98930,2-Oxocyclopentanecarbonitrile,C1CC(C(=O)C1)C#N,,,,,,
8930,98931,"2,4-Dicyano-3-ethyl-3-methylglutarimide",CCC1(C(C(=O)NC(=O)C1C#N)C#N)C,,,,,,
8931,98932,"Tetrahydrothiophene-3-ol 1,1-dioxide",C1CS(=O)(=O)CC1O,,,,,,
8932,98933,"1,2,4-Trimethylpiperazine",CC1CN(CCN1C)C,,,,,,
8933,98934,Epiacorone,CC1CCC2(CC1=O)C(CC(=O)C2C(C)C)C,,,,,,
8934,98935,4-Methyl-2-pyrazolin-5-one,CC1C=NNC1=O,,,,,,
8935,98936,1-{4-[2-Hydroxy-3-(4-hydroxy-4-phenylpiperidin-1-yl)propoxy]phenyl}propan-1-one,CCC(=O)C1=CC=C(C=C1)OCC(CN2CCC(CC2)(C3=CC=CC=C3)O)O,,,,,,
8936,98937,"3-Pyridinamine, 4-(4-(4-chlorophenyl)-3-methyl-1-piperazinyl)-",CC1CN(CCN1C2=CC=C(C=C2)Cl)C3=C(C=NC=C3)N,,,,,,
8937,98938,1-(4-Fluorophenyl)-2-methyl-3-(pyridin-3-ylamino)prop-2-en-1-one,CC(=CNC1=CN=CC=C1)C(=O)C2=CC=C(C=C2)F,,,,,,
8938,98939,"1-(2,4-Dimethylphenyl)-3-(4-phenylpiperazin-1-yl)prop-2-en-1-one",CC1=CC(=C(C=C1)C(=O)C=CN2CCN(CC2)C3=CC=CC=C3)C,,,,,,
8939,98940,"1-(2,4-Dimethylphenyl)-3-[4-(4-methoxyphenyl)piperazin-1-yl]prop-2-en-1-one",CC1=CC(=C(C=C1)C(=O)C=CN2CCN(CC2)C3=CC=C(C=C3)OC)C,,,,,,
8940,98941,Ormeloxifene,CC1(C(C(C2=C(O1)C=C(C=C2)OC)C3=CC=C(C=C3)OCCN4CCCC4)C5=CC=CC=C5)C,,,,,,
8941,98942,"9,10,12,13-Tetrabromooctadecanoic acid",CCCCCC(C(CC(C(CCCCCCCC(=O)O)Br)Br)Br)Br,,,,,,
8942,98943,Bicyclo[3.1.0]hex-2-ene-6-carbaldehyde,C1C=CC2C1C2C=O,,,,,,
8943,98944,CID 98944,COC1=C(C=C2C(=C1)C(=O)NC(=O)C(=N2)C=C(O)OC)Cl,,,,,,
8944,98945,2-Benzylcyclohexanone,C1CCC(=O)C(C1)CC2=CC=CC=C2,,,,,,
8945,98946,(-)-Hibalactone; (-)-Savinin; NSC 150442;Savinine;Hibalactone,C1C(C(=CC2=CC3=C(C=C2)OCO3)C(=O)O1)CC4=CC5=C(C=C4)OCO5,,,,,,
8946,98947,7-(2-Oxocyclopentyl)heptanoic acid,C1CC(C(=O)C1)CCCCCCC(=O)O,,,,,,
8947,98948,"Ethyl 3-(2,4,6-trimethoxyphenyl)prop-2-enoate",CCOC(=O)C=CC1=C(C=C(C=C1OC)OC)OC,,,,,,
8948,98949,"4-Hydroxy-6,10-dimethyl-3-methylidene-3a,4,5,8,9,11a-hexahydrocyclodeca[b]furan-2-one",CC1=CC2C(C(CC(=CCC1)C)O)C(=C)C(=O)O2,,,,,,
8949,98950,2-Chloro-2-phenylacetic acid,C1=CC=C(C=C1)C(C(=O)O)Cl,,,,,,
8950,98951,"Pyrrolo(1,2-a)pyrazine-1,4-dione, hexahydro-3-(1-methylethyl)-",CC(C)C1C(=O)N2CCCC2C(=O)N1,,,,,,
8951,98952,"4a,8-Dimethyl-3-methylidene-2,5-dioxo-2,3,3a,4,4a,5,7a,8,9,9a-decahydroazuleno[6,5-b]furan-4-yl acetate",CC1CC2C(C(C3(C1C=CC3=O)C)OC(=O)C)C(=C)C(=O)O2,,,,,,
8952,98953,3-p-Hydroxyphenyl-1-phenylpropene,C1=CC=C(C=C1)C=CCC2=CC=C(C=C2)O,,,,,,
8953,98954,"7-Ethyl-5-methyl-6,8-dioxabicyclo[3.2.1]octane",CCC1C2CCCC(O2)(O1)C,,,,,,
8954,98955,"2-Propenoic acid, 3-(4-chlorophenyl)-, methyl ester",COC(=O)C=CC1=CC=C(C=C1)Cl,,,,,,
8955,98956,(2-Bromo-1-methoxyethyl)benzene,COC(CBr)C1=CC=CC=C1,,,,,,
8956,98957,"(6,9a-Dimethyl-3-methylidene-2,9-dioxo-3a,4,5,6,6a,7,8,9b-octahydroazuleno[4,5-b]furan-4-yl) acetate",CC1CC(C2C(C3(C1CCC3=O)C)OC(=O)C2=C)OC(=O)C,,,,,,
8957,98958,"6-Hydroxy-5a-methyl-3,9-dimethylidenedecahydronaphtho[1,2-b]furan-2(3h)-one",CC12CCC3C(C1C(=C)CCC2O)OC(=O)C3=C,,,,,,
8958,98959,"4,6-Diaminocyclohexane-1,2,3-triol",C1C(C(C(C(C1N)O)O)O)N,,,,,,
8959,98960,1-[(Benzyloxy)carbonyl]-5-oxoproline,C1CC(=O)N(C1C(=O)O)C(=O)OCC2=CC=CC=C2,,,,,,
8960,98961,"2,2'-O-Cyclouridine",C1=CN2C3C(C(C(O3)CO)O)OC2=NC1=O,,,,,,
8961,98962,1-Butylpiperidin-3-ol,CCCCN1CCCC(C1)O,,,,,,
8962,98963,"3,5-Dimethyl-4,6-diphenyl-1,3,5-thiadiazinane-2-thione",CN1C(N(C(=S)SC1C2=CC=CC=C2)C)C3=CC=CC=C3,,,,,,
8963,98964,"Octahydro-4,7-methano-1H-indene-1,2-diol",C1CC2CC1C3C2C(C(C3)O)O,,,,,,
8964,98965,Methyl lysergate,CN1CC(C=C2C1CC3=CNC4=CC=CC2=C34)C(=O)OC,,,,,,
8965,98966,CID 98966,COC1=CC=C(C=C1)C(=O)C=CC2=CC(=C(C=C2)OC)OC,,,,,,
8966,98967,3-tert-Butyladipic acid,CC(C)(C)C(CCC(=O)O)CC(=O)O,,,,,,
8967,98968,3-Ethyltetracosan-3-ol,CCCCCCCCCCCCCCCCCCCCCC(CC)(CC)O,,,,,,
8968,98969,Ethyl piperidine-3-carboxylate,CCOC(=O)C1CCCNC1,,,,,,
8969,98970,3-Undecanol,CCCCCCCCC(CC)O,,,,,,
8970,98971,4-Undecanol,CCCCCCCC(CCC)O,,,,,,
8971,98972,4-Tridecanol,CCCCCCCCCC(CCC)O,,,,,,
8972,98973,6-Tridecanol,CCCCCCCC(CCCCC)O,,,,,,
8973,98974,6-Pentadecanol,CCCCCCCCCC(CCCCC)O,,,,,,
8974,98975,Ethyl 2-acetylnonanoate,CCCCCCCC(C(=O)C)C(=O)OCC,,,,,,
8975,98976,5-Methyltetradecane,CCCCCCCCCC(C)CCCC,,,,,,
8976,98977,"Tetrahydro-1h-cyclopenta[c]furan-1,3(3ah)-dione",C1CC2C(C1)C(=O)OC2=O,,,,,,
8977,98978,3-Bromo-2-hydroxypropanoic acid,C(C(C(=O)O)O)Br,,,,,,
8978,98979,"Cyclohexanol, 2-(1,1,1,3,3,3-hexafluoro-2-hydroxy-2-propyl)-6-isopropyl-3-methyl-",CC1CCC(C(C1C(C(F)(F)F)(C(F)(F)F)O)O)C(C)C,,,,,,
8979,98980,"3-(2-Chloroethyl)-1-(1,2,3,4-tetrahydro-1-naphthyl)urea",C1CC(C2=CC=CC=C2C1)NC(=O)NCCCl,,,,,,
8980,98981,"3-(1,1,1,3,3,3-Hexafluoro-2-hydroxy-2-propyl)-2-norbornanone",C1CC2CC1C(C2=O)C(C(F)(F)F)(C(F)(F)F)O,,,,,,
8981,98982,1-(2-Chloroethyl)-3-(3-methylcyclohexyl)urea,CC1CCCC(C1)NC(=O)NCCCl,,,,,,
8982,98983,"3-(1,3-Dichloro-2-hydroxy-1,1,3,3-tetrafluoro-2-propyl)-2-norbornanone",C1CC2CC1C(C2=O)C(C(F)(F)Cl)(C(F)(F)Cl)O,,,,,,
8983,98984,"2-Benzyl-4,4,6-trimethyl-5,6-dihydro-4H-1,3-oxazine",CC1CC(N=C(O1)CC2=CC=CC=C2)(C)C,,,,,,
8984,98985,1-Amino-2-propyl sulfate,CC(CN)OS(=O)(=O)O,,,,,,
8985,98986,"2-(1,1,1,3,3,3-Hexafluoro-2-hydroxy-2-propyl)decanophenone",CCCCCCCCC(C(=O)C1=CC=CC=C1)C(C(F)(F)F)(C(F)(F)F)O,,,,,,
8986,98987,"9,12-Octadecadienoyl chloride, (9Z,12Z)-",CCCCCC=CCC=CCCCCCCCC(=O)Cl,,,,,,
8987,98988,"5-Phenoxy-1,1,1-trifluoro-2-trifluoromethyl-2,4-pentanediol",C1=CC=C(C=C1)OCC(CC(C(F)(F)F)(C(F)(F)F)O)O,,,,,,
8988,98989,"6,6,6-Trifluoro-1-phenyl-5-(trifluoromethyl)hexa-1,4-dien-3-one",C1=CC=C(C=C1)C=CC(=O)C=C(C(F)(F)F)C(F)(F)F,,,,,,
8989,98990,1-(2-Chloroethyl)-3-(alpha-methyl-2-furfuryl)urea,CC(C1=CC=CO1)NC(=O)NCCCl,,,,,,
8990,98991,4-(2-Ethylhexanoyl)morpholine,CCCCC(CC)C(=O)N1CCOCC1,,,,,,
8991,98992,"Urea, 1-(2-chloroethyl)-3-(alpha-methylphenethyl)-",CC(CC1=CC=CC=C1)NC(=O)NCCCl,,,,,,
8992,98993,"3-(6-Methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)acrylic acid",CC1=C(C(=O)NC(=O)N1)C=CC(=O)O,,,,,,
8993,98994,Benzylpenicilloic acid,CC1(C(NC(S1)C(C(=O)O)NC(=O)CC2=CC=CC=C2)C(=O)O)C,,,,,,
8994,98995,"2,4-Bis(alpha-methylbenzyl)anisole",CC(C1=CC=CC=C1)C2=CC(=C(C=C2)OC)C(C)C3=CC=CC=C3,,,,,,
8995,98996,{[(Benzyloxy)carbonyl]amino}(phenyl)acetic acid,C1=CC=C(C=C1)COC(=O)NC(C2=CC=CC=C2)C(=O)O,,,,,,
8996,98997,"Cyclopropyl(2,5-dimethylphenyl)methanol",CC1=CC(=C(C=C1)C)C(C2CC2)O,,,,,,
8997,98998,alpha-Cyclopropyl-4-isopropylbenzyl alcohol,CC(C)C1=CC=C(C=C1)C(C2CC2)O,,,,,,
8998,98999,"alpha,2,6-Trimethylmorpholin-4-ylethanol",CC1CN(CC(O1)C)CC(C)O,,,,,,
8999,99000,1-(Dipropylamino)propan-2-ol,CCCN(CCC)CC(C)O,,,,,,
9000,99001,Ethyl gamma-cyano-gamma-methylbenzenebutyrate,CCOC(=O)CCC(C)(C#N)C1=CC=CC=C1,,,,,,
9001,99002,Hexahydro-alpha-methyl-1H-azepine-1-ethanol,CC(CN1CCCCCC1)O,,,,,,
9002,99003,2-(4-Methoxyphenyl)-2-morpholinoacetamide,COC1=CC=C(C=C1)C(C(=O)N)N2CCOCC2,,,,,,
9003,99004,4-Methoxy-alpha-pyridylbenzyl alcohol,COC1=CC=C(C=C1)C(C2=CC=CC=N2)O,,,,,,
9004,99005,2-(4-Methoxyphenyl)-2-pyrrolidin-1-ylacetamide,COC1=CC=C(C=C1)C(C(=O)N)N2CCCC2,,,,,,
9005,99006,2-Phenyl-2-pyrrolidin-1-ylacetamide,C1CCN(C1)C(C2=CC=CC=C2)C(=O)N,,,,,,
9006,99007,"L-Cysteine, S-[2-(pyridinyl)ethyl]-",C1=CC=NC(=C1)CCSC[C@@H](C(=O)O)N,,,,,,
9007,99008,"Cyclohexanecarboxylic acid, 3-(3-(2-chloroethyl)-3-nitrosoureido)-, (Z)-",C1CC(CC(C1)NC(=O)N(CCCl)N=O)C(=O)O,,,,,,
9008,99009,CID 99009,COCCC=CCCl,,,,,,
9009,99010,2-Ethyl-3-(3-nitrophenyl)propenoic acid,CCC(=CC1=CC(=CC=C1)[N+](=O)[O-])C(=O)O,,,,,,
9010,99011,Methyl 3-(azepan-1-yl)-2-methylpropanoate,CC(CN1CCCCCC1)C(=O)OC,,,,,,
9011,99012,"2(1H)-Naphthalenone, octahydro-3,5,5,8,8-pentamethyl-",CC1CC2C(CC1=O)C(CCC2(C)C)(C)C,,,,,,
9012,99013,3-(Dimethylamino)-2-methylpropiophenone,CC(CN(C)C)C(=O)C1=CC=CC=C1,,,,,,
9013,99014,2-Methylpentylamine,CCCC(C)CN,,,,,,
9014,99015,alpha-Methylpyrrolidine-1-ethanol,CC(CN1CCCC1)O,,,,,,
9015,99016,2-(1-Methylbutyl)phenol,CCCC(C)C1=CC=CC=C1O,,,,,,
9016,99017,2-Benzoylamino-4-methylsulfanyl-butyric acid methyl ester,COC(=O)C(CCSC)NC(=O)C1=CC=CC=C1,,,,,,
9017,99018,"(2,5-Dioxopyrrolidin-1-yl) 3-hydroxy-2-[(2-methylpropan-2-yl)oxycarbonylamino]butanoate",CC(C(C(=O)ON1C(=O)CCC1=O)NC(=O)OC(C)(C)C)O,,,,,,
9018,99019,1-Methyl-1-phenylindan,CC1(CCC2=CC=CC=C21)C3=CC=CC=C3,,,,,,
9019,99020,"Ethyl 4,4-diethoxy-2-(ethoxymethylidene)-3-oxobutanoate",CCOC=C(C(=O)C(OCC)OCC)C(=O)OCC,,,,,,
9020,99021,3-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-4-methyl-5-thiazolidineethanol,CC1C(SCN1CC2=CN=C(N=C2N)C)CCO,,,,,,
9021,99022,"7-[(1R,2S)-2-[(3S)-3-hydroxyoct-1-enyl]-5-oxocyclopent-3-en-1-yl]hept-5-enoic acid",CCCCC[C@@H](C=C[C@H]1C=CC(=O)[C@@H]1CC=CCCCC(=O)O)O,,,,,,
9022,99023,"2-Penten-1-ol, 5-(3,3-dimethyl-2-oxiranyl)-3-methyl-, 1-acetate",CC(=CCOC(=O)C)CCC1C(O1)(C)C,,,,,,
9023,99024,1-Benzyl-5-oxopyrrolidine-3-carboxylic acid,C1C(CN(C1=O)CC2=CC=CC=C2)C(=O)O,,,,,,
9024,99025,2-(4-Chlorophenyl)-2-(pyridin-2-yl)acetonitrile,C1=CC=NC(=C1)C(C#N)C2=CC=C(C=C2)Cl,,,,,,
9025,99026,"1,3-Dihydrospiro(2H-imidazo(4,5-b)pyridine-2,3'-(3H)indol)-2'(1'H)-one",C1=CC=C2C(=C1)C3(C(=O)N2)NC4=C(N3)N=CC=C4,,,,,,
9026,99027,"N1,N1-Dimethylpropane-1,2-diamine",CC(CN(C)C)N,,,,,,
9027,99028,"N,N'-dimethylbut-2-ene-1,4-diamine",CNCC=CCNC,,,,,,
9028,99029,"Oxazolidine, 2-(trichloromethyl)-",C1COC(N1)C(Cl)(Cl)Cl,,,,,,
9029,99030,"Benzenesulfonic acid, 4-[4,5-dihydro-4-[[5-hydroxy-3-methyl-1-(4-sulfophenyl)-1H-pyrazol-4-yl]methylene]-3-methyl-5-oxo-1H-pyrazol-1-yl]-",CC1=C(C(=O)N(N1)C2=CC=C(C=C2)S(=O)(=O)O)C=C3C(=NN(C3=O)C4=CC=C(C=C4)S(=O)(=O)O)C,,,,,,
9030,99031,"Thioxanthen-9-one, 1-((2-(2-ethylpiperidino)ethyl)amino)-4-(hydroxymethyl)-",CCC1CCCCN1CCNC2=C3C(=C(C=C2)CO)SC4=CC=CC=C4C3=O,,,,,,
9031,99032,2'-Hydroxy-2-cinnamylideneacetophenone,C1=CC=C(C=C1)C=CC=CC(=O)C2=CC=CC=C2O,,,,,,
9032,99033,"Tetrahydro-2,6-dioxo-2H-pyran-3-propionic acid",C1CC(=O)OC(=O)C1CCC(=O)O,,,,,,
9033,99034,"1,3-Diphenyl-1-propene",C1=CC=C(C=C1)CC=CC2=CC=CC=C2,,,,,,
9034,99035,"2,6-Dichloro-9-thiabicyclo[3.3.1]nonane",C1CC(C2CCC(C1S2)Cl)Cl,,,,,,
9035,99036,CID 99036,COC1=C(C=CC(=C1)C2=CC(=C3C(=O)C=C(C(=C3O2)C4C(C(C(C(O4)CO)O)O)O)O)O)O,,,,,,
9036,99037,"3-Propoxypropane-1,2-diol",CCCOCC(CO)O,,,,,,
9037,99038,"2,6,6-Trimethylbicyclo[3.1.1]heptan-3-ol",CC1C2CC(C2(C)C)CC1O,,,,,,
9038,99039,Ethyl 3-acetyloxybut-2-enoate,CCOC(=O)C=C(C)OC(=O)C,,,,,,
9039,99040,SP 1 (pharmaceutical),CCCCCC(C)C(C)C1=CC(=C2C3=C(CCN(C3)CC#C)C(OC2=C1)(C)C)O,,,,,,
9040,99041,"[5-(7,8-Dimethyl-2,4-dioxopyrimido[4,5-b]quinolin-10-yl)-2,3,4-trihydroxypentyl] dihydrogen phosphate",CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=C2)CC(C(C(COP(=O)(O)O)O)O)O,,,,,,
9041,99042,"4-[(Dimethylamino)methylene]-5-methyl-2-phenyl-2,4-dihydro-3h-pyrazol-3-one",CC1=NN(C(=O)C1=CN(C)C)C2=CC=CC=C2,,,,,,
9042,99043,3-Chloroprop-2-enyl thiocyanate,C(C=CCl)SC#N,,,,,,
9043,99044,2-(dimethylaminomethylidene)-3H-inden-1-one,CN(C)C=C1CC2=CC=CC=C2C1=O,,,,,,
9044,99045,2-(2-(4-(2-((2-Chloro-10-phenothiazinyl)methyl)propyl)-1-piperazinyl)ethoxy)ethanol,CC(CN1CCN(CC1)CCOCCO)CN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,,,,,,
9045,99046,N-[N-[(Phenylmethoxy)carbonyl]glycyl]-L-methionine,CSCC[C@@H](C(=O)O)NC(=O)CNC(=O)OCC1=CC=CC=C1,,,,,,
9046,99047,Benzylcarbonylglycyloxy-L-alanine,CC(C(=O)O)NC(=O)CNC(=O)OCC1=CC=CC=C1,,,,,,
9047,99048,"S-[2-[3-[(2,4-dihydroxy-3,3-dimethylbutanoyl)amino]propanoylamino]ethyl] but-2-ynethioate",CC#CC(=O)SCCNC(=O)CCNC(=O)C(C(C)(C)CO)O,,,,,,
9048,99049,Ergokryptine,CC(C)CC1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CN(C5CC6=CNC7=CC=CC(=C67)C5=C4)C)O,,,,,,
9049,99050,(8-beta)-N-Butyl-6-methylergoline-8-carboxamide,CCCCNC(=O)C1CC2C(CC3=CNC4=CC=CC2=C34)N(C1)C,,,,,,
9050,99051,3-Hydroxy-3-phenacyloxindole,C1=CC=C(C=C1)C(=O)CC2(C3=CC=CC=C3NC2=O)O,,,,,,
9051,99052,anti-Benzene trioxide,C12C(O1)C3C(O3)C4C2O4,,,,,,
9052,99053,Methyl tetrahydropyranylreserpate,COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC6CCCCO6,,,,,,
9053,99054,"D-Ribonic acid, 2-(phenylmethyl)hydrazide",C1=CC=C(C=C1)CNNC(=O)C(C(C(CO)O)O)O,,,,,,
9054,99055,Pummerer's ketone,CC1=CC2=C(C=C1)OC3C2(C=CC(=O)C3)C,,,,,,
9055,99056,"benzyl N-(3,4,5,6-tetrahydroxy-1-oxohexan-2-yl)carbamate",C1=CC=C(C=C1)COC(=O)NC(C=O)C(C(C(CO)O)O)O,,,,,,
9056,99057,"2-Methoxyoxane-3,4,5-triol",COC1C(C(C(CO1)O)O)O,,,,,,
9057,99058,6-o-Phosphonohexose,C(C(C(C(C(C=O)O)O)O)O)OP(=O)(O)O,,,,,,
9058,99059,"(+)-2alpha-Tropan-2-ol, (+-)-2-cyclopentyl-2-phenylglycolate",CN1C2CCC1C(CC2)OC(=O)C(C3CCCC3)(C4=CC=CC=C4)O,,,,,,
9059,99060,"6-Chloro-3-methyl-1,2,3,4-tetrahydro-beta-carboline",CC1CC2=C(CN1)NC3=C2C=C(C=C3)Cl,,,,,,
9060,99061,2-[(Naphthalen-1-yl)methylidene]-1-azabicyclo[2.2.2]octan-3-one,C1CN2CCC1C(=O)C2=CC3=CC=CC4=CC=CC=C43,,,,,,
9061,99062,"2,7-Dimethyl-2,3,4,5-tetrahydropyrano(4,3-b)pyran-4,5-dione",CC1CC(=O)C2=C(O1)C=C(OC2=O)C,,,,,,
9062,99063,"7-Methoxy-2,3-dimethyl-6-(2-nitroethenyl)-1-benzofuran",CC1=C(OC2=C1C=CC(=C2OC)C=C[N+](=O)[O-])C,,,,,,
9063,99064,"5-Methoxy-2,3-dimethyl-6-(2-nitroethenyl)-1-benzofuran",CC1=C(OC2=C1C=C(C(=C2)C=C[N+](=O)[O-])OC)C,,,,,,
9064,99065,"6-Methoxy-2,3-dimethyl-5-(2-nitroethenyl)-1-benzofuran",CC1=C(OC2=C1C=C(C(=C2)OC)C=C[N+](=O)[O-])C,,,,,,
9065,99066,1-Fluoro-2-(2-nitroethenyl)benzene,C1=CC=C(C(=C1)C=C[N+](=O)[O-])F,,,,,,
9066,99067,(2-Isopropilcrotonil)urea,CC=C(C(C)C)C(=O)NC(=O)N,,,,,,
9067,99068,"3-Cyano-3,5,5-trimethylcyclohexanone",CC1(CC(=O)CC(C1)(C)C#N)C,,,,,,
9068,99069,"1-Naphthaleneacetaldehyde, alpha-(2-(dimethylamino)ethyl)-alpha-isobutyl-",CC(C)CC(CCN(C)C)(C=O)C1=CC=CC2=CC=CC=C21,,,,,,
9069,99070,"1-Naphthaleneacetaldehyde, alpha-butyl-alpha-(2-(dimethylamino)ethyl)-",CCCCC(CCN(C)C)(C=O)C1=CC=CC2=CC=CC=C21,,,,,,
9070,99071,"1-Naphthaleneacetaldehyde, alpha-isobutyl-alpha-(2-pyrrolidinoethyl)-",CC(C)CC(CCN1CCCC1)(C=O)C2=CC=CC3=CC=CC=C32,,,,,,
9071,99072,"1-Naphthaleneacetaldehyde, alpha-(2-(dimethylamino)ethyl)-alpha-propyl-",CCCC(CCN(C)C)(C=O)C1=CC=CC2=CC=CC=C21,,,,,,
9072,99073,"1-Naphthaleneacetaldehyde, alpha-butyl-alpha-(2-piperidinoethyl)-",CCCCC(CCN1CCCCC1)(C=O)C2=CC=CC3=CC=CC=C32,,,,,,
9073,99074,"1-Naphthaleneacetaldehyde, alpha-butyl-alpha-(2-pyrrolidinoethyl)-",CCCCC(CCN1CCCC1)(C=O)C2=CC=CC3=CC=CC=C32,,,,,,
9074,99075,"1-Naphthalenepropylamine, gamma,gamma'-nitrilodimethylenebis(N,N-dimethyl-gamma-isobutyl-",CC(C)CC(CCN(C)C)(CN=CC(CCN(C)C)(CC(C)C)C1=CC=CC2=CC=CC=C21)C3=CC=CC4=CC=CC=C43,,,,,,
9075,99076,"1-Naphthaleneacetaldehyde, alpha-butyl-alpha-(2-morpholinoethyl)-",CCCCC(CCN1CCOCC1)(C=O)C2=CC=CC3=CC=CC=C32,,,,,,
9076,99077,"1-Naphthaleneacetaldehyde, alpha-propyl-alpha-(2-pyrrolidinoethyl)-",CCCC(CCN1CCCC1)(C=O)C2=CC=CC3=CC=CC=C32,,,,,,
9077,99078,"1-Naphthaleneacetaldehyde, alpha-isobutyl-alpha-(2-piperidinoethyl)-",CC(C)CC(CCN1CCCCC1)(C=O)C2=CC=CC3=CC=CC=C32,,,,,,
9078,99079,"1-Naphthalenepropylamine, gamma,gamma'-nitrilodimethylenebis(gamma-butyl-N,N-dimethyl-",CCCCC(CCN(C)C)(CN=CC(CCCC)(CCN(C)C)C1=CC=CC2=CC=CC=C21)C3=CC=CC4=CC=CC=C43,,,,,,
9079,99080,"Piperidine, 1,1'-(delta,delta'-nitriloditetramethylene)bis(gamma-butyl-gamma-(1-naphthyl)-",CCCCC(CCN1CCCCC1)(CN=CC(CCCC)(CCN2CCCCC2)C3=CC=CC4=CC=CC=C43)C5=CC=CC6=CC=CC=C65,,,,,,
9080,99081,"1-Naphthalenepropylamine, gamma,gamma'-nitrilodimethylenebis(N,N-dimethyl-gamma-propyl-",CCCC(CCN(C)C)(CN=CC(CCC)(CCN(C)C)C1=CC=CC2=CC=CC=C21)C3=CC=CC4=CC=CC=C43,,,,,,
9081,99082,"Pyrrolidine, 1,1'-(delta,delta'-nitriloditetramethylene)bis(gamma-isobutyl-gamma-(1-naphthyl)-",CC(C)CC(CCN1CCCC1)(CN=CC(CCN2CCCC2)(CC(C)C)C3=CC=CC4=CC=CC=C43)C5=CC=CC6=CC=CC=C65,,,,,,
9082,99083,"Pyrrolidine, 1,1'-(delta,delta'-nitriloditetramethylene)bis(gamma-butyl-gamma-(1-naphthyl)-",CCCCC(CCN1CCCC1)(CN=CC(CCCC)(CCN2CCCC2)C3=CC=CC4=CC=CC=C43)C5=CC=CC6=CC=CC=C65,,,,,,
9083,99084,"1-Naphthaleneacetaldehyde, alpha-sec-butyl-alpha-(2-(diethylamino)ethyl)-",CCC(C)C(CCN(CC)CC)(C=O)C1=CC=CC2=CC=CC=C21,,,,,,
9084,99085,"1,4-Butanediamine, 2-sec-butyl-N1-(2-(2-(dimethylamino)ethyl)-3-methyl-2-(2-naphthyl)pentylidene)-N4,N4-dimethyl-2-(2-naphthyl)-",CCC(C)C(CCN(C)C)(CN=CC(CCN(C)C)(C1=CC2=CC=CC=C2C=C1)C(C)CC)C3=CC4=CC=CC=C4C=C3,,,,,,
9085,99086,"1-Naphthalenepropylamine, gamma,gamma'-nitrilodimethylenebis(N,N-diethyl-gamma-isopropyl-",CCN(CC)CCC(CN=CC(CCN(CC)CC)(C1=CC=CC2=CC=CC=C21)C(C)C)(C3=CC=CC4=CC=CC=C43)C(C)C,,,,,,
9086,99087,"cis-1,2-Acenaphthenediol",C1=CC2=C3C(=C1)C(C(C3=CC=C2)O)O,,,,,,
9087,99088,Ester benzilique de pseudo-tropine,CN1C2CCC1CC(C2)OC(=O)C(C3=CC=CC=C3)(C4=CC=CC=C4)O,,,,,,
9088,99089,"2-Propen-1-one,1-(3-azabicyclo[3.2.2]non-3-YL)-3-phenyl-",C1CC2CCC1CN(C2)C(=O)C=CC3=CC=CC=C3,,,,,,
9089,99090,"Piperidine, 2-methyl-6-undecyl-",CCCCCCCCCCCC1CCCC(N1)C,,,,,,
9090,99091,"1,4-Bis(3,4,5-trimethoxyphenyl)tetrahydro-1H,3H-furo[3,4-c]furan",COC1=CC(=CC(=C1OC)OC)C2C3COC(C3CO2)C4=CC(=C(C(=C4)OC)OC)OC,,,,,,
9091,99092,"O,O-Dimethyl 2,2-dichloro-1-hydroxyethylphosphonate",COP(=O)(C(C(Cl)Cl)O)OC,,,,,,
9092,99093,4-(2-Methylpentyl)cyclohexylamine,CCCC(C)CC1CCC(CC1)N,,,,,,
9093,99094,4-(2-Methylpentyl)benzoic acid,CCCC(C)CC1=CC=C(C=C1)C(=O)O,,,,,,
9094,99095,2-Chloro-2-phenylethanamine,C1=CC=C(C=C1)C(CN)Cl,,,,,,
9095,99096,alpha-((4-Aminophenoxy)methyl)-4-phenyl-1-piperazineethanol,C1CN(CCN1CC(COC2=CC=C(C=C2)N)O)C3=CC=CC=C3,,,,,,
9096,99097,alpha-((4-Aminophenoxy)methyl)-4-(3-methoxyphenyl)-1-piperazineethanol,COC1=CC=CC(=C1)N2CCN(CC2)CC(COC3=CC=C(C=C3)N)O,,,,,,
9097,99098,alpha-((3-Aminophenoxy)methyl)-4-phenyl-1-piperazineethanol,C1CN(CCN1CC(COC2=CC=CC(=C2)N)O)C3=CC=CC=C3,,,,,,
9098,99099,4-((2-Hydroxy-3-(4-nitrophenoxy)propyl)amino)benzoic acid,C1=CC(=CC=C1C(=O)O)NCC(COC2=CC=C(C=C2)[N+](=O)[O-])O,,,,,,
9099,99100,CID 99100,C1=CC(=CC=C1C(=O)N[C@@H](CCC(=O)O)C(=O)O)NCC2=NC3=C(C=C2)NC(=NC3=O)N,,,,,,
9100,99101,"4-N-(7-chloroquinolin-4-yl)-1-N,1-N-diethylpent-2-ene-1,4-diamine",CCN(CC)CC=CC(C)NC1=C2C=CC(=CC2=NC=C1)Cl,,,,,,
9101,99102,"1-(Bromomethyl)-7,7-dimethylbicyclo[2.2.1]heptan-2-one",CC1(C2CCC1(C(=O)C2)CBr)C,,,,,,
9102,99103,"3-(3,4-Diacetoxyphenyl)acrylic acid",CC(=O)OC1=C(C=C(C=C1)C=CC(=O)O)OC(=O)C,,,,,,
9103,99104,CID 99104,CC1(C2CCC1(C(=C2N=O)O)C)C,,,,,,
9104,99105,4-Peroxycyclophosphamide,C1COP(=O)(NC1OOC2CCOP(=O)(N2)N(CCCl)CCCl)N(CCCl)CCCl,,,,,,
9105,99106,"1-Chloro-3,7-dimethyl-octa-2,6-diene",CC(=CCCC(=CCCl)C)C,,,,,,
9106,99107,2-Methyl-6-tridecylpiperidine,CCCCCCCCCCCCCC1CCCC(N1)C,,,,,,
9107,99108,Dregamine,CCC1CN(C2CC3=C(C(=O)CC1C2C(=O)OC)NC4=CC=CC=C34)C,,,,,,
9108,99109,"8-ethylidene-3-hydroxy-2,6-dimethoxy-6,6a,7,9-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-11-one",CC=C1CC2C(NC3=CC(=C(C=C3C(=O)N2C1)OC)O)OC,,,,,,
9109,99110,N-((Benzylthio)cyanomethyl)benzamide,C1=CC=C(C=C1)CSC(C#N)NC(=O)C2=CC=CC=C2,,,,,,
9110,99111,CID 99111,CN(CC1=CC2=C(C=C1)NC(=NC2=O)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,,,,,,
9111,99112,"8,9,13-Trihydroxydocosanoic acid",CCCCCCCCCC(CCCC(C(CCCCCCC(=O)O)O)O)O,,,,,,
9112,99113,2-Bromo-N-phenylpropanamide,CC(C(=O)NC1=CC=CC=C1)Br,,,,,,
9113,99114,"4-Hydroxy-3,6,9-trimethyl-3,3a,4,5,9a,9b-hexahydroazuleno[4,5-b]furan-2,7-dione",CC1C2C(CC(=C3C(C2OC1=O)C(=CC3=O)C)C)O,,,,,,
9114,99115,"4,6-Dihydroxy-6,9-dimethyl-3-methylidene-3a,4,5,6,6a,7,9a,9b-octahydroazuleno[4,5-b]furan-2(3h)-one",CC1=CCC2C1C3C(C(CC2(C)O)O)C(=C)C(=O)O3,,,,,,
9115,99116,"Methyl 15-ethylidene-13-(hydroxymethyl)-3-methyl-3,17-diazapentacyclo[12.3.1.02,10.04,9.012,17]octadeca-2(10),4,6,8-tetraene-13-carboxylate",CC=C1CN2C3CC1C(C2CC4=C3N(C5=CC=CC=C45)C)(CO)C(=O)OC,,,,,,
9116,99117,alpha-Prenyl-alpha-(2-dimethylaminoethyl)-1-naphthylacetamide,CC(=CCC(CCN(C)C)(C1=CC=CC2=CC=CC=C21)C(=O)N)C,,,,,,
9117,99118,alpha-(2-Morpholinoethyl)-alpha-prenyl-1-naphthylacetamide,CC(=CCC(CCN1CCOCC1)(C2=CC=CC3=CC=CC=C32)C(=O)N)C,,,,,,
9118,99119,alpha-(2-Diprenylaminoethyl)-1-naphthylacetamide,CC(=CCN(CCC(C1=CC=CC2=CC=CC=C21)C(=O)N)CC=C(C)C)C,,,,,,
9119,99120,alpha-(2-Ethylmethylaminoethyl)-alpha-prenyl-1-naphthylacetamide,CCN(C)CCC(CC=C(C)C)(C1=CC=CC2=CC=CC=C21)C(=O)N,,,,,,
9120,99121,"1-Naphthaleneacetaldehyde, alpha-(2-(N-ethyl-N-methylamino)ethyl)-alpha-isopropyl-",CCN(C)CCC(C=O)(C1=CC=CC2=CC=CC=C21)C(C)C,,,,,,
9121,99122,"1-Naphthaleneacetaldehyde, alpha-(2-(N-benzyl-N-methylamino)ethyl)-alpha-isopropyl-",CC(C)C(CCN(C)CC1=CC=CC=C1)(C=O)C2=CC=CC3=CC=CC=C32,,,,,,
9122,99123,"1-Naphthalenepropylamine, gamma,gamma'-nitrilodimethylenebis(N,N-diethyl-gamma-(2-(diethylamino)ethyl)-",CCN(CC)CCC(CCN(CC)CC)(CN=CC(CCN(CC)CC)(CCN(CC)CC)C1=CC=CC2=CC=CC=C21)C3=CC=CC4=CC=CC=C43,,,,,,
9123,99124,"Piperidine, 1,1'-(delta,delta'-nitriloditetramethylene)bis(gamma-(1-naphthyl)-gamma-(2-piperidinoethyl)-",C1CCN(CC1)CCC(CCN2CCCCC2)(CN=CC(CCN3CCCCC3)(CCN4CCCCC4)C5=CC=CC6=CC=CC=C65)C7=CC=CC8=CC=CC=C87,,,,,,
9124,99125,"1-Naphthalenepropylamine, gamma,gamma'-nitrilodimethylenebis(N,N-dimethyl-gamma-(2-dimethylaminoethyl)-",CN(C)CCC(CCN(C)C)(CN=CC(CCN(C)C)(CCN(C)C)C1=CC=CC2=CC=CC=C21)C3=CC=CC4=CC=CC=C43,,,,,,
9125,99126,"Morpholine, 4,4'-nitriloditetramethylenebis(gamma-(2-morpholinoethyl)-gamma-(1-naphthyl)-",C1COCCN1CCC(CCN2CCOCC2)(CN=CC(CCN3CCOCC3)(CCN4CCOCC4)C5=CC=CC6=CC=CC=C65)C7=CC=CC8=CC=CC=C87,,,,,,
9126,99127,"1,4-Naphthalenedione, 2-(dodecylthio)-3-hydroxy-",CCCCCCCCCCCCSC1=C(C2=CC=CC=C2C(=O)C1=O)O,,,,,,
9127,99128,2-phenyl-3H-indol-3-one,C1=CC=C(C=C1)C2=NC3=CC=CC=C3C2=O,,,,,,
9128,99129,Methyl (methylsulfinyl)methyl sulfide,CSCS(=O)C,,,,,,
9129,99130,"10H-1,2,4-Triazolo[4',3':2,3][1,2,4]triazino[5,6-b]indole, 3,10-dimethyl-",CC1=NN=C2N1N=C3C4=CC=CC=C4N(C3=N2)C,,,,,,
9130,99131,CID 99131,CNC1=NN=C(S1)S,,,,,,
9131,99132,Gangamicin,C1CCCC(CCC1)NC2=CC(=O)C3=C(C2=O)C=CC=N3,,,,,,
9132,99133,"5,8-Quinolinedione, 6-(2-(4-pyridylmethylamino)ethyl)amino-",C1=CC2=C(C(=O)C=C(C2=O)NCCNCC3=CC=NC=C3)N=C1,,,,,,
9133,99134,"p-Benzoquinone, 2-(hydroxymethyl)-5-methyl-",CC1=CC(=O)C(=CC1=O)CO,,,,,,
9134,99135,2-Bromo-10-(2-(1-methyl-2-piperidyl)ethyl)phenothiazine,CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Br,,,,,,
9135,99136,"1,3-Diethylhexahydropyrimid-2-one",CCN1CCCN(C1=O)CC,,,,,,
9136,99137,"2(1H)-Pyrimidinone, tetrahydro-1,3-dipropyl-",CCCN1CCCN(C1=O)CCC,,,,,,
9137,99138,"Methanethiol, N-(2-(p-tolylthio)ethyl)amidino-, hydrogen thiosulfate",CC1=CC=C(C=C1)SCCN=C(CSS(=O)(=O)O)N,,,,,,
9138,99139,"Methanethiol, N-(2-(p-chlorophenylthio)ethyl)amidino-, hydrogen sulfate (ester)",C1=CC(=CC=C1SCCN=C(CSS(=O)(=O)O)N)Cl,,,,,,
9139,99140,"Methanethiol, N-(3-(3-indolyl)propyl)amidino-, hydrogen thiosulfate",C1=CC=C2C(=C1)C(=CN2)CCCN=C(CSS(=O)(=O)O)N,,,,,,
9140,99141,"Methanethiol, N-(4-phenoxybutyl)amidino-, hydrogen thiosulfate",C1=CC=C(C=C1)OCCCCN=C(CSS(=O)(=O)O)N,,,,,,
9141,99142,"Methanethiol, N-(3,4-dimethylbenzyl)amidino-, hydrogen thiosulfate",CC1=C(C=C(C=C1)CN=C(CSS(=O)(=O)O)N)C,,,,,,
9142,99143,"Methanethiol, N-cyclopropylamidino-, hydrogen thiosulfate",C1CC1N=C(CSS(=O)(=O)O)N,,,,,,
9143,99144,"Methanethiol, N-(3-benzyloxypropyl)amidino-, hydrogen sulfate (ester)",C1=CC=C(C=C1)COCCCN=C(CSS(=O)(=O)O)N,,,,,,
9144,99145,"Methanethiol, N-(2-phenylthioethyl)amidino-, hydrogen thiosulfate",C1=CC=C(C=C1)SCCN=C(CSS(=O)(=O)O)N,,,,,,
9145,99146,"Methanethiol, N-(p-methoxybenzyl)amidino-, hydrogen thiosulfate",COC1=CC=C(C=C1)CN=C(CSS(=O)(=O)O)N,,,,,,
9146,99147,"Pyridine, 2-(methylthio)-, 1-oxide",CSC1=CC=CC=[N+]1[O-],,,,,,
9147,99148,Atromentin,C1=CC(=CC=C1C2=C(C(=O)C(=C(C2=O)O)C3=CC=C(C=C3)O)O)O,,,,,,
9148,99149,"5,8-Quinolinedione, 6-(2-morpholinoethyl)amino-",C1COCCN1CCNC2=CC(=O)C3=C(C2=O)C=CC=N3,,,,,,
9149,99150,"5,8-Quinolinedione, 6-(3-piperidinopropyl)amino-",C1CCN(CC1)CCCNC2=CC(=O)C3=C(C2=O)C=CC=N3,,,,,,
9150,99151,"5,8-Quinolinedione, 6-((3-dibutylamino)propyl)amino-",CCCCN(CCCC)CCCNC1=CC(=O)C2=C(C1=O)C=CC=N2,,,,,,
9151,99152,4-Chloro-2-fluorobenzoic acid,C1=CC(=C(C=C1Cl)F)C(=O)O,,,,,,
9152,99153,"Methanol, pentachlorobenzylthio-",C(C1=C(C(=C(C(=C1Cl)Cl)Cl)Cl)Cl)SCO,,,,,,
9153,99154,"Benzothiazole, 2-(heptylthio)-",CCCCCCCSC1=NC2=CC=CC=C2S1,,,,,,
9154,99155,"Urea, 3-(2-benzothiazolyl)-1,1-dimethyl-",CN(C)C(=O)NC1=NC2=CC=CC=C2S1,,,,,,
9155,99156,"Phosphoro(thiocyanatidic) acid, thio-, diethyl ester",CCOP(=S)(N=C=S)OCC,,,,,,
9156,99157,"2-Butyne-1,4-diol, bis(2,3,6-trichlorobenzoate)",C1=CC(=C(C(=C1Cl)C(=O)OCC#CCOC(=O)C2=C(C=CC(=C2Cl)Cl)Cl)Cl)Cl,,,,,,
9157,99158,"1,4-Bis(cyclohexylamino)-2-butyne",C1CCC(CC1)NCC#CCNC2CCCCC2,,,,,,
9158,99159,N-(2-Benzothiazolyl)phthalimide,C1=CC=C2C(=C1)C(=O)N(C2=O)C3=NC4=CC=CC=C4S3,,,,,,
9159,99160,Pentachlorophenyl propargyl sulfide,C#CCSC1=C(C(=C(C(=C1Cl)Cl)Cl)Cl)Cl,,,,,,
9160,99161,"Acetic acid, ((4,6-dichloro-o-tolyl)oxy)-, methyl ester",CC1=CC(=CC(=C1OCC(=O)OC)Cl)Cl,,,,,,
9161,99162,2-(4-chloro-2-methylphenoxy)-N-[3-(trifluoromethyl)phenyl]acetamide,CC1=C(C=CC(=C1)Cl)OCC(=O)NC2=CC=CC(=C2)C(F)(F)F,,,,,,
9162,99163,"2,4-Dichloro-6-methylphenoxyacetic acid",CC1=CC(=CC(=C1OCC(=O)O)Cl)Cl,,,,,,
9163,99164,Isopropyl ethylcarbamate,CCNC(=O)OC(C)C,,,,,,
9164,99165,"Acetamide, 2,2,2-trichloro-N-(3-methylphenyl)-",CC1=CC(=CC=C1)NC(=O)C(Cl)(Cl)Cl,,,,,,
9165,99166,"3,4-Difluorobenzoic acid",C1=CC(=C(C=C1C(=O)O)F)F,,,,,,
9166,99167,"2-Propenal, (4-nitrophenyl)hydrazone",C=CC=NNC1=CC=C(C=C1)[N+](=O)[O-],,,,,,
9167,99168,2-(4-Bromophenoxy)ethanol,C1=CC(=CC=C1OCCO)Br,,,,,,
9168,99169,Ethyl 2-pentynoate,CCC#CC(=O)OCC,,,,,,
9169,99170,Ethyl 1H-imidazole-4-carboxylate,CCOC(=O)C1=CN=CN1,,,,,,
9170,99171,"Carbamic acid, (2,5-dichloro-3,6-dioxo-1,4-cyclohexadiene-1,4-diyl)bis-, diethyl ester",CCOC(=O)NC1=C(C(=O)C(=C(C1=O)Cl)NC(=O)OCC)Cl,,,,,,
9171,99172,9-Aminoellipticine,CC1=C2C=CN=CC2=C(C3=C1NC4=C3C=C(C=C4)N)C,,,,,,
9172,99173,"Carbamic acid, propyl-, 2-naphthalenyl ester",CCCNC(=O)OC1=CC2=CC=CC=C2C=C1,,,,,,
9173,99174,"3-Phenylfuran-2,5-dione",C1=CC=C(C=C1)C2=CC(=O)OC2=O,,,,,,
9174,99175,"1,4-Bis(endothalimido)-2-butyne",C1CC2C3C(C1O2)C(=O)N(C3=O)CC#CCN4C(=O)C5C6CCC(C5C4=O)O6,,,,,,
9175,99176,2-(Hydroxymethyl)benzamide,C1=CC=C(C(=C1)CO)C(=O)N,,,,,,
9176,99177,"Phosphoric acid, dibutyl 1-Naphthalenyl ester",CCCCOP(=O)(OCCCC)OC1=CC=CC2=CC=CC=C21,,,,,,
9177,99178,"Urea, 1-(2-benzothiazolyl)-3-butyl-",CCCCNC(=O)NC1=NC2=CC=CC=C2S1,,,,,,
9178,99179,"Urea, 1,1-dimethyl-3-(2,4-dinitrophenyl)-",CN(C)C(=O)NC1=C(C=C(C=C1)[N+](=O)[O-])[N+](=O)[O-],,,,,,
9179,99180,"N-(2,4-Dinitrophenyl)-N'-phenylurea",C1=CC=C(C=C1)NC(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])[N+](=O)[O-],,,,,,
9180,99181,"4-Cyclohexene-1,1,2,2-tetracarbonitrile",C1C=CCC(C1(C#N)C#N)(C#N)C#N,,,,,,
9181,99182,"2-Butyne-1,4-diol, bis(p-chlorophenylcarbamate)",C1=CC(=CC=C1NC(=O)OCC#CCOC(=O)NC2=CC=C(C=C2)Cl)Cl,,,,,,
9182,99183,Sucrose octastearate,CCCCCCCCCCCCCCCCCC(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@]2([C@H]([C@@H]([C@H](O2)COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC,,,,,,
9183,99184,"Pyridine, 4-(phenylthio)-",C1=CC=C(C=C1)SC2=CC=NC=C2,,,,,,
9184,99185,S-((N-Cyclohexylpropylamidino)methyl) hydrogen thiosulfate,C1CCC(CC1)CCCN=C(CSS(=O)(=O)O)N,,,,,,
9185,99186,S-((N-Cyclohexylbutylamidino)methyl) hydrogen thiosulfate,C1CCC(CC1)CCCCN=C(CSS(=O)(=O)O)N,,,,,,
9186,99187,S-((N-Cyclohexylmethylamidino)methyl) hydrogen thiosulfate,C1CCC(CC1)CN=C(CSS(=O)(=O)O)N,,,,,,
9187,99188,Tetrangulol,CC1=CC2=C(C(=C1)O)C3=C(C=C2)C(=O)C4=C(C3=O)C=CC=C4O,,,,,,
9188,99189,Rotenolone II,CC(=C)[C@H]1CC2=C(O1)C=CC3=C2O[C@@H]4COC5=CC(=C(C=C5[C@]4(C3=O)O)OC)OC,,,,,,
9189,99190,"(1)Benzopyrano(3,4-b)furo(2,3-h)(1)benzopyran-6(12H)-one, 1,2-dihydro-2-alpha-isopropyl-8,9-dimethoxy-",CC(=C)[C@H]1CC2=C(O1)C=CC3=C2OC4=C(C3=O)C5=CC(=C(C=C5OC4)OC)OC,,,,,,
9190,99191,"3,6-Dichloro-4-hydroxybenzenesulfonyl fluoride",C1=C(C(=CC(=C1Cl)S(=O)(=O)F)Cl)O,,,,,,
9191,99192,"Phosphonic acid, ethylthiomethyl-, dibutyl ester",CCCCOP(=O)(CSCC)OCCCC,,,,,,
9192,99193,"3-Chloro-4-hydroxybenzenesulfonyl fluoride N,N-dimethylthiocarbamate",CN(C)C(=S)OC1=C(C=C(C=C1)S(=O)(=O)F)Cl,,,,,,
9193,99194,"Phenol, 6-tert-butyl-2,4-dinitro-3-methyl-, chloroacetate",CC1=C(C=C(C(=C1[N+](=O)[O-])OC(=O)CCl)C(C)(C)C)[N+](=O)[O-],,,,,,
9194,99195,"1,1-Dimethyl-3-furfurylurea",CN(C)C(=O)NCC1=CC=CO1,,,,,,
9195,99196,CID 99196,CSC1=NC(=CC(=N1)NC2=C(N=C(C=C2)Cl)S)N,,,,,,
9196,99197,"Morpholine, 4-heptanoyl-",CCCCCCC(=O)N1CCOCC1,,,,,,
9197,99198,"1,3-Benzodioxole, 5-((3-methyl-2-butenyl)oxy)-",CC(=CCOC1=CC2=C(C=C1)OCO2)C,,,,,,
9198,99199,"Ibogamine-18-carboxylic acid, 13-methoxy-, methyl ester",CC[C@H]1C[C@@H]2C[C@@]3([C@H]1N(C2)CCC4=C3NC5=C4C=CC(=C5)OC)C(=O)OC,,,,,,
9199,99200,Ethyl 5-methyl-1H-imidazole-4-carboxylate,CCOC(=O)C1=C(NC=N1)C,,,,,,
9200,99201,"Urea, 1-(p-chlorophenyl)-3,3-di(2-propynyl)-",C#CCN(CC#C)C(=O)NC1=CC=C(C=C1)Cl,,,,,,
9201,99202,"3,5-Dichloro-2-hydroxybenzenesulfonyl fluoride",C1=C(C=C(C(=C1S(=O)(=O)F)O)Cl)Cl,,,,,,
9202,99203,"Thiocyanic acid, diethylcarbamoylmethyl ester",CCN(CC)C(=O)CSC#N,,,,,,
9203,99204,"Methanesulfonamide, N-2-benzothiazolyl-",CS(=O)(=O)NC1=NC2=CC=CC=C2S1,,,,,,
9204,99205,"7-Oxabicyclo(2.2.1)hept-5-ene-2,3-dicarboxylic acid, dimethyl ester, (exo,exo)-",COC(=O)[C@@H]1[C@H]2C=C[C@@H]([C@@H]1C(=O)OC)O2,,,,,,
9205,99206,"1,4-Bis((2-methoxyethyl)amino)anthraquinone",COCCNC1=C2C(=C(C=C1)NCCOC)C(=O)C3=CC=CC=C3C2=O,,,,,,
9206,99207,Epsilon-rhodomycinone,CC[C@]1(C[C@@H](C2=C([C@H]1C(=O)OC)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4O)O)O)O,,,,,,
9207,99208,"3-(4-Nitrophenyl)pentane-1,3,5-tricarbonitrile",C1=CC(=CC=C1C(CCC#N)(CCC#N)C#N)[N+](=O)[O-],,,,,,
9208,99209,6-(Dimethylamino)pyridine-3-carboxylic acid,CN(C)C1=NC=C(C=C1)C(=O)O,,,,,,
9209,99210,CID 99210,C1=CC(=CC=C1N=NC2=CC(=O)N=C(N2)N)O,,,,,,
9210,99211,"Cellobiono-1,5-lactone",C([C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O[C@@H]2[C@H](OC(=O)[C@@H]([C@H]2O)O)CO)O)O)O)O,,,,,,
9211,99212,"9,10-Didehydro-6-methyl-8-hydroxymethylergoline",CN1C[C@H](C=C2[C@@H]1CC3=CNC4=CC=CC2=C34)CO,,,,,,
9212,99213,CID 99213,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO[C@@H]4[C@H](O[C@@H]([C@@H]([C@H]4O)O)OC(C(C(C(C(=O)O)O)OP(=O)(O)O)O)C(=O)O)CO)O)O)N,,,,,,
9213,99214,p-(Benzyloxy)phenyl bis(1-aziridinyl)phosphinate,C1CN1P(=O)(N2CC2)OC3=CC=C(C=C3)OCC4=CC=CC=C4,,,,,,
9214,99215,1-(4-(Benzyloxy)-3-methoxyphenyl)ethanone,CC(=O)C1=CC(=C(C=C1)OCC2=CC=CC=C2)OC,,,,,,
9215,99216,"2,4-Quinolinedione, 1,2,3,4-tetrahydro-1,3,3-trimethyl-",CC1(C(=O)C2=CC=CC=C2N(C1=O)C)C,,,,,,
9216,99217,"1,3-Dimethyl-3-ethyl-1,2,3,4-tetrahydro-2,4-quinolinedione",CCC1(C(=O)C2=CC=CC=C2N(C1=O)C)C,,,,,,
9217,99218,"4(1H)-Quinolinone, 2,3-dihydro-1,3,3-trimethyl-",CC1(CN(C2=CC=CC=C2C1=O)C)C,,,,,,
9218,99219,"(1,1-Dimethylethyl)phenylphosphinothioic chloride",CC(C)(C)P(=S)(C1=CC=CC=C1)Cl,,,,,,
9219,99220,2-(2-Furfurylidene)cyclohexan-1-one,C1CCC(=O)C(=CC2=CC=CO2)C1,,,,,,
9220,99221,"3-Benzyl-5-methyl-1,3,5-thiadiazinane-2-thione",CN1CN(C(=S)SC1)CC2=CC=CC=C2,,,,,,
9221,99222,CID 99222,C1=CC(=CN=C1)N=C(N)S,,,,,,
9222,99223,3-Methylhippuric acid,CC1=CC(=CC=C1)C(=O)NCC(=O)O,,,,,,
9223,99224,"N-(2-(4-Oxo-4H-3,1-benzoxazin-2-yl)phenyl)methanesulphonamide",CS(=O)(=O)NC1=CC=CC=C1C2=NC3=CC=CC=C3C(=O)O2,,,,,,
9224,99225,CID 99225,CC1=C(C(=CC=C1)C)N=C(N)S,,,,,,
9225,99226,"S,S-Dimethyl-N-(p-toluenesulfonyl)sulfoximine",CC1=CC=C(C=C1)S(=O)(=O)N=S(=O)(C)C,,,,,,
9226,99227,Diethyl phenylthiomethylphosphonate,CCOP(=O)(CSC1=CC=CC=C1)OCC,,,,,,
9227,99228,"Urea, N'-(4-cyanophenyl)-N,N-dimethyl-",CN(C)C(=O)NC1=CC=C(C=C1)C#N,,,,,,
9228,99229,"Propanedinitrile, [bis(methylthio)methylene]-",CSC(=C(C#N)C#N)SC,,,,,,
9229,99230,Benzyl 2-chloroethyl sulfone,C1=CC=C(C=C1)CS(=O)(=O)CCCl,,,,,,
9230,99231,o-(5-Chloro-2-benzoxazolyl)phenol,C1=CC=C(C(=C1)C2=NC3=C(O2)C=CC(=C3)Cl)O,,,,,,
9231,99232,p-Bromophenyl 2-chloroethyl sulfone,C1=CC(=CC=C1S(=O)(=O)CCCl)Br,,,,,,
9232,99233,p-Chlorobenzyl 2-chloroethyl sulfone,C1=CC(=CC=C1CS(=O)(=O)CCCl)Cl,,,,,,
9233,99234,p-Chlorobenzyl vinyl sulfone,C=CS(=O)(=O)CC1=CC=C(C=C1)Cl,,,,,,
9234,99235,"4,4-Bis(trifluoromethyl)oxetan-2-one",C1C(=O)OC1(C(F)(F)F)C(F)(F)F,,,,,,
9235,99236,2-Isothiocyanatopyridine,C1=CC=NC(=C1)N=C=S,,,,,,
9236,99237,Tetraheptylstannane,CCCCCCC[Sn](CCCCCCC)(CCCCCCC)CCCCCCC,,,,,,
9237,99238,1-Chloro-2-((2-chloroethyl)thio)benzene,C1=CC=C(C(=C1)SCCCl)Cl,,,,,,
9238,99239,"Phenol, 2-nitro-3,4,6-trichloro-, phenylcarbamate",C1=CC=C(C=C1)NC(=O)OC2=C(C(=C(C=C2Cl)Cl)Cl)[N+](=O)[O-],,,,,,
9239,99240,Diethyl 4-chlorobenzylphosphonate,CCOP(=O)(CC1=CC=C(C=C1)Cl)OCC,,,,,,
9240,99241,Ethylene piperidinophosphonite,C1CCN(CC1)P2OCCO2,,,,,,
9241,99242,"Phosphoramidothioic acid, O,O-bis(p-chlorophenyl) ester",C1=CC(=CC=C1OP(=S)(N)OC2=CC=C(C=C2)Cl)Cl,,,,,,
9242,99243,"Phenol, 2-nitro-3,4,6-trichloro-, p-chlorocarbanilate",C1=CC(=CC=C1NC(=O)OC2=C(C(=C(C=C2Cl)Cl)Cl)[N+](=O)[O-])Cl,,,,,,
9243,99244,"Phosphoramidic acid, phenyl-, dibutyl ester",CCCCOP(=O)(NC1=CC=CC=C1)OCCCC,,,,,,
9244,99245,Tripiperidinophosphine sulfide,C1CCN(CC1)P(=S)(N2CCCCC2)N3CCCCC3,,,,,,
9245,99246,"Phenol, 6-nitro-2,4,5-trichloro-, butylcarbamate",CCCCNC(=O)OC1=C(C(=C(C=C1Cl)Cl)Cl)[N+](=O)[O-],,,,,,
9246,99247,"Phosphinous acid, dipiperidino-, butyl ester",CCCCOP(N1CCCCC1)N2CCCCC2,,,,,,
9247,99248,S-Butyl dipiperidinophosphinothioate,CCCCSP(=O)(N1CCCCC1)N2CCCCC2,,,,,,
9248,99249,Benzyldipiperidinophosphine oxide,C1CCN(CC1)P(=O)(CC2=CC=CC=C2)N3CCCCC3,,,,,,
9249,99250,"Phosphinic acid, dipiperidino-, phenyl ester",C1CCN(CC1)P(=O)(N2CCCCC2)OC3=CC=CC=C3,,,,,,
9250,99251,"Phosphine oxide, dipyrrolidinophenyl-",C1CCN(C1)P(=O)(C2=CC=CC=C2)N3CCCC3,,,,,,
9251,99252,"3,5-Dibromo-4-pyridinol",C1=C(C(=O)C(=CN1)Br)Br,,,,,,
9252,99253,CID 99253,C1=CC=C2C(=C1)NC3=NC(=O)NC(=O)C3=N2,,,,,,
9253,99254,"2-Chloro-4,6-dinitrophenyl-2-chloroethyl carbonate",C1=C(C=C(C(=C1[N+](=O)[O-])OC(=O)OCCCl)Cl)[N+](=O)[O-],,,,,,
9254,99255,"Phosphonic acid, (3,4-dichlorobenzyl)-, dibutyl ester",CCCCOP(=O)(CC1=CC(=C(C=C1)Cl)Cl)OCCCC,,,,,,
9255,99256,CID 99256,CC[PbH](CC)CC.CC1=CC=C(C=C1)S(=O)(=O)O,,,,,,
9256,99257,"p-Toluanilide, 4'-nitro-",CC1=CC=C(C=C1)C(=O)NC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
9257,99258,"Phosphine selenide, tripiperidino-",C1CCN(CC1)P(=[Se])(N2CCCCC2)N3CCCCC3,,,,,,
9258,99259,"Stannane, fluorotris(p-chlorophenyl)-",C1=CC(=CC=C1Cl)[Sn](C2=CC=C(C=C2)Cl)(C3=CC=C(C=C3)Cl)F,,,,,,
9259,99260,"1,3,4-Thiadiazole, 2,5-bis((carbamoyl)methylthio)-",C(C(=O)N)SC1=NN=C(S1)SCC(=O)N,,,,,,
9260,99261,"Stannane, chlorotris(4-chlorophenyl)-",C1=CC(=CC=C1Cl)[Sn](C2=CC=C(C=C2)Cl)(C3=CC=C(C=C3)Cl)Cl,,,,,,
9261,99262,CID 99262,C1=CC=C(C=C1)[SnH](C2=CC=CC=C2)C3=CC=CC=C3.C1=CC=C(C=C1)[SnH](C2=CC=CC=C2)C3=CC=CC=C3.C(#CC(=O)O)C(=O)O,,,,,,
9262,99263,"Piperidine, 1,1'-(o-chlorobenzylidene)di-",C1CCN(CC1)C(C2=CC=CC=C2Cl)N3CCCCC3,,,,,,
9263,99264,CID 99264,C#CC(=O)O.C1=CC=C(C=C1)[SnH](C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
9264,99265,CID 99265,C1=CC=C(C=C1)[SnH](C2=CC=CC=C2)C3=CC=CC=C3.C(C#N)C(=O)O,,,,,,
9265,99266,3-Phenyl-1-piperidino-2-propyn-1-one,C1CCN(CC1)C(=O)C#CC2=CC=CC=C2,,,,,,
9266,99267,CID 99267,CC[PbH](CC)CC.C12=C(C(=C(C(=C1Cl)Cl)Cl)Cl)C(=O)[N-]C2=O,,,,,,
9267,99268,"N,N-Dimethyl-1-piperidinecarboxamide",CN(C)C(=O)N1CCCCC1,,,,,,
9268,99269,Phenyl-P-phenylphosphonochloridate,C1=CC=C(C=C1)OP(=O)(C2=CC=CC=C2)Cl,,,,,,
9269,99270,CID 99270,C=CCN=C(NC1=CC=CC=C1C=O)S,,,,,,
9270,99271,"1-Piperidinecarboxamide, N,N-diethylthio-",CCN(CC)C(=S)N1CCCCC1,,,,,,
9271,99272,"Hydantoin, 5,5-diphenyl-3-(trichloromethylthio)-",C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)SC(Cl)(Cl)Cl)C3=CC=CC=C3,,,,,,
9272,99273,"1,5-Bis(dibutylphosphonoformamido)naphthalene",CCCCOP(=O)(C(=O)NC1=CC=CC2=C1C=CC=C2NC(=O)P(=O)(OCCCC)OCCCC)OCCCC,,,,,,
9273,99274,p-Toluoylurea,CC1=CC=C(C=C1)C(=O)NC(=O)N,,,,,,
9274,99275,Ethyl phenethyl carbonate,CCOC(=O)OCCC1=CC=CC=C1,,,,,,
9275,99276,Benzylvinylsulfoxide,C=CS(=O)CC1=CC=CC=C1,,,,,,
9276,99277,N-benzylprop-2-yn-1-amine,C#CCNCC1=CC=CC=C1,,,,,,
9277,99278,Glycyl-L-glutamic acid,C(CC(=O)O)[C@@H](C(=O)O)NC(=O)CN,,,,,,
9278,99279,Glycyldehydroalanine,C=C(C(=O)O)NC(=O)CN,,,,,,
9279,99280,(2S)-3-{[(2R)-2-carboxy-2-acetamidoethyl]disulfanyl}-2-acetamidopropanoic acid,CC(=O)N[C@H](CSSC[C@@H](C(=O)O)NC(=O)C)C(=O)O,,,,,,
9280,99281,4-Glycylaminobutyric acid,C(CC(=O)O)CNC(=O)CN,,,,,,
9281,99282,Glycyl-l-asparagine,C([C@@H](C(=O)O)NC(=O)CN)C(=O)N,,,,,,
9282,99283,"2,2,2-trichloro-N-(2,3-dichlorophenyl)acetamide",C1=CC(=C(C(=C1)Cl)Cl)NC(=O)C(Cl)(Cl)Cl,,,,,,
9283,99284,"Benzamide, N-(2-chloro-5-(trifluoromethyl)phenyl)-2-fluoro-",C1=CC=C(C(=C1)C(=O)NC2=C(C=CC(=C2)C(F)(F)F)Cl)F,,,,,,
9284,99285,"2-Benzylthio-5-amino-1,3,4-thiadiazole",C1=CC=C(C=C1)CSC2=NN=C(S2)N,,,,,,
9285,99286,"Methyl (3alpha,5beta,7alpha,12alpha)-7-acetoxy-3,12-dihydroxycholan-24-oate",C[C@H](CCC(=O)OC)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)OC(=O)C)O)C,,,,,,
9286,99287,O-delta-Aminooxybutylhydroxylamine,C(CCON)CON,,,,,,
9287,99288,L-Alloisoleucine,CC[C@@H](C)[C@@H](C(=O)O)N,,,,,,
9288,99289,L-Allothreonine,C[C@@H]([C@@H](C(=O)O)N)O,,,,,,
9289,99290,"(2R,6S)-2,6-diaminoheptanedioic acid",C(C[C@H](C(=O)O)N)C[C@@H](C(=O)O)N,,,,,,
9290,99291,L-Phenylglycine,C1=CC=C(C=C1)[C@@H](C(=O)O)N,,,,,,
9291,99292,"Carbamothioic acid, phenyl-, S-phenyl ester",C1=CC=C(C=C1)NC(=O)SC2=CC=CC=C2,,,,,,
9292,99293,2-Chloroethyl phenyl sulphoxide,C1=CC=C(C=C1)S(=O)CCCl,,,,,,
9293,99294,"3-Amino-N,N-dimethylbenzylamine",CN(C)CC1=CC(=CC=C1)N,,,,,,
9294,99295,(Methylthio)acetonitrile,CSCC#N,,,,,,
9295,99296,"2-Thiazolamine, 4,5-dihydro-N-(2,4-dimethylphenyl)-",CC1=CC(=C(C=C1)NC2=NCCS2)C,,,,,,
9296,99297,4-Fluoro-1H-imidazole,C1=C(NC=N1)F,,,,,,
9297,99298,Isodiospyrin,CC1=CC2=C(C(=O)C=CC2=O)C(=C1C3=C4C(=O)C=CC(=O)C4=C(C=C3C)O)O,,,,,,
9298,99299,Aclacinomycin B1,CC[C@]1(CC(C2=C(C3=C(C=C2[C@H]1C(=O)OC)C(=O)C4=C(C3=O)C(=CC=C4)O)O)O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O[C@H]6C[C@H]7[C@@H]([C@@H](O6)C)O[C@H]8[C@@H](O7)CC(=O)[C@@H](O8)C)N(C)C)O,,,,,,
9299,99300,"1,4-Dihydroxy-2-methylanthraquinone",CC1=CC(=C2C(=C1O)C(=O)C3=CC=CC=C3C2=O)O,,,,,,
9300,99301,"2,5-Cyclohexadiene-1,4-dione, 2,5-bis(1-aziridinyl)-3,6-difluoro-",C1CN1C2=C(C(=O)C(=C(C2=O)F)N3CC3)F,,,,,,
9301,99302,"(2R,3S,4S,5S)-2-(6-aminopurin-9-yl)-5-(methylsulfanylmethyl)oxolane-3,4-diol",CSC[C@@H]1[C@H]([C@@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O,,,"['Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)', 'Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)']",,,
9302,99303,4-Ketoifosfamide,C1COP(=O)(N(C1=O)CCCl)NCCCl,,,,,,
9303,99304,"1-(beta-Diethylaminoethylamino)-3,4-cyclohexenothiaxanthone",CCN(CC)CCNC1=C2C(=C3CCCCC3=C1)SC4=CC=CC=C4C2=O,,,,,,
9304,99305,5-Vinyluracil,C=CC1=CNC(=O)NC1=O,,,,,,
9305,99306,"7-Chloro-5,6-dimethylbenz(c)acridine",CC1=C(C2=C(C3=CC=CC=C3N=C2C4=CC=CC=C14)Cl)C,,,,,,
9306,99307,"3,5-Bis(benzyloxy)benzoic acid",C1=CC=C(C=C1)COC2=CC(=CC(=C2)C(=O)O)OCC3=CC=CC=C3,,,,,,
9307,99308,CID 99308,CCCCC1=CC=C(C=C1)N2C=NC3=C2NC(=NC3=O)N,,,,,,
9308,99309,N4-Acetylcytosine,CC(=O)NC1=CC=NC(=O)N1,,,,,,
9309,99310,"Uracil, 6-(p-butylanilino)-",CCCCC1=CC=C(C=C1)NC2=CC(=O)NC(=O)N2,,,,,,
9310,99311,6-Methyl-5-phenylazouracil,CC1=C(C(=O)NC(=O)N1)N=NC2=CC=CC=C2,,,,,,
9311,99312,CID 99312,CCCCCCCCC1=C(NC(=NC1=O)N)C,,,,,,
9312,99313,CID 99313,CCCCC1=C(NC(=NC1=O)N)C,,,,,,
9313,99314,"2,4(1H,3H)-Pyrimidinedione, 5-((3-(phenylmethoxy)phenyl)methyl)-",C1=CC=C(C=C1)COC2=CC=CC(=C2)CC3=CNC(=O)NC3=O,,,,,,
9314,99315,4-(Aminomethyl)benzenesulfonyl fluoride,C1=CC(=CC=C1CN)S(=O)(=O)F,,,,,,
9315,99316,N-(Phenoxyacetyl)-4-aminophenoxyacetic acid,C1=CC=C(C=C1)OCC(=O)NC2=CC=C(C=C2)OCC(=O)O,,,,,,
9316,99317,CID 99317,CCC1=C(NC(=NC1=O)N)C,,,,,,
9317,99318,CID 99318,CCCCCCC1=C(NC(=NC1=O)N)C,,,,,,
9318,99319,CID 99319,CCCC1=C(NC(=NC1=O)N)C,,,,,,
9319,99320,CID 99320,C1=CC(=CC=C1C2=NC3=NC=NC(=N)C3=N2)N(O)O,,,,,,
9320,99321,9-(3-Nitrophenyl)-9h-purin-6-amine,C1=CC(=CC(=C1)[N+](=O)[O-])N2C=NC3=C(N=CN=C32)N,,,,,,
9321,99322,Axillarine,C[C@H]([C@]1([C@@H]([C@H](C(=O)O[C@@H]2CCN3[C@@H]2C(=CC3)COC1=O)C(C)C)O)O)O,,,,,,
9322,99323,4-Aminoisofolic acid,C1=CC(=CC=C1CNC2=CN=C3C(=N2)C(=NC(=N3)N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O,,,,,,
9323,99324,CID 99324,C1=CC=C(C=C1)C2=NC3=C(N2)C(=O)N=C(N3)N,,,,,,
9324,99325,N-(2-Carboxyphenyl)phenoxyacetamide,C1=CC=C(C=C1)OCC(=O)NC2=CC=CC=C2C(=O)O,,,,,,
9325,99326,1-Naphthyloxyacetone,CC(=O)COC1=CC=CC2=CC=CC=C21,,,,,,
9326,99327,N-(p-Toluenesulfonyl)-L-phenylalanine,CC1=CC=C(C=C1)S(=O)(=O)N[C@@H](CC2=CC=CC=C2)C(=O)O,,,,,,
9327,99328,"Ethyl 4-amino-3,5-dichlorobenzoate",CCOC(=O)C1=CC(=C(C(=C1)Cl)N)Cl,,,,,,
9328,99329,4-(Bromomethyl)benzenesulfonyl fluoride,C1=CC(=CC=C1CBr)S(=O)(=O)F,,,,,,
9329,99330,CID 99330,CC1=CC2=C(C=C1)N(C(=C2N=NC(=N)S)O)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O,,,,,,
9330,99331,"Urea, N-(4-fluorophenyl)-N'-(5-methyl-3-isoxazolyl)-",CC1=CC(=NO1)NC(=O)NC2=CC=C(C=C2)F,,,,,,
9331,99332,"[(2R,3R,5R,6S)-3,4,5,6-tetraacetyloxyoxan-2-yl]methyl acetate",CC(=O)OC[C@@H]1[C@H](C([C@H]([C@@H](O1)OC(=O)C)OC(=O)C)OC(=O)C)OC(=O)C,,,,,,
9332,99333,"1-Dodecanamine, N-dodecyl-N-nitroso-",CCCCCCCCCCCCN(CCCCCCCCCCCC)N=O,,,,,,
9333,99334,"1(2H)-Naphthalenone, 3,4-dihydro-5,8-dimethyl-",CC1=C2CCCC(=O)C2=C(C=C1)C,,,,,,
9334,99335,"1,2-Bis(2-cyanoethylthio)ethane",C(CSCCSCCC#N)C#N,,,,,,
9335,99336,"Phenol, 2-((bis(2-chloroethyl)amino)methyl)-4-nitro-",C1=CC(=C(C=C1[N+](=O)[O-])CN(CCCl)CCCl)O,,,,,,
9336,99337,"Carbamic acid, (methylenedi-4,1-phenylene)bis-, dimethyl ester",COC(=O)NC1=CC=C(C=C1)CC2=CC=C(C=C2)NC(=O)OC,,,,,,
9337,99338,"2-Methoxy-1,3-butadiene",COC(=C)C=C,,,,,,
9338,99339,"2-(7-Cyano-8,16-dihydroxy-9,11,13,15-tetramethyl-18-oxo-1-oxacyclooctadeca-4,6-dien-2-yl)cyclopentane-1-carboxylic acid",C[C@H]1C[C@H](C[C@@H]([C@H](C(=CC=CC[C@H](OC(=O)C[C@@H]([C@H](C1)C)O)[C@@H]2CCC[C@H]2C(=O)O)C#N)O)C)C,,,,,,
9339,99340,trans-1-(2-Chloroethyl)-3-(4-chloromethylcyclohexyl)-1-nitrosourea,C1CC(CCC1CCl)NC(=O)N(CCCl)N=O,,,,,,
9340,99341,17-Amino-4-azaandrostane,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2N)CC[C@@H]4[C@@]3(CCCN4)C,,,,,,
9341,99342,"6,6'-Methylenebis(1,2-dihydro-2,2,4-trimethylquinoline)",CC1=CC(NC2=C1C=C(C=C2)CC3=CC4=C(C=C3)NC(C=C4C)(C)C)(C)C,,,,,,
9342,99343,Cytoxyl amine,C(CN)COP(=O)(N(CCCl)CCCl)O,,,,,,
9343,99344,"1,4-Butanediamine, N,N'-bis(3-(9-acridinylamino)propyl)-",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NCCCNCCCCNCCCNC4=C5C=CC=CC5=NC6=CC=CC=C64,,,,,,
9344,99345,Musettamycin,CC[C@]1(C[C@@H](C2=C(C3=C(C=C2[C@H]1C(=O)OC)C(=O)C4=C(C=CC(=C4C3=O)O)O)O)O[C@H]5C[C@@H]([C@@H](C(O5)C)O[C@H]6C[C@@H]([C@@H]([C@@H](O6)C)O)O)N(C)C)O,,,,,,
9345,99346,"2-Picoline, 5-(3-piperidino-1-propynyl)-",CC1=NC=C(C=C1)C#CCN2CCCCC2,,,,,,
9346,99347,"2-Pyridinemethanol, butyrate",CCCC(=O)OCC1=CC=CC=N1,,,,,,
9347,99348,"Tetramethyl 7-methyl-4H-quinolizine-1,2,3,4-tetracarboxylate",CC1=CN2C(C(=C(C(=C2C=C1)C(=O)OC)C(=O)OC)C(=O)OC)C(=O)OC,,,,,,
9348,99349,1-(3-Chlorophenyl)-1H-imidazole,C1=CC(=CC(=C1)Cl)N2C=CN=C2,,,,,,
9349,99350,"Benzimidazole, 2,2'-octamethylenebis-",C1=CC=C2C(=C1)NC(=N2)CCCCCCCCC3=NC4=CC=CC=C4N3,,,,,,
9350,99351,CID 99351,C1=CC(=CC(=C1)Br)N2C=CN=C2S,,,,,,
9351,99352,4-Chloro-3-methoxytoluene,CC1=CC(=C(C=C1)Cl)OC,,,,,,
9352,99353,Bis(p-phenoxyphenyl)diphenyltin,C1=CC=C(C=C1)OC2=CC=C(C=C2)[Sn](C3=CC=CC=C3)(C4=CC=CC=C4)C5=CC=C(C=C5)OC6=CC=CC=C6,,,,,,
9353,99354,"3,5-Pyridinedicarboxylic acid, 4-benzyl-1,4-dihydro-2,6-dimethyl-, diethyl ester",CCOC(=O)C1=C(NC(=C(C1CC2=CC=CC=C2)C(=O)OCC)C)C,,,,,,
9354,99355,"1-(3-Oxo-2,2,4-trimethylvaleryl)piperidine",CC(C)C(=O)C(C)(C)C(=O)N1CCCCC1,,,,,,
9355,99356,CID 99356,C1=CC=C(C=C1)CNC2=NC3=CC=CC=C3N=C2S,,,,,,
9356,99357,1-Acetyl-2-(p-bromobenzoyl)hydrazine,CC(=O)NNC(=O)C1=CC=C(C=C1)Br,,,,,,
9357,99358,"3-Butyn-2-ol, 2-methyl-4-(6-methyl-3-pyridyl)-",CC1=NC=C(C=C1)C#CC(C)(C)O,,,,,,
9358,99359,Argvalin,CC(C)C1=NC=C(NC1=O)CCCN=C(N)N,,,,,,
9359,99360,"1-Propanol, 2-(3,4-dichlorobenzylamino)-2-methyl-",CC(C)(CO)NCC1=CC(=C(C=C1)Cl)Cl,,,,,,
9360,99361,"5,8,11-Triazapentadecane, 5,8,11-tributyl-",CCCCN(CCCC)CCN(CCCC)CCN(CCCC)CCCC,,,,,,
9361,99362,"Benzeneboronic acid, 1,2-(4,5-dichlorophenylene) ester",B1(OC2=CC(=C(C=C2O1)Cl)Cl)C3=CC=CC=C3,,,,,,
9362,99363,"Acetamide, 2-(2,4-dichlorophenoxy)-N-(s-triazol-3-yl)-",C1=CC(=C(C=C1Cl)Cl)OCC(=O)NC2=NC=NN2,,,,,,
9363,99364,"Benzeneboronic acid, p-methylthio-, 1,2-(4,5-dichlorophenylene) ester",B1(OC2=CC(=C(C=C2O1)Cl)Cl)C3=CC=C(C=C3)SC,,,,,,
9364,99365,3-Nitrophenyl dibutylphosphinate,CCCCP(=O)(CCCC)OC1=CC=CC(=C1)[N+](=O)[O-],,,,,,
9365,99366,"1-Propanesulfonamide, 3-bromo-N-cyclohexyl-",C1CCC(CC1)NS(=O)(=O)CCCBr,,,,,,
9366,99367,"1-Propanesulfonamide, 3-bromo-N-(1,1,3,3-tetramethylbutyl)-",CC(C)(C)CC(C)(C)NS(=O)(=O)CCCBr,,,,,,
9367,99368,"Sulfurous acid, dibenzyl ester",C1=CC=C(C=C1)COS(=O)OCC2=CC=CC=C2,,,,,,
9368,99369,Dibutyltin;methanesulfonic acid,CCCC[Sn]CCCC.CS(=O)(=O)O.CS(=O)(=O)O,,,,,,
9369,99370,Dipropyltin;methanesulfonic acid,CCC[Sn]CCC.CS(=O)(=O)O.CS(=O)(=O)O,,,,,,
9370,99371,Dipropyltin hydride,CCC[Sn]CCC,,,,,,
9371,99372,CID 99372,CCCC[SnH](CCCC)CCCC.CC(C)(C)C(C)(C)CSCC(=O)O,,,,,,
9372,99373,"2-(2,2,3,3-Tetramethylbutylsulfanyl)acetic acid",CC(C)(C)C(C)(C)CSCC(=O)O,,,,,,
9373,99374,CID 99374,CCCC[SnH](CCCC)CCCC.CS(=O)(=O)O,,,,,,
9374,99375,"Cyclohexanol, 1-(((chloromethyl)dimethylsilyl)ethynyl)-",C[Si](C)(CCl)C#CC1(CCCCC1)O,,,,,,
9375,99376,CID 99376,CC[SnH](CC)CC.C1=CC=C(C=C1)O,,,,,,
9376,99377,CID 99377,C1=CC(=C(C=C1CNC(=NCC2=CC(=C(C=C2)Cl)Cl)S)Cl)Cl,,,,,,
9377,99378,3-Isopropoxy-1-propanol,CC(C)OCCCO,,,,,,
9378,99379,Diallyltin dibromide,C=CC[Sn](CC=C)(Br)Br,,,,,,
9379,99380,3-Chloromethyl-5-nitrosalicylaldehyde,C1=C(C=C(C(=C1CCl)O)C=O)[N+](=O)[O-],,,,,,
9380,99381,"Phenol, 2-iodo-, 3,4,5-triiodobenzoate",C1=CC=C(C(=C1)OC(=O)C2=CC(=C(C(=C2)I)I)I)I,,,,,,
9381,99382,(Iodoethynyl)benzene,C1=CC=C(C=C1)C#CI,,,,,,
9382,99383,9-Methoxyacridine,COC1=C2C=CC=CC2=NC3=CC=CC=C31,,,,,,
9383,99384,CID 99384,CCC[SnH](CCC)CCC.C1=CC=C(C(=C1)C(=O)O)I,,,,,,
9384,99385,CID 99385,CCC[SnH](CCC)CCC.C(=O)(C(Cl)(Cl)Cl)O,,,,,,
9385,99386,"3,6-Bis(methylthio)pyridazine",CSC1=NN=C(C=C1)SC,,,,,,
9386,99387,"Semicarbazide, 1-(p-chlorobenzoyl)-4,4-dimethyl-",CN(C)C(=O)NNC(=O)C1=CC=C(C=C1)Cl,,,,,,
9387,99388,"1,2,4,5-Tetrazin-3-amine, 6-(4-chlorophenyl)-N,N-dimethyl-",CN(C)C1=NN=C(N=N1)C2=CC=C(C=C2)Cl,,,,,,
9388,99389,"3,6-Bis(dimethylamino)pyridazine",CN(C)C1=NN=C(C=C1)N(C)C,,,,,,
9389,99390,2-Methylsulfonyl-imidazole,CS(=O)(=O)C1=NC=CN1,,,,,,
9390,99391,CID 99391,C1(=C(N=C(N1)Cl)[N+](=O)[O-])Cl,,,,,,
9391,99392,Methyldioctylphosphine oxide,CCCCCCCCP(=O)(C)CCCCCCCC,,,,,,
9392,99393,Tribenzylphosphine oxide,C1=CC=C(C=C1)CP(=O)(CC2=CC=CC=C2)CC3=CC=CC=C3,,,,,,
9393,99394,Tripentylphosphine oxide,CCCCCP(=O)(CCCCC)CCCCC,,,,,,
9394,99395,"Phosphine oxide, dibutyloctyl-",CCCCCCCCP(=O)(CCCC)CCCC,,,,,,
9395,99396,"Phosphine sulfide, tris(dibutylaminomethyl)-",CCCCN(CCCC)CP(=S)(CN(CCCC)CCCC)CN(CCCC)CCCC,,,,,,
9396,99397,Tris(2-cyanoethyl)phosphine sulfide,C(CP(=S)(CCC#N)CCC#N)C#N,,,,,,
9397,99398,"Phosphine oxide, cyclohexyldihexyl-",CCCCCCP(=O)(CCCCCC)C1CCCCC1,,,,,,
9398,99399,"Phosphine sulfide, butyldipentyl-",CCCCCP(=S)(CCCC)CCCCC,,,,,,
9399,99400,"Phosphine oxide, butyldipentyl-",CCCCCP(=O)(CCCC)CCCCC,,,,,,
9400,99401,"Phosphine oxide, cyclopentyldibutyl-",CCCCP(=O)(CCCC)C1CCCC1,,,,,,
9401,99402,"Phosphine oxide, cyclopentyldipentyl-",CCCCCP(=O)(CCCCC)C1CCCC1,,,,,,
9402,99403,"Phosphine oxide, dibutylhexyl-",CCCCCCP(=O)(CCCC)CCCC,,,,,,
9403,99404,Isopropyl dicyclopentylphosphinite,CC(C)OP(C1CCCC1)C2CCCC2,,,,,,
9404,99405,1-Decylphosphonoyldecane,CCCCCCCCCCP(=O)CCCCCCCCCC,,,,,,
9405,99406,"Phosphine oxide, cyclohexyldipropyl-",CCCP(=O)(CCC)C1CCCCC1,,,,,,
9406,99407,"Phosphine oxide, cyclohexyldiisobutyl-",CC(C)CP(=O)(CC(C)C)C1CCCCC1,,,,,,
9407,99408,"Phosphine oxide, cyclopentyldiisobutyl-",CC(C)CP(=O)(CC(C)C)C1CCCC1,,,,,,
9408,99409,"Phosphine oxide, dihexylmethyl-",CCCCCCP(=O)(C)CCCCCC,,,,,,
9409,99410,Triisobutylphosphine sulphide,CC(C)CP(=S)(CC(C)C)CC(C)C,,,,,,
9410,99411,Dioctylphosphinic acid,CCCCCCCCP(=O)(CCCCCCCC)O,,,,,,
9411,99412,"Phosphine, P,P'-tetramethylenebis(bis(2-cyanoethyl)-",C(CCP(CCC#N)CCC#N)CP(CCC#N)CCC#N,,,,,,
9412,99413,"Phosphine oxide, tri-2-furanyl-",C1=COC(=C1)P(=O)(C2=CC=CO2)C3=CC=CO3,,,,,,
9413,99414,Monomethyl karbutilate,CC(C)(C)NC(=O)OC1=CC=CC(=C1)NC(=O)NC,,,,,,
9414,99415,"m-(3,3-Dimethylureido)phenyl allylcarbamate",CN(C)C(=O)NC1=CC(=CC=C1)OC(=O)NCC=C,,,,,,
9415,99416,"m-(3,3-Dimethylureido)phenyl isopropylcarbamate",CC(C)NC(=O)OC1=CC=CC(=C1)NC(=O)N(C)C,,,,,,
9416,99417,"Carbamic acid, isobutyl-, m-(3,3-dimethylureido)phenyl ester",CC(C)CNC(=O)OC1=CC=CC(=C1)NC(=O)N(C)C,,,,,,
9417,99418,1-(5-Chloro-2-pyridyl)-3-methylurea,CNC(=O)NC1=NC=C(C=C1)Cl,,,,,,
9418,99419,"3-(6-Butoxy-3-pyridyl)-1,1-dimethylurea",CCCCOC1=NC=C(C=C1)NC(=O)N(C)C,,,,,,
9419,99420,m-Propionamidophenyl tert-butylcarbamate,CCC(=O)NC1=CC(=CC=C1)OC(=O)NC(C)(C)C,,,,,,
9420,99421,m-Isobutyramidophenyl isopropylcarbamate,CC(C)C(=O)NC1=CC(=CC=C1)OC(=O)NC(C)C,,,,,,
9421,99422,m-Isobutyramidophenyl tert-butylcarbamate,CC(C)C(=O)NC1=CC(=CC=C1)OC(=O)NC(C)(C)C,,,,,,
9422,99423,m-Valeramidophenyl methylcarbamate,CCCCC(=O)NC1=CC(=CC=C1)OC(=O)NC,,,,,,
9423,99424,m-(2-Chloro-2-methylvaleramido)phenyl methylcarbamate,CCCC(C)(C(=O)NC1=CC(=CC=C1)OC(=O)NC)Cl,,,,,,
9424,99425,N-(3-hydroxyphenyl)pentanamide,CCCCC(=O)NC1=CC(=CC=C1)O,,,,,,
9425,99426,N-(3-hydroxyphenyl)-2-methylpropanamide,CC(C)C(=O)NC1=CC(=CC=C1)O,,,,,,
9426,99427,"Valeranilide, 2,2-dimethyl-3'-hydroxy-",CCCC(C)(C)C(=O)NC1=CC(=CC=C1)O,,,,,,
9427,99428,"m-(2,2-Dimethylvaleramido)phenyl isopropylcarbamate",CCCC(C)(C)C(=O)NC1=CC(=CC=C1)OC(=O)NC(C)C,,,,,,
9428,99429,"m-(2,2-Dimethylvaleramido)phenyl tert-butylcarbamate",CCCC(C)(C)C(=O)NC1=CC(=CC=C1)OC(=O)NC(C)(C)C,,,,,,
9429,99430,m-Propionamidophenyl isobutylcarbamate,CCC(=O)NC1=CC(=CC=C1)OC(=O)NCC(C)C,,,,,,
9430,99431,1-tert-Butyl-3-(m-hydroxyphenyl)urea tert-butylcarbamate,CC(C)(C)NC(=O)NC1=CC(=CC=C1)OC(=O)NC(C)(C)C,,,,,,
9431,99432,"m-(3,3-Diethylureido)phenyl dimethylcarbamate",CCN(CC)C(=O)NC1=CC(=CC=C1)OC(=O)N(C)C,,,,,,
9432,99433,"Urea, 1,1-diethyl-3-(m-hydroxyphenyl)-, methylcarbamate",CCN(CC)C(=O)NC1=CC(=CC=C1)OC(=O)NC,,,,,,
9433,99434,"1,1-Diethyl-3-(m-hydroxyphenyl)urea tert-butylcarbamate",CCN(CC)C(=O)NC1=CC(=CC=C1)OC(=O)NC(C)(C)C,,,,,,
9434,99435,"N,N-Dimethylsulfamic acid o-aminophenyl ester",CN(C)S(=O)(=O)OC1=CC=CC=C1N,,,,,,
9435,99436,3-Aminophenyl dimethylsulphamate,CN(C)S(=O)(=O)OC1=CC=CC(=C1)N,,,,,,
9436,99437,4-Aminophenyl dimethylsulphamate,CN(C)S(=O)(=O)OC1=CC=C(C=C1)N,,,,,,
9437,99438,"Propionanilide, p-hydroxy-, dimethylsulfamate",CCC(=O)NC1=CC=C(C=C1)OS(=O)(=O)N(C)C,,,,,,
9438,99439,Dibutyl decylphosphonate,CCCCCCCCCCP(=O)(OCCCC)OCCCC,,,,,,
9439,99440,Dibutyl propylphosphonate,CCCCOP(=O)(CCC)OCCCC,,,,,,
9440,99441,"2,5-Cyclohexadien-4-one, pentachloro-4-(diallylphosphono)-",C=CCOP(=O)(C1(C(=C(C(=O)C(=C1Cl)Cl)Cl)Cl)Cl)OCC=C,,,,,,
9441,99442,2-Methylene-N-(m-tolyl)succinimide,CC1=CC(=CC=C1)N2C(=O)CC(=C)C2=O,,,,,,
9442,99443,N-(4-Methoxyphenyl)itaconimide,COC1=CC=C(C=C1)N2C(=O)CC(=C)C2=O,,,,,,
9443,99444,"2,4,5-Trichloro-6-(trichloromethyl)pyrimidine",C1(=C(N=C(N=C1Cl)Cl)C(Cl)(Cl)Cl)Cl,,,,,,
9444,99445,"4-Quinolinol, 3-chloro-2-trichloromethyl-, methylcarbamate",CNC(=O)OC1=C(C(=NC2=CC=CC=C21)C(Cl)(Cl)Cl)Cl,,,,,,
9445,99446,"2-Amino-3,4-dichloroquinoline",C1=CC=C2C(=C1)C(=C(C(=N2)N)Cl)Cl,,,,,,
9446,99447,"2-Quinoxalinol, 3-(trichloromethyl)-",C1=CC=C2C(=C1)NC(=O)C(=N2)C(Cl)(Cl)Cl,,,,,,
9447,99448,2-(Hexylthio)-3-methylpyrazine,CCCCCCSC1=NC=CN=C1C,,,,,,
9448,99449,"Pyrazine, 2-(cyclohexylthio)-3-methyl-",CC1=NC=CN=C1SC2CCCCC2,,,,,,
9449,99450,N-Trimethylsilylmethyl-N-nitrosourea,C[Si](C)(C)CN(C(=O)N)N=O,,,,,,
9450,99451,Tetrathiafulvalene,C1=CSC(=C2SC=CS2)S1,,,,,,
9451,99452,4-Acetylphenyl isocyanate,CC(=O)C1=CC=C(C=C1)N=C=O,,,,,,
9452,99453,"Ethanamine, N-ethoxy-",CCNOCC,,,,,,
9453,99454,"Urea, 1-(4-bromocyclohexyl)-3-(2-chloroethyl)-3-nitroso-",C1CC(CCC1NC(=O)N(CCCl)N=O)Br,,,,,,
9454,99455,cis-4-(3-(2-Fluoroethyl)-3-nitrosoureido)cyclohexanecarboxylic acid,C1CC(CCC1C(=O)O)NC(=O)N(CCF)N=O,,,,,,
9455,99456,"2,5-Dihydroxypyridine",C1=CC(=O)NC=C1O,,,,,,
9456,99457,20alpha-((2-(Dimethylamino)ethyl)amino)-5alpha-pregnan-3beta-ol,C[C@H]([C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC[C@@H](C4)O)C)C)NCCN(C)C,,,,,,
9457,99458,"(3S,8R,9S,10R,13S,14S)-17-((Z)-1-(hydroxyimino)ethyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate",CC(=NO)C1=CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)OC(=O)C)C)C,,,,,,
9458,99459,aldehydo-D-talose,C([C@H]([C@@H]([C@@H]([C@@H](C=O)O)O)O)O)O,,,,,,
9459,99460,"(2S)-2-[(3S,8S,9S,10R,13S,14S,17R)-3-acetyloxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]propanoic acid",C[C@@H]([C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)OC(=O)C)C)C)C(=O)O,,,,,,
9460,99461,N-Acetyl-beta-D-glucosamine tetraacetate,CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1OC(=O)C)COC(=O)C)OC(=O)C)OC(=O)C,,,,,,
9461,99462,"2,3,4,6-Tetra-O-acetyl-beta-D-glucopyranosyl isothiocyanate",CC(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)N=C=S)OC(=O)C)OC(=O)C)OC(=O)C,,,,,,
9462,99463,Hexanoylglycine,CCCCCC(=O)NCC(=O)O,,,,,,
9463,99464,"(2S,3R,4S,6R)-4-amino-6-methoxy-2-methyloxan-3-ol",C[C@H]1[C@@H]([C@H](C[C@@H](O1)OC)N)O,,,,,,
9464,99465,"D-Xylose, (2,4-dinitrophenyl)hydrazone",C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])NN=C[C@@H]([C@H]([C@@H](CO)O)O)O,,,,,,
9465,99466,"4-Thiazolidinone, 3-(3,4-dichlorophenyl)-2-thioxo-",C1C(=O)N(C(=S)S1)C2=CC(=C(C=C2)Cl)Cl,,,,,,
9466,99467,3'-(Trifluoromethyl)phthalanilic acid,C1=CC=C(C(=C1)C(=O)NC2=CC=CC(=C2)C(F)(F)F)C(=O)O,,,,,,
9467,99468,"2,5-O-Methylene-D-mannitol",C1O[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)CO,,,,,,
9468,99469,25-Hydroxycholest-5-en-3beta-yl acetate,C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)OC(=O)C)C)C,,,,,,
9469,99470,26-Hydroxycholesterol,C[C@H](CCCC(C)CO)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,,,,,,
9470,99471,Solasodine diacetate,C[C@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC=C6[C@@]5(CC[C@@H](C6)OC(=O)C)C)C)C)N(C1)C(=O)C,,,,,,
9471,99472,Etienic acid,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)O)CCC4=CC(=O)CC[C@]34C,,,,,,
9472,99473,Isorubijervine,C[C@H]1CC[C@@H]2[C@H]([C@H]3[C@@H](N2C1)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC=C6[C@@]5(CC[C@@H](C6)O)C)CO)C,,,,,,
9473,99474,Diosgenin,C[C@@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC=C6[C@@]5(CC[C@@H](C6)O)C)C)C)OC1,,,,,,
9474,99475,"3-Hydroxy-5,7-pregnadien-20-one",CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3C2=CC=C4[C@@]3(CC[C@@H](C4)O)C)C,,,,,,
9475,99476,Androstenediol 17-benzoate,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2OC(=O)C4=CC=CC=C4)CC=C5[C@@]3(CC[C@@H](C5)O)C,,,,,,
9476,99477,6-Hydroxycoumarin,C1=CC2=C(C=CC(=O)O2)C=C1O,,,,,,
9477,99478,O-acetyl-L-serine,CC(=O)OC[C@@H](C(=O)O)N,,,,,,
9478,99479,"2,2,5,7,8-Pentamethyl-6-chromanol",CC1=C(C2=C(CCC(O2)(C)C)C(=C1O)C)C,,,['Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)'],,,
9479,99480,"2,2,2-trifluoro-N-(2-fluorophenyl)acetamide",C1=CC=C(C(=C1)NC(=O)C(F)(F)F)F,,,,,,
9480,99481,"N,N'-Bis(2,4-dinitrophenyl)ethylenediamine",C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])NCCNC2=C(C=C(C=C2)[N+](=O)[O-])[N+](=O)[O-],,,,,,
9481,99482,"Imidazole, 1-(2,4-dinitrophenyl)-",C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])N2C=CN=C2,,,,,,
9482,99483,S-Methylcysteine S-oxide,CS(=O)C[C@H](C(=O)O)N,,,,,,
9483,99484,"2-Bromo-4,5-dichloro-1H-imidazole",C1(=C(N=C(N1)Br)Cl)Cl,,,,,,
9484,99485,Tricyclopentylphosphine oxide,C1CCC(C1)P(=O)(C2CCCC2)C3CCCC3,,,,,,
9485,99486,Cholesteryl myristate,CCCCCCCCCCCCCC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC=C2C1)CC[C@@H]4[C@H](C)CCCC(C)C)C)C,,,,,,
9486,99487,7-Dehydrocholesterol acetate,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3C2=CC=C4[C@@]3(CC[C@@H](C4)OC(=O)C)C)C,,,,,,
9487,99488,"3-beta,21-Dihydroxypregn-5-en-20-one di(acetate)",CC(=O)OCC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)OC(=O)C)C)C,,,,,,
9488,99489,Phenyl alpha-D-glucopyranoside,C1=CC=C(C=C1)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O,,,,,,
9489,99490,Ubiquinone Q9;CoQ9;Ubiquinone 9,CC1=C(C(=O)C(=C(C1=O)OC)OC)CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C,,,,,,
9490,99491,CID 99491,CC1=C(C(=O)C(=C(C1=O)OC)OC)CC=C(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C,,,,,,
9491,99492,CID 99492,CC1=C(OC(=C[C@@H](C)CCCC(=CCCC(=CCCC2=COC=C2)C)C)C1=O)O,,,,,,
9492,99493,CID 99493,CCCC[SnH].C(CO)N(CCO)CCO,,,,,,
9493,99494,Cyclohexyltriphenylstannane,C1CCC(CC1)[Sn](C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4,,,,,,
9494,99495,Thiobenzamide S-oxide,C1=CC=C(C=C1)C(=S=O)N,,,,,,
9495,99496,"1-Piperazinecarboxaldehyde, N-oxide",C1CN(CCN1C=O)C2=CC=C(C3=NO[N+](=C23)[O-])[N+](=O)[O-],,,,,,
9496,99497,"1-Piperazineethanol, 4-(7-nitrobenzofurazan-4-yl)-",C1CN(CCN1CCO)C2=CC=C(C3=NON=C23)[N+](=O)[O-],,,,,,
9497,99498,1-p-Tolylsemicarbazide,CC1=CC=C(C=C1)NNC(=O)N,,,,,,
9498,99499,"3,6-Dihydroxyphthalimide",C1=CC(=C2C(=C1O)C(=O)NC2=O)O,,,,,,
9499,99500,5-Methoxy-2-methylaniline,CC1=C(C=C(C=C1)OC)N,,,,,,
9500,99501,3-Acetamido-5-amino-4-hydroxybenzenesulfonic acid,CC(=O)NC1=CC(=CC(=C1O)N)S(=O)(=O)O,,,,,,
9501,99502,Ethyl 2-cyano-2-propylpentanoate,CCCC(CCC)(C#N)C(=O)OCC,,,,,,
9502,99503,2-Hydroxyanthracene,C1=CC=C2C=C3C=C(C=CC3=CC2=C1)O,,,,,,
9503,99504,CID 99504,CCOC(=C1CN(C(=O)C1=O)CC2=CC=CC=C2)O,,,,,,
9504,99505,2-Amino-3-(naphthalen-1-yl)propanoic acid,C1=CC=C2C(=C1)C=CC=C2CC(C(=O)O)N,,,,,,
9505,99506,CID 99506,CC1=CC2=C(C=C1)N=C(N2)S,,,,,,
9506,99507,Nicotinoguanamine,C1=CC(=CN=C1)C2=NC(=NC(=N2)N)N,,,,,,
9507,99508,Fluorescein chloride,C1=CC=C2C(=C1)C(=O)OC23C4=C(C=C(C=C4)Cl)OC5=C3C=CC(=C5)Cl,,,,,,
9508,99509,"Phosphinic acid, imino(di-o-phenylene)-",C1=CC=C2C(=C1)NC3=CC=CC=C3P2(=O)O,,,,,,
9509,99510,"2,2-Dimethylpropane-1,3-diyl bisisobutyrate",CC(C)C(=O)OCC(C)(C)COC(=O)C(C)C,,,,,,
9510,99511,CID 99511,C[C@H](C=C[C@H](C)C(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3C2=CCC4[C@@]3(CCC(=O)C4)C)C,,,,,,
9511,99512,Epismilagenin,C[C@@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC[C@H]6[C@@]5(CC[C@H](C6)O)C)C)C)OC1,,,,,,
9512,99513,5-Dehydro-D-fructose,C(C(=O)[C@H]([C@@H](C(=O)CO)O)O)O,,,,,,
9513,99514,Isosteviol,C[C@]12CC[C@H]3[C@@]4(CCC[C@@]([C@H]4CC[C@@]3(C1)CC2=O)(C)C(=O)O)C,,,,,,
9514,99515,alpha-D-Glucosamine pentaacetate,CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@@H]1OC(=O)C)COC(=O)C)OC(=O)C)OC(=O)C,,,,,,
9515,99516,Tigogenin,C[C@@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC[C@@H]6[C@@]5(CC[C@@H](C6)O)C)C)C)OC1,,,,,,
9516,99517,"Galactitol, 1,6-dichloro-1,6-dideoxy-",C([C@H]([C@@H]([C@@H]([C@H](CCl)O)O)O)O)Cl,,,,,,
9517,99518,"1,4-Bis(chloromethoxy)butane",C(CCOCCl)COCCl,,,,,,
9518,99519,"1,4-Bis(bromomethoxy)butane",C(CCOCBr)COCBr,,,,,,
9519,99520,Diethyl 2-(1-ethoxyethylidene)malonate,CCOC(=C(C(=O)OCC)C(=O)OCC)C,,,,,,
9520,99521,2-Chloro-1H-indole-3-carboxylic acid,C1=CC=C2C(=C1)C(=C(N2)Cl)C(=O)O,,,,,,
9521,99522,"1H-Indole-3-carboxylic acid, 2-chloro-1-methyl-",CN1C2=CC=CC=C2C(=C1Cl)C(=O)O,,,,,,
9522,99523,N-4-Chlorobenzoylisatinic acid,C1=CC=C(C(=C1)C(=O)C(=O)O)NC(=O)C2=CC=C(C=C2)Cl,,,,,,
9523,99524,2-Chloro-1-phenyl-1H-indole-3-carboxylic acid,C1=CC=C(C=C1)N2C3=CC=CC=C3C(=C2Cl)C(=O)O,,,,,,
9524,99525,"3-(2,3-Dimethoxyphenyl)prop-2-enoic acid",COC1=CC=CC(=C1OC)C=CC(=O)O,,,,,,
9525,99526,Canarigenin,C[C@]12CC[C@@H](C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@@]3(CC[C@@H]4C5=CC(=O)OC5)O)C)O,,,,,,
9526,99527,tert-Butyl trimethylsilylacetate,CC(C)(C)OC(=O)C[Si](C)(C)C,,,,,,
9527,99528,CID 99528,C1=NC(=O)C2=C(N1)N(C(=N2)Br)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O,,,,,,
9528,99529,"Uridine, 2'-deoxy-5-mercapto-",C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)S)CO)O,,,"['Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. (See all compounds classified as Immunosuppressive Agents.)', 'Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)']",,,
9529,99530,Isobrucein B,CC1=CC(=O)[C@H]([C@]2([C@H]1C[C@@H]3[C@]45[C@@H]2[C@H]([C@@H]([C@]([C@@H]4[C@H](C(=O)O3)OC(=O)C)(OC5)C(=O)OC)O)O)C)O,,,,,,
9530,99531,Bruceolide,CC1=C(C(=O)C[C@]2([C@H]1C[C@@H]3[C@]45[C@@H]2[C@H]([C@@H]([C@]([C@@H]4[C@H](C(=O)O3)O)(OC5)C(=O)OC)O)O)C)O,,,,,,
9531,99532,CID 99532,CC1[C@@H]2[C@H](C(=O)O[C@H]3[C@@]24CO[C@@]([C@@H]1O)([C@@H]4[C@@]5([C@@H](C3)C(=CC(=O)[C@H]5O)C)C)O)OC(=O)C(C)C,,,,,,
9532,99533,CID 99533,CC1=CC(=O)[C@H]([C@]2([C@H]1C[C@@H]3[C@]45[C@@H]2[C@]([C@@H](C(=C)[C@@H]4[C@H](C(=O)O3)OC(=O)C(C)C)O)(OC5)O)C)O,,,,,,
9533,99534,CID 99534,C1=NC(=C(N1[C@H]2[C@@H]([C@@H]([C@H](O2)COC=O)OC=O)OC=O)NC=O)C(=N)S,,,,,,
9534,99535,Podolide,CC(C)[C@@H]1[C@]23[C@H](O2)[C@@H]4[C@@H]5[C@@](C3=CC(=O)O1)(CC=C[C@@]5(C(=O)O4)C)C,,,,,,
9535,99536,"Acetamide, N-((butylnitrosoamino)methyl)-",CCCCN(CNC(=O)C)N=O,,,,,,
9536,99537,5-Methylfuran-2-propionaldehyde,CC1=CC=C(O1)CCC=O,,,,,,
9537,99538,CID 99538,CCOC(=C1C2=C3C(=C(C=C(C3=NC1=O)C)Br)C(=O)C4=CC=CC=C42)O,,,,,,
9538,99539,Copper salicylaldehyde,C1=CC=C(C(=C1)C=O)[O-].C1=CC=C(C(=C1)C=O)[O-].[Cu+2],,,,,,
9539,99540,"2,5-Cyclohexadien-1-one, 4-bromoimino-",C1=CC(=O)C=CC1=NBr,,,,,,
9540,99541,"4-Bromo-2,6-dibromo-2,5-cyclohexadiene-1-one",C1=C(C(=O)C(=CC1=NBr)Br)Br,,,,,,
9541,99542,"2,5-Cyclohexadien-1-one, 4-bromoimino-2,6-dichloro-",C1=C(C(=O)C(=CC1=NBr)Cl)Cl,,,,,,
9542,99543,1-Methylpseudouridine,CN1C=C(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O,,,,,,
9543,99544,Isopropyl p-nitrobenzenesulfonate,CC(C)OS(=O)(=O)C1=CC=C(C=C1)[N+](=O)[O-],,,,,,
9544,99545,"2,6-Diamino-8-phenylpurine",C1=CC=C(C=C1)C2=NC3=NC(=NC(=C3N2)N)N,,,,,,
9545,99546,"p-Benzoquinone, 5-(di-2'-chloroethylamino)-2-methoxy-",COC1=CC(=O)C(=CC1=O)N(CCCl)CCCl,,,,,,
9546,99547,"Benz(a)anthracene, 7,12-bis(bromomethyl)-",C1=CC=C2C(=C1)C=CC3=C(C4=CC=CC=C4C(=C32)CBr)CBr,,,,,,
9547,99548,"Benzenamine, 4-((4-(chloromethyl)phenyl)azo)-N,N-dimethyl-",CN(C)C1=CC=C(C=C1)N=NC2=CC=C(C=C2)CCl,,,,,,
9548,99549,O(6)-Ethyl-2'-deoxyguanosine,CCOC1=NC(=NC2=C1N=CN2[C@H]3C[C@@H]([C@H](O3)CO)O)N,,,,,,
9549,99550,"1,3-Bis(methylthio)-2-propanol",CSCC(CSC)O,,,,,,
9550,99551,"6-(4-Pyridyl)-1,3,5-triazine-2,4-diamine",C1=CN=CC=C1C2=NC(=NC(=N2)N)N,,,,,,
9551,99552,"Butanamide, N-(1,3-dioxobutyl)-N-(2-methylphenyl)-3-oxo-",CC1=CC=CC=C1N(C(=O)CC(=O)C)C(=O)CC(=O)C,,,,,,
9552,99553,"2,2,6,6-Tetrachloro-1-hydroxycyclohexanecarboxamide",C1CC(C(C(C1)(Cl)Cl)(C(=O)N)O)(Cl)Cl,,,,,,
9553,99554,"N,N'-bis[1-isopropyl-2-methylpropyl]ethylenediamine",CC(C)C(C(C)C)NCCNC(C(C)C)C(C)C,,,,,,
9554,99555,"2,1,3-Benzoxadiazol-4-amine, N-[(4-methoxyphenyl)methyl]-7-nitro-",COC1=CC=C(C=C1)CNC2=CC=C(C3=NON=C23)[N+](=O)[O-],,,,,,
9555,99556,1-(Mesitylsulfonyl)-1H-imidazole,CC1=CC(=C(C(=C1)C)S(=O)(=O)N2C=CN=C2)C,,,,,,
9556,99557,Bolton-Hunter reagent,C1CC(=O)N(C1=O)OC(=O)CCC2=CC=C(C=C2)O,,,,,,
9557,99558,S-(2-Aminoethyl)-L-cysteine,C(CSC[C@@H](C(=O)O)N)N,,,"['Compounds which inhibit the synthesis of proteins. They are usually ANTI-BACTERIAL AGENTS or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the A site of ribosomes, the misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins. (See all compounds classified as Protein Synthesis Inhibitors.)']",,,
9558,99559,"(4S)-N,N-bis(2-chloroethyl)-4-methyl-2-oxo-1,3,2lambda5-oxazaphosphinan-2-amine",C[C@H]1CCOP(=O)(N1)N(CCCl)CCCl,,,,,,
9559,99560,"(4R)-N,N-bis(2-chloroethyl)-4-methyl-2-oxo-1,3,2lambda5-oxazaphosphinan-2-amine",C[C@@H]1CCOP(=O)(N1)N(CCCl)CCCl,,,,,,
9560,99561,"1,10-Phenanthroline-2-carboxylic acid",C1=CC2=C(C3=C(C=C2)C=CC(=N3)C(=O)O)N=C1,,,,,,
9561,99562,"3,7-Dimethyl-1-propargylxanthine",CN1C=NC2=C1C(=O)N(C(=O)N2C)CC#C,,,['Compounds that selectively bind to and block the activation of ADENOSINE A2 RECEPTORS. (See all compounds classified as Adenosine A2 Receptor Antagonists.)'],,,
9562,99563,"3,4,5,6,7,8,9,10,11,12,13,14-Dodecahydro-2h-cyclododeca[b]pyran",C1CCCCCC2=C(CCCC1)CCCO2,,,,,,
9563,99564,Dehydrosupinidine,C1CC2=C(C=CN2C1)CO,,,,,,
9564,99565,CID 99565,C(=NO)(N)S,,,,,,
9565,99566,"1,8-Octanediamine, N,N'-bis(4-ethyl-9-acridinyl)-",CCC1=CC=CC2=C(C3=CC=CC=C3N=C21)NCCCCCCCCNC4=C5C=CC=C(C5=NC6=CC=CC=C64)CC,,,,,,
9566,99567,Tartaric acid dihydrazide,[C@@H]([C@H](C(=O)NN)O)(C(=O)NN)O,,,,,,
9567,99568,"3-(4-Methylphenyl)-2-thioxo-1,3-thiazolidin-4-one",CC1=CC=C(C=C1)N2C(=O)CSC2=S,,,,,,
9568,99569,"Propionic acid, 3-selenino-",C(C[Se](=O)O)C(=O)O,,,,,,
9569,99570,4-Bromo-2-methylbenzoic acid,CC1=C(C=CC(=C1)Br)C(=O)O,,,,,,
9570,99571,"(1,1'-Biphenyl)-2,2'-dicarboxylic acid, 4,4',6,6'-tetranitro-",C1=C(C=C(C(=C1C(=O)O)C2=C(C=C(C=C2[N+](=O)[O-])[N+](=O)[O-])C(=O)O)[N+](=O)[O-])[N+](=O)[O-],,,,,,
9571,99572,"3,5-Pyridinedicarboxylic acid, 2,4,6-trimethyl-, diethyl ester",CCOC(=O)C1=C(C(=C(N=C1C)C)C(=O)OCC)C,,,,,,
9572,99573,"Benzo(h)quinoline, 1-oxide",C1=CC=C2C(=C1)C=CC3=C2[N+](=CC=C3)[O-],,,,,,
9573,99574,"Phenol, 2-(((2-hydroxyethyl)amino)methyl)-6-methoxy-4-(2-propenyl)-",COC1=CC(=CC(=C1O)CNCCO)CC=C,,,,,,
9574,99575,2-Methoxy-6-(((2-methoxyethyl)amino)methyl)-4-(2-propenyl)phenol,COCCNCC1=C(C(=CC(=C1)CC=C)OC)O,,,,,,
9575,99576,"Phenol, 2-(((2-ethoxyethyl)amino)methyl)-6-methoxy-4-(2-propenyl)-",CCOCCNCC1=C(C(=CC(=C1)CC=C)OC)O,,,,,,
9576,99577,"Phenol, 2-(((3-hydroxypropyl)amino)methyl)-6-methoxy-4-(2-propenyl)-",COC1=CC(=CC(=C1O)CNCCCO)CC=C,,,,,,
9577,99578,"Phenol, 2-methoxy-6-(((3-methoxypropyl)amino)methyl)-4-(2-propenyl)-",COCCCNCC1=C(C(=CC(=C1)CC=C)OC)O,,,,,,
9578,99579,"Phenol, 2-(((2-hydroxyethyl)methylamino)methyl)-6-methoxy-4-(2-propenyl)-",CN(CCO)CC1=C(C(=CC(=C1)CC=C)OC)O,,,,,,
9579,99580,2-(((3-Ethoxypropyl)amino)methyl)-6-methoxy-4-(2-propenyl)phenol,CCOCCCNCC1=C(C(=CC(=C1)CC=C)OC)O,,,,,,
9580,99581,"Phenol, 2,2'-(((2-hydroxyethyl)imino)bis(methylene))bis(6-methoxy-4-(2-propenyl)-",COC1=CC(=CC(=C1O)CN(CCO)CC2=C(C(=CC(=C2)CC=C)OC)O)CC=C,,,,,,
9581,99582,"Phosphoramidic acid, diethyl-, dimethyl ester",CCN(CC)P(=O)(OC)OC,,,,,,
9582,99583,Mollisin,CC1=CC(=C2C(=O)C=C(C(=O)C2=C1C(=O)C(Cl)Cl)C)O,,,,,,
9583,99584,"(2S)-2-[(3S,5R,10S,13R,14R,16R,17R)-3-acetyloxy-16-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methyl-5-methylideneheptanoic acid",CC(C)C(=C)CC[C@@H]([C@H]1[C@@H](C[C@@]2([C@@]1(CCC3=C2CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)OC(=O)C)C)C)C)O)C(=O)O,,,,,,
9584,99585,Benzodipyrones,C1=CC(=O)OC2=CC3=C(C=C21)OC(=O)C=C3,,,,,,
9585,99586,Aurofusarin,CC1=CC(=O)C2=C(O1)C=C3C(=C2O)C(=O)C(=C(C3=O)OC)C4=C(C(=O)C5=CC6=C(C(=O)C=C(O6)C)C(=C5C4=O)O)OC,,,,,,
9586,99587,(Methylamino)methanesulfonic acid,CNCS(=O)(=O)O,,,,,,
9587,99588,Methylaminomethylphosphonic acid,CNCP(=O)(O)O,,,,,,
9588,99589,"1,1'-Binaphthyl-2,2'-diyl hydrogenphosphate",C1=CC=C2C(=C1)C=CC3=C2C4=C(C=CC5=CC=CC=C54)OP(=O)(O3)O,,,,,,
9589,99590,Methyl (2-methoxyphenyl)acetate,COC1=CC=CC=C1CC(=O)OC,,,,,,
9590,99591,"Urea, N-(2-chloroethyl)-N-nitroso-N'-(2,3,4,6-tetra-O-acetyl-beta-D-glucopyranosyl)-",CC(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)NC(=O)N(CCCl)N=O)OC(=O)C)OC(=O)C)OC(=O)C,,,,,,
9591,99592,3-Methyluridine,CN1C(=O)C=CN(C1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O,,,,,,
9592,99593,"N,N''-(5-(Bis(2-chloroethyl)amino)-1,3-phenylene)bis-urea",C1=C(C=C(C=C1NC(=O)N)N(CCCl)CCCl)NC(=O)N,,,,,,
9593,99594,"(2s)-2-Amino-4-(4-aminocyclohexa-2,5-dien-1-yl)butanoic acid",C1=CC(C=CC1CC[C@@H](C(=O)O)N)N,,,,,,
9594,99595,"5,8-dimethoxy-3,4-dihydronaphthalen-2(1H)-one",COC1=C2CCC(=O)CC2=C(C=C1)OC,,,,,,
9595,99596,Sporidesmin,C[C@@]12C(=O)N3[C@@H]4[C@]([C@H]([C@]3(C(=O)N1C)SS2)O)(C5=CC(=C(C(=C5N4C)OC)OC)Cl)O,,,,,,
9596,99597,Methyl pivaloylacetate,CC(C)(C)C(=O)CC(=O)OC,,,,,,
9597,99598,"Rhodanine, 3-(p-bromophenyl)-",C1C(=O)N(C(=S)S1)C2=CC=C(C=C2)Br,,,,,,
9598,99599,"Rhodanine, 3-(m-chlorophenyl)-",C1C(=O)N(C(=S)S1)C2=CC(=CC=C2)Cl,,,,,,
9599,99600,"3,4-Dihydro-6-(isopropyl)-3-(4-(isopropyl)phenyl)quinazoline",CC(C)C1=CC=C(C=C1)N2CC3=C(C=CC(=C3)C(C)C)N=C2,,,,,,
9600,99601,"3-Benzyl-5-butyl-1,3,5-thiadiazinane-2-thione",CCCCN1CN(C(=S)SC1)CC2=CC=CC=C2,,,,,,
9601,99602,"3-Benzyl-5-ethyl-1,3,5-thiadiazinane-2-thione",CCN1CN(C(=S)SC1)CC2=CC=CC=C2,,,,,,
9602,99603,"1H-Indole-3-acetic acid, 2-chloro-1-phenyl-",C1=CC=C(C=C1)N2C3=CC=CC=C3C(=C2Cl)CC(=O)O,,,,,,
9603,99604,"1-Nitroso-1-(2-chloroethyl)-3,3-dimethylurea",CN(C)C(=O)N(CCCl)N=O,,,,,,
9604,99605,"2,4-Imidazolidinedione, 3-(2-hydroxyethyl)-5,5-dimethyl-",CC1(C(=O)N(C(=O)N1)CCO)C,,,,,,
9605,99606,Bufalone,C[C@]12CCC(=O)C[C@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@@]3(CC[C@@H]4C5=COC(=O)C=C5)O)C,,,,,,
9606,99607,"1,6-Hexanediamine, N,N'-bis(4-ethyl-9-acridinyl)-",CCC1=CC=CC2=C(C3=CC=CC=C3N=C21)NCCCCCCNC4=C5C=CC=C(C5=NC6=CC=CC=C64)CC,,,,,,
9607,99608,"1,6-Hexanediamine, N,N'-bis(4-butoxy-9-acridinyl)-",CCCCOC1=CC=CC2=C(C3=CC=CC=C3N=C21)NCCCCCCNC4=C5C=CC=C(C5=NC6=CC=CC=C64)OCCCC,,,,,,
9608,99609,"1H-Purine-6-methanol, 6,9-dihydro-9-beta-D-ribofuranosyl-, (R)-",C1=N[C@H](C2=C(N1)N(C=N2)C3[C@@H]([C@@H]([C@H](O3)CO)O)O)CO,,,,,,
9609,99610,Jaligonic acid,C[C@@]1(CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(C[C@@H]([C@@H]([C@@]5(C)CO)O)O)C)C)[C@@H]2C1)C)C(=O)O)C(=O)O,,,,,,
9610,99611,"2,2-Dihydroxy-1-phenylethanone",C1=CC=C(C=C1)C(=O)C(O)O,,,,,,
9611,99612,2-Nitro-9H-carbazole,C1=CC=C2C(=C1)C3=C(N2)C=C(C=C3)[N+](=O)[O-],,,,,,
9612,99613,Lecanoric acid,CC1=CC(=CC(=C1C(=O)OC2=CC(=C(C(=C2)C)C(=O)O)O)O)O,,,,,,
9613,99614,Confluentic acid,CCCCCC1=C(C(=CC(=C1)OC(=O)C2=C(C=C(C=C2O)OC)CC(=O)CCCCC)OC)C(=O)O,,,,,,
9614,99615,Betulinaldehyde,CC(=C)[C@@H]1CC[C@]2([C@H]1[C@H]3CC[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)O)C)C=O,,,,,,
9615,99616,"(1S,6S,8S)-3,8,12,16-tetramethyl-7,18-dioxatricyclo[13.3.0.06,8]octadeca-2,11,15-trien-17-one",CC1=CCC[C@]2([C@@H](O2)CCC(=C[C@H]3C(=C(C(=O)O3)C)CC1)C)C,,,,,,
9616,99617,"9H-Pyrrolo(1,2-a)indol-9-one, 6-amino-",C1=CN2C(=C1)C(=O)C3=C2C=C(C=C3)N,,,,,,
9617,99618,CID 99618,CC(=O)O[C@H]1CCC([C@@H]2[C@@]13COC([C@H]2O)([C@]45[C@H]3CC[C@H](C4O)C(=C)C5=O)O)(C)C,,,,,,
9618,99619,7-(2-Aminoethyl)theophylline,CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CCN,,,,,,
9619,99620,Homoaromoline,CN1CCC2=CC(=C(C3=C2[C@@H]1CC4=CC=C(C=C4)OC5=C(C=CC(=C5)C[C@@H]6C7=CC(=C(C=C7CCN6C)OC)O3)OC)O)OC,,,,,,
9620,99621,"6-Oxo-1,4,5,6-tetrahydropyridazine-3-carboxylic acid",C1CC(=O)NN=C1C(=O)O,,,,,,
9621,99622,"Methyl 3,4-dihydroxy-5-methoxybenzoate",COC1=CC(=CC(=C1O)O)C(=O)OC,,,,,,
9622,99623,CID 99623,CC=C1[C@@H]2[C@]3(C=C[C@@H]4[C@H]3[C@H](O2)O[C@H]([C@@H]4C(=O)OC)O)OC1=O,,,,,,
9623,99624,"1,4-Dihydro-1-phenyl-4-(trimethylsilyl)-5H-tetrazol-5-one",C[Si](C)(C)N1C(=O)N(N=N1)C2=CC=CC=C2,,,,,,
9624,99625,Z-L-Phe chloromethyl ketone,C1=CC=C(C=C1)C[C@@H](C(=O)CCl)NC(=O)OCC2=CC=CC=C2,,,,,,
9625,99626,"4-Isoquinolinecarbonitrile, 5,6,7,8-tetrahydro-3-amino-",C1CCC2=C(C(=NC=C2C1)N)C#N,,,,,,
9626,99627,"Pyrimidine, 5-phenylazo-2,4,6-triamino-",C1=CC=C(C=C1)N=NC2=C(N=C(N=C2N)N)N,,,,,,
9627,99628,"1,8-Octanediamine, N,N'-bis(4-butoxy-9-acridinyl)-",CCCCOC1=CC=CC2=C(C3=CC=CC=C3N=C21)NCCCCCCCCNC4=C5C=CC=C(C5=NC6=CC=CC=C64)OCCCC,,,,,,
9628,99629,"1,6-Hexanediamine, N,N'-bis(3-propoxy-9-acridinyl)-",CCCOC1=CC2=NC3=CC=CC=C3C(=C2C=C1)NCCCCCCNC4=C5C=CC(=CC5=NC6=CC=CC=C64)OCCC,,,,,,
9629,99630,CID 99630,C1=NN(C2=C1C(=NC=N2)S)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O,,,,,,
9630,99631,Sudan Red B,CC1=CC(=CC=C1)N=NC2=C(C=C(C=C2)N=NC3=C(C=CC4=CC=CC=C43)O)C,,,,,,
9631,99632,"1-(2,4,6-Trifluorophenyl)-3,3-dimethyltriazene",CN(C)N=NC1=C(C=C(C=C1F)F)F,,,,,,
9632,99633,cis-1-(2-Chloroethyl)-3-(3-hydroxycyclohexyl)-1-nitrosourea,C1C[C@H](C[C@H](C1)O)NC(=O)N(CCCl)N=O,,,,,,
9633,99634,"1,1'-Diacetyl-1,1',4,4'-tetrahydro-4,4'-bipyridine",CC(=O)N1C=CC(C=C1)C2C=CN(C=C2)C(=O)C,,,,,,
9634,99635,"Benz(a)anthracene, 5-methoxy-7,12-dimethyl-",CC1=C2C=C(C3=CC=CC=C3C2=C(C4=CC=CC=C14)C)OC,,,,,,
9635,99636,CID 99636,C(CCl)N(C(=O)N[C@H]1C([C@H]([C@@H]([C@H](O1)CO)O)O)O)N=O,,,,,,
9636,99637,"1-(2,4,6-Tribromophenyl)-3,3-dimethyltriazene",CN(C)N=NC1=C(C=C(C=C1Br)Br)Br,,,,,,
9637,99638,CID 99638,CN(N=NC1=C(C=C(C=C1Cl)Cl)Cl)O,,,,,,
9638,99639,"1-(2,4,6-Trichlorophenyl)-3,3-dimethyltriazene",CN(C)N=NC1=C(C=C(C=C1Cl)Cl)Cl,,,,,,
9639,99640,CID 99640,CC1=C(OC(=C[C@@H](C)CCC[C@H](C)C=CC=C(C)CCCC2=COC=C2)C1=O)O,,,,,,
9640,99641,Dihydronitidine,CN1CC2=CC(=C(C=C2C3=C1C4=CC5=C(C=C4C=C3)OCO5)OC)OC,,,,,,
9641,99642,CID 99642,COC1=C(C=CC(=C1)C2=C(C(=C3C(=CC(=O)C=C3O2)O)O)OC)O,,,,,,
9642,99643,Ethyl 2-phenylpropionate,CCOC(=O)C(C)C1=CC=CC=C1,,,,,,
9643,99644,"1,1'-Hexamethylenebis(3,3-dimethylurea)",CN(C)C(=O)NCCCCCCNC(=O)N(C)C,,,,,,
9644,99645,"Urea, N,N''-1,5-naphthalenediylbis[N',N'-dimethyl-",CN(C)C(=O)NC1=CC=CC2=C1C=CC=C2NC(=O)N(C)C,,,,,,
9645,99646,"2',3',4',5',6'-Pentamethoxychalcone",COC1=C(C(=C(C(=C1OC)OC)OC)OC)C(=O)C=CC2=CC=CC=C2,,,,,,
9646,99647,"Glutarimide, 3-ethyl-3-phenyl-",CCC1(CC(=O)NC(=O)C1)C2=CC=CC=C2,,,,,,
9647,99648,"Carbamic acid, 1H-benzimidazole-2,5-diylbis-, dimethyl ester",COC(=O)NC1=CC2=C(C=C1)N=C(N2)NC(=O)OC,,,,,,
9648,99649,Emodin-8-glucoside,CC1=CC2=C(C(=C1)O)C(=O)C3=C(C2=O)C=C(C=C3O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O,,,,,,
9649,99650,CID 99650,C[C@]12C[C@@]3([C@@H]4C[C@]1([C@@]4(C(O2)O3)COC(=O)C5=CC=C(C=C5)O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)O,,,,,,
9650,99651,Saikogenin A,C[C@]12CC[C@@H]([C@@]([C@@H]1CC[C@@]3([C@@H]2C=CC4=C5CC(CC[C@@]5([C@H](C[C@]43C)O)CO)(C)C)C)(C)CO)O,,,,,,
9651,99652,Rhetsinine,CNC1=CC=CC=C1C(=O)N2CCC3=C(C2=O)NC4=CC=CC=C34,,,,,,
9652,99653,"Anthraquinone, 2-hexanoyl-1,3,8-trihydroxy-6-methoxy-",CCCCCC(=O)C1=C(C=C2C(=C1O)C(=O)C3=C(C2=O)C=C(C=C3O)OC)O,,,,,,
9653,99654,"2-Naphthalenamine, N,N-bis(2-bromoethyl)-(9CI)",C1=CC=C2C=C(C=CC2=C1)N(CCBr)CCBr,,,,,,
9654,99655,"1,4-Benzenediamine, N,N,N',N'-tetrakis(2-chloroethyl)-",C1=CC(=CC=C1N(CCCl)CCCl)N(CCCl)CCCl,,,,,,
9655,99656,"Valeric acid, 5-(p-(bis(2-chloroethyl)amino)phenoxy)-",C1=CC(=CC=C1N(CCCl)CCCl)OCCCCC(=O)O,,,,,,
9656,99657,"Benzamide, m-(bis(2-chloroethyl)amino)-",C1=CC(=CC(=C1)N(CCCl)CCCl)C(=O)N,,,,,,
9657,99658,cis-4-((((2-Chloroethyl)nitrosoamino)carbonyl)methylamino)cyclohexanecarboxylic acid,CN(C1CCC(CC1)C(=O)O)C(=O)N(CCCl)N=O,,,,,,
9658,99659,trans-1-(2-Chloroethyl)-3-(3-hydroxycyclohexyl)-1-nitrosourea,C1C[C@H](C[C@@H](C1)O)NC(=O)N(CCCl)N=O,,,,,,
9659,99660,CID 99660,C1[C@@H](C[C@H]([C@@H]1CO)O)N2C=NC3=C2NC(=NC3=O)N,,,,,,
9660,99661,"1,6-Hexanediamine, N,N'-bis(2-methoxy-9-acridinyl)-",COC1=CC2=C(C3=CC=CC=C3N=C2C=C1)NCCCCCCNC4=C5C=C(C=CC5=NC6=CC=CC=C64)OC,,,,,,
9661,99662,"1,6-Hexanediamine, N,N'-bis(4-methoxy-9-acridinyl)-",COC1=CC=CC2=C(C3=CC=CC=C3N=C21)NCCCCCCNC4=C5C=CC=C(C5=NC6=CC=CC=C64)OC,,,,,,
9662,99663,"1,8-Octanediamine, N,N'-bis(4-methoxy-9-acridinyl)-",COC1=CC=CC2=C(C3=CC=CC=C3N=C21)NCCCCCCCCNC4=C5C=CC=C(C5=NC6=CC=CC=C64)OC,,,,,,
9663,99664,"1,8-Octanediamine, N,N'-bis(3-propoxy-9-acridinyl)-",CCCOC1=CC2=NC3=CC=CC=C3C(=C2C=C1)NCCCCCCCCNC4=C5C=CC(=CC5=NC6=CC=CC=C64)OCCC,,,,,,
9664,99665,"N,N'-Bis(benzo(b)(1,8)napthyridin-5-yl)-1,12-dodecanediamine",C1=CC=C2C(=C1)C(=C3C=CC=NC3=N2)NCCCCCCCCCCCCNC4=C5C=CC=NC5=NC6=CC=CC=C64,,,,,,
9665,99666,"1,4-Benzoquinone-2,5-dimustard",C1=C(C(=O)C=C(C1=O)N(CCCl)CCCl)N(CCCl)CCCl,,,,,,
9666,99667,CID 99667,CCCCOC(=NC1=CC=CC=C1)S,,,,,,
9667,99668,"L-Glutamine, N2-(4-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-",CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)N)C(=O)O,,,,,,
9668,99669,"1,8-Octanediamine, N,N'-bis(2-methoxy-9-acridinyl)-",COC1=CC2=C(C3=CC=CC=C3N=C2C=C1)NCCCCCCCCNC4=C5C=C(C=CC5=NC6=CC=CC=C64)OC,,,,,,
9669,99670,"1,8-Octanediamine, N,N'-bis(3-methoxy-9-acridinyl)-",COC1=CC2=NC3=CC=CC=C3C(=C2C=C1)NCCCCCCCCNC4=C5C=CC(=CC5=NC6=CC=CC=C64)OC,,,,,,
9670,99671,"1,8-Octanediamine, N,N'-bis(4-ethoxy-9-acridinyl)-",CCOC1=CC=CC2=C(C3=CC=CC=C3N=C21)NCCCCCCCCNC4=C5C=CC=C(C5=NC6=CC=CC=C64)OCC,,,,,,
9671,99672,"N,N'-Bis(3-chloro-9-acridinyl)-1,8-octanediamine",C1=CC=C2C(=C1)C(=C3C=CC(=CC3=N2)Cl)NCCCCCCCCNC4=C5C=CC(=CC5=NC6=CC=CC=C64)Cl,,,,,,
9672,99673,"2,3-Dibromobut-2-enedioic acid",C(=C(C(=O)O)Br)(C(=O)O)Br,,,,,,
9673,99674,1-Nitro-4-(phenoxymethyl)benzene,C1=CC=C(C=C1)OCC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
9674,99675,CID 99675,C1=CC=C(C=C1)CN=C(NN)S,,,,,,
9675,99676,"2,6-Diamino-3-nitrosopyridine",C1=CC(=NC(=C1N=O)N)N,,,,,,
9676,99677,2-Amino-5-bromobenzophenone,C1=CC=C(C=C1)C(=O)C2=C(C=CC(=C2)Br)N,,,,,,
9677,99678,1-Amidino-3-beta-D-ribofuranosylurea,C([C@@H]1[C@H]([C@H]([C@@H](O1)NC(=O)N=C(N)N)O)O)O,,,,,,
9678,99679,Calvatic acid,C1=CC(=CC=C1C(=O)O)[N+](=NC#N)[O-],,,,,,
9679,99680,p-Tolylazoxycyanide,CC1=CC=C(C=C1)[N+](=NC#N)[O-],,,,,,
9680,99681,"5,6-Dihydro-5-azacytidine",C1N=C(NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N,,,"['Antimetabolites that are useful in cancer chemotherapy. (See all compounds classified as Antimetabolites, Antineoplastic.)']",,,
9681,99682,"1-Benzoyl-1,2-dihydroquinoline",C1C=CC2=CC=CC=C2N1C(=O)C3=CC=CC=C3,,,,,,
9682,99683,3-amino-1-phenyl-1H-pyrazol-5-ol,C1=CC=C(C=C1)N2C(=O)C=C(N2)N,,,,,,
9683,99684,n-(2-Acetylphenyl)formamide,CC(=O)C1=CC=CC=C1NC=O,,,,,,
9684,99685,2-Methyl-1-(trimethylsilyloxy)-1-propene,CC(=CO[Si](C)(C)C)C,,,,,,
9685,99686,"2,2'-Thiobis(benzamide)",C1=CC=C(C(=C1)C(=O)N)SC2=CC=CC=C2C(=O)N,,,,,,
9686,99687,"2-Bromo-2-phenyl-1H-indene-1,3(2H)-dione",C1=CC=C(C=C1)C2(C(=O)C3=CC=CC=C3C2=O)Br,,,,,,
9687,99688,"1,6-Hexanediamine, N,N'-bis(3-nitro-9-acridinyl)-",C1=CC=C2C(=C1)C(=C3C=CC(=CC3=N2)[N+](=O)[O-])NCCCCCCNC4=C5C=CC(=CC5=NC6=CC=CC=C64)[N+](=O)[O-],,,,,,
9688,99689,"1,8-Octanediamine, N,N'-bis(3-nitro-9-acridinyl)-",C1=CC=C2C(=C1)C(=C3C=CC(=CC3=N2)[N+](=O)[O-])NCCCCCCCCNC4=C5C=CC(=CC5=NC6=CC=CC=C64)[N+](=O)[O-],,,,,,
9689,99690,"1,8-Octanediamine, N,N'-bis(4-(methylthio)-9-acridinyl)-",CSC1=CC=CC2=C(C3=CC=CC=C3N=C21)NCCCCCCCCNC4=C5C=CC=C(C5=NC6=CC=CC=C64)SC,,,,,,
9690,99691,"1,8-Octanediamine, N,N'-bis(3,5-dimethoxy-9-acridinyl)-",COC1=CC2=NC3=C(C=CC=C3OC)C(=C2C=C1)NCCCCCCCCNC4=C5C=CC(=CC5=NC6=C4C=CC=C6OC)OC,,,,,,
9691,99692,"Uridine, 2'-deoxy-5-(2-propynyloxy)-",C#CCOC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)O,,,,,,
9692,99693,Skimmin,C1=CC(=CC2=C1C=CC(=O)O2)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O,,,,,,
9693,99694,"1-Naphthaleneacetaldehyde, alpha-sec-butyl-alpha-(2-piperidinoethyl)-",CCC(C)C(CCN1CCCCC1)(C=O)C2=CC=CC3=CC=CC=C32,,,,,,
9694,99695,"Morpholine, 4,4'-nitriloditetramethylenebis(gamma-isopropyl-gamma-(2-naphthyl)-",CC(C)C(CCN1CCOCC1)(CN=CC(CCN2CCOCC2)(C3=CC4=CC=CC=C4C=C3)C(C)C)C5=CC6=CC=CC=C6C=C5,,,,,,
9695,99696,"2-Naphthaleneacetaldehyde, alpha-sec-butyl-alpha-(2-morpholinoethyl)-",CCC(C)C(CCN1CCOCC1)(C=O)C2=CC3=CC=CC=C3C=C2,,,,,,
9696,99697,"Morpholine, 4,4'-(delta,delta'-nitriloditetramethylene)bis(gamma-sec-butyl-gamma-(2-naphthyl)-",CCC(C)C(CCN1CCOCC1)(CN=CC(CCN2CCOCC2)(C3=CC4=CC=CC=C4C=C3)C(C)CC)C5=CC6=CC=CC=C6C=C5,,,,,,
9697,99698,"1-Naphthaleneacetaldehyde, alpha-(2-piperidinoethyl)-alpha-propyl-",CCCC(CCN1CCCCC1)(C=O)C2=CC=CC3=CC=CC=C32,,,,,,
9698,99699,"1-Naphthaleneacetaldehyde, alpha-isopropyl-alpha-(2-piperidinoethyl)-",CC(C)C(CCN1CCCCC1)(C=O)C2=CC=CC3=CC=CC=C32,,,,,,
9699,99700,"2-Naphthaleneacetaldehyde, alpha-isopropyl-alpha-(2-morpholinoethyl)-",CC(C)C(CCN1CCOCC1)(C=O)C2=CC3=CC=CC=C3C=C2,,,,,,
9700,99701,"1-Naphthaleneacetaldehyde, alpha-sec-butyl-alpha-(2-(diisopropylamino)ethyl)-",CCC(C)C(CCN(C(C)C)C(C)C)(C=O)C1=CC=CC2=CC=CC=C21,,,,,,
9701,99702,"1-Naphthaleneacetaldehyde, alpha-(2-(diisopropylamino)ethyl)-alpha-isopropyl-",CC(C)C(CCN(C(C)C)C(C)C)(C=O)C1=CC=CC2=CC=CC=C21,,,,,,
9702,99703,"6-Methoxy-1,12-dimethyl-5,10-dioxatetracyclo[7.6.1.02,7.012,16]hexadeca-2,7-diene-4,11-dione",CC12CCCC3(C1C(C=C4C2=CC(=O)OC4OC)OC3=O)C,,,,,,
9703,99704,alpha-(2-Piperidinoethyl)-alpha-phenyl-1-naphthylacetamide,CC(=CCC(CCN1CCCCC1)(C2=CC=CC3=CC=CC=C32)C(=O)N)C,,,,,,
9704,99705,"Acetamide, 2-(diethylaminoethyl)-2-(3-methyl-2-butenyl)-2-(1-naphthyl)-",CCN(CC)CCC(CC=C(C)C)(C1=CC=CC2=CC=CC=C21)C(=O)N,,,,,,
9705,99706,"Acetamide, 2-(2-dimethylaminoethyl)-2-(3-methyl-2-butenyl)-2-(2-naphthyl)-",CC(=CCC(CCN(C)C)(C1=CC2=CC=CC=C2C=C1)C(=O)N)C,,,,,,
9706,99707,alpha-(2-Diprenylaminoethyl)-alpha-prenyl-1-naphthylacetamide,CC(=CCC(CCN(CC=C(C)C)CC=C(C)C)(C1=CC=CC2=CC=CC=C21)C(=O)N)C,,,,,,
9707,99708,"2-(Methylamino)-1,2-diphenylethanol",CNC(C1=CC=CC=C1)C(C2=CC=CC=C2)O,,,,,,
9708,99709,Phosphono-methionine-S-sulfoximinyl-L-alanyl-alanine,C[C@@H](C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](CCS(=NP(=O)(O)O)(=O)C)N,,,,,,
9709,99710,4-[Bis(3-methylbut-2-en-1-yl)amino]-2-(1-naphthyl)butanenitrile,CC(=CCN(CCC(C#N)C1=CC=CC2=CC=CC=C21)CC=C(C)C)C,,,,,,
9710,99711,"Methyl 4,6-O-benzylidene-2,3-di(O-methyl)-alpha-D-glucopyranoside",CO[C@H]1[C@H]2[C@@H](COC(O2)C3=CC=CC=C3)O[C@@H]([C@@H]1OC)OC,,,,,,
9711,99712,Ridazin,CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,,,,,,
9712,99713,"Acetamide, N-(5,6,7,9-tetrahydro-1,2,3-trimethoxy-9-oxo-10-((phenylmethyl)thio)benzo(a)heptalen-7-yl)-, (S)-",CC(=O)NC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)SCC4=CC=CC=C4)OC)OC)OC,,,,,,
9713,99714,(2R)-2-acetamido-N-methylpropanamide,C[C@H](C(=O)NC)NC(=O)C,,,,,,
9714,99715,N-Acetylasparagine,CC(=O)N[C@@H](CC(=O)N)C(=O)O,,,,,,
9715,99716,alpha-Glutamylaspartic acid,C(CC(=O)O)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)N,,,,,,
9716,99717,beta-Aspartylglycine,C([C@@H](C(=O)O)N)C(=O)NCC(=O)O,,,,,,
9717,99718,Boc-Asp-OH,CC(C)(C)OC(=O)N[C@@H](CC(=O)O)C(=O)O,,,,,,
9718,99719,Ala-asp,C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)N,,,,,,
9719,99720,"3',4'-dihydro-2'H-spiro[imidazolidine-4,1'-naphthalene]-2,5-dione",C1CC2=CC=CC=C2C3(C1)C(=O)NC(=O)N3,,,,,,
9720,99721,S-((N-Bornylamidino)methyl) hydrogen thiosulfate,CC1(C2CCC1(C(C2)N=C(CSS(=O)(=O)O)N)C)C,,,,,,
9721,99722,"5,6-Dimethoxy-1-methyl-1,2,3,8,9,9a-hexahydro-7H-benzo(de)quinolin-7-one",CN1CCC2=CC(=C(C3=C2C1CCC3=O)OC)OC,,,,,,
9722,99723,2-Methyltetradecanoic acid,CCCCCCCCCCCCC(C)C(=O)O,,,,,,
9723,99724,"Succinimide, 3-chloro-N-(p-methoxyphenyl)-",COC1=CC=C(C=C1)N2C(=O)CC(C2=O)Cl,,,,,,
9724,99725,"3-Cyclohexene-1-carboxylic acid, 6-(aminocarbonyl)-",C1C=CCC(C1C(=O)N)C(=O)O,,,,,,
9725,99726,Dibutyl 1-cyanobutyl phosphate,CCCCOP(=O)(OCCCC)OC(CCC)C#N,,,,,,
9726,99727,"1,3,3a,4,7,7a-Hexahydro-1,3-dioxo-2H-isoindole-2-hexanoic acid",C1C=CCC2C1C(=O)N(C2=O)CCCCCC(=O)O,,,,,,
9727,99728,"L-Phenylalanine, N-(trifluoroacetyl)-",C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(F)(F)F,,,,,,
9728,99729,"Methanethiol, N-cyclopentylamidino-, hydrogen thiosulfate",C1CCC(C1)N=C(CSS(=O)(=O)O)N,,,,,,
9729,99730,1-Adamantanethiol,C1C2CC3CC1CC(C2)(C3)S,,,,,,
9730,99731,"Methanethiol, (N-cyclohexyl)amidino-, hydrogen sulfate (ester)",C1CCC(CC1)N=C(CSS(=O)(=O)O)N,,,,,,
9731,99732,Hexahydro-1-((2-methylcyclohexyl)carbonyl)-1H-azepine,CC1CCCCC1C(=O)N2CCCCCC2,,,,,,
9732,99733,"1H,3H-Naphtho[1,8-cd]pyran-1-one, 3-hydroxy-",C1=CC2=C3C(=C1)C(OC(=O)C3=CC=C2)O,,,,,,
9733,99734,"Ethanol, 1-(1,1-dimethyl-2-propynyloxy)-2,2,2-trichloro-",CC(C)(C#C)OC(C(Cl)(Cl)Cl)O,,,,,,
9734,99735,4-Hydroxycyclophosphamide,C1COP(=O)(NC1O)N(CCCl)CCCl,,,,,,
9735,99736,Ethyl (1-ethoxyethylidene)carbazate,CCOC(=NNC(=O)OCC)C,,,,,,
9736,99737,"Ethyl 4-hydroxy-2-(((5-(4-morpholinylmethyl)-2-oxo-1,3-oxazolidin-3-yl)imino)methyl)furo[2,3-b]pyridine-5-carboxylate",CCOC(=O)C1=CNC2=C(C1=O)C=C(O2)C=NN3CC(OC3=O)CN4CCOCC4,,,,,,
9737,99738,"4-Quinolinol, 1,2,3,4-tetrahydro-1,3,3-trimethyl-",CC1(CN(C2=CC=CC=C2C1O)C)C,,,,,,
9738,99739,3-Acetonylidene-2-oxindole,CC(=O)C=C1C2=CC=CC=C2NC1=O,,,,,,
9739,99740,"p-Phenylenediamine, N,N'-difurfurylidene-",C1=COC(=C1)C=NC2=CC=C(C=C2)N=CC3=CC=CO3,,,,,,
9740,99741,"Thiophene, 2,3-dihydro-3-thiocyanato-, 1,1-dioxide",C1C(C=CS1(=O)=O)SC#N,,,,,,
9741,99742,Dibutyl styrylphosphonate,CCCCOP(=O)(C=CC1=CC=CC=C1)OCCCC,,,,,,
9742,99743,2-(1-Methylnonyl)phenol,CCCCCCCCC(C)C1=CC=CC=C1O,,,,,,
9743,99744,Bis(2-methylpiperidino)phenylphosphine,CC1CCCCN1P(C2=CC=CC=C2)N3CCCCC3C,,,,,,
9744,99745,"Phenol, 2-nitro-3,4,6-trichloro-, cyclohexylcarbamate",C1CCC(CC1)NC(=O)OC2=C(C(=C(C=C2Cl)Cl)Cl)[N+](=O)[O-],,,,,,
9745,99746,"1,5-Diphenylpent-1-en-4-yn-3-one",C1=CC=C(C=C1)C=CC(=O)C#CC2=CC=CC=C2,,,,,,
9746,99747,p-Chlorobenzaldehyde O-carbamoyloxime,C1=CC(=CC=C1C=NOC(=O)N)Cl,,,,,,
9747,99748,"Benzeneacetaldehyde, oxime",C1=CC=C(C=C1)CC=NO,,,,,,
9748,99749,"2,4-Dihydro-2,2'-dioxospiro(benz(c,d)indole-5(1H),3'-indoline)-3-carboxylic acid",C1C(=C2C3=C(C14C5=CC=CC=C5NC4=O)C=CC=C3NC2=O)C(=O)O,,,,,,
9749,99750,(1-Hydroxy-2-methylpropyl)phosphonic acid diethyl ester,CCOP(=O)(C(C(C)C)O)OCC,,,,,,
9750,99751,CID 99751,CCOC(=O)C1(C2=CC=CC=C2N=C(N1CC(CBr)Br)S)O,,,,,,
9751,99752,2-Chlorocyclohexyl(3-nitrophenyl)sulfide,C1CCC(C(C1)SC2=CC=CC(=C2)[N+](=O)[O-])Cl,,,,,,
9752,99753,2-Pentyl p-toluenesulfonate,CCCC(C)OS(=O)(=O)C1=CC=C(C=C1)C,,,,,,
9753,99754,1-Methyl-2-phenyliminopyrrolidine,CN1CCCC1=NC2=CC=CC=C2,,,,,,
9754,99755,1-Methyl-2-(4-nitrophenylimino)pyrrolidine,CN1CCCC1=NC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
9755,99756,3-((p-Dimethylaminobenzylidene)amino)propanol,CN(C)C1=CC=C(C=C1)C=NCCCO,,,,,,
9756,99757,"1-Naphthaleneacetic acid, 2-(4-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-2-naphthacenyl)-2-oxoethyl ester, (2S-cis)-",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)COC(=O)CC6=CC=CC7=CC=CC=C76)O)N)O,,,,,,
9757,99758,N'-(Furfurylidene)benzohydrazide,C1=CC=C(C=C1)C(=O)NN=CC2=CC=CO2,,,,,,
9758,99759,2-Hydroxy-1-naphthylaldehyde benzoyl hydrazone,C1=CC=C(C=C1)C(=O)NN=CC2=C(C=CC3=CC=CC=C32)O,,,,,,
9759,99760,"Urea, N-cyclohexyl-N'-2-pyridinyl-",C1CCC(CC1)NC(=O)NC2=CC=CC=N2,,,,,,
9760,99761,[2-[[2-Chloroethyl(nitroso)carbamoyl]amino]cyclohexyl] acetate,CC(=O)OC1CCCCC1NC(=O)N(CCCl)N=O,,,,,,
9761,99762,Steffimycin B,CC1C(C(C(C(O1)OC2C(C(C(=O)C3=CC4=C(C(=C23)O)C(=O)C5=C(C4=O)C=C(C=C5O)OC)(C)O)OC)OC)O)OC,,,,,,
9762,99763,CID 99763,C1=CC2=C(C=CN=C2C=NN=C(N)S)C(=C1)N,,,,,,
9763,99764,"Spiro[2H-1-benzopyran-2,2'-[2H]indole], 1',3'-dihydro-1',3',3'-trimethyl-",CC1(C2=CC=CC=C2N(C13C=CC4=CC=CC=C4O3)C)C,,,,,,
9764,99765,"Spiro[2H-1-benzopyran-2,2'-indoline], 8-methoxy-1',3',3'-trimethyl-6-nitro-",CC1(C2=CC=CC=C2N(C13C=CC4=C(O3)C(=CC(=C4)[N+](=O)[O-])OC)C)C,,,,,,
9765,99766,"Spiro[2H-1-benzopyran-2,2'-[2H]indole], 1',3'-dihydro-1',3',3'-trimethyl-6-nitro-",CC1(C2=CC=CC=C2N(C13C=CC4=C(O3)C=CC(=C4)[N+](=O)[O-])C)C,,,,,,
9766,99767,Benzyl pyrrolidine-2-carboxylate,C1CC(NC1)C(=O)OCC2=CC=CC=C2,,,,,,
9767,99768,"1,3-Dithiane, urea deriv. (9CI)",CC1S(=O)(=O)CC(CS1(=O)=O)NC(=O)N(CCCl)N=O,,,,,,
9768,99769,4-Hydroperoxyisophosphamide,C1COP(=O)(N(C1OO)CCCl)NCCCl,,,,,,
9769,99770,CID 99770,CN=C(NN=CCSCC=NNC(=NC)S)S,,,,,,
9770,99771,Brevianamide A,CC1(C2CC34CCCN3C(=O)C2(CC15C(=O)C6=CC=CC=C6N5)NC4=O)C,,,,,,
9771,99772,(+)-Thalmelatine,CN1CCC2=CC(=C(C3=C2C1CC4=CC(=C(C=C43)OC)OC5=CC(=C(C=C5CC6C7=CC(=C(C=C7CCN6C)OC)O)OC)OC)OC)OC,,,,,,
9772,99773,"4-Thiazolidinone, 3-(1-phenylethyl)-2-thioxo-",CC(C1=CC=CC=C1)N2C(=O)CSC2=S,,,,,,
9773,99774,Dapmavarone,CC1=C(C2=C(C3=C1OC(C3=O)(C)CC(=O)C)C(=C(C(=O)C2=O)C)O)O,,,,,,
9774,99775,"3-Prop-2-ynoxypropane-1,2-diol",C#CCOCC(CO)O,,,,,,
9775,99776,5-Oxo-4-phenyltetrahydro-2-furoic acid,C1C(C(=O)OC1C(=O)O)C2=CC=CC=C2,,,,,,
9776,99777,3-(4-Bromophenyl)acrylic acid,C1=CC(=CC=C1C=CC(=O)O)Br,,,,,,
9777,99778,"1,1-Diethoxybut-2-ene",CCOC(C=CC)OCC,,,,,,
9778,99779,CID 99779,COC1=C(OC(C1=O)C(CO)O)O,,,,,,
9779,99780,"N-(7-butan-2-yl-5,8-dioxo-3-propan-2-yl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),10,12,15-tetraen-4-yl)-2-(dimethylamino)-3-(1H-indol-3-yl)propanamide",CCC(C)C1C(=O)NC=CC2=CC=C(C=C2)OC(C(C(=O)N1)NC(=O)C(CC3=CNC4=CC=CC=C43)N(C)C)C(C)C,,,,,,
9780,99781,CID 99781,CC(=C)C1CC2=C(O1)C=CC3=C2OC4=C(C3=O)C5=CC(=C(C=C5OC4=O)OC)OC,,,,,,
9781,99782,"(11-Chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-yl) 2-[methyl(3-methylbutanoyl)amino]propanoate",CC1C2CC(C(C=CC=C(CC3=CC(=C(C(=C3)OC)Cl)N(C(=O)CC(C4(C1O4)C)OC(=O)C(C)N(C)C(=O)CC(C)C)C)C)OC)(NC(=O)O2)O,,,,,,
9782,99783,"11-Chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-6,10,12,14(26),16,18-hexaene-8,23-dione",CC1C2CC(C(C=CC=C(CC3=CC(=C(C(=C3)OC)Cl)N(C(=O)C=CC4(C1O4)C)C)C)OC)(NC(=O)O2)O,,,,,,
9783,99784,"11-Chloro-21-hydroxy-12,20-dimethoxy-2,5,16-trimethyl-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-6,10,12,14(26),16,18-hexaene-8,23-dione",CC1C2CC(C(C=CC=C(CC3=CC(=C(C(=C3)OC)Cl)NC(=O)C=CC4(C1O4)C)C)OC)(NC(=O)O2)O,,,,,,
9784,99785,"Phenethylamine, beta-ethoxy-N,N-diethyl-",CCN(CC)CC(C1=CC=CC=C1)OCC,,,,,,
9785,99786,CID 99786,C1OC2=C(O1)C=C(C=C2)C=C3C(=O)N=C(S3)NO,,,,,,
9786,99787,"Pyrrolidine, 1-(beta-ethoxyphenethyl)-",CCOC(CN1CCCC1)C2=CC=CC=C2,,,,,,
9787,99788,"2-Propanol, 1-phenylthio-",CC(CSC1=CC=CC=C1)O,,,,,,
9788,99789,Diethyl 1-phenylethylphosphonate,CCOP(=O)(C(C)C1=CC=CC=C1)OCC,,,,,,
9789,99790,Diethyl 1-phenylpentylphosphonate,CCCCC(C1=CC=CC=C1)P(=O)(OCC)OCC,,,,,,
9790,99791,Diethyl 1-cyanoethyl phosphate,CCOP(=O)(OCC)OC(C)C#N,,,,,,
9791,99792,"2H-Isoindole-2-ethanamine, N,N-diethyloctahydro-",CCN(CC)CCN1CC2CCCCC2C1,,,,,,
9792,99793,"4,7-Methanoisoindoline, 3a,7a-dihydro-2-(diethylaminoethyl)-",CCN(CC)CCN1CC2C3CC(C2C1)C=C3,,,,,,
9793,99794,"Piperidine, 1-(beta-ethoxyphenethyl)-",CCOC(CN1CCCCC1)C2=CC=CC=C2,,,,,,
9794,99795,3-Methylsulfonyloxybutyl methanesulfonate,CC(CCOS(=O)(=O)C)OS(=O)(=O)C,,,,,,
9795,99796,2-Oxo-1-phenylcyclopentanepropionic acid,C1CC(=O)C(C1)(CCC(=O)O)C2=CC=CC=C2,,,,,,
9796,99797,CID 99797,CCOP(=O)(C(C1=CC=C(C=C1)OC)O)OCC.CC(CO)Cl.CC(CO)Cl.[SbH3],,,,,,
9797,99798,Diethyl [hydroxy(4-methoxyphenyl)methyl]phosphonate,CCOP(=O)(C(C1=CC=C(C=C1)OC)O)OCC,,,,,,
9798,99799,"2-Chlorocyclohexyl 2,4-dinitrophenyl sulfoxide",C1CCC(C(C1)S(=O)C2=C(C=C(C=C2)[N+](=O)[O-])[N+](=O)[O-])Cl,,,,,,
9799,99800,Diethyl formylsuccinate diethyl acetal,CCOC(C(CC(=O)OCC)C(=O)OCC)OCC,,,,,,
9800,99801,Diethyl 2-(diethoxymethyl)-3-formylbutanedioate,CCOC(C(C(C=O)C(=O)OCC)C(=O)OCC)OCC,,,,,,
9801,99802,"Phosphonic acid, (2-oxo-3-tetrahydrothienyl)-, dibenzyl ester",C1CSC(=O)C1NP(=O)(OCC2=CC=CC=C2)OCC3=CC=CC=C3,,,,,,
9802,99803,Thiodemecolcine,CNC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)SC)OC)OC)OC,,,,,,
9803,99804,"N-(3'-Morpholinopropyl)-2-norbornene-5,6-dicarboximide",C1COCCN1CCCN2C(=O)C3C4CC(C3C2=O)C=C4,,,,,,
9804,99805,"m-(3,3-Dimethylureido)phenyl sec-butylcarbamate",CCC(C)NC(=O)OC1=CC=CC(=C1)NC(=O)N(C)C,,,,,,
9805,99806,N-(m-Hydroxyphenyl)-2-methylvaleramide tert-butylcarbamate,CCCC(C)C(=O)NC1=CC(=CC=C1)OC(=O)NC(C)(C)C,,,,,,
9806,99807,m-((2-Methylpentanoyl)amino)phenyl isopropylcarbamate,CCCC(C)C(=O)NC1=CC(=CC=C1)OC(=O)NC(C)C,,,,,,
9807,99808,2-Chloro-3'-hydroxyvaleranilide,CCCC(C(=O)NC1=CC(=CC=C1)O)Cl,,,,,,
9808,99809,m-(2-Chlorovaleramido)phenyl methylcarbamate,CCCC(C(=O)NC1=CC(=CC=C1)OC(=O)NC)Cl,,,,,,
9809,99810,"1,6-Diphenylhexa-1,5-diene-3,4-diol",C1=CC=C(C=C1)C=CC(C(C=CC2=CC=CC=C2)O)O,,,,,,
9810,99811,CID 99811,CC12C(CC34CCN5CC(=C)C6CC5C3(O1)N(C6C(=O)OC)C7=CC=CC=C47)C8CC9C1=C(CC(C8CO2)N9C)C2=CC=CC=C2N1C,,,,,,
9811,99812,alpha-Methylchalcone,CC(=CC1=CC=CC=C1)C(=O)C2=CC=CC=C2,,,,,,
9812,99813,"Actinomycin d, 2-deamino-",CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)C,,,,,,
9813,99814,2-N-(gamma-Hydroxypropyl)actinomycin D,CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)NCCCO)C,,,,,,
9814,99815,3-Oxoindane-1-carboxylic acid,C1C(C2=CC=CC=C2C1=O)C(=O)O,,,,,,
9815,99816,2-Cyclohexylpropanoic acid,CC(C1CCCCC1)C(=O)O,,,,,,
9816,99817,Ethyl 2-cyano-3-hydrazinoacrylate,CCOC(=O)C(=CNN)C#N,,,,,,
9817,99818,Ethyl 3-hydroxy-3-phenylpropanoate,CCOC(=O)CC(C1=CC=CC=C1)O,,,,,,
9818,99819,"3,5-Di-tert-butyl-4-hydroxycinnamic acid, (E)-",CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)C=CC(=O)O,,,,,,
9819,99820,"N-(7-butan-2-yl-5,8-dioxo-3-propan-2-yl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),10,12,15-tetraen-4-yl)-2-(dimethylamino)-3-phenylpropanamide",CCC(C)C1C(=O)NC=CC2=CC=C(C=C2)OC(C(C(=O)N1)NC(=O)C(CC3=CC=CC=C3)N(C)C)C(C)C,,,,,,
9820,99821,"N-[6-[(3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-2,4-dihydro-1H-tetracen-1-yl)oxy]-3-hydroxy-2-methyloxan-4-yl]formamide",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)NC=O)O,,,,,,
9821,99822,"3-Bromo-2,3-dihydrothiophene 1,1-dioxide",C1C(C=CS1(=O)=O)Br,,,,,,
9822,99823,2-Hydroxy-3-methylbutyric acid,CC(C)C(C(=O)O)O,,,,,,
9823,99824,2-Hydroxyhexanoic acid,CCCCC(C(=O)O)O,,,,,,
9824,99825,"2-Decanone, (2,4-dinitrophenyl)hydrazone",CCCCCCCCC(=NNC1=C(C=C(C=C1)[N+](=O)[O-])[N+](=O)[O-])C,,,,,,
9825,99826,"Glyoxylate 2,4-dinitrophenylhydrazone",C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])NN=CC(=O)O,,,,,,
9826,99827,"1,5-Bis(4-methoxyphenyl)-N-hydroxy-3-hydroxyimino-1-pent-4-enamine",COC1=CC=C(C=C1)C=CC(=NO)CC(C2=CC=C(C=C2)OC)NO,,,,,,
9827,99828,3-Amino-5-benzylidenerhodanine,C1=CC=C(C=C1)C=C2C(=O)N(C(=S)S2)N,,,,,,
9828,99829,N-Benzoyl-D-glucosamine,C1=CC=C(C=C1)C(=O)NC(C=O)C(C(C(CO)O)O)O,,,,,,
9829,99830,"A 128, A-128, Antibiotic 128, C-159, EINECS 242-913-9, Telomycin",CC1C(C(=O)NC(C(=O)NC(C(=O)NCC(=O)N2CCC(C2C(=O)NC(=CC3=CNC4=CC=CC=C43)C(=O)NC(C(=O)NC(C(=O)N5CCC(C5C(=O)O1)O)C(C(C)C)O)C(C)C6=CNC7=CC=CC=C76)O)C)C(C)O)CNC(=O)C(CO)NC(=O)CC(C(=O)O)N,,,,,,
9830,99831,"2-(Bis(2-chloroethyl)amino)-6-trifluoromethyltetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide",C1CNP(=O)(OC1C(F)(F)F)N(CCCl)CCCl,,,,,,
9831,99832,Karwinskia toxin T-544,CC1CC2=C(C3=C(C(=CC(=C3)OC)OC)C(=C2C(O1)C)O)C4=C(C5=C(C6=C(CC(CC6=O)(C)O)C=C5C=C4)O)O,,,,,,
9832,99833,1-(4-Fluorophenyl)-2-methyl-3-(4-phenyl-1-piperazinyl)-2-propen-1-one,CC(=CN1CCN(CC1)C2=CC=CC=C2)C(=O)C3=CC=C(C=C3)F,,,,,,
9833,99834,"2,5-Furandione, 3,4-dibromodihydro-",C1(C(C(=O)OC1=O)Br)Br,,,,,,
9834,99835,"2,3-Norbornanedicarboxylic Acid",C1CC2CC1C(C2C(=O)O)C(=O)O,,,,,,
9835,99836,CID 99836,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)SCC2=CN=C3C(=N2)C(=O)N=C(N3)N,,,,,,
9836,99837,"1,5-Dioxaspiro[5.5]undecane, 8,8,10-trimethyl-",CC1CC(CC2(C1)OCCCO2)(C)C,,,,,,
9837,99838,CID 99838,CCCCCCC=CC=CC(=O)OC1C(C23C4C=C(C(=O)C4(C(C5(C(C2C6C1(OC(O6)(O3)C7=CC=CC=C7)C(=C)C)O5)CO)O)O)C)C,,,,,,
9838,99839,"[6,7-Dihydroxy-8-(hydroxymethyl)-4,18-dimethyl-5-oxo-14-phenyl-16-prop-1-en-2-yl-9,13,15,19-tetraoxahexacyclo[12.4.1.01,11.02,6.08,10.012,16]nonadec-3-en-17-yl] deca-2,4,6-trienoate",CCCC=CC=CC=CC(=O)OC1C(C23C4C=C(C(=O)C4(C(C5(C(C2C6C1(OC(O6)(O3)C7=CC=CC=C7)C(=C)C)O5)CO)O)O)C)C,,,,,,
9839,99840,3-Bromodihydro-3-methylfuran-2(3H)-one,CC1(CCOC1=O)Br,,,,,,
9840,99841,"Daphnetoxin,12-hydroxy",CC1C(C2(C3C4C1(C5C=C(C(=O)C5(C(C6(C4O6)CO)O)O)C)OC(O3)(O2)C7=CC=CC=C7)C(=C)C)O,,,,,,
9841,99842,"3,4-Dichlorophenyl-2-lactic acid",CC(C1=CC(=C(C=C1)Cl)Cl)(C(=O)O)O,,,,,,
9842,99843,"3,3-Dimethylbicyclo[2.2.1]heptane-2-carboxylic acid",CC1(C2CCC(C2)C1C(=O)O)C,,,,,,
9843,99844,"2-(3'-Methoxy-4'-hydroxybenzylidene)cyclopentene-1,3-dione",COC1=C(C=CC(=C1)C=C2C(=O)C=CC2=O)O,,,,,,
9844,99845,"2-(4'-Hydroxybenzylidene)cyclopentene-1,3-dione",C1=CC(=CC=C1C=C2C(=O)C=CC2=O)O,,,,,,
9845,99846,2-Chloro-4-nitrosophenol,C1=CC(=C(C=C1N=O)Cl)O,,,,,,
9846,99847,"4-Hydroxyimino-2-methoxy-2,5-cyclohexadiene-1-one",COC1=C(C=CC(=C1)N=O)O,,,,,,
9847,99848,3-Chloro-4-nitrosophenol,C1=CC(=C(C=C1O)Cl)N=O,,,,,,
9848,99849,3-Bromo-4-nitrosophenol,C1=CC(=C(C=C1O)Br)N=O,,,,,,
9849,99850,"4-Hydroxyimino-3-iodo-2,5-cyclohexadiene-1-one",C1=CC(=C(C=C1O)I)N=O,,,,,,
9850,99851,1-(Pyridin-2-yl)ethanone oxime,CC(=NO)C1=CC=CC=N1,,,,,,
9851,99852,"2,4,5-Triamino-6-styrylpyrimidine",C1=CC=C(C=C1)C=CC2=C(C(=NC(=N2)N)N)N,,,,,,
9852,99853,4-(Bis(2-chloroethyl)amino)benzaldehyde oxime,C1=CC(=CC=C1C=NO)N(CCCl)CCCl,,,,,,
9853,99854,"2,2,6-Trichloro-7-oxabicyclo[4.1.0]heptane-1-carboxamide",C1CC2(C(O2)(C(C1)(Cl)Cl)C(=O)N)Cl,,,,,,
9854,99855,2-Bromo-3-(1h-imidazol-4-yl)propanoic acid,C1=C(NC=N1)CC(C(=O)O)Br,,,,,,
9855,99856,Cyperene,CC1CCC2CC3=C(CCC13C2(C)C)C,,,,,,
9856,99857,"trans-N,N'-Diethyl-5-norbornene-2,3-dicarboxamide",CCNC(=O)C1C2CC(C1C(=O)NCC)C=C2,,,,,,
9857,99858,"Glutarimide, 2-(hexahydrophthalimido)-",C1CCC2C(C1)C(=O)N(C2=O)C3CCC(=O)NC3=O,,,,,,
9858,99859,13-Hydroxyimino-oxacyclohexadecan-2-one,C1CCCCCC(=O)OCCCC(=NO)CCCC1,,,,,,
9859,99860,"2,5-Dibromoadipic acid",C(CC(C(=O)O)Br)C(C(=O)O)Br,,,,,,
9860,99861,3-Propenylveratrole,CC=CC1=C(C(=CC=C1)OC)OC,,,,,,
9861,99862,2-Methyl-3-phenylpropanoic acid,CC(CC1=CC=CC=C1)C(=O)O,,,,,,
9862,99863,2-(((2-Hydroxypropyl)amino)methyl)-6-methoxy-4-(2-propenyl)phenol,CC(CNCC1=C(C(=CC(=C1)CC=C)OC)O)O,,,,,,
9863,99864,2-(((1-(Hydroxymethyl)propyl)amino)methyl)-6-methoxy-4-(2-propenyl)phenol,CCC(CO)NCC1=C(C(=CC(=C1)CC=C)OC)O,,,,,,
9864,99865,alpha-((((2-Hydroxy-3-methoxy-5-(2-propenyl)phenyl)methyl)amino)methyl)benzenemethanol,COC1=CC(=CC(=C1O)CNCC(C2=CC=CC=C2)O)CC=C,,,,,,
9865,99866,Azetomycin II,CC1C(C(=O)NC(C(=O)N2CCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)N)C,,,,,,
9866,99867,"1,1-Diphenyl-2-propanol",CC(C(C1=CC=CC=C1)C2=CC=CC=C2)O,,,,,,
9867,99868,5-Decanol,CCCCCC(CCCC)O,,,,,,
9868,99869,1-phenyl-N-(1-phenylpropan-2-yl)propan-2-amine,CC(CC1=CC=CC=C1)NC(C)CC2=CC=CC=C2,,,,,,
9869,99870,4-Methyl-4-phenylpentan-2-ol,CC(CC(C)(C)C1=CC=CC=C1)O,,,,,,
9870,99871,Nitrocaphane,C1=CC(=C(C=C1[N+](=O)[O-])CC(C(=O)O)N)CN(CCCl)CCCl,,,,,,
9871,99872,"Glyoxylic acid, 2-((phenylsulfonyl)hydrazone)",C1=CC=C(C=C1)S(=O)(=O)NN=CC(=O)O,,,,,,
9872,99873,2-Methylcyclopropanecarboxylic acid,CC1CC1C(=O)O,,,,,,
9873,99874,"1,2-Cyclohexanediol, dimethanesulfonate",CS(=O)(=O)OC1CCCCC1OS(=O)(=O)C,,,,,,
9874,99875,"6-Hepta-1,3-dienyl-3,4-dihydroxy-2-oxocyclohexane-1-carbaldehyde",CCCC=CC=CC1CC(C(C(=O)C1C=O)O)O,,,,,,
9875,99876,CID 99876,CCC1C(C2C(O2)(C=CC(=O)C(CC(C(C(C(CC(=O)O1)O)C)OC3C(C(C(C(O3)C)O)N(C)C)O)CC=C)C)C)C,,,,,,
9876,99877,CID 99877,CCCCCCCC1C(=O)N=C(S1)S,,,,,,
9877,99878,Sporidesmin B,CC12C(=O)N3C4C(CC3(C(=O)N1C)SS2)(C5=CC(=C(C(=C5N4C)OC)OC)Cl)O,,,,,,
9878,99879,Xanthochymol,CC(=CCC1CC2(C(=O)C(=C(C3=CC(=C(C=C3)O)O)O)C(=O)C(C2=O)(C1(C)C)CC=C(C)C)CC(CCC(=C)C)C(=C)C)C,,,,,,
9879,99880,2-(3-Pyridylmethylene)1-indanone,C1C2=CC=CC=C2C(=O)C1=CC3=CN=CC=C3,,,,,,
9880,99881,5-Benzylpyrrolidin-2-one,C1CC(=O)NC1CC2=CC=CC=C2,,,,,,
9881,99882,Bufalitoxin,C[C@]12CC[C@@H](C[C@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@@]3(CC[C@@H]4C5=COC(=O)C=C5)O)C)OC(=O)CCCCCCC(=O)N[C@@H](CCCN=C(N)N)C(=O)O,,,,,,
9882,99883,"4-Bromo-2-(1,2-dimethylbicyclo[3.1.0]hex-2-yl)-5-methylphenol",CC1=CC(=C(C=C1Br)C2(CCC3C2(C3)C)C)O,,,,,,
9883,99884,3-Methyl-2-pentenedioic acid,CC(=CC(=O)O)CC(=O)O,,,,,,
9884,99885,"Urea, 1-(2-chloroethyl)-3-(10-methylthio-9-oxo-1,2,3-trimethoxy-5,6,7,9-tetrahydrobenzo(a)heptalen-7-yl)-",COC1=C(C(=C2C(=C1)CCC(C3=CC(=O)C(=CC=C32)SC)NC(=O)NCCCl)OC)OC,,,,,,
9885,99886,2-[2-Methoxy-4-[[(3-methyl-3H-benzothiazol-2-ylidene)hydrazono]methyl]phenoxy]ethyl methacrylate,CC(=C)C(=O)OCCOC1=C(C=C(C=C1)C=NN=C2N(C3=CC=CC=C3S2)C)OC,,,,,,
9886,99887,4-Nitrochalcone oxide,C1=CC=C(C=C1)C(=O)C2C(O2)C3=CC=C(C=C3)[N+](=O)[O-],,,,,,
9887,99888,5-Methyl-1-heptene,CCC(C)CCC=C,,,,,,
9888,99889,"9,10-Dihydrophenanthrene-9,10-diol",C1=CC=C2C(=C1)C(C(C3=CC=CC=C32)O)O,,,,,,
9889,99890,CID 99890,CC1=CC(=O)C(=CO)C2=C1C(=O)OC3=C(C(=O)C(=C(O)O)C(=C3O2)C)COC(=O)C=CC(=O)O,,,,,,
9890,99891,2-Dodecyl-3-methylbutanedioic acid,CCCCCCCCCCCCC(C(C)C(=O)O)C(=O)O,,,,,,
9891,99892,"6,6-Dimethylbicyclo[3.1.1]heptan-2-OL",CC1(C2CCC(C1C2)O)C,,,,,,
9892,99893,Nepetefolin,CC(=O)OC1CC2(CO2)C3(CCC4(O3)COC=C4)C56C1C(CCC5)(C(=O)OC6)C,,,,,,
9893,99894,"Ethanimidic acid, N-hydroxy-, ethyl ester",CCOC(=NO)C,,,,,,
9894,99895,"Pyrrolo[1,2-a]pyrazine-1,4-dione, hexahydro-3-(phenylmethyl)-",C1CC2C(=O)NC(C(=O)N2C1)CC3=CC=CC=C3,,,,,,
9895,99896,4-(9H-xanthen-9-yl)phenol,C1=CC=C2C(=C1)C(C3=CC=CC=C3O2)C4=CC=C(C=C4)O,,,,,,
9896,99897,"Phenol, 2-(((4-phenyl-2-thiazolyl)imino)methyl)-",C1=CC=C(C=C1)C2=CSC(=N2)N=CC3=CC=CC=C3O,,,,,,
9897,99898,"3-[3,4-dihydroxy-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-14-hydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,6,7,8,9,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthrene-10-carbaldehyde",CC12CCC3C(C1(CCC2C4=CC(=O)OC4)O)CCC5=CC(CCC35C=O)OC6C(C(C(CO6)OC7C(C(C(C(O7)CO)O)O)O)O)O,,,,,,
9898,99899,Ipomeamarone,CC(C)CC(=O)CC1(CCC(O1)C2=COC=C2)C,,,,,,
9899,99900,N-Octanoyldaunorubicin,CCCCCCCC(=O)NC1CC(OC(C1O)C)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O,,,,,,
9900,99901,"(8S-cis)-8-Acetyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-((2,3,6-trideoxy-3-((1-oxododecyl)amino)-alpha-L-lyxo-hexopyranosyl)oxy)-5,12-naphthacenedione",CCCCCCCCCCCC(=O)NC1CC(OC(C1O)C)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O,,,,,,
9901,99902,N-Palmitoyldaunomycin,CCCCCCCCCCCCCCCC(=O)NC1CC(OC(C1O)C)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O,,,,,,
9902,99903,"5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(1-hydroxyethyl)-1-methoxy-",CC(C1(CCC2=C(C1)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4OC)O)O)O,,,,,,
9903,99904,Isodeoxyelephantopin,CC1=CC2C(C(CC3=CC(C1)OC3=O)OC(=O)C(=C)C)C(=C)C(=O)O2,,,,,,
9904,99905,2-(((4-(4-Methylphenyl)-2-thiazolyl)amino)methyl)phenol,CC1=CC=C(C=C1)C2=CSC(=N2)N=CC3=CC=CC=C3O,,,,,,
9905,99906,1-Amino-6-(bis(2-chloroethyl)amino)-1-indancarboxylic acid,C1CC(C2=C1C=CC(=C2)N(CCCl)CCCl)(C(=O)O)N,,,,,,
9906,99907,"p-Benzoquinoneimine, N-(p-(di-2''-chloroethylamino)phenyl)-",C1=CC(=O)C=CC1=NC2=CC=C(C=C2)N(CCCl)CCCl,,,,,,
9907,99908,N-(4'-Di-2''-chloroethylaminophenyl)-3-methylbenzoquinoneimine,CC1=CC(=O)C=CC1=NC2=CC=C(C=C2)N(CCCl)CCCl,,,,,,
9908,99909,"2,3-Butanediol, dimethanesulfonate",CC(C(C)OS(=O)(=O)C)OS(=O)(=O)C,,,,,,
9909,99910,"Acetamide, 2-chloro-N-(5,6,7,9-tetrahydro-1,2,3-trimethoxy-10-(methylthio)-9-oxobenzo(a)heptalen-7-yl)-, (S)-",COC1=C(C(=C2C(=C1)CCC(C3=CC(=O)C(=CC=C32)SC)NC(=O)CCl)OC)OC,,,,,,
9910,99911,"2,6-Piperazinedione, 4,4'-(1,2-cyclopropanediyl)bis-, trans-",C1C(C1N2CC(=O)NC(=O)C2)N3CC(=O)NC(=O)C3,,,,,,
9911,99912,"5,12-Naphthacenedione, 8-acetyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-((2,3,6-trideoxy-3-((4-pyridinylcarbonyl)amino)-alpha-L-lyxo-hexopyranosyl)oxy)-, (8S-cis)-",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)NC(=O)C6=CC=NC=C6)O,,,,,,
9912,99913,"1-(2-Chloroethyl)-3-(2,6-dihydroxycyclohexyl)-1-nitrosourea",C1CC(C(C(C1)O)NC(=O)N(CCCl)N=O)O,,,,,,
9913,99914,Ethyl 2-benzoylacetoacetate,CCOC(=O)C(C(=O)C)C(=O)C1=CC=CC=C1,,,,,,
9914,99915,"Ethanone, 1,2-diphenyl-, hydrazone",C1=CC=C(C=C1)CC(=NN)C2=CC=CC=C2,,,,,,
9915,99916,CID 99916,C1=CC=C(C=C1)CC2=C3C(=NC=N3)N=CN2,,,,,,
9916,99917,"7-Oxabicyclo(4.1.0)hept-3-ene-2,5-dione, 3-methyl-",CC1=CC(=O)C2C(C1=O)O2,,,,,,
9917,99918,CID 99918,C1=CC=C(C=C1)CN2C=CN=C2C=NN=C(N)S,,,,,,
9918,99919,CID 99919,C1=CC2=C3C=C(NC(=C3N=C2C=C1)C(CO)O)CO,,,,,,
9919,99920,Adenosine dialdehyde,C1=NC(=C2C(=N1)N(C=N2)C(C=O)OC(CO)C=O)N,,,,,,
9920,99921,"7-(3-Aminopyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid",C1CC1N2C=C(C(=O)C3=CC(=C(N=C32)N4CCC(C4)N)F)C(=O)O,,,,,,
9921,99922,"4-Cyclopentene-1,3-dione, 2-((4-hydroxy-3,5-dimethoxyphenyl)methylene)-",COC1=CC(=CC(=C1O)OC)C=C2C(=O)C=CC2=O,,,,,,
9922,99923,N-Trifluoroacetyladriamycinol,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(CO)O)O)NC(=O)C(F)(F)F)O,,,,,,
9923,99924,Lycoctonine,CCN1CC2(CCC(C34C2C(C(C31)(C5(CC(C6CC4C5C6OC)OC)O)O)OC)OC)CO,,,,,,
9924,99925,Chloroactinomycin D,CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)Cl)C,,,,,,
9925,99926,4-Methoxydalbergione,COC1=CC(=O)C(=CC1=O)C(C=C)C2=CC=CC=C2,,,,,,
9926,99927,Variamycin,CC1C(C(CC(O1)OC2CC(OC(C2O)C)OC3=CC4=CC5=C(C(=O)C(C(C5)C(C(=O)C(C(C)O)O)OC)OC6CC(C(C(O6)C)O)OC7CC(C(C(O7)C)O)OC8CC(C(C(O8)C)OC)O)C(=C4C(=C3C)O)O)O)O,,,,,,
9927,99928,"N,N-Diethyl-4-methyl-1,3,2-dioxaphospholan-2-amine",CCN(CC)P1OCC(O1)C,,,,,,
9928,99929,"16-Hydroxy-19-(1-hydroxyethyl)-6,15,27-trimethylspiro[2,5,11,14,18,25-hexaoxahexacyclo[24.2.1.03,9.04,6.09,27.013,15]nonacosa-20,22-diene-28,2'-oxirane]-12,24-dione",CC(C1C=CC=CC(=O)OC2CC3C4(C2(C5(CCC6(C(C5O3)O6)C)COC(=O)C7C(O7)(C(CO1)O)C)C)CO4)O,,,,,,
9929,99930,"Oxiranemethanamine, N-(2-methylphenyl)-N-(oxiranylmethyl)-",CC1=CC=CC=C1N(CC2CO2)CC3CO3,,,,,,
9930,99931,"1,2-Dipalmitoyl-rac-glycerol",CCCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCCCCC,,,,,,
9931,99932,"1-Benzoxepin-5(2H)-one, 3,4-dihydro-4-((4-methoxyphenyl)methylene)-7-methyl-",CC1=CC2=C(C=C1)OCCC(=CC3=CC=C(C=C3)OC)C2=O,,,,,,
9932,99933,"4(3H)-Pyrimidinone, 3-(2-fluorophenyl)-2-(methylthio)-",CSC1=NC=CC(=O)N1C2=CC=CC=C2F,,,,,,
9933,99934,"Tryptophan, N-acetyl-, 4-nitrophenyl ester",CC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)OC3=CC=C(C=C3)[N+](=O)[O-],,,,,,
9934,99935,2-Acetamido-3-(2-fluorophenyl)propanoic acid,CC(=O)NC(CC1=CC=CC=C1F)C(=O)O,,,,,,
9935,99936,"10-Bromo-1,2,3,4,5,6,7,8,13,13,14,14-dodecachloro-1,4,4a,4b,5,8,8a,12b-octahydro-11-nitro-1,4-5,8-dimethanotriphenylene",C1=C2C3C(C4C(C2=CC(=C1[N+](=O)[O-])Br)C5(C(=C(C4(C5(Cl)Cl)Cl)Cl)Cl)Cl)C6(C(=C(C3(C6(Cl)Cl)Cl)Cl)Cl)Cl,,,,,,
9936,99937,"Hexahydrofuro[3,2-b]furan-3,6-diol",C1C(C2C(O1)C(CO2)O)O,,,,,,
9937,99938,Wikstromol,COC1=C(C=CC(=C1)CC2COC(=O)C2(CC3=CC(=C(C=C3)O)OC)O)O,,,,,,
9938,99939,alpha-Methylene-gamma-valerolactone,CC1CC(=C)C(=O)O1,,,,,,
9939,99940,"4,6,8-Trihydroxy-3a,12a-dihydroanthra[2,3-b]furo[3,2-d]furan-5,10-dione",C1=COC2C1C3=C(O2)C=C4C(=C3O)C(=O)C5=C(C4=O)C=C(C=C5O)O,,,,,,
9940,99941,"scyllo-Inositol, 1-((((2-chloroethyl)nitrosoamino)carbonyl)amino)-1-deoxy-",C(CCl)N(C(=O)NC1C(C(C(C(C1O)O)O)O)O)N=O,,,,,,
9941,99942,Phenylazoxycyanide,C1=CC=C(C=C1)[N+](=NC#N)[O-],,,,,,
9942,99943,Cinnamosmolide B812927K029,CC(=O)OC1C=C2C(=O)OCC2(C3(C1C(CCC3)(C)C)C)O,,,,,,
9943,99944,"2,3-Dihydro-6-fluoro-2-((4-(4-methoxyphenyl)-1-piperazinyl)methylene)-1H-inden-1-one",COC1=CC=C(C=C1)N2CCN(CC2)C=C3CC4=C(C3=O)C=C(C=C4)F,,,,,,
9944,99945,"2,3-Dihydro-4-fluoro-2-((4-phenyl-1-piperazinyl)methylene)-1H-inden-1-one",C1CN(CCN1C=C2CC3=C(C2=O)C=CC=C3F)C4=CC=CC=C4,,,,,,
9945,99946,"2,3-Dihydro-4-fluoro-2-((4-(4-methoxyphenyl)-1-piperazinyl)methylene)-1H-inden-1-one",COC1=CC=C(C=C1)N2CCN(CC2)C=C3CC4=C(C3=O)C=CC=C4F,,,,,,
9946,99947,"2,3-Dihydro-4-chloro-2-((4-phenyl-1-piperazinyl)methylene)-1H-inden-1-one",C1CN(CCN1C=C2CC3=C(C2=O)C=CC=C3Cl)C4=CC=CC=C4,,,,,,
9947,99948,"2,3-Dihydro-4-chloro-2-(((2-(3,4-dimethoxyphenyl)ethyl)amino)methylene)-1H-inden-1-one",COC1=C(C=C(C=C1)CCNC=C2CC3=C(C2=O)C=CC=C3Cl)OC,,,,,,
9948,99949,"2,3-Dihydro-4-chloro-2-((4-(4-chlorophenyl)-3-methyl-1-piperazinyl)methylene)-1H-inden-1-one",CC1CN(CCN1C2=CC=C(C=C2)Cl)C=C3CC4=C(C3=O)C=CC=C4Cl,,,,,,
9949,99950,Phorbolol myristate acetate,CCCCCCCCCCCCCC(=O)OC1C(C2(C(C=C(CC3(C2C=C(C3O)C)O)CO)C4C1(C4(C)C)OC(=O)C)O)C,,,,,,
9950,99951,"5-Chloro-2,4-dihydroxy-6-methyl-3-[3-methyl-5-(1,2,6-trimethyl-3-oxocyclohexyl)penta-2,4-dienyl]benzaldehyde",CC1CCC(=O)C(C1(C)C=CC(=CCC2=C(C(=C(C(=C2O)Cl)C)C=O)O)C)C,,,,,,
9951,99952,gamma-Guanidino-beta-hydroxybutyric acid,C(C(CN=C(N)N)O)C(=O)O,,,,,,
9952,99953,((Nonyloxy)methyl)oxirane,CCCCCCCCCOCC1CO1,,,,,,
9953,99954,"Alkaloid TGL 4,from Triclisia gilletii",CN1CCC2=CC(=C3C4=C2C1CC5=CC(=C(C=C5)OC)OC6=CC=C(CC7C8=C(O3)C(=C(C=C8CCN7)O)O4)C=C6)OC,,,,,,
9954,99955,"3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(2-pyridyl)-, diethyl ester",CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=N2)C(=O)OCC)C)C,,,,,,
9955,99956,beta-Peltatin A-alpha-L-arabinofuranoside,COC1=CC(=CC(=C1OC)OC)C2C3C(CC4=C(C5=C(C=C24)OCO5)OC6C(C(C(O6)CO)O)O)COC3=O,,,,,,
9956,99957,Ansamitocin P 3,CC1C2CC(C(C=CC=C(CC3=CC(=C(C(=C3)OC)Cl)N(C(=O)CC(C4(C1O4)C)OC(=O)C(C)C)C)C)OC)(NC(=O)O2)O,,,['Agents that interact with TUBULIN to inhibit or promote polymerization of MICROTUBULES. (See all compounds classified as Tubulin Modulators.)'],,,
9957,99958,"(11-Chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-yl) 3-methylbutanoate",CC1C2CC(C(C=CC=C(CC3=CC(=C(C(=C3)OC)Cl)N(C(=O)CC(C4(C1O4)C)OC(=O)CC(C)C)C)C)OC)(NC(=O)O2)O,,,,,,
9958,99959,"L-Glutamic acid, N-(N-(4-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-L-alpha-glutamyl)-",CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)O,,,,,,
9959,99960,"Galactitol, 1,2:5,6-dianhydro-, diacetate",CC(=O)OC(C1CO1)C(C2CO2)OC(=O)C,,,,,,
9960,99961,"7-hydroperoxy-10-methyl-3,6-dimethylidene-4,5,7,8,9,11a-hexahydro-3aH-cyclodeca[b]furan-2-one",CC1=CC2C(CCC(=C)C(CC1)OO)C(=C)C(=O)O2,,,,,,
9961,99962,"7-hydroxy-10-methyl-3,6-dimethylidene-4,5,7,8,9,11a-hexahydro-3aH-cyclodeca[b]furan-2-one",CC1=CC2C(CCC(=C)C(CC1)O)C(=C)C(=O)O2,,,,,,
9962,99963,2-Amino-3-butenoic acid,C=CC(C(=O)O)N,,,,,,
9963,99964,"methyl 4-[5-[5-[(3-amino-6-methyl-5-oxo-2H-pyran-2-yl)oxy]-4-hydroxy-6-methyloxan-2-yl]oxy-4-(dimethylamino)-6-methyloxan-2-yl]oxy-2-ethyl-2,5,7,10-tetrahydroxy-6,11-dioxo-3,4-dihydro-1H-tetracene-1-carboxylate",CCC1(CC(C2=C(C3=C(C=C2C1C(=O)OC)C(=O)C4=C(C=CC(=C4C3=O)O)O)O)OC5CC(C(C(O5)C)OC6CC(C(C(O6)C)OC7C(=CC(=O)C(O7)C)N)O)N(C)C)O,,,,,,
9964,99965,Taxoquinone,CC(C)C1=C(C2=C(C(=O)C1=O)C3(CCCC(C3CC2O)(C)C)C)O,,,,,,
9965,99966,"5-(7-methoxy-1,3-benzodioxol-5-yl)-5a,8,8a,9-tetrahydro-5H-[2]benzofuro[5,6-f][1,3]benzodioxol-6-one",COC1=CC(=CC2=C1OCO2)C3C4C(CC5=CC6=C(C=C35)OCO6)COC4=O,,,,,,
9966,99967,Grossheimin,CC1C2C(CC1=O)C(=C)CC(C3C2OC(=O)C3=C)O,,,,,,
9967,99968,"2H-1,4-Benzodiazepin-2-one, 7-chloro-3-ethoxy-1,3-dihydro-5-phenyl-",CCOC1C(=O)NC2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3,,,,,,
9968,99969,N-(1-Phenylethyl)benzenesulfonamide,CC(C1=CC=CC=C1)NS(=O)(=O)C2=CC=CC=C2,,,,,,
9969,99970,CID 99970,CC1CCOC(=O)C=CC=CC(=O)OC2CC(C3(C2C)CO3)OC4CC(C(=O)CC4COC(C1O)O)C,,,,,,
9970,99971,"3-Formyl-2,2,5-trimethyl-1,3-thiazolidine-4-carboxylic acid",CC1C(N(C(S1)(C)C)C=O)C(=O)O,,,,,,
9971,99972,"7,7a,8,9,10,12-Hexahydrobenzo(h)pyrrolo(1,2-b)isoquinoline",C1CC2CC3=C(CN2C1)C4=CC=CC=C4C=C3,,,,,,
9972,99973,Castalin,C1=C2C(=C(C(=C1O)O)O)C3=C4C(=C(C(=C3O)O)O)C5=C6C(=C(C(=C5O)O)O)C(C(C(C(C(OC2=O)CO)O)OC4=O)OC6=O)O,,,,,,
9973,99974,"5-Methyl-2-[(3-methyl-4-oxo-1,3-thiazolidin-2-ylidene)hydrazinylidene]-3-(2-methylprop-2-enyl)-1,3-thiazolidin-4-one",CC1C(=O)N(C(=NN=C2N(C(=O)CS2)C)S1)CC(=C)C,,,,,,
9974,99975,"2,3-Dihydro-1h-3a,7a-epoxyinden-2-ol",C1C(CC23C1(O2)C=CC=C3)O,,,,,,
9975,99976,Stramonin-B,CC1CCC2C(C3(C1C=CC3=O)C)OC(=O)C24CO4,,,,,,
9976,99977,"(10-Acetyloxy-11-hydroxy-1,5-dimethylspiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2'-oxirane]-2-yl)methyl acetate",CC1=CC2C(CC1)(C3(C(C(C(C34CO4)O2)OC(=O)C)O)C)COC(=O)C,,,,,,
9977,99978,1-(3-Mercapto-1-oxopropyl)-L-proline,C1C[C@H](N(C1)C(=O)CCS)C(=O)O,,,,,,
9978,99979,5-Hydroxymethyltubercidin,C1=C(C2=C(N=CN=C2N1C3C(C(C(O3)CO)O)O)N)CO,,,,,,
9979,99980,"17-(Furan-3-yl)-6-hydroxy-4,4,8-trimethyl-3,7-dioxo-14,15-epoxyandrosta-1,5-dien-11-yl acetate",CC(=O)OC1CC2(C(CC3C2(O3)C4(C1C5(C=CC(=O)C(C5=C(C4=O)O)(C)C)C)C)C6=COC=C6)C,,,,,,
9980,99981,Melianone,CC1(C2CC=C3C(C2(CCC1=O)C)CCC4(C3(CCC4C5CC(OC5O)C6C(O6)(C)C)C)C)C,,,,,,
9981,99982,Rohitukin,CC(C)CC(=O)OC1C(C(C(=C)C2(C1(C(CC2=O)C3=COC=C3)C)O)C4(C5CC(=O)OCC5(OC(=O)CC4OC(=O)C)C)C)OC=O,,,,,,
9982,99983,"Adenosine,8-(butylamino)-(9ci)",CCCCNC1=NC2=C(N=CN=C2N1C3C(C(C(O3)CO)O)O)N,,,,,,
9983,99984,2-Hydroxy-N-10-nitrosofolic acid,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)N(CC2=CN=C3C(=N2)C(=O)NC(=O)N3)N=O,,,,,,
9984,99985,2-(4-Pyridyl)thiazolidine-4-carboxylic acid,C1C(NC(S1)C2=CC=NC=C2)C(=O)O,,,,,,
9985,99986,"2-Hydroxy-3-(3,4-dichlorophenylthio)propylamine",C1=CC(=C(C=C1SCC(CN)O)Cl)Cl,,,,,,
9986,99987,"2-Oxazoline, 2-amino-5-((3,4-dichlorophenyl)thiomethyl)-",C1C(OC(=N1)N)CSC2=CC(=C(C=C2)Cl)Cl,,,,,,
9987,99988,Benzhydryl 2-(benzothiazol-2-yldithio)-alpha-(isopropenyl)-4-oxo-3-((phenoxyacetyl)amino)azetidine-1-acetate,CC(=C)C(C(=O)OC(C1=CC=CC=C1)C2=CC=CC=C2)N3C(C(C3=O)NC(=O)COC4=CC=CC=C4)SSC5=NC6=CC=CC=C6S5,,,,,,
9988,99989,Alcindoromycin,CCC1(CC(C2=C(C3=C(C=C2C1C(=O)OC)C(=O)C4=C(C=CC(=C4C3=O)O)O)O)OC5CC(C(C(O5)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)O)O)NC)O,,,,,,
9989,99990,Collinemycin,CCC1(CC(C2=C(C3=C(C=C2C1C(=O)OC)C(=O)C4=C(C=CC(=C4C3=O)O)O)O)OC5CC(C(C(O5)C)OC6CC(C(C(O6)C)O)O)N(C)C)O,,,,,,
9990,99991,Mimimycin,CCC1(CC(C2=C(C3=C(C=C2C1C(=O)OC)C(=O)C4=C(C=CC(=C4C3=O)O)O)O)OC5CC(C(C(O5)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)O)O)N(C)C)O,,,['Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)'],,,
9991,99992,4-Amino-5-phenylpentan-1-ol,C1=CC=C(C=C1)CC(CCCO)N,,,,,,
9992,99993,4-Amino-5-(m-methoxyphenyl)pentan-1-ol,COC1=CC=CC(=C1)CC(CCCO)N,,,,,,
9993,99994,"8-Methoxy-1,2,3,5,10,10a-hexahydropyrrolo(1,2-b)isoquinoline",COC1=CC2=C(CN3CCCC3C2)C=C1,,,,,,
9994,99995,"2-(1,3-Dithiolan-2-yl)cyclooctanone",C1CCCC(=O)C(CC1)C2SCCS2,,,,,,
9995,99996,"3,7-Octadienal, 5,6-dichloro-2-(chloromethylene)-6-methyl-",CC(C=C)(C(C=CC(=CCl)C=O)Cl)Cl,,,,,,
9996,99997,"7-bromo-3,3a,6,8b-tetramethyl-2,3-dihydro-1H-cyclopenta[b]benzofuran",CC1CCC2(C1(OC3=C2C=C(C(=C3)C)Br)C)C,,,,,,
9997,99998,"DL-Phenylalanine, N-benzoyl-4-chloro-",C1=CC=C(C=C1)C(=O)NC(CC2=CC=C(C=C2)Cl)C(=O)O,,,,,,
9998,99999,"2(3H)-Furanone, dihydro-5,5-dimethyl-4-(2-methyl-1-propenyl)-",CC(=CC1CC(=O)OC1(C)C)C,,,,,,
9999,100000,Dbmtx,CCCCOC(=O)CCC(C(=O)OCCCC)NC(=O)C1=CC=C(C=C1)N(C)CC2=CN=C3C(=N2)C(=NC(=N3)N)N,,,,,,
